PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fazilleau, N; McHeyzer-Williams, LJ; Rosen, H; McHeyzer-Williams, MG				Fazilleau, Nicolas; McHeyzer-Williams, Louise J.; Rosen, Hugh; McHeyzer-Williams, Michael G.			The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER FORMATION; IN-VIVO; B-CELLS; REPERTOIRE SELECTION; CYTOKINE EXPRESSION; IMMUNE-RESPONSES; MEMORY; EFFECTOR; BLIMP-1; DIFFERENTIATION	How follicular helper T cells (T-FH cells) differentiate to regulate B cell immunity is critical for effective protein vaccination. Here we define three transcription factor T- bet - expressing antigen- specific effector helper T cell subsets with distinguishable function, migratory properties and developmental programming in vivo. Expression of the transcriptional repressor Blimp- 1 distinguished T zone 'lymphoid' effector helper T cells (CD62L(hi)CCR7(hi)) from CXCR5(lo) 'emigrant' effector helper T cells and CXCR5(hi) 'resident' T-FH cells expressing the transcriptional repressor Bcl-6 (CD62L(lo)CCR7(lo)). We then show by adoptive transfer and intact polyclonal responses that helper T cells with the highest specific binding of peptide - major histocompatibility complex class II and the most restricted T cell antigen receptor junctional diversity 'preferentially' developed into the antigen- specific effector T-FH compartment. Our studies demonstrate a central function for differences in the binding strength of the T cell antigen receptor in the antigen- specific mechanisms that 'program' specialized effector T-FH function in vivo.	[Fazilleau, Nicolas; McHeyzer-Williams, Louise J.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	McHeyzer-Williams, LJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Fazilleau, Nicolas/J-9883-2014	Fazilleau, Nicolas/0000-0002-3574-5614	National Institutes of Health [AI047231, AI040215, AI059475]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047231, R01AI040215, R01AI059475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health (AI047231, AI040215 and AI059475 to M. G. M.-W.). This is manuscript 19762 from The Scripps Research Institute.	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014	49	355	370	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					375	384		10.1038/ni.1704	http://dx.doi.org/10.1038/ni.1704			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19252493	Green Accepted			2022-12-18	WOS:000264425800011
J	Marzo, AL; Klonowski, KD; Le Bon, A; Borrow, P; Tough, DF; Lefrancois, L				Marzo, AL; Klonowski, KD; Le Bon, A; Borrow, P; Tough, DF; Lefrancois, L			Initial T cell frequency dictates memory CD8(+) T cell lineage commitment	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; VIRAL-INFECTION; IN-VIVO; ANTIGEN; GENERATION; NAIVE; SUBSETS; DIFFERENTIATION; LYMPHOCYTES; RESPONSES	Memory T cells can be divided into central memory T cell (TCM cell) and effector memory T cell (TEM cell) subsets based on homing characteristics and effector functions. Whether TEM and TCM cells represent interconnected or distinct lineages is unclear, although the present paradigm suggests that TEM and TCM cells follow a linear differentiation pathway from naive T cells to effector T cells to TEM cells to TCM cells. We show here that naive T cell precursor frequency profoundly influenced the pathway along which CD8(+) memory T cells developed. At low precursor frequency, those TEM cells generated represented a stable cell lineage that failed to further differentiate into TCM cells. These findings do not adhere to the present dogma regarding memory T cell generation and provide a means for identifying factors controlling memory T cell lineage commitment.	Univ Connecticut, Ctr Hlth, Div Immunol, Farmington, CT 06030 USA; Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Div Immunol, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu	Le Bon, Agnes/L-3237-2017	Le Bon, Agnes/0000-0003-4204-8136; Marzo, amanda/0000-0002-5839-0430; Borrow, Persephone/0000-0002-3877-9780	NIAID NIH HHS [AI41576, R01 AI041576, F32 AI053970, R01 AI041576-10, AI053970] Funding Source: Medline; NIDDK NIH HHS [R01 DK045260-15, R01 DK045260, DK45260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, F32AI053970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roberts AD, 2004, J IMMUNOL, V172, P6533, DOI 10.4049/jimmunol.172.11.6533; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	31	355	362	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					793	799		10.1038/ni1227	http://dx.doi.org/10.1038/ni1227			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16025119	Green Accepted			2022-12-18	WOS:000230646200020
J	Matzinger, P				Matzinger, Polly			Friendly and dangerous signals: is the tissue in control?	NATURE IMMUNOLOGY			English	Editorial Material							INTRAEPITHELIAL LYMPHOCYTES; CELLS; SELF	In their own defense, tissues send a panoply of signals that initiate immunity and guide the choice of effector class. T(H)1-T(H)2 and T-reg is far too simple a representation of the breathtaking variety of the resulting responses.	NIAID, Ghost Lab, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Matzinger, P (corresponding author), NIAID, Ghost Lab, Cellular & Mol Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pcm@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000581, ZIAAI000581] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Havran WL, 2005, AM J PHYSIOL-GASTR L, V289, pG627, DOI 10.1152/ajpgi.00224.2005; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Zamiri P, 2006, INVEST OPHTH VIS SCI, V47, P3912, DOI 10.1167/iovs.05-1267	11	353	375	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					11	13		10.1038/ni0107-11	http://dx.doi.org/10.1038/ni0107-11			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179963	Green Published			2022-12-18	WOS:000242934400005
J	Stefanova, I; Hemmer, B; Vergelli, M; Martin, R; Biddison, WE; Germain, RN				Stefanova, I; Hemmer, B; Vergelli, M; Martin, R; Biddison, WE; Germain, RN			TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways	NATURE IMMUNOLOGY			English	Article							T-CELL RECEPTOR; PROTEIN-TYROSINE-PHOSPHATASE; ALTERED PEPTIDE LIGANDS; N-TERMINAL REGION; ANTIGEN RECEPTOR; CUTTING EDGE; ZETA-PHOSPHORYLATION; LINEAGE COMMITMENT; PARTIAL AGONISTS; KINASE P56(LCK)	Functional discrimination between structurally similar self and foreign antigens is a main attribute of adaptive immunity. Here we describe two feedback mechanisms in T lymphocytes that together sharpen and amplify initial signaling differences related to the quality of T cell receptor (TCR) engagement. Weakly binding ligands predominantly trigger a negative feedback loop leading to rapid recruitment of the tyrosine phosphatase SHP-1, followed by receptor desensitization through inactivation of Lck kinase. In contrast, strongly binding ligands efficiently activate a positive feedback circuit involving Lck modification by ERK, preventing SHP-1 recruitment and allowing the long-lasting signaling necessary for gene activation. The characteristics of these pathways suggest that they constitute an important part of the mechanism allowing T cells to discriminate between self and foreign ligands.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; NINDS, Cellular Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 10 Ctr Dr,MSC-1892, Bethesda, MD 20892 USA.	rgermain@nih.gov	Hemmer, Bernhard/AAT-8388-2021; Germain, Ronald N./Z-1945-2019; Hemmer, Bernhard/GPX-8451-2022; Germain, Ronald/ABE-7090-2020	Hemmer, Bernhard/0000-0001-5985-6784; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002603, Z01NS002205, Z01NS002204, ZIANS002204] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Bommhardt U, 1999, J IMMUNOL, V163, P715; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; Daniels MA, 1999, J IMMUNOL, V162, P3761; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DING L, 1993, J IMMUNOL, V151, P1224; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Hemmer B, 1998, J IMMUNOL, V160, P5807; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KOYASU S, 1994, P NATL ACAD SCI USA, V91, P6693, DOI 10.1073/pnas.91.14.6693; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Liu HY, 1999, J IMMUNOL, V163, P599; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Micheletti F, 2000, J IMMUNOL, V165, P4264, DOI 10.4049/jimmunol.165.8.4264; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Plas DR, 1999, J IMMUNOL, V162, P5680; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Raab M, 1996, BIOCHEM BIOPH RES CO, V222, P50, DOI 10.1006/bbrc.1996.0696; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Robertson JM, 1999, J IMMUNOL, V163, P1750; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SloanLancaster J, 1996, J EXP MED, V184, P1525, DOI 10.1084/jem.184.4.1525; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WATTS JD, 1993, J BIOL CHEM, V268, P23275; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Xu R, 1999, J IMMUNOL, V163, P1110; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	60	353	361	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					248	254		10.1038/ni895	http://dx.doi.org/10.1038/ni895			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12577055				2022-12-18	WOS:000181201000013
J	Perdiguero, EG; Geissmann, F				Perdiguero, Elisa Gomez; Geissmann, Frederic			The development and maintenance of resident macrophages	NATURE IMMUNOLOGY			English	Review							HEMATOPOIETIC STEM-CELLS; COLONY-STIMULATING FACTOR; EPIDERMAL LANGERHANS CELLS; MOUSE YOLK-SAC; MONONUCLEAR PHAGOCYTE SYSTEM; HUMAN ALVEOLAR MACROPHAGE; CENTRAL-NERVOUS-SYSTEM; RED PULP MACROPHAGES; C-MYB; AORTIC ENDOTHELIUM	The molecular and cellular mechanisms that underlie the many roles of macrophages in health and disease states in vivo remain poorly understood. The purpose of this Review is to present and discuss current knowledge on the developmental biology of macrophages, as it underlies the concept of a layered myeloid system composed of 'resident' macrophages that originate mainly from progenitor cells generated in the yolk sac and of 'passenger' or 'transitory' myeloid cells that originate and renew from bone marrow hematopoietic stem cells, and to provide a framework for investigating the functions of macrophages in vivo.	[Perdiguero, Elisa Gomez] Inst Pasteur, Dept Dev & Stem Cell Biol, Macrophages & Endothelial Cells Grp, CNRS URA 2578, Paris, France; [Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10021 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Memorial Sloan Kettering Cancer Center	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.	geissmaf@mskcc.org	Perdiguero, Elisa Gomez/U-2120-2018	Perdiguero, Elisa Gomez/0000-0002-7717-7897	National Cancer Institute of the US National Institutes of Health [P30CA008748]; Wellcome Trust [WT101853MA]; European Research Council [2010-StG-261299]; Institut Pasteur; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Institut Pasteur(European Commission); Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute of the US National Institutes of Health (P30CA008748 to F.G.), the Wellcome Trust (WT101853MA to F.G.), the European Research Council (2010-StG-261299 to F.G.), the Institut Pasteur (E.G.P.) and Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73 to E.G.P.).	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; AKAGAWA KS, 1988, J IMMUNOL, V141, P3383; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bartunek P, 2003, ONCOGENE, V22, P1927, DOI 10.1038/sj.onc.1206281; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; CHEN BD, 1988, J IMMUNOL, V141, P139; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; DEIMANN W, 1978, DEV BIOL, V66, P43, DOI 10.1016/0012-1606(78)90272-5; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Garceau V, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0121-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GOLDE DW, 1974, NATURE, V247, P373, DOI 10.1038/247373a0; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kanitakis J, 2011, EXP DERMATOL, V20, P145, DOI 10.1111/j.1600-0625.2010.01146.x; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; LIESCHKE GJ, 1994, BLOOD, V84, P27; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; NAITO M, 1990, J LEUKOCYTE BIOL, V48, P27, DOI 10.1002/jlb.48.1.27; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rampon C, 2003, INT J DEV BIOL, V47, P273; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; SAWYER RT, 1982, LAB INVEST, V46, P165; Schultze JL, 2015, SEMIN IMMUNOL, V27, P44, DOI 10.1016/j.smim.2015.02.001; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; TAKAHASHI K, 1983, CELL TISSUE RES, V232, P539, DOI 10.1007/BF00216427; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Tober J, 2008, BLOOD, V111, P2636, DOI 10.1182/blood-2007-11-124685; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; YAMADA M, 1990, J LEUKOCYTE BIOL, V47, P195, DOI 10.1002/jlb.47.3.195; Yamamoto T, 2008, CELL TISSUE RES, V332, P245, DOI 10.1007/s00441-008-0586-8; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zovein AC, 2010, BLOOD, V116, P3435, DOI 10.1182/blood-2010-04-279497	103	352	361	4	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					2	8		10.1038/ni.3341	http://dx.doi.org/10.1038/ni.3341			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681456	Green Accepted, Green Submitted			2022-12-18	WOS:000366675800002
J	Bailey, SL; Schreiner, B; McMahon, EJ; Miller, SD				Bailey, Samantha L.; Schreiner, Bettina; McMahon, Eileen J.; Miller, Stephen D.			CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4(+) T-H-17 cells in relapsing EAE	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; PLASMACYTOID DENDRITIC CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN CHOROID-PLEXUS; MULTIPLE-SCLEROSIS; T-CELLS; ANTIGEN; PROGRESSION; EXPRESSION; BETA	Peripherally derived CD11b(+) myeloid dendritic cells (mDCs), plasmacytoid DCs, CD8 alpha(+) DCs and macrophages accumulate in the central nervous system during relapsing experimental autoimmune encephalomyelitis (EAE). During acute relapsing EAE induced by a proteolipid protein peptide of amino acids 178 - 191, transgenic T cells (139TCR cells) specific for the relapse epitope consisting of proteolipid protein peptide amino acids 139 - 151 clustered with mDCs in the central nervous system, were activated and differentiated into T helper cells producing interleukin 17 (T-H-17 cells). CNS mDCs presented endogenously acquired peptide, driving the proliferation of and production of interleukin 17 by naive 139TCR cells in vitro and in vivo. The mDCs uniquely biased T-H-17 and not T(H)1 differentiation, correlating with their enhanced expression of transforming growth factor-beta 1 and interleukins 6 and 23. Plasmacytoid DCs and CD8 alpha(+) DCs were superior to macrophages but were much less efficient than mDCs in presenting endogenous peptide to induce T-H-17 cells. Our findings indicate a critical function for CNS mDCs in driving relapses in relapsing EAE.	Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Miller, SD (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu			NIAID NIH HHS [AI-07476] Funding Source: Medline; NINDS NIH HHS [NS-30871, NS-26543] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030871, R01NS026543] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonysamy MA, 1999, J IMMUNOL, V162, P577; Archambault AS, 2005, EUR J IMMUNOL, V35, P1076, DOI 10.1002/eji.200425864; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Begolka WS, 1998, J IMMUNOL, V161, P4437; BEHI EL, 2005, IMMUNOL LETT, V96, P11; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Fischer HG, 1999, INT IMMUNOL, V11, P1265, DOI 10.1093/intimm/11.8.1265; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hanly A, 1998, HUM PATHOL, V29, P88, DOI 10.1016/S0046-8177(98)90395-1; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Huang YM, 1999, J NEUROIMMUNOL, V99, P82, DOI 10.1016/S0165-5728(99)00106-X; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lopez C, 2006, J NEUROIMMUNOL, V175, P183, DOI 10.1016/j.jneuroim.2006.03.010; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McMahon EJ, 2006, NEUROCHEM INT, V49, P195, DOI 10.1016/j.neuint.2006.04.004; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Neville KL, 2002, J NEUROIMMUNOL, V123, P18, DOI 10.1016/S0165-5728(01)00479-9; Newman TA, 2005, J NEUROIMMUNOL, V166, P167, DOI 10.1016/j.jneuroim.2005.04.026; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Plumb J, 2003, MULT SCLER, V9, P142, DOI 10.1191/1352458503ms890oa; Sanna A, 2006, CLIN EXP IMMUNOL, V143, P357, DOI 10.1111/j.1365-2249.2006.02997.x; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Serot JM, 1997, NEUROREPORT, V8, P1995, DOI 10.1097/00001756-199705260-00039; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Suter T, 2003, EUR J IMMUNOL, V33, P2998, DOI 10.1002/eji.200323611; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Tuohy VK, 1999, J EXP MED, V189, P1033, DOI 10.1084/jem.189.7.1033; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777	61	352	368	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					172	180		10.1038/ni1430	http://dx.doi.org/10.1038/ni1430			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17206145				2022-12-18	WOS:000243597600015
J	Dower, NA; Stang, SL; Bottorff, DA; Ebinu, JO; Dickie, P; Ostergaard, HL; Stone, JC				Dower, NA; Stang, SL; Bottorff, DA; Ebinu, JO; Dickie, P; Ostergaard, HL; Stone, JC			RasGRP essential for mouse thymocyte differentiation and TCR signaling	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; ELEMENT-BINDING PROTEIN; TYROSINE KINASES; NEGATIVE SELECTION; MICE LACKING; RECEPTOR; TRANSDUCTION; LYMPHOCYTES; PATHWAY; ACTIVATION	The Ras signaling pathway plays a critical role in thymopoiesis and T cell activation, but the mechanism of Ras regulation is controversial. At least one mode of Ras regulation in T cells involves the messenger diacylglycerol (DAG). RasGRP, a Ras activator with a DAG-binding Cl domain, is expressed inT cells and thymocytes. Here we show that thymi of RasGRP-null mutant mice have approximately normal numbers of immature thymocytes but a marked deficiency of mature, single-positive (CD4(+)CD8(-) and CD4(-)CD8(+)) thymocytes. In Ras signaling and proliferation assays, mutant thymocytes showed a complete lack of response to DAG analogs or T cell receptor (TCR) stimulation by antibodies. Thus, TCR and DAG are linked through RasGRP to Ras signaling.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Stone, JC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	jim.stone@ualberta.ca						AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bottorff D, 1999, MAMM GENOME, V10, P358, DOI 10.1007/s003359901001; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Hsueh YP, 1997, J IMMUNOL, V158, P85; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; PETTIT GR, 1982, J AM CHEM SOC, V104, P6846, DOI 10.1021/ja00388a092; ROBERTSON EJ, 1987, TERATOCARCINOMAS EMB, P112; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; SAIOJIN KV, 1999, J BIOL CHEM, V275, P5966; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	39	352	360	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					317	321		10.1038/79766	http://dx.doi.org/10.1038/79766			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017103				2022-12-18	WOS:000089869700014
J	Itano, AA; Jenkins, MK				Itano, AA; Jenkins, MK			Antigen presentation to naive CD4 T cells in the lymph node	NATURE IMMUNOLOGY			English	Review							CLASS-II COMPLEXES; VIRUS-SPECIFIC CD4(+); DENDRITIC CELLS; IN-VIVO; B-CELLS; LANGERHANS CELLS; MONOCLONAL-ANTIBODY; APOPTOTIC CELLS; QUANTITATIVE-ANALYSIS; CYTOKINE PRODUCTION	Although the presentation of peptide-major histocompatibility complex class II (pMHC class II) complexes to CD4 T cells has been studied extensively in vitro, knowledge of this process in vivo is limited. Unlike the in vitro situation, antigen presentation in vivo takes place within a complex microenvironment in which the movements of antigens, antigen-presenting cells (APCs) and T cells are governed by anatomic constraints. Here we review developments in the areas of lymph node architecture, APC subsets and T cell activation that have shed light on how antigen presentation occurs in the lymph nodes.	Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Dept Microbiol, MMC 334,420 Delaware St SE, Minneapolis, MN 55455 USA.		Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Itano, Andrea/0000-0002-4766-6876				Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; ASKEW D, 1995, CELL IMMUNOL, V166, P62, DOI 10.1006/cimm.1995.0008; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Byersdorfer CA, 2001, J IMMUNOL, V167, P6756, DOI 10.4049/jimmunol.167.12.6756; CASSELL DJ, 1994, J EXP MED, V180, P1829, DOI 10.1084/jem.180.5.1829; CHANG MDY, 1995, CELL IMMUNOL, V162, P146, DOI 10.1006/cimm.1995.1062; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; CUMBERBATCH M, 1992, IMMUNOLOGY, V75, P257; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; DING L, 1993, J IMMUNOL, V151, P1224; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; EPSTEIN MM, 1995, J EXP MED, V182, P915, DOI 10.1084/jem.182.4.915; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lappin MB, 1996, ARCH DERMATOL RES, V288, P109, DOI 10.1007/BF02505819; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MacPherson G, 1999, IMMUNOL REV, V172, P325, DOI 10.1111/j.1600-065X.1999.tb01376.x; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; NALEFSKI EA, 1993, J IMMUNOL, V150, P3806; Okada S, 2002, MICROSC MICROANAL, V8, P116, DOI 10.1017/S1431927601020049; PEELER JS, 1986, J IMMUNOL, V136, P4362; Picker Louis J., 1993, P145; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Qu CF, 2003, J IMMUNOL, V170, P1010, DOI 10.4049/jimmunol.170.2.1010; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Romani N, 2001, INT REV CYTOL, V207, P237; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Ruedl C, 2001, J IMMUNOL, V166, P7178, DOI 10.4049/jimmunol.166.12.7178; Salomon B, 1998, J IMMUNOL, V160, P708; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Topham DJ, 1996, J IMMUNOL, V157, P2947; Townsend SE, 1998, J EXP MED, V187, P1611, DOI 10.1084/jem.187.10.1611; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Vremec D, 1997, J IMMUNOL, V159, P565; Wang BH, 1999, J LEUKOCYTE BIOL, V66, P33, DOI 10.1002/jlb.66.1.33; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Yrlid U, 2002, J IMMUNOL, V169, P108, DOI 10.4049/jimmunol.169.1.108; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673	88	350	362	1	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					733	739		10.1038/ni957	http://dx.doi.org/10.1038/ni957			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888794				2022-12-18	WOS:000184441500009
J	Diefenbach, A; Tomasello, E; Lucas, M; Jamieson, AM; Hsia, JK; Vivier, E; Raulet, DH				Diefenbach, A; Tomasello, E; Lucas, M; Jamieson, AM; Hsia, JK; Vivier, E; Raulet, DH			Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D	NATURE IMMUNOLOGY			English	Article							KILLER NK CELLS; T-CELLS; MURINE NKG2D; RECEPTOR; ACTIVATION; COMPLEX; FAMILY; IMMUNORECEPTOR; CYTOTOXICITY; EXPRESSION	Optimal lymphocyte activation requires the simultaneous engagement of stimulatory and costimulatory receptors. Stimulatory immunoreceptors are usually composed of a ligand-binding transmembrane protein and noncovalently associated signal-transducing subunits. Here, we report that alternative splicing leads to two distinct NKG2D polypeptides that associate differentially with the DAP10 and KARAP (also known as DAP12) signaling subunits. We found that differential expression of these isoforms and of signaling proteins determined whether NKG2D functioned as a costimulatory receptor in the adaptive immune system (CD8(+) T cells) or as both a primary recognition structure and a costimulatory receptor in the innate immune system (natural killer cells and macrophages). This strategy suggests a rationale for the multisubunit structure of stimulatory immunoreceptors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@udink4.berkeley.edu	Vivier, Eric/F-8939-2010; Jamieson, Amanda/U-7169-2019; Diefenbach, Andreas/T-2589-2018	Vivier, Eric/0000-0001-7022-8287; Jamieson, Amanda/0000-0002-5781-9231; Diefenbach, Andreas/0000-0002-9176-9530; Raulet, David/0000-0002-1257-8649; Tomasello, Elena/0000-0002-6839-5219				Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BROOKS CG, 1983, IMMUNOL REV, V72, P43, DOI 10.1111/j.1600-065X.1983.tb01072.x; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chang CW, 1999, J IMMUNOL, V163, P4651; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; HOWARD FD, 1990, P NATL ACAD SCI USA, V87, P7015, DOI 10.1073/pnas.87.18.7015; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Lucas M, 2002, EUR J IMMUNOL, V32, P2653, DOI 10.1002/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Olcese L, 1997, J IMMUNOL, V158, P5083; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Uhrberg M, 2001, J IMMUNOL, V166, P3923, DOI 10.4049/jimmunol.166.6.3923; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; VIVIER E, 1991, J IMMUNOL, V146, P206; Wilson MJ, 2001, IMMUNOGENETICS, V53, P347, DOI 10.1007/s002510100333; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	43	350	376	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1142	1149		10.1038/ni858	http://dx.doi.org/10.1038/ni858			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12426565				2022-12-18	WOS:000179467800011
J	Gao, YL; Souza-Fonseca-Guimaraes, F; Bald, T; Ng, SS; Young, A; Ngiow, SF; Rautela, J; Straube, J; Waddell, N; Blake, SJ; Yan, JM; Bartholin, L; Lee, JS; Vivier, E; Takeda, K; Messaoudene, M; Zitvogel-, L; Teng, MWL; Belz, GT; Engwerda, CR; Huntington, ND; Nakamura, K; Holzel, M; Smyth, MJ				Gao, Yulong; Souza-Fonseca-Guimaraes, Fernando; Bald, Tobias; Ng, Susanna S.; Young, Arabella; Ngiow, Shin Foong; Rautela, Jai; Straube, Jasmin; Waddell, Nic; Blake, Stephen J.; Yan, Juming; Bartholin, Laurent; Lee, Jason S.; Vivier, Eric; Takeda, Kazuyoshi; Messaoudene, Meriem; Zitvogel-, Laurence; Teng, Michele W. L.; Belz, Gabrielle T.; Engwerda, Christian R.; Huntington, Nicholas D.; Nakamura, Kyohei; Hoelzel, Michael; Smyth, Mark J.			Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; NATURAL-KILLER-CELLS; TGF-BETA; IFN-GAMMA; CANCER-IMMUNOTHERAPY; GENE-EXPRESSION; BREAST-CANCER; DECIDUAL NK; T-CELLS; DIFFERENTIATION	Avoiding destruction by immune cells is a hallmark of cancer, yet how tumors ultimately evade control by natural killer (NK) cells remains incompletely defined. Using global transcriptomic and flow-cytometry analyses and genetically engineered mouse models, we identified the cytokine-TGF-beta-signaling-dependent conversion of NK cells (CD49a(-)CD49b(+) Eomes(+)) into intermediate type 1 innate lymphoid cell (intILC1) (CD49a(+)CD49b(+)Eomes(+)) populations and ILC1 (CD49a(+)CD49b(-)Eomes(int)) populations in the tumor microenvironment. Strikingly, intILC1s and ILC1s were unable to control local tumor growth and metastasis, whereas NK cells favored tumor immunosurveillance. Experiments with an antibody that neutralizes the cytokine TNF suggested that escape from the innate immune system was partially mediated by TNF-producing ILC1s. Our findings provide new insight into the plasticity of group 1 ILCs in the tumor microenvironment and suggest that the TGF-beta-driven conversion of NK cells into ILC1s is a previously unknown mechanism by which tumors escape surveillance by the innate immune system.	[Gao, Yulong; Souza-Fonseca-Guimaraes, Fernando; Bald, Tobias; Young, Arabella; Ngiow, Shin Foong; Nakamura, Kyohei; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect, Herston, Qld, Australia; [Gao, Yulong; Young, Arabella; Yan, Juming; Teng, Michele W. L.; Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Souza-Fonseca-Guimaraes, Fernando; Rautela, Jai; Belz, Gabrielle T.; Huntington, Nicholas D.] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Dept Med Biol, Parkville, Vic, Australia; [Souza-Fonseca-Guimaraes, Fernando; Rautela, Jai; Belz, Gabrielle T.; Huntington, Nicholas D.] Univ Melbourne, Parkville, Vic, Australia; [Souza-Fonseca-Guimaraes, Fernando] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Ng, Susanna S.; Engwerda, Christian R.] QIMR Berghofer Med Res Inst, Immunol & Infect, Herston, Qld, Australia; [Ng, Susanna S.] Griffith Univ, Sch Nat Sci, Nathan, Qld, Australia; [Straube, Jasmin; Waddell, Nic] QIMR Berghofer Med Res Inst, Med Genom, Herston, Qld, Australia; [Blake, Stephen J.; Yan, Juming; Teng, Michele W. L.] QIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy, Herston, Qld, Australia; [Bartholin, Laurent] Univ Claude Bernard Lyon 1, CNRS 5286, Ctr Leon Berard, INSERM 1052,Ctr Rech Cancerol Lyon, Lyon, France; [Lee, Jason S.] QIMR Berghofer Med Res Inst, Control Gene Express Lab, Herston, Qld, Australia; [Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; [Takeda, Kazuyoshi] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Div Cell Biol,Bunkyo Ku, Tokyo, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Grad Sch Med, Dept Biofunct Microbiota, Bunkyo Ku, Tokyo, Japan; [Messaoudene, Meriem] Gustave Roussy Canc Campus, INSERM, U1015, Villejuif, France; [Messaoudene, Meriem; Zitvogel-, Laurence] Gustave Roussy Canc Campus, Villejuif, France; [Zitvogel-, Laurence] Univ Paris Saclay, Paris, France; [Zitvogel-, Laurence] Gustave Roussy Canc Campus, CIC1428, Villejuif, France; [Hoelzel, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, Bonn, Germany	QIMR Berghofer Medical Research Institute; University of Queensland; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Griffith University; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; QIMR Berghofer Medical Research Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Juntendo University; Juntendo University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Bonn	Smyth, MJ (corresponding author), QIMR Berghofer Med Res Inst, Immunol Canc & Infect, Herston, Qld, Australia.; Smyth, MJ (corresponding author), Univ Queensland, Sch Med, Herston, Qld, Australia.	mark.smyth@qimrberghofer.edu.au	Engwerda, Christian/I-3072-2015; Vivier, Eric/F-8939-2010; Belz, Gabrielle T/C-9350-2013; Nakamura, Kyohei/AAH-4823-2019; Teng, Michele WL/S-5055-2016; Waddell, Nicola/H-4929-2015; Straube, Jasmin/Y-1355-2018; Guimarães, Fernando/AAQ-2535-2021; Huntington, NICHOLAS/AAV-4704-2020; Bartholin, Laurent/Q-6655-2017; Ng, Susanna S/L-9906-2014; Lee, Jason S/M-7522-2016	Vivier, Eric/0000-0001-7022-8287; Belz, Gabrielle T/0000-0002-9660-9587; Nakamura, Kyohei/0000-0002-6631-9028; Teng, Michele WL/0000-0003-1886-9145; Waddell, Nicola/0000-0002-3950-2476; Straube, Jasmin/0000-0002-1748-0659; Guimarães, Fernando/0000-0002-2718-8993; Huntington, NICHOLAS/0000-0002-5267-7211; Bartholin, Laurent/0000-0002-5637-3223; Ng, Susanna S/0000-0002-8494-7722; Lee, Jason S/0000-0003-0879-934X; ZITVOGEL, laurence/0000-0003-1596-0998; Young, Arabella/0000-0002-6845-9753; Souza-Fonseca-Guimaraes, Fernando/0000-0002-2037-8946; Gao, Yulong/0000-0003-1438-0772; Yan, Juming/0000-0003-0857-8870; Engwerda, Christian/0000-0003-2813-4804	National Health and Medical Research Council of Australia [1078671, 1088703, 1124690, 1027472, 1066770, 1057852, 1112113]; Cancer Research Institute Clinical and Laboratory Integration Programs; Queensland Institute of Medical Research Berghofer International PhD Scholarship; University of Queensland International Scholarship; National Breast Cancer Foundation [PF-15-008]; Cure Cancer Australia [1082709, 1120725]; European Molecular Biology Organization [ALTF 945-2015]; Naito Foundation; Cancer Council Queensland; Griffith University; Inserm-Avenir-Grant; Ligue Nationale Contre le Cancer; Fondation ARC Pour la Recherche sur le Cancer; Victorian State Government Operational Infrastructure Scheme; Harry J Lloyd Charitable Trust; DFG Excellence Cluster Immunosensation [EXC 1023]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Institute Clinical and Laboratory Integration Programs; Queensland Institute of Medical Research Berghofer International PhD Scholarship; University of Queensland International Scholarship; National Breast Cancer Foundation; Cure Cancer Australia; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Naito Foundation(Naito Memorial Foundation); Cancer Council Queensland(Cancer Council Queensland); Griffith University(Griffith University); Inserm-Avenir-Grant(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation ARC Pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Victorian State Government Operational Infrastructure Scheme; Harry J Lloyd Charitable Trust; DFG Excellence Cluster Immunosensation(German Research Foundation (DFG))	We thank R. Schreiber (Washington University School of Medicine) for MCA1956 fibrosarcoma cells and anti-IFN-gamma and anti-TNF hybridomas; the animal house and flow cytometry facilities at QIMR Berghofer Medical Research Institute and Walter and Eliza Hall Institute of Medical Research; E. Loza, K. Elder, L. Town, L. Spencer, T. Camilleri and T. Kratina, for mouse breeding, maintenance and genotyping; and K. MacDonald, D. Smith, A. Kallies, L. Beattie, R. Allan, G. Hill and S. Nutt for discussion, comments and advice on this project. Supported by the National Health and Medical Research Council of Australia (Senior Principal Research Fellowship 1078671 to M.J.S.; Peter Doherty Early Career Fellowship 1088703 to F.S.-F.-G. and 1124690 to T.B.; project grant 1027472 to G.T.B.; Elizabeth Blackburn NHMRC Fellowship to G.T.B.; Independent Research Institute Infrastructure Support scheme grant to G.T.B.; project grants 1066770 & 1057852 N.D.H.; and RD Wright Career development Fellowship 1112113 to N.W.), the Cancer Research Institute Clinical and Laboratory Integration Programs (M.J.S. and N.D.H.), Queensland Institute of Medical Research Berghofer International PhD Scholarship (Y.G. and J.Y.), University of Queensland International Scholarship (Y.G. and J.Y.), the National Breast Cancer Foundation (PF-15-008 to F.S.-F.-G.), Cure Cancer Australia (Priority-Driven Young Investigator Project Grant 1082709 and 1120725 to F.S.-F.-G.), European Molecular Biology Organization (long-term fellowship ALTF 945-2015 to T.B.), the Naito Foundation (K.N.), Cancer Council Queensland (PhD fellowship to A.Y.), Griffith University (PhD scholarships to S.S.N.), Inserm-Avenir-Grant (L.B.), Ligue Nationale Contre le Cancer (L.B.), Fondation ARC Pour la Recherche sur le Cancer (L.B.), the Victorian State Government Operational Infrastructure Scheme (G.T.B.), the Harry J Lloyd Charitable Trust (Melanoma Research Grant to N.D.H.) and the DFG Excellence Cluster Immunosensation (EXC 1023 to M.H.).	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Bruno A, 2013, NEOPLASIA, V15, P133, DOI 10.1593/neo.121758; Chaput N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23080; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Crome SQ, 2017, NAT MED, V23, P368, DOI 10.1038/nm.4278; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689; Donatelli SS, 2014, P NATL ACAD SCI USA, V111, P4203, DOI 10.1073/pnas.1319269111; Fuchs A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00104; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gill S, 2012, BLOOD, V119, P5758, DOI 10.1182/blood-2012-03-415364; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hayakawa Y, 2002, BLOOD, V100, P1728; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Johnstone CN, 2015, DIS MODEL MECH, V8, P237, DOI 10.1242/dmm.017830; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Krasnova Y, 2017, CLIN IMMUNOL, V177, P50, DOI 10.1016/j.clim.2015.10.001; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Levi I, 2015, ONCOTARGET, V6, P1, DOI 10.18632/oncotarget.3453; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lima PDA, 2014, CELL MOL IMMUNOL, V11, P522, DOI 10.1038/cmi.2014.63; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Rautela J, 2015, CANCER IMMUNOL RES, V3, P1207, DOI 10.1158/2326-6066.CIR-15-0065; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Seillet C, 2016, INT IMMUNOL, V28, P3, DOI 10.1093/intimm/dxv051; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; SMYTH MJ, 1991, J IMMUNOL, V146, P3289; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terabe M, 2009, CLIN CANCER RES, V15, P6560, DOI 10.1158/1078-0432.CCR-09-1066; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; Vallentin B, 2015, CANCER IMMUNOL RES, V3, P1109, DOI 10.1158/2326-6066.CIR-15-0222; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Wilson EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022842; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002	65	349	359	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					1004	+		10.1038/ni.3800	http://dx.doi.org/10.1038/ni.3800			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28759001				2022-12-18	WOS:000408137700010
J	Bieniasz, PD				Bieniasz, PD			Intrinsic immunity: a front-line defense against viral attack	NATURE IMMUNOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; URACIL DNA GLYCOSYLASE; LOCUS AFFECTING RESISTANCE; VIRION INFECTIVITY FACTOR; HEPATITIS-B-VIRUS; VIF PROTEIN; ANTIVIRAL ACTIVITY; FV-1 RESTRICTION; CYCLOPHILIN-A	In addition to the conventional innate and acquired immune responses, complex organisms have evolved an array of dominant, constitutively expressed genes that suppress or prevent viral infections. Two major cellular defenses against infection by retroviruses are the Fv1 and TRIM5 class of inhibitors that target incoming retroviral capsids and the APOBEC3 class of cytidine deaminases that hypermutate and destabilize retroviral genomes. Additional, less well characterized activities also inhibit viral replication. Here, the present understanding of these 'intrinsic' immune mechanisms is reviewed and their role in protection from retroviral infection is discussed.	Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA		Bieniasz, PD (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	pbienias@adarc.org	Liu, FL/D-1795-2009					Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; BASSIN RH, 1978, J VIROL, V26, P306, DOI 10.1128/JVI.26.2.306-315.1978; Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bishop KN, 2001, J VIROL, V75, P5182, DOI 10.1128/JVI.75.11.5182-5188.2001; Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; BOONE LR, 1990, J VIROL, V64, P3376, DOI 10.1128/JVI.64.7.3376-3381.1990; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; DECLEVE A, 1975, VIROLOGY, V65, P320, DOI 10.1016/0042-6822(75)90038-0; DESGROSEILLERS L, 1983, J VIROL, V48, P685, DOI 10.1128/JVI.48.3.685-696.1983; Dorfman T, 1996, J VIROL, V70, P5751, DOI 10.1128/JVI.70.9.5751-5757.1996; DURANTROISE G, 1977, CELL, V10, P479, DOI 10.1016/0092-8674(77)90035-6; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; GARDNER MB, 1980, P NATL ACAD SCI-BIOL, V77, P531, DOI 10.1073/pnas.77.1.531; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HARTLEY JW, 1970, J VIROL, V5, P221, DOI 10.1128/JVI.5.2.221-225.1970; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hatziioannou T, 2003, EMBO J, V22, P385, DOI 10.1093/emboj/cdg042; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999; IKEDA H, 1989, J VIROL, V63, P5405, DOI 10.1128/JVI.63.12.5405-5412.1989; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kozak CA, 1996, VIROLOGY, V225, P300, DOI 10.1006/viro.1996.0604; KOZAK CA, 1985, J VIROL, V55, P281, DOI 10.1128/JVI.55.2.281-285.1985; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; LILLY F, 1967, SCIENCE, V155, P461, DOI 10.1126/science.155.3761.461; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Miller AD, 1997, J VIROL, V71, P4531, DOI 10.1128/JVI.71.6.4531-4535.1997; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Mura M, 2004, P NATL ACAD SCI USA, V101, P11117, DOI 10.1073/pnas.0402877101; Ngui SL, 1999, REV MED VIROL, V9, P183, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;183::AID-RMV248&gt;3.0.CO;2-P; OKADA T, 1965, JPN J EXP MED, V35, P311; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; PINCUS T, 1971, J EXP MED, V133, P1219, DOI 10.1084/jem.133.6.1219; PINCUS T, 1975, VIROLOGY, V65, P333, DOI 10.1016/0042-6822(75)90039-2; PRYCIAK PM, 1992, J VIROL, V66, P5959, DOI 10.1128/JVI.66.10.5959-5966.1992; RASHEED S, 1983, INT J CANCER, V31, P491, DOI 10.1002/ijc.2910310415; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; ROWE WP, 1972, J EXP MED, V136, P1286, DOI 10.1084/jem.136.5.1286; ROWE WP, 1972, J EXP MED, V136, P1272, DOI 10.1084/jem.136.5.1272; SAKAI H, 1995, J GEN VIROL, V76, P2717, DOI 10.1099/0022-1317-76-11-2717; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; SCHAFER A, IN PRESS VIROLOGY; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Sleigh R, 1998, VIROLOGY, V245, P338, DOI 10.1006/viro.1998.9159; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; SUZUKI S, 1975, JPN J EXP MED, V45, P473; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Taylor William R, 2004, BMC Struct Biol, V4, P1, DOI 10.1186/1472-6807-4-1; TENNANT RW, 1979, VIROLOGY, V99, P349, DOI 10.1016/0042-6822(79)90014-X; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Xu LX, 2003, EXP CELL RES, V288, P84, DOI 10.1016/S0014-4827(03)00187-3; YAP L, 1991, GASTROENTEROLOGY, V101, P786, DOI 10.1016/0016-5085(91)90540-2; Yap MW, 2003, VIROLOGY, V307, P76, DOI 10.1016/S0042-6822(02)00053-3; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; ZENNOU V, IN PRESS J VIROLOGY; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	101	348	357	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1109	1115		10.1038/ni1125	http://dx.doi.org/10.1038/ni1125			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496950				2022-12-18	WOS:000224692700007
J	Levine, AG; Arvey, A; Jin, W; Rudensky, AY				Levine, Andrew G.; Arvey, Aaron; Jin, Wei; Rudensky, Alexander Y.			Continuous requirement for the TCR in regulatory T cell function	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IRF4; TREG CELLS; DIFFERENTIATION; INTERLEUKIN-2; EXPRESSION; RECEPTOR; TARGET; SELF; INFLAMMATION; HOMEOSTASIS	Foxp3(+) regulatory T cells (T-reg cells) maintain immunological tolerance, and their deficiency results in fatal multiorgan autoimmunity. Although heightened signaling via the T cell antigen receptor (TCR) is critical for the differentiation of T-reg cells, the role of TCR signaling in T-reg cell function remains largely unknown. Here we demonstrated that inducible ablation of the TCR resulted in T-reg cell dysfunction that could not be attributed to impaired expression of the transcription factor Foxp3, decreased expression of T-reg cell signature genes or altered ability to sense and consume interleukin 2 (IL-2). Instead, TCR signaling was required for maintaining the expression of a limited subset of genes comprising 25% of the activated T-reg cell transcriptional signature. Our results reveal a critical role for the TCR in the suppressor capacity of T-reg cells.	[Levine, Andrew G.; Arvey, Aaron; Jin, Wei; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Levine, Andrew G.; Arvey, Aaron; Jin, Wei; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org		Arvey, Aaron/0000-0002-8789-0290	US National Institutes of Health [R37AI034206]; Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schmidt-Supprian (Technical University Munich) and K. Rajewsky (Max Delbruck Center) for Trac<SUP>FL</SUP> mice. Supported by the US National Institutes of Health (R37AI034206 to A.Y.R.), the Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center (A.Y.R.) and the Howard Hughes Medical Institute (A.Y.R.).	Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hoelzinger DB, 2010, J IMMUNOL, V184, P6833, DOI 10.4049/jimmunol.0904084; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Reinwald S, 2008, J IMMUNOL, V180, P5890, DOI 10.4049/jimmunol.180.9.5890; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Sawant DV, 2012, J IMMUNOL, V189, P4759, DOI 10.4049/jimmunol.1201794; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zou T, 2012, J IMMUNOL, V189, P28, DOI 10.4049/jimmunol.1200507	50	347	353	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1070	1078		10.1038/ni.3004	http://dx.doi.org/10.1038/ni.3004			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25263123	Green Accepted			2022-12-18	WOS:000343640700013
J	Marais, A; Cherfils-Vicini, J; Viant, C; Degouve, S; Viel, S; Fenis, A; Rabilloud, J; Mayol, K; Tavares, A; Bienvenu, J; Gangloff, YG; Gilson, E; Vivier, E; Walzer, T				Marais, Antoine; Cherfils-Vicini, Julien; Viant, Charlotte; Degouve, Sophie; Viel, Sebastien; Fenis, Aurore; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Bienvenu, Jacques; Gangloff, Yann-Gael; Gilson, Eric; Vivier, Eric; Walzer, Thierry			The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; NATURAL-KILLER; MAMMALIAN TARGET; LYMPHOID-CELLS; MATURATION; PATHWAYS; EFFECTOR; PHOSPHORYLATION; DIFFERENTIATION; P110-DELTA	Interleukin 15 (IL-15) controls both the homeostasis and the peripheral activation of natural killer (NK) cells. The molecular basis for this duality of action remains unknown. Here we found that the metabolic checkpoint kinase mTOR was activated and boosted bioenergetic metabolism after exposure of NK cells to high concentrations of IL-15, whereas low doses of IL-15 triggered only phosphorylation of the transcription factor STAT5. mTOR stimulated the growth and nutrient uptake of NK cells and positively fed back on the receptor for IL-15. This process was essential for sustaining NK cell proliferation during development and the acquisition of cytolytic potential during inflammation or viral infection. The mTORC 1 inhibitor rapamycin inhibited NK cell cytotoxicity both in mice and humans; this probably contributes to the immunosuppressive activity of this drug in different clinical settings.	[Marais, Antoine; Degouve, Sophie; Viel, Sebastien; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Walzer, Thierry] Int Ctr Infectiol Res, Lyon, France; [Marais, Antoine; Degouve, Sophie; Viel, Sebastien; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Walzer, Thierry] INSERM, U1111, F-69008 Lyon, France; [Marais, Antoine; Degouve, Sophie; Viel, Sebastien; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Gangloff, Yann-Gael; Walzer, Thierry] Ecole Normale Super Lyon, F-69364 Lyon, France; [Marais, Antoine; Degouve, Sophie; Viel, Sebastien; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Walzer, Thierry] Univ Lyon 1, F-69365 Lyon, France; [Marais, Antoine; Degouve, Sophie; Viel, Sebastien; Rabilloud, Jessica; Mayol, Katia; Tavares, Armelle; Walzer, Thierry] CNRS, UMR5308, Lyon, France; [Cherfils-Vicini, Julien; Gilson, Eric] Univ Nice, Fac Med, CNRS INSERM UMR7284 U1081, Inst Res Canc & Aging, Nice, France; [Viant, Charlotte; Fenis, Aurore; Vivier, Eric] Aix Marseille Univ, UM2, CNRS UMR7280, Ctr Immunol Marseille Luminy,INSERM U1104, Marseille, France; [Viel, Sebastien; Bienvenu, Jacques] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Immunol Lab, Lyon, France; [Gangloff, Yann-Gael] CNRS, UMR 5239, Lab Biol Mol & Cellulaire, Lyon, France; [Gilson, Eric] CHU Nice, Archet Hosp 2, Dept Med Genet, F-06202 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Nice	Walzer, T (corresponding author), Int Ctr Infectiol Res, Lyon, France.	thierry.walzer@inserm.fr	Walzer, Thierry/L-9418-2014; Marçais, Antoine/F-4341-2017; Viel, Sebastien/A-7258-2016; Cherfils-Vicini, Julien/L-1997-2019; Vivier, Eric/F-8939-2010; GANGLOFF, Yann-Gaël/I-2161-2014; bienvenu, jacques/F-2917-2013	Walzer, Thierry/0000-0002-0857-8179; Marçais, Antoine/0000-0002-3591-6268; Viel, Sebastien/0000-0002-5085-443X; Cherfils-Vicini, Julien/0000-0001-7813-1527; Vivier, Eric/0000-0001-7022-8287; GANGLOFF, Yann-Gaël/0000-0001-9031-1184; 	FINOVI foundation; Agence Nationale de la Recherche; European Research Council [ERC-Stg 281025]; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universit Claude Bernard Lyon1; Ecole Normale Superieure de Lyon; Ligue contre le Cancer; Aix-Marseille University; CG06; INSERM; FEDER	FINOVI foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universit Claude Bernard Lyon1; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Ligue contre le Cancer(Ligue nationale contre le cancer); Aix-Marseille University; CG06; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FEDER(European Commission)	We thank the Plateau de Biologie Experimentale de la Souris, and the flow cytometry facility of the SFR Biosciences Gerland and of Institute for Research on Cancer and Aging, Nice (the Cytomed platform funded by the CG06, INSERM and FEDER). Supported by the FINOVI foundation (T.W. laboratory), Agence Nationale de la Recherche (for the T.W. laboratory), the European Research Council (ERC-Stg 281025 for the T.W. laboratory and a THINK Advanced Grant for the E.V. laboratory), Institut National de la Sante et de la Recherche Medicale (T.W. and E.V. laboratories), Centre National de la Recherche Scientifique (T.W. and E.V. laboratories), Universit Claude Bernard Lyon1 (T.W. laboratory), Ecole Normale Superieure de Lyon (T.W. laboratory), the "Ligue contre le Cancer" ("quipe labelisee"; E.G. and E.V. laboratories) and Aix-Marseille University to Centre d'Immunologie de Marseille Luminy (E.V. laboratory).	Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Clinthorne JF, 2013, J IMMUNOL, V190, P712, DOI 10.4049/jimmunol.1201837; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee GA, 2011, J IMMUNOL, V187, P1212, DOI 10.4049/jimmunol.1100331; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Orr SJ, 2010, J IMMUNOL, V185, P1393, DOI 10.4049/jimmunol.0903528; Orr SJ, 2009, J IMMUNOL METHODS, V340, P158, DOI 10.1016/j.jim.2008.10.014; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90	50	347	355	4	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					749	+		10.1038/ni.2936	http://dx.doi.org/10.1038/ni.2936			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24973821	Green Accepted			2022-12-18	WOS:000339323000010
J	Ouyang, W; Beckett, O; Ma, QA; Paik, JH; DePinho, RA; Li, MO				Ouyang, Weiming; Beckett, Omar; Ma, Qian; Paik, Ji-hye; DePinho, Ronald A.; Li, Ming O.			Foxo proteins cooperatively control the differentiation of Foxp3(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; LINEAGE COMMITMENT; DENDRITIC CELLS; TGF-BETA; AKT-MTOR; RECEPTOR; EXPRESSION; HOMEOSTASIS; SPECIFICATION	CD4(+) regulatory T cells (T-reg cells) characterized by expression of the transcription factor Foxp3 have a pivotal role in maintaining immunological tolerance. Here we show that mice with T cell-specific deletion of both the Foxo1 and Foxo3 transcription factors (collectively called 'Foxo proteins' here) developed a fatal multifocal inflammatory disorder due in part to T-reg cell defects. Foxo proteins functioned in a T-reg cell-intrinsic manner to regulate thymic and transforming growth factor-beta (TGF-beta)-induced Foxp3 expression, in line with the ability of Foxo proteins to bind to Foxp3 locus and control Foxp3 promoter activity. Transcriptome analyses showed that Foxo proteins regulated the expression of additional T-reg cell-associated genes and were essential for inhibiting the acquisition of effector T cell characteristics by T-reg cells. Thus, Foxo proteins have crucial roles in specifying the T-reg cell lineage.	[Ouyang, Weiming; Beckett, Omar; Ma, Qian; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med,Belfer Inst Appl Canc Sci, Dana Farber Canc Inst, Dept Oncol,Dept Med, Boston, MA 02115 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	lim@mskcc.org		DePinho, Ronald/0000-0002-5625-577X; li, ming/0000-0002-1383-0535	Starr Cancer Consortium [13-A123]; National Institute of Arthritis, Musculoskeletal and Skin Diseases [K01 AR053595]; Arthritis Foundation; Robert A. and Renee E. Belfer Family Foundation; Damon-Runyon Cancer Research Foundation; Rita Allen Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053595] Funding Source: NIH RePORTER	Starr Cancer Consortium; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Robert A. and Renee E. Belfer Family Foundation; Damon-Runyon Cancer Research Foundation; Rita Allen Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell (Yale University) for the Foxp3-RFP mouse strain; S. Ghosh (Columbia University) for luciferase reporter constructs; A. Brunet (Stanford University) for the Foxo3-specific antibody; and A. Rudensky, M. Huse and Y. Zheng for discussions. Supported by the Starr Cancer Consortium (13-A123 to M.O.L.), the National Institute of Arthritis, Musculoskeletal and Skin Diseases (K01 AR053595 to M.O.L.), the Arthritis Foundation (M.O.L.), the Robert A. and Renee E. Belfer Family Foundation (R.A.D.), the Damon-Runyon Cancer Research Foundation (J.-h.P.) and the Rita Allen Foundation (M.O.L.).	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	50	347	361	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					618	U91		10.1038/ni.1884	http://dx.doi.org/10.1038/ni.1884			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20467422				2022-12-18	WOS:000278926400018
J	Takenaka, K; Prasolava, TK; Wang, JCY; Mortin-Toth, SM; Khalouei, S; Gan, OI; Dick, JE; Danska, JS				Takenaka, Katsuto; Prasolava, Tatiana K.; Wang, Jean C. Y.; Mortin-Toth, Steven M.; Khalouei, Sam; Gan, Olga I.; Dick, John E.; Danska, Jayne S.			Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							SIGNAL-REGULATORY-PROTEIN; NATURAL-KILLER-CELLS; BONE-MARROW; NOD MOUSE; T-CELLS; GRAFT-REJECTION; CD122(+) CELLS; DENDRITIC CELL; DEFICIENT MICE; SCID MICE	Graft failure in the transplantation of hematopoietic stem cells occurs despite donor-host genetic identity of human leukocyte antigens, suggesting that additional factors modulate engraftment. With the nobese diabetic ( NOD) -severe combined immunodeficiency ( SCID) xenotransplantation model, we found that the NOD background allowed better hematopoietic engraftment than did other strains with equivalent immunodeficiency-related mutations. We used positional genetics to characterize the molecular basis for this strain specificity and found that the NOD Sirpa allele conferred support for human hematopoiesis. NOD SIRP-alpha showed enhanced binding to the human CD47 ligand, and its expression on mouse macrophages was required for support of human hematopoiesis. Thus, we have identified Sirpa polymorphism as a potent genetic determinant of the engraftment of human hematopoietic stem cells.	Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Univ Hlth Network, Dept Med, Div Hematol & Med Oncol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Dept Mol Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Dept Immunol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Danska, JS (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jayne.danska@sickkids.ca		Dick, John/0000-0002-9527-8317; Wang, Jean/0000-0001-7543-3917				ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; DORSHKIND K, 1985, J IMMUNOL, V134, P3798; GALE RP, 1981, BLOOD, V57, P9; Gan OI, 1999, EXP HEMATOL, V27, P1097, DOI 10.1016/S0301-472X(99)00037-5; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; GREINER DL, 1995, AM J PATHOL, V146, P888; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; HAUSER SP, 1995, J HISTOCHEM CYTOCHEM, V43, P371, DOI 10.1177/43.4.7897180; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; ISSAAD C, 1993, BLOOD, V81, P2916; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Sano S, 1999, BIOCHEM J, V344, P667, DOI 10.1042/0264-6021:3440667; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2003, EXP HEMATOL, V31, P551, DOI 10.1016/S0301-472X(03)00076-6; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; STORB R, 1977, NEW ENGL J MED, V296, P61, DOI 10.1056/NEJM197701132960201; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; THOMAS ED, 1977, BLOOD, V49, P511; van den Nieuwenhof IM, 2001, J CELL SCI, V114, P1321; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; WANG JC, 2001, HEMATOPOIESIS DEV AP, P99; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	51	347	383	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1313	1323		10.1038/ni1527	http://dx.doi.org/10.1038/ni1527			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17982459				2022-12-18	WOS:000251267000012
J	Kirstetter, P; Anderson, K; Porse, BT; Jacobsen, SEW; Nerlov, C				Kirstetter, Peggy; Anderson, Kristina; Porse, Bo T.; Jacobsen, Sten Eirik W.; Nerlov, Claus			Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block	NATURE IMMUNOLOGY			English	Article							BETA-CATENIN; T-CELL; SIGNALING PATHWAY; SELF-RENEWAL; C/EBP-ALPHA; MYELOID PROGENITOR; GENE FAMILY; TRANSCRIPTION; EXPRESSION; PU.1	Wnt signaling increases hematopoietic stem cell self-renewal and is activated in both myeloid and lymphoid malignancies, indicating involvement in both normal and malignant hematopoiesis. We report here activated canonical Wnt signaling in the hematopoietic system through conditional expression of a stable form of beta-catenin. This enforced expression led to hematopoietic failure associated with loss of myeloid lineage commitment at the granulocyte-macrophage progenitor stage; blocked erythrocyte differentiation; disruption of lymphoid development; and loss of repopulating stem cell activity. Loss of hematopoietic stem cell function was associated with decreased expression of Cdkn1a ( encoding the cell cycle inhibitor p21(cdk)), Sfpi1, Hoxb4 and Bmi1 ( encoding the transcription factors PU.1, HoxB4 and Bmi-1, respectively) and altered integrin expression in Lin(-)Sca-1(+)c-Kit(+) cells, whereas PU.1 was upregulated in erythroid progenitors. Constitutive activation of canonical Wnt signaling therefore causes multilineage differentiation block and compromised hematopoietic stem cell maintenance.	European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; Lund Univ, Dept Stem Cell Biol, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden; Univ Copenhagen, Lab Gene Therapy Res, DK-2100 Copenhagen, Denmark	European Molecular Biology Laboratory (EMBL); Lund University; University of Copenhagen	Nerlov, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy.	nerlov@embl-monterotondo.it	Porse, Bo/B-1332-2012; Jacobsen, Sten Eirik W/D-3974-2018; Kirstetter, Peggy/I-9582-2016	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Kirstetter, Peggy/0000-0001-7592-8004; Porse, Bo/0000-0001-6043-0844				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ANGRAND PO, 1999, NUCLEIC ACIDS RES, V27, P16; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kennell JA, 2003, MOL CELL BIOL, V23, P5366, DOI 10.1128/MCB.23.15.5366-5375.2003; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	55	347	375	1	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1048	1056		10.1038/ni1381	http://dx.doi.org/10.1038/ni1381			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16951689				2022-12-18	WOS:000241437100010
J	Davis, SJ; van der Merwe, PA				Davis, Simon J.; van der Merwe, P. Anton			The kinetic-segregation model: TCR triggering and beyond	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; IMMUNOLOGICAL SYNAPSE; ACTIVATION; CD45; PEPTIDE; COMPLEX; MICROCLUSTERS; RECOGNITION; INDUCTION; MOLECULES	How the T cell receptor engages antigen is known, but not how that 'triggers' intracellular signaling. The first direct support for a mechanism based on the spatial reorganization of signaling proteins, proposed 10 years ago and referred to as the 'kinetic-segregation' model, is now beginning to emerge, along with indications that it may also apply to the triggering of nonclonotypic receptors. We describe here the development of the model, review new data and suggest how the model fits a broader conceptual framework for receptor triggering. We also consider the capacity of the model, versus that of other proposals, to account for the established features of TCR triggering.	Univ Oxford, Nuffield Dept Clin Med, Oxford, England; John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford	Davis, SJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	simon.davis@ndm.ox.ac.uk; anton.vandermerwe@path.ox.ac.uk			MRC [G9722488] Funding Source: UKRI; Medical Research Council [G19/31, G9722488] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; BURROUGHS MJ, 2006, IN PRESS BIOPHYS J; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chikuma S, 2005, J IMMUNOL, V175, P177, DOI 10.4049/jimmunol.175.1.177; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Davis SJ, 2003, TRENDS IMMUNOL, V24, P624, DOI 10.1016/j.it.2003.10.009; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GLAESER RM, 1986, BIOPHYS J, V50, P913, DOI 10.1016/S0006-3495(86)83532-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; SCHILHAM MW, 1993, EUR J IMMUNOL, V23, P1299, DOI 10.1002/eji.1830230617; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Siefken R, 1997, CELL IMMUNOL, V176, P59, DOI 10.1006/cimm.1996.1066; Sperling AI, 1998, J IMMUNOL, V161, P6459; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; VARMA R, IN PRESS IMMUNITY; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; WILLIAMS AF, 1992, NATURE, V356, P746, DOI 10.1038/356746a0; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	61	346	356	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					803	809		10.1038/ni1369	http://dx.doi.org/10.1038/ni1369			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855606				2022-12-18	WOS:000239147200015
J	Yang, YP; Huang, CT; Huang, XP; Pardoll, DM				Yang, YP; Huang, CT; Huang, XP; Pardoll, DM			Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance	NATURE IMMUNOLOGY			English	Article							THERAPEUTIC ANTITUMOR IMMUNITY; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; IN-VIVO; TUMOR-ANTIGEN; MELANOMA PATIENTS; CANCER VACCINES; SELF-ANTIGENS; GENE-TRANSFER; RECOMBINANT	One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8(+) T cells. However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4(+)CD25(+) regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the coadministration of a Toll-like receptor (TLR) ligand or irrelevant virus. These results demonstrate that virus provides TLR signals required for bypassing regulatory T cell-mediated tolerance and emphasize the importance of persistent TLR signals for immunotherapy in the setting of established tolerance.	Duke Univ, Med Ctr, Dept Med & Immunol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Chang Gung Univ, Sch Med & Hosp, Taoyuan, Taiwan	Duke University; Johns Hopkins University; Chang Gung University	Yang, YP (corresponding author), Duke Univ, Med Ctr, Dept Med & Immunol, Durham, NC 27710 USA.	yang0029@mc.duke.edu; dmpardol@jhmi.edu	Chuang, shengHao/C-8217-2012		NCI NIH HHS [CA93659] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA093659] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Adler AJ, 2000, J IMMUNOL, V164, P649, DOI 10.4049/jimmunol.164.2.649; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; DRANOFF G, 1995, ADV IMMUNOL, V58, P417, DOI 10.1016/S0065-2776(08)60624-0; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; Elzey BD, 2001, INT J CANCER, V94, P842, DOI 10.1002/ijc.1556; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; HUI K, 1984, NATURE, V311, P750, DOI 10.1038/311750a0; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morgan DJ, 1999, J IMMUNOL, V163, P723; Morgan DJ, 1996, J IMMUNOL, V157, P978; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Onizuka S, 1999, CANCER RES, V59, P3128; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PAOLETTI E, 1995, DEV BIOL STAND, V84, P159; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Schuler G, 1997, J EXP MED, V186, P1183, DOI 10.1084/jem.186.8.1183; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Specht JM, 1997, J EXP MED, V186, P1213, DOI 10.1084/jem.186.8.1213; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Su Z, 2002, CANCER RES, V62, P5041; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Vaidya SA, 2003, CURR OPIN IMMUNOL, V15, P402, DOI 10.1016/S0952-7915(03)00070-0; Yang Y, 1996, GENE THER, V3, P412; YE XH, 1994, P NATL ACAD SCI USA, V91, P3916, DOI 10.1073/pnas.91.9.3916	47	346	362	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					508	515		10.1038/ni1059	http://dx.doi.org/10.1038/ni1059			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15064759				2022-12-18	WOS:000221101100015
J	Latz, E; Verma, A; Visintin, A; Gong, M; Sirois, CM; Klein, DCG; Monks, BG; McKnight, CJ; Lamphier, MS; Duprex, WP; Espevik, T; Golenbock, DT				Latz, Eicke; Verma, Anjali; Visintin, Alberto; Gong, Mei; Sirois, Cherilyn M.; Klein, Dionne C. G.; Monks, Brian G.; McKnight, C. James; Lamphier, Marc S.; Duprex, W. Paul; Espevik, Terje; Golenbock, Douglas T.			Ligand-induced conformational changes allosterically activate Toll-like receptor 9	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; GREEN FLUORESCENT PROTEIN; PLASMACYTOID DENDRITIC CELLS; SYSTEMIC AUTOIMMUNE-DISEASE; BACTERIAL CPG-DNA; CRYSTAL-STRUCTURE; ERYTHROPOIETIN RECEPTOR; ENDOGENOUS LIGANDS; BINDING DOMAIN; TLR9	Microbial and synthetic DNA rich in CpG dinucleotides stimulates Toll-like receptor 9 (TLR9), whereas DNA lacking CpG either is inert or can inhibit TLR9 activation. The molecular mechanisms by which TLR9 becomes activated or is inhibited are not well understood. Here we show that TLR9 bound to stimulatory and inhibitory DNA; however, only stimulatory DNA led to substantial conformational changes in the TLR9 ectodomain. In the steady state, 'inactive' TLR9 homodimers formed in an inactivated conformation. Binding of DNA containing CpG, but not of DNA lacking CpG, to TLR9 dimers resulted in allosteric changes in the TLR9 cytoplasmic signaling domains. In endosomes, conformational changes induced by DNA containing CpG resulted in close apposition of the cytoplasmic signaling domains, a change that is probably required for the recruitment of signaling adaptor molecules. Our results indicate that the formation of TLR9 dimers is not sufficient for its activation but instead that TLR9 activation is regulated by conformational changes induced by DNA containing CpG.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Phys, N-7489 Trondheim, Norway; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; Queens Univ Belfast, Sch Biomed Sci, Ctr Canc Res & Cell Biol, Belfast BT7 9BL, Antrim, North Ireland; Eisai Res Inst, Andover, MA 01810 USA	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Boston University; Queens University Belfast; Eisai Co Ltd	Latz, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	eicke.latz@umassmed.edu; douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015; Verma, Anjali/HHN-5385-2022; Latz, Eicke/H-3951-2014	Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666; Sirois, Cherilyn M./0000-0002-5472-4288; McKnight, Christopher/0000-0002-3237-0896; Duprex, W Paul/0000-0003-1716-6376	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI065483] Funding Source: Medline; NIGMS NIH HHS [R01GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal S, 2002, TRENDS MOL MED, V8, P114, DOI 10.1016/S1471-4914(01)02264-X; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ashman RF, 2005, INT IMMUNOL, V17, P411, DOI 10.1093/intimm/dxh222; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gorden KKB, 2006, J IMMUNOL, V177, P8164, DOI 10.4049/jimmunol.177.11.8164; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jeong J, 2006, BIOCHEM BIOPH RES CO, V339, P647, DOI 10.1016/j.bbrc.2005.11.056; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; TAYLOR IA, 1994, EMBO J, V13, P5772, DOI 10.1002/j.1460-2075.1994.tb06915.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Winkler F. K., 1992, CURR OPIN STRUC BIOL, V2, P93; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210	46	345	356	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					772	779		10.1038/ni1479	http://dx.doi.org/10.1038/ni1479			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17572678				2022-12-18	WOS:000247718100018
J	Butler, NS; Moebius, J; Pewe, LL; Traore, B; Doumbo, OK; Tygrett, LT; Waldschmidt, TJ; Crompton, PD; Harty, JT				Butler, Noah S.; Moebius, Jacqueline; Pewe, Lecia L.; Traore, Boubacar; Doumbo, Ogobara K.; Tygrett, Lorraine T.; Waldschmidt, Thomas J.; Crompton, Peter D.; Harty, John T.			Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection	NATURE IMMUNOLOGY			English	Article							CD4 T-CELLS; FALCIPARUM-MALARIA; IMMUNE-RESPONSES; B-CELLS; PERSISTENCE; VACCINATION; EXHAUSTION; EXPRESSION; EXPOSURE; PATHWAY	Infection of erythrocytes with Plasmodium species induces clinical malaria. Parasite-specific CD4(+) T cells correlate with lower parasite burdens and severity of human malaria and are needed to control blood-stage infection in mice. However, the characteristics of CD4(+) T cells that determine protection or parasite persistence remain unknown. Here we show that infection of humans with Plasmodium falciparum resulted in higher expression of the inhibitory receptor PD-1 associated with T cell dysfunction. In vivo blockade of the PD-1 ligand PD-L1 and the inhibitory receptor LAG-3 restored CD4(+) T cell function, amplified the number of follicular helper T cells and germinal-center B cells and plasmablasts, enhanced protective antibodies and rapidly cleared blood-stage malaria in mice. Thus, chronic malaria drives specific T cell dysfunction, and proper function can be restored by inhibitory therapies to enhance parasite control.	[Moebius, Jacqueline; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Butler, Noah S.; Pewe, Lecia L.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Traore, Boubacar; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Tygrett, Lorraine T.; Waldschmidt, Thomas J.; Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Waldschmidt, Thomas J.; Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa; University of Bamako; University of Iowa; University of Iowa	Crompton, PD (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	pcrompton@niaid.nih.gov; john-harty@uiowa.edu	Crompton, Peter/N-1130-2016	Harty, John/0000-0001-7266-2802; Butler, Noah/0000-0002-1429-0796; Waldschmidt, Thomas/0000-0001-6147-6991	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases; US National Institutes of Health [AI085515, AI42767]; Department of Microbiology, University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155, R37AI042767, R01AI085515, R01AI042767, R21AI042767] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology, University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the residents of Kambila, Mali, for their participation; F. Lund (University of Rochester) for C57BL/6 Aicda<SUP>-/-</SUP> mice lacking the immunoglobulin heavy-chain mu-chain secretory domain; D. A. A. Vignali (St. Jude Children's Research Hospital) for hybridoma clone C9B7W; and S. Perlman, N. Schmidt and V. Badovinac for comments. Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, the US National Institutes of Health (for work in Mali; and AI085515 and AI42767 for work in the J.T.H. laboratory) and the Department of Microbiology, University of Iowa (for work in the J.T.H. laboratory).	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; AMANTE FH, 2001, CURR PROTOC IMMUNOL, V29; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chandele A, 2011, IMMUNOLOGY, V132, P273, DOI 10.1111/j.1365-2567.2010.03363.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Elliott SR, 2005, INFECT IMMUN, V73, P2478, DOI 10.1128/IAI.73.4.2478-2485.2005; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Kline J, 2010, CURR OPIN INVEST DR, V11, P1354; KRAJDEN S, 1991, T ROY SOC TROP MED H, V85, P731, DOI 10.1016/0035-9203(91)90434-Z; KUMAR S, 1990, IMMUNOL LETT, V25, P109, DOI 10.1016/0165-2478(90)90100-5; LANGHORNE J, 1989, PARASITOL TODAY, V5, P362, DOI 10.1016/0169-4758(89)90113-0; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; REVEL MP, 1988, T ROY SOC TROP MED H, V82, P832, DOI 10.1016/0035-9203(88)90008-9; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Theunissen C, 2009, EMERG INFECT DIS, V15, P115, DOI 10.3201/eid1501.080909; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; VINETZ JM, 1990, J IMMUNOL, V144, P1069; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; Wipasa J, 2009, INFECT IMMUN, V77, P817, DOI 10.1128/IAI.01063-08; World Health Organization, 2010, WORLD MAL REP 2010; Wykes M, 2007, INT J PARASITOL, V37, P705, DOI 10.1016/j.ijpara.2007.02.007; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	50	344	371	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					188	195		10.1038/ni.2180	http://dx.doi.org/10.1038/ni.2180			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22157630	Green Accepted			2022-12-18	WOS:000299315000016
J	Li, J; Barreda, DR; Zhang, YA; Boshra, H; Gelman, AE; LaPatra, S; Tort, L; Sunyer, JO				Li, Jun; Barreda, Daniel R.; Zhang, Yong-An; Boshra, Hani; Gelman, Andrew E.; LaPatra, Scott; Tort, Lluis; Sunyer, J. Oriol			B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities	NATURE IMMUNOLOGY			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; MONOCLONAL-ANTIBODIES; 1ST IDENTIFICATION; CELLS; MACROPHAGES; EXPRESSION; RECEPTOR; PHYLOGENY; LINEAGES	The present paradigm dictates that phagocytosis is accomplished mainly by 'professional' phagocytes ( such as macrophages and monocytes), whereas B cells lack phagocytic capabilities. Here we demonstrate that B cells from teleost fish have potent in vitro and in vivo phagocytic activities. Particle uptake by B cells induced activation of 'downstream' degradative pathways, leading to 'phagolysosome' formation and intracellular killing of ingested microbes. Those results indicate a previously unknown function for B cells in the innate immunity of these primitive animals. A considerable proportion of Xenopus laevis B cells were also phagocytic. Our findings support the idea that B cells evolved from an ancestral phagocytic cell type and provide an evolutionary framework for understanding the close relationship between mammalian B lymphocytes and macrophages.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Washington Univ, Sch Med, Dept Cardiothorac Surg, St Louis, MO 63110 USA; Clear Springs Foods, Div Res, Buhl, ID 83316 USA; Univ Autonoma Barcelona, Unit Anim Physiol, Dept Cell Biol Physiol & Immunol, Bellaterra 08193, Spain	University of Pennsylvania; University of Pennsylvania; Washington University (WUSTL); Autonomous University of Barcelona	Sunyer, JO (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	sunyer@vet.upenn.edu	Barreda, Daniel/A-2613-2014; Tort, Lluis/H-5650-2011; Boshra, Hani/M-2619-2014	Barreda, Daniel/0000-0003-4630-2840; Boshra, Hani/0000-0001-9924-8126; Li, Jun/0000-0002-5190-0733; Zhang, Yong-An/0000-0002-9956-3879; Tort, Lluis/0000-0002-3907-722X				Abrahao TB, 2003, IMMUNOBIOLOGY, V208, P401, DOI 10.1078/0171-2985-00287; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Afonso A, 1997, FISH SHELLFISH IMMUN, V7, P335, DOI 10.1006/fsim.1997.0089; ANDERSSON E, 1993, IMMUNOGENETICS, V38, P243, DOI 10.1007/BF00188800; Barreda DR, 2005, DEV COMP IMMUNOL, V29, P879, DOI 10.1016/j.dci.2005.02.006; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; Boshra H, 2005, J IMMUNOL, V175, P2427, DOI 10.4049/jimmunol.175.4.2427; Boshra H, 2004, J IMMUNOL, V172, P4381, DOI 10.4049/jimmunol.172.7.4381; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; DAVIDSON WF, 1992, ANN NY ACAD SCI, V651, P112; DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706; Desjardins M, 2005, IMMUNOL REV, V207, P158, DOI 10.1111/j.0105-2896.2005.00319.x; Endo Y, 1998, J IMMUNOL, V161, P4924; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Flajnik MF, 2000, CURR TOP MICROBIOL, V252, P233; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Honda T, 2005, MOL IMMUNOL, V42, P1, DOI 10.1016/j.molimm.2004.07.002; HSU E, 1984, MOL IMMUNOL, V21, P257, DOI 10.1016/0161-5890(84)90096-8; IWAMA G, 1997, FISH PHYSL SERIES, P63; Jansson E, 2003, FISH SHELLFISH IMMUN, V14, P239, DOI 10.1006/fsim.2002.0434; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Li J, 2004, DEV COMP IMMUNOL, V28, P1005, DOI 10.1016/j.dci.2004.03.004; MARTIN M, 1993, J IMMUNOL, V150, P4395; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; MILLER NW, 1987, DEV COMP IMMUNOL, V11, P739, DOI 10.1016/0145-305X(87)90061-9; MILLER NW, 1994, J IMMUNOL, V152, P2180; Miyadai T, 2004, FISH SHELLFISH IMMUN, V17, P211, DOI 10.1016/j.fsi.2004.03.005; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Mori M, 2000, J IMMUNOL, V164, P5704, DOI 10.4049/jimmunol.164.11.5704; Morisawa Y, 1998, J NEUROL SCI, V160, P175, DOI 10.1016/S0022-510X(98)00242-1; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; PIER GB, 2004, IMMUNOLOGY INFECT IM, pCH3; Plytycz B, 1999, IMMUNOL TODAY, V20, P53, DOI 10.1016/S0167-5699(98)01383-8; POLLIACK A, 1973, J EXP MED, V138, P607, DOI 10.1084/jem.138.3.607; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Rombout JHWM, 2005, FISH SHELLFISH IMMUN, V19, P441, DOI 10.1016/j.fsi.2005.03.007; Secombes C. J., 1992, Annual Review of Fish Diseases, V2, P53, DOI 10.1016/0959-8030(92)90056-4; Shen LL, 2004, DEV COMP IMMUNOL, V28, P139, DOI 10.1016/S0145-305X(03)00119-8; Solem ST, 2006, DEV COMP IMMUNOL, V30, P57, DOI 10.1016/j.dci.2005.06.007; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TANAKA T, 1994, EUR J IMMUNOL, V24, P1544, DOI 10.1002/eji.1830240713; Vidard L, 1996, J IMMUNOL, V156, P2809; VOSBECK K, 1984, ANTIMICROB AGENTS CH, V25, P735, DOI 10.1128/AAC.25.6.735; Wines BD, 2004, J BIOL CHEM, V279, P26339, DOI 10.1074/jbc.M403684200; Worth RG, 2001, BLOOD, V98, P3429, DOI 10.1182/blood.V98.12.3429; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zapata A, 2000, CURR TOP MICROBIOL, V248, P67	53	344	356	4	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1116	1124		10.1038/ni1389	http://dx.doi.org/10.1038/ni1389			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16980980				2022-12-18	WOS:000241437100022
J	Jackson, SH; Devadas, S; Kwon, J; Pinto, LA; Williams, MS				Jackson, SH; Devadas, S; Kwon, J; Pinto, LA; Williams, MS			T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation	NATURE IMMUNOLOGY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; DINUCLEOTIDE PHOSPHATE-OXIDASE; OXYGEN-SPECIES GENERATION; FAS LIGAND EXPRESSION; SMOOTH-MUSCLE-CELLS; REACTIVE-OXYGEN; ANGIOTENSIN-II; HYDROGEN-PEROXIDE; KINASE ACTIVATION; NAD(P)H OXIDASE	T cell receptor (TCR) stimulation induces rapid generation of reactive oxygen species, although the mechanisms for this are unclear. Here we found that T cells expressed a functional phagocyte-type nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. TCR crosslinking induced oxidase activation through the recruitment of preformed Fas ligand and Fas. TCR stimulation induced three separable events generating reactive oxygen species: rapid hydrogen peroxide production independent of Fas or NADPH oxidase; sustained hydrogen peroxide production dependent on both Fas and NADPH oxidase; and delayed superoxide production that was dependent on Fas ligand and Fas yet independent of NADPH oxidase. NADPH oxidase-deficient T cells showed enhanced activation of the kinase Erk and a relative increase in T helper type 1 cytokine secretion. Thus, mature T cells express a phagocyte-type NADPH oxidase that regulates elements of TCR signaling.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Amer Red Cross, Dept Immunol, Rockville, MD 20855 USA; Sci Applicat Int Corp, Natl Canc Inst, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); American Red Cross; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Williams, MS (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	willmark@usa.redcross.org		Kwon, Jaeyul/0000-0002-2452-4111	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000792, ZIAAI000792] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Condino-Neto A, 1998, ARCH BIOCHEM BIOPHYS, V360, P158, DOI 10.1006/abbi.1998.0958; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; EMMENDORFFER A, 1994, CYTOMETRY, V18, P147, DOI 10.1002/cyto.990180306; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Hasebe T, 1999, FEBS LETT, V455, P257, DOI 10.1016/S0014-5793(99)00905-9; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jayanthi S, 1999, MOL BRAIN RES, V72, P158, DOI 10.1016/S0169-328X(99)00216-8; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P543, DOI 10.1042/bj3070543; Kwon J, 2003, FREE RADICAL BIO MED, V35, P406, DOI 10.1016/S0891-5849(03)00318-6; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Leavey PJ, 2002, J BIOL CHEM, V277, P45181, DOI 10.1074/jbc.M202869200; Lee JR, 1998, EUR J IMMUNOL, V28, P4188, DOI 10.1002/(SICI)1521-4141(199812)28:12<4188::AID-IMMU4188>3.0.CO;2-B; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; MALY FE, 1989, J IMMUNOL, V142, P1260; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; MartinezLorenzo MJ, 1996, IMMUNOLOGY, V89, P511, DOI 10.1046/j.1365-2567.1996.d01-782.x; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segal BH, 1999, INFECT IMMUN, V67, P1659; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Tsunawaki S, 2000, J BIOCHEM-TOKYO, V128, P777, DOI 10.1093/oxfordjournals.jbchem.a022815; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; van Reyk DM, 2001, FREE RADICAL BIO MED, V30, P82, DOI 10.1016/S0891-5849(00)00449-4; WILIAMS MS, 2004, FREE RADIC BIOL 0620; Williams MS, 1996, J IMMUNOL, V157, P2395; Yamauchi A, 2001, MICROBIOL IMMUNOL, V45, P249, DOI 10.1111/j.1348-0421.2001.tb02614.x; Yang SX, 2002, J IMMUNOL, V168, P5840, DOI 10.4049/jimmunol.168.11.5840; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017	52	344	348	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					818	827		10.1038/ni1096	http://dx.doi.org/10.1038/ni1096			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15258578				2022-12-18	WOS:000222955600013
J	Blander, JM; Longman, RS; Iliev, ID; Sonnenberg, GF; Artis, D				Blander, J. Magarian; Longman, Randy S.; Iliev, Iliyan D.; Sonnenberg, Gregory F.; Artis, David			Regulation of inflammation by microbiota interactions with the host	NATURE IMMUNOLOGY			English	Review							ARYL-HYDROCARBON RECEPTOR; CHAIN FATTY-ACIDS; T-CELL RESPONSES; INNATE LYMPHOID-CELLS; HUMAN GUT MICROBIOTA; COMMENSAL BACTERIA; INTESTINAL MICROBIOTA; BOWEL-DISEASE; CROHNS-DISEASE; IMMUNE HOMEOSTASIS	The study of the intestinal microbiota has begun to shift from cataloging individual members of the commensal community to understanding their contributions to the physiology of the host organism in health and disease. Here, we review the effects of the microbiome on innate and adaptive immunological players from epithelial cells and antigen-presenting cells to innate lymphoid cells and regulatory T cells. We discuss recent studies that have identified diverse microbiota-derived bioactive molecules and their effects on inflammation within the intestine and distally at sites as anatomically remote as the brain. Finally, we highlight new insights into how the microbiome influences the host response to infection, vaccination and cancer, as well as susceptibility to autoimmune and neurodegenerative disorders.	[Blander, J. Magarian; Longman, Randy S.; Iliev, Iliyan D.; Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian; Longman, Randy S.; Iliev, Iliyan D.; Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian; Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Sandra & Edward Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Blander, JM (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Sandra & Edward Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA.	jmblander@med.cornell.edu		Blander, Julie Magarian/0000-0001-9207-1700; Artis, David/0000-0002-1753-4100	NIH [DK072201, DK111862, AI073899, AI123284, AI127658, DK099381, DK098310, AI123819, DP5OD012116, AI123368, DK110262, AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI097333]; Searle Scholars Program; Burroughs Wellcome Fund; American Cancer Society; Leukemia & Lymphoma Society; Crohn's and Colitis Foundation Senior Research Award [346814]; Charina Foundation; Crohn's and Colitis Foundation; American Asthma Foundation Scholar Award; Crohn's & Colitis Foundation of America [AI095608, AI102942, AI097333]; NATIONAL CANCER INSTITUTE [R21CA201829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087990, R01AI102942, R01AI061570, R56AI073899, R01AI123368, U01AI095608, R01AI073899, R01AI095245, R01AI095466, R01AI123284, R01AI097333, R21AI083480, R01AI074878, R21AI123819, R01AI127658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201, R21DK110262, K08DK099381, K99DK098310, R00DK098310, R01DK111862] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation Senior Research Award; Charina Foundation; Crohn's and Colitis Foundation; American Asthma Foundation Scholar Award; Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank all their past and present laboratory members for their contributions. We thank our funding agencies for their support to our laboratories: NIH grants DK072201, DK111862, AI073899, AI123284 and AI127658, the Searle Scholars Program, the Burroughs Wellcome Fund, the American Cancer Society and the Leukemia & Lymphoma Society to J.M.B.; NIH grant DK099381, the Crohn's and Colitis Foundation Senior Research Award 346814 and the Charina Foundation to R.S.L.; NIH grants DK098310 and AI123819, and Kenneth Rainin Foundation Innovator and Breakthrough awards to I.D.I.; NIH grants DP5OD012116, AI123368 and DK110262, and the Crohn's and Colitis Foundation, the Searle Scholars Program and the American Asthma Foundation Scholar Award to G.F.S.; NIH grants AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942 and AI097333, Burroughs Wellcome Fund and the Crohn's & Colitis Foundation of America to D.A. AI095608, AI102942 and AI097333, Burroughs Wellcome Fund and the Crohn's & Colitis Foundation of America to D.A.	[Anonymous], 2017, BRAIN BEHAV IMMUN; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Asquith MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2151, DOI 10.1002/art.39681; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bach J. F., 2012, PERSPECT MED, V2; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Blander JM, 2016, FEBS J, V283, P2720, DOI 10.1111/febs.13771; Blander JM, 2012, IMMUNOL RES, V54, P50, DOI 10.1007/s12026-012-8311-9; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Calderon-Gomez E, 2016, GASTROENTEROLOGY, V151, P489, DOI 10.1053/j.gastro.2016.05.050; Campisi L, 2016, NAT IMMUNOL, V17, P1084, DOI 10.1038/ni.3512; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Ciccia F, 2017, ANN RHEUM DIS, V76, P1123, DOI 10.1136/annrheumdis-2016-210000; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Escalante NK, 2016, J EXP MED, V213, P2841, DOI 10.1084/jem.20161776; Fan D, 2015, NAT MED, V21, P808, DOI 10.1038/nm.3871; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hoarau G, 2016, MBIO, V7, DOI [10.1128/mBio.01250-16, 10.1128/mbio.01250-16]; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iliev I. D., 2017, NAT REV IMMUNOL; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kim D, 2016, NAT MED, V22, P524, DOI 10.1038/nm.4075; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kunisawa J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00065; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Levin BJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai8386; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Liguori G, 2016, J CROHNS COLITIS, V10, P296, DOI 10.1093/ecco-jcc/jjv209; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Longman RS, 2015, CURR OPIN RHEUMATOL, V27, P381, DOI 10.1097/BOR.0000000000000190; Manoury B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00299; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pitt JM, 2016, CANCER RES, V76, P4602, DOI 10.1158/0008-5472.CAN-16-0448; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Rangan KJ, 2016, SCIENCE, V353, P1434, DOI 10.1126/science.aaf3552; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13; Ruane D, 2016, J EXP MED, V213, P53, DOI 10.1084/jem.20150567; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schloss PD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-25; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smith PA, 2015, NATURE, V526, P312, DOI 10.1038/526312a; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Suhr MJ, 2016, LETT APPL MICROBIOL, V62, P209, DOI 10.1111/lam.12539; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thaiss CA, 2015, GUT MICROBES, V6, P137, DOI 10.1080/19490976.2015.1016690; Valdezi Y, 2014, TRENDS IMMUNOL, V35, P526, DOI 10.1016/j.it.2014.07.003; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Wu GD, 2016, GUT, V65, P63, DOI 10.1136/gutjnl-2014-308209; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	133	343	355	6	235	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					851	860		10.1038/ni.3780	http://dx.doi.org/10.1038/ni.3780			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722709	Green Accepted			2022-12-18	WOS:000405821100005
J	Wen, HT; Ting, JPY; O'Neill, LAJ				Wen, Haitao; Ting, Jenny P-Y; O'Neill, Luke A. J.			A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?	NATURE IMMUNOLOGY			English	Review							HYPOXIA-INDUCIBLE FACTOR-1; GENOME-WIDE ASSOCIATION; ISLET AMYLOID POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; APOE-DEFICIENT MICE; INSULIN-RESISTANCE; NALP3 INFLAMMASOME; T-CELLS; ACTIVATED MACROPHAGES; SYSTEMIC INFLAMMATION	The inflammasome is a protein complex that comprises an intracellular sensor (typically a Nod-like receptor), the precursor procaspase-1 and the adaptor ASC. Inflammasome activation leads to the maturation of caspase-1 and the processing of its substrates, interleukin 1 beta (IL-1 beta) and IL-18. Although initially the inflammasome was described as a complex that affects infection and inflammation, subsequent evidence has suggested that inflammasome activation influences many metabolic disorders, including atherosclerosis, type 2 diabetes, gout and obesity. Another feature of inflammation in general and the inflammasome specifically is that the activation process has a profound effect on aerobic glycolysis (the 'Warburg effect'). Here we explore how the Warburg effect might be linked to inflammation and inflammasome activation.	[Wen, Haitao; Ting, Jenny P-Y] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Wen, Haitao; Ting, Jenny P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ting, Jenny P-Y] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Inst Inflammatory Dis, Chapel Hill, NC USA; [O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trin Biomed Sci Inst, Dublin, Ireland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Trinity College Dublin	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu; laoneill@tcd.ie	Wen, Haitao/AAJ-7621-2020	O'Neill, Luke/0000-0002-4333-2748	US National Institutes of Health [R37-AI029564-17, CA-156330-01]; Cancer Research Institute; Science Foundation Ireland; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (R37-AI029564-17 and CA-156330-01 to J.P.-Y.T.), the Cancer Research Institute (H.W.) and Science Foundation Ireland (L.A.J.O.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Emanuelli B, 2004, DIABETES, V53, pS97, DOI 10.2337/diabetes.53.suppl_3.S97; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Gonzalez-Gay MA, 2010, ANN NY ACAD SCI, V1193, P153, DOI 10.1111/j.1749-6632.2009.05287.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schlesinger N, 2011, ANN RHEUM DIS, V70, P1264, DOI 10.1136/ard.2010.144063; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; So A, 2010, ARTHRITIS RHEUM-US, V62, P3064, DOI 10.1002/art.27600; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	88	341	375	5	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					352	357		10.1038/ni.2228	http://dx.doi.org/10.1038/ni.2228			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430788	Green Submitted, Green Accepted			2022-12-18	WOS:000301886800009
J	Mellor, AL; Sivakumar, J; Chandler, P; Smith, K; Molina, H; Mao, DL; Munn, DH				Mellor, AL; Sivakumar, J; Chandler, P; Smith, K; Molina, H; Mao, DL; Munn, DH			Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy	NATURE IMMUNOLOGY			English	Article							TOLERANCE	Indoleamine 2,3 dioxygenase (IDO) activity during pregnancy protects developing fetuses from maternal immune responses in CBA mice. We show here that fetal allografts were rejected only in mating combinations where paternally, inherited tissue antigens elicited potent maternal T cell responses after exposure to IDO inhibitor. IDO inhibitor treatment triggered extensive inflammation at the maternal-fetal interface in susceptible mating combinations, which was characterized by complement deposition and hemorrhagic necrosis. Identical inflammatory responses occurred in B cell-deficient (RAG-1(-/-)) mothers that carried a monoclonal cohort of CD8(+)T cells specific for a single paternally inherited fetal major histocompatibility complex antigen. Thus, fetal allograft rejection was accompanied by a unique form of inflammation that was characterized by T cell-dependent, antibody-independent activation of complement. In contrast, no inflammation, complement deposition or T cell infiltration was elicited when mice carrying syngeneic fetuses were exposed to IDO inhibitor. These data show that IDO activity protects the fetus by suppressing T cell-driven local inflammatory responses to fetal alloantigens.	Med Coll Georgia, Dept Med, Inst Mol Med & Genet, Program Mol Immunol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Vet Adm Ctr, St Louis, MO 63106 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Washington University (WUSTL); Washington University (WUSTL)	Mellor, AL (corresponding author), Med Coll Georgia, Dept Med, Inst Mol Med & Genet, Program Mol Immunol, 1120 15th St, Augusta, GA 30912 USA.			Munn, David/0000-0002-7711-2858	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040576, R01AI044219, R01AI044912] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60137] Funding Source: Medline; NIAID NIH HHS [AI44219, AI40576, AI44912] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; BRENT L, 1997, HIST TRANSPLANTATION, P403; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Hagmann M, 2000, SCIENCE, V287, P408, DOI 10.1126/science.287.5452.408; Jiang SP, 1998, J IMMUNOL, V160, P3086; KLEIN J, 1975, BIOL MOUSE HISTOCOMP, V2; Lambert NC, 2000, J IMMUNOL, V164, P5545, DOI 10.4049/jimmunol.164.11.5545; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; YEOMAN H, 1992, INT IMMUNOL, V4, P59, DOI 10.1093/intimm/4.1.59; Zhou M, 1998, J REPROD IMMUNOL, V40, P47, DOI 10.1016/S0165-0378(98)00030-8	16	341	370	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					64	68		10.1038/83183	http://dx.doi.org/10.1038/83183			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135580				2022-12-18	WOS:000166261500016
J	Coyle, AJ; Gutierrez-Ramos, JC				Coyle, AJ; Gutierrez-Ramos, JC			The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function	NATURE IMMUNOLOGY			English	Review							FOLLICULAR DENDRITIC CELL; CXC CHEMOKINE RECEPTOR-5; CUTTING EDGE; SOLUBLE FORM; CTLA-4; EXPRESSION; ANTIGEN; ACTIVATION; MOLECULE; CD28	Upon encounter with specific antigen, naive T helper precursor (THP) cells become activated,This event is regulated not only by engagement of the T cell receptor (TCR) with peptide presented in the context of major histocompatibility complex (MHC) class II molecules but by a number of costimulatory signals, CD28 engagement by B7-1 and B7-2 on resting THP cells provides a critical signal for initial cell cycle progression, interleukin 2 production and clonal expansion. However, largely as a consequence of the unraveling of the human genome, it is becoming clear that B7-1 and B7-2 are part of a larger family of related counter-receptors that play an essential role in regulating the fate of primed, rather then vesting,THP cells,These molecules play an important sequential role and act, together with B7-1- and B7-2-primed T cells, in the acquisition of effector function and/or tolerance induction.	Millennium PHarmaceut Inc, Inflammat Div, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Coyle, AJ (corresponding author), Millennium PHarmaceut Inc, Inflammat Div, 45-75 Sidney St, Cambridge, MA 02139 USA.							Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; CORRY DB, 1994, J IMMUNOL, V153, P4142; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong HD, 1999, NAT MED, V5, P1365; FREEDMAN AS, 1987, J IMMUNOL, V139, P3260; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gause WC, 1996, EXP PARASITOL, V84, P264, DOI 10.1006/expr.1996.0112; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Gonzalo JA, 2001, J IMMUNOL, V166, P1; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Henry J, 1999, IMMUNOL TODAY, V20, P285, DOI 10.1016/S0167-5699(98)01418-2; Hur DY, 2000, IMMUNOL LETT, V72, P107, DOI 10.1016/S0165-2478(00)00166-8; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; ISHIKAWA Y, 1996, COMPUTATIONAL CHEM R, V1, P1; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; Khattri R, 1999, J IMMUNOL, V162, P5784; KINGSBURY G, 2001, IN PRESS J EXP MED; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kozono Y, 1998, J IMMUNOL, V160, P1565; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; Mathur M, 1999, AM J RESP CELL MOL, V21, P498, DOI 10.1165/ajrcmb.21.4.3714; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; NISHIMUR AH, 1998, INT IMMUNOL; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tada Y, 1999, J IMMUNOL, V162, P203; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tang AM, 1996, J IMMUNOL, V157, P117; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; YOKOCHI T, 1982, J IMMUNOL, V128, P823; Yoshinaga SK, 2000, INT IMMUNOL, V12, P1439, DOI 10.1093/intimm/12.10.1439; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	72	339	437	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					203	209		10.1038/85251	http://dx.doi.org/10.1038/85251			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224518				2022-12-18	WOS:000167413800011
J	Roediger, B; Kyle, R; Yip, KH; Sumaria, N; Guy, TV; Kim, BS; Mitchell, AJ; Tay, SS; Jain, R; Forbes-Blom, E; Chen, X; Tong, PL; Bolton, HA; Artis, D; Paul, WE; Fazekas de St Groth, B; Grimbaldeston, MA; Le Gros, G; Weninger, W				Roediger, Ben; Kyle, Ryan; Yip, Kwok Ho; Sumaria, Nital; Guy, Thomas V.; Kim, Brian S.; Mitchell, Andrew J.; Tay, Szun S.; Jain, Rohit; Forbes-Blom, Elizabeth; Chen, Xi; Tong, Philip L.; Bolton, Holly A.; Artis, David; Paul, William E.; Fazekas de St Groth, Barbara; Grimbaldeston, Michele A.; Le Gros, Graham; Weninger, Wolfgang			Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA3; EXPRESSION; LUNG; RECEPTOR; IL-13; MICE; GENE; INTERLEUKIN-13; KERATINOCYTES	Type 2 immunity is critical for defense against cutaneous infections but also underlies the development of allergic skin diseases. We report the identification in normal mouse dermis of an abundant, phenotypically unique group 2 innate lymphoid cell (ILC2) subset that depended on interleukin 7 (IL-7) and constitutively produced IL-13. Intravital multiphoton microscopy showed that dermal ILC2 cells specifically interacted with mast cells, whose function was suppressed by IL-13. Treatment of mice deficient in recombination-activating gene 1 (Rag1(-/-)) with IL-2 resulted in the population expansion of activated, IL-5-producing dermal ILC2 cells, which led to spontaneous dermatitis characterized by eosinophil infiltrates and activated mast cells. Our data show that ILC2 cells have both pro-and anti-inflammatory properties and identify a previously unknown interactive pathway between two innate populations of cells of the immune system linked to type 2 immunity and allergic diseases.	[Roediger, Ben; Sumaria, Nital; Guy, Thomas V.; Mitchell, Andrew J.; Tay, Szun S.; Jain, Rohit; Tong, Philip L.; Bolton, Holly A.; Fazekas de St Groth, Barbara; Weninger, Wolfgang] Centenary Inst, Newtown, Tas, Australia; [Kyle, Ryan; Forbes-Blom, Elizabeth; Le Gros, Graham] Malaghan Inst Med Res, Wellington, New Zealand; [Yip, Kwok Ho; Grimbaldeston, Michele A.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Kim, Brian S.; Artis, David] Perelman Sch Med Philadelphia, Dept Microbiol, Philadelphia, PA USA; [Kim, Brian S.; Artis, David] Perelman Sch Med Philadelphia, Inst Immunol, Philadelphia, PA USA; [Kim, Brian S.] Perelman Sch Med Philadelphia, Dept Dermatol, Philadelphia, PA USA; [Chen, Xi; Paul, William E.] Natl Inst Allerg Dis, NIH, Bethesda, MD USA; [Tong, Philip L.; Fazekas de St Groth, Barbara; Weninger, Wolfgang] Univ Sydney, Discipline Dermatol, Camperdown, NSW, Australia; [Tong, Philip L.; Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW 2050, Australia; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Sydney; Centenary Institute; Malaghan Institute; Victoria University Wellington; Centre for Cancer Biology; SA Pathology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney; University of Sydney; University of Pennsylvania	Weninger, W (corresponding author), Centenary Inst, Newtown, Tas, Australia.	glegros@malaghan.org.nz; w.weninger@centenary.org.au	Mitchell, Andrew/C-2714-2009; de St Groth, Barbara Fazekas/O-3017-2017; Kim, Brian/GZK-6649-2022; Le Gros, Graham/C-6725-2011; Jain, Rohit/O-2015-2019; Forbes-Blom, Elizabeth/I-3648-2013	Mitchell, Andrew/0000-0003-4454-853X; de St Groth, Barbara Fazekas/0000-0001-6817-9690; Kim, Brian/0000-0002-8100-7161; Jain, Rohit/0000-0002-4905-462X; Le Gros, Graham/0000-0002-5721-0442; Tay, Szun S/0000-0003-0186-8154; Artis, David/0000-0002-1753-4100; Kyle, Ryan/0000-0002-8146-7504; Weninger, Wolfgang/0000-0003-3133-8699; Roediger, Ben/0000-0002-4593-091X; Yip, Kwok Ho/0000-0002-8453-0118; Bolton, Holly/0000-0003-4628-7708	Australian National Health; Medical Research Council; Health Research Council of New Zealand; Marjorie Barclay Trust; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); Cancer Institute New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, ZIAAI000926, R01AI102942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217] Funding Source: NIH RePORTER	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Council of New Zealand(Health Research Council of New Zealand); Marjorie Barclay Trust; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health); Cancer Institute New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Ho Cho and J. Sprent (Garvan Institute) for mice deficient in IL-7, IL-15 or Jak3; M. Kleinschek (DNAX) for Il25<SUP>-/-</SUP> mice; P. Besmer (Sloan Kettering Institute) for c-Kit-eGFP mice; Z. Eshar (Weizmann Institute of Science) for mouse SPE-7 hybridoma cells that produce IgE monoclonal antibody specific for 2,4-dinitrophenyl; A. Smith, S. Allen, S. Dervish, C. Zhu, A. Terry, Y. Wen Loh, K. Price and M. Camberis for technical assistance; M. Rizk and J. Qin for animal husbandry; L. Feigenbaum for help in preparing mice with transgenic expression of a bacterial artificial chromosome; N. Kolesnikoff and H. Taing for help with culturing bone marrow-derived mast cells; and L. Cavanagh for administrative assistance. Supported by the Australian National Health and Medical Research Council (M.A.G.), the Health Research Council of New Zealand, the Marjorie Barclay Trust, the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (US National Institutes of Health) and the Cancer Institute New South Wales (W.W.).	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Berrozpe G, 2006, MOL CELL BIOL, V26, P5850, DOI 10.1128/MCB.01854-05; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cohn L, 1999, J IMMUNOL, V162, P6178; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Herbst T, 2012, P NATL ACAD SCI USA, V109, P14954, DOI 10.1073/pnas.1117584109; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mitchell AJ, 2010, J LEUKOCYTE BIOL, V88, P597, DOI 10.1189/jlb.0310184; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; Roediger B, 2008, HISTOCHEM CELL BIOL, V130, P1131, DOI 10.1007/s00418-008-0531-7; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295	50	338	352	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					564	+		10.1038/ni.2584	http://dx.doi.org/10.1038/ni.2584			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23603794	Green Accepted			2022-12-18	WOS:000319107600009
J	Ramiro, AR; Stavropoulos, P; Jankovic, M; Nussenzweig, MC				Ramiro, AR; Stavropoulos, P; Jankovic, M; Nussenzweig, MC			Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand	NATURE IMMUNOLOGY			English	Article							CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; CIRCULAR DNA; B-CELLS; POLYMERASE-ETA; MUTATION; PROMOTER; IG; RECRUITMENT	Somatic hypermutation and class switch recombination are DNA modification reactions that alter the genes encoding antibodies in B lymphocytes. Both of these distinct reactions require activation-induced deaminase (AID) and transcription. Here we show that in Escherichia coli, as in eukaryotic cells, the mutation frequency is directly proportional to the transcription of target genes. Transcription enhances mutation of the nontemplate DNA strand, which is exposed as single-stranded DNA during the elongation reaction, but not mutation of the template DNA strand, which is protected by E. coli RNA polymerase. Our results establish a direct link between AID and transcription and suggest that the role of transcription in facilitating mutation is to provide AID with access to single-stranded DNA.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ramiro, Almudena R/H-6037-2015	Ramiro, Almudena R/0000-0002-7539-3844				Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	58	338	345	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					452	456		10.1038/ni920	http://dx.doi.org/10.1038/ni920			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12692548				2022-12-18	WOS:000182665400012
J	Yan, N; Chen, ZJJ				Yan, Nan; Chen, Zhijian J.			Intrinsic antiviral immunity	NATURE IMMUNOLOGY			English	Review							DOUBLE-STRANDED-RNA; IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; RESTRICTION FACTOR SAMHD1; VIRION INFECTIVITY FACTOR; SMALL INTERFERING RNAS; INFLUENZA-A VIRUSES; GENE PROTECTS MICE; RIG-I PATHWAY; INNATE IMMUNITY	Intrinsic antiviral immunity refers to a form of innate immunity that directly restricts viral replication and assembly, thereby rendering a cell nonpermissive to a specific class or species of viruses. Intrinsic immunity is conferred by restriction factors that are mostly preexistent in certain cell types, although these factors can be further induced by viral infection. Intrinsic virus-restriction factors recognize specific viral components, but unlike other pattern-recognition receptors that inhibit viral infection indirectly by inducing interferons and other antiviral molecules, intrinsic antiviral factors block viral replication immediately and directly. This review focuses on recent advances in understanding of the roles of intrinsic antiviral factors that restrict infection by human immunodeficiency virus and influenza virus.	[Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yan, N (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu; zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI093967] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lehner T, 2008, VACCINE, V26, P2997, DOI 10.1016/j.vaccine.2007.11.060; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mehle A, 2010, VIRUSES-BASEL, V2, P566, DOI 10.3390/v2020566; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nicholl MJ, 2000, J GEN VIROL, V81, P2215, DOI 10.1099/0022-1317-81-9-2215; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Plaisance-Bonstaff K, 2011, METHODS MOL BIOL, V721, P43, DOI 10.1007/978-1-61779-037-9_3; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Salomon R, 2007, CELL CYCLE, V6, P2417, DOI 10.4161/cc.6.19.4779; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Towers G, 2002, J VIROL, V76, P2548, DOI 10.1128/JVI.76.5.2548-2550.2002; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	124	337	348	6	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					214	222		10.1038/ni.2229	http://dx.doi.org/10.1038/ni.2229			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344284	Green Accepted			2022-12-18	WOS:000300510600007
J	Doulatov, S; Notta, F; Eppert, K; Nguyen, LT; Ohashi, PS; Dick, JE				Doulatov, Sergei; Notta, Faiyaz; Eppert, Kolja; Nguyen, Linh T.; Ohashi, Pamela S.; Dick, John E.			Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development	NATURE IMMUNOLOGY			English	Article							HUMAN CORD BLOOD; MULTIPOTENT HEMATOPOIETIC PROGENITORS; BONE-MARROW; LINEAGE COMMITMENT; STEM-CELLS; T-CELLS; B-CELLS; MYELOID PROGENITOR; THYMIC PROGENITORS; IDENTIFICATION	The classical model of hematopoiesis posits the segregation of lymphoid and myeloid lineages as the earliest fate decision. The validity of this model in the mouse has been questioned; however, little is known about the lineage potential of human progenitors. Here we provide a comprehensive analysis of the human hematopoietic hierarchy by clonally mapping the developmental potential of seven progenitor classes from neonatal cord blood and adult bone marrow. Human multilymphoid progenitors, identified as a distinct population of Thy-1(neg-lo)CD45RA(+) cells in the CD34(+)CD38(-) stem cell compartment, gave rise to all lymphoid cell types, as well as monocytes, macrophages and dendritic cells, which indicated that these myeloid lineages arise in early lymphoid lineage specification. Thus, as in the mouse, human hematopoiesis does not follow a rigid model of myeloid-lymphoid segregation.	[Doulatov, Sergei; Notta, Faiyaz; Eppert, Kolja; Dick, John E.] Ontario Canc Inst, Campbell Family Canc Res Inst, Dept Stem Cell & Dev Biol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Doulatov, Sergei; Notta, Faiyaz; Eppert, Kolja; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Nguyen, Linh T.; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Canc Res Inst, Dept Med Biophys, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Nguyen, Linh T.; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Canc Res Inst, Dept Immunol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dick, JE (corresponding author), Ontario Canc Inst, Campbell Family Canc Res Inst, Dept Stem Cell & Dev Biol, Univ Hlth Network, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	jdick@uhnres.utoronto.ca		Ohashi, Pamela S./0000-0003-2915-9317; Eppert, Kolja/0000-0001-9061-8856; Dick, John/0000-0002-9527-8317	Canadian Institutes for Health Research; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society; Canada Research; Ontario Ministry of Health and Long Term Care	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canada Research; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We thank K. Moore and the obstetrics unit of Trillium Hospital for providing cord blood samples; P. A. Penttil, S. Zhao and L. Jamieson at the SickKids-UHN Flow Cytometry Facility for sorting; and N. Iscove for critical review of the manuscript. Supported by the Canadian Institutes for Health Research (F. N. and S. D.), the Stem Cell Network of Canadian National Centres of Excellence, the Canadian Cancer Society Research Institute, the Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, the Ontario Institute for Cancer Research, the province of Ontario, the Leukemia and Lymphoma Society, Canada Research and the Ontario Ministry of Health and Long Term Care. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arrighi JF, 1999, BLOOD, V93, P2244, DOI 10.1182/blood.V93.7.2244.407a29_2244_2252; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; LAMOTTEMOHS RN, 2004, BLOOD; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Saran N, 2010, BLOOD, V115, P1137, DOI 10.1182/blood-2009-07-230821; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Yoshikawa Y, 1999, HUM IMMUNOL, V60, P75, DOI 10.1016/S0198-8859(98)00094-9	49	337	345	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					585	U52		10.1038/ni.1889	http://dx.doi.org/10.1038/ni.1889			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20543838				2022-12-18	WOS:000278926400014
J	Uematsu, S; Jang, MH; Chevrier, N; Guo, ZJ; Kumagai, Y; Yamamoto, M; Kato, H; Sougawa, N; Matsui, H; Kuwata, H; Hemmi, H; Coban, C; Kawai, T; Ishii, KJ; Takeuchi, O; Miyasaka, M; Takeda, K; Akira, S				Uematsu, Satoshi; Jang, Myoung Ho; Chevrier, Nicolas; Guo, Zijin; Kumagai, Yutaro; Yamamoto, Masahiro; Kato, Hiroki; Sougawa, Nagako; Matsui, Hidenori; Kuwata, Hirotaka; Hemmi, Hiroaki; Coban, Cevayir; Kawai, Taro; Ishii, Ken J.; Takeuchi, Osamu; Miyasaka, Masayuki; Takeda, Kiyoshi; Akira, Shizuo			Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c(+) lamina propria cells	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; SALMONELLA-TYPHIMURIUM; IMMUNE-SYSTEM; CUTTING EDGE; FLAGELLIN; TOLERANCE; ANTIGEN; INNATE; GENE; TLR5	Toll-like receptors (TLRs) recognize distinct microbial components and induce innate immune responses. TLR5 is triggered by bacterial flagellin. Here we generated Tlr5(-/-) mice and assessed TLR5 function in vivo. Unlike other TLRs, TLR5 was not expressed on conventional dendritic cells or macrophages. In contrast, TLR5 was expressed mainly on intestinal CD11c(+) lamina propria cells (LPCs). CD11c(+) LPCs detected pathogenic bacteria and secreted proinflammatory cytokines in a TLR5-dependent way. However, CD11c+ LPCs do not express TLR4 and did not secrete proinflammatory cytokines after exposure to a commensal bacterium. Notably, transport of pathogenic Salmonella typhimurium from the intestinal tract to mesenteric lymph nodes was impaired in Tlr5(-/-) mice. These data suggest that CD11c(+) LPCs, via TLR5, detect and are used by pathogenic bacteria in the intestinal lumen.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med C8, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka 5650871, Japan; Kitasato Inst, Immunoregulat Lab, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; Kitasato Inst, Grad Sch Infect, Minato Ku, Tokyo 1088641, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 8128582, Japan; Osaka Univ, Combined Program Microbiol & Immunol, 21st Century COE, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, ERATO, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Kyushu University; Osaka University; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeda, Kiyoshi/C-9331-2009; Akira, Shizuo/C-3134-2009; COBAN, Cevayir/P-1928-2019; Kumagai, Yutaro/L-7732-2018; Jang, Myoung Ho/D-1714-2009; Coban, Cevayir/B-2129-2012; Kuwata, Hiro/N-2023-2019; Miyasaka, Masayuki/AAM-6343-2020; Takeuchi, Osamu/D-6007-2011; Ishii, Ken J/B-1685-2012	Takeuchi, Osamu/0000-0002-1260-6232; COBAN, Cevayir/0000-0002-4467-7799; Kumagai, Yutaro/0000-0002-5039-3979; Jang, Myoung Ho/0000-0001-8909-4725; Kuwata, Hiro/0000-0002-5023-1777; Ishii, Ken J/0000-0002-6728-3872; Kawai, Taro/0000-0001-7510-4662; Takeda, Kiyoshi/0000-0002-1778-6332				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; KUTSUKAKE K, 1988, MOL GEN GENET, V214, P11, DOI 10.1007/BF00340172; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; MAYRHOFER G, 1983, EUR J IMMUNOL, V13, P112, DOI 10.1002/eji.1830130206; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Niedergang F, 2004, TRENDS MICROBIOL, V12, P79, DOI 10.1016/j.tim.2003.12.011; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Patel JC, 2005, TRENDS PHARMACOL SCI, V26, P564, DOI 10.1016/j.tips.2005.09.005; PAVLI P, 1990, IMMUNOLOGY, V70, P40; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Salazar-Gonzalez RM, 2005, IMMUNOL LETT, V101, P117, DOI 10.1016/j.imlet.2005.05.004; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	28	337	358	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					868	874		10.1038/ni1362	http://dx.doi.org/10.1038/ni1362			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16829963				2022-12-18	WOS:000239147200023
J	Benedict, CA; Norris, PS; Ware, CF				Benedict, CA; Norris, PS; Ware, CF			To kill or be killed: viral evasion of apoptosis	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS TYPE-16; UBIQUITIN-PROTEIN LIGASE; SIMPLEX-VIRUS TYPE-1; FACTOR RECEPTOR; HUMAN CYTOMEGALOVIRUS; INHIBITS APOPTOSIS; DENDRITIC CELLS; BCL-2 FAMILY	In the struggle between virus and host, control over the cell's death machinery is crucial for survival. Viruses are obligatory intracellular parasites and, as such, must modulate apoptotic pathways to control the lifespan of their host in order to complete their replication cycle. Many of the counter-assaults mounted by the immune system incorporate activation of the apoptotic pathway-particularly by members of the tumor necrosis factor cytokine family-as a mechanism to restrict viral replication. Thus, apoptosis serves as a powerful selective pressure for the virus to evade. However, for the host, success is harsh and potentially costly, as apoptosis often contributes to pathogenesis. Here we examine some of the molecular mechanisms by which viruses manipulate the apoptotic machinery to their advantage and how we (as vertebrates) have evolved and learned to cope with viral evasion.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Ware, CF (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	cware@liai.org						Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Benedict CA, 1999, J IMMUNOL, V162, P6967; Benedict CA, 2001, IMMUNITY, V15, P617, DOI 10.1016/S1074-7613(01)00222-9; Benedict CA, 2001, J BIOL CHEM, V276, P3270, DOI 10.1074/jbc.M008218200; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Henry H, 2002, ONCOGENE, V21, P748, DOI 10.1038/sj.onc.1205125; Huang HK, 2000, J BIOL CHEM, V275, P26661; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Marshall WL, 1999, VIROLOGY, V256, P1, DOI 10.1006/viro.1999.9599; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; MIYASHITA T, 1995, CELL, V80, P293; Munger J, 2001, P NATL ACAD SCI USA, V98, P10410, DOI 10.1073/pnas.181344498; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; NEILAN JG, 1993, J VIROL, V67, P4391, DOI 10.1128/JVI.67.7.4391-4394.1993; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Raftery MJ, 1999, J EXP MED, V190, P1103, DOI 10.1084/jem.190.8.1103; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Reading PC, 2002, VIROLOGY, V292, P285, DOI 10.1006/viro.2001.1236; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schreiber M, 1997, J VIROL, V71, P2171, DOI 10.1128/JVI.71.3.2171-2181.1997; Sedger LM, 1999, J IMMUNOL, V163, P920; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shisler J, 1997, J VIROL, V71, P8299, DOI 10.1128/JVI.71.11.8299-8306.1997; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; STEWART AR, 1995, J VIROL, V69, P172, DOI 10.1128/JVI.69.1.172-181.1995; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; Vidalain PO, 2000, J VIROL, V74, P556, DOI 10.1128/JVI.74.1.556-559.2000; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WANG XW, 1995, CANCER RES, V55, P6012; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; White E, 1998, SEMIN VIROL, V8, P505, DOI 10.1006/smvy.1998.0155; WHITE E, 1991, J VIROL, V65, P2968, DOI 10.1128/JVI.65.6.2968-2978.1991; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141	80	337	353	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1013	1018		10.1038/ni1102-1013	http://dx.doi.org/10.1038/ni1102-1013			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407409				2022-12-18	WOS:000179073000006
J	Chu, HT; Mazmanian, SK				Chu, Hiutung; Mazmanian, Sarkis K.			Innate immune recognition of the microbiota promotes host-microbial symbiosis	NATURE IMMUNOLOGY			English	Review							INTESTINAL ALKALINE-PHOSPHATASE; TOLL-LIKE RECEPTOR; LECTIN REGIII-GAMMA; BACTERIAL-COLONIZATION; COMMENSAL BACTERIA; DROSOPHILA TOLL; PROTECT MICE; T-CELLS; PEPTIDOGLYCAN; EXPRESSION	Pattern-recognition receptors (PRRs) are traditionally known to sense microbial molecules during infection to initiate inflammatory responses. However, ligands for PRRs are not exclusive to pathogens and are abundantly produced by the resident microbiota during normal colonization. Mechanism(s) that underlie this paradox have remained unclear. Recent studies reveal that gut bacterial ligands from the microbiota signal through PRRs to promote development of host tissue and the immune system, and protection from disease. Evidence from both invertebrate and vertebrate models reveals that innate immune receptors are required to promote long-term colonization by the microbiota. This emerging perspective challenges current models in immunology and suggests that PRRs may have evolved, in part, to mediate the bidirectional cross-talk between microbial symbionts and their hosts.	[Chu, Hiutung; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Chu, Hiutung/0000-0001-7489-0446	Burroughs Wellcome Fund; Crohn's and Colitis Foundation; US National Institutes of Health [DK078938, GM099535]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078938, R01DK078938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099535] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Khosravi, S. W. McBride, G. Sharon, Y. Lee and M. Flajnik for comments on the manuscript. Supported by the Burroughs Wellcome Fund, Crohn's and Colitis Foundation and US National Institutes of Health (DK078938 and GM099535).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; De Rienzo G, 2012, ZEBRAFISH, V9, P97, DOI 10.1089/zeb.2012.0770; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Franzenburg S, 2013, ISME J, V7, P781, DOI 10.1038/ismej.2012.156; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Fraune S, 2010, P NATL ACAD SCI USA, V107, P18067, DOI 10.1073/pnas.1008573107; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kubinak JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002785; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2012, SEMIN IMMUNOL, V24, P3, DOI 10.1016/j.smim.2011.11.006; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; MCFALLNGAI MJ, 1991, SCIENCE, V254, P1491, DOI 10.1126/science.1962208; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nyholm SV, 2012, NAT REV MICROBIOL, V10, P815, DOI 10.1038/nrmicro2894; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Pham LN, 2008, NAT PROTOC, V3, P1862, DOI 10.1038/nprot.2008.186; Rader BA, 2012, MBIO, V3, DOI 10.1128/mBio.00093-12; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ryu JH, 2004, MOL CELL BIOL, V24, P172, DOI 10.1128/MCB.24.1.172-185.2004; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Sullivan C, 2009, J IMMUNOL, V183, P5896, DOI 10.4049/jimmunol.0803285; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wang JW, 2012, P NATL ACAD SCI USA, V109, P10552, DOI 10.1073/pnas.1116431109; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	91	336	354	11	209	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					668	675		10.1038/ni.2635	http://dx.doi.org/10.1038/ni.2635			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778794	Green Accepted			2022-12-18	WOS:000320509100005
J	Hirota, K; Turner, JE; Villa, M; Duarte, JH; Demengeot, J; Steinmetz, OM; Stockinger, B				Hirota, Keiji; Turner, Jan-Eric; Villa, Matteo; Duarte, Joao H.; Demengeot, Jocelyne; Steinmetz, Oliver M.; Stockinger, Brigitta			Plasticity of T(H)17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; SEGMENTED FILAMENTOUS BACTERIA; FOLLICULAR HELPER-CELL; CENTER B-CELL; RECEPTOR; DIFFERENTIATION; GENERATION; INFECTION; OCCURS; FOXP3	Intestinal Peyer's patches are essential lymphoid organs for the generation of T cell-dependent immunoglobulin A (IgA) for gut homeostasis. Through the use of interleukin 17 (IL-17) fate-reporter mice, we found here that endogenous cells of the T(H)17 subset of helper T cells in lymphoid organs of naive mice 'preferentially' homed to the intestines and were maintained independently of IL-23. In Peyer's patches, such T(H)17 cells acquired a follicular helper T cell (T-FH cell) phenotype and induced the development of IgA-producing germinal center B cells. Mice deficient in TH17 cells failed to generate antigen-specific IgA responses, which provides evidence that T(H)17 cells are the crucial subset required for the production of high-affinity T cell-dependent IgA.	[Hirota, Keiji; Turner, Jan-Eric; Villa, Matteo; Duarte, Joao H.; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Demengeot, Jocelyne] Inst Gulbenkian Ciencias, Dept Lymphocyte Physiol, Oeiras, Portugal; [Steinmetz, Oliver M.] Univ Klinikum Hamburg Eppendorf, Med Klin 3, Eppendorf, Germany	MRC National Institute for Medical Research; Instituto Gulbenkian de Ciencia; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	demengeot, jocelyne/K-8072-2014; Turner, Jan-Eric/ABC-1214-2021; Turner, Jerrold/H-1502-2019	demengeot, jocelyne/0000-0002-4761-614X; Villa, Matteo/0000-0003-2684-0596; Hirota, Keiji/0000-0002-4737-0661; Stockinger, Brigitta/0000-0001-8781-336X; Duarte, Joao H./0000-0001-7186-4947	European Mouse Mutant Archive; European Union; Medical Research Council UK [U117512792]; Deutsche Forschungsgemeinschaft [TU 316/1-1]; Boehringer Ingelheim Fonds; Medical Research Council [MC_U117512792] Funding Source: researchfish; MRC [MC_U117512792] Funding Source: UKRI	European Mouse Mutant Archive; European Union(European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Cua (Merck Research Laboratories) for the Il23a<SUP>-/-</SUP> mouse strain; A. Hayday (King's College London) for Tcra<SUP>-/-</SUP> mice; A. Zal and T. Zal (MD Anderson) for advice on microscopy of PP; the flow facility of the Medical Research Council National Institute for Medical Research for cell sorting; and Biological Services of the Medical Research Council National Institute for Medical Research for the breeding and maintenance of mouse strains. Supported by The European Mouse Mutant Archive, the European Union Framework Programme 7 Capacities Specific Program (for axenization), Medical Research Council UK (U117512792), Deutsche Forschungsgemeinschaft (TU 316/1-1 to. J.-E.T.) and Boehringer Ingelheim Fonds (M.V.).	Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	45	336	352	7	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					372	379		10.1038/ni.2552	http://dx.doi.org/10.1038/ni.2552			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23475182	Green Accepted			2022-12-18	WOS:000316648700012
J	Pichlmair, A; Lassnig, C; Eberle, CA; Gorna, MW; Baumann, CL; Burkard, TR; Burckstummer, T; Stefanovic, A; Krieger, S; Bennett, KL; Rulicke, T; Weber, F; Colinge, J; Muller, M; Superti-Furga, G				Pichlmair, Andreas; Lassnig, Caroline; Eberle, Carol-Ann; Gorna, Maria W.; Baumann, Christoph L.; Burkard, Thomas R.; Buerckstuemmer, Tilmann; Stefanovic, Adrijana; Krieger, Sigurd; Bennett, Keiryn L.; Ruelicke, Thomas; Weber, Friedemann; Colinge, Jacques; Mueller, Mathias; Superti-Furga, Giulio			IFIT1 is an antiviral protein that recognizes 5 '-triphosphate RNA	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; MASS-SPECTROMETRY DATA; DOUBLE-STRANDED-RNA; INFLUENZA-A VIRUS; RIG-I; FAMILY; IDENTIFICATION; PROTEOMICS; NETWORKS; STRAINS	Antiviral innate immunity relies on the recognition of microbial structures. One such structure is viral RNA that carries a triphosphate group on its 5' terminus (PPP-RNA). By an affinity proteomics approach with PPP-RNA as the 'bait', we found that the antiviral protein IFIT1 (interferon-induced protein with tetratricopeptide repeats 1) mediated binding of a larger protein complex containing other IFIT family members. IFIT1 bound PPP-RNA with nanomolar affinity and required the arginine at position 187 in a highly charged carboxy-terminal groove of the protein. In the absence of IFIT1, the growth and pathogenicity of viruses containing PPP-RNA was much greater. In contrast, IFIT proteins were dispensable for the clearance of pathogens that did not generate PPP-RNA. On the basis of this specificity and the great abundance of IFIT proteins after infection, we propose that the IFIT complex antagonizes viruses by sequestering specific viral nucleic acids.	[Pichlmair, Andreas; Eberle, Carol-Ann; Gorna, Maria W.; Baumann, Christoph L.; Burkard, Thomas R.; Buerckstuemmer, Tilmann; Stefanovic, Adrijana; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria; [Lassnig, Caroline; Mueller, Mathias] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria; [Lassnig, Caroline; Ruelicke, Thomas; Mueller, Mathias] Biomodels Austria, Univ Vet Med, Vienna, Austria; [Krieger, Sigurd] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Weber, Friedemann] Univ Marburg, Inst Virol, D-35032 Marburg, Germany	Austrian Academy of Sciences; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Philipps University Marburg	Superti-Furga, G (corresponding author), Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Colinge, Jacques/Z-2613-2019; Górna, Maria/F-4269-2014; Superti-Furga, Giulio/F-4755-2015; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/AAE-5681-2019; Weber, Friedemann/AAB-3425-2019	Colinge, Jacques/0000-0003-2466-4824; Górna, Maria/0000-0002-1769-4542; Superti-Furga, Giulio/0000-0002-0570-1768; Colinge, Jacques/0000-0003-2466-4824; Burkard, Thomas/0000-0002-0884-2929; Weber, Friedemann/0000-0001-9737-337X; Muller, Mathias/0000-0002-7879-3552; Bennett, Keiryn L./0000-0001-9356-7708; Burckstummer, Tilmann/0000-0001-5681-8045; Buerckstuemmer, Tilmann/0000-0002-5961-0829; Stefanovic, Adrijana/0000-0002-5497-8843; LASSNIG, Caroline/0000-0001-7905-3620	Austrian Academy of Sciences; European Research Council; European Molecular Biology Organization [ATLF 4632008]; European Union; Deutsche Forschungsgemeinschaft [We 2616/5-2, SFB 593/B13]; Research Austria program Austromouse; Bioinformatics Integration Network; Austrian Science Fund (FWF) [SFB F28]; Austrian Science Fund (FWF) [F 2808] Funding Source: researchfish	Austrian Academy of Sciences; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Austria program Austromouse; Bioinformatics Integration Network; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the NIH Knockout Mouse Project for embryonic stem cells with a targeted Ifit1 allele; L. Andersen for population expansion of embryonic stem cells; K. Kandasamy for bioinformatics support; G. Kochs (University of Freiburg) for plasmid Pol-I FF-luc; T. Decker (University of Vienna) for IRF3-deficient MEFs. Supported by the Austrian Academy of Sciences, the European Research Council (G. S.- F.), the European Molecular Biology Organization (C. L. B.; and ATLF 4632008 to A. P.), the European Union (Marie Curie Fellowship to C. L. B.), Deutsche Forschungsgemeinschaft (We 2616/5-2 and SFB 593/B13 to F. W.), the Austrian Federal Ministry for Science and Genome Research in the Research Austria program Austromouse (T. R. and M. M.), the Bioinformatics Integration Network (J.C.) and the Austrian Science Fund (FWF SFB F28 to M. M.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	45	336	350	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					624	U177		10.1038/ni.2048	http://dx.doi.org/10.1038/ni.2048			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21642987	Green Submitted			2022-12-18	WOS:000291936400010
J	Haworth, O; Cernadas, M; Yang, R; Serhan, CN; Levy, BD				Haworth, Oliver; Cernadas, Manuela; Yang, Rong; Serhan, Charles N.; Levy, Bruce D.			Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A(4) to promote the resolution of allergic airway inflammation	NATURE IMMUNOLOGY			English	Article							T-CELLS; GENE-EXPRESSION; IL-23; IL-17; MEDIATORS; RECEPTOR; OMEGA-3-FATTY-ACIDS; HYPERRESPONSIVENESS; PROTECTIN-D1; LYMPHOCYTES	Interleukin 23 (IL-23) is integral to the pathogenesis of chronic inflammation. The resolution of acute inflammation is an active process mediated by specific signals and mediators such as resolvin E1 (RvE1). Here we provide evidence that RvE1, in nanogram quantities, promoted the resolution of inflammatory airway responses in part by directly suppressing the production of IL-23 and IL-6 in the lung. Also contributing to the pro-resolution effects of RvE1 treatment were higher concentrations of interferon-gamma in the lungs of RvE1-treated mice. Our findings indicate a pivotal function for IL-23 and IL-6, which promote the survival and differentiation of IL-17-producing T helper cells, in maintaining inflammation and also identify an RvE1-initiated resolution program for allergic airway responses.	[Haworth, Oliver; Cernadas, Manuela; Levy, Bruce D.] Brigham & Womens Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Yang, Rong; Serhan, Charles N.; Levy, Bruce D.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Internal Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	blevy@partners.org	Yang, Rong/ABA-7587-2021	Yang, Rong/0000-0001-8837-0089	NIAID NIH HHS [AI068084, R56 AI068084, R01 AI068084, R01 AI068084-03, R01 AI068084-04] Funding Source: Medline; NIDCR NIH HHS [P50 DE016191-040004, P50 DE016191, P50-DE016191] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068084, R56AI068084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betti M, 2006, ANN ONCOL, V17, P235; Bonnans C, 2007, BIOMED PHARMACOTHER, V61, P261, DOI 10.1016/j.biopha.2007.02.016; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; De Rose V, 2004, J LEUKOCYTE BIOL, V76, P423, DOI 10.1189/jlb.0503247; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ivanov S, 2007, AM J RESP CELL MOL, V36, P442, DOI 10.1165/rcmb.2006-0020OC; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 1999, FASEB J, V13, P903, DOI 10.1096/fasebj.13.8.903; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCHWARTZ J, 1994, EUR RESPIR J, V7, P1821, DOI 10.1183/09031936.94.07101821; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tong JK, 2006, J EXP MED, V203, P1173, DOI 10.1084/jem.20051680; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshida M, 2002, AM J RESP CRIT CARE, V166, P451, DOI 10.1164/rccm.200202-095OC; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	51	336	353	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					873	879		10.1038/ni.1627	http://dx.doi.org/10.1038/ni.1627			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18568027	Green Accepted			2022-12-18	WOS:000257780700010
J	Adams, GB; Scadden, DT				Adams, GB; Scadden, DT			The hematopoietic stem cell in its place	NATURE IMMUNOLOGY			English	Review							SELF-RENEWAL; NICHE; MARROW; OSTEOPONTIN; GERMLINE; OSTEOBLASTS; PROGENITORS; COMPONENT; DIVISION; MICE	A signature characteristic of stem cells is their ability to self-renew, affording a theoretically limitless ability to produce daughter cells and their descendents. This near-timeless dimension of stem cell function is not free of the constraints of place. The idea that highly specialized `microenvironmental' cues participate in the regulation of stem cells has evidence in classic embryology and more recently in adult stem cells through the use of model organisms. There is now ample evidence that an anatomically defined, specifically constituted place represents the niche for hematopoietic and other tissue-specific stem cells. This review provides a conceptual framework and detailed account of the hematopoietic stem cell niche as defined at present. The components are assembling into a more complex view of the niche and may now be amenable to examination as a system and possibly to alteration to affect outcomes in immune regeneration.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu			NHLBI NIH HHS [HL081030, HL44851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U54HL081030] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Crittenden SL, 2003, PHILOS T ROY SOC B, V358, P1359, DOI 10.1098/rstb.2003.1333; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Frimberger AE, 2001, BRIT J HAEMATOL, V112, P644, DOI 10.1046/j.1365-2141.2001.02542.x; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Palis J, 1999, DEVELOPMENT, V126, P5073; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; STEWART FM, 1993, BLOOD, V81, P2566; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x; Udani M, 2005, STEM CELLS DEV, V14, P478, DOI 10.1089/scd.2005.14.478; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	336	351	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					333	337		10.1038/ni1331	http://dx.doi.org/10.1038/ni1331			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550195				2022-12-18	WOS:000236171000003
J	Ghosh, D; Porter, E; Shen, B; Lee, SK; Wilk, D; Drazba, J; Yadav, SP; Crabb, JW; Ganz, T; Bevins, CL				Ghosh, D; Porter, E; Shen, B; Lee, SK; Wilk, D; Drazba, J; Yadav, SP; Crabb, JW; Ganz, T; Bevins, CL			Paneth cell trypsin is the processing enzyme for human defensin-5	NATURE IMMUNOLOGY			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; HUMAN INTESTINAL DEFENSIN-5; ANTIMICROBIAL PEPTIDE GENE; INNATE HOST-DEFENSE; EPITHELIAL-CELLS; GASTROINTESTINAL-TRACT; PHOSPHOLIPASE A(2); ALPHA-DEFENSINS; STEM-CELLS; EXPRESSION	The antimicrobial peptide human alpha-defensin 5 (HD5) is expressed in Paneth cells, secretory epithelial cells in the small intestine. Unlike other characterized defensins, HD5 is stored in secretory vesicles as a propeptide. The storage quantities of HD5 are similar to90-450 mug per cm(2) of mucosal surface area, which is sufficient to generate microbicidal concentrations in the intestinal lumen. HD5 peptides isolated from the intestinal lumen are proteolytically processed forms-HD5(56-94) and HD5(63-94)-that are cleaved at the Arg(55)-Ala(56) and Arg(62)-Thr(63) sites, respectively. We show here that a specific pattern of trypsin isozymes is expressed in Paneth cells, that trypsin colocalizes with HD5 and that this protease can efficiently cleave HD5 propeptide to forms identical to those isolated in vivo. By acting as a prodefensin convertase in human Paneth cells, trypsin is involved in the regulation of innate immunity in the small intestine.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State University Los Angeles	Bevins, CL (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bevinsc@ccf.org	Ganz, Tomas/AAN-3308-2020; Bevins, Charles L/P-4438-2015; Ganz, Tomas/D-4567-2009	Bevins, Charles L/0000-0003-2725-2622; Ganz, Tomas/0000-0002-2830-5469	NEI NIH HHS [EY06603] Funding Source: Medline; NHLBI NIH HHS [HL46809] Funding Source: Medline; NIAID NIH HHS [AI32738] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032738] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alm AK, 2000, BIOCHEM BIOPH RES CO, V275, P77, DOI 10.1006/bbrc.2000.3267; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belham CL, 1996, BIOCHEM J, V320, P939, DOI 10.1042/bj3200939; Bevins C L, 1997, Methods Mol Biol, V78, P151; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; Bohe H, 1997, J GASTROENTEROL, V32, P623, DOI 10.1007/BF02934111; BOHE M, 1986, J CLIN PATHOL, V39, P786, DOI 10.1136/jcp.39.7.786; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Borson N D, 1992, PCR Methods Appl, V2, P144; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; CHO JH, 2002, FASEB J, V30, DOI DOI 10.1096/FJ.001-0736FJE; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; DIAMOND G, 1993, P NATL ACAD SCI USA, V90, P4596, DOI 10.1073/pnas.90.10.4596; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; HARWIG SSL, 1992, BLOOD, V79, P1532; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kawabata A, 2001, J CLIN INVEST, V107, P1443, DOI 10.1172/JCI10806; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; LEHRER RI, 1998, MUCOSAL IMMUNOLOGY, P89; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; NEVALAINEN TJ, 1995, LAB INVEST, V72, P201; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; Ouellette AJ, 1999, AM J PHYSIOL-GASTR L, V277, pG257, DOI 10.1152/ajpgi.1999.277.2.G257; Paju A, 2000, AM J PATHOL, V157, P2011, DOI 10.1016/S0002-9440(10)64840-7; Panyutich A, 1997, INFECT IMMUN, V65, P978, DOI 10.1128/IAI.65.3.978-985.1997; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Simon Gary L., 1995, P53; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; YOUNGMAN KR, 1993, GASTROENTEROLOGY, V104, P749, DOI 10.1016/0016-5085(93)91010-F; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	336	357	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					583	590		10.1038/ni797	http://dx.doi.org/10.1038/ni797			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021776				2022-12-18	WOS:000175874700019
J	Chang, JT; Wherry, EJ; Goldrath, AW				Chang, John T.; Wherry, E. John; Goldrath, Ananda W.			Molecular regulation of effector and memory T cell differentiation	NATURE IMMUNOLOGY			English	Review							FOLLICULAR HELPER-CELL; RESIDENT MEMORY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CUTTING EDGE; SELECTIVE EXPRESSION; BICOID PROTEIN; CD8(+); TISSUE; BATF	Immunological memory is a cardinal feature of adaptive immunity and an important goal of vaccination strategies. Here we highlight advances in the understanding of the diverse T lymphocyte subsets that provide acute and long-term protection from infection. These include new insights into the transcription factors, and the upstream 'pioneering' factors that regulate their accessibility to key sites of gene regulation, as well as metabolic regulators that contribute to the differentiation of effector and memory subsets; ontogeny and defining characteristics of tissue-resident memory lymphocytes; and origins of the remarkable heterogeneity exhibited by activated T cells. Collectively, these findings underscore progress in delineating the underlying pathways that control diversification in T cell responses but also reveal gaps in the knowledge, as well as the challenges that arise in the application of this knowledge to rationally elicit desired T cell responses through vaccination and immunotherapy.	[Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	changj@ucsd.edu; wherry@mail.med.upenn.edu; agoldrath@ucsd.edu	Wherry, John/ABI-1280-2020	Chang, John/0000-0003-0873-6218	US National Institutes of Health [OD008469, DK093507, AI095277, AI072117, AI067545, AI083022, AI082630, AI095608, AI05343, AI112521, HHSN266200500030C]; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, R01AI096852, R01AI095277, R01AI072117, P01AI112521, U19AI082630, U01AI095608, R01AI067545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093507] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of our laboratories for discussions, and L. Shaw for assistance with figures. Supported by the US National Institutes of Health (OD008469, DK093507 and AI095277 to J.T.C.; AI072117 and AI067545 to A.W.G.; and AI083022, AI082630, AI095608, AI05343, AI112521 and HHSN266200500030C to E.J.W.), the Leukemia and Lymphoma Society (A.W.G.) and the Howard Hughes Medical Institute (J.T.C.).	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Carbone FR, 2013, CURR OPIN IMMUNOL, V25, P329, DOI 10.1016/j.coi.2013.05.007; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Mollo SB, 2014, J LEUKOCYTE BIOL, V95, P705, DOI 10.1189/jlb.0813429; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paley MA, 2013, J LEUKOCYTE BIOL, V93, P307, DOI 10.1189/jlb.0812400; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zediak VP, 2011, J IMMUNOL, V186, P2705, DOI 10.4049/jimmunol.1003741; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	141	335	347	5	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1104	1115		10.1038/ni.3031	http://dx.doi.org/10.1038/ni.3031			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25396352	Green Accepted			2022-12-18	WOS:000344841900007
J	Spilianakis, CG; Flavell, RA				Spilianakis, CG; Flavell, RA			Long-range intrachromosomal interactions in the T helper type 2 cytokine locus	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; BETA-GLOBIN GENE; CHROMATIN-STRUCTURE; CUTTING EDGE; HYPERSENSITIVE SITES; HISTONE ACETYLATION; PROMOTER REGION; TH2 CELLS; EXPRESSION; IL-4	The T helper type 2 (T(H)2) locus control region is important in the regulation of the genes encoding the cytokines interleukins 4, 5 and 13. Using the chromosome conformation capture technique, we found that in T cells, natural killer cells, B cells and fibroblasts, the promoters for the genes encoding T(H)2 cytokines are located in close spatial proximity, forming an initial chromatin core configuration. In CD4(+) T cells and natural killer cells, but not B cells and fibroblasts, the T(H)2 locus control region participates in this configuration. The transcription factors GATA3 and STAT6 are essential for the establishment and/or maintenance of these interactions. Intrachromosomal interactions in the T(H)2 cytokine locus may form the basis for the coordinated transcriptional regulation of cytokine-encoding genes by the T(H)2 locus control region.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Carey M, 2000, TRANSCRIPTIONAL REGU; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; KOVAC Z, 1985, J IMMUNOL, V134, P3233; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; LJUNGMAN M, 1995, NUCLEIC ACIDS RES, V23, P1782, DOI 10.1093/nar/23.10.1782; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Okamura H, 2001, CURR OPIN CELL BIOL, V13, P239, DOI 10.1016/S0955-0674(00)00203-9; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wang XY, 1997, NUCLEIC ACIDS RES, V25, P3478, DOI 10.1093/nar/25.17.3478; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	42	335	351	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1017	1027		10.1038/ni1115	http://dx.doi.org/10.1038/ni1115			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15378057				2022-12-18	WOS:000224156600025
J	Couillault, C; Pujol, N; Reboul, J; Sabatier, L; Guichou, JF; Kohara, Y; Ewbank, JJ				Couillault, C; Pujol, N; Reboul, J; Sabatier, L; Guichou, JF; Kohara, Y; Ewbank, JJ			TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM	NATURE IMMUNOLOGY			English	Article							ANTIMICROBIAL PEPTIDE; C-ELEGANS; WILD-TYPE; DROSOPHILA; TOLL; EXPRESSION; INFECTION; GENES; IDENTIFICATION; PATHWAYS	Both plants and animals respond to infection by synthesizing compounds that directly inhibit or kill invading pathogens. We report here the identification of infection-inducible antimicrobial peptides in Caenorhabditis elegans. Expression of two of these peptides, NLP-29 and NLP-31, was differentially regulated by fungal and bacterial infection and was controlled in part by tir-1, which encodes an ortholog of SARM, a Toll-interleukin 1 receptor (TIR) domain protein. Inactivation of tir-1 by RNA interference caused increased susceptibility to infection. We identify protein partners for TIR-1 and show that the small GTPase Rab1 and the f subunit of ATP synthase participate specifically in the control of antimicrobial peptide gene expression. As the activity of tir-1 was independent of the single nematode Toll-like receptor, TIR-1 may represent a component of a previously uncharacterized, but conserved, innate immune signaling pathway.	Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; Inst J Paoli I Calmettes, INSERM, U119, F-13009 Marseille, France; Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France; Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048,INSERM,UMR 554, F-34090 Montpellier, France; Natl Inst Genet, Mishima, Shizuoka 411, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ewbank, JJ (corresponding author), Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille 9, France.	ewbank@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010; Reboul, Jerome/P-9103-2016; Pujol, Nathalie/K-3880-2012	Ewbank, Jonathan J/0000-0002-1257-6862; Reboul, Jerome/0000-0002-5513-4546; Pujol, Nathalie/0000-0001-8889-3197; guichou, jean-francois/0000-0002-7699-3235				Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Bilak H, 2003, BIOCHEM SOC T, V31, P648, DOI 10.1042/bst0310648; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Harris TW, 2003, NUCLEIC ACIDS RES, V31, P133, DOI 10.1093/nar/gkg053; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Imler JL, 2002, CURR TOP MICROBIOL, V270, P63; JANSSON HB, 1994, J NEMATOL, V26, P430; Jebanathirajah JA, 2002, TRENDS PLANT SCI, V7, P388, DOI 10.1016/S1360-1385(02)02309-9; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lambert RW, 2002, NEUROPEPTIDES, V36, P246, DOI 10.1016/S0143-4179(02)00020-3; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metz-Boutigue MH, 2003, TRENDS MICROBIOL, V11, P585, DOI 10.1016/j.tim.2003.10.001; Millet ACM, 2004, CURR OPIN IMMUNOL, V16, P4, DOI 10.1016/j.coi.2003.11.005; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vouldoukis I, 1996, FEBS LETT, V380, P237, DOI 10.1016/0014-5793(96)00050-6; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	47	335	382	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					488	494		10.1038/ni1060	http://dx.doi.org/10.1038/ni1060			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15048112				2022-12-18	WOS:000221101100012
J	Gilfillan, S; Ho, EL; Cella, M; Yokoyama, WM; Colonna, M				Gilfillan, S; Ho, EL; Cella, M; Yokoyama, WM; Colonna, M			NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; DELTA T-CELLS; CUTTING EDGE; IN-VIVO; RECEPTOR; EXPRESSION; KINASE; DAP12; CYTOTOXICITY; RECOGNITION	NKG2D is a receptor on natural killer (NK) cells and cytotoxic T lymphocytes that binds major histocompatibility complex (MHC) class I-like ligands expressed primarily on virally infected and neoplastic cells. In vitro studies indicate that NKG2D provides costimulation through an associated adapter, DAP10, which recruits phosphatidylinositol-3 kinase. Here we show that in DAP10-deficient mice, CD8(+) T cells lack NKG2D expression and are incapable of mounting tumor-specific responses. However, DAP10-deficient NK cells express a functional NKG2D receptor due to the association of NKG2D with another adapter molecule, DAP12 (also known as KARAP), which recruits protein tyrosine kinases. Thus, NKG2D is a versatile receptor that, depending on the availability of adapter partners, mediates costimulation in T cells and/or activation in NK cells.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Barnes Jewish Hosp, Dept Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL); Barnes-Jewish Hospital; Howard Hughes Medical Institute; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid, St Louis, MO 63110 USA.		Calabrese, Massimiliano/I-6195-2012; Cella, Marina/ABA-8564-2020; Cella, Marina/G-8850-2011	Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313				Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chang CW, 1999, J IMMUNOL, V163, P4651; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DIEFENBACH A, 2002, NATURE IMMUNOL  1111; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kelly JM, 2002, J IMMUNOL, V168, P4472, DOI 10.4049/jimmunol.168.9.4472; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 2002, SEMIN CANCER BIOL, V12, P57, DOI 10.1006/scbi.2001.0398; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Riegert P, 1999, J IMMUNOL, V162, P3471; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	33	335	352	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1150	1155		10.1038/ni857	http://dx.doi.org/10.1038/ni857			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12426564	Green Published			2022-12-18	WOS:000179467800012
J	Murphy, KM; Stockinger, B				Murphy, Kenneth M.; Stockinger, Brigitta			Effector T cell plasticity: flexibility in the face of changing circumstances	NATURE IMMUNOLOGY			English	Review							ARYL-HYDROCARBON RECEPTOR; FOLLICULAR-HELPER-CELLS; CXC CHEMOKINE RECEPTOR-5; TH17 CELLS; RETINOIC-ACID; ROR-GAMMA; IFN-GAMMA; TGF-BETA; IN-VIVO; LINEAGE DIFFERENTIATION	As more states of CD4 T cell differentiation are uncovered, their flexibility is also beginning to be recognized. Components that control the plasticity of CD4 T cell populations include cellular conditions, clonality, transcriptional circuitry and chromatin modifications. Appearance of cellular flexibility may arise from truly flexible genetic programs or, alternatively, from heterogeneous populations. New tools will be needed to define the rules that allow or prohibit cellular transitions.	[Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England	Howard Hughes Medical Institute; Washington University (WUSTL); MRC National Institute for Medical Research	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu; bstocki@nimr.mrc.ac.uk		Stockinger, Brigitta/0000-0001-8781-336X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI076427, R01 AI076427-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ahmadzadeh M, 2002, P NATL ACAD SCI USA, V99, P11802, DOI 10.1073/pnas.192263099; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Arguni E, 2006, INT IMMUNOL, V18, P1079, DOI 10.1093/intimm/dxl041; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Finkelman FD, 2009, IMMUNOL CELL BIOL, V87, P568, DOI 10.1038/icb.2009.67; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kikuchi M, 2000, ONCOGENE, V19, P4941, DOI 10.1038/sj.onc.1203864; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2003, NAT IMMUNOL, V4, P645, DOI 10.1038/ni0703-645; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PALIARD X, 1988, J IMMUNOL, V141, P849; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rannug A, 2006, BIOL CHEM, V387, P1149, DOI 10.1515/BC.2006.143; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; ROUBENOFF R, 1990, ARTHRITIS RHEUM, V33, P930, DOI 10.1002/art.1780330703; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sornasse T, 1996, J EXP MED, V184, P473, DOI 10.1084/jem.184.2.473; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	111	334	353	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					674	680		10.1038/ni.1899	http://dx.doi.org/10.1038/ni.1899			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644573	Green Accepted			2022-12-18	WOS:000280149400005
J	English, L; Chemali, M; Duron, J; Rondeau, C; Laplante, A; Gingras, D; Alexander, D; Leib, D; Norbury, C; Lippe, R; Desjardins, M				English, Luc; Chemali, Magali; Duron, Johanne; Rondeau, Christiane; Laplante, Annie; Gingras, Diane; Alexander, Diane; Leib, David; Norbury, Christopher; Lippe, Roger; Desjardins, Michel			Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; CROSS-PRESENTATION; TOXOPLASMA-GONDII; GLYCOPROTEIN-B; INNATE; CELLS; PROTEIN; FUSION; NEUROVIRULENCE; REPLICATION	Viral proteins are usually processed by the 'classical' major histocompatibility complex (MHC) class I presentation pathway. Here we showed that although macrophages infected with herpes simplex virus type 1 (HSV-1) initially stimulated CD8(+) T cells by this pathway, a second pathway involving a vacuolar compartment was triggered later during infection. Morphological and functional analyses indicated that distinct forms of autophagy facilitated the presentation of HSV-1 antigens on MHC class I molecules. One form of autophagy involved a previously unknown type of autophagosome that originated from the nuclear envelope. Whereas interferon-gamma stimulated classical MHC class I presentation, fever-like hyperthermia and the pyrogenic cytokine interleukin 1 beta activated autophagy and the vacuolar processing of viral peptides. Viral peptides in autophagosomes were further processed by the proteasome, which suggests a complex interaction between the vacuolar and MHC class I presentation pathways.	[English, Luc; Chemali, Magali; Duron, Johanne; Rondeau, Christiane; Laplante, Annie; Gingras, Diane; Lippe, Roger; Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Alexander, Diane; Leib, David] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Norbury, Christopher] Penn State Univ, Milton S Hershey Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Desjardins, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Desjardins, Michel] Capr Pharmaceut, Montreal, PQ, Canada	Universite de Montreal; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universite de Montreal	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Succursale Ctr Ville, Montreal, PQ, Canada.	michel.desjardins@umontreal.ca		Desjardins, Michel/0000-0002-5684-5980; Lippe, Roger/0000-0001-5066-3070	Canadian Institutes for Health Research; Natural Science and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec; US National Institutes of Health [EY09083]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY009083] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Thibodeau and C. Perreault for critical reading of the manuscript; K. Rock (University of Massachusetts Medical School) for BMA cells; W. Heath (University of Melbourne) for the HSV-2.3.2E2 hybridoma; G. Arthur (University of Manitoba) for the wild-type and Atg5<SUP>-/-</SUP> mouse embryonic fibroblasts produced by N. Mizushima (Medical and Dental University, Tokyo); P. Desai (Johns Hopkins University) for the HSV-1 K26-GFP mutant; and M. Bendayan for assistance with electron microscopy. Supported by the Canadian Institutes for Health Research (R. L. and M. D.), the Natural Science and Engineering Research Council of Canada (L. E.), Fonds de la Recherche en Sante du Quebec (L. E.), the US National Institutes of Health (EY09083) and Research to Prevent Blindness (D. L.)	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BOLOVAN CA, 1994, J VIROL, V68, P48, DOI 10.1128/JVI.68.1.48-55.1994; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; EPPERSON DE, 1992, J IMMUNOL, V149, P3297; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jarvis MA, 2006, J VIROL, V80, P5588, DOI 10.1128/JVI.00060-06; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Komata T, 2004, J NEURO-ONCOL, V68, P101, DOI 10.1023/B:NEON.0000027739.33842.6c; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Stannard LM, 1996, ARCH VIROL, V141, P505, DOI 10.1007/BF01718314; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176	42	334	357	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					480	487		10.1038/ni.1720	http://dx.doi.org/10.1038/ni.1720			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19305394	Green Accepted			2022-12-18	WOS:000265394400009
J	Virgin, HW; Levine, B				Virgin, Herbert W.; Levine, Beth			Autophagy genes in immunity	NATURE IMMUNOLOGY			English	Review							GENOME-WIDE ASSOCIATION; NH2-TERMINAL KINASE (JNK)1; CELL-DEATH; CROHNS-DISEASE; INNATE IMMUNITY; BECLIN 1; PHOSPHATIDYLINOSITOL 3-KINASE; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR PATHOGENS; LYMPHOCYTE DEVELOPMENT	In its classical form, autophagy is a pathway by which cytoplasmic constituents, including intracellular pathogens, are sequestered in a double-membrane-bound autophagosome and delivered to the lysosome for degradation. This pathway has been linked to diverse aspects of innate and adaptive immunity, including pathogen resistance, production of type I interferon, antigen presentation, tolerance and lymphocyte development, as well as the negative regulation of cytokine signaling and inflammation. Most of these links have emerged from studies in which genes encoding molecules involved in autophagy are inactivated in immune effector cells. However, it is not yet known whether all of the critical functions of such genes in immunity represent 'classical autophagy' or possible as-yet-undefined autophagolysosome-independent functions of these genes. This review summarizes phenotypes that result from the inactivation of autophagy genes in the immune system and discusses the pleiotropic functions of autophagy genes in immunity.	[Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu; beth.levine@utsouthwestern.edu		Virgin, Herbert/0000-0001-8580-7628	US National Institutes of Health [R01 CA074730, R01 CA096511, R01 AI054483, R01 AI065982, U54 AI057160, R01 AI151267, R01 CA109618]; Howard Hughes Medical Institute; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA096511, R01CA074730, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051367, R01AI065982, R01AI054483, U54AI057160] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Diehl for medical illustration. Supported by the US National Institutes of Health (R01 CA074730, R01 CA096511, R01 AI054483, R01 AI065982 and U54 AI057160 to H. W. V., and R01 AI151267 and R01 CA109618 to B. L.), the Howard Hughes Medical Institute (B. L.) and the Ellison Medical Foundation (B. L.).	Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Arsov I, 2008, CELL DEATH DIFFER, V15, P1385, DOI 10.1038/cdd.2008.59; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Conze D, 2002, J EXP MED, V195, P811, DOI 10.1084/jem.20011508; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lunemann JD, 2009, CELL DEATH DIFFER, V16, P79, DOI 10.1038/cdd.2008.113; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Papic N, 2008, J BIOL CHEM, V283, P32143, DOI 10.1074/jbc.M804846200; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STEPHENSON LM, AUTOPHAGY IN PRESS; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2004, YEAST, V21, P1057, DOI 10.1002/yea.1152; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	79	334	352	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					461	470		10.1038/ni.1726	http://dx.doi.org/10.1038/ni.1726			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381141	Green Accepted, Green Submitted			2022-12-18	WOS:000265394400007
J	Liu, K; Waskow, C; Liu, XT; Yao, KH; Hoh, J; Nussenzweig, M				Liu, Kang; Waskow, Claudia; Liu, Xiangtao; Yao, Kaihui; Hoh, Josephine; Nussenzweig, Michel			Origin of dendritic cells in peripheral lymphoid organs of mice	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; STEADY-STATE CONDITIONS; IN-VIVO; T-CELLS; MYELOID PROGENITORS; MOUSE SPLEEN; LIFE-SPAN; ANTIGEN; MONOCYTES; HOMEOSTASIS	Parabiosis experiments demonstrating that dendritic cells (DCs) do not equilibrate between mice even after prolonged joining by parabiosis have suggested that DCs are derived from self-renewing progenitors that divide in situ. However, here we found that unequal exchange of DCs between mice joined by parabiosis reflected uneven distribution of DC precursors in blood due to their short half-life in circulation. DCs underwent only a limited number of divisions in the spleen or lymph nodes over a 10- to 14-day period and were replenished from blood-borne precursors at a rate of nearly 4,300 cells per hour. Daughter DCs presented antigens captured by their progenitors, suggesting that DC division in peripheral lymphoid organs can prolong the duration of antigen presentation in vivo.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Yale Univ, Dept Math Appl, New Haven, CT 06520 USA; Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Yale University; Yale University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.	nussen@rockefeller.edu	Waskow, Claudia/F-8146-2010; Nussenzweig, Michel/AAE-7292-2019	Waskow, Claudia/0000-0003-3261-0922; 				Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Harris RBS, 1997, AM J PHYSIOL-REG I, V272, pR1800, DOI 10.1152/ajpregu.1997.272.6.R1800; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Manz MG, 2001, ANN NY ACAD SCI, V938, P167; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; NISHIZAWA Y, 1980, AM J PHYSIOL, V239, pR344, DOI 10.1152/ajpregu.1980.239.3.R344; PUGH CW, 1983, J EXP MED, V157, P1758, DOI 10.1084/jem.157.6.1758; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Redmond WL, 2003, J IMMUNOL, V171, P6349, DOI 10.4049/jimmunol.171.12.6349; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; STEINMAN RM, 1980, IMMUNOL REV, V53, P127, DOI 10.1111/j.1600-065X.1980.tb01042.x; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	49	334	338	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					578	583		10.1038/ni1462	http://dx.doi.org/10.1038/ni1462			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17450143				2022-12-18	WOS:000246703300011
J	Ansel, KM; Lee, DU; Rao, A				Ansel, KM; Lee, DU; Rao, A			An epigenetic view of helper T cell differentiation	NATURE IMMUNOLOGY			English	Review							CYTOKINE GENE-EXPRESSION; HISTONE H3; LINEAGE COMMITMENT; IFN-GAMMA; IN-VIVO; LYMPHOCYTE DEVELOPMENT; HYPERSENSITIVE SITES; IL-4 PRODUCTION; CUTTING EDGE; TH2 CELLS	Antigen and cytokine receptor signals act in synergy to direct the differentiation of CD4(+) T cells. These signals initiate reciprocal activation and silencing of the interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) cytokine gene loci, changes that are heritably maintained in the resulting T helper type I (T(H)1) or T(H)2 cells and their progeny. Early, unpolarized transcription and chromatin remodeling of the poised cytokine genes of naive T cells is followed by consolidation and spreading of epigenetic changes and the establishment of self-reinforcing transcription factor networks. Recent studies have begun to elucidate the molecular mechanisms that establish and maintain polarized cytokine gene expression, and thus the cellular identity of differentiated helper T cells.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.							Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; Guo J, 2001, J BIOL CHEM, V276, P48871, DOI 10.1074/jbc.M101592200; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hawwari A, 2002, J IMMUNOL, V169, P1876, DOI 10.4049/jimmunol.169.4.1876; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rogan DF, 1999, BIOCHEM BIOPH RES CO, V255, P556, DOI 10.1006/bbrc.1999.0241; SAD S, 1994, J IMMUNOL, V153, P3514; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Scotet E, 2001, BLOOD, V98, P2568, DOI 10.1182/blood.V98.8.2568; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	99	334	350	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					616	623		10.1038/ni0703-616	http://dx.doi.org/10.1038/ni0703-616			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830136				2022-12-18	WOS:000183952500004
J	Zitvogel, L; Kepp, O; Galluzzi, L; Kroemer, G				Zitvogel, Laurence; Kepp, Oliver; Galluzzi, Lorenzo; Kroemer, Guido			Inflammasomes in carcinogenesis and anticancer immune responses	NATURE IMMUNOLOGY			English	Review							RECEPTOR ANTAGONIST ANAKINRA; CELL-DEATH; NLRP3 INFLAMMASOME; CROHNS-DISEASE; ADAPTIVE IMMUNITY; SUPPRESSOR-CELLS; INNATE IMMUNITY; PROTECTS MICE; IFN-GAMMA; CANCER	In the complex interplay between malignant cells and their microenvironment, caspase-1 activation complexes (inflammasomes) have contrasting roles. Inflammasomes may operate at the cell-autonomous level to eliminate malignant precursors through programmed cell death or, conversely, may stimulate the production of trophic factors for cancer cells and their stroma. In inflammatory cells, caspase-1 activation can fuel a cycle that leads to sterile inflammation and carcinogenesis, whereas in antigen-presenting cells, inflammasomes can stimulate anticancer immune responses. The inhibition of inflammasomes or neutralization of their products, mainly interleukin 1 beta (IL-1 beta) and IL-18, has profound effects on carcinogenesis and tumor progression. Thus, inflammasomes are promising therapeutic targets in cancer-related clinical conditions. Here we discuss present and future indications for the clinical use of inflammasome inhibitors.	[Zitvogel, Laurence; Kroemer, Guido] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Zitvogel, Laurence; Kepp, Oliver; Galluzzi, Lorenzo] Univ Paris 11, Villejuif, France; [Kepp, Oliver; Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U848, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France.	kroemer@igr.fr	Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; Kepp, Oliver/GPX-8627-2022; Kepp, Oliver/N-2763-2017; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/K-2709-2012	Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; Galluzzi, Lorenzo/0000-0003-2257-8500; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue Nationale Contre le Cancer; Agence Nationale pour la Recherche; Fondation pour la Recherche Medicate; Institut National du Cancer; Canceropole Ile-de-France; European Commission; Art Force; Chemo Res; Death-Train; Lab Ex OncoImmunology; Institut National de la Sante et de la Recherche Medicale	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); European Commission(European CommissionEuropean Commission Joint Research Centre); Art Force; Chemo Res; Death-Train; Lab Ex OncoImmunology; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	Supported by the Ligue Nationale Contre le Cancer (Equipes Labellisee; L.Z. and G.K.), Agence Nationale pour la Recherche (L.Z. and G.K.), Fondation pour la Recherche Medicate (L.Z. and G.K.), Institut National du Cancer (L.Z. and G.K.), Canceropole Ile-de-France (L.Z. and G.K.), the European Commission (Apo-Sys (L.Z., C.K. and L.G.), Art Force (L.Z. and G.K.), Chemo Res (L.Z. and G.K.) and Death-Train (L.Z. and G.K.)), Lab Ex OncoImmunology (L.Z. and G.K.) and Institut National de la Sante et de la Recherche Medicale (O.K.)	Alessi P, 2009, EUR CYTOKINE NETW, V20, P225, DOI 10.1684/ecn.2009.0175; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Baamonde A, 2007, LIFE SCI, V81, P673, DOI 10.1016/j.lfs.2007.07.003; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; El-Osta H, 2010, MOL CANCER THER, V9, P1485, DOI 10.1158/1535-7163.MCT-10-0156; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ericsson AC, 2010, NEOPLASIA, V12, P1054, DOI 10.1593/neo.10940; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujita K, 2011, INT J CANCER, V129, P424, DOI 10.1002/ijc.25705; Gabay E, 2011, EUR J PAIN, V15, P242, DOI 10.1016/j.ejpain.2010.07.012; Galeotti C, 2008, J PEDIAT HEMATOL ONC, V30, P920, DOI 10.1097/MPH.0b013e31818ab31f; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Graziano F, 2009, PHARMACOGENOMICS J, V9, P78, DOI 10.1038/tpj.2008.16; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harnack U, 2010, ANTICANCER RES, V30, P3959; Hosgood HD, 2011, BRIT J HAEMATOL, V152, P721, DOI 10.1111/j.1365-2141.2010.08518.x; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Keller M, 2009, J IMMUNOL, V183, P5593, DOI 10.4049/jimmunol.0900476; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kunzli BM, 2011, PURINERG SIGNAL, V7, P231, DOI 10.1007/s11302-011-9228-9; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maker AV, 2011, CLIN CANCER RES, V17, P1502, DOI 10.1158/1078-0432.CCR-10-1561; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Micallef MJ, 1997, CANCER IMMUNOL IMMUN, V43, P361, DOI 10.1007/s002620050345; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Orengo AM, 2011, INT J CANCER, V129, P1116, DOI 10.1002/ijc.25757; Osaki T, 1998, J IMMUNOL, V160, P1742; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Petit F, 1996, J VIROL, V70, P5860, DOI 10.1128/JVI.70.9.5860-5866.1996; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qin Y, 2011, MOL CANCER RES, V9, P1537, DOI 10.1158/1541-7786.MCR-11-0279; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schauer IG, 2011, NEOPLASIA, V13, P393, DOI 10.1593/neo.101720; Scheede-Bergdahl C, 2012, CLIN NUTR, V31, P85, DOI 10.1016/j.clnu.2011.07.010; Scherbarth S, 1997, CANCER RES, V57, P4105; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Srivastava S, 2010, CURR MED CHEM, V17, P3353, DOI 10.2174/092986710793176348; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; van de Veerdonk FL, 2011, EUR J IMMUNOL, V41, P2260, DOI 10.1002/eji.201041226; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Weinreich DM, 2003, CANCER RES, V63, P5957; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Winter RN, 2004, ANTICANCER RES, V24, P1377; Winter RN, 2001, CANCER RES, V61, P1227; Wu ZQ, 2011, CANCER CHEMOTH PHARM, V68, P87, DOI 10.1007/s00280-010-1451-5; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang RX, 2008, NEUROSCIENCE, V154, P1533, DOI 10.1016/j.neuroscience.2008.04.072; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016; Zhu JZ, 2010, EUR J PHARMACOL, V643, P247, DOI 10.1016/j.ejphar.2010.06.024; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	126	333	351	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					343	351		10.1038/ni.2224	http://dx.doi.org/10.1038/ni.2224			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430787				2022-12-18	WOS:000301886800008
J	Kao, C; Oestreich, KJ; Paley, MA; Crawford, A; Angelosanto, JM; Ali, MAA; Intlekofer, AM; Boss, JM; Reiner, SL; Weinmann, AS; Wherry, EJ				Kao, Charlly; Oestreich, Kenneth J.; Paley, Michael A.; Crawford, Alison; Angelosanto, Jill M.; Ali, Mohammed-Alkhatim A.; Intlekofer, Andrew M.; Boss, Jeremy M.; Reiner, Steven L.; Weinmann, Amy S.; Wherry, E. John			Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8(+) T cell responses during chronic infection	NATURE IMMUNOLOGY			English	Article							CHRONIC VIRAL-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ELEVATED FREQUENCIES; DISEASE PROGRESSION; PROGRAMMED DEATH-1; INTERFERON-GAMMA; EXHAUSTION; TIM-3; DIFFERENTIATION; ACTIVATION	T cell exhaustion has a major role in failure to control chronic infection. High expression of inhibitory receptors, including PD-1, and the inability to sustain functional T cell responses contribute to exhaustion. However, the transcriptional control of these processes remains unclear. Here we demonstrate that the transcription factor T-bet regulated the exhaustion of CD8(+) T cells and the expression of inhibitory receptors. T-bet directly repressed transcription of the gene encoding PD-1 and resulted in lower expression of other inhibitory receptors. Although a greater abundance of T-bet promoted terminal differentiation after acute infection, high T-bet expression sustained exhausted CD8(+) T cells and repressed the expression of inhibitory receptors during chronic viral infection. Persistent antigenic stimulation caused downregulation of T-bet, which resulted in more severe exhaustion of CD8(+) T cells. Our observations suggest therapeutic opportunities involving higher T-bet expression during chronic infection.	[Kao, Charlly; Paley, Michael A.; Crawford, Alison; Angelosanto, Jill M.; Ali, Mohammed-Alkhatim A.; Wherry, E. John] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kao, Charlly; Paley, Michael A.; Crawford, Alison; Angelosanto, Jill M.; Ali, Mohammed-Alkhatim A.; Intlekofer, Andrew M.; Reiner, Steven L.; Wherry, E. John] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Oestreich, Kenneth J.; Weinmann, Amy S.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Intlekofer, Andrew M.; Reiner, Steven L.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Pennsylvania; Emory University	Wherry, EJ (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; crawford, alison/AAS-3155-2020; Crawford, Alison/N-3234-2014	Paley, Michael/0000-0001-8724-3176; Crawford, Alison/0000-0002-4591-6341; Intlekofer, Andrew/0000-0001-9046-6549	US National Institutes of Health [AI007518, AI071309, AI082630, AI083022, AI078897, HHSN266200500030C, AI061699, AI076458]; Foundation for the National Institutes of Health and Grand Challenge in Global Health; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076458, R01AI042370, P01AI078897, U19AI083022, R01AI076458, U19AI082630, R01AI071309, T32AI007518, R01AI061699] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health and Grand Challenge in Global Health; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Pear (University of Pennsylvania) for human embryonic kidney 293T cells; members of the Wherry and Reiner laboratories as well as M. R. Betts for comments and insights; and N. Cereb, S.Y. Yang and L. Boring for assistance with construction of loxP-flanked Tbx21. Supported by the US National Institutes of Health (AI007518 to C. K.; AI071309, AI082630, AI083022, AI078897 and HHSN266200500030C to E.J.W.; and AI061699 and AI076458 to S. L. R.), the Foundation for the National Institutes of Health and Grand Challenge in Global Health (E.J.W.) and the Dana Foundation (E.J.W.).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Louten J, 2006, J IMMUNOL, V177, P3266, DOI 10.4049/jimmunol.177.5.3266; Mackerness KJ, 2010, J IMMUNOL, V185, P3643, DOI 10.4049/jimmunol.1000841; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	40	333	350	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					663	U117		10.1038/ni.2046	http://dx.doi.org/10.1038/ni.2046			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21623380	Green Accepted			2022-12-18	WOS:000291936400015
J	Vig, M; DeHaven, WI; Bird, GS; Billingsley, JM; Wang, H; Rao, PE; Hutchings, AB; Jouvin, MH; Putney, JW; Kinet, JP				Vig, Monika; DeHaven, Wayne I.; Bird, Gary S.; Billingsley, James M.; Wang, Huiyun; Rao, Patricia E.; Hutchings, Amy B.; Jouvin, Marie-Helene; Putney, James W.; Kinet, Jean-Pierre			Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels	NATURE IMMUNOLOGY			English	Article							CAPACITATIVE CA2+ ENTRY; FC-EPSILON-RI; LEUKOTRIENE C-4 SECRETION; AFFINITY IGE RECEPTOR; INTRACELLULAR CALCIUM; TRANSCRIPTION FACTORS; ADENYLYL CYCLASES; PLASMA-MEMBRANE; T-CELLS; PROTEINS	CRACM1 (also called Orai1) constitutes the pore subunit of store-operated calcium release-activated calcium channels. A point mutation in the gene encoding CRACM1 is associated with severe combined immunodeficiency disease in humans. Here we generated CRACM1-deficient mice in which P-galactosidase activity 'reported' CRACM1 expression. CRACM1-deficient mice were smaller in size. Mast cells derived from CRACM1-deficient mice showed grossly defective degranulation and cytokine secretion, and the allergic reactions elicited in vivo were inhibited in CRACM1-deficient mice. We detected robust CRACM1 expression in skeletal muscles and some regions of the brain, heart and kidney but not in the lymphoid regions of thymus and spleen. In contrast, we found CRACM2 expression to be much higher in mouse T cells. In agreement with those findings, the store-operated calcium influx and development and proliferation of CRACM1-deficient T cells was unaffected. Thus, CRACM1 is crucial in mouse mast cell effector function, but mouse T cell calcium release-activated calcium channels are functional in the absence of CRACM1.	[Vig, Monika; Billingsley, James M.; Wang, Huiyun; Jouvin, Marie-Helene; Kinet, Jean-Pierre] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [DeHaven, Wayne I.; Putney, James W.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Rao, Patricia E.; Hutchings, Amy B.] Synta Pharmaceut, Lexington, MA 02421 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Vig, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA.	mvig@bidmc.harvard.edu	Putney, James W/F-7247-2019; Bird, Gary/AAI-8186-2021	Putney, James W/0000-0002-3379-4789; Bird, Gary/0000-0003-1389-8748; Vig, Monika/0000-0002-4770-8853	Intramural NIH HHS [Z99 ES999999, Z01 ES090087-11] Funding Source: Medline; NIGMS NIH HHS [GM 053950, R37 GM053950, R01 GM053950] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087, Z01ES102485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053950, R01GM053950] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; COOPER DMF, 1994, BIOCHEM J, V297, P437, DOI 10.1042/bj2970437; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Klein M, 2006, J IMMUNOL, V177, P6667, DOI 10.4049/jimmunol.177.10.6667; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Nadler MJS, 2002, NAT IMMUNOL, V3, P707, DOI 10.1038/ni0802-707; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PENNER R, 1988, FEBS LETT, V226, P307, DOI 10.1016/0014-5793(88)81445-5; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	40	333	343	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					89	96		10.1038/ni1550	http://dx.doi.org/10.1038/ni1550			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18059270	Green Accepted			2022-12-18	WOS:000251820800015
J	Saveanu, L; Carroll, O; Lindo, V; Del Val, M; Lopez, D; Lepelletier, Y; Greer, F; Schomburg, L; Fruci, D; Niedermann, G; van Endert, PM				Saveanu, L; Carroll, O; Lindo, V; Del Val, M; Lopez, D; Lepelletier, Y; Greer, F; Schomburg, L; Fruci, D; Niedermann, G; van Endert, PM			Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; EPITOPE PRECURSOR PEPTIDES; HAMSTER OVARY CELLS; ANTIGEN PRESENTATION; THIMET OLIGOPEPTIDASE; PRESENTED PEPTIDES; TRANSPORTERS; PROTEIN; ER; TRANSLOCATION	The generation of many HLA class 1 peptides entails a final trimming step in the endoplasmic reticulum that, in humans, is accomplished by two 'candidate' aminopeptidases. We show here that one of these, ERAP1, was unable to remove several N-terminal amino acids that were trimmed efficiently by the second enzyme, ERAP2. This trimming of a longer peptide required the concerted action of both ERAP1 and ERAP2, both for in vitro digestion and in vivo for cellular antigen presentation. ERAP1 and ERAP2 localized together in vivo and associated physically in complexes that were most likely heterodimeric. Thus, the human endoplasmic reticulum is equipped with a pair of trimming aminopeptidases that have complementary functions in HLA class I peptide presentation.	Univ Paris 05, INSERM, Unite 580, F-75015 Paris, France; M SCAN, Wokingham RG41 2TZ, Berks, England; Inst Salud Carlos III, Ctr Nacl Microbiol, Majadahonda 28220, Spain; CNRS, UMR 8147, Necker Inst, F-75015 Paris, France; Inst Expt Endocrinol, D-10117 Berlin, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	van Endert, PM (corresponding author), Univ Paris 05, INSERM, Unite 580, F-75015 Paris, France.	vanender@necker.fr	Schomburg, Lutz/D-8096-2013; Saveanu, Loredana/K-6821-2017; Del Val, Margarita/E-4769-2010; van Endert, Peter/R-4606-2017; SAVEANU, Loredana/Q-1241-2019; lepelletier, yves/AAF-1546-2020; Fruci, Doriana/AAA-8218-2019; López, Daniel/I-2632-2014	Schomburg, Lutz/0000-0001-9445-1555; Del Val, Margarita/0000-0001-6769-4279; van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; lepelletier, yves/0000-0001-7746-5170; Fruci, Doriana/0000-0003-3388-7296; López, Daniel/0000-0003-0268-5878				Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Daniel S, 1998, J IMMUNOL, V161, P617; Fourneau JM, 2004, J IMMUNOL METHODS, V285, P253, DOI 10.1016/j.jim.2003.11.011; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; MARKS MS, 2000, CURRENT PROTOCOLS CE, V1; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; NEISIG A, 1995, J IMMUNOL, V154, P1273; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	33	333	348	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					689	697		10.1038/ni1208	http://dx.doi.org/10.1038/ni1208			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15908954				2022-12-18	WOS:000229975500012
J	Yang, JH; Lin, Y; Guo, ZJ; Cheng, JK; Huang, JY; Deng, L; Liao, W; Chen, ZJ; Liu, ZG; Su, B				Yang, JH; Lin, Y; Guo, ZJ; Cheng, JK; Huang, JY; Deng, L; Liao, W; Chen, ZJ; Liu, ZG; Su, B			The essential role of MEKK3 in TNF-induced NF-kappa B activation	NATURE IMMUNOLOGY			English	Article							INDUCED CELL-DEATH; KINASE-ALPHA; INDUCED APOPTOSIS; RIP; BETA; IKK; PROTEIN; COMPLEX; PHOSPHORYLATION; RECRUITMENT	Activation of I kappaB kinase (IKK) is the key step in stimulation of the transcription factor NF-kappaB, which regulates many genes in the inflammatory response pathway. The molecular mechanism that underlies IKK activation in response to tumor necrosis factor (TNF) is still unknown. Using mitogen-activated protein kinase kinase kinase 3 (MEKK3)-deficient fibroblast cells, we found that MEKK3 plays a critical role in TNF-induced NF-kappaB activation. We have shown that MEKK3 is required for IKK activation and functions downstream of receptor-interacting protein (RIP) and TNF receptor-associated factor 2. We have also shown that MEKK3 interacts with RIP and directly phosphorylates IKK. The kinase activity of MEKK3 is pivotal to its function and, therefore, MEKK3 links RIP and IKK in TNF-induced NF-kappaB activation.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; NCI, Dept Cell & Canc Biol, Med Branch, Div Clin Sci,NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75235 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Su, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.				NCI NIH HHS [CA16672] Funding Source: Medline; NIAID NIH HHS [AI44016] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044016] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mosmann T., 1983, J IMMUNOL METHODS, V65, p55e63; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	31	332	351	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					620	624		10.1038/89769	http://dx.doi.org/10.1038/89769			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429546				2022-12-18	WOS:000169682100015
J	Coornaert, B; Baens, M; Heyninck, K; Bekaert, T; Haegman, M; Staal, J; Sun, LJ; Chen, ZJJ; Marynen, P; Beyaert, R				Coornaert, Beatrice; Baens, Mathijs; Heyninck, Karen; Bekaert, Tine; Haegman, Mira; Staal, Jens; Sun, Lijun; Chen, Zhijian J.; Marynen, Peter; Beyaert, Rudi			T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappa B inhibitor A20	NATURE IMMUNOLOGY			English	Article							DEPENDENT GENE-EXPRESSION; CHROMOSOMAL TRANSLOCATION; CYTOKINE PRODUCTION; SIGNALING PATHWAY; UBIQUITIN LIGASE; LIPID RAFTS; ACTIVATION; BCL10; LYMPHOMA; CARMA1	The paracaspase MALT1 mediates T cell antigen receptor-induced signaling to the transcription factor NF-kappa B and is indispensable for T cell activation and proliferation. Enhanced expression of MALT1 or aberrant expression of a fusion protein of the apoptosis inhibitor API2 and MALT1 has been linked to mucosa-associated lymphoid tissue lymphoma. Despite the presence of a caspase-like domain, MALT1 proteolytic activity has not yet been demonstrated. Here we show that T cell antigen receptor stimulation induced recruitment of the NF-kappa B inhibitor A20 into a complex of MALT1 and the adaptor protein Bcl-10, leading to MALT1-mediated processing of A20. API2-MALT1 expression likewise resulted in cleavage of A20. MALT1 cleaved human A20 after arginine 439 and impaired its NF-kappa B-inhibitory function. Our studies identify A20 as a substrate of MALT1 and emphasize the importance of MALT1 proteolytic activity in the 'fine tuning' of T cell antigen receptor signaling.	[Coornaert, Beatrice; Heyninck, Karen; Bekaert, Tine; Haegman, Mira; Staal, Jens; Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; [Coornaert, Beatrice; Heyninck, Karen; Bekaert, Tine; Haegman, Mira; Staal, Jens; Beyaert, Rudi] VIB, Unit Mol Signal Transduct Inflammat, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Baens, Mathijs; Marynen, Peter] Catholic Univ Louvain, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Baens, Mathijs; Marynen, Peter] VIB, Dept Mol & Dev Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA	Ghent University; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Beyaert, R (corresponding author), Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium.	rudi.beyaert@dmbr.ugent.be	Chen, Zhijian/C-6039-2012; Beyaert, Rudi/B-2589-2009; Sun, Lijun/ABD-4470-2021; Staal, Jens/B-7383-2008	Chen, Zhijian/0000-0002-8475-8251; Staal, Jens/0000-0003-2664-3357; Beyaert, Rudi/0000-0002-5704-582X; Haegman, Mira/0000-0002-4883-312X				Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ferch U, 2007, NAT IMMUNOL, V8, P984, DOI 10.1038/ni1493; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Klinkenberg M, 2001, FEBS LETT, V498, P93, DOI 10.1016/S0014-5793(01)02504-2; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TEWARI M, 1995, J IMMUNOL, V154, P1699; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	39	331	349	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					263	271		10.1038/ni1561	http://dx.doi.org/10.1038/ni1561			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18223652				2022-12-18	WOS:000253406700012
J	Oppenheim, DE; Roberts, SJ; Clarke, SL; Filler, R; Lewis, JM; Tigelaar, RE; Girardi, M; Hayday, AC				Oppenheim, DE; Roberts, SJ; Clarke, SL; Filler, R; Lewis, JM; Tigelaar, RE; Girardi, M; Hayday, AC			Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NK CELL-FUNCTION; DELTA T-CELLS; DENDRITIC CELLS; CELIAC-DISEASE; CUTTING EDGE; MIC LIGANDS; NOD MICE; GAMMA; MOLECULES	Upregulation of the inducible gene products MICA ( human) and Rae- 1 ( mouse) may promote tumor surveillance and autoimmunity by engaging the activating receptor NKG2D on natural killer ( NK) cells and T cells. Nevertheless, sustained expression of MICA by tumors can also elicit NKG2D downregulation, perhaps indicating ' immunoevasion'. Investigating this paradox, we report here that constitutive Rae- 1 epsilon transgene expression in normal epithelium elicited local and systemic NKG2D downregulation, generalized but reversible defects in NK cell - mediated cytotoxicity and mild CD8(+) T cell defects. The extent of NKG2D downregulation correlated well with the incidence and progression of cutaneous carcinogenesis, emphasizing the utility of NKG2D as a marker of tumor resistance. Thus, NKG2D engagement is a natural mediator of immunosurveillance, which can be compromised by locally sustained ligand expression but potentially restored by innate immune activation.	Univ London Kings Coll, Guys Kings St Thomas Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06511 USA	University of London; King's College London; Yale University	Hayday, AC (corresponding author), Univ London Kings Coll, Guys Kings St Thomas Sch Med, Peter Gorer Dept Immunobiol, Guys Hosp Campus, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343	Wellcome Trust [071534] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Girardi M, 2004, J INVEST DERMATOL, V122, P699, DOI 10.1111/j.0022-202X.2004.22342.x; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johansson SE, 2004, INT IMMUNOL, V16, P1, DOI 10.1093/intimm/dxh002; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Kiessling R, 1978, Contemp Top Immunobiol, V8, P171; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Masuda H, 2002, BIOCHEM BIOPH RES CO, V290, P140, DOI 10.1006/bbrc.2001.6165; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Millrain M, 2001, J IMMUNOL, V167, P3756, DOI 10.4049/jimmunol.167.7.3756; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Pende D, 2002, CANCER RES, V62, P6178; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	50	331	349	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					928	937		10.1038/ni1239	http://dx.doi.org/10.1038/ni1239			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116470				2022-12-18	WOS:000231369800023
J	Triantafilou, K; Triantafilou, M; Dedrick, RL				Triantafilou, K; Triantafilou, M; Dedrick, RL			A CD14-independent LPS receptor cluster	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-4; CELL-SURFACE; LIPOPOLYSACCHARIDE LPS; ENERGY-TRANSFER; PROTEIN; BINDING; CD14; ACTIVATION; IDENTIFICATION; MACROPHAGES	Bacterial lipopolysaccharide (LPS), the major structural component of the outer wall of Gram-negative bacteria, is a potent initiator of an inflammatory response and serves as an indicator of bacterial infection. Although CD14 has been identified as the main LPS receptor, accumulating evidence has suggested the possible existence of other functional receptor(s). In this study, using affinity chromatography, peptide mass fingerprinting and fluorescence resonance energy transfer, we have identified four new proteins that form an activation cluster after LPS ligation and are involved in LPS signal transduction. Here we present evidence that implicates heat shock proteins 70 and 90, chemokine receptor 4 and growth differentiation factor 5 as the main mediators of activation by bacterial lipopolysaccharide.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; XOMA US LLC, Mol Immunol, Berkeley, CA 94710 USA	University of Essex	Triantafilou, K (corresponding author), Univ Portsmouth, Sch Biol Sci, King Henry Bldg,King Henry I St, Portsmouth PO1 2DY, Hants, England.	kathy.triantafilou@port.ac.uk						ARNOLD DFS, 1995, J EXP MED, V162, P3757; Birk OS, 1999, P NATL ACAD SCI USA, V96, P5159, DOI 10.1073/pnas.96.9.5159; Blondin C, 1997, EUR J IMMUNOL, V27, P3303, DOI 10.1002/eji.1830271229; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Breloer M, 1999, J IMMUNOL, V162, P3141; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GESSANI S, 1993, J IMMUNOL, V151, P3758; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Guzhova IV, 1998, CELL STRESS CHAPERON, V3, P67, DOI 10.1379/1466-1268(1998)003<0067:EOESPO>2.3.CO;2; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hirai I, 1998, CELL STRUCT FUNCT, V23, P153, DOI 10.1247/csf.23.153; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; KAUR I, 1993, J IMMUNOL, V150, P2046; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KENWORTHY AK, 1998, METHOD MOL BIOL, P37; KIRIKAE T, 1988, MICROBIOL IMMUNOL, V32, P33, DOI 10.1111/j.1348-0421.1988.tb01363.x; KIRKLAND TN, 1990, J BIOL CHEM, V265, P9520; LEI MG, 1993, IMMUNOL LETT, V36, P245, DOI 10.1016/0165-2478(93)90096-K; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; MANTHEY CL, 1994, J ENDOTOXIN RES, V1, P189; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Moriuchi M, 1998, J CLIN INVEST, V102, P1540, DOI 10.1172/JCI4151; Multhoff G, 1997, J IMMUNOL, V158, P4341; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; SZOLLOSI J, 1989, J IMMUNOL, V143, P208; Takashima S, 1996, J IMMUNOL, V157, P3391; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Tohme ZN, 1999, INFECT IMMUN, V67, P3215, DOI 10.1128/IAI.67.7.3215-3220.1999; Triantafilou K, 2001, HUM IMMUNOL, V62, P50, DOI 10.1016/S0198-8859(00)00222-6; Triantafilou M, 2000, EUR J BIOCHEM, V267, P2218, DOI 10.1046/j.1432-1327.2000.01222.x; Troelstra A, 1997, INFECT IMMUN, V65, P2272, DOI 10.1128/IAI.65.6.2272-2277.1997; TSUBOI N, 1994, HYBRIDOMA, V48, P2798; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664	49	331	347	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					338	345		10.1038/86342	http://dx.doi.org/10.1038/86342			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276205				2022-12-18	WOS:000167982900015
J	Shi, HX; Wang, Y; Li, XH; Zhan, XM; Tang, M; Fina, M; Su, LJ; Pratt, D; Bu, CH; Hildebrand, S; Lyon, S; Scott, L; Quan, JX; Sun, QH; Russell, J; Arnett, S; Jurek, P; Chen, D; Kravchenko, VV; Mathison, JC; Moresco, EMY; Monson, NL; Ulevitch, RJ; Beutler, B				Shi, Hexin; Wang, Ying; Li, Xiaohong; Zhan, Xiaoming; Tang, Miao; Fina, Maggy; Su, Lijing; Pratt, David; Bu, Chun Hui; Hildebrand, Sara; Lyon, Stephen; Scott, Lindsay; Quan, Jiexia; Sun, Qihua; Russell, Jamie; Arnett, Stephanie; Jurek, Peter; Chen, Ding; Kravchenko, Vladimir V.; Mathison, John C.; Marie Y Moresco, Eva; Monson, Nancy L.; Ulevitch, Richard J.; Beutler, Bruce			NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; KINASE; ENCEPHALOMYELITIS; MITOCHONDRIA; CENTROSOME	The NLRP3 inflammasome responds to microbes and danger signals by processing and activating proinflammatory cytokines, including interleukin 1 beta (IL-1 beta) and IL-18. We found here that activation of the NLRP3 inflammasome was restricted to interphase of the cell cycle by NEK7, a serine-threonine kinase previously linked to mitosis. Activation of the NLRP3 inflammasome required NEK7, which bound to the leucine-rich repeat domain of NLRP3 in a kinase-independent manner downstream of the induction of mitochondrial reactive oxygen species (ROS). This interaction was necessary for the formation of a complex containing NLRP3 and the adaptor ASC, oligomerization of ASC and activation of caspase-1. NEK7 promoted the NLRP3-dependent cellular inflammatory response to intraperitoneal challenge with monosodium urate and the development of experimental autoimmune encephalitis in mice. Our findings suggest that NEK7 serves as a cellular switch that enforces mutual exclusivity of the inflammasome response and cell division.	[Shi, Hexin; Wang, Ying; Li, Xiaohong; Zhan, Xiaoming; Tang, Miao; Fina, Maggy; Su, Lijing; Pratt, David; Bu, Chun Hui; Hildebrand, Sara; Lyon, Stephen; Scott, Lindsay; Quan, Jiexia; Sun, Qihua; Russell, Jamie; Arnett, Stephanie; Jurek, Peter; Marie Y Moresco, Eva; Beutler, Bruce] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Chen, Ding; Monson, Nancy L.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Kravchenko, Vladimir V.; Mathison, John C.; Ulevitch, Richard J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute	Beutler, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA.	bruce.beutler@utsouthwestern.edu	Ulevitch, Richard J/Q-3393-2017	Moresco, Eva Marie/0000-0002-2049-7291; Hildebrand, Sara/0000-0002-5534-3604; Scott, Lindsay/0000-0003-4243-4010	US National Institutes of Health [U19 AI100627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Zaki (University of Texas Southwestern Medical Center) for Nlrp3<SUP>-/-</SUP>(B6.129S6_Nlrp3<SUP>tm1Bhk</SUP>/J mice; and F. Shao (National Institute of Biological Sciences, Beijing, China) for the NLRC4 plasmid. Supported by the US National Institutes of Health (U19 AI100627).	Aksentijevich I, 2006, ARTHRITIS RHEUM, V54, P2703, DOI 10.1002/art.22022; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cooper G.M., 2000, CELL MOL APPROACH; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; JACOBS CA, 1991, J IMMUNOL, V146, P2983; Jesus AA, 2008, J CLIN IMMUNOL, V28, P134, DOI 10.1007/s10875-007-9150-7; Kandli M, 2000, GENOMICS, V68, P187, DOI 10.1006/geno.2000.6293; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; MARTIN D, 1995, J NEUROIMMUNOL, V61, P241, DOI 10.1016/0165-5728(95)00108-E; Matsubayashi T, 2006, ACTA PAEDIATR, V95, P246, DOI 10.1080/08035250500341451; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang T, 2015, P NATL ACAD SCI USA, V112, pE440, DOI 10.1073/pnas.1423216112; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	34	330	342	4	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					250	258		10.1038/ni.3333	http://dx.doi.org/10.1038/ni.3333			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26642356	Green Accepted			2022-12-18	WOS:000370469300009
J	Ilarregui, JM; Croci, DO; Bianco, GA; Toscano, MA; Salatino, M; Vermeulen, ME; Geffner, JR; Rabinovich, GA				Ilarregui, Juan M.; Croci, Diego O.; Bianco, German A.; Toscano, Marta A.; Salatino, Mariana; Vermeulen, Monica E.; Geffner, Jorge R.; Rabinovich, Gabriel A.			Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTING CELLS; CENTRAL-NERVOUS-SYSTEM; AUTOIMMUNE ENCEPHALOMYELITIS; GLYCAN INTERACTIONS; TUMOR-CELLS; EXPRESSION; INNATE; CYTOKINE; EFFECTOR; IMMUNITY	Despite their central function in orchestrating immunity, dendritic cells (DCs) can respond to inhibitory signals by becoming tolerogenic. Here we show that galectin-1, an endogenous glycan-binding protein, can endow DCs with tolerogenic potential. After exposure to galectin-1, DCs acquired an interleukin 27 (IL-27)-dependent regulatory function, promoted IL-10-mediated T cell tolerance and suppressed autoimmune neuroinflammation. Consistent with its regulatory function, galectin-1 had its highest expression on DCs exposed to tolerogenic stimuli and was most abundant from the peak through the resolution of autoimmune pathology. DCs lacking galectin-1 had greater immunogenic potential and an impaired ability to halt inflammatory disease. Our findings identify a tolerogenic circuit linking galectin-1 signaling, IL-27-producing DCs and IL-10-secreting T cells, which has broad therapeutic implications in immunopathology.	[Ilarregui, Juan M.; Croci, Diego O.; Bianco, German A.; Toscano, Marta A.; Salatino, Mariana; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Ilarregui, Juan M.; Croci, Diego O.; Bianco, German A.; Toscano, Marta A.; Salatino, Mariana; Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Div Inmunogenet, Buenos Aires, DF, Argentina; [Vermeulen, Monica E.; Geffner, Jorge R.] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires	Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina.	gabyrabi@gmail.com	Croci, Diego/AAJ-5709-2021; Toscano, Marta/HGU-4103-2022	Croci, Diego/0000-0002-8623-0645; Toscano, Marta/0000-0003-0502-8929; Ilarregui, Juan Martin/0000-0002-6871-6764	National Agency for Promotion of Science and Technology (Argentina); Sales Foundation for Cancer Research (Argentina); National Council of Scientific and Technical Investigation (Argentina); University of Buenos Aires (Argentina); Fiorini Foundation (Argentina); Cancer Research Institute (USA); Mizutani Foundation for Glycoscience (Japan); Prostate Cancer Foundation (UK)	National Agency for Promotion of Science and Technology (Argentina)(ANPCyT); Sales Foundation for Cancer Research (Argentina); National Council of Scientific and Technical Investigation (Argentina); University of Buenos Aires (Argentina)(University of Buenos Aires); Fiorini Foundation (Argentina); Cancer Research Institute (USA); Mizutani Foundation for Glycoscience (Japan); Prostate Cancer Foundation (UK)	We thank F. Poirier (Institut Jacques Monod) for Lgals1<SUP>-/-</SUP> mice; C. J. Saris (Amgen) for Il27ra<SUP>-/-</SUP> mice; H. Rosenberg (National Institutes of Health) for critical reading of the manuscript; L. Baum (University of California at Los Angeles) for plasmids; M. Doenhoff (University of Nottingham) for endotoxin-free SEA; J. Correale, N. Rubinstein, S. Blois and N. Zwirner for advice; M. Barboza and J. Stupirski for technical assistance; C. Ricordi for support; the staff of the Animal Facilities of the Institute of Biology and Experimental Medicine and the Faculty of Exact and Natural Sciences (University of Buenos Aires); and the Ferioli and Ostry families for donations. Dedicated to the memory of E. Massouh. Supported by The National Agency for Promotion of Science and Technology (Argentina), Sales Foundation for Cancer Research (Argentina), National Council of Scientific and Technical Investigation (Argentina), University of Buenos Aires (Argentina), Fiorini Foundation (Argentina), Cancer Research Institute (USA), Mizutani Foundation for Glycoscience (Japan) and Prostate Cancer Foundation (UK).	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bettelli E, 1998, J IMMUNOL, V161, P3299; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Chorny A, 2005, P NATL ACAD SCI USA, V102, P13562, DOI 10.1073/pnas.0504484102; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kotera Y, 2001, CANCER RES, V61, P8105; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Sarter K, 2009, BIOCHEM BIOPH RES CO, V379, P155, DOI 10.1016/j.bbrc.2008.12.024; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Urzainqui A, 2007, J IMMUNOL, V179, P7457, DOI 10.4049/jimmunol.179.11.7457; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	54	330	347	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					981	U75		10.1038/ni.1772	http://dx.doi.org/10.1038/ni.1772			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19668220				2022-12-18	WOS:000269120900012
J	Yan, MH; Wang, M; Chan, B; Roose-Girma, M; Erickson, S; Baker, T; Tumas, D; Grewal, IS; Dixit, VM				Yan, MH; Wang, M; Chan, B; Roose-Girma, M; Erickson, S; Baker, T; Tumas, D; Grewal, IS; Dixit, VM			Activation and accumulation of B cells in TACI-deficient mice	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR FAMILY; LYMPHOCYTE STIMULATOR; RECEPTOR SUPERFAMILY; AUTOIMMUNE-DISEASE; HUMORAL IMMUNITY; TNF FAMILY; KAPPA-B; MEMBER; BLYS; TALL-1	The tumor necrosis factor (TNF)-related ligand B lymphocyte stimulator (BLyS) binds two TNF receptor family members, transmembrane activator and calcium-modulating and cyclophilin ligand interactor (TACI) and B cell maturation molecule (BCMA). Mice that are transgenic for BLyS show a cell accumulation, activation and autoimmune lupus-like nephritis. The existence of at least two distinct BLyS receptors raises the question of the relative contribution of each to B cell functions. We therefore generated mice that were deficient in TACI, TACI(-/-) mice showed increased a cell accumulation and marked splenomegaly. isolated TACI(-/-) B cells hyperproliferated and produced increased amounts of immunoglobulins in vitro. In vivo antigen challenge resulted in enhanced antigen-specific antibody production. Thus, TACI may play an unexpected inhibitory role in a cell activation that helps maintain immunological homeostasis.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	iqbal@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Grewal, Iqbal S/0000-0002-4775-055X				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Khare SD, 2001, TRENDS IMMUNOL, V22, P61, DOI 10.1016/S1471-4906(00)01843-3; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	28	329	344	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					638	643		10.1038/89790	http://dx.doi.org/10.1038/89790			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429549				2022-12-18	WOS:000169682100018
J	Hartner, JC; Walkley, CR; Lu, J; Orkin, SH				Hartner, Jochen C.; Walkley, Carl R.; Lu, Jun; Orkin, Stuart H.			ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; ADENOSINE-DEAMINASE ADAR1; SLAM FAMILY RECEPTORS; EDITING ENZYME ADAR1; STEM-CELLS; GENE-EXPRESSION; HUMAN TRANSCRIPTOME; ACTIVATION; INFECTION; MUTATION	The deaminase ADAR1 edits adenosines in nuclear transcripts of nervous tissue and is required in the fetal liver of the developing mouse embryo. Here we show by inducible gene disruption in mice that ADAR1 is essential for maintenance of both fetal and adult hematopoietic stem cells. Loss of ADAR1 in hematopoietic stem cells led to global upregulation of type I and II interferon-inducible transcripts and rapid apoptosis. Our findings identify ADAR1 as an essential regulator of hematopoietic stem cell maintenance and suppressor of interferon signaling that may protect organisms from the deleterious effects of interferon activation associated with many pathological processes, including chronic inflammation, autoimmune disorders and cancer.	[Hartner, Jochen C.; Walkley, Carl R.; Lu, Jun; Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hartner, Jochen C.; Walkley, Carl R.; Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Lu, Jun] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Walkley, Carl/AAO-6021-2020	Walkley, Carl/0000-0002-4784-9031	Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Leukemia and Lymphoma Society ( C. R. W.) and the Howard Hughes Medical Institute ( S. H. O.).	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 2008, VIROLOGY, V380, P338, DOI 10.1016/j.virol.2008.07.029; Gordon KM, 2003, J IMMUNOL METHODS, V275, P113, DOI 10.1016/S0022-1759(03)00009-7; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; OKADA S, 1992, BLOOD, V80, P3044; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sinclair A, 1996, BLOOD, V87, P2750, DOI 10.1182/blood.V87.7.2750.bloodjournal8772750; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TSAI FY, 1994, GATANATURE, V371, P221; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	43	328	342	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					109	115		10.1038/ni.1680	http://dx.doi.org/10.1038/ni.1680			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19060901	Green Accepted			2022-12-18	WOS:000261788800018
J	Hsu, YMS; Zhang, YL; You, Y; Wang, DH; Li, HX; Duramad, O; Qin, XF; Dong, C; Lin, X				Hsu, Yen-Michael S.; Zhang, Yongliang; You, Yun; Wang, Donghai; Li, Hongxiu; Duramad, Omar; Qin, Xiao-Feng; Dong, Chen; Lin, Xin			The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; RIG-I; SIGNALING PATHWAY; RECOGNITION; ACTIVATION; CARMA1; VIRUS; TRAF3	The caspase-recruitment domain-containing adaptor protein CARD9 regulates the innate signaling responses to fungal infection. Here we show that CARD9 is required for innate immune responses against intracellular pathogens. We generated Card9(-/-) mice and found that CARD9-deficient macrophages had defects in activation of the kinases p38 and Jnk but not of transcription factor NF-kappa B after bacterial and viral infection. CARD9-deficient mice failed to clear infection and showed altered cytokine production after challenge with Listeria monocytogenes. In wild-type cells, we found CARD9 inducibly associated with both the intracellular 'biosensor' Nod2 and the serine-threonine kinase RICK. Our data demonstrate that CARD9 has a critical function in Nod2-mediated activation of p38 and Jnk in innate immune responses to intracellular pathogens.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lin, X (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	xllin@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; QIN, FRANK XIAOFENG/0000-0002-5395-0304				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	33	327	347	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					198	205		10.1038/ni1426	http://dx.doi.org/10.1038/ni1426			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17187069	Green Published			2022-12-18	WOS:000243597600018
J	Silke, J; Rickard, JA; Gerlic, M				Silke, John; Rickard, James A.; Gerlic, Motti			The diverse role of RIP kinases in necroptosis and inflammation	NATURE IMMUNOLOGY			English	Review							RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; NF-KAPPA-B; CELL-DEATH; PROGRAMMED NECROSIS; MEDIATES NECROPTOSIS; MOUSE MODEL; CASPASE-8; ACTIVATION	Inflammation is a healthy response to infection or danger and should be rapid, specific and terminated once the threat has passed. Inflammatory diseases, where this regulation fails, cause considerable human suffering. Treatments have successfully targeted pro-inflammatory cytokines, such as tumor-necrosis factor (TNF), that directly induce genes encoding inflammatory products. Inflammatory signals, including TNF, may also directly induce caspase-independent cell death (necroptosis), which can also elicit inflammation. Necroptosis was originally defined as being dependent on the kinase RIPK1 but is now known to be dependent on RIPK3 and the pseudo-kinase MLKL. Therefore, RIPK1, RIPK3 and MLKL are potential therapeutic targets. RIPK1 and RIPK3 also directly regulate inflammatory signaling, which complicates interpretation of their function but might alter their therapeutic utility. This Review examines the role of cell death, particularly necroptosis, in inflammation, in the context of recent insights into the roles of the key necroptosis effector molecules RIPK1, RIPK3 and MLKL.	[Silke, John; Rickard, James A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Silke, John; Rickard, James A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Gerlic, Motti] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Tel Aviv University; Sackler Faculty of Medicine	Silke, J (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	j.silke@latrobe.edu.au; mgerlic@post.tau.ac.il	gerlic, Motti/I-5492-2019; Gerlic, Motti/U-3484-2017; Silke, John/B-7622-2008	gerlic, Motti/0000-0001-9518-1833; Gerlic, Motti/0000-0001-9518-1833; Silke, John/0000-0002-7611-5774				Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Croker BA, 2014, CURR OPIN IMMUNOL, V26, P128, DOI 10.1016/j.coi.2013.12.002; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dobbelstein M, 1996, J VIROL, V70, P6479, DOI 10.1128/JVI.70.9.6479-6485.1996; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Dowling JP, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00012; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Feldmann M, 2010, J IMMUNOL, V185, P791, DOI 10.4049/jimmunol.1090051; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gerlic M, 2013, P NATL ACAD SCI USA, V110, P7808, DOI 10.1073/pnas.1215995110; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Grobner S, 2007, APOPTOSIS, V12, P1813, DOI 10.1007/s10495-007-0100-x; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Madrigal AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002723; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Moulin M, 2012, EMBO J, V31, P1679, DOI 10.1038/emboj.2012.18; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Omoto S, 2015, J BIOL CHEM, V290, P11635, DOI 10.1074/jbc.M115.646042; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093944; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Roderick JE, 2014, P NATL ACAD SCI USA, V111, P14436, DOI 10.1073/pnas.1409389111; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Silke J, 2015, SEMIN CELL DEV BIOL, V39, P97, DOI 10.1016/j.semcdb.2014.12.004; Silke J, 2013, CURR OPIN IMMUNOL, V25, P436, DOI 10.1016/j.coi.2013.05.011; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vucur M, 2013, CELL REP, V4, P776, DOI 10.1016/j.celrep.2013.07.035; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhu S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.94	124	326	342	12	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					689	697		10.1038/ni.3206	http://dx.doi.org/10.1038/ni.3206			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086143				2022-12-18	WOS:000356445600005
J	Ben-Neriah, Y				Ben-Neriah, Y			Regulatory functions of ubiquitination in the immune system	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; NUCLEAR EXPORT SIGNAL; GLYCINE-RICH REGION; CBL-B; NEGATIVE REGULATOR; MEDIATED UBIQUITINATION; TRANSCRIPTION FACTOR; LIGASE ACTIVITY; PRECURSOR P105; KINASE COMPLEX	Protein modification via covalent attachment of ubiquitin has emerged as one of the most common regulatory processes in all eukaryotes; it is possibly second only to phosphorylation. In fact, ubiquitination and phosphorylation have much in common: both occur rapidly-often in response to an extracellular signal-and both are quickly reversed by a large set of dedicated enzymes termed deubiquitination enzymes and phosphatases, respectively. In addition, these two protein-modification events often cooperate in mobilizing a particular cellular pathway. Traditionally, ubiquitination has been associated with proteolytic events, mostly in conjunction with the 26S proteosome. Recently, however, ubiquitination has been implicated in other regulatory mechanisms. Some involve proteosome-independent protein degradation, whereas others are entirely proteolysis-independent, ranging from protein kinase activation to translation control. Therefore, it is not surprising that the ever-evolving immune system is an excellent mirror for the multiple roles played by ubiquitination within an organism.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel.	yinon@cc.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019					ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krawczyk C, 2001, TRENDS CELL BIOL, V11, P212, DOI 10.1016/S0962-8924(01)01981-X; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Mansour S, 2001, AM J MED GENET, V99, P172, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y; Migone TS, 2001, BLOOD, V98, P1935, DOI 10.1182/blood.V98.6.1935; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Orian A, 1999, MOL CELL BIOL, V19, P3664; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Pawson T, 2000, GENE DEV, V14, P1027; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; TARN WF, 2001, J BIOL CHEM, V276, P7701; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	86	326	340	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					20	26		10.1038/ni0102-20	http://dx.doi.org/10.1038/ni0102-20			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753406				2022-12-18	WOS:000173148700010
J	PrabhuDas, M; Bonney, E; Caron, K; Dey, S; Erlebacher, A; Fazleabas, A; Fisher, S; Golos, T; Matzuk, M; McCune, JM; Mor, G; Schulz, L; Soares, M; Spencer, T; Strominger, J; Way, SS; Yoshinaga, K				PrabhuDas, Mercy; Bonney, Elizabeth; Caron, Kathleen; Dey, Sudhansu; Erlebacher, Adrian; Fazleabas, Asgerally; Fisher, Susan; Golos, Thaddeus; Matzuk, Martin; McCune, Joseph M.; Mor, Gil; Schulz, Laura; Soares, Michael; Spencer, Thomas; Strominger, Jack; Way, Sing Sing; Yoshinaga, Koji			Immune mechanisms at the maternal-fetal interface: perspectives and challenges	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; PLACENTA; IMPLANTATION; SYSTEM		[PrabhuDas, Mercy] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA; [Bonney, Elizabeth] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Caron, Kathleen] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Dey, Sudhansu] Cincinnati Childrens Hosp, Div Reprod Sci, Cincinnati, OH USA; [Erlebacher, Adrian] NYU, Sch Med, Dept Pathol, New York, NY USA; [Fazleabas, Asgerally] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Fisher, Susan] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Golos, Thaddeus] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Matzuk, Martin] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [McCune, Joseph M.] San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94110 USA; [McCune, Joseph M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mor, Gil] Yale Univ, Sch Med, Div Reprod Sci, New Haven, CT USA; [Schulz, Laura] Univ Missouri, Div Reprod & Pernatal Res, Columbia, MO USA; [Soares, Michael] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66103 USA; [Spencer, Thomas] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Strominger, Jack] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Way, Sing Sing] Cincinnati Childrens Hosp, Div Infect Dis, Cincinnati, OH USA; [Yoshinaga, Koji] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Fertil & Infertil Branch, Div Extramural Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Vermont; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; New York University; Michigan State University; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Yale University; University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center; Washington State University; Harvard University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	PrabhuDas, M (corresponding author), NIAID, Div Allergy Immunol & Transplantat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mprabhudas@niaid.nih.gov	Spencer, Thomas/AAD-6434-2020	Spencer, Thomas/0000-0003-2815-766X; Way, Sing Sing/0000-0001-8948-1952; Caron, Kathleen/0000-0002-7033-9232; Schulz, Laura/0000-0001-8722-6616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD079363, R21HD082535, R01HD042280, R01HD067759, R01HD020676] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055231, R01HD043185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; NICHD NIH HHS [R00 HD055231, R01 HD067759, R01 HD043185, R01 HD042280, R01 HD020676, R21 HD082535, P01 HD079363] Funding Source: Medline; NIEHS NIH HHS [P30 ES010126] Funding Source: Medline; NIH HHS [P51 OD011106] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Burton GJ, 2011, J REPROD IMMUNOL, V89, P118, DOI 10.1016/j.jri.2011.02.005; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Co EC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.099465; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Giuliani E, 2014, AM J REPROD IMMUNOL, V72, P262, DOI 10.1111/aji.12259; Global Health Observatory, 2013, WORLD HLTH OBS GHO D; Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Klein KR, 2014, DEV CELL, V30, P528, DOI 10.1016/j.devcel.2014.07.012; Krow-Lucal ER, 2014, BLOOD, V123, P1897, DOI 10.1182/blood-2013-11-536094; Li MY, 2008, BIOL REPROD, V79, P1169, DOI 10.1095/biolreprod.108.069336; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Raj RS, 2014, REPROD SCI, V21, P1434, DOI 10.1177/1933719114537720; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; The Partnership for Maternal Newborn and Child Health, 2012, PMNCH PROGR REP 2012; WHO, 2012, BORN TOO SOON GLOBAL; Xin LJ, 2014, J IMMUNOL, V192, P2970, DOI 10.4049/jimmunol.1302678	29	325	340	8	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					328	334		10.1038/ni.3131	http://dx.doi.org/10.1038/ni.3131			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789673	Green Accepted			2022-12-18	WOS:000351333700002
J	Sage, PT; Francisco, LM; Carman, CV; Sharpe, AH				Sage, Peter T.; Francisco, Loise M.; Carman, Christopher V.; Sharpe, Arlene H.			The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood	NATURE IMMUNOLOGY			English	Article							HELPER-CELLS; EXPRESSION; DIFFERENTIATION; GENERATION; BLIMP-1; IMMUNITY; SUBSET; FOXP3; BCL6	CD4(+)CXCR5(+)Foxp3(+) follicular regulatory T cells (T-FR cells) inhibit humoral immunity mediated by CD4(+)CXCR5(+)Foxp3(-) follicular helper T cells (T-FH cells). Although the inhibitory receptor PD-1 is expressed by both cell types, its role in the differentiation of T-FR cells is unknown. Here we found that mice deficient in PD-1 and its ligand PD-L1 had a greater abundance of T-FR cells in the lymph nodes and that those T-FR cells had enhanced suppressive ability. We also found substantial populations of T-FR cells in mouse blood and demonstrated that T-FR cells in the blood homed to lymph nodes and potently inhibited T-FH cells in vivo. T-FR cells in the blood required signaling via the costimulatory receptors CD28 and ICOS but were inhibited by PD-1 and PD-L1. Our findings demonstrate mechanisms by which the PD-1 pathway regulates antibody production and help reconcile inconsistencies surrounding the role of this pathway in humoral immunity.	[Sage, Peter T.; Francisco, Loise M.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA; [Sage, Peter T.; Carman, Christopher V.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Francisco, Loise M.; Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA.	arlene_sharpe@hms.harvard.edu	Carman, Christopher V./AAX-8995-2020; Carman, Christopher/L-8108-2016	Carman, Christopher V./0000-0001-7358-2548; Carman, Christopher/0000-0001-7358-2548; Sharpe, Arlene/0000-0002-9736-2109	US National Institutes of Health [T32 AI070085, R01 AI40614, P01 78897, R37 AI38310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040614, P01AI056299, T32AI070085, R37AI038310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Ortega, C. Armet, F. Gonzalez, N. Chouaki, D. Brown and S. Lee for technical assistance; G. Freeman for comments on the manuscript; and M. Carroll (Harvard Medical School) for the mouse anti-NP standard. Supported by the US National Institutes of Health (T32 AI070085 to P.T.S.; and R01 AI40614, P01 78897 and R37 AI38310 to A.H.S.).	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hamel KM, 2010, EUR J IMMUNOL, V40, P3117, DOI 10.1002/eji.201040690; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Polanczyk MJ, 2007, INT IMMUNOL, V19, P337, DOI 10.1093/intimm/dxl151; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang CH, 2010, J NEUROSCI RES, V88, P7, DOI 10.1002/jnr.22181; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	31	325	348	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					152	161		10.1038/ni.2496	http://dx.doi.org/10.1038/ni.2496			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23242415	Green Accepted			2022-12-18	WOS:000313918400010
J	Han, CF; Jin, J; Xu, S; Liu, HB; Li, N; Cao, XT				Han, Chaofeng; Jin, Jing; Xu, Sheng; Liu, Haibo; Li, Nan; Cao, Xuetao			Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; CROSS-REGULATION; DIFFERENTIATE; MEDIATOR; ADAPTERS; DISEASE	Integrins are critical for the migration and function of leukocytes in inflammation. However, the interaction between integrin alpha(M) (CD11b), which has high expression in monocytes and macrophages, and Toll-like receptor (TLR)-triggered innate immunity remains unclear. Here we report that CD11b deficiency enhanced TLR-mediated responses in macrophages, rendering mice more susceptible to endotoxin shock and Escherichia coli-caused sepsis. CD11b was activated by TLR-triggered phosphatidylinositol 3-OH kinase (PI(3) K) and the effector RapL and fed back to inhibit TLR signaling by activating the tyrosine kinases Src and Syk. Syk interacted with and induced tyrosine phosphorylation of MyD88 and TRIF, which led to degradation of these adaptor molecules by the E3 ubiquitin ligase Cbl-b. Thus, TLR-triggered, active CD11b integrin engages in crosstalk with the MyD88 and TRIF pathways and subsequently inhibits TLR signaling in innate immune responses.	[Han, Chaofeng; Xu, Sheng; Liu, Haibo; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Han, Chaofeng; Xu, Sheng; Liu, Haibo; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Jin, Jing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@immunol.org		Han, Chaofeng/0000-0002-8489-6478; xu, sheng/0000-0002-9547-8052	National Natural Science Foundation of China [30721091, 30572121]; National Key Basic Research Program of China [2007CB512403, 2010CB911903]; Shanghai Committee of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank H. An, M. Zhang, T. Zhang, J. Hou, X. Liu and T. Chen for discussions; F. He for statistical assistance; Y. Li and M. Jin for technical assistance; C. Ni for pathological analysis; S. Akira (Research Institute for Microbial Diseases, Osaka University) for Myd88-deficient mice; H. Yao (Zhejiang University) for E. coli; H. Shen (University of Pennsylvania School of Medicine) for L. monocytogenes; and M. Liu (Shanghai Institute of Biochemistry and Cell Biology) for lentiviral vector. Supported by the National Natural Science Foundation of China (30721091 and 30572121), the National Key Basic Research Program of China (2007CB512403 and 2010CB911903) and the Shanghai Committee of Science and Technology.	Abdelbaqi M, 2006, LAB INVEST, V86, P380, DOI 10.1038/labinvest.3700398; Abram C.L., 2007, SCI STKE, V2007, pre2; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; ASHLEY M, 2006, NAT IMMUNOL, V7, P148; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Hu XZ, 2010, J LEUKOCYTE BIOL, V87, P397, DOI 10.1189/jlb.1009654; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Li Q, 2008, EUR J IMMUNOL, V38, P2751, DOI 10.1002/eji.200838542; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; NIKOLAJ B, 1999, J MOL BIOL, V294, P1351; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Silver KL, 2007, EUR J IMMUNOL, V37, P2734, DOI 10.1002/eji.200737293; SUSANNAH E, 2005, BIOCHEM BIOPH RES CO, V337, P142; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; TATSUKATA K, 2009, NAT IMMUNOL, V10, P965; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	45	325	337	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					734	U104		10.1038/ni.1908	http://dx.doi.org/10.1038/ni.1908			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20639876				2022-12-18	WOS:000280149400015
J	Barbalat, R; Lau, L; Locksley, RM; Barton, GM				Barbalat, Roman; Lau, Laura; Locksley, Richard M.; Barton, Gregory M.			Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands	NATURE IMMUNOLOGY			English	Article							CYTOSOLIC DNA; CYTOKINE RESPONSES; DENDRITIC CELLS; MICE LACKING; INNATE; RECOGNITION; ACTIVATION; VIRUS; TLR2; FLAGELLIN	Despite the paradigm that the innate immune system uses nucleic acid-specific receptors to detect viruses because of a lack of other conserved features, many viruses are recognized by Toll-like receptor 2 (TLR2) and TLR4. The relevance of this recognition for antiviral immunity remains largely unexplained. Here we report that TLR2 activation by viruses led to the production of type I interferon. TLR2-dependent induction of type I interferon occurred only in response to viral ligands, which indicates that TLR2 is able to discriminate between pathogen classes. We demonstrate that this specialized response was mediated by Ly6C(hi) inflammatory monocytes. Thus, the innate immune system can detect certain non-nucleic acid features of viruses and links this recognition to the induction of specific antiviral genes.	[Barbalat, Roman; Lau, Laura; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	barton@berkeley.edu		Barton, Gregory/0000-0002-3793-0100	University of California; Hellman Family Faculty Fund; US National Institutes of Health [AI072429, GM007232]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429, R21AI079358, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	University of California(University of California System); Hellman Family Faculty Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Akira (Osaka University) for Myd88<SUP>-/-</SUP> Trif<SUP>-/-</SUP> mice; D. Portnoy (University of California, Berkeley) for Irf3<SUP>-/-</SUP> and Ifnar1<SUP>-/-</SUP> mice and ISRE- L929 cells; K. Fitzgerald (University of Massachusetts) for Irf7<SUP>-/-</SUP> and Irf3<SUP>-/-</SUP> Irf7<SUP>-/-</SUP> mice; Z. Chen (University of Texas Southwestern Medical Center) for Mavs<SUP>-/-</SUP> mice; D. Raulet (University of California, Berkeley) for vaccinia virus (Western Reserve strain); L. Coscoy (University of California, Berkeley) for MCMV (Smith strain); M. Tokuyama, M. Fontana and K. Camfield for early contributions to this work; M. Mouchess for technical assistance; N. An (Infectious Disease BL2 Core of the Berkeley Center for Host-Pathogen Studies) for help with the production of vaccinia virus; D. Stetson (University of Washington) for key reagents; members of the Barton and Vance labs for discussions and advice; R. Vance and L. Coscoy for comments on the manuscript; and H. Nolla for assistance with flow cytometry. Supported by University of California, the Hellman Family Faculty Fund and the US National Institutes of Health (AI072429 to G. M. B., and GM007232 to R. B.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Chang S, 2007, J LEUKOCYTE BIOL, V82, P479, DOI 10.1189/jlb.0207128; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Crimmins GT, 2008, P NATL ACAD SCI USA, V105, P10191, DOI 10.1073/pnas.0804170105; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Steven AC, 2006, SCIENCE, V313, P177, DOI 10.1126/science.1129761; Szomolanyi-Tsuda E, 2006, J VIROL, V80, P4286, DOI 10.1128/JVI.80.9.4286-4291.2006; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	56	325	346	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1200	U87		10.1038/ni.1792	http://dx.doi.org/10.1038/ni.1792			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19801985	Green Accepted			2022-12-18	WOS:000270955900013
J	Gascoyne, DM; Long, E; Veiga-Fernandes, H; de Boer, J; Williams, O; Seddon, B; Coles, M; Kioussis, D; Brady, HJM				Gascoyne, Duncan M.; Long, Elaine; Veiga-Fernandes, Henrique; de Boer, Jasper; Williams, Owen; Seddon, Benedict; Coles, Mark; Kioussis, Dimitris; Brady, Hugh J. M.			The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development	NATURE IMMUNOLOGY			English	Article							CIRCADIAN CLOCK; NK CELLS; DIFFERENTIATION; GENERATION; EXPRESSION; MATURATION; LYMPHOCYTES; REGULATOR; DIVERSITY; REPRESSOR	Natural killer (NK) cells are a subset of lymphocytes crucial for innate immunity and modification of adaptive immune responses. In contrast to commitment to the T cell or B cell lineage, little is known about NK cell lineage commitment. Here we show that the basic leucine zipper (bZIP) transcription factor E4BP4 (also called NFIL3) is essential for generation of the NK cell lineage. E4BP4-deficient mice (Nfil3(-/-); called 'E4bp4(-/-)' here) had B cells, T cells and NKT cells but specifically lack NK cells and showed severely impaired NK cell-mediated cytotoxicity. Overexpression of E4bp4 was sufficient to increase NK cell production from hematopoietic progenitor cells. E4BP4 acted in a cell-intrinsic manner 'downstream' of the interleukin 15 receptor (IL-15R) and through the transcription factor Id2. E4bp4(-/-) mice may provide a model for definitive analysis of the contribution of NK cells to immune responses and pathologies.	[Gascoyne, Duncan M.; Long, Elaine; de Boer, Jasper; Williams, Owen; Brady, Hugh J. M.] UCL, Mol Haematol & Canc Biol Unit, Inst Child Hlth, London, England; [Gascoyne, Duncan M.; Long, Elaine; de Boer, Jasper; Williams, Owen; Brady, Hugh J. M.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Veiga-Fernandes, Henrique; Kioussis, Dimitris] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Seddon, Benedict] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Coles, Mark] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Coles, Mark] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Brady, Hugh J. M.] Univ London Imperial Coll Sci Technol & Med, Immunol & Infect Sect, Div Cell & Mol Biol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of York - UK; University of Hull; University of York - UK; Imperial College London	Brady, HJM (corresponding author), UCL, Mol Haematol & Canc Biol Unit, Inst Child Hlth, London, England.	h.brady@imperial.ac.uk	de Boer, Jasper/B-5067-2013; Williams, Owen/B-5003-2013	de Boer, Jasper/0000-0002-3220-8776; Williams, Owen/0000-0002-1760-6880; Brady, Hugh/0000-0002-3152-067X; Seddon, Benedict/0000-0003-4352-3373; Veiga-Fernandes, Henrique/0000-0001-6216-1836	Children with Leukaemia; Leukaemia Research Fund; MRC [G0601156, MC_U117512796, MC_U117573801] Funding Source: UKRI; Medical Research Council [G0601156, MC_U117573801, MC_U117512796] Funding Source: researchfish	Children with Leukaemia; Leukaemia Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Zhuang (University of Liverpool) for pMSCV-Mcl-1; M. Woodward (King's College London) for pMSCV-E4bp4; A. O'Garra (Medical Research Council, National Institute for Medical Research) and A. Potocnik (Medical Research Council, National Institute for Medical Research) for additional reagents; and A. Eddaoudi for help with cell sorting. Supported by Children with Leukaemia (H.J.M.B.) and the Leukaemia Research Fund.	Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Boos MD, 2008, IMMUNOL RES, V40, P193, DOI 10.1007/s12026-007-8006-9; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; FERNANDES G, 1979, J IMMUNOL, V123, P622; Hough C, 2005, BLOOD, V105, P1531, DOI 10.1182/blood-2002-10-3093; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Morrow M, 2004, BLOOD, V103, P3890, DOI 10.1182/blood-2003-10-3695; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Priceman SJ, 2006, BIOCHEM BIOPH RES CO, V344, P491, DOI 10.1016/j.bbrc.2006.03.169; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Silvestris F, 2008, CLIN CANCER RES, V14, P6081, DOI 10.1158/1078-0432.CCR-08-0219; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Westerhuis G, 2005, BLOOD, V106, P2215, DOI 10.1182/blood-2005-04-1391; Williams NS, 1999, J IMMUNOL, V163, P2648; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	42	325	333	1	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1118	U99		10.1038/ni.1787	http://dx.doi.org/10.1038/ni.1787			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19749763				2022-12-18	WOS:000270006900016
J	Cinamon, G; Matloubian, M; Lesneski, MJ; Xu, Y; Low, C; Lu, T; Proia, RL; Cyster, JG				Cinamon, G; Matloubian, M; Lesneski, MJ; Xu, Y; Low, C; Lu, T; Proia, RL; Cyster, JG			Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone	NATURE IMMUNOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; LYMPHOCYTE TRAFFICKING; T-CELLS; SPHINGOSINE-1-PHOSPHATE; FTY720; EXPRESSION; MEMORY; S1P(1); EGRESS; RESPONSIVENESS	The factors directing marginal zone B cells to the splenic marginal zone are not well understood. Here we report that FTY720, a drug that targets sphingosine 1-phosphate (S1P) receptors, induced marginal zone B cell migration into follicles. Marginal zone B cells expressed S1P receptors 1 and 3 (S1P(1) and S1P(3), respectively). Using gene-targeted mice, we show that S1P(1) but not S1P(3) was required for localization in the marginal zone. In mice lacking the chemokine CXCL13, S1P(1)-deficient marginal zone B cells reacquired a marginal zone distribution. Exposure to lipopolysaccharide or antigen caused marginal zone B cells to downregulate S1P(1) and S1P 3 and to migrate into the splenic white pulp. These data suggest that marginal zone B cell localization to the marginal zone depends on responsiveness to the blood lysophospholipid S1P, with S1P(1) signaling overcoming the recruiting activity of CXCL13.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu	Proia, Richard L/A-7908-2012	Lu, Theresa/0000-0002-5707-8744; Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Chiba K, 1998, J IMMUNOL, V160, P5037; CHU P, 2003, J BIOL, V2; Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; GROENEVELD PHP, 1985, IMMUNOBIOLOGY, V170, P402, DOI 10.1016/S0171-2985(85)80064-4; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Hla T, 2001, PROSTAG OTH LIPID M, V64, P135, DOI 10.1016/S0090-6980(01)00109-5; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2	38	325	334	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					713	720		10.1038/ni1083	http://dx.doi.org/10.1038/ni1083			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15184895				2022-12-18	WOS:000222331200024
J	Cinamon, G; Shinder, V; Alon, R				Cinamon, G; Shinder, V; Alon, R			Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines	NATURE IMMUNOLOGY			English	Article							CELL-ADHESION MOLECULE-1; MEMORY T-CELLS; TRANSENDOTHELIAL MIGRATION; NEUTROPHIL MIGRATION; ADHERENS JUNCTIONS; FLOW CONDITIONS; ACTIVATION; INTEGRIN; ARREST; STRESS	Leukocyte transendothelial migration (TEM) is thought to be a chemotactic process controlled by chemokine gradients across the endothelium. Using cytokine-activated human umbilical vascular endothelial cells (HUVECs) as a model of inflamed endothelium, we have shown that apical endothelial chemokines can trigger robust peripheral blood lymphocyte (PBL) migration across endothelial cells, Lymphocyte TEM was promoted by physiological shear stress applied continuously to migrating lymphocytes. Lymphocyte integrins, intact actin cytoskeleton and G(i) protein-mediated chemokine signaling, but not a chemotactic gradient, were mandatory for TEM, PBL TEM did not require intracellular free calcium or intact phosphatidyl inositol kinase activity in migrating lymphocytes. Thus, lymphocyte TEM is promoted by fluid shear-induced mechanical signals coupled to G(i) protein signals at apical endothelial zones.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.		ALON, RONEN/GRX-6987-2022	Cinamon, Guy/0000-0002-6988-1817; Alon, Ronen/0000-0001-9161-6369				Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bianchi E, 1997, IMMUNOL TODAY, V18, P586, DOI 10.1016/S0167-5699(97)01162-6; Burns AR, 2000, J CELL SCI, V113, P45; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Carr MW, 1996, IMMUNITY, V4, P179, DOI 10.1016/S1074-7613(00)80682-2; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; Ding ZQ, 2000, J LEUKOCYTE BIOL, V67, P825, DOI 10.1002/jlb.67.6.825; Dwir O, 1998, CELL ADHES COMMUN, V6, P349, DOI 10.3109/15419069809010793; Eddy RJ, 2000, J CELL SCI, V113, P1287; Gotsch U, 1997, J CELL SCI, V110, P583; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HONDA S, 1994, J IMMUNOL, V152, P4026; HUANG AJ, 1993, J CELL BIOL, V120, P1371, DOI 10.1083/jcb.120.6.1371; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Kawai T, 1999, J IMMUNOL, V163, P3269; KUIJPERS TW, 1993, J EXP MED, V178, P279, DOI 10.1084/jem.178.1.279; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Levenberg S, 1998, J CELL SCI, V111, P347; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Luscinskas FW, 1996, J IMMUNOL, V157, P326; Luu NT, 2000, J IMMUNOL, V164, P5961, DOI 10.4049/jimmunol.164.11.5961; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Manolopoulos VG, 2000, GEN PHARMACOL-VASC S, V34, P107, DOI 10.1016/S0306-3623(00)00052-5; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Okuyama M, 1996, J CELL BIOCHEM, V63, P432; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Shang XZ, 1998, EUR J IMMUNOL, V28, P1970, DOI 10.1002/(SICI)1521-4141(199806)28:06<1970::AID-IMMU1970>3.0.CO;2-H; Shinder V, 1998, NEUROREPORT, V9, P3997, DOI 10.1097/00001756-199812210-00002; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Su WH, 2000, BLOOD, V96, P3816, DOI 10.1182/blood.V96.12.3816.h8003816_3816_3822; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tinsley JH, 1999, J BIOL CHEM, V274, P24930, DOI 10.1074/jbc.274.35.24930; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.3.CO;2-T; Yamamoto K, 2000, CIRC RES, V87, P385	53	325	335	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					515	522		10.1038/88710	http://dx.doi.org/10.1038/88710			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376338				2022-12-18	WOS:000169078000014
J	Cheng, SC; Scicluna, BP; Arts, RJW; Gresnigt, MS; Lachmandas, E; Giamarellos-Bourboulis, EJ; Kox, M; Manjeri, GR; Wagenaars, JAL; Cremer, OL; Leentjens, J; van der Meer, AJ; van de Veerdonk, FL; Bonten, MJ; Schultz, MJ; Willems, PHGM; Pickkers, P; Joosten, LAB; van der Poll, T; Netea, MG				Cheng, Shih-Chin; Scicluna, Brendon P.; Arts, Rob J. W.; Gresnigt, Mark S.; Lachmandas, Ekta; Giamarellos-Bourboulis, Evangelos J.; Kox, Matthijs; Manjeri, Ganesh R.; Wagenaars, Jori A. L.; Cremer, Olaf L.; Leentjens, Jenneke; van der Meer, Anne J.; van de Veerdonk, Frank L.; Bonten, Marc J.; Schultz, Marcus J.; Willems, Peter H. G. M.; Pickkers, Peter; Joosten, Leo A. B.; van der Poll, Tom; Netea, Mihai G.			Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA TRANSLATION; INTERFERON-GAMMA; IFN-GAMMA; SYSTEMIC INFLAMMATION; CELLULAR-METABOLISM; SIRTUIN 1; ACTIVATION; EXPRESSION; MACROPHAGES; DYSFUNCTION	The acute phase of sepsis is characterized by a strong inflammatory reaction. At later stages in some patients, immunoparalysis may be encountered, which is associated with a poor outcome. By transcriptional and metabolic profiling of human patients with sepsis, we found that a shift from oxidative phosphorylation to aerobic glycolysis was an important component of initial activation of host defense. Blocking metabolic pathways with metformin diminished cytokine production and increased mortality in systemic fungal infection in mice. In contrast, in leukocytes rendered tolerant by exposure to lipopolysaccharide or after isolation from patients with sepsis and immunoparalysis, a generalized metabolic defect at the level of both glycolysis and oxidative metabolism was apparent, which was restored after recovery of the patients. Finally, the immunometabolic defects in humans were partially restored by therapy with recombinant interferon-gamma, which suggested that metabolic processes might represent a therapeutic target in sepsis.	[Cheng, Shih-Chin; Arts, Rob J. W.; Gresnigt, Mark S.; Lachmandas, Ekta; Leentjens, Jenneke; van de Veerdonk, Frank L.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Cheng, Shih-Chin; Arts, Rob J. W.; Gresnigt, Mark S.; Lachmandas, Ekta; Kox, Matthijs; Leentjens, Jenneke; van de Veerdonk, Frank L.; Pickkers, Peter; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Scicluna, Brendon P.; van der Meer, Anne J.; van der Poll, Tom] Univ Amsterdam, Amsterdam Med Ctr, Ctr Expt & Mol Med, Div Infect Dis, Amsterdam, Netherlands; [Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece; [Kox, Matthijs; Leentjens, Jenneke; Pickkers, Peter] Radboud Univ Nijmegen, Dept Intens Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Manjeri, Ganesh R.; Wagenaars, Jori A. L.; Willems, Peter H. G. M.] Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands; [Manjeri, Ganesh R.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Bonten, Marc J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bonten, Marc J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen; University of Birmingham; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands.; van der Poll, T (corresponding author), Univ Amsterdam, Amsterdam Med Ctr, Ctr Expt & Mol Med, Div Infect Dis, Amsterdam, Netherlands.	t.vanderpoll@amc.uva.nl; mihai.netea@radboudumc.nl	Manjeri, Ganesh/AAB-7551-2020; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; van de Veerdonk, Frank L/C-7256-2008; Schultz, Marcus/AAB-6379-2021; Kox, Matthijs/L-4454-2015; Willems, P.H.G.M./L-4759-2015; Cheng, Shih-Chin/H-4567-2015; Joosten, Leo AB/H-3138-2015; Arts, Rob JW/P-8678-2015; CHENG, SHIH-CHIN/M-3773-2019; Lachmandas, Ekta/G-6682-2016; Leentjens, Jenneke/P-8300-2015; Scicluna, Brendon/T-8112-2018; Netea, Mihai/N-5155-2014; Pickkers, P./H-8080-2014; Gresnigt, Mark/H-3530-2015; Cremer, Olaf L/G-3855-2016	van de Veerdonk, Frank L/0000-0002-1121-4894; Schultz, Marcus/0000-0003-3969-7792; Willems, P.H.G.M./0000-0002-0915-1599; Cheng, Shih-Chin/0000-0003-1251-8774; Joosten, Leo AB/0000-0001-6166-9830; Arts, Rob JW/0000-0002-6649-7190; CHENG, SHIH-CHIN/0000-0003-1251-8774; Leentjens, Jenneke/0000-0003-3356-3910; Scicluna, Brendon/0000-0003-2826-0341; Pickkers, P./0000-0002-1104-4303; Gresnigt, Mark/0000-0002-9514-4634; Cremer, Olaf L/0000-0003-4264-1108; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911	European Research Council [ERC-StG-310372]; Center for Translational Molecular Medicine (Molecular Diagnosis and Risk Stratification of Sepsis project) [04I-201]	European Research Council(European Research Council (ERC)European Commission); Center for Translational Molecular Medicine (Molecular Diagnosis and Risk Stratification of Sepsis project)	Supported by the European Research Council (ERC-StG-310372 to M.G.N.) and the Center for Translational Molecular Medicine (Molecular Diagnosis and Risk Stratification of Sepsis project; 04I-201).	Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brudecki L, 2013, IMMUNOL CELL BIOL, V91, P532, DOI 10.1038/icb.2013.37; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen T, 2009, PROTEOM CLIN APPL, V3, P1000, DOI 10.1002/prca.200800016; Cheng SC, 2014, CYTOKINE GROWTH F R, V25, P707, DOI 10.1016/j.cytogfr.2014.06.008; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; Delsing CE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-166; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Drosatos K, 2013, CIRC-HEART FAIL, V6, P550, DOI 10.1161/CIRCHEARTFAILURE.112.000177; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ferreira AE, 2014, J IMMUNOL, V192, P2357, DOI 10.4049/jimmunol.1302375; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hoeksema MA, 2015, J IMMUNOL, V194, P3909, DOI 10.4049/jimmunol.1402077; Imaizumi T, 2010, AM J NEPHROL, V32, P462, DOI 10.1159/000321365; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Martin FPJ, 2009, J PROTEOME RES, V8, P2376, DOI 10.1021/pr801006e; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; R Core Team, 2014, R LANG ENV STAT COMP; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Scicluna BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079051; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; van der Meer AJ, 2015, CRIT CARE MED, V43, pE199, DOI 10.1097/CCM.0000000000000949; van Lieshout MH, 2014, AM J RESP CELL MOL, V50, P699, DOI 10.1165/rcmb.2013-0015OC; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zhu LN, 2015, INT REV IMMUNOL, V34, P82, DOI 10.3109/08830185.2014.969421	62	324	346	7	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					406	+		10.1038/ni.3398	http://dx.doi.org/10.1038/ni.3398			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26950237				2022-12-18	WOS:000372508000014
J	Wang, RN; Green, DR				Wang, Ruoning; Green, Douglas R.			Metabolic checkpoints in activated T cells	NATURE IMMUNOLOGY			English	Review							ARYL-HYDROCARBON RECEPTOR; PYRUVATE-KINASE M2; IMPAIRED B-CELL; CALORIE RESTRICTION; PROTEIN-KINASE; POLY(ADP-RIBOSE) POLYMERASE; CUTTING EDGE; HISTONE ACETYLATION; ANTIGEN RECEPTOR; GAMMA-RADIATION	The immunological process of clonal selection requires a rapid burst in lymphocyte proliferation, and this involves a metabolic shift to provide energy and the building blocks of new cells. After activation, naive and memory T cells switch from the oxidation of free fatty acids to glycolysis and glutaminolysis to meet these demands. Beyond this, however, the availability of specific metabolites and the pathways that process them interconnect with signaling events in the cell to influence cell cycle, differentiation, cell death and immunological function. Here we define 'metabolic checkpoints' that represent such interconnections and provide examples of how these checkpoints sense metabolic status and transduce signals to affect T lymphocyte responses.	[Wang, Ruoning; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Wang, RN (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ruoning.wang@stjude.org; douglas.green@stjude.org	Green, Douglas R/N-8083-2018; Wang, Ruoning/C-1683-2014	Green, Douglas R/0000-0002-7332-1417; 	St. Jude Children's Research Hospital; US National Institutes of Health [AI40646, GM52735]; American Lebanese and Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Chi and L. Shi for discussions. Supported by St. Jude Children's Research Hospital (George J. Mitchell fellowship to R.W.), the US National Institutes of Health (AI40646 and GM52735 to D.R.G.) and the American Lebanese and Syrian Associated Charities.	Ahmed T, 2009, J GERONTOL A-BIOL, V64, P1107, DOI 10.1093/gerona/glp101; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; BERGER SJ, 1987, EXP CELL RES, V173, P379, DOI 10.1016/0014-4827(87)90278-3; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; GOODWIN PM, 1978, BIOCHIM BIOPHYS ACTA, V543, P576, DOI 10.1016/0304-4165(78)90312-4; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Ignacak J, 2003, COMP BIOCHEM PHYS B, V134, P425, DOI 10.1016/S1096-4959(02)00283-X; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kojima H, 2003, CURR PHARM DESIGN, V9, P1827, DOI 10.2174/1381612033454388; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu YY, 2012, J IMMUNOL, V188, P2070, DOI 10.4049/jimmunol.1102835; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Marijuan PC, 2010, BIOSYSTEMS, V99, P94, DOI 10.1016/j.biosystems.2009.09.004; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001454, 10.1079/BJN2001455]; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MOSES V, 1966, J THEOR BIOL, V10, P336, DOI 10.1016/0022-5193(66)90131-7; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Mustapha O, 2006, J IMMUNOL, V177, P6489, DOI 10.4049/jimmunol.177.9.6489; Nasta F, 2010, J IMMUNOL, V184, P3470, DOI 10.4049/jimmunol.0901568; Nicholson LB, 2009, CURR MOL MED, V9, P23, DOI 10.2174/156652409787314499; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okkenhaug K, 2002, SCIENCE, V297, P1031; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pae M, 2012, AGING DIS, V3, P91; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Petro TM, 2011, INT IMMUNOPHARMACOL, V11, P310, DOI 10.1016/j.intimp.2010.07.011; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; Powell JD, 1999, J IMMUNOL, V162, P2775; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schults MA, 2010, J BIOL CHEM, V285, P14558, DOI 10.1074/jbc.M109.076323; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenova G, 2012, MOL CELL, V45, P583, DOI 10.1016/j.molcel.2012.02.014; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shaw Reuben J, 2012, F1000 Biol Rep, V4, P2, DOI 10.3410/B4-2; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; SKIDMORE CJ, 1979, EUR J BIOCHEM, V101, P135, DOI 10.1111/j.1432-1033.1979.tb04225.x; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Sun DX, 2004, CELL IMMUNOL, V228, P54, DOI 10.1016/j.cellimm.2004.04.001; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wang R., 2012, F1000 BIOL REPORTS, V4, P5; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	144	324	341	5	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					907	915		10.1038/ni.2386	http://dx.doi.org/10.1038/ni.2386			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990888				2022-12-18	WOS:000309038600003
J	Klenerman, P; Hill, A				Klenerman, P; Hill, A			T cells and viral persistence: lessons from diverse infections	NATURE IMMUNOLOGY			English	Review							HEPATITIS-C VIRUS; EPSTEIN-BARR-VIRUS; MURINE CYTOMEGALOVIRUS-INFECTION; IN-VITRO PROLIFERATION; MHC CLASS-I; IMMUNE-RESPONSES; MEMORY CELLS; HCV INFECTION; EX-VIVO; IMMUNODEFICIENCY-VIRUS	Persistent virus infections create specific problems for their hosts. Although the dynamics of immune responses after acute infection are well studied and very consistent, especially in mouse models, the patterns of responses noted during persistent infection are more complex and differ depending on the infection. In particular, CD8(+) T cell responses differ widely in quantity and quality. In this review we examine these diverse responses and ask how they may arise; in particular, we discuss the function of antigen re- encounter and the CD4(+) T cell responses to and the escape strategies of specific viruses. We focus on studies of four main human pathogens, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus and hepatitis C virus, and their animal models.	Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England; Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	University of Oxford; Oregon Health & Science University	Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England.	paul.klenerman@ndm.ox.ac.uk; hillan@ohsu.edu	Yang, Chen/G-1379-2010	klenerman, paul/0000-0003-4307-9161	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047206] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47206] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bachmann MF, 2004, EUR J IMMUNOL, V34, P317, DOI 10.1002/eji.200324717; Badovinac VP, 2002, MICROBES INFECT, V4, P441, DOI 10.1016/S1286-4579(02)01558-7; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Callan MFC, 2003, VIRAL IMMUNOL, V16, P3, DOI 10.1089/088282403763635401; Ciurea A, 2001, J EXP MED, V193, P297, DOI 10.1084/jem.193.3.297; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Dunne PJ, 2005, BLOOD, V106, P558, DOI 10.1182/blood-2004-11-4469; Dunne PJ, 2002, BLOOD, V100, P933, DOI 10.1182/blood-2002-01-0160; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Gold MC, 2004, J IMMUNOL, V172, P6944, DOI 10.4049/jimmunol.172.11.6944; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hoji A, 2005, IMMUNOLOGY, V115, P239, DOI 10.1111/j.1365-2567.2005.02135.x; Holtappels R, 2004, J EXP MED, V199, P131, DOI 10.1084/jem.20031582; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Komatsu H, 2003, CLIN EXP IMMUNOL, V134, P9, DOI 10.1046/j.1365-2249.2003.02266.x; KOMATSU H, IN PRESS J VIRAL HEP; Kuijpers TW, 2003, J IMMUNOL, V170, P4342, DOI 10.4049/jimmunol.170.8.4342; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Loewendorf A, 2004, J VIROL, V78, P13062, DOI 10.1128/JVI.78.23.13062-13071.2004; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Northfield J, 2005, IMMUNOL CELL BIOL, V83, P182, DOI 10.1111/j.1440-1711.2005.01321.x; Obar JJ, 2004, J IMMUNOL, V172, P1213, DOI 10.4049/jimmunol.172.2.1213; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Reddehase MJ, 2000, CURR OPIN IMMUNOL, V12, P390, DOI 10.1016/S0952-7915(00)00106-0; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Rouse BT, 2004, J IMMUNOL, V173, P2211, DOI 10.4049/jimmunol.173.4.2211; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scriba TJ, 2005, J CLIN INVEST, V115, P443, DOI 10.1172/JCI200523084; Semmo N, 2005, HEPATOLOGY, V41, P1019, DOI 10.1002/hep.20669; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swigut T, 2004, J VIROL, V78, P13335, DOI 10.1128/JVI.78.23.13335-13344.2004; Thursz M, 1999, LANCET, V354, P2119, DOI 10.1016/S0140-6736(99)91443-5; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Ward SM, 2004, EUR J IMMUNOL, V34, P1526, DOI 10.1002/eji.200324275; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zafiropoulos A, 2004, P ROY SOC B-BIOL SCI, V271, pS53, DOI 10.1098/rsbl.2003.0088; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	98	324	335	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					873	879		10.1038/ni1241	http://dx.doi.org/10.1038/ni1241			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116467				2022-12-18	WOS:000231369800016
J	Gringhuis, SI; den Dunnen, J; Litjens, M; van der Vlist, M; Wevers, B; Bruijns, SCM; Geijtenbeek, TBH				Gringhuis, Sonja I.; den Dunnen, Jeroen; Litjens, Manja; van der Vlist, Michiel; Wevers, Brigitte; Bruijns, Sven C. M.; Geijtenbeek, Teunis B. H.			Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappa B activation through Raf-1 and Syk	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASE INHIBITOR; GROWTH-FACTOR-BETA; C-TYPE LECTINS; DENDRITIC CELLS; INNATE IMMUNITY; DC-SIGN; ENDOTOXIN TOLERANCE; INDUCTION; RECEPTOR; GENE	The C-type lectin dectin-1 activates the transcription factor NF-kappa B through a Syk kinase-dependent signaling pathway to induce antifungal immunity. Here we show that dectin- 1 expressed on human dendritic cells activates not only the Syk-dependent canonical NF-kappa B subunits p65 and c-Rel, but also the noncanonical NF-kappa B subunit RelB. Dectin-1, when stimulated by the beta-glucan curdlan or by Candida albicans, induced a second signaling pathway mediated by the serine-threonine kinase Raf-1, which integrated with the Syk pathway at the point of NF-kappa B activation. Raf-1 antagonized Syk-induced RelB activation by promoting sequestration of RelB into inactive p65-RelB dimers, thereby altering T helper cell differentiation. Thus, dectin-1 activates two independent signaling pathways, one through Syk and one through Raf-1, to induce immune responses.	[Gringhuis, Sonja I.; den Dunnen, Jeroen; Litjens, Manja; van der Vlist, Michiel; Wevers, Brigitte; Bruijns, Sven C. M.; Geijtenbeek, Teunis B. H.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MC Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Geijtenbeek, TBH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MC Amsterdam, Netherlands.	t.geijtenbeek@vumc.nl	Geijtenbeek, Teunis/C-2229-2009; van der Vlist, Michiel/B-1899-2010; Dunnen, Jeroen den/O-9760-2019; van der Vlist, Michiel/AAC-4939-2019; den Dunnen, Jeroen/K-4252-2012	Dunnen, Jeroen den/0000-0002-7199-8619; den Dunnen, Jeroen/0000-0002-7199-8619; van der Vlist, Michiel/0000-0003-0931-8982; Gringhuis, Sonja/0000-0003-0383-4978	Netherlands Organisation for Scientific Research [NWO 917-46-367, 912-04-025]; AIDS Foundation [2007036]; Dutch Asthma Foundation [3.2.03.39]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); AIDS Foundation; Dutch Asthma Foundation	We thank Y. van Kooyk and R. Mebius for critically reading the manuscript, M. Oudhoff (Academic Centre for Dentistry Amsterdam) for C. albicans and K. Kristiansen (University of Southern Denmark) for the GST-p65 expression plasmid. This work was supported by the Netherlands Organisation for Scientific Research (NWO 917-46-367 to M. L. and NWO 912-04-025 to J. d. D.), the AIDS Foundation (2007036 to M. v. d. V.) and the Dutch Asthma Foundation (3.2.03.39 to S. I. G.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Huffnagle GB, 2003, CURR OPIN MICROBIOL, V6, P344, DOI 10.1016/S1369-5274(03)00089-4; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	50	323	339	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					203	213		10.1038/ni.1692	http://dx.doi.org/10.1038/ni.1692			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19122653				2022-12-18	WOS:000263178500014
J	Raulet, DH				Raulet, DH			Interplay of natural killer cells and their receptors with the adaptive immune response	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; AUTOLOGOUS DENDRITIC CELLS; VIRUS-INFECTED CELLS; CLASS-I MOLECULES; HUMAN NK CELLS; NKG2D RECEPTOR; VIRAL-INFECTION; CUTTING EDGE; CYTOTOXICITY RECEPTORS; INHIBITORY RECEPTORS	Although natural killer (NK) cells are defined as a component of the innate immune system, they exhibit certain features generally considered characteristic of the adaptive immune system. NK cells also participate directly in adaptive immune responses, mainly by interacting with dendritic cells. Such interactions can positively or negatively regulate dendritic cell activity. Reciprocally, dendritic cells regulate NK cell function. In addition, 'NK receptors' are frequently expressed by T cells and can directly regulate the functions of these cells. In these distinct ways, NK cells and their receptors influence the adaptive immune response.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink.berkeley.edu		Raulet, David/0000-0002-1257-8649				Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; ANFOSSI N, IN PRESS J IMMUNOL; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hayakawa Y, 2004, NAT IMMUNOL, V5, P590, DOI 10.1038/ni1069; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McMahon CW, 2002, J IMMUNOL, V169, P1444, DOI 10.4049/jimmunol.169.3.1444; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Tanamachi DM, 2001, J EXP MED, V193, P307, DOI 10.1084/jem.193.3.307; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Ugolini S, 2001, NAT IMMUNOL, V2, P430, DOI 10.1038/87740; Valiante NM, 1997, IMMUNOL REV, V155, P155, DOI 10.1111/j.1600-065X.1997.tb00948.x; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2002, SCIENCE, V296, P1248, DOI 10.1126/science.1072447; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Westwood JA, 2004, J IMMUNOL, V172, P757, DOI 10.4049/jimmunol.172.2.757; Wilson JL, 1999, J IMMUNOL, V163, P6365; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	83	323	345	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					996	1002		10.1038/ni1114	http://dx.doi.org/10.1038/ni1114			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454923				2022-12-18	WOS:000224156600006
J	Siegel, RM; Chan, FKM; Chun, HJ; Lenardo, MJ				Siegel, RM; Chan, FKM; Chun, HJ; Lenardo, MJ			The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity	NATURE IMMUNOLOGY			English	Review							DOMAIN-CONTAINING RECEPTOR; NECROSIS-FACTOR RECEPTOR; MATURE T-LYMPHOCYTES; DEATH-DOMAIN; LYMPHOPROLIFERATIVE SYNDROME; MEDIATED APOPTOSIS; ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODY; DECOY RECEPTOR; TNF RECEPTORS	Originally identified as a cell surface receptor that triggered the death of lymphocytes and tumor cells, it is now recognized that pas (also known as CD95 or Apo-I) has distinct functions in the life and death of different cell types in the immune system, pas signaling may also be involved in T cell costimulation and proliferation. Although pas deficiency in humans and mice predisposes them towards systemic autoimmunity, Fas-FasL interactions can also facilitate organ-specific immunopathology. Proximal signaling by pas and related receptors depends on subunit preassembly, which accounts for the dominant-negative effect of pathogenic receptor mutants and natural splice variants.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Chan, Francis/ABB-1895-2021; Chun, Hyung/K-1859-2013; chun, hyung/AAE-1463-2020; Chan, Francis Ka-Ming/E-9647-2014; Siegel, Richard/C-7592-2009	Chan, Francis Ka-Ming/0000-0002-4803-8353; Siegel, Richard/0000-0001-5953-9893; Chun, Hyung/0000-0003-3508-2678	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, Z01AI000718, ZIAAI000718, ZIAAI000769] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Allison J, 1997, P NATL ACAD SCI USA, V94, P3943, DOI 10.1073/pnas.94.8.3943; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bellairs P, 1995, AUSTRALAS I MIN MET, V95, P63; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dittel BN, 1999, J IMMUNOL, V162, P6392; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Feldman M, 1998, TRANSPLANT P, V30, P4126, DOI 10.1016/S0041-1345(98)01365-7; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Foote LC, 1996, J IMMUNOL, V157, P1878; Golstein P, 1997, CURR BIOL, V7, pR750, DOI 10.1016/S0960-9822(06)90000-1; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hornung F, 1997, J IMMUNOL, V159, P3816; Inaba M, 1999, J IMMUNOL, V163, P1315; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itoh N, 1997, J EXP MED, V186, P613, DOI 10.1084/jem.186.4.613; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kang SM, 1997, NAT MED, V3, P738, DOI 10.1038/nm0797-738; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Kikuchi H, 1996, J LEUKOCYTE BIOL, V60, P778, DOI 10.1002/jlb.60.6.778; Kim S, 2000, J IMMUNOL, V164, P2931, DOI 10.4049/jimmunol.164.6.2931; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Koppi TA, 1997, EUR J IMMUNOL, V27, P3161, DOI 10.1002/eji.1830271212; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenardo M J, 1995, Int Rev Immunol, V13, P115, DOI 10.3109/08830189509061742; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NALSMITH JH, 1998, TRENDS BIOCHEM SCI, V23, P74; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Okuda Y, 1998, MOL IMMUNOL, V35, P317, DOI 10.1016/S0161-5890(98)00049-2; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; Sabelko-Downes KA, 1999, J EXP MED, V189, P1195, DOI 10.1084/jem.189.8.1195; SARIN A, 1995, J IMMUNOL, V155, P3716; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SNELLER MC, 1992, J CLIN INVEST, V90, P334, DOI 10.1172/JCI115867; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Su X, 2000, J IMMUNOL, V164, P2523, DOI 10.4049/jimmunol.164.5.2523; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Wahlsten JL, 2000, J IMMUNOL, V165, P5480, DOI 10.4049/jimmunol.165.10.5480; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wong B, 1997, J EXP MED, V186, P1939, DOI 10.1084/jem.186.11.1939; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zaks TZ, 1999, J IMMUNOL, V162, P3273; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	115	323	329	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					469	474		10.1038/82712	http://dx.doi.org/10.1038/82712			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101867				2022-12-18	WOS:000165724600009
J	Veldhoen, M; Hocking, RJ; Flavell, RA; Stockinger, B				Veldhoen, Marc; Hocking, Richard J.; Flavell, Richard A.; Stockinger, Brigitta			Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; TGF-BETA; IFN-GAMMA; TNF-ALPHA; MICE; INDUCTION; IL-17; DIFFERENTIATION	It is unclear whether TGF-beta, a critical differentiation factor for T cells producing interleukin 17 ( T-H-17 cells), is required for the initiation of experimental autoimmune encephalomyelitis ( EAE) in vivo. Here we show that mice whose T cells cannot respond to TGF-b signaling lack T-H-17 cells and do not develop EAE despite the presence of T helper cell type 1 infiltrates in the spinal cord. Local but not systemic antibody blockade of TGF-beta prevented T-H-17 cell differentiation and the onset of EAE. The pathogen stimulus zymosan, like mycobacterium, induced T-H-17 cells and initiated EAE, but the disease was transient and correlated with reduced production of interleukin 23. These data show that TGF-beta is essential for the initiation of EAE and suggest that disease progression may require ongoing chronic inflammation and production of interleukin 23.	Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021	Veldhoen, Marc/0000-0002-1478-9562; Stockinger, Brigitta/0000-0001-8781-336X				Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Cautain B, 2001, EUR J IMMUNOL, V31, P1132, DOI 10.1002/1521-4141(200104)31:4<1132::AID-IMMU1132>3.0.CO;2-N; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Ferber IA, 1996, J IMMUNOL, V156, P5; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lafaille JJ, 1998, CYTOKINE GROWTH F R, V9, P139, DOI 10.1016/S1359-6101(98)00009-4; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Murano M, 2006, J LEUKOCYTE BIOL, V79, P140, DOI 10.1189/jlb.0505271; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POWELL MB, 1990, INT IMMUNOL, V2, P539, DOI 10.1093/intimm/2.6.539; Riley LW, 2006, J CLIN INVEST, V116, P1475, DOI 10.1172/JCI28734; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SMITH SB, 1969, J PATHOL, V99, P237, DOI 10.1002/path.1710990307; Szczepanik M, 2005, J NEUROIMMUNOL, V164, P105, DOI 10.1016/j.jneuroim.2005.04.007; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; WAHL SM, 1993, J EXP MED, V177, P225, DOI 10.1084/jem.177.1.225; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhang XM, 2006, INT IMMUNOL, V18, P495, DOI 10.1093/intimm/dxh390	52	322	343	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1151	1156		10.1038/ni1391	http://dx.doi.org/10.1038/ni1391			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	16998492				2022-12-18	WOS:000241437200009
J	Huse, M; Lillemeier, BF; Kuhns, MS; Chen, DS; Davis, MM				Huse, M; Lillemeier, BF; Kuhns, MS; Chen, DS; Davis, MM			T cells use two directionally distinct pathways for cytokine secretion	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOLOGICAL SYNAPSE; LINEAGE COMMITMENT; SNARE COMPLEX; CUTTING EDGE; PROTEIN; ACTIVATION; TNF; COMPARTMENT; EXOCYTOSIS	Activated T helper cells produce many cytokines, some of which are secreted through the immunological synapse toward the antigen-presenting cell. Here we have used immunocytochemistry, live-cell imaging and a surface-mediated secretion assay to show that there are two cytokine export pathways in T helper cells. Some cytokines, including interleukin 2 and interferon-gamma, were secreted into the synapse, whereas others, including tumor necrosis factor and the chemokine CCL3 (MIP-1 alpha), were released multidirectionally. Each secretion pathway was associated with different trafficking proteins, indicating that they are molecularly distinct processes. These data suggest that T helper cells release some cytokines into the immunological synapse to impart specific communication and others multidirectionally to promote inflammation and to establish chemokine gradients.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu	Chen, Daniel Shin-Yu/AGD-8923-2022	Chen, Daniel Shin-Yu/0000-0001-5085-3579; Davis, Mark/0000-0001-6868-657X; Lillemeier, Bjorn/0000-0002-9425-6327				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boisvert J, 2004, J IMMUNOL, V173, P3647, DOI 10.4049/jimmunol.173.6.3647; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; CROFT M, 1991, J IMMUNOL, V146, P4055; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Glimcher LH, 2000, GENE DEV, V14, P1693; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Spiliotis ET, 2003, CURR OPIN CELL BIOL, V15, P430, DOI 10.1016/S0955-0674(03)00074-7; Steinman L, 2004, SCIENCE, V305, P212, DOI 10.1126/science.1099896; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Taylor PC, 2004, CURR OPIN BIOTECH, V15, P557, DOI 10.1016/j.copbio.2004.09.005; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	54	322	330	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					247	255		10.1038/ni1304	http://dx.doi.org/10.1038/ni1304			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16444260				2022-12-18	WOS:000235360400009
J	Pandey, A; Ozaki, K; Baumann, H; Levin, SD; Puel, A; Farr, AG; Ziegler, SF; Leonard, WJ; Lodish, HF				Pandey, A; Ozaki, K; Baumann, H; Levin, SD; Puel, A; Farr, AG; Ziegler, SF; Leonard, WJ; Lodish, HF			Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin	NATURE IMMUNOLOGY			English	Article							COMMON GAMMA-CHAIN; JAK-3 JANUS KINASE; IGM(+) B-CELLS; IL-2 RECEPTOR; BETA-CHAIN; INTERLEUKIN-7 RECEPTOR; FUNCTIONAL COMPONENT; LYMPHOID DEVELOPMENT; CYTOPLASMIC DOMAINS; CYTOKINE RECEPTORS	Signaling by type 1 cytokines involves the formation of receptor homodimers, heterodimers or higher order receptor oligomers. Here we report the cloning of a type I cytokine receptor subunit that is most closely related to the common cytokine receptor gamma chain (gamma(c)). Binding and crosslinking experiments demonstrate that this protein is the receptor for a recently described interleukin 7 (IL-7)-like factor, thymic stromal lymphopoietin (TSLP). Binding of TSLP to the thymic stromal lymphopoietin receptor (TSLPR) is increased markedly in the presence of the IL-7 receptor alpha chain (IL-7R alpha). IL-7R alpha-expressing but not parental 32D cells proliferate in the presence of exogenous TSLP, Moreover, a combination of IL-7R alpha and TSLPR is required for TSLP-dependent activation of a STAT5-dependent reporter construct. Thus it is shown that IL-7R alpha is a component of both the IL-7 and TSLP receptors, which helps to explain why deletion of the gene that encodes IL-7R alpha affects the lymphoid system more severely than deletion of the gene encoding IL-7 does. Cloning of TSLPR should facilitate an understanding of TSLP function and its signaling mechanism.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Virginia Mason Res Ctr, Seattle, WA 98101 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Roswell Park Cancer Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; Massachusetts Institute of Technology (MIT)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.		Pandey, Akhilesh/B-4127-2009; Puel, Anne/H-7305-2017; Leonard, Warren/AAA-1397-2022	Pandey, Akhilesh/0000-0001-9943-6127; Puel, Anne/0000-0003-2603-0323; 	NATIONAL CANCER INSTITUTE [R01CA026122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044259, R01AI044160] Funding Source: NIH RePORTER; NCI NIH HHS [CA 26122] Funding Source: Medline; NHLBI NIH HHS [HL 32262] Funding Source: Medline; NIAID NIH HHS [AI 44160, AI 44259] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Burdach S, 1998, Curr Opin Hematol, V5, P177, DOI 10.1097/00062752-199805000-00005; Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6; CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FRIEND SL, 1994, EXP HEMATOL, V22, P321; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; He YW, 1997, J IMMUNOL, V158, P2592; Hilton DJ, 1996, J BIOL CHEM, V271, P4699; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Isaksen DE, 1999, J IMMUNOL, V163, P5971; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KOBAYASHI N, 1993, GENE, V130, P303, DOI 10.1016/0378-1119(93)90436-7; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; Kondoh K., 1987, COMPUT MECH, V2, P1; KUMAKI S, 1993, BIOCHEM BIOPH RES CO, V193, P356, DOI 10.1006/bbrc.1993.1631; LEE G, 1989, J IMMUNOL, V142, P3875; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levin SD, 1999, J IMMUNOL, V162, P677; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Miyajima Atsushi, 1997, Leukemia (Basingstoke), V11, P418; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIELSEN M, 1994, EUR J IMMUNOL, V24, P3082, DOI 10.1002/eji.1830241225; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Peschon JJ, 1998, CONT IMMUN, P37; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SUDA T, 1989, BLOOD, V74, P1936; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; von Freeden-Jeffry U, 1998, CONT IMMUN, P21; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; ZIEGLER SF, 1995, EUR J IMMUNOL, V25, P399, DOI 10.1002/eji.1830250214	49	322	347	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					59	64		10.1038/76923	http://dx.doi.org/10.1038/76923			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881176				2022-12-18	WOS:000089814800015
J	Lasry, A; Zinger, A; Ben-Neriah, Y				Lasry, Audrey; Zinger, Adar; Ben-Neriah, Yinon			Inflammatory networks underlying colorectal cancer	NATURE IMMUNOLOGY			English	Review							ANTI-TNF THERAPY; GENOME-WIDE ASSOCIATION; KAPPA-B ACTIVATION; ASPIRIN USE; I INTERFERON; BARRIER DYSFUNCTION; LYMPHOID STRUCTURES; INTESTINAL BARRIER; TUMOR INITIATION; MISMATCH-REPAIR	Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors remains unclear. Whereas a minority of solid tumors are associated with overt inflammation, long-term treatment with non-steroidal anti-inflammatory drugs is remarkably effective in reducing cancer rate and death. This indicates that inflammation might have many as-yet-unrecognized facets, among which an indolent course might be far more prevalent than previously appreciated. In this Review, we explore the various inflammatory processes underlying the development and progression of colorectal cancer and discuss anti-inflammatory means for its prevention and treatment.	[Lasry, Audrey; Zinger, Adar; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, IL-91010 Jerusalem, Israel.	yinonb@ekmd.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019		Israeli Science Foundation Centers of Excellence; European Research Council Framework Programme 7 [294390 PICHO]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; I-CORE program of the Israel Science Foundation [41/11]; Israel Cancer Research Fund	Israeli Science Foundation Centers of Excellence; European Research Council Framework Programme 7; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; I-CORE program of the Israel Science Foundation; Israel Cancer Research Fund	Supported by Israeli Science Foundation Centers of Excellence, the European Research Council Framework Programme 7 (294390 PICHO), The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the I-CORE program of the Israel Science Foundation (41/11) and the Israel Cancer Research Fund (Y.B.-N.).	Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249; Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ali T, 2013, DRUG HEALTHC PATIENT, V5, P79, DOI 10.2147/DHPS.S28801; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Angevin E, 2014, CLIN CANCER RES, V20, P2192, DOI 10.1158/1078-0432.CCR-13-2200; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; BeazerBarclay Y, 1996, CARCINOGENESIS, V17, P1757, DOI 10.1093/carcin/17.8.1757; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; Biffi A, 2010, NEUROLOGY, V75, P693, DOI 10.1212/WNL.0b013e3181eee40f; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bondar T, 2013, CANCER CELL, V24, P143, DOI 10.1016/j.ccr.2013.07.016; Bos CL, 2006, ONCOGENE, V25, P6447, DOI 10.1038/sj.onc.1209658; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cascinu S, 2007, AM J CLIN ONCOL-CANC, V30, P526, DOI 10.1097/COC.0b013e318054675c; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Deisseroth A, 2015, CLIN CANCER RES, V21, P950, DOI 10.1158/1078-0432.CCR-14-1678; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Dihlmann S, 2014, INT J CANCER, V135, P2387, DOI 10.1002/ijc.28891; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; FORMAN D, 1993, LANCET, V341, P1359; Fraser DM, 2014, BRIT J CANCER, V111, P623, DOI 10.1038/bjc.2014.264; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han SL, 2003, DIGEST SURG, V20, P107, DOI 10.1159/000069384; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herfs M, 2009, TRENDS MOL MED, V15, P245, DOI 10.1016/j.molmed.2009.04.002; Holmes MD, 2011, BREAST CANCER RES TR, V130, P657, DOI 10.1007/s10549-011-1651-7; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Hoshi D, 2012, MOD RHEUMATOL, V22, P122, DOI 10.1007/s10165-011-0488-6; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Ijssennagger N, 2015, P NATL ACAD SCI USA, V112, P10038, DOI 10.1073/pnas.1507645112; Jess T, 2013, CLIN GASTROENTEROL H, V11, P43, DOI 10.1016/j.cgh.2012.09.026; Jiang XJ, 2015, J CLIN INVEST, V125, P47, DOI 10.1172/JCI73942; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karsdal MA, 2012, SEMIN ARTHRITIS RHEU, V42, P131, DOI 10.1016/j.semarthrit.2012.01.004; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kemp MG, 2012, CELL CYCLE, V11, P2997, DOI 10.4161/cc.21126; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Komhoff M, 2000, AM J PATHOL, V157, P29, DOI 10.1016/S0002-9440(10)64513-0; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; LABAYLE D, 1991, GASTROENTEROLOGY, V101, P635, DOI 10.1016/0016-5085(91)90519-Q; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Levy J, 2015, NAT CELL BIOL, V17, P1062, DOI 10.1038/ncb3206; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu XH, 2010, BIOCHEM BIOPH RES CO, V394, P715, DOI 10.1016/j.bbrc.2010.03.057; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mercer LK, 2012, ANN RHEUM DIS, V71, P869, DOI 10.1136/annrheumdis-2011-200622; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Ng K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju345; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ordonez ME, 2013, INFLAMM BOWEL DIS, V19, P2490, DOI 10.1097/MIB.0b013e31828f1fba; Ouakrim DA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv170; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Peyrin-Biroulet L, 2010, Minerva Gastroenterol Dietol, V56, P233; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rommereim LM, 2015, CELL, V162, P18, DOI 10.1016/j.cell.2015.06.041; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sellin ME, 2015, TRENDS IMMUNOL, V36, P442, DOI 10.1016/j.it.2015.06.002; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Streicher SA, 2014, CANCER EPIDEM BIOMAR, V23, P1254, DOI 10.1158/1055-9965.EPI-13-1284; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tsiaoussis GI, 2015, WORLD J HEPATOL, V7, P2058, DOI 10.4254/wjh.v7.i17.2058; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Vitale I, 2015, INT J DEV BIOL, V59, P95, DOI 10.1387/ijdb.150082iv; WADDELL WR, 1989, AM J SURG, V157, P175, DOI 10.1016/0002-9610(89)90442-X; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang Y, 2014, MUCOSAL IMMUNOL, V7, P1106, DOI 10.1038/mi.2013.126; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Williams C S, 1999, Expert Opin Investig Drugs, V8, P1, DOI 10.1517/13543784.8.1.1; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	162	321	339	11	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					230	240		10.1038/ni.3384	http://dx.doi.org/10.1038/ni.3384			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882261				2022-12-18	WOS:000370469300007
J	Schenkel, AR; Mamdouh, Z; Muller, WA				Schenkel, AR; Mamdouh, Z; Muller, WA			Locomotion of monocytes on endothelium is a critical step during extravasation	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; JUNCTIONAL ADHESION MOLECULE; TRANSENDOTHELIAL MIGRATION; IN-VITRO; FACTOR-ALPHA; CELLS; FLOW; LEUKOCYTES; TRANSMIGRATION; CD11B/CD18	Monocytes, like all leukocytes, undergo a series of sequential steps during extravasation from blood into tissues: tethering, rolling, adhesion and diapedesis. We have discovered an essential step, which we call locomotion, in which the monocyte moves from a site of firm adhesion to the nearest junction to begin diapedesis. Blocking CD11a-CD18 and CD11b-CD18 on human monocytes or adhesion molecules ICAM-1 and ICAM-2 on endothelial cells prevented the monocytes from reaching junctions. The blocked monocytes spun in circles as if they were unable to direct their movement despite being able to adhere and polarize normally. This step fills a gap in the paradigm of extravasation as a multistep process.	Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Cornell University	Schenkel, AR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, Room C320,1300 York Ave, New York, NY 10021 USA.	als2015@med.cornell.edu	Schenkel, Alan/G-1880-2017	Schenkel, Alan/0000-0002-1603-5713	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046849, F32HL010311, R01HL064774, R37HL064774] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL10311, HL46849, HL64774] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERMAN ME, 1995, J IMMUNOL, V154, P299; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cunningham SA, 2002, J BIOL CHEM, V277, P27589, DOI 10.1074/jbc.C200331200; Cuvelier SL, 2001, J EXP MED, V194, P1699, DOI 10.1084/jem.194.12.1699; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; Gopalan PK, 2000, J LEUKOCYTE BIOL, V68, P47; Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117, DOI 10.1002/jlb.65.1.117; Johnson-Leger C, 2003, CELL TISSUE RES, V314, P93, DOI 10.1007/s00441-003-0775-4; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kitayama J, 2000, CELL IMMUNOL, V203, P39, DOI 10.1006/cimm.2000.1671; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Liu Y, 2000, J CELL SCI, V113, P2363; LUSCINSKAS FW, 1995, J EXP MED, V181, P1179, DOI 10.1084/jem.181.3.1179; MAY MJ, 1992, EUR J IMMUNOL, V22, P219, DOI 10.1002/eji.1830220132; McLaughlin F, 1998, CELL ADHES COMMUN, V6, P381, DOI 10.3109/15419069809109147; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; NORTAMO P, 1991, EUR J IMMUNOL, V21, P2629, DOI 10.1002/eji.1830211049; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ozaki H, 1999, J IMMUNOL, V163, P553; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; POBER JS, 1986, J IMMUNOL, V137, P1893; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wojciechowski JC, 2002, FASEB J, V16, pA596; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734	37	321	327	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					393	400		10.1038/ni1051	http://dx.doi.org/10.1038/ni1051			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15021878				2022-12-18	WOS:000220515900012
J	Maekawa, T; Kufer, TA; Schulze-Lefert, P				Maekawa, Takaki; Kufer, Thomas A.; Schulze-Lefert, Paul			NLR functions in plant and animal immune systems: so far and yet so close	NATURE IMMUNOLOGY			English	Review							ARABIDOPSIS RESISTANCE PROTEIN; RICH REPEAT PROTEIN; NB-LRR PROTEIN; DISEASE-RESISTANCE; CELL-DEATH; MILDEW RESISTANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TIR DOMAIN; HYPERSENSITIVE RESPONSE	In plants and animals, the NLR family of receptors perceives non-self and modified-self molecules inside host cells and mediates innate immune responses to microbial pathogens. Despite their similar biological functions and protein architecture, animal NLRs are normally activated by conserved microbe-or damage-associated molecular patterns, whereas plant NLRs typically detect strain-specific pathogen effectors. Plant NLRs recognize either the effector structure or effector-mediated modifications of host proteins. The latter indirect mechanism for the perception of non-self, as well as the within-species diversification of plant NLRs, maximize the capacity to recognize non-self through the use of a finite number of innate immunoreceptors. We discuss recent insights into NLR activation, signal initiation through the homotypic association of N-terminal domains and subcellular receptor dynamics in plants and compare those with NLR functions in animals.	[Maekawa, Takaki; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany	Max Planck Society; University of Cologne	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany.	schlef@mpiz.mpg.de	Kufer, Thomas A/I-5146-2015; Schulze-Lefert, Paul/B-6707-2011	Kufer, Thomas A/0000-0003-4563-0412; 	German Research Foundation in the collaborative research centre [SFB670]; Max Planck Society	German Research Foundation in the collaborative research centre; Max Planck Society(Max Planck SocietyFoundation CELLEX)	Supported by German Research Foundation in the collaborative research centre SFB670 (T.M., T.A.K. and P.S.-L.) and the Max Planck Society (P.S.-L.).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bhullar NK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-88; Bittner-Eddy P, 1999, MOL PLANT MICROBE IN, V12, P792, DOI 10.1094/MPMI.1999.12.9.792; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Bulgarelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012599; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Frost D, 2004, MOL PLANT MICROBE IN, V17, P224, DOI 10.1094/MPMI.2004.17.2.224; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Hall SA, 2009, MOL PLANT PATHOL, V10, P449, DOI [10.1111/J.1364-3703.2009.00544.X, 10.1111/j.1364-3703.2009.00544.x]; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kuang H, 2008, PLANT J, V54, P69, DOI 10.1111/j.1365-313X.2008.03408.x; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kwon SI, 2009, PLANT J, V57, P109, DOI 10.1111/j.1365-313X.2008.03669.x; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Lawrence GJ, 2010, MOL PLANT PATHOL, V11, P19, DOI [10.1111/j.1364-3703.2009.00563.X, 10.1111/j.1364-3703.2009.00563.x]; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Mazourek M, 2009, GENETICS, V182, P1351, DOI 10.1534/genetics.109.101022; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Nishimura MT, 2010, PLANT J, V61, P1053, DOI 10.1111/j.1365-313X.2010.04131.x; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seeholzer S, 2010, MOL PLANT MICROBE IN, V23, P497, DOI 10.1094/MPMI-23-4-0497; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Shen QH, 2007, EMBO J, V26, P4293, DOI 10.1038/sj.emboj.7601854; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tapping RI, 2009, SEMIN IMMUNOL, V21, P175, DOI 10.1016/j.smim.2009.05.003; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; Wang CIA, 2007, PLANT CELL, V19, P2898, DOI 10.1105/tpc.107.053611; Weaver LM, 2006, PLANT J, V47, P829, DOI 10.1111/j.1365-313X.2006.02834.x; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhang Q, 2010, IMMUNOGENETICS, V62, P263, DOI 10.1007/s00251-010-0428-1; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	144	320	337	6	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					818	826		10.1038/ni.2083	http://dx.doi.org/10.1038/ni.2083			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21852785				2022-12-18	WOS:000294461200005
J	Sprent, J; Surh, CD				Sprent, Jonathan; Surh, Charles D.			Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells	NATURE IMMUNOLOGY			English	Review							LYMPHOPENIA-INDUCED PROLIFERATION; CLASS-II MOLECULES; NF-KAPPA-B; DENDRITIC CELLS; POSITIVE SELECTION; IN-VIVO; SIGNAL-TRANSDUCTION; AUTOIMMUNE-DISEASE; SELF-RECOGNITION; FOREIGN ANTIGEN	Weak T cell antigen receptor (TCR) signals from contact with self ligands act in synergy with antiapoptotic signals induced by interleukin 7 (IL-7) to promote the survival of naive T cells in a resting state. The amount of background TCR signaling in naive T cells is set by post-thymic TCR tuning and operates at an intensity just below that required to induce entry into the cell cycle. Costimulation from higher concentrations of IL-7 and other common gamma-chain cytokines can induce T cells to undergo homeostatic proliferation and conversion into cells with a memory phenotype; many of these memory phenotype cells may be the progeny of cells responding to self antigens. The molecular mechanisms that control the conversion of naive resting T cells into memory-phenotype cells TCR-dependent in normal animals are beginning to be understood.	[Sprent, Jonathan] Garvan Inst Med Res, Sydney, NSW, Australia; [Sprent, Jonathan; Surh, Charles D.] Pohang Univ Sci & Technol, World Class Univ Program, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Surh, Charles D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Garvan Institute of Medical Research; Pohang University of Science & Technology (POSTECH); Scripps Research Institute	Sprent, J (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.	j.sprent@garvan.org.au			National Health and Medical Research Council (Australia); National Institutes of Health (USA); National Research Foundation (Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090610, R01AI075164] Funding Source: NIH RePORTER	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation (Korea)(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Health and Medical Research Council (Australia), the National Institutes of Health (USA) and a World Class University program from the National Research Foundation (Korea).	Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; BYRNE JA, 1994, J IMMUNOL, V152, P3098; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; Fischer UB, 2007, P NATL ACAD SCI USA, V104, P7181, DOI 10.1073/pnas.0608299104; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Garbi N, 2010, CURR OPIN IMMUNOL, V22, P601, DOI 10.1016/j.coi.2010.08.007; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hale JS, 2010, J IMMUNOL, V185, P6528, DOI 10.4049/jimmunol.1002696; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Hua XX, 2001, NAT IMMUNOL, V2, P1097, DOI 10.1038/ni1201-1097; Huang T, 2005, CLIN IMMUNOL, V117, P221, DOI 10.1016/j.clim.2005.09.012; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Jubala C, 2009, CANCER IMMUNOL IMMUN, V58, P171, DOI 10.1007/s00262-008-0535-0; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; LIU JO, 2005, SCI STKE, V265, pRE1; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Maroof A, 2009, J IMMUNOL, V183, P7095, DOI 10.4049/jimmunol.0901330; Martin B, 2003, P NATL ACAD SCI USA, V100, P6021, DOI 10.1073/pnas.1037754100; Martin CE, 2010, NAT IMMUNOL, V11, P547, DOI 10.1038/ni0710-547; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stephen TL, 2009, J IMMUNOL, V183, P5554, DOI 10.4049/jimmunol.0901104; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Szabolcs P, 2003, EXP HEMATOL, V31, P708, DOI 10.1016/S0301-472X(03)00160-7; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Teh CE, 2010, P NATL ACAD SCI USA, V107, P14709, DOI 10.1073/pnas.1009209107; Teh SJ, 1997, BLOOD, V89, P1308, DOI 10.1182/blood.V89.4.1308; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; VOS Q, 1992, J IMMUNOL, V149, P1204; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730	108	320	333	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					478	484		10.1038/ni.2018	http://dx.doi.org/10.1038/ni.2018			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739670	Green Accepted			2022-12-18	WOS:000290707100005
J	Scheller, M; Huelsken, J; Rosenbauer, F; Taketo, MM; Birchmeier, W; Tenen, DG; Leutz, A				Scheller, Marina; Huelsken, Joerg; Rosenbauer, Frank; Taketo, Makoto M.; Birchmeier, Walter; Tenen, Daniel G.; Leutz, Achim			Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation	NATURE IMMUNOLOGY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; WNT GENE FAMILY; SELF-RENEWAL; BONE-MARROW; FUNCTIONAL INTERACTION; TRANSCRIPTION FACTORS; PROGENITORS; ENGRAFTMENT; EXPRESSION; APOPTOSIS	Gain of Wnt signaling through b-catenin has been ascribed a critical function in the stimulation of hematopoietic stem cell self-renewal, whereas loss of b-catenin is reportedly dispensable for hematopoiesis. Here we have used conditional mouse genetics and transplantation assays to demonstrate that constitutive activation of b-catenin blocked multilineage differentiation, leading to the death of mice. Blood cell depletion was accompanied by failure of hematopoietic stem cells to repopulate irradiated hosts and to differentiate into mature cells. Activation of b-catenin enforced cell cycle entry of hematopoietic stem cells, thus leading to exhaustion of the long-term stem cell pool. Our data suggest that fine-tuned Wnt stimulation is essential for hematopoiesis and is thus critical for therapeutic hematopoietic stem cell population expansion.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Ecole Polytech Fed Lausanne, Inst Suisse Rech Expt Canc, CH-1066 Epalinges, Switzerland; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Harvard Univ, Inst Med, Boston, MA 02115 USA; Harvard Stem Cell Inst, Boston, MA 02115 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Kyoto University; Harvard University; Harvard University	Leutz, A (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	aleutz@mdc-berlin.de	Leutz, Achim/K-9643-2013; Huelsken, Joerg/AAC-9581-2021	Leutz, Achim/0000-0001-8259-927X; Huelsken, Joerg/0000-0003-3105-9606; Rosenbauer, Frank/0000-0001-7977-9421; Scheller, Marina/0000-0001-6108-0831; Tenen, Daniel/0000-0002-6423-3888				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams JM, 1999, COLD SPRING HARB SYM, V64, P351, DOI 10.1101/sqb.1999.64.351; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Feng ZL, 2004, BIOCHEM BIOPH RES CO, V324, P1333, DOI 10.1016/j.bbrc.2004.09.206; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; MAGLI MC, 1982, NATURE, V295, P527, DOI 10.1038/295527a0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin Patrice J, 2003, Cancer Treat Res, V115, P169; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Orschell-Traycoff CM, 2000, BLOOD, V96, P1380, DOI 10.1182/blood.V96.4.1380.h8001380_1380_1387; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Passegue E, 2005, CELL CYCLE, V4, P266; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Qiang YW, 2004, FRONT BIOSCI-LANDMRK, V9, P1000, DOI 10.2741/1309; Rattis FM, 2004, CURR OPIN HEMATOL, V11, P88, DOI 10.1097/01.moh.0000133649.61121.ec; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; ROLINK A, 1991, EUR J IMMUNOL, V21, P2895, DOI 10.1002/eji.1830211137; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; WEISSMAN I, 1991, NATURE, V353, P26, DOI 10.1038/353026a0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419	59	320	337	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1037	1047		10.1038/ni1387	http://dx.doi.org/10.1038/ni1387			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16951686				2022-12-18	WOS:000241437100009
J	Smith, CM; Wilson, NS; Waithman, J; Villadangos, JA; Carbone, FR; Heath, WR; Belz, GT				Smith, CM; Wilson, NS; Waithman, J; Villadangos, JA; Carbone, FR; Heath, WR; Belz, GT			Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; CUTTING EDGE; LYMPH-NODES; CD8-T-CELL MEMORY; CD40 EXPRESSION; CD4-T-CELL HELP; ACUTE INFECTION; GENERATION; RESPONSES; INVIVO	Several studies have indicated that CD8(+) T cells require CD4(+) T cell help for memory formation. Evidence suggests that such help can be antigen independent, challenging whether the 'licensing' of dendritic cells (DCs) by CD4(+) T cells is ever required for cytotoxic T lymphocyte (CTL) responses. We show here that help is essential for the generation of CTL immunity to herpes simplex virus 1 and that CD4(+) T cells mediate help in a cognate, antigen-specific way. We provide direct in vivo evidence for DC licensing by helper T cells and show that licensing is rapid and essential for the formation of effector and memory CTLs. In situations in which DCs are poorly licensed by pathogen-derived signals, our findings suggest that CTL immunity may be heavily dependent on cognate DC licensing.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Cooperat Res Ctr Vaccine Technol, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	heath@wehi.edu.au; belz@wehi.edu.au	Carbone, Francis/ABF-2141-2020; Belz, Gabrielle T/C-9350-2013; Villadangos, Jose A/AAU-1404-2020	Belz, Gabrielle T/0000-0002-9660-9587; Villadangos, Jose A/0000-0001-6771-8891; Waithman, Jason/0000-0003-4940-0155; Heath, William/0000-0001-9670-259X				AHMED R, 1988, J VIROL, V62, P2102, DOI 10.1128/JVI.62.6.2102-2106.1988; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; CASSELL D, 1988, ANN NY ACAD SCI, V532, P51, DOI 10.1111/j.1749-6632.1988.tb36325.x; GOSGROVE D, 1991, CELL, V66, P1051; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUSMANN LA, 1988, ANN NY ACAD SCI, V532, P158, DOI 10.1111/j.1749-6632.1988.tb36335.x; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Jones CM, 2000, J VIROL, V74, P2414, DOI 10.1128/JVI.74.5.2414-2419.2000; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; LIU Y, 1989, IMMUNOL CELL BIOL, V67, P413, DOI 10.1038/icb.1989.58; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHERMAN LA, 1981, IMMUNOGENETICS, V12, P183, DOI 10.1007/BF01561661; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; WEISS EH, 1983, NATURE, V301, P671, DOI 10.1038/301671a0	40	320	332	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1143	1148		10.1038/ni1129	http://dx.doi.org/10.1038/ni1129			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15475958				2022-12-18	WOS:000224692700011
J	Albert, ML; Jegathesan, M; Darnell, RB				Albert, ML; Jegathesan, M; Darnell, RB			Dendritic cell maturation is required for the cross-tolerization of CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; SELF-ANTIGENS; APOPTOTIC CELLS; CUTTING EDGE; TOLERANCE; ACTIVATION; HELP; DELETION; LYMPHOCYTES	In vivo models have shown that tissue-restricted antigen may be captured by bone marrow-derived cells and cross-presented for the tolerization of CD8(+) T cells. Although these studies have shown peripheral tolerization of CD8(+) T cells, the mechanism of antigen transfer and the nature of the antigen-presenting cell (APC) remain undefined. We report here the establishment of an in vitro system for the study of cross-tolerance and show that dendritic cells (DCs) phagocytose apoptotic cells and tolerize antigen-specific CD8(+) T cells when cognate CD4(+) T helper cells are absent. Using this system, we directly tested the "two-signal" hypothesis for the regulation of priming versus tolerance. We found that the same CD83(+) myeloid-derived DCs were required for both cross-priming and cross-tolerance. These data suggested that the current model for peripheral T cell tolerance, "signal 1 in the absence of signal 2", requires refinement: the critical checkpoint is not DC maturation, but instead the presence of a third signal, which is active at the DC-CD4(+) T cell interface.	Rockefeller Univ, Lab Neurooncol, New York, NY 10021 USA	Rockefeller University	Albert, ML (corresponding author), Rockefeller Univ, Lab Neurooncol, 1230 York Ave,Box 26, New York, NY 10021 USA.	albertm@rockvax.rockefeller.edu	Darnell, Robert B/B-9022-2008; Albert, Matthew L/C-9782-2009	Darnell, Robert B/0000-0002-5134-8088; 				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Austyn JM, 1999, NAT MED, V5, P1232, DOI 10.1038/15182; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cyster JG, 2000, CURR BIOL, V10, pR30, DOI 10.1016/S0960-9822(99)00253-5; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Green DR, 2000, NATURE, V405, P28, DOI 10.1038/35011175; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; Guerder S, 1995, Int Rev Immunol, V13, P135, DOI 10.3109/08830189509061743; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; JOHNSON JG, 1993, IMMUNOL RES, V12, P48, DOI 10.1007/BF02918368; Khanna R, 1997, J IMMUNOL, V159, P5782; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.iy.10.040192.000411; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rieser C, 1997, J EXP MED, V186, P1603, DOI 10.1084/jem.186.9.1603; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075	37	320	348	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1010	1017		10.1038/ni722	http://dx.doi.org/10.1038/ni722			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11590405				2022-12-18	WOS:000172049800013
J	Wensveen, FM; Jelencic, V; Valentic, S; Sestan, M; Wensveen, TT; Theurich, S; Glasner, A; Mendrila, D; Stimac, D; Wunderlich, FT; Bruning, JC; Mandelboim, O; Polic, B				Wensveen, Felix M.; Jelencic, Vedrana; Valentic, Sonja; Sestan, Marko; Wensveen, Tamara Turk; Theurich, Sebastian; Glasner, Ariella; Mendrila, Davor; Stimac, Davor; Wunderlich, F. Thomas; Bruening, Jens C.; Mandelboim, Ofer; Polic, Bojan			NK cells link obesity-induced adipose stress to inflammation and insulin resistance	NATURE IMMUNOLOGY			English	Article							INTERFERON-GAMMA; T-CELLS; ADAPTIVE IMMUNITY; GLOBAL TRENDS; TISSUE; GLUCOSE; INNATE; DIFFERENTIATION; CYTOKINE; FAT	An important cause of obesity-induced insulin resistance is chronic systemic inflammation originating in visceral adipose tissue (VAT). VAT inflammation is associated with the accumulation of proinflammatory macrophages in adipose tissue, but the immunological signals that trigger their accumulation remain unknown. We found that a phenotypically distinct population of tissue-resident natural killer (NK) cells represented a crucial link between obesity-induced adipose stress and VAT inflammation. Obesity drove the upregulation of ligands of the NK cell-activating receptor NCR1 on adipocytes; this stimulated NK cell proliferation and interferon-gamma (IFN-gamma) production, which in turn triggered the differentiation of proinflammatory macrophages and promoted insulin resistance. Deficiency of NK cells, NCR1 or IFN-gamma prevented the accumulation of proinflammatory macrophages in VAT and greatly ameliorated insulin sensitivity. Thus NK cells are key regulators of macrophage polarization and insulin resistance in response to obesity-induced adipocyte stress.	[Wensveen, Felix M.; Jelencic, Vedrana; Valentic, Sonja; Sestan, Marko; Polic, Bojan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; [Wensveen, Tamara Turk; Stimac, Davor] Univ Hosp Rijeka, Dept Internal Med, Rijeka, Croatia; [Theurich, Sebastian; Wunderlich, F. Thomas; Bruening, Jens C.] Max Planck Inst Metab Res Cologne, Cologne, Germany; [Glasner, Ariella; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Mendrila, Davor] Univ Hosp Rijeka, Dept Surg, Rijeka, Croatia	University of Rijeka; University of Rijeka; Hebrew University of Jerusalem; University of Rijeka	Polic, B (corresponding author), Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia.	bojan.polic@medri.uniri.hr	Theurich, Sebastian/AAB-2855-2022; Wensveen, Felix/O-3122-2018; Šestan, Marko/S-1092-2018; Stimac, Davor/S-7420-2018; Jelenčić, Vedrana/S-4624-2018; Štimac, Davor/ABF-7086-2020; Šestan, Marko/S-4142-2018; Polic, Bojan/B-8622-2014; Theurich, Sebastian/C-9995-2018; Marinović, Sonja/S-2859-2018; Turk Wensveen, Tamara/R-9514-2018	Theurich, Sebastian/0000-0001-5706-8258; Wensveen, Felix/0000-0002-1333-8882; Šestan, Marko/0000-0002-1473-6647; Stimac, Davor/0000-0001-8243-2453; Jelenčić, Vedrana/0000-0001-8606-9313; Šestan, Marko/0000-0002-1473-6647; Polic, Bojan/0000-0003-3930-9630; Marinović, Sonja/0000-0002-4054-338X; Turk Wensveen, Tamara/0000-0003-3813-1535; Mandelboim, Ofer/0000-0002-9354-1855	European Foundation; Unity through Knowledge Fund [15/13]; University of Rijeka [13.06.1.1.03]; Netherlands Organization for Scientific Research [91614029]; European Commission [PCIG14-GA-2013-630827]	European Foundation(European Science Foundation (ESF)); Unity through Knowledge Fund; University of Rijeka; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank S. Slavic-Stupac, M. Samsa and K. Miklic for technical assistance and D. Jurisic-Erzen and M. Zelic for help with study setup. Supported by the European Foundation for the Study of Diabetes (New Horizons Program), the Unity through Knowledge Fund (15/13 to B.P.), the University of Rijeka (13.06.1.1.03 to B.P.), the Netherlands Organization for Scientific Research (91614029 to F.M.W.) and the European Commission (PCIG14-GA-2013-630827 to F.M.W.).	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huebner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075703; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zafirova B, 2011, CELL MOL LIFE SCI, V68, P3519, DOI 10.1007/s00018-011-0797-0	49	319	336	4	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					376	385		10.1038/ni.3120	http://dx.doi.org/10.1038/ni.3120			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25729921				2022-12-18	WOS:000351333700010
J	Gringhuis, SI; den Dunnen, J; Litjens, M; van der Vlist, M; Geijtenbeek, TBH				Gringhuis, Sonja I.; den Dunnen, Jeroen; Litjens, Manja; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.			Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL-FUNCTION; TOLL-LIKE RECEPTORS; C-TYPE LECTINS; NF-KAPPA-B; SCAFFOLD PROTEIN; STRUCTURAL BASIS; EGG ANTIGENS; IN-VITRO; T-CELLS; ACTIVATION	Cooperation between different innate signaling pathways induced by pattern-recognition receptors (PRRs) on dendritic cells (DCs) is crucial for tailoring adaptive immunity to pathogens. Here we show that carbohydrate-specific signaling through the C-type lectin DC-SIGN tailored cytokine production in response to distinct pathogens. DC-SIGN was constitutively associated with a signalosome complex consisting of the scaffold proteins LSP1, KSR1 and CNK and the kinase Raf-1. Mannose-expressing Mycobacterium tuberculosis and human immunodeficiency virus type 1 (HIV-1) induced the recruitment of effector proteins to the DC-SIGN signalosome to activate Raf-1, whereas fucose-expressing pathogens such as Helicobacter pylori actively dissociated the KSR1-CNK-Raf-1 complex from the DC-SIGN signalosome. This dynamic regulation of the signalosome by mannose- and fucose-expressing pathogens led to the enhancement or suppression of proinflammatory responses, respectively. Our study reveals another level of plasticity in tailoring adaptive immunity to pathogens.	[Gringhuis, Sonja I.; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Gringhuis, Sonja I.; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Gringhuis, Sonja I.; den Dunnen, Jeroen; Litjens, Manja; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gringhuis, SI (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.i.gringhuis@amc.uva.nl; t.b.geijtenbeek@amc.uva.nl	Dunnen, Jeroen den/O-9760-2019; den Dunnen, Jeroen/K-4252-2012; van der Vlist, Michiel/AAC-4939-2019; van der Vlist, Michiel/B-1899-2010	Dunnen, Jeroen den/0000-0002-7199-8619; den Dunnen, Jeroen/0000-0002-7199-8619; Gringhuis, Sonja/0000-0003-0383-4978; van der Vlist, Michiel/0000-0003-0931-8982	US National Institutes of Health [HHSN266200400091C]; Dutch Scientific Research Program [NWO 912-04-025]; AIDS Foundation [2007036]; Dutch Asthma Foundation [3.2.03.39]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Scientific Research Program; AIDS Foundation; Dutch Asthma Foundation	ManLAM and M. tuberculosis were gifts from J. Belisle (Colorado State University; as part of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health contract HHSN266200400091C, "Tuberculosis Vaccine Testing and Research Materials"); H. pylori strains were gifts from B. Appelmelk (Vrije University Medical Center); and ICAM-3-Fc was a gift from D. Simmons (University of Oxford). Supported by the Dutch Scientific Research Program (NWO 912-04-025 to J.d.D.), the AIDS Foundation (2007036 to M.d.v.V.) and the Dutch Asthma Foundation (3.2.03.39 to S.I.G.).	Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harrison RE, 2004, J CELL SCI, V117, P2151, DOI 10.1242/jcs.00955; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Remans PHJ, 2004, J IMMUNOL, V173, P920, DOI 10.4049/jimmunol.173.2.920; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Uematsu Satoshi, 2008, V183, P1; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Ziogas A, 2005, J BIOL CHEM, V280, P24205, DOI 10.1074/jbc.M413327200	48	319	335	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1081	U58		10.1038/ni.1778	http://dx.doi.org/10.1038/ni.1778			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19718030				2022-12-18	WOS:000270006900011
J	Burgdorf, S; Scholz, C; Kautz, A; Tampe, R; Kurts, C				Burgdorf, Sven; Schoelz, Christian; Kautz, Andreas; Tampe, Robert; Kurts, Christian			Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation	NATURE IMMUNOLOGY			English	Article							CLASS-I PRESENTATION; DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; SOLUBLE-ANTIGENS; SELF-ANTIGENS; TAP; TRANSPORTER; COMPARTMENT; COMPLEXES; MOLECULES	Antiviral or antitumor immunity requires activation of cytotoxic CD8(+) T cells by dendritic cells, which present viral or tumor antigens on major histocompatibility complex (MHC) class I molecules. The intracellular mechanisms facilitating MHC class I-restricted presentation of extracellular antigens (`cross-presentation') are unclear. Here we demonstrate that cross-presentation of soluble antigen occurred in an early endosomal compartment distinct from the endoplasmic reticulum where endogenous antigen is loaded onto MHC class I. Efficient cross-presentation required endotoxin-induced, Toll-like receptor 4- and signaling molecule MyD88-dependent relocation of the transporter associated with antigen processing, essential for loading of MHC class I, to early endosomes. Transport of cross-presented antigen from endosomes to the cell surface was inhibited by primaquine, which blocks endosomal trafficking. Thus, cross-presentation is spatially and mechanistically separated from endogenous MHC class I-restricted antigen presentation and is biased toward antigens containing microbial molecular patterns.	[Burgdorf, Sven; Kautz, Andreas; Kurts, Christian] Univ Bonn, Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany; [Schoelz, Christian; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany	University of Bonn; Goethe University Frankfurt	Burgdorf, S (corresponding author), Univ Bonn, Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany.	sven.burgdorf@ukb.uni-bonn.de; ckurts@web.de	Schölz, Christian/K-2855-2014; Schölz, Christian/F-1261-2010; Tampé, Robert/H-2953-2015	Schölz, Christian/0000-0002-1633-2072; Tampé, Robert/0000-0002-0403-2160				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CIECHANOVER A, 1983, J CELL BIOCHEM, V23, P107, DOI 10.1002/jcb.240230111; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Maurer T, 2002, EUR J IMMUNOL, V32, P2356, DOI 10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Song R, 1996, J IMMUNOL, V156, P4182; Song R, 1999, IMMUNOLOGY, V97, P316; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Van Meirvenne S, 2002, CANCER GENE THER, V9, P787, DOI 10.1038/sj.cgt.7700499; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Villadangos JA, 2007, TRENDS IMMUNOL, V28, P45, DOI 10.1016/j.it.2006.12.008; Watanabe J, 2003, J BIOL CHEM, V278, P42361, DOI 10.1074/jbc.M307752200; Weck MM, 2007, BLOOD, V109, P3890, DOI 10.1182/blood-2006-04-015719	50	319	326	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					558	566		10.1038/ni.1601	http://dx.doi.org/10.1038/ni.1601			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18376402				2022-12-18	WOS:000255153500018
J	Montecino-Rodriguez, E; Leathers, H; Dorshkind, K				Montecino-Rodriguez, E; Leathers, H; Dorshkind, K			Identification of a B-1B cell-specified progenitor	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; IGM(+) B-CELLS; MARGINAL ZONE; BONE-MARROW; IN-VITRO; PRO-B; RECEPTOR; LINEAGE; EXPRESSION; LYMPHOCYTES	The B-1 subpopulation of B lymphocytes differs phenotypically and functionally from conventional B-2 B cells. B-1 B cells are proposed to derive from a distinct progenitor, but such a population has not been isolated. Here we identify and characterize a B- 1 B cell progenitor whose numbers peaked in fetal bone marrow but were less abundant in postnatal bone marrow. These Lin(-)CD45R(lo-neg)CD19(+) cells responded to thymic stromal lymphopoietin and 'preferentially' reconstituted functional slgwM(hi)CD11b(+)CD5(lo-neg) B-1 B cells, but not slgM(+)CD11b(-) B-2 B cells, in vivo. These data indicate that the CD45R(lo-neg)CD19(+) population includes B-1 B cell-specified progenitors and support models proposing distinct developmental pathways for B-1 B cells.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Hematopoiet Malignancies Program, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu		Montecino Rodriguez, Encarnacion/0000-0002-2826-7503	NCI NIH HHS [CA16042] Funding Source: Medline; NHLBI NIH HHS [HL54850] Funding Source: Medline; NIAID NIH HHS [AI21256] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021256, R37AI021256] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; COLLINS LS, 1987, J IMMUNOL, V138, P1082; de Andres B, 2002, BLOOD, V100, P4074, DOI 10.1182/blood-2002-03-0809; Dzierzak Elaine, 1998, P3; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Herz P, 2002, ST HIST REL, V93, P81; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; JOHNSON P, 1989, J EXP MED, V169, P1179, DOI 10.1084/jem.169.3.1179; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Knoops L, 2004, J IMMUNOL, V172, P6101, DOI 10.4049/jimmunol.172.10.6101; LALOR PA, 1989, EUR J IMMUNOL, V19, P501, DOI 10.1002/eji.1830190314; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Levin SD, 1999, J IMMUNOL, V162, P677; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; NISHIMURA H, 1992, CELL IMMUNOL, V140, P432, DOI 10.1016/0008-8749(92)90209-8; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pelayo R, 2005, CURR OPIN IMMUNOL, V17, P100, DOI 10.1016/j.coi.2005.01.012; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1996, J IMMUNOL, V157, P4371; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P2262, DOI 10.1073/pnas.96.5.2262; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Yang YG, 1998, TRANSPLANTATION, V66, P89, DOI 10.1097/00007890-199807150-00014	48	319	326	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					293	301		10.1038/ni1301	http://dx.doi.org/10.1038/ni1301			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16429139				2022-12-18	WOS:000235360400014
J	Laouar, Y; Sutterwala, FS; Gorelik, L; Flavell, RA				Laouar, Y; Sutterwala, FS; Gorelik, L; Flavell, RA			Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma	NATURE IMMUNOLOGY			English	Article							IL-12 RECEPTOR BETA-1; TGF-BETA; IFN-GAMMA; DENDRITIC CELLS; NK CELLS; LEISHMANIA-MAJOR; INTERLEUKIN-12; ACTIVATION; RESISTANCE; CYTOKINE	Interferon-gamma and interleukin 12 produced by the innate arm of the immune system are important regulators of T helper type 1 (T(H)1) cell development, but signals that negatively regulate their expression remain controversial. Here we show that transforming growth factor-beta ( TGF-beta) controlled T(H)1 differentiation through the regulation of interferon-gamma produced by natural killer (NK) cells. Blockade of TGF-beta signaling in NK cells caused the accumulation of a large pool of NK cells secreting copious interferon-gamma, responsible for T(H)1 differentiation and protection from leishmania infection. In contrast, blockade of TGF-beta signaling in dendritic cells did not affect dendritic cell homeostasis or interleukin 12 production, thus indicating a previously undescribed demarcation of the function of TGF-beta in NK cells versus dendritic cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Cassel, Suzanne/AAI-3947-2021; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; 				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; BELLONE G, 1995, J IMMUNOL, V155, P1066; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bottinger EP, 1997, CANCER RES, V57, P5564; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Chakir H, 2001, CELL IMMUNOL, V212, P71, DOI 10.1006/cimm.2001.1844; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; CHUA AO, 1995, J IMMUNOL, V155, P4286; Colucci F, 2000, BLOOD, V95, P984, DOI 10.1182/blood.V95.3.984.003k40_984_991; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DESAI BB, 1992, J IMMUNOL, V148, P3125; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Du CG, 1998, J LEUKOCYTE BIOL, V64, P92, DOI 10.1002/jlb.64.1.92; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorham JD, 1998, J IMMUNOL, V161, P1664; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; HUNTER CA, 1995, EUR J IMMUNOL, V25, P994, DOI 10.1002/eji.1830250420; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lieberman LA, 2002, MICROBES INFECT, V4, P1531, DOI 10.1016/S1286-4579(02)00036-9; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Pardoux C, 1999, BLOOD, V93, P1448, DOI 10.1182/blood.V93.5.1448.403k36_1448_1455; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; SADICK MD, 1986, J IMMUNOL, V136, P655; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; SCOTT P, 1991, J IMMUNOL, V147, P3149; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; SU HC, 1993, J IMMUNOL, V151, P4874; Sudarshan C, 1999, J IMMUNOL, V162, P2974; Tada Y, 2001, EUR J IMMUNOL, V31, P294; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Xu H, 2000, J NEUROIMMUNOL, V108, P53, DOI 10.1016/S0165-5728(00)00278-2; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang M, 1999, J IMMUNOL, V162, P2441	55	319	349	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					600	607		10.1038/ni1197	http://dx.doi.org/10.1038/ni1197			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15852008	Bronze			2022-12-18	WOS:000229385900015
J	Huppa, JB; Gleimer, M; Sumen, C; Davis, MM				Huppa, JB; Gleimer, M; Sumen, C; Davis, MM			Continuous T cell receptor signaling required for synapse maintenance and full effector potential	NATURE IMMUNOLOGY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; IMMUNOLOGICAL SYNAPSE; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; ACTIVATION; DIFFERENTIATION; ACCUMULATION; STIMULATION; COMPLEXES; TCR	Although signals through the T cell receptor (TCR) are essential for the initiation of T helper cell activation, it is unclear what function such signals have during the prolonged T cell-antigen-presenting cell contact. Here we simultaneously tracked TCR-CD3 complex and phosphoinositide 3-kinase activity in single T cells using three-dimensional video microscopy. Despite rapid internalization of most of the TCR-CD3, TCR-dependant signaling was still evident up to 10 h after conjugate formation. Blocking this interaction caused dissolution of the synapse and proportional reductions in interleukin 2 production and cellular proliferation. Thus TCR signaling persists for hours, has a cumulative effect and is necessary for the maintenance of the immunological synapse.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B221, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 279 Campus Dr, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu		Davis, Mark/0000-0001-6868-657X; Huppa, Johannes/0000-0003-2634-8198				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; FREDRICKSON GG, 1994, DEV COMP IMMUNOL, V18, P251, DOI 10.1016/0145-305X(94)90017-5; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Labadia ME, 1998, J IMMUNOL, V161, P836; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; OZATO K, 1980, J IMMUNOL, V124, P533; PAWELEC G, 1985, HUM IMMUNOL, V12, P165, DOI 10.1016/0198-8859(85)90333-7; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	49	319	327	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					749	755		10.1038/ni951	http://dx.doi.org/10.1038/ni951			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12858171				2022-12-18	WOS:000184441500011
J	Deban, L; Russo, RC; Sironi, M; Moalli, F; Scanziani, M; Zambelli, V; Cuccovillo, I; Bastone, A; Gobbi, M; Valentino, S; Doni, A; Garlanda, C; Danese, S; Salvatori, G; Sassano, M; Evangelista, V; Rossi, B; Zenaro, E; Constantin, G; Laudanna, C; Bottazzi, B; Mantovani, A				Deban, Livija; Russo, Remo Castro; Sironi, Marina; Moalli, Federica; Scanziani, Margherita; Zambelli, Vanessa; Cuccovillo, Ivan; Bastone, Antonio; Gobbi, Marco; Valentino, Sonia; Doni, Andrea; Garlanda, Cecilia; Danese, Silvio; Salvatori, Giovanni; Sassano, Marica; Evangelista, Virgilio; Rossi, Barbara; Zenaro, Elena; Constantin, Gabriela; Laudanna, Carlo; Bottazzi, Barbara; Mantovani, Alberto			Regulation of leukocyte recruitment by the long pentraxin PTX3	NATURE IMMUNOLOGY			English	Article							C-REACTIVE PROTEIN; SELECTIN GLYCOPROTEIN LIGAND-1; HUMORAL INNATE IMMUNITY; AMYLOID-P COMPONENT; COMPLEMENT; ADHESION; RECOGNITION; MECHANISMS; INFECTION; BINDING	Pentraxins are a superfamily of conserved proteins involved in the acute-phase response and innate immunity. Pentraxin 3 (PTX3), a prototypical member of the long pentraxin subfamily, is a key component of the humoral arm of innate immunity that is essential for resistance to certain pathogens. A regulatory role for pentraxins in inflammation has long been recognized, but the underlying mechanisms remain unclear. Here we report that PTX3 bound P-selectin and attenuated neutrophil recruitment at sites of inflammation. PTX3 released from activated leukocytes functioned locally to dampen neutrophil recruitment and regulate inflammation. Antibodies have glycosylation-dependent regulatory effect on inflammation. Therefore, PTX3, which is an essential component of humoral innate immunity, and immunoglobulins share functional outputs, including complement activation, opsonization and, as shown here, glycosylation-dependent regulation of inflammation.	[Deban, Livija; Russo, Remo Castro; Sironi, Marina; Moalli, Federica; Cuccovillo, Ivan; Valentino, Sonia; Doni, Andrea; Garlanda, Cecilia; Danese, Silvio; Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas, Inst Ricovero & Cura Carattere Sci, Lab Immunol & Inflammat, Rozzano, Italy; [Russo, Remo Castro] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil; [Zambelli, Vanessa; Bastone, Antonio; Gobbi, Marco] Mario Negri Inst Pharmacol Res, Milan, Italy; [Scanziani, Margherita; Zambelli, Vanessa] Univ Milano Bicocca, Dept Expt Med, Milan, Italy; [Salvatori, Giovanni] Sigma Tau Res & Dev, Pomezia, Italy; [Sassano, Marica] Tecnogen, Ric & Sviluppo, Piana Monte Verna, Italy; [Evangelista, Virgilio] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Rossi, Barbara; Zenaro, Elena; Constantin, Gabriela; Laudanna, Carlo] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Mantovani, Alberto] Univ Milan, Dipartimento Med Traslaz, Milan, Italy	IRCCS Humanitas Research Hospital; Universidade Federal de Minas Gerais; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milano-Bicocca; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Verona; University of Milan	Mantovani, A (corresponding author), Ist Clin Humanitas, Inst Ricovero & Cura Carattere Sci, Lab Immunol & Inflammat, Rozzano, Italy.	alberto.mantovani@humanitasresearch.it	Garlanda, Cecilia/K-4601-2016; Danese, Silvio/ABH-9571-2020; Russo, Remo Castro/F-9048-2010; Mantovani, Alberto/HCI-7449-2022; Gobbi, Marco/J-2638-2016; Valentino, Sonia/AAB-4066-2020; sironi, marina/AAB-5757-2020; Moalli, Federica/I-8176-2018; Cuccovillo, Ivan/AAN-2209-2020; bottazzi, barbara/ABH-9274-2020; Russo, Remo Castro/O-8980-2019	Garlanda, Cecilia/0000-0002-1510-7703; Danese, Silvio/0000-0001-7341-1351; Russo, Remo Castro/0000-0002-1715-3834; Mantovani, Alberto/0000-0001-5578-236X; Gobbi, Marco/0000-0003-1014-6225; Valentino, Sonia/0000-0001-8652-3168; sironi, marina/0000-0002-3342-1149; Moalli, Federica/0000-0002-8426-2571; Cuccovillo, Ivan/0000-0003-0394-5539; bottazzi, barbara/0000-0002-1930-9257; Russo, Remo Castro/0000-0002-1715-3834; Zambelli, Vanessa/0000-0001-8002-5205; Doni, Andrea/0000-0001-9203-5814; Constantin, Gabriela/0000-0001-8978-3539; Zenaro, Elena/0000-0003-3928-6272; ROSSI, Barbara/0000-0003-4711-1528	NHLBI NIH HHS [HL080166] Funding Source: Medline; Telethon [GGP05095] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Cotena A, 2007, J IMMUNOL, V179, P6311, DOI 10.4049/jimmunol.179.9.6311; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Dole VS, 2005, BLOOD, V106, P2334, DOI 10.1182/blood-2005-04-1530; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Hartwell DW, 1999, THROMB HAEMOSTASIS, V82, P850, DOI 10.1055/s-0037-1615922; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; LEE GW, 1993, J IMMUNOL, V150, P1804; Ley K, 2006, Handb Exp Pharmacol, P97; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Miotla JM, 2001, BRIT J PHARMACOL, V133, P550, DOI 10.1038/sj.bjp.0704118; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; MULLIGAN MS, 1993, NATURE, V364, P149, DOI 10.1038/364149a0; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Pinho V, 2007, J IMMUNOL, V179, P7891, DOI 10.4049/jimmunol.179.11.7891; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rodriguez W, 2007, J IMMUNOL, V178, P530, DOI 10.4049/jimmunol.178.1.530; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Stibenz D, 2006, EUR J IMMUNOL, V36, P446, DOI 10.1002/eji.200425360; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Vestweber D, 1993, Curr Top Microbiol Immunol, V184, P65; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	53	318	322	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					328	U74		10.1038/ni.1854	http://dx.doi.org/10.1038/ni.1854			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20208538	Bronze			2022-12-18	WOS:000275849500012
J	Niederkorn, JY				Niederkorn, JY			See no evil, hear no evil, do no evil: the lessons of immune privilege	NATURE IMMUNOLOGY			English	Review							DELTA-T-CELLS; COMPLEMENT REGULATORY PROTEINS; DECAY-ACCELERATING FACTOR; MIGRATION INHIBITORY FACTOR; CORNEAL ALLOGRAFT SURVIVAL; EARLY-PREGNANCY DECIDUA; SPLENIC B-CELLS; ANTERIOR-CHAMBER; HLA-G; AQUEOUS-HUMOR	Immune-mediated inflammation and allograft rejection are greatly reduced in certain organs, a phenomenon called 'immune privilege'. Immune privilege is well developed in three regions of the body: the eye, the brain and the pregnant uterus. Immune-mediated inflammation has devastating consequences in the eye and brain, which have limited capacity for regeneration. Likewise, loss of immune privilege at the maternal-fetal interface culminates in abortion in rodents. However, all three regions share many adaptations that restrict the induction and expression of immune-mediated inflammation. A growing body of evidence from rodent studies suggests that a breakdown in immune privilege contributes to multiple sclerosis, uveitis, corneal allograft rejection and possibly even immune abortion.	Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Niederkorn, JY (corresponding author), Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA.	jerry.niederkorn@utsouthwestern.edu						ABIHANNA D, 1988, TRANSPLANTATION, V45, P610, DOI 10.1097/00007890-198803000-00021; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Apte RS, 1997, INVEST OPHTH VIS SCI, V38, P1277; Apte RS, 1996, J IMMUNOL, V156, P2667; Apte RS, 1998, J IMMUNOL, V160, P5693; Arck PC, 1999, CELL IMMUNOL, V196, P71, DOI 10.1006/cimm.1999.1535; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P492; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Bertrams J, 1971, Bibl Haematol, V37, P98; BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; D'Orazio TJ, 1998, IMMUNOLOGY, V95, P47; DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112; Dorr J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0001.2002; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Faunce DE, 2002, J IMMUNOL, V169, P31, DOI 10.4049/jimmunol.169.1.31; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Gimsa U, 2004, J MOL MED-JMM, V82, P364, DOI 10.1007/s00109-004-0531-6; Goldschneider I, 2003, TRENDS IMMUNOL, V24, P77, DOI 10.1016/S1471-4906(02)00038-8; GORDON LB, 1992, J NEUROIMMUNOL, V40, P81, DOI 10.1016/0165-5728(92)90215-7; Gregory MS, 2002, J IMMUNOL, V169, P2727, DOI 10.4049/jimmunol.169.5.2727; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; HARLINGBERG C, 1989, J NEUROIMMUNOL, V25, P185, DOI 10.1016/0165-5728(89)90136-7; HARLINGBERG CJ, 1991, J NEUROIMMUNOL, V35, P45, DOI 10.1016/0165-5728(91)90160-9; Harrower TP, 2004, XENOTRANSPLANTATION, V11, P60, DOI 10.1111/j.1399-3089.2004.00084.x; HOLMES CH, 1992, EUR J IMMUNOL, V22, P1579, DOI 10.1002/eji.1830220635; HOLMES CH, 1990, J IMMUNOL, V144, P3099; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; James E, 2003, BLOOD, V102, P388, DOI 10.1182/blood-2002-10-3170; JAYARAMAN S, 1993, J IMMUNOL, V151, P5777; Jerzak M, 2002, EUR J OBSTET GYN R B, V100, P138, DOI 10.1016/S0301-2115(01)00431-6; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; Katagiri K, 2002, J IMMUNOL, V169, P84, DOI 10.4049/jimmunol.169.1.84; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LAMPSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P6476, DOI 10.1073/pnas.81.20.6476; LASS JH, 1990, INVEST OPHTH VIS SCI, V31, P1136; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; Lee HO, 2002, J IMMUNOL, V169, P4739, DOI 10.4049/jimmunol.169.9.4739; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LENGEROVA A, 1963, FOLIA BIOL-PRAGUE, V9, P72; Li XY, 2004, J NEUROIMMUNOL, V153, P40, DOI 10.1016/j.jneuroim.2004.04.008; LJUNGGREN HG, 1991, INT J CANCER, P38; MALINA HZ, 1993, GRAEF ARCH CLIN EXP, V231, P482, DOI 10.1007/BF02044236; Malina HZ, 1996, GRAEF ARCH CLIN EXP, V234, P457, DOI 10.1007/BF02539413; MASSA PT, 1993, J EXP MED, V178, P1357, DOI 10.1084/jem.178.4.1357; MCLEAN JM, 1970, J ANAT, V107, P39; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; MinchevaNilsson L, 1997, J IMMUNOL, V159, P3266; MIZUNO K, 1989, CURR EYE RES, V8, P113, DOI 10.3109/02713688909013900; Mochizuki M, 2000, CORNEA, V19, pS24, DOI 10.1097/00003226-200005001-00006; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nagaeva O, 2002, AM J REPROD IMMUNOL, V48, P9, DOI 10.1034/j.1600-0897.2002.01131.x; Nakamura T, 2003, J IMMUNOL, V171, P1266, DOI 10.4049/jimmunol.171.3.1266; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Niederkorn JY, 1996, INVEST OPHTH VIS SCI, V37, P2700; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Niederkorn JY, 1999, TRANSPLANTATION, V68, P1790, DOI 10.1097/00007890-199912150-00025; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pearlman E, 1997, CHEM IMMUNOL, V66, P26; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; Phillips TA, 1999, J IMMUNOL, V162, P6053; Robertson SA, 1997, AM J REPROD IMMUNOL, V37, P438; Robertson SA, 2002, J REPROD IMMUNOL, V57, P109, DOI 10.1016/S0165-0378(02)00015-3; ROONEY IA, 1993, IMMUNOL RES, V12, P276, DOI 10.1007/BF02918258; Rouas-Freiss N, 1999, TRANSPLANT P, V31, P724, DOI 10.1016/S0041-1345(98)01622-4; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Sata M, 2000, ARTERIOSCL THROM VAS, V20, P309, DOI 10.1161/01.ATV.20.2.309; SHE SC, 1990, INVEST OPHTH VIS SCI, V31, P1950; Singhrao SK, 1999, LAB INVEST, V79, P1247; Skelsey ME, 2003, IMMUNOLOGY, V110, P18, DOI 10.1046/j.1365-2567.2003.01676.x; Skelsey ME, 2003, INVEST OPHTH VIS SCI, V44, P5242, DOI 10.1167/iovs.03-0768; Skelsey ME, 2001, J IMMUNOL, V166, P4327, DOI 10.4049/jimmunol.166.7.4327; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Sonoda KH, 2002, J IMMUNOL, V168, P2028, DOI 10.4049/jimmunol.168.4.2028; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; SONODA Y, 1993, J IMMUNOL, V150, P1727; STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Sugita S, 2000, BRIT J OPHTHALMOL, V84, P1130, DOI 10.1136/bjo.84.10.1130; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Taylor A W, 1999, Chem Immunol, V73, P72; Taylor Andrew W., 1994, Neuroimmunomodulation, V1, P188, DOI 10.1159/000097167; Taylor AW, 1998, INVEST OPHTH VIS SCI, V39, P1372; TAYLOR AW, 1994, J IMMUNOL, V153, P1080; Taylor AW, 2003, INVEST OPHTH VIS SCI, V44, P2644, DOI 10.1167/iovs.02-1216; Tremellen KP, 1998, BIOL REPROD, V58, P1217, DOI 10.1095/biolreprod58.5.1217; Tremellen KP, 2000, HUM REPROD, V15, P2653, DOI 10.1093/humrep/15.12.2653; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; van Dooremaal J.C., 1873, A VONGRAEFES ARCH OP, V19, P358; Walsh K, 1999, MOL MED TODAY, V5, P61, DOI 10.1016/S1357-4310(98)01415-4; Wang SX, 2003, J IMMUNOL, V171, P2789, DOI 10.4049/jimmunol.171.6.2789; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; Wenkel H, 2000, J IMMUNOL, V164, P5125, DOI 10.4049/jimmunol.164.10.5125; WHITTUM JA, 1983, CURR EYE RES, V2, P691; Wiendl H, 2003, SEMIN CANCER BIOL, V13, P343, DOI 10.1016/S1044-579X(03)00025-7; WILBANKS GA, 1991, J IMMUNOL, V146, P2610; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Xu YJ, 2002, INVEST OPHTH VIS SCI, V43, P3473; Xu YJ, 2001, IMMUNOLOGY, V104, P142, DOI 10.1046/j.1365-2567.2001.01285.x; Yamagami S, 1997, TRANSPLANTATION, V64, P1107, DOI 10.1097/00007890-199710270-00004; YAMASAKI T, 1989, CELL IMMUNOL, V120, P387, DOI 10.1016/0008-8749(89)90206-2; Yoshida M, 2000, INVEST OPHTH VIS SCI, V41, P811	113	318	329	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					354	359		10.1038/ni1328	http://dx.doi.org/10.1038/ni1328			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550198				2022-12-18	WOS:000236171000006
J	Pincetic, A; Bournazos, S; DiLillo, DJ; Maamary, J; Wang, TT; Dahan, R; Fiebiger, BM; Ravetch, JV				Pincetic, Andrew; Bournazos, Stylianos; DiLillo, David J.; Maamary, Jad; Wang, Taia T.; Dahan, Rony; Fiebiger, Benjamin-Maximillian; Ravetch, Jeffrey V.			Type I and type II Fc receptors regulate innate and adaptive immunity	NATURE IMMUNOLOGY			English	Review							IVIG-MEDIATED AMELIORATION; DENDRITIC CELL MATURATION; DENGUE HEMORRHAGIC-FEVER; GAMMA-RIIB; ANTIINFLAMMATORY ACTIVITY; ANTITUMOR ACTIVITIES; MONOCLONAL-ANTIBODIES; THERAPEUTIC ACTIVITY; CRYSTAL-STRUCTURE; SIALIC-ACID	Antibodies produced in response to a foreign antigen are characterized by polyclonality, not only in the diverse epitopes to which their variable domains bind but also in the various effector molecules to which their constant regions (Fc domains) engage. Thus, the antibody's Fc domain mediates diverse effector activities by engaging two distinct classes of Fc receptors (type I and type II) on the basis of the two dominant conformational states that the Fc domain may adopt. These conformational states are regulated by the differences among antibody subclasses in their amino acid sequence and by the complex, biantennary Fc-associated N-linked glycan. Here we discuss the diverse downstream proinflammatory, anti-inflammatory and immunomodulatory consequences of the engagement of type I and type II Fc receptors in the context of infectious, autoimmune, and neoplastic disorders.	[Pincetic, Andrew; Bournazos, Stylianos; DiLillo, David J.; Maamary, Jad; Wang, Taia T.; Dahan, Rony; Fiebiger, Benjamin-Maximillian; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Bournazos, Stylianos/ABH-1578-2021; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Dahan, Rony/0000-0002-8420-7601	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI109946] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Albert H, 2008, P NATL ACAD SCI USA, V105, P15005, DOI 10.1073/pnas.0808248105; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; Borthakur S, 2011, BIOCHEMISTRY-US, V50, P4608, DOI 10.1021/bi200019y; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Bournazos S, 2014, J CLIN INVEST, V124, P725, DOI 10.1172/JCI72676; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crow AR, 2007, BLOOD, V109, P155, DOI 10.1182/blood-2006-05-023796; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Crow AR, 2001, BRIT J HAEMATOL, V115, P679, DOI 10.1046/j.1365-2141.2001.03136.x; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; De Stahl TD, 2001, SCAND J IMMUNOL, V54, P495, DOI 10.1046/j.1365-3083.2001.01000.x; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Espy C, 2011, ARTHRITIS RHEUM-US, V63, P2105, DOI 10.1002/art.30362; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Guihot A, 2014, AM J RESP CRIT CARE, V189, P1240, DOI 10.1164/rccm.201311-2071OC; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hess C, 2013, J CLIN INVEST, V123, P3788, DOI 10.1172/JCI65938; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; IMBACH P, 1981, LANCET, V1, P1228; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kimberly RP, 2002, IMMUNOL RES, V26, P177, DOI 10.1385/IR:26:1-3:177; KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Li FB, 2013, P NATL ACAD SCI USA, V110, P19501, DOI 10.1073/pnas.1319502110; Li FB, 2012, CELL CYCLE, V11, P3343, DOI 10.4161/cc.21842; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Lux A, 2011, ADV EXP MED BIOL, V780, P113, DOI 10.1007/978-1-4419-5632-3_10; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Narciso JET, 2011, NEW BIOTECHNOL, V28, P435, DOI 10.1016/j.nbt.2011.03.012; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Portman MA, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-32; Ravetch J.V., 2004, MOL BIOL B CELLS, P275; Ravetch JV, 2007, NAT IMMUNOL, V8, P337, DOI 10.1038/ni0407-337; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230; Schwab I, 2012, EUR J IMMUNOL, V42, P826, DOI 10.1002/eji.201142260; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tedder TF, 2006, SPRINGER SEMIN IMMUN, V28, P351, DOI 10.1007/s00281-006-0057-9; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; TOMANA M, 1988, ARTHRITIS RHEUM, V31, P333, DOI 10.1002/art.1780310304; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Varchetta S, 2007, CANCER RES, V67, P11991, DOI 10.1158/0008-5472.CAN-07-2068; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; White AL, 2011, J IMMUNOL, V187, P1754, DOI 10.4049/jimmunol.1101135; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	105	316	333	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					707	716		10.1038/ni.2939	http://dx.doi.org/10.1038/ni.2939			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	25045879	Green Accepted			2022-12-18	WOS:000339323000006
J	Heath, WR; Carbone, FR				Heath, William R.; Carbone, Francis R.			Dendritic cell subsets in primary and secondary T cell responses at body surfaces	NATURE IMMUNOLOGY			English	Review							HERPES-SIMPLEX-VIRUS; IN-VIVO DEPLETION; EPIDERMAL LANGERHANS CELLS; ANTIGEN-PRESENTING CELLS; MIXED LEUKOCYTE REACTION; STEADY-STATE CONDITIONS; BLOOD MONOCYTE SUBSETS; MOUSE LYMPH-NODES; CONTACT HYPERSENSITIVITY; EFFICIENT PRESENTATION	We examine the role of dendritic cells subsets in immunity to peripheral infections, with emphasis on the differences in the regulation of primary and secondary T cell responses to viruses. Our major focus is on new developments in the understanding of immunity to infections of the skin and lung, which are crucial entry points for a variety of infectious pathogens. Initially we describe a diverse network of dendritic cell subsets, but then we argue for a more generalized model of reduced complexity.	[Heath, William R.; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	wrheath@unimelb.edu.au; fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Heath, William/0000-0001-9670-259X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, J IMMUNOL, V179, P6830, DOI 10.4049/jimmunol.179.10.6830; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Brenan M, 1997, EUR J IMMUNOL, V27, P3070, DOI 10.1002/eji.1830271145; Brewig N, 2009, J IMMUNOL, V182, P774, DOI 10.4049/jimmunol.182.2.774; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Courreges MC, 2007, J VIROL, V81, P3769, DOI 10.1128/JVI.02728-06; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; Dai J, 2007, EUR J IMMUNOL, V37, P706, DOI 10.1002/eji.200636643; de Jong JMH, 2006, IMMUNOLOGY, V119, P499, DOI 10.1111/j.1365-2567.2006.02464.x; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Eidsmo L, 2009, J IMMUNOL, V182, P3165, DOI 10.4049/jimmunol.0802950; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOLT PG, 1994, J IMMUNOL, V153, P256; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2003, J EXP MED, V198, P185, DOI 10.1084/jem.20030737; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jakob T, 1999, J INVEST DERMATOL, V112, P102, DOI 10.1046/j.1523-1747.1999.00475.x; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; KILSHAW PJ, 1993, EUR J IMMUNOL, V23, P3365, DOI 10.1002/eji.1830231246; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Scandella E, 2007, J IMMUNOL, V178, P1468, DOI 10.4049/jimmunol.178.3.1468; Scumpia PO, 2005, J IMMUNOL, V175, P3282, DOI 10.4049/jimmunol.175.5.3282; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; STEINMAN RM, 1980, J INVEST DERMATOL, V75, P14, DOI 10.1111/1523-1747.ep12521052; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	114	316	326	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1237	1244		10.1038/ni.1822	http://dx.doi.org/10.1038/ni.1822			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19915624				2022-12-18	WOS:000271872800006
J	Rosenberger, P; Schwab, JM; Mirakaj, V; Masekowsky, E; Mager, A; Morote-Garcia, JC; Unertl, K; Eltzschig, HK				Rosenberger, Peter; Schwab, Jan M.; Mirakaj, Valbona; Masekowsky, Eva; Mager, Alice; Morote-Garcia, Julio C.; Unertl, Klaus; Eltzschig, Holger K.			Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia	NATURE IMMUNOLOGY			English	Article							ADENOSINE A2B RECEPTOR; ISCHEMIA-REPERFUSION INJURY; INDUCED VASCULAR LEAK; KAPPA-B ACTIVITY; AXON GUIDANCE; FACTOR-I; NUCLEOTIDE PHOSPHOHYDROLYSIS; HIF-1-DEPENDENT REPRESSION; ECTO-5'-NUCLEOTIDASE CD73; EXTRACELLULAR ADENOSINE	The neuronal guidance molecule netrin-1 is linked to the coordination of inflammatory responses. Given that mucosal surfaces are particularly prone to hypoxia-elicited inflammation, we sought to determine the function of netrin-1 in hypoxia-induced inflammation. We detected hypoxia-inducible factor 1 alpha (HIF-1 alpha)-dependent induction of expression of the gene encoding netrin-1 (Ntn1) in hypoxic epithelia. Neutrophil transepithelial migration studies showed that by engaging A2B adenosine receptor (A2BAR) on neutrophils, netrin-1 attenuated neutrophil transmigration. Exogenous netrin-1 suppressed hypoxia-elicited inflammation in wild-type but not in A2BAR-deficient mice, and inflammatory hypoxia was enhanced in Ntn1(+/-) mice relative to that in Ntn1(+/+) mice. Our studies demonstrate that HIF-1 alpha-dependent induction of netrin-1 attenuates hypoxia-elicited inflammation at mucosal surfaces.	[Rosenberger, Peter; Mirakaj, Valbona; Masekowsky, Eva; Mager, Alice; Morote-Garcia, Julio C.; Unertl, Klaus; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany; [Schwab, Jan M.] Humboldt Univ, Dept Neurol & Expt Neurol, Sch Med, Charite, D-10098 Berlin, Germany; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO 80045 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Colorado System; University of Colorado Anschutz Medical Campus	Eltzschig, HK (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany.	holger.eltzschig@uchsc.edu		Schwab, Jan/0000-0001-6784-4919; Mirakaj, Valbona/0000-0002-6907-6455	University of Turbingen [1639-0-0, 1778-0-0]; Deutsche Forschungsgemeinschaft [EL 274/2-1, RO 3671/21]; Foundation for Anesthesia Education and Research	University of Turbingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Foundation for Anesthesia Education and Research	We thank M. Faigle, D. Kohler and S. Laucher for technical support; BayerHealthcare for BAY 60-6583; and S. P. Colgan (University of Colorado Denver), M. Tessier-Lavigne (Genentech) and C. Ledent (Universite Libre de Bruxelles) for breeding pairs of gene-targeted mice. Supported by the University of Turbingen (Forturne grants 1639-0-0 to P. R. and 1778-0-0 to V. M.), Deutsche Forschungsgemeinschaft (EL 274/2-1 to H. K. E., and EL 274/2-1 and RO 3671/21 to P. R.) and the Foundation for Anesthesia Education and Research (H. K. E.).	Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Guckelberger O, 2004, THROMB HAEMOSTASIS, V91, P576, DOI 10.1160/TH03-06-0373; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Karhausen J, 2003, CELL MOL BIOL, V49, P77; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Komatsuzaki K, 2002, BIOCHEM BIOPH RES CO, V297, P898, DOI 10.1016/S0006-291X(02)02277-5; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; McKenna WL, 2008, J NEUROCHEM, V104, P1081, DOI 10.1111/j.1471-4159.2007.05040.x; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Naka Y, 1997, P NATL ACAD SCI USA, V94, P757, DOI 10.1073/pnas.94.2.757; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5	50	316	323	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					195	202		10.1038/ni.1683	http://dx.doi.org/10.1038/ni.1683			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19122655				2022-12-18	WOS:000263178500013
J	Villagra, A; Cheng, F; Wang, HW; Suarez, I; Glozak, M; Maurin, M; Nguyen, D; Wright, KL; Atadja, PW; Bhalla, K; Pinilla-Ibarz, J; Seto, E; Sotomayor, EM				Villagra, Alejandro; Cheng, Fengdong; Wang, Hong-Wei; Suarez, Ildelfonso; Glozak, Michelle; Maurin, Michelle; Nguyen, Danny; Wright, Kenneth L.; Atadja, Peter W.; Bhalla, Kapil; Pinilla-Ibarz, Javier; Seto, Edward; Sotomayor, Eduardo M.			The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance	NATURE IMMUNOLOGY			English	Article							IL-10 GENE-EXPRESSION; DENDRITIC CELLS; CHROMATIN MODIFICATIONS; T-CELLS; TRANSCRIPTION; INFLAMMATION; REPRESSION; RECEPTOR; ANTIGENS; ACTIVATION	Antigen-presenting cells (APCs) induce T cell activation as well as T cell tolerance. The molecular basis of the regulation of this critical 'decision' is not well understood. Here we show that HDAC11, a member of the HDAC histone deacetylase family with no prior defined physiological function, negatively regulated expression of the gene encoding interleukin 10 (IL-10) in APCs. Overexpression of HDAC11 inhibited IL-10 expression and induced inflammatory APCs that were able to prime naive T cells and restore the responsiveness of tolerant CD4(+) T cells. Conversely, disruption of HDAC11 in APCs led to upregulation of expression of the gene encoding IL-10 and impairment of antigen-specific T cell responses. Thus, HDAC11 represents a molecular target that influences immune activation versus immune tolerance, a critical 'decision' with substantial implications in autoimmunity, transplantation and cancer immunotherapy.	[Villagra, Alejandro; Cheng, Fengdong; Wang, Hong-Wei; Suarez, Ildelfonso; Maurin, Michelle; Nguyen, Danny; Wright, Kenneth L.; Pinilla-Ibarz, Javier; Sotomayor, Eduardo M.] H Lee Moffitt Canc Ctr & Res Inst, Div Immunol, Tampa, FL 33612 USA; [Suarez, Ildelfonso] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA; [Glozak, Michelle; Seto, Edward; Sotomayor, Eduardo M.] H Lee Moffitt Canc Ctr & Res Inst, Div Mol Oncol, Tampa, FL 33612 USA; [Glozak, Michelle; Wright, Kenneth L.; Pinilla-Ibarz, Javier; Seto, Edward; Sotomayor, Eduardo M.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Atadja, Peter W.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Bhalla, Kapil] Med Coll Georgia, Augusta, GA 30912 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Novartis; University System of Georgia; Augusta University	Sotomayor, EM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Div Immunol, Tampa, FL 33612 USA.	alejandro.villagra@moffitt.org; eduardo.sotomayor@moffitt.org		Nguyen, Danny/0000-0002-2479-2271; Villagra, Alejandro/0000-0001-9346-8355; Bhalla, Kapil/0000-0001-5209-5126	NCI NIH HHS [CA78656, R01 CA134807, R01 CA100850, R01 CA087583, CA87583] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100850, R01CA087583, K08CA078656, R01CA134807] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Reuss E, 2002, GENES IMMUN, V3, P407, DOI 10.1038/sj.gene.6363920; Rezai-Zadeh N, 2004, METHOD ENZYMOL, V377, P167; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vicente-Suarez I, 2007, EUR J IMMUNOL, V37, P3164, DOI 10.1002/eji.200737306; Villagra A, 2007, J BIOL CHEM, V282, P35457, DOI 10.1074/jbc.M701719200; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282	39	316	335	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					92	100		10.1038/ni.1673	http://dx.doi.org/10.1038/ni.1673			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19011628	Green Accepted			2022-12-18	WOS:000261788800016
J	Koch, M; Stronge, VS; Shepherd, D; Gadola, SD; Mathew, B; Ritter, G; Fersht, AR; Besra, GS; Schmidt, RR; Jones, EY; Cerundolo, V				Koch, M; Stronge, VS; Shepherd, D; Gadola, SD; Mathew, B; Ritter, G; Fersht, AR; Besra, GS; Schmidt, RR; Jones, EY; Cerundolo, V			The crystal structure of human CD1d with and without alpha-galactosylceramide	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; OXIDATIVE REFOLDING CHROMATOGRAPHY; NKT CELLS; ANTIGEN PRESENTATION; IN-VIVO; GLYCOLIPID ANTIGENS; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-MECHANISM; MOUSE CD1; RECOGNITION	The glycolipid alpha-galactosylceramide binds with high affinity to CD1d and stimulates natural killer T cells. Here we report the crystal structure of human CD1d in complex with synthetic alpha-galactosylceramide at a resolution of 3.0 angstrom. The structure shows a tightly fit lipid in the CD1d binding groove, with the sphingosine chain bound in the C' pocket and the longer acyl chain anchored in the A' pocket. We also present the CD1d structure without lipid, which has a more open conformation of the binding groove, suggesting a dual conformation of CD1d in which the 'open' conformation is more able to load lipids. These structures provide clues as to how CD1 molecules load glycolipids as well as data to guide the design of new therapeutic agents.	Canc Res UK, Receptor Struct Res Grp, Oxford OX3 7BN, England; Univ Oxford, Weatherall Inst Mol Md, Nuffield Dept Med, Canc Res UK Tumor Immunol Grp, Oxford OX3 9DS, England; Univ Bern, Inselspital, Dept Rheumatol & Clin Immunol, CH-3010 Bern, Switzerland; Univ Konstanz, Dept Chem, D-78457 Constance, Germany; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA; MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Cancer Research UK; University of Oxford; University of Bern; University Hospital of Bern; University of Konstanz; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; University of Cambridge; University of Birmingham	Jones, EY (corresponding author), Canc Res UK, Receptor Struct Res Grp, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; vincenzo.cerundolo@imm.ox.ac.uk	Jones, Yvonne/J-2293-2016; Fersht, Alan R/B-2189-2008; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Shepherd, Dawn/0000-0003-1304-6051; Cerundolo, Vincenzo/0000-0003-0040-3793; Besra, Gurdyal/0000-0002-5605-0395				Altamirano MM, 2001, P NATL ACAD SCI USA, V98, P3288, DOI 10.1073/pnas.041596598; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1998, J IMMUNOL, V161, P5124; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Figueroa-Perez S, 2000, CARBOHYD RES, V328, P95, DOI 10.1016/S0008-6215(00)00092-6; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lawton AP, 2004, IMMUNOL CELL BIOL, V82, P295, DOI 10.1111/j.0818-9641.2004.01258.x; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Naidenko OV, 2000, MICROBES INFECT, V2, P621, DOI 10.1016/S1286-4579(00)00363-4; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539; Walter TS, 2003, J APPL CRYSTALLOGR, V36, P308, DOI 10.1107/S0021889803001997; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	57	316	329	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					819	826		10.1038/ni1225	http://dx.doi.org/10.1038/ni1225			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16007090				2022-12-18	WOS:000230646200023
J	Weber, ANR; Tauszig-Delamasure, S; Hoffmann, JA; Lelievre, E; Gascan, H; Ray, KP; Morse, MA; Imler, JL; Gay, NJ				Weber, ANR; Tauszig-Delamasure, S; Hoffmann, JA; Lelievre, E; Gascan, H; Ray, KP; Morse, MA; Imler, JL; Gay, NJ			Binding of the Drosophila cytokine Spatzle to Toll is direct and establishes signaling	NATURE IMMUNOLOGY			English	Article							HOST-DEFENSE; IMMUNE-RESPONSE; GROWTH-FACTOR; CELL-LINES; RECEPTORS; ACTIVATION; LIPOPOLYSACCHARIDE; RECOGNITION; PROTEIN; INFECTION	The extracellular protein Spatzle is required for activation of the Toll signaling pathway in the embryonic development and innate immune defense of Drosophila. Spatzle is synthesized as a pro-protein and is processed to a functional form by a serine protease. We show here that the mature form of Spatzle triggers a Toll-dependent immune response after injection into the hemolymph of flies. Spatzle specifically bound to Drosophila cells and to Cos-7 cells expressing Toll. Furthermore, in vitro experiments showed that the mature form of Spatzle bound to the Toll ectodomain with high affinity and with a stoichiometry of one Spatzle dimer to two receptors. The Spatzle pro-protein was inactive in all these assays, indicating that the pro-domain sequence, which is natively unstructured, acts to prevent interaction of the cytokine and its receptor Toll. These results show that, in contrast to the human Toll-like receptors, Drosophila Toll requires only an endogenous protein ligand for activation and signaling.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France; GlaxoSmithKline Med Res Ctr, RI CEDD, Stevenage SG1 2NY, Herts, England; CHU Angers, INSERM, U564, F-49033 Angers 01, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Imler, JL (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.		Lelievre, Eric/M-2878-2015; Imler, Jean-Luc/GXH-4323-2022; Tauszig-Delamasure, Servane/AAJ-6493-2020; Tauszig-Delamasure, Servane/G-7192-2017	Tauszig-Delamasure, Servane/0000-0003-4926-0199; Tauszig-Delamasure, Servane/0000-0003-4926-0199; Weber, Alexander/0000-0002-8627-7056; lelievre, eric/0000-0002-4132-4023	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [5P01AI44220-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; GASCAN H, 1990, J IMMUNOL, V144, P2592; Holbrook MR, 2000, BIOCHEM J, V352, P99, DOI 10.1042/0264-6021:3520099; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Luo C, 2001, INSECT MOL BIOL, V10, P457, DOI 10.1046/j.0962-1075.2001.00284.x; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mitsuzawa H, 2001, J BIOL CHEM, V276, P41350, DOI 10.1074/jbc.M104177200; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	42	316	344	3	55	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					794	800		10.1038/ni955	http://dx.doi.org/10.1038/ni955			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12872120				2022-12-18	WOS:000184441500017
J	Hornef, MW; Wick, MJ; Rhen, M; Normark, S				Hornef, MW; Wick, MJ; Rhen, M; Normark, S			Bacterial strategies for overcoming host innate and adaptive immune responses	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; ENTERICA SEROVAR TYPHIMURIUM; NITRIC-OXIDE PRODUCTION; CLASS-II EXPRESSION; SALMONELLA-TYPHIMURIUM; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL PEPTIDE; SHIGELLA-FLEXNERI; HELICOBACTER-PYLORI; ESCHERICHIA-COLI	In higher organisms a variety of host defense mechanisms control the resident microflora and, in most cases, effectively prevent invasive microbial disease. However, it appears that microbial organisms have coevolved with their hosts to overcome protective host barriers and, in selected cases, actually take advantage of innate host responses. Many microbial pathogens avoid host recognition or dampen the subsequent immune activation through sophisticated interactions with host responses, but some pathogens benefit from the stimulation of inflammatory reactions. This review will describe the spectrum of strategies used by microbes to avoid or provoke activation of the host's immune response as well as our current understanding of the role this immunomodulatory interference plays during microbial pathogenesis.	Karolinska Inst, Ctr Microbiol & Tumor Biol, MTC, SE-17177 Stockholm, Sweden; Univ Gothenburg, Dept Clin Immunol, SE-41346 Gothenburg, Sweden	Karolinska Institutet; University of Gothenburg	Normark, S (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, MTC, Nobelsvag 16, SE-17177 Stockholm, Sweden.			Hornef, Mathias/0000-0001-6096-9110				Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brodsky IE, 2002, J BACTERIOL, V184, P3203, DOI 10.1128/JB.184.12.3203-3213.2002; BROWN JL, 1983, ADV STUD BEHAV, V13, P1, DOI 10.1016/S0065-3454(08)60284-3; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Diamond G, 2000, INFECT IMMUN, V68, P113, DOI 10.1128/IAI.68.1.113-119.2000; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; FALLMAN M, 1995, INFECT IMMUN, V63, P3117; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Flak TA, 1999, CELL MICROBIOL, V1, P51, DOI 10.1046/j.1462-5822.1999.00004.x; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Hmama Z, 1998, J IMMUNOL, V161, P4882; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kayal S, 2002, MOL MICROBIOL, V44, P1407, DOI 10.1046/j.1365-2958.2002.02973.x; Kayal S, 1999, MOL MICROBIOL, V31, P1709, DOI 10.1046/j.1365-2958.1999.01305.x; Lindmark H, 2001, J IMMUNOL, V167, P6920, DOI 10.4049/jimmunol.167.12.6920; MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1070, P259, DOI 10.1016/0005-2736(91)90173-6; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Molinari M, 1998, J EXP MED, V187, P135, DOI 10.1084/jem.187.1.135; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; RAMSI S, 2002, J CELL BIOL, V156, P943; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Ruckdeschel K, 2002, J IMMUNOL, V168, P4601, DOI 10.4049/jimmunol.168.9.4601; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Stenger S, 1998, J IMMUNOL, V161, P3582; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; Ting LM, 1999, J IMMUNOL, V163, P3898; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Ullrich HJ, 2000, J IMMUNOL, V165, P6073, DOI 10.4049/jimmunol.165.11.6073; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; VanHeyningen TK, 1997, J IMMUNOL, V158, P330; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Wang J, 2001, J IMMUNOL, V167, P926, DOI 10.4049/jimmunol.167.2.926; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; WICK MJ, 1995, MOL MICROBIOL, V16, P465, DOI 10.1111/j.1365-2958.1995.tb02411.x; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Wurzner R, 1999, MOL IMMUNOL, V36, P249, DOI 10.1016/S0161-5890(99)00049-8; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	101	316	333	0	75	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1033	1040		10.1038/ni1102-1033	http://dx.doi.org/10.1038/ni1102-1033			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407412				2022-12-18	WOS:000179073000009
J	Park, YH; Wood, G; Kastner, DL; Chae, JJ				Park, Yong Hwan; Wood, Geryl; Kastner, Daniel L.; Chae, Jae Jin			Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS	NATURE IMMUNOLOGY			English	Article							FAMILIAL MEDITERRANEAN FEVER; NLRP3 INFLAMMASOME; CYCLIC-AMP; PROTEIN; MUTATIONS; KINASE; PHOSPHORYLATION; RECEPTOR; GENE; RESISTANCE	Mutations in the genes encoding pyrin and mevalonate kinase (MVK) cause distinct interleukin-1 beta (IL-1 beta)-mediated autoinflammatory diseases: familial Mediterranean fever (FMF) and hyperimmunoglobulinemia D syndrome (HIDS). Pyrin forms an inflammasome when mutant or in response to bacterial modification of the GTPase RhoA. We found that RhoA activated the serine-threonine kinases PKN1 and PKN2 that bind and phosphorylate pyrin. Phosphorylated pyrin bound to 14-3-3 proteins, regulatory proteins that in turn blocked the pyrin inflammasome. The binding of 14-3-3 and PKN proteins to FMF-associated mutant pyrin was substantially decreased, and the constitutive IL-1 beta release from peripheral blood mononuclear cells of patients with FMF or HIDS was attenuated by activation of PKN1 and PKN2. Defects in prenylation, seen in HIDS, led to RhoA inactivation and consequent pyrin inflammasome activation. These data suggest a previously unsuspected fundamental molecular connection between two seemingly distinct autoinflammatory disorders.	[Park, Yong Hwan; Wood, Geryl; Kastner, Daniel L.; Chae, Jae Jin] NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kastner, DL; Chae, JJ (corresponding author), NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; chaej@mail.nih.gov		Chae, Jae Jin/0000-0003-0719-4349	National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the patients enrolled in our clinical protocols for providing research specimens, B. Barham, A. Jones, T. Romeo, P. Hoffmann, D. Stone, P. Pinto-Patarroyo, A. Ombrello and K. Barron for help with caring for patients, I. Aksentijevich for assistance in genotyping patients and for discussions, V. Dixit (Genentech) for ASC-, NLRP3- and NLRC4-deficient mice, R. Flavell (Yale University) for caspase-1-deficient mice, E. Alnemri (Thomas Jefferson University) for AIM2-deficient mice, and S. Masters and F. Shao for sharing data before publication. This work was supported by the Intramural Research Program of the National Human Genome Research Institute.	Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Aksentijevich I, 1997, CELL, V90, P797; Aldea A, 2004, AM J MED GENET A, V124A, P67, DOI 10.1002/ajmg.a.20296; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Falk MD, 2014, BIOSCIENCE REP, V34, P93, DOI 10.1042/BSR20140010; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Jeru I, 2005, ARTHRITIS RHEUM-US, V52, P1848, DOI 10.1002/art.21050; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Normand S, 2009, EUR CYTOKINE NETW, V20, P101, DOI 10.1684/ecn.2009.0163; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476	40	315	325	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					914	+		10.1038/ni.3457	http://dx.doi.org/10.1038/ni.3457			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27270401	Green Accepted			2022-12-18	WOS:000380647000008
J	Kopf, M; Schneider, C; Nobs, SP				Kopf, Manfred; Schneider, Christoph; Nobs, Samuel P.			The development and function of lung-resident macrophages and dendritic cells	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; COLONY-STIMULATING FACTOR; HUMAN ALVEOLAR MACROPHAGES; INNATE IMMUNE-RESPONSE; INFLUENZA-VIRUS; GM-CSF; IN-VIVO; STREPTOCOCCUS-PNEUMONIAE; AIRWAY INFLAMMATION; TISSUE MACROPHAGES	Gas exchange is the vital function of the lungs. It occurs in the alveoli, where oxygen and carbon dioxide diffuse across the alveolar epithelium and the capillary endothelium surrounding the alveoli, separated only by a fused basement membrane 0.2-0.5 mu m in thickness. This tenuous barrier is exposed to dangerous or innocuous particles, toxins, allergens and infectious agents inhaled with the air or carried in the blood. The lung immune system has evolved to ward off pathogens and restrain inflammation-mediated damage to maintain gas exchange. Lung-resident macrophages and dendritic cells are located in close proximity to the epithelial surface of the respiratory system and the capillaries to sample and examine the air-borne and blood-borne material. In communication with alveolar epithelial cells, they set the threshold and the quality of the immune response.	[Kopf, Manfred; Schneider, Christoph; Nobs, Samuel P.] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kopf, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland.	manfred.kopf@ethz.ch	Kopf, Manfred/B-6907-2009; Nobs, Samuel Philip/N-4819-2019	Kopf, Manfred/0000-0002-0628-7140; Nobs, Samuel Philip/0000-0003-0627-892X; Schneider, Christoph/0000-0002-0452-2960	Swiss National Science Foundation [310030-124922/1]; Swiss Federal Institute of Technology Zurich [ETH-34 13-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Technology Zurich(ETH Zurich)	Supported by the Swiss National Science Foundation (310030-124922/1) and Swiss Federal Institute of Technology Zurich (ETH-34 13-1).	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Archambaud C, 2010, EUR J IMMUNOL, V40, P3458, DOI 10.1002/eji.201040497; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bachem A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00214; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Baker AD, 2010, J LIPID RES, V51, P1325, DOI 10.1194/jlr.M001651; Baldan A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Bonfield TL, 2003, AM J RESP CELL MOL, V29, P677, DOI 10.1165/rcmb.2003-0148OC; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; CHELEN CJ, 1995, J CLIN INVEST, V95, P1415, DOI 10.1172/JCI117796; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Furuhashi Kazuki, 2012, Am J Respir Cell Mol Biol, V46, P165, DOI 10.1165/rcmb.2011-0070OC; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; GOLDE DW, 1974, NEW ENGL J MED, V290, P875, DOI 10.1056/NEJM197404182901603; GOLDE DW, 1974, NATURE, V247, P373, DOI 10.1038/247373a0; GOLDSTEIN E, 1974, J CLIN INVEST, V54, P519, DOI 10.1172/JCI107788; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; GREEN GM, 1964, J EXP MED, V119, P167, DOI 10.1084/jem.119.1.167; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Heer AK, 2008, J IMMUNOL, V181, P6984, DOI 10.4049/jimmunol.181.10.6984; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Huang XZ, 1998, AM J RESP CELL MOL, V19, P636, DOI 10.1165/ajrcmb.19.4.3293; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kandasamy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003115; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Koth LL, 2007, AM J RESP CELL MOL, V37, P651, DOI 10.1165/rcmb.2006-0428OC; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Langlois RA, 2010, J IMMUNOL, V184, P4440, DOI 10.4049/jimmunol.0902984; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Lombardi V, 2012, MUCOSAL IMMUNOL, V5, P432, DOI 10.1038/mi.2012.20; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; NAITO M, 1990, J LEUKOCYTE BIOL, V48, P27, DOI 10.1002/jlb.48.1.27; NAITO M, 1989, J LEUKOCYTE BIOL, V46, P1; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nakano H, 2013, MUCOSAL IMMUNOL, V6, P678, DOI 10.1038/mi.2012.106; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; PEAO MND, 1993, ACTA ANAT, V147, P227; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Purnama C, 2014, EUR J IMMUNOL, V44, P2003, DOI 10.1002/eji.201344359; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Revoir W. H., 1997, RESPIRATORY PROTECTI; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; SODERLAN.SC, 1973, NATURE, V245, P151; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Strickland D, 1996, IMMUNOLOGY, V87, P242, DOI 10.1046/j.1365-2567.1996.460541.x; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Trapnell BC, 2009, CURR OPIN IMMUNOL, V21, P514, DOI 10.1016/j.coi.2009.09.004; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; van Helden MJ, 2013, CURR OPIN IMMUNOL, V25, P745, DOI 10.1016/j.coi.2013.10.002; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Walzer T, 2005, J ALLERGY CLIN IMMUN, V115, P192, DOI 10.1016/j.jaci.2004.08.046; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watanabe Y, 2005, BIOCHEM BIOPH RES CO, V337, P881, DOI 10.1016/j.bbrc.2005.09.133; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	153	315	327	13	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					36	44		10.1038/ni.3052	http://dx.doi.org/10.1038/ni.3052			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521683				2022-12-18	WOS:000346494200007
J	Gubser, PM; Bantug, GR; Razik, L; Fischer, M; Dimeloe, S; Hoenger, G; Durovic, B; Jauch, A; Hess, C				Gubser, Patrick M.; Bantug, Glenn R.; Razik, Leyla; Fischer, Marco; Dimeloe, Sarah; Hoenger, Gideon; Durovic, Bojana; Jauch, Annaise; Hess, Christoph			Rapid effector function of memory CD8(+) T cells requires an immediate-early glycolytic switch	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL GENE-EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CYTOKINE PRODUCTION; ENERGY-METABOLISM; GLUCOSE; PATHWAY; ANTIGEN; MTORC2; MICE; AKT	Antigen-experienced memory T cells acquire effector function with innate-like kinetics; however, the metabolic requirements of these cells are unknown. Here we show that rapid interferon-gamma (IFN-gamma) production of effector memory (EM) CD8(+) T cells, activated through stimulation mediated by the T cell antigen receptor (TCR) and the costimulatory receptor CD28 or through cognate interactions, was linked to increased glycolytic flux. EM CD8(+) T cells exhibited more glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity at early time points, before proliferation commenced, than did naive cells activated under similar conditions. CD28 signaling via the serine-threonine kinase Akt and the metabolic-checkpoint kinase mTORC2 was needed to sustain TCR-mediated immediate-early glycolysis. Unlike glycolysis in proliferating cells, immediate-early glycolysis in memory CD8(+) T cells was rapamycin insensitive. Thus, CD8(+) memory T cells have an Akt-dependent 'imprinted' glycolytic potential that is required for efficient immediate-early IFN-gamma recall responses.	[Gubser, Patrick M.; Bantug, Glenn R.; Razik, Leyla; Fischer, Marco; Dimeloe, Sarah; Hoenger, Gideon; Durovic, Bojana; Jauch, Annaise; Hess, Christoph] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel	Hess, C (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	chess@uhbs.ch	Muller-Durovic, Bojana/AAY-1699-2021	Fischer, Marco/0000-0002-2704-7912; Muller-Durovic, Bojana/0000-0002-9672-3750; Dimeloe, Sarah/0000-0002-4598-6518; Bantug, Glenn Robert/0000-0003-2253-6028	Swiss National Science Foundation [31003A_135677, 323630-128881, 323530-139181]; Roche	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding)	We thank E. Palmer and J.A. Schifferli for discussion of data; E. Traunecker and T. Krebs for technical support with cell sorting; B. Erne for help with imaging; A. Buser (University Hospital Basel) for buffy coats; and M. Stern for statistical help. Supported by the Swiss National Science Foundation (31003A_135677 to C. H., 323630-128881 to P. M. G. and 323530-139181 to M. F.) and Roche (S.D.).	Bhagwat SV, 2011, MOL CANCER THER, V10, P1394, DOI 10.1158/1535-7163.MCT-10-1099; Bihl FK, 2005, J TRANSL MED, V3; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Grujic M, 2010, J IMMUNOL, V185, P1730, DOI 10.4049/jimmunol.0903894; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2009, J VIROL, V83, P2862, DOI 10.1128/JVI.02528-08; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Juelich T, 2009, J IMMUNOL, V183, P7063, DOI 10.4049/jimmunol.0901522; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Matsumoto Y, 2004, FEBS LETT, V572, P135, DOI 10.1016/j.febslet.2004.07.023; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zediak VP, 2011, J IMMUNOL, V186, P2705, DOI 10.4049/jimmunol.1003741	50	315	319	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1064	+		10.1038/ni.2687	http://dx.doi.org/10.1038/ni.2687			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23955661				2022-12-18	WOS:000324584700015
J	Gandhi, R; Kumar, D; Burns, EJ; Nadeau, M; Dake, B; Laroni, A; Kozoriz, D; Weiner, HL; Quintana, FJ				Gandhi, Roopali; Kumar, Deepak; Burns, Evan J.; Nadeau, Meghan; Dake, Ben; Laroni, Alice; Kozoriz, Deneen; Weiner, Howard L.; Quintana, Francisco J.			Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA-BINDING PROTEINS; FACTOR C-MAF; TGF-BETA; GENE-EXPRESSION; DIFFERENTIATION; IKAROS; INDUCTION; TOLERANCE; RESPONSES	The aryl hydrocarbon receptor (AhR) participates in the differentiation of mouse regulatory T cells (T-reg cells) and interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells), but its role in human T cell differentiation is unknown. We investigated the role of AhR in the differentiation of human induced T-reg cells (iT(reg) cells). We found that AhR activation promoted the differentiation of CD4(+) Foxp3(-) T cells, which produce IL-10 and control responder T cells through granzyme B. However, activation of AhR in the presence of transforming growth factor-beta 1 induced Foxp3(+) iT(reg) cells, which suppress responder T cells through the ectonucleoside triphosphate diphosphohydrolase CD39. The induction of functional Foxp3(+) iT(reg) cells required coordinated action of the transcriptional regulators Smad1 and Aiolos. Thus, AhR is a potential target through which functional iT(reg) cells could be induced in human autoimmune disorders.	[Gandhi, Roopali; Burns, Evan J.; Nadeau, Meghan; Dake, Ben; Laroni, Alice; Kozoriz, Deneen; Weiner, Howard L.; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020; Laroni, Alice/K-4714-2016	Laroni, Alice/0000-0001-5599-9788	US National Institutes of Health [AI435801, NS38037, 1K99AI075285]; National Multiple Sclerosis Society [RG4151A12, RG4111A1]; Harvard Medical School Office for Diversity and Community Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R56AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Harvard Medical School Office for Diversity and Community Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Kuchroo (Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School) for discussions and the IL10 promoter reporter construct; Y. Tone and M. Tone (Cedars-Sinai Medical Center) for reporter constructs for FOXP3 +2079 to +2198; and E. Ballestar (Bellvitge Biomedical Research Institute) for vectors encoding Aiolos and its isoforms. Supported by the US National Institutes of Health (AI435801 and NS38037 to H. L. W. and 1K99AI075285 to F.J.Q.), the National Multiple Sclerosis Society (RG4151A12 to H. L. W. and RG4111A1 to F.J.Q.) and the Harvard Medical School Office for Diversity and Community Partnership (to F.J.Q.).	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bynoel MS, 2008, TRENDS IMMUNOL, V29, P99, DOI 10.1016/j.it.2007.12.005; Caballero R, 2007, J CELL SCI, V120, P2619, DOI 10.1242/jcs.007344; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; PERDEW GH, 1991, NUTR CANCER, V16, P209, DOI 10.1080/01635589109514159; Planque N, 2001, J BIOL CHEM, V276, P35751, DOI 10.1074/jbc.M104523200; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tran DQ, 2009, HUM IMMUNOL, V70, P294, DOI 10.1016/j.humimm.2009.02.007; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	47	315	330	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					846	U103		10.1038/ni.1915	http://dx.doi.org/10.1038/ni.1915			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20676092	Green Accepted			2022-12-18	WOS:000281115500013
J	Malhotra, D; Fletcher, AL; Astarita, J; Lukacs-Kornek, V; Tayalia, P; Gonzalez, SF; Elpek, KG; Chang, SK; Knoblich, K; Hemler, ME; Brenner, MB; Carroll, MC; Mooney, DJ; Turley, SJ				Malhotra, Deepali; Fletcher, Anne L.; Astarita, Jillian; Lukacs-Kornek, Veronika; Tayalia, Prakriti; Gonzalez, Santiago F.; Elpek, Kutlu G.; Chang, Sook Kyung; Knoblich, Konstantin; Hemler, Martin E.; Brenner, Michael B.; Carroll, Michael C.; Mooney, David J.; Turley, Shannon J.		Immunological Genome Project	Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; T-CELLS; DENDRITIC CELLS; CONDUIT SYSTEM; ANTIGEN; EXPRESSION; COLLAGEN; TOLERANCE; TISSUES; INFLAMMATION	Lymph node stromal cells (LNSCs) closely regulate immunity and self-tolerance, yet key aspects of their biology remain poorly elucidated. Here, comparative transcriptomic analyses of mouse LNSC subsets demonstrated the expression of important immune mediators, growth factors and previously unknown structural components. Pairwise analyses of ligands and cognate receptors across hematopoietic and stromal subsets suggested a complex web of crosstalk. Fibroblastic reticular cells (FRCs) showed enrichment for higher expression of genes relevant to cytokine signaling, relative to their expression in skin and thymic fibroblasts. LNSCs from inflamed lymph nodes upregulated expression of genes encoding chemokines and molecules involved in the acute-phase response and the antigen-processing and antigen-presentation machinery. Poorly studied podoplanin (gp38)-negative CD31-LNSCs showed similarities to FRCs but lacked expression of interleukin 7 (IL-7) and were identified as myofibroblastic pericytes that expressed integrin alpha(7). Together our data comprehensively describe the transcriptional characteristics of LNSC subsets.	[Malhotra, Deepali; Fletcher, Anne L.; Astarita, Jillian; Lukacs-Kornek, Veronika; Elpek, Kutlu G.; Knoblich, Konstantin; Hemler, Martin E.; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Malhotra, Deepali; Astarita, Jillian] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Tayalia, Prakriti; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gonzalez, Santiago F.; Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gonzalez, Santiago F.; Carroll, Michael C.] Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Immune Dis Inst, Boston, MA USA; [Gonzalez, Santiago F.; Carroll, Michael C.] Harvard Univ, Childrens Hosp, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chang, Sook Kyung; Brenner, Michael B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Brenner, Michael B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu	Heng, Tracy/AAR-5712-2021; Knoblich, Konstantin/B-5980-2009; Heng, Tracy/B-9847-2015; Gazit, Roi/J-3352-2017; Gautier, Emmanuel L./E-2259-2017	Heng, Tracy/0000-0003-4147-8986; Knoblich, Konstantin/0000-0002-5646-837X; Heng, Tracy/0000-0003-4147-8986; Gautier, Emmanuel L./0000-0003-2976-7566; Tayalia, Prakriti/0000-0002-4056-2628; Fletcher, Anne/0000-0003-1534-1142; Mooney, David/0000-0001-6299-1194; Kim, Charles/0000-0001-6474-8227; Tata, Nageswara Rao/0000-0002-9928-5944; Gazit, Roi/0000-0002-0548-2147; Malhotra, Deepali/0000-0002-8215-7639; F. Gonzalez, Santiago/0000-0003-4166-7664; kang, joonsoo/0000-0001-8419-7995	US National Institutes of Health [R01 DK074500, P01 AI045757, R24 AI072073, R01 AI063428-06, R01 DE019917, GM38903]; Dana-Farber Cancer Institute; European Union [220044]; NATIONAL CANCER INSTITUTE [R01CA154947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073, R01AI067545, R01AI063428, P01AI045757, R01AI072117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038903] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute; European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Fisher (US National Institutes of Health) for polyclonal anti-decorin, anti-fibromodulin and anti-biglycan; M. Koch (University of Cologne) for polyclonal anti-collagen XIV; M. Curry for technical assistance in sorting stromal-cell populations; J.B. Lewis for discussions during analysis of microarray data; eBioscience, Affymetrix and Expression Analysis for support of the ImmGen Project; and K. W. Wucherpfennig for critical reading of the manuscript. Supported by the US National Institutes of Health (R01 DK074500 and P01 AI045757 to S.J.T.; R24 AI072073 to the ImmGen Consortium; R01 AI063428-06 to M. B. B.; R01 DE019917 to D.J.M.; and GM38903 to M. E. H. and K. K.), the Dana-Farber Cancer Institute (K. K. and V.L.-K.) and the Seventh Framework Programme of the European Union (Marie Curie International Outgoing Fellowship 220044 to S.F.G.).	Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chang SK, 2010, IMMUNOL REV, V233, P256, DOI 10.1111/j.0105-2896.2009.00854.x; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; GILBERT DL, 1988, INT J PHARMACEUT, V47, P79, DOI 10.1016/0378-5173(88)90217-7; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kenins L, 2008, J EXP MED, V205, P523, DOI 10.1084/jem.20072065; KHAN KD, 1990, MOL CELL BIOL, V10, P5150, DOI 10.1128/MCB.10.10.5150; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Moll R, 2009, CELL TISSUE RES, V335, P109, DOI 10.1007/s00441-008-0700-y; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; VANDENBERG TK, 1993, AM J PATHOL, V143, P1098; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Yamamura H, 2007, CANCER SCI, V98, P757, DOI 10.1111/j.1349-7006.2007.00452.x; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	50	314	316	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					499	U107		10.1038/ni.2262	http://dx.doi.org/10.1038/ni.2262			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22466668	Green Submitted, Green Accepted			2022-12-18	WOS:000303048400014
J	Safford, M; Collins, S; Lutz, MA; Allen, A; Huang, CT; Kowalski, J; Blackford, A; Horton, MR; Drake, C; Schwartz, RH; Powell, JD				Safford, M; Collins, S; Lutz, MA; Allen, A; Huang, CT; Kowalski, J; Blackford, A; Horton, MR; Drake, C; Schwartz, RH; Powell, JD			Egr-2 and Egr-3 are negative regulators of T cell activation	NATURE IMMUNOLOGY			English	Article							E3 UBIQUITIN LIGASE; IN-VIVO; TRANSCRIPTION FACTOR; TOLERANCE INDUCTION; ANERGY INDUCTION; CLONAL ANERGY; FAS LIGAND; EXPRESSION; GENE; CD28	T cell receptor engagement in the absence of proper accessory signals leads to T cell anergy. E3 ligases are involved in maintaining the anergic state. However, the specific molecules responsible for the induction of anergy have yet to be elucidated. Using microarray analysis we have identified here early growth response gene 2 (Egr- 2) and Egr- 3 as key negative regulators of T cell activation. Overexpression of Egr2 and Egr3 was associated with an increase in the E3 ubiquitin ligase Cbl-b and inhibition of T cell activation. Conversely, T cells from Egr3(-/-) mice had lower expression of Cbl-b and were resistant to in vivo peptide-induced tolerance. These data support the idea that Egr-2 and Egr-3 are involved in promoting a T cell receptor-induced negative regulatory genetic program.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Care Ctr, Baltimore, MD 21205 USA; Chang Gung Univ, Sch Med & Hosp, Taipei, Taiwan; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Chang Gung University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Care Ctr, Baltimore, MD 21205 USA.	poweljo@jhmi.edu	Chuang, shengHao/C-8217-2012	Kowalski, Jeanne/0000-0003-3458-3024	NATIONAL CANCER INSTITUTE [R01CA098109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000485] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098109-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AJ, 2000, J IMMUNOL, V164, P649, DOI 10.4049/jimmunol.164.2.649; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; HAMMERLING GJ, 1991, IMMUNOL REV, V122, P47, DOI 10.1111/j.1600-065X.1991.tb00596.x; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kowalski J, 2004, BIOINFORMATICS, V20, P364, DOI 10.1093/bioinformatics/btg418; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Lin JX, 1997, MOL CELL BIOL, V17, P3714, DOI 10.1128/MCB.17.7.3714; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO;2-G; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Turman JE, 2001, DEV NEUROSCI-BASEL, V23, P113, DOI 10.1159/000048703; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	32	314	328	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					472	480		10.1038/ni1193	http://dx.doi.org/10.1038/ni1193			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15834410				2022-12-18	WOS:000228634300019
J	Zhang, MH; Tang, H; Guo, ZH; An, HZ; Zhu, XJ; Song, WG; Guo, J; Huang, X; Chen, TY; Wang, JL; Cao, XT				Zhang, MH; Tang, H; Guo, ZH; An, HZ; Zhu, XJ; Song, WG; Guo, J; Huang, X; Chen, TY; Wang, JL; Cao, XT			Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; CD4 T-CELLS; IN-VIVO; ANTIGEN; GENERATION; IMMUNITY; IL-10; MOUSE; PROGENITORS; MATURATION	The fates of dendritic cells (DCs) after antigen presentation have been studied extensively, but the influence of lymphoid microenvironments on DCs is mostly unknown. Here, using splenic stromal cells to mimic the immune microenvironment, we show that contact with stromal cells promoted mature DCs to proliferate in a fibronectin-dependent way and that both stromal cell contact and stromal cell-derived transforming growth factor-beta induced their differentiation into a new regulatory DC subset. We have identified an in vivo counterpart in the spleen with similar phenotype and functions. These differentiated DCs secreted nitric oxide, which mediated the suppression of T cell proliferation in response to antigen presentation by mature DCs. Thus, our findings identify an important mechanism by which the microenvironment regulates immune responses.	Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; Zhejiang Univ, Inst Immunol, Hangzhou 310027, Peoples R China	Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.	caoxt@public3.sta.net.cn	Guo, Zhenhong/HGB-4912-2022					Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; FRANCOIS BJ, 2003, NAT REV IMMUNOL, V3, P189; Geissmann F, 1999, J IMMUNOL, V162, P4567; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kronin V, 1996, J IMMUNOL, V157, P3819; Kubsch S, 2003, EUR J IMMUNOL, V33, P1988, DOI 10.1002/eji.200323600; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Matsue H, 1999, J IMMUNOL, V162, P5287; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; McLellan AD, 2000, CELL DEATH DIFFER, V7, P933, DOI 10.1038/sj.cdd.4400734; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Ni KP, 2000, IMMUNOL CELL BIOL, V78, P196, DOI 10.1046/j.1440-1711.2000.00897.x; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Sato K, 2002, CELL IMMUNOL, V215, P186, DOI 10.1016/S0008-8749(02)00021-7; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 1997, ADV EXP MED BIOL, V417, P1; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Yoshikawa Y, 2000, LEUKEMIA, V14, P727, DOI 10.1038/sj.leu.2401713	34	314	344	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1124	1133		10.1038/ni1130	http://dx.doi.org/10.1038/ni1130			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15475957				2022-12-18	WOS:000224692700009
J	Hu, GQ; Tang, QS; Sharma, S; Yu, F; Escobar, TM; Muljo, SA; Zhu, JF; Zhao, KJ				Hu, Gangqing; Tang, Qingsong; Sharma, Suveena; Yu, Fang; Escobar, Thelma M.; Muljo, Stefan A.; Zhu, Jinfang; Zhao, Keji			Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE IDENTIFICATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; INTEGRATIVE ANNOTATION; CUTTING EDGE; STEM-CELLS; REVEALS; SEQ; POPULATIONS; INTERFERON	Although intergenic long noncoding RNAs (lincRNAs) have been linked to gene regulation in various tissues, little is known about lincRNA transcriptomes in the T cell lineages. Here we identified 1,524 lincRNA clusters in 42 T cell samples, from early T cell progenitors to terminally differentiated helper T cell subsets. Our analysis revealed highly dynamic and cell-specific expression patterns for lincRNAs during T cell differentiation. These lincRNAs were located in genomic regions enriched for genes that encode proteins with immunoregulatory functions. Many were bound and regulated by the key transcription factors T-bet, GATA-3, STAT4 and STAT6. We found that the lincRNA LincR-Ccr2-5'AS, together with GATA-3, was an essential component of a regulatory circuit in gene expression specific to the T(H)2 subset of helper T cells and was important for the migration of T(H)2 cells.	[Hu, Gangqing; Tang, Qingsong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Sharma, Suveena; Yu, Fang; Escobar, Thelma M.; Muljo, Stefan A.; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov; zhaok@nhlbi.nih.gov	HU, GANGQING/K-5849-2012; Hu, Gangqing/ABA-3507-2020; Zhu, Jinfang/B-7574-2012; Muljo, Stefan A/F-5671-2015	HU, GANGQING/0000-0001-5453-6888; Zhu, Jinfang/0000-0002-0117-4745; Muljo, Stefan A/0000-0003-1013-446X; Escobar, Thelma/0000-0001-5352-3903	Division of Intramural Research of the NHLBI and NIAID (US National Institutes of Health); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIGHL006020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131, ZIAAI001169] Funding Source: NIH RePORTER	Division of Intramural Research of the NHLBI and NIAID (US National Institutes of Health); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the DNA Sequencing Core facility of the National Heart, Lung and Blood Institute (NHLBI) for sequencing the ChIP-Seq and RNA-Seq libraries; J. Edwards for most cell-sorting experiments; the flow cytometry core of NHLBI for some cell-sorting experiments and analysis; H. Cao for comments on the knockdown of lincRNA by shRNA; D. Northrup for critical reading and editing of the manuscript; H. Zhang for sharing experience with chemokines and chemokine receptors; P. Burr for RNA-Seq; and X. Zheng for sharing code for binomial tests. This study used the Biowulf Linux cluster of the US National Institutes of Health. Supported by the Division of Intramural Research of the NHLBI and NIAID (US National Institutes of Health).	Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hollander M, 1973, NONPARAMETRIC STAT M; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pagani M, 2013, IMMUNOL REV, V253, P82, DOI 10.1111/imr.12055; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	313	335	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1190	U118		10.1038/ni.2712	http://dx.doi.org/10.1038/ni.2712			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24056746	Green Accepted			2022-12-18	WOS:000326023400016
J	Danilova, N; Bussmann, J; Jekosch, K; Steiner, LA				Danilova, N; Bussmann, J; Jekosch, K; Steiner, LA			The immunoglobulin heavy-chain locus in zebrafish: identification and expression of a previously unknown isotype, immunoglobulin Z	NATURE IMMUNOLOGY			English	Article							CONSTANT-REGION GENE; GADUS-MORHUA L; CHANNEL CATFISH; ICTALURUS-PUNCTATUS; ATLANTIC SALMON; PARALICHTHYS-OLIVACEUS; NUCLEOTIDE-SEQUENCES; GENOMIC ORGANIZATION; V(D)J RECOMBINATION; JAPANESE FLOUNDER	The only immunoglobulin heavy-chain classes known so far in teleosts have been mu and delta. We identify here a previously unknown class, immunoglobulin zeta, expressed in zebrafish and other teleosts. In the zebrafish heavy-chain locus, variable (V) gene segments lie upstream of two tandem diversity, joining and constant (DJC) clusters, resembling the mouse T cell receptor alpha (Tcra) and delta (Tcrd) locus. V genes rearrange to (DJC)(zeta) or to (DJC)(mu) without evidence of switch rearrangement. The zebrafish immunoglobulin zeta gene (ighz) and mouse Tcrd, which are proximal to the V gene array, are expressed earlier in development. In adults, ighz was expressed only in kidney and thymus, which are primary lymphoid organs in teleosts. This additional class adds complexity to the immunoglobulin repertoire and raises questions concerning the evolution of immunoglobulins and the regulation of the differential expression of ighz and ighm.	MIT, Dept Biol, Cambridge, MA 02139 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute	Steiner, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsteiner@mit.edu	Bussmann, Jeroen/D-8106-2011	Bussmann, Jeroen/0000-0003-2814-3305; Howe, Kerstin/0000-0003-2237-513X	NIAID NIH HHS [R01 AI08054] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008054] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMEMIYA CT, 1990, P NATL ACAD SCI USA, V87, P811, DOI 10.1073/pnas.87.2.811; Andersson E, 1996, RES IMMUNOL, V147, P233, DOI 10.1016/0923-2494(96)87226-9; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BENGTEN E, 1991, EUR J IMMUNOL, V21, P3027, DOI 10.1002/eji.1830211219; Bengten E, 2002, J IMMUNOL, V169, P2488, DOI 10.4049/jimmunol.169.5.2488; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Cioffi CC, 2001, J BIOL CHEM, V276, P27825, DOI 10.1074/jbc.M100110200; DAGGFELDT A, 1993, IMMUNOGENETICS, V38, P199; Danilova N, 2000, IMMUNOGENETICS, V52, P81, DOI 10.1007/s002510000255; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Diaz M, 2002, IMMUNOGENETICS, V54, P501, DOI 10.1007/s00251-002-0479-z; ELLESTAD KK, IN PRESS IMMUNOGENET; GHAFFARI SH, 1989, J IMMUNOL, V143, P2730; Ghaffari SH, 1999, J IMMUNOL, V162, P1519; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hirono I, 2003, FISH SHELLFISH IMMUN, V15, P63, DOI 10.1016/S1050-4648(02)00139-0; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Hordvik I, 1999, SCAND J IMMUNOL, V50, P202; Hordvik I, 1998, IMMUNOL REV, V166, P153, DOI 10.1111/j.1600-065X.1998.tb01260.x; Hordvik I, 2002, MOL IMMUNOL, V39, P85, DOI 10.1016/S0161-5890(02)00043-3; HORDVIK I, 1992, EUR J IMMUNOL, V22, P2957, DOI 10.1002/eji.1830221130; Kabat EA, 1991, SEQUENCES PROTEINS I; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; LEE MA, 1993, MOL IMMUNOL, V30, P641, DOI 10.1016/0161-5890(93)90075-M; MAGOR BG, 1994, J IMMUNOL, V153, P5556; Magor BG, 1999, IMMUNOL TODAY, V20, P13, DOI 10.1016/S0167-5699(98)01380-2; OTA T, 1994, MOL BIOL EVOL, V11, P469; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Rothstein TL, 2002, J IMMUNOL, V168, P4257, DOI 10.4049/jimmunol.168.9.4257; Rumfelt LL, 2001, P NATL ACAD SCI USA, V98, P1775, DOI 10.1073/pnas.98.4.1775; Saha NR, 2004, IMMUNOGENETICS, V56, P438, DOI 10.1007/s00251-004-0693-y; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Sleckman BP, 2001, IMMUNOLOGY, V104, P11, DOI 10.1046/j.1365-2567.2001.01304.x; Srisapoome P, 2004, IMMUNOGENETICS, V56, P292, DOI 10.1007/s00251-004-0689-7; Stenvik J, 2000, IMMUNOGENETICS, V51, P452, DOI 10.1007/s002510050644; VENTURAHOLMAN T, 1994, MOL IMMUNOL, V31, P823, DOI 10.1016/0161-5890(94)90020-5; Waters WR, 1996, INFECT IMMUN, V64, P1854, DOI 10.1128/IAI.64.5.1854-1857.1996; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Wiersma EJ, 1997, J IMMUNOL, V158, P1719; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; WILSON MR, 1990, NUCLEIC ACIDS RES, V18, P5227, DOI 10.1093/nar/18.17.5227; Zapata A, 2000, CURR TOP MICROBIOL, V248, P67; Zhao YF, 2005, DEV COMP IMMUNOL, V29, P61, DOI 10.1016/j.dci.2004.05.005	50	313	354	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					295	302		10.1038/ni1166	http://dx.doi.org/10.1038/ni1166			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15685175				2022-12-18	WOS:000227117400022
J	Gapin, L; Matsuda, JL; Surh, CD; Kronenberg, M				Gapin, L; Matsuda, JL; Surh, CD; Kronenberg, M			NKT cells derive from double-positive thymocytes that are positively selected by CDId	NATURE IMMUNOLOGY			English	Article							NK1.1(+) T-CELLS; RECEPTOR-BETA-CHAIN; CLASS-I MOLECULES; RECEPTOR-ALPHA/BETA(+) CELLS; NEGATIVE SELECTION; ALPHA-BETA; INTRATHYMIC SELECTION; MEMBRANE LYMPHOTOXIN; GENE REARRANGEMENT; CUTTING EDGE	CDId-reactive NKT cells are a separate T cell sublineage. Instructive models propose that NKT cells branch off the mainstream developmental pathway because of their T cell antigen receptor specificity, whereas stochastic models would propose that they develop from precursor cells committed to this sublineage before variable-gene rearrangement. We show here that immature double-positive (DP) thymocytes form the canonical rearranged V-alpha gene of NKT cells at nearly equivalent frequencies in the presence or absence of CDId expression. After interacting with CDId in the thymus, these cells give rise to expanded populations of NKT cells - including both CD4(+) and double-negative lymphocytes in the thymus and periphery - that express this alpha chain. These results confirm the existence of a DP intermediate for CDId-reactive NKT cells. They also show that the early developmental stages of these T cells are not governed by a distinct mechanism, which is consistent with the TCR-instructive model of differentiation.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; IMM26 Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Scripps Research Institute	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org	Calabrese, Massimiliano/I-6195-2012	Gapin, Laurent/0000-0001-9730-5174; Matsuda, Jennifer/0000-0002-9191-9893	NCI NIH HHS [R01 CA52511] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052511] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Baldwin KK, 1999, J IMMUNOL, V163, P689; Behar SM, 1999, J IMMUNOL, V162, P161; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Burdin N, 1998, J IMMUNOL, V161, P3271; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; CURNOW SJ, 1995, IMMUNITY, V3, P427; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eberl G, 1999, J IMMUNOL, V162, P6410; Eberl G, 1999, J IMMUNOL, V163, P4091; Elewaut D, 2000, J IMMUNOL, V165, P671, DOI 10.4049/jimmunol.165.2.671; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hogquist KA, 2000, METH MOL B, V156, P219; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; Iwabuchi C, 1998, P NATL ACAD SCI USA, V95, P8199, DOI 10.1073/pnas.95.14.8199; Iwabuchi K, 2001, BLOOD, V97, P1765, DOI 10.1182/blood.V97.6.1765; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lantz O, 1997, J EXP MED, V185, P1395, DOI 10.1084/jem.185.8.1395; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Legendre V, 1999, EUR J IMMUNOL, V29, P2330, DOI 10.1002/(SICI)1521-4141(199907)29:07<2330::AID-IMMU2330>3.3.CO;2-7; LEITEDEMORAES MD, 1995, J IMMUNOL, V155, P4544; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; MacDonald HR, 2000, J EXP MED, V192, pF15, DOI 10.1084/jem.192.5.F15; MacDonald HR, 1998, J EXP MED, V187, P2109, DOI 10.1084/jem.187.12.2109; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Michie AM, 1998, J IMMUNOL, V160, P1735; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Ohteki T, 1997, J IMMUNOL, V159, P5931; Ohteki T, 1996, J EXP MED, V183, P1277, DOI 10.1084/jem.183.3.1277; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; PAGE DM, 1993, J IMMUNOL, V151, P1868; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759; Schulz RJ, 1996, J IMMUNOL, V157, P4379; Shimamura M, 1997, EUR J IMMUNOL, V27, P1576, DOI 10.1002/eji.1830270638; Shimamura M, 1997, J IMMUNOL, V158, P3682; Shimizu T, 1999, MICROBIOL IMMUNOL, V43, P595, DOI 10.1111/j.1348-0421.1999.tb02446.x; SHORES EW, 1991, EUR J IMMUNOL, V21, P973, DOI 10.1002/eji.1830210417; SWAT W, 1992, EUR J IMMUNOL, V22, P2367, DOI 10.1002/eji.1830220928; TAKAHAMA Y, 1991, J IMMUNOL, V146, P1134; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Tilloy F, 1999, EUR J IMMUNOL, V29, P3313, DOI 10.1002/(SICI)1521-4141(199910)29:10<3313::AID-IMMU3313>3.0.CO;2-8; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; WU L, 1990, INT IMMUNOL, V2, P51, DOI 10.1093/intimm/2.1.51	71	313	316	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					971	978		10.1038/ni710	http://dx.doi.org/10.1038/ni710			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11550008				2022-12-18	WOS:000171361500018
J	Schlitzer, A; Sivakamasundari, V; Chen, JM; Bin Sumatoh, HR; Schreuder, J; Lum, J; Malleret, B; Zhang, SQ; Larbi, A; Zolezzi, F; Renia, L; Poidinger, M; Naik, S; Newell, EW; Robson, P; Ginhoux, F				Schlitzer, Andreas; Sivakamasundari, V.; Chen, Jinmiao; Bin Sumatoh, Hermi Rizal; Schreuder, Jaring; Lum, Josephine; Malleret, Benoit; Zhang, Sanqian; Larbi, Anis; Zolezzi, Francesca; Renia, Laurent; Poidinger, Michael; Naik, Shalin; Newell, Evan W.; Robson, Paul; Ginhoux, Florent			Identification of cDC1-and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; CLASSICAL DENDRITIC CELLS; TRANSCRIPTION-FACTOR; COMMITTED PROGENITORS; LYMPHOID-TISSUE; HOMEOSTASIS; EXPRESSION; RECEPTOR; MOUSE; DYNAMICS	Mouse conventional dendritic cells (cDCs) can be classified into two functionally distinct lineages: the CD8 alpha(+) (CD103(+)) cDC1 lineage, and the CD11b(+) cDC2 lineage. cDCs arise from a cascade of bone marrow (BM) DC-committed progenitor cells that include the common DC progenitors (CDPs) and pre-DCs, which exit the BM and seed peripheral tissues before differentiating locally into mature cDCs. Where and when commitment to the cDC1 or cDC2 lineage occurs remains poorly understood. Here we found that transcriptional signatures of the cDC1 and cDC2 lineages became evident at the single-cell level from the CDP stage. We also identified Siglec-H and Ly6C as lineage markers that distinguished pre-DC subpopulations committed to the cDC1 lineage (Siglec-H(-)Ly6C(-)pre-DCs) or cDC2 lineage (Siglec-H(-)Ly6C(+) pre-DCs). Our results indicate that commitment to the cDC1 or cDC2 lineage occurs in the BM and not in the periphery.	[Schlitzer, Andreas; Chen, Jinmiao; Bin Sumatoh, Hermi Rizal; Lum, Josephine; Malleret, Benoit; Zhang, Sanqian; Larbi, Anis; Zolezzi, Francesca; Renia, Laurent; Poidinger, Michael; Newell, Evan W.; Ginhoux, Florent] Agcy Sci Technol & Res, Si3gapore Immunol Network, Singapore, Singapore; [Sivakamasundari, V.; Robson, Paul] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Schreuder, Jaring; Naik, Shalin] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia; [Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Microbiol, Singapore 117595, Singapore; [Naik, Shalin] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Royal Melbourne Hospital; Walter & Eliza Hall Institute; National University of Singapore; University of Melbourne	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Si3gapore Immunol Network, Singapore, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Schlitzer, Andreas/R-2237-2016; Naik, Shalin/AFD-5605-2022; Larbi, Anis/ABE-5868-2020; Chen, Jinmiao/ABE-5601-2021; Newell, Evan W/F-9711-2012; Renia, Laurent/E-2117-2011; Malleret, Benoit/E-9159-2011; Robson, Paul/A-3464-2009	Schlitzer, Andreas/0000-0001-7662-3712; Newell, Evan W/0000-0002-2889-243X; Renia, Laurent/0000-0003-0349-1557; Malleret, Benoit/0000-0001-9658-7528; Robson, Paul/0000-0002-0191-3958; chen, jinmiao/0000-0001-7547-6423; Schreuder, Jaring/0000-0002-7579-0006; Naik, Shalin/0000-0003-0299-3301; Poidinger, Michael/0000-0002-1047-2277	Singapore Immunology Network; Agency for Science, Technology and Research (BMRC Young Investigator grant); Genomics Institute of Singapore; Singapore Medical Research Council [NMRC/CBRG/0047/2013]	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (BMRC Young Investigator grant)(Agency for Science Technology & Research (A*STAR)); Genomics Institute of Singapore; Singapore Medical Research Council	We thank L. Robinson for critical review and editing of the manuscript; M.L. Ng, S.H. Tan, T.B. Lu, I. Low and N.B. Shadan for technical assistance; K. Murphy (University of Washington) for ZBTB46-GFP BM; and G. Belz (Walter & Eliza Hall Institute) for Id2-GFP BM. Supported by Singapore Immunology Network (F.G.), Agency for Science, Technology and Research (BMRC Young Investigator grant to A.S.), the Genomics Institute of Singapore (P.R.) and the Singapore Medical Research Council (NMRC/CBRG/0047/2013 to B.M.).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentleman R., 2006, BRIEF BIOINFORM, V8, P136; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2010, EUR J IMMUNOL, V40, P2099, DOI 10.1002/eji.201040501; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Prendergast AM, 2014, ANN NY ACAD SCI, V1310, P51, DOI 10.1111/nyas.12400; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Shalek A.K., 2014, NATURE, V510, P1; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Swiecki M, 2014, J IMMUNOL, V192, P4409, DOI 10.4049/jimmunol.1303135; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757	53	312	322	7	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					718	+		10.1038/ni.3200	http://dx.doi.org/10.1038/ni.3200			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26054720				2022-12-18	WOS:000356445600008
J	Satpathy, AT; Wu, XD; Albring, JC; Murphy, KM				Satpathy, Ansuman T.; Wu, Xiaodi; Albring, Joern C.; Murphy, Kenneth M.			Re(de)fining the dendritic cell lineage	NATURE IMMUNOLOGY			English	Review							IN-VIVO DEPLETION; PERIPHERAL LYMPHOID ORGANS; ANTIGEN CROSS-PRESENTATION; INTERFERON-PRODUCING CELLS; TRANSCRIPTION FACTOR E2-2; LANGERHANS CELLS; T-CELLS; FLT3 LIGAND; GM-CSF; REGULATES IMMUNITY	Dendritic cells (DCs) are essential mediators of innate and adaptive immune responses. Study of these critical cells has been complicated by their similarity to other hematopoietic lineages, particularly monocytes and macrophages. Progress has been made in three critical areas of DC biology: the characterization of lineage-restricted progenitors in the bone marrow, the identification of cytokines and transcription factors required during differentiation, and the development of genetic tools for the visualization and depletion of DCs in vivo. Collectively, these advances have clarified the nature of the DC lineage and have provided novel insights into their function during health and disease.	[Satpathy, Ansuman T.; Wu, Xiaodi; Albring, Joern C.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	murphyk@pathology.wustl.edu		Satpathy, Ansuman/0000-0002-5167-537X; Albring, Jorn/0000-0002-5534-7250	Howard Hughes Medical Institute; US National Institutes of Health [AI076427-02]; US Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005]; German Research Foundation [AL 1038/1-1]; National Cancer Institute [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Immunological Genome Project Consortium for use of their database<SUP>110</SUP>, and the Alvin J. Siteman Cancer Center at Washington University in St. Louis for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. Supported by the Howard Hughes Medical Institute, the US National Institutes of Health (AI076427-02 to K.M.M.), the US Department of Defense (W81XWH-09-1-0185 to K.M.M.), the American Heart Association (12PRE8610005 to A.T.S.), the German Research Foundation (AL 1038/1-1 to J.C.A.) and the National Cancer Institute (P30 CA91842 for the Alvin J. Siteman Cancer Center).	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; de Brito C, 2011, J IMMUNOL, V186, P1503, DOI 10.4049/jimmunol.1001022; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Elpek KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023921; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Maraskovsky E, 1997, ADV EXP MED BIOL, V417, P33; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy KM, 2011, SCIENCE, V333, DOI 10.1126/science.1198277; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Park CS, 2012, J LEUKOCYTE BIOL, V91, P739, DOI 10.1189/jlb.0811413; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	161	312	327	0	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1145	1154		10.1038/ni.2467	http://dx.doi.org/10.1038/ni.2467			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160217	Green Accepted			2022-12-18	WOS:000311217900007
J	Anderson, P				Anderson, Paul			Post-transcriptional control of cytokine production	NATURE IMMUNOLOGY			English	Review							AU-RICH-ELEMENT; MESSENGER-RNA STABILITY; TUMOR-NECROSIS-FACTOR; MICRORNA-DEPENDENT LOCALIZATION; IL-2 GENE-EXPRESSION; BINDING PROTEINS HUR; INDOLEAMINE 2,3-DIOXYGENASE; TNF-ALPHA; IN-VIVO; T-CELLS	The cytokine-encoding messenger RNA ( mRNA) molecules transcribed in the nucleus acquire a protein coat that facilitates nuclear export, influences cytoplasmic localization, and determines stability and translational competence. The composition of this coat is determined by sequence elements that recruit proteins that influence the rate of translation and/or mRNA decay. Some of these regulatory proteins direct their associated mRNA molecules to discrete cytoplasmic foci ( stress granules and processing bodies) that are essential in 'programming' mRNA 'metabolism'. Studies have begun to identify how these various mechanisms are integrated and regulated to determine the amount of cytokine production in cells involved in immune responses. Understanding of these mechanisms has identified targets for the development of new classes of immunomodulatory drugs.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Anderson, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu						Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Bamba S, 2003, AM J PHYSIOL-GASTR L, V285, pG529, DOI 10.1152/ajpgi.00050.2003; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brown CY, 1996, P NATL ACAD SCI USA, V93, P13721, DOI 10.1073/pnas.93.24.13721; Bufler P, 2004, BIOCHEM J, V381, P503, DOI 10.1042/BJ20040217; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2000, GENE DEV, V14, P1236; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; David PS, 2007, RNA, V13, P1453, DOI 10.1261/rna.501707; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Ding CH, 2006, CURR OPIN INVEST DR, V7, P1020; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Esnault S, 2006, J IMMUNOL, V177, P6999, DOI 10.4049/jimmunol.177.10.6999; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grosset C, 2004, J BIOL CHEM, V279, P13354, DOI 10.1074/jbc.M308003200; Hamilton TA, 2007, J LEUKOCYTE BIOL, V82, P213, DOI 10.1189/jlb.1206754; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Khabar KSA, 2007, J LEUKOCYTE BIOL, V81, P1335, DOI 10.1189/jlb.0207109; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Mestas J, 2005, INT IMMUNOL, V17, P737, DOI 10.1093/intimm/dxh255; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Putland RA, 2002, MOL CELL BIOL, V22, P1664, DOI 10.1128/MCB.22.6.1664-1673.2002; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rothe F, 2006, BIOCHEM BIOPH RES CO, V343, P57, DOI 10.1016/j.bbrc.2006.02.112; Sanchez-Lockhart M, 2006, J IMMUNOL, V176, P4778, DOI 10.4049/jimmunol.176.8.4778; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Sedlmayr P, 2007, CURR DRUG METAB, V8, P205, DOI 10.2174/138920007780362491; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stoecklin G, 2007, GENE DEV, V21, P627, DOI 10.1101/gad.1538807; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	107	312	341	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					353	359		10.1038/ni1584	http://dx.doi.org/10.1038/ni1584			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349815				2022-12-18	WOS:000254123200010
J	Shamri, R; Grabovsky, V; Gauguet, JM; Feigelson, S; Manevich, E; Kolanus, W; Robinson, MK; Staunton, DE; von Andrian, UH; Alon, R				Shamri, R; Grabovsky, V; Gauguet, JM; Feigelson, S; Manevich, E; Kolanus, W; Robinson, MK; Staunton, DE; von Andrian, UH; Alon, R			Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines	NATURE IMMUNOLOGY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; FUNCTION-ASSOCIATED ANTIGEN-1; I-DOMAIN; VASCULAR ENDOTHELIUM; INTEGRIN AVIDITY; SHEAR-FLOW; L-SELECTIN; CA2+-DEPENDENT EPITOPE; CYTOPLASMIC DOMAIN; TALIN BINDING	It is widely believed that rolling lymphocytes require successive chemokine-induced signaling for lymphocyte function associated antigen 1 (LFA-1) to achieve a threshold avidity that will mediate lymphocyte arrest. Using an in vivo model of lymphocyte arrest, we show here that LFA-1-mediated arrest of lymphocytes rolling on high endothelial venules bearing LFA-1 ligands and chemokines was abrupt. In vitro flow chamber models showed that endothelium-presented but not soluble chemokines triggered instantaneous extension of bent LFA-1 in the absence of LFA-1 ligand engagement. To support lymphocyte adhesion, this extended LFA-1 conformation required immediate activation by its ligand, intercellular adhesion molecule 1. These data show that chemokine-triggered lymphocyte adhesiveness involves a previously unrecognized extension step that primes LFA-1 for ligand binding and firm adhesion.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Harvard Univ, Sch Med, CBR, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Bonn, Inst Mol Physiol & Dev Biol, Dept Cellular Biochem, D-53115 Bonn, Germany; Celltech Grp, Slough SL1 4EN, Berks, England	Weizmann Institute of Science; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Bonn; Celltech Group Ltd	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	von Andrian, Ulrich H/A-5775-2008; ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL056949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abitorabi MA, 1997, J CELL BIOL, V139, P563, DOI 10.1083/jcb.139.2.563; Alon R, 2003, BLOOD, V101, P4437, DOI 10.1182/blood-2002-11-3427; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Finger EB, 1996, J IMMUNOL, V157, P5085; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Grabovsky V, 2002, J BIOL CHEM, V277, P20640, DOI 10.1074/jbc.M201763200; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PRIES AR, 1988, INT J MICROCIRC, V7, P327; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Sasaki K, 1996, ANAT REC, V244, P105; Shamri R, 2002, J BIOL CHEM, V277, P40027, DOI 10.1074/jbc.M206806200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhang N, 2003, J BIOL CHEM, V278, P12729, DOI 10.1074/jbc.M300430200	49	312	324	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					497	506		10.1038/ni1194	http://dx.doi.org/10.1038/ni1194			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15834409				2022-12-18	WOS:000228634300022
J	Netea, MG; Balkwill, F; Chonchol, M; Cominelli, F; Donath, MY; Giamarellos-Bourboulis, EJ; Golenbock, D; Gresnigt, MS; Heneka, MT; Hoffman, HM; Hotchkiss, R; Joosten, LAB; Kastner, DL; Korte, M; Latz, E; Libby, P; Mandrup-Poulsen, T; Mantovani, A; Mills, KHG; Nowak, KL; O'Neill, LA; Pickkers, P; van der Poll, T; Ridker, PM; Schalkwijk, J; Schwartz, DA; Siegmund, B; Steer, CJ; Tilg, H; van der Meer, JWM; van de Veerdonk, FL; Dinarello, CA				Netea, Mihai G.; Balkwill, Frances; Chonchol, Michel; Cominelli, Fabio; Donath, Marc Y.; Giamarellos-Bourboulis, Evangelos J.; Golenbock, Douglas; Gresnigt, Mark S.; Heneka, Michael T.; Hoffman, Hal M.; Hotchkiss, Richard; Joosten, Leo A. B.; Kastner, Daniel L.; Korte, Martin; Latz, Eicke; Libby, Peter; Mandrup-Poulsen, Thomas; Mantovani, Alberto; Mills, Kingston H. G.; Nowak, Kristen L.; O'Neill, Luke A.; Pickkers, Peter; van der Poll, Tom; Ridker, Paul M.; Schalkwijk, Joost; Schwartz, David A.; Siegmund, Britta; Steer, Clifford J.; Tilg, Herbert; van der Meer, Jos W. M.; van de Veerdonk, Frank L.; Dinarello, Charles A.			A guiding map for inflammation	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; DOUBLE-BLIND; SEPSIS; RECEPTORS; CELLS; RECOGNITION; INDUCTION; CYTOKINES; ARTHRITIS; INSIGHTS	Biologists, physicians and immunologists have contributed to the understanding of the cellular participants and biological pathways involved in inflammation. Here, we provide a general guide to the cellular and humoral contributors to inflammation as well as to the pathways that characterize inflammation in specific organs and tissues.	[Netea, Mihai G.; Gresnigt, Mark S.; Joosten, Leo A. B.; van der Meer, Jos W. M.; van de Veerdonk, Frank L.; Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Netea, Mihai G.; Gresnigt, Mark S.; Joosten, Leo A. B.; van der Meer, Jos W. M.; van de Veerdonk, Frank L.; Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Netea, Mihai G.] Craiova Univ Med & Pharm, Human Genom Lab, Craiova, Romania; [Balkwill, Frances] Queen Mary Univ London, Barts Canc Inst, London, England; [Chonchol, Michel; Nowak, Kristen L.] Univ Colorado, Div Renal Dis & Hypertens, Aurora, CO USA; [Cominelli, Fabio] Case Western Reserve Univ, Digest Hlth Res Inst, Cleveland, OH 44106 USA; [Donath, Marc Y.] Univ Basel, Univ Hosp, Clin Endocrinol Diabet & Metab, Basel, Switzerland; [Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece; [Golenbock, Douglas; Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Heneka, Michael T.] Univ Bonn, Dept Neurodegenerat Dis & Gerontopsychiat Neurol, Bonn, Germany; [Heneka, Michael T.; Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Hoffman, Hal M.] Univ Calif San Diego, Div Pediat Allergy Immunol & Rheumatol, San Diego, CA 92103 USA; [Hoffman, Hal M.] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA; [Hotchkiss, Richard] Washington Univ, Sch Med, Dept Anesthesiol Med & Surg, St Louis, MO USA; [Joosten, Leo A. B.] Iuliu Hatieganu Univ Med & Pharm, Dept Med Genet, Cluj Napoca, Romania; [Kastner, Daniel L.] US Natl Inst Hlth, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, NHGRI, Bethesda, MD USA; [Korte, Martin] TU Braunschweig, Zool Inst, Braunschweig, Germany; [Korte, Martin] AG NIND, HZI, Braunschweig, Germany; [Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Libby, Peter; Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Mantovani, Alberto] Humanitas Univ, Humanitas Clin Res Ctr, Milan, Italy; [Mills, Kingston H. G.; O'Neill, Luke A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands; [Schwartz, David A.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Siegmund, Britta] Charite Univ Med Berlin, Rheumatol, Dept Med, Gastroenterol,Infect Dis, Berlin, Germany; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Tilg, Herbert] Med Univ Innsbruck, Dept Internal Med Gastroenterol Hepatol & Endocri, Innsbruck, Austria; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Medicine & Pharmacy of Craiova; University of London; Queen Mary University London; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; University of Basel; National & Kapodistrian University of Athens; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Iuliu Hatieganu University of Medicine & Pharmacy; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Copenhagen; Humanitas University; Trinity College Dublin; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Radboud University Nijmegen; University of Colorado System; University of Colorado Anschutz Medical Campus; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Medical University of Innsbruck; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.; Netea, MG (corresponding author), Craiova Univ Med & Pharm, Human Genom Lab, Craiova, Romania.	mihai.netea@radboudumc.nl	Dinarello, Charles/C-8524-2013; Latz, Eicke/H-3951-2014; Heneka, Michael/AAE-8011-2019; Mills, Kingston H/F-5684-2013; van de Veerdonk, Frank L/C-7256-2008; Netea, Mihai/N-5155-2014; Schalkwijk, Joost/R-7509-2019; Siegmund, Britta/E-6929-2018; Schalkwijk, Joost/N-1774-2013; Gresnigt, Mark/H-3530-2015; Mantovani, Alberto/HCI-7449-2022; van der Meer, Jos W.M./C-8521-2013; Libby, Peter/AAY-6404-2021; Nowak, Kristen L/D-4391-2012; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Joosten, Leo AB/H-3138-2015; Pickkers, P./H-8080-2014; Heneka, Michael/E-8072-2015	Latz, Eicke/0000-0003-1488-5666; Mills, Kingston H/0000-0003-3646-8222; van de Veerdonk, Frank L/0000-0002-1121-4894; Schalkwijk, Joost/0000-0002-1308-1319; Siegmund, Britta/0000-0002-0055-958X; Gresnigt, Mark/0000-0002-9514-4634; Mantovani, Alberto/0000-0001-5578-236X; van der Meer, Jos W.M./0000-0001-5120-3690; Libby, Peter/0000-0002-1502-502X; Nowak, Kristen L/0000-0001-9364-3256; Joosten, Leo AB/0000-0001-6166-9830; Pickkers, P./0000-0002-1104-4303; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; O'Neill, Luke/0000-0002-4333-2748; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Heneka, Michael/0000-0003-4996-1630	Intramural Research Program of the National Human Genome Research Institute (NHGRI) at the US National Institutes of Health; ERC Consolidator Grant [310372]; Spinoza Grant from the Netherlands Organization for Scientific Research; Competitiveness Operational Programme Grant from the Romanian Ministry of European Funds (FUSE); American Heart Association [12POST11920023]; NIH [DK042191, DK055812, DK091222, DK097948, AI15614, R01-HL097163]; ERC Advanced Grant [ERC322566]; Cancer Research UK Programme Grant [A16354]; Competitiveness Operational Programme grant from the Romanian Ministry of European Funds (HINT) [P_37_762, MySMIS 103587]; Dutch Arthritis Foundation [NR-12-2-303]; Science Foundation Ireland; RRM Charitable Fund; National Heart, Lung, and Blood Institute [R01 HL080472]; German Research Foundation [SPP1656, 749/7-1, 749/10-1]; German Cancer Foundation; German Israel Foundation; Horizon 2020 program; ERC; AIRC; Fondazione Cariplo; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL120770, R01HL080472, R01HL097163] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015614, R01AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042191, R37DK042191, P01DK091222, P30DK097948, R01DK042191, R01DK055812] Funding Source: NIH RePORTER; Cancer Research UK [16354] Funding Source: researchfish	Intramural Research Program of the National Human Genome Research Institute (NHGRI) at the US National Institutes of Health; ERC Consolidator Grant(European Research Council (ERC)); Spinoza Grant from the Netherlands Organization for Scientific Research; Competitiveness Operational Programme Grant from the Romanian Ministry of European Funds (FUSE); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Advanced Grant(European Research Council (ERC)); Cancer Research UK Programme Grant(Cancer Research UK); Competitiveness Operational Programme grant from the Romanian Ministry of European Funds (HINT); Dutch Arthritis Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); RRM Charitable Fund; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation(German Research Foundation (DFG)); German Cancer Foundation; German Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Horizon 2020 program; ERC(European Research Council (ERC)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK)	We thank all our colleagues in the field for their contributions to knowledge of inflammation. D.L.K. was supported by the Intramural Research Program of the National Human Genome Research Institute (NHGRI) at the US National Institutes of Health. M.G.N. was supported by an ERC Consolidator Grant (no. 310372), a Spinoza Grant from the Netherlands Organization for Scientific Research and a Competitiveness Operational Programme Grant from the Romanian Ministry of European Funds (FUSE). K.L.N. was supported by American Heart Association postdoctoral fellowship award 12POST11920023. F.C. was supported by NIH grants DK042191, DK055812, DK091222 and DK097948. F.B. was supported by an ERC Advanced Grant (ERC322566) and a Cancer Research UK Programme Grant (A16354). C.A.D. was supported by NIH grant AI15614. L.A.J. was supported by a Competitiveness Operational Programme grant from the Romanian Ministry of European Funds (HINT, ID P_37_762; MySMIS 103587) and a Dutch Arthritis Foundation grant (NR-12-2-303). K.H.G.M. was supported by grants from Science Foundation Ireland. P.L. was supported by the RRM Charitable Fund and The National Heart, Lung, and Blood Institute (R01 HL080472). B.S. was supported by the German Research Foundation SPP1656, 749/7-1, 749/10-1, the German Cancer Foundation, the German Israel Foundation and the Horizon 2020 program. D.A.S. was supported by NIH grant R01-HL097163. A.M. was supported by ERC, AIRC and Fondazione Cariplo.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bamias G, 2016, TRANSL RES, V167, P104, DOI 10.1016/j.trsl.2015.09.002; Blom A. M., 2017, J INTERN MED; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Burns KD, 2002, KIDNEY INT, V62, P346, DOI 10.1046/j.1523-1755.2002.00439.x; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dinarello CA, 1996, CURR TOP MICROBIOL, V216, P133; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dinarello CA, 2016, EUR J IMMUNOL, V46, P1067, DOI 10.1002/eji.201545828; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Englbrecht M, 2010, ARTHRIT CARE RES, V62, P977, DOI 10.1002/acr.20161; Eyerich K, 2017, EUR J IMMUNOL, V47, P607, DOI 10.1002/eji.201646723; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Joosten LAB, 2016, ANN RHEUM DIS, V75, P1219, DOI 10.1136/annrheumdis-2014-206966; Kanni T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130522; Ketelhuth DFJ, 2016, CIRC RES, V118, P668, DOI 10.1161/CIRCRESAHA.115.306427; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Mantovani A., 2017, NAT REV CLIN ONCOL; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Noda S, 2015, J ALLERGY CLIN IMMUN, V135, P324, DOI 10.1016/j.jaci.2014.11.015; Nowak KL, 2017, J AM SOC NEPHROL, V28, P971, DOI 10.1681/ASN.2016040453; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Shattuck EC, 2015, AM J PHYS ANTHROPOL, V157, P1, DOI 10.1002/ajpa.22698; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194	54	311	321	18	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					826	831		10.1038/ni.3790	http://dx.doi.org/10.1038/ni.3790			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722720	Green Accepted, Green Submitted			2022-12-18	WOS:000405821100002
J	Dejnirattisai, W; Wongwiwat, W; Supasa, S; Zhang, XK; Dai, XH; Rouvinsky, A; Jumnainsong, A; Edwards, C; Quyen, NTH; Duangchinda, T; Grimes, JM; Tsai, WY; Lai, CY; Wang, WK; Malasit, P; Farrar, J; Simmons, CP; Zhou, ZH; Rey, FA; Mongkolsapaya, J; Screaton, GR				Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Supasa, Sunpetchuda; Zhang, Xiaokang; Dai, Xinghong; Rouvinsky, Alexander; Jumnainsong, Amonrat; Edwards, Carolyn; Nguyen Than Ha Quyen; Duangchinda, Thaneeya; Grimes, Jonathan M.; Tsai, Wen-Yang; Lai, Chih-Yun; Wang, Wei-Kung; Malasit, Prida; Farrar, Jeremy; Simmons, Cameron P.; Zhou, Z. Hong; Rey, Felix A.; Mongkolsapaya, Juthathip; Screaton, Gavin R.			A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus	NATURE IMMUNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; TICK-BORNE ENCEPHALITIS; ENVELOPE GLYCOPROTEIN; FUSION-LOOP; STRUCTURAL-CHANGES; HEMORRHAGIC-FEVER; IMMUNE-RESPONSE; MEMBRANE-FUSION; T-CELLS; MATURATION	Dengue is a rapidly emerging, mosquito-borne viral infection, with an estimated 400 million infections occurring annually. To gain insight into dengue immunity, we characterized 145 human monoclonal antibodies (mAbs) and identified a previously unknown epitope, the envelope dimer epitope (EDE), that bridges two envelope protein subunits that make up the 90 repeating dimers on the mature virion. The mAbs to EDE were broadly reactive across the dengue serocomplex and fully neutralized virus produced in either insect cells or primary human cells, with 50% neutralization in the low picomolar range. Our results provide a path to a subunit vaccine against dengue virus and have implications for the design and monitoring of future vaccine trials in which the induction of antibody to the EDE should be prioritized.	[Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Supasa, Sunpetchuda; Jumnainsong, Amonrat; Edwards, Carolyn; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Div Immunol & Inflammat, London, England; [Supasa, Sunpetchuda; Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Supasa, Sunpetchuda] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok 10700, Thailand; [Zhang, Xiaokang; Rouvinsky, Alexander; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France; [Zhang, Xiaokang; Rouvinsky, Alexander; Rey, Felix A.] CNRS, UMR Virol 3569, Paris, France; [Dai, Xinghong; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Dai, Xinghong; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Jumnainsong, Amonrat] Khon Kaen Univ, Ctr Res & Dev, Med Diagnost Labs, Fac Associated Med Sci, Khon Kaen, Thailand; [Nguyen Than Ha Quyen; Farrar, Jeremy; Simmons, Cameron P.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Program, Ho Chi Minh City, Vietnam; [Duangchinda, Thaneeya; Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England; [Grimes, Jonathan M.] Univ Oxford, Oxford Prot Prod Facil, Wellcome Trust Ctr Human Genet, Oxford, England; [Grimes, Jonathan M.] Diamond Light Source, Div Sci, Didcot, Oxon, England; [Tsai, Wen-Yang; Lai, Chih-Yun; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Simmons, Cameron P.] Univ Melbourne, Dept Microbiol & Immunol, Carlton, Vic 3053, Australia	Imperial College London; Mahidol University; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; University of Hawaii System; University of Hawaii Manoa; University of Melbourne	Screaton, GR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.	j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk	Farrar, Jeremy J./HGA-7610-2022; Zhang, Xiaokang/AHE-3776-2022; de Villers, Thierry/AAF-3646-2021; Rey, Felix/B-6497-2012; Wongwiwat, Wiyada/AAJ-8936-2021; Simmons, Cameron P/ABA-3896-2021; Zhou, Z Hong/HDN-0747-2022	Zhang, Xiaokang/0000-0001-5073-2582; Simmons, Cameron P/0000-0002-9039-7392; Rey, Felix/0000-0002-9953-7988; Wongwiwat, Wiyada/0000-0002-5889-0929; Grimes, Jonathan Mark/0000-0001-9698-0389; Dai, Xinghong/0000-0002-4102-3175; Screaton, Gavin/0000-0002-3549-4309; Farrar, Jeremy/0000-0002-2700-623X	University of California Los Angeles; US National Institutes of Health [1S10OD018111, NSF DBI-1338135, GM071940, AI094386]; Medical Research Council UK; Wellcome Trust; National Institutes for Health Research Biomedical Research Centre; European Commission Seventh Framework Programme (FP7; DENFREE project) [282 378]; Direct For Biological Sciences [1338135] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Medical Research Council [G0801508, G0400720] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; MRC [G0400720, G0801508] Funding Source: UKRI	University of California Los Angeles(University of California System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes for Health Research Biomedical Research Centre; European Commission Seventh Framework Programme (FP7; DENFREE project); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Armed Forces Research Institute of Medical Sciences of Thailand (AFRIMS), C. Puttikhunt (National Center for Genetic Engineering and Biotechnology, Thailand) and W. Kasinrerk (Chiang Mai University) for the mouse mAb 4G2 to DENV E protein and mAb 1H10 to DENV; E. Harris (University of California Berkeley School of Public Health) for mAb E1D8 to DENV NS3 protein; H. Wardemann (Max Planck Institute for Infection Biology) for expression vectors for IgG1 or immunoglobulin kappa-chain or lambda-chain; A Flanagan (University of Oxford) for recombinant soluble E protein; the staff at Oxford University Clinical Research Unit Viet Nam for sample collection; and N. Ferguson (Imperial College London) for statistical advice. We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines, supported by University of California Los Angeles and the US National Institutes of Health (1S10OD018111 and NSF DBI-1338135). Supported by the Medical Research Council UK, the Wellcome Trust (G.R.S.), the National Institutes for Health Research Biomedical Research Centre, the US National Institutes of Health (GM071940 and AI094386) and European Commission Seventh Framework Programme (FP7/2007-2013; DENFREE project, 282 378).	ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Plevka P, 2014, J STRUCT BIOL, V185, P27, DOI 10.1016/j.jsb.2013.11.001; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Puttikhunt C, 2008, J MED VIROL, V80, P125, DOI 10.1002/jmv.21047; Rouvinski A., NATURE IN PRESS; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SITTISOMBUT N, 1995, J MED VIROL, V45, P43, DOI 10.1002/jmv.1890450109; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Smith ST, 2013, P I CIVIL ENG-STR B, V166, P1, DOI 10.1680/stbu.2012.166.1.1; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13; Weikl TR, 2014, PROTEIN SCI, V23, P1508, DOI 10.1002/pro.2539; Westaway E. G., 1997, P147; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	51	311	326	5	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					170	+		10.1038/ni.3058	http://dx.doi.org/10.1038/ni.3058			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25501631	Green Accepted, Green Published			2022-12-18	WOS:000348143100009
J	Mayor, A; Martinon, F; De Smedt, T; Petrilli, V; Tschopp, J				Mayor, Annick; Martinon, Fabio; De Smedt, Thibaut; Petrilli, Virginie; Tschopp, Juerg			A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses	NATURE IMMUNOLOGY			English	Article							BACTERIAL MURAMYL DIPEPTIDE; DISEASE-RESISTANCE; MOLECULAR CHAPERONE; CASPASE-1; ACTIVATION; PROTEIN; RECOGNITION; COMPLEX; IPAF; RAR1	The family of mammalian Nod-like receptors (NLRs) consists of critical intracellular immune proteins structurally related to plant resistance proteins. The NLRs NALP3 and IPAF, for example, can each form a multiprotein proinflammatory complex called the 'inflammasome', and mutations in the gene encoding Nod2, another NLR, are positively associated with Crohn disease. Here we show that many NLRs interacted with the ubiquitin ligase-associated protein SGT1 and heat-shock protein 90 (HSP90), both of which have plant orthologs essential for R-protein responses. 'Knockdown' of SGT1 by small interfering RNA or chemical inhibition of HSP90 abrogated inflammasome activity, and inhibition of HSP90 blocked Nod2-mediated activation of the transcription factor NF-kappa B and reduced NALP3-mediated gout-like inflammation in mice. Our data demonstrate a similarity in one type of innate immunity in plants and mammals that is consistent with convergent evolution of a shared mechanism.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Apoxis, CH-1004 Lausanne, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Petrilli, Virginie/ABI-8199-2020; Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X; Petrilli, Virginie/0000-0001-8502-6979				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Holt J, 2003, PUBL ASTRON SOC AUST, V20, P25, DOI 10.1071/AS02038; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	40	311	337	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					497	503		10.1038/ni1459	http://dx.doi.org/10.1038/ni1459			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17435760				2022-12-18	WOS:000245831600014
J	Tager, AM; Bromley, SK; Medoff, BD; Islam, SA; Bercury, SD; Friedrich, EB; Carafone, AD; Gerszten, RE; Luster, AD				Tager, AM; Bromley, SK; Medoff, BD; Islam, SA; Bercury, SD; Friedrich, EB; Carafone, AD; Gerszten, RE; Luster, AD			Leukotriene B-4 receptor BLT1 mediates early effector T cell recruitment	NATURE IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; ARACHIDONIC-ACID; ALVEOLAR MACROPHAGES; POLARIZED T-HELPER-1; CHEMOKINE PRODUCTION; MOUSE MODEL; IN-VITRO; RELEASE; GENERATION; EXPRESSION	Leukotriene B-4 (LTB4) was originally described as a potent lipid myeloid cell chemoattractant, rapidly generated from innate immune cells, that activates leukocytes through the G protein-coupled receptor BLT1. We report here that BLT1 is expressed on effector CD4(+) T cells generated in vitro as well as in vivo when effector T cells migrate out of the lymphoid compartment and are recruited into peripheral tissues. BLT1 mediated LTB4-induced T helper type 1 (T(H)1) and T(H)2 cell chemotaxis and firm adhesion to endothelial cells under flow, as well as early CD4(+) and CD8(+) T cell recruitment into the airway in an asthma model. Our findings show that the LTB4-BLT1 pathway is involved in linking early immune system activation and early effector T cell recruitment.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Luster, AD (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02114 USA.	luster@helix.mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Medoff, Benjamin/0000-0002-2558-0449	NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065584, K08HL004087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI050399, R01AI040618, R01AI046999, F32AI054107, R01AI050892] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA69212] Funding Source: Medline; NHLBI NIH HHS [R01-HL65584, K08-HL04087] Funding Source: Medline; NIAID NIH HHS [F32-AI54107, F32-AI50399, R01-AI050892, R01-AI40618, R01-AI46999] Funding Source: Medline; NIDDK NIH HHS [DK5005] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALLAITH M, 1993, ALLERGY, V48, P608, DOI 10.1111/j.1398-9995.1993.tb00757.x; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; ARCOLEO F, 1995, INT J IMMUNOPHARMACO, V17, P457, DOI 10.1016/0192-0561(95)00038-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BORGEAT P, 1979, J BIOL CHEM, V254, P2643; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Colantonio L, 2002, EUR J IMMUNOL, V32, P1264, DOI 10.1002/1521-4141(200205)32:5<1264::AID-IMMU1264>3.0.CO;2-S; Csoma Z, 2002, AM J RESP CRIT CARE, V166, P1345, DOI 10.1164/rccm.200203-233OC; DEJONG EMGJ, 1992, CLIN EXP DERMATOL, V17, P413; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Haeggstrom JZ, 2002, CELL MOL LIFE SCI, V59, P742, DOI 10.1007/s00018-002-8463-1; HEAVEY DJ, 1988, J IMMUNOL, V140, P1953; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; HSUEH W, 1987, EXP LUNG RES, V13, P385, DOI 10.3109/01902148709069600; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; KATZ HR, 1992, J IMMUNOL, V148, P868; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; KRUMP E, 1994, BBA-LIPID LIPID MET, V1213, P135, DOI 10.1016/0005-2760(94)90019-1; MacLean JA, 1999, AM J RESP CELL MOL, V20, P379, DOI 10.1165/ajrcmb.20.3.3291; MacLean JA, 1996, J EXP MED, V184, P1461, DOI 10.1084/jem.184.4.1461; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; PATERSON NAM, 1976, J IMMUNOL, V117, P1356; RANKIN JA, 1989, J CLIN INVEST, V83, P1691, DOI 10.1172/JCI114069; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SAMPSON AP, 1995, ARCH DIS CHILD, V73, P221, DOI 10.1136/adc.73.3.221; SHINDO K, 1995, EUR RESPIR J, V8, P605; SMITH MJH, 1980, J PHARM PHARMACOL, V32, P517, DOI 10.1111/j.2042-7158.1980.tb12985.x; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; YAMAOKA KA, 1993, EUR J IMMUNOL, V23, P2392, DOI 10.1002/eji.1830231003; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	53	311	326	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					982	990		10.1038/ni970	http://dx.doi.org/10.1038/ni970			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12949531				2022-12-18	WOS:000185590100014
J	Bjorklund, AK; Forkel, M; Picelli, S; Konya, V; Theorell, J; Friberg, D; Sandberg, R; Mjosberg, J				Bjorklund, Asa K.; Forkel, Marianne; Picelli, Simone; Konya, Viktoria; Theorell, Jakob; Friberg, Danielle; Sandberg, Rickard; Mjosberg, Jenny			The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing	NATURE IMMUNOLOGY			English	Article							T-CELL; GENE-EXPRESSION; NK CELLS; SEQ; NOTCH; INDUCER; FETAL; DIFFERENTIATION; TRANSCRIPTOME; PACKAGE	Innate lymphoid cells (ILCs) are increasingly appreciated as important participants in homeostasis and inflammation. Substantial plasticity and heterogeneity among ILC populations have been reported. Here we have delineated the heterogeneity of human ILCs through single-cell RNA sequencing of several hundreds of individual tonsil CD127(+) ILCs and natural killer (NK) cells. Unbiased transcriptional clustering revealed four distinct populations, corresponding to ILC1 cells, ILC2 cells, ILC3 cells and NK cells, with their respective transcriptomes recapitulating known as well as unknown transcriptional profiles. The single-cell resolution additionally divulged three transcriptionally and functionally diverse subpopulations of ILC3 cells. Our systematic comparison of single-cell transcriptional variation within and between ILC populations provides new insight into ILC biology during homeostasis, with additional implications for dysregulation of the immune system.	[Bjorklund, Asa K.; Picelli, Simone; Sandberg, Rickard] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Bjorklund, Asa K.; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Bjorklund, Asa K.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Forkel, Marianne; Konya, Viktoria; Theorell, Jakob; Mjosberg, Jenny] Karolinska Inst, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden; [Friberg, Danielle] Karolinska Univ Hosp, Dept Otorhinolaryngol, Stockholm, Sweden; [Friberg, Danielle] Karolinska Inst, CLINTEC, Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sandberg, R (corresponding author), Ludwig Inst Canc Res, S-10401 Stockholm, Sweden.; Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Mjosberg, J (corresponding author), Karolinska Inst, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.	rickard.sandberg@ki.se; jenny.mjosberg@ki.se	; Bjorklund, Asa K/J-4587-2013	Picelli, Simone/0000-0002-1747-614X; Konya, Viktoria/0000-0002-7999-9093; Mjosberg, Jenny/0000-0002-1119-0976; Sandberg, Rickard/0000-0001-6473-1740; Bjorklund, Asa K/0000-0003-2224-7090; Friberg, Danielle/0000-0001-8327-1292	FACSAria sorting; Karolinska Institutet; Swedish Research Council; Swedish Cancer Society; Swedish Society for Medical Research; Swedish Foundation for Strategic Research; Torsten Soderberg's Foundation; Jonas Soderquist Foundation; European Union's Horizon research and innovation program [655677]; Stockholm County Government	FACSAria sorting; Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society for Medical Research; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten Soderberg's Foundation; Jonas Soderquist Foundation; European Union's Horizon research and innovation program; Stockholm County Government	We thank I. Douagi and R. Mansson for support with FACSAria sorting; J. Michaelsson, M. Karlsson and Y. Bryceson for discussions and critical reading of the manuscript; and M. Holm (Uppsala University) for Python scripts and input on coding. Supported by the Karolinska Institutet (J.M., M.F. and J.T.), the Swedish Research Council (J.M., M.F. and R.S.), the Swedish Cancer Society (J.M. and M.F.), the Swedish Society for Medical Research (J.M. and M.F.), the Swedish Foundation for Strategic Research (J.M., M.F. and R.S.), Torsten Soderberg's Foundation (J.M. and M.F.), the Jonas Soderquist Foundation (J.M. and M.F.), the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie 655677 for V.K.) and the Stockholm County Government (J.T.).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bandyopadhyay S, 2014, MOL CELL BIOL, V34, P233, DOI 10.1128/MCB.00902-13; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boyd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108649; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; De Smedt M, 2007, BLOOD, V110, P2696, DOI 10.1182/blood-2007-03-082206; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gentek R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00334; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Holmes ML, 2014, EMBO J, V33, P2721, DOI 10.15252/embj.201487900; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Krijthe JH, RTSNE T DISTRIBUTED; Larabee JL, 2013, J BIOL CHEM, V288, P21526, DOI 10.1074/jbc.M113.465120; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Neuwirth E, 2011, RCOLORBREWER COLORBR; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	58	310	322	5	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					451	+		10.1038/ni.3368	http://dx.doi.org/10.1038/ni.3368			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26878113				2022-12-18	WOS:000372508000019
J	Vig, M; Kinet, JP				Vig, Monika; Kinet, Jean-Pierre			Calcium signaling in immune cells	NATURE IMMUNOLOGY			English	Review							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; ACTIVATED T-CELLS; CRAC CHANNEL; STORE DEPLETION; SENSOR STIM1; PORE SUBUNIT; MICE LACKING; MAST-CELLS; ORAI1	Calcium acts as a second messenger in many cell types, including lymphocytes. Resting lymphocytes maintain a low concentration of Ca2+. However, engagement of antigen receptors induces calcium influx from the extracellular space by several routes. A chief mechanism of Ca2+ entry in lymphocytes is through store-operated calcium (SOC) channels. The identification of two important molecular components of SOC channels, CRACM1 ( the pore-forming subunit) and STIM1 (the sensor of stored calcium), has allowed genetic and molecular manipulation of the SOC entry pathway. In this review, we highlight advances in the understanding of Ca2+ signaling in lymphocytes with special emphasis on SOC entry. We also discuss outstanding questions and probable future directions of the field.	[Vig, Monika] Beth Israel Deaconess Med Ctr, Dept Pathol, Lab Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Vig, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Lab Allergy & Immunol, Boston, MA 02115 USA.	mvig@bidmc.harvard.edu		Vig, Monika/0000-0002-4770-8853	Cancer Research Institute-Irvington Institute Fellowship Program; US National Institutes of Health [GM 053950]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053950, R37GM053950] Funding Source: NIH RePORTER	Cancer Research Institute-Irvington Institute Fellowship Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Rao and D. Okuhara for discussions and J. W. Putney for critical reading of this manuscript, and we apologize to those colleagues whose work we could not cite because of space limitations. Supported by the Cancer Research Institute-Irvington Institute Fellowship Program ( M. V.) and the US National Institutes of Health (GM 053950 to J.-P. K.).	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; BALASUBRAMANYAM M, 1994, J CLIN INVEST, V94, P2002, DOI 10.1172/JCI117553; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; COWEN DS, 1989, J CLIN INVEST, V83, P1651, DOI 10.1172/JCI114064; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GAO EK, 1988, NATURE, V336, P176, DOI 10.1038/336176a0; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; Guerini D, 2005, CELL CALCIUM, V38, P281, DOI 10.1016/j.ceca.2005.06.032; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; GWACK Y, 2008, MOL CELL BIOL; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; JENKINS MK, 1988, SCIENCE, V241, P1655, DOI 10.1126/science.3262237; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Leslie M, 2007, SCIENCE, V317, P614, DOI 10.1126/science.317.5838.614; LEWIS RR, 1989, WETLAND CREATION RES, V2, P1; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Nadler MJS, 2002, NAT IMMUNOL, V3, P707, DOI 10.1038/ni0802-707; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Rao GK, 2006, J LEUKOCYTE BIOL, V79, P202, DOI 10.1189/jlb.0505274; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Saris NEL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P187, DOI 10.1007/s10541-005-0100-9; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Telford WG, 1996, CYTOMETRY, V24, P243, DOI 10.1002/(SICI)1097-0320(19960701)24:3<243::AID-CYTO7>3.3.CO;2-P; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Villereal ML, 2006, SEMIN CELL DEV BIOL, V17, P618, DOI 10.1016/j.semcdb.2006.10.010; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	92	310	321	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					21	27		10.1038/ni.f.220	http://dx.doi.org/10.1038/ni.f.220			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088738	Green Accepted			2022-12-18	WOS:000261788800008
J	Schneider, C; Nobs, SP; Kurrer, M; Rehrauer, H; Thiele, C; Kopf, M				Schneider, Christoph; Nobs, Samuel P.; Kurrer, Michael; Rehrauer, Hubert; Thiele, Christoph; Kopf, Manfred			Induction of the nuclear receptor PPAR-gamma by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages	NATURE IMMUNOLOGY			English	Article							LANGERHANS CELLS; GENE-EXPRESSION; STEADY-STATE; REVEALS; INFLAMMATION; POPULATIONS; DIVERSITY; PATHWAYS; DERIVE; ROLES	Tissue-resident macrophages constitute heterogeneous populations with unique functions and distinct gene-expression signatures. While it has been established that they originate mostly from embryonic progenitor cells, the signals that induce a characteristic tissue-specific differentiation program remain unknown. We found that the nuclear receptor PPAR-gamma determined the perinatal differentiation and identity of alveolar macrophages (AMs). In contrast, PPAR-gamma was dispensable for the development of macrophages located in the peritoneum, liver, brain, heart, kidneys, intestine and fat. Transcriptome analysis of the precursors of AMs from newborn mice showed that PPAR-gamma conferred a unique signature, including several transcription factors and genes associated with the differentiation and function of AMs. Expression of PPAR-gamma in fetal lung monocytes was dependent on the cytokine GM-CSF. Therefore, GM-CSF has a lung-specific role in the perinatal development of AMs through the induction of PPAR-gamma in fetal monocytes.	[Schneider, Christoph; Nobs, Samuel P.; Kopf, Manfred] Swiss Fed Inst Technol Zurich, Dept Biol, Inst Mol Hlth Sci, Zurich, Switzerland; [Kurrer, Michael] Inst Pathol, Zurich, Switzerland; [Rehrauer, Hubert] Funct Genom Ctr, Zurich, Switzerland; [Thiele, Christoph] Univ Bonn, LIMES Inst, Bonn, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn	Kopf, M (corresponding author), Swiss Fed Inst Technol Zurich, Dept Biol, Inst Mol Hlth Sci, Zurich, Switzerland.	manfred.kopf@ethz.ch	Nobs, Samuel Philip/N-4819-2019; Kopf, Manfred/B-6907-2009	Nobs, Samuel Philip/0000-0003-0627-892X; Kopf, Manfred/0000-0002-0628-7140; Schneider, Christoph/0000-0002-0452-2960	Swiss National Science Foundation [310030-124922/1]; Swiss Federal Institute of Technology Zurich [ETH-34 13-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Technology Zurich(ETH Zurich)	We thank P. Chambon (Universite Louis Pasteur) for Pparg<SUP>fl/fl</SUP> mice<SUP>20</SUP>; B. Becher (University of Zurich) for Csf2<SUP>-/-</SUP> and Csf2rb<SUP>-/-</SUP> mice; and C. Halin (Swiss Federal Institute of Technology Zurich) for Rosa26-stop<SUP>flox</SUP>-tdRFP mice<SUP>43</SUP>. Supported by the Swiss National Science Foundation (310030-124922/1) and Swiss Federal Institute of Technology Zurich (ETH-34 13-1).	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baker AD, 2010, BIOCHEM BIOPH RES CO, V393, P682, DOI 10.1016/j.bbrc.2010.02.056; Bonfield TL, 2003, AM J RESP CELL MOL, V29, P677, DOI 10.1165/rcmb.2003-0148OC; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Han CZ, 2011, CELL, V147, P1442, DOI 10.1016/j.cell.2011.12.006; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	40	309	316	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1026	1037		10.1038/ni.3005	http://dx.doi.org/10.1038/ni.3005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25263125				2022-12-18	WOS:000343640700008
J	Divanovic, S; Trompette, A; Atabani, SF; Madan, R; Golenbock, DT; Visintin, A; Finberg, RW; Tarakhovsky, A; Vogel, SN; Belkaid, Y; Kurt-Jones, EA; Karp, CL				Divanovic, S; Trompette, A; Atabani, SF; Madan, R; Golenbock, DT; Visintin, A; Finberg, RW; Tarakhovsky, A; Vogel, SN; Belkaid, Y; Kurt-Jones, EA; Karp, CL			Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105	NATURE IMMUNOLOGY			English	Article							CELL-SURFACE EXPRESSION; CUTTING EDGE; B-CELLS; LIPOPOLYSACCHARIDE-BINDING; ENDOTOXIN TOLERANCE; DROSOPHILA EMBRYO; MOLECULAR-CLONING; PROTEIN; ACTIVATION; RECOGNITION	Activation of Toll-like receptor (TLR) signaling by microbial signatures is critical to the induction of immune responses. Such responses demand tight regulation. RP105 is a TLR homolog thought to be mostly B cell specific, lacking a signaling domain. We report here that RP105 expression was wide, directly mirroring that of TLR4 on antigen-presenting cells. Moreover, RP105 was a specific inhibitor of TLR4 signaling in HEK 293 cells, a function conferred by its extracellular domain. Notably, RP105 and its helper molecule, MD-1, interacted directly with the TLR4 signaling complex, inhibiting its ability to bind microbial ligand. Finally, RP105 regulated TLR4 signaling in dendritic cells as well as endotoxin responses in vivo. Thus, our results identify RP105 as a physiological negative regulator of TLR4 responses.	Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; Rockefeller University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Karp, CL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Belkaid, Yasmine/0000-0001-9962-3571; Karp, Christopher/0000-0002-0832-2659	NIAID NIH HHS [T32 AI 055406, T32 AI055406, R21 AI063183-01, R21 AI063183] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063183, T32AI055406] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Ardizzone S, 2002, J INTERN MED, V252, P475, DOI 10.1046/j.1365-2796.2002.01067.x; Atabani SF, 2001, J INFECT DIS, V184, P1, DOI 10.1086/321009; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bingham CO, 2002, J RHEUMATOL, V29, P3; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cross AS, 2002, J ENDOTOXIN RES, V8, P83, DOI 10.1179/096805102125000227; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FugierVivier I, 1997, EUR J IMMUNOL, V27, P1824, DOI 10.1002/eji.1830270734; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Miura Y, 1996, GENOMICS, V38, P299, DOI 10.1006/geno.1996.0632; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Miyake K, 1998, J IMMUNOL, V161, P1348; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Roshak AK, 1999, J LEUKOCYTE BIOL, V65, P43, DOI 10.1002/jlb.65.1.43; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsuneyoshi N, 2005, J IMMUNOL, V174, P340, DOI 10.4049/jimmunol.174.1.340; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Vogel SN, 1999, J IMMUNOL, V162, P5666; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; WINANS KA, 1995, MOL BIOL CELL, V6, P587, DOI 10.1091/mbc.6.5.587; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; 1994, LAB ANIM, V28, P13	52	309	332	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					571	578		10.1038/ni1198	http://dx.doi.org/10.1038/ni1198			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15852007	Green Accepted			2022-12-18	WOS:000229385900011
J	Jaattela, M; Tschopp, J				Jaattela, M; Tschopp, J			Caspase-independent cell death in T lymphocytes	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; APOPTOSIS-INDUCING FACTOR; CATHEPSIN-B; PHOSPHOLIPASE A(2); FAS-LIGAND; POLY(ADP-RIBOSE) POLYMERASE; CYTOCHROME-C; BCL-2 FAMILY; FACTOR-ALPHA	T lymphocyte death is essential for proper function of the immune system. During the decline of an immune response, most of the activated T cells die. Cell death is also responsible for eliminating autoreactive lymphocytes. Although recent studies have focused on caspase-dependent apoptotic signals, much evidence now shows that caspase-independent, necrotic cell death pathways are as important. An understanding of the molecular control of these alternative pathways is beginning to emerge. Damage of organelles including mitochondria, endoplasmic reticulum or lysozymes, leading to an increase in calcium and reactive oxygen species and the release of effector proteins, is frequently involved in caspase-independent cell death.	Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, DK-2100 Copenhagen, Denmark; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Danish Cancer Society; University of Lausanne	Jaattela, M (corresponding author), Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, Strandblvd 49, DK-2100 Copenhagen, Denmark.	mhj@biobase.dk; jurg.tschopp@ib.unil.ch	Jäättelä, Marja/AAT-7932-2021	Jäättelä, Marja/0000-0001-5950-7111				Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bao JJ, 2002, CANCER RES, V62, P7264; Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556; Bidere N, 2001, APOPTOSIS, V6, P371, DOI 10.1023/A:1011390103783; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; CATALDO AM, 1994, BRAIN RES, V640, P68, DOI 10.1016/0006-8993(94)91858-9; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chi SJ, 1999, ONCOGENE, V18, P2281, DOI 10.1038/sj.onc.1202538; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Davidson WF, 2002, J IMMUNOL, V169, P6218, DOI 10.4049/jimmunol.169.11.6218; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hirt UA, 2000, J IMMUNOL, V164, P6520, DOI 10.4049/jimmunol.164.12.6520; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; HOLLER P, 1989, MAR GEOTECHNOL, V8, P1, DOI 10.1080/10641198909379855; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Katz E, 2001, J IMMUNOL, V166, P137, DOI 10.4049/jimmunol.166.1.137; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khwaja A, 1999, J BIOL CHEM, V274, P36817, DOI 10.1074/jbc.274.51.36817; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kronke M, 2002, FEBS LETT, V531, P18, DOI 10.1016/S0014-5793(02)03407-5; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Mathiasen IS, 2002, TRENDS MOL MED, V8, P212, DOI 10.1016/S1471-4914(02)02328-6; Mathiasen IS, 2002, J BIOL CHEM, V277, P30738, DOI 10.1074/jbc.M201558200; Mathiasen IS, 2001, INT J CANCER, V93, P224, DOI 10.1002/ijc.1325; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pettersen RD, 2001, J IMMUNOL, V166, P4931, DOI 10.4049/jimmunol.166.8.4931; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Roberg K, 1998, AM J PATHOL, V152, P1151; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Roberg K, 2001, LAB INVEST, V81, P149, DOI 10.1038/labinvest.3780222; Roberg K, 1999, FREE RADICAL BIO MED, V27, P1228, DOI 10.1016/S0891-5849(99)00146-X; Roberts Lewis R., 1999, Cell Biochemistry and Biophysics, V30, P71, DOI 10.1007/BF02737885; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Sayers TJ, 2000, J LEUKOCYTE BIOL, V68, P81; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCOTT DE, 1993, J IMMUNOL, V150, P664; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Uzzo RG, 2001, BIOCHEM BIOPH RES CO, V287, P895, DOI 10.1006/bbrc.2001.5678; van Eijk M, 1999, J IMMUNOL, V163, P2478; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Vonarbourg C, 2002, EUR J IMMUNOL, V32, P2376, DOI 10.1002/1521-4141(200208)32:8<2376::AID-IMMU2376>3.0.CO;2-V; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Waterman WH, 1996, BIOCHEM J, V319, P17, DOI 10.1042/bj3190017; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zeuner A, 1999, CELL DEATH DIFFER, V6, P1075, DOI 10.1038/sj.cdd.4400596; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	125	309	325	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					416	423		10.1038/ni0503-416	http://dx.doi.org/10.1038/ni0503-416			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719731				2022-12-18	WOS:000182665400005
J	Lee, KH; Wucherpfennig, KW; Wiley, DC				Lee, KH; Wucherpfennig, KW; Wiley, DC			Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type I diabetes	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GLUTAMIC-ACID DECARBOXYLASE; MYELIN BASIC-PROTEIN; T-CELL EPITOPE; HLA-DQ; PEPTIDE-BINDING; CELIAC-DISEASE; CRYSTAL-STRUCTURE; NOD MOUSE; SELF-PEPTIDES	The class II major histocompatibility complex (MHC) glycoproteins HLA-DQ8 and HLA-DQ2 in humans and I-A(g7) in nonobese diabetic (NOD) mice are the major risk factors for increased susceptibility to type I diabetes. using X-ray crystallography, we have determined the three-dimen-sional structure of DQ8 complexed with an immunodominant peptide from insulin. The similarity of the DQ8, DQ2 and I-A(g7) peptide-binding pockets suggests that diabetes is caused by the same antigen-presentation event(s) in humans and NOD mice. Correlating type I diabetes epidemiology and MHC sequences with the DQ8 structure suggests that other structural features of the P9 pocket in addition to position 57 contribute to susceptibility to type I diabetes.	Childrens Hosp, Dept Med, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Wiley, DC (corresponding author), Childrens Hosp, Dept Med, Mol Med Lab, 320 Longwood Ave, Boston, MA 02115 USA.	dcwadmin@crystal.harvard.edu			NIAID NIH HHS [P01 AI39619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Abraham RS, 2000, DIABETES, V49, P548, DOI 10.2337/diabetes.49.4.548; ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; AWATA T, 1992, DIABETOLOGIA, V35, P419, DOI 10.1007/BF02342437; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Bieg S, 1998, AUTOIMMUNE DISEASES, THIRD EDITION, P431; Boyton RJ, 1998, INT IMMUNOL, V10, P1765, DOI 10.1093/intimm/10.12.1765; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CHUANG LM, 1995, DIABETES CARE, V18, P1483, DOI 10.2337/diacare.18.11.1483; *COLL COMP PROJ, 1994, ACTA CRYST D, V50; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; FERNANDEZVINA M, 1993, TISSUE ANTIGENS, V41, P57, DOI 10.1111/j.1399-0039.1993.tb01980.x; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; Hoover ML, 1997, SCAND J IMMUNOL, V45, P193, DOI 10.1046/j.1365-3083.1997.d01-389.x; Israel S, 1998, HUM IMMUNOL, V59, P728, DOI 10.1016/S0198-8859(98)00074-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kwok WW, 1996, J EXP MED, V183, P1253, DOI 10.1084/jem.183.3.1253; Kwok WW, 1996, J IMMUNOL, V156, P2171; Latek RR, 2000, P NATL ACAD SCI USA, V97, P11460, DOI 10.1073/pnas.210384197; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; MARSH SGE, 1995, TISSUE ANTIGENS, V46, P258, DOI 10.1111/j.1399-0039.1995.tb03125.x; MIJOVIC CH, 1991, DIABETES, V40, P748, DOI 10.2337/diabetes.40.6.748; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; NELSON CA, 2000, IMMUNITY, V12, P699; NEPOM GT, 1993, DIABETES REV, V1, P93; Noble JA, 1996, AM J HUM GENET, V59, P1134; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paliakasis K, 1996, J STRUCT BIOL, V117, P145, DOI 10.1006/jsbi.1996.0079; REICH EP, 1994, J IMMUNOL, V152, P2279; Reizis B, 1998, IMMUNOL TODAY, V19, P212, DOI 10.1016/S0167-5699(97)01238-3; ROUTSIAS J, 1995, DIABETOLOGIA, V38, P1251; SANJEEVI CB, 1995, DIABETES, V44, P125, DOI 10.2337/diabetes.44.1.125; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SHEEHY MJ, 1992, DIABETES, V41, P123, DOI 10.2337/diabetes.41.2.123; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Slover RH, 1997, ENDOCR REV, V18, P241, DOI 10.1210/er.18.2.241; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratmann T, 2000, J IMMUNOL, V165, P3214, DOI 10.4049/jimmunol.165.6.3214; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; van de Wal Y, 1998, J IMMUNOL, V161, P1585; vandeWal Y, 1997, IMMUNOGENETICS, V46, P484, DOI 10.1007/s002510050309; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Wen L, 2000, J EXP MED, V191, P97, DOI 10.1084/jem.191.1.97; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wilson N, 2001, IMMUNITY, V14, P513, DOI 10.1016/S1074-7613(01)00140-6; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935; YAMAGATA K, 1989, DIABETOLOGIA, V32, P762, DOI 10.1007/BF00274539; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	74	309	320	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					501	507		10.1038/88694	http://dx.doi.org/10.1038/88694			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376336				2022-12-18	WOS:000169078000012
J	Tripp, RA; Jones, LP; Haynes, LM; Zheng, HQ; Murphy, PM; Anderson, LJ				Tripp, RA; Jones, LP; Haynes, LM; Zheng, HQ; Murphy, PM; Anderson, LJ			CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA EXPRESSION; BALB/C MICE; F-PROTEIN; CHEMOTACTIC RECEPTOR; VIRAL REPLICATION; TRACT DISEASE; RSV CHALLENGE; SUBGROUP-B; IN-VITRO; INFECTION	Chemokines are chemoattractant proteins that are divided into subfamilies based upon cysteine signature motifs termed C, CC, CXC and CX3C. Chemokines have roles in immunity and inflammation that affect cell trafficking and activation of T cells as well as cells of the innate immune system. We report here CX3C chemokine mimicry for the G glycoprotein of respiratory syncytial virus (RSV) and show binding to CX3CRI-the specific receptor for the CX3C chemokine fractalkine-and induction of leukocyte chemotaxis. We also show that CX3CRI facilitates RSV infection of cells. Thus, G glycoprotein interaction with CX3CRI probably plays a key role in the biology of RSV infection.	Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Resp & Enter Virus Branch, Atlanta, GA USA; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tripp, RA (corresponding author), Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Resp & Enter Virus Branch, Mailstop G-09,1600 Clifton Rd, Atlanta, GA USA.	rgt3@cdc.gov	Tripp, Ralph/F-5218-2011	Tripp, Ralph/0000-0002-2924-9956	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000615, ZIAAI000615] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Beisser PS, 2001, J VIROL, V75, P5949, DOI 10.1128/JVI.75.13.5949-5957.2001; Bourgeois C, 1998, J VIROL, V72, P7221, DOI 10.1128/JVI.72.9.7221-7227.1998; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BRIGHT H, 1995, VACCINE, V13, P915, DOI 10.1016/0264-410X(95)00013-Q; CHANOCK RM, 1992, PEDIATRICS, V90, P137; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Combadiere C, 1998, BIOCHEM BIOPH RES CO, V253, P728, DOI 10.1006/bbrc.1998.9849; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; DRISCOLL KE, 1994, EXP LUNG RES, V20, P473, DOI 10.3109/01902149409031733; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Fixler DE, 1996, PEDIATR CARDIOL, V17, P163, DOI 10.1007/BF02505206; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Groothuis JR, 1998, J INFECT DIS, V177, P467, DOI 10.1086/517377; Hall CB, 1999, J PEDIATR-US, V135, pS2; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Koopmann W, 1999, J IMMUNOL, V163, P2120; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Loetscher P, 2000, Adv Immunol, V74, P127; McDermott DH, 2000, SPRINGER SEMIN IMMUN, V22, P393, DOI 10.1007/s002810000052; McIntosh K, 1980, Prog Med Virol, V26, P94; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Roder C, 2000, J CHROMATOGR B, V737, P97, DOI 10.1016/S0378-4347(99)00442-9; Schall T, 1997, IMMUNOL TODAY, V18, P147, DOI 10.1016/S0167-5699(97)84655-5; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Srikiatkhachorn A, 1997, J VIROL, V71, P678, DOI 10.1128/JVI.71.1.678-685.1997; STOTT EJ, 1987, J VIROL, V61, P3855, DOI 10.1128/JVI.61.12.3855-3861.1987; SULLENDER W, 1995, VIROLOGY, V209, P70, DOI 10.1006/viro.1995.1231; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Tripp RA, 2000, J VIROL, V74, P6227, DOI 10.1128/JVI.74.13.6227-6229.2000; WEIBEL RE, 1966, AM REV RESPIR DIS, V94, P362; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9	46	308	329	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					732	738		10.1038/90675	http://dx.doi.org/10.1038/90675			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477410				2022-12-18	WOS:000170230100016
J	Collison, LW; Delgoffe, GM; Guy, CS; Vignali, KM; Chaturvedi, V; Fairweather, D; Satoskar, AR; Garcia, KC; Hunter, CA; Drake, CG; Murray, PJ; Vignali, DAA				Collison, Lauren W.; Delgoffe, Greg M.; Guy, Clifford S.; Vignali, Kate M.; Chaturvedi, Vandana; Fairweather, DeLisa; Satoskar, Abhay R.; Garcia, K. Christopher; Hunter, Christopher A.; Drake, Charles G.; Murray, Peter J.; Vignali, Dario A. A.			The composition and signaling of the IL-35 receptor are unconventional	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; CRYSTAL-STRUCTURE; CUTTING EDGE; CYTOKINE; IL-27; DIFFERENTIATION; COMPLEX; STAT4; GP130; TH1	Interleukin 35 (IL-35) belongs to the IL-12 family of heterodimeric cytokines but has a distinct functional profile. IL-35 suppresses T cell proliferation and converts naive T cells into IL-35-producing induced regulatory T cells (iTr35 cells). Here we found that IL-35 signaled through a unique heterodimer of receptor chains IL-12Rb2 and gp130 or homodimers of each chain. Conventional T cells were sensitive to IL-35-mediated suppression in the absence of one receptor chain but not both receptor chains, whereas signaling through both chains was required for IL-35 expression and conversion into iTr35 cells. Signaling through the IL-35 receptor required the transcription factors STAT1 and STAT4, which formed a unique heterodimer that bound to distinct sites in the promoters of the genes encoding the IL-12 subunits p35 and Ebi3. This unconventional mode of signaling, distinct from that of other members of the IL-12 family, may broaden the spectrum and specificity of IL-35-mediated suppression.	[Collison, Lauren W.; Delgoffe, Greg M.; Guy, Clifford S.; Vignali, Kate M.; Chaturvedi, Vandana; Murray, Peter J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Fairweather, DeLisa] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Drake, Charles G.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Drake, Charles G.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Dept Immunol, Baltimore, MD USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; St Jude Children's Research Hospital	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Satoskar, Abhay/AAB-7748-2019; Delgoffe, Greg M./HCH-2805-2022; Murray, Peter J/K-4725-2018	Delgoffe, Greg M./0000-0002-2957-8135; Murray, Peter J/0000-0001-6329-9802	US National Institutes of Health [R01 AI091977, F32 AI072816]; NovoNordisk; National Cancer Institute Comprehensive Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098383, R01AI091977, F32AI072816] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NovoNordisk(Novo Nordisk); National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Fairweather and J.A. Frisancho (Johns Hopkins University) for spleens and lymph nodes from Il12rb1<SUP>-/-</SUP> mice; M. Karin and S. Grivennikov (University of California at San Diego) for Il6st<SUP>Delta T</SUP> mice; C. Hunter and J. Stumhofer (University of Pennsylvania) for Il27ra<SUP>-/-</SUP> mice; A. Satoskar and P. Reville (Ohio State University) for Stat1<SUP>-/-</SUP> mice; C. Drake and H. R. Yen (Johns Hopkins University) for Stat3<SUP>Delta T</SUP> mice; R. McEver (University of Oklahoma Health Sciences Center) for mice used to establish the colony of CD4cre x Il6st<SUP>fl/fl</SUP> mice at St. Jude Children's Research Hospital; M. J. Turk (Dartmouth College) for B16-F10 melanoma; J. A. Frisancho, S. Grivennikov, M. Karin, J. Stumhofer, P. Reville and H. R. Yen for assistance with the collection and shipping of spleens and lymph nodes; J. Partridge and P. Brindle for assistance in designing ChIP experiments; K. Forbes, A. Castellaw and A. Krause for the maintenance, breeding and genotyping of mouse colonies; R. Cross, G. Lennon and S. Morgan for flow cytometry; the staff of the Shared Animal Resource Center at St. Jude Children's Research Hospital for the animal husbandry; and the Hartwell Center for Biotechnology and Bioinformatics at St. Jude Children's Research Hospital for the synthesis of real-time PCR primers and probes. Supported by the US National Institutes of Health (R01 AI091977 to D. A. A. V. and F32 AI072816 to L. W. C.), NovoNordisk (D. A. A. V.), the National Cancer Institute Comprehensive Cancer Center (CA21765 to D. A. A. V.) and the American Lebanese Syrian Associated Charities (D.A.A.V.).	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Betz UAK, 1998, INT IMMUNOL, V10, P1175, DOI 10.1093/intimm/10.8.1175; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Canda-Sanchez A, 2009, J MEMBRANE BIOL, V227, P1, DOI 10.1007/s00232-008-9127-3; Charlot-Rabiega P, 2011, J BIOL CHEM, V286, P27350, DOI 10.1074/jbc.M111.221010; CHUA AO, 1995, J IMMUNOL, V155, P4286; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Delgoffe GM, 2011, CURR OPIN IMMUNOL, V23, P632, DOI 10.1016/j.coi.2011.07.013; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Matsui E, 1999, BIOCHEM BIOPH RES CO, V266, P551, DOI 10.1006/bbrc.1999.1859; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pistoia V, 2009, J CLIN ONCOL, V27, P4809, DOI 10.1200/JCO.2008.21.3579; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Stern AS, 1997, CHEM IMMUNOL, V68, P23; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Xu YB, 2010, J BIOL CHEM, V285, P21214, DOI 10.1074/jbc.C110.129502; Yamamoto K, 1997, BIOCHEM BIOPH RES CO, V233, P126, DOI 10.1006/bbrc.1997.6415; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	50	307	342	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					290	U115		10.1038/ni.2227	http://dx.doi.org/10.1038/ni.2227			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22306691	Green Accepted			2022-12-18	WOS:000300510600016
J	Liang, HE; Reinhardt, RL; Bando, JK; Sullivan, BM; Ho, IC; Locksley, RM				Liang, Hong-Erh; Reinhardt, R. Lee; Bando, Jennifer K.; Sullivan, Brandon M.; Ho, I-Cheng; Locksley, Richard M.			Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity	NATURE IMMUNOLOGY			English	Article							T-CELLS; TYPE-2 IMMUNITY; DIFFERENTIATION; GATA-3; ROLES; TRANSCRIPTION; INHIBITION; RESPONSES; RECEPTOR; ASTHMA	Interleukin 4 (IL-4) and IL-13 are critical for responses to parasitic helminthes. We used genetically engineered reporter mice to assess the temporal and spatial production of these cytokines in vivo. In lymph nodes, IL-4, but not IL-13, was made by follicular helper T cells (T-FH cells). In contrast, tissue type 2 helper T cells (T(H)2 cells) produced both cytokines. There was also divergent production of IL-4 and IL-13 among cells of the innate immune system, whereby basophils produced IL-4, whereas innate helper type 2 cells (Ih2 cells) produced IL-13. IL-13 production by T(H)2 and Ih2 cells was dependent on the transcription factor GATA-3, which was present in large amounts in these cells, and in contrast to the small amount of GATA-3 in T-FH cells and basophils. The distinct localization and cellular expression of IL-4 and IL-13 explains their unique roles during allergic immunity.	[Liang, Hong-Erh; Reinhardt, R. Lee; Bando, Jennifer K.; Sullivan, Brandon M.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Liang, Hong-Erh; Reinhardt, R. Lee; Bando, Jennifer K.; Sullivan, Brandon M.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Liang, Hong-Erh; Reinhardt, R. Lee; Bando, Jennifer K.; Sullivan, Brandon M.; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Ho, I-Cheng] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Bando, Jennifer/0000-0002-1331-7424	National Institutes of Allergy and Infectious Diseases [AI026918, AI030663, AI077439]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R01AI030663, R01AI026918, R37AI026918] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Kelsoe (Duke University) for the anti-NP IgG1 clone H33L lambda 1/lambda 1; the US National Institutes of Health Tetramer Core for reagents; A. McKenzie (University of Cambridge, UK) and Z. Werb (University of California San Francisco) for mice; D. Ehrle and M. Ansel for review and comments; and N. Flores and Z. Wang for technical expertise. Supported by the National Institutes of Allergy and Infectious Diseases (AI026918, AI030663 and AI077439), the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at the University of California San Francisco.	Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fallon PG, 2001, J IMMUNOL, V166, P2712, DOI 10.4049/jimmunol.166.4.2712; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Harris MB, 2005, J BIOL CHEM, V280, P13114, DOI 10.1074/jbc.M412649200; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Ozawa H, 2005, IMMUNOL LETT, V99, P228, DOI 10.1016/j.imlet.2005.03.005; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	44	307	315	0	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					58	U83		10.1038/ni.2182	http://dx.doi.org/10.1038/ni.2182			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22138715	Green Accepted			2022-12-18	WOS:000298412800012
J	Cao, WP; Manicassamy, S; Tang, H; Kasturi, SP; Pirani, A; Murthy, N; Pulendran, B				Cao, Weiping; Manicassamy, Santhakumar; Tang, Hua; Kasturi, Sudhir Pai; Pirani, Ali; Murthy, Niren; Pulendran, Bali			Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway	NATURE IMMUNOLOGY			English	Article							MAMMALIAN TARGET; MTOR; TRANSLATION; IRF-7; SIGNALS; ROLES; EIF4E; TLR9; PI3K; TRIF	Robust production of type I interferon (IFN-alpha/beta) in plasmacytoid dendritic cells (pDCs) is crucial for antiviral immunity. Here we show involvement of the mammalian target of rapamycin ( mTOR) pathway in regulating interferon production by pDCs. Inhibition of mTOR or its 'downstream' mediators, the p70 ribosomal S6 protein kinases p70S6K1 and p70S6K2, during pDC activation by Toll-like receptor 9 (TLR9) blocked the interaction of TLR9 with the adaptor MyD88 and subsequent activation of the interferon-regulatory factor IRF7, which resulted in impaired IFN-alpha/beta production. Microarray analysis confirmed that inhibition of mTOR by the immunosuppressive drug rapamycin suppressed antiviral and anti-inflammatory gene expression. Consistent with this, targeting rapamycin-encapsulated microparticles to antigen-presenting cells in vivo resulted in less IFN-alpha/beta production in response to CpG DNA or the yellow fever vaccine virus strain 17D. Thus, mTOR signaling is crucial in TLR-mediated IFN-alpha/beta responses by pDCs.	[Cao, Weiping; Manicassamy, Santhakumar; Tang, Hua; Kasturi, Sudhir Pai; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Pirani, Ali] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Murthy, Niren] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021	Cao, Weiping/0000-0002-5794-9685	National Institutes of Health [AI0564499, AI048638, AI05726601, DK057665, AI057157, AI50019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048638, R37AI048638, U54AI057157, R01AI048638, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Aguilar Mertens and L. Bronner for assistance with cell sorting; D. Kalman for assistance with deconvolution microscopy; K. Schaefer- Hales for assistance with confocal microscopy; T. Querec for YF- 17D virus preparation; T. Denning for data discussion and technical advice; R. Nair for in vivo experiments; Y. Wang for immunofluorescence staining; J. Jiang for plasmid preparation; T. Taniguchi (University of Tokyo) for cyan fluorescent protein tagged MyD88 and YFP- tagged IRF7 plasmids; D. Segal (National Cancer Institute) for GFP- tagged TLR9; D. Golenbock (University of Massachusetts) for the YFP- tagged TLR9 plasmid; B. Beutler (The Scripps Research Institute) for the hemagglutinin- tagged MyD88 plasmid; J. Hiscott ( McGill University) for constitutively active IRF7; R. Ahmed (Emory University) for YF- 17D subpassaged from YF- VAX in SW- 480 cells; R. R. Amara (Emory University) for modified vaccinia virus Ankara; T. Van Dyke ( Boston University) for highly purified E. coli LPS (strain 25922); S. Zughaier (Emory University) for the RAW264.7 cell line; and S. C. Kozma (Friedrich Miescher Institute for Biomedical Research) and N. Sonenberg (McGill University) for Rps6k1<SUP>-/-</SUP> Rps6k2<SUP>-/-</SUP> double- knockout mice. Supported by the National Institutes of Health (AI0564499, AI048638, AI05726601, DK057665, AI057157 and AI50019 to B. P.)	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Janus A, 2005, CELL MOL BIOL LETT, V10, P479; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Krieg AM, 2001, TRENDS MICROBIOL, V9, P249, DOI 10.1016/S0966-842X(01)02039-X; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Proud CG, 2004, DNA REPAIR, V3, P927, DOI 10.1016/j.dnarep.2004.03.012; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Sehgal SN, 1998, CLIN BIOCHEM, V31, P335, DOI 10.1016/S0009-9120(98)00045-9; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Waibler Z, 2007, J VIROL, V81, P12102, DOI 10.1128/JVI.01190-07; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Young DA, 2005, CURR OPIN PHARMACOL, V5, P418, DOI 10.1016/j.coph.2005.03.004	40	307	324	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1157	1164		10.1038/ni.1645	http://dx.doi.org/10.1038/ni.1645			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18758466	Green Accepted			2022-12-18	WOS:000259315600014
J	Herzenberg, LA; Tung, J; Moore, WA; Herzenberg, LA; Parks, DR				Herzenberg, Leonore A.; Tung, James; Moore, Wayne A.; Herzenberg, Leonard A.; Parks, David R.			Interpreting flow cytometry data: a guide for the perplexed	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATED CELL SORTER; VISUALIZATION; COMPENSATION	Recent advances in flow cytometry technologies are changing how researchers collect, look at and present their data.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Herzenberg, LA (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	leeherz@stanford.edu						Herzenberg LA, 2002, CLIN CHEM, V48, P1819; LOKEN MR, 1977, J HISTOCHEM CYTOCHEM, V25, P899, DOI 10.1177/25.7.330738; PARKS DR, IN PRESS CYTOMETRY A; Roederer M, 2004, METHOD CELL BIOL, V75, P241; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Tung James W, 2004, Methods Mol Biol, V271, P37; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016	7	307	322	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					681	685		10.1038/ni0706-681	http://dx.doi.org/10.1038/ni0706-681			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785881				2022-12-18	WOS:000238377700002
J	Rooijakkers, SHM; Ruyken, M; Roos, A; Daha, MR; Presanis, JS; Sim, RB; van Wamel, WJB; van Kessel, KPM; van Strijp, JAG				Rooijakkers, SHM; Ruyken, M; Roos, A; Daha, MR; Presanis, JS; Sim, RB; van Wamel, WJB; van Kessel, KPM; van Strijp, JAG			Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases	NATURE IMMUNOLOGY			English	Article							ALTERNATIVE PATHWAY; BINDING LECTIN; CLASSICAL PATHWAY; INNATE IMMUNITY; C5A RECEPTOR; WHOLE-BLOOD; ACTIVATION; AUREUS; PROTEIN; MODULATION	The complement system is pivotal in host defense but also contributes to tissue injury in several diseases. The assembly of C3 convertases ( C4b2a and C3bBb) is a prerequisite for complement activation. The convertases catalyze C3b deposition on activator surfaces. Here we describe the identification of staphylococcal complement inhibitor, an excreted 9.8- kilodalton protein that blocks human complement by specific interaction with C4b2a and C3bBb. Staphylococcal complement inhibitor bound and stabilized C3 convertases, interfering with additional C3b deposition through the classical, lectin and alternative complement pathways. This led to a substantial decrease in phagocytosis and killing of Staphylococcus aureus by human neutrophils. As a highly active and small soluble protein that acts exclusively on surfaces, staphylococcal complement inhibitor may represent a promising anti- inflammatory molecule.	Univ Utrecht, Med Ctr, Eijkman Winkler Inst, NL-3584 CX Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford	Rooijakkers, SHM (corresponding author), Univ Utrecht, Med Ctr, Eijkman Winkler Inst, NL-3584 CX Utrecht, Netherlands.	s.h.m.rooijakkers@azu.nl	van Strijp, Jos A.G./J-9549-2014; Sim, Bob/A-1354-2008	van Strijp, Jos A.G./0000-0001-6253-0830; Sim, Bob/0000-0002-2855-7455				Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; de Haas CJC, 1998, BIOCHEM BIOPH RES CO, V252, P492, DOI 10.1006/bbrc.1998.9675; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; DOHLSTEN M, 1993, IMMUNOLOGY, V79, P520; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; FEARON DT, 1977, P NATL ACAD SCI USA, V74, P1683, DOI 10.1073/pnas.74.4.1683; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Haas PJ, 2004, J IMMUNOL, V173, P5704, DOI 10.4049/jimmunol.173.9.5704; He SP, 1997, FEBS LETT, V412, P506, DOI 10.1016/S0014-5793(97)00803-X; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kaya Z, 2001, NAT IMMUNOL, V2, P739, DOI 10.1038/90686; Laich A, 2001, BBA-PROTEIN STRUCT M, V1544, P96, DOI 10.1016/S0167-4838(00)00208-9; LEIJH PCJ, 1981, INFECT IMMUN, V33, P714, DOI 10.1128/IAI.33.3.714-724.1981; Moller-Kristensen M, 2003, SCAND J IMMUNOL, V57, P556, DOI 10.1046/j.1365-3083.2003.01270.x; Mollnes TE, 2002, BLOOD, V100, P1869; Nakao M, 2002, DEV COMP IMMUNOL, V26, P533, DOI 10.1016/S0145-305X(01)00083-0; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Nilsson B, 1998, BLOOD, V92, P1661, DOI 10.1182/blood.V92.5.1661; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Rahimpour R, 1999, J IMMUNOL, V162, P2299; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Riedemann NC, 2003, AM J PATHOL, V162, P363, DOI 10.1016/S0002-9440(10)63830-8; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4; SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; SERVAIS G, 1991, J IMMUNOL METHODS, V140, P93, DOI 10.1016/0022-1759(91)90130-8; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Van Wamel WJB, 1998, FEMS MICROBIOL LETT, V163, P1, DOI 10.1016/S0378-1097(98)00132-3; Veldkamp KE, 2000, INFECT IMMUN, V68, P5908, DOI 10.1128/IAI.68.10.5908-5913.2000; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	44	307	325	1	32	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					920	927		10.1038/ni1235	http://dx.doi.org/10.1038/ni1235			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16086019				2022-12-18	WOS:000231369800022
J	Sinclair, LV; Finlay, D; Feijoo, C; Cornish, GH; Gray, A; Ager, A; Okkenhaug, K; Hagenbeek, TJ; Spits, H; Cantrell, DA				Sinclair, Linda V.; Finlay, David; Feijoo, Carmen; Cornish, Georgina H.; Gray, Alex; Ager, Ann; Okkenhaug, Klaus; Hagenbeek, Thijs J.; Spits, Hergen; Cantrell, Doreen A.			Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking	NATURE IMMUNOLOGY			English	Article							ALPHA-CONVERTING ENZYME; L-SELECTIN EXPRESSION; CELL-MIGRATION; PHOSPHOINOSITIDE 3-KINASES; DOWN-REGULATION; POTENTIAL ROLE; B-CELL; ACTIVATION; EFFECTOR; ANTIGEN	Phosphatidylinositol-3-OH kinase (PI(3) K) and the nutrient sensor mTOR are evolutionarily conserved regulators of cell metabolism. Here we show that PI(3) K and mTOR determined the repertoire of adhesion and chemokine receptors expressed by T lymphocytes. The key lymph node-homing receptors CD62L (L-selectin) and CCR7 were highly expressed on naive T lymphocytes but were downregulated after immune activation. CD62L downregulation occurred through ectodomain proteolysis and suppression of gene transcription. The p110 delta subunit of PI(3) K controlled CD62L proteolysis through mitogen-activated protein kinases, whereas control of CD62L transcription by p110d was mediated by mTOR through regulation of the transcription factor KLF2. PI(3) K-mTOR nutrient-sensing pathways also determined expression of the chemokine receptor CCR7 and regulated lymphocyte trafficking in vivo. Hence, lymphocytes use PI(3) K and mTOR to match metabolism and trafficking.	[Sinclair, Linda V.; Finlay, David; Feijoo, Carmen; Cantrell, Doreen A.] Univ Dundee, Dept Cell Biol & Immunol, Dundee DD1 5EH, Scotland; [Cornish, Georgina H.] Natl Inst Med Res, Immune Cell Biol, London NW7 1AA, England; [Gray, Alex] Univ Dundee, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Ager, Ann] Cardiff Univ, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales; [Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; [Hagenbeek, Thijs J.; Spits, Hergen] Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands; [Spits, Hergen] Genentech Inc, Dept Immunol Discovery, San Francisco, CA 94080 USA	University of Dundee; MRC National Institute for Medical Research; University of Dundee; Cardiff University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Netherlands Cancer Institute; Roche Holding; Genentech	Cantrell, DA (corresponding author), Univ Dundee, Dept Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk	Ager, Ann/Z-4966-2019; Spits, Hergen/N-2581-2019; Okkenhaug, Klaus/H-3154-2019; Okkenhaug, Klaus/D-5149-2012; Finlay, David/H-5840-2018	Spits, Hergen/0000-0003-3269-8338; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Finlay, David/0000-0003-2716-6679; Cornish, Georgina/0000-0002-1984-6677; Cantrell, Doreen/0000-0001-7525-3350; Gray, Alexander/0000-0001-9227-0363; Ager, Ann/0000-0002-5763-8908	MRC [G9403619] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [JF19128] Funding Source: Medline; Medical Research Council [G9403619] Funding Source: Medline; Wellcome Trust [GR065975, 065975] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chao CC, 1997, J IMMUNOL, V159, P1686; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; JUNG TM, 1988, J IMMUNOL, V141, P4110; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Matheu MP, 2007, J IMMUNOL, V179, P2261, DOI 10.4049/jimmunol.179.4.2261; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Preece G, 1996, J BIOL CHEM, V271, P11634, DOI 10.1074/jbc.271.20.11634; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Richards H, 2008, J IMMUNOL, V180, P198, DOI 10.4049/jimmunol.180.1.198; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tang MLK, 1998, J IMMUNOL, V160, P5113; Unsoeld H, 2004, J IMMUNOL, V173, P3013, DOI 10.4049/jimmunol.173.5.3013; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Venturi GM, 2007, J IMMUNOL, V178, P291, DOI 10.4049/jimmunol.178.1.291; Ward SG, 2006, TRENDS IMMUNOL, V27, P80, DOI 10.1016/j.it.2005.12.004; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0	49	306	317	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					513	521		10.1038/ni.1603	http://dx.doi.org/10.1038/ni.1603			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18391955	Green Accepted			2022-12-18	WOS:000255153500013
J	Jain, A; Ma, CA; Liu, SY; Brown, M; Cohen, J; Strober, W				Jain, A; Ma, CA; Liu, SY; Brown, M; Cohen, J; Strober, W			Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; X-LINKED IMMUNODEFICIENCY; CD40 LIGAND; DEFECTIVE INTERLEUKIN-1; IMMUNE-RESPONSES; KINASE COMPLEX; HUMAN HOMOLOG; ACTIVATION; CELLS; PROTEIN	The gene that encodes nuclear factor kappaB (NF-kappaB) essential modulator (or NEMO, also known as IKK gamma) is required for activation of the transcription factor NF-kappaB. We describe mutations in the putative zinc-finger domain of NEMO that result in an X-linked primary immunodeficiency characterized by hyper-IgM syndrome and hypohydrotic ectodermal dysplasia (XHM-ED). These mutations prevent CD40 ligand (CD40L)-mediated degradation of inhibitor of NF-kappaB alpha (I kappaB-alpha) and account for the following observations: B cells from XHM-ED patients are unable to undergo immunoglobulin class-switch recombination and antigen-presenting cells (APCs) are unable to synthesize the NF-kappaB-regulated cytokines interleukin 12 (IL-12) or tumor necrosis factor alpha (TNF-alpha) when stimulated with CD40L. Nevertheless, innate immunity is preserved in XHM-ED patients because APCs retain the capacity to respond to stimulation by lipopolysaccharide or Staphylococcus aureus Cowan's antigen (SAC). Overall, the phenotype observed in XHM-ED patients shows that the putative zinc-finger domain of NEMO has a regulatory function and demonstrates the definite requirement of CD40-mediated NF-kappaB activation for B cell immunoglobulin class-switching.	NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; NIH, Ctr Clin, Dept Nursing, Bethesda, MD 20892 USA; NIH, Ctr Clin, Dept Lab Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Strober, W (corresponding author), NIAID, Clin Invest Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000590] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBAS A, 1998, CELLULER MOL IMMUNOL; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grammer AC, 1998, J IMMUNOL, V161, P1183; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HAN SH, 1995, J IMMUNOL, V155, P556; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jain A, 1999, J CLIN INVEST, V103, P1151, DOI 10.1172/JCI5891; Jin DY, 1999, J BIOMED SCI, V6, P115, DOI 10.1007/BF02256442; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; Smahi A, 2000, NATURE, V405, P466; Sutherland CL, 1996, J IMMUNOL, V157, P3381; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; ZONANA J, 2000, AM J HUM GENET, V67	30	306	318	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					223	228		10.1038/85277	http://dx.doi.org/10.1038/85277			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224521				2022-12-18	WOS:000167413800014
J	Robinson, N; McComb, S; Mulligan, R; Dudani, R; Krishnan, L; Sad, S				Robinson, Nirmal; McComb, Scott; Mulligan, Rebecca; Dudani, Renu; Krishnan, Lakshmi; Sad, Subash			Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; ANTIGEN PRESENTATION; PROGRAMMED NECROSIS; APOPTOSIS; ACTIVATION; RESISTANCE; CASPASE-1; INFLAMMASOME; RECEPTOR; KINASE	Salmonella enterica serovar Typhimurium (S. Typhimurium) is a virulent pathogen that induces rapid host death. Here we observed that host survival after infection with S. Typhimurium was enhanced in the absence of type I interferon signaling, with improved survival of mice deficient in the receptor for type I interferons (Ifnar1(-/-) mice) that was attributed to macrophages. Although there was no impairment in cytokine expression or inflammasome activation in Ifnar1(-/-) macrophages, they were highly resistant to S. Typhimurium-induced cell death. Specific inhibition of the kinase RIP1 or knockdown of the gene encoding the kinase RIP3 prevented the death of wild-type macrophages, which indicated that necroptosis was a mechanism of cell death. Finally, RIP3-deficient macrophages, which cannot undergo necroptosis, had similarly less death and enhanced control of S. Typhimurium in vivo. Thus, we propose that S. Typhimurium induces the production of type I interferon, which drives necroptosis of macrophages and allows them to evade the immune response.	[Robinson, Nirmal; McComb, Scott; Mulligan, Rebecca; Dudani, Renu; Krishnan, Lakshmi; Sad, Subash] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Robinson, Nirmal; McComb, Scott; Mulligan, Rebecca; Krishnan, Lakshmi; Sad, Subash] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	National Research Council Canada; University of Ottawa	Sad, S (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	subash.sad@nrc.ca	Robinson, Nirmal/AAJ-1996-2020	Robinson, Nirmal/0000-0002-7361-9491; Sad, Subash/0000-0002-2462-7137	Canadian Institutes of Health Research; Ontario Institute of Cancer Research; National Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute of Cancer Research; National Research Council of Canada	We thank K. Murali-Krishna (Emory University) for Ifnar<SUP>-/-</SUP> mice; V. Dixit (Genentech) for Rip3<SUP>-/-</SUP> mice; B. Beutler (The University of Texas Southwestern Medical Center) for the L929-ISRE cell line; and S. Thurston for technical help. Supported by the Canadian Institutes of Health Research (S.S.), the Ontario Institute of Cancer Research (L.K.) and the National Research Council of Canada.	Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Khan R, 2012, GENES IMMUN, V13, P175, DOI 10.1038/gene.2011.69; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; OBRIEN AD, 1979, INFECT IMMUN, V25, P513, DOI 10.1128/IAI.25.2.513-520.1979; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wong CE, 2009, INFECT IMMUN, V77, P4750, DOI 10.1128/IAI.00545-09	50	305	311	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					954	962		10.1038/ni.2397	http://dx.doi.org/10.1038/ni.2397			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22922364	Green Accepted			2022-12-18	WOS:000309038600011
J	Kanneganti, TD; Dixit, VD				Kanneganti, Thirumala-Devi; Dixit, Vishwa Deep			Immunological complications of obesity	NATURE IMMUNOLOGY			English	Article							INDUCED WEIGHT-LOSS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; T-CELLS; NLRP3 INFLAMMASOME; REPERTOIRE DIVERSITY; IMMUNE-RESPONSE; M2 MACROPHAGES; B-CELLS; ACTIVATION	Current approaches for the treatment of obesity, including diet and lifestyle changes, have not been successful in curtailing the obesity epidemic. The higher incidence of inflammation-associated chronic disease and greater susceptibility to infection in obese people represents a growing health threat. Improved understanding of the immunological processes that regulate obesity may yield new treatments for obesity-associated disorders.	[Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Dixit, Vishwa Deep] Louisiana State Univ Syst, Immunobiol Lab, Pennington Biomed Res Ctr, Baton Rouge, LA USA	St Jude Children's Research Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org; vishwa.dixit@pbrc.edu	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556] Funding Source: NIH RePORTER; NIAID NIH HHS [AI101935] Funding Source: Medline; NIAMS NIH HHS [R01 AR056296, AR056296] Funding Source: Medline; NIDDK NIH HHS [DK090556] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fuji S, 2009, BIOL BLOOD MARROW TR, V15, P73, DOI 10.1016/j.bbmt.2008.10.029; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Karisson EA, 2010, J IMMUNOL, V184, P3127, DOI 10.4049/jimmunol.0903220; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim YH, 2012, J INFECT DIS, V205, P244, DOI 10.1093/infdis/jir731; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lukens JR, 2011, DISCOV MED, V11, P65; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P439, DOI 10.1038/nri3012; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; WEBER DJ, 1986, NEW ENGL J MED, V314, P1393; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Youm YH, 2012, CELL REP, V1, P56, DOI 10.1016/j.celrep.2011.11.005; Youm YH, 2011, ENDOCRINOLOGY, V152, P4039, DOI 10.1210/en.2011-1326; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	67	305	313	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					707	712		10.1038/ni.2343	http://dx.doi.org/10.1038/ni.2343			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814340				2022-12-18	WOS:000306569600002
J	Ramirez-Carrozzi, V; Sambandam, A; Luis, E; Lin, ZG; Jeet, S; Lesch, J; Hackney, J; Kim, J; Zhou, MJ; Lai, J; Modrusan, Z; Sai, T; Lee, W; Xu, M; Caplazi, P; Diehl, L; de Voss, J; Balazs, M; Gonzalez, L; Singh, H; Ouyang, W; Pappu, R				Ramirez-Carrozzi, Vladimir; Sambandam, Arivazhagan; Luis, Elizabeth; Lin, Zhongua; Jeet, Surinder; Lesch, Justin; Hackney, Jason; Kim, Janice; Zhou, Meijuan; Lai, Joyce; Modrusan, Zora; Sai, Tao; Lee, Wyne; Xu, Min; Caplazi, Patrick; Diehl, Lauri; de Voss, Jason; Balazs, Mercedesz; Gonzalez, Lino, Jr.; Singh, Harinder; Ouyang, Wenjun; Pappu, Rajita			IL-17C regulates the innate immune function of epithelial cells in an autocrine manner	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; NEUTROPHIL RECRUITMENT; SKIN INFLAMMATION; FAMILY-MEMBERS; HOST-DEFENSE; MOUSE MODEL; TH17 CELLS; KAPPA-B	Interleukin 17C (IL-17C) is a member of the IL-17 family that is selectively induced in epithelia by bacterial challenge and inflammatory stimuli. Here we show that IL-17C functioned in a unique autocrine manner, binding to a receptor complex consisting of the receptors IL-17RA and IL-17RE, which was preferentially expressed on tissue epithelial cells. IL-17C stimulated epithelial inflammatory responses, including the expression of proinflammatory cytokines, chemokines and antimicrobial peptides, which were similar to those induced by IL-17A and IL-17F. However, IL-17C was produced by distinct cellular sources, such as epithelial cells, in contrast to IL-17A, which was produced mainly by leukocytes, especially those of the T(H)17 subset of helper T cells. Whereas IL-17C promoted inflammation in an imiquimod-induced skin-inflammation model, it exerted protective functions in dextran sodium sulfate-induced colitis. Thus, IL-17C is an essential autocrine cytokine that regulates innate epithelial immune responses.	[Ramirez-Carrozzi, Vladimir; Sambandam, Arivazhagan; Lin, Zhongua; Jeet, Surinder; Lesch, Justin; Kim, Janice; Zhou, Meijuan; Lee, Wyne; Xu, Min; de Voss, Jason; Balazs, Mercedesz; Singh, Harinder; Ouyang, Wenjun; Pappu, Rajita] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Luis, Elizabeth; Gonzalez, Lino, Jr.] Genentech Inc, Dept Prot Chem, San Francisco, CA USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Lai, Joyce; Sai, Tao] Genentech Inc, Dept Antibody Engn, San Francisco, CA USA; [Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Caplazi, Patrick; Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Pappu, R (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	pappu.rajita@gene.com	Gonzalez, Lino/E-4102-2012; Ouyang, Wenjun/ABA-8763-2020	Gonzalez, Lino/0000-0003-3817-6450; Hackney, Jason/0000-0002-5922-563X; Ouyang, Wenjun/0000-0002-1811-5864; Caplazi, Patrick/0000-0002-3411-1257				Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Johansen C, 2011, J BIOL CHEM, V286, P25487, DOI 10.1074/jbc.M111.240671; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li TS, 2006, CELL SIGNAL, V18, P1287, DOI 10.1016/j.cellsig.2005.10.010; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; REITER MJ, 1994, J LEUKOCYTE BIOL, V55, P234, DOI 10.1002/jlb.55.2.234; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Spriggs MK, 1997, J CLIN IMMUNOL, V17, P366, DOI 10.1023/A:1027360106635; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	50	305	340	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1159	U46		10.1038/ni.2156	http://dx.doi.org/10.1038/ni.2156			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	21993848				2022-12-18	WOS:000297202700010
J	van Stipdonk, MJB; Hardenberg, G; Bijker, MS; Lemmens, EE; Droin, NM; Green, DR; Schoenberger, SP				van Stipdonk, MJB; Hardenberg, G; Bijker, MS; Lemmens, EE; Droin, NM; Green, DR; Schoenberger, SP			Dynamic programming of CD8(+) T lymphocyte responses	NATURE IMMUNOLOGY			English	Article							CROSS-PRESENTATION; DENDRITIC CELLS; SELF-ANTIGENS; DIFFERENTIATION; INFECTION; TOLERANCE; EXPANSION; EFFECTOR; RECEPTOR; DELETION	The initial encounter with an antigen-presenting cell (APC) is the primary force behind the expansion, differentiation and survival of naive T cells. Using an APC that permits temporal control of priming, we examined whether the duration of antigenic stimulation can influence the functional development of CD8(+) cytotoxic T lymphocytes (CTLs) in vivo. Whereas CTLs given a 4-h stimulus underwent an abortive clonal expansion with transient surface CD25 expression, those given a 20-h stimulus sustained CD25 up-regulation, proliferated extensively, and efficiently mediated destruction of peripheral target tissues. Our results show that an instructional program preceding the first cell division integrates differences in signal strength into the decision to activate versus tolerize specific CTL clones.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92024 USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92024 USA.	sps@liai.org	Droin, Nathalie M/Y-5506-2018; Green, Douglas R/N-8083-2018	Droin, Nathalie M/0000-0002-6099-5324; Green, Douglas R/0000-0002-7332-1417				Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Dai ZH, 2000, J IMMUNOL, V165, P3031, DOI 10.4049/jimmunol.165.6.3031; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Schoenberger SP, 1998, CANCER RES, V58, P3094; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864	26	305	311	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					361	365		10.1038/ni912	http://dx.doi.org/10.1038/ni912			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12640451				2022-12-18	WOS:000181987700016
J	Yu, G; Boone, T; Delaney, J; Hawkins, N; Kelley, M; Ramakrishnan, M; McCabe, S; Qiu, W; Kornuc, M; Xia, XZ; Guo, J; Stolina, M; Boyle, WJ; Sarosi, I; Hsu, HL; Senaldi, G; Theill, LE				Yu, G; Boone, T; Delaney, J; Hawkins, N; Kelley, M; Ramakrishnan, M; McCabe, S; Qiu, W; Kornuc, M; Xia, XZ; Guo, J; Stolina, M; Boyle, WJ; Sarosi, I; Hsu, HL; Senaldi, G; Theill, LE			APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR FAMILY; B-CELL GROWTH; TNF RECEPTOR; LIGAND; MEMBER; SUPERFAMILY; DEATH; DIFFERENTIATION; ACTIVATION; APOPTOSIS	We report that the tumor neurosis factor homolog APRIL (a proliferation-inducing ligand) stimulates in vitro proliferation of primary B and T cells and increases spleen weight due to accumulation of B cells in vivo. APRIL functions via binding to BCMA (B cell maturation antigen) and TACI (transmembrane activator and CAML-interactor) and competes with TALL-I (also called BLyS or BAFF) for receptor binding. Soluble BCMA and TACI specifically prevent binding of APRIL and block APRIL-stimulated proliferation of primary B cells. BCMA-Fc also inhibits production of antibodies against keyhole limpet hemocyanin and Pneumovax in mice, indicating that APRIL and/or TALL-I signaling via BCMA and/or TACI are required for generation of humoral immunity. Thus, APRIL-TALL-I and BCMA-TACI form a two ligands-two receptors pathway involved in stimulation of B and T cell function.	Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Proc Sci, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Prot Chem, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Pharmacol & Pathol, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Theill, LE (corresponding author), Amgen Inc, Dept Inflammat, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	ltheill@amgen.com						Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ARMITAGE RJ, 1995, CURR OPIN IMMUNOL, V7, P243, DOI 10.1016/0952-7915(95)80009-3; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Frade JM, 1996, NATURE, V383, P166; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Kelly K, 2000, CANCER RES, V60, P1021; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; LAMAM JD, 1996, T CELL INDEPENDENT T; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; SHANEBECK KD, 1995, EUR J IMMUNOL, V25, P2147, DOI 10.1002/eji.1830250805; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137	28	305	390	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					252	256		10.1038/79802	http://dx.doi.org/10.1038/79802			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973284				2022-12-18	WOS:000089815100025
J	Dominguez-Villar, M; Hafler, DA				Dominguez-Villar, Margarita; Hafler, David A.			Regulatory T cells in autoimmune disease	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR FOXP3; TH1-LIKE TREG GENERATION; SUPPRESSIVE FUNCTION; NEONATAL THYMECTOMY; FUNCTIONAL DEFECT; SELF-TOLERANCE; HELPER-CELLS; CIS-ELEMENT; PPAR-GAMMA; TH17 CELLS	In recent years, the understanding of regulatory T cell (Treg cell) biology has expanded considerably. Key observations have challenged the traditional definition of Treg cells and have provided insight into the underlying mechanisms responsible for the development of autoimmune diseases, with new therapeutic strategies that improve disease outcome. This Review summarizes the newer concepts of Treg cell instability, Treg cell plasticity and tissue-specific Treg cells, and their relationship to autoimmunity. Those three main concepts have changed the understanding of Treg cell biology: how they interact with other immune and nonimmune cells; their functions in specific tissues; and the implications of this for the pathogenesis of autoimmune diseases.	[Dominguez-Villar, Margarita; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hafler, David A.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University; Yale University	Dominguez-Villar, M; Hafler, DA (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Hafler, DA (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	margarita.dominguez-villar@yale.edu; david.hafler@yale.edu		Dominguez-Villar, Margarita/0000-0002-9719-0028	NIAID NIH HHS [P01 AI073748] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arterbery AS, 2016, J IMMUNOL, V196, P4040, DOI 10.4049/jimmunol.1502276; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Balandina A, 2005, BLOOD, V105, P735, DOI 10.1182/blood-2003-11-3900; Barbi J, 2015, IMMUNOL REV, V266, P27, DOI 10.1111/imr.12312; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Beier UH, 2011, CURR OPIN IMMUNOL, V23, P670, DOI 10.1016/j.coi.2011.07.002; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Bin Dhuban K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai9297; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Bonelli M, 2008, INT IMMUNOL, V20, P861, DOI 10.1093/intimm/dxn044; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Butcher MJ, 2016, CIRC RES, V119, P1190, DOI 10.1161/CIRCRESAHA.116.309764; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Dawson NAJ, 2017, TRANSL RES, V187, P53, DOI 10.1016/j.trsl.2017.06.009; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Deng GP, 2015, J BIOL CHEM, V290, P20211, DOI 10.1074/jbc.M115.638221; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hamaguchi M, 2012, CELL METAB, V16, P4, DOI 10.1016/j.cmet.2012.06.007; Haseda F, 2013, CLIN EXP IMMUNOL, V173, P207, DOI 10.1111/cei.12116; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Huehn J, 2015, SEMIN IMMUNOL, V27, P10, DOI 10.1016/j.smim.2015.02.002; Hui SP, 2017, DEV CELL, V43, P659, DOI 10.1016/j.devcel.2017.11.010; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jin HS, 2013, J CLIN INVEST, V123, P4923, DOI 10.1172/JCI69355; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Kasheta M, 2017, J EXP MED, V214, P3519, DOI 10.1084/jem.20162084; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kitani A, 2008, MUCOSAL IMMUNOL, V1, pS43, DOI 10.1038/mi.2008.51; Kitz A, 2017, CELL MOL LIFE SCI, V74, P4059, DOI 10.1007/s00018-017-2569-y; Kitz A, 2016, EMBO REP, V17, P1169, DOI 10.15252/embr.201541905; Kluger MA, 2016, KIDNEY INT, V89, P158, DOI 10.1038/ki.2015.296; Kluger MA, 2014, J AM SOC NEPHROL, V25, P1291, DOI 10.1681/ASN.2013080904; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Li ZY, 2014, J BIOL CHEM, V289, P26872, DOI 10.1074/jbc.M114.586651; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; MacDonald KG, 2015, J ALLERGY CLIN IMMUN, V135, P946, DOI 10.1016/j.jaci.2014.12.1932; Marek-Trzonkowska N, 2014, CLIN IMMUNOL, V153, P23, DOI 10.1016/j.clim.2014.03.016; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Moes N, 2010, GASTROENTEROLOGY, V139, P770, DOI 10.1053/j.gastro.2010.06.006; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; PENHALE WJ, 1973, CLIN EXP IMMUNOL, V15, P225; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Singh K, 2013, J IMMUNOL, V190, P2544, DOI 10.4049/jimmunol.1202399; Smith A. A., 2016, J IMMUNOL, V196; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Tan TG, 2016, P NATL ACAD SCI USA, V113, P14103, DOI 10.1073/pnas.1616710113; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thiruppathi M, 2012, ANN NY ACAD SCI, V1274, P68, DOI 10.1111/j.1749-6632.2012.06840.x; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; van Roon JAG, 2010, RHEUMATOLOGY, V49, P2084, DOI 10.1093/rheumatology/keq237; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xiao Y, 2014, CELL REP, V7, P1471, DOI 10.1016/j.celrep.2014.04.021; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yamada A, 2015, AM J PATHOL, V185, P2886, DOI 10.1016/j.ajpath.2015.07.007; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yu XH, 2015, CURR PHARM DESIGN, V21, P2308, DOI 10.2174/1381612821666150316115412; Zhang B, 2008, CLIN EXP IMMUNOL, V153, P182, DOI 10.1111/j.1365-2249.2008.03686.x; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014; Zhang ZM, 2017, J IMMUNOL, V198, P2612, DOI 10.4049/jimmunol.1601409; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	135	304	317	15	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					665	673		10.1038/s41590-018-0120-4	http://dx.doi.org/10.1038/s41590-018-0120-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925983	Green Accepted			2022-12-18	WOS:000436341300012
J	Taylor, PR; Roy, S; Leal, SM; Sun, Y; Howell, SJ; Cobb, BA; Li, XX; Pearlman, E				Taylor, Patricia R.; Roy, Sanhita; Leal, Sixto M., Jr.; Sun, Yan; Howell, Scott J.; Cobb, Brian A.; Li, Xiaoxia; Pearlman, Eric			Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, ROR gamma t and dectin-2	NATURE IMMUNOLOGY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; PATTERN-RECOGNITION RECEPTOR; BETA-GLUCAN RECEPTOR; HOST-DEFENSE; PROINFLAMMATORY IL-17(+); CELL-DIFFERENTIATION; LECTIN RECEPTORS; TH17 CELLS; CYTOKINES; ASPERGILLUS	Here we identified a population of bone marrow neutrophils that constitutively expressed the transcription factor ROR gamma t and produced and responded to interleukin 17A (IL-17A (IL-17)). IL-6, IL-23 and ROR gamma t, but not T cells or natural killer (NK) cells, were required for IL-17 production in neutrophils. IL-6 and IL-23 induced expression of the receptors IL-17RC and dectin-2 on neutrophils, and IL-17RC expression was augmented by activation of dectin-2. Autocrine activity of IL-17A and its receptor induced the production of reactive oxygen species (ROS), and increased fungal killing in vitro and in a model of Aspergillus-induced keratitis. Human neutrophils also expressed ROR gamma t and induced the expression of IL-17A, IL-17RC and dectin-2 following stimulation with IL-6 and IL-23. Our findings identify a population of human and mouse neutrophils with autocrine IL-17 activity that probably contribute to the etiology of microbial and inflammatory diseases.	[Taylor, Patricia R.; Roy, Sanhita; Leal, Sixto M., Jr.; Sun, Yan; Howell, Scott J.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Cobb, Brian A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	eric.pearlrnan@case.edu		Leal, Sixto/0000-0001-6939-9572; Pearlman, Eric/0000-0003-0137-7582; ROY, SANHITA/0000-0002-0407-8177	US National Institutes of Health [RO1 EY018612, P30 EY011373, F32 EY022278, F31 EY019841, R01GM082916, R01NS071996]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007157, F32EY022278, R01EY018612, P30EY011373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Ouyang (Genentech) for Il17rc<SUP>+/-</SUP> and Il17rc<SUP>-/-</SUP> mice (under a material-transfer agreement with X. Li.); Y. Iwakura (University of Tokyo) for Il17a<SUP>-/-</SUP>, dectin-1-deficient (Clec7a<SUP>-/-</SUP>) and dectin-2 deficient (Clec4n<SUP>-/-</SUP>) mice (under a material-transfer agreement with E.P.); and M.-J. Chang and G. Yakubenko for technical assistance. Supported by the US National Institutes of Health (RO1 EY018612 and P30 EY011373 to E.P., F32 EY022278 to P.R.T., F31 EY019841 to S.M.L., R01GM082916 to B.A.C., and R01NS071996 to X.L.), the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.	Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Ding ZM, 1999, J IMMUNOL, V163, P5029; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fontao L, 2012, BRIT J DERMATOL, V166, P687, DOI 10.1111/j.1365-2133.2011.10647.x; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Katayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062231; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Leal SM, 2012, J CLIN INVEST, V122, P2482, DOI 10.1172/JCI63239; Leal SM, 2012, CYTOKINE, V58, P107, DOI 10.1016/j.cyto.2011.12.022; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Sadik CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026342; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wu SY, 2013, J IMMUNOL, V190, P3427, DOI 10.4049/jimmunol.1202122; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	50	304	321	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					143	151		10.1038/ni.2797	http://dx.doi.org/10.1038/ni.2797			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24362892	Green Submitted, Green Accepted			2022-12-18	WOS:000330150600008
J	Snelgrove, RJ; Goulding, J; Didierlaurent, AM; Lyonga, D; Vekaria, S; Edwards, L; Gwyer, E; Sedgwick, JD; Barclay, AN; Hussell, T				Snelgrove, Robert J.; Goulding, John; Didierlaurent, Arnaud M.; Lyonga, Daphne; Vekaria, Seema; Edwards, Lorna; Gwyer, Emily; Sedgwick, Jonathon D.; Barclay, A. Neil; Hussell, Tracy			A critical function for CD200 in lung immune homeostasis and the severity of influenza infection	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; COLLAGEN-INDUCED ARTHRITIS; NF-KAPPA-B; EPITHELIAL-CELLS; DOWN-REGULATION; NITRIC-OXIDE; ALVEOLAR MACROPHAGES; NEGATIVE REGULATION; OX2 GLYCOPROTEIN; T-CELLS	The lung must maintain a high threshold of immune 'ignorance' to innocuous antigens to avoid inflammatory disease that depends on the balance of positive inflammatory signals and repressor pathways. We demonstrate here that airway macrophages had higher expression of the negative regulator CD200 receptor (CD200R) than did their systemic counterparts. Lung macrophages were restrained by CD200 expressed on airway epithelium. Mice lacking CD200 had more macrophage activity and enhanced sensitivity to influenza infection, which led to delayed resolution of inflammation and, ultimately, death. The administration of agonists that bind CD200R, however, prevented inflammatory lung disease. Thus, CD200R is critical for lung macrophage immune homeostasis in the resting state and limits inflammatory amplitude and duration during pulmonary influenza infection.	[Snelgrove, Robert J.; Goulding, John; Didierlaurent, Arnaud M.; Lyonga, Daphne; Vekaria, Seema; Edwards, Lorna; Gwyer, Emily; Hussell, Tracy] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, London W6 8LH, England; [Barclay, A. Neil] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Sedgwick, Jonathon D.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Imperial College London; University of Oxford; University of Oxford; Eli Lilly	Hussell, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, London W6 8LH, England.	t.hussell@imperial.ac.uk	Hussell, Tracy/O-4630-2014; Cerveto, Thomas/S-2584-2019	Hussell, Tracy/0000-0001-7186-6141; Gwyer Findlay, Emily/0000-0002-2311-6589; Didierlaurent, Arnaud/0000-0002-4736-9003	Medical Research Council [G0400808, G0400795] Funding Source: Medline; MRC [G0400795, G0400808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Akaike T, 2001, REV MED VIROL, V11, P87, DOI 10.1002/rmv.303; ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; Banerjee D, 2004, OCUL IMMUNOL INFLAMM, V12, P115, DOI 10.1080/09273940490895326; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; BARCLAY AN, 1982, EUR J BIOCHEM, V129, P447, DOI 10.1111/j.1432-1033.1982.tb07070.x; Bingisser RM, 2001, SWISS MED WKLY, V131, P171; Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; BUKOVSKY A, 1984, IMMUNOLOGY, V52, P631; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen Z, 1997, BBA-MOL BASIS DIS, V1362, P6, DOI 10.1016/S0925-4439(97)00058-6; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Copland DA, 2007, AM J PATHOL, V171, P580, DOI 10.2353/ajpath.2007.070272; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; DONG KK, 2007, NAT MED, V13, P1248; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Gorczynski RM, 1999, J IMMUNOL, V163, P1654; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hussell T, 1996, J GEN VIROL, V77, P2447, DOI 10.1099/0022-1317-77-10-2447; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; MCCAUGHAN GW, 1987, IMMUNOGENETICS, V25, P329, DOI 10.1007/BF00404426; Mestecky J, 2007, J IMMUNOL, V179, P5633, DOI 10.4049/jimmunol.179.9.5633; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nathan C, 2001, NAT IMMUNOL, V2, P17, DOI 10.1038/83124; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Raz E, 2007, NAT IMMUNOL, V8, P3, DOI 10.1038/ni0107-3; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Snelgrove RJ, 2006, J IMMUNOL, V177, P5509, DOI 10.4049/jimmunol.177.8.5509; Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Taylor N, 2005, J IMMUNOL, V174, P143, DOI 10.4049/jimmunol.174.1.143; Tuthill TJ, 2003, J GEN VIROL, V84, P2829, DOI 10.1099/vir.0.19109-0; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786	56	304	311	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1074	1083		10.1038/ni.1637	http://dx.doi.org/10.1038/ni.1637			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18660812				2022-12-18	WOS:000258559600020
J	Kawagoe, T; Sato, S; Matsushita, K; Kato, H; Matsui, K; Kumagai, Y; Saitoh, T; Kawai, T; Takeuchi, O; Akira, S				Kawagoe, Tatsukata; Sato, Shintaro; Matsushita, Kazufumi; Kato, Hiroki; Matsui, Kosuke; Kumagai, Yutaro; Saitoh, Tatsuya; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo			Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; KINASE IRAK; SIGNALING PATHWAY; BACTERIAL-INFECTIONS; ADAPTER MOLECULE; PROTECTIVE IMMUNITY; INTERFERON-BETA; INNATE IMMUNITY; MICE LACKING; IL-1	Members of the IRAK family of kinases mediate Toll-like receptor (TLR) signaling. Here we show that IRAK2 was essential for sustaining TLR-induced expression of genes encoding cytokines and activation of the transcription factor NF-kappa B, despite the fact that IRAK2 was dispensable for activation of the initial signaling cascades. IRAK2 was activated 'downstream' of IRAK4, like IRAK1, and TLR-induced cytokine production was abrogated in the absence of both IRAK1 and IRAK2. Whereas the kinase activity of IRAK1 decreased within 1 h of TLR2 stimulation, coincident with IRAK1 degradation, the kinase activity of IRAK2 was sustained and peaked at 8 h after stimulation. Thus, IRAK2 is critical in late-phase TLR responses, and IRAK1 and IRAK2 are essential for the initial responses to TLR stimulation.	[Kawagoe, Tatsukata; Matsushita, Kazufumi; Kato, Hiroki; Kumagai, Yutaro; Saitoh, Tatsuya; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Kawagoe, Tatsukata; Matsushita, Kazufumi; Kato, Hiroki; Matsui, Kosuke; Kumagai, Yutaro; Saitoh, Tatsuya; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Osaka 5650871, Japan; [Sato, Shintaro; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Japan Sci & Technol Agcy, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, 3-1 Yamada Oka, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Kumagai, Yutaro/L-7732-2018; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Kawai, Taro/0000-0001-7510-4662; Sato, Shintaro/0000-0001-5156-3354	NIAID NIH HHS [AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jensen LE, 2001, J BIOL CHEM, V276, P29037, DOI 10.1074/jbc.M103815200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Maschera B, 1999, BIOCHEM J, V339, P227, DOI 10.1042/0264-6021:3390227; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Thomas JA, 1999, J IMMUNOL, V163, P978; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	48	304	323	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					684	691		10.1038/ni.1606	http://dx.doi.org/10.1038/ni.1606			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18438411				2022-12-18	WOS:000256067900019
J	Schmidt-Supprian, M; Rajewsky, K				Schmidt-Supprian, Marc; Rajewsky, Klaus			Vagaries of conditional gene targeting	NATURE IMMUNOLOGY			English	Editorial Material							CRE RECOMBINASE; CELL DEVELOPMENT; B-LYMPHOCYTES; MAINTENANCE; EXPRESSION; TOXICITY	Conditional gene targeting based on excision or inversion of loxP-flanked DNA segments by Cre recombinase is a powerful technology for the analysis of gene function, but unexpected expression patterns of cre transgenes, variability of recombination efficiency depending on the target gene and potential toxicity of Cre recombinase represent serious challenges for the experimenter.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR, Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Schmidt-Supprian, M (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	supprian@cbr.med.harvard.edu; rajewsky@cbr.med.harvard.edu	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Rajewsky, Klaus/0000-0002-6633-6370				Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Heidmann D, 2001, DEV GENES EVOL, V211, P458, DOI 10.1007/s004270100167; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Mahonen AJ, 2004, BIOCHEM BIOPH RES CO, V320, P366, DOI 10.1016/j.bbrc.2004.05.175; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Patsch C, 2007, Handb Exp Pharmacol, P203; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sato S, 2004, MOL IMMUNOL, V41, P1123, DOI 10.1016/j.molimm.2004.06.025; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; SCHMIDTSUPPRIAN M, IN PRESS TRANSGENIC; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; SEMPRINI S, 2007, NUCL ACIDS RES; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Zabel MD, 2001, INT IMMUNOPHARMACOL, V1, P483, DOI 10.1016/S1567-5769(00)00046-1	34	304	317	1	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					665	668		10.1038/ni0707-665	http://dx.doi.org/10.1038/ni0707-665			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579640				2022-12-18	WOS:000247718100003
J	Karp, CL; Grupe, A; Schadt, E; Ewart, SL; Keane-Moore, M; Cuomo, PJ; Kohl, J; Wahl, L; Kuperman, D; Germer, S; Aud, D; Peltz, G; Wills-Karp, M				Karp, CL; Grupe, A; Schadt, E; Ewart, SL; Keane-Moore, M; Cuomo, PJ; Kohl, J; Wahl, L; Kuperman, D; Germer, S; Aud, D; Peltz, G; Wills-Karp, M			Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma	NATURE IMMUNOLOGY			English	Article							INDUCED AIRWAY HYPERRESPONSIVENESS; TUMOR-NECROSIS-FACTOR; GENOME-WIDE SEARCH; HEMOLYTICALLY INACTIVE C5B67; POLYMORPHONUCLEAR LEUKOCYTES; INFLAMMATORY RESPONSES; COMPONENT C5; IL-12; ACTIVATION; RECEPTOR	The prevalence and severity of allergic asthma continue to rise, lending urgency to the search for environmental triggers and genetic substrates. Using microarray analysis of pulmonary gene expression and single nucleotide polymorphism-based genotyping, combined with quantitative trait locus analysis, we identified the gene encoding complement factor 5 (CS) as a susceptibility locus for allergen-induced airway hyperresponsiveness in a murine model of asthma. A deletion in the coding sequence of CS leads to C5-deficiency and susceptibility. Interleukin 12 (IL-12) is able to prevent or reverse experimental allergic asthma. Blockade of the C5a receptor rendered human monocytes unable to produce IL-12, mimicking blunted IL-12 production by macrophages from C5-deficient mice and providing a mechanism for the regulation of susceptibility to asthma by C5. The role of complement in modulating susceptibility to asthma highlights the importance of immunoregulatory events at the interface of innate and adaptive immunity in disease pathogenesis.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Roche Biosci, Palo Alto, CA 94304 USA; Michigan State Univ, Dept Large Anim Sci, E Lansing, MI 48824 USA; Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany; Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; Roche Mol Syst Inc, Alameda, CA 94501 USA	Johns Hopkins University; Johns Hopkins University; Roche Holding; Michigan State University; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Roche Holding	Wills-Karp, M (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St, Baltimore, MD 21205 USA.	mkarp@welch.jhu.edu	Koehl, Joerg/C-8531-2011	Koehl, Joerg/0000-0003-1121-3178; Karp, Christopher/0000-0002-0832-2659	NCRR NIH HHS [RR00097] Funding Source: Medline; NHLBI NIH HHS [HL58527] Funding Source: Medline; NIAID NIH HHS [AI40507] Funding Source: Medline; NIDCR NIH HHS [DE12167] Funding Source: Medline; NIEHS NIH HHS [ES09606] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000097] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009606] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARTON PA, 1993, INFECT IMMUN, V61, P1474, DOI 10.1128/IAI.61.4.1474-1481.1993; BERGH K, 1992, J IMMUNOL METHODS, V152, P79, DOI 10.1016/0022-1759(92)90091-7; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; CAVAILLON JM, 1990, EUR J IMMUNOL, V20, P253, DOI 10.1002/eji.1830200204; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; EVANS R, 1987, CHEST, V91, pS65, DOI 10.1378/chest.91.6_Supplement.65S; EWART SE, AM J RESP CELL MOL B; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; GERVAIS F, 1984, J IMMUNOL, V132, P2078; Heller T, 1999, J IMMUNOL, V163, P985; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; HONG K, 1979, J IMMUNOL, V122, P2418; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; JOHNSON E, 1988, SCAND J IMMUNOL, V27, P489, DOI 10.1111/j.1365-3083.1988.tb02375.x; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Keane-Myers A, 1998, J IMMUNOL, V161, P919; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Marsh DG, 1997, NAT GENET, V15, P389; MORGAN EL, 1992, J IMMUNOL, V148, P3937; Mosser DM, 1999, CURR OPIN IMMUNOL, V11, P406, DOI 10.1016/S0952-7915(99)80068-5; Naseer T, 1997, AM J RESP CRIT CARE, V155, P845, DOI 10.1164/ajrccm.155.3.9117015; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sam H, 1999, CLIN EXP IMMUNOL, V117, P343; SCHINDLER R, 1990, BLOOD, V76, P1631; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Tsuji RF, 1997, J EXP MED, V186, P1015, DOI 10.1084/jem.186.7.1015; Vogel SN, 1999, J IMMUNOL, V162, P5666; Wang C, 1996, J IMMUNOL, V156, P786; WANG C, 1995, BLOOD, V85, P2570, DOI 10.1182/blood.V85.9.2570.bloodjournal8592570; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wittmann M, 1999, J IMMUNOL, V162, P6763; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; WOZENCRAFT AO, 1986, J EXP MED, V164, P1332, DOI 10.1084/jem.164.4.1332	42	304	334	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					221	226		10.1038/79759	http://dx.doi.org/10.1038/79759			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973279				2022-12-18	WOS:000089815100020
J	Rudra, D; deRoos, P; Chaudhry, A; Niec, RE; Arvey, A; Samstein, RM; Leslie, C; Shaffer, SA; Goodlett, DR; Rudensky, AY				Rudra, Dipayan; deRoos, Paul; Chaudhry, Ashutosh; Niec, Rachel E.; Arvey, Aaron; Samstein, Robert M.; Leslie, Christina; Shaffer, Scott A.; Goodlett, David R.; Rudensky, Alexander Y.			Transcription factor Foxp3 and its protein partners form a complex regulatory network	NATURE IMMUNOLOGY			English	Article							T-CELL FUNCTION; SUPPRESSIVE FUNCTION; TARGET GENES; IPEX; MUTATIONS; PROGRAM; DRIVEN	The transcription factor Foxp3 is indispensible for the differentiation and function of regulatory T cells (T-reg cells). To gain insights into the molecular mechanisms of Foxp3-mediated gene expression, we purified Foxp3 complexes and explored their composition. Biochemical and mass-spectrometric analyses revealed that Foxp3 forms multiprotein complexes of 400-800 kDa or larger and identified 361 associated proteins, similar to 30% of which were transcription related. Foxp3 directly regulated expression of a large proportion of the genes encoding its cofactors. Some transcription factor partners of Foxp3 facilitated its expression. Functional analysis of the cooperation of Foxp3 with one such partner, GATA-3, provided additional evidence for a network of transcriptional regulation afforded by Foxp3 and its associates to control distinct aspects of T-reg cell biology.	[Rudra, Dipayan; deRoos, Paul; Chaudhry, Ashutosh; Niec, Rachel E.; Arvey, Aaron; Samstein, Robert M.; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY USA; [Rudra, Dipayan; deRoos, Paul; Chaudhry, Ashutosh; Niec, Rachel E.; Arvey, Aaron; Samstein, Robert M.; Rudensky, Alexander Y.] Sloan Kettering Inst, Program Immunol, New York, NY USA; [Arvey, Aaron; Leslie, Christina] Sloan Kettering Inst, Computat Biol Program, New York, NY USA; [Shaffer, Scott A.; Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY USA.	rudenska@mskcc.org	Rudra, Dipayan/AAZ-5426-2020	Rudra, Dipayan/0000-0002-9667-5891; Niec, Rachel/0000-0002-8525-3693; Arvey, Aaron/0000-0002-8789-0290; Samstein, Robert/0000-0001-6860-2401; Chaudhry, Ashutosh/0000-0003-3379-5236	US National Institutes of Health [R37 AI034206]; Howard Hughes Medical Institute; Arthritis Foundation postdoctoral fellowship; Cancer Research Institute; National Institutes of Health Medical Scientist Training Program grant [GM07739]; National Institute of Neurological Disorders and Stroke [1F31NS073203-01]; National Institutes of Health [DK091968]; Medical Scientist Training Program [GM07739]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073203] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Arthritis Foundation postdoctoral fellowship; Cancer Research Institute; National Institutes of Health Medical Scientist Training Program grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Lee, A. Bravo, J. Herlihy and). Gerard for help with the mouse colony management and technical assistance; I.-C. Ho (Harvard Medical School) for Gata3<SUP>fl/fl</SUP> mice, D. Littman (New York University) for Runxl antibody, I. Taniuchi (RIKEN Research Center for Allergy and Immunology) for Cbf beta andtibody and K. Georgopoulos (Massachusetts General Hospital) for Ikzf1 and Ikzf3 antibodies. This work was supported by US National Institutes of Health R37 AI034206 grant and the Howard Hughes Medical Institute (A.Y.R.). D.R. was supported by Arthritis Foundation postdoctoral fellowship. A.C. is supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. R.E.N. is supported by National Institutes of Health Medical Scientist Training Program grant GM07739 and National Institute of Neurological Disorders and Stroke grant 1F31NS073203-01. R.M.S. is supported by National Institutes of Health DK091968 and Medical Scientist Training Program GM07739 grants.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; MORKOWSKI S, 1995, J EXP MED, V182, P1403, DOI 10.1084/jem.182.5.1403; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein R.M, CELL IN PRESS; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	46	303	317	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					1010	1019		10.1038/ni.2402	http://dx.doi.org/10.1038/ni.2402			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22922362	Green Accepted			2022-12-18	WOS:000309038600017
J	Cayrol, R; Wosik, K; Berard, JL; Dodelet-Devillers, A; Ifergan, I; Kebir, H; Haqqani, AS; Kreymborg, K; Krug, S; Moumdjian, R; Bouthillier, A; Becher, B; Arbour, N; David, S; Stanimirovic, D; Prat, A				Cayrol, Romain; Wosik, Karolina; Berard, Jennifer L.; Dodelet-Devillers, Aurore; Ifergan, Igal; Kebir, Hania; Haqqani, Arsalan S.; Kreymborg, Katharina; Krug, Sebastian; Moumdjian, Robert; Bouthillier, Alain; Becher, Burkhard; Arbour, Nathalie; David, Samuel; Stanimirovic, Danica; Prat, Alexandre			Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system	NATURE IMMUNOLOGY			English	Article							BRAIN ENDOTHELIAL-CELLS; MULTIPLE-SCLEROSIS; MONOCYTE MIGRATION; EXPRESSION; ALCAM; RECRUITMENT; RELEVANCE; DISEASE; ICAM-1; PROLIFERATION	Adhesion molecules of the immunoglobulin superfamily are crucial effectors of leukocyte trafficking into the central nervous system. Using a lipid raft-based proteomic approach, we identified ALCAM as an adhesion molecule involved in leukocyte migration across the blood-brain barrier (BBB). ALCAM expressed on BBB endothelium localized together with CD6 on leukocytes and with BBB endothelium transmigratory cups. ALCAM expression on BBB cells was upregulated in active multiple sclerosis and experimental autoimmune encephalomyelitis lesions. Moreover, ALCAM blockade restricted the transmigration of CD4(+) lymphocytes and monocytes across BBB endothelium in vitro and in vivo and reduced the severity and delayed the time of onset of experimental autoimmune encephalomyelitis. Our findings indicate an important function for ALCAM in the recruitment of leukocytes into the brain and identify ALCAM as a potential target for the therapeutic dampening of neuroinflammation.	[Cayrol, Romain; Wosik, Karolina; Dodelet-Devillers, Aurore; Ifergan, Igal; Kebir, Hania; Krug, Sebastian; Arbour, Nathalie; Prat, Alexandre] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Ctr Excellence Neurom,Neuroimmunol Res Lab, Montreal, PQ H2L 4M1, Canada; [Berard, Jennifer L.; David, Samuel] McGill Univ, Ctr Hlth, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; [Haqqani, Arsalan S.; Stanimirovic, Danica] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Kreymborg, Katharina; Becher, Burkhard] Univ Zurich, Neuroimmunol Div, CH-8057 Zurich, Switzerland; [Moumdjian, Robert; Bouthillier, Alain] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Dept Neurosurg, Montreal, PQ H2L 4M1, Canada; [Prat, Alexandre] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Dept Neurol,Multiple Sclerosis Clin, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; McGill University; National Research Council Canada; University of Zurich; Universite de Montreal; Universite de Montreal	Prat, A (corresponding author), Univ Montreal, Notre Dame Hosp, Ctr Hosp, Ctr Excellence Neurom,Neuroimmunol Res Lab, Montreal, PQ H2L 4M1, Canada.	a.prat@umontreal.ca	Becher, Burkhard/ABE-4225-2020; Ifergan, Igal/AAI-9734-2020; Ifergan, Igal/AAR-7849-2021	Becher, Burkhard/0000-0002-1541-7867; Ifergan, Igal/0000-0003-2945-2580; Arbour, Nathalie/0000-0002-3718-1584; Kebir, Hania/0000-0001-6174-8846; Prat, Alexandre/0000-0001-6188-0580				Amos C, 2001, ARTERIOSCL THROM VAS, V21, P810, DOI 10.1161/01.ATV.21.5.810; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Biernacki K, 2001, J NEUROPATH EXP NEUR, V60, P1127, DOI 10.1093/jnen/60.12.1127; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Engelhardt Britta, 2006, V43, P259, DOI 10.1007/020; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hordijk PL, 2006, FEBS J, V273, P4408, DOI 10.1111/j.1742-4658.2006.05440.x; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1998, SEMIN NEUROL, V18, P337, DOI 10.1055/s-2008-1040885; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Masedunskas A, 2006, FEBS LETT, V580, P2637, DOI 10.1016/j.febslet.2006.04.013; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nummer D, 2007, J NATL CANCER I, V99, P1188, DOI 10.1093/jnci/djm064; Nusrat A, 2000, J CELL SCI, V113, P1771; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P129, DOI 10.1093/jnen/59.2.129; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Seguin R, 2003, J NEUROPATH EXP NEUR, V62, P412, DOI 10.1093/jnen/62.4.412; Shang XZ, 1998, J IMMUNOL, V160, P467; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tomita K, 2000, BIOCHEM BIOPH RES CO, V267, P870, DOI 10.1006/bbrc.1999.2040; Turowski P, 2005, CELL MOL NEUROBIOL, V25, P153, DOI 10.1007/s10571-004-1380-0; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Virgintino D, 2002, NEUROSCIENCE, V115, P145, DOI 10.1016/S0306-4522(02)00374-3; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Walters CE, 2002, J IMMUNOL, V168, P4087, DOI 10.4049/jimmunol.168.8.4087; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	47	303	313	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					137	145		10.1038/ni1551	http://dx.doi.org/10.1038/ni1551			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18157132				2022-12-18	WOS:000252503000010
J	Montminy, SW; Khan, N; McGrath, S; Walkowicz, MJ; Sharp, F; Conlon, JE; Fukase, K; Kusumoto, S; Sweet, C; Miyake, K; Akira, S; Cotter, RJ; Goguen, JD; Lien, E				Montminy, Sara W.; Khan, Naseema; McGrath, Sara; Walkowicz, Mitchell J.; Sharp, Fiona; Conlon, Joseph E.; Fukase, Koichi; Kusumoto, Shoichi; Sweet, Charles; Miyake, Kensuke; Akira, Shizuo; Cotter, Robert J.; Goguen, Jon D.; Lien, Egil			Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response	NATURE IMMUNOLOGY			English	Article							LIPID-A STRUCTURE; RECEPTOR 4; PATHOGENIC YERSINIAE; SIGNALING PATHWAY; ESCHERICHIA-COLI; GENETIC-ANALYSIS; GENOME SEQUENCE; CAUSATIVE AGENT; CUTTING EDGE; LPS	At mammalian body temperature, the plague bacillus Yersinia pestis synthesizes lipopolysaccharide (LPS)-lipid A with poor Toll-like receptor 4 (TLR4)-stimulating activity. To address the effect of weak TLR4 stimulation on virulence, we modified Y. pestis to produce a potent TLR4-stimulating LPS. Modified Y. pestis was completely avirulent after subcutaneous infection even at high challenge doses. Resistance to disease required TLR4, the adaptor protein MyD88 and coreceptor MD-2 and was considerably enhanced by CD14 and the adaptor Mal. Both innate and adaptive responses were required for sterilizing immunity against the modified strain, and convalescent mice were protected from both subcutaneous and respiratory challenge with wild-type Y. pestis. Despite the presence of other established immune evasion mechanisms, the modified Y. pestis was unable to cause systemic disease, demonstrating that the ability to evade the LPS-induced inflammatory response is critical for Y. pestis virulence. Evading TLR4 activation by lipid A alteration may contribute to the virulence of various Gram-negative bacteria.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo 1088639, Japan; Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka 5650871, Japan	University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; University of Tokyo; Osaka University	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	egil.lien@umassmed.edu	Akira, Shizuo/C-3134-2009	McGrath, Sara/0000-0003-4773-4784	NIAID NIH HHS [R01 AI057588] Funding Source: Medline; NIDDK NIH HHS [DK 32520] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agrawal S, 2003, ANN NY ACAD SCI, V1002, P30, DOI 10.1196/annals.1281.005; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Knirel YA, 2005, BIOCHEMISTRY-US, V44, P1731, DOI 10.1021/bi048430f; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Vinogradov EV, 2002, CARBOHYD RES, V337, P775, DOI 10.1016/S0008-6215(02)00074-5; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; WESTPHAL O, 1952, Z NATURFORSCH B, V7, P148, DOI 10.1515/znb-1952-0303; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	50	303	333	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1066	1073		10.1038/ni1386	http://dx.doi.org/10.1038/ni1386			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16980981	Bronze			2022-12-18	WOS:000241437100012
J	Stanislawski, T; Voss, RH; Lotz, C; Sadovnikova, E; Willemsen, RA; Kuball, J; Ruppert, T; Bolhuis, RLH; Melief, CJ; Huber, C; Stauss, HJ; Theobald, M				Stanislawski, T; Voss, RH; Lotz, C; Sadovnikova, E; Willemsen, RA; Kuball, J; Ruppert, T; Bolhuis, RLH; Melief, CJ; Huber, C; Stauss, HJ; Theobald, M			Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; CYTOTOXIC T-LYMPHOCYTES; DENDRITIC CELLS; HIGH-AFFINITY; P53 PROTEIN; MHC; PEPTIDE; IMMUNOTHERAPY; PROTEASOME; RECEPTOR	We identified a tumor-associated cytotoxic T lymphocyte (CTL) epitope derived from the widely expressed human MDM2 oncoprotein and were able to bypass self-tolerance to this tumor antigen in HLA-A*0201 (A2.1) transgenic mice and by generating A2.1-negative, allo-A2.1-restricted human T lymphocytes. A broad range of malignant, as opposed to nontransformed cells, were killed by high-avidity transgenic mouse and allogeneic human CTLs specific for the A2.1-presented MDM2 epitope. Whereas the self-A2.1-restricted human T cell repertoire gave rise only to low-avidity CTLs unable to recognize the natural MDM2 peptide, human A2.1(+) T lymphocytes were turned into efficient MDM2-specific CTLs upon expression of wild-type and partially humanized high-affinity T cell antigen receptor (TCR) genes derived from the transgenic mice. These results demonstrate that TCR gene transfer can be used to circumvent self-tolerance of autologous T lymphocytes to universal tumor antigens and thus provide the basis for a TCR gene transfer-based broad-spectrum immunotherapy of malignant disease.	Univ Mainz, Dept Hematol & Oncol, D-55101 Mainz, Germany; Hammersmith Hosp, Imperial Coll Sch Med, Dept Immunol, London W12 0NN, England; Dr Daniel Den Hoed Canc Ctr, Dept Clin & Tumor Immunol, NL-3075 EA Rotterdam, Netherlands; Univ Munich, Max Von Pettenkofer Inst Virol, D-80336 Munich, Germany; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands	Johannes Gutenberg University of Mainz; Imperial College London; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Theobald, M (corresponding author), Univ Mainz, Dept Hematol & Oncol, D-55101 Mainz, Germany.		Stauss, Hans J/A-6569-2011; Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266				Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Clay TM, 1999, J IMMUNOL, V163, P507; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Drexler I, 1999, CANCER RES, V59, P4955; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Freedman DA, 1999, CANCER RES, V59, P1; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; MATZINGER P, 1984, NATURE, V308, P738, DOI 10.1038/308738a0; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Munz C, 1999, J IMMUNOL, V162, P25; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Orentas RJ, 2001, CLIN IMMUNOL, V98, P220, DOI 10.1006/clim.2000.4977; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RAMMENSEE HG, 1984, NATURE, V308, P741, DOI 10.1038/308741a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; ROTZSCHKE O, 1991, J EXP MED, V174, P1059, DOI 10.1084/jem.174.5.1059; Sadovnikova E, 1998, EUR J IMMUNOL, V28, P193, DOI 10.1002/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.3.CO;2-B; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; Sant'Angelo DB, 2001, P NATL ACAD SCI USA, V98, P6824, DOI 10.1073/pnas.121179998; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Stauss HJ, 1999, IMMUNOL TODAY, V20, P180, DOI 10.1016/S0167-5699(99)01443-7; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Stohwasser R, 1997, EUR J IMMUNOL, V27, P1182, DOI 10.1002/eji.1830270520; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Theobald M, 1995, P NATL ACAD SCI USA, V92, P11993, DOI 10.1073/pnas.92.26.11993; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Theobald M, 1998, J EXP MED, V188, P1017, DOI 10.1084/jem.188.6.1017; Willemsen RA, 2000, GENE THER, V7, P1369, DOI 10.1038/sj.gt.3301253; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; YONDERHELDE RH, 1999, IMMUNITY, V10, P673	44	302	375	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					962	970		10.1038/ni1001-962	http://dx.doi.org/10.1038/ni1001-962			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577350				2022-12-18	WOS:000171361500017
J	Buttgereit, A; Lelios, I; Yu, XY; Vrohlings, M; Krakoski, NR; Gautier, EL; Nishinakamura, R; Becher, B; Greter, M				Buttgereit, Anne; Lelios, Iva; Yu, Xueyang; Vrohlings, Melissa; Krakoski, Natalie R.; Gautier, Emmanuel L.; Nishinakamura, Ryuichi; Becher, Burkhard; Greter, Melanie			Sall1 is a transcriptional regulator defining microglia identity and function	NATURE IMMUNOLOGY			English	Article							TOWNES-BROCKS-SYNDROME; MONOCYTES; REVEALS; MOUSE; GENE; MACROPHAGES; PROGENITOR; CELL; IDENTIFICATION; SIGNATURE	Microglia are the resident macrophages of the central nervous system (CNS). Gene expression profiling has identified Sall1, which encodes a transcriptional regulator, as a microglial signature gene. We found that Sall1 was expressed by microglia but not by other members of the mononuclear phagocyte system or by other CNS-resident cells. Using Sall1 for microglia-specific gene targeting, we found that the cytokine receptor CSF1R was involved in the maintenance of adult microglia and that the receptor for the cytokine TGF-beta suppressed activation of microglia. We then used the microglia-specific expression of Sall1 to inducibly inactivate the murine Sall1 locus in vivo, which resulted in the conversion of microglia from resting tissue macrophages into inflammatory phagocytes, leading to altered neurogenesis and disturbed tissue homeostasis. Collectively, our results show that transcriptional regulation by Sall1 maintains microglial identity and physiological properties in the CNS and allows microglia-specific manipulation in vivo.	[Buttgereit, Anne; Lelios, Iva; Yu, Xueyang; Vrohlings, Melissa; Krakoski, Natalie R.; Becher, Burkhard; Greter, Melanie] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Gautier, Emmanuel L.] UPMC Univ Paris 06, Sorbonne Univ, Pitie Salpetriere Hosp, INSERM UMR S 1166, Paris, France; [Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto, Japan	University of Zurich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Kumamoto University	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	greter@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; Gautier, Emmanuel L./E-2259-2017	Becher, Burkhard/0000-0002-1541-7867; Gautier, Emmanuel L./0000-0003-2976-7566; Yu, Xueyang/0000-0003-1372-5353; Greter, Melanie/0000-0002-7220-5369	Swiss National Science Foundation [BSSGI0_155832, PP00P3_144781, 316030 150768, 310030 146130, CRSII3 136203]; Swiss Multiple Sclerosis Society; European Union; National Agency of Research; Fondation de France [00056835]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Multiple Sclerosis Society; European Union(European Commission); National Agency of Research(French National Research Agency (ANR)); Fondation de France(Fondation de France)	We thank V. Tosevski and F. Mair for technical help and flow cytometry sorting; J. Jaberg, S. Nemetz and J. Candreia for technical support; A.L. Croxford for critical reading of the manuscript; S. Jessberger, B. Schreiner and C. Raposo for critical discussions; J.K. Georgijevic and W. Qi for performing the next generation sequencing analysis at the Functional Genomics Centre Zurich (FGCZ); Plexxikon (P. Singh and B. West) for PLX5622-containing and control diets; and the Neuroscience Center Zurich, and the Microbiology and Immunology PhD program, University of Zurich and ETH, Zurich, Switzerland. Cx3cr1<SUP>CreER</SUP> were kindly provided by S. Jung (Weizmann Institute of Science). Csf1r<SUP>fl/fl</SUP> mice were kindly provided by J. Pollard (Albert Einstein College of Medicine). Supported by the Swiss National Science Foundation (BSSGI0_155832, PP00P3_144781, 316030 150768, 310030 146130, and CRSII3 136203 for M.G. and B.B.), the Swiss Multiple Sclerosis Society (M.G. and B.B.), the European Union FP7 project TargetBraIn, NeuroKine, ATECT (B.B.), the National Agency of Research (LIPOCAMD and MACLEAR for E.L.G.) and the Fondation de France (00056835 for E.L.G.).	Abedin MJ, 2011, NEPHRON EXP NEPHROL, V119, pE75, DOI 10.1159/000328925; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Harrison SJ, 2012, DIS MODEL MECH, V5, P351, DOI 10.1242/dmm.002873; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hirsch S, 2015, AM J PHYSIOL-RENAL, V309, pE852, DOI 10.1152/ajprenal.00222.2015; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kimura A, 2014, INT IMMUNOL, V26, P209, DOI 10.1093/intimm/dxt067; Kohlhase J, 2000, HUM MUTAT, V16, P460, DOI 10.1002/1098-1004(200012)16:6<460::AID-HUMU2>3.0.CO;2-4; Koso H, 2016, GLIA, V64, P2005, DOI 10.1002/glia.23038; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ohmori T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15676; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Schreiner B, 2009, SEMIN IMMUNOPATHOL, V31, P479, DOI 10.1007/s00281-009-0181-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shemer A, 2015, TRENDS IMMUNOL, V36, P614, DOI 10.1016/j.it.2015.08.003; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Takasato M, 2004, MECH DEVELOP, V121, P547, DOI 10.1016/j.mod.2004.04.007; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Vodopiutz J, 2013, J PEDIATR-US, V162, P612, DOI 10.1016/j.jpeds.2012.08.042; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	51	301	308	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1397	1406		10.1038/ni.3585	http://dx.doi.org/10.1038/ni.3585			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27776109	Green Submitted			2022-12-18	WOS:000388056400010
J	Burton, DR; Mascola, JR				Burton, Dennis R.; Mascola, John R.			Antibody responses to envelope glycoproteins in HIV-1 infection	NATURE IMMUNOLOGY			English	Review							BROADLY NEUTRALIZING ANTIBODIES; DEPENDENT CELLULAR CYTOTOXICITY; MUCOSAL SHIV CHALLENGE; IMMUNODEFICIENCY-VIRUS; MONOCLONAL-ANTIBODIES; NONNEUTRALIZING ANTIBODIES; MEDIATED CYTOTOXICITY; PASSIVE TRANSFER; FC-RECEPTOR; ENV TRIMERS	Antibody responses to the HIV-1 envelope glycoproteins can be classified into three groups. Binding but non-neutralizing responses are directed to epitopes that are expressed on isolated envelope glycoproteins but not on the native envelope trimer found on the surface of virions and responsible for mediating the entry of virus into target cells. Strain-specific responses and broadly neutralizing responses, in contrast, target epitopes that are expressed on the native trimer, as revealed by recently resolved structures. The past few years have seen the isolation of many broadly neutralizing antibodies of remarkable potency that have shown prophylactic and therapeutic activities in animal models. These antibodies are helping to guide rational vaccine design and therapeutic strategies for HIV-1.	[Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02115 USA; [Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; jmascola@nih.gov	Mascola, John/AAI-7193-2021		National Institute of Allergy and Infectious Diseases; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; Ragon Institute of MGH, MIT and Harvard; Vaccine Research Center, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute of MGH, MIT and Harvard; Vaccine Research Center, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Diseases (D.R.B.), the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (D.R.B.), the International AIDS Vaccine Initiative (D.R.B.), the Bill and Melinda Gates Foundation (D.R.B.), the Ragon Institute of MGH, MIT and Harvard (D.R.B.) and the intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (J.R.M.).	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Alpert MD, 2012, J VIROL, V86, P12039, DOI 10.1128/JVI.01650-12; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Baum LL, 1996, J IMMUNOL, V157, P2168; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; BUCHACHER A, 1992, VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P191; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dugast AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097229; Fahrbach KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076176; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; Forthal D, 2013, CURR OPIN HIV AIDS, V8, P393, DOI 10.1097/COH.0b013e328363d486; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; MONTEFIORI DC, 1991, VIROLOGY, V182, P635, DOI 10.1016/0042-6822(91)90604-A; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Moore PL, 2015, TRENDS MICROBIOL, V23, P204, DOI 10.1016/j.tim.2014.12.007; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pegu A, 2014, SCI TRANSL MED, V6; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smalls-Mantey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074858; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	108	301	331	3	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					571	576		10.1038/ni.3158	http://dx.doi.org/10.1038/ni.3158			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988889	Green Accepted			2022-12-18	WOS:000354751900005
J	Henrickson, SE; Mempel, TR; Mazo, IB; Liu, B; Artyomov, MN; Zheng, H; Peixoto, A; Flynn, MP; Senman, B; Junt, T; Wong, HC; Chakraborty, AK; von Andrian, UH				Henrickson, Sarah E.; Mempel, Thorsten R.; Mazo, Irina B.; Liu, Bai; Artyomov, Maxim N.; Zheng, Huan; Peixoto, Antonio; Flynn, Michael P.; Senman, Balimkiz; Junt, Tobias; Wong, Hing C.; Chakraborty, Arup K.; von Andrian, Ulrich H.			T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation	NATURE IMMUNOLOGY			English	Article							LYMPH-NODES; IN-VIVO; IMMUNOLOGICAL SYNAPSE; RECEPTOR MICROCLUSTERS; CROSS-PRESENTATION; STOP SIGNAL; TOLERANCE; IMMUNITY; DYNAMICS; NAIVE	After homing to lymph nodes, CD8(+) T cells are primed by dendritic cells (DCs) in three phases. During phase one, T cells undergo brief serial contacts with DCs for several hours, whereas phase two is characterized by stable T cell-DC interactions. We show here that the duration of phase one and T cell activation kinetics correlated inversely with the number of complexes of cognate peptide and major histocompatibility complex (pMHC) per DC and with the density of antigen-presenting DCs per lymph node. Very few pMHC complexes were necessary for the induction of full-fledged T cell activation and effector differentiation. However, neither T cell activation nor transition to phase two occurred below a threshold antigen dose determined in part by pMHC stability. Thus, phase one permits T cells to make integrated 'measurements' of antigen dose that determine subsequent T cell participation in immune responses.	[Henrickson, Sarah E.; Mempel, Thorsten R.; Mazo, Irina B.; Peixoto, Antonio; Flynn, Michael P.; Senman, Balimkiz; Junt, Tobias; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Henrickson, Sarah E.; Mempel, Thorsten R.; Mazo, Irina B.; Peixoto, Antonio; Flynn, Michael P.; Senman, Balimkiz; Junt, Tobias; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Liu, Bai; Wong, Hing C.] Altor Biosci, Miramar, FL 33025 USA; [Zheng, Huan; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021	Wong, Hing C./0000-0002-6865-4313; Henrickson, Sarah/0000-0001-5569-4132; Peixoto, Antonio/0000-0001-9493-1954	NCI NIH HHS [P01 CA071932-11A2, P01 CA071932] Funding Source: Medline; NHLBI NIH HHS [HL066987, T32 HL066987, T32 HL007623, HL07623] Funding Source: Medline; NIAID NIH HHS [AI072252, R01 AI072252, R01 AI069259, AI069259, P01 AI071195, P01 AI071195-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195, R01AI069259, R01AI072252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LIU LB, 2006, J IMMUNOL, V178; MANNING LS, 1992, BRIT J CANCER, V66, P1088, DOI 10.1038/bjc.1992.415; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhu X, 2006, J IMMUNOL, V176, P3223, DOI 10.4049/jimmunol.176.5.3223	54	301	309	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					282	291		10.1038/ni1559	http://dx.doi.org/10.1038/ni1559			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18204450	Green Accepted			2022-12-18	WOS:000253406700014
J	Walzer, T; Chiossone, L; Chaix, J; Calver, A; Carozzo, C; Garrigue-Antar, L; Jacques, Y; Baratin, M; Tomasello, E; Vivier, E				Walzer, Thierry; Chiossone, Laura; Chaix, Julie; Calver, Andrew; Carozzo, Claude; Garrigue-Antar, Laure; Jacques, Yannick; Baratin, Myriam; Tomasello, Elena; Vivier, Eric			Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor	NATURE IMMUNOLOGY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; HETEROTRIMERIC G-PROTEINS; NK-CELLS; T-CELLS; LYMPH-NODES; ANTITUMOR RESPONSES; IFN-GAMMA; 2 SUBSETS; ACTIVATION; EXPRESSION	Consistent with their function in immune surveillance, natural killer (NK) cells are distributed throughout lymphoid and nonlymphoid tissues. However, the mechanisms governing the steady-state trafficking of NK cells remain unknown. The lysophospholipid sphingosine 1-phosphate (S1P), by binding to its receptor S1P(1), regulates the recirculation of T and B lymphocytes. In contrast, S1P(5) is detected in the brain and regulates oligodendrocyte migration and survival in vitro. Here we show that S1P(5) was also expressed in NK cells in mice and humans and that S1P(5)- deficient mice had aberrant NK cell homing during steady-state conditions. In addition, we found that S1P(5) was required for the mobilization of NK cells to inflamed organs. Our data emphasize distinct mechanisms regulating the circulation of various lymphocyte subsets and raise the possibility that NK cell trafficking may be manipulated by therapies specifically targeting S1P(5).	Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, U631, F-13288 Marseille, France; CNRS, UMR6102, F-13288 Marseille, France; GlaxoSmithKline, New Frontiers Sci Pk, Harlow CM19 5AW, Essex, England; Univ Lyon, UR RT12B, F-69003 Lyon, France; Ecole Natl Vet, F-69280 Lyon, France; Inst Natl Sante & Rech Med, Grp Rech Cytokines & Recepteurs, U601, Inst Biol, F-44093 Nantes, France; Univ Nantes, Inst Biol, Unite Format & Rech Med, IFR26, F-44093 Nantes, France; Hop Conception, Assistance Publ Hop Marseille, F-13005 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); GlaxoSmithKline; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, U631, Case 906,Campus Luminy, F-13288 Marseille, France.	walzer@ciml.univ-mrs.fr; vivier@ciml.univ-mrs.fr	Chiossone, Laura/D-3062-2011; Walzer, Thierry/L-9418-2014; Vivier, Eric/F-8939-2010	Chiossone, Laura/0000-0002-9097-5869; Walzer, Thierry/0000-0002-0857-8179; Vivier, Eric/0000-0001-7022-8287; Tomasello, Elena/0000-0002-6839-5219; Garrigue-Antar, Laure/0000-0001-6331-8882				Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bottino C, 2006, CURR TOP MICROBIOL, V298, P175; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; GREGOIRE C, IN PRESS IMMUNOL REV; Hanessian S, 2007, BIOORG MED CHEM LETT, V17, P491, DOI 10.1016/j.bmcl.2006.10.014; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Kveberg L, 2002, EUR J IMMUNOL, V32, P1856, DOI 10.1002/1521-4141(200207)32:7<1856::AID-IMMU1856>3.0.CO;2-B; Lavergne E, 2003, CANCER RES, V63, P7468; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; Terai K, 2003, NEUROSCIENCE, V116, P1053, DOI 10.1016/S0306-4522(02)00791-1; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Vaessen LMB, 2006, TRANSPL IMMUNOL, V15, P281, DOI 10.1016/j.trim.2006.02.002; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Walzer T, 2002, J IMMUNOL, V168, P2704, DOI 10.4049/jimmunol.168.6.2704; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang J, 2005, CELL MOL IMMUNOL, V2, P449; Wang WG, 2004, FASEB J, V18, P1043, DOI 10.1096/fj.04-1555fje; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660	51	301	317	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1337	1344		10.1038/ni1523	http://dx.doi.org/10.1038/ni1523			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17965716				2022-12-18	WOS:000251267000014
J	Hardison, SE; Brown, GD				Hardison, Sarah E.; Brown, Gordon D.			C-type lectin receptors orchestrate antifungal immunity	NATURE IMMUNOLOGY			English	Review							CHRONIC MUCOCUTANEOUS CANDIDIASIS; T-CELL RESPONSES; PATTERN-RECOGNITION RECEPTOR; TOLL-LIKE RECEPTORS; HUMAN DENDRITIC CELLS; HYPER-IGE SYNDROME; NF-KAPPA-B; HOST-DEFENSE; MANNOSE RECEPTOR; FUNGAL-INFECTIONS	Immunity to pathogens critically requires pattern-recognition receptors (PRRs) to trigger intracellular signaling cascades that initiate and direct innate and adaptive immune responses. For fungal infections, these responses are primarily mediated by members of the C-type lectin receptor family. In this Review, we highlight recent advances in the understanding of the roles and mechanisms of these multifunctional receptors, explore how these PRRs orchestrate antifungal immunity and briefly discuss progress in the use of these receptors as targets for antifungal and other vaccines.	[Hardison, Sarah E.; Brown, Gordon D.] Univ Aberdeen, Sect Immunol & Infect, Aberdeen Fungal Grp, Aberdeen, Scotland	University of Aberdeen	Brown, GD (corresponding author), Univ Aberdeen, Sect Immunol & Infect, Aberdeen Fungal Grp, Aberdeen, Scotland.	gordon.brown@abdn.ac.uk	Hardison, Sarah/ABB-1606-2021; Hardison, Sarah E./AAC-7510-2019	brown, gordon/0000-0002-0287-5383	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the Wellcome Trust for funding.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ameen M, 2009, CLIN EXP DERMATOL, V34, P849, DOI 10.1111/j.1365-2230.2009.03415.x; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Bar E, 2012, J IMMUNOL, V188, P5636, DOI 10.4049/jimmunol.1200594; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bourgeois C, 2011, J IMMUNOL, V186, P3104, DOI 10.4049/jimmunol.1002599; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Cohen NR, 2011, CELL HOST MICROBE, V10, P437, DOI 10.1016/j.chom.2011.09.011; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Cruz LJ, 2012, BIOMATERIALS, V33, P4229, DOI 10.1016/j.biomaterials.2012.02.036; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; Dan JM, 2008, INFECT IMMUN, V76, P2362, DOI 10.1128/IAI.00095-08; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Empey KM, 2007, INFECT IMMUN, V75, P3382, DOI 10.1128/IAI.00174-07; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Lang R, 2011, IMMUNOBIOLOGY, V216, P1184, DOI 10.1016/j.imbio.2011.06.005; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Netea MG, 2003, EUR J IMMUNOL, V33, P3409, DOI 10.1002/eji.200323737; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Netea MG, 2010, MED MYCOL, V48, P897, DOI 10.3109/13693781003621575; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rachini A, 2007, INFECT IMMUN, V75, P5085, DOI 10.1128/IAI.00278-07; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Roy RM, 2012, CELL HOST MICROBE, V11, P436, DOI 10.1016/j.chom.2012.04.005; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Settler S., 2012, THESCIENTIFICWORLDJO; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Spellberg Brad, 2011, F1000 Med Rep, V3, P13, DOI 10.3410/M3-13; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Sun WK, 2012, EUR J CLIN MICROBIOL, V31, P2755, DOI 10.1007/s10096-012-1624-8; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van de Veerdonk FL, 2011, EUR J IMMUNOL, V41, P2260, DOI 10.1002/eji.201041226; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weindl G, 2010, J DENT RES, V89, P666, DOI 10.1177/0022034510368784; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	99	300	315	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					817	822		10.1038/ni.2369	http://dx.doi.org/10.1038/ni.2369			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910394	Green Accepted			2022-12-18	WOS:000307863600009
J	Rangel-Moreno, J; Carragher, DM; Garcia-Hernandez, MD; Hwang, JY; Kusser, K; Hartson, L; Kolls, JK; Khader, SA; Randall, TD				Rangel-Moreno, Javier; Carragher, Damian M.; Garcia-Hernandez, Maria de la Luz; Hwang, Ji Young; Kusser, Kim; Hartson, Louise; Kolls, Jay K.; Khader, Shabaana A.; Randall, Troy D.			The development of inducible bronchus-associated lymphoid tissue depends on IL-17	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; CD45(+)CD4(+)CD3(-) CELLS; RETINOIC ACID; TH17 CELLS; LYMPHOTOXIN; EXPRESSION; SECONDARY; CHEMOKINES; ALPHA; DIFFERENTIATION	Ectopic or tertiary lymphoid tissues, such as inducible bronchus-associated lymphoid tissue (iBALT), form in nonlymphoid organs after local infection or inflammation. However, the initial events that promote this process remain unknown. Here we show that iBALT formed in mouse lungs as a consequence of pulmonary inflammation during the neonatal period. Although we found CD4(+)CD3(-) lymphoid tissue-inducer cells (LTi cells) in neonatal lungs, particularly after inflammation, iBALT was formed in mice that lacked LTi cells. Instead, we found that interleukin 17 (IL-17) produced by CD4(+) T cells was essential for the formation of iBALT. IL-17 acted by promoting lymphotoxin-a-independent expression of the chemokine CXCL13, which was important for follicle formation. Our results suggest that IL-17-producing T cells are critical for the development of ectopic lymphoid tissues.	[Rangel-Moreno, Javier; Garcia-Hernandez, Maria de la Luz; Hwang, Ji Young; Kusser, Kim; Hartson, Louise; Randall, Troy D.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Carragher, Damian M.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Kolls, Jay K.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA USA; [Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA	University of Rochester; Trudeau Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Randall, TD (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	troy_randall@urmc.rochester.edu	Carragher, Damian/E-6673-2016; Carragher, Damian/O-4183-2019; Kolls, Jay/AAH-1829-2019	Carragher, Damian/0000-0003-4341-4943; Carragher, Damian/0000-0003-4341-4943; Kolls, Jay/0000-0001-5151-6304; A Khader, Shabaana/0000-0002-9545-4982; Rangel-Moreno, Javier/0000-0002-9738-1182; Garcia-Hernandez, Maria de la luz/0000-0001-9268-2464	University of Rochester; US National Institutes of Health [HL069409, AI072689, AI061511, HL105427]; Children's Hospital of Pittsburgh; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409, R21HL104601, R01HL105427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072689, R01AI061511] Funding Source: NIH RePORTER	University of Rochester; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. LaMere and A. Boucher for animal husbandry; S. Lira (Mount Sinai School of Medicine) for Ccr6<SUP>-/-</SUP> mice; D. Littman (New York University) for Rorc<SUP>-/-</SUP> and Id2<SUP>-/-</SUP> mice; J. Cyster (University of California, San Francisco) for Cxcl13<SUP>-/-</SUP> and plt/plt mice; L. Haynes (Trudeau Institute) for rederived OT-II mice; and J. Browning (Biogen Idec) for soluble LT beta R. Supported by the University of Rochester, the US National Institutes of Health (HL069409, AI072689 and AI061511 to T. D. R.; and HL105427 to S. A. K.) and the Children's Hospital of Pittsburgh.	Bagavant H, 2002, INT IMMUNOL, V14, P1397, DOI 10.1093/intimm/dxf105; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; CASTELLON JDE, 1992, HISTOL HISTOPATHOL, V7, P321; Chen SC, 2002, J IMMUNOL, V168, P1001, DOI 10.4049/jimmunol.168.3.1001; Chiavolini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011156; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cupedo T, 2002, IMMUNOL REV, V189, P41, DOI 10.1034/j.1600-065X.2002.18905.x; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Ersch J, 2005, PEDIAT ALLERG IMM-UK, V16, P295, DOI 10.1111/j.1399-3038.2005.00269.x; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Furtado GC, 2007, P NATL ACAD SCI USA, V104, P5026, DOI 10.1073/pnas.0606697104; Gatumu MK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2617; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Heier I, 2008, THORAX, V63, P703, DOI 10.1136/thx.2007.082974; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Segal B, 2010, SEMIN IMMUNOPATHOL, V32, P71, DOI 10.1007/s00281-009-0186-z; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sue-Chu M, 1998, AM J RESP CRIT CARE, V158, P597, DOI 10.1164/ajrccm.158.2.9711012; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tschernig T, 2000, PATHOBIOLOGY, V68, P1, DOI 10.1159/000028109; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	55	300	308	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					639	U195		10.1038/ni.2053	http://dx.doi.org/10.1038/ni.2053			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21666689	Green Accepted			2022-12-18	WOS:000291936400012
J	Ackerman, AL; Cresswell, P				Ackerman, AL; Cresswell, P			Cellular mechanisms governing cross-presentation of exogenous antigens	NATURE IMMUNOLOGY			English	Review							MHC CLASS-I; HUMAN DENDRITIC CELLS; CYTOTOXIC T-CELLS; MINOR H-ANTIGENS; ENDOPLASMIC-RETICULUM; HEAVY-CHAINS; PEPTIDE BINDING; SOLUBLE-ANTIGEN; VIRUS PROTEIN; CUTTING EDGE	The recent discovery of fusion of endoplasmic reticulum membrane with nascent phagosomes suggests that this peripheral compartment in macrophages and dendritic cells may serve as an organelle optimized for major histocompatibility complex (MHC) class I-restricted cross-presentation of exogenous antigens. The process allows intersection of the endosomal system with the endoplasmic reticulum, the classical site of MHC class I peptide loading, and may reconcile the seemingly conflicting evidence indicating both of these sites are crucial in cross-presentation. Here we discuss the potential mechanisms involved in loading exogenous antigens onto MHC class I molecules and the implications of this new evidence for the in vivo function of dendritic cells.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, POB 208011, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Ackerman, A. Lenore/AAP-9844-2021; Ackerman, Anne/ABG-8182-2020		NIAID NIH HHS [F31 AI101347] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Chefalo PJ, 2001, J IMMUNOL, V167, P1274, DOI 10.4049/jimmunol.167.3.1274; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; DACONCEICAOSILVA F, 1994, EUR J IMMUNOL, V24, P2813, DOI 10.1002/eji.1830241135; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Gredmark S, 2003, J VIROL, V77, P10943, DOI 10.1128/JVI.77.20.10943-10956.2003; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HARDING CV, 1994, J IMMUNOL, V153, P4925; Hemmelder MH, 1998, J LAB CLIN MED, V132, P390, DOI 10.1016/S0022-2143(98)90110-X; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; KALEAB B, 1990, EUR J IMMUNOL, V20, P2651, DOI 10.1002/eji.1830201219; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Radcliffe CM, 2002, J BIOL CHEM, V277, P46415, DOI 10.1074/jbc.M202466200; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1992, J IMMUNOL, V148, P3028; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; SZALAY G, 1994, EUR J IMMUNOL, V24, P1471, DOI 10.1002/eji.1830240703; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	75	300	324	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					678	684		10.1038/ni1082	http://dx.doi.org/10.1038/ni1082			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224093				2022-12-18	WOS:000222331200004
J	Hazenberg, MD; Hamann, D; Schuitemaker, H; Miedema, F				Hazenberg, MD; Hamann, D; Schuitemaker, H; Miedema, F			T cell depletion in HIV-I infection: how CD4(+) T cells go out of stock	NATURE IMMUNOLOGY			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; TELOMERE LENGTH; RAPID TURNOVER; DISEASE; NAIVE; LYMPHOCYTES; PROGRESSION; ACTIVATION; MEMORY	HIV-I infection is characterized by a gradual loss of CD4(+) T cells and progressive immune deficiency that leads to opportunistic infections, otherwise rare malignancies and ultimately death. Extensive research over the past two decades has increased our insight into the pathogenic mechanisms underlying these features of HIV-I infection. Here, we will give a brief overview of the most recent findings and present a model that fits most of the relevant aspects of HIV-I infection as known. We hypothesize that HIV-I infection depletes T cell supplies (which are not replaced because of low and static thymic function) by direct infection and killing of cells and through hyperactivation of the immune system.	Univ Amsterdam, Acad Med Ctr, Dept Clin Viroimmunol, CLB, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt & Clin Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hazenberg, MD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Viroimmunol, CLB, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	M_Hazenberg@CLB.nl						Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Breit TM, 1997, J IMMUNOL, V159, P4341; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Clark DR, 2000, BLOOD, V96, P242, DOI 10.1182/blood.V96.1.242.013k30_242_249; Clark DR, 1999, ADV IMMUNOL, V73, P301, DOI 10.1016/S0065-2776(08)60789-0; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; de Vries E, 2000, BONE MARROW TRANSPL, V25, P267, DOI 10.1038/sj.bmt.1702141; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, J INFECT DIS, V181, P1479, DOI 10.1086/315398; EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; Fleury S, 1998, NAT MED, V4, P794, DOI 10.1038/nm0798-794; Franco JM, 2000, CLIN EXP IMMUNOL, V119, P493, DOI 10.1046/j.1365-2249.2000.01152.x; George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Grossman Z, 1997, NAT MED, V3, P486, DOI 10.1038/nm0597-486; Grossman Z, 1999, SCIENCE, V284, p555a, DOI [DOI 10.1126/SCIENCE.284.5414.555A, 10.1126/science.284.5414.555a]; GRUTERS RA, 1991, AIDS, V5, P837, DOI 10.1097/00002030-199107000-00007; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; HAZENBERG MD, 1999, AIDS REV, V1, P67; Hellerstein MK, 1997, IMMUNITY, V7, P583, DOI 10.1016/S1074-7613(00)80379-9; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; HONG R, 1991, Immunodeficiency Reviews, V3, P1; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; KANESHIMA H, 1994, J VIROL, V68, P8188, DOI 10.1128/JVI.68.12.8188-8192.1994; Kitchen SG, 1997, J VIROL, V71, P5713, DOI 10.1128/JVI.71.8.5713-5722.1997; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kostense S, 1998, AIDS, V12, pF235, DOI 10.1097/00002030-199818000-00001; Livak F, 1996, MOL CELL BIOL, V16, P609; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; MAHALINGAM M, 1993, CLIN EXP IMMUNOL, V93, P337, DOI 10.1111/j.1365-2249.1993.tb08182.x; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; Messele T, 1999, CLIN EXP IMMUNOL, V115, P443; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; Michel P, 2000, J INFECT DIS, V181, P64, DOI 10.1086/315170; MIEDEMA F, 1990, IMMUNOL TODAY, V11, P293, DOI 10.1016/0167-5699(90)90116-Q; MIEDEMA F, 1995, IMMUNOLOGIST, V3, P228; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; MOHRI H, 2000, 7 C RETR OPP INF SAN; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; Rep MHG, 1997, J CLIN INVEST, V99, P2225, DOI 10.1172/JCI119396; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenzweig M, 1998, P NATL ACAD SCI USA, V95, P6388, DOI 10.1073/pnas.95.11.6388; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SIMMONDS P, 1991, LANCET, V338, P1159, DOI 10.1016/0140-6736(91)92029-2; Smith KY, 2000, J INFECT DIS, V181, P141, DOI 10.1086/315169; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; STEEL CM, 1988, LANCET, V1, P1185; Stuart JWTC, 1998, AIDS, V12, P2155, DOI 10.1097/00002030-199816000-00010; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; VANROSSUM AMC, 2000, UNPUB IMMUNE RECONST; Vigano' A, 1999, AIDS, V13, pF29, DOI 10.1097/00002030-199904010-00001; Vigano A, 2000, AIDS, V14, P251, DOI 10.1097/00002030-200002180-00007; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wolthers KC, 1999, AIDS RES HUM RETROV, V15, P1053, DOI 10.1089/088922299310340; Wolthers KC, 1998, IMMUNOL TODAY, V19, P44, DOI 10.1016/S0167-5699(97)01188-2; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	76	300	308	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					285	289		10.1038/79724	http://dx.doi.org/10.1038/79724			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017098				2022-12-18	WOS:000089869700009
J	Liao, W; Lin, JX; Wang, L; Li, P; Leonard, WJ				Liao, Wei; Lin, Jian-Xin; Wang, Lu; Li, Peng; Leonard, Warren J.			Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages	NATURE IMMUNOLOGY			English	Article							ALPHA-CHAIN EXPRESSION; TH2 DIFFERENTIATION; INTERFERON-GAMMA; BET; INTERLEUKIN-2; PROLIFERATION; LYMPHOCYTES; INDUCTION; SIGNALS; STAT5B	Helper T cells control host defense against pathogens. The receptors for interleukin 12 (IL-12), IL-4 and IL-6 are required for differentiation into the T(H)1, T(H)2 and T(H)17 subsets of helper T cells, respectively. IL-2 signaling via the transcription factor STAT5 controls T(H)2 differentiation by regulating both the T(H)2 cytokine gene cluster and expression of Il4ra, the gene encoding the IL-4 receptor a-chain. Here we show that IL-2 regulated T(H)1 differentiation, inducing STAT5-dependent expression of the IL-12 receptor beta 2-chain (IL-12R beta 2) and the transcription factor T-bet, with impaired human T(H)1 differentiation when IL-2 was blocked. T(H)1 differentiation was also impaired in mouse Il2(-/-) T cells but was restored by IL-12Rb2 expression. Consistent with the inhibition of T(H)17 differentiation by IL-2, treatment with IL-2 resulted in lower expression of the genes encoding the IL-6 receptor a-chain (Il6ra) and the IL-6 signal transducer gp130 (encoded by Il6st), and retroviral transduction of Il6st augmented T(H)17 differentiation even when IL-2 was present. Thus, IL-2 influences helper T cell differentiation by modulating the expression of cytokine receptors to help specify and maintain differentiated states.	[Liao, Wei; Lin, Jian-Xin; Wang, Lu; Li, Peng; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022		Division of Intramural Research of the National Heart, Lung, and Blood Institute (US National Institutes of Health); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005401, ZIAHL005402] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung, and Blood Institute (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Robinson and L. Hennighausen (National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health) for mice with loxP-flanked Stat5a-Stat5b; K. Zhao and D. Schones for discussions; R. H. Schwartz, R. Spolski and Y. Rochman for comments; K. Cui for help in generating ChIP-Seq data; T. A. Waldmann (National Cancer Institute) for anti-human IL-2R alpha (anti-Tac) and IL-2R beta (Mik beta 1); K. Murphy (Washington University St. Louis) for the pRV-Il12rb2 retroviral construct; and J. Zhu (National Institute of Allergy and Infectious Diseases of the US National Institutes of Health) for the pRV-Tbx21 construct. Supported by the Division of Intramural Research of the National Heart, Lung, and Blood Institute (US National Institutes of Health).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Chang JT, 2000, J IMMUNOL, V164, P100, DOI 10.4049/jimmunol.164.1.100; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Maldonado RA, 2009, J EXP MED, V206, P877, DOI 10.1084/jem.20082900; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	35	299	314	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					551	U247		10.1038/ni.2030	http://dx.doi.org/10.1038/ni.2030			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21516110	Green Accepted			2022-12-18	WOS:000290707100016
J	Yarilina, A; Park-Min, KH; Antoniv, T; Hu, XY; Ivashkiv, LB				Yarilina, Anna; Park-Min, Kyung-Hyun; Antoniv, Taras; Hu, Xiaoyu; Ivashkiv, Lionel B.			TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes	NATURE IMMUNOLOGY			English	Article							REGULATORY FACTOR-I; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; IKK-EPSILON; NUCLEAR-FACTOR; BETA; INDUCTION; GAMMA	Rapid induction of inflammatory genes by tumor necrosis factor (TNF) has been well studied, but little is known about delayed and chronic TNF responses. Here we investigated the kinetics of primary macrophage responses to TNF and discovered that TNF initiates an interferon-beta-mediated autocrine loop that sustains expression of inflammatory genes and induces delayed expression of interferon-response genes such as those encoding the transcription factors STAT1 and IRF7, which enhance macrophage responses to stimulation of cytokines and Toll-like receptors. TNF-induced interferon-beta production depended on interferon-response factor 1, and downstream gene expression was mediated by synergy between small amounts of interferon-beta and canonical TNF-induced signals. Thus, TNF activates a 'feed-forward' loop that sustains inflammation but avoids the potential toxicity associated with the high interferon production induced by stimulation of Toll-like receptors.	[Yarilina, Anna; Park-Min, Kyung-Hyun; Antoniv, Taras; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Ivashkiv, Lionel B.] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbiol Pathogenesis, New York, NY 10021 USA	Cornell University	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthritis & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998; Yarilina, Anna/0000-0002-7925-856X	NIAID NIH HHS [AI46712] Funding Source: Medline; NIAMS NIH HHS [AR050401, AR46713] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Antoniv TT, 2006, ARTHRITIS RHEUM, V54, P2711, DOI 10.1002/art.22055; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Elkon KB, 1997, P NATL ACAD SCI USA, V94, P9814, DOI 10.1073/pnas.94.18.9814; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Imanishi D, 2000, J IMMUNOL, V165, P3907, DOI 10.4049/jimmunol.165.7.3907; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MOLDAWER L, 2003, FUNDAMENTAL IMMUNOLO, P749; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; SENGUPTA TK, 1995, J EXP MED, V181, P1015, DOI 10.1084/jem.181.3.1015; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Sweeney SE, 2007, ARTHRITIS RHEUM-US, V56, P743, DOI 10.1002/art.22421; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; van Holten J, 2005, ANN RHEUM DIS, V64, P1780, DOI 10.1136/ard.2005.040477; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	50	299	309	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					378	387		10.1038/ni1576	http://dx.doi.org/10.1038/ni1576			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18345002				2022-12-18	WOS:000254123200013
J	Slifka, MK; Whitton, JL				Slifka, MK; Whitton, JL			Functional avidity maturation of CD8(+)T cells without selection of higher affinity TCR	NATURE IMMUNOLOGY			English	Article							CYTOTOXIC T-LYMPHOCYTES; SIGNAL-TRANSDUCTION; RECEPTOR REPERTOIRE; CHORIOMENINGITIS VIRUS; VIRAL-INFECTION; ANTIGEN; MEMORY; CD8; COMPLEXES; ACTIVATION	Unlike B cells, T cells lack the capacity to improve the affinity of their antigen receptors by somatic mutation. It is, therefore, believed that optimization of cellular immunity is mediated almost exclusively through selective expansion of T cells bearing receptors with the highest affinity for antigen. We show here that T cell responsiveness to peptide (termed "functional avidity") increased > 50-fold during the early stages of viral infection. This indicated that T cells, like B cells, undergo extensive functional maturation in vivo. However, in contrast to B cells, maturation of the T cell response can occur without any appreciable change in T cell receptor affinity.	Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute	Slifka, MK (corresponding author), OHSU, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI027028, R21AI027028, R01AI027028] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000163] Funding Source: Medline; NIAID NIH HHS [R01 AI027028, AI-27028] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1994, SEMIN VIROL, V5, P319, DOI 10.1006/smvy.1994.1035; AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; BUCHMEIER MJ, 1999, PERSISTENT VIRAL INF, P575; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HOLLANDER N, 1982, IMMUNOL REV, V68, P43, DOI 10.1111/j.1600-065X.1982.tb01059.x; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; HORWITZ MS, 1994, J VIROL, V68, P352, DOI 10.1128/JVI.68.1.352-357.1994; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; NAKAYAMA E, 1982, IMMUNOL REV, V68, P117, DOI 10.1111/j.1600-065X.1982.tb01062.x; Nugent CT, 2000, J IMMUNOL, V164, P191, DOI 10.4049/jimmunol.164.1.191; Oehen S, 1998, J IMMUNOL, V161, P5338; OLDSTONE MBA, 1985, BRIT MED BULL, V41, P70, DOI 10.1093/oxfordjournals.bmb.a072029; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Reichstetter S, 2000, J IMMUNOL, V165, P6994, DOI 10.4049/jimmunol.165.12.6994; Salzmann M, 1998, MOL IMMUNOL, V35, P65, DOI 10.1016/S0161-5890(98)00020-0; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Sourdive DJD, 1998, J EXP MED, V188, P71, DOI 10.1084/jem.188.1.71; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whelan JA, 1999, J IMMUNOL, V163, P4342; WHITTON JL, 1990, SEMIN VIROL, V1, P257; Yee C, 1999, J IMMUNOL, V162, P2227; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	46	299	306	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					711	717		10.1038/90650	http://dx.doi.org/10.1038/90650			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477407				2022-12-18	WOS:000170230100013
J	Shibuya, A; Sakamoto, N; Shimizu, Y; Shibuya, K; Osawa, M; Hiroyama, T; Eyre, HJ; Sutherland, GR; Endo, Y; Fujita, T; Miyabayashi, T; Sakano, S; Tsuji, T; Nakayama, E; Phillips, JH; Lanier, LL; Nakauchi, H				Shibuya, A; Sakamoto, N; Shimizu, Y; Shibuya, K; Osawa, M; Hiroyama, T; Eyre, HJ; Sutherland, GR; Endo, Y; Fujita, T; Miyabayashi, T; Sakano, S; Tsuji, T; Nakayama, E; Phillips, JH; Lanier, LL; Nakauchi, H			Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes	NATURE IMMUNOLOGY			English	Article							DILEUCINE MOTIF; POLYMERIC IG; ANTIGEN PRESENTATION; ADHESION MOLECULE; BINDING-SITE; MU-RECEPTOR; CELLS; GAMMA; INTERNALIZATION; SPECIFICITY	IgM is the first antibody to be produced in a humoral immune response and plays an important role in the primary stages of immunity. Here we describe a mouse pc receptor, designated Fc alpha/muR, and its human homolog, that bind both IgM and IgA with intermediate or high affinity. Fc alpha/muR is constitutively expressed on the majority of B lymphocytes and macrophages. Cross-linking Fc alpha/muR expressed on a pro-B cell line Ba/F3 transfectant with soluble IgM or IgM-coated microparticles induced internalization of the receptor. Fc alpha/muR also mediated primary B lymphocyte endocytosis of IgM-coated Staphylococcus aureus. Thus, Fc alpha/muR is involved in the primary stages of the immune response to microbes.	Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; TOREST, JST, Tsukuba, Ibaraki 3058575, Japan; CREST, JST, Tsukuba, Ibaraki 3058575, Japan; Okayama Univ, Sch Med, Dept Med 1, Okayama 7008558, Japan; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA 5006, Australia; Fukushima Med Univ, Dept Biochem 2, Fukushima 9601295, Japan; Asahi Chem Ind Co Ltd, Cent Technol Lab, Res Dept 2, Shizuoka 4168501, Japan; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Tsukuba; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Okayama University; Womens & Childrens Hospital Australia; Fukushima Medical University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shibuya, A (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ashibuya@md.tsukuba.ac.jp	Sakano, Seiji/AAG-1640-2019; Lanier, Lewis L/E-2139-2014; Sutherland, Grant Robert/D-2606-2012	Lanier, Lewis L/0000-0003-1308-3952; 				AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; BAKOS MA, 1991, J IMMUNOL, V147, P3419; BAKOS MA, 1993, J IMMUNOL, V151, P1346; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DAVIS W, 1995, EMBO J, V14, P432, DOI 10.1002/j.1460-2075.1995.tb07019.x; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; ERCOLANI L, 1981, J IMMUNOL, V127, P2044; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; MAO SY, 1991, J IMMUNOL, V146, P958; MATHUR A, 1988, J IMMUNOL, V141, P1855; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; NAKAMURA T, 1993, J IMMUNOL, V151, P6933; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; OHNO T, 1990, J EXP MED, V172, P1165, DOI 10.1084/jem.172.4.1165; PRICOP L, 1993, J IMMUNOL, V151, P3018; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Roe M, 1999, J IMMUNOL, V162, P6046; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; SILVAIN C, 1995, J IMMUNOL, V155, P1606; STIEF A, 1994, J IMMUNOL, V152, P3378; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; WHELAN CA, 1981, IMMUNOL LETT, V3, P249, DOI 10.1016/0165-2478(81)90083-3; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	36	299	313	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					441	446		10.1038/80886	http://dx.doi.org/10.1038/80886			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062505	Green Submitted			2022-12-18	WOS:000165076100018
J	Bal, SM; Bernink, JH; Nagasawa, M; Groot, J; Shikhagaie, MM; Golebski, K; van Drunen, CM; Lutter, R; Jonkers, RE; Hombrink, P; Bruchard, M; Villaudy, J; Munneke, JM; Fokkens, W; Erjefalt, JS; Spits, H; Ros, XR				Bal, Suzanne M.; Bernink, Jochem H.; Nagasawa, Maho; Groot, Jelle; Shikhagaie, Medya M.; Golebski, Kornel; van Drunen, Cornelis M.; Lutter, Rene; Jonkers, Rene E.; Hombrink, Pleun; Bruchard, Melanie; Villaudy, Julien; Munneke, J. Marius; Fokkens, Wytske; Erjefalt, Jonas S.; Spits, Hergen; Ros, Xavier Romero			IL-1 beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs	NATURE IMMUNOLOGY			English	Article							NASAL POLYPS; ASTHMA; EXPRESSION; DUPILUMAB; ADULTS	Group 2 innate lymphoid cells (ILC2s) secrete type 2 cytokines, which protect against parasites but can also contribute to a variety of inflammatory airway diseases. We report here that interleukin 1 beta (IL-1 beta) directly activated human ILC2s and that IL-12 induced the conversion of these activated ILC2s into interferon-gamma (IFN-gamma )-producing ILC1s, which was reversed by IL-4. The plasticity of ILCs was manifested in diseased tissues of patients with severe chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP), which displayed IL-12 or IL-4 signatures and the accumulation of ILC1s or ILC2s, respectively. Eosinophils were a major cellular source of IL-4, which revealed cross-talk between IL-5-producing ILC2s and IL-4-producing eosinophils. We propose that IL-12 and IL-4 govern ILC2 functional identity and that their imbalance results in the perpetuation of type 1 or type 2 inflammation.	[Bal, Suzanne M.; Bernink, Jochem H.; Nagasawa, Maho; Groot, Jelle; Shikhagaie, Medya M.; Golebski, Kornel; Bruchard, Melanie; Spits, Hergen; Ros, Xavier Romero] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Golebski, Kornel; van Drunen, Cornelis M.; Fokkens, Wytske] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene; Jonkers, Rene E.] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hombrink, Pleun] Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Villaudy, Julien] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Munneke, J. Marius] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; [Erjefalt, Jonas S.] Lund Univ, Dept Expt Med Sci, Unit Airway Inflammat, Lund, Sweden	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Lund University	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Bruchard, Melanie/E-6508-2017; Bal, Suzanne/J-1306-2019; Fokkens, Wytske WJ/ABF-2185-2020; Spits, Hergen/N-2581-2019	Bruchard, Melanie/0000-0003-0004-2887; Bal, Suzanne/0000-0002-3133-6450; Spits, Hergen/0000-0003-3269-8338; Shikhagaie, Medya Mara/0000-0003-1978-8048; van Drunen, Cornelis M/0000-0001-5503-066X; Erjefalt, Jonas/0000-0002-6716-3010	European Research Council (Advanced ERC grant-AsthmaVir) [341038]	European Research Council (Advanced ERC grant-AsthmaVir)(European Research Council (ERC))	We thank B. Hooibrink for help with flow cytometry; staff of the Bloemenhove clinic in Heemstede, the Netherlands, for fetal tissues; K. Weijer for processing fetal material; B. Dierdorp and T. Dekker for performing the multiplex assay; E. van Rijnstra for help with the animal experiments; E. de Groot, D. van Egmond and Britt-Marie Nilsson for immunohistochemical staining; C. Loftus (Medetect AB) for computer simulations of spatial cell distributions. Y. Pineros for isolating eosinophils, and J. Fergusson for critical reading of the manuscript. Supported by the European Research Council (Advanced ERC grant 341038-AsthmaVir).	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Hackett TL, 2014, AM J RESP CELL MOL, V51, P830, DOI 10.1165/rcmb.2013-0369OC; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lee BJ, 2011, EXP MOL MED, V43, P169, DOI 10.3858/emm.2011.43.4.018; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Nagakumar P., 2015, J ALLERGY CLIN IMMUN, V137; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P105, DOI 10.2500/ajra.2010.24.3446; Roediger B, 2015, ADV IMMUNOL, V125, P111, DOI 10.1016/bs.ai.2014.09.004; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Southworth T, 2012, BRIT J PHARMACOL, V166, P2070, DOI 10.1111/j.1476-5381.2012.01907.x; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	46	298	310	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					636	+		10.1038/ni.3444	http://dx.doi.org/10.1038/ni.3444			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27111145				2022-12-18	WOS:000376162200008
J	Benoist, C; Mathis, D				Benoist, C; Mathis, D			Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?	NATURE IMMUNOLOGY			English	Review							SURFACE PROTEIN-A; HERPES STROMAL KERATITIS; RESISTANT LYME ARTHRITIS; SIMPLEX VIRUS TYPE-1; BORRELIA-BURGDORFERI; MOLECULAR MIMICRY; DISEASE; IDENTIFICATION; ASSOCIATION; REACTIVITY	Autoimmune diseases remain one of the mysteries that perplex immunologists. What makes the immune system, which has evolved to protect an organism from foreign invaders, turn on the organism itself? A popular answer to this question involves the lymphoid network's primordial function: autoimmunity is a by-product of the immune response to microbial infection. For decades there have been tantalizing associations between infectious agents and autoimmunity: beta -hemolytic streptococci and rheumatic fever; B3 Coxsackieviruses and myocarditis; Trypanosoma cruzi and Chagas' disease; diverse viruses and multiple sclerosis; Borrelia burgdorfii and Lyme arthritis; and B4 Coxsackievirus, cytomegalovirus or rubella and type I diabetes, to name the most frequently cited examples'. In addition, animal models have provided direct evidence that infection with a particular microbe can incite a particular autoimmune disease(2). Nonetheless, many of the associations appear less than convincing and, even for those that seem to be on solid footing' there is no real understanding of the underlying mechanism(s).	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Mathis, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02115 USA.							Akin E, 2001, INFECT IMMUN, V69, P1774, DOI 10.1128/IAI.69.3.1774-1780.2001; AVERY AC, 1995, NATURE, V376, P431, DOI 10.1038/376431a0; Chen J, 1999, ARTHRITIS RHEUM, V42, P1813, DOI 10.1002/1529-0131(199909)42:9&lt;1813::AID-ANR4&gt;3.0.CO;2-0; Deshpande SP, 2001, J VIROL, V75, P3077, DOI 10.1128/JVI.75.7.3077-3088.2001; DUTT JE, 1993, INVEST OPHTH VIS SCI, V34, P1347; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Foster C S, 1987, Trans Am Ophthalmol Soc, V85, P293; Fujinami RS, 2001, J AUTOIMMUN, V16, P229, DOI 10.1006/jaut.2000.0484; Gangappa S, 2000, INVEST OPHTH VIS SCI, V41, P453; Gross DM, 1998, J IMMUNOL, V160, P1022; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Gross DM, 2000, CELL MOL LIFE SCI, V57, P1562, DOI 10.1007/PL00000641; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; Hemmer B, 1999, NAT MED, V5, P1375; KALISH RA, 1995, INFECT IMMUN, V63, P2228, DOI 10.1128/IAI.63.6.2228-2235.1995; KALISH RA, 1993, INFECT IMMUN, V61, P2774, DOI 10.1128/IAI.61.7.2774-2779.1993; Kanangat S, 1996, J IMMUNOL, V156, P1110; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lawson CM, 2000, CELL MOL LIFE SCI, V57, P552, DOI 10.1007/PL00000717; LENGLJANSSEN B, 1994, J EXP MED, V180, P2069, DOI 10.1084/jem.180.6.2069; Maier B, 2000, EUR J IMMUNOL, V30, P448, DOI 10.1002/1521-4141(200002)30:2&lt;448::AID-IMMU448&gt;3.0.CO;2-9; Martin R, 2001, J AUTOIMMUN, V16, P187, DOI 10.1006/jaut.2000.0501; Maverakis E, 2001, J AUTOIMMUN, V16, P201, DOI 10.1006/jaut.2000.0493; Meyer AL, 2000, P NATL ACAD SCI USA, V97, P11433, DOI 10.1073/pnas.190335897; OPREMCAK EM, 1990, INVEST OPHTH VIS SCI, V31, P305; OPREMCAK EM, 1988, INVEST OPHTH VIS SCI, V29, P749; Panoutsakopoulou V, 2001, J AUTOIMMUN, V16, P341, DOI 10.1006/jaut.2000.0480; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Sigal LH, 1999, ARTHRITIS RHEUM, V42, P1809, DOI 10.1002/1529-0131(199909)42:9&lt;1809::AID-ANR3&gt;3.0.CO;2-N; Steere AC, 2001, J AUTOIMMUN, V16, P263, DOI 10.1006/jaut.2000.0495; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 1998, ARTHRITIS RHEUM, V41, pS81; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Trollmo C, 2001, J IMMUNOL, V166, P5286, DOI 10.4049/jimmunol.166.8.5286; Wucherpfennig KW, 2001, J AUTOIMMUN, V16, P293, DOI 10.1006/jaut.2000.0499; YSSEL H, 1991, J EXP MED, V174, P593, DOI 10.1084/jem.174.3.593; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344	41	298	317	0	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					797	801		10.1038/ni0901-797	http://dx.doi.org/10.1038/ni0901-797			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526389				2022-12-18	WOS:000170781200014
J	Glass, CK; Natoli, G				Glass, Christopher K.; Natoli, Gioacchino			Molecular control of activation and priming in macrophages	NATURE IMMUNOLOGY			English	Review							INDUCIBLE GENE-EXPRESSION; TRANSCRIPTION FACTORS; INNATE IMMUNITY; FUNCTIONAL POLARIZATION; NUCLEOSOME OCCUPANCY; ENHANCER RNAS; HUMAN GENOME; CPG ISLANDS; PPAR-GAMMA; CELL-TYPES	In tissues, macrophages are exposed to metabolic, homeostatic and immunoregulatory signals of local or systemic origin that influence their basal functions and responses to danger signals. Signal-transduction pathways regulated by extracellular signals are coupled to distinct sets of broadly expressed stimulus-regulated transcription factors whose ability to elicit gene-expression changes is influenced by the accessibility of their binding sites in the macrophage genome. In turn, accessibility of macrophage-specific transcriptional regulatory elements (enhancers and promoters) is specified by transcription factors that determine the macrophage lineage or impose their tissue-specific properties. Here we review recent findings that advance the understanding of mechanisms underlying priming and signal-dependent activation of macrophages and discuss the effect of genetic variation on these processes.	[Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; IRCCS European Institute of Oncology (IEO)	Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Natoli, gioacchino/ABB-8679-2020; Glass, Christopher/AAI-3933-2021; Natoli, gioacchino/J-2100-2018	Glass, Christopher/0000-0003-4344-3592; Natoli, Gioacchino/0000-0003-0711-2411	NATIONAL CANCER INSTITUTE [R01CA173903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA173903] Funding Source: Medline; NIDDK NIH HHS [P01 DK074868, R01 DK091183] Funding Source: Medline; NIGMS NIH HHS [P50 GM085764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chan CH, 2015, EUR J IMMUNOL, V45, P287, DOI 10.1002/eji.201444862; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li SKH, 2015, MOL CELL BIOL, V35, P1619, DOI 10.1128/MCB.00117-15; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rogatsky I, 2014, MOL CELL, V54, P245, DOI 10.1016/j.molcel.2014.03.038; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	86	297	305	10	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					26	33		10.1038/ni.3306	http://dx.doi.org/10.1038/ni.3306			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681459	Green Accepted			2022-12-18	WOS:000366675800005
J	Tseng, PH; Matsuzawa, A; Zhang, WZ; Mino, T; Vignali, DAA; Karin, M				Tseng, Ping-Hui; Matsuzawa, Atsushi; Zhang, Weizhou; Mino, Takashi; Vignali, Dario A. A.; Karin, Michael			Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; TOLL-LIKE RECEPTORS; TNF-ALPHA; INNATE IMMUNITY; INFLAMMATION; INDUCTION; KINASE; APOPTOSIS; MOLECULE	Balanced production of type I interferons and proinflammatory cytokines after engagement of Toll-like receptors (TLRs), which signal through adaptors containing a Toll-interleukin 1 receptor (TIR) domain, such as MyD88 and TRIF, has been proposed to control the pathogenesis of autoimmune disease and tumor responses to inflammation. Here we show that TRAF3, a ubiquitin ligase that interacts with both MyD88 and TRIF, regulated the production of interferon and proinflammatory cytokines in different ways. Degradative ubiquitination of TRAF3 during MyD88-dependent TLR signaling was essential for the activation of mitogen-activated protein kinases (MAPKs) and production of inflammatory cytokines. In contrast, TRIF-dependent signaling triggered noncanonical TRAF3 self-ubiquitination that activated the interferon response. Inhibition of degradative ubiquitination of TRAF3 prevented the expression of all proinflammatory cytokines without affecting the interferon response.	[Tseng, Ping-Hui; Matsuzawa, Atsushi; Zhang, Weizhou; Mino, Takashi; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Tseng, Ping-Hui; Matsuzawa, Atsushi; Zhang, Weizhou; Mino, Takashi; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Tseng, Ping-Hui] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Matsuzawa, Atsushi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Yang Ming Chiao Tung University; University of Tokyo; St Jude Children's Research Hospital	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Mino, Takashi/GRO-0332-2022; Matsuzawa, Atsushi/GLU-1387-2022	Mino, Takashi/0000-0002-9562-008X; Matsuzawa, Atsushi/0000-0001-8303-3905	National Institutes of Health [AI043477, AI52199]; American Cancer Society; American Lung Association of California; Global Center of Excellence; Toyobo Biotechnology Foundation; National Cancer Institute [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA132586, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI052199, R56AI052199, R21AI052199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Lung Association of California; Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toyobo Biotechnology Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Ichijo (University of Tokyo) for providing A. M. with space and support for some of this work described above; S. Akira (Osaka University) for Myd88<SUP>-/-</SUP> mice; B. Beutler (Scripps Research Institute) for Trif Lps2/ Lps2 mice; R. Fonseca (Mayo Clinic) for multiple myeloma cells; X. Wang (University of Texas Southwestern Medical Center) for SM; H. Wang (St. Jude Children's Research Hospital) for generating monoclonal antibody HWA4C4, specific for K63-linked ubiquitin; I. Verma (Salk Institute) for pLV-CMV-delta 8.2; and Millipore for the antibody to K48-linked polyubiquitin. Supported by the National Institutes of Health (AI043477 to M. K. and AI52199 to D. A. A. V.), the American Cancer Society (M. K.), the American Lung Association of California (P.-H. T.), the Global Center of Excellence program (A. M.), the Toyobo Biotechnology Foundation (T. M.), the National Cancer Institute (CA21765 to D. A. A. V.) and the American Lebanese Syrian Associated Charities (D. A. A. V.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BEAUMELLE BD, 1990, J CELL BIOL, V111, P1811, DOI 10.1083/jcb.111.5.1811; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; JOHNSON GL, 1977, BIOCHEM BIOPH RES CO, V78, P792, DOI 10.1016/0006-291X(77)90249-2; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Werneburg BG, 2001, J BIOL CHEM, V276, P43334, DOI 10.1074/jbc.M104994200; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	43	297	317	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					70	1819		10.1038/ni.1819	http://dx.doi.org/10.1038/ni.1819			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	19898473	Green Accepted			2022-12-18	WOS:000272855300015
J	Rubic, T; Lametschwandtner, G; Jost, S; Hinteregger, S; Kund, J; Carballido-Perrig, N; Schwarzler, C; Junt, T; Voshol, H; Meingassner, JG; Mao, XH; Werner, G; Rot, A; Carballido, JM				Rubic, Tina; Lametschwandtner, Guenther; Jost, Sandra; Hinteregger, Sonja; Kund, Julia; Carballido-Perrig, Nicole; Schwaerzler, Christoph; Junt, Tobias; Voshol, Hans; Meingassner, Josef G.; Mao, Xiaohong; Werner, Gudrun; Rot, Antal; Carballido, Jose M.			Triggering the succinate receptor GPR91 on dendritic cells enhances immunity	NATURE IMMUNOLOGY			English	Article							PROTEIN MICROARRAYS; ADAPTIVE IMMUNITY; LANGERHANS CELLS; DYING CELLS; IN-VITRO; DANGER; ACID; RESPONSES; SIGNAL; MODEL	Succinate acts as an extracellular mediator signaling through the G protein-coupled receptor GPR91. Here we show that dendritic cells had high expression of GPR91. In these cells, succinate triggered intracellular calcium mobilization, induced migratory responses and acted in synergy with Toll-like receptor ligands for the production of proinflammatory cytokines. Succinate also enhanced antigen-specific activation of human and mouse helper T cells. GPR91-deficient mice had less migration of Langerhans cells to draining lymph nodes and impaired tetanus toxoid-specific recall T cell responses. Furthermore, GPR91-deficient allografts elicited weaker transplant rejection than did the corresponding grafts from wild-type mice. Our results suggest that the succinate receptor GPR91 is involved in sensing immunological danger, which establishes a link between immunity and a metabolite of cellular respiration.	[Rubic, Tina; Lametschwandtner, Guenther; Jost, Sandra; Hinteregger, Sonja; Kund, Julia; Carballido-Perrig, Nicole; Schwaerzler, Christoph; Junt, Tobias; Meingassner, Josef G.; Werner, Gudrun; Rot, Antal; Carballido, Jose M.] Novartis Inst Biomed Res, A-1235 Vienna, Austria; [Rubic, Tina; Carballido-Perrig, Nicole; Schwaerzler, Christoph; Junt, Tobias; Voshol, Hans; Carballido, Jose M.] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Mao, Xiaohong] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis; Novartis; Novartis	Carballido, JM (corresponding author), Novartis Inst Biomed Res, A-1235 Vienna, Austria.	jose.carballido@novartis.com	Junt, Tobias/AAE-4389-2021	Rot, Antal/0000-0002-9730-6166				Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Lametschwandtner G, 2004, J ALLERGY CLIN IMMUN, V113, P987, DOI 10.1016/j.jaci.2004.02.004; LARRICK JW, 1980, J IMMUNOL, V125, P6; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MULLERDECKER K, 1994, TOXICOL APPL PHARM, V127, P99, DOI 10.1006/taap.1994.1144; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Parker LC, 2007, CLIN EXP IMMUNOL, V147, P199, DOI 10.1111/j.1365-2249.2006.03203.x; Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E; ROTSTEIN OD, 1985, INFECT IMMUN, V48, P402, DOI 10.1128/IAI.48.2.402-408.1985; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Wulfkuhle JD, 2003, PROTEOMICS, V3, P2085, DOI 10.1002/pmic.200300591; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52	28	297	319	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1261	1269		10.1038/ni.1657	http://dx.doi.org/10.1038/ni.1657			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18820681				2022-12-18	WOS:000260248600013
J	Yano, T; Mita, S; Ohmori, H; Oshima, Y; Fujimoto, Y; Ueda, R; Takada, H; Goldman, WE; Fukase, K; Silverman, N; Yoshimori, T; Kurata, S				Yano, Tamaki; Mita, Shizuka; Ohmori, Hiroko; Oshima, Yoshiteru; Fujimoto, Yukari; Ueda, Ryu; Takada, Haruhiko; Goldman, William E.; Fukase, Koichi; Silverman, Neal; Yoshimori, Tamotsu; Kurata, Shoichiro			Autophagic control of listeria through intracellular innate immune recognition in drosophila	NATURE IMMUNOLOGY			English	Article							HOST-DEFENSE; TOXOPLASMA-GONDII; FAT-BODY; PGRP-LC; PEPTIDOGLYCAN; MONOCYTOGENES; PROTEIN; INFECTION; MACROPHAGES; RECEPTOR	Autophagy, an evolutionally conserved homeostatic process for catabolizing cytoplasmic components, has been linked to the elimination of intracellular pathogens during mammalian innate immune responses. However, the mechanisms underlying cytoplasmic infection-induced autophagy and the function of autophagy in host survival after infection with intracellular pathogens remain unknown. Here we report that in drosophila, recognition of diaminopimelic acid-type peptidoglycan by the pattern-recognition receptor PGRP-LE was crucial for the induction of autophagy and that autophagy prevented the intracellular growth of Listeria monocytogenes and promoted host survival after this infection. Autophagy induction occurred independently of the Toll and IMD innate signaling pathways. Our findings define a pathway leading from the intracellular pattern-recognition receptors to the induction of autophagy to host defense.	[Yano, Tamaki; Mita, Shizuka; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Ohmori, Hiroko; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Ohmori, Hiroko; Yoshimori, Tamotsu] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1030027, Japan; [Fujimoto, Yukari] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Ueda, Ryu] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Takada, Haruhiko] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Goldman, William E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Tohoku University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Worcester	Kurata, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	kurata@mail.pharm.tohoku.ac.jp	Yano, Tamaki/AHB-5620-2022; Fujimoto, Yukari/M-7282-2014	Yano, Tamaki/0000-0002-5576-1128; Silverman, Neal/0000-0002-4259-456X; Goldman, William/0000-0002-1551-6718; Fujimoto, Yukari/0000-0001-5320-3192	NIAID NIH HHS [R56 AI060025, R01 AI060025, AI074958, R01 AI074958, R01 AI060025-04, R01 AI074958-01A1, R01 AI060025-05, AI60025] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060025, R01AI060025, R01AI074958] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KITAURA Y, 1982, J MED CHEM, V25, P335, DOI 10.1021/jm00346a001; KOTANI S, 1975, BIKEN J, V18, P93; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	40	296	304	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					908	916		10.1038/ni.1634	http://dx.doi.org/10.1038/ni.1634			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604211	Green Accepted			2022-12-18	WOS:000257780700014
J	Anderson, HA; Maylock, CA; Williams, JA; Paweletz, CP; Shu, HJ; Shacter, E				Anderson, HA; Maylock, CA; Williams, JA; Paweletz, CP; Shu, HJ; Shacter, E			Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells	NATURE IMMUNOLOGY			English	Article							MACROPHAGE RECOGNITION; VITRONECTIN RECEPTOR; BLOOD-COAGULATION; GENERAL FEATURE; CLEARANCE; GAS6; LYMPHOCYTES; EXPOSURE; ANTIBODIES; INHIBITION	Rapid phagocytosis of apoptotic cells is thought to limit the development of inflammation and autoimmune disease. Serum enhances macrophage phagocytosis of apoptotic cells. Here we identified protein S as the factor responsible for serum-stimulated phagocytosis of apoptotic cells. Protein S is best known for its anti-thrombotic activity, serving as a cofactor for protein C. Purified protein S was equivalent to serum in its ability to stimulate macrophage phagocytosis of apoptotic lymphoma cells, and immunodepletion of protein S eliminated the prophagocytic activity of serum. Protein S acted by binding to phosphatidylserine expressed on the apoptotic cell surface. Protein S is thus a multifunctional protein that can facilitate clearance of early apoptotic cells in addition to regulating blood coagulation.	US FDA, Biochem Lab, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20815 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, Dept Pharmacol, SW Med Ctr, Dallas, TX 75390 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shacter, E (corresponding author), US FDA, Biochem Lab, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA.							Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Anderson HA, 2002, CELL DEATH DIFFER, V9, P616, DOI 10.1038/sj.cdd.4401013; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Carreras LO, 1996, HAEMOSTASIS, V26, P340; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6; ESMON CT, 1989, J BIOL CHEM, V264, P4743; ESMON CT, 1995, CURR BIOL, V5, P743, DOI 10.1016/S0960-9822(95)00150-3; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAY WS, 1985, J MEMBRANE BIOL, V88, P205, DOI 10.1007/BF01871086; Merrill J T, 2001, Curr Rheumatol Rep, V3, P293, DOI 10.1007/s11926-001-0033-2; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Moffatt OD, 1999, J IMMUNOL, V162, P6800; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Rand JH, 2002, CIRC RES, V90, P29, DOI 10.1161/hh0102.102795; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; Stenflo J, 1999, CRIT REV EUKAR GENE, V9, P59, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.50; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Thomas RH, 2001, ARCH INTERN MED, V161, P2433, DOI 10.1001/archinte.161.20.2433; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; WALKER FJ, 1980, J BIOL CHEM, V255, P5521	42	296	304	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					87	91		10.1038/ni871	http://dx.doi.org/10.1038/ni871			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12447359				2022-12-18	WOS:000180053000019
J	Stark, K; Eckart, A; Haidari, S; Tirniceriu, A; Lorenz, M; von Bruhl, ML; Gartner, F; Khandoga, AG; Legate, KR; Pless, R; Hepper, I; Lauber, K; Walzog, B; Massberg, S				Stark, Konstantin; Eckart, Annekathrin; Haidari, Selgai; Tirniceriu, Anca; Lorenz, Michael; von Bruehl, Marie-Luise; Gaertner, Florian; Khandoga, Alexander Georg; Legate, Kyle R.; Pless, Robert; Hepper, Ingrid; Lauber, Kirsten; Walzog, Barbara; Massberg, Steffen			Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs	NATURE IMMUNOLOGY			English	Article							MIGRATION; CELLS; NEUTROPHIL; ADHESION; INFLAMMATION; ACTIVATION; EXPRESSION; RESPONSES; MOLECULE; SYSTEM	Coordinated navigation within tissues is essential for cells of the innate immune system to reach the sites of inflammatory processes, but the signals involved are incompletely understood. Here we demonstrate that NG2(+) pericytes controlled the pattern and efficacy of the interstitial migration of leukocytes in vivo. In response to inflammatory mediators, pericytes upregulated expression of the adhesion molecule ICAM-1 and released the chemoattractant MIF. Arteriolar and capillary pericytes attracted and interacted with myeloid leukocytes after extravasating from postcapillary venules, 'instructing' them with pattern-recognition and motility programs. Inhibition of MIF neutralized the migratory cues provided to myeloid leukocytes by NG2(+) pericytes. Hence, our results identify a previously unknown role for NG2(+) pericytes as an active component of innate immune responses, which supports the immunosurveillance and effector function of extravasated neutrophils and macrophages.	[Stark, Konstantin; Eckart, Annekathrin; Haidari, Selgai; Tirniceriu, Anca; Lorenz, Michael; von Bruehl, Marie-Luise; Gaertner, Florian; Khandoga, Alexander Georg; Legate, Kyle R.; Massberg, Steffen] Univ Munich, Med Klin & Poliklin 1, Klinikum Univ, Munich, Germany; [Stark, Konstantin; Eckart, Annekathrin; Haidari, Selgai; Tirniceriu, Anca; Lorenz, Michael; von Bruehl, Marie-Luise; Gaertner, Florian; Khandoga, Alexander Georg; Legate, Kyle R.; Massberg, Steffen] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Legate, Kyle R.] Univ Munich, Ctr NanoSci, Dept Appl Phys, Munich, Germany; [Pless, Robert] Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; [Hepper, Ingrid; Walzog, Barbara] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Lauber, Kirsten] Univ Munich, Div Mol Oncol, Dept Radiat Oncol, Munich, Germany	University of Munich; German Heart Centre Munich; Technical University of Munich; University of Munich; Washington University (WUSTL); University of Munich; University of Munich	Massberg, S (corresponding author), Univ Munich, Med Klin & Poliklin 1, Klinikum Univ, Munich, Germany.	steffen.massberg@med.uni-muenchen.de	Gaertner, Florian/AAY-1420-2021; Massberg, Steffen/AAN-6054-2021; Stark, Konstantin/AAJ-2815-2020; Gaertner, Florian/GXG-7213-2022; Pless, Robert B/I-4698-2013	Stark, Konstantin/0000-0002-5369-8399; Gaertner, Florian/0000-0001-6120-3723; Legate, Kyle/0000-0003-3243-579X	Collaborative Research Center [SFB 914]; Deutsche Forschungsgemeinschaft Forschergruppe [923]; Framework Programme 7 of the European Union (PRESTIGE); Direct For Computer & Info Scie & Enginr [1111398] Funding Source: National Science Foundation	Collaborative Research Center; Deutsche Forschungsgemeinschaft Forschergruppe(German Research Foundation (DFG)); Framework Programme 7 of the European Union (PRESTIGE); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank A. Suhr, N. Blount and A. Vens for technical assistance; T. Graf (Center for Genomic Regulation) for LysM-eGFP mice; and S. Jung (Weizmann Institute of Science) for CX3CRI-GFP mice. Supported by Collaborative Research Center SFB 914 (S.M., A.G.K., K.L. and B.W), Deutsche Forschungsgemeinschaft Forschergruppe 923 (S.M.) and Framework Programme 7 of the European Union (PRESTIGE; S.M.).	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Balabanov R, 1999, J NEUROSCI RES, V55, P578, DOI 10.1002/(SICI)1097-4547(19990301)55:5<578::AID-JNR5>3.0.CO;2-E; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Edelman DA, 2007, AM J SURG, V193, P730, DOI 10.1016/j.amjsurg.2006.08.086; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Siffrin V, 2009, BRAIN, V132, P1247, DOI 10.1093/brain/awn354; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	44	295	299	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					41	51		10.1038/ni.2477	http://dx.doi.org/10.1038/ni.2477			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23179077				2022-12-18	WOS:000312433800009
J	Goodnow, CC; Vinuesa, CG; Randall, KL; Mackay, F; Brink, R				Goodnow, Christopher C.; Vinuesa, Carola G.; Randall, Katrina L.; Mackay, Fabienne; Brink, Robert			Control systems and decision making for antibody production	NATURE IMMUNOLOGY			English	Review							B-CELL RECEPTOR; PRIMARY IMMUNE-RESPONSE; HELPER T-CELLS; GERMINAL-CENTER; PLASMA-CELLS; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; AFFINITY MATURATION; DENDRITIC CELLS; SELF-TOLERANCE	This paper synthesizes recent progress toward understanding the integrated control systems and fail-safes that guide the quality and quantity of antibody produced by B cells. We focus on four key decisions: (1) the choice between proliferation or death in perifollicular B cells in the first 3 days after antigen encounter; (2) differentiation of proliferating perifollicular B cells into extrafollicular plasma cells or germinal center B cells; (3) positive selection of B cell antigen receptor (BCR) affinity for foreign antigen versus negative selection of BCR affinity for self antigen in germinal center B cells; and (4) survival versus death of antibody-secreting plasma cells. Understanding the engineering of these control systems represents a challenging future step for treating disorders of antibody production in autoimmunity, allergy and immunodeficiency.	[Goodnow, Christopher C.; Vinuesa, Carola G.; Randall, Katrina L.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Randall, Katrina L.] Canberra Hosp, Dept Immunol, Garran, ACT, Australia; [Mackay, Fabienne] Monash Univ, Dept Immunol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Brink, Robert] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Brink, Robert] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital; Monash University; Garvan Institute of Medical Research; University of New South Wales Sydney	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Randall, Katrina L/F-1883-2013; Goodnow, Christopher C/V-8108-2018; Mackay, Fabienne/B-7440-2008; Brink, Robert/B-7910-2010; Vinuesa, Carola G/B-1108-2010	Goodnow, Christopher C/0000-0001-5296-6155; Mackay, Fabienne/0000-0002-6074-2693; Brink, Robert/0000-0002-9586-3655; Vinuesa, Carola G/0000-0001-9799-0298	Australian National Health and Medical Research Council; Australian Research Council; Wellcome Trust; US National Institutes of Health's National Institute of Allergy and Infectious Diseases	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our collaborators and colleagues for input. Supported by the Australian National Health and Medical Research Council, Australian Research Council, Wellcome Trust and US National Institutes of Health's National Institute of Allergy and Infectious Diseases.	Alabyev B, 2007, J IMMUNOL, V178, P5623, DOI 10.4049/jimmunol.178.9.5623; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; DORNA HE, 2009, BLOOD, V113, P3969; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; Ekland EH, 2004, J IMMUNOL, V172, P4700, DOI 10.4049/jimmunol.172.8.4700; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Gatto B, 2008, CURR OPIN INVEST DR, V9, P1216; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow C C, 1989, Semin Immunol, V1, P125; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Huard B, 2004, INT IMMUNOL, V16, P467, DOI 10.1093/intimm/dxh043; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; KRAJEWSKI S, 1994, AM J PATHOL, V145, P515; Kusam S, 2004, ONCOGENE, V23, P839, DOI 10.1038/sj.onc.1207065; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; MOLLER G, 1975, TRANSPLANT REV, V23, P126; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; NOSSAL GJV, 1963, NATURE, V199, P1259, DOI 10.1038/1991259a0; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Phan TG, 2009, CURR OPIN IMMUNOL, V21, P258, DOI 10.1016/j.coi.2009.05.006; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	132	295	299	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					681	688		10.1038/ni.1900	http://dx.doi.org/10.1038/ni.1900			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644574				2022-12-18	WOS:000280149400006
J	Arbibe, L; Kim, DW; Batsche, E; Pedron, T; Mateescu, B; Muchardt, C; Parsot, C; Sansonetti, PJ				Arbibe, Laurence; Kim, Dong Wook; Batsche, Eric; Pedron, Thierry; Mateescu, Bogdan; Muchardt, Christian; Parsot, Claude; Sansonetti, Philippe J.			An injected bacterial effector targets chromatin access for transcription factor NF-kappa B to alter transcription of host genes involved in immune responses	NATURE IMMUNOLOGY			English	Article							MAP KINASE; HISTONE H3; EPITHELIAL-CELLS; PHOSPHOACETYLATION; ACTIVATION; EXPRESSION; SECRETION; PHOSPHORYLATION; PHOSPHATASES; SPECIFICITY	Phosphorylation of histone H3 at Ser10 increases chromatin accessibility to transcription factor NF-kappa B on a subset of genes involved in immune responses. Here we report that a bacterial pathogen abrogated phosphorylation of histone H3 to 'shape' the transcriptional responses of infected host cells. We identify the Shigella flexneri protein effector OspF as a dually specific phosphatase that dephosphorylated mitogen-activated protein kinases in the nucleus, thus preventing histone H3 phosphorylation at Ser10 in a gene-specific way. That activity of OspF enabled shigella to block the activation of a subset of NF-kappa B-responsive genes, leading to compromised recruitment of polymorphonuclear leukocytes to infected tissues. S. flexneri has thus evolved the capacity to precisely modulate host cell epigenetic 'information' as a strategy for repressing innate immunity.	Inst Pasteur, Unite Pathogene Microbienne Mol, F-75724 Paris 15, France; INSERM, U786, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA1644, Dept Dev Biol, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Arbibe, L (corresponding author), Inst Pasteur, Unite Pathogene Microbienne Mol, F-75724 Paris 15, France.	arbibe@pasteur.fr	Mateescu, bogdan/A-3101-2014; Kim, Dong Wook/H-8253-2015; mateescu, bogdan/C-5194-2012	Mateescu, bogdan/0000-0002-0937-352X; Kim, Dong Wook/0000-0001-5351-7597; mateescu, bogdan/0000-0002-0937-352X; Batsche, Eric/0000-0002-5145-5270; Arbibe, Laurence/0000-0001-7102-346X				Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Fahy OL, 2004, LAB INVEST, V84, P1501, DOI 10.1038/labinvest.3700176; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Harper Jane V., 2004, V296, P157; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kennelly PJ, 2001, CHEM REV, V101, P2291, DOI 10.1021/cr0002543; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Muegge K, 2002, NAT IMMUNOL, V3, P16, DOI 10.1038/ni0102-16; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; PERDOMO JJ, 1994, J CLIN INVEST, V93, P633, DOI 10.1172/JCI117015; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Volmat V, 2001, J CELL SCI, V114, P3433; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Xia CL, 2004, FEBS LETT, V561, P217, DOI 10.1016/S0014-5793(04)00157-7; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	40	295	315	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					47	56		10.1038/ni1423	http://dx.doi.org/10.1038/ni1423			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17159983				2022-12-18	WOS:000242934400013
J	Sonnenburg, JL; Angenent, LT; Gordon, JI				Sonnenburg, JL; Angenent, LT; Gordon, JI			Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?	NATURE IMMUNOLOGY			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; BACTEROIDES-THETAIOTAOMICRON; GASTROINTESTINAL-TRACT; ESCHERICHIA-COLI; GENE-EXPRESSION; PHYLOGENETIC ANALYSIS; MICROBIAL ECOSYSTEM; VIRULENCE GENES; HUMAN GUT; FREE MICE	The gut contains our largest collection of resident microorganisms. One obvious question is how microbial communities establish and maintain themselves within a perfused intestine. The answers, which may come in part from observations made by environmental engineers and glycobiologists, have important implications for immunologists who wish to understand how indigenous microbial communities are accommodated. Here we propose that the mucus gel layer overlying the intestinal epithelium is a key contributor to the structural and functional stability of this microbiota and its tolerance by the host.	Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Ctr Genome Sci, St Louis, MO 63110 USA; Washington Univ, Dept Chem Engn, St Louis, MO 63110 USA; Washington Univ, Environm Engn Sci Program, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu	Angenent, Largus T/A-6219-2018	Angenent, Largus T/0000-0003-0180-1865	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIYAMA Y, 1995, PHARMACEUT RES, V12, P397, DOI 10.1023/A:1016208703380; Angenent LT, 2004, ENVIRON MICROBIOL, V6, P315, DOI 10.1111/j.1462-2920.2004.00597.x; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bollinger RR, 2003, IMMUNOLOGY, V109, P580; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Buckley MR, 2003, MICROBIAL COMMUNITIE; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; De Boever P, 2000, J NUTR, V130, P2599; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; HWA V, 1992, APPL ENVIRON MICROB, V58, P869, DOI 10.1128/AEM.58.3.869-876.1992; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; JENSEN ET, 1992, APMIS, V100, P727, DOI 10.1111/j.1699-0463.1992.tb03991.x; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Lee YK, 2004, APPL ENVIRON MICROB, V70, P670, DOI 10.1128/AEM.70.2.670-674.2004; LETTINGA G, 1980, BIOTECHNOL BIOENG, V22, P699, DOI 10.1002/bit.260220402; Macfarlane S, 1997, Adv Dent Res, V11, P59; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; MELULENI GJ, 1995, J IMMUNOL, V155, P2029; Moller S, 1998, APPL ENVIRON MICROB, V64, P721; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Nyholm SV, 2003, APPL ENVIRON MICROB, V69, P3932, DOI 10.1128/AEM.69.7.3932-3937.2003; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Probert H M, 2002, Curr Issues Intest Microbiol, V3, P23; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RITTMANN B, 2000, ENV BIOTECHNOLOGY; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; SALYERS AA, 1988, APPL ENVIRON MICROB, V54, P1970, DOI 10.1128/AEM.54.8.1970-1976.1988; Sarti A, 2001, BIORESOURCE TECHNOL, V78, P231, DOI 10.1016/S0960-8524(01)00025-6; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schreiber S, 1999, INFECT IMMUN, V67, P5151, DOI 10.1128/IAI.67.10.5151-5156.1999; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Stahl D., 2002, MICROBIAL ECOLOGY GE; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walter J, 2003, APPL ENVIRON MICROB, V69, P2044, DOI 10.1128/AEM.69.4.2044-2051.2003; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	53	294	310	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					569	573		10.1038/ni1079	http://dx.doi.org/10.1038/ni1079			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164016				2022-12-18	WOS:000221664000014
J	Naramura, M; Jang, IK; Kole, H; Huang, F; Haines, D; Gu, H				Naramura, M; Jang, IK; Kole, H; Huang, F; Haines, D; Gu, H			c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation	NATURE IMMUNOLOGY			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; ADAPTER PROTEIN SLP-76; NEGATIVE REGULATOR; UBIQUITIN LIGASE; TYROSINE KINASES; RING-TYPE; COMPLEX; ZAP-70; MICE; PHOSPHORYLATION	How Cbl family proteins regulate T cell responses is unclear. We found that c-Cbl Cbl-b double knockout (dKO) T cells became hyperresponsive upon anti-CD3 stimulation, even though the major T cell antigen receptor (TCR) signaling pathways were not enhanced. The dKO T cells did not down-modulate surface TCR after ligand engagement, which resulted in sustained TCR signaling. However, these cells showed normal ligand-independent TCR internalization, and trafficking of internalized TCR to the lysosome compartment after ligand engagement was reduced. These findings show that Cbl family proteins negatively regulate T cell activation by promoting clearance of engaged TCR from the cell surface, a process that is apparently essential for the termination of TCR signals.	NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA; NCI, Pathol Histotechnol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Gu, H (corresponding author), NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA.			Jang, Ihn Kyung/0000-0001-8899-7930; Naramura, Mayumi/0000-0003-3658-0767	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	40	294	308	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1192	1199		10.1038/ni855	http://dx.doi.org/10.1038/ni855			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12415267				2022-12-18	WOS:000179467800018
J	Dick, SA; Macklin, JA; Nejat, S; Momen, A; Clemente-Casares, X; Althagafi, MG; Chen, JM; Kantores, C; Hosseinzadeh, S; Aronoff, L; Wong, A; Zaman, R; Barbu, I; Besla, R; Lavine, KJ; Razani, B; Ginhoux, F; Husain, M; Cybulsky, MI; Robbins, CS; Epelman, S				Dick, Sarah A.; Macklin, Jillian A.; Nejat, Sara; Momen, Abdul; Clemente-Casares, Xavier; Althagafi, Marwan G.; Chen, Jinmiao; Kantores, Crystal; Hosseinzadeh, Siyavash; Aronoff, Laura; Wong, Anthony; Zaman, Rysa; Barbu, Iulia; Besla, Rickvinder; Lavine, Kory J.; Razani, Babak; Ginhoux, Florent; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.; Epelman, Slava			Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; MONOCYTE; IDENTIFICATION; INFLAMMATION; PROGRESSION; DIVERGENT; PATHWAYS; PREVENTS; DYNAMICS; ORIGINS	Macrophages promote both injury and repair after myocardial infarction, but discriminating functions within mixed populations remains challenging. Here we used fate mapping, parabiosis and single-cell transcriptomics to demonstrate that at steady state, TIMD4(+)LYVE1(+)MHC-II(lo)CCR2(-) resident cardiac macrophages self-renew with negligible blood monocyte input. Monocytes partially replaced resident TIMD4(-)LYVE1(-)MHC-II(hi)CCR2(-) macrophages and fully replaced TIMD4(-)LYVE1(-)MHC(-)II(hi)CCR2(+) macrophages, revealing a hierarchy of monocyte contribution to functionally distinct macrophage subsets. Ischemic injury reduced TIMD4(+) and TIMD4(-) resident macrophage abundance, whereas CCR2(+) monocyte-derived macrophages adopted multiple cell fates within infarcted tissue, including those nearly indistinguishable from resident macrophages. Recruited macrophages did not express TIMD4, highlighting the ability of TIMD4 to track a subset of resident macrophages in the absence of fate mapping. Despite this similarity, inducible depletion of resident macrophages using a Cx3cr1-based system led to impaired cardiac function and promoted adverse remodeling primarily within the peri-infarct zone, revealing a nonredundant, cardioprotective role of resident cardiac macrophages.	[Dick, Sarah A.; Macklin, Jillian A.; Nejat, Sara; Momen, Abdul; Clemente-Casares, Xavier; Althagafi, Marwan G.; Kantores, Crystal; Hosseinzadeh, Siyavash; Aronoff, Laura; Wong, Anthony; Zaman, Rysa; Barbu, Iulia; Besla, Rickvinder; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.; Epelman, Slava] UHN, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Dick, Sarah A.; Macklin, Jillian A.; Husain, Mansoor; Epelman, Slava] Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Macklin, Jillian A.; Husain, Mansoor; Epelman, Slava] Univ Toronto, Dept Med, Toronto, ON, Canada; [Macklin, Jillian A.; Althagafi, Marwan G.; Hosseinzadeh, Siyavash; Aronoff, Laura; Besla, Rickvinder; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.; Epelman, Slava] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Chen, Jinmiao; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Chen, Jinmiao; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China; [Wong, Anthony; Zaman, Rysa; Barbu, Iulia; Robbins, Clinton S.; Epelman, Slava] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Lavine, Kory J.; Razani, Babak] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA; [Razani, Babak] John Cochran VA Med Ctr, St Louis, MO USA; [Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.; Epelman, Slava] Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Toronto; Washington University (WUSTL); University of Toronto; Peter Munk Cardiac Centre	Epelman, S (corresponding author), UHN, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Epelman, S (corresponding author), Ted Rogers Ctr Heart Res, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Epelman, S (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON, Canada.	slava.epelman@uhn.ca	Cybulsky, Myron I./AAD-6539-2019; Zaman, Rysa/AAT-5881-2021; Epelman, Slava/AAO-1728-2020; Chen, Jinmiao/ABE-5601-2021; Zaman, Rysa Zuaira/AGY-0565-2022	Zaman, Rysa/0000-0002-0007-4128; Epelman, Slava/0000-0003-3400-4475; Zaman, Rysa Zuaira/0000-0002-0007-4128; Robbins, Clinton/0000-0001-9848-1495; Kantores, Crystal/0000-0003-4530-2371; Macklin, Jillian/0000-0003-0223-6263; Wong, Anthony/0000-0001-6047-8944; Husain, Mansoor/0000-0002-3740-6739; Nejat, Sara/0000-0002-2374-5430; Clemente-Casares, Xavier/0000-0002-8627-4971; Althagafi, Marwan G./0000-0002-7064-3306; chen, jinmiao/0000-0001-7547-6423	Canadian Institutes of Health Research [PJT364831]; Heart and Stroke Foundation; March of Dimes; Ted Rogers Centre for Heart Research; Peter Munk Cardiac Centre; National Institutes of Health [K08HL112826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139714, R01HL138466, K08HL123519] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); March of Dimes(March of Dimes); Ted Rogers Centre for Heart Research; Peter Munk Cardiac Centre(University of Toronto); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Canadian Institutes of Health Research (S.E., PJT364831; J.A.M. and S.A.D.), Heart and Stroke Foundation (S.E.), March of Dimes (S.E.), Ted Rogers Centre for Heart Research (S.E., S.A.D. and J.A.M.), the Peter Munk Cardiac Centre (S.E.) and the National Institutes of Health (S.E. K08HL112826). We thank D. Mann for his insight and advice, and S. Wilson for editorial assistance. Thanks to N. Winegarden and N. Khuu for help with processing single-cell RNA sequencing samples.	Aronoff L, 2018, JOVE-J VIS EXP, V138, P7; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11988; Clemente-Casares X, 2017, IMMUNITY, V47, P974, DOI 10.1016/j.immuni.2017.10.011; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lun Aaron T L, 2016, F1000Res, V5, P2122; Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van der Borght K, 2017, CELL REP, V18, P3005, DOI 10.1016/j.celrep.2017.02.079; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	293	299	14	103	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					29	+		10.1038/s41590-018-0272-2	http://dx.doi.org/10.1038/s41590-018-0272-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538339	Green Accepted			2022-12-18	WOS:000456273900012
J	Ueno, H; Banchereau, J; Vinuesa, CG				Ueno, Hideki; Banchereau, Jacques; Vinuesa, Carola G.			Pathophysiology of T follicular helper cells in humans and mice	NATURE IMMUNOLOGY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CENTER B-CELL; SIMIAN IMMUNODEFICIENCY VIRUS; CHRONIC LYMPHOCYTIC-LEUKEMIA; GERMINAL CENTER FORMATION; PROTEIN-COUPLED RECEPTOR; CXC CHEMOKINE RECEPTOR-5; NONOBESE DIABETIC MICE; MEMORY TFH CELLS; ANTIBODY-RESPONSES	Follicular helper T cells (T-FH cells) compose a heterogeneous subset of CD4(+) T cells that induce the differentiation of B cells into plasma cells and memory cells. They are found within and in proximity to germinal centers in secondary lymphoid organs, and their memory compartment also circulates in the blood. Our knowledge on the biology of T-FH cells has increased significantly during the past decade, largely as a result of mouse studies. However, recent studies on human T-FH cells isolated from lymphoid organ and blood samples and recent observations on the developmental mechanism of human T-FH cells have revealed both similarities and differences between human and mouse T-FH cells. Here we present the similarities and differences between mouse and human lymphoid organ-resident T-FH cells and discuss the role of T-FH cells in response to vaccines and in disease pathogenesis.	[Ueno, Hideki] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Banchereau, Jacques] Hop Henri Mondor, INSERM, U955, Vaccine Res Inst, F-94010 Creteil, France; [Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia	Baylor Scott & White Health; Jackson Laboratory; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Australian National University; John Curtin School of Medical Research	Ueno, H (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	hidekiu@baylorhealth.edu; Jacques.banchereau@Jax.org; carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Ueno, Hideki/L-1237-2016	Vinuesa, Carola G/0000-0001-9799-0298; Ueno, Hideki/0000-0001-7747-0738	US National Institutes of Health [U19-AI057234, U19-AI082715, U19-AI089987]; Alliance for Lupus Research; Australian National Health and Medical Research Council; Baylor Health Care System; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, U19AI089987, U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR070594] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Baylor Health Care System; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the US National Institutes of Health (U19-AI057234, U19-AI082715 and U19-AI089987), the Alliance for Lupus Research, the Baylor Health Care System (H.U.) and the Australian National Health and Medical Research Council (C.G.V.).	Ahearne MJ, 2013, BRIT J HAEMATOL, V162, P360, DOI 10.1111/bjh.12401; Ahlers JD, 2014, DISCOV MED, V17, P187; Akashi T, 1997, INT IMMUNOL, V9, P1159, DOI 10.1093/intimm/9.8.1159; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Cetinozman F, 2012, AM J SURG PATHOL, V36, P109, DOI 10.1097/PAS.0b013e318230df87; Cha ZS, 2013, TUMOR BIOL, V34, P3579, DOI 10.1007/s13277-013-0937-2; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Dubois B, 1998, J IMMUNOL, V161, P2223; Ekland EH, 2004, J IMMUNOL, V172, P4700, DOI 10.4049/jimmunol.172.8.4700; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Federico M, 2013, J CLIN ONCOL, V31, P240, DOI 10.1200/JCO.2011.37.3647; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Glas AM, 2007, J CLIN ONCOL, V25, P390, DOI 10.1200/JCO.2006.06.1648; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; HAN SH, 1995, J IMMUNOL, V155, P556; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Inoue Y, 2007, J IMMUNOL, V179, P764, DOI 10.4049/jimmunol.179.2.764; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Maine CJ, 2014, J IMMUNOL, V192, P1415, DOI 10.4049/jimmunol.1302418; Martini H, 2011, CLIN EXP IMMUNOL, V164, P381, DOI 10.1111/j.1365-2249.2011.04377.x; Mazerolles F., 2013, J ALLERGY CLIN IMMUN, V131, pe1141; Mazerolles F, 2013, J ALLERGY CLIN IMMUN, V131, P1146, DOI 10.1016/j.jaci.2012.12.1519; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Meyerson HJ, 2013, MODERN PATHOL, V26, P32, DOI 10.1038/modpathol.2012.124; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Park JH, 2014, AM J DERMATOPATH, V36, P465, DOI 10.1097/DAD.0b013e3182a72f8c; Pascutti MF, 2013, BLOOD, V122, P3010, DOI 10.1182/blood-2012-11-467670; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; PORWITKSIAZEK A, 1983, SCAND J IMMUNOL, V18, P485, DOI 10.1111/j.1365-3083.1983.tb00882.x; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rawal S, 2013, J IMMUNOL, V190, P6681, DOI 10.4049/jimmunol.1201363; RINGLER DJ, 1989, AM J PATHOL, V134, P373; Pinilla SMR, 2009, AM J SURG PATHOL, V33, P81, DOI 10.1097/PAS.0b013e31818e52fe; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shi WW, 2014, DNA CELL BIOL, V33, P355, DOI 10.1089/dna.2013.2332; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Silva DG, 2011, DIABETES, V60, P2102, DOI 10.2337/db10-1344; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stranger BE, 2012, CURR OPIN IMMUNOL, V24, P544, DOI 10.1016/j.coi.2012.09.002; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; TENNERRACZ K, 1994, RES VIROLOGY, V145, P177, DOI 10.1016/S0923-2516(07)80020-3; VELARDI A, 1986, J IMMUNOL, V137, P2808; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2012, J CLIN INVEST, V122, P3059, DOI 10.1172/JCI65175; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang ZL, 2014, TUMOR BIOL, V35, P9355, DOI 10.1007/s13277-014-2208-2; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zhang M, 2014, EXP NEUROL, V254, P200, DOI 10.1016/j.expneurol.2014.01.024; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	174	293	309	7	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					142	152		10.1038/ni.3054	http://dx.doi.org/10.1038/ni.3054			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594465	Green Accepted			2022-12-18	WOS:000348143100006
J	Chan, CJ; Martinet, L; Gilfillan, S; Souza-Fonseca-Guimaraes, F; Chow, MT; Town, L; Ritchie, DS; Colonna, M; Andrews, DM; Smyth, MJ				Chan, Christopher J.; Martinet, Ludovic; Gilfillan, Susan; Souza-Fonseca-Guimaraes, Fernando; Chow, Melvyn T.; Town, Liam; Ritchie, David S.; Colonna, Marco; Andrews, Daniel M.; Smyth, Mark J.			The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions	NATURE IMMUNOLOGY			English	Article							NECTIN-LIKE PROTEINS; ADHESION RECEPTOR; DENDRITIC CELLS; NK CELLS; T-CELLS; SELF-TOLERANCE; DNAM-1; ACTIVATION; CD155; CYTOTOXICITY	CD96, CD226 (DNAM-1) and TIGIT belong to an emerging family of receptors that interact with nectin and nectin-like proteins. CD226 activates natural killer (NK) cell-mediated cytotoxicity, whereas TIGIT reportedly counterbalances CD226. In contrast, the role of CD96, which shares the ligand CD155 with CD226 and TIGIT, has remained unclear. In this study we found that CD96 competed with CD226 for CD155 binding and limited NK cell function by direct inhibition. As a result, Cd96(-/-) mice displayed hyperinflammatory responses to the bacterial product lipopolysaccharide (LPS) and resistance to carcinogenesis and experimental lung metastases. Our data provide the first description, to our knowledge, of the ability of CD96 to negatively control cytokine responses by NK cells. Blocking CD96 may have applications in pathologies in which NK cells are important	[Chan, Christopher J.; Andrews, Daniel M.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Trescowthick Res Labs, Canc Immunol Program, Cellular Immun Lab, East Melbourne, Vic, Australia; [Chan, Christopher J.; Smyth, Mark J.] Monash Univ, Dept Immunol, Prahran, Vic, Australia; [Martinet, Ludovic; Souza-Fonseca-Guimaraes, Fernando; Chow, Melvyn T.; Town, Liam; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Gilfillan, Susan; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ritchie, David S.] Peter MacCallum Canc Ctr, Hematol Immunol Translat Res Lab, East Melbourne, Vic, Australia; [Ritchie, David S.; Smyth, Mark J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia	Peter Maccallum Cancer Center; Monash University; QIMR Berghofer Medical Research Institute; Washington University (WUSTL); Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Queensland	Smyth, MJ (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Res Labs, Canc Immunol Program, Cellular Immun Lab, East Melbourne, Vic, Australia.	mark.smyth@qimrberghofer.edu.au	Guimarães, Fernando/AAQ-2535-2021; Smyth, Mark J/H-8709-2014; Martinet, ludovic/O-9693-2014	Guimarães, Fernando/0000-0002-2718-8993; Smyth, Mark J/0000-0001-7098-7240; Martinet, ludovic/0000-0002-0867-7724; Andrews, Dan/0000-0002-5896-7885; Colonna, Marco/0000-0001-5222-4987; Souza-Fonseca-Guimaraes, Fernando/0000-0002-2037-8946	Leukaemia Foundation of Australia (C. J. C.); Monash University Faculty of Medicine; National Health and Medical Research Council [1013667, 1044392, 628623]; US National Institutes of Health [P30AR048335]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	Leukaemia Foundation of Australia (C. J. C.); Monash University Faculty of Medicine(Monash University); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Godfrey (University of Melbourne) for CD1d tetramer loaded with alpha-galactosylceramide; J. Sutton and K. Elder for the care and maintenance of the mouse colonies. Supported by the Leukaemia Foundation of Australia (C. J. C.), the Monash University Faculty of Medicine (C. J. C.), the National Health and Medical Research Council (D. M. A. and M. J. S.; 1013667, 1044392 and 628623) and the US National Institutes of Health (P30AR048335 for the Speed Congenics Facility of the Rheumatic Diseases Core Center at the Washington University School of Medicine).	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Anthony DA, 2010, J IMMUNOL, V185, P1794, DOI 10.4049/jimmunol.1000430; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2010, LEUKEMIA, V24, P1607, DOI 10.1038/leu.2010.149; Chan CJ, 2014, CELL DEATH DIFFER, V21, P5, DOI 10.1038/cdd.2013.26; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Croxford JL, 2013, BLOOD, V121, P2512, DOI 10.1182/blood-2012-08-449025; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Sanchez-Correa B, 2012, IMMUNOL CELL BIOL, V90, P109, DOI 10.1038/icb.2011.15; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2010, FEBS LETT, V584, P4895, DOI 10.1016/j.febslet.2010.08.047; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; WANG PL, 1992, J IMMUNOL, V148, P2600; Weber J, 2010, SEMIN ONCOL, V37, P430, DOI 10.1053/j.seminoncol.2010.09.005; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	41	293	320	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					431	438		10.1038/ni.2850	http://dx.doi.org/10.1038/ni.2850			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24658051				2022-12-18	WOS:000334667900008
J	Lanier, LL				Lanier, LL			On guard - activating NK cell receptors	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; PROTEIN-TYROSINE KINASE; DELTA T-CELLS; FC-GAMMA-RIII; PHOSPHATIDYLINOSITOL 3-KINASE; CUTTING EDGE; SIGNAL-TRANSDUCTION; MOLECULAR CHARACTERIZATION; COSTIMULATORY SIGNALS; INHIBITORY RECEPTORS	Although natural killer (NK) cells are known to preferentially kill cells that tack major histocompatibility complex class I antigens, we do not know what signals the attack of these targets. Several membrane receptors have recently been implicated in this process and include molecules with immunoreceptor tyrosine-based activation motifs (ITAM) and motifs that bind phosphoinositide-3 kinase (PI3K). Evidence is emerging that NK cells may use a combination of several receptors and signaling pathways to protect the host against infection and possibly against malignancies.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Calabrese, Massimiliano/I-6195-2012; Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				Algarra I, 2000, HUM IMMUNOL, V61, P65, DOI 10.1016/S0198-8859(99)00156-1; ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; AZUMA M, 1992, J IMMUNOL, V149, P1115; AZZONI L, 1995, J IMMUNOL, V154, P491; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Berg SF, 1998, INT IMMUNOL, V10, P379, DOI 10.1093/intimm/10.4.379; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chalupny J, 2000, FASEB J, V14, pA1018; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chang CW, 1999, J IMMUNOL, V163, P4651; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Colucci F, 1999, J IMMUNOL, V163, P1769; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Galea-Lauri J, 1999, J IMMUNOL, V163, P62; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; George TC, 1999, J IMMUNOL, V163, P1859; Gonzalez-Cabrero J, 1999, P NATL ACAD SCI USA, V96, P1019, DOI 10.1073/pnas.96.3.1019; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; HELDHOF AB, 1995, CANCER RES, V55, P2730; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Hunter CA, 1997, J IMMUNOL, V158, P2285; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Isakov N, 1998, ADV IMMUNOL, V69, P183, DOI 10.1016/S0065-2776(08)60608-2; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; KLAMAN LD, 1995, J VIROL, V69, P871, DOI 10.1128/JVI.69.2.871-881.1995; Kubin MZ, 1999, EUR J IMMUNOL, V29, P3466, DOI 10.1002/(SICI)1521-4141(199911)29:11<3466::AID-IMMU3466>3.0.CO;2-9; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; LANIER LL, 1991, J IMMUNOL, V146, P1571; LANIER LL, 1983, J IMMUNOL, V131, P1789; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; LANIER LL, 1995, J IMMUNOL, V154, P97; Latchman Y, 1998, J IMMUNOL, V161, P5809; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MATHEW PA, 1993, J IMMUNOL, V151, P5328; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nakamura MC, 1999, J IMMUNOL, V163, P4694; NANDI D, 1994, J IMMUNOL, V152, P3361; Ni HT, 1996, J IMMUNOL, V157, P2243; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Olcese L, 1997, J IMMUNOL, V158, P5083; ORTALDO JR, 1995, J EXP MED, V181, P339, DOI 10.1084/jem.181.1.339; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Perussia B, 2000, NAT IMMUNOL, V1, P372, DOI 10.1038/80808; PERUSSIA B, 1983, J IMMUNOL, V130, P2142; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SCHUHMACHERS G, 1995, EUR J IMMUNOL, V25, P1117, DOI 10.1002/eji.1830250440; SEEMAYER TA, 1999, PEDIATR RES, V38, P471; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Smith KM, 1998, J IMMUNOL, V161, P7; SONGYANG Z, 1996, CELL, V72, P767; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; TRUITT KE, 1995, J IMMUNOL, V155, P4702; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Winter CC, 1998, J IMMUNOL, V161, P571; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; YOKOYAMA S, 1991, J IMMUNOL, V146, P2192	100	293	316	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					23	27		10.1038/83130	http://dx.doi.org/10.1038/83130			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135574				2022-12-18	WOS:000166261500010
J	Andrews, DM; Scalzo, AA; Yokoyama, WM; Smyth, MJ; Degli-Esposti, MA				Andrews, DM; Scalzo, AA; Yokoyama, WM; Smyth, MJ; Degli-Esposti, MA			Functional interactions between dendritic cells and NK cells during viral infection	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; MURINE CYTOMEGALOVIRUS-INFECTION; IFN-GAMMA; CD8 EXPRESSION; GENE-COMPLEX; MOUSE THYMUS; RESPONSES; IL-12; RESISTANCE; RECEPTOR	Ly49H(+)NK1.1(+) natural killer (NK) cells are essential for the control of murine cytomegalovirus (MCMV) during the acute stage of infection. This cell subset expands at the later stages of infection in an MCMV-specific fashion. Here we demonstrate a critical interaction between Ly49H(+) NK cells and CD8alpha(+) dendritic cells (DCs) whereby the presence of Ly49H(+) NK cells results in maintenance of CD8alpha(+) DCs in the spleen during acute MCMV infection. Reciprocally, CD8alpha(+) DCs are essential for the expansion of Ly49H(+) NK cells by a mechanism involving interleukin 18 (IL-18) and IL-12. This study provides evidence for a functional interrelationship between DCs and NK cells during viral infection and defines some of the critical cytokines.	Univ Western Australia, Dept Microbiol, Sch Biomed & Chem Sci, Perth, WA 6009, Australia; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA; Peter MacCallum Canc Inst, Canc Immunol Program, Sir Donald & Lady Trescowthick Labs, Melbourne, Vic, Australia	University of Western Australia; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peter Maccallum Cancer Center	Degli-Esposti, MA (corresponding author), Univ Western Australia, Dept Microbiol, Sch Biomed & Chem Sci, Perth, WA 6009, Australia.	mariapia@cyllene.uwa.edu.au	Degli-Esposti, Mariapia/H-9073-2014; Smyth, Mark J/H-8709-2014; Degli-Esposti, Mariapia/E-9529-2013	Smyth, Mark J/0000-0001-7098-7240; Andrews, Dan/0000-0002-5896-7885; Degli-Esposti, Mariapia/0000-0002-7808-5935				ALFORD CA, 1996, VIROLOGY, P629; ALLAN JE, 1984, ARCH VIROL, V81, P139, DOI 10.1007/BF01309303; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BANCROFT GJ, 1981, J IMMUNOL, V126, P988; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1984, J VIROL, V52, P119, DOI 10.1128/JVI.52.1.119-128.1984; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dokun AO, 2001, J IMMUNOL, V167, P5286, DOI 10.4049/jimmunol.167.9.5286; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Forbes CA, 1997, GENOMICS, V41, P406, DOI 10.1006/geno.1997.4667; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Lathbury LJ, 1996, J GEN VIROL, V77, P2605, DOI 10.1099/0022-1317-77-10-2605; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; Martin P, 2002, BLOOD, V99, P1282, DOI 10.1182/blood.V99.4.1282; MESSERLE M, 1992, VIROLOGY, V191, P355, DOI 10.1016/0042-6822(92)90198-X; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Naniche D, 2000, CELL MOL LIFE SCI, V57, P1399, DOI 10.1007/PL00000625; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Reichlin A, 1998, IMMUNOL CELL BIOL, V76, P143, DOI 10.1046/j.1440-1711.1998.00726.x; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; SHELLAM GR, 1981, P NATL ACAD SCI-BIOL, V78, P5104, DOI 10.1073/pnas.78.8.5104; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Stober D, 2001, J IMMUNOL, V167, P957, DOI 10.4049/jimmunol.167.2.957; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; TALMADGE JE, 1980, NATURE, V284, P622, DOI 10.1038/284622a0; TRINCHIERI G, 1995, AM J PATHOL, V147, P1534; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WELSH RM, 1994, NAT IMMUN, V13, P239	47	292	299	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					175	181		10.1038/ni880	http://dx.doi.org/10.1038/ni880			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12496964				2022-12-18	WOS:000180686500018
J	Bonasio, R; Scimone, ML; Schaerli, P; Grabie, N; Lichtman, AH; von Andrian, UH				Bonasio, Roberto; Scimone, M. Lucila; Schaerli, Patrick; Grabie, Nir; Lichtman, Andrew H.; von Andrian, Ulrich H.			Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus	NATURE IMMUNOLOGY			English	Article							COMMON PRECURSOR POPULATION; REGULATORY T-CELLS; EPITHELIAL-CELLS; BONE-MARROW; ADHESION MOLECULE-1; IMMUNE-RESPONSES; LYMPH-NODES; MICE; TOLERANCE; ANTIGEN	Dendritic cell ( DC) presentation of self antigen to thymocytes is essential to the establishment of central tolerance. We show here that circulating DCs were recruited to the thymic medulla through a three-step adhesion cascade involving P-selectin, interactions of the integrin VLA-4 with its ligand VCAM-1, and pertussis toxin-sensitive chemoattractant signaling. Ovalbumin-specific OT-II thymocytes were selectively deleted after intravenous injection of antigen-loaded exogenous DCs. We documented migration of endogenous DCs to the thymus in parabiotic mice and after painting mouse skin with fluorescein isothiocyanate. Antibody to VLA-4 blocked the accumulation of peripheral tissue-derived DCs in the thymus and also inhibited the deletion of OT-II thymocytes in mice expressing membrane-bound ovalbumin in cardiac myocytes. These findings identify a migratory route by which peripheral DCs may contribute to central tolerance.	Harvard Univ, Sch Med, Brigham & Womens Hosp, CBR Inst Biomed Res,Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Immunol Res,Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol,Vasc Res Div, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, CBR Inst Biomed Res,Dept Pathol, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	Bonasio, Roberto/P-1356-2014; von Andrian, Ulrich H/A-5775-2008	Bonasio, Roberto/0000-0002-0767-0889; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, R01HL072056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663, R01AI059610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56949, HL072056] Funding Source: Medline; NIAID NIH HHS [AI059610, AI061663] Funding Source: Medline; NIAMS NIH HHS [AR42689] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; Duncan SR, 2002, J CLIN INVEST, V109, P755, DOI 10.1172/JCI200212142; FARR AG, 1985, J IMMUNOL, V134, P2971; Fong L, 2001, J IMMUNOL, V166, P4254, DOI 10.4049/jimmunol.166.6.4254; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Goldschneider I, 2003, TRENDS IMMUNOL, V24, P77, DOI 10.1016/S1471-4906(02)00038-8; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Volkmann A, 1997, J IMMUNOL, V158, P693; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001	50	291	293	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1092	1100		10.1038/ni1385	http://dx.doi.org/10.1038/ni1385			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16951687				2022-12-18	WOS:000241437100016
J	Anderson, HA; Hiltbold, EM; Roche, PA				Anderson, HA; Hiltbold, EM; Roche, PA			Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; INFLUENZA-VIRUS HEMAGGLUTININ; GPI-ANCHORED PROTEINS; MEMBRANE DOMAINS; PEPTIDE COMPLEXES; CAVEOLAE MEMBRANE; HIGH-AFFINITY; RECEPTOR; MICRODOMAINS; CHOLESTEROL	The plasma membranes of eukaryotic cells are not uniform and possess distinct cholesterol- and sphingolipid-rich raft microdomains that are enriched in proteins known to be essential for cellular function. Lipid raft microdomains are important for T cell receptor (TCR)-mediated activation of T cells. However, the importance of lipid rafts on antigen presenting cells (APCs) and their role in major histocompatibility (MHC) class II-restricted antigen presentation has not been examined. MHC class II molecules were found to be constitutively present in plasma membrane lipid rafts in B cells. Disruption of these microdomains dramatically inhibited antigen presentation at limiting concentrations of antigen. The inhibitory effect of raft disruption on antigen presentation could be overcome by loading the APCs with exceptionally high doses of antigen, showing that raft association concentrates MHC class II molecules into microdomains that allow efficient antigen presentation at low ligand densities.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	NATIONAL CANCER INSTITUTE [Z01BC009404] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson HA, 1998, J IMMUNOL, V160, P4850; Barisas BG, 1999, MOL IMMUNOL, V36, P701, DOI 10.1016/S0161-5890(99)00091-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Glickman JN, 1996, J CELL BIOL, V132, P769, DOI 10.1083/jcb.132.5.769; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Huby RDJ, 1999, J BIOL CHEM, V274, P22591, DOI 10.1074/jbc.274.32.22591; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jenei A, 1997, P NATL ACAD SCI USA, V94, P7269, DOI 10.1073/pnas.94.14.7269; JENKINS MK, 1987, IMMUNOL REV, V95, P113, DOI 10.1111/j.1600-065X.1987.tb00502.x; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; RONCHESE F, 1987, NATURE, V329, P254, DOI 10.1038/329254a0; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang W, 1997, J IMMUNOL, V158, P5797; WATTS TH, 1988, J IMMUNOL, V141, P3708; WATTS TH, 1984, P NATL ACAD SCI-BIOL, V81, P7564, DOI 10.1073/pnas.81.23.7564; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	41	291	296	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					156	162		10.1038/77842	http://dx.doi.org/10.1038/77842			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248809				2022-12-18	WOS:000089814900017
J	Burdette, DL; Vance, RE				Burdette, Dara L.; Vance, Russell E.			STING and the innate immune response to nucleic acids in the cytosol	NATURE IMMUNOLOGY			English	Review							CYCLIC DI-GMP; DNA-DEPENDENT ACTIVATOR; I IFN PRODUCTION; REGULATORY FACTOR; PROTEIN REVEALS; DAI DLM-1/ZBP1; INTERFERON; RECOGNITION; SENSOR; ADAPTER	Cytosolic detection of pathogen-derived nucleic acids is critical for the initiation of innate immune defense against diverse bacterial, viral and eukaryotic pathogens. Conversely, inappropriate responses to cytosolic nucleic acids can produce severe autoimmune pathology. The host protein STING has been identified as a central signaling molecule in the innate immune response to cytosolic nucleic acids. STING seems to be especially critical for responses to cytosolic DNA and the unique bacterial nucleic acids called 'cyclic dinucleotides'. Here we discuss advances in the understanding of STING and highlight the many unresolved issues in the field.	[Burdette, Dara L.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu			US National Institutes of Health [AI091100, AI063302, AI075039, AI082357]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075039, P01AI063302, R21AI082357, F32AI091100] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our colleagues in the field of STING biology and members of the Vance and Barton laboratories for discussions. Supported by the US National Institutes of Health (AI091100 to D.L.B., and AI063302, AI075039 and AI082357 to R.E.V.) and the Burroughs Wellcome Fund (R.E.V.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen QY, 2012, WORLD J GASTROENTERO, V18, P2850, DOI 10.3748/wjg.v18.i22.2850; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; Conrady CD, 2012, MUCOSAL IMMUNOL, V5, P173, DOI 10.1038/mi.2011.63; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Furr SR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-99; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015142; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Lippmann J, 2008, CELL MICROBIOL, V10, P2579, DOI 10.1111/j.1462-5822.2008.01232.x; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Nazmi A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00347; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stein SC, 2012, J VIROL, V86, P4527, DOI 10.1128/JVI.07071-11; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	76	290	324	4	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					19	26		10.1038/ni.2491	http://dx.doi.org/10.1038/ni.2491			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG					2022-12-18	WOS:000312433800006
J	Yang, PY; An, HZ; Liu, XG; Wen, MY; Zheng, YY; Rui, YC; Cao, XT				Yang, Pengyuan; An, Huazhang; Liu, Xingguang; Wen, Mingyue; Zheng, Yuanyuan; Rui, Yaocheng; Cao, Xuetao			The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSES; LEUCINE-RICH REPEAT; RIG-I; TRANSCRIPTION FACTORS; DAI DLM-1/ZBP1; DNA; RECOGNITION; BINDING; ACTIVATION	Intracellular nucleic acid sensors detect microbial RNA and DNA and trigger the production of type I interferon. However, the cytosolic nucleic acid-sensing system remains to be fully identified. Here we show that the cytosolic nucleic acid-binding protein LRRFIP1 contributed to the production of interferon-beta (IFN-beta) induced by vesicular stomatitis virus (VSV) and Listeria monocytogenes in macrophages. LRRFIP1 bound exogenous nucleic acids and increased the expression of IFN-beta induced by both double-stranded RNA and double-stranded DNA. LRRFIP1 interacted with beta-catenin and promoted the activation of beta-catenin, which increased IFN-beta expression by binding to the C-terminal domain of the transcription factor IRF3 and recruiting the acetyltransferase p300 to the IFN-beta enhanceosome via IRF3. Therefore, LRRFIP1 and its downstream partner beta-catenin constitute another coactivator pathway for IRF3-mediated production of type I interferon.	[Yang, Pengyuan; An, Huazhang; Liu, Xingguang; Wen, Mingyue; Zheng, Yuanyuan; Rui, Yaocheng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Yang, Pengyuan; An, Huazhang; Liu, Xingguang; Wen, Mingyue; Zheng, Yuanyuan; Rui, Yaocheng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	anhz@immunol.org; caoxt@immunol.org			National Natural Science Foundation of China [30825036, 30721091]; National Key Basic Research Program of China [2007CB512403]; National Grand Program on Key Infectious Disease [2009ZX10004-309]; Ministry of Education of China [NCET-07-0143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Grand Program on Key Infectious Disease; Ministry of Education of China(Ministry of Education, China)	We thank X. Ma and T. Zuo for technical assistance; W. Pan (Second Military Medical University) for VSV; and H. Shen (University of Pennsylvania School of Medicine) for L. monocytogenes. Supported by the National Natural Science Foundation of China (30825036 and 30721091), the National Key Basic Research Program of China (2007CB512403), the National Grand Program on Key Infectious Disease (2009ZX10004-309) and the Program for New Century Excellent Talents in University of the Ministry of Education of China (NCET-07-0143).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; FERNANDESALNEMR.T, 2010, NAT IMMUNOL; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mokrani H, 2006, MOL CELL BIOL, V26, P8551, DOI 10.1128/MCB.00420-06; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RATHINAM VA, 2010, NAT IMMUNOL; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wilson SA, 1998, NUCLEIC ACIDS RES, V26, P3460, DOI 10.1093/nar/26.15.3460; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	50	290	318	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					487	U50		10.1038/ni.1876	http://dx.doi.org/10.1038/ni.1876			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20453844				2022-12-18	WOS:000277821300009
J	Karaghiosoff, M; Steinborn, R; Kovarik, P; Kriegshauser, G; Baccarini, M; Donabauer, B; Reichart, U; Kolbe, T; Bogdan, C; Leanderson, T; Levy, D; Decker, T; Muller, M				Karaghiosoff, M; Steinborn, R; Kovarik, P; Kriegshauser, G; Baccarini, M; Donabauer, B; Reichart, U; Kolbe, T; Bogdan, C; Leanderson, T; Levy, D; Decker, T; Muller, M			Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; MICE LACKING; CUTTING EDGE; IFN-GAMMA; GENE-EXPRESSION; NITRIC-OXIDE; TRANSCRIPTION FACTORS; INTERLEUKIN-12 IL-12; REGULATORY FACTOR-3	Toll-like receptor-4 activation by lipopolysaccharide (LPS) induces the expression of interferon-P (IFN-beta) in a MyD88-independent manner. Here we report that mice devoid of the JAK protein tyrosine kinase family member, Tyk2, were resistant to shock induced by high doses of LPS. Basal and LPS-induced expression of IFN-beta and IFN-alpha4 mRNA in Tyk2-null macrophages were diminished. However, Tyk2-null mice showed normal systemic production of nitric oxide and proinflammatory cytokines and the in vivo response to tumor necrosis factor (TNF) was unperturbed. IFN-beta-null but not STAT1-null mice were also resistant to high dose LPS treatment. Together, these data suggest that Tyk2 and IFN-beta are essential effectors in LPS induced lethality.	Vet Univ Vienna, Inst Genet & Anim Breeding, A-1210 Vienna, Austria; Ludwig Boltzmann Inst Immunocyto & Mol Genet, A-1210 Vienna, Austria; Vienna Bioctr, Inst Microbiol & Genet, A-1030 Vienna, Austria; ViennaLab Lab Diagnost GmbH, A-1110 Vienna, Austria; IFA Tulln, Dept Biotechnol Anim Prod, A-3430 Tulln, Austria; Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; Lund Univ, Dept Cell & Mol Biol, Immunol Sect, S-22184 Lund, Sweden; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA	University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; Vienna Biocenter (VBC); University of Natural Resources & Life Sciences, Vienna; University of Erlangen Nuremberg; Lund University; New York University; New York University	Muller, M (corresponding author), Vet Univ Vienna, Inst Genet & Anim Breeding, A-1210 Vienna, Austria.	matthias.muellter@vu-wien.ac.at	Levy, David/AAG-6202-2019; Kovarik, Pavel/D-1184-2014; Baccarini, Manuela/B-6481-2014; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; Kovarik, Pavel/0000-0003-2956-0944; Baccarini, Manuela/0000-0002-3033-391X; Muller, Mathias/0000-0002-7879-3552; Reichart, Ursula/0000-0001-9709-0919; Bogdan, Christian/0000-0002-2300-0631				Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Heinzel FP, 1996, J IMMUNOL, V157, P4521; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hochholzer P, 2000, INFECT IMMUN, V68, P3502, DOI 10.1128/IAI.68.6.3502-3508.2000; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hoshino K, 1999, J IMMUNOL, V162, P3749; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kobierski LA, 2000, NEUROSCI LETT, V281, P61, DOI 10.1016/S0304-3940(99)00953-2; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mattner F, 1997, INFECT IMMUN, V65, P4734, DOI 10.1128/IAI.65.11.4734-4737.1997; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Shimoda K, 2002, BLOOD, V99, P2094, DOI 10.1182/blood.V99.6.2094; Shinobu N, 2002, FEBS LETT, V517, P251, DOI 10.1016/S0014-5793(02)02636-4; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	58	290	302	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					471	477		10.1038/ni910	http://dx.doi.org/10.1038/ni910			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12679810				2022-12-18	WOS:000182665400015
J	Hugues, S; Fetler, L; Bonifaz, L; Helft, J; Amblard, F; Amigorena, S				Hugues, S; Fetler, L; Bonifaz, L; Helft, J; Amblard, F; Amigorena, S			Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; ANTIGEN PRESENTATION; IN-VIVO; MOTILITY; DEC-205	Induction of immunity and peripheral tolerance requires contacts between antigen-bearing dendritic cells (DCs) and cognate T cells. Using real-time two-photon microscopy, we have analyzed the dynamics of CD8(+) T cells in lymph nodes during the induction of antigen-specific immunity or tolerance. At 15-20 h after the induction of immunity, T cells stopped moving and established prolonged interactions with DCs. In tolerogenic conditions, despite effective initial T cell activation and proliferation, naive T cells remained motile and established serial brief contacts with multiple DCs. Thus, stable DC-T cell interactions occur during the induction of priming, whereas brief contacts may contribute to the induction of T cell tolerance.	Inst Curie, Inst Natl Sante & Rech Med, U365, F-75248 Paris 05, France; Inst Curie, CNRS, Lab Physicochim Curie, UMR 168, F-75248 Paris 05, France; Rockefeller Univ, Cellular Physiol & Immunol Lab, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Inst Curie, Inst Natl Sante & Rech Med, U520, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Rockefeller University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Amigorena, S (corresponding author), Inst Curie, Inst Natl Sante & Rech Med, U365, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Amblard, Francois/F-4552-2015; Fetler, luc/M-9034-2018	Amblard, Francois/0000-0002-7247-3873; Amigorena, Sebastian/0000-0001-8583-8416; hugues, stephanie/0000-0002-1031-5909; Helft, Julie/0000-0002-2733-1972				Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	18	288	296	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1235	1242		10.1038/ni1134	http://dx.doi.org/10.1038/ni1134			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15516925				2022-12-18	WOS:000225353500012
J	Karp, CL; Flick, LM; Park, KW; Softic, S; Greer, TM; Keledjian, R; Yang, R; Uddin, J; Guggino, WB; Atabani, SF; Belkaid, Y; Xu, Y; Whitsett, JA; Accurso, FJ; Wills-Karp, M; Petasis, NA				Karp, CL; Flick, LM; Park, KW; Softic, S; Greer, TM; Keledjian, R; Yang, R; Uddin, J; Guggino, WB; Atabani, SF; Belkaid, Y; Xu, Y; Whitsett, JA; Accurso, FJ; Wills-Karp, M; Petasis, NA			Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway	NATURE IMMUNOLOGY			English	Article							ANTI-INFLAMMATION; PSEUDOMONAS-AERUGINOSA; LUNG INFECTION; RECEPTOR; ANALOGS; IDENTIFICATION; EPITHELIUM; EXPRESSION; RESOLUTION; RESPONSES	In cystic fibrosis, dysregulated neutrophilic inflammation and chronic infection lead to progressive destruction of the airways. The underlying mechanisms have remained unclear. Lipoxins are anti-inflammatory lipid mediators that modulate neutrophilic inflammation. We report here that lipoxin concentrations in airway fluid were significantly suppressed in patients with cystic fibrosis compared to patients with other inflammatory lung conditions. We also show that administration of a metabolically stable lipoxin analog in a mouse model of the chronic airway inflammation and infection associated with cystic fibrosis suppressed neutrophilic inflammation, decreased pulmonary bacterial burden and attenuated disease severity. These findings suggest that there is a pathophysiologically important defect in lipoxin-mediated anti-inflammatory activity in the cystic fibrosis lung and that lipoxins have therapeutic potential in this lethal autosomal disease.	Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21287 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21287 USA; Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Univ Colorado, Childrens Hosp, Mike McMorris Cyst Fibrosis Res & Treatment Ctr, Hlth Sci Ctr,Dept Pediat, Denver, CO 80218 USA; Cincinnati Childrens Hosp, Med Ctr, Div Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Johns Hopkins University; University of Southern California; Johns Hopkins University; Cincinnati Children's Hospital Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cincinnati Children's Hospital Medical Center	Karp, CL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Petasis, Nicos/B-3162-2009; Softic, Samir/ABD-4612-2020; Yang, Rong/ABA-7587-2021	Petasis, Nicos/0000-0002-8864-4446; Belkaid, Yasmine/0000-0001-9962-3571; , Yan/0000-0003-2025-027X; Softic, Samir/0000-0003-1419-9789; Karp, Christopher/0000-0002-0832-2659; Yang, Rong/0000-0001-8837-0089	NCRR NIH HHS [M01 RR00069] Funding Source: Medline; NHLBI NIH HHS [R01 HL079312] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079312] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS PC, 1982, ANAL BIOCHEM, V127, P346, DOI 10.1016/0003-2697(82)90185-3; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Bonnans C, 2003, J BIOL CHEM, V278, P10879, DOI 10.1074/jbc.M210294200; Bonnans C, 2002, AM J RESP CRIT CARE, V165, P1531, DOI 10.1164/rccm.200201-053OC; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Fierro IM, 2001, BRAZ J MED BIOL RES, V34, P555, DOI 10.1590/S0100-879X2001000500002; Freedman S D, 2000, Curr Opin Pulm Med, V6, P530, DOI 10.1097/00063198-200011000-00012; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; HOPEN UE, 1996, NATURE, V383, P25; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lynch KR, 1999, NATURE, V399, P789; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; Muhlebach MS, 2002, AM J RESP CRIT CARE, V165, P911, DOI 10.1164/ajrccm.165.7.2107114; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; ROSENBERG HF, 1999, FUNDAMENTAL IMMUNOLO, P1051; Sanak M, 2000, EUR RESPIR J, V16, P44, DOI 10.1034/j.1399-3003.2000.16a08.x; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, E SCHERING RES FDN W, V31, P143; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; SERHAN CN, 2002, PROSTAG OTH LIPID M, V69, P433; Stotland PK, 2000, PEDIATR PULM, V30, P413, DOI 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; van Heeckeren AM, 2002, LAB ANIM-UK, V36, P291, DOI 10.1258/002367702320162405; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; WELCH WJ, 2001, METABOLIC MOL BASES, P521; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200	38	288	309	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					388	392		10.1038/ni1056	http://dx.doi.org/10.1038/ni1056			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15034576				2022-12-18	WOS:000220515900011
J	Li, PW; Morris, DL; Willcox, BE; Steinle, A; Spies, T; Strong, RK				Li, PW; Morris, DL; Willcox, BE; Steinle, A; Spies, T; Strong, RK			Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; DELTA T-CELLS; CRYSTAL-STRUCTURE; INHIBITORY RECEPTOR; HLA-E; RECOGNITION; BINDING; MOLECULES; EXPRESSION; PROTEINS	The major histocompatibility complex (MHC) class I homolog, MICA, is a stress-inducible ligand for NKG2D, a C-type lectin-like activating immunoreceptor,The crystal structure of this ligand-receptor complex that we report here reveals an NKG2D homodimer bound to a MICA monomer in an interaction that is analogous to that seen in T cell receptor-MHC class I protein complexes. Similar surfaces on each NKG2D monomer interact with different surfaces on either the alpha1 or alpha2 domains of MICA.The binding interactions are large in area and highly complementary.The central section of the alpha2-domain helix, disordered in the structure of MICA alone, is ordered in the complex and forms part of the NKG2D interface.The extensive flexibility of the interdomain linker of MICA is shown by its altered conformation when crystallized alone or in complex with NKG2D.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; California Institute of Technology; Fred Hutchinson Cancer Center	Strong, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98109 USA.		Steinle, Alexander/E-6131-2012	Steinle, Alexander/0000-0001-5081-8503	NCI NIH HHS [CA18221] Funding Source: Medline; NIAID NIH HHS [AI30581, AI42200] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030581, R01AI030581, R01AI042200] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1998, ACTA CRYSTALLOGR D, V54, P451, DOI 10.1107/S0907444997015229; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lopez-Botet M, 1999, CURR OPIN IMMUNOL, V11, P301, DOI 10.1016/S0952-7915(99)80048-X; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Steinle A, 1998, P NATL ACAD SCI USA, V95, P12510, DOI 10.1073/pnas.95.21.12510; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	53	288	327	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					443	451		10.1038/87757	http://dx.doi.org/10.1038/87757			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323699				2022-12-18	WOS:000168549800018
J	Arazi, A; Rao, DA; Berthier, CC; Davidson, A; Liu, YY; Hoover, PJ; Chicoine, A; Eisenhaure, TM; Jonsson, AH; Li, SQ; Lieb, DJ; Zhang, F; Slowikowski, K; Browne, EP; Noma, A; Sutherby, D; Steelman, S; Smilek, DE; Tosta, P; Apruzzese, W; Massarotti, E; Dall'Era, M; Park, M; Kamen, DL; Furie, RA; Payan-Schober, F; Pendergraft, WF; McInnis, EA; Buyon, JP; Petri, MA; Putterman, C; Kalunian, KC; Woodle, ES; Lederer, JA; Hildeman, DA; Nusbaum, C; Raychaudhuri, S; Kretzler, M; Anolik, JH; Brenner, MB; Wofsy, D; Hacohen, N; Diamond, B; Waguespack, D; Connery, SM; McMahon, MA; McCune, WJ; Kado, RB; Hsu, R; Cunningham, MA; Utz, PJ; Pichavant, M; Maecker, HT; Gupta, R; James, JA; Guthridge, JM; Fonseka, C; Der, E; Clancy, R; Tuschl, T; Suryawanshi, H; Fava, A; Goldman, DH				Arazi, Arnon; Rao, Deepak A.; Berthier, Celine C.; Davidson, Anne; Liu, Yanyan; Hoover, Paul J.; Chicoine, Adam; Eisenhaure, Thomas M.; Jonsson, A. Helena; Li, Shuqiang; Lieb, David J.; Zhang, Fan; Slowikowski, Kamil; Browne, Edward P.; Noma, Akiko; Sutherby, Danielle; Steelman, Scott; Smilek, Dawn E.; Tosta, Patti; Apruzzese, William; Massarotti, Elena; Dall'Era, Maria; Park, Meyeon; Kamen, Diane L.; Furie, Richard A.; Payan-Schober, Fernanda; Pendergraft, William F., III; McInnis, Elizabeth A.; Buyon, Jill P.; Petri, Michelle A.; Putterman, Chaim; Kalunian, Kenneth C.; Woodle, E. Steve; Lederer, James A.; Hildeman, David A.; Nusbaum, Chad; Raychaudhuri, Soumya; Kretzler, Matthias; Anolik, Jennifer H.; Brenner, Michael B.; Wofsy, David; Hacohen, Nir; Diamond, Betty; Waguespack, Dia; Connery, Sean M.; McMahon, Maureen A.; McCune, William J.; Kado, Ruba B.; Hsu, Raymond; Cunningham, Melissa A.; Utz, Paul J.; Pichavant, Mina; Maecker, Holden T.; Gupta, Rohit; James, Judith A.; Guthridge, Joel M.; Fonseka, Chamith; der, Evan; Clancy, Robert; Tuschl, Thomas; Suryawanshi, Hemant; Fava, Andrea; Goldman, Daniel H.		Accelerating Medicines Partnershi	The immune cell landscape in kidneys of patients with lupus nephritis	NATURE IMMUNOLOGY			English	Article							STAGE RENAL-DISEASE; SELF-RENEWAL; B-CELL; EXPRESSION; AUTOIMMUNITY; EXHAUSTION; PHENOTYPE; GATEWAYS; C1Q	Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, Tcells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.	[Arazi, Arnon; Hoover, Paul J.; Eisenhaure, Thomas M.; Li, Shuqiang; Lieb, David J.; Noma, Akiko; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA USA; [Arazi, Arnon; Rao, Deepak A.; Liu, Yanyan; Chicoine, Adam; Jonsson, A. Helena; Zhang, Fan; Slowikowski, Kamil; Apruzzese, William; Massarotti, Elena; Raychaudhuri, Soumya; Brenner, Michael B.; Fonseka, Chamith] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Rheumatol,Immunol,Allergy, Boston, MA 02115 USA; [Berthier, Celine C.; Kretzler, Matthias; McCune, William J.; Kado, Ruba B.] Univ Michigan, Dept Nephrol, Internal Med, Ann Arbor, MI 48109 USA; [Davidson, Anne; Diamond, Betty] Northwell Hlth, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Browne, Edward P.] Univ N Carolina, UNC HIV Cure Ctr, Chapel Hill, NC USA; [Browne, Edward P.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Sutherby, Danielle] Celsius Therapeut, Cambridge, MA USA; [Steelman, Scott; Nusbaum, Chad] Cellarity Inc, Cambridge, MA USA; [Smilek, Dawn E.; Tosta, Patti] Univ Calif San Francisco, Lupus Nephritis Trials Network, San Francisco, CA 94143 USA; [Smilek, Dawn E.; Tosta, Patti] Univ Calif San Francisco, Immune Tolerance Network, San Francisco, CA 94143 USA; [Dall'Era, Maria; Wofsy, David] Univ Calif San Francisco, Rheumatol Div, San Francisco, CA 94143 USA; [Park, Meyeon; Hsu, Raymond] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Kamen, Diane L.; Cunningham, Melissa A.] Med Univ South Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Furie, Richard A.] Northwell Hlth, Div Rheumatol, Great Neck, NY USA; [Payan-Schober, Fernanda; Connery, Sean M.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Med, El Paso, TX USA; [Pendergraft, William F., III] PLLC, Integrat Med Clin North Carolina, Chapel Hill, NC USA; [McInnis, Elizabeth A.] UNC, Sch Med, Dept Med, Kidney Ctr,Div Nephrol & Hypertens, Chapel Hill, NC USA; [Buyon, Jill P.; Clancy, Robert] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA; [Petri, Michelle A.; Fava, Andrea; Goldman, Daniel H.] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [Putterman, Chaim; der, Evan] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10467 USA; [Putterman, Chaim; der, Evan] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Putterman, Chaim; der, Evan] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Kalunian, Kenneth C.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Woodle, E. Steve] Univ Cincinnati, Coll Med, Dept Surg, Div Transplantat, Cincinnati, OH USA; [Lederer, James A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Hildeman, David A.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Hildeman, David A.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Anolik, Jennifer H.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Waguespack, Dia] Univ Texas Houston, Dept Internal Med, Houston, TX USA; [McMahon, Maureen A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Utz, Paul J.; Pichavant, Mina] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Maecker, Holden T.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Gupta, Rohit] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [James, Judith A.; Guthridge, Joel M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Tuschl, Thomas; Suryawanshi, Hemant] Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10021 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan; Northwell Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Immune Tolerance Network; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical University of South Carolina; Northwell Health; Texas Tech University System; Texas Tech University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; New York University; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Rochester; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University; Oklahoma Medical Research Foundation; Rockefeller University	Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Diamond, B (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	nhacohen@mgh.harvard.edu; BDiamond@northwell.edu	Fava, Andrea/AAF-8515-2019; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Kalunian, Kenneth/AAK-6424-2020; Hildeman, David/AAA-1757-2020; Slowikowski, Kamil/K-3728-2016; Zhang, Fan/ABD-7525-2021; Putterman, Chaim/AFR-0429-2022; Woodle, E. Steve/N-8059-2013	Fava, Andrea/0000-0001-6738-4836; Hildeman, David/0000-0002-0421-8483; Slowikowski, Kamil/0000-0002-2843-6370; Zhang, Fan/0000-0002-6102-2970; Woodle, E. Steve/0000-0003-4280-0842; Buyon, Jill/0000-0002-3852-7129; Raychaudhuri, Soumya/0000-0002-1901-8265; Jonsson, Anna Helena/0000-0002-9558-2474; Kalunian, Kenneth/0000-0003-0261-3102; Cunningham, Melissa/0000-0002-9207-1986; Anolik, Jennifer/0000-0002-1450-1549; Eisenhaure, Thomas/0000-0003-3999-3540	Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; AbbVie Inc.; Arthritis Foundation; Foundation for the National Institutes of Health; Lupus Foundation of America; Lupus Research Alliance; Merck Sharp Dohme Corp.; National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Pfizer Inc., Rheumatology Research Foundation; Takeda Pharmaceuticals International, Inc.; National Institutes of Health [UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694, UM2-AR067678]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067688, UH2AR067677] Funding Source: NIH RePORTER	Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; AbbVie Inc.(AbbVie); Arthritis Foundation; Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of America; Lupus Research Alliance; Merck Sharp Dohme Corp.(Merck & Company); National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Pfizer Inc., Rheumatology Research Foundation(Pfizer); Takeda Pharmaceuticals International, Inc.(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network. AMP is a public-private partnership (AbbVie Inc., Arthritis Foundation, Bristol-Myers Squibb Company, Foundation for the National Institutes of Health, Janssen Pharmaceuticals, Lupus Foundation of America, Lupus Research Alliance, Merck Sharp & Dohme Corp., National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Pfizer Inc., Rheumatology Research Foundation, Sanofi and Takeda Pharmaceuticals International, Inc.) created to develop new ways of identifying and validating promising biological targets for diagnostics and drug development. Funding was provided through grants from the National Institutes of Health (UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694 and UM2-AR067678). N. H. was supported by the David P. Ryan, MD Endowed Chair in Cancer Research. We thank participating Lupus Nephritis Trials Network clinical sites and participants.	Adamson SE, 2016, J CLIN INVEST, V126, P1311, DOI 10.1172/JCI79590; Allan DSJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03256-0; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Banchereau R, 2016, CELL, V165, P1548, DOI 10.1016/j.cell.2016.05.057; Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Chen LY, 2017, CURR OPIN RHEUMATOL, V29, P423, DOI 10.1097/BOR.0000000000000411; Chung SA, 2014, J AM SOC NEPHROL, V25, P2859, DOI 10.1681/ASN.2013050446; Costenbader KH, 2011, ARTHRITIS RHEUM-US, V63, P1681, DOI 10.1002/art.30293; Davidson A, 2016, NAT REV RHEUMATOL, V12, P143, DOI 10.1038/nrrheum.2015.159; Davidson A, 2014, ARTHRITIS RHEUMATOL, V66, P3251, DOI 10.1002/art.38885; Dehn S, 2018, FASEB J, V32, P254, DOI 10.1096/fj.201700450R; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Ghebrehiwet B, 2017, MOL IMMUNOL, V84, P26, DOI 10.1016/j.molimm.2016.11.003; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hua ZL, 2013, CELL MOL IMMUNOL, V10, P103, DOI 10.1038/cmi.2012.61; Huen SC, 2017, ANNU REV PHYSIOL, V79, P449, DOI 10.1146/annurev-physiol-022516-034219; Hulsebus HJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00230; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Ikezumi Y, 2005, NEPHROL DIAL TRANSPL, V20, P2704, DOI 10.1093/ndt/gfi105; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; Kreslavsky T, 2017, NAT IMMUNOL, V18, P442, DOI 10.1038/ni.3694; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Madan-Lala R, 2014, J IMMUNOL, V192, P4263, DOI 10.4049/jimmunol.1303185; Matsuda S, 2017, J IMMUNOL, V199, P2316, DOI 10.4049/jimmunol.1700719; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Myles A, 2017, CELL IMMUNOL, V321, P3, DOI 10.1016/j.cellimm.2017.09.004; Narain S, 2016, CURR OPIN RHEUMATOL, V28, P469, DOI 10.1097/BOR.0000000000000311; Nemesh J, 2016, DROP SEQ CORE COMPUT; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tektonidou MG, 2016, ARTHRITIS RHEUMATOL, V68, P1432, DOI 10.1002/art.39594; Thanou A, 2014, NAT REV RHEUMATOL, V10, P23, DOI 10.1038/nrrheum.2013.145; Tilstra JS, 2018, J CLIN INVEST, V128, P4884, DOI 10.1172/JCI120859; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varghese B, 2016, INFLAMMATION, V39, P1345, DOI 10.1007/s10753-016-0366-7; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1589, DOI 10.1002/art.33488; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114	58	287	292	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					902	+		10.1038/s41590-019-0398-x	http://dx.doi.org/10.1038/s41590-019-0398-x			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31209404	Green Accepted, Green Submitted			2022-12-18	WOS:000471891900020
J	Gerriets, VA; Kishton, RJ; Johnson, M; Cohen, S; Siska, PJ; Nichols, AG; Warmoes, MO; de Cubas, AA; Maclver, NJ; Locasale, JW; Turka, LA; Wells, AD; Rathmell, JC				Gerriets, Valerie A.; Kishton, Rigel J.; Johnson, Marc O.; Cohen, Sivan; Siska, Peter J.; Nichols, Amanda G.; Warmoes, Marc O.; de Cubas, Aguirre A.; Maclver, Nancie J.; Locasale, Jason W.; Turka, Laurence A.; Wells, Andrew D.; Rathmell, Jeffrey C.			Foxp3 and Toll-like receptor signaling balance T-reg cell anabolic metabolism for suppression	NATURE IMMUNOLOGY			English	Article							ACTIVATION; AKT; DIFFERENTIATION; INFLAMMATION; EXPRESSION; TOLERANCE; PROMOTES; KINASE; GLUT1	CD4(+) effector T cells (T-eff cells) and regulatory T cells (T-reg cells) undergo metabolic reprogramming to support proliferation and immunological function. Although signaling via the lipid kinase PI(3)K (phosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase complex mTORC1 induces both expression of the glucose transporter Glut1 and aerobic glycolysis for T-eff cell proliferation and inflammatory function, the mechanisms that regulate T-reg cell metabolism and function remain unclear. We found that Toll-like receptor (TLR) signals that promote T-reg cell proliferation increased PI(3)K-Akt-mTORC1 signaling, glycolysis and expression of Glut1. However, TLR-induced mTORC1 signaling also impaired T-reg cell suppressive capacity. Conversely, the transcription factor Foxp3 opposed PI(3)K-Akt-mTORC1 signaling to diminish glycolysis and anabolic metabolism while increasing oxidative and catabolic metabolism. Notably, Glut1 expression was sufficient to increase the number of T-reg cells, but it reduced their suppressive capacity and Foxp3 expression. Thus, inflammatory signals and Foxp3 balance mTORC1 signaling and glucose metabolism to control the proliferation and suppressive function of Treg cells.	[Gerriets, Valerie A.; Kishton, Rigel J.; Johnson, Marc O.; Cohen, Sivan; Nichols, Amanda G.; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Johnson, Marc O.; Siska, Peter J.; Rathmell, Jeffrey C.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Vanderbilt Ctr Immunobiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Johnson, Marc O.] Univ Kentucky, Dept Toxicol & Canc Biol, Ctr Environm & Syst Biochem, Lexington, KY USA; [Johnson, Marc O.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [de Cubas, Aguirre A.] Vanderbilt Univ, Div Hematol & Oncol, Dept Med, Med Ctr, Nashville, TN USA; [Maclver, Nancie J.] Duke Univ, Div Pediat Endocrinol & Diabet, Durham, NC USA; [Turka, Laurence A.] Massachusetts Gen Hosp, Ctr Transplantat Sci, Boston, MA 02114 USA; [Wells, Andrew D.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wells, Andrew D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Duke University; Vanderbilt University; University of Kentucky; University of Kentucky; Vanderbilt University; Duke University; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Rathmell, JC (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Vanderbilt Ctr Immunobiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	jeff.rathmell@vanderbilt.edu	Locasale, Jason W/ABE-6505-2020; Gerriets, Valerie/AAD-6611-2019	Locasale, Jason W/0000-0002-7766-3502; Warmoes, Marc/0000-0002-6632-3764; Siska, Peter/0000-0002-1521-6213; MacIver, Nancie/0000-0003-3676-9391; Gerriets, Valerie/0000-0002-1553-2590	Crohn's and Colitis Foundation of America; Alliance for Lupus Research; US National Institutes of Health [R01HL 108006, R01105550DK, P01HL018646, F31CA183529, R00CA168997, R01AI070807, P01AI073489]; German Research Foundation (Deutsche Forschungsgemeinschaft); NATIONAL CANCER INSTITUTE [T32CA009582, R00CA168997, F31CA183529] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006, P01HL018646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070807, P01AI056299, P01AI073489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Alliance for Lupus Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Rathmell and Wells laboratories for discussions, and the Immunological Genome Project. Supported by the Crohn's and Colitis Foundation of America (Senior Research Grant to J.C.R.), the Alliance for Lupus Research (J.C.R.), the US National Institutes of Health (R01HL 108006 and R01105550DK to J.C.R.; P01HL018646 to L.A.T. and J.C.R.; F31CA183529 to R.J.K.; R00CA168997 to J.W.L.; and R01AI070807 and P01AI073489 to A.D.W.), and the German Research Foundation (Deutsche Forschungsgemeinschaft; P.J.S.).	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Basu S, 2015, J LEUKOCYTE BIOL, V97, P279, DOI 10.1189/jlb.2AB0514-273RR; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Byng-Maddick R, 2015, RHEUMATOLOGY, V54, P768, DOI 10.1093/rheumatology/keu487; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Leifer C. A., J LEUKOC BIOL; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Ohl K, 2015, EUR J IMMUNOL, V45, P344, DOI 10.1002/eji.201344280; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	45	287	300	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1459	1466		10.1038/ni.3577	http://dx.doi.org/10.1038/ni.3577			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27695003	Green Accepted			2022-12-18	WOS:000388056400016
J	Boisson, B; Laplantine, E; Prando, C; Giliani, S; Israelsson, E; Xu, ZH; Abhyankar, A; Israel, L; Trevejo-Nunez, G; Bogunovic, D; Cepika, AM; MacDuff, D; Chrabieh, M; Hubeau, M; Bajolle, F; Debre, M; Mazzolari, E; Vairo, D; Agou, F; Virgin, HW; Bossuyt, X; Rambaud, C; Facchetti, F; Bonnet, D; Quartier, P; Fournet, JC; Pascual, V; Chaussabel, D; Notarangelo, LD; Puel, A; Israel, A; Casanova, JL; Picard, C				Boisson, Bertrand; Laplantine, Emmanuel; Prando, Carolina; Giliani, Silvia; Israelsson, Elisabeth; Xu, Zhaohui; Abhyankar, Avinash; Israel, Laura; Trevejo-Nunez, Giraldina; Bogunovic, Dusan; Cepika, Alma-Martina; MacDuff, Donna; Chrabieh, Maya; Hubeau, Marjorie; Bajolle, Fanny; Debre, Marianne; Mazzolari, Evelina; Vairo, Donatella; Agou, Fabrice; Virgin, Herbert W.; Bossuyt, Xavier; Rambaud, Caroline; Facchetti, Fabio; Bonnet, Damien; Quartier, Pierre; Fournet, Jean-Christophe; Pascual, Virginia; Chaussabel, Damien; Notarangelo, Luigi D.; Puel, Anne; Israel, Alain; Casanova, Jean-Laurent; Picard, Capucine			Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; ANHIDROTIC ECTODERMAL DYSPLASIA; PYOGENIC BACTERIAL-INFECTIONS; SEQUENCING-BASED DISCOVERY; CHAIN ASSEMBLY COMPLEX; GLYCOGENOSIS TYPE-IV; LAFORA DISEASE; MYD88 DEFICIENCY; SHARPIN; INFLAMMATION	We report the clinical description and molecular dissection of a new fatal human inherited disorder characterized by chronic autoinflammation, invasive bacterial infections and muscular amylopectinosis. Patients from two kindreds carried biallelic loss-of-expression and loss-of-function mutations in HOIL1 (RBCK1), a component of the linear ubiquitination chain assembly complex (LUBAC). These mutations resulted in impairment of LUBAC stability. NF-kappa B activation in response to interleukin 1 beta (IL-1 beta) was compromised in the patients' fibroblasts. By contrast, the patients' mononuclear leukocytes, particularly monocytes, were hyper-responsive to IL-1 beta. The consequences of human HOIL-1 and LUBAC deficiencies for IL-1 beta responses thus differed between cell types, consistent with the unique association of autoinflammation and immunodeficiency in these patients. These data suggest that LUBAC regulates NF-kappa B-dependent IL-1 beta responses differently in different cell types.	[Boisson, Bertrand; Prando, Carolina; Abhyankar, Avinash; Trevejo-Nunez, Giraldina; Bogunovic, Dusan; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Laplantine, Emmanuel; Israel, Alain] CNRS, Unite Rech Assoc URA 2582, Lab Mol Signaling & Cell Activat, Inst Pasteur, Paris, France; [Giliani, Silvia; Mazzolari, Evelina; Vairo, Donatella] Univ Brescia, Spedali Civili & Pediat Clin, Dept Pathol, Lab Genet Disorders Childhood,A Nocivelli Inst Mo, Brescia, Italy; [Giliani, Silvia; Mazzolari, Evelina; Vairo, Donatella] Univ Brescia, Spedali Civili & Pediat Clin, Dept Pathol, Pediat Clin,A Nocivelli Inst Mol Med, Brescia, Italy; [Israelsson, Elisabeth; Chaussabel, Damien] Benaroya Res Inst Virginia Mason, Dept Syst Immunol, Seattle, WA USA; [Xu, Zhaohui; Cepika, Alma-Martina; Pascual, Virginia; Chaussabel, Damien] Baylor Res Inst, Dallas, TX USA; [Xu, Zhaohui; Cepika, Alma-Martina; Pascual, Virginia; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX USA; [Israel, Laura; Chrabieh, Maya; Hubeau, Marjorie; Puel, Anne; Casanova, Jean-Laurent; Picard, Capucine] Necker Med Sch, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Israel, Laura; Chrabieh, Maya; Hubeau, Marjorie; Bonnet, Damien; Quartier, Pierre; Fournet, Jean-Christophe; Puel, Anne; Casanova, Jean-Laurent; Picard, Capucine] Paris Descartes Univ, Paris, France; [MacDuff, Donna; Virgin, Herbert W.] Washington Univ, Sch Med, St Louis, MO USA; [MacDuff, Donna; Virgin, Herbert W.] Midwest Reg Ctr Excellence Biodef & Emerging, St Louis, MO USA; [Bajolle, Fanny; Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Reference Ctr Complex Congenital Heart Defects, Paris, France; [Debre, Marianne; Quartier, Pierre; Casanova, Jean-Laurent; Picard, Capucine] Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Rheumatol Unit, Paris, France; [Agou, Fabrice] CNRS, URA 2185, Struct & Cellular Biochem Unit, Inst Pasteur, Paris, France; [Bossuyt, Xavier] Catholic Univ Louvain, Biomed Sci Grp, Dept Microbiol & Immunol, Expt Immunol Lab, B-3000 Louvain, Belgium; [Rambaud, Caroline] AP HP, Pathol Lab, Garches, France; [Facchetti, Fabio] Univ Brescia, Brescia, Italy; [Facchetti, Fabio] Spedali Civil Brescia, Dept Pathol, I-25125 Brescia, Italy; [Fournet, Jean-Christophe] Hop Necker Enfants Malad, AP HP, Pathol Lab, Paris, France; [Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Sch Med, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; [Picard, Capucine] Hop Necker Enfants Malad, Study Ctr Primary Immunodeficiencies, AP HP, Paris, France	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Brescia; University of Brescia; Benaroya Research Institute; Virginia Mason Medical Center; Baylor Scott & White Health; Baylor University Medical Center; Baylor Scott & White Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; University of Brescia; Hospital Spedali Civili Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.	casanova@rockefeller.edu	MacDuff, Donna/AAD-2786-2019; Giliani, Silvia/AAX-8843-2020; chrabieh, maya/H-7370-2017; Prando, Carolina/C-4689-2015; Boisson, Bertrand/I-2485-2017; Casanova, Jean-Laurent/I-3418-2017; Boisson, Bertrand/AAC-6058-2019; Chaussabel, Damien/AAX-1909-2020; , AGOU/GXA-2760-2022; Facchetti, Fabio/E-7190-2010; Puel, Anne/H-7305-2017; Pascual, Virginia/ABD-3099-2020; Picard, Capucine/H-3914-2017; Notarangelo, Luigi D/F-9718-2016; Bossuyt, Xavier/B-2085-2019	MacDuff, Donna/0000-0002-6183-6827; Giliani, Silvia/0000-0001-8137-4642; chrabieh, maya/0000-0003-0772-4805; Prando, Carolina/0000-0002-9570-9770; Boisson, Bertrand/0000-0001-5240-3555; Boisson, Bertrand/0000-0001-5240-3555; Facchetti, Fabio/0000-0003-4975-2388; Puel, Anne/0000-0003-2603-0323; Picard, Capucine/0000-0001-8788-5056; Notarangelo, Luigi D/0000-0002-8335-0262; Bossuyt, Xavier/0000-0001-6856-8485; Casanova, Jean-Laurent/0000-0002-7782-4169; Virgin, Herbert/0000-0001-8580-7628; Quartier, Pierre/0000-0002-1769-549X; Cepika, Alma-Martina/0000-0003-2862-1901; Xu, Zhaohui/0000-0003-0645-1737; Chaussabel, Damien/0000-0002-6131-7242	US National Center for Advancing Translational Sciences; US National Center for Research Resources, US National Institutes of Health (NIH) [8UL1TR000043]; St. Giles Foundation; Jeffrey Modell Foundation; Rockefeller University; INSERM; Paris Descartes University; US National Institute of Allergy and Infectious Diseases [R21AI085523]; NIH [5P01AI061093, R01AR050770]; Canceropole Ile de France; European Community Network of Excellence-Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation [LSHC-CT-2005-018683]; Thrasher Research Fund; Institut de Recherches Servier; Manton Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061093, R21AI085523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770] Funding Source: NIH RePORTER	US National Center for Advancing Translational Sciences; US National Center for Research Resources, US National Institutes of Health (NIH); St. Giles Foundation; Jeffrey Modell Foundation; Rockefeller University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canceropole Ile de France(Region Ile-de-France); European Community Network of Excellence-Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation; Thrasher Research Fund; Institut de Recherches Servier; Manton Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the children and their families for participating, and F. Iserin, V. Colomb, F. Ruemmele and V. Valayannopoulos for taking care of them. We particularly thank L. Abel, A. Durandy, P. Genin, B. Neven, M. Veron, J.W. Verbsky and R. Weil. H. Walczak (Imperial College London), K. Iwai (Osaka University) and A. Smahi (INSERM U781 Necker hospital, Paris Cite Sorbonne University) provided antibodies and cells. This work was partly funded by US National Center for Advancing Translational Sciences and National Center for Research Resources, US National Institutes of Health (NIH; 8UL1TR000043), St. Giles Foundation, Jeffrey Modell Foundation, Rockefeller University, INSERM, Paris Descartes University, US National Institute of Allergy and Infectious Diseases (R21AI085523; J.-L.C. and D.C.), NIH (5P01AI061093; J.-L.C.), NIH (R01AR050770; V.P.), Canceropole Ile de France (2007; A.I.), European Community Network of Excellence-Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (LSHC-CT-2005-018683; E.L. and A.I.), Thrasher Research Fund (C. Prando), Institut de Recherches Servier (E.L., F.A. and A.I.) and Manton Foundation (L.D.N.).	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bruno C, 2004, NEUROLOGY, V63, P1053, DOI 10.1212/01.WNL.0000138429.11433.0D; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ewert R, 1999, Z KARDIOL, V88, P850, DOI 10.1007/s003920050361; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Hostager BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023061; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lesca G, 2010, EPILEPSIA, V51, P1691, DOI 10.1111/j.1528-1167.2010.02692.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monaghan TS, 2010, CNS DRUGS, V24, P549, DOI 10.2165/11319250-000000000-00000; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Pellissier J F, 1981, Acta Neuropathol Suppl, V7, P292; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smahi A, 2000, NATURE, V405, P466; Tatematsu K, 1998, BIOCHEM BIOPH RES CO, V247, P392, DOI 10.1006/bbrc.1998.8795; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; von Bernuth H, 2005, CLIN INFECT DIS, V41, pS436, DOI 10.1086/431994; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Zak DE, 2011, P NATL ACAD SCI USA, V108, P11536, DOI 10.1073/pnas.1107577108	46	287	300	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1178	+		10.1038/ni.2457	http://dx.doi.org/10.1038/ni.2457			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23104095	Green Submitted, Green Accepted			2022-12-18	WOS:000311217900011
J	Phan, TG; Green, JA; Gray, EE; Xu, Y; Cyster, JG				Phan, Tri Giang; Green, Jesse A.; Gray, Elizabeth E.; Xu, Ying; Cyster, Jason G.			Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation	NATURE IMMUNOLOGY			English	Article							LYMPH-NODES; SOMATIC MUTATION; DENDRITIC CELLS; MICE DEFICIENT; ANTIGEN; RECEPTOR; MOUSE; DISRUPTION; EXPRESSION; TRANSPORT	Subcapsular sinus (SCS) macrophages capture antigens from lymph and present them intact for B cell encounter and follicular delivery. However, the properties of SCS macrophages are poorly defined. Here we show SCS macrophage development depended on lymphotoxin-alpha 1 beta 2, and the cells had low lysosomal enzyme expression and retained opsonized antigens on their surface. Intravital imaging revealed immune complexes moving along macrophage processes into the follicle. Moreover, noncognate B cells relayed antigen opsonized by newly produced antibodies from the subcapsular region to the germinal center, and affinity maturation was impaired when this transport process was disrupted. Thus, we characterize SCS macrophages as specialized antigen-presenting cells functioning at the apex of an antigen transport chain that promotes humoral immunity.	[Phan, Tri Giang; Green, Jesse A.; Gray, Elizabeth E.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Phan, Tri Giang; Green, Jesse A.; Gray, Elizabeth E.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Phan, Tri Giang] Garvan Inst Med Res, Sydney, NSW, Australia	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Garvan Institute of Medical Research	Phan, TG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	t.phan@garvan.org.au; jason.cyster@ucsf.edu	Phan, Tri Giang/G-3937-2012	Phan, Tri Giang/0000-0002-4909-2984	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI45073, R01 AI045073-11, N01AI40098, R37 AI040098, R01 AI045073, R37 AI040098-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, R01AI040098, R37AI040098] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boes M, 1998, J IMMUNOL, V160, P4776; Brady LJ, 2005, INFECT IMMUN, V73, P671, DOI 10.1128/IAI.73.2.671-678.2005; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; DE TP, 1994, SCIENCE, V264, P703; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Getahun A, 2006, IMMUNOL LETT, V104, P38, DOI 10.1016/j.imlet.2005.11.005; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; SMITHGILL SJ, 1984, J IMMUNOL, V133, P384; Song HF, 1998, IMMUNOL REV, V162, P211, DOI 10.1111/j.1600-065X.1998.tb01443.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	49	287	292	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					786	U153		10.1038/ni.1745	http://dx.doi.org/10.1038/ni.1745			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19503106	Green Accepted, Green Submitted			2022-12-18	WOS:000267142600019
J	Chuang, TH; Ulevitch, RJ				Chuang, TH; Ulevitch, RJ			Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors	NATURE IMMUNOLOGY			English	Article							RING-FINGER PROTEINS; INTERACTING PROTEIN; NEGATIVE REGULATION; ALPHA-SYNUCLEIN; FAMILY-MEMBERS; PARKIN; LIPOPOLYSACCHARIDE; DEGRADATION; PATHWAY; KINASE	Activation of Toll-like receptors (TLRs) results in a proinflammatory response needed to combat infection. Thus, limiting TLR signaling is essential for preventing a protective response from causing injury to the host. Here we describe how a RING finger protein, Triad3A, acts as an E3 ubiquitin-protein ligase and enhances ubiquitination and proteolytic degradation of some TLRs. Triad3A overexpression promoted substantial degradation of TLR4 and TLR9 with a concomitant decrease in signaling, but did not affect TLR2 expression or signaling. Conversely, a reduction in endogenous Triad3A by small interfering RNA increased TLR expression and enhanced TLR activation. Thus, ubiquitination by Triad3A represents one pathway by which the intensity and duration of TLR signaling is controlled.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ulevitch@scripps.edu	Chuang, Tsung-Hsien/F-9679-2010; Ulevitch, Richard J/Q-3393-2017		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523, R01AI015136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028485, R37GM028485] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54523, AI15136] Funding Source: Medline; NIGMS NIH HHS [GM28485] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aguilera M, 2000, GENETICS, V155, P1231; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Barton GHM, 2003, NAT IMMUNOL, V4, P432, DOI 10.1038/ni0503-432; Bochud PY, 2003, BMJ-BRIT MED J, V326, P262, DOI 10.1136/bmj.326.7383.262; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Daun JM, 2000, J INTERF CYTOK RES, V20, P843, DOI 10.1089/10799900050163217; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GROPPER R, 1991, J BIOL CHEM, V266, P3602; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Marsik C, 2003, BRIT J HAEMATOL, V121, P653, DOI 10.1046/j.1365-2141.2003.04350.x; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; Sabroe I, 2002, CLIN EXP ALLERGY, V32, P984, DOI 10.1046/j.1365-2745.2002.01451.x; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Strous GJ, 2002, FEBS LETT, V529, P102, DOI 10.1016/S0014-5793(02)03187-3; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	49	287	316	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					495	502		10.1038/ni1066	http://dx.doi.org/10.1038/ni1066			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15107846				2022-12-18	WOS:000221101100013
J	Dahl, R; Walsh, JC; Lancki, D; Laslo, P; Iyer, SR; Singh, H; Simon, MC				Dahl, R; Walsh, JC; Lancki, D; Laslo, P; Iyer, SR; Singh, H; Simon, MC			Regulation of macrophage and neutrophil cell fates by the PU.1 : C/EBP ratio and granulocyte colony-stimulating factor	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR PU.1; BINDING PROTEIN ALPHA; MYELOID PROGENITORS; LINEAGE COMMITMENT; DEFICIENT MICE; ERYTHROID-DIFFERENTIATION; STEM-CELLS; SPI-B; EXPRESSION; GENE	Hematopoietic transcription factors are essential for specifying cell fates; however, the function of cytokines in such developmental decisions is unresolved. We demonstrate here that haploinsufficiency for the gene encoding the transcription factor PU.1 partially suppresses the neutropenia of mice deficient in granulocyte colony-stimulating factor. This suppression was due to an increase in granulocytic progenitors and a diminution of monocytic progenitors. With PU.1(+/-) ES cells as well as PU.1(-/-) hematopoietic progenitors, we show that higher expression of PU.1 is needed for macrophage than for neutrophil development. In a PU.1(-/-) progenitor cell line, in which graded activity of PU.1 regulates neutrophil versus macrophage development, granulocyte colony-stimulating factor signaling supported the neutrophil cell fate by increasing expression of the neutrophil transcription factor C/EBPalpha in relation to expression of PU.1. Collectively, these results indicate that cytokines can promote cell fate decisions by altering the relative concentrations of lineage-determining transcriptional regulators.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Singh, H (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.		Simon, Celeste/AAG-3941-2021	Dahl, Richard/0000-0002-6341-5604	NHLBI NIH HHS [5R01HL052094, 5T32HL07237] Funding Source: Medline; NIGMS NIH HHS [5T32GM07151] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237, R01HL052094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007151] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Dahl R, 2002, EMBO J, V21, P2220, DOI 10.1093/emboj/21.9.2220; DAHL R, 2001, HEMATOPOIESIS DEV AP, P391; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Kim J, 2002, MOL CELL BIOL, V22, P1903, DOI 10.1128/MCB.22.6.1903-1918.2002; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lieschke GJ, 1997, CIBA F SYMP, V204, P60; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; McIvor Z, 2003, EXP HEMATOL, V31, P39, DOI 10.1016/S0301-472X(02)01017-2; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Schaller E, 2002, MOL CELL BIOL, V22, P8035, DOI 10.1128/MCB.22.22.8035-8043.2002; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; SHIVDASANI RA, 1996, BLOOD, V87, P1025; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	41	287	297	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					1029	1036		10.1038/ni973	http://dx.doi.org/10.1038/ni973			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12958595				2022-12-18	WOS:000185590100020
J	Messi, M; Giacchetto, I; Nagata, K; Lanzavecchia, A; Natoli, G; Sallusto, F				Messi, M; Giacchetto, I; Nagata, K; Lanzavecchia, A; Natoli, G; Sallusto, F			Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes	NATURE IMMUNOLOGY			English	Article							HUMAN TH2 CELLS; CD4 T-CELLS; TRANSCRIPTION FACTOR; IFN-GAMMA; SELECTIVE EXPRESSION; POLARIZED T-HELPER-1; HISTONE ACETYLATION; CHEMOKINE RECEPTORS; CHROMATIN-STRUCTURE; LINEAGE COMMITMENT	CD4(+) T cell priming under T helper type I (T(H)1) or T(H)2 conditions gives rise to polarized cytokine gene expression. We found that in these conditions human naive T cells acquired stable histone hyperacetylation at either the Ifng or Il4 promoter. Effector memory T cells showed polarized cytokine gene acetylation patterns in vivo, whereas central memory T cells had hypoacetylated cytokine genes but acquired polarized acetylation and expression after appropriate stimulation. However, hypoacetylation of the nonexpressed cytokine gene did not lead to irreversible silencing because most T(H)1 and T(H)2 cells acetylated and expressed the alternative gene when stimulated under opposite T-H conditions. Such cytokine flexibility was absent in a subset of T(H)2 cells that failed to upregulate T- bet and to express interferon- when stimulated under T(H)1 conditions. Thus, most human CD4(+) T cells retain both memory and flexibility of cytokine gene expression.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; R&D Ctr, Kawagoe, Saitama 3501101, Japan	Universita della Svizzera Italiana	Sallusto, F (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Natoli, Gioacchino/0000-0003-0711-2411				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Annunziato F, 2001, J ALLERGY CLIN IMMUN, V108, P815; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim CH, 2001, TRENDS IMMUNOL, V22, P527, DOI 10.1016/S1471-4906(01)02029-4; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nagata K, 1999, J IMMUNOL, V162, P1278; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PALIARD X, 1988, J IMMUNOL, V141, P849; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Smits HH, 2001, EUR J IMMUNOL, V31, P1055, DOI 10.1002/1521-4141(200104)31:4<1055::AID-IMMU1055>3.0.CO;2-7; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vitolo JM, 2000, MOL CELL BIOL, V20, P2167, DOI 10.1128/MCB.20.6.2167-2175.2000; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	63	287	300	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					78	86		10.1038/ni872	http://dx.doi.org/10.1038/ni872			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12447360				2022-12-18	WOS:000180053000018
J	Wandstrat, A; Wakeland, E				Wandstrat, A; Wakeland, E			The genetics of complex autoimmune diseases: non-MHC susceptibility genes	NATURE IMMUNOLOGY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT DIABETES-MELLITUS; CONGENIC MOUSE STRAINS; SINGLE-NUCLEOTIDE POLYMORPHISMS; COLLAGEN-INDUCED ARTHRITIS; QUANTITATIVE TRAIT LOCI; BARR-VIRUS INFECTION; GENOME-WIDE SEARCH; MULTIPLE-SCLEROSIS; LINKAGE DISEQUILIBRIUM	Susceptibility to complex autoimmune diseases (AIDs) is a multigenic phenotype affected by a variety of genetic and environmental or stochastic factors. After over a decade of linkage analyses, the identification of non-major histocompatibility complex (non-MHC) susceptibility alleles has proved to be difficult, predominantly because of extensive genetic heterogeneity and possible epistatic interactions among the multiple genes required for disease development. Despite these difficulties, progress has been made in elucidating the genetic mechanisms that influence the inheritance of susceptibility, and the pace of gene discovery is accelerating. An intriguing new finding has been the colocalization of sever. al AID susceptibility genes in both rodent models and human linkage studies. This may indicate that several susceptibility alleles affect multiple AIDs, or alternatively that genomic organization has resulted in the clustering of many immune system genes. The completion of the human genome sequence, coupled with the imminent completion of the mouse genome, should yield key information that will dramatically enhance the rate of gene discovery in complex conditions such as AID susceptibility.	Univ Texas, SW Med Ctr, Dept Immunol, Ctr Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wakeland, E (corresponding author), Univ Texas, SW Med Ctr, Dept Immunol, Ctr Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	edward.wakeland@utsouthwestern.edu						Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Becker KG, 1999, DIABETES, V48, P1353, DOI 10.2337/diabetes.48.7.1353; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1984, AM J HUM GENET, V37, P188; Bennett ST, 1997, NAT GENET, V17, P350, DOI 10.1038/ng1197-350; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carroll MC, 1998, NAT GENET, V19, P3, DOI 10.1038/ng0598-3; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chan OTM, 1999, J IMMUNOL, V163, P3592; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cordell HJ, 1998, GENET RES, V71, P51, DOI 10.1017/S0016672398003152; Criswell LA, 2000, J CLIN INVEST, V105, P1501; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DRAKE CG, 1995, J IMMUNOL, V154, P2441; Eaves IA, 2000, NAT GENET, V25, P320; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EISENBERG RA, 1987, J CLIN INVEST, V80, P691, DOI 10.1172/JCI113123; FOSSATI L, 1993, INT IMMUNOL, V5, P525, DOI 10.1093/intimm/5.5.525; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; GELEHRTER TD, 1990, PRINCIPLES MED GENET; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2; GULKO PS, 1999, LUPUS MOL CELLULAR P, P101; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harley JB, 1999, ARTHRITIS RHEUM, V42, P1782, DOI 10.1002/1529-0131(199908)42:8<1782::AID-ANR36>3.0.CO;2-X; Hattori M, 1999, J IMMUNOL, V163, P1721; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Hogarth MB, 1998, J IMMUNOL, V161, P2753; Holmdahl R, 1998, CURR OPIN IMMUNOL, V10, P710, DOI 10.1016/S0952-7915(98)80093-9; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Jirholt J, 1998, EUR J IMMUNOL, V28, P3321, DOI 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M; Kalman B, 1999, BIOMED PHARMACOTHER, V53, P358, DOI 10.1016/S0753-3322(99)80107-3; KELLEY VE, 1980, CLIN IMMUNOL IMMUNOP, V16, P142, DOI 10.1016/0090-1229(80)90198-1; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; KOTZIN BL, 1995, SAMTERS IMMUNOLOGIC, P667; KURTZKE JF, 1980, NEUROLOGY, V30, P61, DOI 10.1212/WNL.30.7_Part_2.61; Kurtzke JF, 1996, ACTA NEUROL SCAND, V93, P110; Leech NJ, 1995, AUTOIMMUNITY, V22, P27, DOI 10.3109/08916939508995296; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; LORD CJ, 1995, MAMM GENOME, V6, P563, DOI 10.1007/BF00352359; Lundberg C, 2001, J COMP NEUROL, V431, P75; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Marron MP, 2000, DIABETES, V49, P492, DOI 10.2337/diabetes.49.3.492; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; McDuffie M, 1998, CURR OPIN IMMUNOL, V10, P704, DOI 10.1016/S0952-7915(98)80092-7; McDuffie M, 2000, CLIN IMMUNOL, V96, P119, DOI 10.1006/clim.2000.4893; McIndoe RA, 1999, P NATL ACAD SCI USA, V96, P2210, DOI 10.1073/pnas.96.5.2210; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; Morel L, 1997, J IMMUNOL, V158, P6019; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Podolin PL, 1997, J IMMUNOL, V159, P1835; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Quigg RJ, 1998, KIDNEY INT, V53, P320, DOI 10.1046/j.1523-1755.1998.00723.x; Redondo MJ, 1999, BRIT MED J, V318, P698; RISCH N, 1993, AM J HUM GENET, V53, P702; ROSE NR, 1999, AUTOIMMUNE DIS; ROWE RE, 1995, NAT GENET, V10, P240, DOI 10.1038/ng0695-240; Rozzo SJ, 1996, P NATL ACAD SCI USA, V93, P15164, DOI 10.1073/pnas.93.26.15164; Rozzo SJ, 2000, J IMMUNOL, V164, P5515, DOI 10.4049/jimmunol.164.10.5515; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Serreze DV, 1998, J IMMUNOL, V160, P1472; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; She JX, 1998, CURR OPIN IMMUNOL, V10, P682, DOI 10.1016/S0952-7915(98)80089-7; Siegmund T, 2000, DIABETES, V49, P1612, DOI 10.2337/diabetes.49.9.1612; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; Spielman RS, 1996, AM J HUM GENET, V59, P983; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; THEOFILOPOULOS AN, 1989, ADV IMMUNOL, V46, P61, DOI 10.1016/S0065-2776(08)60651-3; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; Vafiadis P, 1998, DIABETES, V47, P831, DOI 10.2337/diabetes.47.5.831; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Vyse TJ, 1998, AUTOIMMUNE DISEASES, THIRD EDITION, P85; Walport MJ, 1998, IMMUNOBIOLOGY, V199, P265, DOI 10.1016/S0171-2985(98)80032-6; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WARREN RW, 1984, CLIN IMMUNOL IMMUNOP, V31, P65, DOI 10.1016/0090-1229(84)90190-9; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Willer CJ, 2000, CURR OPIN NEUROL, V13, P241, DOI 10.1097/00019052-200006000-00002; Winchester R., 1992, SYSTEMIC LUPUS ERYTH, P65; Wright S, 1934, GENETICS, V19, P0506; Wu JM, 1996, J IMMUNOL, V157, P2498	109	287	295	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					802	809		10.1038/ni0901-802	http://dx.doi.org/10.1038/ni0901-802			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526390				2022-12-18	WOS:000170781200015
J	Tipton, CM; Fucile, CF; Darce, J; Chida, A; Ichikawa, T; Gregoretti, I; Schieferl, S; Hom, J; Jenks, S; Feldman, RJ; Mehr, R; Wei, CW; Lee, FEH; Cheung, WC; Rosenberg, AF; Sanz, I				Tipton, Christopher M.; Fucile, Christopher F.; Darce, Jaime; Chida, Asiya; Ichikawa, Travis; Gregoretti, Ivan; Schieferl, Sandra; Hom, Jennifer; Jenks, Scott; Feldman, Ron J.; Mehr, Ramit; Wei, Chungwen; Lee, F. Eun-Hyung; Cheung, Wan Cheung; Rosenberg, Alexander F.; Sanz, Inaki			Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; PERIPHERAL-BLOOD; GERMINAL CENTER; MONOCLONAL-ANTIBODIES; AFFINITY MATURATION; ACTIVATION; AUTOIMMUNITY; RESPONSES; ANTIGEN; SLE	Acute systemic lupus erythematosus (SLE) courses with surges of antibody-secreting cells (ASCs) whose origin, diversity and contribution to serum autoantibodies remain unknown. Here, deep sequencing, proteomic profiling of autoantibodies and single-cell analysis demonstrated highly diversified ASCs punctuated by clones expressing the variable heavy-chain region VH4-34 that produced dominant serum autoantibodies. A fraction of ASC clones contained autoantibodies without mutation, a finding consistent with differentiation outside the germinal centers. A substantial ASC segment was derived from a distinct subset of newly activated naive cells of considerable clonality that persisted in the circulation for several months. Thus, selection of SLE autoreactivities occurred during polyclonal activation, with prolonged recruitment of recently activated naive B cells. Our findings shed light on the pathogenesis of SLE, help explain the benefit of agents that target B cells and should facilitate the design of future therapies.	[Tipton, Christopher M.; Chida, Asiya; Ichikawa, Travis; Hom, Jennifer; Jenks, Scott; Wei, Chungwen; Sanz, Inaki] Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Fucile, Christopher F.; Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Darce, Jaime; Gregoretti, Ivan; Schieferl, Sandra; Cheung, Wan Cheung] Cell Signaling Technol, Danvers, MA USA; [Feldman, Ron J.] Emory Univ, Dept Dermatol, Atlanta, GA 30322 USA; [Mehr, Ramit] Bar Ilan Univ, Ramat Gan, Israel; [Lee, F. Eun-Hyung] Emory Univ, Dept Pulmonol, Atlanta, GA 30322 USA	Emory University; University of Rochester; Emory University; Bar Ilan University; Emory University	Sanz, I (corresponding author), Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA.	ignacio.sanz@emory.edu		Tipton, Christopher/0000-0002-5049-2571; Mehr, Ramit/0000-0002-4303-6834; Feldman, Ron/0000-0001-5766-5132	Autoimmunity Center of Excellence [U19 AI110483, 5P01AI078907, 5R37AI049660]; United States-Israel Binational Science Foundation [2013432]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110483, P01AI078907, R37AI049660] Funding Source: NIH RePORTER	Autoimmunity Center of Excellence; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Stevenson (University of Southampton) for the 9G4 hybridoma; E. Meffre (Yale University) for expression vectors; and the blood donors and research coordinators involved in this study. Supported by the Autoimmunity Center of Excellence (U19 AI110483, 5P01AI078907 and 5R37AI049660) and the United States-Israel Binational Science Foundation (2013432).	Barak M, 2008, J IMMUNOL METHODS, V338, P67, DOI 10.1016/j.jim.2008.06.006; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Chevrier S, 2014, IMMUNOL CELL BIOL, V92, P12, DOI 10.1038/icb.2013.71; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; DELESPESSE G, 1989, J IMMUNOL, V142, P134; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; GHARAVI AE, 1988, ARTHRITIS RHEUM, V31, P1337, DOI 10.1002/art.1780311101; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Infantino S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005105; Isenberg DA, 1998, ANN RHEUM DIS, V57, P566, DOI 10.1136/ard.57.9.566; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Jacobi AM, 2008, ANN RHEUM DIS, V67, P450, DOI 10.1136/ard.2007.075762; Jenks SA, 2013, ARTHRITIS RHEUM-US, V65, P3165, DOI 10.1002/art.38138; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; KLINMAN DM, 1987, J EXP MED, V165, P1755, DOI 10.1084/jem.165.6.1755; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Masilamani M, 2003, EUR J IMMUNOL, V33, P2391, DOI 10.1002/eji.200323843; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI200112462; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; ZUBLER RH, 1982, J EXP MED, V156, P415, DOI 10.1084/jem.156.2.415	50	286	291	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					755	+		10.1038/ni.3175	http://dx.doi.org/10.1038/ni.3175			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26006014	Green Accepted			2022-12-18	WOS:000356445600012
J	Hirai, H; Zhang, P; Dayaram, T; Hetherington, CJ; Mizuno, S; Imanishi, J; Akashi, K; Tenen, DG				Hirai, Hideyo; Zhang, Pu; Dayaram, Tajhal; Hetherington, Christopher J.; Mizuno, Shin-ichi; Imanishi, Jiro; Akashi, Koichi; Tenen, Daniel G.			C/EBP beta is required for 'emergency' granulopoiesis	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; BINDING PROTEIN-ALPHA; TRANSCRIPTION FACTOR; GRANULOCYTIC DIFFERENTIATION; HEPATOCYTE PROLIFERATION; DEFICIENT MICE; G-CSF; EXPRESSION; MACROPHAGE; PHOSPHORYLATION	During 'emergency' situations such as infections, host defense requires rapid mobilization of bone marrow granulocyte progenitors. 'Steady-state' granulopoiesis is absolutely dependent on the C/EBP alpha transcription factor, but the transcriptional mechanisms underlying emergency granulopoiesis remain unclear. Here we show that large numbers of granulocytes were generated from C/EBP alpha-deficient progenitors after cytokine stimulation in vivo. Cytokine treatment or fungal infection induced upregulation of C/EBP beta but not C/EBP alpha or C/EBP epsilon transcripts in granulocyte progenitors, and C/EBP beta-deficient progenitors showed decreased emergency-induced granulopoiesis in vitro and in vivo. C/EBPb inhibited proliferation less severely than did C/EBP alpha. These data suggest a critical function for C/EBP beta in emergency granulopoiesis, which demands both differentiation and proliferation of granulocyte precursors.	Harvard Univ, Inst Med, Boston, MA 02115 USA; Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; Kyoto Prefectural Univ Med, Dept Microbiol, Kyoto 602, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8120034, Japan	Harvard University; Harvard University; Kyoto Prefectural University of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kyushu University	Tenen, DG (corresponding author), Harvard Univ, Inst Med, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu		Tenen, Daniel/0000-0002-6423-3888	NHLBI NIH HHS [HL56745] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Basu S, 2000, BLOOD, V95, P3725; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; CHEERS C, 1988, INFECT IMMUN, V56, P247, DOI 10.1128/IAI.56.1.247-251.1988; Collins SJ, 2001, BLOOD, V98, P2382, DOI 10.1182/blood.V98.8.2382; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Guibal F, 2005, BLOOD, V106, p844A; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; METCALF D, 1983, J CELL PHYSIOL, V116, P198, DOI 10.1002/jcp.1041160211; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NATSUKA S, 1992, BLOOD, V79, P460; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Popernack PM, 2001, J HEMATOTH STEM CELL, V10, P631, DOI 10.1089/152581601753193841; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; SUTHERLAND JA, 1986, J BIOL RESP MODIF, V5, P250; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang QF, 2003, ONCOGENE, V22, P2548, DOI 10.1038/sj.onc.1206360; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; WATARI K, 1989, BLOOD, V73, P117; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang P, 2002, BLOOD, V99, P4406, DOI 10.1182/blood.V99.12.4406; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	60	286	288	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					732	739		10.1038/ni1354	http://dx.doi.org/10.1038/ni1354			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16751774				2022-12-18	WOS:000238377700018
J	Wilson, NS; Behrens, GMN; Lundie, RJ; Smith, CM; Waithman, J; Young, L; Forehan, SP; Mount, A; Steptoe, RJ; Shortman, KD; de Koning-Ward, TF; Belz, GT; Carbone, FR; Crabb, BS; Heath, WR; Villadangos, JA				Wilson, NS; Behrens, GMN; Lundie, RJ; Smith, CM; Waithman, J; Young, L; Forehan, SP; Mount, A; Steptoe, RJ; Shortman, KD; de Koning-Ward, TF; Belz, GT; Carbone, FR; Crabb, BS; Heath, WR; Villadangos, JA			Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity	NATURE IMMUNOLOGY			English	Article							ANTIGEN PRESENTATION; CUTTING EDGE; TRANSGENIC MOUSE; LANGERHANS CELLS; T-CELLS; EXPRESSION; CD8(+); VIRUS; MATURATION; GENERATION	The mechanisms responsible for the immunosuppression associated with sepsis or some chronic blood infections remain poorly understood. Here we show that infection with a malaria parasite (Plasmodium berghei) or simple systemic exposure to bacterial or viral Toll-like receptor ligands inhibited cross-priming. Reduced cross-priming was a consequence of downregulation of cross-presentation by activated dendritic cells due to systemic activation that did not otherwise globally inhibit T cell proliferation. Although activated dendritic cells retained their capacity to present viral antigens via the endogenous major histocompatibility complex class I processing pathway, antiviral responses were greatly impaired in mice exposed to Toll-like receptor ligands. This is consistent with a key function for cross-presentation in antiviral immunity and helps explain the immunosuppressive effects of systemic infection. Moreover, inhibition of cross-presentation was overcome by injection of dendritic cells bearing antigen, which provides a new strategy for generating immunity during immunosuppressive blood infections.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Cooperat Res Ctr Vaccine Technol, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Univ Queensland, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Queensland	Crabb, BS (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	crabb@wehi.edu.au; heath@wehi.edu.au; villadangos@wehi.edu.au	de Koning-Ward, Tania F/N-3572-2017; Villadangos, Jose A/AAU-1404-2020; Crabb, Brendan/F-5287-2013; Carbone, Francis/ABF-2141-2020; Behrens, Georg MN/Q-4486-2016; Belz, Gabrielle T/C-9350-2013; Steptoe, Raymond/B-3843-2011	de Koning-Ward, Tania F/0000-0001-5810-8063; Villadangos, Jose A/0000-0001-6771-8891; Belz, Gabrielle T/0000-0002-9660-9587; Steptoe, Raymond/0000-0002-6513-6406; Waithman, Jason/0000-0003-4940-0155; Heath, William/0000-0001-9670-259X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Leisewitz AL, 2004, INFECT IMMUN, V72, P4233, DOI 10.1128/IAI.72.7.4233-4239.2004; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Luyendyk J, 2002, INFECT IMMUN, V70, P2941, DOI 10.1128/IAI.70.6.2941-2949.2002; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Norbury CC, 2003, CURR OPIN IMMUNOL, V15, P82, DOI 10.1016/S0952791502000031; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Urban BC, 2003, J EXP MED, V197, P137, DOI 10.1084/jem.20022003; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WILLIAMSON WA, 1978, LANCET, V1, P1328; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	51	286	293	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					165	172		10.1038/ni1300	http://dx.doi.org/10.1038/ni1300			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16415871				2022-12-18	WOS:000234801700017
J	Pengo, N; Scolari, M; Oliva, L; Milan, E; Mainoldi, F; Raimondi, A; Fagioli, C; Merlini, A; Mariani, E; Pasqualetto, E; Orfanelli, U; Ponzoni, M; Sitia, R; Casola, S; Cenci, S				Pengo, Niccolo; Scolari, Maria; Oliva, Laura; Milan, Enrico; Mainoldi, Federica; Raimondi, Andrea; Fagioli, Claudio; Merlini, Arianna; Mariani, Elisabetta; Pasqualetto, Elena; Orfanelli, Ugo; Ponzoni, Maurilio; Sitia, Roberto; Casola, Stefano; Cenci, Simone			Plasma cells require autophagy for sustainable immunoglobulin production	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; DIFFERENTIATION; BLIMP-1; STRESS; IMMUNITY; MICE	The role of autophagy in plasma cells is unknown. Here we found notable autophagic activity in both differentiating and long-lived plasma cells and investigated its function through the use of mice with conditional deficiency in the essential autophagic molecule Atg5 in B cells. Atg5(-/-) differentiating plasma cells had a larger endoplasmic reticulum (ER) and more ER stress signaling than did their wild-type counterparts, which led to higher expression of the transcriptional repressor Blimp-1 and immunoglobulins and more antibody secretion. The enhanced immunoglobulin synthesis was associated with less intracellular ATP and more death of mutant plasma cells, which identified an unsuspected autophagy-dependent cytoprotective trade-off between immunoglobulin synthesis and viability. In vivo, mice with conditional deficiency in Atg5 in B cells had defective antibody responses, complete selection in the bone marrow for plasma cells that escaped Atg5 deletion and fewer antigen-specific long-lived bone marrow plasma cells than did wild-type mice, despite having normal germinal center responses. Thus, autophagy is specifically required for plasma cell homeostasis and long-lived humoral immunity.	[Pengo, Niccolo; Scolari, Maria; Oliva, Laura; Milan, Enrico; Fagioli, Claudio; Merlini, Arianna; Mariani, Elisabetta; Pasqualetto, Elena; Orfanelli, Ugo; Sitia, Roberto; Cenci, Simone] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Pengo, Niccolo; Milan, Enrico; Merlini, Arianna; Sitia, Roberto; Cenci, Simone] Univ Vita Salute San Raffaele, Milan, Italy; [Mainoldi, Federica; Casola, Stefano] Italian Fdn Canc Res FIRC, Inst Mol Oncol IFOM, Milan, Italy; [Raimondi, Andrea] Ist Sci San Raffaele, Imaging Res Ctr, I-20132 Milan, Italy; [Mariani, Elisabetta; Sitia, Roberto] Ist Sci San Raffaele, Div Genet & Cell Biol, Bone Pathophysiol Program BoNetwork, I-20132 Milan, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Myeloma Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cenci, S (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.	cenci.simone@hsr.it	Casola, Stefano/O-3922-2014; Sitia, Roberto/AAB-5005-2019; Milan, Enrico/AAH-3354-2021; Pengo, Niccolò/K-5009-2012; Casola, Stefano/AAN-8319-2021; Pasqualetto, Elena/ABG-4473-2020; Raimondi, Andrea/AAN-2475-2020; Milan, Enrico/J-8343-2016; Cenci, Simone/J-7700-2016; Orfanelli, Ugo/AAN-4787-2020; Fagioli, Claudio/AAN-4147-2020; Pasqualetto, Elena/AAN-2239-2020	Sitia, Roberto/0000-0001-7086-4152; Milan, Enrico/0000-0003-3094-4275; Pengo, Niccolò/0000-0002-9249-4786; Casola, Stefano/0000-0001-5580-0986; Pasqualetto, Elena/0000-0003-2130-1577; Milan, Enrico/0000-0003-3094-4275; Cenci, Simone/0000-0003-1215-7518; Fagioli, Claudio/0000-0001-9889-4695; Orfanelli, Ugo/0000-0003-3792-9174; Merlini, Arianna/0000-0002-9567-2250; Raimondi, Andrea/0000-0002-4563-386X; , laura/0000-0001-7515-2218	Italian Ministry of Health [1143560]; Multiple Myeloma Research Foundation; Italian Association for Cancer Research [9965]; Giovanni Armenise-Harvard Foundation Career Development Program; Italian Foundation for Cancer Research	Italian Ministry of Health(Ministry of Health, Italy); Multiple Myeloma Research Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Giovanni Armenise-Harvard Foundation Career Development Program; Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	We thank I. Braakman (University of Utrecht) for anti-PDI antiserum; N. Mizushima (Tokyo University) for GFP-LC3 mice; H.W. Virgin (Washington University) for Atg5<SUP>f/f</SUP>CD19-Cre mice; H. Auner, A. Bachi, M. Bertolotti, P. Cascio, P. Dellabona, F. Fontana, J. Garcia, M. Glickman, M. Iannacone, L. Maiuri, A. Manfredi, G. Merlini, A. Mondino, A. Orsi, L. Rampoldi, I. Rowe, S. Tooze, E. Tonti and E. van Anken for discussions and suggestions; T. Pengo, C. Covino and the staff of the Advanced Light and Electron Microscopy Bioimaging Center for support with microscopy; E. Canonico and I. Muradore for cell sorting; L. Spagnuolo for immunohistochemistry; and F. Loro for secretarial assistance. Supported by the Italian Ministry of Health (S. Casola; and Giovani Ricercatori 1143560 to S. Cenci), the Multiple Myeloma Research Foundation (S. Cenci), the Italian Association for Cancer Research (S. Casola; and Special Program Molecular Clinical Oncology 5 per mille 9965 to R.S. and S. Cenci), the Giovanni Armenise-Harvard Foundation Career Development Program (S. Casola) and the Italian Foundation for Cancer Research (S. Casola).	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bertolotti M, 2012, ANTIOXID REDOX SIGN, V16, P1139, DOI 10.1089/ars.2011.4252; Cascio P, 2008, EUR J IMMUNOL, V38, P658, DOI 10.1002/eji.200737743; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Cenci S, 2011, CURR OPIN CELL BIOL, V23, P216, DOI 10.1016/j.ceb.2010.11.004; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Doody GM, 2006, EUR J IMMUNOL, V36, P1572, DOI 10.1002/eji.200535646; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Goldfinger M, 2011, EUR J IMMUNOL, V41, P491, DOI 10.1002/eji.201040677; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hsu MC, 2006, P NATL ACAD SCI USA, V103, P5905, DOI 10.1073/pnas.0601502103; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; MASON JO, 1988, GENE DEV, V2, P1003, DOI 10.1101/gad.2.8.1003; Milcarek C., 2011, RNA PROCESSING, P27; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4	41	285	302	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					298	305		10.1038/ni.2524	http://dx.doi.org/10.1038/ni.2524			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23354484				2022-12-18	WOS:000315065400020
J	Martins, GA; Cimmino, L; Shapiro-Shelef, M; Szabolcs, M; Herron, A; Magnusdottir, E; Calame, K				Martins, GA; Cimmino, L; Shapiro-Shelef, M; Szabolcs, M; Herron, A; Magnusdottir, E; Calame, K			Transcriptional repressor Blimp-1 regulates T cell homeostasis and function	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; SECRETING PLASMA-CELLS; NF-KAPPA-B; LYMPHOCYTE DIFFERENTIATION; EXPRESSION; ACTIVATION; BCL-6; INHIBITION; MATURATION; RECEPTOR	The B lymphocyte-induced maturation protein 1 (Blimp-1) transcriptional repressor is required for terminal differentiation of B lymphocytes. Here we document a function for Blimp-1 in the T cell lineage. Blimp-1-deficient thymocytes showed decreased survival and Blimp-1-deficient mice had more peripheral effector T cells. Mice lacking Blimp-1 developed severe colitis as early as 6 weeks of age, and Blimp-1-deficient regulatory T cells were defective in blocking the development of colitis. Blimp-1 mRNA expression increased substantially in response to T cell receptor stimulation. Compared with wild-type CD4(+) T cells, Blimp-1-deficient CD4(+) T cells proliferated more and produced excess interleukin 2 and interferon-gamma but reduced interleukin 10 after T cell receptor stimulation. These results emphasize a crucial function for Blimp-1 in controlling T cell homeostasis and activation.	Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Inst Comparat Med, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Biol Sci, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Calame, K (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA.	klc1@columbia.edu	Magnúsdóttir, Erna/T-8993-2019; Magnúsdóttir, Erna/H-5181-2013	Magnúsdóttir, Erna/0000-0002-3369-4390; Shelef, Miriam/0000-0002-8842-0303	NIAID NIH HHS [R01 AI43576, R01 AI50659] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050659, R01AI043576] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Angelin-Duclos C, 2002, EUR J IMMUNOL, V32, P3765, DOI 10.1002/1521-4141(200212)32:12<3765::AID-IMMU3765>3.0.CO;2-I; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cattoretti G, 2005, J PATHOL, V206, P76, DOI 10.1002/path.1752; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Grossman Z, 2004, NAT REV IMMUNOL, V4, P387, DOI 10.1038/nri1355; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Iwashima M, 2003, IMMUNOL REV, V191, P196, DOI 10.1034/j.1600-065X.2003.00024.x; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jang IK, 2003, CURR OPIN IMMUNOL, V15, P315, DOI 10.1016/S0952-7915(03)00048-7; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Koh WP, 1999, J IMMUNOL, V162, P7208; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu Jun O, 2005, Sci STKE, V2005, pre1; Ludviksson BR, 1997, J IMMUNOL, V158, P104; Lund RJ, 2003, EUR J IMMUNOL, V33, P1105, DOI 10.1002/eji.200323899; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	52	285	306	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					457	465		10.1038/ni1320	http://dx.doi.org/10.1038/ni1320			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16565721				2022-12-18	WOS:000237008800010
J	Ganesan, AP; Clarke, J; Wood, O; Garrido-Martin, EM; Chee, SJ; Mellows, T; Samaniego-Castruita, D; Singh, D; Seumois, G; Alzetani, A; Woo, E; Friedmann, PS; King, EV; Thomas, GJ; Sanchez-Elsner, T; Vijayanand, P; Ottensmeier, CH				Ganesan, Anusha-Preethi; Clarke, James; Wood, Oliver; Garrido-Martin, Eva M.; Chee, Serena J.; Mellows, Toby; Samaniego-Castruita, Daniela; Singh, Divya; Seumois, Gregory; Alzetani, Aiman; Woo, Edwin; Friedmann, Peter S.; King, Emma V.; Thomas, Gareth J.; Sanchez-Elsner, Tilman; Vijayanand, Pandurangan; Ottensmeier, Christian H.			Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer	NATURE IMMUNOLOGY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; IMMUNE CELLS; EXPRESSION; ANTIGEN; ACTIVATION; MELANOMA; CHECKPOINT; EXHAUSTION; EFFECTOR; RECEPTOR	Therapies that boost the anti-tumor responses of cytotoxic T lymphocytes (CTLs) have shown promise; however, clinical responses to the immunotherapeutic agents currently available vary considerably, and the molecular basis of this is unclear. We performed transcriptomic profiling of tumor-infiltrating CTLs from treatment-naive patients with lung cancer to define the molecular features associated with the robustness of anti-tumor immune responses. We observed considerable heterogeneity in the expression of molecules associated with activation of the T cell antigen receptor (TCR) and of immunological-checkpoint molecules such as 4-1BB, PD-1 and TIM-3. Tumors with a high density of CTLs showed enrichment for transcripts linked to tissue-resident memory cells (T-RM cells), such as CD103, and CTLs from CD103(hi) tumors displayed features of enhanced cytotoxicity. A greater density of T-RM cells in tumors was predictive of a better survival outcome in lung cancer, and this effect was independent of that conferred by CTL density. Here we define the 'molecular fingerprint' of tumor-infiltrating CTLs and identify potentially new targets for immunotherapy.	[Ganesan, Anusha-Preethi; Clarke, James; Samaniego-Castruita, Daniela; Singh, Divya; Seumois, Gregory; Vijayanand, Pandurangan] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Ganesan, Anusha-Preethi] Univ Calif San Diego, Rady Childrens Hosp, Div Pediat Hematol Oncol, San Diego, CA 92103 USA; [Clarke, James; Wood, Oliver; Chee, Serena J.; King, Emma V.; Thomas, Gareth J.; Ottensmeier, Christian H.] Univ Southampton, Fac Med, Canc Sci Unit, Southampton, Hants, England; [Garrido-Martin, Eva M.; Mellows, Toby; Friedmann, Peter S.; Sanchez-Elsner, Tilman; Vijayanand, Pandurangan] Univ Southampton, Clin & Expt Sci, Sir Henry Wellcome Labs, Fac Med, Southampton, Hants, England; [Chee, Serena J.; Alzetani, Aiman; Woo, Edwin; Ottensmeier, Christian H.] Southampton Univ Hosp NHS Fdn Trust, Southampton, Hants, England	La Jolla Institute for Immunology; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Southampton; University of Southampton	Vijayanand, P (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.; Vijayanand, P (corresponding author), Univ Southampton, Clin & Expt Sci, Sir Henry Wellcome Labs, Fac Med, Southampton, Hants, England.	vijay@lji.org	Martin, Eva Maria Garrido/A-9497-2017; Garrido Martín, Eva María/HHM-3287-2022; Ottensmeier, Christian/ABE-9056-2020	Martin, Eva Maria Garrido/0000-0002-8094-2668; Garrido Martín, Eva María/0000-0002-8094-2668; Ottensmeier, Christian/0000-0003-3619-1657; Sanchez-Elsner, Tilman/0000-0003-1915-2410; Seumois, Gregory/0000-0002-8164-6852; Ganesan, Anusha-Preethi/0000-0003-3775-9996	Wessex Clinical Research Network; National Institute of Health Research, UK; Cancer Research UK [C11512/A20256]; William K. Bowes Jr Foundation; Faculty of Medicine of the University of Southampton; Cancer Research UK [22795, 18161, 18158, 21998, 23904, 20613, 15951] Funding Source: researchfish; Medical Research Council [MR/P024351/1] Funding Source: researchfish; Versus Arthritis [18892] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016262] Funding Source: NIH RePORTER; MRC [MR/P024351/1] Funding Source: UKRI	Wessex Clinical Research Network; National Institute of Health Research, UK(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); William K. Bowes Jr Foundation; Faculty of Medicine of the University of Southampton; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Chamberlain, K. Amer, C. Fixmer and B. Johnson for assistance with recruitment of study subjects and processing of samples; A. Easton for help with the assignment of scores to TILs; Z. Fu and J. Greenbaum for help with the processing and analysis of sequencing data; and H. Cheroutre, M. Kronenberg and J. Moore for reviewing the manuscript and providing insight. Supported by the Wessex Clinical Research Network and the National Institute of Health Research, UK (sample collection), Cancer Research UK (O.W., E.V.K., C.H.O.; and C11512/A20256, for CD103 pathology analysis), the William K. Bowes Jr Foundation (P.V. and A.-P.G.) and the Faculty of Medicine of the University of Southampton (P.V., T.S.-E. and C.H.O.).	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Collins N, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3491.3491; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kuhny M, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0040-3; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Montes CL, 2008, CANCER RES, V68, P870, DOI 10.1158/0008-5472.CAN-07-2282; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Munoz P, 2008, BLOOD, V111, P3653, DOI 10.1182/blood-2007-07-101600; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Bono MR, 2015, FEBS LETT, V589, P3454, DOI 10.1016/j.febslet.2015.07.027; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Wang ZQ, 2016, CLIN CANCER RES, V22, P6290, DOI 10.1158/1078-0432.CCR-16-0732; Ward MJ, 2014, BRIT J CANCER, V110, P489, DOI 10.1038/bjc.2013.639; Webb JR, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27668; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Willoughby JE, 2014, J IMMUNOL, V193, P244, DOI 10.4049/jimmunol.1301217; Wisniewski A, 2015, TISSUE ANTIGENS, V85, P466, DOI 10.1111/tan.12561; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Wolkers MC, 2012, BLOOD, V119, P798, DOI 10.1182/blood-2011-08-373910; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871	62	284	292	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					940	+		10.1038/ni.3775	http://dx.doi.org/10.1038/ni.3775			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28628092	Green Accepted			2022-12-18	WOS:000405821100017
J	Eskan, MA; Jotwani, R; Abe, T; Chmelar, J; Lim, JH; Liang, S; Ciero, PA; Krauss, JL; Li, FG; Rauner, M; Hofbauer, LC; Choi, EY; Chung, KJ; Hashim, A; Curtis, MA; Chavakis, T; Hajishengallis, G				Eskan, Mehmet A.; Jotwani, Ravi; Abe, Toshiharu; Chmelar, Jindrich; Lim, Jong-Hyung; Liang, Shuang; Ciero, Paul A.; Krauss, Jennifer L.; Li, Fenge; Rauner, Martina; Hofbauer, Lorenz C.; Choi, Eun Young; Chung, Kyoung-Jin; Hashim, Ahmed; Curtis, Michael A.; Chavakis, Triantafyllos; Hajishengallis, George			The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss	NATURE IMMUNOLOGY			English	Article							PERIODONTAL-DISEASE; IN-VITRO; T-CELLS; NEUTROPHILS; IL-17; INTERLEUKIN-17; RECRUITMENT; MIGRATION; CHEMOKINE; CYTOKINE	Aging is linked to greater susceptibility to chronic inflammatory diseases, several of which, including periodontitis, involve neutrophil-mediated tissue injury. Here we found that aging-associated periodontitis was accompanied by lower expression of Del-1, an endogenous inhibitor of neutrophil adhesion dependent on the integrin LFA-1, and by reciprocal higher expression of interleukin 17 (IL-17). Consistent with that, IL-17 inhibited gingival endothelial cell expression of Del-1, thereby promoting LFA-1-dependent recruitment of neutrophils. Young Del-1-deficient mice developed spontaneous periodontitis that featured excessive neutrophil infiltration and IL-17 expression; disease was prevented in mice doubly deficient in Del-1 and LFA-1 or in Del-1 and the IL-17 receptor. Locally administered Del-1 inhibited IL-17 production, neutrophil accumulation and bone loss. Therefore, Del-1 suppressed LFA-1-dependent recruitment of neutrophils and IL-17-triggered inflammatory pathology and may thus be a promising therapeutic agent for inflammatory diseases.	[Eskan, Mehmet A.; Jotwani, Ravi; Abe, Toshiharu; Liang, Shuang; Ciero, Paul A.; Krauss, Jennifer L.; Li, Fenge; Hajishengallis, George] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Chmelar, Jindrich; Lim, Jong-Hyung; Choi, Eun Young; Chung, Kyoung-Jin; Chavakis, Triantafyllos] Tech Univ Dresden, Dept Med, Div Vasc Inflammat Diabet & Kidney, D-01062 Dresden, Germany; [Chmelar, Jindrich; Lim, Jong-Hyung; Choi, Eun Young; Chung, Kyoung-Jin; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Physiol, D-01062 Dresden, Germany; [Rauner, Martina; Hofbauer, Lorenz C.] Tech Univ Dresden, Dept Med, Div Endocrinol Diabet & Bone Dis, D-01062 Dresden, Germany; [Choi, Eun Young] Univ Ulsan, Grad Sch, Dept Med, Seoul, South Korea; [Choi, Eun Young; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Hashim, Ahmed; Curtis, Michael A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Immunol & Infect Dis, Blizard Inst, London, England; [Eskan, Mehmet A.; Hajishengallis, George] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; University of Ulsan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; University of Louisville	Hajishengallis, G (corresponding author), Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.	geoh@upenn.edu	Hajishengallis, George N./K-1117-2019; Hofbauer, Lorenz C/G-2490-2010; Chavakis, Triantafyllos/ABE-8845-2020; Eskan, Mehmet A/AAP-5940-2021; Chmelař, Jindřich/U-1750-2017; Rauner, Martina/A-1665-2015	Hajishengallis, George N./0000-0001-7392-8852; Hofbauer, Lorenz C/0000-0002-8691-8423; Chmelař, Jindřich/0000-0002-7089-6143; Curtis, Mike A/0000-0002-1563-9953; Hashim, Ahmed/0000-0001-5079-3203; MEHMET AKIF, ESKAN/0000-0002-5440-0291	US National Institutes of Health, National Cancer Institute; Deutsche Forschungsgemeinschaft [SFB655/TPB10, CH279/5-1]; Medical Faculty of the University of Dresden (MedDrive); Medical Research Council UK [G0900408]; US National Institutes of Health [DE015254, DE018292, DE021580, DE021685]; Medical Research Council [MR/J011118/1, G0900408] Funding Source: researchfish; MRC [MR/J011118/1, G0900408] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015254, R01DE021685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC4DE021580, R01DE018292] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Dresden (MedDrive); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank T. Quertermous and R. Kundu (Stanford University School of Medicine) for Edil3<SUP>-/-</SUP> mice; C. M. Ballantyne (Baylor College of Medicine) for Itgal<SUP>-/-</SUP> mice; Amgen for Il17ra<SUP>-/-</SUP> mice and mAb to IL-17 (M210); Novartis for LFA878; Valentis for Del-1; and S. Gaffen for discussions and advice. Supported by the Intramural Research Program of the US National Institutes of Health, the National Cancer Institute (T. C.), Deutsche Forschungsgemeinschaft (SFB655/TPB10 and CH279/5-1 to T. C.), the Medical Faculty of the University of Dresden (MedDrive to K.-J.C.), the Medical Research Council UK (G0900408 to M. A. C.) and the Extramural Research Program of the US National Institutes of Health (DE015254, DE018292, DE021580 and DE021685 to G.H.).	Armitage GC, 2002, PERIODONTOL 2000, V30, P9, DOI 10.1034/j.1600-0757.2002.03002.x; Baker PJ, 2000, INFECT IMMUN, V68, P5864, DOI 10.1128/IAI.68.10.5864-5868.2000; Brodlie M, 2011, EUR RESPIR J, V37, P1378, DOI 10.1183/09031936.00067110; Cascao R, 2010, AUTOIMMUN REV, V9, P531, DOI 10.1016/j.autrev.2009.12.013; Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chavakis E, 2009, THROMB HAEMOSTASIS, V102, P191, DOI 10.1160/TH08-12-0844; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Genco RJ, 2010, NAT REV CARDIOL, V7, P479, DOI 10.1038/nrcardio.2010.120; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Hajishengallis G, 2010, MOL ORAL MICROBIOL, V25, P25, DOI 10.1111/j.2041-1014.2009.00562.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Huttner EA, 2009, SPEC CARE DENT, V29, P149, DOI 10.1111/j.1754-4505.2009.00082.x; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liang S, 2010, J PERIODONTAL RES, V45, P574, DOI 10.1111/j.1600-0765.2009.01245.x; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Nussbaum G, 2011, J CLIN PERIODONTOL, V38, P49, DOI 10.1111/j.1600-051X.2010.01678.x; Ohyama H, 2009, J DENT RES, V88, P633, DOI 10.1177/0022034509339889; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Weitz-Schmidt G, 2004, J BIOL CHEM, V279, P46764, DOI 10.1074/jbc.M407951200; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116	48	284	303	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					465	U64		10.1038/ni.2260	http://dx.doi.org/10.1038/ni.2260			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22447028	Green Accepted			2022-12-18	WOS:000303048400010
J	Aliberti, J; Sousa, CRE; Schito, M; Hieny, S; Wells, T; Huffnagle, GB; Sher, A				Aliberti, J; Sousa, CRE; Schito, M; Hieny, S; Wells, T; Huffnagle, GB; Sher, A			CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha(+) dendritic cells	NATURE IMMUNOLOGY			English	Article							TOXOPLASMA-GONDII; CHEMOKINE RECEPTOR-5; MACROPHAGE FUNCTION; ACUTE INFECTION; TROPIC HIV-1; IFN-GAMMA; IMMUNITY; INTERLEUKIN-12; MICE; RESPONSIVENESS	The activation of dendritic cells (DC) to produce interleukin 12 (IL-12) is thought to be a key step in the initiation of cell-mediated immunity to intracellular pathogens. Here we show that ligation of the C-C chemokine receptor (CCR) 5 can provide a major signal for the induction of IL-12 synthesis by the CD8 alpha(+) subset of DC and that this pathway is important in establishing interferon gamma-dependent resistance to the protozoan parasite Toxoplasma gondii. These findings support the concept that the early induction of chemokines by invading pathogens is a critical step not only for the recruitment of DC but also for the determination of their subsequent immunologic function.	NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Ares Serono Pharmaceut Res Inst SA, Geneva, Switzerland; Imperial Canc Res Fund, Immunobiol Lab, London WC2A 3PX, England; Univ Michigan, Med Ctr, Dept Pulm Med, Ann Arbor, MI USA; Univ Michigan, Med Ctr, Dept Immunol Microbiol, Ann Arbor, MI USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cancer Research UK; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aliberti, J (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Reis e Sousa, Caetano/ABD-7322-2021; Aliberti, Julio/G-4565-2012; Reis e Sousa, Caetano/O-1657-2014; Aliberti, Julio/I-7354-2013	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Aliberti, Julio/0000-0003-3420-8478; Wells, Timothy/0000-0001-9796-847X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, Z01AI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfano M, 1999, J EXP MED, V190, P597, DOI 10.1084/jem.190.5.597; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Lukacs NW, 1997, AM J PATHOL, V150, P1861; Meyer L, 1999, J INFECT DIS, V180, P920, DOI 10.1086/314933; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Sato N, 1999, J IMMUNOL, V163, P5519; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Sher A, 1998, EUR CYTOKINE NETW, V9, P65; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Sozzani S, 1997, J IMMUNOL, V159, P1993; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3; Zhou YH, 1998, J IMMUNOL, V160, P4018	26	284	296	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					83	87		10.1038/76957	http://dx.doi.org/10.1038/76957			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881180				2022-12-18	WOS:000089814800019
J	PrabhuDas, M; Adkins, B; Gans, H; King, C; Levy, O; Ramilo, O; Siegrist, CA				PrabhuDas, Mercy; Adkins, Becky; Gans, Hayley; King, Christopher; Levy, Ofer; Ramilo, Octavio; Siegrist, Claire-Anne			Challenges in infant immunity: implications for responses to infection and vaccines	NATURE IMMUNOLOGY			English	Article							RECENT THYMIC EMIGRANTS; CD4(+) T-CELLS; ADAPTIVE IMMUNITY; VACCINATION; AGE; DEFICIENCY; EXPRESSION; NEWBORNS; INNATE		[PrabhuDas, Mercy] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA; [Adkins, Becky] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Gans, Hayley] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [King, Christopher] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Levy, Ofer] Childrens Hosp Boston, Dept Med, Boston, MA USA; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Ramilo, Octavio] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA; [Ramilo, Octavio] Ohio State Univ, Columbus, OH 43210 USA; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Miami; Stanford University; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Geneva	PrabhuDas, M (corresponding author), NIAID, Div Allergy Immunol & Transplantat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mprabhudas@niaid.nih.gov		Levy, Ofer/0000-0002-5859-1945				Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Knuf M, 2010, J PEDIATR-US, V156, P675, DOI 10.1016/j.jpeds.2009.12.019; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Platt JL, 2009, PEDIATR TRANSPLANT, V13, P814, DOI 10.1111/j.1399-3046.2009.01143.x; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; UNICEF, 2009, STATE WORLDS CHILDRE; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; World Health Organization/United Nations (WHO/UN), 2009, GLOB ACT PLAN PREV C; Yorita KL, 2008, PEDIATRICS, V121, P244, DOI 10.1542/peds.2007-1392	25	283	286	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					189	194		10.1038/ni0311-189	http://dx.doi.org/10.1038/ni0311-189			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21321588				2022-12-18	WOS:000287354400002
J	Sambandam, A; Maillard, I; Zediak, VP; Xu, LW; Gerstein, RM; Aster, JC; Pear, WS; Bhandoola, A				Sambandam, A; Maillard, I; Zediak, VP; Xu, LW; Gerstein, RM; Aster, JC; Pear, WS; Bhandoola, A			Notch signaling controls the generation and differentiation of early T lineage progenitors	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; CELL FATE; DENDRITIC CELLS; FLT3 LIGAND; STEM-CELLS; B-CELLS; PRECURSORS; THYMUS; SPECIFICATION; THYMOCYTES	Signaling by the transmembrane receptor Notch is critical for T lineage development, but progenitor subsets that first receive Notch signals have not been defined. Here we identify an immature subset of early T lineage progenitors (ETPs) in the thymus that expressed the tyrosine kinase receptor Flt3 and had preserved B lineage potential at low progenitor frequency. Notch signaling was active in ETPs and was required for generation of the ETP population. Additionally, Notch signals contributed to the subsequent differentiation of ETPs. In contrast, multipotent hematopoietic progenitors circulated in the blood even in the absence of Notch signaling, suggesting that critical Notch signals during early T lineage development are delivered early after thymic entry.	Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Inst Med Engn, Philadelphia, PA 19104 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Aster, Jon C/B-6857-2009	Maillard, Ivan/0000-0003-1312-6748	NCI NIH HHS [T32-CA-09140] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Buza-Vidas N, 2004, BLOOD, V104, p35A; Carlyle JR, 1998, IMMUNOL REV, V165, P63, DOI 10.1111/j.1600-065X.1998.tb01230.x; Ceredig R, 2002, INT IMMUNOL, V14, P87, DOI 10.1093/intimm/14.1.87; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashimoto Y, 2002, BLOOD, V100, P3504, DOI 10.1182/blood-2002-03-0733; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Moore TA, 1997, J IMMUNOL, V158, P4187; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Perry SS, 2003, J IMMUNOL, V170, P1877, DOI 10.4049/jimmunol.170.4.1877; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834	53	283	293	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					663	670		10.1038/ni1216	http://dx.doi.org/10.1038/ni1216			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15951813				2022-12-18	WOS:000229975500009
J	Huynh, A; DuPage, M; Priyadharshini, B; Sage, PT; Quiros, J; Borges, CM; Townamchai, N; Gerriets, VA; Rathmell, JC; Sharpe, AH; Bluestone, JA; Turka, LA				Huynh, Alexandria; DuPage, Michel; Priyadharshini, Bhavana; Sage, Peter T.; Quiros, Jason; Borges, Christopher M.; Townamchai, Natavudh; Gerriets, Valerie A.; Rathmell, Jeffrey C.; Sharpe, Arlene H.; Bluestone, Jeffrey A.; Turka, Laurence A.			Control of PI(3) kinase in T-reg cells maintains homeostasis and lineage stability	NATURE IMMUNOLOGY			English	Article							FOXP3 EXPRESSION; PTEN; ACTIVATION; LEADS; IL-2; DIFFERENTIATION; INSTABILITY; EXPANSION; PROGRAMS; PATHWAYS	Foxp3(+) regulatory T cells (T-reg cells) are required for immunological homeostasis. One notable distinction between conventional T cells (T-conv cells) and T-reg cells is differences in the activity of phosphatidylinositol-3-OH kinase (PI(3)K); only T-conv cells downregulate PTEN, the main negative regulator of PI(3)K, upon activation. Here we found that control of PI(3)K in T-reg cells was essential for lineage homeostasis and stability. Mice lacking Pten in T-reg cells developed an autoimmune-lymphoproliferative disease characterized by excessive T helper type 1 (T(H)1) responses and B cell activation. Diminished control of PI(3)K activity in T-reg cells led to reduced expression of the interleukin-2 (IL-2) receptor alpha subunit CD25, accumulation of Foxp3(+) CD25(-) cells and, ultimately, loss of expression of the transcription factor Foxp3 in these cells. Collectively, our data demonstrate that control of PI(3)K signaling by PTEN in T-reg cells is critical for maintaining their homeostasis, function and stability.	[Huynh, Alexandria; Borges, Christopher M.; Turka, Laurence A.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02138 USA; [Huynh, Alexandria; Priyadharshini, Bhavana; Borges, Christopher M.; Turka, Laurence A.] Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA; [DuPage, Michel; Quiros, Jason; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [DuPage, Michel; Quiros, Jason; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Sage, Peter T.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol, Div Immunol, Boston, MA USA; [Townamchai, Natavudh] Chulalongkorn Univ, Dept Med, Div Nephrol, Bangkok, Thailand; [Townamchai, Natavudh] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Gerriets, Valerie A.; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Chulalongkorn University; Chulalongkorn University; Duke University	Turka, LA (corresponding author), Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02138 USA.	lturka@partners.org	Gerriets, Valerie/AAD-6611-2019	Gerriets, Valerie/0000-0002-1553-2590	US National Institutes of Health [R56AI083304, 01HL018646, R21AI105607, T32AI007529, P01AI56299]; Cancer Research Institute [1S10RR023440]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627, R01HL108006, P01HL018646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007529, R56AI083304, R21AI105607, T32AI007334, R01AI046643, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550, P30DK063720] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Rudensky (Memorial Sloan Kettering Cancer Center) for Foxp3-YFP-Cre mice and Foxp3<SUP>eGFP-Cre-ERT2</SUP>Rosa26-YFP mice. Supported by the US National Institutes of Health (R56AI083304 and 01HL018646 to L.A.T.; R21AI105607 to L.A.T. and J.A.B.; T32AI007529 to C.M.B.; and P01AI56299 to P.T.S., A.H.S. and L.A.T.), the Cancer Research Institute (A.H.) and (1S10RR023440).	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Badea TC, 2003, J NEUROSCI, V23, P2314; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huynh A, 2014, IMMUNOL REV, V258, P117, DOI 10.1111/imr.12148; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu XH, 2010, J CLIN INVEST, V120, P2497, DOI 10.1172/JCI42382; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Xiong HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084841; Zanin-Zhorov A, 2012, P NATL ACAD SCI USA, V109, P1625, DOI 10.1073/pnas.1110120109; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	50	282	297	4	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					188	+		10.1038/ni.3077	http://dx.doi.org/10.1038/ni.3077			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25559257	Green Submitted, Green Accepted			2022-12-18	WOS:000348143100011
J	Kidani, Y; Elsaesser, H; Hock, MB; Vergnes, L; Williams, KJ; Argus, JP; Marbois, BN; Komisopoulou, E; Wilson, EB; Osborne, TF; Graeber, TG; Reue, K; Brooks, DG; Bensinger, SJ				Kidani, Yoko; Elsaesser, Heidi; Hock, M. Benjamin; Vergnes, Laurent; Williams, Kevin J.; Argus, Joseph P.; Marbois, Beth N.; Komisopoulou, Evangelia; Wilson, Elizabeth B.; Osborne, Timothy F.; Graeber, Thomas G.; Reue, Karen; Brooks, David G.; Bensinger, Steven J.			Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity	NATURE IMMUNOLOGY			English	Article							FATTY-ACID SYNTHESIS; ANTIGEN RECEPTOR; LIPID RAFTS; CHOLESTEROL; MEMORY; MICE; HOMEOSTASIS; ACTIVATION; PATHWAY; MYC	Newly activated CD8(+) T cells reprogram their metabolism to meet the extraordinary biosynthetic demands of clonal expansion; however, the signals that mediate metabolic reprogramming remain poorly defined. Here we demonstrate an essential role for sterol regulatory element-binding proteins (SREBPs) in the acquisition of effector-cell metabolism. Without SREBP signaling, CD8(+) T cells were unable to blast, which resulted in attenuated clonal expansion during viral infection. Mechanistic studies indicated that SREBPs were essential for meeting the heightened lipid requirements of membrane synthesis during blastogenesis. SREBPs were dispensable for homeostatic proliferation, which indicated a context-specific requirement for SREBPs in effector responses. Our studies provide insights into the molecular signals that underlie the metabolic reprogramming of CD8(+) T cells during the transition from quiescence to activation.	[Kidani, Yoko; Hock, M. Benjamin; Williams, Kevin J.; Argus, Joseph P.; Marbois, Beth N.; Graeber, Thomas G.; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Kidani, Yoko; Hock, M. Benjamin; Williams, Kevin J.; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Elsaesser, Heidi; Wilson, Elizabeth B.; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Elsaesser, Heidi; Wilson, Elizabeth B.; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Argus, Joseph P.; Komisopoulou, Evangelia; Graeber, Thomas G.; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Marbois, Beth N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Osborne, Timothy F.] Sanford Burnham Med Res Inst, Diabet & Obes Ctr, Metab Signaling & Dis Program, Orlando, FL USA; [Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Bensinger, SJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA.	sbensinger@mednet.ucla.edu		Brooks, David/0000-0001-7763-8764; vergnes, laurent/0000-0002-8804-589X; Graeber, Thomas/0000-0001-8574-9181	US National Institutes of Health [AI093768, AI082975, AI085043]; Jonsson Comprehensive Cancer Center Foundation of the University of California, Los Angeles; National Center for Research Resources [S10RR026744]; National Cancer Institute of the US National Institutes of Health [T32-CA009120-36]; US Public Health Service [T32-GM008469]; University of California, Los Angeles, Graduate Division; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL048044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768, R01AI085043, U01AI082975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center Foundation of the University of California, Los Angeles; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of California, Los Angeles, Graduate Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tone and M. Tone (Cedars-Sinai Medical Center) for retroviral vector MIGR1; T. Osborne (Sanford-Burnham Medical Research Institute) for polyclonal antibody to SREBP1 or SREBP2; A. Do, L. Pang, A. Armijo and C. Radu for technical assistance; and P. Tontonoz and M. Day for critical feedback on the manuscript. Supported by the US National Institutes of Health (AI093768 to S.J.B., and AI082975 and AI085043 to D. G. B.), the Jonsson Comprehensive Cancer Center Foundation of the University of California, Los Angeles (S.J.B. and Y. K.), the National Center for Research Resources (S10RR026744 to L. V. and K. R.), the National Cancer Institute of the US National Institutes of Health (T32-CA009120-36 to K.J.W.), the US Public Health Service (T32-GM008469 to J.P.A.) and the University of California, Los Angeles, Graduate Division (J.P.A.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boren J, 2001, J BIOL CHEM, V276, P37747; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Geyeregger R, 2009, J LEUKOCYTE BIOL, V86, P1039, DOI 10.1189/jlb.1008663; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; He HT, 2005, SEMIN IMMUNOL, V17, P23, DOI 10.1016/j.smim.2004.09.001; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	37	282	293	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					489	+		10.1038/ni.2570	http://dx.doi.org/10.1038/ni.2570			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23563690	Green Accepted, Green Submitted			2022-12-18	WOS:000317732100014
J	Yu, P; Lee, YJ; Liu, WH; Chin, RK; Wang, J; Wang, Y; Schietinger, A; Philip, M; Schreiber, H; Fu, YX				Yu, P; Lee, YJ; Liu, WH; Chin, RK; Wang, J; Wang, Y; Schietinger, A; Philip, M; Schreiber, H; Fu, YX			Priming of naive T cells inside tumors leads to eradication of established tumors	NATURE IMMUNOLOGY			English	Article							HERPESVIRUS ENTRY MEDIATOR; SECONDARY LYMPHOID-TISSUES; LYMPHOTOXIN BETA-RECEPTOR; ANTIGENIC CANCER-CELLS; IN-VIVO; IMMUNOLOGICAL IGNORANCE; DENDRITIC CELLS; NECROSIS-FACTOR; STROMAL CELLS; GENE-TRANSFER	The tumor barrier comprised of nonantigenic stromal cells may contribute to the failure of tumor rejection. The tumor-necrosis factor superfamily member LIGHT (also known as TNFSF-14) is a ligand of stromal cell-expressed lymphotoxin-receptor and T cell-expressed herpes viral entry mediator (HVEM). Here we show that forced expression of LIGHT in the tumor environment induces a massive infiltration of naive T lymphocytes that correlates with an upregulation of both chemokine production and expression of adhesion molecules. Activation of these infiltrating T cells, possibly through HVEM, leads to the rejection of established, highly progressive tumors at local and distal sites. Our study indicates that targeting the tumor barrier may be an effective strategy for cancer immunotherapy.	Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Fu, YX (corresponding author), Univ Chicago, Comm Immunol, MC3083, Chicago, IL 60637 USA.	yfu@midway.uchicago.edu	Wang, Jing Hong/M-7813-2015	Wang, Jing Hong/0000-0003-4343-2527; fu, yang-xin/0000-0001-8441-6617	NCI NIH HHS [P01 CA 09296-01] Funding Source: Medline; NICHD NIH HHS [R01 HD 37104] Funding Source: Medline; NIDDK NIH HHS [R01 DK 58897, 5T32 DK 07074] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058897, T32DK007074] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai XF, 2001, CANCER RES, V61, P6860; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; Chen LP, 1998, IMMUNOL TODAY, V19, P27, DOI 10.1016/S0167-5699(97)01180-8; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Harrop JA, 1998, J IMMUNOL, V161, P1786; HATHCOCK KS, 1991, CURRENT PROTOCOLS IM; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Lee KH, 1999, J IMMUNOL, V163, P6292; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; PERDRIZET GA, 1990, J EXP MED, V171, P1205, DOI 10.1084/jem.171.4.1205; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Rosenberg SA, 2001, J INTERN MED, V250, P462, DOI 10.1046/j.1365-2796.2001.00911.x; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Schrama D, 2001, IMMUNITY, V14, P111, DOI 10.1016/S1074-7613(09)00094-6; Sharma S, 2000, J IMMUNOL, V164, P4558, DOI 10.4049/jimmunol.164.9.4558; Sharma Sherven, 2003, Mol Cancer, V2, P22; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Tamada K, 2000, NAT MED, V6, P283; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Wang J, 2002, EUR J IMMUNOL, V32, P1969, DOI 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Yu P, 2003, J EXP MED, V197, P985, DOI 10.1084/jem.20021804; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	49	282	309	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					141	149		10.1038/ni1029	http://dx.doi.org/10.1038/ni1029			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14704792				2022-12-18	WOS:000188512000009
J	Di Paolo, NC; Shayakhmetov, DM				Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.			Interleukin 1 alpha and the inflammatory process	NATURE IMMUNOLOGY			English	Review							SYSTEMIC-SCLEROSIS FIBROBLASTS; PANCREATIC-CANCER CELLS; SMOOTH-MUSCLE-CELLS; N-TERMINAL PROPIECE; KAPPA-B ACTIVATION; ENDOGENOUS IL-1-ALPHA; STERILE INFLAMMATION; CUTTING EDGE; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS	Inflammation occurs after disruption of tissue homeostasis by cell stress, injury or infection and ultimately involves the recruitment and retention of cells of hematopoietic origin, which arrive at the affected sites to resolve damage and initiate repair. Interleukin 1 alpha (IL-1 alpha) and IL-1 beta are equally potent inflammatory cytokines that activate the inflammatory process, and their deregulated signaling causes devastating diseases manifested by severe acute or chronic inflammation. Although much attention has been given to understanding the biogenesis of IL-1 beta, the biogenesis of IL-1 alpha and its distinctive role in the inflammatory process remain poorly defined. In this review we examine key aspects of IL-1 alpha biology and regulation and discuss its emerging importance in the initiation and maintenance of inflammation that underlie the pathology of many human diseases.	[Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.] Emory Univ, Sch Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Sch Med, Dept Pediat, Ctr Transplantat & Immune Mediated Disorders, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Sch Med, Dept Pediat, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Shayakhmetov, Dmitry M.] Emory Univ, Sch Med, Dept Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Shayakhmetov, DM (corresponding author), Emory Univ, Sch Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.; Shayakhmetov, DM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr Transplantat & Immune Mediated Disorders, Atlanta, GA 30322 USA.; Shayakhmetov, DM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Shayakhmetov, DM (corresponding author), Emory Univ, Sch Med, Dept Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	dmitryshay@emory.edu			US National Institutes of Health (NIH) [AI065429, AI126816, AI107960, AI123126]; Children's Healthcare of Atlanta Research Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123126, R01AI065429, R21AI126816, R01AI107960] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta Research Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (NIH) grants AI065429, AI126816 and AI107960 (D.M.S.), AI123126 (N.C.D.P.) and the Children's Healthcare of Atlanta Research Trust (D.M.S.).	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Ainscough JS, 2014, J BIOL CHEM, V289, P35582, DOI 10.1074/jbc.M114.595686; Alheim K, 1996, NEUROCHEM INT, V29, P487, DOI 10.1016/0197-0186(96)00017-4; Bailly S, 1996, EUR CYTOKINE NETW, V7, P125; BAKOUCHE O, 1987, J IMMUNOL, V138, P4249; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Berda-Haddad Y, 2011, P NATL ACAD SCI USA, V108, P20684, DOI 10.1073/pnas.1116848108; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; BEUSCHER HU, 1988, J BIOL CHEM, V263, P4023; BRODY DT, 1989, J IMMUNOL, V143, P1183; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; cDNA, 1984, P NATL ACAD SCI US, V81, P7907; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Charbonneau B, 2014, CANCER RES, V74, P852, DOI 10.1158/0008-5472.CAN-13-1051; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; Di Paolo NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004035; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1974, J EXP MED, V139, P1369, DOI 10.1084/jem.139.6.1369; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello Charles Anthony, 2014, Mol Med, V20 Suppl 1, pS43, DOI 10.2119/molmed.2014.00232; Dinarello CA, 2014, LANCET ONCOL, V15, P552, DOI 10.1016/S1470-2045(14)70164-0; Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; England H, 2014, J BIOL CHEM, V289, P15942, DOI 10.1074/jbc.M114.557561; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; GIRI JG, 1985, J IMMUNOL, V134, P343; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hong DS, 2014, LANCET ONCOL, V15, P656, DOI 10.1016/S1470-2045(14)70155-X; Idan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14756; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kawaguchi Y, 2004, J RHEUMATOL, V31, P1946; KAWAGUCHI Y, 1992, BIOCHEM BIOPH RES CO, V184, P1504, DOI 10.1016/S0006-291X(05)80053-1; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; Kawaguchi Y, 2007, IMMUNOGENETICS, V59, P441, DOI 10.1007/s00251-007-0213-y; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kimura H, 1998, CYTOKINE, V10, P872, DOI 10.1006/cyto.1998.0369; KOBAYASHI Y, 1988, J IMMUNOL, V140, P2279; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; KURTJONES EA, 1986, J IMMUNOL, V137, P10; KURTJONES EA, 1987, J IMMUNOL, V139, P2317; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; KURTJONES EA, 1985, J IMMUNOL, V135, P1548; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lamacchia C, 2013, CYTOKINE, V63, P135, DOI 10.1016/j.cyto.2013.04.010; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Leon X, 2015, ONCOTARGET, V6, P37407, DOI 10.18632/oncotarget.6054; Loffek S, 2005, J INVEST DERMATOL, V124, P638, DOI 10.1111/j.0022-202X.2005.23629.x; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; Lugrin J, 2015, J IMMUNOL, V194, P499, DOI 10.4049/jimmunol.1401948; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Maffei CML, 2004, INFECT IMMUN, V72, P2338, DOI 10.1128/IAI.72.4.2338-2349.2004; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mandinova A, 2003, J CELL SCI, V116, P2687, DOI 10.1242/jcs.00471; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McCarthy DA, 2013, J BIOL CHEM, V288, P32149, DOI 10.1074/jbc.M113.493841; McCarthy DA, 2013, REDOX BIOL, V1, P218, DOI 10.1016/j.redox.2013.03.001; McDowell TL, 2005, CYTOKINE, V30, P141, DOI 10.1016/j.cyto.2004.12.010; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Murakami Y, 2013, J BIOL CHEM, V288, P25025, DOI 10.1074/jbc.M113.472068; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Niu JG, 2004, J BIOL CHEM, V279, P16452, DOI 10.1074/jbc.M309789200; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Stevenson FT, 1997, P NATL ACAD SCI USA, V94, P508, DOI 10.1073/pnas.94.2.508; STEVENSON FT, 1993, P NATL ACAD SCI USA, V90, P7245, DOI 10.1073/pnas.90.15.7245; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Tjomsland V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070874; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; van Rietschoten JGI, 2006, BLOOD, V108, P2143, DOI 10.1182/blood-2006-01-021147; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Zamostna B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041801; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	107	281	287	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					906	913		10.1038/ni.3503	http://dx.doi.org/10.1038/ni.3503			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434011	Green Accepted			2022-12-18	WOS:000380647000007
J	Nold-Petry, CA; Lo, CY; Rudloff, I; Elgass, KD; Li, SZ; Gantier, MP; Lotz-Havla, AS; Gersting, SW; Cho, SX; Lao, JC; Ellisdon, AM; Rotter, B; Azam, T; Mangan, NE; Rossello, FJ; Whisstock, JC; Bufler, P; Garlanda, C; Mantovani, A; Dinarello, CA; Nold, MF				Nold-Petry, Claudia A.; Lo, Camden Y.; Rudloff, Ina; Elgass, Kirstin D.; Li, Suzhao; Gantier, Michael P.; Lotz-Havla, Amelie S.; Gersting, Soren W.; Cho, Steven X.; Lao, Jason C.; Ellisdon, Andrew M.; Rotter, Bjoern; Azam, Tania; Mangan, Niamh E.; Rossello, Fernando J.; Whisstock, James C.; Bufler, Philip; Garlanda, Cecilia; Mantovani, Alberto; Dinarello, Charles A.; Nold, Marcel F.			IL-37 requires the receptors IL-18R alpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction	NATURE IMMUNOLOGY			English	Article							FAMILY-MEMBER; NEGATIVE REGULATOR; TOLL; INFLAMMATION; CELLS; EXPRESSION; INHIBITOR; TIR8/SIGIRR; MOLECULES; INFECTION	Interleukin 37 (IL-37) and IL-1R8 (SIGIRR or TIR8) are anti-inflammatory orphan members of the IL-1 ligand family and IL-1 receptor family, respectively. Here we demonstrate formation and function of the endogenous ligand-receptor complex IL-37-IL-1R8-IL-18R alpha. The tripartite complex assembled rapidly on the surface of peripheral blood mononuclear cells upon stimulation with lipopolysaccharide. Silencing of IL-1R8 or IL-18R alpha impaired the anti-inflammatory activity of IL-37. Whereas mice with transgenic expression of IL-37 (IL-37tg mice) with intact IL-1R8 were protected from endotoxemia, IL-1R8-deficient IL-37tg mice were not. Proteomic and transcriptomic investigations revealed that IL-37 used IL-1R8 to harness the anti-inflammatory properties of the signaling molecules Mer, PTEN, STAT3 and p62(dok) and to inhibit the kinases Fyn and TAK1 and the transcription factor NF-kappa B, as well as mitogen-activated protein kinases. Furthermore, IL-37-IL-1R8 exerted a pseudo-starvational effect on the metabolic checkpoint kinase mTOR. IL-37 thus bound to IL-18R alpha and exploited IL-1R8 to activate a multifaceted intracellular anti-inflammatory program.	[Nold-Petry, Claudia A.; Lo, Camden Y.; Rudloff, Ina; Cho, Steven X.; Lao, Jason C.; Nold, Marcel F.] MIMR PHI Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Nold-Petry, Claudia A.; Rudloff, Ina; Cho, Steven X.; Lao, Jason C.; Nold, Marcel F.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Lo, Camden Y.; Elgass, Kirstin D.] Monash Univ, Monash Micro Imaging, Melbourne, Vic 3004, Australia; [Li, Suzhao; Azam, Tania; Dinarello, Charles A.; Nold, Marcel F.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Gantier, Michael P.] MIMR PHI Inst Med Res, Ctr Canc Res, Melbourne, Vic, Australia; [Gantier, Michael P.] Monash Univ, Dept Mol & Translat Sci, Melbourne, Vic 3004, Australia; [Lotz-Havla, Amelie S.; Gersting, Soren W.] Univ Munich, Mol Pediat, Munich, Germany; [Ellisdon, Andrew M.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Ellisdon, Andrew M.; Whisstock, James C.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic 3004, Australia; [Rotter, Bjoern] GenXPro, Frankfurt, Germany; [Mangan, Niamh E.] MIMR PHI Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic, Australia; [Rossello, Fernando J.] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Bufler, Philip] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Rozzano, Italy; [Mantovani, Alberto] Humanitas Univ, Rozzano, Italy; [Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Prince Henry's Institute of Medical Research; Monash University; Monash University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Prince Henry's Institute of Medical Research; Monash University; University of Munich; Monash University; Monash University; Prince Henry's Institute of Medical Research; Monash University; University of Munich; IRCCS Humanitas Research Hospital; Humanitas University; IRCCS Humanitas Research Hospital; Radboud University Nijmegen	Nold, MF (corresponding author), MIMR PHI Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.	marcel.nold@monash.edu	Cho, Steven/P-6535-2019; Garlanda, Cecilia/K-4601-2016; Gantier, Michael/H-7954-2019; Rossello, Fernando/B-1208-2015; Mantovani, Alberto/HCI-7449-2022; Gantier, Michael/B-7512-2011; Dinarello, Charles/C-8524-2013; Rudloff, Ina/P-4222-2019; Gersting, Soeren/D-4612-2011	Garlanda, Cecilia/0000-0002-1510-7703; Gantier, Michael/0000-0003-3740-698X; Rossello, Fernando/0000-0003-3885-8777; Mantovani, Alberto/0000-0001-5578-236X; Gantier, Michael/0000-0003-3740-698X; Rudloff, Ina/0000-0002-7885-110X; Bufler, Philip/0000-0002-5742-8273; Nold, Marcel/0000-0001-9682-4618; Mangan, Niamh/0000-0003-3844-0709; Ellisdon, Andrew/0000-0002-2248-9914; Gersting, Soeren/0000-0001-7482-4748; Cho, Steven/0000-0002-4057-2092; Lo, Camden/0000-0002-6215-2363; Whisstock, James/0000-0003-4200-5611; Nold, Claudia/0000-0002-7439-3834	National Health and Medical Research Council [1012353, 1043845, 1022144]; National Heart Foundation of Australia [100480]; Monash University (Larkins Fellowship); MIMR-PHI (Star Recruitment Fellowship); Australian Research Council [DP110103616]; US National Institutes of Health [AI-15614, AR-45584, CA-04 6934]; Deutsche Forschungsgemeinschaft [Bu 1222/3-3]; American Heart Association [12Post12030134]; Victorian Government's Operational Infrastructure Support Program; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015614, R01AI015614, R37AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Monash University (Larkins Fellowship); MIMR-PHI (Star Recruitment Fellowship); Australian Research Council(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Heart Association(American Heart Association); Victorian Government's Operational Infrastructure Support Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Gould and L. D'Andrea for technical support; S.-H. Kim for scientific insights; and C. Nowell (Monash Institute of Pharmaceutical Science) for access to and assisting with the use of the Leica GSD microscope. Supported by the National Health and Medical Research Council (1012353 and 1043845 to C.A.N.-P. and M.F.N.; 1022144 to MPG), the National Heart Foundation of Australia (100480 to C.A.N.-P.), Monash University (Larkins Fellowship to M.F.N.), MIMR-PHI (Star Recruitment Fellowship to M.F.N.), Australian Research Council (DP110103616 to N.E.M.), the US National Institutes of Health (AI-15614, AR-45584 to C.A.D.; core facilities of CA-04 6934 to CAD.), Deutsche Forschungsgemeinschaft (Bu 1222/3-3 to P.B.), the American Heart Association (12Post12030134 to S.L.) and the Victorian Government's Operational Infrastructure Support Program.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Ballak DB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5711; Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bozza S, 2008, J IMMUNOL, V180, P4022, DOI 10.4049/jimmunol.180.6.4022; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; De Paula ML, 2014, GLIA, V62, P64, DOI 10.1002/glia.22584; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Drexler SK, 2010, ARTHRITIS RHEUM-US, V62, P2249, DOI 10.1002/art.27517; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Heindl M, 2012, GASTROENTEROLOGY, V142, P1093, DOI 10.1053/j.gastro.2012.01.011; Horne DJ, 2012, J INFECT DIS, V205, P586, DOI 10.1093/infdis/jir785; Korb M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-7; Kumar S, 2002, COMPUT SCI ENG, V4, P18, DOI 10.1109/MCISE.2002.976433; Lech M, 2007, KIDNEY INT, V72, P182, DOI 10.1038/sj.ki.5002293; Lee TWA, 2013, DIABETES, V62, P1537, DOI 10.2337/db12-0920; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Polentarutti N, 2003, EUR CYTOKINE NETW, V14, P211; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Ward PA, 2013, NAT MED, V19, P1368, DOI 10.1038/nm.3387; Wermeling F, 2013, P NATL ACAD SCI USA, V110, P13487, DOI 10.1073/pnas.1312525110	46	281	309	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					354	365		10.1038/ni.3103	http://dx.doi.org/10.1038/ni.3103			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25729923				2022-12-18	WOS:000351333700008
J	Vavassori, S; Kumar, A; Wan, GS; Ramanjaneyulu, GS; Cavallari, M; El Daker, S; Beddoe, T; Theodossis, A; Williams, NK; Gostick, E; Price, DA; Soudamini, DU; Voon, KK; Olivo, M; Rossjohn, J; Mori, L; De Libero, G				Vavassori, Stefano; Kumar, Anil; Wan, Gan Siok; Ramanjaneyulu, Gundimeda S.; Cavallari, Marco; El Daker, Sary; Beddoe, Travis; Theodossis, Alex; Williams, Neal K.; Gostick, Emma; Price, David A.; Soudamini, Dinish U.; Voon, Kong Kien; Olivo, Malini; Rossjohn, Jamie; Mori, Lucia; De Libero, Gennaro			Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gamma delta T cells	NATURE IMMUNOLOGY			English	Article							PRENYL PYROPHOSPHATE ANTIGENS; NONPEPTIDE ANTIGENS; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; MOLECULES; RECOGNITION; ACTIVATION; RECEPTOR; COMPLEX; METABOLITES	Human T cells that express a T cell antigen receptor (TCR) containing g-chain variable region 9 and gamma-chain variable region 2 (V(gamma)9V(delta)2) recognize phosphorylated prenyl metabolites as antigens in the presence of antigen-presenting cells but independently of major histocompatibility complex (MHC), the MHC class I-related molecule MR1 and antigen-presenting CD1 molecules. Here we used genetic approaches to identify the molecule that binds and presents phosphorylated antigens. We found that the butyrophilin BTN3A1 bound phosphorylated antigens with low affinity, at a stoichiometry of 1:1, and stimulated mouse T cells with transgenic expression of a human V(gamma)9V(delta)2 TCR. The structures of the BTN3A1 distal domain in complex with host-or microbe-derived phosphorylated antigens had an immunoglobulin-like fold in which the antigens bound in a shallow pocket. Soluble V(gamma)9V(delta)2 TCR interacted specifically with BTN3A1-antigen complexes. Accordingly, BTN3A1 represents an antigen-presenting molecule required for the activation of V(gamma)9V(delta)2 T cells.	[Vavassori, Stefano; Ramanjaneyulu, Gundimeda S.; Cavallari, Marco; Mori, Lucia; De Libero, Gennaro] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Kumar, Anil; Wan, Gan Siok; El Daker, Sary; Mori, Lucia; De Libero, Gennaro] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Beddoe, Travis; Theodossis, Alex; Williams, Neal K.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gostick, Emma; Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Soudamini, Dinish U.; Voon, Kong Kien; Olivo, Malini] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Singapore, Singapore	University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Monash University; Cardiff University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	De Libero, G (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	gennaro.delibero@unibas.ch	Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014; Price, David A/C-7876-2013; Vavassori, Stefano/AAI-9606-2020; De Libero, Gennaro/P-2694-2017	Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Price, David A/0000-0001-9416-2737; Vavassori, Stefano/0000-0002-7452-7978; De Libero, Gennaro/0000-0003-0853-7868; Olivo, Malini/0000-0002-1795-8683	Singapore Immunology Network of the Agency for Science, Technology and Research; Swiss National Foundation; Oncosuisse; Wellcome Trust; Medical Research Council Australia; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Singapore Immunology Network of the Agency for Science, Technology and Research; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Oncosuisse; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Australia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H.-J. Gober, M. Kistowska, A. Donda and Y. Uematsu for 'pioneer' experiments; S. Sansano, L. Angman and J.Y. Siew for technical assistance; F. Zolezzi, J. Lum, H. H. Jang, J. Chen and M. Poidinger for microarray data and analysis; P. Cresswell (Yale University) for the 721.174, 721.221 and 721.220 cell lines; K.-H. Grzeschik (Philipps University of Marburg) for the Call A9.1.9.9 and Call A9.1.13.10 cell lines; E. Mellins (Stanford University) for the 5.2.4 cell line; M. Heim (University of Basel) for the HuH7 line; G. Spagnoli (University of Basel) for the BS125-3 cell line and the MART-1-specific, HLA-2-restricted T cell clone; E. Palmer (University of Basel) for OT-II mice; C.-H. Chiang and G. Gruber for assistance with structural studies; and N. McCarthy for revising the manuscript. Supported by Singapore Immunology Network of the Agency for Science, Technology and Research, the Swiss National Foundation (G. D. L.), Oncosuisse (L. M. and G. D. L.), the Wellcome Trust (D. A. P.) and Medical Research Council Australia (J.R.).	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; BURK MR, 1995, EUR J IMMUNOL, V25, P2052, DOI 10.1002/eji.1830250737; Carena I, 1997, J EXP MED, V186, P1769, DOI 10.1084/jem.186.10.1769; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; GOODFELLOW PN, 1982, P NATL ACAD SCI-BIOL, V79, P1190, DOI 10.1073/pnas.79.4.1190; Green AE, 2004, CLIN EXP IMMUNOL, V136, P472, DOI 10.1111/j.1365-2249.2004.02472.x; Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kato Y, 2003, J IMMUNOL, V170, P3608, DOI 10.4049/jimmunol.170.7.3608; KHILKO SN, 1995, J IMMUNOL METHODS, V183, P77, DOI 10.1016/0022-1759(95)00033-7; Kho KW, 2012, ACS NANO, V6, P4892, DOI 10.1021/nn300352b; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; LANG F, 1995, J IMMUNOL, V154, P5986; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Messal N, 2011, EUR J IMMUNOL, V41, P3443, DOI 10.1002/eji.201141404; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 2001, J IMMUNOL, V167, P36, DOI 10.4049/jimmunol.167.1.36; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; ORPHANOS V, 1995, MAMM GENOME, V6, P285, DOI 10.1007/BF00352418; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; PAPPAS GJ, 1995, GENOMICS, V25, P124, DOI 10.1016/0888-7543(95)80117-5; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Reichenberg A, 2003, BIOORG MED CHEM LETT, V13, P1257, DOI 10.1016/S0960-894X(03)00138-0; SAKAGUCHI AY, 1984, MOL CELL BIOL, V4, P989, DOI 10.1128/MCB.4.5.989; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TRENT JM, 1989, CANCER RES, V49, P420; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156	50	281	283	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					908	+		10.1038/ni.2665	http://dx.doi.org/10.1038/ni.2665			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23872678				2022-12-18	WOS:000323377700008
J	Banchereau, J; Pascual, V; O'Garra, A				Banchereau, Jacques; Pascual, Virginia; O'Garra, Anne			From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; IMMUNOLOGICAL SELF-TOLERANCE; LATENT TGF-BETA; DENDRITIC CELLS; IN-VIVO; INTERLEUKIN-2 DEFICIENT; IMMUNE DYSREGULATION; EXPRESSION; INDUCTION	Feedback regulatory circuits provided by regulatory T cells (T-reg cells) and suppressive cytokines are an intrinsic part of the immune system, along with effector functions. Here we discuss some of the regulatory cytokines that have evolved to permit tolerance to components of self as well as the eradication of pathogens with minimal collateral damage to the host. Interleukin 2 (IL-2), IL-10 and transforming growth factor-beta (TGF-beta) are well characterized, whereas IL-27, IL-35 and IL-37 represent newcomers to the spectrum of anti-inflammatory cytokines. We also emphasize how information accumulated through in vitro as well as in vivo studies of genetically engineered mice can help in the understanding and treatment of human diseases.	[Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London, England	Baylor Scott & White Health; MRC National Institute for Medical Research	Banchereau, J (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	jacques.banchereau@gmail.com	Pascual, Virginia/ABD-3099-2020	O'Garra, Anne/0000-0001-9845-6134	Medical Research Council, UK [U117565642]; US National Institutes of Health [AR050770-02, AIO82715]; MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770] Funding Source: NIH RePORTER	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Howes for reading and proofing the manuscript. Supported by the Medical Research Council, UK (U117565642 to A.O.G.) and the US National Institutes of Health (AR050770-02 and AIO82715 to VP.).	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Deenick EK, 2011, CURR OPIN IMMUNOL, V23, P111, DOI 10.1016/j.coi.2010.10.007; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Dibra D, 2012, HEPATOLOGY, V55, P1204, DOI 10.1002/hep.24814; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hippen KL, 2011, SEMIN IMMUNOL, V23, P462, DOI 10.1016/j.smim.2011.07.008; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kumar S, 2002, COMPUT SCI ENG, V4, P18, DOI 10.1109/MCISE.2002.976433; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Liston A, 2007, IMMUNOL CELL BIOL, V85, P338, DOI 10.1038/sj.icb.7100049; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Malek TR, 2012, IMMUNITY, V36, P702, DOI 10.1016/j.immuni.2012.05.005; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Miyara M, 2009, J ALLERGY CLIN IMMUN, V123, P749, DOI 10.1016/j.jaci.2009.03.001; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rabinovitch A, 2002, DIABETES, V51, P638, DOI 10.2337/diabetes.51.3.638; Regateiro FS, 2011, CURR OPIN IMMUNOL, V23, P660, DOI 10.1016/j.coi.2011.07.003; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schwager K, 2011, HUM REPROD, V26, P2344, DOI 10.1093/humrep/der195; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Seyer M, 2010, EUR J IMMUNOL, V40, P321, DOI 10.1002/eji.200939527; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	131	281	302	0	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					925	931		10.1038/ni.2406	http://dx.doi.org/10.1038/ni.2406			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990890	Green Accepted			2022-12-18	WOS:000309038600005
J	Carretero, R; Sektioglu, IM; Garbi, N; Salgado, OC; Beckhove, P; Hammerling, GJ				Carretero, Rafael; Sektioglu, Ibrahim M.; Garbi, Natalio; Salgado, Oscar C.; Beckhove, Philipp; Haemmerling, Guenter J.			Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							VASCULAR NORMALIZATION; MYELOID CELLS; IMMUNOTHERAPY; MICE; INTERLEUKIN-4; DISEASE; HEALTH; GROWTH; TUMORIGENESIS; INFLAMMATION	Tumor-associated eosinophilia is frequently observed in cancer. However, despite numerous studies of patients with cancer and mouse models of cancer, it has remained uncertain if eosinophils contribute to tumor immunity or are mere bystander cells. Here we report that activated eosinophils were essential for tumor rejection in the presence of tumor-specific CD8(+) T cells. Tumor-homing eosinophils secreted chemoattractants that guided T cells into the tumor, which resulted in tumor eradication and survival. Activated eosinophils initiated substantial changes in the tumor microenvironment, including macrophage polarization and normalization of the tumor vasculature, which are known to promote tumor rejection. Thus, our study presents a new concept for eosinophils in cancer that may lead to novel therapeutic strategies.	[Carretero, Rafael; Sektioglu, Ibrahim M.; Garbi, Natalio; Salgado, Oscar C.; Haemmerling, Guenter J.] German Canc Res Ctr, Div Mol Immunol, Heidelberg, Germany; [Beckhove, Philipp] German Canc Res Ctr, Div Translat Immunol, Heidelberg, Germany; [Beckhove, Philipp] Univ Clin, Regensburg Ctr Intervent Immunol, Regensburg, Germany; [Beckhove, Philipp] Univ Regensburg, D-93053 Regensburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; University of Regensburg	Hammerling, GJ (corresponding author), German Canc Res Ctr, Div Mol Immunol, Heidelberg, Germany.	hammerling@dkfz.de			Wilhelm Sander Stiftung [2009.022.2]; German Cancer Research Center; Israel Ministry of Science, Technology and Space; Bonn Cluster of Excellence	Wilhelm Sander Stiftung; German Cancer Research Center(Helmholtz Association); Israel Ministry of Science, Technology and Space; Bonn Cluster of Excellence	We thank S. Schmitt for technical assistance; L. Umansky for multiplex analysis of cytokines; and T. Tuting (University of Bonn) for HCmel melanoma cells. Supported by Wilhelm Sander Stiftung (2009.022.2 to G.J.H.), the Cooperation Program in Cancer Research by the German Cancer Research Center, the Israel Ministry of Science, Technology and Space (G.J.H.) and the Bonn Cluster of Excellence to (N.G.).	Cormier SA, 2006, J LEUKOCYTE BIOL, V79, P1131, DOI 10.1189/jlb.0106027; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Davis BP, 2014, CANCER IMMUNOL RES, V2, P1, DOI 10.1158/2326-6066.CIR-13-0196; Delyon J, 2013, ANN ONCOL, V24, P1697, DOI 10.1093/annonc/mdt027; Domschke C, 2009, CANCER RES, V69, P8420, DOI 10.1158/0008-5472.CAN-09-1627; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Ganss R, 2002, CANCER RES, V62, P1462; Garbi N, 2004, J IMMUNOL, V172, P5861, DOI 10.4049/jimmunol.172.10.5861; Gatault S, 2012, CANCER IMMUNOL IMMUN, V61, P1527, DOI 10.1007/s00262-012-1288-3; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; HULAND E, 1992, J CANCER RES CLIN, V118, P463, DOI 10.1007/BF01629431; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kita H, 2011, IMMUNOL REV, V242, P161, DOI 10.1111/j.1600-065X.2011.01026.x; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; KRUGERKRASAGAKES S, 1993, EUR J IMMUNOL, V23, P992, DOI 10.1002/eji.1830230438; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liu LY, 2007, J IMMUNOL, V179, P4840, DOI 10.4049/jimmunol.179.7.4840; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Melo RCN, 2013, ALLERGY, V68, P274, DOI 10.1111/all.12103; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Munitz A, 2004, ALLERGY, V59, P268, DOI 10.1111/j.1398-9995.2003.00442.x; Noffz G, 1998, J IMMUNOL, V160, P345; Reinbach G., 1893, ARCH KLIN CHIR, V46, P486; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Ryschich E, 2002, INT J CANCER, V97, P719, DOI 10.1002/ijc.10074; Samoszuk M, 2004, AM J PATHOL, V165, P449, DOI 10.1016/S0002-9440(10)63310-X; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Sosman JA, 1995, CLIN CANCER RES, V1, P805; Stockmann C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00069; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	47	280	286	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					609	+		10.1038/ni.3159	http://dx.doi.org/10.1038/ni.3159			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25915731				2022-12-18	WOS:000354751900013
J	Mocsai, A; Abram, CL; Jakus, Z; Hu, YM; Lanier, LL; Lowell, CA				Mocsai, Attila; Abram, Clare L.; Jakus, Zoltan; Hu, Yongmei; Lanier, Lewis L.; Lowell, Clifford A.			Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs	NATURE IMMUNOLOGY			English	Article							SRC-FAMILY KINASES; BETA-CYTOPLASMIC DOMAINS; RESPIRATORY BURST; SYK; RECEPTOR; ADHESION; PROTEINS; MICE; ALPHA(IIB)BETA(3); DEGRANULATION	At sites of inflammation, ligation of leukocyte integrins is critical for the activation of cellular effector functions required for host defense. However, the signaling pathways linking integrin ligation to cellular responses are poorly understood. Here we show that integrin signaling in neutrophils and macrophages requires adaptors containing immunoreceptor tyrosine-based activation motifs (ITAMs). Neutrophils and macrophages lacking two ITAM-containing adaptor proteins, DAP12 and FcR gamma, were defective in integrin-mediated responses. Activation of the tyrosine kinase Syk by integrins required that DAP12 and FcRy were first phosphorylated by Src family kinases. Retroviral transduction of neutrophils and macrophages with wild-type and mutant Syk or DAP12 demonstrated that the Src homology 2 domains of Syk and the ITAM of DAP12 were required for integrin signaling. Our data show that integrin signaling for the activation of cellular responses in neutrophils and macrophages proceeds by an immunoreceptor-like mechanism.	Semmelweis Univ, Sch Med, Dept Physiol, H-1088 Budapest, Hungary; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	Semmelweis University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mocsai, A (corresponding author), Semmelweis Univ, Sch Med, Dept Physiol, H-1088 Budapest, Hungary.	mocsai@puskin.sote.hu; clifford.lowell@ucsf.edu	Jakus, Zoltán/O-1762-2015; Mocsai, Attila/B-2792-2008; Lanier, Lewis L/E-2139-2014	Jakus, Zoltán/0000-0002-6304-2369; Lanier, Lewis L/0000-0003-1308-3952; Mocsai, Attila/0000-0002-0512-1157	FOGARTY INTERNATIONAL CENTER [R03TW006831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129, R43AI065150, R01AI065495] Funding Source: NIH RePORTER; FIC NIH HHS [TW006831, R03 TW006831] Funding Source: Medline; NIAID NIH HHS [R01 AI065495, AI065150, R01 AI068129, AI068129, AI065495, R43 AI065150] Funding Source: Medline; Wellcome Trust [073976] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Jakus Z, 2004, J IMMUNOL, V173, P2068, DOI 10.4049/jimmunol.173.3.2068; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Mocsai A, 1997, BIOCHEM PHARMACOL, V54, P781, DOI 10.1016/S0006-2952(97)00245-1; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 1999, J IMMUNOL, V162, P1120; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Newbrough SA, 2003, IMMUNITY, V19, P759; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Obergfell A, 2001, J BIOL CHEM, V276, P5916, DOI 10.1074/jbc.M010639200; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pereira S, 2001, J IMMUNOL, V166, P4115, DOI 10.4049/jimmunol.166.6.4115; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Suen PW, 1999, J CELL SCI, V112, P4067; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thomas RM, 2004, IMMUNITY, V20, P181, DOI 10.1016/S1074-7613(04)00023-8; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	37	280	288	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1326	1333		10.1038/ni1407	http://dx.doi.org/10.1038/ni1407			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17086186	Green Accepted			2022-12-18	WOS:000242125200015
J	Arnon, TI; Achdout, H; Levi, O; Markel, G; Saleh, N; Katz, G; Gazit, R; Gonen-Gross, T; Hanna, J; Nahari, E; Porgador, A; Honigman, A; Plachter, B; Mevorach, D; Wolf, DG; Mandelboim, O				Arnon, TI; Achdout, H; Levi, O; Markel, G; Saleh, N; Katz, G; Gazit, R; Gonen-Gross, T; Hanna, J; Nahari, E; Porgador, A; Honigman, A; Plachter, B; Mevorach, D; Wolf, DG; Mandelboim, O			Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTED CELLS; DENDRITIC CELLS; PROTEIN PP65; APOPTOTIC CELLS; MEDIATED LYSIS; NKG2D LIGANDS; NK CELLS; RECOGNITION; CYTOTOXICITY	Human cytomegalovirus, a chief pathogen in immunocompromised people, can persist in a healthy immunocompetent host throughout life without being eliminated by the immune system. Here we show that pp65, the main tegument protein of human cytomegalovirus, inhibited natural killer cell cytotoxicity by an interaction with the activating receptor NKp30. This interaction was direct and specific, leading to dissociation of the linked CD3 zeta from NKp30 and, consequently, to reduced killing. Thus, pp65 is a ligand for the NKp30 receptor and demonstrates a unique mechanism by which an intracellular viral protein causes general suppression of natural killer cell cytotoxicity by specific interaction with an activating receptor.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; Hadassah Med Ctr, Dept Clin Microbiol & Infect Dis, Clin Virol Unit, IL-91120 Jerusalem, Israel; Hadassah Hebrew Univ, Dept Med, Rheumatol Unit, Cellular & Mol Immunol Lab, IL-91120 Jerusalem, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Virol, IL-91120 Jerusalem, Israel; Univ Mainz, Inst Virol, D-55101 Mainz, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Johannes Gutenberg University of Mainz	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel.	oferman@md2.huji.ac.il	wang, edwin/G-5372-2010; Gazit, Roi/J-3352-2017; Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449; Gazit, Roi/0000-0002-0548-2147; Arnon, Tal/0000-0003-4629-5820				Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Arrode G, 2000, J VIROL, V74, P10018, DOI 10.1128/JVI.74.21.10018-10024.2000; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Browne EP, 2003, P NATL ACAD SCI USA, V100, P11439, DOI 10.1073/pnas.1534570100; Carayannopoulos LN, 2004, CURR OPIN IMMUNOL, V16, P26, DOI 10.1016/j.coi.2003.11.003; Carr WH, 2002, CLIN IMMUNOL, V105, P126, DOI 10.1006/clim.2002.5273; Cerboni C, 2000, J IMMUNOL, V164, P4775, DOI 10.4049/jimmunol.164.9.4775; Cerwenka A, 2003, TISSUE ANTIGENS, V61, P335, DOI 10.1034/j.1399-0039.2003.00070.x; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fridmann Y, 2002, BIOCHEMISTRY-US, V41, P5938, DOI 10.1021/bi020117v; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Kano Y, 2000, J DERMATOL SCI, V22, P196, DOI 10.1016/S0923-1811(99)00085-7; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; Karre K, 2002, NAT IMMUNOL, V3, P505, DOI 10.1038/ni0602-505; Krosky PM, 2003, J VIROL, V77, P7720, DOI 10.1128/JVI.77.14.7720-7727.2003; Long EO, 2002, SEMIN CANCER BIOL, V12, P57, DOI 10.1006/scbi.2001.0398; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Muller TF, 2002, J CLIN VIROL, V24, P45, DOI 10.1016/S1386-6532(01)00228-1; Odeberg J, 2003, BLOOD, V101, P4870, DOI 10.1182/blood-2002-05-1504; OHLIN M, 1995, CLIN DIAGN LAB IMMUN, V2, P325, DOI 10.1128/CDLI.2.3.325-329.1995; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Sanchez V, 1998, J VIROL, V72, P3321, DOI 10.1128/JVI.72.4.3321-3329.1998; SCHMOLKE S, 1995, J VIROL, V69, P5959, DOI 10.1128/JVI.69.10.5959-5968.1995; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; Tanaka N, 2002, ARCH VIROL, V147, P2405, DOI 10.1007/s00705-002-0860-0; Van Zanten J, 2002, SCAND J IMMUNOL, V56, P254, DOI 10.1046/j.1365-3083.2002.01125.x; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wolf DG, 2003, BLOOD, V101, P463, DOI 10.1182/blood-2002-07-1982	44	280	297	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					515	523		10.1038/ni1190	http://dx.doi.org/10.1038/ni1190			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15821739				2022-12-18	WOS:000228634300024
J	Kelly, JM; Darcy, PK; Markby, JL; Godfrey, DI; Takedo, K; Yagita, H; Smyth, MJ				Kelly, JM; Darcy, PK; Markby, JL; Godfrey, DI; Takedo, K; Yagita, H; Smyth, MJ			Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; H-2-DEFICIENT LYMPHOMA VARIANTS; LEUKEMIA-VIRUS; COSTIMULATORY MOLECULES; ACCESSORY FUNCTION; INTERFERON-GAMMA; DENDRITIC CELLS; NECROSIS-FACTOR; NKG2D RECEPTOR; CRUCIAL ROLE	Natural killer (NK) cells may modulate the development of adaptive immune responses, but until now there has been little evidence to support this hypothesis. We investigated the primary and secondary immunity elicited by various tumor cell lines that express CD70 and interact with CD70 ligand (CD27), which is constitutively expressed on NK cells. CD70 expression enhanced primary tumor rejection in vivo as well as T cell immunity against secondary tumor challenge. Primary rejection of major histocompatibility complex (MHC) class I-deficient RMA-S.CD70 tumor cells was mediated by NK cells and perforin- and interferon-gamma-dependent mechanisms. This NK cell-mediated process also efficiently evoked the subsequent development of tumor-specific cytotoxic and T helper type I responses to the parental, MHC class I-sufficient, RMA tumor cells. Thus CD27-CD70 interactions provide a key link between innate NK cell responses and adaptive T cell immunity.	Peter MacCallum Canc Inst, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, Melbourne, Vic, Australia; Monash Univ Sch Med, Dept Pathol & Immunol, Prahran, Vic, Australia; Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo, Japan	Peter Maccallum Cancer Center; Monash University; Juntendo University	Smyth, MJ (corresponding author), Peter MacCallum Canc Inst, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, St Andrews Pl, Melbourne, Vic, Australia.	m.smyth@pmci.unimelb.edu.au	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Darcy, Phillip/0000-0002-5303-9561; Godfrey, Dale/0000-0002-3009-5472				Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; AZUMA M, 1992, J IMMUNOL, V149, P1115; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BURLINGTON DB, 1984, J IMMUNOL, V132, P3154; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chen W, 1996, J VIROL, V70, P7773, DOI 10.1128/JVI.70.11.7773-7782.1996; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; GELDHOF AB, 1995, CANCER RES, V55, P2730; Geldhof AB, 1998, ADV EXP MED BIOL, V451, P203; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Herbst H, 1996, J PATHOL, V179, P54, DOI 10.1002/(SICI)1096-9896(199605)179:1<54::AID-PATH537>3.0.CO;2-2; HINTZEN RQ, 1994, IMMUNOL TODAY, V15, P307, DOI 10.1016/0167-5699(94)90077-9; Johnstone RW, 2001, J BIOL CHEM, V276, P16667, DOI 10.1074/jbc.M010774200; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KLEIN G, 1966, J NATL CANCER I, V36, P607, DOI 10.1093/jnci/36.4.607; KOS FJ, 1995, J IMMUNOL, V155, P578; Kos FJ, 1998, IMMUNOL RES, V17, P303, DOI 10.1007/BF02786453; Kos FJ, 1996, IMMUNOL TODAY, V17, P174, DOI 10.1016/0167-5699(96)80616-5; KUROSAWA S, 1995, IMMUNOLOGY, V85, P338; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lens SMA, 1998, SEMIN IMMUNOL, V10, P491, DOI 10.1006/smim.1998.0154; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Lorenz MGO, 1999, HUM GENE THER, V10, P1095, DOI 10.1089/10430349950018094; MCCOY JL, 1967, CANCER RES, V27, P2267; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; NANDI D, 1994, J IMMUNOL, V152, P3361; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; RYAN JC, 1992, J IMMUNOL, V149, P1631; Shi FD, 2000, NAT IMMUNOL, V1, P245, DOI 10.1038/79792; SIJTS AJAM, 1994, J VIROL, V68, P6038, DOI 10.1128/JVI.68.9.6038-6046.1994; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Smyth MJ, 1999, J IMMUNOL, V162, P6658; Smyth MJ, 1998, J EXP MED, V188, P1611, DOI 10.1084/jem.188.9.1611; Smyth MJ, 1999, TRANSPLANTATION, V68, P840, DOI 10.1097/00007890-199909270-00017; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Smyth MJ, 1998, EUR J IMMUNOL, V28, P4162, DOI 10.1002/(SICI)1521-4141(199812)28:12<4162::AID-IMMU4162>3.3.CO;2-5; STITZ L, 1986, J IMMUNOL, V136, P4674; STUKART MJ, 1982, J IMMUNOL, V128, P1360; SUGITA K, 1992, J IMMUNOL, V149, P1199; SUZUKI R, 1985, J IMMUNOL, V134, P2139; Takeda K, 2000, J IMMUNOL, V164, P1741, DOI 10.4049/jimmunol.164.4.1741; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; WHITESIDE TL, 1994, CLIN DIAGN LAB IMMUN, V1, P125, DOI 10.1128/CDLI.1.2.125-133.1994; Wilson JL, 1999, J IMMUNOL, V163, P6365; Wilson JL, 1999, J IMMUNOL, V163, P4207; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Wolthers KC, 1996, EUR J IMMUNOL, V26, P1700, DOI 10.1002/eji.1830260806; ZHOU F, 1992, CANCER RES, V52, P6287	56	280	294	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					83	90		10.1038/ni746	http://dx.doi.org/10.1038/ni746			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11743585				2022-12-18	WOS:000173148700019
J	Satpathy, AT; Briseno, CG; Lee, JS; Ng, D; Manieri, NA; Wumesh, KC; Wu, XD; Thomas, SR; Lee, WL; Turkoz, M; McDonald, KG; Meredith, MM; Song, C; Guidos, CJ; Newberry, RD; Ouyang, WJ; Murphy, TL; Stappenbeck, TS; Gommerman, JL; Nussenzweig, MC; Colonna, M; Kopan, R; Murphy, KM				Satpathy, Ansuman T.; Briseno, Carlos G.; Lee, Jacob S.; Ng, Dennis; Manieri, Nicholas A.; Wumesh, K. C.; Wu, Xiaodi; Thomas, Stephanie R.; Lee, Wan-Ling; Turkoz, Mustafa; McDonald, Keely G.; Meredith, Matthew M.; Song, Christina; Guidos, Cynthia J.; Newberry, Rodney D.; Ouyang, Wenjun; Murphy, Theresa L.; Stappenbeck, Thaddeus S.; Gommerman, Jennifer L.; Nussenzweig, Michel C.; Colonna, Marco; Kopan, Raphael; Murphy, Kenneth M.			Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; LY6C(HI) MONOCYTES; SIGNALING CONTROLS; STEM-CELLS; DIFFERENTIATION; MIGRATION; HOMEOSTASIS; EXPRESSION; INFECTION	Defense against attaching-and-effacing bacteria requires the sequential generation of interleukin 23 (IL-23) and IL-22 to induce protective mucosal responses. Although CD4(+) and NKp46(+) innate lymphoid cells (ILCs) are the critical source of IL-22 during infection, the precise source of IL-23 is unclear. We used genetic techniques to deplete mice of specific subsets of classical dendritic cells (cDCs) and analyzed immunity to the attaching-and-effacing pathogen Citrobacter rodentium. We found that the signaling receptor Notch2 controlled the terminal stage of cDC differentiation. Notch2-dependent intestinal CD11b(+) cDCs were an obligate source of IL-23 required for survival after infection with C. rodentium, but CD103(+) cDCs dependent on the transcription factor Batf3 were not. Our results demonstrate a nonredundant function for CD11b(+) cDCs in the response to pathogens in vivo.	[Satpathy, Ansuman T.; Briseno, Carlos G.; Lee, Jacob S.; Manieri, Nicholas A.; Wumesh, K. C.; Wu, Xiaodi; Thomas, Stephanie R.; Lee, Wan-Ling; Song, Christina; Murphy, Theresa L.; Stappenbeck, Thaddeus S.; Colonna, Marco; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Ng, Dennis; Guidos, Cynthia J.; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Turkoz, Mustafa; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [McDonald, Keely G.; Newberry, Rodney D.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Meredith, Matthew M.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Guidos, Cynthia J.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Toronto; Washington University (WUSTL); Washington University (WUSTL); Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Roche Holding; Genentech; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu	Nussenzweig, Michel/AAE-7292-2019; Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022; Ouyang, Wenjun/ABA-8763-2020	Satpathy, Ansuman/0000-0002-5167-537X; Newberry, Rodney/0000-0002-4152-5191; Ouyang, Wenjun/0000-0002-1811-5864; Briseno, Carlos/0000-0002-4159-3864; Kopan, Raphael/0000-0002-0350-2730; Manieri, Nicholas/0000-0002-5648-5989; Colonna, Marco/0000-0001-5222-4987; Gommerman, Jennifer/0000-0003-4576-6168	Howard Hughes Medical Institute; US National Institutes of Health [AI076427-02, R01 GM55479, R01 DE021255-01, U01 AI095542-01, R01 DK071619, R01 DK064798]; US Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005, 12PRE12050419]; Canadian Institutes of Health Research [MOP 67157, FRN 11530]; National Cancer Institute [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427, U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071619, R01DK064798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Sleckman (Washington University in St. Louis) for Nik<SUP>-/-</SUP> mice; T. Watts (University of Toronto) for Ifnar1<SUP>-/-</SUP> mice; J. Boothroyd (Stanford University) for the plasmid PRU-FLuc-GFP; the Immunological Genome Project consortium for use of their database<SUP>54</SUP>; and the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. Supported by the Howard Hughes Medical Institute, the US National Institutes of Health (AI076427-02 to K. M. M., R01 GM55479 to R. K., R01 DE021255-01 and U01 AI095542-01 to M. C., R01 DK071619 to T. S. S. and R01 DK064798 to R.D.N.), the US Department of Defense (W81XWH-09-1-0185 to K. M. M.), the American Heart Association (12PRE8610005 to A. T. S. and 12PRE12050419 to W. K.), the Canadian Institutes of Health Research (MOP 67157 to J. L. G. and FRN 11530 to C. J. G.) and the National Cancer Institute (P30 CA91842 for the Alvin J. Siteman Cancer Center).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Keskintepe L, 2007, TRANSGENIC RES, V16, P751, DOI 10.1007/s11248-007-9125-8; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manieri NA, 2012, GASTROENTEROLOGY, V143, P110, DOI 10.1053/j.gastro.2012.03.037; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	63	279	282	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					937	+		10.1038/ni.2679	http://dx.doi.org/10.1038/ni.2679			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23913046	Green Accepted			2022-12-18	WOS:000323377700011
J	Franchi, L; Kamada, N; Nakamura, Y; Burberry, A; Kuffa, P; Suzuki, S; Shaw, MH; Kim, YG; Nunez, G				Franchi, Luigi; Kamada, Nobuhiko; Nakamura, Yuumi; Burberry, Aaron; Kuffa, Peter; Suzuki, Shiho; Shaw, Michael H.; Kim, Yun-Gi; Nunez, Gabriel			NLRC4-driven production of IL-1 beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense	NATURE IMMUNOLOGY			English	Article							NOD-LIKE RECEPTORS; INFLAMMASOME RECEPTORS; ACTIVATES CASPASE-1; PATTERN-RECOGNITION; NLRP3 INFLAMMASOME; MACROPHAGES; SECRETION; FLAGELLIN; INTERLEUKIN-1-BETA; INFECTION	Intestinal phagocytes transport oral antigens and promote immune tolerance, but their role in innate immune responses remains unclear. Here we found that intestinal phagocytes were anergic to ligands for Toll-like receptors (TLRs) or commensals but constitutively expressed the precursor to interleukin 1 beta (pro-IL-1 beta). After infection with pathogenic Salmonella or Pseudomonas, intestinal phagocytes produced mature IL-1 beta through the NLRC4 inflammasome but did not produce tumor necrosis factor (TNF) or IL-6. BALB/c mice deficient in NLRC4 or the IL-1 receptor were highly susceptible to orogastric but not intraperitoneal infection with Salmonella. That enhanced lethality was preceded by impaired expression of endothelial adhesion molecules, lower neutrophil recruitment and poor intestinal pathogen clearance. Thus, NLRC4-dependent production of IL-1 beta by intestinal phagocytes represents a specific response that discriminates pathogenic bacteria from commensal bacteria and contributes to host defense in the intestine.	[Franchi, Luigi; Kamada, Nobuhiko; Nakamura, Yuumi; Burberry, Aaron; Kuffa, Peter; Suzuki, Shiho; Shaw, Michael H.; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Franchi, Luigi; Kamada, Nobuhiko; Nakamura, Yuumi; Burberry, Aaron; Kuffa, Peter; Suzuki, Shiho; Shaw, Michael H.; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Suzuki, Shiho/Z-4458-2019; Nuñez, Gabriel/A-7160-2014; Kamada, Nobuhiko/AAW-3299-2020; Nakamura, Yuumi/H-8459-2017	Kamada, Nobuhiko/0000-0002-1980-4178; Nakamura, Yuumi/0000-0001-6256-8302; Suzuki, Shiho/0000-0003-3168-1729	US National Institutes of Health [R01 DK61707, T32-HL007517, T32 HD007505]; University of Michigan Comprehensive Cancer Center [5 P30 CA46592, CA46952]; Crohn's and Colitis Foundation of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK061707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Comprehensive Cancer Center; Crohn's and Colitis Foundation of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. L. Rosenzweig (Oregon Health & Science University) for Il1r1 <SUP>/</SUP> BALB/c mice; P. Vandenabeele (Ghent University) for purified caspase-1; G.Y. Chen for critically reading the manuscript; and the University of Michigan Flow Cytometry Core, Immune Monitoring Core and Tissue Procurement Service for assistance. Supported by the US National Institutes of Health (R01 DK61707 to G.N.; T32-HL007517 to M. H. S.; and T32 HD007505 to A. B.), the University of Michigan Comprehensive Cancer Center (5 P30 CA46592), the Crohn's and Colitis Foundation of America (L. F. and N.K.) and the Tissue Core of the University of Michigan Comprehensive Cancer Center (CA46952).	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00008; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	50	279	296	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					449	U45		10.1038/ni.2263	http://dx.doi.org/10.1038/ni.2263			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22484733	Green Accepted			2022-12-18	WOS:000303048400008
J	Scandella, E; Bolinger, B; Lattmann, E; Miller, S; Favre, S; Littman, DR; Finke, D; Luther, SA; Junt, T; Ludewig, B				Scandella, Elke; Bolinger, Beatrice; Lattmann, Evelyn; Miller, Simone; Favre, Stephanie; Littman, Dan R.; Finke, Daniela; Luther, Sanjiv A.; Junt, Tobias; Ludewig, Burkhard			Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; ANTIVIRAL IMMUNE-RESPONSES; SPLENIC WHITE PULP; ROR-GAMMA-T; DENDRITIC CELLS; CD4(+)CD3(-) CELLS; VIRAL PERSISTENCE; NODE DEVELOPMENT; OX40 LIGAND; B-CELLS	The generation of lymphoid microenvironments in early life depends on the interaction of lymphoid tissue-inducer cells with stromal lymphoid tissue-organizer cells. Whether this cellular interface stays operational in adult secondary lymphoid organs has remained elusive. We show here that during acute infection with lymphocytic choriomeningitis virus, antiviral cytotoxic T cells destroyed infected T cell zone stromal cells, which led to profound disruption of secondary lymphoid organ integrity. Furthermore, the ability of the host to respond to secondary antigens was lost. Restoration of the lymphoid microanatomy was dependent on the proliferative accumulation of lymphoid tissue-inducer cells in secondary lymphoid organs during the acute phase of infection and lymphotoxin alpha(1)beta(2) signaling. Thus, crosstalk between lymphoid tissue-inducer cells and stromal cells is reactivated in adults to maintain secondary lymphoid organ integrity and thereby contributes to the preservation of immunocompetence.	[Scandella, Elke; Bolinger, Beatrice; Lattmann, Evelyn; Miller, Simone; Ludewig, Burkhard] Kantonal Hosp St Gallen, Res Dept, CH-9007 St Gallen, Switzerland; [Favre, Stephanie; Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; [Finke, Daniela] Univ Basel, Ctr Biomed, CH-4058 Basel, Switzerland; [Junt, Tobias] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Junt, Tobias] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Junt, Tobias] Novartis Inst BioMed Res, A-1235 Vienna, Austria	Kantonsspital St. Gallen; University of Lausanne; Howard Hughes Medical Institute; New York University; University of Basel; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Novartis	Ludewig, B (corresponding author), Kantonal Hosp St Gallen, Res Dept, CH-9007 St Gallen, Switzerland.	burkhard.ludewig@kssg.ch	Junt, Tobias/AAE-4389-2021; Luther, Sanjiv A/B-4380-2016; Luther, Sanjiv/AAP-6525-2020; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; , Sanjiv/0000-0002-0614-561X				Alos L, 2005, MODERN PATHOL, V18, P127, DOI 10.1038/modpathol.3800267; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ato M, 2004, J IMMUNOL, V173, P4815, DOI 10.4049/jimmunol.173.8.4815; Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; BAILEY MJ, 1989, VIROLOGY, V169, P323, DOI 10.1016/0042-6822(89)90157-8; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004; Cohen DE, 2001, CLIN INFECT DIS, V32, P1756, DOI 10.1086/320759; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Cyster JG, 2000, IMMUNOL REV, V176, P181; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Finke D, 2005, CURR OPIN IMMUNOL, V17, P144, DOI 10.1016/j.coi.2005.01.006; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Junt T, 2006, EUR J IMMUNOL, V36, P2061, DOI 10.1002/eji.200626255; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kim MY, 2007, BLOOD, V109, P1602, DOI 10.1182/blood-2006-04-018465; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Koopman G, 1999, AIDS RES HUM RETROV, V15, P365, DOI 10.1089/088922299311330; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Ludewig B, 1998, J VIROL, V72, P3812, DOI 10.1128/JVI.72.5.3812-3818.1998; Ludewig B, 2000, EUR J IMMUNOL, V30, P185, DOI 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.3.CO;2-C; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Probst HC, 2005, J IMMUNOL, V174, P3920, DOI 10.4049/jimmunol.174.7.3920; Scandella E, 2007, J IMMUNOL, V178, P1468, DOI 10.4049/jimmunol.178.3.1468; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Withers DR, 2007, EUR J IMMUNOL, V37, P3240, DOI 10.1002/eji.200737541; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0	57	279	285	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					667	675		10.1038/ni.1605	http://dx.doi.org/10.1038/ni.1605			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18425132				2022-12-18	WOS:000256067900017
J	Veldhoen, M				Veldhoen, Marc			Interleukin 17 is a chief orchestrator of immunity	NATURE IMMUNOLOGY			English	Review							DELTA-T-CELLS; COLLAGEN-INDUCED ARTHRITIS; INNATE LYMPHOID-CELLS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; ARYL-HYDROCARBON RECEPTOR; NECROSIS-FACTOR-ALPHA; MUCOSAL HOST-DEFENSE; TH17 CELLS; RHEUMATOID-ARTHRITIS; TNF-ALPHA	Increased understanding of the biology of interleukin 17 (IL-17) has revealed that this cytokine is a central player in immunity at the sites most exposed to microorganisms. Although it has been strongly associated with immunopathology, IL-17 also has an important role in host defense. The regulation of IL-17 secretion seems to be shared among various cell types, each of which can concomitantly secrete additional products. IL-17 has only modest activity on its own; its impact in immunity arises from its synergistic action with other factors, its self-sustaining feedback loop and, in some cases, its role as a counterpart of interferon-gamma (IFN-gamma). Together these attributes provide a robust response against microorganisms, but they can equally contribute to immune pathology. Here we focus on a discussion of the role of IL-17 during infection.	[Veldhoen, Marc] Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal	Universidade de Lisboa	Veldhoen, M (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal.	marc.veldhoen@medicina.ulisboa.pt	Veldhoen, Marc/AAM-5357-2021; Veldhoen, Marc/AAJ-2759-2020	Veldhoen, Marc/0000-0002-1478-9562	European Union [667824-EXCELLtoINNOV]; BBSRC [BB/E021638/1, BBS/E/B/000C0409] Funding Source: UKRI	European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M.V. receives funding via the European Union H2020 ERA project (no. 667824-EXCELLtoINNOV).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Amatya N., 2017, TRENDS IMMUNOL; Andoh A, 2002, J IMMUNOL, V169, P1683, DOI 10.4049/jimmunol.169.4.1683; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Barin JG, 2016, AM J PATHOL, V186, P2337, DOI 10.1016/j.ajpath.2016.07.001; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Bronte V, 2008, BLOOD, V112, P214, DOI 10.1182/blood-2008-04-149260; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Brucklacher-Waldert V, 2016, J IMMUNOL, V196, P4893, DOI 10.4049/jimmunol.1600137; Brucklacher-Waldert V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00488; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO;2-X; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dixon BREA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148514; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Farahnik B, 2016, DERMATOLOGY THER, V6, P25, DOI 10.1007/s13555-016-0102-0; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fragoulis GE, 2016, ANNU REV MED, V67, P337, DOI 10.1146/annurev-med-051914-021944; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2011, J IMMUNOL, V187, P4389, DOI 10.4049/jimmunol.1102576; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Han QF, 2015, J IMMUNOL, V195, P5440, DOI 10.4049/jimmunol.1500892; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Iyoda M, 2010, AM J PHYSIOL-RENAL, V298, pF779, DOI 10.1152/ajprenal.00198.2009; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kap YS, 2011, J NEUROIMMUNE PHARM, V6, P341, DOI 10.1007/s11481-010-9238-3; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kezic JM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3697; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Li ZG, 2007, J IMMUNOL, V179, P1568, DOI 10.4049/jimmunol.179.3.1568; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin DP, 2015, IMMUNOLOGY, V144, P472, DOI 10.1111/imm.12395; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mease PJ, 2017, ANN RHEUM DIS, V76, P79, DOI 10.1136/annrheumdis-2016-209709; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Molesworth-Kenyon SJ, 2008, J LEUKOCYTE BIOL, V83, P401, DOI 10.1189/jlb.0807571; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Nonaka M, 2009, WORLD ALLERGY ORGAN, V2, P218, DOI 10.1097/WOX.0b013e3181bdd219; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Papotto R.J., 2017, NAT IMMUNOL, V18, P604; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rabeony H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101937; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Romagnoli PA, 2016, P NATL ACAD SCI USA, V113, P8502, DOI 10.1073/pnas.1600713113; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savan R, 2011, BLOOD, V117, P575, DOI 10.1182/blood-2010-05-285908; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Stange J, 2013, SEMIN IMMUNOPATHOL, V35, P645, DOI 10.1007/s00281-013-0389-1; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trentini MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00898; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wang CQF, 2013, J INVEST DERMATOL, V133, P2741, DOI 10.1038/jid.2013.237; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Won HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018168; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Yue FY, 2008, J VIROL, V82, P6767, DOI 10.1128/JVI.02550-07; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	167	278	287	4	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					612	621		10.1038/ni.3742	http://dx.doi.org/10.1038/ni.3742			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28518156				2022-12-18	WOS:000401520900006
J	Yoshida, H; Okabe, Y; Kawane, K; Fukuyama, H; Nagata, S				Yoshida, H; Okabe, Y; Kawane, K; Fukuyama, H; Nagata, S			Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA	NATURE IMMUNOLOGY			English	Article							MOLECULAR-CLONING; DENDRITIC CELLS; EXPRESSION; ALPHA; MACROPHAGE; GENES; PROTEIN; SYSTEM; GROWTH; FETAL	The livers of DNase II-deficient mouse embryos contain many macrophages carrying undigested DNA, and the embryos die in utero. Here we report that erythroid precursor cells underwent apoptosis in the livers of DNase II-deficient embryos and that in the liver, interferon-beta mRNA was expressed by the resident macrophages. When the DNase II-deficient mice were crossed with mice deficient in type I interferon receptor, the resultant 'double-mutant' mice were born healthy. The double-mutant embryos expressed interferon-beta mRNA, but the expression of a subset of the interferon-responsive genes dysregulated in DNase II-deficient embryos was restored to normal. These results indicate that the inability to degrade DNA derived from erythroid precursors results in interferon-beta production that induces expression of a specific set of interferon-responsive genes associated with embryonic lethality in DNase II-deficient mice.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrat Biol Labs, Genet Lab, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nagata@genetic.med.osaka-u.ac.jp	Fukuyama, Hidehiro/AAY-6256-2021; Fukuyama, Hidehiro/N-5276-2018; Nagata, Shigekazu/AAG-3203-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483; Okabe, Yasutaka/0000-0002-1913-7280				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BERNARD J, 1991, BLOOD CELLS, V17, P5; BERNARDI G, 1971, ENZYMES, V3, P271; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carlow DA, 1998, J IMMUNOL, V161, P2348; Chou SF, 2002, BIOCHEM BIOPH RES CO, V296, P48, DOI 10.1016/S0006-291X(02)00835-5; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842; GRESSER I, 1981, AM J PATHOL, V102, P396; GRESSER I, 1975, NATURE, V258, P76, DOI 10.1038/258076a0; HIGASHI Y, 1983, J BIOL CHEM, V258, P9522; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE CGL, 1994, J IMMUNOL, V152, P5758; LUSTER AD, 1987, P NATL ACAD SCI USA, V84, P2868, DOI 10.1073/pnas.84.9.2868; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAGATA S, 1980, NATURE, V287, P401, DOI 10.1038/287401a0; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Pfeffer LM, 1998, CANCER RES, V58, P2489; RUTHERFORD MN, 1991, NUCLEIC ACIDS RES, V19, P1917, DOI 10.1093/nar/19.8.1917; Sadahira Y, 1999, PATHOL INT, V49, P841, DOI 10.1046/j.1440-1827.1999.00954.x; Sambrook J, 2001, MOL CLONING LAB MANU; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sasaki K, 1997, MICROSC RES TECHNIQ, V39, P398, DOI 10.1002/(SICI)1097-0029(19971201)39:5<398::AID-JEMT2>3.0.CO;2-D; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; SHAW GD, 1983, NUCLEIC ACIDS RES, V11, P555, DOI 10.1093/nar/11.3.555; SHIFMAN MI, 1995, J NEUROSCI METH, V59, P205, DOI 10.1016/0165-0270(94)00184-I; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1	46	278	290	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					49	56		10.1038/ni1146	http://dx.doi.org/10.1038/ni1146			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15568025				2022-12-18	WOS:000225888500017
J	Xu, XJ; Araki, K; Li, SZ; Han, JH; Ye, LL; Tan, WG; Konieczny, BT; Bruinsma, MW; Martinez, J; Pearce, EL; Green, DR; Jones, DP; Virgin, HW; Ahmed, R				Xu, Xiaojin; Araki, Koichi; Li, Shuzhao; Han, Jin-Hwan; Ye, Lilin; Tan, Wendy G.; Konieczny, Bogumila T.; Bruinsma, Monique W.; Martinez, Jennifer; Pearce, Erika L.; Green, Douglas R.; Jones, Dean P.; Virgin, Herbert W.; Ahmed, Rafi			Autophagy is essential for effector CD8(+) T cell survival and memory formation	NATURE IMMUNOLOGY			English	Article							SELECTIVE AUTOPHAGY; EXPRESSION; PROTEIN; PERSISTENCE; ACTIVATION; MAINTAINS; IL-7	The importance of autophagy in the generation of memory CD8(+) T cells in vivo is not well defined. We report here that autophagy was dynamically regulated in virus-specific CD8(+) T cells during acute infection of mice with lymphocytic choriomeningitis virus. In contrast to the current paradigm, autophagy decreased in activated proliferating effector CD8(+) T cells and was then upregulated when the cells stopped dividing just before the contraction phase. Consistent with those findings, deletion of the gene encoding either of the autophagy-related molecules Atg5 or Atg7 had little to no effect on the proliferation and function of effector cells, but these autophagy-deficient effector cells had survival defects that resulted in compromised formation of memory T cells. Our studies define when autophagy is needed during effector and memory differentiation and warrant reexamination of the relationship between T cell activation and autophagy.	[Xu, Xiaojin; Araki, Koichi; Han, Jin-Hwan; Ye, Lilin; Tan, Wendy G.; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Xu, Xiaojin; Araki, Koichi; Han, Jin-Hwan; Ye, Lilin; Tan, Wendy G.; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Li, Shuzhao; Jones, Dean P.] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA; [Bruinsma, Monique W.; Pearce, Erika L.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Microbiol & Immunol, St Louis, MO USA; [Martinez, Jennifer; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Emory University; Emory University; Emory University; Washington University (WUSTL); St Jude Children's Research Hospital	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	karaki@emory.edu; virgin@wustl.edu; rahmed@emory.edu	Martinez, Jennifer/C-3740-2019; Green, Douglas R/N-8083-2018	Martinez, Jennifer/0000-0002-3060-2518; Green, Douglas R/0000-0002-7332-1417; Virgin, Herbert/0000-0001-8580-7628; Bruinsma, Monique/0000-0001-8213-1060; Li, Shuzhao/0000-0002-7386-2539; Araki, Koichi/0000-0003-3478-6315; Ye, Lilin/0000-0003-0778-3311	US National Institutes of Health [R01 AI030048, R01 AI084887]; Merieux Foundation; Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965, R01AI030048, U19AI109725, R01AI040646] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merieux Foundation; Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Rao (La Jolla Institute for Allergy and Immunology) for the MSCV-IRES-Thy-1.1 retroviral vector; J. Jacob (Emory University) for Gzmb-Cre transgenic mice; V. Tran for the LC-MS experiments; R. Karaffa and S. Durham for sorting cells by flow cytometry at the Emory Flow Cytometry Core Facility; and A. Rae for assistance in the use of ImageStream. Supported by the US National Institutes of Health (R01 AI030048 to R.A. and R01 AI084887 to H.W.V.), the Merieux Foundation (R.A.) and the Crohn's and Colitis Foundation (H.W.V.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	44	277	288	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1152	1161		10.1038/ni.3025	http://dx.doi.org/10.1038/ni.3025			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25362489	Green Accepted, Green Published			2022-12-18	WOS:000344841900012
J	Pathak, SK; Basu, S; Basu, KK; Banerjee, A; Pathak, S; Bhattacharyya, A; Kaisho, T; Kundu, M; Basu, J				Pathak, Sushil Kumar; Basu, Sanchita; Basu, Kunal Kumar; Banerjee, Anirban; Pathak, Shresh; Bhattacharyya, Asima; Kaisho, Tsuneyasu; Kundu, Manikuntala; Basu, Joyoti			Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; GENE INDUCTION-PROGRAM; NEGATIVE REGULATION; KAPPA-B; ADAPTER MOLECULE; CELL-ACTIVATION; INNATE IMMUNITY; IRAK FAMILY; KINASE; RECOGNITION	Expression of early secreted antigenic target protein 6 (ESAT-6) by Mycobacterium tuberculosis is associated with lower innate immune responses to infection. Here we show that ESAT-6 inhibited activation of transcription factor NF-kappa B and interferon-regulatory factors (IRFs) after Toll- like receptor (TLR) signaling; inhibition of TLR signaling by ESAT-6 required the kinase Akt. Direct binding of ESAT-6 to TLR2 activated Akt and prevented interaction between the adaptor MyD88 and 'downstream' kinase IRAK4, thus abrogating NF-kappa B activation. The six carboxy-terminal amino acid residues of ESAT-6 were required and sufficient for the TLR2-mediated inhibitory effect. A critical function for the carboxy-terminal peptide of ESAT-6 in restricting MyD88-dependent TLR signaling emphasizes the possibility that mimetic inhibitory peptides could be used to restrict innate immune responses in situations in which prolonged TLR signaling has deleterious effects.	Bose Inst, Dept Chem, Kolkata 700009, W Bengal, India; RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Department of Science & Technology (India); Bose Institute; RIKEN	Basu, J (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, W Bengal, India.	joyoti@vsnl.com	Kaisho, Tsuneyasu/B-4130-2012; PATHAK, SHRESH/I-6938-2012; Bhattacharyya, Asima/J-7423-2012	Bhattacharyya, Asima/0000-0001-7292-6644; Banerjee, Anirban/0000-0001-7678-1868; PATHAK, SHRESH/0000-0001-5275-1816				Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; Hazeki K, 2006, MOL PHARMACOL, V69, P1717, DOI 10.1124/mol.105.021162; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Mukherjee P, 2007, CLIN MICROBIOL INFEC, V13, P146, DOI 10.1111/j.1469-0691.2006.01660.x; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	50	277	293	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					610	618		10.1038/ni1468	http://dx.doi.org/10.1038/ni1468			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17486091				2022-12-18	WOS:000246703300015
J	Lee, JW; Epardaud, M; Sun, J; Becker, JE; Cheng, AC; Yonekura, AR; Heath, JK; Turley, SJ				Lee, Je-Wook; Epardaud, Mathieu; Sun, Jing; Becker, Jessica E.; Cheng, Alexander C.; Yonekura, Ai-ris; Heath, Joan K.; Turley, Shannon J.			Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; EPITHELIAL-CELLS; IN-VIVO; PRESENTING CELLS; STEADY-STATE; A33 ANTIGEN; INDUCTION; THYMUS; IMMUNITY; DIFFERENTIATION	The intestinal epithelium functions to absorb nutrients and to protect the organism against microbes. To prevent autoimmune attack on this vital tissue, T cell tolerance to intestinal self-antigens must be established. Central tolerance mechanisms involve medullary thymic epithelial cells (mTECs), which use endogenously expressed peripheral-tissue antigens (PTAs) to delete self-reactive thymocytes. The prevailing model for the induction of peripheral tolerance involves cross-presentation of tissue antigens by quiescent dendritic cells. Here we show that lymph node stromal cells present endogenously expressed PTAs to T cells. Moreover, antigen presentation by lymph node stroma is sufficient to induce primary activation and subsequent tolerance among CD8(+) T cells. Thus, lymph node stromal cells are functionally akin to mTECs and provide a direct strategy for purging the peripheral repertoire of self-reactive T cells.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; INRA, UR892, F-78352 Jouy En Josas, France; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; Post Off Royal Melbourne Hosp, Melbourne Branch, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Harvard University; Harvard Medical School	Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu	Heath, Joan/D-3054-2012	Heath, Joan/0000-0001-6955-232X; Becker, Jessica/0000-0003-0522-2836	NIDDK NIH HHS [P30 DK36836-19] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abud HE, 2000, MECH DEVELOP, V98, P111, DOI 10.1016/S0925-4773(00)00438-X; Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Arnold B, 2003, IMMUNOL LETT, V89, P225, DOI 10.1016/S0165-2478(03)00150-0; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Garcia CA, 2005, J IMMUNOL, V175, P2111, DOI 10.4049/jimmunol.175.4.2111; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Johnstone CN, 2000, AM J PHYSIOL-GASTR L, V279, pG500, DOI 10.1152/ajpgi.2000.279.3.G500; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maemura K, 2006, TISSUE ANTIGENS, V67, P198, DOI 10.1111/j.1399-0039.2006.00548.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2003, PATHOL BIOL, V51, P59, DOI 10.1016/S0369-8114(03)00096-8; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2	46	277	289	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					181	190		10.1038/ni1427	http://dx.doi.org/10.1038/ni1427			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17195844				2022-12-18	WOS:000243597600016
J	Gyory, I; Wu, J; Fejer, G; Seto, E; Wright, KL				Gyory, I; Wu, J; Fejer, G; Seto, E; Wright, KL			PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing	NATURE IMMUNOLOGY			English	Article							II TRANSACTIVATOR EXPRESSION; SECRETING PLASMA-CELLS; FINGER GENE RIZ; LYSINE METHYLATION; BLIMP-1 EXPRESSION; CONTAINING PROTEIN; CHROMATIN DOMAINS; B-LYMPHOCYTES; ZINC FINGERS; REPRESSION	PRDI-BF1, the human ortholog of mouse Blimp-1, is a DNA-binding protein involved in postinduction repression of interferon-beta gene transcription in response to viral infection. PRDI-BF1 also has an essential function in driving terminal differentiation of B lymphocytes and therein silences multiple genes. Here we show PRDI-BF1 assembles silent chromatin over the interferon-beta promoter in the osteosarcoma cell line U2OS through recruitment of the histone H3 lysine methyltransferase G9a. G9a is recruited only when in a complex with PRDI-BF1. G9a catalytic activity is required for the accumulation of methylated histone H3 and transcriptional silencing mediated by PRDI-BF1 in vivo. This establishes a mechanism for the recruitment of G9a, the main mammalian euchromatic methyltransferase, and defines nonembryonic targets of G9a.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Biochem & Mol Biol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Wright, KL (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, 12902 Magnolia Dr,MRC4E, Tampa, FL 33612 USA.	wrightkl@moffitt.usf.edu	Fejer, Gyorgy/D-5080-2011; Fejer, Gyorgy/F-8515-2019	Fejer, Gyorgy/0000-0001-6761-0506	NCI NIH HHS [CA 80990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abel KJ, 1996, GENOMICS, V37, P161, DOI 10.1006/geno.1996.0537; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; FICHELSON S, 1992, LEUKEMIA, V6, P93; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Gyory I, 2003, J IMMUNOL, V170, P3125, DOI 10.4049/jimmunol.170.6.3125; He LS, 1998, CANCER RES, V58, P4238; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jiang GL, 1999, INT J CANCER, V83, P541, DOI 10.1002/(SICI)1097-0215(19991112)83:4<541::AID-IJC17>3.0.CO;2-F; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Liu LM, 1997, J BIOL CHEM, V272, P2984, DOI 10.1074/jbc.272.5.2984; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Oberley MJ, 2003, J BIOL CHEM, V278, P42466, DOI 10.1074/jbc.M307733200; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Turner BM, 2003, NAT CELL BIOL, V5, P390, DOI 10.1038/ncb0503-390; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Xie M, 1997, J BIOL CHEM, V272, P26360, DOI 10.1074/jbc.272.42.26360; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	52	277	290	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					299	308		10.1038/ni1046	http://dx.doi.org/10.1038/ni1046			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985713				2022-12-18	WOS:000189344600013
J	Lamhamedi-Cherradi, SE; Zheng, SJ; Maguschak, KA; Peschon, J; Chen, YH				Lamhamedi-Cherradi, SE; Zheng, SJ; Maguschak, KA; Peschon, J; Chen, YH			Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice	NATURE IMMUNOLOGY			English	Article							FADD-DEPENDENT APOPTOSIS; NF-KAPPA-B; NEGATIVE SELECTION; LIGAND TRAIL; CELL-DEATH; CLONAL DELETION; CD95 LIGAND; RECEPTORS 1; ACTIVATION; FAMILY	TRAIL, the tumor necrosis factor-related apoptosis-inducing ligand, selectively induces apoptosis of tumor cells, but not most normal cells. Its role in normal, nontransformed tissues is not clear. We report here that mice deficient in TRAIL have a severe defect in thymocyte apoptosis-thus, thymic deletion induced by T cell receptor ligation is severely impaired. TRAIL-deficient mice are also hypersensitive to collagen-induced arthritis and streptozotocin-induced diabetes and develop heightened autoimmune responses. Thus, TRAIL mediates thymocyte apoptosis and is important in the induction of autoimmune diseases.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Amgen Inc, Seattle, WA 98101 USA	University of Pennsylvania; Amgen	Chen, YH (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu	Lamhamedi-Cherradi, Salah-Eddine/ABD-6091-2020; Chen, Youhai/AAJ-4031-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040447, R01NS040188] Funding Source: NIH RePORTER; NIAID NIH HHS [AI50059] Funding Source: Medline; NINDS NIH HHS [NS40447, NS40188] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abulencia JP, 2002, FASEB J, V16, pA883; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; CALNAN BJ, 1995, IMMUNITY, V3, P273; Castro JE, 1996, IMMUNITY, V5, P617, DOI 10.1016/S1074-7613(00)80275-7; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHEN YH, 1995, J IMMUNOL, V155, P910; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Horwitz MS, 2002, J CLIN INVEST, V109, P79, DOI 10.1172/JCI200211198; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.3.CO;2-K; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MULLER KP, 1995, EUR J IMMUNOL, V25, P2996, DOI 10.1002/eji.1830251043; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Page DM, 1998, J IMMUNOL, V160, P120; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pechhold K, 2001, J IMMUNOL, V166, P2531, DOI 10.4049/jimmunol.166.4.2531; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sheikh MS, 1998, CANCER RES, V58, P1593; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simon AK, 2001, P NATL ACAD SCI USA, V98, P5158, DOI 10.1073/pnas.091100398; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TOMONARI K, 1993, IMMUNOL REV, V131, P131, DOI 10.1111/j.1600-065X.1993.tb01534.x; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; WOODLAND DL, 1991, NATURE, V349, P529, DOI 10.1038/349529a0; Wu GS, 1999, CANCER RES, V59, P2770; YUI K, 1988, IMMUNOL REV, V104, P121, DOI 10.1111/j.1600-065X.1988.tb00761.x; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang XD, 2001, CANCER RES, V61, P7339; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	53	277	305	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					255	260		10.1038/ni894	http://dx.doi.org/10.1038/ni894			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12577054				2022-12-18	WOS:000181201000014
J	Gaide, O; Favier, B; Legler, DF; Bonnet, D; Brissoni, B; Valitutti, S; Bron, C; Tschopp, J; Thome, M				Gaide, O; Favier, B; Legler, DF; Bonnet, D; Brissoni, B; Valitutti, S; Bron, C; Tschopp, J; Thome, M			CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR; MALT LYMPHOMA; SIGNAL-TRANSDUCTION; MAGUK FAMILY; ANCHORED PROTEINS; PKC-THETA; C-THETA; MEMBRANE	CARMA1 is a lymphocyte-specific member of the membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins, which coordinate signaling pathways emanating from the plasma membrane. CARMA1 interacts with Bcl10 via its caspase-recruitment domain (CARD). Here we investigated the role of CARMA1 in T cell activation and found that T cell receptor (TCR) stimulation induced a physical association of CARMA1 with the TCR and Bcl10. We found that CARMA1 was constitutively associated with lipid rafts, whereas cytoplasmic Bcl10 translocated into lipid rafts upon TCR engagement. A CARMA1 mutant, defective for Bcl10 binding, had a dominant-negative (DN) effect on TCR-induced NF-kappaB activation and IL-2 production and on the c-Jun NH2-terminal kinase (Jnk) pathway when the TCR was coengaged with CD28. Together, our data show that CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappaB activation and CD28 costimulation-dependent Jnk activation.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; CHU Purpan, INSERM, U563, Inst Claude Preval, F-31059 Toulouse, France	University of Lausanne; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Thome, M (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.		FAVIER, Benoit/W-7379-2019; Thome, Margot/F-8167-2011; Valitutti, Salvatore/M-2999-2014	Thome, Margot/0000-0002-5656-2139; Valitutti, Salvatore/0000-0002-6432-4421; Legler, Daniel F./0000-0001-8610-4764				Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bi K, 2001, SEMIN IMMUNOL, V13, P139, DOI 10.1006/smim.2000.0305; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Doucey MA, 2001, EUR J IMMUNOL, V31, P1561, DOI 10.1002/1521-4141(200105)31:5&lt;1561::AID-IMMU1561&gt;3.0.CO;2-W; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; HSI ED, 1989, J BIOL CHEM, V264, P10836; Ilangumaran S, 2000, IMMUNOL TODAY, V21, P2, DOI 10.1016/S0167-5699(99)01494-2; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Mayer BJ, 2001, J CELL SCI, V114, P1253; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Morgan JA, 1999, CANCER RES, V59, P6205; Penna D, 1999, J IMMUNOL, V163, P50; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2001, J CELL BIOL, V152, P1115, DOI 10.1083/jcb.152.5.1115; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	50	277	284	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					836	843		10.1038/ni830	http://dx.doi.org/10.1038/ni830			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12154360	Green Submitted			2022-12-18	WOS:000177694900012
J	Moretta, A; Bottino, C; Mingari, MC; Biassoni, R; Moretta, L				Moretta, A; Bottino, C; Mingari, MC; Biassoni, R; Moretta, L			What is a natural killer cell?	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTORS; MOLECULES		Univ Genoa, Dipartimento Med Sperimentale, I-16145 Genoa, Italy; Ist Nazl Ric Canc, I-16132 Genoa, Italy; Univ Genoa, Dipartimento Oncol Biol & Genet, I-16145 Genoa, Italy; Ist Giannina Gaslini, I-16148 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Moretta, L (corresponding author), Univ Genoa, Dipartimento Med Sperimentale, I-16145 Genoa, Italy.	lorenzomoretta@ospedale-gaslini.ge.it	BIASSONI, ROBERTO/J-4677-2018; Moretta, Lorenzo/AAA-7239-2020; Mingari, Maria Cristina/AAB-1315-2019; Bottino, Cristina/J-9977-2016	BIASSONI, ROBERTO/0000-0002-4365-8166; Moretta, Lorenzo/0000-0003-4658-1747; Bottino, Cristina/0000-0001-6695-1739	Telethon [E.0892] Funding Source: Medline	Telethon(Fondazione Telethon)		Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; De Maria A, 2001, EUR J IMMUNOL, V31, P3546, DOI 10.1002/1521-4141(200112)31:12<3546::AID-IMMU3546>3.0.CO;2-W; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Ruggeri L, 2001, CURR OPIN HEMATOL, V8, P355, DOI 10.1097/00062752-200111000-00007; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P176; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	18	277	291	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					6	8		10.1038/ni0102-6	http://dx.doi.org/10.1038/ni0102-6			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753399				2022-12-18	WOS:000173148700004
J	Jiang, K; Zhong, B; Gilvary, DL; Corliss, BC; Hong-Geller, E; Wei, S; Djeu, JY				Jiang, K; Zhong, B; Gilvary, DL; Corliss, BC; Hong-Geller, E; Wei, S; Djeu, JY			Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells	NATURE IMMUNOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; T-CELLS; TYROSINE KINASE; ADAPTER PROTEIN; EXCHANGE FACTOR; ACTIVATION; RECEPTOR; PATHWAY; RAC	The mitogen-activated protein kinase-extracellular signal-regulated kinase signaling element (MAPK-ERK) plays a critical role in natural killer (NK) cell lysis of tumor cells, but its upstream effecters were previously unknown. We show that inhibition of phosphoinositide-3 kinase (PI3K) in NK cells blocks p21-activated kinase 1 (PAK1), MAPK kinase (MEK) and ERK activation by target cell ligation, interferes with perforin and granzyme B movement toward target cells and suppresses NK cytotoxicity. Dominant-negative N17Rac1 and PAK I mimic the suppressive effects of PI3K inhibitors, whereas constitutively active V12Rac1 has the opposite effect. V12Rac1 restores the activity of downstream effecters and lytic function in LY294002- or wortmannin-treated, but not PD98059-treated, NK cells,These results document a specific PI3K-->Rac1-->PAK1->MEK-->ERK pathway in NK cells that effects lysis.	Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr,Immunol Program, Tampa, FL 33612 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; United States Department of Energy (DOE); Los Alamos National Laboratory	Djeu, JY (corresponding author), Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr,Immunol Program, Tampa, FL 33612 USA.	djeu@moffitt.usf.edu			NCI NIH HHS [CA83146] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.0.CO;2-I; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; BUDAY L, 1994, J BIOL CHEM, V269, P9019; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gismondi A, 2000, J IMMUNOL, V164, P2272, DOI 10.4049/jimmunol.164.5.2272; Gringhuis SI, 1998, MOL CELL BIOL, V18, P1725, DOI 10.1128/MCB.18.3.1725; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; NOBES CD, 1995, J CELL SCI, V108, P225; Palmieri G, 1999, J IMMUNOL, V162, P7181; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Trotta R, 1998, J IMMUNOL, V161, P6648; von Willebrand M, 1998, CELL SIGNAL, V10, P407, DOI 10.1016/S0898-6568(97)00139-3; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	32	277	291	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					419	425		10.1038/80859	http://dx.doi.org/10.1038/80859			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062502				2022-12-18	WOS:000165076100015
J	Parvatiyar, K; Zhang, ZQ; Teles, RM; Ouyang, SY; Jiang, Y; Iyer, SS; Zaver, SA; Schenk, M; Zeng, S; Zhong, WW; Liu, ZJ; Modlin, RL; Liu, YJ; Cheng, GH				Parvatiyar, Kislay; Zhang, Zhiqiang; Teles, Rosane M.; Ouyang, Songying; Jiang, Yan; Iyer, Shankar S.; Zaver, Shivam A.; Schenk, Mirjam; Zeng, Shang; Zhong, Wenwan; Liu, Zhi-Jie; Modlin, Robert L.; Liu, Yong-jun; Cheng, Genhong			The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response	NATURE IMMUNOLOGY			English	Article							INNATE; RECEPTORS; ADAPTER; FACTOR-3; REVEALS; SENSOR	The induction of type I interferons by the bacterial secondary messengers cyclic di-GMP (c-di-GMP) or cyclic di-AMP (c-di-AMP) is dependent on a signaling axis that involves the adaptor STING, the kinase TBK1 and the transcription factor IRF3. Here we identified the heliase DDX41 as a pattern-recognition receptor (PRR) that sensed both c-di-GMP and c-di-AMP. DDX41 specifically and directly interacted with c-di-GMP. Knockdown of DDX41 via short hairpin RNA in mouse or human cells inhibited the induction of genes encoding molecules involved in the innate immune response and resulted in defective activation of STING, TBK1 and IRF3 in response to c-di-GMP or c-di-AMP. Our results suggest a mechanism whereby c-di-GMP and c-di-AMP are detected by DDX41, which forms a complex with STING to signal to TBK1-IRF3 and activate the interferon response.	[Parvatiyar, Kislay; Iyer, Shankar S.; Zaver, Shivam A.; Modlin, Robert L.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhang, Zhiqiang; Liu, Yong-jun] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX USA; [Teles, Rosane M.; Schenk, Mirjam; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Ouyang, Songying; Jiang, Yan; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Zeng, Shang; Zhong, Wenwan] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; Baylor Scott & White Health; Baylor University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Riverside	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	yong-jun.liu@baylorhealth.com; gcheng@mednet.ucla.edu	Modlin, Robert L/M-7941-2014; Liu, Zhi-Jie/A-3946-2012; Teles, Rosane/E-9607-2017; Teles, Rosane/AAQ-3436-2020	Modlin, Robert L/0000-0003-4720-031X; Liu, Zhi-Jie/0000-0001-7279-2893; Teles, Rosane/0000-0003-2908-3244; Teles, Rosane/0000-0003-2908-3244; Schenk, Mirjam/0000-0002-1637-0730; Zaver, Shivam/0000-0001-5254-0963	US National Institutes of Health [T32-AR058921, P50 AR063020, R01 AI022553, R01 AI073539 AI056154, AI067769, AI047868, AR63020]; Ministry of Science and Technology of China [2009DFB30310, 2013CB911103]; National Natural Science Foundation of China [31070660, 31200559]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073539, R01AI056154, R37AI047868, R01AI069120, R01AI047868, U19AI067769, R01AI022553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR058921, P50AR063020] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Kelly-Scumpia for technical assistance; A. Dev for critical reading of the manuscript; and members of the Cheng and Modlin laboratories for discussion. Supported by the US National Institutes of Health (T32-AR058921 to K.P.; and P50 AR063020, R01 AI022553 and R01 AI073539 AI056154, AI067769, AI047868 and AR63020). Also supported in part by the Ministry of Science and Technology of China (2009DFB30310, 2013CB911103) and the National Natural Science Foundation of China (31070660, 31200559).	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hengge R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3149pe44; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; McCoy CE, 2008, FRONT BIOSCI-LANDMRK, V13, P62, DOI 10.2741/2660; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stein SC, 2012, J VIROL, V86, P4527, DOI 10.1128/JVI.07071-11; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	36	276	305	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1155	+		10.1038/ni.2460	http://dx.doi.org/10.1038/ni.2460			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23142775	Green Submitted, Green Accepted			2022-12-18	WOS:000311217900008
J	Freiberg, BA; Kupfer, H; Maslanik, W; Delli, J; Kappler, J; Zaller, DM; Kupfer, A				Freiberg, BA; Kupfer, H; Maslanik, W; Delli, J; Kappler, J; Zaller, DM; Kupfer, A			Staging and resetting T cell activation in SMACs	NATURE IMMUNOLOGY			English	Article							CD45 TYROSINE PHOSPHATASE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; MEMBRANE DOMAINS; KINASE; PROTEIN; ZAP-70; PHOSPHORYLATION; SRC; LCK	During the productive interaction of T cells with antigen-presenting cells (APCs), engaged receptors, including the T cell antigen receptors and their associated tyrosine kinases, assemble into spatially segregated supramolecular activation clusters (SMACs) at the area of cell contact. Here, we studied intracellular signaling in SMACs by three-dimensional immunofluorescence microscopic localization of CD3, CD45, talin, phosphotyrosine, Lck and phosphorylated ZAP-70 in T cell-APC conjugates. Two distinct phases of spatial-temporal activation, one before and one after SMAC formation, which were separated by a brief state of inactivation caused by CD45, were observed at the T cell-APC contact area. We propose that pre-SMAC signals are sufficient to activate cell adhesion, but not productive T cell responses, which require orchestrated signaling in SMACs.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Cellular & Struct Biol, Denver, CO 80262 USA; Merck Res Labs, Rahway, NJ 07065 USA	National Jewish Health; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Merck & Company	Kupfer, A (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, 1400 Jackson St, Denver, CO 80206 USA.							Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; D'Oro U, 1999, J IMMUNOL, V162, P1879; GOLD MR, 1994, J IMMUNOL, V153, P2369; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Shenoi H, 1999, J IMMUNOL, V162, P7120; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Stone JD, 1997, J IMMUNOL, V158, P5773; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	36	276	287	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					911	917		10.1038/ni836	http://dx.doi.org/10.1038/ni836			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244310				2022-12-18	WOS:000178242100010
J	Fang, DY; Elly, C; Gao, BX; Fang, N; Altman, Y; Joazeiro, C; Hunter, T; Copeland, N; Jenkins, N; Liu, YC				Fang, DY; Elly, C; Gao, BX; Fang, N; Altman, Y; Joazeiro, C; Hunter, T; Copeland, N; Jenkins, N; Liu, YC			Dysregulation of T lymphocyte function in itchy mice: a role for itch in T(H)2 differentiation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; MOTH-EATEN; CBL-B; UBIQUITIN; EXPRESSION; MUTATIONS; PROTEOLYSIS; ACTIVATION; LIGASE; LOCUS	Itch is an E3 ubiquitin ligase that is disrupted in nonagouti-lethal or itchy mice. Itch deficiency leads to severe immune and inflammatory disorders and constant itching of the skin. Here we show that Itch(-/-) T cells show an activated phenotype and enhanced proliferation. Production of the type 2 T helper (T(H)2) cell cytokines interleukin 4 (IL-4) and IL-5 by Itch-/- T cells was augmented upon stimulation, and the T(H)2-dependent serum concentrations of immunoglobulin G1 (IgG1) and IgE in itchy mice were also increased. Molecularly, Itch associated with and induced ubiquitination of JunB, a transcription factor that is involved in T(H)2 differentiation. These results provide a molecular link between Itch deficiency and the aberrant activation of immune responses in itchy mice.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; NCI, Frederick, MD 21702 USA	La Jolla Institute for Immunology; Salk Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA.	yuncail@liai.org	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; Altman, Yoav/0000-0001-6075-1111; LIU, YUN-CAI/0000-0002-0996-7109	NIDDK NIH HHS [R01DK56558] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056558] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BAZEIRO CA, 1999, SCIENCE, V286, P309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HUSTAD CM, 1995, GENETICS, V140, P255; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sperling AI, 2001, NAT IMMUNOL, V2, P573, DOI 10.1038/89709; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	30	276	297	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					281	287		10.1038/ni763	http://dx.doi.org/10.1038/ni763			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11828324				2022-12-18	WOS:000174074000017
J	Xu, HX; Zhu, J; Smith, S; Foldi, J; Zhao, BH; Chung, AY; Outtz, H; Kitajewski, J; Shi, C; Weber, S; Saftig, P; Li, YM; Ozato, K; Blobel, CP; Ivashkiv, LB; Hu, XY				Xu, Haixia; Zhu, Jimmy; Smith, Sinead; Foldi, Julia; Zhao, Baohong; Chung, Allen Y.; Outtz, Hasina; Kitajewski, Jan; Shi, Chao; Weber, Silvio; Saftig, Paul; Li, Yueming; Ozato, Keiko; Blobel, Carl P.; Ivashkiv, Lionel B.; Hu, Xiaoyu			Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization	NATURE IMMUNOLOGY			English	Article							SEQUENCE-BINDING-PROTEIN; DENDRITIC CELLS; GENE-TRANSCRIPTION; CROSS-TALK; CONSENSUS; ACTIVATION; EXPRESSION; RESPONSES; MURINE; INDUCTION	Emerging concepts suggest that the functional phenotype of macrophages is regulated by transcription factors that define alternative activation states. We found that RBP-J, the main nuclear transducer of signaling via Notch receptors, augmented Toll-like receptor 4 (TLR4)-induced expression of key mediators of classically activated M1 macrophages and thus of innate immune responses to Listeria monocytogenes. Notch-RBP-J signaling controlled expression of the transcription factor IRF8 that induced downstream M1 macrophage-associated genes. RBP-J promoted the synthesis of IRF8 protein by selectively augmenting kinase IRAK2-dependent signaling via TLR4 to the kinase MNK1 and downstream translation-initiation control through eIF4E. Our results define a signaling network in which signaling via Notch-RBP-J and TLRs is integrated at the level of synthesis of IRF8 protein and identify a mechanism by which heterologous signaling pathways can regulate the TLR-induced inflammatory polarization of macrophages.	[Xu, Haixia; Zhu, Jimmy; Smith, Sinead; Zhao, Baohong; Chung, Allen Y.; Blobel, Carl P.; Ivashkiv, Lionel B.; Hu, Xiaoyu] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Xu, Haixia] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Foldi, Julia; Shi, Chao; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA; [Outtz, Hasina; Kitajewski, Jan] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Shi, Chao; Li, Yueming] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Weber, Silvio; Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Ozato, Keiko] NICHHD, NIH, Bethesda, MD 20892 USA; [Hu, Xiaoyu] Weill Cornell Med Coll, Dept Med, New York, NY USA	Sun Yat Sen University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University; Memorial Sloan Kettering Cancer Center; University of Kiel; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University	Hu, XY (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	hux@hss.edu	Saftig, Paul/A-7966-2010; Shi, Chao/B-5455-2008; LI, Yue/GRS-8071-2022; Hu, Xiaoyu/D-5403-2017; Smith, Sinead M./AAW-1408-2020	Hu, Xiaoyu/0000-0002-4289-6998; Smith, Sinead M./0000-0003-3460-3590; zhu, jimmy/0000-0003-4957-8885; Reed, Hasina/0000-0001-8259-9616	American College of Rheumatology; US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, K99AR062047, R01AR056729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	American College of Rheumatology(General Electric); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank T. Honjo (Kyoto University) for Rbpj<SUP>flox/flox</SUP> mice; T. Gridley (Maine Medical Center Research Institute) for Notch1<SUP>+/-</SUP> mice; R. Kopan (Washington University) for NICD1 expression plasmids; S. Smale (University of California, Los Angeles) for Il12b promoter reporter constructs; M. Takami (Showa University) for the IRF8 expression construct; S. Akira (Osaka University) for IRAK2 retroviral constructs; J.A. Cooper (Fred Hutchinson Cancer Research Center) for MNK1 expression plasmids; E. Kieff (Harvard Medical School); J.C. Aster (Harvard Medical School) for anti-RBP-J rabbit serum; E. G. Pamer for discussions about the L. monocytogenes infection experiments; and K. Au for technical assistance. Supported by the American College of Rheumatology (X.H.) and the US National Institutes of Health (L.B.I. and X.H.).	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shelton CC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-22; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	50	275	296	2	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					642	+		10.1038/ni.2304	http://dx.doi.org/10.1038/ni.2304			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22610140	Bronze, Green Accepted			2022-12-18	WOS:000305483800009
J	Yoshimoto, T; Mizutani, H; Tsutsui, H; Noben-Trauth, N; Yamanaka, K; Tanaka, M; Izumi, S; Okamura, H; Paul, WE; Nakanishi, K				Yoshimoto, T; Mizutani, H; Tsutsui, H; Noben-Trauth, N; Yamanaka, K; Tanaka, M; Izumi, S; Okamura, H; Paul, WE; Nakanishi, K			IL-18 induction of IgE: dependence on CD4(+) T cells, IL-4 and STAT6	NATURE IMMUNOLOGY			English	Article							GAMMA-INDUCING FACTOR; B-CELLS; TH2 CELLS; INTERLEUKIN-18; RECEPTOR; CYTOKINE; LYMPHOKINE; EXPRESSION; INVIVO; ACTIVATION	Overproduction of immunoglobulin E (IgE) and T helper cell type 2 (T(H)2) cytokines, including interleukin 4 (IL-4), IL-5 and IL-13, can result in allergic disorders. Although it is known that IL-4 is critical to the polarization of naive CD4(+) T cells to a T(H)2 phenotype, both in vitro and in many in vivo systems, other factors that regulate in vivo IL-4 production and T(H)2 commitment are poorly understood. IL-18, an IL-1-like cytokine that requires cleavage with caspase-1 to become active, was found to increase IgE production in a CD4(+) T cells-, IL-4- and STAT6-dependent fashion. IL-18 and T cell receptor-mediated stimulation could induce naive CD4(+) T cells to develop into IL-4-producing cells in vitro. Thus, caspase-1 and IL-18 may be critical in regulation of IgE production in vivo, providing a potential therapeutic target for allergic disorders.	Hyogo Coll Med, Inst Adv Med Sci, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan; Mie Univ, Fac Med, Dept Dermatol, Tsu, Mie 5148507, Japan; Mie Univ, Fac Med, Dept Biochem, Tsu, Mie 5148507, Japan; Natl Leprosarium, Kagawa 7610198, Japan; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Mie University; Mie University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Japan Science & Technology Agency (JST)	Nakanishi, K (corresponding author), Hyogo Coll Med, Inst Adv Med Sci, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan.	nakaken@hyo-med.ac.jp	Yoshimoto, Tomohiro/E-2224-2014	Tsutsui, Hiroko/0000-0001-7928-4875	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cameron LA, 1999, EUR RESPIR J, V14, P553, DOI 10.1034/j.1399-3003.1999.14c12.x; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hoshino T, 1999, J IMMUNOL, V162, P5070; Kohno K, 1997, J IMMUNOL, V158, P1541; Kumano K, 1999, AM J RESP CRIT CARE, V160, P873, DOI 10.1164/ajrccm.160.3.9805026; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; PAUL WE, 1993, ADV IMMUNOL, V53, P1, DOI 10.1016/S0065-2776(08)60496-4; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Stoll S, 1997, J IMMUNOL, V159, P298; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; YAMANAKA K, 2000, IN PRESS J IMMUNOL; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	34	275	287	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					132	137		10.1038/77811	http://dx.doi.org/10.1038/77811			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248805				2022-12-18	WOS:000089814900013
J	Hombrink, P; Helbig, C; Backer, RA; Piet, B; Oja, AE; Stark, R; Brasser, G; Jongejan, A; Jonkers, RE; Nota, B; Basak, O; Clevers, HC; Moerland, PD; Amsen, D; van Lier, RAW				Hombrink, Pleun; Helbig, Christina; Backer, Ronald A.; Piet, Berber; Oja, Anna E.; Stark, Regina; Brasser, Giso; Jongejan, Aldo; Jonkers, Rene E.; Nota, Benjamin; Basak, Onur; Clevers, Hans C.; Moerland, Perry D.; Amsen, Derk; van Lier, Rene A. W.			Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells	NATURE IMMUNOLOGY			English	Article							NOTCH CONTROLS; TGF-BETA; EFFECTOR; DIFFERENTIATION; PROTECTION; INFECTION; VIRUS; ACTIVATION; EXPRESSION; CHALLENGE	Tissue-resident memory T cells (TRM cells) in the airways mediate protection against respiratory infection. We characterized TRM cells expressing integrin alpha(E) (CD103) that reside within the epithelial barrier of human lungs. These cells had specialized profiles of chemokine receptors and adhesion molecules, consistent with their unique localization. Lung TRM cells were poised for rapid responsiveness by constitutive expression of deployment-ready mRNA encoding effector molecules, but they also expressed many inhibitory regulators, suggestive of programmed restraint. A distinct set of transcription factors was active in CD103(+) TRM cells, including Notch. Genetic and pharmacological experiments with mice revealed that Notch activity was required for the maintenance of CD103(+) T-RM cells. We have thus identified specialized programs underlying the residence, persistence, vigilance and tight control of human lung TRM cells.	[Hombrink, Pleun; Helbig, Christina; Backer, Ronald A.; Oja, Anna E.; Stark, Regina; Brasser, Giso; Amsen, Derk; van Lier, Rene A. W.] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands; [Piet, Berber] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Jongejan, Aldo; Moerland, Perry D.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Jonkers, Rene E.] Acad Med Ctr, Dept Resp Med, Amsterdam, Netherlands; [Nota, Benjamin] Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Basak, Onur; Clevers, Hans C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Amsen, D (corresponding author), Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands.	d.amsen@sanquin.nl	Moerland, Perry/AAG-1425-2020; Basak, Onur/GLV-6113-2022; Piet, Berber/AAD-2746-2020	Moerland, Perry/0000-0002-2357-3659; Basak, Onur/0000-0002-6864-3403; Piet, Berber/0000-0002-9069-3597; Stark, Regina/0000-0001-7693-799X; Nota, Benjamin/0000-0001-7500-5760	Landsteiner Stichting voor Bloedtransfusie Research [1136]; Netherlands Asthma Foundation [3.2.06.020]; Alexander von Humboldt Foundation; Netherlands organization for scientific research (NWO-ALW)	Landsteiner Stichting voor Bloedtransfusie Research; Netherlands Asthma Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Netherlands organization for scientific research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	We thank K.P. Gisbergen and I.J. ten Berge for discussions; E. Mul and T. Poplonski for assistance with flow cytometry sorting; J. Kloek, M. Jonker, E. Hendriks, J. Weening, H. Stel, E. Prins, G. Nossent and E. Verschuuren for help with obtaining patient material; A. ten Brinke (Sanquin, Amsterdam) for tetramer reagents; and R. Lutter, B.S. Dierdorp and T. Dekker for coordinating technical assistance. Supported by the Landsteiner Stichting voor Bloedtransfusie Research (1136 to R.A.W.v.L.), the Netherlands Asthma Foundation (3.2.06.020 to R.A.Wv.L.), the Alexander von Humboldt Foundation (R.S.) and the Netherlands organization for scientific research (NWO-ALW; to D.A.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Amsen D, 2015, TRENDS IMMUNOL, V36, P802, DOI 10.1016/j.it.2015.10.007; Anderson KG, 2014, J LEUKOCYTE BIOL, V95, P199, DOI 10.1189/jlb.0913493; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Backer RA, 2014, NAT IMMUNOL, V15, P1143, DOI 10.1038/ni.3027; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kuijk LM, 2013, BLOOD, V121, P2638, DOI 10.1182/blood-2012-07-442962; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pezzulo AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016166; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang WH, 2015, STEM CELLS, V33, P2280, DOI 10.1002/stem.2031; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	50	274	275	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1467	1478		10.1038/ni.3589	http://dx.doi.org/10.1038/ni.3589			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27776108				2022-12-18	WOS:000388056400017
J	Doherty, PC; Turner, SJ; Webby, RG; Thomas, PG				Doherty, PC; Turner, SJ; Webby, RG; Thomas, PG			Influenza and the challenge for immunology	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; A-VIRUS; ANTIBODY-RESPONSE; DENDRITIC CELLS; BONE-MARROW; IN-VIVO; IMMUNODOMINANCE HIERARCHY; ANTIGEN PRESENTATION; PANDEMIC INFLUENZA; H5N1 VIRUSES	The continued westward dissemination of H5N1 influenza A viruses in avian populations and the nearly 50% mortality rate of humans infected with H5N1 are a source of great international concern. A mutant H5N1 virus with the capability to spread rapidly between humans could cause a global catastrophe. Governments have reacted by developing national response plans, stockpiling antiviral drugs and speeding up the development and approval of vaccines. Here we summarize what is known about the interaction between influenza A viruses and the mammalian host response, specifically emphasizing issues that might be of interest to the broader immunology community.	Univ Melbourne, Sch Med, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of Melbourne; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Doherty, PC (corresponding author), Univ Melbourne, Sch Med, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	pcd@unimelb.edu.au	Turner, Stephen/GXM-4654-2022; Webby, Richard J/N-5657-2018; Thomas, Paul G./H-1063-2018; Doherty, Peter Charles/C-4185-2013	Thomas, Paul G./0000-0001-7955-0256; Turner, Stephen/0000-0002-1002-0000; Doherty, Peter Charles/0000-0002-5028-3489	NIAID NIH HHS [AI29579, AI95357, AI065097] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065097, R01AI029579, R37AI029579, N01AI095357] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreansky SS, 2005, J VIROL, V79, P4329, DOI 10.1128/JVI.79.7.4329-4339.2005; [Anonymous], FIELDS VIROLOGY; Barry John, 2004, THE GREAT INFLUENZA; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Brands R, 1999, Dev Biol Stand, V98, P93; Bueving HJ, 2004, VACCINE, V23, P91, DOI 10.1016/j.vaccine.2004.03.067; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cho Y, 2003, J VIROL, V77, P4679, DOI 10.1128/JVI.77.8.4679-4684.2003; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Coleclough C, 2005, SCAND J IMMUNOL, V62, P73, DOI 10.1111/j.1365-3083.2005.01613.x; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Engelhardt OG, 2004, J GEN VIROL, V85, P2315, DOI 10.1099/vir.0.79795-0; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Feng JQ, 2002, J VIROL, V76, P1369, DOI 10.1128/JVI.76.3.1369-1378.2002; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; KEDZIERSKA K, IN PRESS IMMUNOL REV; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Lamb RA, 2005, NAT MED, V11, P1154, DOI 10.1038/nm1105-1154; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Lipatov AS, 2005, J INFECT DIS, V191, P1216, DOI 10.1086/428951; Marshall DR, 2005, P NATL ACAD SCI USA, V102, P6074, DOI 10.1073/pnas.0501960102; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rudenko LG, 2000, VACCINE, V19, P308, DOI 10.1016/S0264-410X(00)00153-5; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Topham DJ, 1997, J IMMUNOL, V159, P5197; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tripp RA, 1997, J IMMUNOL, V158, P3716; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Turner SJ, 2001, J IMMUNOL, V167, P2753, DOI 10.4049/jimmunol.167.5.2753; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Turner SJ, 2003, IMMUNITY, V18, P549, DOI 10.1016/S1074-7613(03)00087-6; Voeten JTM, 2000, VACCINE, V19, P514, DOI 10.1016/S0264-410X(00)00179-1; vonItzstein M, 1996, CURR OPIN STRUC BIOL, V6, P703, DOI 10.1016/S0959-440X(96)80038-8; Walker WS, 1997, J IMMUNOL, V159, P2563; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; ZWEERINK HJ, 1977, EUR J IMMUNOL, V7, P630, DOI 10.1002/eji.1830070910	100	274	281	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					449	455		10.1038/ni1343	http://dx.doi.org/10.1038/ni1343			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622432	Bronze			2022-12-18	WOS:000237008800009
J	Lazarevic, V; Chen, X; Shim, JH; Hwang, ES; Jang, E; Bolm, AN; Oukka, M; Kuchroo, VK; Glimcher, LH				Lazarevic, Vanja; Chen, Xi; Shim, Jae-Hyuck; Hwang, Eun-Sook; Jang, Eunjung; Bolm, Alexandra N.; Oukka, Mohamed; Kuchroo, Vijay K.; Glimcher, Laurie H.			T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR gamma t	NATURE IMMUNOLOGY			English	Article							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR; TH17 CELLS; TGF-BETA; IN-VIVO; ALLOGRAFT-REJECTION; HELPER TYPE-1; LINEAGE; STAT3; INTERLEUKIN-17	Overactive responses by interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) are tightly linked to the development of autoimmunity, yet the factors that negatively regulate the differentiation of this lineage remain unknown. Here we report that the transcription factor T-bet suppressed development of the T(H)17 cell lineage by inhibiting transcription of Rorc (which encodes the transcription factor ROR gamma t). T-bet interacted with the transcription factor Runx1, and this interaction blocked Runx1-mediated transactivation of Rorc. T-bet Tyr304 was required for formation of the T-bet-Runx1 complex, for blockade of Runx1 activity and for inhibition of the T(H)17 differentiation program. Our data reinforce the idea of master regulators that shape immune responses by simultaneously activating one genetic program while silencing the activity of competing regulators in a common progenitor cell.	[Lazarevic, Vanja; Chen, Xi; Shim, Jae-Hyuck; Bolm, Alexandra N.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Hwang, Eun-Sook; Jang, Eunjung] Ewha Womans Univ, Coll Pharm, Div Life & Pharmaceut Sci, Seoul, South Korea; [Oukka, Mohamed] Seattle Childrens Res Inst, Dept Pediat, Seattle, WA USA; [Kuchroo, Vijay K.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Ewha Womans University; Seattle Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Lazarevic, V (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	vlazarev@hsph.harvard.edu; lglimche@hsph.harvard.edu	Chen, Xi/C-6889-2012; Lazarevic, Vanja/B-1160-2009	Lazarevic, Vanja/0000-0002-5783-7130; Chen, Xi/0000-0002-7995-6202; Shim, Jae-Hyuck/0000-0002-4947-3293	US National Institutes of Health [P01 NS038037]; Ragon Institute of MIT, MGH and Harvard; National Cancer Research Center [R15-2006-020]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [ZIABC011431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MIT, MGH and Harvard; National Cancer Research Center; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for help in cell sorting; W. Strober (National Institute of Allergy and Infectious Diseases) for retroviral plasmids encoding Runx1 and dominant negative Runx1; S. L. Reiner (University of Pennsylvania) for mice with loxP-flanked Tbx21 alleles; C. B. Wilson (The Bill and Melinda Gates Foundation) for mice with expression of Cre recombinase driven by the Cd4 promoter; and A.-H. Lee, T. Staton-Winslow, M. Greenblatt and M. Wein for critical review of the manuscript. Supported by the US National Institutes of Health (P01 NS038037), the Ragon Institute of MIT, MGH and Harvard (L. H. G.), the National Cancer Research Center (R15-2006-020 to E. S. H.) and the Cancer Research Institute (V.L.).	Abromson-Leeman S, 2009, J NEUROIMMUNOL, V215, P10, DOI 10.1016/j.jneuroim.2009.07.007; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Burrell BE, 2008, J IMMUNOL, V181, P3906, DOI 10.4049/jimmunol.181.6.3906; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Guo SQ, 2009, J IMMUNOL, V182, P6179, DOI 10.4049/jimmunol.0803821; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	46	273	287	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					96	U124		10.1038/ni.1969	http://dx.doi.org/10.1038/ni.1969			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21151104	Green Accepted			2022-12-18	WOS:000285465100018
J	Ariel, A; Fredman, G; Sun, YP; Kantarci, A; Van Dyke, TE; D Luster, A; Serhan, CN				Ariel, Amiram; Fredman, Gabrielle; Sun, Yee-Ping; Kantarci, Alpdogan; Van Dyke, Thomas E.; D Luster, Andrew; Serhan, Charles N.			Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression	NATURE IMMUNOLOGY			English	Article							RECEPTOR SPECIFICITY; IMPAIRED CLEARANCE; STABLE ANALOGS; TGF-BETA; PHAGOCYTOSIS; INFLAMMATION; ASPIRIN; LIPOXINS; ATHEROGENESIS; SUPPRESSION	During the resolution phase of inflammation, the 'corpses' of apoptotic leukocytes are gradually cleared by macrophages. Here we report that during the resolution of peritonitis, the CCR5 chemokine receptor ligands CCL3 and CCL5 persisted in CCR5-deficient mice. CCR5 expression on apoptotic neutrophils and activated apoptotic T cells sequestered and effectively cleared CCL3 and CCL5 from sites of inflammation. CCR5 expression on late apoptotic human polymorphonuclear cells was downregulated by proinflammatory stimuli, including tumor necrosis factor, and was upregulated by 'proresolution' lipid mediators, including lipoxin A(4), resolvin E1 and protectin D1. Our results suggest that CCR5(+) apoptotic leukocytes act as 'terminators' of chemokine signaling during the resolution of inflammation.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Grad Dent, Boston, MA 02118 USA; Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp,Div Rheumatol Allergy & Im, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts General Hospital	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu			NCRR NIH HHS [M01 RR000533] Funding Source: Medline; NIDCR NIH HHS [P50-DE016191, P50 DE016191] Funding Source: Medline; NIDDK NIH HHS [R01 DK074448, DK-074449, DK-074448, R01 DK074449] Funding Source: Medline; NIGMS NIH HHS [GM38765, R37 GM038765, R01 GM038765] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074449, R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R29GM038765, R37GM038765] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bandeira-Melo C, 2000, J IMMUNOL, V164, P1029, DOI 10.4049/jimmunol.164.2.1029; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Brunetti M, 2000, THROMB HAEMOSTASIS, V84, P478; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Chan A, 2001, GLIA, V33, P87, DOI 10.1002/1098-1136(20010101)33:1<87::AID-GLIA1008>3.0.CO;2-S; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Gilroy DW, 2005, CURR OPIN PHARMACOL, V5, P405, DOI 10.1016/j.coph.2005.02.006; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Guan E, 2002, J BIOL CHEM, V277, P32348, DOI 10.1074/jbc.M203077200; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hebert MJ, 1996, J IMMUNOL, V157, P3105; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Majno G., 2004, CELLS TISSUES DIS PR; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Ness TL, 2004, J IMMUNOL, V173, P6938, DOI 10.4049/jimmunol.173.11.6938; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; ROSSI AG, 1998, LUNG BIOL HEALTH DIS, V112, P9; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2004, HISTOCHEM CELL BIOL, V122, P305, DOI 10.1007/s00418-004-0695-8; Serhan CN, 1997, PROSTAG OTH LIPID M, V53, P107, DOI 10.1016/S0090-6980(97)00001-4; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Wahl SM, 2004, J LEUKOCYTE BIOL, V76, P15, DOI 10.1189/jlb.1103539; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Wysocki CA, 2004, J IMMUNOL, V173, P845, DOI 10.4049/jimmunol.173.2.845	50	273	284	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1209	1216		10.1038/ni1392	http://dx.doi.org/10.1038/ni1392			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17013391	Green Accepted			2022-12-18	WOS:000241437200016
J	Kaneko, T; Yano, T; Aggarwal, K; Lim, JH; Ueda, K; Oshima, Y; Peach, C; Erturk-Hasdemir, D; Goldman, WE; Oh, BH; Kurata, S; Silverman, N				Kaneko, Takashi; Yano, Tamaki; Aggarwal, Kamna; Lim, Jae-Hong; Ueda, Kazunori; Oshima, Yoshiteru; Peach, Camilla; Erturk-Hasdemir, Deniz; Goldman, William E.; Oh, Byung-Ha; Kurata, Shoichiro; Silverman, Neal			PGRP-LC and PGRP-LE have essential yet distinct functions in the drosophila immune response to monomeric DAP-type peptidoglycan	NATURE IMMUNOLOGY			English	Article							PATTERN-RECOGNITION RECEPTOR; IMD-PATHWAY; BORDETELLA-PERTUSSIS; TRACHEAL CYTOTOXIN; IN-VITRO; PROTEIN; ACTIVATION; COMPLEX; IDENTIFICATION; MELANOGASTER	Drosophila rely entirely on an innate immune response to combat microbial infection. Diaminopimelic acid-containing peptidoglycan, produced by Gram-negative bacteria, is recognized by two receptors, PGRP-LC and PGRP-LE, and activates a homolog of transcription factor NF-kappa B through the Imd signaling pathway. Here we show that full-length PGRP-LE acted as an intracellular receptor for monomeric peptidoglycan, whereas a version of PGRP-LE containing only the PGRP domain functioned extracellularly, like the mammalian CD14 molecule, to enhance PGRP-LC-mediated peptidoglycan recognition on the cell surface. Interaction with the imd signaling protein was not required for PGRP-LC signaling. Instead, PGRP-LC and PGRP-LE signaled through a receptor-interacting protein homotypic interaction motif-like motif. These data demonstrate that like mammals, drosophila use both extracellular and intracellular receptors, which have conserved signaling mechanisms, for innate immune recognition.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA; Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Pohang Univ Sci & Technol, Dept Life Sci, Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Massachusetts System; University of Massachusetts Worcester; Tohoku University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Washington University (WUSTL)	Silverman, N (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA.	kurata@mail.pharm.tohoku.ac.jp; neal.silverman@umassmed.edu	Yano, Tamaki/AHB-5620-2022; Oh, Byung-Ha/C-2061-2011	Yano, Tamaki/0000-0002-5576-1128; Goldman, William/0000-0002-1551-6718; Silverman, Neal/0000-0002-4259-456X; Kaneko, Takashi/0000-0001-9276-5550	NIAID NIH HHS [AI060025] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, R56AI060025] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; COOKSON BT, 1989, INFECT IMMUN, V57, P2223, DOI 10.1128/IAI.57.7.2223-2229.1989; COOKSON BT, 1989, BIOCHEMISTRY-US, V28, P1744, DOI 10.1021/bi00430a048; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Ito K, 1997, DEVELOPMENT, V124, P761; Kaneko T, 2005, J ENDOTOXIN RES, V11, P383, DOI 10.1179/096805105X76823; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu LP, 2001, GENETICS, V159, P189; Yajima M, 2003, BIOCHEM J, V371, P205, DOI 10.1042/BJ20021603	32	273	288	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					715	723		10.1038/ni1356	http://dx.doi.org/10.1038/ni1356			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16767093				2022-12-18	WOS:000238377700016
J	Woodruff, MC; Ramonell, RP; Nguyen, DC; Cashman, KS; Saini, AS; Haddad, NS; Ley, AM; Kyu, S; Howell, JC; Ozturk, T; Lee, SY; Suryadevara, N; Case, JB; Bugrovsky, R; Chen, WR; Estrada, J; Morrison-Porter, A; Derrico, A; Anam, FA; Sharma, M; Wu, HM; Le, SN; Jenks, SA; Tipton, CM; Staitieh, B; Daiss, JL; Ghosn, E; Diamond, MS; Carnahan, RH; Crowe, JE; Hu, WT; Lee, FEH; Sanz, I				Woodruff, Matthew C.; Ramonell, Richard P.; Nguyen, Doan C.; Cashman, Kevin S.; Saini, Ankur Singh; Haddad, Natalie S.; Ley, Ariel M.; Kyu, Shuya; Howell, J. Christina; Ozturk, Tugba; Lee, Saeyun; Suryadevara, Naveenchandra; Case, James Brett; Bugrovsky, Regina; Chen, Weirong; Estrada, Jacob; Morrison-Porter, Andrea; Derrico, Andrew; Anam, Fabliha A.; Sharma, Monika; Wu, Henry M.; Le, Sang N.; Jenks, Scott A.; Tipton, Christopher M.; Staitieh, Bashar; Daiss, John L.; Ghosn, Eliver; Diamond, Michael S.; Carnahan, Robert H.; Crowe, James E., Jr.; Hu, William T.; Lee, F. Eun-Hyung; Sanz, Ignacio			Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19	NATURE IMMUNOLOGY			English	Article							DENGUE VIRUS-INFECTION; SOMATIC HYPERMUTATION; EFFECTOR; POPULATION; ACTIVATION	A wide spectrum of clinical manifestations has become a hallmark of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the immunological underpinnings of diverse disease outcomes remain to be defined. We performed detailed characterization of B cell responses through high-dimensional flow cytometry to reveal substantial heterogeneity in both effector and immature populations. More notably, critically ill patients displayed hallmarks of extrafollicular B cell activation and shared B cell repertoire features previously described in autoimmune settings. Extrafollicular activation correlated strongly with large antibody-secreting cell expansion and early production of high concentrations of SARS-CoV-2-specific neutralizing antibodies. Yet, these patients had severe disease with elevated inflammatory biomarkers, multiorgan failure and death. Overall, these findings strongly suggest a pathogenic role for immune activation in subsets of patients with COVID-19. Our study provides further evidence that targeted immunomodulatory therapy may be beneficial in specific patient subpopulations and can be informed by careful immune profiling. Sanz and colleagues examine B cell subsets in a cohort of patients with COVID-19. Severely ill patients have higher frequencies of activated extrafollicular T-bet(+)B cells that form antibody-secreting cells, the majority of which express germline sequences and are reminiscent of antibody responses observed in patients with systemic lupus erythematosus during flares.	[Woodruff, Matthew C.; Cashman, Kevin S.; Saini, Ankur Singh; Lee, Saeyun; Bugrovsky, Regina; Chen, Weirong; Estrada, Jacob; Anam, Fabliha A.; Sharma, Monika; Le, Sang N.; Jenks, Scott A.; Tipton, Christopher M.; Ghosn, Eliver; Sanz, Ignacio] Emory Univ, Dept Med, Div Rheumatol, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Woodruff, Matthew C.; Jenks, Scott A.; Tipton, Christopher M.; Sanz, Ignacio] Emory Univ, Emory Autoimmun Ctr Excellence, Atlanta, GA 30322 USA; [Ramonell, Richard P.; Nguyen, Doan C.; Haddad, Natalie S.; Ley, Ariel M.; Kyu, Shuya; Lee, Saeyun; Morrison-Porter, Andrea; Derrico, Andrew; Le, Sang N.; Staitieh, Bashar; Lee, F. Eun-Hyung] Emory Univ, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA 30322 USA; [Haddad, Natalie S.; Daiss, John L.] MicroB Plex, Atlanta, GA USA; [Howell, J. Christina; Ozturk, Tugba; Hu, William T.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Suryadevara, Naveenchandra; Carnahan, Robert H.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Case, James Brett; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Wu, Henry M.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA; [Carnahan, Robert H.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Emory University; Emory University; Emory University; Emory University; Vanderbilt University; Washington University (WUSTL); Emory University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University	Sanz, I (corresponding author), Emory Univ, Dept Med, Div Rheumatol, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.; Sanz, I (corresponding author), Emory Univ, Emory Autoimmun Ctr Excellence, Atlanta, GA 30322 USA.; Lee, FEH (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA 30322 USA.	f.e.lee@emory.edu; ignacio.sanz@emory.edu	Suryadevara, Naveenchandra/AAQ-7626-2021; Crowe, James/B-5549-2009; Saini, Ankur/AAF-8507-2019; Chen, Weirong/L-5212-2019; Carnahan, Robert H/N-7429-2013	Crowe, James/0000-0002-0049-1079; Saini, Ankur/0000-0003-3963-6586; Carnahan, Robert H/0000-0001-5230-1532; Woodruff, Matthew/0000-0002-5252-7539; Nguyen, Doan/0000-0002-5389-6731; Ramonell, Richard/0000-0002-2385-0636; suryadevara, naveenchandra/0000-0003-2571-1290; Haddad, Natalie/0000-0002-1348-3094; Cashman, Kevin/0000-0002-2907-9264	National Institutes of Health grants [UL TR000424, R01-AG054991, U19-AI110483, P01-AI125180-01, R37-AI049660, 1R01AI121252, 1U01AI141993, R01 AI127828, T32-HL116271-07]; HHS/NIAID/NIH contract [75N93019C00074]; Defense Advanced Research Project Agency [HR001117S0019]; Dolly Parton COVID-19 Research Fund at Vanderbilt; Fast Grants Award	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS/NIAID/NIH contract; Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Dolly Parton COVID-19 Research Fund at Vanderbilt; Fast Grants Award	We thank all of the healthy individuals, patients and their families for their selfless participation in this study. We also thank the nurses, staff and providers in the 71 ICU in Emory University Hospital Midtown and the 2E ICU in Emory Saint Joseph's Hospital without whom our work would not have been possible. We acknowledge the contributions of D. Murphy, W. Bender, C. Swenson, C. Coleman, M. Horwath, D. Alter, V. Engineer, M. Hernandez and J. Varghese and their time and expertise. Extensive efforts by the Pediatric/Winship Flow Cytometry Core and the Flow Cytometry Core at the Emory Vaccine Center made this work possible. This work was supported by National Institutes of Health grants UL TR000424 (Emory Library IT), R01-AG054991 (to W.T.H.), U19-AI110483 Emory Autoimmunity Center of Excellence (to I.S.), P01-AI125180-01 (to I.S. and F.E.-H.L.), R37-AI049660 (to I.S.), 1R01AI121252 (to F.E.-H.L.), 1U01AI141993 (to F.E.-H.L.), R01 AI127828 (to J.E.C. and M.S.D.) and T32-HL116271-07 (to R.P.R.); HHS/NIAID/NIH contract 75N93019C00074 (to J.E.C.); Defense Advanced Research Project Agency grant HR001117S0019 (to J.E.C.); the Dolly Parton COVID-19 Research Fund at Vanderbilt; and a Fast Grants Award (to J.E.C.)	Allman D, 2019, IMMUNOL REV, V288, P128, DOI 10.1111/imr.12754; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Fang YT, 2010, MOL IMMUNOL, V47, P1000, DOI 10.1016/j.molimm.2009.11.019; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Gustave CA, 2018, J IMMUNOL, V200, P2418, DOI 10.4049/jimmunol.1700929; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harrison C, 2020, NAT BIOTECHNOL, V38, P905, DOI 10.1038/s41587-020-0634-9; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Hoepel W., 2020, IMMUNOLOGY, DOI [10.1101/2020.07.13.190140, DOI 10.1101/2020.07.13.190140]; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Ingraham NE, 2020, LANCET RESP MED, V8, P544, DOI 10.1016/S2213-2600(20)30226-5; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Kiprov D, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102856; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Lam JH, 2020, VIRAL IMMUNOL, V33, P294, DOI 10.1089/vim.2019.0207; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Leon Beatriz, 2012, Infectious Disorders - Drug Targets, V12, P213; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Liu Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1438-2; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Manni M, 2018, NAT IMMUNOL, V19, P407, DOI 10.1038/s41590-018-0056-8; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Menard LC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87310; National Institutes of Health, 2020, COVID 19 TREATM GUID; Pioli PD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02768; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Rodriguez-Bayona B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3042; Rubtsov AV, 2015, J IMMUNOL, V195, P71, DOI 10.4049/jimmunol.1500055; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Scharer CD, 2019, NAT IMMUNOL, V20, P1071, DOI 10.1038/s41590-019-0419-9; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P3692, DOI 10.1002/art.30599; Stone SL, 2019, IMMUNITY, V50, P1172, DOI 10.1016/j.immuni.2019.04.004; Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tipton CM, 2018, IMMUNOL REV, V284, P120, DOI 10.1111/imr.12660; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Dang VD, 2014, CURR OPIN IMMUNOL, V28, P77, DOI 10.1016/j.coi.2014.02.009; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Wec AZ, 2020, P NATL ACAD SCI USA, V117, P6675, DOI 10.1073/pnas.1921388117; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Xiao M, 2020, ARTHRITIS RHEUMATOL, V72, P1998, DOI 10.1002/art.41425; Yang J, 2019, NEUROINFORMATICS, V17, P185, DOI 10.1007/s12021-018-9392-y; Yang XY, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06936-w; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zeng Q, 2014, J CLIN INVEST, V124, P1052, DOI 10.1172/JCI70084; Zhang WQ, 2019, P NATL ACAD SCI USA, V116, P18550, DOI 10.1073/pnas.1901340116; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zumaquero E, 2019, ELIFE, V8, DOI 10.7554/eLife.41641	65	272	278	3	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1506	+		10.1038/s41590-020-00814-z	http://dx.doi.org/10.1038/s41590-020-00814-z		OCT 2020	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33028979	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000576667200001
J	Leong, YA; Chen, YP; Ong, HS; Wu, D; Man, KV; Deleage, C; Minnich, M; Meckiff, BJ; Wei, YB; Hou, ZH; Zotos, D; Fenix, KA; Atnerkar, A; Preston, S; Chipman, JG; Beilman, GJ; Allison, CC; Sun, L; Wang, P; Xu, JW; Toe, JG; Lu, HK; Tao, Y; Palendira, U; Dent, AL; Landay, AL; Pellegrini, M; Comerford, I; McColl, SR; Schacker, TW; Long, HM; Estes, JD; Busslinger, M; Belz, GT; Lewin, SR; Kallies, A; Yu, D				Leong, Yew Ann; Chen, Yaping; Ong, Hong Sheng; Wu, Di; Man, Kevin; Deleage, Claire; Minnich, Martina; Meckiff, Benjamin J.; Wei, Yunbo; Hou, Zhaohua; Zotos, Dimitra; Fenix, Kevin A.; Atnerkar, Anurag; Preston, Simon; Chipman, Jeffrey G.; Beilman, Greg J.; Allison, Cody C.; Sun, Lei; Wang, Peng; Xu, Jiawei; Toe, Jesse G.; Lu, Hao K.; Tao, Yong; Palendira, Umaimainthan; Dent, Alexander L.; Landay, Alan L.; Pellegrini, Marc; Comerford, Iain; McColl, Shaun R.; Schacker, Timothy W.; Long, Heather M.; Estes, Jacob D.; Busslinger, Meinrad; Belz, Gabrielle T.; Lewin, Sharon R.; Kallies, Axel; Yu, Di			CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles	NATURE IMMUNOLOGY			English	Article							HELPER-CELLS; VIRUS-INFECTION; HIV-INFECTION; DIFFERENTIATION; TRANSCRIPTION; BLIMP-1; EXPRESSION; EFFECTOR; TCF-1; BCL6	During unresolved infections, some viruses escape immunological control and establish a persistant reservoir in certain cell types, such as human immunodeficiency virus (HIV), which persists in follicular helper T cells (T-FH cells), and Epstein-Barr virus (EBV), which persists in B cells. Here we identified a specialized group of cytotoxic T cells (T-C cells) that expressed the chemokine receptor CXCR5, selectively entered B cell follicles and eradicated infected TFH cells and B cells. The differentiation of these cells, which we have called 'follicular cytotoxic T cells' (T-FC cells), required the transcription factors Bcl6, E2A and TCF-1 but was inhibited by the transcriptional regulators Blimp1, Id2 and Id3. Blimp1 and E2A directly regulated Cxcr5 expression and, together with Bcl6 and TCF-1, formed a transcriptional circuit that guided T-FC cell development. The identification of T-FC cells has far-reaching implications for the development of strategies to control infections that target B cells and T-FH cells and to treat B cell-derived malignancies.	[Leong, Yew Ann; Chen, Yaping; Ong, Hong Sheng; Atnerkar, Anurag; Yu, Di] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Leong, Yew Ann; Chen, Yaping; Ong, Hong Sheng; Atnerkar, Anurag; Yu, Di] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Wu, Di] Univ North Carolina Chapel Hill, Sch Dent, Chapel Hill, NC USA; [Man, Kevin; Zotos, Dimitra; Preston, Simon; Allison, Cody C.; Toe, Jesse G.; Pellegrini, Marc; Belz, Gabrielle T.; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Man, Kevin; Zotos, Dimitra; Preston, Simon; Allison, Cody C.; Toe, Jesse G.; Pellegrini, Marc; Belz, Gabrielle T.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Deleage, Claire; Estes, Jacob D.] Frederick Natl Lab Canc Res, Leidos Biomed Res, AIDS & Canc Virus Program, Frederick, MD USA; [Minnich, Martina; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Meckiff, Benjamin J.; Long, Heather M.] Univ Birmingham, Ctr Human Virol, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Meckiff, Benjamin J.; Long, Heather M.] Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England; [Wei, Yunbo; Hou, Zhaohua; Yu, Di] Shandong Acad Sci, Shandong Anal & Test Ctr, Jinan, Peoples R China; [Fenix, Kevin A.; Comerford, Iain; McColl, Shaun R.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA, Australia; [Chipman, Jeffrey G.; Beilman, Greg J.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Sun, Lei; Wang, Peng] Capital Med Univ, Beijing Ditan Hosp, Dept Pathol, Beijing, Peoples R China; [Xu, Jiawei] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Lu, Hao K.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lu, Hao K.; Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Tao, Yong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Palendira, Umaimainthan] Centenary Inst, Newtown, Tas, Australia; [Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Schacker, Timothy W.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Lewin, Sharon R.] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Yu, Di] Monash Univ, Sch Clin Sci, Ctr Inflammatory Dis, Clayton, Vic, Australia	Monash University; Monash University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Walter & Eliza Hall Institute; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Birmingham; University of Birmingham; Qilu University of Technology; University of Adelaide; University of Minnesota System; University of Minnesota Twin Cities; Capital Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of Melbourne; Royal Melbourne Hospital; Capital Medical University; University of Sydney; Centenary Institute; Indiana University System; Indiana University Bloomington; Rush University; University of Minnesota System; University of Minnesota Twin Cities; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Yu, D (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Yu, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Kallies, A (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Yu, D (corresponding author), Shandong Acad Sci, Shandong Anal & Test Ctr, Jinan, Peoples R China.; Yu, D (corresponding author), Monash Univ, Sch Clin Sci, Ctr Inflammatory Dis, Clayton, Vic, Australia.	kallies@wehi.edu.au; di.yu@monash.edu	Wu, Di/AAB-7566-2021; Yu, Di/C-2163-2009; Lewin, Sharon/Z-3297-2019; Palendira, Umaimainthan/AAA-6447-2022; Xu, Jiawei/AAT-3955-2021; Fenix, Kevin Aaron/AAW-4700-2021; Hou, Zhaohua/A-1046-2018; Belz, Gabrielle T/C-9350-2013; Wei, Yunbo/AHE-8248-2022; Busslinger, Meinrad/J-1249-2016	Wu, Di/0000-0001-8331-2357; Yu, Di/0000-0003-1721-8922; Fenix, Kevin Aaron/0000-0003-1619-1406; Hou, Zhaohua/0000-0003-3093-0279; Belz, Gabrielle T/0000-0002-9660-9587; Meckiff, Benjamin/0000-0002-6930-5545; Man, Kevin/0000-0002-6585-9532; Preston, Simon/0000-0001-8969-8297; Busslinger, Meinrad/0000-0002-9111-9351; Leong, Yew Ann/0000-0002-0999-7084; Lewin, Sharon Ruth/0000-0002-0330-8241; Comerford, Iain/0000-0001-8753-4774; Kallies, Axel/0000-0002-6312-6968; Beilman, Gregory/0000-0001-5036-3027; Pellegrini, Marc/0000-0003-3627-3126	Birmingham Science City - Experimental Medicine Network of Excellence project; National Health and Medical Research Council of Australia [GNT1085509, GNT1085151]; Monash University; amfAR Research Consortium on HIV Eradication [109327-59-RGRL]; Creative and Novel Ideas in HIV Research Program of The International AIDS Society; Australian Centre for HIV and Hepatitis Virology Research [2015-69]; Priority Research Program of Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Sylvia and Charles Viertel Foundation; Delaney AIDS Research Enterprise; Martin Delaney Collaboratories; National Institute for Allergy and Infectious Diseases of the US National Institutes of Health [U19 AI096109]; Bloodwise, UK [15021]; National Cancer Institute of the US National Institutes of Health [HHSN261200800001E]; Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109] Funding Source: NIH RePORTER	Birmingham Science City - Experimental Medicine Network of Excellence project; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); amfAR Research Consortium on HIV Eradication; Creative and Novel Ideas in HIV Research Program of The International AIDS Society; Australian Centre for HIV and Hepatitis Virology Research; Priority Research Program of Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Sylvia and Charles Viertel Foundation; Delaney AIDS Research Enterprise; Martin Delaney Collaboratories; National Institute for Allergy and Infectious Diseases of the US National Institutes of Health; Bloodwise, UK; National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the facilities, scientific and technical assistance of Flowcore, Monash Micro Imaging, and Monash Bioinformatics Platform (S. Archer and K. Tsyganov) at Monash University, and University of Birmingham's Human Biomaterials Resource Centre (supported through Birmingham Science City - Experimental Medicine Network of Excellence project). We thank L. Ye (Third Military Medical University) for Thy1.1 reporter constructs; C. Vinuesa (Australian National University) and S. Nutt (Walter and Eliza Hall Institute of Medical Research) for mice; R. Gloury and L. Mackiewicz for technical support; C. Dong for the list of Bcl6-bound genes; and H. Xue for the list of TCF-1-bound genes. Supported by the National Health and Medical Research Council of Australia (Y.A.L. and S.R.L.; GNT1085509 to D.Y.; and GNT1085151 to A.K.), Monash University (D.Y.), the amfAR Research Consortium on HIV Eradication (109327-59-RGRL, D.Y., S. R. L. and A. L. L.), The Creative and Novel Ideas in HIV Research Program of The International AIDS Society (D.Y.), Australian Centre for HIV and Hepatitis Virology Research (2015-69 to D.Y.), The Priority Research Program of Shandong Academy of Sciences (D.Y.), Shandong Province Taishan Scholar Program (D.Y.), the Sylvia and Charles Viertel Foundation (A.K.), the Delaney AIDS Research Enterprise to find a cure, Martin Delaney Collaboratories, the National Institute for Allergy and Infectious Diseases of the US National Institutes of Health (U19 AI096109 to S.R.L., T.W.S. and J.D.E.), Bloodwise, UK (15021 to H.M.L. and B.J.M.), the National Cancer Institute of the US National Institutes of Health (HHSN261200800001E), and the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Afshar-Sterle S, 2014, NAT MED, V20, P283, DOI 10.1038/nm.3442; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen YP, 2015, TRENDS IMMUNOL, V36, P758, DOI 10.1016/j.it.2015.11.001; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Deleage Claire, 2016, Pathog Immun, V1, P68; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gaspar M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002346; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Homann D, 2004, J IMMUNOL, V172, P6239, DOI 10.4049/jimmunol.172.10.6239; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Jia JY, 2003, VIROLOGY, V306, P236, DOI 10.1016/S0042-6822(02)00027-2; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jones CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090855; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Korns Johnson D., 2012, PLOS ONE, V7; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pissani F, 2014, TRENDS IMMUNOL, V35, P278, DOI 10.1016/j.it.2014.02.010; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650	62	272	281	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1187	+		10.1038/ni.3543	http://dx.doi.org/10.1038/ni.3543			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27487330	Green Published			2022-12-18	WOS:000384302900010
J	Moro, K; Kabata, H; Tanabe, M; Koga, S; Takeno, N; Mochizuki, M; Fukunaga, K; Asano, K; Betsuyaku, T; Koyasu, S				Moro, Kazuyo; Kabata, Hiroki; Tanabe, Masanobu; Koga, Satoshi; Takeno, Natsuki; Mochizuki, Miho; Fukunaga, Koichi; Asano, Koichiro; Betsuyaku, Tomoko; Koyasu, Shigeo			Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses	NATURE IMMUNOLOGY			English	Article							NATURAL HELPER-CELLS; THYMIC STROMAL LYMPHOPOIETIN; DENDRITIC CELLS; ACTIVATION; CYTOKINES; INFLAMMATION; EXPRESSION; INDUCTION; GAMMA; WORLD	Group 2 innate lymphoid cells (ILC2 cells) are type 2 cytokine-producing cells of the innate immune system with important roles in helminth infection and allergic inflammation. Here we found that tissue-resident ILC2 cells proliferated in situ without migrating during inflammatory responses. Both type I and type II interferons and interleukin 27 (IL-27) suppressed ILC2 function in a manner dependent on the transcription factor STAT1. ILC2-mediated lung inflammation was enhanced in the absence of the interferon-gamma (IFN-gamma) receptor on ILC2 cells in vivo. IFN-gamma effectively suppressed the function of tissue-resident ILC2 cells but not that of inflammatory ILC2 cells, and IL-27 suppressed tissue-resident ILC2 cells but not tissue-resident TH2 cells during lung inflammation induced by Alternaria alternata. Our results demonstrate that suppression mediated by interferon and IL-27 is a negative feedback mechanism for ILC2 function in vivo.	[Moro, Kazuyo; Kabata, Hiroki; Koga, Satoshi; Takeno, Natsuki; Mochizuki, Miho; Fukunaga, Koichi; Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan; [Moro, Kazuyo; Kabata, Hiroki; Koga, Satoshi; Takeno, Natsuki; Mochizuki, Miho; Fukunaga, Koichi] RIKEN Ctr Integrat Med Sci, Lab Innate Immune Syst, Yokohama, Kanagawa, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Moro, Kazuyo; Koga, Satoshi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunol, Yokohama, Kanagawa 232, Japan; [Kabata, Hiroki; Fukunaga, Koichi; Asano, Koichiro; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 160, Japan; [Tanabe, Masanobu] Keio Univ, Sch Med, Dept Infect Dis, Tokyo, Japan; [Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa 25912, Japan; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Yokohama City University; Keio University; Keio University; Tokai University; Keio University	Moro, K (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan.	kazuyo.moro@riken.jp	Fukunaga, Koichi/R-5338-2019; Moro, Kazuyo/A-5987-2016; Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038; Moro, Kazuyo/0000-0002-7377-1303; Kabata, Hiroki/0000-0001-8853-6149	Precursory Research for Embryonic Science and Technology from Japan Science and Technology Agency Japan Society for the Promotion of Science [26293110, 24659373, 22229004]; Ministry of Education, Culture, Sports, Science and Technology of Japan [15H01166]; Grants-in-Aid for Scientific Research [14J07705] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology from Japan Science and Technology Agency Japan Society for the Promotion of Science(Japan Science & Technology Agency (JST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Kubo (Tokyo University of Science) for Ifng<SUP>Venus/+</SUP> mice; M. Miyasaka (Osaka University) for antibody to mouse IL-2R beta (TM-beta 1); S. Wada, T. Yamamoto, T. Shitamichi, U. Tran and S. Tada for animal care; M. Yamamoto, S. Kagawa, T. Fukushima and J. Furusawa for help in some experiments; Kafi N. Ealey for critical reading of this manuscript; and members of the Laboratory for Immune Cell Systems at RIKEN Integrative Medical Sciences for discussion. Supported by Precursory Research for Embryonic Science and Technology from Japan Science and Technology Agency Japan Society for the Promotion of Science (Grant-in Aid for Scientific Research (B) 26293110; Grant-in-Aid for Challenging Exploratory Research 24659373 to K.M.; Grant-in-Aid for Scientific Research (S) 22229004 to S.K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas 15H01166 to K.M.).	Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Conroy DM, 1997, MEM I OSWALDO CRUZ, V92, P183, DOI 10.1590/S0074-02761997000800024; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Culley FJ, 2002, EUR J IMMUNOL, V32, P1376, DOI 10.1002/1521-4141(200205)32:5<1376::AID-IMMU1376>3.0.CO;2-8; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Elbim C, 2010, EUR CYTOKINE NETW, V21, P1, DOI 10.1684/ecn.2009.0183; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kehrl JH, 2009, CURR TOP MICROBIOL, V334, P107, DOI 10.1007/978-3-540-93864-4_5; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HK, 2014, INT ARCH ALLERGY IMM, V163, P92, DOI 10.1159/000356341; Koyasu S, 2010, ADV IMMUNOL, V108, P21, DOI 10.1016/S0065-2776(10)08002_8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Matsuzaki J, 2005, AUTOIMMUNITY, V38, P369, DOI 10.1080/08916930500124122; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024972; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Siegernund S, 2007, IMMUNOBIOLOGY, V212, P739, DOI 10.1016/j.imbio.2007.09.004; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhao GG, 2012, EXERC IMMUNOL REV, V18, P98; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	45	272	280	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					76	+		10.1038/ni.3309	http://dx.doi.org/10.1038/ni.3309			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26595888				2022-12-18	WOS:000366675800013
J	Dominguez-Sola, D; Victora, GD; Ying, CY; Phan, RT; Saito, M; Nussenzweig, MC; Dalla-Favera, R				Dominguez-Sola, David; Victora, Gabriel D.; Ying, Carol Y.; Phan, Ryan T.; Saito, Masumichi; Nussenzweig, Michel C.; Dalla-Favera, Riccardo			The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry	NATURE IMMUNOLOGY			English	Article							CENTER B-CELLS; RESPONSES IN-VIVO; T-CELL; C-MYC; IMMUNE-RESPONSE; AFFINITY MATURATION; EXPRESSION; BCL6; ACTIVATION; DYNAMICS	After antigenic challenge, B cells enter the dark zone (DZ) of germinal centers (GCs) to proliferate and hypermutate their immunoglobulin genes. Mutants with greater affinity for the antigen are positively selected in the light zone (LZ) to either differentiate into plasma and memory cells or reenter the DZ. The molecular circuits that govern positive selection in the GC are not known. We show here that the GC reaction required biphasic regulation of expression of the cell-cycle regulator c-Myc that involved its transient induction during early GC commitment, its repression by Bcl-6 in DZ B cells and its reinduction in B cells selected for reentry into the DZ. Inhibition of c-Myc in vivo led to GC collapse, which indicated an essential role for c-Myc in GCs. Our results have implications for the mechanism of GC selection and the role of c-Myc in lymphomagenesis.	[Dominguez-Sola, David; Ying, Carol Y.; Phan, Ryan T.; Saito, Masumichi; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Victora, Gabriel D.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	Columbia University; Rockefeller University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	nussen@mail.rockefeller.edu; rd10@columbia.edu	Nussenzweig, Michel/AAE-7292-2019; Victora, Gabriel/C-5946-2011	Dominguez-Sola, David/0000-0001-9569-8402; Victora, Gabriel/0000-0001-8807-348X	US National Institutes of Health [P01-CA092625, R01-CA37295, R01-AI037526]; Leukemia and Lymphoma Society; National Cancer Institute [K99/R00-CA151827]; Whitehead Institute for Biomedical Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA037295, R00CA151827, K99CA151827, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R01AI072529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Whitehead Institute for Biomedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Sleckman (Washington University) for GFP-c-Myc mice; S. Artandi (Stanford University) for mice with transgenic expression of rtTA-actin; G. Evan (University of Cambridge, UK) and L. Soucek (Vall d'Hebron Institute of Oncology) for TRE-Omomyc rtTA-Actin mice; L. Reavie, I. Aifantis (New York University), M. Chesi and L. Bergsagel (Mayo Clinic) for access to these mice; F.W. Alt for advice on immunization protocols; R. Bosch for experimental help; K. Basso, A.B. Holmes, L. Pasqualucci, M. Bansal, C. Lefebvre, P. Sumazin and A. Califano for advice on data analysis; T. Mo for mouse husbandry; H. Tang, Q. Shen, V. Miljkovic, K. Gordon, C. Liu, and S. Tetteh for technical assistance; S. Serrano (Parc de Salut Mar, Barcelona) for human tissue samples; M. Jara-Acevedo for technical advice; and U. Klein for insights and for critical reading of this manuscript. Supported by the US National Institutes of Health (P01-CA092625 and R01-CA37295 to R.D.-F., and R01-AI037526 to M.C.N.), the Leukemia and Lymphoma Society (RD.-E), the National Cancer Institute (K99/R00-CA151827 to D.D.-S.), the Whitehead Institute for Biomedical Research (G.D.V.) and the Howard Hughes Medical Institute (M.C.N.).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Cutrona G, 1997, ANN NY ACAD SCI, V815, P436, DOI 10.1111/j.1749-6632.1997.tb52096.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; KLAUS SJ, 1992, J IMMUNOL, V149, P1867; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Oprea M, 1997, J IMMUNOL, V158, P5155; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	51	272	275	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1083	1091		10.1038/ni.2428	http://dx.doi.org/10.1038/ni.2428			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23001145	Green Accepted			2022-12-18	WOS:000310091700011
J	Norbury, CC; Malide, D; Gibbs, JS; Bennink, JR; Yewdell, JW				Norbury, CC; Malide, D; Gibbs, JS; Bennink, JR; Yewdell, JW			Visualizing priming of virus-specific CD8(+) T cells by infected dendritic cells in vivo	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; ANTIGEN-PRESENTING CELLS; EXOGENOUS ANTIGEN; IMMUNE-RESPONSE; EXPRESSION; MICE; DEGRADATION; MECHANISMS; MOLECULES; MATURATION	The rational design of vaccines that elicit CD8(+) T cell responses requires knowledge of the identity of the antigen-presenting cell (APC), the location and time of presentation and the nature of the antigen presented by the APC. Here we address these questions for an antigen encoded by a recombinant vaccinia virus. We found that, following local infection, vaccinia virus infected macrophages and dendritic cells in draining lymph nodes. However, only the dendritic cells presented antigen to naive CD8(+) T cells, as determined by direct visualization of sectioned nodes by confocal microscopy. Presentation occurred as rapidly as 6 h after inoculation and quickly declined in parallel with the number of infected cells present in the nodes. These data provide direct evidence that virus-infected APCs prime naive CD8(+) T cells in vivo.	NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000814, Z01AI000814] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Bender A, 1998, IMMUNOBIOLOGY, V198, P552, DOI 10.1016/S0171-2985(98)80078-8; Bronte V, 1997, P NATL ACAD SCI USA, V94, P3183, DOI 10.1073/pnas.94.7.3183; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; COUPAR BEH, 1986, EUR J IMMUNOL, V16, P1479, DOI 10.1002/eji.1830161203; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Lenz LL, 2000, J EXP MED, V192, P1135, DOI 10.1084/jem.192.8.1135; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Motta I, 2001, J IMMUNOL, V167, P1795, DOI 10.4049/jimmunol.167.3.1795; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Prasad SA, 2001, J IMMUNOL, V166, P4809, DOI 10.4049/jimmunol.166.8.4809; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Wasilenko ST, 2001, J VIROL, V75, P11437, DOI 10.1128/JVI.75.23.11437-11448.2001; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579	40	272	275	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					265	271		10.1038/ni762	http://dx.doi.org/10.1038/ni762			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11828323				2022-12-18	WOS:000174074000015
J	Weil, J; Long, LY; Yang, K; Guyl, C; Shresthal, S; Chen, ZJ; Wu, C; Voge, P; Neale, G; Green, DR; Chi, HB				Weil, Jun; Long, Lingyun; Yang, Kai; Guyl, Cliff; Shresthal, Sharad; Chen, Zuojia; Wu, Chuan; Voge, Peter; Neale, Geoffrey; Green, Douglas R.; Chi, Hongbo			Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; CIS-ELEMENT; DIFFERENTIATION; EFFECTOR; ACTIVATION; SURVIVAL; INSTABILITY; INHIBITION; EXPRESSION; GENERATION	Regulatory T(T-reg) cells respond to immune and inflammatory signals to mediate immunosuppression, but how the functional integrity of T-reg cells is maintained under activating environments is unclear. Here we show that autophagy is active in T-reg cells and supports their lineage stability and survival fitness. T-reg cell-specific deletion of Atg7 or Atg5, two essential genes in autophagy, leads to loss of T-reg cells, greater tumor resistance and development of inflammatory disorders. Atg7-deficient T-reg cells show increased apoptosis and readily lose expression of the transcription factor Foxp3, especially after activation. Mechanistically, autophagy deficiency upregulates metabolic regulators mTORC1 and c-Myc and glycolysis, which contribute to defective T-reg function. Therefore, autophagy couples environmental signals and metabolic homeostasis to protect lineage and survival integrity of T-reg cells in activating contexts.	[Weil, Jun; Long, Lingyun; Yang, Kai; Guyl, Cliff; Shresthal, Sharad; Green, Douglas R.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chen, Zuojia; Wu, Chuan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA USA; [Voge, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Long, Lingyun/C-2455-2019; Vogel, Peter/N-2490-2018; Green, Douglas R/N-8083-2018; Chi, Hongbo/M-9397-2018; Chen, Zuojia/AAM-9465-2020; Wei, Jun/J-1295-2019; Wu, Chuan/H-6379-2013	Long, Lingyun/0000-0002-8565-4948; Vogel, Peter/0000-0002-7535-0545; Green, Douglas R/0000-0002-7332-1417; Chi, Hongbo/0000-0002-9997-2496; Wei, Jun/0000-0002-6769-847X; Wu, Chuan/0000-0003-2288-353X	US National Institutes of Health [NIH AI105887, AI101407, CA176624, NS064599]; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA176624, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105887, R37AI105887, R00AI110649, R01AI101407, R21AI094089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge B. Rhode, C. Cloer and S. Rankin for animal colony management, X. Du for help with immunoblot analysis, N. Kalupahana for initial analysis of Atg7-deficient mice, N. Mizushima for GFP-LC3 mice, A. Rudensky for Foxp3<SUP>YFP-Cre</SUP> mice, J.E. Bradner for providing the JQ-1 compound, St. Jude Immunology FACS core facility for cell sorting and Y. Wang for editing. Supported by US National Institutes of Health (NIH AI105887, AI101407, CA176624 and NS064599 to H.C.), and the Crohn's and Colitis Foundation of America (to H.C.).	Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jiang XJ, 2015, J CLIN INVEST, V125, P47, DOI 10.1172/JCI73942; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	45	271	280	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					277	285		10.1038/ni.3365	http://dx.doi.org/10.1038/ni.3365			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26808230	Green Accepted, Green Submitted			2022-12-18	WOS:000370469300012
J	Martin, NT; Martin, MU				Martin, Nikolas T.; Martin, Michael U.			Interleukin 33 is a guardian of barriers and a local alarmin	NATURE IMMUNOLOGY			English	Review							RECEPTOR ACCESSORY PROTEIN; NF-KAPPA-B; THYMIC STROMAL LYMPHOPOIETIN; IL-1 FAMILY-MEMBERS; MAST-CELL; DENDRITIC CELLS; CYTOKINE IL-33; NUCLEAR IL-33; SOLUBLE ST2; TRANSCRIPTIONAL REGULATION	Interleukin 33 (IL-33) is a member of the IL-1 family of cytokines with a growing number of target cells and a plethora of biological functions. Although it has commonalities with other IL-1 cytokines, IL-33 exhibits some unique features. Here we review the biology of IL-33 and its receptor and develop a working model that describes two 'lives' for IL-33 one intracellular and one extracellular. Under healthy conditions, constitutively produced, intracellular IL-33 participates in maintaining barrier function by regulating gene expression as a nuclear protein. In parallel, nuclear IL-33 functions as a stored alarmin that is released when barriers are breached. Extracellular IL-33 coordinates immune defense and repair mechanisms while also initiating differentiation of helper T cells as the adaptive immune response is triggered.	[Martin, Nikolas T.] Hannover Med Sch, Ctr Biochem, Inst Cellular Chem, Hannover, Germany; [Martin, Michael U.] Univ Giessen, Immunol FB08, D-35390 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Martin, MU (corresponding author), Univ Giessen, Immunol FB08, D-35390 Giessen, Germany.	michael.martin@bio.uni-giessen.de						Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Ahmed A, 2015, SCAND J IMMUNOL, V82, P118, DOI 10.1111/sji.12312; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Ali S, 2010, BIOCHEM BIOPH RES CO, V391, P1512, DOI 10.1016/j.bbrc.2009.12.107; Arshad MI, 2011, EUR J IMMUNOL, V41, P2341, DOI 10.1002/eji.201041332; Arshad MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074278; Arshad MI, 2012, HEPATOLOGY, V56, P2353, DOI 10.1002/hep.25893; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Baumann C, 2015, P NATL ACAD SCI USA, V112, P4056, DOI 10.1073/pnas.1418549112; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Bianchetti L, 2012, BIOCHEM BIOPH RES CO, V426, P116, DOI 10.1016/j.bbrc.2012.08.047; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Byrne SN, 2011, AM J PATHOL, V179, P211, DOI 10.1016/j.ajpath.2011.03.010; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Choi YS, 2012, BIOCHEM BIOPH RES CO, V421, P305, DOI 10.1016/j.bbrc.2012.04.005; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Connolly DJ, 2013, J BIOL CHEM, V288, P5616, DOI 10.1074/jbc.M112.403899; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Demyanets S, 2013, J MOL CELL CARDIOL, V60, P16, DOI 10.1016/j.yjmcc.2013.03.020; Divekar R, 2015, CURR OPIN ALLERGY CL, V15, P98, DOI 10.1097/ACI.0000000000000133; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Gachter T, 1996, J BIOL CHEM, V271, P124; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hayashi H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/738625; Holtzman Michael J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS287, DOI 10.1513/AnnalsATS.201402-056AW; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hu WT, 2014, MOL HUM REPROD, V20, P358, DOI 10.1093/molehr/gat094; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Jaras M, 2010, P NATL ACAD SCI USA, V107, P16280, DOI 10.1073/pnas.1004408107; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Kempuraj D, 2013, J NEUROIMMUNE PHARM, V8, P643, DOI 10.1007/s11481-013-9439-7; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kim LK, 2015, P NATL ACAD SCI USA, V112, pE2891, DOI 10.1073/pnas.1507393112; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Kopach P, 2014, J BIOL CHEM, V289, P11829, DOI 10.1074/jbc.M113.534396; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kurokawa M, 2011, INT ARCH ALLERGY IMM, V155, P12, DOI 10.1159/000327259; Lee J.S., 2015, EXP DERMATOL; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Lei Y., 2015, PLOS ONE, V10; Li CW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003918; Liang Y., 2015, EUR J IMMUNOL; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Madouri F, 2015, J MOL CELL BIOL, V7, P351, DOI 10.1093/jmcb/mjv012; Martin MU, 2013, SEMIN IMMUNOL, V25, P449, DOI 10.1016/j.smim.2013.10.006; Martin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4143; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; Maywald RL, 2015, P NATL ACAD SCI USA, V112, pE2487, DOI 10.1073/pnas.1422445112; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Meephansan J, 2013, J DERMATOL SCI, V71, P107, DOI 10.1016/j.jdermsci.2013.04.014; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Morita H, 2015, IMMUNITY, V43, P175, DOI 10.1016/j.immuni.2015.06.021; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mueller T, 2015, AM J CARDIOL, V115, p8B, DOI 10.1016/j.amjcard.2015.01.035; Nile CJ, 2010, IMMUNOLOGY, V130, P172, DOI 10.1111/j.1365-2567.2009.03221.x; Nomura K, 2012, LARYNGOSCOPE, V122, P1185, DOI 10.1002/lary.23261; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Pascual-Figal DA, 2015, AM J CARDIOL, V115, p3B, DOI 10.1016/j.amjcard.2015.01.034; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Pinto SM, 2015, PROTEOMICS, V15, P532, DOI 10.1002/pmic.201400303; Pollheimer J, 2013, ARTERIOSCL THROM VAS, V33, pE47, DOI 10.1161/ATVBAHA.112.253427; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; PRIESTLE JP, 1988, EMBO J, V7, P339, DOI 10.1002/j.1460-2075.1988.tb02818.x; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Saidi S, 2011, CYTOKINE, V53, P347, DOI 10.1016/j.cyto.2010.11.021; Saluja R, 2015, MOL IMMUNOL, V63, P80, DOI 10.1016/j.molimm.2014.06.018; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sattler S, 2014, J AUTOIMMUN, V50, P107, DOI 10.1016/j.jaut.2014.01.032; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmieder A, 2012, CYTOKINE, V60, P514, DOI 10.1016/j.cyto.2012.06.286; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Shan J, 2015, J GASTROENTEROL, V50, P414, DOI 10.1007/s00535-014-0988-1; Shao DM, 2014, BIOCHEM BIOPH RES CO, V451, P8, DOI 10.1016/j.bbrc.2014.06.111; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Sponheim J, 2010, AM J PATHOL, V177, P2804, DOI 10.2353/ajpath.2010.100378; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Su Z, 2013, MUCOSAL IMMUNOL, V6, P921, DOI 10.1038/mi.2012.130; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Sundlisaeter E, 2012, AM J PATHOL, V181, P1099, DOI 10.1016/j.ajpath.2012.06.003; Sundnes O, 2015, J INVEST DERMATOL, V135, P1771, DOI 10.1038/jid.2015.85; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; Talabot-Ayer D, 2015, J IMMUNOL, V194, P750, DOI 10.4049/jimmunol.1402057; Talabot-Ayer D, 2014, CYTOKINE, V69, P68, DOI 10.1016/j.cyto.2014.05.007; Talabot-Ayer D, 2012, J LEUKOCYTE BIOL, V91, P119, DOI 10.1189/jlb.0811425; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tao LQ, 2014, INT J CLIN EXP PATHO, V7, P4930; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134, P706, DOI 10.1016/j.jaci.2014.06.013; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Tsuda H, 2012, J INVEST DERMATOL, V132, P2661, DOI 10.1038/jid.2012.180; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Turnquist HR, 2009, EUR J IMMUNOL, V39, P3292, DOI 10.1002/eji.200940026; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yanagawa Y, 2011, BRAIN BEHAV IMMUN, V25, P1427, DOI 10.1016/j.bbi.2011.04.012; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U; Yariagawa Y, 2011, IMMUNOL LETT, V141, P55, DOI 10.1016/j.imlet.2011.07.005; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Zhang FL, 2014, ANN CLIN TRANSL NEUR, V1, P307, DOI 10.1002/acn3.47; Zhang HF, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-120; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zhao J, 2015, J IMMUNOL, V194, P795, DOI 10.4049/jimmunol.1401414; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhao WH, 2012, CYTOKINE, V58, P267, DOI 10.1016/j.cyto.2012.01.019; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	160	271	281	7	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					122	131		10.1038/ni.3370	http://dx.doi.org/10.1038/ni.3370			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784265				2022-12-18	WOS:000368571500005
J	Shinohara, ML; Lu, LR; Bu, J; Werneck, MBF; Kobayashi, KS; Glimcher, LH; Cantor, H				Shinohara, ML; Lu, LR; Bu, J; Werneck, MBF; Kobayashi, KS; Glimcher, LH; Cantor, H			Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells	NATURE IMMUNOLOGY			English	Article							ADAPTIVE IMMUNE-RESPONSES; MICE LACKING OSTEOPONTIN; TOLL-LIKE RECEPTOR-9; CD8 T-CELLS; I INTERFERON; CRESCENTIC GLOMERULONEPHRITIS; INTRACELLULAR OSTEOPONTIN; MULTIPLE-SCLEROSIS; CROSS-PRESENTATION; LUPUS	The observation that the T-bet transcription factor allows tissue-specific upregulation of intracellular osteopontin (Opn-i) in plasmacytoid dendritic cells (pDCs) suggests that Opn might contribute to the expression of interferon-alpha (IFN-alpha) in those cells. Here we show that Opn deficiency substantially reduced Toll-like receptor 9 (TLR9)-dependent IFN-alpha responses but spared expression of transcription factor NF-kappa B-dependent proinflammatory cytokines. Shortly after TLR9 engagement, colocalization of Opn-i and the adaptor molecule MyD88 was associated with induction of transcription factor IRF7-dependent IFN-alpha gene expression, whereas deficient expression of Opn-i was associated with defective nuclear translocation of IRF7 in pDCs. The importance of the Opn-IFN-alpha pathway was emphasized by its essential involvement in cross-presentation in vitro and in anti herpes simplex virus 1 IFN-alpha response in vivo. The finding that Opn-i selectively coupled TLR9 signaling to expression of IFN-alpha but not to that of other proinflammatory cytokines provides new molecular insight into the biology of pDCs.	Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Cantor, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu	Lu, Linrong/A-1429-2013; Werneck, Miriam B.F./H-5802-2012	Werneck, Miriam/0000-0003-1287-8526; Kobayashi, Koichi/0000-0003-2930-0114; Lu, Linrong/0000-0002-0171-4115; Shinohara, Mari/0000-0002-6808-9844	NCI NIH HHS [T32 CA70083, T32 CA070083, CA48126] Funding Source: Medline; NIAID NIH HHS [R37 AI012184, R01 AI048125, AI48125, AI12184, AI56296, P01 AI056296, R01 AI048126] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296, R37AI012184, R01AI048126, R01AI012184, R01AI048125] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Ballas ZK, 2001, J IMMUNOL, V167, P4878, DOI 10.4049/jimmunol.167.9.4878; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Cantor H, 2000, ADV IMMUNOL, V75, P209, DOI 10.1016/S0065-2776(00)75005-X; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Haeryfar SMM, 2005, TRENDS IMMUNOL, V26, P311, DOI 10.1016/j.it.2005.04.002; Heit A, 2003, J IMMUNOL, V170, P2802, DOI 10.4049/jimmunol.170.6.2802; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hron JD, 2004, J IMMUNOL, V173, P2134, DOI 10.4049/jimmunol.173.3.2134; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Hudkins KL, 2000, KIDNEY INT, V57, P105, DOI 10.1046/j.1523-1755.2000.00813.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee SW, 2000, J IMMUNOL, V165, P3631, DOI 10.4049/jimmunol.165.7.3631; Li JW, 2005, ARTHRITIS RHEUM-US, V52, P3063, DOI 10.1002/art.21307; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; McCarty N, 2005, NAT IMMUNOL, V6, P65, DOI 10.1038/ni1145; Miyazaki T, 2005, EUR J IMMUNOL, V35, P1510, DOI 10.1002/eji.200425672; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nau GJ, 1999, INFECT IMMUN, V67, P4223, DOI 10.1128/IAI.67.8.4223-4230.1999; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Sibalic V, 1997, NEPHROL DIAL TRANSPL, V12, P1344, DOI 10.1093/ndt/12.7.1344; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219; Wilson HL, 2003, BLOOD, V102, P1661, DOI 10.1182/blood-2002-08-2426; Xu GW, 2005, J CLIN INVEST, V115, P1060; Yu XQ, 1998, P ASSOC AM PHYSICIAN, V110, P50; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	60	271	290	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					498	506		10.1038/ni1327	http://dx.doi.org/10.1038/ni1327			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16604075	Green Accepted			2022-12-18	WOS:000237008800015
J	Ozkaynak, E; Gao, W; Shemmeri, N; Wang, CC; Gutierrez-Ramos, JC; Amaral, J; Qin, SX; Rottman, JB; Coyle, AJ; Hancock, WW				Ozkaynak, E; Gao, W; Shemmeri, N; Wang, CC; Gutierrez-Ramos, JC; Amaral, J; Qin, SX; Rottman, JB; Coyle, AJ; Hancock, WW			Importance of ICOS-B7RP-I costimulation in acute and chronic allograft rejection	NATURE IMMUNOLOGY			English	Article							T-CELL COSTIMULATION; TRANSPLANT ARTERIOSCLEROSIS; MOLECULE ICOS; CD154; CD40; CD28; EXPRESSION; RESPONSES; BLOCKADE; LIGAND	Primary T cell activation requires B7-CD28 and CD40-CD154 costimulation, but effector T cell functions are considered to be largely independent of these costimulatory pathways. Although blockade of costimulation with cytolytic T lymphocyte-associated antigen 4-immunoglobulin (CTLA-4-lg) or monoclonal antibody (mAb) to CD154 prolongs allograft survival, chronic rejection follows, which suggests that additional key costimulatory pathways are active in vivo. We found that both antibody to inducible costimulator (anti-ICOS) and an ICOS-Ig fusion protein suppressed intragraft T cell activation and cytokine expression and prolonged allograft survival in a manner similar to that in ICOS-/- allograft recipients. The combination of anti-ICOS therapy and cyclosporin A led to permanent engraftment. In addition, ICOS-B7RP-I costimulation was required for the development of chronic rejection after CD40-CD 154 blockade. These data demonstrate a key role for the ICOS-B7RP-I pathway in acute and chronic rejection and highlight the benefits of targeting this pathway in combination with the use of conventional immunosuppressive agent.	Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Hancock, WW (corresponding author), Millennium Pharmaceut Inc, 75 Sidney St, Cambridge, MA 02139 USA.				NIAID NIH HHS [AI40152] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI040152] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORRY DB, 1994, J IMMUNOL, V153, P4142; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ensminger SM, 2000, TRANSPLANTATION, V69, P2609, DOI 10.1097/00007890-200006270-00022; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hancock WW, 1998, NAT MED, V4, P1392, DOI 10.1038/3982; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; HANCOCK WW, 1999, CURR OPIN ORGAN TRAN, V4, P3; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jones ND, 2000, J IMMUNOL, V165, P1111, DOI 10.4049/jimmunol.165.2.1111; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Sayegh MH, 1997, TRANSPLANTATION, V64, P1646, DOI 10.1097/00007890-199712270-00003; Shimizu K, 2000, J IMMUNOL, V165, P3506, DOI 10.4049/jimmunol.165.6.3506; Smiley ST, 2000, TRANSPLANTATION, V70, P415, DOI 10.1097/00007890-200008150-00005; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	34	271	315	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					591	596		10.1038/89731	http://dx.doi.org/10.1038/89731			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429542				2022-12-18	WOS:000169682100011
J	Chattopadhyay, PK; Gierahn, TM; Roederer, M; Love, JC				Chattopadhyay, Pratip K.; Gierahn, Todd M.; Roederer, Mario; Love, J. Christopher			Single-cell technologies for monitoring immune systems	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; FLOW-CYTOMETRY; MIGRATION BEHAVIOR; GENE-EXPRESSION; MASS CYTOMETRY; ACTIVATION; ANTIBODIES; SECRETION; HIERARCHY; RESPONSES	The complex heterogeneity of cells, and their interconnectedness with each other, are major challenges to identifying clinically relevant measurements that reflect the state and capability of the immune system. Highly multiplexed, single-cell technologies may be critical for identifying correlates of disease or immunological interventions as well as for elucidating the underlying mechanisms of immunity. Here we review limitations of bulk measurements and explore advances in single-cell technologies that overcome these problems by expanding the depth and breadth of functional and phenotypic analysis in space and time. The geometric increases in complexity of data make formidable hurdles for exploring, analyzing and presenting results. We summarize recent approaches to making such computations tractable and discuss challenges for integrating heterogeneous data obtained using these single-cell technologies.	[Chattopadhyay, Pratip K.; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gierahn, Todd M.; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Massachusetts Institute of Technology (MIT)	Love, JC (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	clove@mit.edu	Roederer, Mario/G-1887-2011	Chattopadhyay, Pratip/0000-0002-5457-9666	W.M. Keck Foundation; US National Institute of Allergy And Infectious Diseases [1U19AI089992, 1R56AI104274, 5R21AI106025]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106025, U19AI089992, R56AI104274, ZIAAI005020, ZIAAI005021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); US National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the W.M. Keck Foundation and the US National Institute of Allergy And Infectious Diseases (1U19AI089992, 1R56AI104274 and 5R21AI106025). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institute of Allergy And Infectious Diseases or the US National Institutes of Health. We thank A. Shalek for helpful comments on scRNA-seq and N. Aghaeepour for discussions about data-analysis tools. J.C.L. is a Camille Dreyfus Teacher-Scholar. We acknowledge the service to the MIT community of the late Sean Collier.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2012, CYTOM PART A, V81A, P1022, DOI 10.1002/cyto.a.22209; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Beum PV, 2006, J IMMUNOL METHODS, V317, P90, DOI 10.1016/j.jim.2006.09.012; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bradshaw EM, 2008, CLIN IMMUNOL, V129, P10, DOI 10.1016/j.clim.2008.06.009; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Catania A, 2013, BREAST CANCER RES TR, V141, P55, DOI 10.1007/s10549-013-2667-y; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Chattopadhyay PK, 2012, CYTOM PART A, V81A, P456, DOI 10.1002/cyto.a.22043; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Frisk TW, 2011, BIOMED MICRODEVICES, V13, P683, DOI 10.1007/s10544-011-9538-2; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gong YA, 2010, LAB CHIP, V10, P2334, DOI 10.1039/c004847j; Guldevall K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015453; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Hong S, 2012, INTEGR BIOL-UK, V4, P374, DOI 10.1039/c2ib00166g; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kamphuis MMJ, 2010, J AM CHEM SOC, V132, P15881, DOI 10.1021/ja106405c; Khorshidi MA, 2011, INTEGR BIOL-UK, V3, P770, DOI 10.1039/c1ib00007a; Konry T, 2011, BIOSENS BIOELECTRON, V26, P2707, DOI 10.1016/j.bios.2010.09.006; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lindstrom S, 2010, LAB CHIP, V10, P3363, DOI [10.1039/c0lc00150c, 10.1039/c01c00150c]; Love JC, 2010, AICHE J, V56, P2496, DOI 10.1002/aic.12413; Lu Y, 2013, ANAL CHEM, V85, P2548, DOI 10.1021/ac400082e; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Nolan J.P., 2001, CURRENT PROTOCOLS CY; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Safeukui I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060150; Sanders CK, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.037004; Schiffenbauer YS, 2009, LAB CHIP, V9, P2965, DOI 10.1039/b904778f; Sendra VG, 2013, METHODS, V64, P153, DOI 10.1016/j.ymeth.2013.06.018; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shi QH, 2012, P NATL ACAD SCI USA, V109, P419, DOI 10.1073/pnas.1110865109; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Torres AJ, 2013, LAB CHIP, V13, P90, DOI 10.1039/c2lc40869d; Vanherberghen B, 2013, BLOOD, V121, P1326, DOI 10.1182/blood-2012-06-439851; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Wabnitz GH, 2011, EUR J IMMUNOL, V41, P3157, DOI 10.1002/eji.201041366; Wang J, 2012, NANO LETT, V12, P6101, DOI 10.1021/nl302748q; Yalcin Ayca, 2012, Methods Mol Biol, V853, P211, DOI 10.1007/978-1-61779-567-1_16; Yamanaka YJ, 2012, INTEGR BIOL-UK, V4, P1175, DOI [10.1039/c2ib20167d, 10.1039/c2ib200157d]; Yin HB, 2012, CURR OPIN BIOTECH, V23, P110, DOI 10.1016/j.copbio.2011.11.002; Zaretsky I, 2012, LAB CHIP, V12, P5007, DOI 10.1039/c2lc40808b; Zhu H, 2009, ANAL CHEM, V81, P8150, DOI 10.1021/ac901390j	63	270	278	8	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					128	135		10.1038/ni.2796	http://dx.doi.org/10.1038/ni.2796			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448570	Green Published, Green Accepted			2022-12-18	WOS:000330150600004
J	Meyers, JH; Chakravarti, S; Schlesinger, D; Illes, Z; Waldner, H; Umetsu, SE; Kenny, J; Zheng, XX; Umetsu, DT; DeKruyff, RH; Strom, TB; Kuchroo, VK				Meyers, JH; Chakravarti, S; Schlesinger, D; Illes, Z; Waldner, H; Umetsu, SE; Kenny, J; Zheng, XX; Umetsu, DT; DeKruyff, RH; Strom, TB; Kuchroo, VK			TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; GENE; FAMILY; IDENTIFICATION; ASSOCIATION; AUTOIMMUNE; RESPONSES; RECEPTOR; DOMAIN	The newly identified TIM family of proteins is associated with regulation of T helper type 1 (T(H)1) and T(H)2 immune responses. TIM-1 is genetically linked to asthma and is a receptor for hepatitis A virus, but the endogenous ligand of TIM-1 is not known. Here we show that TIM-4, which is expressed by antigen-presenting cells, is the ligand for TIM-1. In vivo administration of either soluble TIM-1-immunoglobulin (TIM-1-Ig) fusion protein or TIM-4-Ig fusion protein resulted in hyperproliferation of T cells, and TIM-4-Ig costimulated T cell proliferation mediated by CD3 and CD28 in vitro. These data suggest that the TIM-1-TIM-4 interaction is involved in regulating T cell proliferation.	Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Pediat, Div Immunol, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Stanford University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Strom, Terry B./E-9268-2010	Strom, Terry B./0000-0002-7570-0736; Illes, Zsolt/0000-0001-9655-0450	NIAID NIH HHS [2P01AI39671-07, 1R01AI44880-03] Funding Source: Medline; NIGMS NIH HHS [1F31GM20927-01] Funding Source: Medline; NINDS NIH HHS [1PO1NS38037-04, 2R01NS35685-06, 2R37NS30843-11, 1R01NS045937-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, R01AI044880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS045937, R37NS030843, R01NS035685] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chae SC, 2003, HUM IMMUNOL, V64, P1177, DOI 10.1016/j.humimm.2003.09.011; Chae SC, 2003, BIOCHEM BIOPH RES CO, V312, P346, DOI 10.1016/j.bbrc.2003.10.125; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Eisenbarth SC, 2003, CURR OPIN IMMUNOL, V15, P620, DOI 10.1016/j.coi.2003.09.003; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; KINGSMORE SF, 1995, IMMUNOGENETICS, V42, P59, DOI 10.1007/BF00164988; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shakhov AN, 2004, EUR J IMMUNOL, V34, P494, DOI 10.1002/eji.200324590; Silberstein E, 2003, J VIROL, V77, P8765, DOI 10.1128/JVI.77.16.8765-8774.2003; UMETSU SE, IN PRESS NAT IMMUNOL	27	270	313	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					455	464		10.1038/ni1185	http://dx.doi.org/10.1038/ni1185			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15793576				2022-12-18	WOS:000228634300017
J	Sacks, D; Sher, A				Sacks, D; Sher, A			Evasion of innate immunity by parasitic protozoa	NATURE IMMUNOLOGY			English	Review							LEISHMANIA-MAJOR PROMASTIGOTES; HUMAN DENDRITIC CELLS; FALCIPARUM-INFECTED ERYTHROCYTES; COMPLEMENT REGULATORY PROTEIN; TOXOPLASMA-GONDII TACHYZOITES; CD4(+) T-CELLS; TRYPANOSOMA-CRUZI; ANTIGENIC VARIATION; SERUM RESISTANCE; IL-12 PRODUCTION	Parasitic protozoa are a major cause of global infectious disease. These eukaryotic pathogens have evolved with the vertebrate immune system and typically produce long-lasting chronic infections. A critical step in their host interaction is the evasion of innate immune defenses. The ability to avoid attack by humoral effector mechanisms, such as complement lysis, is of particular importance to extracellular parasites, whereas intracellular protozoa must resist killing by lysosomal enzymes and toxic metabolites. They do so by remodeling the phagosomal compartments in which they reside and by interfering with signaling pathways that lead to cellular activation. In addition, there is growing evidence that protozoan pathogens modify the antigen-presenting and immunoregulatory functions of dendritic cells, a process that facilitates their evasion of both innate and adaptive immunity.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sacks, D (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	dsacks@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000494, ZIAAI000494, Z01AI000579, ZIAAI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bennett CL, 2001, EUR J IMMUNOL, V31, P876, DOI 10.1002/1521-4141(200103)31:3&lt;876::AID-IMMU876&gt;3.0.CO;2-I; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Borst P, 1996, ARCH MED RES, V27, P379; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Brodskyn C, 2002, INFECT IMMUN, V70, P3736, DOI 10.1128/IAI.70.7.3736-3743.2002; Butcher BA, 2001, J IMMUNOL, V167, P2193, DOI 10.4049/jimmunol.167.4.2193; Courret N, 2002, J CELL SCI, V115, P2303; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Gorak PMA, 1998, EUR J IMMUNOL, V28, P687, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;687::AID-IMMU687&gt;3.0.CO;2-N; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; HALL BF, 1992, J EXP MED, V176, P313, DOI 10.1084/jem.176.2.313; HUNTER C, 2001, IMMUNOLOGY INFECT DI, P111; Ilg T, 2001, J BIOL CHEM, V276, P4988, DOI 10.1074/jbc.M008030200; Jebbari H, 2002, INFECT IMMUN, V70, P1023, DOI 10.1128/IAI.70.2.1023-1026.2002; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Konecny P, 1999, EUR J IMMUNOL, V29, P1803, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1803::AID-IMMU1803&gt;3.0.CO;2-F; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Lingelbach K, 1998, J CELL SCI, V111, P1467; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Marovich MA, 2000, J IMMUNOL, V164, P5858, DOI 10.4049/jimmunol.164.11.5858; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; McDowell MA, 2002, INFECT IMMUN, V70, P3994, DOI 10.1128/IAI.70.8.3994-4001.2002; McDowell MA, 1999, CURR OPIN MICROBIOL, V2, P438, DOI 10.1016/S1369-5274(99)80077-0; Milner JD, 1999, MOL BIOCHEM PARASIT, V104, P271, DOI 10.1016/S0166-6851(99)00151-6; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; MOORE KJ, 1993, J IMMUNOL, V150, P4457; MOORE KJ, 1994, J LEUKOCYTE BIOL, V55, P91, DOI 10.1002/jlb.55.1.91; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; MOSSER DM, 1985, J IMMUNOL, V135, P2785; NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995; Nash PB, 1998, J IMMUNOL, V160, P1824; Nash TE, 2002, MOL MICROBIOL, V45, P585, DOI 10.1046/j.1365-2958.2002.03029.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Neyer LE, 1997, INFECT IMMUN, V65, P1675, DOI 10.1128/IAI.65.5.1675-1682.1997; NORRIS KA, 1991, J IMMUNOL, V147, P2240; Norris KA, 1998, INFECT IMMUN, V66, P2460, DOI 10.1128/IAI.66.6.2460-2465.1998; OLIVIER M, 1992, P NATL ACAD SCI USA, V89, P7481, DOI 10.1073/pnas.89.16.7481; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; PEARCE EJ, 1999, FUNDAMENTAL IMMUNOLO, P1271; Piedrafita D, 1999, EUR J IMMUNOL, V29, P235, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;235::AID-IMMU235&gt;3.0.CO;2-S; Ponte-Sucre A, 2001, IMMUNOLOGY, V104, P462, DOI 10.1046/j.1365-2567.2001.01333.x; PUENTES SM, 1990, J IMMUNOL, V145, P4311; Qi H, 2001, J IMMUNOL, V167, P4534, DOI 10.4049/jimmunol.167.8.4534; Raper J, 1999, INFECT IMMUN, V67, P1910; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; SCHWARZER E, 1993, BIOCHIM BIOPHYS ACTA, V1181, P51, DOI 10.1016/0925-4439(93)90089-J; Shapira S, 2002, J INFECT DIS, V185, pS66, DOI 10.1086/338000; Sibley LD, 2000, TRAFFIC, V1, P100, DOI 10.1034/j.1600-0854.2000.010202.x; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Subauste CS, 2000, J IMMUNOL, V165, P1498, DOI 10.4049/jimmunol.165.3.1498; Turco SJ, 2001, TRENDS PARASITOL, V17, P223, DOI 10.1016/S1471-4922(01)01895-5; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Van Overtvelt L, 1999, INFECT IMMUN, V67, P4033, DOI 10.1128/IAI.67.8.4033-4040.1999; von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Xu X, 2001, J IMMUNOL, V167, P235, DOI 10.4049/jimmunol.167.1.235	81	270	287	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1041	1047		10.1038/ni1102-1041	http://dx.doi.org/10.1038/ni1102-1041			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407413				2022-12-18	WOS:000179073000010
J	Hu, JJ; Liu, X; Xia, SY; Zhang, ZB; Zhang, Y; Zhao, JX; Ruan, JB; Luo, XM; Lou, XW; Bai, Y; Wang, JH; Hollingsworth, LR; Magupalli, VG; Zhao, L; Luo, HBR; Kim, J; Lieberman, J; Wu, H				Hu, Jun Jacob; Liu, Xing; Xia, Shiyu; Zhang, Zhibin; Zhang, Ying; Zhao, Jingxia; Ruan, Jianbin; Luo, Xuemei; Lou, Xiwen; Bai, Yang; Wang, Junhong; Hollingsworth, L. Robert; Magupalli, Venkat Giri; Zhao, Li; Luo, Hongbo R.; Kim, Justin; Lieberman, Judy; Wu, Hao			FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation	NATURE IMMUNOLOGY			English	Article							COLD AUTOINFLAMMATORY SYNDROME; INFLAMMASOME; GSDMD; ACTIVATION; CASPASE-11; MECHANISM; SEPSIS; HEALTH; KINASE	Disulfiram is an FDA-approved drug for treating alcoholism. Wu and colleagues show that disulfiram can be repurposed to efficiently inhibit pyroptosis by specifically blocking gasdermin-mediated pore formation. Cytosolic sensing of pathogens and damage by myeloid and barrier epithelial cells assembles large complexes called inflammasomes, which activate inflammatory caspases to process cytokines (IL-1 beta) and gasdermin D (GSDMD). Cleaved GSDMD forms membrane pores, leading to cytokine release and inflammatory cell death (pyroptosis). Inhibiting GSDMD is an attractive strategy to curb inflammation. Here we identify disulfiram, a drug for treating alcohol addiction, as an inhibitor of pore formation by GSDMD but not other members of the GSDM family. Disulfiram blocks pyroptosis and cytokine release in cells and lipopolysaccharide-induced septic death in mice. At nanomolar concentration, disulfiram covalently modifies human/mouse Cys191/Cys192 in GSDMD to block pore formation. Disulfiram still allows IL-1 beta and GSDMD processing, but abrogates pore formation, thereby preventing IL-1 beta release and pyroptosis. The role of disulfiram in inhibiting GSDMD provides new therapeutic indications for repurposing this safe drug to counteract inflammation, which contributes to many human diseases.	[Hu, Jun Jacob; Liu, Xing; Xia, Shiyu; Zhang, Zhibin; Zhang, Ying; Zhao, Jingxia; Ruan, Jianbin; Hollingsworth, L. Robert; Magupalli, Venkat Giri; Lieberman, Judy; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hu, Jun Jacob; Xia, Shiyu; Zhao, Jingxia; Ruan, Jianbin; Hollingsworth, L. Robert; Magupalli, Venkat Giri; Kim, Justin; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liu, Xing; Zhang, Zhibin; Zhang, Ying; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Liu, Xing; Lou, Xiwen; Bai, Yang; Wang, Junhong] Chinese Acad Sci, Inst Pasteur Shanghai, Ctr Microbes Dev & Hlth, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Zhao, Jingxia] Capital Med Univ, Beijing Inst Tradit Chinese Med, Beijing Hosp Tradit Chinese Med, Beijing, Peoples R China; [Ruan, Jianbin] Univ Connecticut, Hlth Ctr, Dept Immunol, Farmington, CT USA; [Luo, Xuemei] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX 77555 USA; [Zhao, Li; Luo, Hongbo R.] Boston Childrens Hosp, Dept Lab Med, Stem Cell Program, Boston, MA USA; [Zhao, Li; Luo, Hongbo R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Zhao, Li; Luo, Hongbo R.] Dana Farber Harvard Canc Ctr, Boston, MA USA; [Kim, Justin] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Capital Medical University; University of Connecticut; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Liu, X; Lieberman, J; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Liu, X; Lieberman, J (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Liu, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Ctr Microbes Dev & Hlth, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	xingliu@ips.ac.cn; judy.lieberman@childrens.harvard.edu; wu@crystal.harvard.edu	Kim, Justin/AAA-6025-2022	Kim, Justin/0000-0002-4076-2005; Magupalli, Venkat/0000-0003-4638-3062; Zhao, Li/0000-0003-3329-7376; Zhang, Ying/0000-0002-1116-2182; Zhang, Zhibin/0000-0003-1349-2713; Hollingsworth, Louis/0000-0002-4130-3580; Hu, Jun/0000-0001-7098-6272; Xia, Shiyu/0000-0001-9024-0689	US National Institutes of Health [DP1HD087988, R01Al139914, R01AI123265, R01 AI142642, R01 AI145274, R01 AI141386, R01HL092020, P01HL095489]; National Natural Science Foundation of China [31972897]; Key Research Program of the Chinese Academy of Sciences [ZDBS-LY-SM008]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; Rising-Star Program of Shanghai Science and Technology Committee [19QA1409800]; FAMRI [CIA 123008]; Cancer Research Institute Irvington Postdoctoral Fellowship Program; Charles A. King Trust Postdoctoral Fellowship Program; US DOD Breast Cancer Research Program Breakthrough Fellowship Award	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Science and Technology Major Project; Rising-Star Program of Shanghai Science and Technology Committee; FAMRI; Cancer Research Institute Irvington Postdoctoral Fellowship Program; Charles A. King Trust Postdoctoral Fellowship Program; US DOD Breast Cancer Research Program Breakthrough Fellowship Award	This work was supported by the US National Institutes of Health (grant nos. DP1HD087988 to H.W.; R01Al139914 to H.W. and J.L.; R01AI123265 to J.L.; and R01 AI142642, R01 AI145274, R01 AI141386, R01HL092020 and P01HL095489 to H.R.L.), National Natural Science Foundation of China (grant no. 31972897), Key Research Program of the Chinese Academy of Sciences (grant no. ZDBS-LY-SM008), Shanghai Municipal Science and Technology Major Project (grant no. 2019SHZDZX02), Rising-Star Program of Shanghai Science and Technology Committee (grant no. 19QA1409800 to X.L.), a grant from FAMRI (no. CIA 123008 to H.R.L.), Cancer Research Institute Irvington Postdoctoral Fellowship Program (to J.J.H.), Charles A. King Trust Postdoctoral Fellowship Program (to J.R., X.L., Z.Z.) and a US DOD Breast Cancer Research Program Breakthrough Fellowship Award (Y.Z.). We thank J. Smith, G. Frey, J. Nale, D. Wrobel and the entire staff of the ICCB-L for their outstanding technical support.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Castillo-Villanueva A, 2017, INT J PARASITOL-DRUG, V7, P425, DOI 10.1016/j.ijpddr.2017.11.003; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cvek B, 2012, DRUG DISCOV TODAY, V17, P409, DOI 10.1016/j.drudis.2011.12.010; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Hagn F, 2018, NAT PROTOC, V13, P79, DOI 10.1038/nprot.2017.094; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; MUCKLE TJ, 1962, Q J MED, V31, P235; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nasr ML, 2017, NAT METHODS, V14, P49, DOI [10.1038/NMETH.4079, 10.1038/nmeth.4079]; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; PETERSEN EN, 1992, ACTA PSYCHIAT SCAND, V86, P7, DOI 10.1111/j.1600-0447.1992.tb03309.x; Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rello J, 2017, ADV THER, V34, P2393, DOI 10.1007/s12325-017-0622-8; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Shen ML, 2001, BIOCHEM PHARMACOL, V61, P537, DOI 10.1016/S0006-2952(00)00586-4; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	42	269	286	27	137	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					736	+		10.1038/s41590-020-0669-6	http://dx.doi.org/10.1038/s41590-020-0669-6		MAY 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32367036	Green Accepted, Green Submitted			2022-12-18	WOS:000530283200002
J	Pulendran, B; Tang, H; Manicassamy, S				Pulendran, Bali; Tang, Hua; Manicassamy, Santhakumar			Programming dendritic cells to induce T(H)2 and tolerogenic responses	NATURE IMMUNOLOGY			English	Review							T-HELPER-CELL; SIGNAL-REGULATED KINASE; ACTIVATED PROTEIN-KINASE; ANTIGEN-PRESENTING CELLS; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR FOXP3; INNATE IMMUNE-SYSTEM; IN-VIVO; TH2 RESPONSES; AIRWAY INFLAMMATION	A fundamental puzzle in immunology is how the immune system decides what types of immune responses to launch against different stimuli. Although much is known about control of T helper type 1 (T(H)1) and T(H)17 responses, the mechanisms that initiate T(H)2 and T regulatory (T-reg) responses remain obscure. Emerging studies suggest a fundamental role for the innate immune system, particularly dendritic cells (DCs), in this process. We review these studies, and suggest that the innate control of T(H)2 and T-reg responses can be viewed as different hierarchies of organization, in which DCs, their innate receptors and signaling networks, and their interactions with other cells and local microenvironments represent different levels of the hierarchy.	[Pulendran, Bali; Tang, Hua; Manicassamy, Santhakumar] Emory Vaccine Ctr, Atlanta, GA USA	Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	US National Institutes of Health; Bill and Melinda Gates Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank H. Nakaya for assistance with the figures. We gratefully acknowledge the generous support of the US National Institutes of Health and the Bill and Melinda Gates Foundation in our work. We regret not being able to cite many relevant references because of space limitations.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson CF, 2004, J IMMUNOL, V173, P955, DOI 10.4049/jimmunol.173.2.955; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Grainger JR, 2010, IMMUNOL REV, V234, P305, DOI 10.1111/j.0105-2896.2009.00880.x; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kaji R, 2010, J IMMUNOL, V184, P3505, DOI 10.4049/jimmunol.0901569; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kambayashi T, 2008, BLOOD, V111, P1489, DOI 10.1182/blood-2007-07-102111; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Karumuthil-Melethil S, 2008, J IMMUNOL, V181, P8323, DOI 10.4049/jimmunol.181.12.8323; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; KOUZAKI H, 2009, IMMUNOLOGY, V183, P1427; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Liu T, 2007, MOL IMMUNOL, V44, P3580, DOI 10.1016/j.molimm.2007.03.004; Loures FV, 2009, J IMMUNOL, V183, P1279, DOI 10.4049/jimmunol.0801599; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Luo XQ, 2005, EXP DERMATOL, V14, P303, DOI 10.1111/j.0906-6705.2005.00325.x; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; MANICASSAMY S, SCIENCE IN PRESS; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; MARTH T, 1987, J EXP MED, V185, P1995; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nichols JR, 2009, J IMMUNOL, V182, P7119, DOI 10.4049/jimmunol.0802656; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; STEINFELDER S, 2009, EXP MED, V206, P1681; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	129	268	285	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					647	655		10.1038/ni.1894	http://dx.doi.org/10.1038/ni.1894			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644570				2022-12-18	WOS:000280149400002
J	Baba, Y; Nishida, K; Fujii, Y; Hirano, T; Hikida, M; Kurosaki, T				Baba, Yoshihiro; Nishida, Keigo; Fujii, Yoko; Hirano, Toshio; Hikida, Masaki; Kurosaki, Tomohiro			Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses	NATURE IMMUNOLOGY			English	Article							SIGNAL-REGULATED KINASE; JUN NH2-TERMINAL KINASE; AFFINITY IGE RECEPTOR; OPERATED CA2+ ENTRY; CURRENT I-CRAC; FACTOR-KAPPA-B; PROTEIN-KINASE; PLASMA-MEMBRANE; ANTIGEN-RECEPTOR; TRANSCRIPTION FACTORS	Mast cells have key functions as effectors of immunoglobulin E-mediated allergic inflammatory diseases. Allergen stimulation induces Ca(2+) influx and elicits the secretion of inflammatory mediators from mast cells. Here we show that the Ca(2+)-binding endoplasmic reticulum protein STIM1 is critical to mast cell function. STIM1-deficient fetal liver-derived mast cells had impaired W, influx mediated by the high-affinity immunoglobulin E receptor Fc epsilon RI and activation of the transcription factors NF-kappa B and NFAT. Mast cells lacking STIM1 also had much less degranulation and cytokine production after Fc epsilon RI stimulation. In addition, alterations in STIM1 expression affected the sensitivity of immunoglobulin E-mediated immediate-phase anaphylactic responses in vivo. Thus, STIM1 is key in promoting the W, influx that is essential for Fc epsilon RI-mediated mast cell activation and anaphylaxis.	[Baba, Yoshihiro; Fujii, Yoko; Hikida, Masaki; Kurosaki, Tomohiro] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, Kanagawa 2303345, Japan; [Nishida, Keigo; Hirano, Toshio] RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa 2303345, Japan	RIKEN; RIKEN	Kurosaki, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, 1-7-22 Suehirocho, Kanagawa 2303345, Japan.	kurosaki@rcai.riken.jp	Hirano, Toshio/C-8194-2009; Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen YH, 2007, J IMMUNOL, V178, P49, DOI 10.4049/jimmunol.178.1.49; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Klein M, 2006, J IMMUNOL, V177, P6667, DOI 10.4049/jimmunol.177.10.6667; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Mathes C, 1998, J BIOL CHEM, V273, P25020, DOI 10.1074/jbc.273.39.25020; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Putney Jr JW, 2004, SCI STKE, ppe37; Rivera J, 2006, TRENDS IMMUNOL, V27, P251, DOI 10.1016/j.it.2006.04.001; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	53	268	275	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					81	88		10.1038/ni1546	http://dx.doi.org/10.1038/ni1546			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18059272				2022-12-18	WOS:000251820800014
J	Mueller, DL				Mueller, Daniel L.			Mechanisms maintaining peripheral tolerance	NATURE IMMUNOLOGY			English	Review							T-CELL TOLERANCE; DENDRITIC CELLS; CLONAL ANERGY; CROSS-PRESENTATION; IN-VIVO; CYCLE PROGRESSION; TRANSGENIC MICE; SELF-ANTIGENS; REGULATORS BIM; CUTTING EDGE	The presentation of self-peptide-MHC complexes in the periphery to potentially autoreactive T cells that have escaped negative selection in the thymus poses an important problem to the immune system. In this review, I discuss data that reveal barriers preventing peripheral T cell recognition of self-peptide-MHC complexes, as well as the physiological mechanisms that ensure the elimination or functional inactivation (anergy) of T cells that do come to recognize self-peptide-MHC and threaten the health of the individual.	[Mueller, Daniel L.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Mueller, Daniel L.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, DL (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	muell002@umn.edu		Mueller, Daniel/0000-0003-1621-0419	US National Institutes of Health [P01 AI35296, R01 AI080764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080764, P01AI035296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (P01 AI35296 and R01 AI080764).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barron L, 2008, J IMMUNOL, V180, P2762, DOI 10.4049/jimmunol.180.5.2762; Bianchi T, 2009, J IMMUNOL, V182, P4665, DOI 10.4049/jimmunol.0803628; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Bursch LS, 2009, J IMMUNOL, V182, P4657, DOI 10.4049/jimmunol.0803656; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Colombetti S, 2002, J IMMUNOL, V169, P6178, DOI 10.4049/jimmunol.169.11.6178; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Eggena MP, 2004, J EXP MED, V199, P1725, DOI 10.1084/jem.20040124; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; Knoechel B, 2005, J IMMUNOL, V175, P21, DOI 10.4049/jimmunol.175.1.21; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Laufer TM, 1999, J IMMUNOL, V162, P5078; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; LO D, 1989, J EXP MED, V170, P87, DOI 10.1084/jem.170.1.87; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MILLER JD, 1995, SUGAR CANE, V1, P3; Mondino A, 2007, SEMIN IMMUNOL, V19, P162, DOI 10.1016/j.smim.2007.02.008; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Powell JD, 1999, J IMMUNOL, V162, P2775; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Vanasek TL, 2001, J IMMUNOL, V167, P5636, DOI 10.4049/jimmunol.167.10.5636; Vanasek TL, 2006, J IMMUNOL, V176, P5880, DOI 10.4049/jimmunol.176.10.5880; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	87	267	296	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					21	27		10.1038/ni.1817	http://dx.doi.org/10.1038/ni.1817			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016506				2022-12-18	WOS:000272855300005
J	Dar, A; Goichberg, P; Shinder, V; Kalinkovich, A; Kollet, O; Netzer, N; Margalit, R; Zsak, M; Nagler, A; Hardan, I; Resnick, I; Rot, A; Lapidot, T				Dar, A; Goichberg, P; Shinder, V; Kalinkovich, A; Kollet, O; Netzer, N; Margalit, R; Zsak, M; Nagler, A; Hardan, I; Resnick, I; Rot, A; Lapidot, T			Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells	NATURE IMMUNOLOGY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEMATOPOIETIC PROGENITOR CELLS; FACTOR-I; STEM-CELLS; DUFFY ANTIGEN; NOD/SCID MICE; CD34(+) CELLS; T-CELLS; CXCR4; EXPRESSION	Regulation of the availability of chemokine SDF-1 (CXCL12) in bone marrow is still not fully understood. Here we describe a unique function for the chemokine receptor CXCR4 expressed on bone marrow endothelial cells, which efficiently internalize circulating SDF-1, resulting in its translocation into the bone marrow. Translocated SDF-1 increased the homing of transplanted human CD34(+) hematopoietic progenitors to the bone marrow. The chemokine transporter function of CXCR4 was a characteristic of endothelial and stromal cells but not of hematopoietic cells. Thus, chemokine translocation across the blood - bone marrow barrier allows effective transfer of functional SDF-1 from the periphery to the stem cell niche in the bone marrow during both homeostasis and 'alarm' situations.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Electron Microscopy Unit, IL-76100 Rehovot, Israel; Novartis Inst Biomed Res, A-1230 Vienna, Austria; Chaim Sheba Med Ctr, Bone Marrow Transplantat Dept, IL-52662 Tel Hashomer, Israel; Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Novartis; Chaim Sheba Medical Center	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Kollet, Orit/A-6861-2008; Lapidot, Tsvee/A-1812-2010	Rot, Antal/0000-0002-9730-6166				Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chaudhuri A, 1997, BLOOD, V89, P701, DOI 10.1182/blood.V89.2.701; Chaussalet M, 2004, BIOCHEM BIOPH RES CO, V316, P170, DOI 10.1016/j.bbrc.2004.02.027; Dzenko KA, 2001, J NEUROSCI, V21, P9214, DOI 10.1523/JNEUROSCI.21-23-09214.2001; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Horuk R, 1996, J LEUKOCYTE BIOL, V59, P29, DOI 10.1002/jlb.59.1.29; Imai K, 1999, BRIT J HAEMATOL, V106, P905, DOI 10.1046/j.1365-2141.1999.01644.x; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; KOLLET O, BLOOD, V104, pA364; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; LAMBERTSEN RH, 1984, BLOOD, V63, P287; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Netelenbos T, 2003, LEUKEMIA, V17, P175, DOI 10.1038/sj.leu.2402738; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Pablos JL, 2003, J IMMUNOL, V170, P2147, DOI 10.4049/jimmunol.170.4.2147; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pelletier AJ, 2000, BLOOD, V96, P2682; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; RAFII S, 1994, BLOOD, V84, P10; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Sierra MD, 2004, BLOOD, V103, P2452; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Suzuki G, 1998, INT IMMUNOL, V10, P1049, DOI 10.1093/intimm/10.8.1049; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	52	267	287	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1038	1046		10.1038/ni1251	http://dx.doi.org/10.1038/ni1251			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16170318				2022-12-18	WOS:000232027200023
J	Rogozin, IB; Pavlov, YI; Bebenek, K; Matsuda, T; Kunkel, TA				Rogozin, IB; Pavlov, YI; Bebenek, K; Matsuda, T; Kunkel, TA			Somatic mutation hotspots correlate with DNA polymerase eta error spectrum	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRAND BREAKS; IMMUNOGLOBULIN GENES; XERODERMA-PIGMENTOSUM; CLONAL SELECTION; V-KAPPA; HYPERMUTATION; SEQUENCES; HYPERMUTAGENESIS; SPECIFICITY; MUTAGENESIS	Mutational spectra analysis of 15 immunoglobulin genes suggested that consensus motifs R (G) under bar YW and W (A) under bar were universal descriptors of somatic hypermutation. Highly mutable sites, "hotspots", that matched W (A) under bar were preferentially found in one DNA strand and R (G) under bar YW hotspots were found in both strands, Analysis of base-substitution hotspots in DNA polymerase error spectra showed that 33 of 36 hotspots in the human polymerase eta spectrum conformed to the W (A) under bar consensus. This and four other characteristics of polymerase eta substitution specificity suggest that errors introduced by this enzyme during synthesis of the nontranscribed DNA strand in variable regions may contribute to strand-specific somatic hypermutagenesis of immunoglobulin genes at A-T base pairs.	NIEHS, Labs Mol Genet, Res Triangle Pk, NC 27709 USA; Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kunkel, TA (corresponding author), NIEHS, Labs Mol Genet, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Pavlov, Youri/T-7532-2017	Kunkel, Thomas A./0000-0002-9900-1788; Pavlov, Youri/0000-0003-1179-5796; Rogozin, Igor/0000-0003-0802-4851	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070, Z01ES065070] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bachl J, 1997, EUR J IMMUNOL, V27, P3398, DOI 10.1002/eji.1830271239; Bebenek K, 2001, J BIOL CHEM, V276, P2317, DOI 10.1074/jbc.C000690200; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Glazko GB, 1998, J THEOR BIOL, V192, P475, DOI 10.1006/jtbi.1998.0668; GOLDING GB, 1987, GENETICS, V115, P169; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; GONZALEZFERNANDEZ A, 1994, P NATL ACAD SCI USA, V91, P12614, DOI 10.1073/pnas.91.26.12614; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979; HACKETT J, 1990, J EXP MED, V172, P131, DOI 10.1084/jem.172.1.131; Harris RS, 1999, MUTAT RES-REV MUTAT, V436, P157, DOI 10.1016/S1383-5742(99)00003-4; Hsu E, 1998, IMMUNOL REV, V162, P25, DOI 10.1111/j.1600-065X.1998.tb01426.x; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Kim N, 1998, J EXP MED, V187, P1729, DOI 10.1084/jem.187.11.1729; Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;317::AID-IMMU317&gt;3.0.CO;2-S; KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Lanning DK, 1997, J IMMUNOL, V159, P4403; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Oprea M, 2001, J IMMUNOL, V166, P892, DOI 10.4049/jimmunol.166.2.892; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; RADA C, 1994, EUR J IMMUNOL, V24, P1453, DOI 10.1002/eji.1830240632; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Roberts J.D., 1996, DNA REPLICATION EUKA, P217; Rogozin IB, 1996, BBA-GENE STRUCT EXPR, V1306, P171, DOI 10.1016/0167-4781(95)00241-3; ROGOZIN IB, 1991, BIOCHIM BIOPHYS ACTA, V1089, P175, DOI 10.1016/0167-4781(91)90005-7; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rogozin IB, 2001, HUM MUTAT, V17, P83, DOI 10.1002/1098-1004(200102)17:2<83::AID-HUMU1>3.0.CO;2-E; Shapiro GS, 1999, J IMMUNOL, V163, P259; Smith DS, 1996, J IMMUNOL, V156, P2642; Spencer J, 1999, J IMMUNOL, V162, P6596; Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689; Storb U, 1998, CURR TOP MICROBIOL, V229, P11; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; WEBER JS, 1991, J IMMUNOL, V146, P3652; WEBER JS, 1994, J IMMUNOL, V153, P3594; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	55	267	274	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					530	536		10.1038/88732	http://dx.doi.org/10.1038/88732			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376340				2022-12-18	WOS:000169078000016
J	Murphy, PM				Murphy, PM			Viral exploitation and subversion of the immune system through chemokine mimicry	NATURE IMMUNOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTOR; SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN CYTOMEGALOVIRUS; BETA-CHEMOKINE; HIV-1 INFECTION; TAT PROTEIN; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; CX3C CHEMOKINE	The chemokine superfamily of leukocyte chemo-attractants coordinates development and deployment of the immune system by signaling through a family of G protein-coupled receptors. The importance of this system to antimicrobial host defense has been supported by the discovery of numerous herpesviruses and poxviruses that encode chemokine mimics able to block chemokine action. However, specific herpesviruses and lentiviruses can also exploit the immune system through chemokine mimicry, for example, to facilitate viral dissemination or, as in the case of HIV-1, to directly infect leukocyte target cells. The study of viral mimicry of chemokines and chemokine receptors is providing important new concepts in viral immunopathogenesis, new anti-inflammatory drug leads and new targets and concepts for antiviral drug and vaccine development.	NIAID, Host Def Lab, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIAID, Host Def Lab, Mol Signaling Sect, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615, Z01AI000615] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; AHUJA SK, 1993, J BIOL CHEM, V268, P20691; Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Arthos J, 2000, J VIROL, V74, P6418, DOI 10.1128/JVI.74.14.6418-6424.2000; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Beisser PS, 1998, J VIROL, V72, P2352, DOI 10.1128/JVI.72.3.2352-2363.1998; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Berson JF, 1998, SEMIN IMMUNOL, V10, P237, DOI 10.1006/smim.1998.0130; Billstrom MA, 1999, AM J RESP CELL MOL, V21, P163, DOI 10.1165/ajrcmb.21.2.3673; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Camarda G, 1999, J VIROL, V73, P9843, DOI 10.1128/JVI.73.12.9843-9848.1999; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; de Paulis A, 2000, J IMMUNOL, V165, P7171, DOI 10.4049/jimmunol.165.12.7171; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dittmer D, 1998, BIOESSAYS, V20, P367, DOI 10.1002/(SICI)1521-1878(199805)20:5<367::AID-BIES3>3.0.CO;2-L; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; GAO JL, 1994, J BIOL CHEM, V269, P28539; Geras-Raaka E, 1998, BIOCHEM BIOPH RES CO, V253, P725, DOI 10.1006/bbrc.1998.9557; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Isegawa Y, 1998, J VIROL, V72, P6104, DOI 10.1128/JVI.72.7.6104-6112.1998; Iyengar S, 1999, J IMMUNOL, V162, P6263; Kirshner JR, 1999, J VIROL, V73, P6006, DOI 10.1128/JVI.73.7.6006-6014.1999; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Krathwohl MD, 1997, P NATL ACAD SCI USA, V94, P9875, DOI 10.1073/pnas.94.18.9875; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; Lalani AS, 1999, CYTOKINE GROWTH F R, V10, P219, DOI 10.1016/S1359-6101(99)00018-0; Lalani AS, 1999, VIROLOGY, V256, P233, DOI 10.1006/viro.1999.9617; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Lapham CK, 1999, NAT MED, V5, P303, DOI 10.1038/6523; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Lee S, 2000, J VIROL, V74, P6946, DOI 10.1128/JVI.74.15.6946-6952.2000; Lee S, 2000, J VIROL, V74, P5016, DOI 10.1128/JVI.74.11.5016-5023.2000; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; LUSSO P, 1995, IMMUNOL TODAY, V16, P67, DOI 10.1016/0167-5699(95)80090-5; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; MacDonald MR, 1999, J VIROL, V73, P3682, DOI 10.1128/JVI.73.5.3682-3691.1999; MALKEVITCH N, 2001, IN PRESS VIROLOGY; Margulies BJ, 1996, VIROLOGY, V225, P111, DOI 10.1006/viro.1996.0579; Martin WJ, 1999, EXP MOL PATHOL, V66, P15; Martin WJ, 2000, EXP MOL PATHOL, V69, P10, DOI 10.1006/exmp.2000.2305; MCDERMOTT DA, 2000, SCIENCE, V290, pS499; McFadden G, 2000, CURR OPIN MICROBIOL, V3, P371, DOI 10.1016/S1369-5274(00)00107-7; Michael NL, 1998, J VIROL, V72, P6040, DOI 10.1128/JVI.72.7.6040-6047.1998; Milne RSB, 2000, J IMMUNOL, V164, P2396, DOI 10.4049/jimmunol.164.5.2396; MOSER B, 1993, BIOCHEM J, V294, P285, DOI 10.1042/bj2940285; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nicholas J, 1996, J VIROL, V70, P5975, DOI 10.1128/JVI.70.9.5975-5989.1996; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Pleskoff O, 1998, J VIROL, V72, P6389, DOI 10.1128/JVI.72.8.6389-6397.1998; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SCHWARZ M, UNPUB J IMMUNOL; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; Stine JT, 2000, BLOOD, V95, P1151, DOI 10.1182/blood.V95.4.1151.004k37_1151_1157; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998; Zhang YJ, 1998, J VIROL, V72, P9337, DOI 10.1128/JVI.72.11.9337-9344.1998; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou P, 1999, J VIROL, V73, P5926, DOI 10.1128/JVI.73.7.5926-5933.1999	107	267	278	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					116	122		10.1038/84214	http://dx.doi.org/10.1038/84214			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175803	Bronze			2022-12-18	WOS:000166778700006
J	Spits, H; Bernink, JH; Lanier, L				Spits, Hergen; Bernink, Jochem H.; Lanier, Lewis			NK cells and type 1 innate lymphoid cells: partners in host defense	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; T-BET; CUTTING EDGE; EXPRESSION; DISTINCT; IDENTIFICATION; PROGENITOR; SUBSET; EOMES; INFLAMMATION	Innate lymphoid cells (ILCs) are effectors and regulators of innate immunity and tissue modeling and repair. Researchers have identified subsets of ILCs with differing functional activities, capacities to produce cytokines and transcription factors required for development and function. Natural killer (NK) cells represent the prototypical member of the ILC family. Together with ILC1s, NK cells constitute group 1 ILCs, which are characterized by their capacity to produce interferon-gamma and their functional dependence on the transcription factor T-bet. NK cells and ILC1s are developmentally distinct but share so many features that they are difficult to distinguish, particularly under conditions of infection and inflammation. Here we review current knowledge of NK cells and the various ILC1 subsets.	[Spits, Hergen; Bernink, Jochem H.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Spits, Hergen; Bernink, Jochem H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lanier, Lewis] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Amsterdam; University of Amsterdam; University of California System; University of California San Francisco	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Lanier, Lewis L/E-2139-2014; Spits, Hergen/N-2581-2019	Lanier, Lewis L/0000-0003-1308-3952; Spits, Hergen/0000-0003-3269-8338	European Research Council [341038]; US National Institutes of Health [AI068129]	European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.S. is supported by an advanced European Research Council grant 341038. L.L. is an American Cancer Society Professor and is supported by US National Institutes of Health grant AI068129.	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; HU PF, 1995, J ACQ IMMUN DEF SYND, V10, P331; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; LANIER LL, 1986, J IMMUNOL, V137, P2735; LANIER LL, 1986, J IMMUNOL, V136, P4480; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Marquardt N, 2015, J IMMUNOL, V194, P2467, DOI 10.4049/jimmunol.1402756; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Michel T, 2016, J IMMUNOL, V196, P2923, DOI 10.4049/jimmunol.1502570; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; NAGLER A, 1989, J IMMUNOL, V143, P3183; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Ohne Y., 2016, NAT IMMUNOL; Papewalis C, 2008, J IMMUNOL, V180, P1462, DOI 10.4049/jimmunol.180.3.1462; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Peters CP, 2016, IMMUNOL LETT, V172, P124, DOI 10.1016/j.imlet.2015.10.004; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Silver J.S., 2016, NAT IMMUNOL; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	64	266	276	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					758	764		10.1038/ni.3482	http://dx.doi.org/10.1038/ni.3482			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328005	Green Published			2022-12-18	WOS:000378283200007
J	Silver, JS; Kearley, J; Copenhaver, AM; Sanden, C; Mori, M; Yu, L; Pritchard, GH; Berlin, AA; Hunter, CA; Bowler, R; Erjefalt, JS; Kolbeck, R; Humbles, AA				Silver, Jonathan S.; Kearley, Jennifer; Copenhaver, Alan M.; Sanden, Caroline; Mori, Michiko; Yu, Li; Pritchard, Gretchen Harms; Berlin, Aaron A.; Hunter, Christopher A.; Bowler, Russell; Erjefalt, Jonas S.; Kolbeck, Roland; Humbles, Alison A.			Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; NATURAL-KILLER-CELLS; ROR-GAMMA-T; BET; INFECTION; TYPE-1; PATHOGENESIS; DIFFERENTIATION; PROGENITOR; CYTOKINES	Innate lymphoid cells (ILCs) are critical mediators of mucosal immunity, and group 1 ILCs (ILC1 cells) and group 3 ILCs (ILC3 cells) have been shown to be functionally plastic. Here we found that group 2 ILCs (ILC2 cells) also exhibited phenotypic plasticity in response to infectious or noxious agents, characterized by substantially lower expression of the transcription factor GATA-3 and a concomitant switch to being ILC1 cells that produced interferon-gamma (IFN-gamma). Interleukin 12 (IL-12) and IL-18 regulated this conversion, and during viral infection, ILC2 cells clustered within inflamed areas and acquired an ILC1-like phenotype. Mechanistically, these ILC1 cells augmented virus-induced inflammation in a manner dependent on the transcription factor T-bet. Notably, IL-12 converted human ILC2 cells into ILC1 cells, and the frequency of ILC1 cells in patients with chronic obstructive pulmonary disease (COPD) correlated with disease severity and susceptibility to exacerbations. Thus, functional plasticity of ILC2 cells exacerbates anti-viral immunity, which may have adverse consequences in respiratory diseases such as COPD.	[Silver, Jonathan S.; Kearley, Jennifer; Copenhaver, Alan M.; Berlin, Aaron A.; Kolbeck, Roland; Humbles, Alison A.] Medimmune Inc, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA; [Sanden, Caroline; Mori, Michiko; Erjefalt, Jonas S.] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Sanden, Caroline; Erjefalt, Jonas S.] Medetect, Lund, Sweden; [Yu, Li] Medimmune Inc, Dept Translat Sci, Nonclin Biostat, Gaithersburg, MD 20878 USA; [Pritchard, Gretchen Harms; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Bowler, Russell] Natl Jewish Hlth, Denver, CO USA	AstraZeneca; Medimmune; Lund University; AstraZeneca; Medimmune; University of Pennsylvania; National Jewish Health	Humbles, AA (corresponding author), Medimmune Inc, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA.	humblesa@medimmune.com		Copenhaver, Alan/0000-0001-5952-0455; Erjefalt, Jonas/0000-0002-6716-3010	NHLBI NIH HHS [U01 HL089897, U01 HL089856, R01 HL089856, R01 HL089897] Funding Source: Medline; NIAID NIH HHS [R01 AI110201, T32 AI007532] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, R01HL089856, U01HL089897, R01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110201, T32AI007532] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal S. M., 2016, NAT IMMUNOL; Bauer CMT, 2013, CHEST, V143, P196, DOI 10.1378/chest.12-0930; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Hoyler T, 2013, CURR OPIN IMMUNOL, V25, P139, DOI 10.1016/j.coi.2013.02.007; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; MacDonald M, 2013, RESPIROLOGY, V18, P1280, DOI 10.1111/resp.12197; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohne Y., 2016, NAT IMMUNOL; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Roberts M. E. P., 2016, J COPD FDN, V2, P268; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318	52	266	273	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					626	+		10.1038/ni.3443	http://dx.doi.org/10.1038/ni.3443			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27111143	Green Accepted			2022-12-18	WOS:000376162200007
J	Woolf, E; Grigorova, I; Sagiv, A; Grabovsky, V; Feigelson, SW; Shulman, Z; Hartmann, T; Sixt, M; Cyster, JG; Alon, R				Woolf, Eilon; Grigorova, Irina; Sagiv, Adi; Grabovsky, Valentin; Feigelson, Sara W.; Shulman, Ziv; Hartmann, Tanja; Sixt, Michael; Cyster, Jason G.; Alon, Ronen			Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forcesm	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; IN-VIVO; PERIPHERAL-TISSUES; SYNAPSE FORMATION; BOUND CHEMOKINES; MIGRATION; ADHESION; ACTIVATION; RECEPTOR; ANTIGEN	Lymphocyte motility in lymph nodes is regulated by chemokines, but the contribution of integrins to this motility remains obscure. Here we examined lymphocyte migration over CCR7-binding chemokines that 'decorate' lymph node stroma. In a shear-free environment, surface-bound lymph node chemokines but not their soluble counterparts promoted robust and sustained T lymphocyte motility. The chemokine CCL21 induced compartmentalized clustering of the integrins LFA-1 and VLA-4 in motile lymphocytes, but both integrins remained nonadhesive to ligands on lymphocytes, dendritic cells and stroma. The application of shear stress to lymphocytes interacting with CCL21 and integrin ligands promoted robust integrin-mediated adhesion. Thus, lymph node chemokines that promote motility and strongly activate lymphocyte integrins under shear forces fail to stimulate stable integrin adhesiveness in extravascular shear-free environments.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Max Planck Inst Biochem, D-82152 Munich, Germany	Weizmann Institute of Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Max Planck Society	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	Grigorova, Irina/AAR-8795-2020; Sixt, Michael/F-3925-2010; Hartmann, Tanja Nicole/C-9345-2017; Hartmann, Tanja Nicole/AAA-6735-2020; ALON, RONEN/GRX-6987-2022; Hartmann, Tanja Nicole/C-9345-2017	Grigorova, Irina/0000-0002-4963-7403; Hartmann, Tanja Nicole/0000-0002-0377-7179; Hartmann, Tanja Nicole/0000-0002-0377-7179; Alon, Ronen/0000-0001-9161-6369; Hartmann, Tanja Nicole/0000-0002-2633-7301; Sixt, Michael/0000-0002-6620-9179	NIAID NIH HHS [AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Westermann J, 2005, J IMMUNOL, V174, P2517, DOI 10.4049/jimmunol.174.5.2517; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Zhou XM, 2001, J BIOL CHEM, V276, P44762, DOI 10.1074/jbc.M104029200	47	266	270	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1076	1085		10.1038/ni1499	http://dx.doi.org/10.1038/ni1499			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17721537				2022-12-18	WOS:000249691400022
J	Zhang, JY; Wang, XM; Xing, XD; Xu, Z; Zhang, C; Song, JW; Fan, X; Xia, P; Fu, JL; Wang, SY; Xu, RN; Dai, XP; Shi, L; Huang, L; Jiang, TJ; Shi, M; Zhang, YX; Zumla, A; Maeurer, M; Bai, F; Wang, FS				Zhang, Ji-Yuan; Wang, Xiang-Ming; Xing, Xudong; Xu, Zhe; Zhang, Chao; Song, Jin-Wen; Fan, Xing; Xia, Peng; Fu, Jun-Liang; Wang, Si-Yu; Xu, Ruo-Nan; Dai, Xiao-Peng; Shi, Lei; Huang, Lei; Jiang, Tian-Jun; Shi, Ming; Zhang, Yuxia; Zumla, Alimuddin; Maeurer, Markus; Bai, Fan; Wang, Fu-Sheng			Single-cell landscape of immunological responses in patients with COVID-19	NATURE IMMUNOLOGY			English	Article							DELTA T-CELLS; VIRAL LOAD; LYMPHOCYTES; PNEUMONIA; SARS	In coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the relationship between disease severity and the host immune response is not fully understood. Here we performed single-cell RNA sequencing in peripheral blood samples of 5 healthy donors and 13 patients with COVID-19, including moderate, severe and convalescent cases. Through determining the transcriptional profiles of immune cells, coupled with assembled T cell receptor and B cell receptor sequences, we analyzed the functional properties of immune cells. Most cell types in patients with COVID-19 showed a strong interferon-alpha response and an overall acute inflammatory response. Moreover, intensive expansion of highly cytotoxic effector T cell subsets, such as CD4(+)effector-GNLY (granulysin), CD8(+)effector-GNLY and NKT CD160, was associated with convalescence in moderate patients. In severe patients, the immune landscape featured a deranged interferon response, profound immune exhaustion with skewed T cell receptor repertoire and broad T cell expansion. These findings illustrate the dynamic nature of immune responses during disease progression. Severe COVID-19 is characterized-among other things-by a hyperinflammatory state. Wang and colleagues describe the single-cell transcriptional landscape of moderate, severe and convalescent cases of patients with COVID-19.	[Zhang, Ji-Yuan; Xu, Zhe; Zhang, Chao; Song, Jin-Wen; Fan, Xing; Xia, Peng; Fu, Jun-Liang; Wang, Si-Yu; Xu, Ruo-Nan; Dai, Xiao-Peng; Shi, Lei; Huang, Lei; Jiang, Tian-Jun; Shi, Ming; Wang, Fu-Sheng] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Dept Infect Dis, Beijing, Peoples R China; [Wang, Xiang-Ming; Bai, Fan] Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Sch Life Sci, Beijing, Peoples R China; [Xing, Xudong] Tsinghua Univ, Sch Life Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing, Peoples R China; [Zhang, Yuxia] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England; [Maeurer, Markus] Champalimaud Ctr Unknown, Immunotherapy Programme, Lisbon, Portugal; [Maeurer, Markus] Johannes Gutenberg Univ Mainz, Med Clin 1, Mainz, Germany	Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Peking University; Tsinghua University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Fundacao Champalimaud; Johannes Gutenberg University of Mainz	Wang, FS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Dept Infect Dis, Beijing, Peoples R China.; Bai, F (corresponding author), Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Sch Life Sci, Beijing, Peoples R China.	fbai@pku.edu.cn; fswang302@163.com	Song, Jin-Wen/GLN-3340-2022; Zhang, Chao/ABG-8934-2020; ZUMLA, Alimuddin/ABA-8208-2020; lei, huang/AFS-7785-2022; shi, lei/HGE-9964-2022	Song, Jin-Wen/0000-0002-8582-8012; Zhang, Chao/0000-0001-8126-8145; ZUMLA, Alimuddin/0000-0002-5111-5735; shi, lei/0000-0002-5727-3590; Fan, Xing/0000-0002-0809-9207; Maeurer, Markus/0000-0002-8436-8077; Xing, Xudong/0000-0003-0681-9378; Wang, Fu-Sheng/0000-0002-8043-6685; Wang, Xiangming/0000-0002-6453-1893	National Key Research and Development Program of China from the Ministry of Science and Technology of China [2020YFC0841900, 2020YFC0844000]; European and Developing Countries Clinical Trials Partnership; UK NIHR Senior Investigator Award	National Key Research and Development Program of China from the Ministry of Science and Technology of China; European and Developing Countries Clinical Trials Partnership; UK NIHR Senior Investigator Award	We thank the study participants who provided blood samples and C.-B. Zhou and J.-H. Yuan for flow cytometry analysis. J. Hou provided guidance for safely handling samples from patients with COVID-19. This work was supported by the National Key Research and Development Program of China (grant nos. 2020YFC0841900 and 2020YFC0844000) to F.-S.W. from the Ministry of Science and Technology of China. A.Z. is co-PI of the Pan-African Network on Emerging and Re-emerging Infections (PANDORA-ID-NET) funded by the European and Developing Countries Clinical Trials Partnership. A.Z. is in receipt of a UK NIHR Senior Investigator Award.	Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Couzi L, 2009, J INFECT DIS, V200, P1415, DOI 10.1086/644509; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Farnault L, 2013, BONE MARROW TRANSPL, V48, P1478, DOI 10.1038/bmt.2013.75; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Fujishima N, 2007, CLIN EXP IMMUNOL, V149, P70, DOI 10.1111/j.1365-2249.2007.03388.x; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; O'Brien TR, 2020, CLIN INFECT DIS, V71, P1410, DOI 10.1093/cid/ciaa453; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pizzolato G, 2019, P NATL ACAD SCI USA, V116, P11906, DOI 10.1073/pnas.1818488116; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Raveney BJE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9437; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Wang FS, 2020, LANCET, V395, P391, DOI 10.1016/S0140-6736(20)30300-7; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	47	265	275	12	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1107	+		10.1038/s41590-020-0762-x	http://dx.doi.org/10.1038/s41590-020-0762-x		AUG 2020	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32788748	Green Submitted, Bronze			2022-12-18	WOS:000559354200001
J	De Nardo, D; Labzin, LI; Kono, H; Seki, R; Schmidt, SV; Beyer, M; Xu, DK; Zimmer, S; Lahrmann, C; Schildberg, FA; Vogelhuber, J; Kraut, M; Ulas, T; Kerksiek, A; Krebs, W; Bode, N; Grebe, A; Fitzgerald, ML; Hernandez, NJ; Williams, BRG; Knolle, P; Kneilling, M; Rocken, M; Lutjohann, D; Wright, SD; Schultze, JL; Latz, E				De Nardo, Dominic; Labzin, Larisa I.; Kono, Hajime; Seki, Reiko; Schmidt, Susanne V.; Beyer, Marc; Xu, Dakang; Zimmer, Sebastian; Lahrmann, Catharina; Schildberg, Frank A.; Vogelhuber, Johanna; Kraut, Michael; Ulas, Thomas; Kerksiek, Anja; Krebs, Wolfgang; Bode, Niklas; Grebe, Alena; Fitzgerald, Michael L.; Hernandez, Nicholas J.; Williams, Bryan R. G.; Knolle, Percy; Kneilling, Manfred; Roecken, Martin; Luetjohann, Dieter; Wright, Samuel D.; Schultze, Joachim L.; Latz, Eicke			High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3	NATURE IMMUNOLOGY			English	Article							LIPID RAFTS; ATHEROSCLEROSIS; HDL; ACTIVATION; MICE; RECOGNITION; MODULATION; RECEPTORS; BIOLOGY	High-density lipoprotein (HDL) mediates reverse cholesterol transport and is known to be protective against atherosclerosis. In addition, HDL has potent anti-inflammatory properties that may be critical for protection against other inflammatory diseases. The molecular mechanisms of how HDL can modulate inflammation, particularly in immune cells such as macrophages, remain poorly understood. Here we identify the transcriptional regulator ATF3, as an HDL-inducible target gene in macrophages that downregulates the expression of Toll-like receptor (TLR)-induced proinflammatory cytokines. The protective effects of HDL against TLR-induced inflammation were fully dependent on ATF3 in vitro and in vivo. Our findings may explain the broad anti-inflammatory and metabolic actions of HDL and provide the basis for predicting the success of new HDL-based therapies.	[De Nardo, Dominic; Labzin, Larisa I.; Vogelhuber, Johanna; Grebe, Alena; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, Biomed Ctr, Bonn, Germany; [Kono, Hajime] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Seki, Reiko] Teikyo Univ, Fac Med Technol, Dept Clin Lab Sci, Tokyo 173, Japan; [Schmidt, Susanne V.; Beyer, Marc; Kraut, Michael; Ulas, Thomas; Krebs, Wolfgang; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [Xu, Dakang; Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Xu, Dakang] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou, Zhejiang, Peoples R China; [Zimmer, Sebastian; Lahrmann, Catharina; Bode, Niklas] Univ Bonn, Dept Med Cardiol, Bonn, Germany; [Schildberg, Frank A.; Knolle, Percy] Univ Bonn, Inst Mol Med, Bonn, Germany; [Schildberg, Frank A.; Knolle, Percy] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Kerksiek, Anja] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Fitzgerald, Michael L.; Hernandez, Nicholas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA USA; [Knolle, Percy] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany; [Kneilling, Manfred; Roecken, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Kneilling, Manfred] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Wright, Samuel D.] CSL Ltd, Cardiovasc Therapeut, Parkville, Vic, Australia; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Bonn; Teikyo University; Teikyo University; University of Bonn; Monash University; Hangzhou Normal University; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Harvard University; Harvard Medical School; Massachusetts General Hospital; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Siemens AG; CSL; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Latz, E (corresponding author), Univ Bonn, Univ Hosp, Inst Innate Immun, Biomed Ctr, Bonn, Germany.	eicke.latz@uni-bonn.de	Labzin, Larisa/AAC-8618-2020; Schultze, Joachim L/D-7794-2011; Schmidt, Susanne/AAU-6827-2021; Williams, Bryan R. G./A-5021-2009; Latz, Eicke/H-3951-2014; Schultze, Joachim L./ABA-8176-2020; Beyer, Marc/ABE-1408-2021	Schultze, Joachim L/0000-0003-2812-9853; Williams, Bryan R. G./0000-0002-4969-1151; Latz, Eicke/0000-0003-1488-5666; Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Kono, Hajime/0000-0002-4578-8677; Knolle, Percy A./0000-0003-2983-0414; De Nardo, Dominic/0000-0002-7045-4695; Labzin, Larisa/0000-0001-9098-4493; Rocken, Martin/0000-0003-3795-7001	US National Institutes of Health [1R01HL093262, 1R01HL112661]; German Research foundation [SFB670, SFB685]; Excellence Cluster ImmunoSensation; Australian National Health and Medical Research Council [1006588]; Operational Infrastructure Support Program (Victoria state Government, Australia); Naito Foundation (Japan); Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661, R01HL093262] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research foundation(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program (Victoria state Government, Australia); Naito Foundation (Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge C. Thiele (University of Bonn) for helpful discussions and J.-C. Hernandez (University of Medellin) for help with experiments. We thank C.M. De Nardo for critical reading of the manuscript. We thank T. Hai (Ohio State University) for the original Atf3-deficient mice. The work was funded by grants from US National Institutes of Health (1R01HL093262 to E.L., and 1R01HL112661 to E.L. and M.L.F.), the German Research foundation (SFB670 to E.L., SFB685 to M.Kn. and M.R.), the Excellence Cluster ImmunoSensation to E.L. and J.L.S., the Australian National Health and Medical Research Council (1006588), the Operational Infrastructure Support Program (Victoria state Government, Australia) to B.R.G.W. and D.X., and the Naito Foundation (Japan) and the Ministry of Health, Labour and Welfare and Grant-in-Aid for Scientific Research on Innovative Areas for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H.K. E.L. is a member of the Center for Molecular Inflammation Research at the Norwegian University of Science and Technology.	Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Carmeliet P, 1997, AM J PATHOL, V150, P761; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lerch PG, 1998, THROMB HAEMOSTASIS, V80, P316; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Petoumenos V, 2009, J CELL MOL MED, V13, P4623, DOI 10.1111/j.1582-4934.2008.00472.x; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Seneviratne AN, 2012, CLIN CHIM ACTA, V413, P3, DOI 10.1016/j.cca.2011.08.021; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Triantafilou M, 2002, J CELL SCI, V115, P2603; ULEVITCH RJ, 1978, J CLIN INVEST, V62, P1313, DOI 10.1172/JCI109252; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486; Zimarino M, 2007, ATHEROSCLEROSIS, V193, P94, DOI 10.1016/j.atherosclerosis.2006.08.047; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	42	265	270	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					152	160		10.1038/ni.2784	http://dx.doi.org/10.1038/ni.2784			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24317040	Green Accepted, Green Submitted			2022-12-18	WOS:000330150600009
J	Schmitt, TM; de Pooter, RF; Gronski, MA; Cho, SK; Ohashi, PS; Zuniga-Pflucker, JC				Schmitt, TM; de Pooter, RF; Gronski, MA; Cho, SK; Ohashi, PS; Zuniga-Pflucker, JC			Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE LINEAGE COMMITMENT; ALPHA-BETA; HEMATOPOIETIC PROGENITORS; YOLK-SAC; THYMOCYTES; NOTCH1; EXPRESSION; MICE; PU.1; CD4	Embryonic stem cells (ESCs) have the potential to serve as a renewable source of transplantable tissue-specific stem cells. However, the molecular cues necessary to direct the differentiation of ESCs toward specific cell lineages remain obscure. Here we report the successful induction of ESC differentiation into mature functional T lymphocytes with a simple in vitro coculture system. The directed differentiation of ESCs into T cells required the engagement of Notch receptors by Delta-like 1 ligand (DL1) expressed on the OP9-DL1 stromal cell line. We found a normal program of T cell differentiation in ESC-OP9-DL1 cell cocultures. ESC-derived T cell progenitors effectively reconstituted the T cell compartment of immunodeficient mice, enabling an effective response to a viral infection. These findings provide a powerful tool for the molecular analysis of T cell development and open new avenues for the development of immunotherapeutic approaches using defined sources of stem cells.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Immunol, Toronto, ON M4N 3M5, Canada; Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2M9, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zuniga-Pflucker, JC (corresponding author), Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Immunol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jc.zuniga.pflucker@utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012; Schmitt, Tom/AAG-9941-2020	Gronski, Matthew/0000-0003-4779-5720; Schmitt, Thomas/0000-0002-0736-4195; Ohashi, Pamela S./0000-0003-2915-9317; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Cho SK, 2003, METHOD ENZYMOL, V365, P158; de Pooter RF, 2003, BLOOD, V102, P1649, DOI 10.1182/blood-2003-01-0224; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0; Orkin SH, 2002, NATURE, V418, P25, DOI 10.1038/418025a; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robertson E J, 1997, Methods Mol Biol, V75, P173; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Rothenberg EV, 1999, BIOESSAYS, V21, P726, DOI 10.1002/(SICI)1521-1878(199909)21:9<726::AID-BIES4>3.0.CO;2-S; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	38	265	287	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					410	417		10.1038/ni1055	http://dx.doi.org/10.1038/ni1055			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15034575				2022-12-18	WOS:000220515900014
J	Wakabayashi, Y; Watanabe, H; Inoue, J; Takeda, N; Sakata, J; Mishima, Y; Hitomi, J; Yamamoto, T; Utsuyama, M; Niwa, O; Aizawa, S; Kominami, R				Wakabayashi, Y; Watanabe, H; Inoue, J; Takeda, N; Sakata, J; Mishima, Y; Hitomi, J; Yamamoto, T; Utsuyama, M; Niwa, O; Aizawa, S; Kominami, R			Bcl11b is required for differentiation and survival of alpha beta T lymphocytes	NATURE IMMUNOLOGY			English	Article							THYMOCYTE DEVELOPMENT; CELL RECEPTOR; DEFICIENT MICE; STEM-CELLS; PROTEIN; GENE; APOPTOSIS; BCL-2; ACTIVATION; FAMILY	The gene Bcl11b, which encodes zinc finger proteins, and its paralog, Bcl11a, are associated with immune-system malignancies. We have generated Bcl11b-deficient mice that show a block at the CD4(-)CD8(-) double-negative stage of thymocyte development without any impairment in cells of B- or gammadelta T cell lineages. The Bcl11b(-/-) thymocytes showed unsuccessful recombination of V-beta to D-beta and lacked the pre-T cell receptor (TCR) complex on the cell surface, owing to the absence of Tcrb mRNA expression. In addition, we saw profound apoptosis in the thymus of neonatal Bcl11b(-/-) mice. These results suggest that Bcl11b is a key regulator of both differentiation and survival during thymocyte development.	Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518122, Japan; Univ Ryukyus, Ctr Mol Biosci, Div Cellular & Mol Immunol, Okinawa 9030213, Japan; Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Niigata Univ, Grad Sch Med & Dent Sci, Dept Cellular Funct, Niigata 9518122, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Pathol & Immunol, Bunkyo Ku, Tokyo 1138519, Japan; Kyoto Univ, Ctr Radiat Biol, Sakyo Ku, Kyoto 6068315, Japan	Niigata University; University of the Ryukyus; Kumamoto University; Niigata University; Tokyo Medical & Dental University (TMDU); Kyoto University	Kominami, R (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Asachimachi 1-757, Niigata 9518122, Japan.	rykomina@med.niigata-u.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754				Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HIROKAWA K, 1986, THYMUS, V8, P349; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; NISHA NH, 2001, P NATL ACAD SCI USA, V98, P6307; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Shinbo T, 1999, ONCOGENE, V18, P4131, DOI 10.1038/sj.onc.1202767; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Toba K, 2000, EUR J HAEMATOL, V64, P10, DOI 10.1034/j.1600-0609.2000.09005.x; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; WAKABAYASHI Y, BIOPHYS BIOCH RES CO, V301, P598; Wang XD, 2001, GENE DEV, V15, P2922; Watanabe H, 1996, J EXP MED, V184, P687, DOI 10.1084/jem.184.2.687; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820	46	265	280	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					533	539		10.1038/ni927	http://dx.doi.org/10.1038/ni927			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12717433				2022-12-18	WOS:000183175500011
J	Nagase, T; Uozumi, N; Ishii, S; Kume, K; Izumi, T; Ouchi, Y; Shimizu, T				Nagase, T; Uozumi, N; Ishii, S; Kume, K; Izumi, T; Ouchi, Y; Shimizu, T			Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A(2)	NATURE IMMUNOLOGY			English	Article							PLATELET-ACTIVATING-FACTOR; RESPIRATORY-DISTRESS SYNDROME; FACTOR-RECEPTOR; MOLECULAR-CLONING; INFLAMMATORY RESPONSE; ARACHIDONIC-ACID; MICE; EXPRESSION; CDNA; LEUKOTRIENES	Adult respiratory distress syndrome (ARDS) is characterized by acute lung injury with a high mortality rate and yet its mechanism is poorly understood. Sepsis syndrome and acid aspiration are the most frequent causes of ARDS, leading to increased lung permeability, enhanced polymorphonuclear neutrophil (PMN) sequestration and respiratory failure. Using a murine model of acute lung injury induced by septic syndrome or acid aspiration, we investigated the role of cytosolic phospholipase A(2) (cPLA(2)) in ARDS. We found that disruption of the gene encoding cPLA(2) significantly reduced pulmonary edema, PMN sequestration and deterioration of gas exchange caused by lipopolysaccharide and zymosan administration, Acute lung injury induced by acid aspiration was similarly reduced in mice with a disrupted cpla2 gene. Our observations suggest that cPLA(2) is a mediator of acute lung injury induced by sepsis syndrome or acid aspiration,Thus, the inhibition of cPLA(2)-initiated pathways may provide a therapeutic approach to acute lung injury, for which no pharmaceutical agents are currently effective.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.		Uozumi, Nobuyuki/AAG-3252-2019	Kume, Kazuhiko/0000-0003-4232-1657				BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DONNELLY SC, 1992, THORAX, V47, P260, DOI 10.1136/thx.47.4.260; EIJKING EP, 1993, ANESTHESIOLOGY, V78, P1145, DOI 10.1097/00000542-199306000-00019; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; FOWLER AA, 1983, ANN INTERN MED, V98, P593, DOI 10.7326/0003-4819-98-5-593; GOLDMAN G, 1992, J APPL PHYSIOL, V73, P571, DOI 10.1152/jappl.1992.73.2.571; GOLDMAN G, 1992, SURGERY, V111, P55; Hardman JG, 1999, EUR J ANAESTH, V16, P404, DOI 10.1046/j.1365-2346.1999.00513.x; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 1996, BIOCHEM J, V314, P671, DOI 10.1042/bj3140671; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KUNZ D, 1992, J BIOL CHEM, V267, P9101; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Levy R, 2000, BLOOD, V95, P660, DOI 10.1182/blood.V95.2.660; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lynch KR, 1999, NATURE, V399, P789; Marion D W, 1991, Neurosurg Clin N Am, V2, P411; Miotla JM, 1996, AM J RESP CELL MOL, V14, P363, DOI 10.1165/ajrcmb.14.4.8600941; Nagase T, 1999, J CLIN INVEST, V104, P1071, DOI 10.1172/JCI7727; Nagase T, 1997, AM J RESP CRIT CARE, V156, P1621, DOI 10.1164/ajrccm.156.5.9703016; Nagase T, 1996, AM J RESP CRIT CARE, V154, P504, DOI 10.1164/ajrccm.154.2.8756829; Nagase T, 1997, J APPL PHYSIOL, V83, P46, DOI 10.1152/jappl.1997.83.1.46; Nagase T, 1998, AM J RESP CRIT CARE, V157, P560, DOI 10.1164/ajrccm.157.2.9706009; NAGASE T, 1991, CRIT CARE MED, V19, P950, DOI 10.1097/00003246-199107000-00021; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; SHARP JD, 1991, J BIOL CHEM, V266, P14850; STEWART AG, 1990, P NATL ACAD SCI USA, V87, P3215, DOI 10.1073/pnas.87.8.3215; SUGIMOTO T, 1992, BIOCHEM BIOPH RES CO, V189, P617, DOI 10.1016/0006-291X(92)92245-S; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; UTSUNOMIYA T, 1982, AM J PHYSIOL, V243, pH903, DOI 10.1152/ajpheart.1982.243.6.H903; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	42	265	274	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					42	46		10.1038/76897	http://dx.doi.org/10.1038/76897			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881173				2022-12-18	WOS:000089814800012
J	Li, T; Morgan, MJ; Choksi, S; Zhang, Y; Kim, YS; Liu, ZG				Li, Tao; Morgan, Michael J.; Choksi, Swati; Zhang, Yan; Kim, You-Sun; Liu, Zheng-gang			MicroRNAs modulate the noncanonical transcription factor NF-kappa B pathway by regulating expression of the kinase IKK alpha during macrophage differentiation	NATURE IMMUNOLOGY			English	Article							CONTROLS PROSTATE-CANCER; GENE-EXPRESSION; ACTIVATION; P100; INFLAMMATION; RECOGNITION; NF-KAPPA-B2; GENERATION; SURVIVAL; BIOLOGY	MicroRNAs are key regulators of many biological processes including cell differentiation. Here we show that during human monocyte-macrophage differentiation expression of the microRNAs miR-223 miR-15a and miR-16 decreased considerably which led to higher expression of the serine-threonine kinase IKK alpha in macrophages. In macrophages higher IKK alpha expression in conjunction with stabilization of the kinase NIK induced larger amounts of p52. Because of low expression of the transcription factor ReIB in untreated macrophages high p52 expression repressed basal transcription of both canonical and noncanonical NF-kappa B target genes. However proinflammatory stimuli in macrophages resulted in greater induction of noncanonical NF-kappa B target genes. Thus a decrease in certain microRNAs probably prevents macrophage hyperactivation yet primes the macrophage for certain responses to proinflammatory stimuli.	[Kim, You-Sun] Ajou Univ, Sch Med, Inst Med Sci, Suwon 441749, South Korea; [Li, Tao; Morgan, Michael J.; Choksi, Swati; Zhang, Yan; Liu, Zheng-gang] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, YS (corresponding author), Ajou Univ, Sch Med, Inst Med Sci, Suwon 441749, South Korea.	yousunkim@ajou.ac.kr; zgliu@helix.nih.gov		Li, Tao/0000-0002-0746-8322	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010783, ZIASC010376] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Preclinical Repository of the National Cancer Institute for the antibody to the p100 C terminus and the National Institutes of Health Blood Bank for elutriated monocytes. Supported by the Intramural Research Program of The Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Hashimoto S, 2001, J IMMUNOL, V167, P3619, DOI 10.4049/jimmunol.167.7.3619; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Komuro I, 2005, J BIOL CHEM, V280, P41137, DOI 10.1074/jbc.M509793200; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Petrocca F, 2009, ADV IMMUNOL, V102, P227, DOI 10.1016/S0065-2776(09)01204-8; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	40	264	290	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					799	U48		10.1038/ni.1918	http://dx.doi.org/10.1038/ni.1918			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20711193	Green Submitted, Green Accepted			2022-12-18	WOS:000281115500007
J	Chen, K; Xu, WF; Wilson, M; He, B; Miller, NW; Bengten, E; Edholm, ES; Santini, PA; Rath, P; Chiu, A; Cattalini, M; Litzman, J; Bussel, JB; Huang, BH; Meini, A; Riesbeck, K; Cunningham-Rundles, C; Plebani, A; Cerutti, A				Chen, Kang; Xu, Weifeng; Wilson, Melanie; He, Bing; Miller, Norman W.; Bengten, Eva; Edholm, Eva-Stina; Santini, Paul A.; Rath, Poonam; Chiu, April; Cattalini, Marco; Litzman, Jiri; Bussel, James B.; Huang, Bihui; Meini, Antonella; Riesbeck, Kristian; Cunningham-Rundles, Charlotte; Plebani, Alessandro; Cerutti, Andrea			Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils	NATURE IMMUNOLOGY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; CLASS-SWITCH RECOMBINATION; CHANNEL CATFISH; MAST-CELLS; T-CELLS; IGD; REGION; GENE; EXPRESSION; INDUCTION	Immunoglobulin D (IgD) is an enigmatic antibody isotype that mature B cells express together with IgM through alternative RNA splicing. Here we report active T cell-dependent and T cell-independent IgM-to-IgD class switching in B cells of the human upper respiratory mucosa. This process required activation-induced cytidine deaminase (AID) and generated local and circulating IgD-producing plasmablasts reactive to respiratory bacteria. Circulating IgD bound to basophils through a calcium-mobilizing receptor that induced antimicrobial, opsonizing, inflammatory and B cell-stimulating factors, including cathelicidin, interleukin 1 (IL-1), IL-4 and B cell-activating factor (BAFF), after IgD crosslinking. By showing dysregulation of IgD class-switched B cells and 'IgD-armed' basophils in autoinflammatory syndromes with periodic fever, our data indicate that IgD orchestrates an ancestral surveillance system at the interface between immunity and inflammation.	[Chen, Kang; Xu, Weifeng; He, Bing; Santini, Paul A.; Rath, Poonam; Chiu, April; Cerutti, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Chen, Kang; Santini, Paul A.; Rath, Poonam; Huang, Bihui; Cerutti, Andrea] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA; [Wilson, Melanie; Miller, Norman W.; Bengten, Eva; Edholm, Eva-Stina] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Cattalini, Marco; Meini, Antonella; Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Cattalini, Marco; Meini, Antonella; Plebani, Alessandro] Univ Brescia, Ist Med Mol A Nocivelli, Brescia, Italy; [Litzman, Jiri] Masaryk Univ, St Annes Univ Hosp, Dept Clin Immunol & Allergol, Brno, Czech Republic; [Bussel, James B.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Huang, Bihui] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Riesbeck, Kristian] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Cunningham-Rundles, Charlotte] Mt Sinai Med Ctr, New York, NY 10029 USA	Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Mississippi; University of Mississippi Medical Center; University of Brescia; University of Brescia; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Cornell University; Cornell University; Lund University; Skane University Hospital; Icahn School of Medicine at Mount Sinai	Cerutti, A (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA.	acerutti@med.cornell.edu	Plebani, Alessandro/C-8593-2011; Cattalini, Marco/AFK-4529-2022; Litzman, Jiri/E-2746-2012	Cattalini, Marco/0000-0002-7500-8838; Huang, Bihui/0000-0003-3084-7096; Bengten, Eva/0000-0001-9618-0197; Riesbeck, Kristian/0000-0001-6274-6965; Litzman, Jiri/0000-0002-1926-5426; Cerutti, Andrea/0000-0003-3026-4704	US National Institutes of Health [R01 AI057653, R01 AI074378, T32 AI07621]; Cancer Research Institute; Irma T. Hirschl Charitable Trust; Ministerio de Ciencia e Innovacion; Desarrollo e Innovacion Tecnologica [SAF 2008-02725]; Fondazione C. Golgi and Centro Immunodeficienze Mario Di Martino; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074378, T32AI007621, R01AI057653, P01AI061093] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Irma T. Hirschl Charitable Trust; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Desarrollo e Innovacion Tecnologica; Fondazione C. Golgi and Centro Immunodeficienze Mario Di Martino; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Kirshenbaum and D. Metcalfe (US National Institutes of Health) for the mast cell line LAD2; F. Facchetti (Universita di Brescia) for tissue samples; and R. Silver, R. Schreiner and F. Diaz (Weill Medical College of Cornell University) for primary lung mast cells and discussion of transcytosis assays. Supported by the US National Institutes of Health (R01 AI057653, R01 AI057653 supplement and R01 AI074378 to A. C.; and funds from T32 AI07621 to W. X.), the Cancer Research Institute (P. A. S.), The Irma T. Hirschl Charitable Trust (A. C.), the Ministerio de Ciencia e Innovacion (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica SAF 2008-02725 to A. C.) and Fondazione C. Golgi and Centro Immunodeficienze Mario Di Martino (A. P.).	Arpin C, 1998, J EXP MED, V187, P1169, DOI 10.1084/jem.187.8.1169; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Bekeredjian-Ding I, 2008, J IMMUNOL, V181, P8267, DOI 10.4049/jimmunol.181.12.8267; Bengten E, 2002, J IMMUNOL, V169, P2488, DOI 10.4049/jimmunol.169.5.2488; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Butler JE, 1996, INT IMMUNOL, V8, P1897, DOI 10.1093/intimm/8.12.1897; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Drenth JPH, 1996, IMMUNOLOGY, V88, P355, DOI 10.1046/j.1365-2567.1996.d01-672.x; Gala FA, 2002, J BIOL CHEM, V277, P29005, DOI 10.1074/jbc.M203258200; Garibyan L, 2007, J CLIN INVEST, V117, P1550, DOI 10.1172/JCI31023; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Johansen FE, 2005, BLOOD, V106, P593, DOI 10.1182/blood-2004-12-4630; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kluin PM, 1995, EUR J IMMUNOL, V25, P3504, DOI 10.1002/eji.1830251244; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; Lutz C, 1998, NATURE, V393, P797, DOI 10.1038/31716; MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; MILLER NW, 1994, J IMMUNOL, V152, P2180; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; MONROE JG, 1983, EUR J IMMUNOL, V13, P208, DOI 10.1002/eji.1830130306; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NITSCHKE L, 1993, P NATL ACAD SCI USA, V90, P1887, DOI 10.1073/pnas.90.5.1887; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; PLEBANI A, 1983, CLIN EXP IMMUNOL, V53, P689; Preud'homme JL, 2000, MOL IMMUNOL, V37, P871, DOI 10.1016/S0161-5890(01)00006-2; Riesbeck K, 2006, CRIT REV IMMUNOL, V26, P353, DOI 10.1615/CritRevImmunol.v26.i4.40; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; Ryan JG, 2008, CURR TOP MICROBIOL, V321, P169; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Vladutiu AO, 2000, CLIN DIAGN LAB IMMUN, V7, P131, DOI 10.1128/CDLI.7.2.131-140.2000; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; XUE B, 1984, J EXP MED, V159, P103, DOI 10.1084/jem.159.1.103; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408	59	264	295	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					889	U121		10.1038/ni.1748	http://dx.doi.org/10.1038/ni.1748			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19561614	Green Accepted			2022-12-18	WOS:000268141400019
J	Kitamura, H; Morikawa, H; Kamon, H; Iguchi, M; Hojyo, S; Fukada, T; Yamashita, S; Kaisho, T; Akira, S; Murakami, M; Hirano, T				Kitamura, Hidemitsu; Morikawa, Hideyuki; Kamon, Hokuto; Iguchi, Megumi; Hojyo, Shintaro; Fukada, Toshiyuki; Yamashita, Susumu; Kaisho, Tsuneyasu; Akira, Shizuo; Murakami, Masaaki; Hirano, Toshio			Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function	NATURE IMMUNOLOGY			English	Article							CLASS-II TRANSPORT; ENDOCYTOSIS; DEFICIENCY; MATURATION; PEPTIDE; FAMILY	Zinc is a trace element that is essential for the function of many enzymes and transcription factors. Zinc deficiency results in defects in innate and acquired immune responses. However, little is known about the mechanism(s) by which zinc affects immune cell function. Here we show that stimulation with the Toll-like receptor 4 agonist lipopolysaccharide (LPS) altered the expression of zinc transporters in dendritic cells and thereby decreased intracellular free zinc. A zinc chelator mimicked the effects of LPS, whereas zinc supplementation or overexpression of the gene encoding Zip6, a zinc transporter whose expression was reduced by LPS, inhibited LPS-induced upregulation of major histocompatibility complex class II and costimulatory molecules. These results establish a link between Toll-like receptor signaling and zinc homeostasis.	RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Kanagawa 2300045, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; RIKEN; Osaka University	Hirano, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa 2300045, Japan.	hirano@molonc.med.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Kitamura, Hidemitsu/A-8184-2012; Kaisho, Tsuneyasu/B-4130-2012; Hirano, Toshio/C-8194-2009	, Masaaki/0000-0001-7159-7279				Aballay A, 1999, J CELL SCI, V112, P2549; Ashworth A, 1998, EUR J CLIN NUTR, V52, P223, DOI 10.1038/sj.ejcn.1600553; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; FISHER WC, 2004, ANNU REV NUTR, V24, P255; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282, DOI 10.1177/154411130401500504; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Hosea HJ, 2003, J NUTR, V133, P4239, DOI 10.1093/jn/133.12.4239; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Licastro F, 2001, BRAIN RES BULL, V55, P313, DOI 10.1016/S0361-9230(01)00476-2; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; PRASAD AS, 1995, NUTRITION, V11, P93; Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916; Siklar Z, 2003, J TROP PEDIATRICS, V49, P187, DOI 10.1093/tropej/49.3.187; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	39	264	275	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					971	977		10.1038/ni1373	http://dx.doi.org/10.1038/ni1373			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16892068				2022-12-18	WOS:000239942300016
J	Shakhar, G; Lindquist, RL; Skokos, D; Dudziak, D; Huang, JH; Nussenzweig, MC; Dustin, ML				Shakhar, G; Lindquist, RL; Skokos, D; Dudziak, D; Huang, JH; Nussenzweig, MC; Dustin, ML			Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo	NATURE IMMUNOLOGY			English	Article							STEADY-STATE CONDITIONS; LYMPH-NODES; ANTIGEN PRESENTATION; DYING CELLS; INDUCTION; SELF; ACTIVATION; DYNAMICS; MOTILITY; UNRESPONSIVENESS	The maturation status of dendritic cells (DCs) determines whether they prime or tolerize T cells. We targeted ovalbumin peptide exclusively to DCs in situ using an antibody to DEC-205 and studied the interaction of DCs with naive CD4(+) T cells in tolerizing or priming conditions. We used two-photon microscopy to simultaneously track antigen-specific OT-II T cells, nonspecific T cells and DCs in lymph nodes of living mice. In both tolerance and immunity, OT-II cells arrested on DCs near high endothelial venules beginning shortly after extravasation and regained their baseline speed by 18 h. Thus, early antigen-dependent T cell arrest on DCs is a shared feature of tolerance and priming associated with activation and proliferation.	NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY 10016 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	New York University; New York University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, 550 1St Ave, New York, NY 10016 USA.	nussen@mail.rockefeller.edu; dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019; Dudziak, Diana/B-2432-2017	Dustin, Michael/0000-0003-4983-6389; Dudziak, Diana/0000-0001-9358-134X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573, R01AI055037, R21AI055037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI055037, AI051573, AI055037, P01 AI051573, R01 AI055037] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Redmond WL, 2003, J IMMUNOL, V171, P6349, DOI 10.4049/jimmunol.171.12.6349; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	48	264	274	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					707	714		10.1038/ni1210	http://dx.doi.org/10.1038/ni1210			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15924144	Green Accepted			2022-12-18	WOS:000229975500014
J	Billadeau, DD; Upshaw, JL; Schoon, RA; Dick, CJ; Leibson, PJ				Billadeau, DD; Upshaw, JL; Schoon, RA; Dick, CJ; Leibson, PJ			NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; SIGNAL-TRANSDUCTION; GENETIC-EVIDENCE; NKG2D RECEPTOR; CUTTING EDGE; ACTIVATION; GAMMA; FC; FAMILY; EXPRESSION	The immune recognition receptor complex NKG2D-DAP10 on natural killer cells is stimulated by specific ligands carried on virus-infected and malignant cells. Because DAP10 does not have an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic tail, its ability to trigger killing has been debated. Here we show that a crucial Tyr-Ile-Asn-Met amino acid motif in the cytoplasmic tail of DAP10 couples receptor stimulation to the downstream activation of phosphatidylinositol 3-kinase, Vav1, Rho family GTPases and phospholipase C. Unlike that of ITAM-containing receptors, the activation of NKG2D-DAP10 proceeds independently of Syk family protein tyrosine kinases. Yet the signals initiated by NKG2D-DAP10 are fully capable of inducing killing. Our findings identify a previously unknown mechanism by which receptor complexes that lack ITAM motifs can trigger lymphocyte activation.	Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Grad Sch, Div Oncol Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Leibson, PJ (corresponding author), Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	leibson.paul@mayo.edu						ANDERSON P, 1989, NATURE, V341, P159, DOI 10.1038/341159a0; AZUMA M, 1992, J IMMUNOL, V149, P1115; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Jevremovic D, 1999, J IMMUNOL, V162, P2453; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; LANIER LL, 1991, J IMMUNOL, V146, P1571; Lanier LL, 2001, NAT MED, V7, P1178, DOI 10.1038/nm1101-1178; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676; PROSS HF, 1986, IMMUNOBIOLOGY NATURA, V1, P2; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Shigematsu H, 1997, J BIOL CHEM, V272, P14334, DOI 10.1074/jbc.272.22.14334; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKAYAMA H, 1987, J IMMUNOL METHODS, V104, P183, DOI 10.1016/0022-1759(87)90502-3; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TING AT, 1995, J BIOL CHEM, V270, P16415, DOI 10.1074/jbc.270.27.16415; Walker C, 1998, J IMMUNOL, V161, P1962; WENG WK, 1994, J BIOL CHEM, V269, P32514; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; WINDEBANK KP, 1988, J IMMUNOL, V141, P3951; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	39	264	284	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					557	564		10.1038/ni929	http://dx.doi.org/10.1038/ni929			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12740575				2022-12-18	WOS:000183175500015
J	Su, TT; Guo, BC; Kawakami, Y; Sommer, K; Chae, K; Humphries, LA; Kato, RM; Kang, S; Patrone, L; Wall, R; Teitell, M; Leitges, M; Kawakami, T; Rawlings, DJ				Su, TT; Guo, BC; Kawakami, Y; Sommer, K; Chae, K; Humphries, LA; Kato, RM; Kang, S; Patrone, L; Wall, R; Teitell, M; Leitges, M; Kawakami, T; Rawlings, DJ			PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling	NATURE IMMUNOLOGY			English	Article							BRUTONS TYROSINE KINASE; CELL RECEPTOR; IKK-ALPHA; EXPRESSION; LYMPHOMA; MATURE; THETA; PROLIFERATION; INHIBITOR; PHOSPHORYLATION	NF-kappaB signaling is required for the maintenance of normal B lymphocytes, whereas dysregulated NF-kappaB activation contributes to B cell lymphomas. The events that regulate NF-kappaB signaling in B lymphocytes are poorly defined. Here, we demonstrate that PKC-beta is specifically required for B cell receptor (BCR)-mediated NF-kappaB activation. B cells from protein kinase C-beta (PKC-beta)-deficient mice failed to recruit the IkappaB kinase (IKK) complex into lipid rafts, activate IKK, degrade IkappaB or up-regulate NF-kappaB-dependent survival signals. Inhibition of PKC-beta promoted cell death in B lymphomas characterized by exaggerated NF-kappaB activity. Together, these data define an essential role for PKC-beta in BCR survival signaling and highlight PKC-beta as a key therapeutic target for B-lineage malignancies.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Max Planck Inst, Hannover, Germany	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; La Jolla Institute for Immunology; Max Planck Society	Rawlings, DJ (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	drawling@u.washington.edu	Rawlings, David/CAI-4751-2022; Leitges, Michael/AAN-1953-2021; Kawakami, Toshiaki/O-1616-2015	Patrone, Lisa/0000-0002-9515-7785	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA074929, R01CA081140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038348, R01AI033617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NCI NIH HHS [CA74929, CA09120, CA81140] Funding Source: Medline; NIAID NIH HHS [AI33617, AI38348] Funding Source: Medline; NICHD NIH HHS [HD37091] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bendall HH, 1999, MOL IMMUNOL, V36, P187, DOI 10.1016/S0161-5890(99)00031-0; Bi K, 2001, SEMIN IMMUNOL, V13, P139, DOI 10.1006/smim.2000.0305; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Brorson K, 1997, J IMMUNOL, V159, P135; Cariappa A, 1999, J IMMUNOL, V162, P4417; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Choi MSK, 1996, EUR J IMMUNOL, V26, P676, DOI 10.1002/eji.1830260325; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami Y, 2000, P NATL ACAD SCI USA, V97, P7423, DOI 10.1073/pnas.120175097; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Krappmann D, 2001, MOL CELL BIOL, V21, P6640, DOI 10.1128/MCB.21.19.6640-6650.2001; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1999, CLIN IMMUNOL, V91, P243, DOI 10.1006/clim.1999.4732; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ren H, 2002, J IMMUNOL, V168, P577, DOI 10.4049/jimmunol.168.2.577; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Solvason N, 1998, J EXP MED, V187, P1081, DOI 10.1084/jem.187.7.1081; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Teicher BA, 2001, CLIN CANCER RES, V7, P634; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	48	263	275	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					780	786		10.1038/ni823	http://dx.doi.org/10.1038/ni823			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12118249				2022-12-18	WOS:000177118500018
J	Tran, E; Robbins, PF; Rosenberg, SA				Tran, Eric; Robbins, Paul F.; Rosenberg, Steven A.			'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations	NATURE IMMUNOLOGY			English	Review							CYTOLYTIC T-LYMPHOCYTES; TUMOR-INFILTRATING LYMPHOCYTES; EXOME ANALYSIS REVEALS; POINT MUTATION; PD-1 BLOCKADE; METASTATIC MELANOMA; PEPTIDE VACCINATION; CELLS; ANTIGEN; GENE	Effective clinical cancer immunotherapies, such as administration of the cytokine IL-2, adoptive cell transfer (ACT) and the recent success of blockade of the checkpoint modulators CTLA-4 and PD-1, have been developed without clear identification. of the immunogenic targets expressed by human cancers in vivo. Immunotherapy of patients with cancer through the use of ACT with autologous lymphocytes has provided an opportunity to directly investigate the antigen recognition of lymphocytes that mediate cancer regression in humans. High-throughput immunological testing of such lymphocytes in combination with improvements in deep sequencing of the autologous cancer have provided new insight into the molecular characterization and incidence of anti-tumor lymphocytes present in patients with cancer. Here we highlight evidence suggesting that T cells that target tumor neoantigens arising from cancer mutations are the main mediators of many effective cancer immunotherapies in humans.	[Tran, Eric; Robbins, Paul F.; Rosenberg, Steven A.] NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	sar@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZICBC010948, ZIABC010984] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Beck-Engeser GB, 2001, J EXP MED, V194, P285, DOI 10.1084/jem.194.3.285; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cohen CJ, 2015, J CLIN INVEST, V125, P3981, DOI 10.1172/JCI82416; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Echchakir H, 2001, CANCER RES, V61, P4078; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gjertsen MK, 1997, INT J CANCER, V72, P784, DOI 10.1002/(SICI)1097-0215(19970904)72:5<784::AID-IJC14>3.0.CO;2-9; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gueguen M, 1998, J IMMUNOL, V160, P6188; Hogan KT, 1998, CANCER RES, V58, P5144; Huang JP, 2004, J IMMUNOL, V172, P6057, DOI 10.4049/jimmunol.172.10.6057; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ito D, 2007, INT J CANCER, V120, P2618, DOI 10.1002/ijc.22584; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalaora S, 2016, ONCOTARGET, V7, P5110, DOI 10.18632/oncotarget.6960; Karanikas V, 2001, CANCER RES, V61, P3718; Kerkar SP, 2016, J IMMUNOTHER, V39, P181, DOI 10.1097/CJI.0000000000000119; Kloor M, 2016, TRENDS CANCER, V2, P121, DOI 10.1016/j.trecan.2016.02.004; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Parkhurst M.R., 2016, CLIN CANC RES; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Prickett TD, 2016, CANCER IMMUNOL RES, V4, P669, DOI 10.1158/2326-6066.CIR-15-0215; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; SIBILLE C, 1990, J EXP MED, V172, P35, DOI 10.1084/jem.172.1.35; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stevanovic S, 2015, J CLIN ONCOL, V33, P1543, DOI 10.1200/JCO.2014.58.9093; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; van Steenwijk PJD, 2014, CANCER IMMUNOL IMMUN, V63, P147, DOI 10.1007/s00262-013-1499-2; VANPEL A, 1991, ANN NY ACAD SCI, V636, P43; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wick DA, 2014, CLIN CANCER RES, V20, P1125, DOI 10.1158/1078-0432.CCR-13-2147; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007	77	262	273	3	109	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					255	262		10.1038/ni.3682	http://dx.doi.org/10.1038/ni.3682			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28198830	Green Accepted			2022-12-18	WOS:000394413400005
J	Lupfer, C; Thomas, PG; Anand, PK; Vogel, P; Milasta, S; Martinez, J; Huang, GH; Green, M; Kundu, M; Chi, HB; Xavier, RJ; Green, DR; Lamkanfi, M; Dinarello, CA; Doherty, PC; Kanneganti, TD				Lupfer, Christopher; Thomas, Paul G.; Anand, Paras K.; Vogel, Peter; Milasta, Sandra; Martinez, Jennifer; Huang, Gonghua; Green, Maggie; Kundu, Mondira; Chi, Hongbo; Xavier, Ramnik J.; Green, Douglas R.; Lamkanfi, Mohamed; Dinarello, Charles A.; Doherty, Peter C.; Kanneganti, Thirumala-Devi			Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; 1918 INFLUENZA; LISTERIA-MONOCYTOGENES; DENDRITIC CELLS; IMMUNE-RESPONSE; AUTOPHAGY; INNATE; NOD2; CRYOPYRIN/NALP3; NEUTRALIZATION	NOD2 receptor and the cytosolic protein kinase RIPK2 regulate NF-kappa B and MAP kinase signaling during bacterial infections, but the role of this immune axis during viral infections has not been addressed. We demonstrate that Nod2(-/-) and Ripk2(-/-) mice are hypersusceptible to infection with influenza A virus. Ripk2(-/-) cells exhibited defective autophagy of mitochondria (mitophagy), leading to enhanced mitochondrial production of superoxide and accumulation of damaged mitochondria, which resulted in greater activation of the NLRP3 inflammasome and production of IL-18. RIPK2 regulated mitophagy in a kinase-dependent manner by phosphorylating the mitophagy inducer ULK1. Accordingly, Ulk1(-/-) cells exhibited enhanced mitochondrial production of superoxide and activation of caspase-1. These results demonstrate a role for NOD2-RIPK2 signaling in protection against virally triggered immunopathology by negatively regulating activation of the NLRP3 inflammasome and production of IL-18 via ULK1-dependent mitophagy.	[Lupfer, Christopher; Thomas, Paul G.; Anand, Paras K.; Milasta, Sandra; Martinez, Jennifer; Huang, Gonghua; Green, Maggie; Chi, Hongbo; Green, Douglas R.; Doherty, Peter C.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Doherty, Peter C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Melbourne	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Kundu, Mondira/N-8139-2018; Thomas, Paul G./H-1063-2018; Vogel, Peter/N-2490-2018; Green, Douglas R/N-8083-2018; Martinez, Jennifer/C-3740-2019; Chi, Hongbo/M-9397-2018; Dinarello, Charles/C-8524-2013; Kanneganti, Thirumala-Devi/Y-2503-2019; Doherty, Peter Charles/C-4185-2013	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kundu, Mondira/0000-0001-9946-2472; Thomas, Paul G./0000-0001-7955-0256; Vogel, Peter/0000-0002-7535-0545; Green, Douglas R/0000-0002-7332-1417; Martinez, Jennifer/0000-0002-3060-2518; Chi, Hongbo/0000-0002-9997-2496; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Doherty, Peter Charles/0000-0002-5028-3489; Anand, Paras/0000-0003-2503-3653	EU Framework Program 7 [256432]; European Research Council [281600]; Fund for Scientific Research Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; US National Institutes of Health [AR056296, AI101935, CA163507]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI044828, R01AI047891, R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	EU Framework Program 7; European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research Flanders(FWO); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Veterinary Pathology Core lab at St. Jude for their work in processing of hematoxylin and eosin-stained and immunohistochemistry slides, members of the Cell and Tissue Imaging Core facility for their help in preparing and imaging transmission electron microscopy samples, and A. Coyle, E. Grant, J. Bertin (Millennium Pharmaceuticals), T. Mak (University of Toronto) and R. Flavell (Yale University) for providing mutant mice. M. L. is supported by grants from the EU Framework Program 7 (Marie-Curie grant 256432), European Research Council (grant 281600) and the Fund for Scientific Research Flanders (G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00). This work was supported by US National Institutes of Health grants (AR056296, AI101935 and CA163507) and the American Lebanese Syrian Associated Charities to T.-D.K.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dugan JW, 2009, MOL IMMUNOL, V47, P560, DOI 10.1016/j.molimm.2009.09.025; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ishikawa H, 2010, VIROLOGY, V407, P325, DOI 10.1016/j.virol.2010.08.030; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MORTIMORE GE, 1983, P NATL ACAD SCI-BIOL, V80, P2179, DOI 10.1073/pnas.80.8.2179; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002; Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	49	262	274	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					480	+		10.1038/ni.2563	http://dx.doi.org/10.1038/ni.2563			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23525089	Green Accepted, Green Submitted			2022-12-18	WOS:000317732100013
J	Nakano, H; Lin, KL; Yanagita, M; Charbonneau, C; Cook, DN; Kakiuchi, T; Gunn, MD				Nakano, Hideki; Lin, Kaifeng Lisa; Yanagita, Manabu; Charbonneau, Chantal; Cook, Donald N.; Kakiuchi, Terutaka; Gunn, Michael D.			Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses	NATURE IMMUNOLOGY			English	Article							MICE LACKING EXPRESSION; STEADY-STATE; IN-VIVO; MONOCYTE RECRUITMENT; AIRWAY INFLAMMATION; ADAPTIVE IMMUNITY; CHEMOKINES CCL19; ORGAN CHEMOKINE; KNOCKOUT MICE; ANTIGEN	T helper type 1 (T(H)1)- polarized immune responses, which confer protection against intracellular pathogens, are thought to be initiated by dendritic cells (DCs) that enter lymph nodes from peripheral tissues. Here we found after viral infection or immunization, inflammatory monocytes were recruited into lymph nodes directly from the blood to become CD11c(+) CD11b(hi)Gr-1(+) inflammatory DCs, which produced abundant interleukin 12p70 and potently stimulated T(H)1 responses. This monocyte extravasation required the chemokine receptor CCR2 but not the chemokine CCL2 or receptor CCR7. Thus, the accumulation of inflammatory DCs and T(H)1 responses were much lower in Ccr2(-/-) mice, were preserved in Ccl2(-/-) mice and were relatively higher in CCL19-CCL21-Ser-deficient plt mutant mice, in which all other lymph node DC types were fewer in number. We conclude that blood-derived inflammatory DCs are important in the development of T(H)1 immune responses.	[Nakano, Hideki; Yanagita, Manabu; Charbonneau, Chantal; Gunn, Michael D.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA; [Nakano, Hideki; Lin, Kaifeng Lisa; Gunn, Michael D.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Nakano, Hideki; Cook, Donald N.] Natl Inst Environm Hlth Sci, Lab Resp Biol, NIH, Res Triangle Pk, NC USA; [Kakiuchi, Terutaka] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Toho University	Gunn, MD (corresponding author), Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA.	michael.gunn@duke.edu	Cook, Donald/E-5079-2019	Cook, Donald/0000-0002-0052-3755; Gunn, Michael/0000-0003-4602-0667	National Institutes of Health [AI047262, HL085473]; Japanese Ministry of Science and Technology [1579054, 14021121]; Duke Human Vaccine Institute; Japan Health Sciences Foundation [KH51052]; Japan Society for the Promotion of Science [10670606, 12670621]; Japan Society for the Promotion of Science for Young Scientists; National Institute of Environmental Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Science and Technology; Duke Human Vaccine Institute; Japan Health Sciences Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank K. Nakano for technical assistance, and J. Whitesides, P. McDermott and L. Olive for cell sorting. Supported by the National Institutes of Health (AI047262 and HL085473 to M. D. G.), the Japanese Ministry of Science and Technology (1579054 to H. N., and 14021121 to T. K.), the Duke Human Vaccine Institute (H. N.), the Japan Health Sciences Foundation (KH51052 to T. K.), the Japan Society for the Promotion of Science (10670606, 12670621 to T. K.), the Japan Society for the Promotion of Science for Young Scientists (M. Y.) and the intramural branch of the National Institute of Environmental Health Sciences of the National Institutes of Health.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; DePaolo RW, 2003, J IMMUNOL, V171, P3560, DOI 10.4049/jimmunol.171.7.3560; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Grinnan D, 2006, J ALLERGY CLIN IMMUN, V118, P1234, DOI 10.1016/j.jaci.2006.07.036; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Heer AK, 2008, J IMMUNOL, V181, P6984, DOI 10.4049/jimmunol.181.10.6984; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Xu B, 2007, INT IMMUNOL, V19, P775, DOI 10.1093/intimm/dxm046; Yasuda T, 2007, BLOOD, V109, P449, DOI 10.1182/blood-2006-04-018101	44	262	271	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					394	402		10.1038/ni.1707	http://dx.doi.org/10.1038/ni.1707			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19252492	Green Accepted			2022-12-18	WOS:000264425800013
J	Hur, EM; Youssef, S; Haws, ME; Zhang, SY; Sobel, RA; Steinman, L				Hur, Eun Mi; Youssef, Sawsan; Haws, M. Edward; Zhang, Susan Y.; Sobel, Raymond A.; Steinman, Lawrence			Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MEDIATED-IMMUNITY; APOPTOSIS; ENCEPHALOMYELITIS; MICE; DEATH; EXPRESSION; PROMOTES; ETA-1	Relapses and disease exacerbations are vexing features of multiple sclerosis. Osteopontin ( Opn), which is expressed in multiple sclerosis lesions, is increased in patients' plasma during relapses. Here, in models of multiple sclerosis including relapsing, progressive and multifocal experimental autoimmune encephalomyelitis ( EAE), Opn triggered recurrent relapses, promoted worsening paralysis and induced neurological deficits, including optic neuritis. Increased inflammation followed Opn administration, whereas its absence resulted in more cell death of brain-infiltrating lymphocytes. Opn promoted the survival of activated T cells by inhibiting the transcription factor Foxo3a, by activating the transcription factor NF-kappa B through induction of phosphorylation of the kinase IKK beta and by altering expression of the proapoptotic proteins Bim, Bak and Bax. Those mechanisms collectively suppressed the death of myelin-reactive T cells, linking Opn to the relapses and insidious progression characterizing multiple sclerosis.	Stanford Univ, Med Ctr, Sch Med, Interdepartmental Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Sch Med, Dept Pathol Neuropathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Steinman, L (corresponding author), Stanford Univ, Med Ctr, Sch Med, Interdepartmental Program Immunol, Stanford, CA 94305 USA.	steinman@stanford.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Sobel, Raymond/0000-0002-0477-9002; Haws, Michael/0000-0002-5468-6218; Steinman, Lawrence/0000-0002-2437-2250				Adler B, 2001, CELL IMMUNOL, V210, P30, DOI 10.1006/cimm.2001.1800; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Gold R, 1997, TRENDS NEUROSCI, V20, P399, DOI 10.1016/S0166-2236(97)01079-5; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LAMPE MA, 1991, J IMMUNOL, V147, P2902; Letterio JJ, 2005, ONCOGENE, V24, P5701, DOI 10.1038/sj.onc.1208922; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; *NAT I HLTH, 2002, NAT I HLTH AUT DIS C; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; Palmer EM, 2001, J IMMUNOL, V167, P749, DOI 10.4049/jimmunol.167.2.749; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Skundric DS, 2003, J NEUROIMMUNOL, V136, P34, DOI 10.1016/S0165-5728(03)00005-5; Smith PA, 2005, J NEUROIMMUNOL, V164, P76, DOI 10.1016/j.jneuroim.2005.04.006; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TABI Z, 1994, EUR J IMMUNOL, V24, P2609, DOI 10.1002/eji.1830241107; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wittig BM, 2000, J EXP MED, V191, P2053, DOI 10.1084/jem.191.12.2053; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xu GW, 2005, J CLIN INVEST, V115, P1060; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8	50	262	277	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					74	83		10.1038/ni1415	http://dx.doi.org/10.1038/ni1415			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17143274				2022-12-18	WOS:000242934400016
J	Molon, B; Gri, G; Bettella, M; Gomez-Mouton, C; Lanzavecchia, A; Martinez-A, C; Manes, S; Viola, A				Molon, B; Gri, G; Bettella, M; Gomez-Mouton, C; Lanzavecchia, A; Martinez-A, C; Manes, S; Viola, A			T cell costimulation by chemokine receptors	NATURE IMMUNOLOGY			English	Article							HETEROTRIMERIC G-PROTEINS; IMMUNOLOGICAL SYNAPSE; LIPID RAFTS; DENDRITIC CELLS; LEADING-EDGE; MOVING CELLS; ACTIVATION; ACCUMULATION; SEGREGATION; INDUCTION	Signals mediated by chemokine receptors may compete with T cell receptor stop signals and determine the duration of T cell antigen-presenting cell interactions. Here we show that during T cell stimulation by antigen-presenting cells, T cell chemokine receptors coupled to G(q) and/or G(11) protein were recruited to the immunological synapse by a G(i)-independent mechanism. When chemokine receptors were sequestered at the immunological synapse, T cells became insensitive to chemotactic gradients, formed more stable conjugates and finally responded with enhanced proliferation and cytokine production. We suggest that chemokine receptor trapping at the immunological synapse enhances T cell activation by improving T cell-antigen-presenting cell attraction and impeding the 'distraction' of successfully engaged T cells by other chemokine sources.	Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid 28049, Spain; Univ Padua, Venetian Inst Mol Med, I-35100 Padua, Italy; Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Padua; Veneto Institute Molecular Medicine; University of Padua; Universita della Svizzera Italiana	Manes, S (corresponding author), Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid 28049, Spain.	smanes@cnb.uam.es; antonella.viola@unipd.it	Manes, Santos/E-4725-2011; Agatea, Lisa/L-8267-2016; Viola, Antonella/A-4321-2015	GRI, Giorgia/0000-0002-2826-0459; Manes, Santos/0000-0001-8023-957X; Viola, Antonella/0000-0002-0125-9271; GOMEZ-MOUTON, CONCEPCION/0000-0002-1595-6027				Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Carvalho-Pinto C, 2004, EUR J IMMUNOL, V34, P548, DOI 10.1002/eji.200324285; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Giarratana N, 2004, J IMMUNOL, V173, P2280, DOI 10.4049/jimmunol.173.4.2280; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Guan E, 2001, J BIOL CHEM, V276, P12404, DOI 10.1074/jbc.M006327200; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kveberg L, 2002, EUR J IMMUNOL, V32, P1856, DOI 10.1002/1521-4141(200207)32:7<1856::AID-IMMU1856>3.0.CO;2-B; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Manes S, 2004, TRENDS CELL BIOL, V14, P275, DOI 10.1016/j.tcb.2004.04.008; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mira E, 2001, EMBO REP, V2, P151, DOI 10.1093/embo-reports/kve027; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Pizzo P, 2004, MICROBES INFECT, V6, P686, DOI 10.1016/j.micinf.2004.02.017; Rimoldi V, 2003, ONCOGENE, V22, P6054, DOI 10.1038/sj.onc.1206612; Rodriguez-Frade JM, 2001, TRENDS IMMUNOL, V22, P612, DOI 10.1016/S1471-4906(01)02036-1; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tybulewicz VLJ, 2002, IMMUNOLOGY, V106, P287, DOI 10.1046/j.1365-2567.2002.01467.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	45	262	269	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					465	471		10.1038/ni1191	http://dx.doi.org/10.1038/ni1191			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15821738	Green Published			2022-12-18	WOS:000228634300018
J	Murre, C				Murre, C			Helix-loop-helix proteins and lymphocyte development	NATURE IMMUNOLOGY			English	Review							B-CELL FACTOR; T-LINEAGE SPECIFICATION; DNA-BINDING; TRANSCRIPTION FACTORS; MICE LACKING; E2A ACTIVITY; ACTIVATES TRANSCRIPTION; THYMOCYTE DEVELOPMENT; V(D)J RECOMBINATION; GENE-EXPRESSION	Helix-loop-helix (HLH) proteins are transcriptional regulators that control a wide variety of developmental pathways in both invertebrate and vertebrate organisms. Results obtained in the past decade have shown that HLH proteins also contribute to the development of lymphoid lineages. A subset of HLH proteins, the 'E proteins', seems to be particularly important for proper lymphoid development. Members of the E protein family include E12, E47, E2-2 and HEB. The E proteins contribute to B lineage- and T lineage-specific gene expression programs, regulate lymphocyte survival and cellular proliferation, activate the rearrangement of antigen receptor genes and control progression through critical developmental checkpoints. This review discusses HLH proteins in lymphocyte development and homeostasis.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92903 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92903 USA.	murre@biomail.ucsd.edu						Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; Asp J, 1998, FEBS LETT, V438, P85, DOI 10.1016/S0014-5793(98)01268-X; Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergman Y, 2004, NAT REV IMMUNOL, V4, P753, DOI 10.1038/nri1458; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Engel I, 1999, CURR OPIN GENET DEV, V9, P575, DOI 10.1016/S0959-437X(99)00008-8; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Goldfarb AN, 1996, MOL IMMUNOL, V33, P947, DOI 10.1016/S0161-5890(96)00047-8; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Greenbaum S, 2004, J BIOL CHEM, V279, P45028, DOI 10.1074/jbc.M400061200; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Jaleco AC, 1999, BLOOD, V94, P2637, DOI 10.1182/blood.V94.8.2637.420k22_2637_2646; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kee BL, 2002, EMBO J, V21, P103, DOI 10.1093/emboj/21.1.103; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Look AT, 1997, CURR TOP MICROBIOL, V220, P45; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Massari ME, 1996, MOL CELL BIOL, V16, P121; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Norton JD, 2000, J CELL SCI, V113, P3897; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Park ST, 1999, J EXP MED, V189, P501, DOI 10.1084/jem.189.3.501; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; Sun XH, 2004, ADV IMMUNOL, V84, P43, DOI 10.1016/S0065-2776(04)84002-1; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Van der Put E, 2004, J IMMUNOL, V173, P818, DOI 10.4049/jimmunol.173.2.818; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zhao F, 2001, MOL CELL BIOL, V21, P6346, DOI 10.1128/MCB.21.18.6346-6357.2001; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031	111	261	266	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1079	1086		10.1038/ni1260	http://dx.doi.org/10.1038/ni1260			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239924				2022-12-18	WOS:000232833300008
J	Hozumi, K; Negishi, N; Suzuki, D; Abe, N; Sotomaru, Y; Tamaoki, N; Mailhos, C; Ish-Horowicz, D; Habu, S; Owen, MJ				Hozumi, K; Negishi, N; Suzuki, D; Abe, N; Sotomaru, Y; Tamaoki, N; Mailhos, C; Ish-Horowicz, D; Habu, S; Owen, MJ			Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo	NATURE IMMUNOLOGY			English	Article							ALLELIC EXCLUSION; DELTA-HOMOLOG; NOTCH LIGAND; STEM-CELLS; C-KIT; GENE; EXPRESSION; RECEPTOR; REVEALS; LYMPHOPOIESIS	Notch receptors and their ligands contribute to many developmental systems, but it is not apparent how they function after birth, as their null mutants develop severe defects during embryogenesis. Here we used the Cre-loxP system to delete the Delta-like 1 gene (Dll1) after birth and demonstrated the complete disappearance of splenic marginal zone B cells in Dll1-null mice. In contrast, T cell development was unaffected. These results demonstrated that Dll1 was dispensable as a ligand for Notch1 at the branch point of T cell-B cell development but was essential for the generation of marginal zone B cells. Thus, Notch signaling is essential for lymphocyte development in vivo, but there is a redundancy of Notch-Notch ligand signaling that can drive T cell development within the thymus.	Tokai Univ, Sch Med, Dept Immunol, Kanagawa 2591193, Japan; Tokai Univ, Sch Med, Ctr Embryogenesis & Organogenesis, Kanagawa 2591193, Japan; Canc Res UK, Lymphocyte Mol Biol Lab, London WC2A 3PX, England; Cent Inst Expt Anim, Kanagawa 2160001, Japan; Canc Res UK, Dev Genet Lab, London WC2A 3PX, England; GlaxoSmithKline, Stevenage SG1 2NY, Herts, England	Tokai University; Tokai University; Cancer Research UK; Cancer Research UK; GlaxoSmithKline	Habu, S (corresponding author), Tokai Univ, Sch Med, Dept Immunol, Kanagawa 2591193, Japan.	sonoko@is.icc.u-tokai.ac.jp		Ish-Horowicz, David/0000-0001-5684-7129				Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hozumi K, 1996, INT IMMUNOL, V8, P1473, DOI 10.1093/intimm/8.10.1473; Hozumi K, 2003, J IMMUNOL, V170, P4973, DOI 10.4049/jimmunol.170.10.4973; HOZUMI K, 1994, EUR J IMMUNOL, V24, P1339, DOI 10.1002/eji.1830240615; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; KODAMA H, 1994, EXP HEMATOL, V22, P979; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roark JH, 1998, J IMMUNOL, V160, P3121; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Shutter JR, 2000, GENE DEV, V14, P1313; SIMPSON P, 1995, NATURE, V375, P736, DOI 10.1038/375736a0; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793	40	261	270	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					638	644		10.1038/ni1075	http://dx.doi.org/10.1038/ni1075			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15146182				2022-12-18	WOS:000221664000023
J	Matsuda, JL; Gapin, L; Sidobre, S; Kieper, WC; Tan, JYT; Ceredig, R; Surh, CD; Kronenberg, M				Matsuda, JL; Gapin, L; Sidobre, S; Kieper, WC; Tan, JYT; Ceredig, R; Surh, CD; Kronenberg, M			Homeostasis of V(alpha)14i NKT cells	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; NATURAL-KILLER; CUTTING EDGE; IN-VIVO; TRANSCRIPTION FACTOR; PROLIFERATION; MICE; CD4(+); NAIVE; IL-7	CD1d-reactive natural killer T (NKT) cells with an invariant V(alpha)14 rearrangement (V(alpha)14i) are a distinct subset of T lymphocytes that likely have important immune-regulatory functions. Little is known regarding the factors responsible for their peripheral survival. Using alpha-galactosylceramide-containing CD1d tetramers to detect V(alpha)14i NKT cells, we show here that the expansion of V(alpha)14i NKT cells in lymphopenic mice was not dependent on CD1d expression and was unaffected by the presence of host NKT cells. Additionally, we found that IL-15 was important in the expansion and/or survival of V(alpha)14i NKT cells, with IL-7 playing a lesser role. These results demonstrate that the homeostatic requirements for CD1d-restricted NKT cells, which are CD4(+) or CD4(-)CD8(-), resemble those of CD8(+) memory T cells. We propose that this expansion and/or survival in the periphery of V(alpha)14i NKT cells is affected by competition for IL-15, and that IL-15-requiring cells-such as NK cells and CD8(+) memory cells-may define the V(alpha)14i NKT cell niche.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; CEA Grenoble, INSERM, U548, F-38054 Grenoble, France	La Jolla Institute for Immunology; Scripps Research Institute; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org	Ceredig, Rhodri/A-7077-2010	Ceredig, Rhodri/0000-0002-4393-727X	NCI NIH HHS [CA52511] Funding Source: Medline; NIAID NIH HHS [AI45809, AI07244] Funding Source: Medline; PHS HHS [H07196] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045809] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Carnaud C, 1999, J IMMUNOL, V163, P4647; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Eberl G, 1999, J IMMUNOL, V162, P6410; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Husson H, 2000, CELL IMMUNOL, V203, P134, DOI 10.1006/cimm.2000.1688; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kojo S, 2001, ARTHRITIS RHEUM-US, V44, P1127, DOI 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Ma A, 2000, J EXP MED, V191, P753, DOI 10.1084/jem.191.5.753; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Ohteki T, 1997, J IMMUNOL, V159, P5931; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; TOUGH DF, 1995, STEM CELLS, V13, P242, DOI 10.1002/stem.5530130305; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; Vicari AP, 1996, INT IMMUNOL, V8, P1759, DOI 10.1093/intimm/8.11.1759; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Zeng D, 2000, J IMMUNOL, V164, P5000, DOI 10.4049/jimmunol.164.10.5000; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	51	261	264	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					966	974		10.1038/ni837	http://dx.doi.org/10.1038/ni837			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244311				2022-12-18	WOS:000178242100018
J	de Jong, YP; Abadia-Molina, AC; Satoskar, AR; Clarke, K; Rietdijk, ST; Faubion, WA; Mizoguchi, E; Metz, CN; Al Sahli, M; ten Hove, T; Keates, AC; Lubetsky, JB; Farrell, RJ; Michetti, P; van Deventer, SJ; Lolis, E; David, JR; Bhan, AK; Terhorst, C				de Jong, YP; Abadia-Molina, AC; Satoskar, AR; Clarke, K; Rietdijk, ST; Faubion, WA; Mizoguchi, E; Metz, CN; Al Sahli, M; ten Hove, T; Keates, AC; Lubetsky, JB; Farrell, RJ; Michetti, P; van Deventer, SJ; Lolis, E; David, JR; Bhan, AK; Terhorst, C			Development of chronic colitis is dependent on the cytokine MIF	NATURE IMMUNOLOGY			English	Article							MIGRATION-INHIBITORY FACTOR; INFLAMMATORY BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; CD4(+) T-CELLS; CROHNS-DISEASE; IN-VIVO; MACROPHAGE; MICE; CD45RB(HIGH); ACTIVATION	The cytokine macrophage-migration inhibitory factor (MIF) is secreted by a number of cell types upon induction by lipopolysaccharide (LPS). Because colitis is dependent on interplay between the mucosal immune system and intestinal bacteria, we investigated the role of MIF in experimental colitis. MIF-deficient mice failed to develop disease, but reconstitution of MIF-deficient mice with wild-type innate immune cells restored colitis. In addition, established colitis could be treated with anti-MIF immunoglobulins. Thus, murine colitis is dependent on continuous MIF production by the innate immune system. Because we found increased plasma MIF concentrations in patients with Crohn's disease, these data suggested that MIF is a new target for intervention in Crohn's disease.	Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Massachusetts Gen Hosp, Immunopathol Unit, Boston, MA 02114 USA; Picower Inst Med Res, Manhasset, NY 11030 USA; Univ Amsterdam, Acad Med Ctr, Expt Med Lab, NL-1105 AZ Amsterdam, Netherlands; Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Northwell Health; University of Amsterdam; Academic Medical Center Amsterdam; Yale University	Terhorst, C (corresponding author), Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA.		Abadia-Molina, Ana/H-7855-2015; Rietdijk, Svend/AAH-7519-2021	Lolis, Elias/0000-0002-7902-7868; Christine, Metz/0000-0002-1013-1691	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047677, R01DK052510, P30DK043351] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25532] Funding Source: Medline; NIDDK NIH HHS [DK43351, DK47677, DK52510] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Corazza N, 1999, J EXP MED, V190, P1479, DOI 10.1084/jem.190.10.1479; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Davidson NJ, 1998, J IMMUNOL, V161, P3143; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; Higgins LM, 1999, J IMMUNOL, V162, P486; Keates AC, 2000, GASTROENTEROLOGY, V119, P972, DOI 10.1053/gast.2000.18164; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Papamichos E, 2000, MECH COHES-FRICT MAT, V5, P1; Parronchi P, 1997, AM J PATHOL, V150, P823; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Simpson S J, 2000, Int Rev Immunol, V19, P1, DOI 10.3109/08830180009048387; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Veltkamp C, 2001, GASTROENTEROLOGY, V120, P900, DOI 10.1053/gast.2001.22547; Yoshida EM, 1999, CAN J GASTROENTEROL, V13, P65, DOI 10.1155/1999/506915	32	261	267	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1061	1066		10.1038/ni720	http://dx.doi.org/10.1038/ni720			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668338				2022-12-18	WOS:000172049800020
J	Lantz, O; Grandjean, I; Matzinger, P; Di Santo, JP				Lantz, O; Grandjean, I; Matzinger, P; Di Santo, JP			gamma chain required for naive CD4(+) T cell survival but not for antigen proliferation	NATURE IMMUNOLOGY			English	Article							CYTOKINE RECEPTORS; POSITIVE SELECTION; MICE DEFICIENT; IN-VIVO; MEMORY; BCL-2; DIFFERENTIATION; LYMPHOCYTES; VIRGIN; MODEL	Lymphoid homeostasis is required to ensure immune responsiveness and to prevent immunodeficiency, As such, the immune system must maintain distinct populations of naive T cells that are able to respond to new antigens as well as memory T cells specific to those antigens it has already encountered,Though both naive and memory T cells reside in and traffic through secondary lymphoid organs, there is growing evidence that the two populations may be regulated differently,We show here that naive T cell survival and memory T cell survival have different requirements for cytokines (including the interleukins IL-2, IL-4, IL-7, IL-9 and IL-15) that use the common cytokine receptor gamma chain (gamma(c)). Using monoclonal populations of antigen-specific CD4(+) T cells, we found that naive T cells cannot survive without gamma(c), whereas memory T cells show no such requirement. In contrast, neither naive nor gamma(c)-deficient memory T cells were impaired in their ability to proliferate and produce cytokines in response to in vivo antigenic stimulation,These data call into question the physiological role of gamma(c)-dependent cytokines as T cell growth factors and show that naive and memory CD4(+)T cell survival is maintained by distinct mechanisms.	Inst Pasteur, Unite Cytokines & Dev Lymphoide, Paris, France; NIAID, Ghost Lab, LCMI, NIH, Bethesda, MD 20892 USA; Univ Paris 11, Le Kremlin Bicetre, France; Hop Necker Enfants Malad, INSERM, U25, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Di Santo, JP (corresponding author), Inst Pasteur, Unite Cytokines & Dev Lymphoide, Paris, France.		Lantz, Olivier J/J-4960-2012; Di Santo, James P/M-4298-2014	Lantz, Olivier J/0000-0003-3161-7719; Di Santo, James P/0000-0002-7146-1862	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, Z01AI000581] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALARD P, 1993, BIOTECHNIQUES, V15, P730; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Colucci F, 1999, J IMMUNOL, V162, P2761; Di Rosa F, 1999, J IMMUNOL, V163, P1253; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563; DiSanto JP, 1996, J EXP MED, V183, P1111, DOI 10.1084/jem.183.3.1111; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LASSILA O, 1988, NATURE, V334, P235; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEONARD WJ, 1994, CURR OPIN IMMUNOL, V6, P631, DOI 10.1016/0952-7915(94)90152-X; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakajima H, 1999, J IMMUNOL, V162, P782; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; PATTEN PA, 1993, J IMMUNOL, V150, P2281; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Sharara LI, 1997, EUR J IMMUNOL, V27, P990, DOI 10.1002/eji.1830270428; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8	33	261	268	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					54	58		10.1038/76917	http://dx.doi.org/10.1038/76917			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881175				2022-12-18	WOS:000089814800014
J	Stittrich, AB; Haftmann, C; Sgouroudis, E; Kuhl, AA; Hegazy, AN; Panse, I; Riedel, R; Flossdorf, M; Dong, J; Fuhrmann, F; Heinz, GA; Fang, Z; Li, N; Bissels, U; Hatam, F; Jahn, A; Hammoud, B; Matz, M; Schulze, FM; Baumgrass, R; Bosio, A; Mollenkopf, HJ; Grun, J; Thiel, A; Chen, W; Hofer, T; Loddenkemper, C; Lohning, M; Chang, HD; Rajewsky, N; Radbruch, A; Mashreghi, MF				Stittrich, Anna-Barbara; Haftmann, Claudia; Sgouroudis, Evridiki; Kuehl, Anja Andrea; Hegazy, Ahmed Nabil; Panse, Isabel; Riedel, Rene; Flossdorf, Michael; Dong, Jun; Fuhrmann, Franziska; Heinz, Gitta Anne; Fang, Zhuo; Li, Na; Bissels, Ute; Hatam, Farahnaz; Jahn, Angelina; Hammoud, Ben; Matz, Mareen; Schulze, Felix-Michael; Baumgrass, Ria; Bosio, Andreas; Mollenkopf, Hans-Joachim; Gruen, Joachim; Thiel, Andreas; Chen, Wei; Hoefer, Thomas; Loddenkemper, Christoph; Loehning, Max; Chang, Hyun-Dong; Rajewsky, Nikolaus; Radbruch, Andreas; Mashreghi, Mir-Farzin			The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes	NATURE IMMUNOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; IN-VIVO; INTERLEUKIN-7 RECEPTOR; EFFECTOR FUNCTION; FACTOR FKHR-L1; CELLS; EXPRESSION; FOXO1; DIFFERENTIATION; PROLIFERATION	After being activated by antigen, helper T lymphocytes switch from a resting state to clonal expansion. This switch requires inactivation of the transcription factor Foxo1, a suppressor of proliferation expressed in resting helper T lymphocytes. In the early antigen-dependent phase of expansion, Foxo1 is inactivated by antigen receptor-mediated post-translational modifications. Here we show that in the late phase of expansion, Foxo1 was no longer post-translationally regulated but was inhibited post-transcriptionally by the interleukin 2 (IL-2)-induced microRNA miR-182. Specific inhibition of miR-182 in helper T lymphocytes limited their population expansion in vitro and in vivo. Our results demonstrate a central role for miR-182 in the physiological regulation of IL-2-driven helper T cell-mediated immune responses and open new therapeutic possibilities.	[Stittrich, Anna-Barbara; Haftmann, Claudia; Sgouroudis, Evridiki; Hegazy, Ahmed Nabil; Panse, Isabel; Riedel, Rene; Dong, Jun; Fuhrmann, Franziska; Heinz, Gitta Anne; Hatam, Farahnaz; Jahn, Angelina; Hammoud, Ben; Baumgrass, Ria; Gruen, Joachim; Loehning, Max; Chang, Hyun-Dong; Radbruch, Andreas; Mashreghi, Mir-Farzin] Deutsch Rheuma Forschungszentrum Berlin, Berlin, Germany; [Kuehl, Anja Andrea; Loddenkemper, Christoph] Charite, Inst Pathol, Charite Res Ctr ImmunoSci, D-13353 Berlin, Germany; [Hegazy, Ahmed Nabil; Panse, Isabel; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, Campus Charite Mitte, D-13353 Berlin, Germany; [Flossdorf, Michael; Hoefer, Thomas] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Dong, Jun; Thiel, Andreas] Charite, Campus Virchow Klinikum, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Fuhrmann, Franziska] Robert Koch Inst, D-1000 Berlin, Germany; [Fang, Zhuo; Li, Na; Chen, Wei; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bissels, Ute; Bosio, Andreas] Miltenyi Biotec, Bergisch Gladbach, Germany; [Matz, Mareen] Charite, Campus Charite Mitte, Dept Nephrol, D-13353 Berlin, Germany; [Schulze, Felix-Michael] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Miltenyi Biotec; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald; Max Planck Society	Mashreghi, MF (corresponding author), Deutsch Rheuma Forschungszentrum Berlin, Berlin, Germany.	mashreghi@drfz.de	Höfer, Thomas/G-5665-2013; Mollenkopf, Hans-Joachim/AAH-2500-2019; Chen, Wei/C-1273-2011; Löhning, Max/AAL-2967-2021; Chang, Hyun-Dong/T-3697-2017; Thiel, Andreas/F-1539-2013; Mashreghi, Mir-Farzin/S-2911-2019	Höfer, Thomas/0000-0003-3560-8780; Löhning, Max/0000-0001-6382-7281; Chang, Hyun-Dong/0000-0002-7341-4533; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Bosio, Andreas/0000-0001-9776-2535; Grun, Joachim R./0000-0002-2875-3691; Matz, Mareen/0000-0003-1874-6284; Chen, Wei/0000-0003-3263-1627; Key, Felix M/0000-0003-2812-6636; Baumgrass, Ria/0000-0002-3289-1608; Thiel, Andreas/0000-0002-5515-4002; Rajewsky, Nikolaus/0000-0002-4785-4332; Riedel, Rene/0000-0003-4752-0196; Li, Na/0000-0001-6163-1648; Heinz, Gitta Anne/0000-0002-9330-3689; Hegazy, Ahmed N./0000-0002-2946-8251; Radbruch, Andreas/0000-0001-5753-0000; Kuhl, Anja/0000-0003-2293-5387; Mollenkopf, Hans-Joachim/0000-0003-1167-4783	Deutsche Forschungsgemeinschaft [GRK1121, SFB 618, SFB 650, SFB 633, SFB TR52]; International Max Planck Research School for Infectious Diseases and Immunology; Volkswagen Foundation; Federal Ministry of Education and Research; European Union MUGEN (Integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease) Network of Excellence	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School for Infectious Diseases and Immunology; Volkswagen Foundation(Volkswagen); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union MUGEN (Integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease) Network of Excellence(European Commission)	We thank T. Berg (Max Planck Institute for Biochemistry) for the STAT5 inhibitor; D. Trono (Ecole Polytechnique Federale de Lausanne) for the plasmid pLVTHM; H. Schliemann, T. Geske, H. Hecker-Kia, A. Peddinghaus, T. Kaiser and J. Kirsch for technical assistance; and Miltenyi Biotec for the miRXplore microarray experiments. Supported by Deutsche Forschungsgemeinschaft (GRK1121 for A.-B.S. and A.N.H.; and SFB 618, SFB 650, SFB 633 and SFB TR52), the International Max Planck Research School for Infectious Diseases and Immunology (C.H.), the Volkswagen Foundation (M.L.), the FORSYS (Forschungseinheiten zur Systembiologie) program of the Federal Ministry of Education and Research and the European Union MUGEN (Integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease) Network of Excellence.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan SE, 2003, CLIN INFECT DIS, V37, P807, DOI 10.1086/377605; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Mashreghi MF, 2008, J IMMUNOL, V180, P7919, DOI 10.4049/jimmunol.180.12.7919; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Oxenius A, 1997, J IMMUNOL, V158, P5717; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Salio M, 1997, EUR J IMMUNOL, V27, P1769, DOI 10.1002/eji.1830270726; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wells AD, 2000, J IMMUNOL, V165, P2432, DOI 10.4049/jimmunol.165.5.2432; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	41	260	279	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1057	U111		10.1038/ni.1945	http://dx.doi.org/10.1038/ni.1945			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20935646	Green Submitted			2022-12-18	WOS:000283127800016
J	Stadinski, BD; Delong, T; Reisdorph, N; Reisdorph, R; Powell, RL; Armstrong, M; Piganelli, JD; Barbour, G; Bradley, B; Crawford, F; Marrack, P; Mahata, SK; Kappler, JW; Haskins, K				Stadinski, Brian D.; Delong, Thomas; Reisdorph, Nichole; Reisdorph, Richard; Powell, Roger L.; Armstrong, Michael; Piganelli, Jon D.; Barbour, Gene; Bradley, Brenda; Crawford, Frances; Marrack, Philippa; Mahata, Sushil K.; Kappler, John W.; Haskins, Kathryn			Chromogranin A is an autoantigen in type 1 diabetes	NATURE IMMUNOLOGY			English	Article							T-CELL-CLONES; PEPTIDE-FLANKING RESIDUES; CLASS-II MOLECULE; NOD MICE; GASTROENTEROPANCREATIC SYSTEM; CELIAC-DISEASE; MHC; RECEPTOR; ANTIGEN; WE-14	Autoreactive CD4(+) T cells are involved in the pathogenesis of many autoimmune diseases, but the antigens that stimulate their responses have been difficult to identify and in most cases are not well defined. In the nonobese diabetic (NOD) mouse model of type 1 diabetes, we have identified the peptide WE14 from chromogranin A (ChgA) as the antigen for highly diabetogenic CD4(+) T cell clones. Peptide truncation and extension analysis shows that WE14 bound to the NOD mouse major histocompatibility complex class II molecule I-A(g7) in an atypical manner, occupying only the carboxy-terminal half of the I-A(g7) peptide-binding groove. This finding extends the list of T cell antigens in type 1 diabetes and supports the idea that autoreactive T cells respond to unusually presented self peptides.	[Stadinski, Brian D.; Delong, Thomas; Reisdorph, Nichole; Reisdorph, Richard; Powell, Roger L.; Armstrong, Michael; Piganelli, Jon D.; Barbour, Gene; Bradley, Brenda; Crawford, Frances; Marrack, Philippa; Kappler, John W.; Haskins, Kathryn] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Stadinski, Brian D.; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO USA; [Reisdorph, Richard] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Denver, CO 80202 USA; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Mahata, Sushil K.] VA San Diego Healthcare Syst, San Diego, CA USA; [Kappler, John W.] Univ Colorado, Program Biomol Struct, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Denver; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Colorado System; University of Colorado Denver	Haskins, K (corresponding author), Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA.	katie.haskins@ucdenver.edu	Mahata, Sushil/AAF-8781-2021; Reisdorph, Nichole/AAX-8774-2020; Marrack, Philippa/AHE-6316-2022	Reisdorph, Nichole/0000-0002-0425-8012; Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [RO1 DK50561, T32 AI007405, P30 DK057516, 5 U19-AI050864, RO1 AI17134, RO1 AI18785]; National Center for Research Resources [S10RR023703]; Juvenile Diabetes Research Foundation [1-2008-132]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, T32AI007405, R01AI017134, R01AI018785, U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516, R01DK050561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Pratt for technical assistance. Supported by the National Institutes of Health (RO1 DK50561 to K.H.; T32 AI007405 to T.D.; BioResources Core of DERC P30 DK057516 to K.H.; 5 U19-AI050864 to B.D.S. and J.W.K.; and RO1 AI17134 and RO1 AI18785 to B.D.S., P.M. and J.W.K.), the National Center for Research Resources (S10RR023703 to N.R.) and the Juvenile Diabetes Research Foundation (1-2008-132 to K.H. and N.R.).	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; Bergman B, 2000, J AUTOIMMUN, V14, P343, DOI 10.1006/jaut.2000.0377; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CURRY WJ, 1992, FEBS LETT, V301, P319, DOI 10.1016/0014-5793(92)80266-J; Curry WJ, 2002, ANN NY ACAD SCI, V971, P311, DOI 10.1111/j.1749-6632.2002.tb04485.x; Curry WJ, 1997, ADV EXP MED BIOL, V426, P139; Curry WJ, 2000, ADV EXP MED BIOL, V482, P205; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gleeson CM, 1996, J ENDOCRINOL, V151, P409, DOI 10.1677/joe.0.1510409; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hovhannisyan Z, 2008, NATURE, V456, P534, DOI 10.1038/nature07524; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Pauza ME, 2004, DIABETES, V53, P978, DOI 10.2337/diabetes.53.4.978; Portela-Gomes GM, 2008, REGUL PEPTIDES, V151, P19, DOI 10.1016/j.regpep.2008.07.005; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; WALKER E, 1982, J IMMUNOL, V128, P2164; WHITE J, 1989, J IMMUNOL, V143, P1822; Yoshida K, 2002, INT IMMUNOL, V14, P1439, DOI 10.1093/intimm/dxf106	44	260	271	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					225	U5		10.1038/ni.1844	http://dx.doi.org/10.1038/ni.1844			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20139986	Green Accepted			2022-12-18	WOS:000274605800010
J	Deddouche, S; Matt, N; Budd, A; Mueller, S; Kemp, C; Galiana-Arnoux, D; Dostert, C; Antoniewski, C; Hoffmann, JA; Imler, JL				Deddouche, Safia; Matt, Nicolas; Budd, Aidan; Mueller, Stefanie; Kemp, Cordula; Galiana-Arnoux, Delphine; Dostert, Catherine; Antoniewski, Christophe; Hoffmann, Jules A.; Imler, Jean-Luc			The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in drosophila	NATURE IMMUNOLOGY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DISTINCT ROLES; PROTEIN; RNAI; SINGLE; VIRUS; IMMUNITY; DOMAIN; GENE; SUPPRESSION	Drosophila, like other invertebrates and plants, relies mainly on RNA interference for its defense against viruses. In flies, viral infection also triggers the expression of many genes. One of the genes induced, Vago, encodes a 18-kilodalton cysteine-rich polypeptide. Here we provide genetic evidence that the Vago gene product controlled viral load in the fat body after infection with drosophila C virus. Induction of Vago was dependent on the helicase Dicer-2. Dicer-2 belongs to the same DExD/H-box helicase family as do the RIG-I-like receptors, which sense viral infection and mediate interferon induction in mammals. We propose that this family represents an evolutionary conserved set of sensors that detect viral nucleic acids and direct antiviral responses.	[Deddouche, Safia; Matt, Nicolas; Mueller, Stefanie; Kemp, Cordula; Galiana-Arnoux, Delphine; Dostert, Catherine; Hoffmann, Jules A.; Imler, Jean-Luc] Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9022, F-67084 Strasbourg, France; [Antoniewski, Christophe] Inst Pasteur, URA2578, CNRS, Dept Dev Biol, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Imler, JL (corresponding author), Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9022, F-67084 Strasbourg, France.	jl.imler@ibmc.u-strasbg.fr	Becker, Stefanie/AEM-2050-2022; Dostert, Catherine/AAJ-5473-2020; Budd, Aidan/F-8550-2013; Antoniewski, Christophe/G-4519-2011; Imler, Jean-Luc/GXH-4323-2022	Budd, Aidan/0000-0003-0196-9051; Antoniewski, Christophe/0000-0001-7709-2116; MATT, Nicolas/0000-0003-0323-1851	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Louis Pasteur University; Alsace Region; US National Institutes of Health [PO1 AI070167]; Agence Nationale de Recherche Microbiologie-Maladie Emergentes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Louis Pasteur University; Alsace Region(Region Grand-Est); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche Microbiologie-Maladie Emergentes(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Santiago and S. Ozkan for technical expertise; R. Carthew (Northwestern University), J.-M. Reichhart (Unite Propre de Recherche 9022 Centre National de la Recherche Scientifique) and M. Siomi (University of Tokushima) for fly stocks; A. Schneeman (The Scripps Research Institute) for FHV and anti-FHV; D. Ferrandon for critical reading of the manuscript and comments; and E. Levashina for discussions. Confocal microscopy was done at the Strasbourg Esplanade Cellular Imaging Facility (funded by the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Louis Pasteur University and Alsace Region). Supported by the US National Institutes of Health (PO1 AI070167), Agence Nationale de Recherche Microbiologie-Maladie Emergentes and Centre National de la Recherche Scientifique.	Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; BRAND AH, 1993, DEVELOPMENT, V118, P401; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kleinjung J, 2004, NUCLEIC ACIDS RES, V32, P2464, DOI 10.1093/nar/gkh566; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Krishna NK, 2003, VIROLOGY, V305, P10, DOI 10.1006/viro.2002.1740; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Smit AB, 2004, FASEB J, V18, P845, DOI 10.1096/fj.03-0590fje; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	44	260	264	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1425	1432		10.1038/ni.1664	http://dx.doi.org/10.1038/ni.1664			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18953338				2022-12-18	WOS:000260888700018
J	Goodarzi, K; Goodarzi, M; Tager, AM; Luster, AD; von Andrian, UH				Goodarzi, K; Goodarzi, M; Tager, AM; Luster, AD; von Andrian, UH			Leukotriene B-4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues	NATURE IMMUNOLOGY			English	Article							IN-VIVO; MURINE MODEL; L-SELECTIN; MEMORY; RECEPTOR; ADHESION; MICE; INFLAMMATION; NAIVE; DIFFERENTIATION	Leukotriene B-4 (LTB4) is a potent chemoattractant for myeloid leukocytes, which express BLT1, the high-affinity receptor for LTB4. We report here that BLT1 is induced substantially in CD8(+) effector T cells and at lower amounts in CD8(+) central memory T cells. LTB4 elicited BLT1-dependent chemotaxis in effector cells, but not in naive or central memory cells. Intravital microscopy showed that BLT1 signaling induced rapid integrin-mediated arrest of rolling effector and central memory cells in postcapillary venules. In competitive homing experiments, wild-type effector cells were three times more efficient at migrating to the inflamed peritoneal cavity than were BLT-deficient effector cells. These results identify LTB4-BLT1 as a potent nonchemokine pathway for cytotoxic effector cell traffic.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	Luster, Andrew/ABE-6504-2020; von Andrian, Ulrich H/A-5775-2008	Luster, Andrew/0000-0001-9679-7912; 	NHLBI NIH HHS [HL54936, HL56949, HL48675, HL04087] Funding Source: Medline; NIAID NIH HHS [AI46999, AI050892] Funding Source: Medline; NIDDK NIH HHS [DK5005] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050892, R01AI046999] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gladue RP, 1996, J EXP MED, V183, P1893, DOI 10.1084/jem.183.4.1893; GOETZL EJ, 1988, ANN NY ACAD SCI, V524, P345; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Nohgawa M, 1997, J LEUKOCYTE BIOL, V62, P203, DOI 10.1002/jlb.62.2.203; PAYAN DG, 1984, P NATL ACAD SCI-BIOL, V81, P3501, DOI 10.1073/pnas.81.11.3501; ROSENGREN S, 1991, J APPL PHYSIOL, V71, P1322, DOI 10.1152/jappl.1991.71.4.1322; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serhan CN, 2000, J EXP MED, V192, pF5, DOI 10.1084/jem.192.3.F5; Showell HJ, 1996, BRIT J PHARMACOL, V117, P1127, DOI 10.1111/j.1476-5381.1996.tb16706.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168	42	260	274	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					965	973		10.1038/ni972	http://dx.doi.org/10.1038/ni972			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12949533				2022-12-18	WOS:000185590100012
J	Liu, ZH; Lee, J; Krummey, S; Lu, W; Cai, HB; Lenardo, MJ				Liu, Zhihua; Lee, Jinwoo; Krummey, Scott; Lu, Wei; Cai, Huaibin; Lenardo, Michael J.			The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease	NATURE IMMUNOLOGY			English	Article							PARKINSONS-DISEASE; ULCERATIVE-COLITIS; SUSCEPTIBILITY LOCI; DENDRITIC CELLS; ALPHA-SYNUCLEIN; CROHNS-DISEASE; ACTIVATION; CYCLOSPORINE; MUTATIONS; GENE	Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.	[Liu, Zhihua; Lee, Jinwoo; Krummey, Scott; Lu, Wei; Lenardo, Michael J.] NIAID, Immunol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Cai, Huaibin] NIA, Unit Transgenesis, Neurogenet Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Lee, Jinwoo/AAA-9510-2020; Cai, Huaibin/H-3359-2013	Lee, Jinwoo/0000-0003-2991-4183; Cai, Huaibin/0000-0002-8596-6108	US National Institutes of Health, National Institute of Allergy and Infectious Diseases; National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566, ZIAAI000769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000944] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Cookson (National Institute on Aging) for plasmid pCMV-2XMyc-LRRK2 expressing Myc-tagged wild-type or kinase-dead LRRK2; N. Bidere (Institut National de la Sante et de la Recherche Medicale) for luciferase constructs of NFAT and NF-kappa B and a renilla luciferase construct; N. Bidere, R. Germain, C. Kanellopoulou, B. Lo, A. Snow, J. Qin and H. Su for suggestions and comments; and colleagues at the Harvard Drosophila Screening Center for sharing screen results via the World Wide Web. Supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Institute on Aging.	ABARRATEGUI JA, 2009, AUTOPHAGY, V5, P1208; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Aliprantis AO, 2010, ADV EXP MED BIOL, V658, P69, DOI 10.1007/978-1-4419-1050-9_8; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Ghia JE, 2008, AM J PHYSIOL-GASTR L, V294, pG770, DOI 10.1152/ajpgi.00453.2007; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; HASKALOVAHOGENO.H, 2005, ANN NY ACAD SCI, V1051, P787; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; MAXWELL JR, 2009, CURR PROTOC PHARM, V5, P1; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou Loukia, 2010, Commun Integr Biol, V3, P396, DOI 10.4161/cib.3.5.12286; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Satoh Y, 2009, AM J PHYSIOL-GASTR L, V297, pG514, DOI 10.1152/ajpgi.90608.2008; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shih TC, 2008, WORLD J GASTROENTERO, V14, P1759, DOI 10.3748/wjg.14.1759; Soriano-izquierdo A, 2004, INFLAMM BOWEL DIS, V10, P789, DOI 10.1097/00054725-200411000-00014; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; UMENO J, 2011, INFLAMM BOWEL D 0223, DOI DOI 10.1002/IBD.21651; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	48	259	274	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1063	U65		10.1038/ni.2113	http://dx.doi.org/10.1038/ni.2113			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21983832	Green Accepted			2022-12-18	WOS:000296500100011
J	Liu, GW; Burns, S; Huang, GH; Boyd, K; Proia, RL; Flavell, RA; Chi, HB				Liu, Guangwei; Burns, Samir; Huang, Gonghua; Boyd, Kelli; Proia, Richard L.; Flavell, Richard A.; Chi, Hongbo			The receptor S1P(1) overrides regulatory T cell-mediated immune suppression through Akt-mTOR	NATURE IMMUNOLOGY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; TOLL-LIKE; LYMPHOCYTE EGRESS; FOXP3 EXPRESSION; SPHINGOSINE-1-PHOSPHATE; FTY720; TRAFFICKING; REVERSAL; SURVIVAL; ANTIGEN	Regulatory T cells (T-reg cells) are critically involved in maintaining immunological tolerance, but this potent suppression must be 'quenched' to allow the generation of adaptive immune responses. Here we report that sphingosine 1-phosphate (S1P) receptor type 1 (S1P(1)) delivers an intrinsic negative signal to restrain the thymic generation, peripheral maintenance and suppressive activity of T-reg cells. Combining loss-and gain-of-function genetic approaches, we found that S1P1 blocked the differentiation of thymic T-reg precursors and function of mature T-reg cells and affected T-reg cell-mediated immune tolerance. S1P1 induced selective activation of the Akt-mTOR kinase pathway to impede the development and function of T-reg cells. Dynamic regulation of S1P1 contributed to lymphocyte priming and immune homeostasis. Thus, by antagonizing T-reg cell-mediated immune suppression, the lipid-activated S1P(1)-Akt-mTOR pathway orchestrates adaptive immune responses.	[Liu, Guangwei; Burns, Samir; Huang, Gonghua; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Proia, Richard L.] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Flavell, Richard A.; Chi, Hongbo] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Yale University; Yale University	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Proia, Richard L/A-7908-2012; Chi, Hongbo/M-9397-2018	Chi, Hongbo/0000-0002-9997-2496; Proia, Richard/0000-0003-0456-1270; Liu, Guangwei/0000-0002-6008-2891	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAMS NIH HHS [K01 AR053573-03, K01 AR053573-02, K01 AR053573-01A1, K01 AR053573] Funding Source: Medline; NINDS NIH HHS [R01 NS064599] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grahler MH, 2005, J IMMUNOL, V174, P1997; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sawicka E, 2005, J IMMUNOL, V175, P7973, DOI 10.4049/jimmunol.175.12.7973; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	49	259	271	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					769	U132		10.1038/ni.1743	http://dx.doi.org/10.1038/ni.1743			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19483717	Green Accepted			2022-12-18	WOS:000267142600017
J	Depoil, D; Fleire, S; Treanor, BL; Weber, M; Harwood, NE; Marchbank, KL; Tybulewicz, VLJ; Batista, FD				Depoil, David; Fleire, Sebastian; Treanor, Bebhinn L.; Weber, Michele; Harwood, Naomi E.; Marchbank, Kevin L.; Tybulewicz, Victor L. J.; Batista, Facundo D.			CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand	NATURE IMMUNOLOGY			English	Article							LYMPH-NODE; T-CELLS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; SYNAPSE FORMATION; IMMUNE-RESPONSE; DENDRITIC CELLS; LYMPHOCYTES-B; MICE; COMPLEX	Here we describe the spatiotemporal architecture, at high molecular resolution, of receptors and signaling molecules during the early events of mouse B cell activation. In response to membrane-bound ligand stimulation, antigen aggregation occurs in B cell antigen receptor (BCR) microclusters containing immunoglobulin (Ig) M and IgD that recruit the kinase Syk and transiently associate with the coreceptor CD19. Unexpectedly, CD19-deficient B cells were significantly defective in initiation of BCR-dependent signaling, accumulation of downstream effectors and cell spreading, defects that culminated in reduced microcluster formation. Hence, we have defined the dynamics of assembly of the main constituents of the BCR 'signalosome' and revealed an essential role for CD19, independent of the costimulatory molecule CD21, in amplifying early B cell activation events in response to membrane-bound ligand stimulation.	[Depoil, David; Fleire, Sebastian; Treanor, Bebhinn L.; Weber, Michele; Harwood, Naomi E.; Batista, Facundo D.] Canc Res, London Res Inst, Lymphocyte Interact Lab, London WC2A 3PX, England; [Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Batista, FD (corresponding author), Canc Res, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk		marchbank, kevin james/0000-0003-1312-5411; Tybulewicz, Victor/0000-0003-2439-0798; Weber, Michele/0000-0003-2056-3751	Medical Research Council [MC_U117527252] Funding Source: Medline; MRC [MC_U117527252] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Carter RH, 1997, J IMMUNOL, V158, P3062; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fujimoto M, 1999, IMMUNITY, V11, P191, DOI 10.1016/S1074-7613(00)80094-1; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; KIM KM, 1995, J EXP MED, V181, P1005, DOI 10.1084/jem.181.3.1005; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEE GM, 1993, J CELL BIOL, V120, P25, DOI 10.1083/jcb.120.1.25; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PESANDO JM, 1989, J EXP MED, V170, P2159, DOI 10.1084/jem.170.6.2159; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sato S, 1997, J IMMUNOL, V159, P3278; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Wu JH, 1996, J IMMUNOL, V157, P3404; Wykes M, 1998, J IMMUNOL, V161, P1313; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	50	259	262	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					63	72		10.1038/ni1547	http://dx.doi.org/10.1038/ni1547			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18059271				2022-12-18	WOS:000251820800012
J	Ta, VT; Nagaoka, H; Catalan, N; Durandy, A; Fischer, A; Imai, K; Nonoyama, S; Tashiro, J; Ikegawa, M; Ito, S; Kinoshita, K; Muramatsu, M; Honjo, T				Ta, VT; Nagaoka, H; Catalan, N; Durandy, A; Fischer, A; Imai, K; Nonoyama, S; Tashiro, J; Ikegawa, M; Ito, S; Kinoshita, K; Muramatsu, M; Honjo, T			AID mutant analyses indicate requirement for class-switch-specific cofactors	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; APOBEC-1 COMPLEMENTATION FACTOR; RNA EDITING ENZYME; HYPER-IGM SYNDROME; SOMATIC HYPERMUTATION; ANTIBODY DIVERSIFICATION; GENE CONVERSION; MESSENGER-RNA; CELL-LINE	Activation-induced cytidine deaminase (AID) is the essential and sole B cell-specific factor required for class-switch recombination (CSR) and somatic hypermutation (SHM). However, it is not known how AID differentially regulates these two independent events. Involvement of several cofactors interacting with AID has been indicated by scattered distribution of loss-of-function point mutations and evolutionary conservation of the entire 198-amino-acid protein. Here, we report that human AID mutant proteins with insertions, replacements or truncations in the C-terminal region retained strong SHM activity but almost completely lost CSR activity. These results indicate that AID requires interaction with a cofactor(s) specific to CSR.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Hop Necker Enfants Malad, INSERM, U429, Paris, France; Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598513, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan	Kyoto University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Defense Medical College - Japan; Tokyo Medical & Dental University (TMDU)	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.		Imai, Kohsuke/Q-2602-2015; Honjo, Tasuku/N-4470-2016; Ikegawa, Masaya/AAG-5327-2020; Durandy, Anne/H-7475-2017; Muramatsu, Masamichi/C-4339-2015	Imai, Kohsuke/0000-0003-2132-8403; Durandy, Anne/0000-0001-7706-8466; Muramatsu, Masamichi/0000-0002-0153-3533				Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MUSSMANN R, 1997, EUR J IMMUNOL, V27, P1610; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; REABAN ME, 1994, J BIOL CHEM, V269, P21850; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sowden MP, 2002, J CELL SCI, V115, P1027; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	47	259	266	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					843	848		10.1038/ni964	http://dx.doi.org/10.1038/ni964			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12910268				2022-12-18	WOS:000185002200010
J	Kane, LP; Andres, PG; Howland, KC; Abbas, AK; Weiss, A				Kane, LP; Andres, PG; Howland, KC; Abbas, AK; Weiss, A			Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not T(H)2 cytokines	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; NF-KAPPA-B; ACCESSORY MOLECULE CD28; PROTEIN-KINASE-B; INTERLEUKIN-2 GENE-EXPRESSION; ANTIGEN RECEPTOR COMPLEX; PHOSPHOINOSITIDE 3-KINASE; RESPONSE ELEMENT; C-REL; PHOSPHATIDYLINOSITOL 3-KINASE	A region of the interleukin-2 (IL-2) promoter known as the RE/AP element is activated in concert by signals that originate from the T cell antigen receptor and the CD28 coreceptor. We show here that the serine-threonine kinase Akt can provide a costimulatory signal for RE/AP activation that is indistinguishable from the signal provided by CD28. This includes the ability of Akt, like antibodies to CD28, to synergize with protein kinase C theta (PKC-theta) in the induction of RE/AP. Retrovirus-mediated expression of activated Akt in primary T cells from CD28-deficient mice is capable of selectively restoring production of IL-2 and interferon gamma, but not IL-4 or IL-5. Our results provide evidence that CD28 costimulation of different cytokines is mediated by discrete signaling pathways, one of which includes Akt.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.			Kane, Lawrence/0000-0001-5198-516X	NIAID NIH HHS [AI35297, AI25022] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025022, R37AI025022, P01AI035297] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ballester A, 1997, J IMMUNOL, V159, P1613; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; CERDAN C, 1992, J IMMUNOL, V149, P2255; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CIVIL A, 1992, EUR J IMMUNOL, V22, P3041, DOI 10.1002/eji.1830221142; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; Curtiss VE, 1996, MOL CELL BIOL, V16, P3567; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; Eder AM, 1998, J BIOL CHEM, V273, P28025, DOI 10.1074/jbc.273.43.28025; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Hehner SP, 2000, MOL CELL BIOL, V20, P2556, DOI 10.1128/MCB.20.7.2556-2568.2000; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Hutchcroft JE, 1996, J IMMUNOL, V156, P4071; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Khattri R, 1999, J IMMUNOL, V162, P5784; King CL, 1996, EUR J IMMUNOL, V26, P2448, DOI 10.1002/eji.1830261027; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kubo M, 1999, J IMMUNOL, V163, P2432; LAI JH, 1994, J BIOL CHEM, V269, P30077; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Li-Weber M, 1998, J BIOL CHEM, V273, P32460, DOI 10.1074/jbc.273.49.32460; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Maggirwar SB, 1997, MOL CELL BIOL, V17, P2605, DOI 10.1128/MCB.17.5.2605; MANGER B, 1987, J IMMUNOL, V139, P2755; McGuire KL, 1997, J IMMUNOL, V159, P1319; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Noel PJ, 1996, ADV EXP MED BIOL, V406, P209; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Reif K, 1997, CURR BIOL, V7, P285, DOI 10.1016/S0960-9822(06)00151-5; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; Rulifson IC, 1997, J IMMUNOL, V158, P658; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Shapiro VS, 1998, J IMMUNOL, V161, P6455; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Stack RM, 1998, J IMMUNOL, V160, P2255; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Tuosto L, 2000, EUR J IMMUNOL, V30, P2445, DOI 10.1002/1521-4141(200009)30:9<2445::AID-IMMU2445>3.0.CO;2-4; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; Villegas EN, 1999, J IMMUNOL, V163, P3344; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WARD SG, 1995, EUR J IMMUNOL, V25, P526, DOI 10.1002/eji.1830250233; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; WECHSLER AS, 1994, J IMMUNOL, V153, P2515; WEISS A, 1986, J IMMUNOL, V137, P819; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	75	259	265	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					37	44		10.1038/83144	http://dx.doi.org/10.1038/83144			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135576				2022-12-18	WOS:000166261500012
J	Zajonc, DM; Cantu, C; Mattner, J; Zhou, DP; Savage, PB; Bendelac, A; Wilson, IA; Teyton, L				Zajonc, DM; Cantu, C; Mattner, J; Zhou, DP; Savage, PB; Bendelac, A; Wilson, IA; Teyton, L			Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor	NATURE IMMUNOLOGY			English	Article							NKT CELLS; IN-VIVO; CRYSTAL-STRUCTURE; HIGH-AFFINITY; ALPHA-GALACTOSYLCERAMIDE; DENDRITIC CELLS; HUMAN CD1B; ANTIGEN; RECOGNITION; ACTIVATION	Natural killer T cells express a conserved, semi-invariant alpha beta T cell receptor that has specificity for self glycosphingolipids and microbial cell wall alpha-glycuronosylceramide antigens presented by CD1d molecules. Here we report the crystal structure of CD1d in complex with a short-chain synthetic variant of alpha-galactosylceramide at a resolution of 2.2 angstrom. This structure elucidates the basis for the high specificity of these microbial ligands and explains the restriction of the alpha-linkage as a unique pathogen-specific pattern-recognition motif. Comparison of the binding of altered lipid ligands to CD1d and T cell receptors suggested that the differential T helper type 1-like and T helper type 2-like properties of natural killer T cells may originate largely from differences in their 'loading' in different cell types and hence in their tissue distribution in vivo.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Brigham Young Univ, Provo, UT 84602 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of Chicago; Brigham Young University; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; lteyton@scripps.edu	Savage, Paul B/E-1448-2011; Zhou, Dapeng/A-6446-2019; zhou, dapeng/GXG-9715-2022; Mattner, Jochen/AAT-7866-2021; Savage, Paul B/HGB-3414-2022	Savage, Paul B/0000-0002-4642-6109; Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058896, CA58896] Funding Source: Medline; NIAID NIH HHS [P01 AI053725, AI053725, P01 AI053725-010002] Funding Source: Medline; NIGMS NIH HHS [GM62116, U54 GM062116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Apostolopoulos V, 2002, J MOL BIOL, V318, P1307, DOI 10.1016/S0022-2836(02)00198-5; Apostolou I, 2000, J IMMUNOL, V165, P2481, DOI 10.4049/jimmunol.165.5.2481; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Brossay L, 1998, J IMMUNOL, V161, P5124; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; DeLano W. L, 2002, PYMOL MOL GENETICS G; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamada N, 2001, INT IMMUNOL, V13, P853, DOI 10.1093/intimm/13.7.853; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kleywegt GJ, 2002, STRUCTURE, V10, P465, DOI 10.1016/S0969-2126(02)00743-8; KOCH M, 2005, NAT IMMUNOL; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	61	258	274	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					810	818		10.1038/ni1224	http://dx.doi.org/10.1038/ni1224			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16007091	Green Accepted			2022-12-18	WOS:000230646200022
J	Badovinac, VP; Porter, BB; Harty, JT				Badovinac, VP; Porter, BB; Harty, JT			CD8(+) T cell contraction is controlled by early inflammation	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; HOMEOSTATIC PROLIFERATION; LISTERIA-MONOCYTOGENES; PROTECTIVE IMMUNITY; MEMORY; EFFECTOR; NAIVE; DIFFERENTIATION; GENERATION; EXPANSION	Pathogen-specific CD8(+) T cells expand in number after infection and then their numbers invariably contract by 90-95%, leaving a stable memory cell pool. The chief features of this response are programmed early after infection; however, the factors regulating contraction are mostly undefined. Here we show that antibiotic treatment before Listeria monocytogenes infection induced numbers of protective memory CD8(+) T cells similar to those in control infected mice, by a pathway without contraction. The absence of contraction correlated with decreased early inflammation and interferon-gamma production and an increased fraction of CD8(+) T cells expressing the interleukin 7 receptor at the peak of the response. Thus, contraction is controlled by early inflammation but is not essential for the generation of protective memory CD8(+) T cells after infection.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	badovinac, Vladimir/O-7760-2015	Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485, R21AI042767, R01AI046653, R37AI042767, R01AI042767] Funding Source: NIH RePORTER; NIAID NIH HHS [AO50073, AI46653, AI42767, T32AI07485] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Badovinac VP, 2000, J IMMUNOL METHODS, V238, P107, DOI 10.1016/S0022-1759(00)00153-8; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NORTH RJ, 1981, J IMMUNOL, V127, P342; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; POSTON RM, 1991, J IMMUNOL, V146, P4333; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864	56	258	268	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					809	817		10.1038/ni1098	http://dx.doi.org/10.1038/ni1098			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15247915				2022-12-18	WOS:000222955600012
J	Hu, D; Ikizawa, K; Lu, LR; Sanchirico, ME; Shinohara, ML; Cantor, H				Hu, D; Ikizawa, K; Lu, LR; Sanchirico, ME; Shinohara, ML; Cantor, H			Analysis of regulatory CD8 T cells in Qa-1-deficient mice	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CLASS IB MOLECULES; NEGATIVE SELECTION; IMMUNE-RESPONSES; VIRAL-INFECTION; IN-VIVO; RECEPTOR; ANTIGEN; PEPTIDE	The mouse protein Qa-1 (HLA-E in humans) is essential for immunological protection and immune regulation. Although Qa-1 has been linked to CD8 T cell-dependent suppression, the physiological relevance of this observation is unclear. We generated mice deficient in Qa-1 to develop an understanding of this process. Qa-1-deficient mice develop exaggerated secondary CD4 responses to foreign and self peptides. Enhanced responses to proteolipid protein self peptide were associated with resistance of Qa-1-deficient CD4 T cells to Qa-1-restricted CD8 T suppressor activity and increased susceptibility to experimental autoimmune encephalomyelitis. These findings delineate a Qa-1-dependent T cell-T cell inhibitory interaction that prevents the pathogenic expansion of autoreactive CD4 T cell populations and consequent autoimmune disease.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu	Lu, Linrong/A-1429-2013	Shinohara, Mari/0000-0002-6808-9844; Lu, Linrong/0000-0002-0171-4115	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013600, R01AI048125] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37562, AI 48125, AI 07386, AI 13600, R01 AI037562] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH CJ, 1992, J IMMUNOL, V149, P3773; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; AVERY AC, 1995, NATURE, V376, P431, DOI 10.1038/376431a0; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Cantor H, 2000, ADV IMMUNOL, V75, P209, DOI 10.1016/S0065-2776(00)75005-X; Davies A, 2003, J IMMUNOL, V170, P5027, DOI 10.4049/jimmunol.170.10.5027; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; Lo WF, 1999, J IMMUNOL, V162, P5398; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Noble A, 1998, J IMMUNOL, V160, P559; Noble A, 1998, J IMMUNOL, V160, P566; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; Seaman MS, 1999, J IMMUNOL, V162, P5429; Slifka MK, 2003, J IMMUNOL, V170, P1231, DOI 10.4049/jimmunol.170.3.1231; SOLOSKI MJ, 1995, IMMUNOL REV, V147, P67, DOI 10.1111/j.1600-065X.1995.tb00088.x; Steinman L, 2001, CURR OPIN IMMUNOL, V13, P597, DOI 10.1016/S0952-7915(00)00266-1; Sullivan BA, 2002, IMMUNITY, V17, P95, DOI 10.1016/S1074-7613(02)00343-6; Tompkins SM, 1998, J EXP MED, V188, P961; TRANSY C, 1987, J EXP MED, V166, P341, DOI 10.1084/jem.166.2.341; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344	41	258	269	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					516	523		10.1038/ni1063	http://dx.doi.org/10.1038/ni1063			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15098030				2022-12-18	WOS:000221101100016
J	Matsumoto, I; Maccioni, M; Lee, DM; Maurice, M; Simmons, B; Brenner, M; Mathis, D; Benoist, C				Matsumoto, I; Maccioni, M; Lee, DM; Maurice, M; Simmons, B; Brenner, M; Mathis, D; Benoist, C			How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease	NATURE IMMUNOLOGY			English	Article							AUTOCRINE MOTILITY FACTOR; RHEUMATOID-ARTHRITIS; PHOSPHOGLUCOSE ISOMERASE; CRYSTAL-STRUCTURE; BINDING-SITE; SIALIC-ACID; FACTOR-H; COMPLEMENT; C3; IDENTIFICATION	Arthritis in the K/BxN mouse model results from pathogenic immunoglobulins (Igs) that recognize the ubiquitous cytoplasmic enzyme glucose-6-phosphate isomerase (GPI). But how is a joint-specific disease of autoimmune and inflammatory nature induced by systemic self-reactivity? No unusual amounts or sequence, splice or modification variants of GPI expression were found in joints. Instead, immunohistological examination revealed the accumulation of extracellular GPI on the lining of the normal articular cavity, most visibly along the cartilage surface. In arthritic mice, these GPI deposits were amplified and localized with IgG and C3 complement. Similar deposits were found in human arthritic joints. We propose that GPI-anti-GPI complexes on articular surfaces initiate an inflammatory cascade via the alternative complement pathway, which is unbridled because the cartilage surface lacks the usual cellular inhibitors. This may constitute a generic scenario of arthritogenesis, in which extra-articular proteins coat the cartilage or joint extracellular matrix.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02115 USA; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Benoist, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02115 USA.	cbdm@joslin.harvard.edu		Maurice, Madelon/0000-0001-6885-5361	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER; NIAMS NIH HHS [1R01 AR/AI46580-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; COOKE TD, 1975, ARTHRITIS RHEUM, V18, P541, DOI 10.1002/art.1780180603; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; FRIES LF, 1984, J EXP MED, V160, P1640, DOI 10.1084/jem.160.6.1640; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gonzalez ML, 2000, J IMMUNOL, V164, P1071, DOI 10.4049/jimmunol.164.2.1071; ISHIKAWA H, 1975, ARTHRITIS RHEUM, V18, P563, DOI 10.1002/art.1780180606; Jasin H E, 1988, Scand J Rheumatol Suppl, V76, P111; Jeffery CJ, 2000, BIOCHEMISTRY-US, V39, P955, DOI 10.1021/bi991604m; Jelezarova E, 2000, BIOCHEM J, V349, P217, DOI 10.1042/0264-6021:3490217; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LANCHBURY JS, 1993, CURR OPIN IMMUNOL, V5, P918, DOI 10.1016/0952-7915(93)90106-3; MACCIONI M, 2002, IMMUNITY, V16, P157; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; PANGBURN MK, 1998, COMPLEMENT SYSTEM, P93; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; SHOHET JM, 1993, J BIOL CHEM, V268, P5866; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P5412, DOI 10.1073/pnas.96.10.5412; TAKAHASHI S, 1993, MOL IMMUNOL, V30, P177; VETTO AA, 1990, RHEUMATOL INT, V10, P13, DOI 10.1007/BF02274776; Vivanco F, 1999, MOL IMMUNOL, V36, P843, DOI 10.1016/S0161-5890(99)00105-4; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; WATANABE H, 1991, J BIOL CHEM, V266, P13442; WEST JD, 1990, GENET RES, V56, P223, DOI 10.1017/S0016672300035321; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Zvaifler N J, 1973, Adv Immunol, V16, P265, DOI 10.1016/S0065-2776(08)60299-0	31	258	268	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					360	365		10.1038/ni772	http://dx.doi.org/10.1038/ni772			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11896391				2022-12-18	WOS:000174623600017
J	Calado, DP; Sasaki, Y; Godinho, SA; Pellerin, A; Kochert, K; Sleckman, BP; de Alboran, IM; Janz, M; Rodig, S; Rajewsky, K				Calado, Dinis Pedro; Sasaki, Yoshiteru; Godinho, Susana A.; Pellerin, Alex; Koechert, Karl; Sleckman, Barry P.; Moreno de Alboran, Ignacio; Janz, Martin; Rodig, Scott; Rajewsky, Klaus			The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers	NATURE IMMUNOLOGY			English	Article							CENTER B-CELLS; TRANSCRIPTION FACTOR; PROTOONCOGENE EXPRESSION; GENE-EXPRESSION; BCL6; RESPONSES; ORIGIN; DIFFERENTIATION; SEQUESTRATION; PATHOGENESIS	Germinal centers (GCs) are sites of intense B cell proliferation and are central for T cell dependent antibody responses. However, the role of c-Myc, a key cell-cycle regulator, in this process has been questioned. Here we identified c-Myc(+) B cell subpopulations in immature and mature GCs and found, by genetic ablation of Myc, that they had indispensable roles in the formation and maintenance of GCs. The identification of these functionally critical cellular subsets has implications for human B cell lymphomagenesis, which originates mostly from GC B cells and frequently involves MYC chromosomal translocations. As these translocations are generally dependent on transcription of the recombining partner loci, the c-Myc(+) GC subpopulations may be at a particularly high risk for malignant transformation.	[Calado, Dinis Pedro; Pellerin, Alex; Rajewsky, Klaus] Harvard Univ, Childrens Hosp, Program Cellular & Mol Med, Sch Med, Boston, MA 02115 USA; [Calado, Dinis Pedro; Pellerin, Alex; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Calado, Dinis Pedro; Koechert, Karl; Janz, Martin; Rajewsky, Klaus] Max Delbruck Ctr Mol Med, Berlin, Germany; [Sasaki, Yoshiteru] Kyoto Univ, Dept Mol & Cellular Physiol, Grad Sch Med, Kyoto, Japan; [Godinho, Susana A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol,Dept Cell Biol, Boston, MA 02115 USA; [Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Moreno de Alboran, Ignacio] Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; [Janz, Martin] Univ Med Sch, Charite, Berlin, Germany; [Rodig, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Kyoto University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Washington University (WUSTL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Brigham & Women's Hospital	Calado, DP (corresponding author), Harvard Univ, Childrens Hosp, Program Cellular & Mol Med, Sch Med, Boston, MA 02115 USA.	dinis.calado@mdc-berlin.de; klaus.rajewsky@mdc-berlin.de	Rodig, Scott/Y-3889-2019; Calado, Dinis/U-8379-2019; Moreno de Alboran, Ignacio/K-1044-2017	Calado, Dinis/0000-0001-8239-7184; Godinho, Susana/0000-0003-0638-065X; Rajewsky, Klaus/0000-0002-6633-6370; Kochert, Karl/0000-0002-5548-2022; Janz, Martin/0000-0002-1127-0044	National Cancer Institute [PO1CA092625]; Leukemia and Lymphoma Society; European Research Council; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Ghitza, J. Wang, J. Grundy, J. Xia, C. Grosse, B. Wollert-Wulff and M. Bamberg for technical assistance; M. Ottaviano and M. Bezohra for administrative assistance; the Rajewsky laboratory members for critical comments and suggestions; and D. Dominguez-Sola and R. Dalla-Favera for sharing unpublished results. Supported by the National Cancer Institute (PO1CA092625 to KR.), the Leukemia and Lymphoma Society (KR. and D.P.C.) and the European Research Council (KR.).	Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cutrona G, 1997, EUR J IMMUNOL, V27, P234, DOI 10.1002/eji.1830270135; Cutrona G, 1997, ANN NY ACAD SCI, V815, P436, DOI 10.1111/j.1749-6632.1997.tb52096.x; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Golay J, 1998, J IMMUNOL, V160, P2786; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Seitz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026837; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Stevenson F, 1998, IMMUNOL REV, V162, P247, DOI 10.1111/j.1600-065X.1998.tb01446.x; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vallespinos M, 2011, J IMMUNOL, V186, P6726, DOI 10.4049/jimmunol.1002753; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047	48	257	260	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1092	1100		10.1038/ni.2418	http://dx.doi.org/10.1038/ni.2418			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23001146	Green Accepted, Green Submitted			2022-12-18	WOS:000310091700012
J	Hamerman, JA; Tchao, NK; Lowell, CA; Lanier, LL				Hamerman, JA; Tchao, NK; Lowell, CA; Lanier, LL			Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; TYROSINE KINASE SYK; INFLAMMATORY RESPONSES; MYELOID CELLS-1; NEGATIVE REGULATOR; CUTTING EDGE; MACROPHAGE ACTIVATION; DAP12-DEFICIENT MICE; ENDOTOXIN TOLERANCE; IMMUNE-RESPONSE	DAP12 is a signaling adaptor containing an immunoreceptor tyrosine-based activation motif (ITAM) that pairs with receptors on myeloid cells and natural killer cells. We examine here the responses of mice lacking DAP12 to stimulation through Toll-like receptors (TLRs). Unexpectedly, DAP12-deficient macrophages produced higher concentrations of inflammatory cytokines in response to a variety of pathogenic stimuli. Additionally, macrophages deficient in spleen tyrosine kinase (Syk), which signals downstream of DAP12, showed a phenotype identical to that of DAP12-deficient macrophages. DAP12-deficient mice were more susceptible to endotoxic shock and had enhanced resistance to infection by the intracellular bacterium Listeria monocytogenes. These data suggest that one or more DAP12-pairing receptors negatively regulate signaling through TLRs.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NCI NIH HHS [R01 CA089294, CA89294] Funding Source: Medline; NIDDK NIH HHS [R01 DK058066, DK58066] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058066] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Chung DH, 2002, EUR J IMMUNOL, V32, P59, DOI 10.1002/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Snyder MR, 2003, J EXP MED, V197, P437, DOI 10.1084/jem.20020383; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	53	257	263	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					579	586		10.1038/ni1204	http://dx.doi.org/10.1038/ni1204			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15895090	Green Accepted, Green Submitted			2022-12-18	WOS:000229385900012
J	Lajoie, S; Lewkowich, IP; Suzuki, Y; Clark, JR; Sproles, AA; Dienger, K; Budelsky, AL; Wills-Karp, M				Lajoie, Stephane; Lewkowich, Ian P.; Suzuki, Yusuke; Clark, Jennifer R.; Sproles, Alyssa A.; Dienger, Krista; Budelsky, Alison L.; Wills-Karp, Marsha			Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma	NATURE IMMUNOLOGY			English	Article							TH17 CELLS; AIRWAY HYPERRESPONSIVENESS; C3A ANAPHYLATOXIN; PROTECTIVE ROLE; COMPONENT C5; MOUSE MODEL; T-CELLS; RECEPTOR; INFLAMMATION; INTERLEUKIN-17	Severe asthma is associated with the production of interleukin 17A (IL-17A). The exact role of IL-17A in severe asthma and the factors that drive its production are unknown. Here we demonstrate that IL-17A mediated severe airway hyperresponsiveness (AHR) in susceptible strains of mice by enhancing IL-13-driven responses. Mechanistically, we demonstrate that IL-17A and AHR were regulated by allergen-driven production of anaphylatoxins, as mouse strains deficient in complement factor 5 (C5) or the complement receptor C5aR mounted robust IL-17A responses, whereas mice deficient in C3aR had fewer IL-17-producing helper T cells (T(H)17 cells) and less AHR after allergen challenge. The opposing effects of C3a and C5a were mediated through their reciprocal regulation of IL-23 production. These data demonstrate a critical role for complement-mediated regulation of the IL-23-T(H)17 axis in severe asthma.	[Lajoie, Stephane; Lewkowich, Ian P.; Suzuki, Yusuke; Clark, Jennifer R.; Sproles, Alyssa A.; Dienger, Krista; Wills-Karp, Marsha] Univ Cincinnati, Coll Med, Dept Pediat, Div Immunobiol,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45221 USA; [Budelsky, Alison L.] Amgen Inc, Seattle, WA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Amgen	Wills-Karp, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Immunobiol,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45221 USA.	wildc7@cchmc.org		Lajoie, Stephane/0000-0002-0514-1801	US National Institutes of Health [HL67736, AI083315, U19A1070235, P50ES015903, AR47363]; Parker B. Francis Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045221, U19AI070235, R01AI083315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015903] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Gerard (Harvard University) for C3ar1-deficient and C5ar1-deficient mice; F. Finkelman (Cincinnati Children's Hospital Medical Center) for IgG2a (GL117); M. Adcock (Imperial College London) for AS602868; and C. Karp for discussions. Supported by the US National Institutes of Health (HL67736, AI083315, U19A1070235 and P50ES015903 to M.W.-K., and AR47363 to the flow cytometry core of Cincinnati Children's Hospital Medical Center) and the Parker B. Francis Fellowship Program (I.P.L.).	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barnes KC, 2006, GENES IMMUN, V7, P27, DOI 10.1038/sj.gene.6364267; Bautsch W, 2000, J IMMUNOL, V165, P5401, DOI 10.4049/jimmunol.165.10.5401; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Droulin SM, 2006, AM J RESP CRIT CARE, V173, P852, DOI 10.1164/rccm.200503-334OC; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Frelin C, 2003, ONCOGENE, V22, P8187, DOI 10.1038/sj.onc.1206963; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasegawa K, 2004, HUM GENET, V115, P295, DOI 10.1007/s00439-004-1157-z; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hofstetter Hh, 2009, Int MS J, V16, P12; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Katz Y, 2000, CLIN EXP IMMUNOL, V120, P22, DOI 10.1046/j.1365-2249.2000.01199.x; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Kurreeman FAS, 2010, ANN RHEUM DIS, V69, P696, DOI 10.1136/ard.2008.106567; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Nakano Y, 2003, J ALLERGY CLIN IMMUN, V112, P525, DOI 10.1067/mai.2003.1710; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schulz KR, 2007, CURR PROTOC IMMUNOL; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Walters DM, 2002, AM J RESP CELL MOL, V27, P413, DOI 10.1165/rcmb.4844; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276	47	256	280	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					928	U79		10.1038/ni.1926	http://dx.doi.org/10.1038/ni.1926			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20802484	Green Accepted			2022-12-18	WOS:000281926900012
J	Phan, RT; Saito, M; Basso, K; Niu, HF; Dalla-Favera, R				Phan, RT; Saito, M; Basso, K; Niu, HF; Dalla-Favera, R			BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; DNA-DAMAGE; LYMPHOCYTE DIFFERENTIATION; NEGATIVE AUTOREGULATION; IMMUNOGLOBULIN GENES; EXPRESSION; P53; MYC; INFLAMMATION	The BCL6 proto-oncogene encodes a transcriptional repressor that is required for germinal center formation and has been linked to lymphomagenesis. BCL6 functions by directly binding to specific DNA sequences and suppressing the transcription of target genes. Here we report an alternative mechanism by which BCL6 controls the transcription of genes lacking a BCL6 binding site and show that this mechanism was required for the prevention of tumor suppressor p53 - independent cell cycle arrest in germinal center B cells. BCL6 interacted with the transcriptional activator Miz-1 and, via Miz-1, bound to the promoter and suppressed transcription of the cell cycle arrest gene CDKN1A. Through this mechanism, BCL6 may facilitate the proliferative expansion of germinal centers during the normal immune response and, when deregulated, the pathological expansion of B cell lymphomas.	Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	rd10@columbia.edu						ALLDAY MJ, 1995, EMBO J, V14, P4994, DOI 10.1002/j.1460-2075.1995.tb00182.x; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chan TA, 2000, GENE DEV, V14, P1584; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 1998, BLOOD, V91, P603, DOI 10.1182/blood.V91.2.603.603_603_607; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fearon DT, 2002, ADV EXP MED BIOL, V512, P21; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; LO CF, 1994, BLOOD, V83, P1757; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Offit K, 1995, LEUKEMIA LYMPHOMA, V20, P85, DOI 10.3109/10428199509054757; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; SHEIKH MS, 1994, ONCOGENE, V9, P3407; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	50	256	269	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1054	1060		10.1038/ni1245	http://dx.doi.org/10.1038/ni1245			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16142238				2022-12-18	WOS:000232027200025
J	Bi, K; Tanaka, Y; Coudronniere, N; Sugie, K; Hong, SJ; van Stipdonk, MJB; Altman, A				Bi, K; Tanaka, Y; Coudronniere, N; Sugie, K; Hong, SJ; van Stipdonk, MJB; Altman, A			Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE-C; KAPPA-B ACTIVATION; LIPID RAFTS; IL-2 PROMOTER; TYROSINE PHOSPHORYLATION; CHOLESTEROL DEPLETION; SIGNAL-TRANSDUCTION; RECEPTOR; TCR; LYMPHOCYTES	Protein kinase C-theta (PKC-theta) is essential for mature T cell activation; however, the mechanism by which it is recruited to the TCR signaling machinery is unknown. Here we show that T cell stimulation by antibodies or peptide-major histocompatibility complex (MHC) induces translocation of PKC-Q to membrane lipid rafts, which localize to the immunological synapse. Raft translocation was mediated by the PKC-theta regulatory domain and required Lck but not ZAP-70. In addition, PKC-theta was associated with Lck in the rafts,An isolated PKC-theta catalytic fragment did not partition into rafts or activate the transcription factor NF-kappaB, although addition of a Lck-derived raft-localization sequence restored these functions. Thus, physiological T cell activation translocates PKC-theta to rafts, which localize to the T cell synapse; this PKC-theta translocation is important for its function.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; La Jolla Institute for Immunology	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.			TANAKA, Yoshihiko/0000-0002-6458-5082	NCI NIH HHS [CA35299] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Avraham A, 1998, EUR J IMMUNOL, V28, P2320, DOI 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO;2-K; BAIER G, 1993, J BIOL CHEM, V268, P4997; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; BI K, 2001, IN PRESS SEMIN IMMUN; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Cerny J, 1996, EUR J IMMUNOL, V26, P2335, DOI 10.1002/eji.1830261010; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; CINEK T, 1992, J IMMUNOL, V149, P2262; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 2000, BLOOD, V95, P3199; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; MINAMI Y, 1991, J BIOL CHEM, V266, P9222; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Villalba M, 1999, J IMMUNOL, V163, P5813; VILLALBA M, 2001, UNPUB RECEPTOR INDUC; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1999, CURR OPIN IMMUNOL, V11, P265, DOI 10.1016/S0952-7915(99)80043-0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	55	256	269	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					556	563		10.1038/88765	http://dx.doi.org/10.1038/88765			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376344				2022-12-18	WOS:000169078000020
J	Becher, B; Schlitzer, A; Chen, JM; Mair, F; Sumatoh, HR; Teng, KWW; Low, D; Ruedl, C; Riccardi-Castagnoli, P; Poidinger, M; Greter, M; Ginhoux, F; Newell, EW				Becher, Burkhard; Schlitzer, Andreas; Chen, Jinmiao; Mair, Florian; Sumatoh, Hermi R.; Teng, Karen Wei Weng; Low, Donovan; Ruedl, Christiane; Riccardi-Castagnoli, Paola; Poidinger, Michael; Greter, Melanie; Ginhoux, Florent; Newell, Evan W.			High-dimensional analysis of the murine myeloid cell system	NATURE IMMUNOLOGY			English	Article							CD11B(+) DENDRITIC CELLS; SUPPRESSOR-CELLS; STEADY-STATE; T-CELLS; GM-CSF; MONOCYTES; MACROPHAGES; IMMUNE; MOUSE; EXPRESSION	Advances in cell-fate mapping have revealed the complexity in phenotype, ontogeny and tissue distribution of the mammalian myeloid system. To capture this phenotypic diversity, we developed a 38-antibody panel for mass cytometry and used dimensionality reduction with machine learning-aided cluster analysis to build a composite of murine (mouse) myeloid cells in the steady state across lymphoid and nonlymphoid tissues. In addition to identifying all previously described myeloid populations, higher-order analysis allowed objective delineation of otherwise ambiguous subsets, including monocyte-macrophage intermediates and an array of granulocyte variants. Using mice that cannot sense granulocyte macrophage-colony stimulating factor GM-CSF (Csf2rb(-/-)), which have discrete alterations in myeloid development, we confirmed differences in barrier tissue dendritic cells, lung macrophages and eosinophils. The methodology further identified variations in the monocyte and innate lymphoid cell compartment that were unexpected, which confirmed that this approach is a powerful tool for unambiguous and unbiased characterization of the myeloid system.	[Becher, Burkhard; Schlitzer, Andreas; Chen, Jinmiao; Sumatoh, Hermi R.; Teng, Karen Wei Weng; Low, Donovan; Riccardi-Castagnoli, Paola; Poidinger, Michael; Ginhoux, Florent; Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Mair, Florian; Greter, Melanie] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Ruedl, Christiane] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Zurich; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Newell, EW (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch; evan_newell@immunol.a-staredu.sg	Ruedl, christiane/A-2219-2011; Becher, Burkhard/ABE-4225-2020; Chen, Jinmiao/ABE-5601-2021; Newell, Evan W/F-9711-2012; Schlitzer, Andreas/R-2237-2016	Ruedl, christiane/0000-0002-5599-6541; Becher, Burkhard/0000-0002-1541-7867; Newell, Evan W/0000-0002-2889-243X; Schlitzer, Andreas/0000-0001-7662-3712; Greter, Melanie/0000-0002-7220-5369; Poidinger, Michael/0000-0002-1047-2277; Mair, Florian/0000-0001-6732-5449	A*STAR/SIgN; Swiss National Science Foundation [PP03P3_144781, 316030_150768, 310030_146130, CRSII3_136203]; European Union FP7 project TargetBraIn; University Research Priority Project 'Translational Cancer Research'; European Union FP7 project NeuroKine; European Union FP7 project Advanced T-cell Engineered for Cancer Therapy (ATECT)	A*STAR/SIgN(Agency for Science Technology & Research (A*STAR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union FP7 project TargetBraIn; University Research Priority Project 'Translational Cancer Research'; European Union FP7 project NeuroKine; European Union FP7 project Advanced T-cell Engineered for Cancer Therapy (ATECT)	The authors thank the SIgN community, the SIgN Flow Cytometry Facility and members of E.W.N.'s, F.G.'s and B.B.'s labs, and L.G. Ng for helpful discussion. Some antibodies used for generating the mass cytometry panels were provided by R. Balderas and A. Tiong (Becton Dickinson). The antibodies generated by BioXcell were provided for this analysis free of charge. B.B. performed this work while on sabbatical at A*STAR/SIgN. Supported by A*STAR/SIgN (P.R.-C., F.G., M.P., E.W.N.) and the Swiss National Science Foundation (PP03P3_144781 (M.G.), 316030_150768, 310030_146130 and CRSII3_136203 (B.B.)), European Union FP7 project TargetBraIn, NeuroKine, Advanced T-cell Engineered for Cancer Therapy (ATECT) and the University Research Priority Project 'Translational Cancer Research' (B.B.).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Codarri L, 2013, TRENDS IMMUNOL, V34, P114, DOI 10.1016/j.it.2012.09.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fiedler K, 2012, AM J BLOOD RES, V2, P57; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Throsby M, 2000, J IMMUNOL, V165, P1965, DOI 10.4049/jimmunol.165.4.1965; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	43	255	256	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1181	1189		10.1038/ni.3006	http://dx.doi.org/10.1038/ni.3006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25306126				2022-12-18	WOS:000344841900015
J	Manis, JP; Morales, JC; Xia, ZF; Kutok, JL; Alt, FW; Carpenter, PB				Manis, JP; Morales, JC; Xia, ZF; Kutok, JL; Alt, FW; Carpenter, PB			53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination	NATURE IMMUNOLOGY			English	Article							B-CELL DIFFERENTIATION; CYTIDINE DEAMINASE AID; SINGLE-STRANDED-DNA; GENOMIC INSTABILITY; SOMATIC HYPERMUTATION; PROTEIN 53BP1; HISTONE H2AX; ACTIVATION; PHOSPHORYLATION; BREAKS	The mammalian protein 53BP1 is activated in many cell types in response to genotoxic stress, including DNA double-strand breaks (DSBs). We now examine potential functions for 53BP1 in the specific genomic alterations that occur in B lymphocytes. Although 53BP1 was dispensable for V(D)J recombination and somatic hypermutation (SHM), the processes by which immunoglobulin (lg) variable region exons are assembled and mutated, it was required for lgh class-switch recombination (CSR), the recombination and deletion process by which lgh constant region genes are exchanged. When stimulated to undergo CSR, 53BP1-deficient cells exhibited no defect in C-H germline transcription or AID expression, however these cells had a profound decrease in switch junctions. The current findings, in combination with the known 53BP1 functions and how it is activated, implicate the DNA damage response to DSBs in the joining phase of class-switch recombination.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Health Science Center Houston	Manis, JP (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	manis@enders.tch.harvard.edu		Morales, Julio/0000-0002-0854-7866	NCI NIH HHS [CA92625] Funding Source: Medline; NIAID NIH HHS [AI3154] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; CHU CC, 1993, J EXP MED, V178, P1381, DOI 10.1084/jem.178.4.1381; Chua KF, 2002, J EXP MED, V195, pF37, DOI 10.1084/jem.20020380; Cook AJL, 2003, J IMMUNOL, V171, P6556, DOI 10.4049/jimmunol.171.12.6556; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	255	256	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					481	487		10.1038/ni1067	http://dx.doi.org/10.1038/ni1067			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15077110				2022-12-18	WOS:000221101100011
J	Moodycliffe, AM; Nghiem, D; Clydesdale, G; Ullrich, SE				Moodycliffe, AM; Nghiem, D; Clydesdale, G; Ullrich, SE			Immune suppression and skin cancer development: regulation by NKT cells	NATURE IMMUNOLOGY			English	Article							NK1.1(+) T-CELLS; ULTRAVIOLET-RADIATION; MICE; ALPHA; INDUCTION; REJECTION; GAMMA; IL-4	Ultraviolet (UV) radiation is carcinogenic and immunosuppressive. UV-induced immune suppression is mediated by antigen-specific T cells, which can transfer suppression to normal recipients. These cells are essential for controlling skin cancer development in the UV-irradiated host and in suppressing other immune responses, such as delayed-type hypersensitivity. Despite their importance in skin cancer development, their exact identity has remained elusive. We show here that natural killer T cells from UV-irradiated donor mice function as suppressor T cells and play a critical role in regulating the growth of UV-induced skin cancers and suppressing adaptive immune responses in vivo.	Grad Sch Biomed Sci, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Ullrich, SE (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sullrich@notes.mdacc.tmc.edu			NATIONAL CANCER INSTITUTE [R01CA075575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007327] Funding Source: NIH RePORTER; NCI NIH HHS [CA75575] Funding Source: Medline; NIEHS NIH HHS [ES07327] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Assarsson E, 2000, J IMMUNOL, V165, P3673, DOI 10.4049/jimmunol.165.7.3673; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BORING CC, 1992, CA-CANCER J CLIN, V42, P19, DOI 10.3322/canjclin.42.1.19; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; DAYNES RA, 1977, CELL IMMUNOL, V31, P182, DOI 10.1016/0008-8749(77)90018-1; FISHER MS, 1977, P NATL ACAD SCI USA, V74, P1688, DOI 10.1073/pnas.74.4.1688; FISHER MS, 1982, SCIENCE, V216, P1133, DOI 10.1126/science.6210958; Ikehara Y, 2000, J CLIN INVEST, V105, P1761, DOI 10.1172/JCI8922; Lee DJ, 1998, J EXP MED, V187, P433, DOI 10.1084/jem.187.3.433; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moodycliffe AM, 1999, J IMMUNOL, V162, P5156; Moore TA, 1996, J IMMUNOL, V157, P2366; PENN I, 1984, IMMUNOL TODAY, V5, P291, DOI 10.1016/0167-5699(84)90152-X; RIVAS JM, 1994, J LEUKOCYTE BIOL, V56, P769, DOI 10.1002/jlb.56.6.769; Singh N, 1999, J IMMUNOL, V163, P2373; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; ULLRICH SE, 1990, J IMMUNOL, V145, P489; ULLRICH SE, 1984, J IMMUNOL, V133, P2786; ULLRICH SE, 1988, TRANSPLANTATION, V46, P115, DOI 10.1097/00007890-198807000-00021; Urbach F, 1997, J PHOTOCH PHOTOBIO B, V40, P3, DOI 10.1016/S1011-1344(97)00029-8; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; YOSHIKAWA T, 1990, J INVEST DERMATOL, V95, P530, DOI 10.1111/1523-1747.ep12504877; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	27	255	268	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					521	525		10.1038/82782	http://dx.doi.org/10.1038/82782			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101875				2022-12-18	WOS:000165724600017
J	Amit, I; Winter, DR; Jung, S				Amit, Ido; Winter, Deborah R.; Jung, Steffen			The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis	NATURE IMMUNOLOGY			English	Review							DETERMINING TRANSCRIPTION FACTORS; DENDRITIC CELL; HISTONE MODIFICATIONS; LY6C(HI) MONOCYTES; ANALYSIS REVEALS; FETAL MONOCYTES; SPI-C; MICROGLIA; CHROMATIN; GENE	Macrophages provide a critical systemic network cells of the innate immune system. Emerging data suggest that in addition, they have important tissue-specific functions that range from clearance of surfactant from the lungs to neuronal pruning and establishment of gut homeostasis. The differentiation and tissue-specific activation of macrophages require precise regulation of gene expression, a process governed by epigenetic mechanisms such as DNA methylation, histone modification and chromatin structure. We argue that epigenetic regulation of macrophages is determined by lineage- and tissue-specific transcription factors controlled by the built-in programming of myeloid development in combination with signaling from the tissue environment. Perturbation of epigenetic mechanisms of tissue macrophage identity can affect normal macrophage tissue function and contribute to pathologies ranging from obesity and autoimmunity to neurodegenerative diseases.	[Amit, Ido; Winter, Deborah R.; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il; s.jung@weizmann.ac.il	Jung, Steffen/K-1409-2012; Winter, Deborah R./AAQ-9253-2020	Jung, Steffen/0000-0003-4290-5716; Winter, Deborah R./0000-0003-1806-673X	European Research Council [309788, 340345]; I-CORE for chromatin and RNA regulation; Israel Science Foundation [703/15, 887/11]; BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung; Azrieli Foundation; European Molecular Biology Organization [ALT766-2014]; European Commission FP7 (Marie Curie Actions, EMBOCOFUND) [GA-2012-600394]	European Research Council(European Research Council (ERC)European Commission); I-CORE for chromatin and RNA regulation; Israel Science Foundation(Israel Science Foundation); BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung; Azrieli Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission FP7 (Marie Curie Actions, EMBOCOFUND)	Supported by the European Research Council (309788 for the I.A. laboratory; 340345 for the S.J. laboratory), the I-CORE for chromatin and RNA regulation (I.A. laboratory), the Israel Science Foundation (703/15 for the I.A. laboratory; 887/11 for the S.J. laboratory), the BLUEPRINT FP7 consortium (I.A. laboratory), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine (I.A. laboratory), Minerva Stiftung (I.A. laboratory), The Azrieli Foundation (D.R.W.), the European Molecular Biology Organization (ALT766-2014 for D.R.W.) and the European Commission FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394 for D.R.W.).	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Bossard P, 1998, DEVELOPMENT, V125, P4909; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Capucha T, 2015, IMMUNITY, V43, P369, DOI 10.1016/j.immuni.2015.06.017; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Cipolletta D, 2011, SEMIN IMMUNOL, V23, P431, DOI 10.1016/j.smim.2011.06.002; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fulde M, 2014, IMMUNOL REV, V260, P21, DOI 10.1111/imr.12190; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guerreiro R, 2013, NEW ENGL J MED, V369, P1569, DOI 10.1056/NEJMc1306509; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2012, CURR TOP MICROBIOL, V356, P1, DOI 10.1007/82_2011_142; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ostuni R, 2013, CURR OPIN CELL BIOL, V25, P759, DOI 10.1016/j.ceb.2013.07.006; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schultze JL, 2015, SEMIN IMMUNOL, V27, P44, DOI 10.1016/j.smim.2015.02.001; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ueno M, 2014, CURR OPIN NEUROBIOL, V27, P8, DOI 10.1016/j.conb.2014.02.004; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	111	254	259	8	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					18	25		10.1038/ni.3325	http://dx.doi.org/10.1038/ni.3325			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681458				2022-12-18	WOS:000366675800004
J	Lynch, L; Michelet, X; Zhang, S; Brennan, PJ; Moseman, A; Lester, C; Besra, G; Vomhof-Dekrey, EE; Tighe, M; Koay, HF; Godfrey, DI; Leadbetter, EA; Sant'Angelo, DB; von Andrian, U; Brenner, MB				Lynch, Lydia; Michelet, Xavier; Zhang, Sai; Brennan, Patrick J.; Moseman, Ashley; Lester, Chantel; Besra, Gurdyal; Vomhof-Dekrey, Emilie E.; Tighe, Mike; Koay, Hui-Fern; Godfrey, Dale I.; Leadbetter, Elizabeth A.; Sant'Angelo, Derek B.; von Andrian, Ulrich; Brenner, Michael B.			Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T-reg cells and macrophages in adipose tissue	NATURE IMMUNOLOGY			English	Article							INVARIANT NKT CELLS; LIPID-ANTIGEN PRESENTATION; CUTTING EDGE; OBESITY; PROGRAM; GAMMA; ACCUMULATION; POLARIZATION; ACTIVATION; POPULATION	Invariant natural killer T cells (iNKT cells) are lipid-sensing innate T cells that are restricted by the antigen-presenting molecule CD1d and express the transcription factor PLZF. iNKT cells accumulate in adipose tissue, where they are anti-inflammatory, but the factors that contribute to their anti-inflammatory nature, as well as their targets in adipose tissue, are unknown. Here we found that iNKT cells in adipose tissue had a unique transcriptional program and produced interleukin 2 (IL-2) and IL-10. Unlike other iNKT cells, they lacked PLZF but expressed the transcription factor E4BP4, which controlled their IL-10 production. The adipose iNKT cells were a tissue-resident population that induced an anti-inflammatory phenotype in macrophages and, through the production of IL-2, controlled the number, proliferation and suppressor function of regulatory T cells (T-reg cells) in adipose tissue. Thus, iNKT cells in adipose tissue are unique regulators of immunological homeostasis in this tissue.	[Lynch, Lydia; Michelet, Xavier; Brennan, Patrick J.; Lester, Chantel; Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Zhang, Sai; Sant'Angelo, Derek B.] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ USA; [Moseman, Ashley; von Andrian, Ulrich] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA USA; [Besra, Gurdyal] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Vomhof-Dekrey, Emilie E.; Tighe, Mike; Leadbetter, Elizabeth A.] Trudeau Inst, Saranac Lake, NY USA; [Koay, Hui-Fern; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Koay, Hui-Fern; Godfrey, Dale I.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Melbourne, Vic 3010, Australia; [Sant'Angelo, Derek B.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard Medical School; University of Birmingham; Trudeau Institute; University of Melbourne; University of Melbourne; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	llynch3@partners.org; mbrenner@research.bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021	Lynch, Lydia/0000-0002-4273-4681; Besra, Gurdyal/0000-0002-5605-0395; Godfrey, Dale/0000-0002-3009-5472; Vomhof-DeKrey, Emilie/0000-0003-3818-5330; Koay, Hui-Fern/0000-0002-3236-9609	Marie Curie Actions; US National Institutes of Health [AI063428, AI028973, DK057521, T32 A1049823]; American Diabetes Association [7-12-IN-07]; American Academy of Allergy, Asthma and Immunology ARTrust; Trudeau Institute; National Health and Medical Research Council of Australia [1013667, a1020770]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01 AI083988, AI059739]; Robert Wood Johnson Foundation [67038]; MRC [G1001750] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063428, K08AI102945, R01AI113046, R01AI028973, T32AI049823, R37AI028973, P01AI112521, R56AI063428, R01AI059739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; Medical Research Council [G1001750] Funding Source: researchfish	Marie Curie Actions(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Academy of Allergy, Asthma and Immunology ARTrust; Trudeau Institute; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Exley (Harvard Medical School) for Cd1d<SUP>-/-</SUP> mice; P.P. Pandolfi (Harvard Medical School) for the use of Plzf<SUP>-/-</SUP> mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3-GFP mice; E. Pamer (Memorial Sloan-Kettering Cancer Center) for the pLD53 SC-AB vector system; and K. Rothamel (Harvard Medical School) and the US National Institutes of Health Tetramer Core for mouse CD1d-PBS57 tetramers; and E. Lynch for assistance with imaging. This work benefited from public data generated by the Immunological Genome Project. Supported by Marie Curie Actions (L.L.), the US National Institutes of Health (AI063428, AI028973 and DK057521 to M.B.B.; and T32 A1049823 to E.E.V.-D.), the American Diabetes Association (7-12-IN-07 to M.B.B.), the American Academy of Allergy, Asthma and Immunology ARTrust (P.J.B.), the Trudeau Institute (M.T., E.E.V.-D. and E.A.L.), The National Health and Medical Research Council of Australia (1013667 to D.I.G. and H.-F.K.; and a1020770 to D.I.G.), the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI083988 and AI059739 to D.B.S.) and the Robert Wood Johnson Foundation (67038 to the Child Health Institute of New Jersey, support for D.B.S.).	Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bosma A, 2012, IMMUNITY, V36, P477, DOI 10.1016/j.immuni.2012.02.008; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Constantinides MG, 2011, J IMMUNOL, V187, P309, DOI 10.4049/jimmunol.1100761; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Lynch L, 2014, IMMUNOLOGY, V142, P337, DOI 10.1111/imm.12269; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Ohteki T, 1999, J IMMUNOL, V162, P3753; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Swann J, 2004, IMMUNOL CELL BIOL, V82, P323, DOI 10.1111/j.1440-1711.2004.01254.x; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2013, ADIPOCYTE, V2, P12, DOI 10.4161/adip.22296; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	50	254	262	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					85	+		10.1038/ni.3047	http://dx.doi.org/10.1038/ni.3047			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25436972	Green Accepted, Green Submitted			2022-12-18	WOS:000346494200012
J	Gerlach, K; Hwang, YY; Nikolaev, A; Atreya, R; Dornhoff, H; Steiner, S; Lehr, HA; Wirtz, S; Vieth, M; Waisinan, A; Rosenbauer, F; McKenzie, ANJ; Weigmann, B; Neurath, MF				Gerlach, Katharina; Hwang, YouYi; Nikolaev, Alexej; Atreya, Raja; Dornhoff, Heike; Steiner, Stefanie; Lehr, Hans-Anton; Wirtz, Stefan; Vieth, Michael; Waisinan, Ari; Rosenbauer, Frank; McKenzie, Andrew N. J.; Weigmann, Benno; Neurath, Markus F.			T(H)9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; TIGHT JUNCTIONS; TH2 CYTOKINE; TGF-BETA; DIFFERENTIATION; OVEREXPRESSION; INDUCTION; IMMUNITY; PROMOTES	The molecular checkpoints that drive inflammatory bowel diseases are incompletely understood. Here we found more T cells expressing the transcription factor PU.1 and interleukin 9 (IL-9) in patients with ulcerative colitis. In an animal model, citrine reporter mice had more IL-9-expressing mucosal T cells in experimental oxazolone-induced colitis. IL-9 deficiency suppressed acute and chronic colitis. Mice with PU.1 deficiency in T cells were protected from colitis, whereas treatment with antibody to IL-9 suppressed colitis. Functionally, IL-9 impaired intestinal barrier function and prevented mucosal wound healing in vivo. Thus, our findings suggest that the T(H)9 subset of helper T cells serves an important role in driving ulcerative colitis by regulating intestinal epithelial cells and that T(H)9 cells represent a likely target for the treatment of chronic intestinal inflammation.	[Gerlach, Katharina; Atreya, Raja; Dornhoff, Heike; Steiner, Stefanie; Wirtz, Stefan; Weigmann, Benno; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Hwang, YouYi; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Nikolaev, Alexej; Waisinan, Ari] Univ Med Ctr Mainz, Inst Mol Med, Mainz, Germany; [Lehr, Hans-Anton] Inst Pathol, Friedrichshafen, Germany; [Vieth, Michael] Bayreuth Clin, Inst Pathol, Bayreuth, Germany; [Rosenbauer, Frank] Univ Munster, Lab Mol Stem Cell Biol, D-48149 Munster, Germany	University of Erlangen Nuremberg; MRC Laboratory Molecular Biology; Johannes Gutenberg University of Mainz; Klinikum Bayreuth; University of Munster	Neurath, MF (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, Kussmaul Campus Med Res, D-91054 Erlangen, Germany.	markus.neurath@uk-erlangen.de	Waisman, Ari/C-7383-2015	Waisman, Ari/0000-0003-4304-8234; Rosenbauer, Frank/0000-0001-7977-9421; Gerlach, Katharina/0000-0001-5855-7205	Clinical Research Group CEDER of the German Research Council; Deutsche Forschungsgemeinschaft [WE 4656/1-1]; Interdisziplinares Zentrum fur Klinische Forschung; Emerging Field Initiative; ELAN programs of the University Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft Collaborative Research Centers [643, 796]; American Asthma Foundation; UK Medical Research Council; Wellcome Trust [100963]; Agency for Science Technology and Research; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	Clinical Research Group CEDER of the German Research Council; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung; Emerging Field Initiative; ELAN programs of the University Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft Collaborative Research Centers(German Research Foundation (DFG)); American Asthma Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Clinical Research Group CEDER of the German Research Council (B.W., R.A. and M.F.N.), Deutsche Forschungsgemeinschaft (WE 4656/1-1 for support of B.W., R.A. and M.F.N.), Interdisziplinares Zentrum fur Klinische Forschung (B.W., R.A. and M.F.N.), the Emerging Field Initiative (B.W., R.A. and MEN.), the ELAN programs of the University Erlangen-Nurnberg (B.W., R.A. and M.F.N.), Deutsche Forschungsgemeinschaft Collaborative Research Centers 643 and 796 (H.D., S.W. and M.F.N.), the American Asthma Foundation, the UK Medical Research Council, the Wellcome Trust (100963 to A.N.J.M.) and the Agency for Science Technology and Research (Y.Y.H.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Devos S, 2006, CLIN EXP ALLERGY, V36, P174, DOI 10.1111/j.1365-2222.2006.02422.x; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Goswami R, 2012, J IMMUNOL, V189, P3026, DOI 10.4049/jimmunol.1201496; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kim HS, 2013, MUCOSAL IMMUNOL, V6, P347, DOI 10.1038/mi.2012.77; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Lejeune D, 2001, BIOCHEM J, V353, P109, DOI 10.1042/bj3530109; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Monteleone I, 2012, CURR MOL MED, V12, P592, DOI 10.2174/156652412800620066; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Mudter J, 2008, J CLIN INVEST, V118, P2415, DOI 10.1172/JCI33227; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ono Y, 2012, GASTROENTEROLOGY, V143, P1288, DOI 10.1053/j.gastro.2012.07.108; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Uyttenhove C, 2010, EUR J IMMUNOL, V40, P2230, DOI 10.1002/eji.200940281; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	46	254	272	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					676	686		10.1038/ni.2920	http://dx.doi.org/10.1038/ni.2920			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24908389				2022-12-18	WOS:000337715600014
J	Zhao, TJ; Yang, L; Sun, Q; Arguello, M; Ballard, DW; Hiscott, J; Lin, RT				Zhao, Tiejun; Yang, Long; Sun, Qiang; Arguello, Meztli; Ballard, Dean W.; Hiscott, John; Lin, Rongtuan			The NEMO adaptor bridges the nuclear factor-kappa B and interferon regulatory factor signaling pathways	NATURE IMMUNOLOGY			English	Article							RIG-I; IKK-EPSILON; TRANSCRIPTION FACTORS; ANTIVIRAL RESPONSES; KINASE IKK; ACTIVATION; VIRUS; PROTEIN; TBK1; RNA	Intracellular detection of RNA virus infection is mediated by the RNA helicase RIG-I, which is recruited to mitochondria by the adaptor protein MAVS and triggers activation of the transcription factors NF-kappa B, IRF3 and IRF7. Here we demonstrate that virus-induced activation of IRF3 and IRF7 depended on the NF-kappa B modulator NEMO, which acted 'upstream' of the kinases TBK1 and IKK epsilon. IRF3 phosphorylation, formation of IRF3 dimers and DNA binding, as well as IRF3-dependent gene expression, were abrogated in NEMO-deficient cells. IRF3 phosphorylation and interferon production were restored by ectopic expression of NEMO. Thus, NEMO, like MAVS, acts as an adaptor protein that allows RIG-I to activate both the NF-kappa B and IRF signaling pathways.	McGill Univ, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; Vanderbilt Univ, Ctr Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Lady Davis Institute; McGill University; McGill University; McGill University; Vanderbilt University	Lin, RT (corresponding author), McGill Univ, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	rongtuan.lin@mcgill.ca	Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503	NCI NIH HHS [CA082556] Funding Source: Medline; NIAID NIH HHS [AI052379] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052379] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Carter RS, 2003, J BIOL CHEM, V278, P19642, DOI 10.1074/jbc.M301705200; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Ku CL, 2005, PEDIATRICS, V115, pE615, DOI 10.1542/peds.2004-1754; Li QT, 2000, GENE DEV, V14, P1729; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nelson DL, 2006, CURR OPIN GENET DEV, V16, P282, DOI 10.1016/j.gde.2006.04.013; Nomura F, 2000, GENES CELLS, V5, P191; Orange JS, 2004, J ALLERGY CLIN IMMUN, V113, P725, DOI 10.1016/j.jaci.2004.01.762; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rudolph D, 2000, GENE DEV, V14, P854; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Uzel G, 2005, CURR OPIN ALLERGY CL, V5, P513, DOI 10.1097/01.all.0000191241.66373.74; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou J, 2001, J VIROL, V75, P5851, DOI 10.1128/JVI.75.13.5851-5859.2001	50	254	265	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					592	600		10.1038/ni1465	http://dx.doi.org/10.1038/ni1465			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17468758				2022-12-18	WOS:000246703300013
J	Yang, CY; Best, JA; Knell, J; Yang, E; Sheridan, AD; Jesionek, AK; Li, HYS; Rivera, RR; Lind, KC; D'Cruz, LM; Watowich, SS; Murre, C; Goldrath, AW				Yang, Cliff Y.; Best, J. Adam; Knell, Jamie; Yang, Edward; Sheridan, Alison D.; Jesionek, Adam K.; Li, Haiyan S.; Rivera, Richard R.; Lind, Kristin Camfield; D'Cruz, Louise M.; Watowich, Stephanie S.; Murre, Cornelis; Goldrath, Ananda W.			The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8(+) T cell subsets	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX PROTEINS; VIRAL-INFECTION; IN-VIVO; EFFECTOR; DIFFERENTIATION; EXPRESSION; SURVIVAL; ROLES; LYMPHOCYTES; INHIBITOR	During infection, naive CD8(+) T cells differentiate into effector cells, which are armed to eliminate pathogens, and memory cells, which are poised to protect against reinfection. The transcriptional program that regulates terminal differentiation into short-lived effector-memory versus long-lived memory cells is not clearly defined. Through the use of mice expressing reporters for the DNA-binding inhibitors Id2 and Id3, we identified Id3(hi) precursors of long-lived memory cells before the peak of T cell population expansion or upregulation of cell-surface receptors that indicate memory potential. Deficiency in Id2 or Id3 resulted in loss of distinct CD8(+) effector and memory populations, which demonstrated unique roles for these inhibitors of E-protein transcription factors. Furthermore, cytokines altered the expression of Id2 and Id3 differently, which provides insight into how external cues influence gene expression.	[Yang, Cliff Y.; Best, J. Adam; Knell, Jamie; Yang, Edward; Sheridan, Alison D.; Jesionek, Adam K.; Rivera, Richard R.; Lind, Kristin Camfield; D'Cruz, Louise M.; Murre, Cornelis; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Li, Haiyan S.; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Watowich, Stephanie S.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu	Li, Haiyan/B-6904-2012	Sheridan, Alison/0000-0002-6831-0668; Watowich, Stephanie/0000-0003-1969-659X	Cancer Research Institute; Pew Charitable Trust; US National Institutes of Health [AI067545, AI072117, AI073587]; University of California San Diego; R.E. Bob Smith Education Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067545, R01AI072117, R21AI073587] Funding Source: NIH RePORTER	Cancer Research Institute; Pew Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego(University of California System); R.E. Bob Smith Education Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Barton, J. Hamerman, S. Turley, A. Fletcher, M. Rubinstein and members of the Goldrath laboratory for advice and critical review of the manuscript; and L. Shaw for help with figure design. Supported by the Cancer Research Institute, Pew Charitable Trust, the US National Institutes of Health (AI067545 and AI072117 to A. W. G.; and AI073587 to S. S. W.), University of California San Diego (Cellular and Molecular Genetics Training Grant to C.Y.Y.) and the R.E. Bob Smith Education Fund (H.S.L.).	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Savitsky D, 2007, ADV EXP MED BIOL, V596, P9; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	50	253	257	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1221	U117		10.1038/ni.2158	http://dx.doi.org/10.1038/ni.2158			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22057289	Green Accepted			2022-12-18	WOS:000297202700017
J	Tordjman, R; Lepelletier, Y; Lemarchandel, V; Cambot, M; Gaulard, P; Hermine, O; Romeo, PH				Tordjman, R; Lepelletier, Y; Lemarchandel, V; Cambot, M; Gaulard, P; Hermine, O; Romeo, PH			A neuronal receptor, neuropilin-I, is essential for the initiation of the primary immune response	NATURE IMMUNOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; IMMUNOLOGICAL SYNAPSE; DENDRITIC CELLS; SEMAPHORIN-III; CONE GUIDANCE; ANTIGEN; IDENTIFICATION; CYTOSKELETON; FAMILY; PLEXIN	The initiation of a primary immune response requires contact between dendritic cells (DCs) and resting T cells. However, little is known about the proteins that mediate this initial contact. We show here that neuropilin-I, a receptor involved in axon guidance, was expressed by human DCs and resting T cells both in vitro and in vivo. The initial contact between DCs and resting T cells led to neuropilin-I polarization on T cells. DCs and resting T cells specifically bound soluble neuropilin-I, and resting T cells formed clusters with neuropilin-I-transfected COS-7 cells in a neuropilin-I-dependent manner. Functionally, preincubation of DCs or resting T cells with blocking neuropilin-I antibodies inhibited DC-induced proliferation of resting T cells. These data suggest that neuropilin-I mediates interactions between DCs and T cells that are essential for initiation of the primary immune response and show parallels between the nervous and immune systems.	Inst Cochin Genet Mol, Dept Hematol, INSERM, U567,CNRS,UMR 8104, F-75014 Paris, France; Hop Necker Enfants Malad, CNRS, UMR 8603, Paris, France; Hop Necker Enfants Malad, Serv Hematol, Paris, France; Hop Henri Mondor, Dept Pathol EA 2348, F-94010 Creteil, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Tordjman, R (corresponding author), Inst Cochin Genet Mol, Dept Hematol, INSERM, U567,CNRS,UMR 8104, F-75014 Paris, France.		Romeo, Paul-Henri/L-5989-2017; Hermine, Olivier/Q-7072-2018; lepelletier, yves/AAF-1546-2020	Romeo, Paul-Henri/0000-0002-8294-0367; lepelletier, yves/0000-0001-7746-5170; Hermine, Olivier/0000-0003-2574-3874; gaulard, philippe/0000-0002-4243-905X				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; Delemarre FGA, 2001, J LEUKOCYTE BIOL, V69, P373; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KRENACS L, 1993, J PATHOL, V171, P99, DOI 10.1002/path.1711710206; Langerhans P, 1868, VIRCHOWS ARCH PATHOL, V44, P325, DOI [DOI 10.1007/BF01959006, 10.1007/BF01959006]; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tordjman R, 1999, BLOOD, V94, P2301, DOI 10.1182/blood.V94.7.2301.419k24_2301_2309; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	28	253	275	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					477	482		10.1038/ni789	http://dx.doi.org/10.1038/ni789			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11953749				2022-12-18	WOS:000175411200017
J	Wu, J; Wu, YQ; Ricklin, D; Janssen, BJC; Lambris, JD; Gros, P				Wu, Jin; Wu, You-Qiang; Ricklin, Daniel; Janssen, Bert J. C.; Lambris, John D.; Gros, Piet			Structure of complement fragment C3b-factor H and implications for host protection by complement regulators	NATURE IMMUNOLOGY			English	Article							HEMOLYTIC-UREMIC-SYNDROME; TRANSLATIONAL MINIREVIEW SERIES; DECAY-ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; DENSE DEPOSIT DISEASE; MEMBRANOPROLIFERATIVE-GLOMERULONEPHRITIS; MACULAR DEGENERATION; FACTOR-B; FACTOR-I; CONFORMATIONAL-CHANGES	Factor H (FH) is an abundant regulator of complement activation and protects host cells from self-attack by complement. Here we provide insight into the regulatory activity of FH by solving the crystal structure of the first four domains of FH in complex with its target, complement fragment C3b. FH interacted with multiple domains of C3b, covering a large, extended surface area. The structure indicated that FH destabilizes the C3 convertase by competition and electrostatic repulsion and that FH enables proteolytic degradation of C3b by providing a binding platform for protease factor I while stabilizing the overall domain arrangement of C3b. Our results offer general models for complement regulation and provide structural explanations for disease-related mutations in the genes encoding both FH and C3b.	[Wu, You-Qiang; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wu, Jin; Janssen, Bert J. C.; Gros, Piet] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Pennsylvania; Utrecht University	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	lambris@upenn.edu; p.gros@uu.nl	Gros, Piet/I-5569-2016; Gros, Piet/AAD-6452-2019; Janssen, Bert/I-3338-2016; Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233	NIAID NIH HHS [R01 AI030040, P01 AI068730-029001, R01 AI030040-14, P01 AI068730] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, R01AI030040] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALSENZ J, 1984, BIOCHEM J, V224, P389, DOI 10.1042/bj2240389; BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Fritzinger DC, 2009, DEV COMP IMMUNOL, V33, P105, DOI 10.1016/j.dci.2008.07.006; GORDON DL, 1995, J IMMUNOL, V155, P348; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Hourcade DE, 2002, J BIOL CHEM, V277, P1107, DOI 10.1074/jbc.M109322200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Kuttner-Kondo L, 2007, J BIOL CHEM, V282, P18552, DOI 10.1074/jbc.M611650200; Lambris JD, 1996, J IMMUNOL, V156, P4821; LAMBRIS JD, 1980, J EXP MED, V152, P1625, DOI 10.1084/jem.152.6.1625; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Licht C, 2006, KIDNEY INT, V70, P42, DOI 10.1038/sj.ki.5000269; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meri S, 2007, ANN NY ACAD SCI, V1109, P93, DOI 10.1196/annals.1398.011; Noris M, 2008, CLIN EXP IMMUNOL, V151, P199, DOI 10.1111/j.1365-2249.2007.03552.x; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Sahu A, 1998, J IMMUNOL, V160, P5596; Saunders RE, 2006, HUM MUTAT, V27, P21, DOI 10.1002/humu.20268; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yadav VN, 2008, J VIROL, V82, P3283, DOI 10.1128/JVI.01935-07	50	252	257	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					728	U79		10.1038/ni.1755	http://dx.doi.org/10.1038/ni.1755			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19503104	Green Accepted			2022-12-18	WOS:000267142600012
J	Hara, H; Ishihara, C; Takeuchi, A; Imanishi, T; Xue, LQ; Morris, SW; Inui, M; Takai, T; Shibuya, A; Saijo, S; Iwakura, Y; Ohno, N; Koseki, H; Yoshida, H; Penninger, JM; Saito, T				Hara, Hiromitsu; Ishihara, Chitose; Takeuchi, Arata; Imanishi, Takayuki; Xue, Liquan; Morris, Stephan W.; Inui, Masanori; Takai, Toshiyuki; Shibuya, Akira; Saijo, Shinobu; Iwakura, Yoichiro; Ohno, Naohito; Koseki, Haruhiko; Yoshida, Hiroki; Penninger, Josef M.; Saito, Takashi			The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; PATTERN-RECOGNITION; IMMUNE-SYSTEM; GAMMA-CHAIN; MAST-CELL; T-CELL; LYMPHOCYTE-ACTIVATION; RIG-I; INNATE	Immunoreceptor tyrosine-based activation motifs (ITAMs) are crucial in antigen receptor signaling in acquired immunity. Although receptors associated with the ITAM-bearing adaptors FcRc and DAP12 on myeloid cells have been suggested to activate innate immune responses, the mechanism coupling those receptors to 'downstream' signaling events is unclear. The CARMA1-Bcl-10-MALT1 complex is critical for the activation of transcription factor NF-kappa B in lymphocytes but has an unclear function in myeloid cells. Here we report that deletion of the gene encoding the Bcl-10 adaptor-binding partner CARD9 resulted in impaired myeloid cell activation of NF-kappa B signaling by several ITAM-associated receptors. Moreover, CARD9 was required for Toll-like receptor-induced activation of dendritic cells through the activation of mitogen-activated protein kinases. Although Bcl10(-/-) and Card9(-/-) mice had similar signaling impairment in myeloid cells, Card11(-/-) (CARMA1-deficient) myeloid cell responses were normal, and although Card11(-/-) lymphocytes were defective in antigen receptor-mediated activation, Card9(-/-) lymphocytes were not. Thus, the activation of lymphoid and myeloid cells through ITAM-associated receptors or Toll-like receptors is regulated by CARMA1-Bcl-10 and CARD9-Bcl-10, respectively.	RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; Saga Univ, Fac Med, Dept Biomol Sci, Saga 8498501, Japan; St Jude Childrens Hosp, Dept Pathol & Oncol, Memphis, TN 38105 USA; Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan; Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 1920392, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Kanagawa 2300045, Japan; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	RIKEN; Saga University; St Jude Children's Research Hospital; Tohoku University; University of Tsukuba; University of Tokyo; Tokyo University of Pharmacy & Life Sciences; RIKEN; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Saito, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan.	harah@cc.saga-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Koseki, Haruhiko/I-3825-2014; Penninger, Josef M/I-6860-2013; Saito, Takashi/C-9684-2009	Iwakura, Yoichiro/0000-0002-9934-5775; Koseki, Haruhiko/0000-0001-8424-5854; Penninger, Josef M/0000-0002-8194-3777; Saito, Takashi/0000-0001-9495-3547; Takeuchi, Arata/0000-0003-0412-533X	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA087064] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA87064, CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hida S, 2006, MICROBIOL IMMUNOL, V50, P453, DOI 10.1111/j.1348-0421.2006.tb03814.x; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Liu YL, 2004, J BIOL CHEM, V279, P37436, DOI 10.1074/jbc.M400241200; Lopez-Botet M, 2000, HUM IMMUNOL, V61, P7, DOI 10.1016/S0198-8859(99)00161-5; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; Merck E, 2004, BLOOD, V104, P1386, DOI 10.1182/blood-2004-03-0850; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yanagawa Y, 2006, IMMUNOLOGY, V117, P526, DOI 10.1111/j.1365-2567.2006.02329.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200	53	252	269	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					619	629		10.1038/ni1466	http://dx.doi.org/10.1038/ni1466			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17486093				2022-12-18	WOS:000246703300016
J	Han, JH; Ulevitch, RJ				Han, JH; Ulevitch, RJ			Limiting inflammatory responses during activation of innate immunity	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; MESSENGER-RNA DECAY; TOLL-LIKE RECEPTORS; AU-RICH ELEMENT; CYTOKINE SIGNALING SOCS; TNF-ALPHA BIOSYNTHESIS; PROTEIN-KINASE P38; GROWTH-FACTOR-BETA; NEGATIVE REGULATOR; INTERLEUKIN-1 RECEPTOR	The idea of the importance of mounting an inflammatory response for effective immunity is supported by a multiplicity of experimental data. It is also well understood that resolution of inflammation is essential for maintaining the balance between health and disease. When the normal regulatory mechanisms are disturbed, the potential for developing chronic inflammatory diseases is increased. Inflammation is a key element in the response of the innate immune system to a variety of challenges, including those provided by bacterial and viral infection as well as by damaged or dying host cells. Here we review elements of innate immunity that lead to inflammation and some of the host mechanisms that allow for the resolution of the inflammatory responses.	Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Xiamen University; Scripps Research Institute	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	jhan@scripps.edu	Ulevitch, Richard J/Q-3393-2017; Han, J/G-4671-2010		NIAID NIH HHS [AI54523, AI54796, AI15136, AI41637] Funding Source: Medline; NIGMS NIH HHS [GM67101, GM28485, GM37696] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054796, R01AI015136, R01AI041637, U54AI054523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696, R37GM028485, R01GM028485, R01GM067101] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Beutler B, 2005, ADV EXP MED BIOL, V560, P29; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CARTNEYFRANCIS N, 2004, J IMMUNOL, V172, P3814; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; DUNNE A, 2003, SCI STKE; Elkins KL, 1999, J IMMUNOL, V162, P2291; Ferrante JV, 2005, J IMMUNOL, V174, P3169, DOI 10.4049/jimmunol.174.6.3169; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Heckelsmiller K, 2002, EUR J IMMUNOL, V32, P3235, DOI 10.1002/1521-4141(200211)32:11<3235::AID-IMMU3235>3.0.CO;2-J; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Latchman David S., 2000, Current Pharmaceutical Biotechnology, V1, P57, DOI 10.2174/1389201003379022; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Monick MM, 2002, J BIOL CHEM, V277, P32992, DOI 10.1074/jbc.M203218200; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reddy KV, 2004, J LEUKOCYTE BIOL, V76, P145, DOI 10.1189/jlb.0204068; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Suzuki N, 2002, TRENDS IMMUNOL, V23, P503, DOI 10.1016/S1471-4906(02)02298-6; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Walker PS, 1999, P NATL ACAD SCI USA, V96, P6970, DOI 10.1073/pnas.96.12.6970; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499; Zimmermann S, 1998, J IMMUNOL, V160, P3627	100	252	268	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1198	1205		10.1038/ni1274	http://dx.doi.org/10.1038/ni1274			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369559				2022-12-18	WOS:000233371900005
J	Minter, LM; Turley, DM; Das, P; Shin, HM; Joshi, I; Lawlor, RG; Cho, OH; Palaga, T; Gottipati, S; Telfer, JC; Kostura, L; Fauq, AH; Simpson, K; Such, KA; Miele, L; Golde, TE; Miller, SD; Osborne, BA				Minter, LM; Turley, DM; Das, P; Shin, HM; Joshi, I; Lawlor, RG; Cho, OH; Palaga, T; Gottipati, S; Telfer, JC; Kostura, L; Fauq, AH; Simpson, K; Such, KA; Miele, L; Golde, TE; Miller, SD; Osborne, BA			Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21	NATURE IMMUNOLOGY			English	Article							A-BETA; TRANSCRIPTION FACTOR; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; LINEAGE COMMITMENT; EXPRESSION; RESPONSES; CELLS; DIFFERENTIATION; STAT1	Notch receptors are processed by gamma secretase acting in synergy with T cell receptor signaling to sustain peripheral T cell activation. Activated CD4(+) T cells differentiate into T helper type 1 ( T(H)1) or T(H)2 subsets. Molecular cues directing TH1 differentiation include expression of the T(H)1-specific transcription factor T-bet, encoded by Tbx21. However, the regulation of Tbx21 remains incompletely defined. Here we report that Notch1 can directly regulate Tbx21 through complexes formed on the Tbx21 promoter. In vitro, gamma-secretase inhibitors extinguished expression of Notch, interferon-gamma and Tbx21 in T(H)1-polarized CD4(+) cells, whereas ectopic expression of activated Notch1 restored Tbx21 transcription. In vivo, administration of gamma-secretase inhibitors substantially impeded T(H)1-mediated disease progression in the mouse experimental autoimmune encephalomyelitis model of multiple sclerosis. Thus, using gamma-secretase inhibitors to modulate Notch signaling may prove beneficial in treating T(H)1-mediated autoimmunity.	Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol & Interdept Immunobiol Ctr, Chicago, IL 60611 USA; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA	University of Massachusetts System; University of Massachusetts Amherst; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Chulalongkorn University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Osborne, BA (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	osborne@vasci.umass.edu	Salzet, Michel/A-7675-2011; Minter, Lisa/H-6539-2014; Such, Kimberly/J-2643-2012	Salzet, Michel/0000-0003-4318-0817; Miele, Lucio/0000-0002-5853-7287				Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Barth H, 2002, J NEUROIMMUNOL, V133, P175, DOI 10.1016/S0165-5728(02)00355-7; Berezovska O, 2001, J BIOL CHEM, V276, P30018, DOI 10.1074/jbc.M008268200; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; DALCANTO MC, 1995, MICROSC RES TECHNIQ, V32, P215, DOI 10.1002/jemt.1070320305; DE SB, 1999, NATURE, V398, P518; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; Hartung AD, 2003, CLIN EXP RHEUMATOL, V21, P481; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kipnis A, 2003, J LEUKOCYTE BIOL, V74, P992, DOI 10.1189/jlb.0603301; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Parronchi P, 1997, AM J PATHOL, V150, P823; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Seki N, 2004, J IMMUNOL, V172, P6158, DOI 10.4049/jimmunol.172.10.6158; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Siemers ER, 2004, NEUROLOGY, V62, pA174; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Weinmann AS, 2004, NAT REV IMMUNOL, V4, P381, DOI 10.1038/nri1353; Wong KK, 2003, J CLIN INVEST, V112, P1741, DOI 10.1172/JCI18020; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhou SF, 2001, MOL CELL BIOL, V21, P6222, DOI 10.1128/MCB.21.18.6222-6232.2001	48	252	265	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					680	688		10.1038/ni1209x	http://dx.doi.org/10.1038/ni1209x			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15991363				2022-12-18	WOS:000229975500011
J	Barda-Saad, M; Braiman, A; Titerence, R; Bunnell, SC; Barr, VA; Samelson, LE				Barda-Saad, M; Braiman, A; Titerence, R; Bunnell, SC; Barr, VA; Samelson, LE			Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton	NATURE IMMUNOLOGY			English	Article							WISKOTT-ALDRICH-SYNDROME; APC CONTACT SITE; IMMUNOLOGICAL SYNAPSE; SYNDROME PROTEIN; SIGNAL-TRANSDUCTION; ARP2/3 COMPLEX; ACTIVATION; LAT; RECRUITMENT; WASP	T cell receptor (TCR) engagement leads to actin polymerization at the site of T cell contact with antigen-presenting cells. Here we have studied the dynamic activity of proteins involved in regulating actin polymerization in live T cells after activation. Two such adaptor proteins, Nck and the Wiskott-Aldrich syndrome protein (WASp), were recruited to the TCR during initial T cell activation, where they colocalized with the tyrosine kinase Zap70. The recruitment of Nck and WASp depended on TCR-induced tyrosine phosphorylation and the LAT and SLP-76 adaptors. Nck and WASp migrated peripherally and accumulated at an actin-rich circumferential ring. Thus, actin polymerization regulated by the TCR begins at the TCR. Molecules recruited to the TCR regulate actin polymerization and this process drives plasma membrane movement and cellular spreading.	NCI, Cellular & Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Samelson, LE (corresponding author), NCI, Cellular & Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA.	samelson@helix.nih.gov	Braiman, Alex/F-2179-2012; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Braiman, Alex/0000-0003-2802-1148; Bunnell, Stephen/0000-0001-6887-0828	NATIONAL CANCER INSTITUTE [ZIABC010304, Z01BC010304] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Astoul E, 2003, J BIOL CHEM, V278, P9267, DOI 10.1074/jbc.M211252200; Badour K, 2003, IMMUNOL REV, V192, P98, DOI 10.1034/j.1600-065X.2003.00031.x; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Derry JM, 1994, CELL, V79, P922; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Finkelstein LD, 2004, TRENDS CELL BIOL, V14, P443, DOI 10.1016/j.tcb.2003.07.001; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Laurence A, 2004, EUR J IMMUNOL, V34, P587, DOI 10.1002/eji.200324598; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; RemoldODonnell E, 1996, BLOOD, V87, P2621, DOI 10.1182/blood.V87.7.2621.bloodjournal8772621; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Szollosi J, 1998, CYTOMETRY, V34, P159; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	43	252	258	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					80	89		10.1038/ni1143	http://dx.doi.org/10.1038/ni1143			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15558067				2022-12-18	WOS:000225888500021
J	Zhang, Y; Lu, LW; Furlonger, C; Wu, GE; Paige, CJ				Zhang, Y; Lu, LW; Furlonger, C; Wu, GE; Paige, CJ			Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis	NATURE IMMUNOLOGY			English	Article							DEFECTIVE LYMPHOID DEVELOPMENT; RECEPTOR-GAMMA CHAIN; SUBSTANCE-P RECEPTOR; PORCINE SPINAL-CORD; BONE-MARROW STROMA; MICE LACKING JAK3; NEUROMEDIN-K; NEUROKININ-1 RECEPTOR; MAMMALIAN TACHYKININ; TARGETED DELETION	We report here the molecular cloning of a newly identified preprotachykinin gene, Pptc, which specifies the sequence for a new preprotachykinin protein and bioactive peptide designated hemokinin 1 (HK-1), PPI-C mRNA was detected primarily in hematopoietic cells in contrast to the previously described Ppta and Pptb genes, which are predominantly expressed in neuronal tissues. HK-1 has several biological activities that are similar to the most studied tachykinin, substance P, such as induction of plasma extravasation and mast cell degranulation. However, HK-1 also has properties that are indicative of a critical role in mouse B cell development. HK-1 stimulated the proliferation of interleukin 7-expanded B cell precursors, whereas substance P had no effect. HK-1, but not substance P, promoted the survival of freshly isolated bone marrow B lineage cells or cultured, lipopolysaccharide-stimulated pre-B cells. N-acetyl-L-trytophan-3,5-bistrifluromethyl benzyl ester, a tachykinin receptor antagonist, increased apoptosis of these cells and in vivo administration of this antagonist led to specific reductions of the B220(low)CD43(-) population (the pre-B cell compartment) in the bone marrow and the IgM(high)IgD(low) population (the newly generated B cells) in the spleen. Thus, HK-1 may be an autocrine factor that is important for the survival of B cell precursors at a critical phase of development.	Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Paige, CJ (corresponding author), Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.		wu, ge/ABE-3285-2020; Lu, Liwei/C-4357-2009	Lu, Liwei/0000-0002-8634-0967				BERTACCINI G, 1976, PHARMACOL REV, V28, P127; Bhatia M, 1998, P NATL ACAD SCI USA, V95, P4760, DOI 10.1073/pnas.95.8.4760; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CASCIERI MA, 1994, J BIOL CHEM, V269, P6587; Castagliuolo I, 1998, J CLIN INVEST, V101, P1547, DOI 10.1172/JCI2039; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; Conley ME, 1998, CURR OPIN IMMUNOL, V10, P399, DOI 10.1016/S0952-7915(98)80112-X; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DEVILLIER P, 1985, EUR J PHARMACOL, V117, P89, DOI 10.1016/0014-2999(85)90475-3; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; ERSPAMER V, 1981, TRENDS NEUROSCI, V4, P267, DOI 10.1016/0166-2236(81)90084-9; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; HARRIS RB, 1989, ARCH BIOCHEM BIOPHYS, V275, P315, DOI 10.1016/0003-9861(89)90379-2; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; KIMURA S, 1983, P JPN ACAD B-PHYS, V59, P101, DOI 10.2183/pjab.59.101; KOTANI H, 1986, P NATL ACAD SCI USA, V83, P7074, DOI 10.1073/pnas.83.18.7074; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; LIU L, 1997, J IMMUNOL, V158, P5136; MACLEOD AM, 1993, J MED CHEM, V36, P2044, DOI 10.1021/jm00066a015; Manske JM, 1995, ADV EXP MED BIOL, V383, P53; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; NAWA H, 1984, LIFE SCI, V34, P1153, DOI 10.1016/0024-3205(84)90087-0; NAWA H, 1983, NATURE, V306, P32, DOI 10.1038/306032a0; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Nussenzweig MC, 1998, CELL, V95, P875, DOI 10.1016/S0092-8674(00)81711-0; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RAMESHWAR P, 1993, BLOOD, V81, P391; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Rameshwar P, 1996, BLOOD, V88, P98; REGOLI D, 1994, PHARMACOL REV, V46, P551; Seabrook GR, 1996, EUR J PHARMACOL, V317, P129, DOI 10.1016/S0014-2999(96)00706-6; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; STODDART A, 1996, NUCLEIC ACIDS RES, V20, P4003; ten Boekel E, 1999, CURR TOP MICROBIOL, V246, P3; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; von Euler US, 1931, J PHYSIOL-LONDON, V72, P74, DOI 10.1113/jphysiol.1931.sp002763; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	46	252	261	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					392	397		10.1038/80826	http://dx.doi.org/10.1038/80826			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062498				2022-12-18	WOS:000165076100011
J	Shrestha, S; Yang, K; Guy, C; Vogel, P; Neale, G; Chi, HB				Shrestha, Sharad; Yang, Kai; Guy, Cliff; Vogel, Peter; Neale, Geoffrey; Chi, Hongbo			T-reg cells require the phosphatase PTEN to restrain T(H)1 and T-FH cell responses	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER; DIFFERENTIATION; IL-2; HOMEOSTASIS; ACTIVATION; STABILITY; FOXP3; LEADS; INSTABILITY; GENERATION	The interplay between effector T cells and regulatory T cells (T-reg cells) is crucial for adaptive immunity, but how T-reg cells control diverse effector responses is elusive. We found that the phosphatase PTEN links T-reg cell stability to repression of type 1 helper T cell (T(H)1 cell) and follicular helper T cell (T-FH cell) responses. Depletion of PTEN in T-reg cells resulted in excessive T-FH cell and germinal center responses and spontaneous inflammatory disease. These defects were considerably blocked by deletion of interferon-gamma, indicating coordinated control of T(H)1 and T-FH responses. Mechanistically, PTEN maintained T-reg cell stability and metabolic balance between glycolysis and mitochondrial fitness. Moreover, PTEN deficiency upregulates activity of the metabolic checkpoint kinase complex mTORC2 and the serine-threonine kinase Akt, and loss of this activity restores functioning of PTEN-deficient T-reg cells. Our studies establish a PTEN-mTORC2 axis that maintains T-reg cell stability and coordinates T-reg cell-mediated control of effector responses.	[Shrestha, Sharad; Yang, Kai; Guy, Cliff; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Shrestha, Sharad; Chi, Hongbo] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Vogel, Peter/N-2490-2018	Chi, Hongbo/0000-0002-9997-2496; Vogel, Peter/0000-0002-7535-0545	US National Institutes of Health [AI105887, AI101407, CA176624, NS064599]; American Cancer Society; Crohn's and Colitis Foundation of America; Arthritis Foundation; NATIONAL CANCER INSTITUTE [R01CA176624, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101407, R37AI105887, R01AI105887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Crohn's and Colitis Foundation of America; Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank J. Wei, D. Bastardo Blanco and S. Brown for help with immunological assays; C. Cloer and B. Rhode for animal colony management; A. Rudensky for Foxp3<SUP>YFP-Cre</SUP> mice and the St. Jude Immunology FACS core facility for cell sorting. Supported by US National Institutes of Health (AI105887, AI101407, CA176624 and NS064599 to H.C.), the American Cancer Society (to H.C.) and the Crohn's and Colitis Foundation of America (to H.C.), and the Arthritis Foundation (to K.Y.).	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Huynh A., 2015, NAT IMMUNOL; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu XH, 2010, J CLIN INVEST, V120, P2497, DOI 10.1172/JCI42382; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin HM, 2013, IMMUNITY, V39, P661, DOI 10.1016/j.immuni.2013.08.032; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Soond DR, 2012, J IMMUNOL, V188, P5935, DOI 10.4049/jimmunol.1102116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Wei J, 2014, J IMMUNOL, V193, P4297, DOI 10.4049/jimmunol.1402042; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zanin-Zhorov A, 2012, P NATL ACAD SCI USA, V109, P1625, DOI 10.1073/pnas.1110120109; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	51	251	269	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					178	+		10.1038/ni.3076	http://dx.doi.org/10.1038/ni.3076			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25559258	Green Accepted			2022-12-18	WOS:000348143100010
J	Man, K; Miasari, M; Shi, W; Xin, A; Henstridge, DC; Preston, S; Pellegrini, M; Belz, GT; Smyth, GK; Febbraio, MA; Nutt, SL; Kallies, A				Man, Kevin; Miasari, Maria; Shi, Wei; Xin, Annie; Henstridge, Darren C.; Preston, Simon; Pellegrini, Marc; Belz, Gabrielle T.; Smyth, Gordon K.; Febbraio, Mark A.; Nutt, Stephen L.; Kallies, Axel			The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells	NATURE IMMUNOLOGY			English	Article							SELECTIVE EXPANSION; MEMORY; EFFECTOR; DIFFERENTIATION; VIRUS; EXPRESSION; THRESHOLD; INFECTION; MIGRATION; BLIMP-1	During immune responses, T cells are subject to clonal competition, which leads to the predominant expansion of high-affinity clones; however, there is little understanding of how this process is controlled. We found here that the transcription factor IRF4 was induced in a manner dependent on affinity for the T cell antigen receptor (TCR) and acted as a dose-dependent regulator of the metabolic function of activated T cells. IRF4 regulated the expression of key molecules required for the aerobic glycolysis of effector T cells and was essential for the clonal expansion and maintenance of effector function of antigen-specific CD8(+) T cells. Thus, IRF4 is an indispensable molecular 'rheostat' that 'translates' TCR affinity into the appropriate transcriptional programs that link metabolic function with the clonal selection and effector differentiation of T cells.	[Man, Kevin; Miasari, Maria; Shi, Wei; Xin, Annie; Preston, Simon; Pellegrini, Marc; Belz, Gabrielle T.; Smyth, Gordon K.; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Man, Kevin; Miasari, Maria; Xin, Annie; Preston, Simon; Pellegrini, Marc; Belz, Gabrielle T.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Henstridge, Darren C.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Baker Heart and Diabetes Institute; University of Melbourne	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Belz, Gabrielle T/C-9350-2013; Pellegrini, Marc/F-7670-2014; Smyth, Gordon/B-5276-2008; Febbraio, Mark/AAE-9632-2019	Nutt, Stephen L/0000-0002-0020-6637; Belz, Gabrielle T/0000-0002-9660-9587; Smyth, Gordon/0000-0001-9221-2892; Pellegrini, Marc/0000-0003-3627-3126; Preston, Simon/0000-0001-8969-8297; Man, Kevin/0000-0002-6585-9532; Kallies, Axel/0000-0002-6312-6968; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council of Australia; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute; Australian Research Council; National Heart Foundation; The Walter and Eliza Hall Institute Genomics Fund	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); National Heart Foundation(National Heart Foundation of Australia); The Walter and Eliza Hall Institute Genomics Fund	We thank T. W. Mak (Campbell Family Cancer Research Institute) for Irf4<SUP>-/-</SUP> mice; U. Klein (Columbia University) for mice with loxP-flanked Irf4 alleles; S. M. Kaech (Yale University School of Medicine) for mice expressing Cre under the control of Gzmb; P. Bouillet (The Walter and Eliza Hall Institute) for Bim<SUP>-/-</SUP> mice; S. Cory (The Walter and Eliza Hall Institute) for mice with transgenic overexpression of Bcl-2 in all hematopoietic cells (Vav-Bcl2tg mice); D. Zehn (Swiss Vaccine Research Institute) for OVA-expressing L. monocytogenes variants; A. M. Lew (The Walter and Eliza Hall Institute) for HKx31-OVA; S. Sterle, R. Cole, N. Iannarella and L. Mackiewicz for technical support; and D. Segal, P. D. Hodgkin, L. M. Corcoran, S. Heinzel, F. Masson (all The Walter and Eliza Hall Institute) and C. Palmer (Burnet Institute) for antibodies and discussions. Supported by the National Health and Medical Research Council of Australia (M. P., G. T. B., G. K. S., S. L. N., M. A. F. and A. K.), the Sylvia and Charles Viertel Foundation (A. K. and G. T. B.), the Howard Hughes Medical Institute (G. T. B.), the Australian Research Council (S. L. N. and A. K.), the National Heart Foundation (D. C. H.) and The Walter and Eliza Hall Institute Genomics Fund (A. K., G. T. B. and W. S.), the Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support scheme.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Belz GT, 2010, CURR OPIN IMMUNOL, V22, P279, DOI 10.1016/j.coi.2010.03.008; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Ritchie RH, 2012, DIABETOLOGIA, V55, P3369, DOI 10.1007/s00125-012-2720-0; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Seah SG, 2012, EUR J IMMUNOL, V42, P1744, DOI 10.1002/eji.201142211; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Smith-Garvin JE, 2010, BLOOD, V116, P5548, DOI 10.1182/blood-2010-06-292748; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wensveen FM, 2010, IMMUNITY, V32, P754, DOI 10.1016/j.immuni.2010.06.005; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	60	251	254	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1155	U79		10.1038/ni.2710	http://dx.doi.org/10.1038/ni.2710			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24056747				2022-12-18	WOS:000326023400012
J	Stewart-Jones, GBE; McMichael, AJ; Bell, JI; Stuart, DI; Jones, EY				Stewart-Jones, GBE; McMichael, AJ; Bell, JI; Stuart, DI; Jones, EY			A structural basis for immunodominant human T cell receptor recognition	NATURE IMMUNOLOGY			English	Article							ELECTRON-DENSITY MAPS; INFLUENZA-A; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; TRANSGENIC MICE; MATRIX PEPTIDE; COMPLEX; TCR; PROTEIN; HLA-A2	The anti-influenza CD8(+) T cell response in HLA-A2-positive adults is almost exclusively directed at residues 58-66 of the virus matrix protein (MP(58-66)). V(beta)17V(alpha)10.2 T cell receptors (TCRs) containing a conserved arginine-serine-serine sequence in complementarity determining region 3 (CDR3) of the V-beta segment dominate this response. To investigate the molecular basis of immunodominant selection in an outbred population, we have determined the crystal structure of V(beta)17V(alpha)10.2 in complex with MP(58-66)-HLA-A2 at a resolution of 1.4 Angstrom. We show that, whereas the TCR typically fits over an exposed side chain of the peptide, in this structure MP(58-66) exposes only main chain atoms. This distinctive orientation of V(beta)17V(alpha)10.2, which is almost orthogonal to the peptide-binding groove of HLA-A2, facilitates insertion of the conserved arginine in V-beta CDR3 into a notch in the surface of MP(58-66)-HLA-A2. This previously unknown binding mode underlies the immunodominant T cell response.	Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Off Regius Prof Med, Oxford OX3 9DS, England; Univ Oxford, Watherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford; University of Oxford; University of Oxford	Jones, EY (corresponding author), Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk	Jones, Yvonne/J-2293-2016; Stewart-Jones, Guillaume/E-7013-2013; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893				ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1994, J MOL BIOL, V239, P581, DOI 10.1006/jmbi.1994.1398; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Hubbard S., 1996, NACCESS COMPUTER PRO; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lawson TM, 2001, INT IMMUNOL, V13, P1373, DOI 10.1093/intimm/13.11.1373; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MAN S, 1994, J IMMUNOL, V153, P4458; MAN S, 1995, INT IMMUNOL, V7, P597, DOI 10.1093/intimm/7.4.597; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	31	251	263	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					657	663		10.1038/ni942	http://dx.doi.org/10.1038/ni942			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12796775				2022-12-18	WOS:000183952500013
J	Theofilopoulos, AN; Kono, DH; Baccala, R				Theofilopoulos, Argyrios N.; Kono, Dwight H.; Baccala, Roberto			The multiple pathways to autoimmunity	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; ARYL-HYDROCARBON RECEPTOR; LONG NONCODING RNA; CHAIN FATTY-ACIDS; I INTERFERON; B-CELLS; NUCLEIC-ACID; MOLECULAR MIMICRY; X-INACTIVATION	Efforts to understand autoimmunity have been pursued relentlessly for several decades. It has become apparent that the immune system evolved multiple mechanisms for controlling self-reactivity, and defects in one or more of these mechanisms can lead to a breakdown of tolerance. Among the multitude of lesions associated with disease, the most common seem to affect peripheral tolerance rather than central tolerance. The initial trigger for both systemic autoimmune disorders and organ-specific autoimmune disorders probably involves the recognition of self or foreign molecules, especially nucleic acids, by innate sensors. Such recognition, in turn, triggers inflammatory responses and the engagement of previously quiescent autoreactive T cells and B cells. Here we summarize the most prominent autoimmune pathways and identify key issues that require resolution for full understanding of pathogenic autoimmunity.	[Theofilopoulos, Argyrios N.; Kono, Dwight H.; Baccala, Roberto] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA	Scripps Research Institute	Theofilopoulos, AN; Baccala, R (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	argyrio@scripps.edu; rbaccala@scripps.edu		Baccala, Roberto/0000-0002-3159-8469	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR065919, AR068910]; National Heart, Lung and Blood Institute [HL114408]; National Institute of Allergy and Infectious Diseases [AI121525, AI117563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117563, R56AI121525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068910, R01AR065919] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. Beutler, D. Burton, L. Teyton and D. Nemazee for manuscript review and advice. Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR065919 and AR068910 to A.N.T.), the National Heart, Lung and Blood Institute (HL114408 to D.H.K.) and the National Institute of Allergy and Infectious Diseases (AI121525 and AI117563 to R.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Anderson MS, 2015, IMMUNITY, V42, P986, DOI 10.1016/j.immuni.2015.06.004; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Baccala R, 2012, J IMMUNOL, V189, P5976, DOI 10.4049/jimmunol.1201477; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Brooks WH, 2010, CLIN REV ALLERG IMMU, V39, P20, DOI 10.1007/s12016-009-8167-5; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Ceeraz S, 2017, ARTHRITIS RHEUMATOL, V69, P814, DOI 10.1002/art.40020; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Doyle HA, 2012, CURR OPIN IMMUNOL, V24, P112, DOI 10.1016/j.coi.2011.12.003; Dragin N, 2016, J CLIN INVEST, V126, P1525, DOI 10.1172/JCI81894; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Friesen TJ, 2016, J EXP MED, V213, P913, DOI 10.1084/jem.20151990; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Garo LP, 2016, CELL MOL LIFE SCI, V73, P2041, DOI 10.1007/s00018-016-2167-4; Getahun A, 2016, J EXP MED, V213, P751, DOI 10.1084/jem.20150537; Glenn F. D., 2016, J INTERFERON CYTOKIN, V36, P347; Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385; Grimaldi CM, 2006, J IMMUNOL, V176, P2703, DOI 10.4049/jimmunol.176.5.2703; Guo JT, 2015, CELL MOL IMMUNOL, V12, P525, DOI 10.1038/cmi.2015.12; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Harris VM, 2016, CLIN IMMUNOL, V168, P25, DOI 10.1016/j.clim.2016.04.002; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kalekar LA, 2016, NAT IMMUNOL, V17, P304, DOI 10.1038/ni.3331; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Knip M, 2016, NAT REV ENDOCRINOL, V12, P154, DOI 10.1038/nrendo.2015.218; Kobayashi T, 2014, IMMUNITY, V41, P375, DOI 10.1016/j.immuni.2014.08.011; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Kono D. H., 2017, KELLEY FIRESTEINS TX, V2, P301; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Lai MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12207; Lamagna C, 2014, J IMMUNOL, V192, P919, DOI 10.4049/jimmunol.1301979; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Miyara M, 2014, NAT REV RHEUMATOL, V10, P543, DOI 10.1038/nrrheum.2014.105; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Neff CP, 2016, CELL HOST MICROBE, V20, P535, DOI 10.1016/j.chom.2016.09.002; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Oltedal B. E., 2015, IMMUNITY, V42, P1185; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prasad S, 2016, J IMMUNOL, V197, P2981, DOI 10.4049/jimmunol.1502045; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Ransal K., 2017, NAT IMMUNOL, V18, P263; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Rubtsova K, 2015, J CLIN INVEST, V125, P2187, DOI 10.1172/JCI78082; Ruff WE, 2015, TRENDS MOL MED, V21, P233, DOI 10.1016/j.molmed.2015.02.006; Sanderson NSR, 2017, P NATL ACAD SCI USA, V114, P734, DOI 10.1073/pnas.1614472114; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Schmitt H, 2016, J EXP MED, V213, P1627, DOI 10.1084/jem.20160189; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Spence A, 2015, CURR OPIN IMMUNOL, V37, P11, DOI 10.1016/j.coi.2015.09.002; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Su LF, 2016, P NATL ACAD SCI USA, V113, pE6192, DOI 10.1073/pnas.1611723113; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; Thiault N, 2015, NAT IMMUNOL, V16, P628, DOI 10.1038/ni.3150; Vatanen T, 2016, CELL, V165, P1551, DOI 10.1016/j.cell.2016.05.056; Visperas A, 2016, J IMMUNOL, V197, P3762, DOI 10.4049/jimmunol.1601118; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Weindel CG, 2015, AUTOPHAGY, V11, P1010, DOI 10.1080/15548627.2015.1052206; Weist BM, 2015, NAT IMMUNOL, V16, P635, DOI 10.1038/ni.3171; Wu GC, 2015, AUTOIMMUN REV, V14, P798, DOI 10.1016/j.autrev.2015.05.004; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11350; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	144	250	263	9	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					716	724		10.1038/ni.3731	http://dx.doi.org/10.1038/ni.3731			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28632714	Green Accepted			2022-12-18	WOS:000403676300006
J	Han, JH; Zhong, CQ; Zhang, DW				Han, Jiahuai; Zhong, Chuan-Qi; Zhang, Duan-Wu			Programmed necrosis: backup to and competitor with apoptosis in the immune system	NATURE IMMUNOLOGY			English	Review							INDUCED CELL-DEATH; KAPPA-B ACTIVATION; KINASE RIP; CASPASE-8; PROTEIN; INHIBITION; FAS; NECROPTOSIS; MACROPHAGES; MECHANISMS	Programmed cell death is essential for the development and maintenance of the immune system and its responses to exogenous and endogenous stimuli. Studies have demonstrated that in addition to caspase-dependent apoptosis, necrosis dependent on the kinases RIP1 and RIP3 (also called necroptosis) is a major programmed cell-death pathway in development and immunity. These two programmed cell-death pathways may suppress each other, and necroptosis also serves as an alternative when caspase-dependent apoptosis is inhibited or absent. Here we summarize recent advancements that have identified the molecular mechanisms that underlie necroptosis and explore the mechanisms that regulate the interplay between apoptosis and necroptosis.	[Han, Jiahuai; Zhong, Chuan-Qi; Zhang, Duan-Wu] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China	Xiamen University	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	jhan@xmu.edu.cn	Han, J/G-4671-2010; Zhang, Duanwu/AAH-1627-2020	Zhang, Duanwu/0000-0003-2946-846X	National Natural Science Foundation of China [30830092, 91029304, 30921005, 81061160512]; 973 program [2009CB522200]; Sino-Swiss International Collaboration [2009DFA32760]; Science Planning Program of Fujian province [2009J1010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Sino-Swiss International Collaboration; Science Planning Program of Fujian province	We thank R. Ulevitch and R. Cook for critical reading of the manuscript. Supported by the National Natural Science Foundation of China (30830092, 91029304, 30921005 and 81061160512; and 973 program 2009CB522200), the Sino-Swiss International Collaboration (2009DFA32760) and the Science Planning Program of Fujian province (2009J1010).	Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Barkla DH, 1999, PATHOLOGY, V31, P230, DOI 10.1080/003130299105043; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Beisner DR, 2003, J IMMUNOL, V171, P247, DOI 10.4049/jimmunol.171.1.247; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Doulias PT, 2007, FREE RADICAL BIO MED, V42, P567, DOI 10.1016/j.freeradbiomed.2006.11.022; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Feig C, 2007, EUR J IMMUNOL, V37, pS61, DOI 10.1002/eji.200737462; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; Galluzzi L, 2010, J Intern Med, V267, P526, DOI 10.1111/j.1365-2796.2010.02223.x; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kim WH, 2005, NEUROCHEM RES, V30, P969, DOI 10.1007/s11064-005-6223-y; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Koterski JF, 2005, INFECT IMMUN, V73, P504, DOI 10.1128/IAI.73.1.504-513.2005; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LASTER SM, 1988, J IMMUNOL, V141, P2629; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li Q, 2010, J BIOL CHEM, V285, P9535, DOI 10.1074/jbc.M109.071332; LIDDIL JD, 1989, CANCER RES, V49, P2722; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lu JV, 2011, P NATL ACAD SCI USA, V108, P15312, DOI 10.1073/pnas.1102779108; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Ono K, 2001, MOL CELL BIOL, V21, P8276, DOI 10.1128/MCB.21.24.8276-8288.2001; Ono K, 2010, PROTEIN CELL, V1, P161, DOI 10.1007/s13238-010-0017-y; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Ray CA, 1996, VIROLOGY, V217, P384, DOI 10.1006/viro.1996.0128; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Roach HI, 2000, J BONE JOINT SURG BR, V82B, P601, DOI 10.1302/0301-620X.82B4.9846; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SUFFYS P, 1991, EUR J BIOCHEM, V195, P465, DOI 10.1111/j.1432-1033.1991.tb15727.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Xu XS, 2010, BRAIN RES, V1343, P206, DOI 10.1016/j.brainres.2010.04.080; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	99	250	264	4	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1143	1149		10.1038/ni.2159	http://dx.doi.org/10.1038/ni.2159			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22089220				2022-12-18	WOS:000297202700008
J	Pepper, M; Jenkins, MK				Pepper, Marion; Jenkins, Marc K.			Origins of CD4(+) effector and central memory T cells	NATURE IMMUNOLOGY			English	Review							ROR-GAMMA-T; IN-VIVO; TH17 CELLS; HELPER-CELLS; DIFFERENTIATION; GENERATION; INFECTION; RECEPTOR; ANTIGEN; ACTIVATION	Lineage-committed effector CD4(+) T cells are generated at the peak of the primary response and are followed by heterogeneous populations of central and effector memory cells. Here we review the evidence that T helper type 1 (T(H)1) effector cells survive the contraction phase of the primary response and become effector memory cells. We discuss the applicability of this idea to the T(H)2 cell, T(H)17 helper T cell, follicular helper T cell (T-FH cell) and induced regulatory T cell lineages. We also discuss how central memory cells are formed, with an emphasis on the role of B cells in this process.	[Jenkins, Marc K.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655	NCI NIH HHS [T32 CA009138] Funding Source: Medline; NIAID NIH HHS [R01 AI039614] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abromson-Leeman S, 2009, J NEUROIMMUNOL, V215, P10, DOI 10.1016/j.jneuroim.2009.07.007; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Colpitts SL, 2009, J IMMUNOL, V182, P5702, DOI 10.4049/jimmunol.0803450; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kadkhoda K, 2010, J IMMUNOL, V184, P3780, DOI 10.4049/jimmunol.0901384; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lin E, 2010, J IMMUNOL, V185, P1692, DOI 10.4049/jimmunol.0904210; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; SWAIN SL, 1990, J IMMUNOL, V144, P1788; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	64	250	256	3	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					467	471		10.1038/ni.2038	http://dx.doi.org/10.1038/ni.2038			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739668	Green Accepted			2022-12-18	WOS:000290707100003
J	Wang, DH; You, Y; Case, SM; McAllister-Lucas, LM; Wang, L; DiStefano, PS; Nunez, G; Bertin, J; Lin, X				Wang, DH; You, Y; Case, SM; McAllister-Lucas, LM; Wang, L; DiStefano, PS; Nunez, G; Bertin, J; Lin, X			A requirement for CARMA1 in TCR-induced NF-kappa B activation	NATURE IMMUNOLOGY			English	Article							CASPASE RECRUITMENT DOMAIN; KINASE C-THETA; MAGUK FAMILY; SIGNALING PATHWAYS; CONTAINING PROTEIN; MALT LYMPHOMA; BCL10; PHOSPHORYLATION; COSTIMULATION; INTERACTS	Stimulation of the T cell receptor (TCR) complex initiates multiple signaling cascades that lead to the activation of several transcription factors, including the NF-kappaB family members. Although various proximal signaling components of the TCR have been intensively studied, the distal components that mediate TCR-induced NF-kappaB activation remain largely unknown. Using a somatic mutagenesis approach, we cloned a CARMA1-deficient T cell line. Deficiency in CARMA1 (originally known as CARDII) resulted in selectively impaired activation of NF-kappaB induced by the TCR and a consequent defect in interleukin-2 (IL-2) production. Reconstitution of the CARMA1-deficient cells with CARMA1 fully rescued this signaling defect. Together, our results show that CARMA1 is an essential signaling component that mediates TCR-induced NF-kappaB activation.	SUNY Buffalo, Dept Microbiol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Lin, X (corresponding author), SUNY Buffalo, Dept Microbiol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.		Nuñez, Gabriel/A-7160-2014					Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205	33	250	256	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					830	835		10.1038/ni824	http://dx.doi.org/10.1038/ni824			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12154356				2022-12-18	WOS:000177694900011
J	Zhao, ED; Maj, T; Kryczek, I; Li, W; Wu, K; Zhao, LL; Wei, S; Crespo, J; Wan, SS; Vatan, L; Szeliga, W; Shao, I; Wang, Y; Liu, Y; Varambally, S; Chinnaiyan, AM; Welling, TH; Marquez, V; Kotarski, J; Wang, HB; Wang, ZH; Zhang, Y; Liu, R; Wang, GB; Zou, WP				Zhao, Ende; Maj, Tomasz; Kryczek, Ilona; Li, Wei; Wu, Ke; Zhao, Lili; Wei, Shuang; Crespo, Joel; Wan, Shanshan; Vatan, Linda; Szeliga, Wojciech; Shao, Irene; Wang, Yin; Liu, Yan; Varambally, Sooryanarayana; Chinnaiyan, Arul M.; Welling, Theodore H.; Marquez, Victor; Kotarski, Jan; Wang, Hongbo; Wang, Zehua; Zhang, Yi; Liu, Rebecca; Wang, Guobin; Zou, Weiping			Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction	NATURE IMMUNOLOGY			English	Article							HISTONE METHYLTRANSFERASE EZH2; GROUP PROTEIN EZH2; TH17 CELLS; SURVIVAL; EXPRESSION; STEMNESS; DIFFERENTIATION; METHYLATION; REPRESSION; INHIBITOR	Aerobic glycolysis regulates T cell function. However, whether and how primary cancer alters T cell glycolytic metabolism and affects tumor immunity in cancer patients remains a question. Here we found that ovarian cancers imposed glucose restriction on T cells and dampened their function via maintaining high expression of microRNAs miR-101 and miR-26a, which constrained expression of the methyltransferase EZH2. EZH2 activated the Notch pathway by suppressing Notch repressors Numb and Fbxw7 via trimethylation of histone H3 at Lys27 and, consequently, stimulated T cell polyfunctional cytokine expression and promoted their survival via Bcl-2 signaling. Moreover, small hairpin RNA-mediated knockdown of human EZH2 in T cells elicited poor antitumor immunity. EZH2(+)CD8(+) T cells were associated with improved survival in patients. Together, these data unveil a metabolic target and mechanism of cancer immune evasion.	[Zhao, Ende; Maj, Tomasz; Kryczek, Ilona; Li, Wei; Wu, Ke; Wei, Shuang; Crespo, Joel; Wan, Shanshan; Vatan, Linda; Szeliga, Wojciech; Shao, Irene; Wang, Yin; Liu, Yan; Welling, Theodore H.; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Zhao, Ende; Li, Wei; Wu, Ke] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, Wuhan 430074, Peoples R China; [Zhao, Lili] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA; [Varambally, Sooryanarayana] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Marquez, Victor] NCI, Ctr Canc Res, Biol Chem Lab, Frederick, MD 21701 USA; [Kotarski, Jan] Med Univ Lublin, Dept Gynecol Oncol & Gynecol 1, Lublin, Poland; [Wang, Hongbo; Wang, Zehua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhang, Yi] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Liu, Rebecca] Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI USA; [Zou, Weiping] Univ Michigan, Grad Programs Immunol & Canc Biol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of Lublin; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	wangguobin1954@126.com; wzou@med.umich.edu	Zhao, Ende/B-9851-2013; Maj, Tomasz/ABH-9964-2020; Marquez, Victor/AAP-3549-2021; Wan, Shanshan/C-3800-2013	Zhao, Ende/0000-0002-1355-6919; Maj, Tomasz/0000-0002-8431-1361; Crespo, Joel/0000-0002-4776-7909; Varambally, Sooryanarayana/0000-0002-2277-1127	US National Institutes of Health (Intramural Research Program) [CA123088, CA099985, CA156685, CA171306, 5P30CA46592]; Chinese Ministry of Science and Technology (973 program) [2015CB554000]; Wuhan Union Hospital Research Fund; Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA123088, R01CA172106, R01CA099985, P30CA046592, R01CA092562, R01CA171306, R01CA190176, R01CA152470, R01CA156685, R01CA193136] Funding Source: NIH RePORTER	US National Institutes of Health (Intramural Research Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology (973 program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Wuhan Union Hospital Research Fund; Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Postiff, M. Vinco, R. Craig and J. Barikdar for tissue procurement core at the University of Michigan; G. Lv, W. Dong and L. Li for assistance; R. Zhang (Wistar Institute) for shEZH2 plasmids; P. King for discussions; and B. Leclair and D. Leclair for support. Supported by the US National Institutes of Health (the Intramural Research Program; and CA123088, CA099985, CA156685, CA171306 and 5P30CA46592), the Chinese Ministry of Science and Technology (973 program, 2015CB554000), the Wuhan Union Hospital Research Fund, the Ovarian Cancer Research Fund, and Marsha Rivkin Center for Ovarian Cancer Research.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.1093/biomet/80.3.557; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tong Q, 2014, J IMMUNOL, V192, P5012, DOI 10.4049/jimmunol.1302943; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wei S, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19440; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	50	249	259	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					95	+		10.1038/ni.3313	http://dx.doi.org/10.1038/ni.3313			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26523864	Green Accepted			2022-12-18	WOS:000366675800015
J	Netea, MG; Wijmenga, C; O'Neill, LAJ				Netea, Mihai G.; Wijmenga, Cisca; O'Neill, Luke A. J.			Genetic variation in Toll-like receptors and disease susceptibility	NATURE IMMUNOLOGY			English	Review							HERPES-SIMPLEX ENCEPHALITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SINGLE-NUCLEOTIDE POLYMORPHISMS; PYOGENIC BACTERIAL-INFECTIONS; DOMAIN-CONTAINING ADAPTERS; STOP CODON POLYMORPHISM; KINASE-4 DEFICIENCY; RHEUMATOID-ARTHRITIS; OTHERWISE REDUNDANT; PROTECTIVE IMMUNITY	Toll-like receptors (TLRs) are key initiators of the innate immune response and promote adaptive immunity. Much has been learned about the role of TLRs in human immunity from studies linking TLR genetic variation with disease. First, monogenic disorders associated with complete deficiency in certain TLR pathways, such as MyD88-IRAK4 or TLR3-Unc93b-TRIF-TRAF3, have demonstrated the specific roles of these pathways in host defense against pyogenic bacteria and herpesviruses, respectively. Second, common polymorphisms in genes encoding several TLRs and associated genes have been associated with both infectious and autoimmune diseases. The study of genetic variation in TLRs in various populations combined with information on infection has demonstrated complex interaction between genetic variation in TLRs and environmental factors. This interaction explains the differences in the effect of TLR polymorphisms on susceptibility to infection and autoimmune disease in various populations.	[O'Neill, Luke A. J.] Univ Dublin, Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Trinity College Dublin; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen	O'Neill, LAJ (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	laoneill@tcd.ie	Wijmenga, Cisca/D-2173-2009; Netea, Mihai/N-5155-2014; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; O'Neill, Luke/0000-0002-4333-2748	Netherlands Organization for Scientific Research; Science Foundation Ireland; European Research Council	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	Supported by the Netherlands Organization for Scientific Research (M.G.N. and C.W.), Science Foundation Ireland (L.A.J.O.) and the European Research Council (L.A.J.O.).	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bousfiha A, 2010, CLIN IMMUNOL, V135, P204, DOI 10.1016/j.clim.2010.02.001; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardenes M, 2006, J PEDIATR-US, V148, P549, DOI 10.1016/j.jpeds.2005.12.012; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Casals F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-202; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chapel H, 2005, CLIN INFECT DIS, V40, P1227, DOI 10.1086/428733; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Comeau JL, 2008, PEDIATR INFECT DIS J, V27, P170, DOI 10.1097/INF.0b013e318157ad01; Davidson DJ, 2006, J IMMUNOL, V177, P8202, DOI 10.4049/jimmunol.177.11.8202; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; De Tiege X, 2008, EUR J PAEDIATR NEURO, V12, P72, DOI 10.1016/j.ejpn.2007.07.007; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durrani O, 2011, RHEUMATOLOGY, V50, P1760, DOI 10.1093/rheumatology/ker200; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fornarino S, 2011, MOL BIOL EVOL, V28, P3087, DOI 10.1093/molbev/msr137; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hamann L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-65; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P10593, DOI 10.1073/pnas.0501165102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Kalla AA, 2003, BEST PRACT RES CL RH, V17, P863, DOI 10.1016/S1521-6942(03)00047-0; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Miao RF, 2011, TUBERCULOSIS, V91, P268, DOI 10.1016/j.tube.2011.01.006; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Plantinga TS, 2012, J INNATE IMMUN, V4, P168, DOI 10.1159/000329492; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Ramasawmy R, 2009, J INFECT DIS, V199, P1838, DOI 10.1086/599212; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Szabo J, 2007, J MED MICROBIOL, V56, P863, DOI 10.1099/jmm.0.47046-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Wlasiuk G, 2009, MOL BIOL EVOL, V26, P937, DOI 10.1093/molbev/msp018; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	90	249	262	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					535	542		10.1038/ni.2284	http://dx.doi.org/10.1038/ni.2284			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22610250				2022-12-18	WOS:000304203900007
J	Kinjo, Y; Illarionov, P; Vela, JL; Pei, B; Girardi, E; Li, XM; Li, YL; Imamura, M; Kaneko, Y; Okawara, A; Miyazaki, Y; Gomez-Velasco, A; Rogers, P; Dahesh, S; Uchiyama, S; Khurana, A; Kawahara, K; Yesilkaya, H; Andrew, PW; Wong, CH; Kawakami, K; Nizet, V; Besra, GS; Tsuji, M; Zajonc, DM; Kronenberg, M				Kinjo, Yuki; Illarionov, Petr; Vela, Jose Luis; Pei, Bo; Girardi, Enrico; Li, Xiangming; Li, Yali; Imamura, Masakazu; Kaneko, Yukihiro; Okawara, Akiko; Miyazaki, Yoshitsugu; Gomez-Velasco, Anaximandro; Rogers, Paul; Dahesh, Samira; Uchiyama, Satoshi; Khurana, Archana; Kawahara, Kazuyoshi; Yesilkaya, Hasan; Andrew, Peter W.; Wong, Chi-Huey; Kawakami, Kazuyoshi; Nizet, Victor; Besra, Gurdyal S.; Tsuji, Moriya; Zajonc, Dirk M.; Kronenberg, Mitchell			Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria	NATURE IMMUNOLOGY			English	Article							NKT CELLS; STREPTOCOCCUS-PNEUMONIAE; ANTIGENS; INNATE; ACTIVATION; CD1D; IDENTIFICATION; INFECTION; DISEASE; BURDEN	Natural killer T cells (NKT cells) recognize glycolipid antigens presented by CD1d. These cells express an evolutionarily conserved, invariant T cell antigen receptor (TCR), but the forces that drive TCR conservation have remained uncertain. Here we show that NKT cells recognized diacylglycerol-containing glycolipids from Streptococcus pneumoniae, the leading cause of community-acquired pneumonia, and group B Streptococcus, which causes neonatal sepsis and meningitis. Furthermore, CD1d-dependent responses by NKT cells were required for activation and host protection. The glycolipid response was dependent on vaccenic acid, which is present in low concentrations in mammalian cells. Our results show how microbial lipids position the sugar for recognition by the invariant TCR and, most notably, extend the range of microbes recognized by this conserved TCR to several clinically important bacteria.	[Kinjo, Yuki; Vela, Jose Luis; Pei, Bo; Khurana, Archana; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; [Kinjo, Yuki; Kaneko, Yukihiro; Okawara, Akiko; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Illarionov, Petr; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Girardi, Enrico; Li, Yali; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Li, Xiangming; Tsuji, Moriya] Rockefeller Univ, HIV & Malaria Vaccine Program, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Imamura, Masakazu; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Imamura, Masakazu; Wong, Chi-Huey] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Gomez-Velasco, Anaximandro] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Rogers, Paul] Kyowa Hakko Kirin Calif Inc, La Jolla, CA USA; [Dahesh, Samira; Uchiyama, Satoshi; Nizet, Victor] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Dahesh, Samira; Uchiyama, Satoshi; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Kawahara, Kazuyoshi] Kanto Gakuin Univ, Dept Appl Mat & Life Sci, Coll Engn, Yokohama, Kanagawa, Japan; [Yesilkaya, Hasan; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Kawakami, Kazuyoshi] Tohoku Univ, Dept Med Microbiol Mycol & Immunol, Grad Sch Med, Sendai, Miyagi 980, Japan	La Jolla Institute for Immunology; National Institute of Infectious Diseases (NIID); University of Birmingham; La Jolla Institute for Immunology; Rockefeller University; Scripps Research Institute; Scripps Research Institute; University of British Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego; Kanto Gakuin University; University of Leicester; Tohoku University	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA.	mitch@liai.org	Girardi, Enrico/AAD-2260-2020; Nizet, Victor/AAF-3190-2019; Andrew, Peter W/G-7526-2012; Kronenberg, Mitchell/AAT-6078-2021; Yesilkaya, Hasan/D-7271-2011; Gómez-Velasco, Anaximandro/E-7951-2019; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723; Nizet, Victor/0000-0003-3847-0422; Besra, Gurdyal/0000-0002-5605-0395; miyazaki, yoshitsugu/0000-0001-8942-0869; Tsuji, Moriya/0000-0001-8587-277X	US National Institutes of Health [AI45053, AI71922, AI074952, AI070258, F32AI083029]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [22689031]; Ministry of Health, Labor and Welfare of Japan [H22seisakusouyakuippan012]; Uehara Memorial Foundation; Wellcome Trust; Royal Society; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922, R01AI045053, R21AI069276, R01AI074952, R56AI074952, R01AI071922, R01AI070258, F32AI083029, R01AI069296, R56AI070258] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Akira (Osaka University) for Myd88<SUP>-/-</SUP> mice; B. Beutler (Scripps Research Institute) for Myd88<SUP>-/-</SUP> Trif<SUP>Lps2/Lps2</SUP> mice; M. Antony (University of Birmingham) for group B Streptococcus A909; N. Yamamoto, T. Kinjo, G.D. Ainge, D. Gibson and G. Painter for suggestions; N. Sato for help with glycolipid analysis; and C. Lena for technical assistance. Supported by the US National Institutes of Health (AI45053 and AI71922 to M.K., AI074952 to D.M.Z.; AI070258 to M.T.; and F32AI083029 to J.L.V.), the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology (22689031), the Ministry of Health, Labor and Welfare of Japan (H22seisakusouyakuippan012), the Uehara Memorial Foundation (Y.Ki.), the Wellcome Trust, the Royal Society, J. Bardrick (G.S.B.) and the Cancer Research Institute (D.M.Z.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; BRUNDISH DE, 1965, BIOCHEM J, V97, P158; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; FISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V487, P74, DOI 10.1016/0005-2760(77)90045-5; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kronenberg M, 2009, CURR OPIN IMMUNOL, V21, P391, DOI 10.1016/j.coi.2009.07.002; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tupin E, 2006, METHOD ENZYMOL, V417, P185, DOI 10.1016/S0076-6879(06)17014-7; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010	41	249	255	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					966	U72		10.1038/ni.2096	http://dx.doi.org/10.1038/ni.2096			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21892173	Green Accepted			2022-12-18	WOS:000295084500012
J	Ruland, J				Ruland, Juergen			Return to homeostasis: downregulation of NF-kappa B responses	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; ALPHA-MEDIATED PHOSPHORYLATION; NEGATIVE FEEDBACK LOOP; EDITING ENZYME A20; IKK-ALPHA; IRAK-M; DEUBIQUITINATING ENZYME; GENE-EXPRESSION; INNATE IMMUNITY; SIGNALING PATHWAY	Activation of NF-kappa B transcription factors by receptors of the innate or adaptive immune system is essential for host defense. However, after danger is eliminated, NF-kappa B signaling needs to be tightly downregulated for the maintenance of tissue homeostasis. This review highlights key negative regulatory principles that affect the amount, localization or conformational properties of NF-kappa B-activating proteins to attenuate the NF-kappa B response. These mechanisms are needed to prevent inflammation, autoimmune disease and oncogenesis.	[Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-8000 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, Neuherberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-8000 Munich, Germany.	jruland@lrz.tum.de	Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich grants).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	87	249	257	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					709	714		10.1038/ni.2055	http://dx.doi.org/10.1038/ni.2055			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772279				2022-12-18	WOS:000292870700006
J	Saitoh, T; Tun-Kyi, A; Ryo, A; Yamamoto, M; Finn, G; Fujita, T; Akira, S; Yamamoto, N; Lu, KP; Yamaoka, S				Saitoh, Tatsuya; Tun-Kyi, Adrian; Ryo, Akihide; Yamamoto, Masahiro; Finn, Greg; Fujita, Takashi; Akira, Shizuo; Yamamoto, Naoki; Lu, Kun Ping; Yamaoka, Shoji			Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; DEPENDENT PHOSPHORYLATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; GENE-EXPRESSION; CELL-CYCLE; ACTIVATION; IRF-3; TRANSACTIVATION	Recognition of double-stranded RNA activates interferon-regulatory factor 3 (IRF3)-dependent expression of antiviral factors. Although the molecular mechanisms underlying the activation of IRF3 have been studied, the mechanisms by which IRF3 activity is reduced have not. Here we report that activation of IRF3 is negatively regulated by the peptidyl-prolyl isomerase Pin1. After stimulation by double-stranded RNA, induced phosphorylation of the Ser339-Pro340 motif of IRF3 led to its interaction with Pin1 and finally polyubiquitination and then proteasome-dependent degradation of IRF3. Suppression of Pin1 by RNA interference or genetic deletion resulted in enhanced IRF-3-dependent production of interferon-beta, with consequent reduction of virus replication. These results elucidate a previously unknown mechanism for controlling innate antiviral responses by negatively regulating IRF3 activity via Pin1.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02115 USA; Yokohama City Univ, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; Kyoto Univ, Inst Virus Res, Genet Mol Lab, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, ERATO, Osaka 5650871, Japan; Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan	Tokyo Medical & Dental University (TMDU); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yokohama City University; Osaka University; Kyoto University; Japan Science & Technology Agency (JST); National Institute of Infectious Diseases (NIID)	Ryo, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan.	aryo@yokohama-cu.ac.jp; shojmmb@tmd.ac.jp	Akira, Shizuo/C-3134-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58556] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lu KP, 1996, NATURE, V380, P544; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Momoi Y, 2000, AIDS RES HUM RETROV, V16, P373, DOI 10.1089/088922200309250; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	43	249	261	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					598	605		10.1038/ni1347	http://dx.doi.org/10.1038/ni1347			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16699525				2022-12-18	WOS:000237751200015
J	Stock, P; Akbari, O; Berry, G; Freeman, GJ; DeKruyff, RH; Umetsu, DT				Stock, P; Akbari, O; Berry, G; Freeman, GJ; DeKruyff, RH; Umetsu, DT			Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity	NATURE IMMUNOLOGY			English	Article							ALLERGEN-SPECIFIC TH1; HEAT-KILLED LISTERIA; DENDRITIC CELLS; INTERFERON-GAMMA; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; MOLECULE ICOS; DYING CELLS; TOLERANCE; ANTIGEN	The range of regulatory T cell (T-R cell) types that control immune responses is poorly understood. We describe here a population of T-R cells that developed in vivo from naive CD4(+)CD25(-) T cells during a T helper type 1 (T(H)1)-polarized response, distinct from CD25(+) T-R cells. These antigen-specific T-R cells were induced by CD8alpha(+) DCs, produced both interleukin 10 and interferon-gamma, and potently inhibited the development of airway hyper-reactivity. These T-R cells expressed the transcription factors Foxp3 and T-bet, indicating that these T-R cells are related to T(H)1 cells. Thus, adaptive T-R cells are heterogeneous and comprise T(H)1-like T-R cells as well as previously described T(H)2-like T-R cells, which express Foxp3 and are induced during the development of respiratory tolerance by CD8alpha(-) DCs.	Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute	Umetsu, DT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Immunol, Karp Res Bldg, Boston, MA 02115 USA.	umetsu@stanford.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Berry, Gerald/0000-0002-6176-2629	NATIONAL CANCER INSTITUTE [R01CA084500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069507, R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, R01AI026322] Funding Source: NIH RePORTER; NCI NIH HHS [CA84500] Funding Source: Medline; NHLBI NIH HHS [HL69507, HL62348] Funding Source: Medline; NIAID NIH HHS [AI26322, AI39671] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; Campbell D, 2000, CLIN IMMUNOL, V97, P193, DOI 10.1006/clim.2000.4926; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; HANSEN G, 2000, J CLIN INVEST, V11, P89; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itoh M, 1999, J IMMUNOL, V162, P5317; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Randolph DA, 1999, J IMMUNOL, V162, P2375; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SANDER B, 1991, SCAND J IMMUNOL, V33, P287, DOI 10.1111/j.1365-3083.1991.tb01774.x; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stock P, 2004, EUR J IMMUNOL, V34, P1817, DOI 10.1002/eji.200324623; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Trinchieri G, 2001, J EXP MED, V194, pF53, DOI 10.1084/jem.194.10.f53; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yeung VP, 1998, J IMMUNOL, V161, P4146	58	249	270	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1149	1156		10.1038/ni1122	http://dx.doi.org/10.1038/ni1122			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15448689				2022-12-18	WOS:000224692700012
J	Hajishengallis, G; Reis, ES; Mastellos, DC; Ricklin, D; Lambris, JD				Hajishengallis, George; Reis, Edimara S.; Mastellos, Dimitrios C.; Ricklin, Daniel; Lambris, John D.			Novel mechanisms and functions of complement	NATURE IMMUNOLOGY			English	Review							INTRACELLULAR COMPLEMENT; STRUCTURAL INSIGHT; MEMBRANE ATTACK; INNATE IMMUNITY; MURINE MODELS; COMPONENT 3; ACTIVATION; INFLAMMATION; RECEPTOR; CANCER	Progress at the beginning of the 21st century transformed the perception of complement from that of a blood-based antimicrobial system to that of a global regulator of immunity and tissue homeostasis. More recent years have witnessed remarkable advances in structure-function insights and understanding of the mechanisms and locations of complement activation, which have added new layers of complexity to the biology of complement. This complexity is readily reflected by the multifaceted and contextual involvement of complement-driven networks in a wide range of inflammatory and neurodegenerative disorders and cancer. This Review provides an updated view of new and previously unanticipated functions of complement and how these affect immunity and disease pathogenesis.	[Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Reis, Edimara S.; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Mastellos, Dimitrios C.] Natl Ctr Sci Res Demokritos Aghia Paraskevi, INRASTES, Div Biodiagnost Sci & Technol, Athens, Greece; [Ricklin, Daniel] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Centre of Scientific Research "Demokritos"; University of Basel	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA.	lambris@upenn.edu	Hajishengallis, George N./K-1117-2019; Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Hajishengallis, George N./0000-0001-7392-8852; Lambris, John/0000-0002-9370-5776; Mastellos, Dimitrios/0000-0002-6634-3271; Ricklin, Daniel/0000-0001-6140-0233	US National Institutes of Health [AI068730, AI030040, DE021685, DE015254, DE026152]; European Community's Seventh Framework Programme [602699]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, R01AI030040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE026152, R01DE015254, R01DE021685] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community's Seventh Framework Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by the US National Institutes of Health (AI068730, AI030040, DE021685, DE015254 and DE026152) and the European Community's Seventh Framework Programme (602699 (DIREKT)).	Abdelbaset-Ismail A, 2017, LEUKEMIA, V31, P446, DOI 10.1038/leu.2016.198; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ager RR, 2010, J NEUROCHEM, V113, P389, DOI 10.1111/j.1471-4159.2010.06595.x; Ajona D, 2017, CANCER DISCOV, V7, P694, DOI 10.1158/2159-8290.CD-16-1184; Ajona D, 2013, JNCI-J NATL CANCER I, V105, P1385, DOI 10.1093/jnci/djt205; Arborea G, 2017, MOL IMMUNOL, V89, P2, DOI 10.1016/j.molimm.2017.05.012; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bennett KM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00089; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Boire A, 2017, CELL, V168, P1101, DOI 10.1016/j.cell.2017.02.025; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Brennan FH, 2016, SEMIN IMMUNOL, V28, P292, DOI 10.1016/j.smim.2016.03.015; Bulla R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10346; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Campagne MV, 2016, IMMUNOBIOLOGY, V221, P733, DOI 10.1016/j.imbio.2015.11.007; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Castellano G, 2016, AM J TRANSPLANT, V16, P325, DOI 10.1111/ajt.13415; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Cho MS, 2016, J IMMUNOL, V196, P1412, DOI 10.4049/jimmunol.1501886; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cook EM, 2016, J IMMUNOL, V197, P1762, DOI 10.4049/jimmunol.1600648; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Doerner SK, 2016, MOL CANCER RES, V14, P953, DOI 10.1158/1541-7786.MCR-16-0153; Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471; Elmlund D, 2017, CURR OPIN STRUC BIOL, V46, P1, DOI 10.1016/j.sbi.2017.03.003; Elvington M, 2017, J CLIN INVEST, V127, P970, DOI 10.1172/JCI89412; Facciabene A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1326442; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Freeley S, 2016, IMMUNOL REV, V274, P16, DOI 10.1111/imr.12472; Guglietta S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11037; Gunn L, 2012, J IMMUNOL, V189, P2985, DOI 10.4049/jimmunol.1200846; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hajishengallis G, 2016, IMMUNOL REV, V274, P233, DOI 10.1111/imr.12467; Hajishengallis G, 2016, SEMIN IMMUNOL, V28, P285, DOI 10.1016/j.smim.2016.03.006; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2013, SEMIN IMMUNOL, V25, P65, DOI 10.1016/j.smim.2013.04.004; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Han X, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hawksworth OA, 2017, MOL IMMUNOL, V84, P17, DOI 10.1016/j.molimm.2016.11.010; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hovingh ES, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02004; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hsieh CC, 2013, BLOOD, V121, P1760, DOI 10.1182/blood-2012-06-440214; Kaida T, 2016, ONCOTARGET, V7, P84798, DOI 10.18632/oncotarget.12656; Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082; Kaya Z, 2001, NAT IMMUNOL, V2, P739, DOI 10.1038/90686; Kemper C, 2013, MOL IMMUNOL, V56, P181, DOI 10.1016/j.molimm.2013.05.223; Khameneh HJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00010; Kim KH, 2016, AUTOPHAGY, V12, P1647, DOI 10.1080/15548627.2016.1196314; Kolev M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00001; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; LAMBRIS JD, 1980, J EXP MED, V152, P1625, DOI 10.1084/jem.152.6.1625; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liszewski MK, 2017, MOL IMMUNOL, V84, P2, DOI 10.1016/j.molimm.2017.01.004; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maekawa T, 2016, J CLIN PERIODONTOL, V43, P238, DOI 10.1111/jcpe.12507; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; MOSSER DM, 1987, NATURE, V327, P329, DOI 10.1038/327329b0; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Ning C, 2015, MUCOSAL IMMUNOL, V8, P1275, DOI 10.1038/mi.2015.18; Nunez-Cruz S, 2012, NEOPLASIA, V14, P994, DOI 10.1593/neo.121262; Pandey MK, 2017, NATURE, V543, P108, DOI 10.1038/nature21368; Papanastasiou M, 2017, J IMMUNOL, V198, P3326, DOI 10.4049/jimmunol.1601864; Rafail S, 2015, J IMMUNOL, V194, P1285, DOI 10.4049/jimmunol.1402354; Reis E. S., NAT REV IMM IN PRESS; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Sumida T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7241; SUNDSMO JS, 1982, FED PROC, V41, P3094; Surace L, 2015, IMMUNITY, V42, P767, DOI 10.1016/j.immuni.2015.03.009; Tam JCH, 2014, SCIENCE, V345, P1134, DOI 10.1126/science.1256070; Taylor RP, 2016, SEMIN IMMUNOL, V28, P309, DOI 10.1016/j.smim.2016.03.003; Thurman JM, 2015, AM J KIDNEY DIS, V65, P156, DOI 10.1053/j.ajkd.2014.06.035; Towner LD, 2016, J BIOL CHEM, V291, P14927, DOI 10.1074/jbc.M115.708446; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; WANG H, P NATL ACAD IN PRESS; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Wang Y, 2016, CANCER DISCOV, V6, P1022, DOI 10.1158/2159-8290.CD-15-1412; Whalley K, 2016, NAT REV NEUROSCI, V17, P336, DOI 10.1038/nrn.2016.52; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Wyatt SK, 2017, EXP NEUROL, V295, P184, DOI 10.1016/j.expneurol.2017.06.009; Xu ST, 2017, P NATL ACAD SCI USA, V114, P3403, DOI 10.1073/pnas.1620881114; Xue XG, 2017, NAT STRUCT MOL BIOL, V24, P643, DOI 10.1038/nsmb.3427; Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002	128	248	257	9	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1288	1298		10.1038/ni.3858	http://dx.doi.org/10.1038/ni.3858			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144501	Green Accepted			2022-12-18	WOS:000415324900007
J	Hara, H; Tsuchiya, K; Kawamura, I; Fang, RD; Hernandez-Cuellar, E; Shen, YN; Mizuguchi, J; Schweighoffer, E; Tybulewicz, V; Mitsuyama, M				Hara, Hideki; Tsuchiya, Kohsuke; Kawamura, Ikuo; Fang, Rendong; Hernandez-Cuellar, Eduardo; Shen, Yanna; Mizuguchi, Junichiro; Schweighoffer, Edina; Tybulewicz, Victor; Mitsuyama, Masao			Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity	NATURE IMMUNOLOGY			English	Article							CASPASE-1 ACTIVATION; NLRP3 INFLAMMASOME; LISTERIA-MONOCYTOGENES; AIM2 INFLAMMASOME; PROTEIN; KINASE; DEATH; INTERLEUKIN-1; MACROPHAGES; IL-1-BETA	The inflammasome adaptor ASC contributes to innate immunity through the activation of caspase-1. Here we found that signaling pathways dependent on the kinases Syk and Jnk were required for the activation of caspase-1 via the ASC-dependent inflammasomes NLRP3 and AIM2. Inhibition of Syk or Jnk abolished the formation of ASC specks without affecting the interaction of ASC with NLRP3. ASC was phosphorylated during inflammasome activation in a Syk-and Jnk-dependent manner, which suggested that Syk and Jnk are upstream of ASC phosphorylation. Moreover, phosphorylation of Tyr144 in mouse ASC was critical for speck formation and caspase-1 activation. Our results suggest that phosphorylation of ASC controls inflammasome activity through the formation of ASC specks.	[Hara, Hideki; Tsuchiya, Kohsuke; Kawamura, Ikuo; Fang, Rendong; Hernandez-Cuellar, Eduardo; Shen, Yanna; Mitsuyama, Masao] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan; [Shen, Yanna] Tianjin Med Univ, Sch Lab Med, Tianjin, Peoples R China; [Mizuguchi, Junichiro] Tokyo Med Univ, Dept Immunol, Tokyo 1608402, Japan; [Mizuguchi, Junichiro] Tokyo Med Univ, Intractable Immunol Res Ctr, Tokyo 1608402, Japan; [Schweighoffer, Edina; Tybulewicz, Victor] Natl Inst Med Res, MRC, London NW7 1AA, England	Kyoto University; Tianjin Medical University; Tokyo Medical University; Tokyo Medical University; MRC National Institute for Medical Research	Mitsuyama, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan.	mituyama@mb.med.kyoto-u.ac.jp	Tsuchiya, Kohsuke/P-6959-2019; Tsuchiya, Kohsuke/D-8463-2015; Hara, Hideki/Y-2735-2018	Tsuchiya, Kohsuke/0000-0001-8540-6920; Tsuchiya, Kohsuke/0000-0001-8540-6920; Tybulewicz, Victor/0000-0003-2439-0798	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Medical Research Council UK [U117527252]; MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24590522, 24590524] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Tschopp and the Institute for Arthritis Research for permission to use Nlrp3<SUP>-/-</SUP> mice; S. Taniguchi (Shinshu University) for Pycard<SUP>-/-</SUP> mice; K. Kuida (Millennium Pharmaceuticals) for Casp1<SUP>-/-</SUP> mice; T. Saito (RIKEN RCAI) for Card9<SUP>-/-</SUP> mice; K. Kawasaki (Doshisha Women's College) for S. Typhimurium 14028; H. Tsutsui (Hyogo Medical University) for Nlrp3<SUP>-/-</SUP> , Pycard<SUP>-/-</SUP> and Casp1<SUP>-/-</SUP> mice; H. Hara (Saga University) for Card9<SUP>-/-</SUP> mice; M. Matsuura (Kyoto University) for S. Typhimurium 14028 and for U937 cells; H. Tanizaki (Kyoto University) for RAW264.7 cells; and K. Sada and Y. Tohyama for advice on Syk experiments. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan, the Japan Society for the Promotion of Science and Medical Research Council UK (U117527252 for E. S. and V.T.).	Balci-Peynircioglu B, 2008, EXP BIOL MED, V233, P1324, DOI 10.3181/0803-RM-106; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Cao YL, 2010, IMMUNOL LETT, V132, P38, DOI 10.1016/j.imlet.2010.05.006; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Chuang YT, 2011, BLOOD, V117, P960, DOI 10.1182/blood-2010-08-303115; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Sumbayev VV, 2006, SCAND J IMMUNOL, V63, P391, DOI 10.1111/j.1365-3083.2006.001764.x; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	49	248	260	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1247	+		10.1038/ni.2749	http://dx.doi.org/10.1038/ni.2749			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24185614	Green Published, Green Submitted, Green Accepted			2022-12-18	WOS:000327149400010
J	Burzyn, D; Benoist, C; Mathis, D				Burzyn, Dalia; Benoist, Christophe; Mathis, Diane			Regulatory T cells in nonlymphoid tissues	NATURE IMMUNOLOGY			English	Review							TOLERANCE INDUCTION; INSULIN-RESISTANCE; EFFECTOR-CELLS; MEMORY; FOXP3; DIFFERENTIATION; ACCUMULATION; INFLAMMATION; CANCER; RECRUITMENT	Both Foxp3(+)CD4(+) regulatory T cells (T-reg cells) and local immune responses in nonlymphoid tissues have long been recognized as important elements of a well-orchestrated immune system, but only recently have these two fields of study begun to intersect. There is growing evidence that T-reg cells are present in various nonlymphoid tissues in health and disease, that they have a unique phenotype and that their functions go beyond the classical modulation of immune responses. Thus, tissue T-reg cells might add yet another level to classification of the T-reg cell compartment into functional and/or phenotypic subtypes. In this Review, we summarize recent findings in this new field, discussing knowns and unknowns about the origin, phenotype, function and memory of nonlymphoid tissue-resident T-reg cells.	[Burzyn, Dalia; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Benoist, C (corresponding author), Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu			US National Institutes of Health [R01DK092541, R37AI051530]; Kaneb Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaneb Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work on tissue T<INF>reg</INF> cells in our laboratory is supported by US National Institutes of Health grants R01DK092541 and R37AI051530 (to C. B. and D. M.). D. B. was supported by a Kaneb Fellowship.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Brincks EL, 2013, J IMMUNOL, V190, P3438, DOI 10.4049/jimmunol.1203140; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Grindebacke H, 2009, J IMMUNOL, V183, P4360, DOI 10.4049/jimmunol.0901091; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Katz SC, 2011, J IMMUNOL, V187, P1150, DOI 10.4049/jimmunol.1004077; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kuczma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013623; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Meng X, 2012, MOL MED, V18, P598, DOI 10.2119/molmed.2011.00471; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Park HJ, 2012, CELL IMMUNOL, V278, P76, DOI 10.1016/j.cellimm.2012.07.001; Leiros CP, 2013, AM J REPROD IMMUNOL, V69, P359, DOI 10.1111/aji.12087; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sanchez AM, 2012, J IMMUNOL, V189, P2805, DOI 10.4049/jimmunol.1200645; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Savage PA, 2013, TRENDS IMMUNOL, V34, P33, DOI 10.1016/j.it.2012.08.005; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155	81	248	260	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1007	1013		10.1038/ni.2683	http://dx.doi.org/10.1038/ni.2683			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048122	Green Accepted			2022-12-18	WOS:000324584700005
J	Luthje, K; Kallies, A; Shimohakamada, Y; Belz, GT; Light, A; Tarlinton, DM; Nutt, SL				Luethje, Katja; Kallies, Axel; Shimohakamada, Yoko; Belz, Gabrielle T.; Light, Amanda; Tarlinton, David M.; Nutt, Stephen L.			The development and fate of follicular helper T cells defined by an IL-21 reporter mouse	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER B; IMMUNOGLOBULIN PRODUCTION; TRANSCRIPTION FACTOR; BCL-6 EXPRESSION; TRANSGENIC MICE; EFFECTOR; DIFFERENTIATION; ACTIVATION; GENERATION; INDUCTION	Germinal centers require CD4(+) follicular helper T cells (T-FH cells), whose hallmark is expression of the transcriptional repressor Bcl-6, the chemokine receptor CXCR5 and interleukin 21 (IL-21). To track the development and fate of T-FH cells, we generated an IL-21 reporter mouse by introducing sequence encoding green fluorescent protein (GFP) into the Il21 locus; these mice had expression of IL-21-GFP in CD4(+)CXCR5(+)PD-1(+)T(FH) cells. IL-21-GFP(+) T-FH cells were multifunctional helper cells that coexpressed several cytokines, including interferon-gamma (IFN-gamma), IL-2 and IL-4. T-FH cells proliferated and gave rise to transferrable memory cells with plasticity, which differentiated after recall into conventional effector helper T cells and T-FH cells. Thus, we demonstrated that T-FH cells were not terminally differentiated but instead retained the flexibility to be recruited into other helper T cell subsets and nonlymphoid tissues.	[Luethje, Katja; Kallies, Axel; Shimohakamada, Yoko; Belz, Gabrielle T.; Light, Amanda; Tarlinton, David M.; Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Tarlinton, DM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	tarlinton@wehi.edu.au; nutt@wehi.edu.au	Belz, Gabrielle T/C-9350-2013; Nutt, Stephen L/C-9256-2013	Belz, Gabrielle T/0000-0002-9660-9587; Nutt, Stephen L/0000-0002-0020-6637; Tarlinton, David/0000-0001-9928-686X; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia; German Academic Exchange Service; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute; Pfizer Australia Research; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pfizer Australia Research(PfizerPfizer Australia); Australian Research Council(Australian Research Council)	We thank L. Corcoran (Walter and Eliza Hall Institute of Medical Research) for antibody to Bcl-6 and antibody to IRF4; and E. Cretney for preliminary experiments. Supported by the National Health and Medical Research Council of Australia (A. K., G. T. B., D. M. T. and S.L.N.), the German Academic Exchange Service (K. L.), the Sylvia and Charles Viertel Foundation (G. T. B.), the Howard Hughes Medical Institute (G. T. B.), Pfizer Australia Research (S.L.N.), the Australian Research Council (A. K. and S.L.N.), the Victorian State Government Operational Infrastructure Support and the National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme of the Australian Government.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	44	248	259	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					491	U93		10.1038/ni.2261	http://dx.doi.org/10.1038/ni.2261			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22466669				2022-12-18	WOS:000303048400013
J	Spiegel, A; Shivtiel, S; Kalinkovich, A; Ludin, A; Netzer, N; Goichberg, P; Azaria, Y; Resnick, I; Hardan, I; Ben-Hur, H; Nagler, A; Rubinstein, M; Lapidot, T				Spiegel, Asaf; Shivtiel, Shoham; Kalinkovich, Alexander; Ludin, Aya; Netzer, Neta; Goichberg, Polina; Azaria, Yaara; Resnick, Igor; Hardan, Izhar; Ben-Hur, Herzel; Nagler, Arnon; Rubinstein, Menachem; Lapidot, Tsvee			Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34(+) cells through Wnt signaling	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELL; SYMPATHETIC-NERVOUS-SYSTEM; BONE-MARROW; PROGENITOR CELLS; BETA-CATENIN; GENE FAMILY; IN-VIVO; MOBILIZATION; ACTIVATION; CXCR4	Catecholamines are important regulators of homeostasis, yet their functions in hematopoiesis are poorly understood. Here we report that immature human CD34(+) cells dynamically expressed dopamine and beta(2)-adrenergic receptors, with higher expression in the primitive CD34(+)CD38(Io) population. The myeloid cytokines G-CSF and GM-CSF upregulated neuronal receptor expression on immature CD34+ cells. Treatment with neurotransmitters increased the motility, proliferation and colony formation of human progenitor cells, correlating with increased polarity, expression of the metalloproteinase MT1-MMP and activity of the metalloproteinase MMP-2. Treatment with catecholamines enhanced human CD34+ cell engraftment of NOD-SCID mice through Wnt signaling activation and increased cell mobilization and bone marrow Sca-1(+)c-Kit(+)Lin(-) cell numbers. Our results identify new functions for neurotransmitters and myeloid cytokines in the direct regulation of human and mouse progenitor cell migration and development.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel; Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Weizmann Institute of Science	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Lapidot, Tsvee/A-1812-2010	Rubinstein, Menachem/0000-0002-3472-6614				Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; AVIGDOR A, 2004, ASH ANN M ABSTR, V104, P2675; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cancelas JA, 2006, NAT MED, V12, P278, DOI 10.1038/nm0306-278; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Goichberg P, 2001, J CELL SCI, V114, P1309; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; HOAGLAND HC, 1982, SEMIN ONCOL, V9, P95; Janowska-Wieczorek ANNA, 2000, Hematology, V4, P515; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; KOLLET O, 2006, ANN REV IMMUNOL; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Larsson J, 2006, CELL, V124, P253, DOI 10.1016/j.cell.2006.01.006; Link DC, 2000, SEMIN HEMATOL, V37, P25, DOI 10.1016/S0037-1963(00)90086-6; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SHIRVAIKAR N, 2004, ASH ANN M ABSTR, V104, P2889; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; To LB, 1997, BLOOD, V89, P2233, DOI 10.1182/blood.V89.7.2233; TOWBRIDGE JJ, 2006, NAT IMMUNOL, V7, P1021; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; YAMAZAKI K, 1991, BLOOD CELLS, V17, P527; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	46	248	260	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1123	1131		10.1038/ni1509	http://dx.doi.org/10.1038/ni1509			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17828268				2022-12-18	WOS:000249691400027
J	Prinz, M; Erny, D; Hagemeyer, N				Prinz, Marco; Erny, Daniel; Hagemeyer, Nora			Ontogeny and homeostasis of CNS myeloid cells	NATURE IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY; PERIVASCULAR MACROPHAGES; CHOROID-PLEXUS; MICROGLIAL CELLS; IMMUNOREGULATORY CELLS; IMMUNE PRIVILEGE; MANNOSE RECEPTOR; ADULT MICROGLIA; STEADY-STATE	Myeloid cells in the central nervous system (CNS) represent a heterogeneous class of innate immune cells that contribute to the maintenance of tissue homeostasis differentially during development and adulthood. The subsets of CNS myeloid cells identified so far, including parenchymal microglia and non-parenchymal meningeal, perivascular and choroid-plexus macrophages, as well as disease-associated monocytes, have classically been distinguished on the basis of their surface epitope expression, localization and morphology. However, studies using cell-specific targeting, in vivo imaging, single-cell expression analysis and other sophisticated tools have now increased the depth of knowledge of this immune-cell compartment and call for reevaluation of the traditional views on the origin, fate and function of distinct CNS myeloid subsets. The concepts of CNS macrophage biology that are emerging from these new insights have broad implications for the understanding and treatment of CNS diseases.	[Prinz, Marco; Erny, Daniel; Hagemeyer, Nora] Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Erny, Daniel] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Erny, Daniel/AAU-7015-2020	Erny, Daniel/0000-0001-6000-8838	competence network of multiple sclerosis - Bundesministerium fur Bildung und Forschung; Sobek-Stiftung; Deutsche Forschungsgemeinschaft [SFB 992, SFB1140, SFB/TRR167]; Deutsche Forschungsgemeinschaft (Reinhart-Koselleck-Grant); Faculty of Medicine of the University of Freiburg (Berta-Ottenstein-Programme)	competence network of multiple sclerosis - Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sobek-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Reinhart-Koselleck-Grant)(German Research Foundation (DFG)); Faculty of Medicine of the University of Freiburg (Berta-Ottenstein-Programme)	We thank A. Parera and C. Gross for critical proofreading. Supported by the competence network of multiple sclerosis funded by Bundesministerium fur Bildung und Forschung (M.P.), Sobek-Stiftung (M.P.), Deutsche Forschungsgemeinschaft (SFB 992, SFB1140, SFB/TRR167 and a Reinhart-Koselleck-Grant to M.P.; and SFB/TRR167 to D.E.) and the Faculty of Medicine of the University of Freiburg (Berta-Ottenstein-Programme; D.E.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Baruch K, 2015, EMBO J, V34, P1816, DOI 10.15252/embj.201591468; Battisti C, 2014, J NEUROL, V261, P768, DOI 10.1007/s00415-014-7257-3; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bianchin MM, 2010, NAT REV NEUROL, V6, P1, DOI 10.1038/nrneurol.2010.17-c1; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; Brendecke SM, 2015, SEMIN IMMUNOPATHOL, V37, P591, DOI 10.1007/s00281-015-0520-6; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; delRio-Hortega P., 1932, CYTOLOGY CELLULAR PA, V2, P483; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Elmquist JK, 1997, J COMP NEUROL, V381, P119, DOI 10.1002/(SICI)1096-9861(19970505)381:2<119::AID-CNE1>3.0.CO;2-6; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Erny D, 2017, IMMUNOLOGY, V150, P7, DOI 10.1111/imm.12645; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Faraco G, 2016, J CLIN INVEST, V126, P4674, DOI 10.1172/JCI86950; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kolmer W., 1921, Anatomischer Anzeiger, V54, P15; Kosel S, 1997, ACTA NEUROPATHOL, V94, P532, DOI 10.1007/s004010050747; Kunis G, 2015, J NEUROSCI, V35, P6381, DOI 10.1523/JNEUROSCI.3644-14.2015; LASSMANN H, 1991, J NEUROSCI RES, V28, P236, DOI 10.1002/jnr.490280211; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; R?o-Hortega P., 1919, B SOC ESP BIOL, V9, P68; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; STREIT WJ, 1989, EXP NEUROL, V105, P115, DOI 10.1016/0014-4886(89)90111-8; Takahashi K, 2015, J NEUROPATH EXP NEUR, V74, P862, DOI 10.1097/NEN.0000000000000234; Vallieres L, 2003, J NEUROSCI, V23, P5197; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	104	247	249	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					385	392		10.1038/ni.3703	http://dx.doi.org/10.1038/ni.3703			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323268				2022-12-18	WOS:000396815800006
J	Dengler, HS; Baracho, GV; Omori, SA; Bruckner, S; Arden, KC; Castrillon, DH; DePinho, RA; Rickert, RC				Dengler, Hart S.; Baracho, Gisele V.; Omori, Sidne A.; Bruckner, Shane; Arden, Karen C.; Castrillon, Diego H.; DePinho, Ronald A.; Rickert, Robert C.			Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation	NATURE IMMUNOLOGY			English	Article							GENE REARRANGEMENTS; INTERLEUKIN-7 RECEPTOR; REGULATORY FACTOR-4; MICE LACKING; EXPRESSION; ACTIVATION; RECOMBINATION; LINEAGE; PROLIFERATION; SPECIFICATION	The transcription factors Foxo1, Foxo3 and Foxo4 modulate cell fate 'decisions' in diverse systems. Here we show that Foxo1-dependent gene expression was critical at many stages of B cell differentiation. Early deletion of Foxo1 caused a substantial block at the pro-B cell stage due to a failure to express interleukin 7 receptor-alpha. Foxo1 inactivation in late pro-B cells resulted in an arrest at the pre-B cell stage due to lower expression of the recombination-activating genes Rag1 and Rag2. Deletion of Foxo1 in peripheral B cells led to fewer lymph node B cells due to lower expression of L-selectin and failed class-switch recombination due to impaired upregulation of the gene encoding activation-induced cytidine deaminase. Thus, Foxo1 regulates a transcriptional program that is essential for early B cell development and peripheral B cell function.	[Dengler, Hart S.; Baracho, Gisele V.; Omori, Sidne A.; Bruckner, Shane; Rickert, Robert C.] Burnham Inst Med Res, Program Inflammatory Dis Res, La Jolla, CA 92037 USA; [Arden, Karen C.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci,Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Rickert, RC (corresponding author), Burnham Inst Med Res, Program Inflammatory Dis Res, La Jolla, CA 92037 USA.	robert@burnham.org		Fitzpatrick, Sidne/0000-0002-5245-4624; DePinho, Ronald/0000-0002-5625-577X	US National Institutes of Health [AI059447]; American Cancer Society; Robert A. and Renee E. Befler Foundation Institute for Innovative Cancer Science; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059447] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Robert A. and Renee E. Befler Foundation Institute for Innovative Cancer Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Rajewsky (Harvard University) and M. Reth (Max-Planck Institute) for Cd21<SUP>Cre</SUP> and mb1<SUP>Cre</SUP> mice, respectively; B. Finlay (Burnham Institute for Medical Research) and K. Mowen (The Scripps Research Institute) for retroviruses expressing Bcl-x<INF>L</INF> and Cre, respectively; and S. Hedrick and members of the Rickert laboratory for discussions and reading of the manuscript. Supported by the US National Institutes of Health (AI059447 to R. C. R.), the American Cancer Society (R. A. D.) and the Robert A. and Renee E. Befler Foundation Institute for Innovative Cancer Science (R. A. D.).	Ait-Azzouzene D, 2005, J EXP MED, V201, P817, DOI 10.1084/jem.20041854; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Itoh N, 1996, INT IMMUNOL, V8, P317, DOI 10.1093/intimm/8.3.317; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Llorian M, 2007, J IMMUNOL, V178, P1981, DOI 10.4049/jimmunol.178.4.1981; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Rush JS, 2002, J IMMUNOL, V168, P2676, DOI 10.4049/jimmunol.168.6.2676; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	50	247	250	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1388	1398		10.1038/ni.1667	http://dx.doi.org/10.1038/ni.1667			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18978794	Green Accepted			2022-12-18	WOS:000260888700014
J	Wolfer, A; Bakker, T; Wilson, A; Nicolas, M; Ioannidis, V; Littman, DR; Wilson, CB; Held, W; MacDonald, HR; Radtke, F				Wolfer, A; Bakker, T; Wilson, A; Nicolas, M; Ioannidis, V; Littman, DR; Wilson, CB; Held, W; MacDonald, HR; Radtke, F			Inactivation of Notch I in immature thymocytes does not perturb CD4 or CD8T cell development	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; ALPHA-BETA; RECEPTOR; DELTA; LINEAGE; FATE; SELECTION; MICE; MATURATION; CD8(+)	Notch proteins influence cell-fate decisions in many developing systems. Several gain-of-function studies have suggested a critical role for Notch1 signaling in CD4-CD8 lineage commitment, maturation and survival in the thymus, However, we show here that tissue-specific inactivation of the gene encoding Notch1 in immature (CD25(+)CD44(-))T cell precursors does not affect subsequent thymocyte development, Neither steady-state numbers nor the rate of production of CD4(+) and CD8(+) mature thymocytes is perturbed in the absence of Notch1, In addition, Notch1-deficient thymocytes are normally sensitive to spontaneous or glucocorticoid-induced apoptosis, In contrast to earlier reports, these data formally exclude an essential role for Notch1 in CD4-CD8 lineage commitment, maturation or survival.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; NYU, Med Ctr, Skirball Inst Biomol, New York, NY 10016 USA; NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Ludwig Institute for Cancer Research; University of Lausanne; New York University; Howard Hughes Medical Institute; New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	MacDonald, HR (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.		Radtke, Freddy/Q-3198-2017; Wilson, Anne/A-7131-2011; Wolfer, Anita/AAK-1720-2021	Radtke, Freddy/0000-0003-4315-4045; Ioannidis, Vassilios/0000-0002-4209-2578				Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; EVANS GA, 1982, NATURE, V300, P755, DOI 10.1038/300755a0; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Jehn BM, 1999, J IMMUNOL, V162, P635; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; LEE PP, 2001, UNPUB SCIENCE; Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RANGARAJAN A, 2001, UNPUB GENES DEV; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; van Meerwijk JPM, 1998, J IMMUNOL, V160, P2730; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Wilson A, 1998, J IMMUNOL, V161, P5851; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	30	247	253	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					235	241		10.1038/85294	http://dx.doi.org/10.1038/85294			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224523				2022-12-18	WOS:000167413800016
J	Divangahi, M; Chen, MJ; Gan, HX; Desjardins, D; Hickman, TT; Lee, DM; Fortune, S; Behar, SM; Remold, HG				Divangahi, Maziar; Chen, Minjian; Gan, Huixian; Desjardins, Danielle; Hickman, Tyler T.; Lee, David M.; Fortune, Sarah; Behar, Samuel M.; Remold, Heinz G.			Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair	NATURE IMMUNOLOGY			English	Article							REGULATES CA2+-DEPENDENT EXOCYTOSIS; EP4 PROSTANOID RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; PHAGOLYSOSOME BIOGENESIS; T-CELLS; LYSOSOMES; MECHANISM; PROTEIN; FUSION; PHOSPHORYLATION	Induction of macrophage necrosis is a strategy used by virulent Mycobacterium tuberculosis (Mtb) to avoid innate host defense. In contrast, attenuated Mtb causes apoptosis, which limits bacterial replication and promotes T cell cross-priming by antigen-presenting cells. Here we show that Mtb infection causes plasma membrane microdisruptions. Resealing of these lesions, a process crucial for preventing necrosis and promoting apoptosis, required translocation of lysosomal and Golgi apparatus-derived vesicles to the plasma membrane. Plasma membrane repair depended on prostaglandin E-2 (PGE(2)), which regulates synaptotagmin 7 (Syt-7), the calcium sensor involved in the lysosome-mediated repair mechanism. By inducing production of lipoxin A(4) (LXA(4)), which blocks PGE(2) biosynthesis, virulent Mtb prevented membrane repair and induced necrosis. Thus, virulent Mtb impairs macrophage plasma membrane repair to evade host defenses.	[Divangahi, Maziar; Chen, Minjian; Gan, Huixian; Desjardins, Danielle; Hickman, Tyler T.; Lee, David M.; Behar, Samuel M.; Remold, Heinz G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA 02115 USA; [Fortune, Sarah] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Remold, HG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA 02115 USA.	sbehar@rics.bwh.harvard.edu; hremold@rics.bwh.harvard.edu	Behar, Samuel M/C-3541-2009	Fortune, Sarah/0000-0001-7565-9975; Hickman, Tyler/0000-0003-2623-3251; Behar, Samuel/0000-0002-3374-6699	National Institutes of Health [AI50216, AI072143]; Fonds de la Recherche en Santedu Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050216, R21AI050216, R01AI072143, R21AI112766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Santedu Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I-C. Ho for critical reading of the manuscript; and B. Koller (University of North Carolina) for Ptges<SUP>-/-</SUP> mice. Supported by the US National Institutes of Health (AI50216 and AI072143 to H. G. R.) and the Fonds de la Recherche en Santedu Quebec (M. D.).	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Craxton M, 1999, FEBS LETT, V460, P417, DOI 10.1016/S0014-5793(99)01382-4; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; HART DNJ, 1993, IMMUNOLOGY, V79, P616; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MCNEIL PL, 1989, METHOD CELL BIOL, V29, P153; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; NOVIKOFF PM, 1983, P NATL ACAD SCI-BIOL, V80, P4364, DOI 10.1073/pnas.80.14.4364; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SIMPSON CS, 1995, NEUROSCIENCE, V68, P97, DOI 10.1016/0306-4522(95)00122-Y; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Togo T, 1999, J CELL SCI, V112, P719; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595	48	246	255	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					899	U123		10.1038/ni.1758	http://dx.doi.org/10.1038/ni.1758			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19561612	Green Accepted			2022-12-18	WOS:000268141400020
J	Kallies, A; Hawkins, ED; Belz, GT; Metcalf, D; Hommel, M; Corcoran, LM; Hodgkin, PD; Nutt, SL				Kallies, A; Hawkins, ED; Belz, GT; Metcalf, D; Hommel, M; Corcoran, LM; Hodgkin, PD; Nutt, SL			Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance	NATURE IMMUNOLOGY			English	Article							FACTOR FOXP3; CUTTING EDGE; MICE; AUTOIMMUNITY; EXPRESSION; LINEAGE; DIFFERENTIATION; EXPANSION; IL-21; INTERLEUKIN-2	T cell homeostasis is crucial for a functional immune system, as the accumulation of T cells resulting from lack of regulatory T cells or an inability to shut down immune responses can lead to inflammation and autoimmune pathology. Here we show that Blimp-1, a transcriptional repressor that is a 'master regulator' of terminal B cell differentiation, was expressed in a subset of antigen-experienced CD4(+) and CD8(+) T cells. Mice reconstituted with fetal liver stem cells expressing a mutant Blimp-1 lacking the DNA-binding domain developed a lethal multiorgan inflammatory disease caused by an accumulation of effector and memory T cells. These data identify Blimp-1 as an essential regulator of T cell homeostasis and suggest that Blimp-1 regulates both B cell and T cell differentiation.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute	Nutt, SL (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au	Belz, Gabrielle T/C-9350-2013; Nutt, Stephen L/C-9256-2013; Corcoran, Lynn M/C-9316-2013; Hommel, Mirja/C-9791-2019	Belz, Gabrielle T/0000-0002-9660-9587; Nutt, Stephen L/0000-0002-0020-6637; Hommel, Mirja/0000-0002-4788-6932; Kallies, Axel/0000-0002-6312-6968; Hodgkin, Philip/0000-0002-8604-1940; Hawkins, Edwin/0000-0002-3686-8261	NATIONAL CANCER INSTITUTE [R01CA022556, R37CA022556] Funding Source: NIH RePORTER; NCI NIH HHS [CA22556] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Bacchetta R, 2005, AUTOIMMUN REV, V4, P491, DOI 10.1016/j.autrev.2005.04.005; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lohr J, 2005, IMMUNOL REV, V204, P116, DOI 10.1111/j.0105-2896.2005.00241.x; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Metcalf D, 2000, P NATL ACAD SCI USA, V97, P9174, DOI 10.1073/pnas.160255197; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taki S, 2002, CYTOKINE GROWTH F R, V13, P379, DOI 10.1016/S1359-6101(02)00023-0; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	49	246	261	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					466	474		10.1038/ni1321	http://dx.doi.org/10.1038/ni1321			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16565720				2022-12-18	WOS:000237008800011
J	Umetsu, SE; Lee, WL; McIntire, JJ; Downey, L; Sanjanwala, B; Akbari, O; Berry, GJ; Nagumo, H; Freeman, GJ; Umetsu, DT; DeKruyff, RH				Umetsu, SE; Lee, WL; McIntire, JJ; Downey, L; Sanjanwala, B; Akbari, O; Berry, GJ; Nagumo, H; Freeman, GJ; Umetsu, DT; DeKruyff, RH			TIM-1 induces T cell activation and inhibits the development of peripheral tolerance	NATURE IMMUNOLOGY			English	Article							HEPATITIS-A VIRUS; SEVERE COMBINED IMMUNODEFICIENCY; COLONY-STIMULATING FACTOR; MOUSE BONE-MARROW; IMMUNOLOGICAL-TOLERANCE; DENDRITIC CELLS; GENE FAMILY; DISEASE; ANTIGEN; HYPERREACTIVITY	We have examined the function of TIM-1, encoded by a gene identified as an 'atopy susceptibility gene' (Havcr1), and demonstrate here that TIM-1 is a molecule that costimulates T cell activation. TIM-1 was expressed on CD4(+) T cells after activation and its expression was sustained preferentially in T helper type 2 (T(H)2) but not T(H)1 cells. In vitro stimulation of CD4+ T cells with a TIM-1-specific monoclonal antibody and T cell receptor ligation enhanced T cell proliferation; in T(H)2 cells, such costimulation greatly enhanced synthesis of interleukin 4 but not interferon-gamma. In vivo, the use of antibody to TIM-1 plus antigen substantially increased production of both interleukin 4 and interferon-gamma in unpolarized T cells, prevented the development of respiratory tolerance, and increased pulmonary inflammation. Our studies suggest that immunotherapies that regulate TIM-1 function may downmodulate allergic inflammatory diseases.	Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Stanford University; Harvard University; Harvard Medical School; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	DeKruyff, RH (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	rosemarie.dekruyff@childrens.harvard.edu	Jones, Jennifer/C-8691-2015; Downey, Laura/GRN-8512-2022; Freeman, Gordon/AAC-5380-2019	Jones, Jennifer/0000-0002-9488-7719; Freeman, Gordon/0000-0002-7210-5616; Downey, Laura/0000-0002-5334-3184; Berry, Gerald/0000-0002-6176-2629	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL69507] Funding Source: Medline; NIAID NIH HHS [P01 AI54456] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Macaulay AE, 1997, J IMMUNOL, V158, P4171; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; MEYERS J, IN PRESS NAT IMMUNOL; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; STOCKINGER B, 1994, INT IMMUNOL, V6, P247, DOI 10.1093/intimm/6.2.247; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Tsitoura DC, 2000, J ALLERGY CLIN IMMUN, V106, P239; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0	27	246	278	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					447	454		10.1038/ni1186	http://dx.doi.org/10.1038/ni1186			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15793575				2022-12-18	WOS:000228634300016
J	Jamieson, T; Cook, DN; Nibbs, RJB; Rot, A; Nixon, C; Mclean, P; Alcami, A; Lira, SA; Wiekowski, M; Graham, GJ				Jamieson, T; Cook, DN; Nibbs, RJB; Rot, A; Nixon, C; Mclean, P; Alcami, A; Lira, SA; Wiekowski, M; Graham, GJ			The chemokine receptor D6 limits the inflammatory response in vivo	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; MAST-CELLS MIGRATE; T-CELLS; ATOPIC-DERMATITIS; INTERFERON-GAMMA; BINDING-PROTEIN; PSORIATIC SKIN; MICE; IDENTIFICATION; DEGRANULATE	How the inflammatory response is initiated has been well defined but relatively little is known about how such responses are resolved. Here we show that the D6 chemokine receptor is involved in the post-inflammatory clearance of beta-chemokines from cutaneous sites. After induction of inflammation by phorbol esters, wild-type mice showed a transient inflammatory response. However, in D6-deficient mice, an excess concentration of residual chemokines caused a notable inflammatory pathology with similarities to human psoriasis. These results suggest that D6 is involved in the resolution of the cutaneous inflammatory response.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Duke Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Durham, NC 27706 USA; Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland; Novartis Inst Biomed Res, A-1230 Vienna, Austria; Univ Glasgow, Dept Vet Pathol, Glasgow G61 1QH, Lanark, Scotland; Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, E-28049 Madrid, Spain; Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Beatson Institute; Duke University; University of Glasgow; Novartis; University of Glasgow; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Icahn School of Medicine at Mount Sinai; Merck & Company; Schering Plough Corporation	Graham, GJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	g.graham@beatson.gla.ac.uk	Alcami, Antonio/F-8512-2015; Graham, Gerard/D-1240-2009; Cook, Donald/E-5079-2019	Alcami, Antonio/0000-0002-3333-6016; Cook, Donald/0000-0002-0052-3755; Nibbs, Robert/0000-0002-8150-0044; Rot, Antal/0000-0002-9730-6166; Graham, Gerard/0000-0002-7801-204X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102025, Z01ES102025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ackermann L, 1998, ARCH DERMATOL RES, V290, P353, DOI 10.1007/s004030050317; Ackermann L, 1999, BRIT J DERMATOL, V140, P624; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bos JD, 1999, IMMUNOL TODAY, V20, P40, DOI 10.1016/S0167-5699(98)01381-4; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Cataisson C, 2003, J IMMUNOL, V171, P2703, DOI 10.4049/jimmunol.171.5.2703; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gisondi Paolo, 2004, Current Drug Targets - Inflammation and Allergy, V3, P175, DOI 10.2174/1568010043343903; Gottlieb AB, 2003, J AM ACAD DERMATOL, V49, pS112, DOI 10.1016/S0190-9622(03)01143-5; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; LEWIS JG, 1987, CARCINOGENESIS, V8, P889, DOI 10.1093/carcin/8.7.889; Mantovani A, 2004, J LEUKOCYTE BIOL, V75, P738, DOI 10.1189/jlb.1003473; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nibbs R, 2003, SEMIN IMMUNOL, V15, P287, DOI 10.1016/j.smim.2003.08.006; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nickoloff BJ, 1999, ARCH DERMATOL, V135, P1104, DOI 10.1001/archderm.135.9.1104; Nilsson G, 1999, BLOOD, V93, P2791; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Oberyszyn TM, 1998, CARCINOGENESIS, V19, P445, DOI 10.1093/carcin/19.3.445; Ovigne JM, 2001, EXP DERMATOL, V10, P168, DOI 10.1034/j.1600-0625.2001.010003168.x; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Prinz JC, 2003, J EUR ACAD DERMATOL, V17, P257, DOI 10.1046/j.1468-3083.2003.00720.x; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P., 2003, METH MOL B, V239, P27; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2003, SEMIN IMMUNOL, V15, P57, DOI 10.1016/S1044-5323(02)00128-8; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schon MP, 1999, J INVEST DERMATOL, V112, P405, DOI 10.1046/j.1523-1747.1999.00538.x; Schon MP, 1997, NAT MED, V3, P183, DOI 10.1038/nm0297-183; SISSKIN EF, 1982, CARCINOGENESIS, V3, P403, DOI 10.1093/carcin/3.4.403; Szabo SK, 1998, J INVEST DERMATOL, V111, P1072, DOI 10.1046/j.1523-1747.1998.00419.x; TAUB D, 1995, J IMMUNOL, V154, P2393; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Wright TW, 2004, J IMMUNOL, V172, P2511, DOI 10.4049/jimmunol.172.4.2511; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	50	246	253	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					403	411		10.1038/ni1182	http://dx.doi.org/10.1038/ni1182			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15750596				2022-12-18	WOS:000227860000015
J	Weisberg, SP; Connors, TJ; Zhu, Y; Baldwin, MR; Lin, WH; Wontakal, S; Szabo, PA; Wells, SB; Dogra, P; Gray, J; Idzikowski, E; Stelitano, D; Bovier, FT; Davis-Porada, J; Matsumoto, R; Poon, MML; Chait, M; Mathieu, C; Horvat, B; Decimo, D; Hudson, KE; Dei Zotti, F; Bitan, ZC; La Carpia, F; Ferrara, SA; Mace, E; Milner, J; Moscona, A; Hod, E; Porotto, M; Farber, DL				Weisberg, Stuart P.; Connors, Thomas J.; Zhu, Yun; Baldwin, Matthew R.; Lin, Wen-Hsuan; Wontakal, Sandeep; Szabo, Peter A.; Wells, Steven B.; Dogra, Pranay; Gray, Joshua; Idzikowski, Emma; Stelitano, Debora; Bovier, Francesca T.; Davis-Porada, Julia; Matsumoto, Rei; Poon, Maya Meimei Li; Chait, Michael; Mathieu, Cyrille; Horvat, Branka; Decimo, Didier; Hudson, Krystalyn E.; Dei Zotti, Flavia; Bitan, Zachary C.; La Carpia, Francesca; Ferrara, Stephen A.; Mace, Emily; Milner, Joshua; Moscona, Anne; Hod, Eldad; Porotto, Matteo; Farber, Donna L.			Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum	NATURE IMMUNOLOGY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NIPAH VIRUS; IDENTIFICATION; EPIDEMIOLOGY; IMMUNITY	Farber and colleagues report distinct antibody responses to SARS-CoV-2 in pediatric cohorts, including those who developed multisystem inflammatory syndrome (MIS-C), and adult COVID-19 cohorts. Clinical manifestations of COVID-19 caused by the new coronavirus SARS-CoV-2 are associated with age(1,2). Adults develop respiratory symptoms, which can progress to acute respiratory distress syndrome (ARDS) in the most severe form, while children are largely spared from respiratory illness but can develop a life-threatening multisystem inflammatory syndrome (MIS-C)(3-5). Here, we show distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts had anti-spike (S) IgG, IgM and IgA antibodies, as well as anti-nucleocapsid (N) IgG antibody, while children with and without MIS-C had reduced breadth of anti-SARS-CoV-2-specific antibodies, predominantly generating IgG antibodies specific for the S protein but not the N protein. Moreover, children with and without MIS-C had reduced neutralizing activity as compared to both adult COVID-19 cohorts, indicating a reduced protective serological response. These results suggest a distinct infection course and immune response in children independent of whether they develop MIS-C, with implications for developing age-targeted strategies for testing and protecting the population.	[Weisberg, Stuart P.; Lin, Wen-Hsuan; Wontakal, Sandeep; Chait, Michael; Hudson, Krystalyn E.; Dei Zotti, Flavia; Bitan, Zachary C.; La Carpia, Francesca; Hod, Eldad] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY USA; [Connors, Thomas J.; Zhu, Yun; Idzikowski, Emma; Stelitano, Debora; Bovier, Francesca T.; Mace, Emily; Milner, Joshua; Moscona, Anne; Porotto, Matteo] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Zhu, Yun; Stelitano, Debora; Bovier, Francesca T.; Moscona, Anne; Porotto, Matteo] Columbia Univ, Ctr Host Pathogen Interact, Irving Med Ctr, New York, NY 10027 USA; [Baldwin, Matthew R.] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA; [Szabo, Peter A.; Dogra, Pranay; Gray, Joshua; Matsumoto, Rei; Poon, Maya Meimei Li; Chait, Michael; Farber, Donna L.] Columbia Univ, Columbia Ctr Translat Immunol, Irving Med Ctr, New York, NY 10027 USA; [Wells, Steven B.] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Stelitano, Debora; Bovier, Francesca T.; Porotto, Matteo] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Davis-Porada, Julia] Columbia Univ, Med Scientist Training Program, New York, NY USA; [Matsumoto, Rei; Farber, Donna L.] Columbia Univ, Irving Med Ctr, Dept Surg, New York, NY 10027 USA; [Mathieu, Cyrille; Horvat, Branka; Decimo, Didier] Claude Bernard Univ Lyon 1, Ctr Int Rech Infectiol, Inst Natl Sante & Rech Med, CNRS,UMR5308,Ecole Normale Super Lyon,U1111,CIRI, Lyon, France; [Ferrara, Stephen A.] Columbia Univ, Sch Nursing, Irving Med Ctr, New York, NY USA; [Moscona, Anne; Farber, Donna L.] Columbia Univ, Dept Microbiol & Immunol, Irving Med Ctr, New York, NY 10027 USA; [Moscona, Anne] Columbia Univ, Dept Physiol & Cellular Biophys, Irving Med Ctr, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Universita della Campania Vanvitelli; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Porotto, M (corresponding author), Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA.; Porotto, M (corresponding author), Columbia Univ, Ctr Host Pathogen Interact, Irving Med Ctr, New York, NY 10027 USA.; Farber, DL (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Irving Med Ctr, New York, NY 10027 USA.; Porotto, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.; Farber, DL (corresponding author), Columbia Univ, Irving Med Ctr, Dept Surg, New York, NY 10027 USA.; Farber, DL (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Irving Med Ctr, New York, NY 10027 USA.	mp3509@cumc.columbia.edu; df2396@cumc.columbia.edu	Horvat, Branka/M-3504-2014; Mathieu, Cyrille/ABF-5074-2020; La Carpia, Francesca/ABH-7087-2020; Baldwin, Matthew/GQY-7234-2022; Mathieu, Cyrille/A-1976-2015	Horvat, Branka/0000-0003-0578-7765; Weisberg, Stuart/0000-0002-8698-5976; Davis-Porada, Julia/0000-0001-9313-4590; Wells, Steven/0000-0001-5428-0683; Mathieu, Cyrille/0000-0002-6682-2029; Connors, Thomas/0000-0002-0199-7733; Szabo, Peter Anthony/0000-0003-1603-761X; , Maya/0000-0002-7927-5853; Baldwin, Matthew/0000-0003-4670-3433; Decimo, Didier/0000-0002-0390-1205; Dogra, Pranay/0000-0003-2031-9855; Lin, Wen-Hsuan Wendy/0000-0002-5414-7900; POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health (NIH) [AI128949, AI100119, AI106697]; NIH [AI121349, NS091263, NS105699, AI146980, K08DK122130, K23 AI141686]; Fondation de France; ANR Flash-Covid-19 [ANR-20-COVI-000];  [AI114736]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation de France(Fondation de France); ANR Flash-Covid-19(French National Research Agency (ANR)); 	We thank F. Cosset for the donation of the Vero E6 cells. We thank the Medical ICU nurse champions, C. Garcellano, T. Drukdak, H. Avila Raymundo, L. Wagner and R. Lee, who all led the efforts to obtain patient samples for the adult ARDS patients; E. Hernandez and L. Gomez for their roles as clinical coordinators; and the nurses and clinical staff in the Pediatric Intensive Care Unit of MSCHONY. We acknowledge the dedication, commitment and sacrifice of the other nurses, providers and personnel who helped care for these patients during the COVID-19 crisis. We acknowledge the suffering and loss of our COVID-19 patients and that of their families and our community. We also acknowledge the staff of the Columbia University Biobank for their efforts in collecting and preserving COVID-19 patient samples for research studies. This work was supported by National Institutes of Health (NIH) grant nos. AI128949, AI100119 and AI106697 awarded to D.L.F.; NIH grant nos. AI121349, NS091263, NS105699 and AI146980 awarded to M.P.; Fondation de France and ANR Flash-Covid-19, ANR-20-COVI-000 awarded to B.H. and M.P.; and grant no. AI114736 awarded to A.M. S.W. is supported by NIH grant no. K08DK122130. T.J.C. is supported by NIH grant no. K23 AI141686. The funders/sponsors had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; the preparation, review or approval of the manuscript; and the decision to submit the manuscript for publication.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], 2020, MULT INFL SYNDR CHIL; Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Chan KH, 2013, J INFECTION, V67, P130, DOI 10.1016/j.jinf.2013.03.015; Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374; Cong YY, 2020, J VIROL, V94, DOI 10.1128/JVI.01925-19; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gruber Conor, 2020, medRxiv, DOI [10.1016/j.cell.2020.09.034, 10.1101/2020.07.04.20142752]; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Hartman H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198528; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Lanzavecchia A, 2016, CURR OPIN IMMUNOL, V41, P62, DOI 10.1016/j.coi.2016.06.001; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Pessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036833; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124; Talekar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030538; Vasilevskis EE, 2016, CRIT CARE MED, V44, P138, DOI 10.1097/CCM.0000000000001375; Wang XL, 2020, CLIN INFECT DIS, V71, P2688, DOI 10.1093/cid/ciaa721; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4	49	245	250	4	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					25	31		10.1038/s41590-020-00826-9	http://dx.doi.org/10.1038/s41590-020-00826-9		NOV 2020	7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33154590	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-18	WOS:000586385000001
J	Michelet, X; Dyck, L; Hogan, A; Loftus, RM; Duquette, D; Wei, K; Beyaz, S; Tavakkoli, A; Foley, C; Donnelly, R; O'Farrelly, C; Raverdeau, M; Vernon, A; Pettee, W; O'Shea, D; Nikolajczyk, BS; Mills, KHG; Brenner, MB; Finlay, D; Lynch, L				Michelet, Xavier; Dyck, Lydia; Hogan, Andrew; Loftus, Roisin M.; Duquette, Danielle; Wei, Kevin; Beyaz, Semir; Tavakkoli, Ali; Foley, Cathriona; Donnelly, Raymond; O'Farrelly, Cliona; Raverdeau, Mathilde; Vernon, Ashley; Pettee, William; O'Shea, Donal; Nikolajczyk, Barbara S.; Mills, Kingston H. G.; Brenner, Michael B.; Finlay, David; Lynch, Lydia			Metabolic reprogramming of natural killer cells in obesity limits antitumor responses	NATURE IMMUNOLOGY			English	Article							LYTIC GRANULE CONVERGENCE; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; ENERGY-METABOLISM; TUMOR PROGRESSION; CANCER; POLARIZATION; ACTIVATION; MTOR; CHECKPOINTS	Up to 49% of certain types of cancer are attributed to obesity, and potential mechanisms include overproduction of hormones, adipokines, and insulin. Cytotoxic immune cells, including natural killer (NK) cells and CD8(+) T cells, are important in tumor surveillance, but little is known about the impact of obesity on immunosurveillance. Here, we show that obesity induces robust peroxisome proliferator-activated receptor (PPAR)-driven lipid accumulation in NK cells, causing complete 'paralysis' of their cellular metabolism and trafficking. Fatty acid administration, and PPAR alpha and PPAR delta (PPAR alpha/delta) agonists, mimicked obesity and inhibited mechanistic target of rapamycin (mTOR)-mediated glycolysis. This prevented trafficking of the cytotoxic machinery to the NK cell-tumor synapse. Inhibiting PPAR alpha/delta or blocking the transport of lipids into mitochondria reversed NK cell metabolic paralysis and restored cytotoxicity. In vivo, NK cells had blunted antitumor responses and failed to reduce tumor growth in obesity. Our results demonstrate that the lipotoxic obese environment impairs immunosurveillance and suggest that metabolic reprogramming of NK cells may improve cancer outcomes in obesity.	[Michelet, Xavier; Duquette, Danielle; Wei, Kevin; Tavakkoli, Ali; Vernon, Ashley; Pettee, William; Brenner, Michael B.; Lynch, Lydia] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Michelet, Xavier; Beyaz, Semir; Brenner, Michael B.; Lynch, Lydia] Harvard Med Sch, Boston, MA USA; [Dyck, Lydia; Loftus, Roisin M.; Foley, Cathriona; Donnelly, Raymond; O'Farrelly, Cliona; Raverdeau, Mathilde; Mills, Kingston H. G.; Finlay, David; Lynch, Lydia] Univ Dublin Trinity Coll, Sch Biochem & Immunol Sch Med, Dublin, Ireland; [Hogan, Andrew; O'Shea, Donal] Human Hlth Inst Maynooth Univ, Maynooth, Kildare, Ireland; [O'Shea, Donal] St Vincents Univ Hosp, Educ Res Ctr, Dublin, Ireland; [Nikolajczyk, Barbara S.] Univ Kentucky, Barnstable Brown Diabet Ctr, Lexington, KY USA; [Finlay, David] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital; University of Kentucky; Trinity College Dublin	Lynch, L (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Lynch, L (corresponding author), Harvard Med Sch, Boston, MA USA.; Lynch, L (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol Sch Med, Dublin, Ireland.	llynch@bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021; Mills, Kingston H/F-5684-2013; Foley, Cathriona/J-6840-2015; Foley, Cathriona/AAE-1477-2022; Finlay, David/H-5840-2018	Mills, Kingston H/0000-0003-3646-8222; Foley, Cathriona/0000-0001-9046-2417; Foley, Cathriona/0000-0001-9046-2417; Hogan, Andrew/0000-0001-5875-230X; O'Shea, Donal/0000-0002-1408-5274; O'Farrelly, Cliona/0000-0002-0616-2874; Lynch, Lydia/0000-0002-4273-4681; Loftus, Roisin/0000-0001-9137-6625; Finlay, David/0000-0003-2716-6679; Beyaz, Semir/0000-0003-4730-4012	National Institutes of Health (NIH) [R01 AI11304603]; European Research Council (ERC) [679173]; Cancer Research Institute CLIP grant [16/FRL/3865]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI134861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); Cancer Research Institute CLIP grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Wilk and J. Barrett for assistance with experiments. This research was supported by National Institutes of Health (NIH) grant R01 AI11304603 (M.B.B.), European Research Council (ERC) Starting Grant 679173, a Cancer Research Institute CLIP grant and 16/FRL/3865 (L.L.).	Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; BJORNTORP P, 1969, ACTA MED SCAND, V185, P351; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Jahn J, 2015, OBESITY, V23, P2233, DOI 10.1002/oby.21229; James AM, 2013, BLOOD, V121, P2627, DOI 10.1182/blood-2012-06-437012; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Liu DF, 2011, IMMUNOL CELL BIOL, V89, P728, DOI 10.1038/icb.2010.167; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; Mace EM, 2009, J IMMUNOL, V182, P948, DOI 10.4049/jimmunol.182.2.948; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Perdu S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85560; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Tuli A, 2013, MOL BIOL CELL, V24, P3721, DOI 10.1091/mbc.E13-05-0259; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; World Health Organization, 2004, GLOBAL STATUS REPORT	45	245	250	11	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1330	+		10.1038/s41590-018-0251-7	http://dx.doi.org/10.1038/s41590-018-0251-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30420624	Green Accepted			2022-12-18	WOS:000452873000014
J	Zuccarino-Catania, GV; Sadanand, S; Weisel, FJ; Tomayko, MM; Meng, HL; Kleinstein, SH; Good-Jacobson, KL; Shlomchik, MJ				Zuccarino-Catania, Griselda V.; Sadanand, Saheli; Weisel, Florian J.; Tomayko, Mary M.; Meng, Hailong; Kleinstein, Steven H.; Good-Jacobson, Kim L.; Shlomchik, Mark J.			CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype	NATURE IMMUNOLOGY			English	Article							MURINE MEMORY; IMMUNOLOGICAL MEMORY; GENE-EXPRESSION; DIFFERENTIATION; HETEROGENEITY; MECHANISMS; RESPONSES; SURVIVAL	Memory B cells (MBCs) are long-lived sources of rapid, isotype-switched secondary antibody-forming cell (AFC) responses. Whether MBCs homogeneously retain the ability to self-renew and terminally differentiate or if these functions are compartmentalized into MBC subsets has remained unclear. It has been suggested that antibody isotype controls MBC differentiation upon restimulation. Here we demonstrate that subcategorizing MBCs on the basis of their expression of CD80 and PD-L2, independently of isotype, identified MBC subsets with distinct functions upon rechallenge. CD8O(+)PD-L2(+) MBCs differentiated rapidly into AFCs but did not generate germinal centers (GCs); conversely, CD8O(-)PD-L2(-) MBCs generated few early AFCs but robustly seeded GCs. The gene-expression patterns of the subsets supported both the identity and function of these distinct MBC types. Hence, the differentiation and regeneration of MBCs are compartmentalized.	[Zuccarino-Catania, Griselda V.; Sadanand, Saheli; Good-Jacobson, Kim L.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Weisel, Florian J.; Good-Jacobson, Kim L.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Tomayko, Mary M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Meng, Hailong; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.	mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Sadanand, Saheli/0000-0001-6675-3492; Good-Jacobson, Kim/0000-0003-1891-7274	US National Institutes of Health [R01-A146303, K08-A1078533]; Deutsche Forschungsgemeinschaft [WE 4752/1-1]; National Health and Medical Research Council of Australia; National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017781, S10RR023431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078533, R01AI043603] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Conter, J. Cullen and E. Song for technical assistance; the Yale Cell Sorter Facility for cell sorting; and the Yale Animal Resource Center and A. Durso for animal care. Supported by the US National Institutes of Health (R01-A146303 to M.J.S. and K08-A1078533 to M.M.T.), Deutsche Forschungsgemeinschaft (WE 4752/1-1 to F.J.W.), the National Health and Medical Research Council of Australia (K.L.G.-J.) and the National Science Foundation (G.V.Z.-C. and S.S.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bar-Or A, 2001, J IMMUNOL, V167, P5669, DOI 10.4049/jimmunol.167.10.5669; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Li ZW, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.09.016; Liu AH, 1996, J EXP MED, V183, P2053, DOI 10.1084/jem.183.5.2053; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tangye SG, 2004, IMMUNOLOGY, V112, P509, DOI 10.1111/j.1365-2567.2004.01950.x; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Weisel FJ, 2010, J IMMUNOL, V185, P4011, DOI 10.4049/jimmunol.1001540; Wong JV, 2011, CELL CYCLE, V10; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371	41	245	247	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					631	637		10.1038/ni.2914	http://dx.doi.org/10.1038/ni.2914			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24880458	Green Accepted			2022-12-18	WOS:000337715600009
J	Mancuso, G; Gambuzza, M; Midiri, A; Biondo, C; Papasergi, S; Akira, S; Teti, G; Beninati, C				Mancuso, Giuseppe; Gambuzza, Maria; Midiri, Angelina; Biondo, Carmelo; Papasergi, Salvatore; Akira, Shizuo; Teti, Giuseppe; Beninati, Concetta			Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells	NATURE IMMUNOLOGY			English	Article							I INTERFERON-PRODUCTION; TRANSCRIPTION FACTOR; STREPTOCOCCUS; IFN; INDUCTION; IMMUNITY; RNA; ALPHA/BETA; ACTIVATION; RESISTANCE	Little is known of how and where bacterial recognition triggers the induction of type I interferon. Whether the type of recognition receptor used in these responses is determined by the subcellular location of bacteria is not understood. Here we show that phagosomal bacteria such as group B streptococcus, but not cytosolic bacteria, potently induced interferon in conventional dendritic cells by a mechanism that required Toll-like receptor 7, the adaptor MyD88 and the transcription factor IRF1, all of which localized together with bacterial products in degradative vacuoles bearing lysosomal markers. Thus, this cell type-specific recognition pathway links lysosomal recognition of bacterial RNA with a robust, host-protective interferon response.	[Mancuso, Giuseppe; Gambuzza, Maria; Midiri, Angelina; Biondo, Carmelo; Papasergi, Salvatore; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Elie Metchnikoff Dept, Messina, Italy; [Akira, Shizuo] Osaka Univ, Host Def Lab, World Premiere Int Immunol Frontier Res Ctr, Suita, Osaka, Japan	University of Messina; Osaka University	Teti, G (corresponding author), Univ Messina, Elie Metchnikoff Dept, Messina, Italy.	gteti@unime.it	Biondo, Carmelo/AAA-3391-2019; papasergi, salvatore/AAE-8818-2021; Akira, Shizuo/C-3134-2009	Midiri, Angelina/0000-0002-4128-9678; BENINATI, Concetta/0000-0001-8305-1337; Mancuso, Giuseppe/0000-0001-5454-3228	Ministero dell'Universita e della Ricerca of Italy	Ministero dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	We thank T. Taniguchi (University of Tokyo) for permission to use Irf1<SUP>-/-</SUP>, Irf3<SUP>-/-</SUP> and Irf7<SUP>-/-</SUP> mice; D. Golenbock, K. Fitzgerald and E. Lien (University of Massachusetts Medical School) for Irf1<SUP>-/-</SUP>, Irf3<SUP>-/-</SUP> and Irf7<SUP>-/-</SUP> mice; T. Leanderson (University of Lund) for Ifnb<SUP>-/-</SUP> mice; G. Grandi (Novartis Vaccines) and D. Portnoy (University of California) for bacterial strains; and F. Ioppolo (Carl Zeiss) for help with fluorescence microscopy. Supported by the Ministero dell'Universita e della Ricerca of Italy (Project 'Innovative vaccine against group A streptococcus').	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Biondo C, 2008, J IMMUNOL, V181, P566, DOI 10.4049/jimmunol.181.1.566; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Loof TG, 2007, J INFECT DIS, V196, P1794, DOI 10.1086/523647; Magliani W, 1998, NAT MED, V4, P705, DOI 10.1038/nm0698-705; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Scumpia PO, 2005, J IMMUNOL, V175, P3282, DOI 10.4049/jimmunol.175.5.3282; Smith PL, 2005, MOL IMMUNOL, V42, P869, DOI 10.1016/j.molimm.2004.11.008; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008	40	245	254	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					587	U48		10.1038/ni.1733	http://dx.doi.org/10.1038/ni.1733			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19430477				2022-12-18	WOS:000266384100010
J	Sigmundsdottir, H; Butcher, EC				Sigmundsdottir, Hekla; Butcher, Eugene C.			Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; ADHESION PROTEIN-1 VAP-1; TRANS-RETINOIC ACID; VITAMIN-D; HOMING RECEPTOR; B-CELLS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; VASCULAR ENDOTHELIUM; IMMUNE SURVEILLANCE; CCR10 EXPRESSION	Lymphocytes are imprinted during activation with trafficking programs (combinations of adhesion and chemoattractant receptors) that target their migration to specific tissues and microenvironments. Cytokines contribute, but, for gut and skin, evolution has cleverly adapted external cues from food (vitamin A) and sunlight (ultraviolet-induced vitamin D3) to imprint lymphocyte homing to the small intestines and T cell migration into the epidermis. Dendritic cells are essential: they process the vitamins to their active metabolites (retinoic acid and 1,25(OH)(2)D3) for presentation with antigen to lymphocytes, and they help export environmental cues through lymphatics to draining lymph nodes, to program the trafficking and effector functions of naive T and B cells.	[Butcher, Eugene C.] Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Butcher, EC (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	ebutcher@stanford.edu			Ruth L. Kirschstein National Research Service [AI 6683501A1]; US National Institutes of Health (NIH) [AI72618, AI47822, AI059635, GM37734, U19 AI057229]; Department of Veterans Affairs; FACS Core Facility of the Stanford Digestive Disease Center [P30 DK56339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059635, R01AI072618, T32AI007290, F32AI066835, R21AI047822, R37AI047822, R01AI059635, U19AI057229, R01AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037734, R37GM037734] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); FACS Core Facility of the Stanford Digestive Disease Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Habtezion and C. Oderup for critical comments on the manuscript. Supported by Ruth L. Kirschstein National Research Service Award AI 6683501A1 (H. S.); by US National Institutes of Health (NIH) grants AI72618, AI47822, AI059635, GM37734 and U19 AI057229 and a Merit Award from the Department of Veterans Affairs (E. C. B.); and by the FACS Core Facility of the Stanford Digestive Disease Center under NIH grant P30 DK56339.	Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Arvilommi AM, 1996, EUR J IMMUNOL, V26, P825, DOI 10.1002/eji.1830260415; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; BUTCHER EC, 1986, CURR TOP MICROBIOL, V128, P85; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butcher EC, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P3; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Enioutina EY, 2008, VACCINE, V26, P601, DOI 10.1016/j.vaccine.2007.11.084; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Honjo M, 2003, P NATL ACAD SCI USA, V100, P1274, DOI 10.1073/pnas.0337528100; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jaimes MC, 2004, J VIROL, V78, P10967, DOI 10.1128/JVI.78.20.10967-10976.2004; JALKANEN S, 1990, J INVEST DERMATOL, V94, P786, DOI 10.1111/1523-1747.ep12874646; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim CH, 2003, J IMMUNOL, V171, P152, DOI 10.4049/jimmunol.171.1.152; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lehmann B, 2000, EXP DERMATOL, V9, P97, DOI 10.1034/j.1600-0625.2000.009002097.x; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Penna G, 2007, J BONE MINER RES, V22, pV69, DOI 10.1359/JBMR.07S217; PICKER LJ, 1993, J IMMUNOL, V150, P1122; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Prystowsky JH, 1996, J AM ACAD DERMATOL, V35, P690, DOI 10.1016/S0190-9622(96)90722-7; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Salmi M, 2005, IMMUNOL REV, V206, P100, DOI 10.1111/j.0105-2896.2005.00285.x; Salmi M, 1997, J EXP MED, V186, P589, DOI 10.1084/jem.186.4.589; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Schon MP, 2003, J INVEST DERMATOL, V121, P951, DOI 10.1046/j.1523-1747.2003.12563.x; Shirakawa AK, 2008, J IMMUNOL, V180, P2786, DOI 10.4049/jimmunol.180.5.2786; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P4, DOI 10.1111/j.1365-2222.2005.02139.x; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Young A J, 1993, Curr Top Microbiol Immunol, V184, P161; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	70	245	252	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					981	987		10.1038/ni.f.208	http://dx.doi.org/10.1038/ni.f.208			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711435	Green Accepted			2022-12-18	WOS:000258559600006
J	Hu, H; Wang, B; Borde, M; Nardone, J; Maika, S; Allred, L; Tucker, PW; Rao, A				Hu, Hui; Wang, Bin; Borde, Madhuri; Nardone, Julie; Maika, Shan; Allred, Laura; Tucker, Philip W.; Rao, Anjana			Foxp1 is an essential transcriptional regulator of B cell development	NATURE IMMUNOLOGY			English	Article							COORDINATE REGULATION; GENE; EXPRESSION; DIFFERENTIATION; MOUSE; RECOMBINATION; E2A; ACTIVATION; INITIATION; PROTEINS	Forkhead transcription factors are key participants in development and immune regulation. Here we demonstrate that absence of the gene encoding the forkhead transcription factor Foxp1 resulted in a profound defect in early B cell development. Foxp1 deficiency was associated with decreased expression of all B lineage genes in B220(+) fetal liver cells as well as with a block in the transition from pro-B cell to pre-B cell involving diminished expression of recombination-activating genes 1 and 2. Foxp1 bound to the Erag enhancer and was involved in controlling variable-(diversity)-joining recombination of the gene encoding immunoglobulin heavy chain in a B cell lineage - specific way. Our results identify Foxp1 as an essential participant in the transcriptional regulatory network of B lymphopoiesis.	Harvard Univ, Sch Med, CBRI Inst Biomed Res, Dept Pathol, Boston, MA 02115 USA; Univ Texas, Dept Mol Genet, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hu, H (corresponding author), Harvard Univ, Sch Med, CBRI Inst Biomed Res, Dept Pathol, Boston, MA 02115 USA.	hu@cbr.med.harvard.edu; arao@cbr.med.harvard.edu			NCI NIH HHS [CA92318, CA31534, CA42471] Funding Source: Medline; NHLBI NIH HHS [HL071160] Funding Source: Medline; NIAID NIH HHS [AI48213, AI44432] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092318, R01CA042471, R01CA031534, R37CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI044432] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Banham AH, 2001, CANCER RES, V61, P8820; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; CONNOR AM, 1995, J IMMUNOL, V155, P5268; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purohit SJ, 2003, EMBO J, V22, P5511, DOI 10.1093/emboj/cdg522; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Rolink A, 1995, Semin Immunol, V7, P155, DOI 10.1016/1044-5323(95)90043-8; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sagara S, 1997, J IMMUNOL, V158, P666; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; WU GE, 1986, EMBO J, V5, P3475, DOI 10.1002/j.1460-2075.1986.tb04672.x; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	54	245	255	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					819	826		10.1038/ni1358	http://dx.doi.org/10.1038/ni1358			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16819554				2022-12-18	WOS:000239147200017
J	Ise, W; Kohyama, M; Schraml, BU; Zhang, TT; Schwer, B; Basu, U; Alt, FW; Tang, J; Oltz, EM; Murphy, TL; Murphy, KM				Ise, Wataru; Kohyama, Masako; Schraml, Barbara U.; Zhang, Tingting; Schwer, Bjoern; Basu, Uttiya; Alt, Frederick W.; Tang, Jun; Oltz, Eugene M.; Murphy, Theresa L.; Murphy, Kenneth M.			The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells	NATURE IMMUNOLOGY			English	Article							NEGATIVE REGULATOR; DENDRITIC CELLS; HELPER-CELLS; C-MAF; EXPRESSION; PROMOTER; DIVISION; IL-21; GENE; DIFFERENTIATION	The transcription factor BATF controls the differentiation of interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) by regulating expression of the transcription factor ROR gamma t itself and ROR gamma t target genes such as Il17. Here we report the mechanism by which BATF controls in vivo class-switch recombination (CSR). In T cells, BATF directly controlled expression of the transcription factors Bcl-6 and c-Maf, both of which are needed for development of follicular helper T cells (T-FH cells). Restoring T-FH cell activity to Batf(-/-) T cells in vivo required coexpression of Bcl-6 and c-Maf. In B cells, BATF directly controlled the expression of both activation-induced cytidine deaminase (AID) and of germline transcripts of the intervening heavy-chain region and constant heavy-chain region (I-H-C-H). Thus, BATF functions at multiple hierarchical levels in two cell types to globally regulate switched antibody responses in vivo.	[Ise, Wataru; Kohyama, Masako; Schraml, Barbara U.; Tang, Jun; Oltz, Eugene M.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Ise, Wataru; Kohyama, Masako; Zhang, Tingting; Schwer, Bjoern; Basu, Uttiya; Alt, Frederick W.; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Zhang, Tingting; Schwer, Bjoern; Basu, Uttiya; Alt, Frederick W.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Zhang, Tingting; Schwer, Bjoern; Basu, Uttiya; Alt, Frederick W.] Harvard Univ, Sch Med, Boston, MA USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu		Schraml, Barbara/0000-0002-5801-0151	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Honjo (Kyoto University) for Aicda<SUP>-/-</SUP> mice; and D. Bhattacharya (Washington University) for retroviruses Bcl-6-GFP RV and CD40L-GFP RV. Supported by the Howard Hughes Medical Institute (K.M.M.).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Deenick EK, 1999, J IMMUNOL, V163, P4707; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	41	244	248	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					536	U245		10.1038/ni.2037	http://dx.doi.org/10.1038/ni.2037			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21572431	Green Accepted			2022-12-18	WOS:000290707100014
J	Rathmell, JC; Lindsten, T; Zong, WX; Cinalli, RM; Thompson, CB				Rathmell, JC; Lindsten, T; Zong, WX; Cinalli, RM; Thompson, CB			Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis	NATURE IMMUNOLOGY			English	Article							INHIBITS MULTIPLE FORMS; T-CELL DEVELOPMENT; BCL-2 FAMILY; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; CYCLE PROGRESSION; CLONAL DELETION; APOPTOSIS; DEATH; MICE	Bak and Bax are required and redundant regulators of an intrinsic mitochondrial cell death pathway. To analyze this pathway in T cell development and homeostasis, we reconstituted mice with Bak(-/-)Bax(-/-) hematopoietic cells. We found that the development and selection of Bak(-/-)Bax(-/-) thymocytes was disrupted, with altered representation of thymic subsets and resistance to both death-by-neglect and antigen receptor-induced apoptosis. Elimination of Bak(-/-)Bax(-/-) T cells that responded to endogenous superantigen was also reduced. Despite more efficient early reconstitution and apoptotic resistance of Bak(-/-)Bax(-/-) thymocytes, thymic cellularity declined over time. Reduced thymic cellularity resulted from a progressive cessation of thymopoiesis. However, animals developed splenomegaly as a result of accumulated memory T cells that were not deleted after antigen-driven expansion. These data indicate that Bak and Bax are required for thymic selection and peripheral lymphoid homeostasis and suggest that thymopoiesis can be negatively regulated by the accumulation of cells that would normally be eliminated by pro-apoptotic Bcl-2-related genes.	Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	drt@mail.med.upenn.edu						Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Falk I, 2001, EUR J IMMUNOL, V31, P3308, DOI 10.1002/1521-4141(200111)31:11<3308::AID-IMMU3308>3.0.CO;2-5; FINK PJ, 1994, J IMMUNOL, V152, P4270; Gao JX, 2002, J EXP MED, V195, P959, DOI 10.1084/jem.20011948; GOLLOB KJ, 1992, P NATL ACAD SCI USA, V89, P5138, DOI 10.1073/pnas.89.11.5138; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Kitchen SG, 2000, J VIROL, V74, P2943, DOI 10.1128/JVI.74.6.2943-2948.2000; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Markert ML, 2001, AIDS RES HUM RETROV, V17, P1635, DOI 10.1089/088922201753342040; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; McGargill MA, 1999, J IMMUNOL, V162, P1237; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PETERSON DO, 1985, J VIROL, V54, P525, DOI 10.1128/JVI.54.2.525-531.1985; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Van Parijs L, 1998, J IMMUNOL, V160, P2065; Vander Heiden MG, 1999, MOL CELL, V3, P159; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wiest DL, 1999, SEMIN IMMUNOL, V11, P251, DOI 10.1006/smim.1999.0181; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams O, 1998, J EXP MED, V188, P1125, DOI 10.1084/jem.188.6.1125; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	43	244	249	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					932	939		10.1038/ni834	http://dx.doi.org/10.1038/ni834			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244308				2022-12-18	WOS:000178242100013
J	Kessels, HWHG; Wolkers, MC; van den Boom, MD; van der Valk, MA; Schumacher, TNM				Kessels, HWHG; Wolkers, MC; van den Boom, MD; van der Valk, MA; Schumacher, TNM			Immunotherapy through TCR gene transfer	NATURE IMMUNOLOGY			English	Article							T-CELL RECEPTOR; BONE-MARROW TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; VERSUS-HOST DISEASE; INFLUENZA PNEUMONIA; ADOPTIVE TRANSFER; LYMPHOCYTES; EXPRESSION; METHYLATION; SPECIFICITY	The antigen specificity of T lymphocytes is dictated solely by the T cell receptor (TC R) a and P chains. Consequently, genetic transfer of TCR chains may be an appealing strategy with which to impose a desirable virus- or tumor-antigen specificity onto cytotoxic or helper T cell populations. We describe here the genetic introduction of a virus-specific TCR into peripheral T cells in a mouse model system. These experiments showed that T cells redirected by TCR gene transfer expanded upon viral infection of mice and efficiently homed to effector sites. In this setting,TCR gene transfer was not associated with any significant autoimmune pathology. In addition, small numbers of TCR-transduced T cells promoted the rejection of antigen-expressing tumors in vivo. These data suggest that the redirection of T cells by TCR gene transfer is a viable strategy for the rapid induction of virus- or tumor-specific immunity.	Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Kessels, Helmut/0000-0002-1122-745X; Wolkers, Monika/0000-0003-3242-1363				Altenschmidt U, 1997, J IMMUNOL, V159, P5509; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Clay TM, 1999, J IMMUNOL, V163, P507; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fujio K, 2000, J IMMUNOL, V165, P528, DOI 10.4049/jimmunol.165.1.528; Glezen WP, 2000, VACCINE, V19, pS56, DOI 10.1016/S0264-410X(00)00279-6; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Haanen JBAG, 1999, EUR J IMMUNOL, V29, P1168, DOI 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J; HARRISON PTC, 1984, LAB ANIM, V18, P325, DOI 10.1258/002367784780865324; Heikkinen T, 2000, ANN MED, V32, P157, DOI 10.3109/07853890008998822; Hekele A, 1996, INT J CANCER, V68, P232, DOI 10.1002/(SICI)1097-0215(19961009)68:2<232::AID-IJC16>3.0.CO;2-C; Heslop HE, 1997, IMMUNOL REV, V157, P217, DOI 10.1111/j.1600-065X.1997.tb00984.x; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kitamura T, 1998, INT J HEMATOL, V67, P351; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Mueller N, 1999, J ACQ IMMUN DEF SYND, V21, pS5; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; Robbins PB, 1998, P NATL ACAD SCI USA, V95, P10182, DOI 10.1073/pnas.95.17.10182; Sandberg JK, 1998, J IMMUNOL, V160, P3163; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Ulivieri C, 2001, J BIOL CHEM, V276, P3574, DOI 10.1074/jbc.M008588200; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Willemsen RA, 2000, GENE THER, V7, P1369, DOI 10.1038/sj.gt.3301253	40	244	265	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					957	961		10.1038/ni1001-957	http://dx.doi.org/10.1038/ni1001-957			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577349				2022-12-18	WOS:000171361500016
J	Nelde, A; Bilich, T; Heitmann, JS; Maringer, Y; Salih, HR; Roerden, M; Lubke, M; Bauer, J; Rieth, J; Wacker, M; Peter, A; Horber, S; Traenkle, B; Kaiser, PD; Rothbauer, U; Becker, M; Junker, D; Krause, G; Strengert, M; Schneiderhan-Marra, N; Templin, MF; Joos, TO; Kowalewski, DJ; Stos-Zweifel, V; Fehr, M; Rabsteyn, A; Mirakaj, V; Karbach, J; Jager, E; Graf, M; Gruber, LC; Rachfalski, D; Preuss, B; Hagelstein, I; Marklin, M; Bakchoul, T; Gouttefangeas, C; Kohlbacher, O; Klein, R; Stevanovic, S; Rammensee, HG; Walz, JS				Nelde, Annika; Bilich, Tatjana; Heitmann, Jonas S.; Maringer, Yacine; Salih, Helmut R.; Roerden, Malte; Luebke, Maren; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Peter, Andreas; Hoerber, Sebastian; Traenkle, Bjoern; Kaiser, Philipp D.; Rothbauer, Ulrich; Becker, Matthias; Junker, Daniel; Krause, Gerard; Strengert, Monika; Schneiderhan-Marra, Nicole; Templin, Markus F.; Joos, Thomas O.; Kowalewski, Daniel J.; Stos-Zweifel, Vlatka; Fehr, Michael; Rabsteyn, Armin; Mirakaj, Valbona; Karbach, Julia; Jaeger, Elke; Graf, Michael; Gruber, Lena-Christin; Rachfalski, David; Preuss, Beate; Hagelstein, Ilona; Maerklin, Melanie; Bakchoul, Tamam; Gouttefangeas, Cecile; Kohlbacher, Oliver; Klein, Reinhild; Stevanovic, Stefan; Rammensee, Hans-Georg; Walz, Juliane S.			SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition	NATURE IMMUNOLOGY			English	Article							ACUTE RESPIRATORY SYNDROME; CROSS-REACTIVITY; MEMORY; PROTECTION; RESPONSES; INFECTION; IMMUNITY; DATABASE; DISEASE	SARS-CoV-2-specific CD4(+)and CD8(+)T cell epitopes are found in both convalescent patients and virus-naive volunteers and are indicative of heterologous recognition shared with seasonal cold viruses. T cell immunity is central for the control of viral infections. To characterize T cell immunity, but also for the development of vaccines, identification of exact viral T cell epitopes is fundamental. Here we identify and characterize multiple dominant and subdominant SARS-CoV-2 HLA class I and HLA-DR peptides as potential T cell epitopes in COVID-19 convalescent and unexposed individuals. SARS-CoV-2-specific peptides enabled detection of post-infectious T cell immunity, even in seronegative convalescent individuals. Cross-reactive SARS-CoV-2 peptides revealed pre-existing T cell responses in 81% of unexposed individuals and validated similarity with common cold coronaviruses, providing a functional basis for heterologous immunity in SARS-CoV-2 infection. Diversity of SARS-CoV-2 T cell responses was associated with mild symptoms of COVID-19, providing evidence that immunity requires recognition of multiple epitopes. Together, the proposed SARS-CoV-2 T cell epitopes enable identification of heterologous and post-infectious T cell immunity and facilitate development of diagnostic, preventive and therapeutic measures for COVID-19.	[Nelde, Annika; Bilich, Tatjana; Heitmann, Jonas S.; Maringer, Yacine; Salih, Helmut R.; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Gruber, Lena-Christin; Rachfalski, David; Hagelstein, Ilona; Maerklin, Melanie; Walz, Juliane S.] Univ Hosp Tubingen, Dept Internal Med, Clin Collaborat Unit Translat Immunol, German Canc Consortium DKTK, Tubingen, Germany; [Nelde, Annika; Bilich, Tatjana; Maringer, Yacine; Roerden, Malte; Luebke, Maren; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Fehr, Michael; Rabsteyn, Armin; Gouttefangeas, Cecile; Stevanovic, Stefan; Rammensee, Hans-Georg; Walz, Juliane S.] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany; [Nelde, Annika; Bilich, Tatjana; Heitmann, Jonas S.; Maringer, Yacine; Salih, Helmut R.; Roerden, Malte; Maerklin, Melanie; Gouttefangeas, Cecile; Rammensee, Hans-Georg; Walz, Juliane S.] Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany; [Salih, Helmut R.; Gouttefangeas, Cecile; Stevanovic, Stefan; Rammensee, Hans-Georg] German Canc Consortium DKTK, Partner Site Tubingen, Tubingen, Germany; [Salih, Helmut R.; Gouttefangeas, Cecile; Stevanovic, Stefan; Rammensee, Hans-Georg] German Canc Res Ctr, Partner Site Tubingen, Tubingen, Germany; [Roerden, Malte; Klein, Reinhild] Univ Hosp Tubingen, Dept Hematol Oncol Clin Immunol & Rheumatol, Tubingen, Germany; [Peter, Andreas; Hoerber, Sebastian] Univ Hosp Tubingen, Inst Clin Chem & Pathobiochem, Dept Diagnost Lab Med, Tubingen, Germany; [Traenkle, Bjoern; Kaiser, Philipp D.; Rothbauer, Ulrich; Becker, Matthias; Junker, Daniel; Schneiderhan-Marra, Nicole; Templin, Markus F.; Joos, Thomas O.] Univ Tubingen, Nat & Med Sci Inst, NMI, Reutlingen, Germany; [Rothbauer, Ulrich] Univ Tubingen, Pharmaceut Biotechnol, Tubingen, Germany; [Krause, Gerard; Strengert, Monika] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [Krause, Gerard; Strengert, Monika] TWINCORE GmbH, Ctr Expt & Clin Infect Res, Hannover, Germany; [Krause, Gerard] German Ctr Infect Res, Braunschweig, Germany; [Kowalewski, Daniel J.; Stos-Zweifel, Vlatka] Immat Biotechnol GmbH, Tubingen, Germany; [Rabsteyn, Armin] Univ Childrens Hosp Tubingen, Dept Gen Pediat, Oncol Hematol, Tubingen, Germany; [Mirakaj, Valbona] Univ Hosp Tubingen, Dept Anesthesia & Intens Care Med, Tubingen, Germany; [Karbach, Julia; Jaeger, Elke] Krankenhaus NW Frankfurt, Dept Oncol & Hematol, Frankfurt, Germany; [Graf, Michael; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, Appl Bioinformat, Tubingen, Germany; [Graf, Michael; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, Tubingen, Germany; [Bakchoul, Tamam] Univ Hosp Tubingen, Inst Clin & Expt Transfus Med, Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Inst Bioinformat & Med Informat, Tubingen, Germany; [Kohlbacher, Oliver] Max Planck Inst Dev Biol, Biomol Interact, Tubingen, Germany; [Kohlbacher, Oliver] Univ Hosp Tubingen, Inst Translat Bioinformat, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Immatics Biotechnologies GmbH; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Krankenhaus Nordwest; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Walz, JS (corresponding author), Univ Hosp Tubingen, Dept Internal Med, Clin Collaborat Unit Translat Immunol, German Canc Consortium DKTK, Tubingen, Germany.; Walz, JS (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany.; Walz, JS (corresponding author), Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany.	juliane.walz@med.uni-tuebingen.de	Bilich, Tatjana/ABH-2314-2020; Märklin, Melanie/AAN-9222-2021; Kohlbacher, Oliver/AAF-3297-2021; Walz, Juliane/ABE-1748-2021; Rothbauer, Ulrich/C-7712-2018; Hörber, Sebastian/AAO-2379-2021	Bilich, Tatjana/0000-0002-8107-0419; Märklin, Melanie/0000-0002-2920-3894; Kohlbacher, Oliver/0000-0003-1739-4598; Walz, Juliane/0000-0001-6404-7391; Rothbauer, Ulrich/0000-0001-5923-8986; Roerden, Malte/0000-0001-7283-9778; Nelde, Annika/0000-0001-8504-8481; Mirakaj, Valbona/0000-0002-6907-6455; Bauer, Jens/0000-0003-3731-2385; Krause, Gerard/0000-0003-3328-8808; Salih, Helmut/0000-0002-6719-1847	Bundesministerium fur Bildung und Forschung [FKZ:01KI20130]; Deutsche Forschungsgemeinschaft (German Research Foundation) [WA 4608/1-2]; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC2180-390900677]; Wilhelm Sander Stiftung [2016.177.2]; Jose Carreras Leukamie-Stiftung [DJCLS 05R/2017]; Fortune Program of the University of Tubingen [2451-0-0, 2581-0-0]; European Union's Horizon 2020 Research and Innovation Program [101003480]; German Cancer Consortium	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); Wilhelm Sander Stiftung; Jose Carreras Leukamie-Stiftung; Fortune Program of the University of Tubingen; European Union's Horizon 2020 Research and Innovation Program; German Cancer Consortium	We thank all SARS and PRE donors for their support of our research. We thank U. Schmidt, C. Bauer, A. Petz, M. Storz, I. Riedlinger, S. Sauter, S. Augstein, C. Rei beta, V. Agrusa, S. Dethling, M. Beller and C. Falkenburger for technical support and project coordination. This work was supported by the Bundesministerium fur Bildung und Forschung (FKZ:01KI20130; J.W.), the Deutsche Forschungsgemeinschaft (German Research Foundation, grant WA 4608/1-2; J.W.), the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy (grant EXC2180-390900677; J.W., S.S., H.-G.R., C.G. and H.R.S.), the German Cancer Consortium (S.S., H.-G.R., C.G. and H.R.S.), the Wilhelm Sander Stiftung (grant 2016.177.2; J.W.), the Jose Carreras Leukamie-Stiftung (grant DJCLS 05R/2017; J.W.) and the Fortune Program of the University of Tubingen (Fortune nos. 2451-0-0 and 2581-0-0; J.W. and M.R.). Multiplex antibody detection against common cold coronaviruses is part of a project that has received funding from the European Union's Horizon 2020 Research and Innovation Program under grant agreement no. 101003480 - CORESMA (G.K. and M.S.).	Acierno Paula M, 2003, J Transl Med, V1, P3, DOI 10.1186/1479-5876-1-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aslan N, 2017, MBIO, V8, DOI 10.1128/mBio.01841-17; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; FALK K, 1994, IMMUNOLOGY, V82, P337; Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Huber SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00171; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Khan S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00187-20; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kruttgen Alexander, 2020, J Clin Virol, V128, P104394, DOI 10.1016/j.jcv.2020.104394; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lubke M, 2020, J EXP MED, V217, DOI 10.1084/jem.20191164; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mo P, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270., DOI 10.1093/CID/CIAA270, 10.1093/cid/ciaa270]; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Petrova G, 2012, CRIT REV IMMUNOL, V32, P349; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robert Koch Institute, 2020, COR DIS 2019 COVID 1; Schlott F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193554; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sidhom J.-W., 2020, ANAL SARS COV 2 SPEC, DOI [10.1101/2020.06.20.160499, DOI 10.1101/2020.06.20.160499]; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; Tan ACL, 2011, J IMMUNOL, V187, P1895, DOI 10.4049/jimmunol.1100664; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Vali B, 2011, J VIROL, V85, P254, DOI 10.1128/JVI.01743-10; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang CT, 2020, J MED VIROL, V92, P667, DOI 10.1002/jmv.25762; Watkin LB, 2017, J ALLERGY CLIN IMMUN, V140, P1206, DOI 10.1016/j.jaci.2017.05.037; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Yin YY, 2009, IMMUNITY, V31, P849, DOI 10.1016/j.immuni.2009.12.002; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10	54	243	249	10	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					74	85		10.1038/s41590-020-00808-x	http://dx.doi.org/10.1038/s41590-020-00808-x		SEP 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	32999467	Bronze, Green Submitted			2022-12-18	WOS:000574099400001
J	Shi, W; Liao, Y; Willis, SN; Taubenheim, N; Inouye, M; Tarlinton, DM; Smyth, GK; Hodgkin, PD; Nutt, SL; Corcoran, LM				Shi, Wei; Liao, Yang; Willis, Simon N.; Taubenheim, Nadine; Inouye, Michael; Tarlinton, David M.; Smyth, Gordon K.; Hodgkin, Philip D.; Nutt, Stephen L.; Corcoran, Lynn M.			Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells	NATURE IMMUNOLOGY			English	Article							SUPER-ENHANCERS; EXPRESSION; GENERATION; BLIMP-1; DIVISION; IDENTITY; SURVIVAL; SUBSETS; FAMILY; MATURE	When B cells encounter an antigen, they alter their physiological state and anatomical localization and initiate a differentiation process that ultimately produces antibody-secreting cells (ASCs). We have defined the transcriptomes of many mature B cell populations and stages of plasma cell differentiation in mice. We provide a molecular signature of ASCs that highlights the stark transcriptional divide between B cells and plasma cells and enables the demarcation of ASCs on the basis of location and maturity. Changes in gene expression correlated with cell-division history and the acquisition of permissive histone modifications, and they included many regulators that had not been previously implicated in B cell differentiation. These findings both highlight and expand the core program that guides B cell terminal differentiation and the production of antibodies.	[Shi, Wei; Liao, Yang; Willis, Simon N.; Taubenheim, Nadine; Inouye, Michael; Tarlinton, David M.; Smyth, Gordon K.; Hodgkin, Philip D.; Nutt, Stephen L.; Corcoran, Lynn M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Liao, Yang; Willis, Simon N.; Taubenheim, Nadine; Tarlinton, David M.; Hodgkin, Philip D.; Nutt, Stephen L.; Corcoran, Lynn M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Inouye, Michael] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Inouye, Michael] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Shi, W (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	shi@wehi.edu.au; nutt@wehi.edu.au; corcoran@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Smyth, Gordon/B-5276-2008	Nutt, Stephen L/0000-0002-0020-6637; Hodgkin, Philip/0000-0002-8604-1940; Inouye, Michael/0000-0001-9413-6520; , Yang/0000-0002-9746-2839; Smyth, Gordon/0000-0001-9221-2892; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) of Australia (NHMRC IRIISS) [361646]; National Health and Medical Research Council (NHMRC) of Australia [575500, 1054925, 1054618, 1023454]; Multiple Myeloma Research Foundation; Australian Research Council (ARC); Victorian State Government through an Operational Infrastructure Support grant	National Health and Medical Research Council (NHMRC) of Australia (NHMRC IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Multiple Myeloma Research Foundation; Australian Research Council (ARC)(Australian Research Council); Victorian State Government through an Operational Infrastructure Support grant	We thank D. Emslie, T. Kratina, M. Everest and S. Heinzel for technical assistance and J. Vasiliadis, J. Leahy and T. Camilleri for animal care. Socs2<SUP>-/-</SUP> mice were a gift from W. Alexander (The Walter and Eliza Hall Institute, Parkville, Victoria, Australia). The institutional flow cytometry facility provided essential services. Supported by the National Health and Medical Research Council (NHMRC) of Australia (NHMRC IRIISS grant 361646; Program Grants 575500 and 1054925 to D. M. T., P.D.H., S.L.N. and L.M.C.; Program Grant 1054618 to G.K.S.; Project Grant 1023454 to G.K.S. and W. S.; and fellowships to G.K.S., D. M. T., P.D.H. and L.M.C.), the Multiple Myeloma Research Foundation (Senior Award to S.L.N.), the Australian Research Council (ARC Future Fellowship to S.L.N.) and the Victorian State Government through an Operational Infrastructure Support grant.	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Cocco M, 2012, J IMMUNOL, V189, P5773, DOI 10.4049/jimmunol.1103720; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fairfax KA, 2007, J IMMUNOL, V178, P4104, DOI 10.4049/jimmunol.178.7.4104; Fujio K, 2013, ANN RHEUM DIS, V72, P85, DOI 10.1136/annrheumdis-2012-202341; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herzenberg LA, 2000, CURR TOP MICROBIOL, V252, P3; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; JEONG HD, 1990, J IMMUNOL, V145, P2725; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Korthuis PM, 2015, LEUKEMIA, V29, P625, DOI 10.1038/leu.2014.259; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kurtz JE, 2010, EXPERT OPIN BIOL TH, V10, P951, DOI 10.1517/14712598.2010.482098; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Peperzak V., NAT IMMUNOL; Perfetti V, 1997, LAB INVEST, V77, P333; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wrammert J, 2002, EUR J IMMUNOL, V32, P97, DOI 10.1002/1521-4141(200201)32:1<97::AID-IMMU97>3.0.CO;2-Y; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zak DE, 2014, ANNU REV IMMUNOL, V32, P547, DOI 10.1146/annurev-immunol-032713-120254; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	50	243	244	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					663	+		10.1038/ni.3154	http://dx.doi.org/10.1038/ni.3154			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25894659				2022-12-18	WOS:000354751900019
J	Zagorska, A; Traves, PG; Lew, ED; Dransfield, I; Lemke, G				Zagorska, Anna; Traves, Paqui G.; Lew, Erin D.; Dransfield, Ian; Lemke, Greg			Diversification of TAM receptor tyrosine kinase function	NATURE IMMUNOLOGY			English	Article							APOPTOTIC CELLS; DENDRITIC CELLS; PLASMA-CONCENTRATIONS; IMMUNE-RESPONSE; BREAST-CANCER; TYRO-3 FAMILY; SOLUBLE FORM; IN-VIVO; CLEARANCE; AXL	The clearance of apoptotic cells is critical for both tissue homeostasis and the resolution of inflammation. We found that the TAM receptor tyrosine kinases Axl and Mer had distinct roles as phagocytic receptors in these two settings, in which they exhibited divergent expression, regulation and activity. Mer acted as a tolerogenic receptor in resting macrophages and during immunosuppression. In contrast, Axl was an inflammatory response receptor whose expression was induced by proinflammatory stimuli. Axl and Mer differed in their ligand specificities, ligand-receptor complex formation in tissues, and receptor shedding upon activation. These differences notwithstanding, phagocytosis by either protein was strictly dependent on receptor activation triggered by bridging of TAM receptor-ligand complexes to the 'eat-me' signal phosphatidylserine on the surface of apoptotic cells.	[Zagorska, Anna; Traves, Paqui G.; Lew, Erin D.; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Dransfield, Ian] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Lemke, Greg] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, La Jolla, CA 92037 USA	Salk Institute; University of Edinburgh; Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lemke@salk.edu		Dransfield, Ian/0000-0001-5848-7059	US National Institutes of Health [R01 AI077058, R01 AI101400, R01 NS085296]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Nomis Foundation; H.N. and Frances C. Berger Foundation; Fritz B. Burns Foundation; HKT Foundation; Francoise Gilot-Salk; Human Frontiers Science Program; Marie Curie Seventh Framework Programme; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101400, R01AI077058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Nomis Foundation; H.N. and Frances C. Berger Foundation; Fritz B. Burns Foundation; HKT Foundation; Francoise Gilot-Salk; Human Frontiers Science Program(Human Frontier Science Program); Marie Curie Seventh Framework Programme; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Joens and J. Fitzpatrick for processing samples and acquiring scanning electron microscopic images; R. Evans (Salk Institute) for nuclear receptor agonists T0901317, GW501516 and BRL49653; J. Hash, P. Burrola and C. Mayer for technical support; and members of the Lemke laboratory and the Nomis Center for discussions. Supported by the US National Institutes of Health (R01 AI077058, R01 AI101400 and R01 NS085296 to G. L.), the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002 to G. L.) the Nomis Foundation, the H.N. and Frances C. Berger Foundation, the Fritz B. Burns Foundation, the HKT Foundation, Francoise Gilot-Salk, the Human Frontiers Science Program (A.Z.), the Marie Curie Seventh Framework Programme (P.G.T.), the Leukemia and Lymphoma Society and the Nomis Foundation (E.D.L.).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; Ekman C, 2010, CLIN BIOCHEM, V43, P110, DOI 10.1016/j.clinbiochem.2009.07.025; Feng XY, 2011, IMMUNOLOGY, V132, P287, DOI 10.1111/j.1365-2567.2010.03364.x; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hsiao FC, 2013, J CLIN ENDOCR METAB, V98, pE267, DOI 10.1210/jc.2012-3179; Inaba K., 2009, CURR PROTOC IMMUNOL, V25, P37; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; Ko CP, 2014, MOL MED REP, V9, P1400, DOI 10.3892/mmr.2014.1933; Lee CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079452; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu XJ, 2014, CLIN BIOCHEM, V47, P173, DOI 10.1016/j.clinbiochem.2013.11.001; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Schroeder GM, 2009, J MED CHEM, V52, P1251, DOI 10.1021/jm801586s; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang X., 2008, CURR PROTOC IMMUNOL, V83, P141; Zhu H, 2014, LUPUS, V23, P624, DOI 10.1177/0961203314520839	53	243	249	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					920	U226		10.1038/ni.2986	http://dx.doi.org/10.1038/ni.2986			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25194421	Green Accepted			2022-12-18	WOS:000342564800007
J	Youn, JI; Kumar, V; Collazo, M; Nefedova, Y; Condamine, T; Cheng, PY; Villagra, A; Antonia, S; McCaffrey, JC; Fishman, M; Sarnaik, A; Horna, P; Sotomayor, E; Gabrilovich, DI				Youn, Je-In; Kumar, Vinit; Collazo, Michelle; Nefedova, Yulia; Condamine, Thomas; Cheng, Pingyan; Villagra, Alejandro; Antonia, Scott; McCaffrey, Judith C.; Fishman, Mayer; Sarnaik, Amod; Horna, Pedro; Sotomayor, Eduardo; Gabrilovich, Dmitry I.			Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer	NATURE IMMUNOLOGY			English	Article							SUPPRESSOR-CELLS; HEMATOPOIETIC STEM; LINEAGE COMMITMENT; TUMOR-SUPPRESSOR; RB; MONOCYTES; IDENTIFICATION; PROLIFERATION; MACROPHAGES; INHIBITION	Two major populations of myeloid-derived suppressor cells (MDSCs), monocytic MDSCs (M-MDSCs) and polymorphonuclear MDSCs (PMN-MDSCs) regulate immune responses in cancer and other pathologic conditions. Under physiologic conditions, Ly6C(hi)Ly6G(-) inflammatory monocytes, which are the normal counterpart of M-MDSCs, differentiate into macrophages and dendritic cells. PMN-MDSCs are the predominant group of MDSCs that accumulates in cancer. Here we show that a large proportion of M-MDSCs in tumor-bearing mice acquired phenotypic, morphological and functional features of PMN-MDSCs. Acquisition of this phenotype, but not the functional attributes of PMN-MDSCs, was mediated by transcriptional silencing of the retinoblastoma gene through epigenetic modifications mediated by histone deacetylase 2 (HDAC-2). These data demonstrate a new regulatory mechanism of myeloid cells in cancer.	[Youn, Je-In; Kumar, Vinit; Collazo, Michelle; Nefedova, Yulia; Condamine, Thomas; Cheng, Pingyan; Villagra, Alejandro; Sotomayor, Eduardo; Gabrilovich, Dmitry I.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Villagra, Alejandro; Horna, Pedro; Sotomayor, Eduardo] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Villagra, Alejandro; Antonia, Scott; McCaffrey, Judith C.; Fishman, Mayer; Sotomayor, Eduardo; Gabrilovich, Dmitry I.] Univ S Florida, Dept Oncol Sci, Tampa, FL USA; [Antonia, Scott; Gabrilovich, Dmitry I.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [McCaffrey, Judith C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Otolaryngol Head & Neck Surg, Tampa, FL 33612 USA; [Fishman, Mayer] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA; [Sarnaik, Amod] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Gabrilovich, DI (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	dmitry.gabrilovich@moffitt.org	Sarnaik, Amod/W-5536-2019; Fishman, Mayer/AAG-6640-2021; Kumar, Vinit/GQP-7755-2022; Gabrilovich, Dmitry/ABE-7122-2020	Villagra, Alejandro/0000-0001-9346-8355; Nefedova, Yulia/0000-0002-5121-9294	US National Institutes of Health [CA84488]; NATIONAL CANCER INSTITUTE [R01CA100062, R01CA084488, P30CA076292] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Beg (H. Lee Moffitt Cancer Center) for providing us with Kras/mCC10 mice and D.J. McCance (Queen's University Belfast, UK) for providing us with Ad-Rb1 vectors. This work was supported by US National Institutes of Health grant CA84488.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bergh G, 1999, BLOOD, V94, P1971; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fan LX, 2012, KIDNEY INT, V81, P76, DOI 10.1038/ki.2011.296; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Jeisy-Scott V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025242; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Sonda N, 2011, CURR OPIN IMMUNOL, V23, P279, DOI 10.1016/j.coi.2010.12.006; Takaki T, 2004, BIOCHEM BIOPH RES CO, V316, P252, DOI 10.1016/j.bbrc.2004.02.044; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhu XM, 2010, CRIT CARE CLIN, V26, P491, DOI 10.1016/j.ccc.2010.04.004	45	243	252	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					211	220		10.1038/ni.2526	http://dx.doi.org/10.1038/ni.2526			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23354483	Green Accepted			2022-12-18	WOS:000315065400010
J	Williamson, DJ; Owen, DM; Rossy, J; Magenau, A; Wehrmann, M; Gooding, JJ; Gaus, K				Williamson, David J.; Owen, Dylan M.; Rossy, Jeremie; Magenau, Astrid; Wehrmann, Matthias; Gooding, J. Justin; Gaus, Katharina			Pre-existing clusters of the adaptor Lat do not participate in early T cell signaling events	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; RECEPTOR MICROCLUSTERS; SURFACE-PROTEINS; ACTIVATION; PALMITOYLATION; LOCALIZATION; RECRUITMENT; ACCUMULATION; CONDENSATION	Engaged T cell antigen receptors (TCRs) initiate signaling through the adaptor protein Lat. In quiescent T cells, Lat is segregated into clusters on the cell surface, which raises the question of how TCR triggering initiates signaling. Using super-resolution fluorescence microscopy, we found that pre-existing Lat domains were neither phosphorylated nor laterally transported to TCR activation sites, which suggested that these clusters do not participate in TCR signaling. Instead, TCR activation resulted in the recruitment and phosphorylation of Lat from subsynaptic vesicles. Studies of Lat mutants confirmed that recruitment preceded and was essential for phosphorylation and that both processes were independent of surface clustering of Lat. Our data suggest that TCR ligation preconditions the membrane for vesicle recruitment and bulk activation of the Lat signaling network.	[Williamson, David J.; Owen, Dylan M.; Rossy, Jeremie; Magenau, Astrid; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Wehrmann, Matthias; Gooding, J. Justin] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Wehrmann, Matthias; Gooding, J. Justin] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Gaus, K (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	k.gaus@unsw.edu.au	Rossy, Jeremie/N-8554-2016; Williamson, David J/G-2265-2012	Rossy, Jeremie/0000-0002-5128-5283; Williamson, David J/0000-0002-6222-6297; Gooding, John Justin/0000-0002-5398-0597; Gaus, Katharina/0000-0002-8009-9658	National Health and Medical Research Council of Australia; Australian Research Council; Human Frontier Science Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Human Frontier Science Program(Human Frontier Science Program)	Supported by the National Health and Medical Research Council of Australia (D.J.W., J.J.G. and K. G.), the Australian Research Council (D.M.O., J.J.G. and K. G.) and Human Frontier Science Program (K.G.).	Aguado E, 2006, TRANSPL IMMUNOL, V17, P23, DOI 10.1016/j.trim.2006.09.013; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Tanimura N, 2006, BIOCHEM BIOPH RES CO, V341, P1177, DOI 10.1016/j.bbrc.2006.01.076; Tanimura N, 2003, J CELL BIOL, V160, P125, DOI 10.1083/jcb.200207096; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	50	243	245	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					655	U214		10.1038/ni.2049	http://dx.doi.org/10.1038/ni.2049			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21642986				2022-12-18	WOS:000291936400014
J	Wulfing, C; Sumen, C; Sjaastad, MD; Wu, LC; Dustin, ML; Davis, MM				Wulfing, C; Sumen, C; Sjaastad, MD; Wu, LC; Dustin, ML; Davis, MM			Costimulation and endogenous MHC ligands contribute to T cell recognition	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; IMMUNOLOGICAL SYNAPSE; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; TRANSGENIC MICE; BINDING-SITE; ACTIVATION; RECEPTOR; COMPLEX; CD4	To initiate an immune response, key receptor-ligand pairs must cluster in "immune synapses" at the T cell-antigen-presenting cell (APC) interface. We visualized the accumulation of a major histocompatibility complex (MHC) class 11 molecule, I-E-k, at a T cell-B cell interface and found it was dependent on both antigen recognition and costimulation. This suggests that costimulation-driven active transport of T cell surface molecules helps to drive immunological synapse formation. Although only agonist peptide-MHC class 11 (agonist pMHC class 11) complexes can initiate T cell activation, endogenous pMHC class 11 complexes also appeared to accumulate. To test this directly, we labeled a "null" pMHC class 11 complex and found that, although it lacked major TCR contact residues, it could be driven into the synapse in a TCR-dependant manner. Thus, low-affinity ligands can contribute to synapse formation and T cell signaling.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Universal Imaging Corp, Downingtown, PA 19335 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Washington University (WUSTL)	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.		Dustin, Michael/AAM-4611-2020	Davis, Mark/0000-0001-6868-657X; Dustin, Michael/0000-0003-4983-6389; Wuelfing, Christoph/0000-0002-6156-9861				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Anderson MT, 1996, P NATL ACAD SCI USA, V93, P8508, DOI 10.1073/pnas.93.16.8508; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Blair PJ, 1997, BIOCHEM SOC T, V25, P651, DOI 10.1042/bst0250651; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Chaminade M, 1996, NEUROCHEM INT, V28, P155, DOI 10.1016/0197-0186(95)00079-8; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; DAVIS MM, 1984, IMMUNOL REV, V81, P235, DOI 10.1111/j.1600-065X.1984.tb01113.x; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Gilfillan S, 1998, J IMMUNOL, V161, P6629; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Jung P, 1997, NATURE, V385, P291, DOI 10.1038/385291a0; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; LO D, 1986, IMMUNOL RES, V5, P221, DOI 10.1007/BF02919203; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mostaghel EA, 1998, J IMMUNOL, V161, P6559; Motyka B, 1998, J IMMUNOL, V160, P77; REAY PA, 1994, J IMMUNOL, V152, P3946; Riberdy JM, 1998, P NATL ACAD SCI USA, V95, P4493, DOI 10.1073/pnas.95.8.4493; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Sandberg JK, 1999, J EXP MED, V189, P883, DOI 10.1084/jem.189.6.883; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shapiro VS, 1998, J IMMUNOL, V161, P6455; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; vanKooyk Y, 1997, BIOCHEM SOC T, V25, P515, DOI 10.1042/bst0250515; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yelon D, 1999, J IMMUNOL, V162, P1348	54	243	248	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					42	47		10.1038/ni741	http://dx.doi.org/10.1038/ni741			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11731799				2022-12-18	WOS:000173148700013
J	Odendall, C; Dixit, E; Stavru, F; Bierne, H; Franz, KM; Durbin, AF; Boulant, S; Gehrke, L; Cossart, P; Kagan, JC				Odendall, Charlotte; Dixit, Evelyn; Stavru, Fabrizia; Bierne, Helene; Franz, Kate M.; Durbin, Ann Fiegen; Boulant, Steeve; Gehrke, Lee; Cossart, Pascale; Kagan, Jonathan C.			Diverse intracellular pathogens activate type III interferon expression from peroxisomes	NATURE IMMUNOLOGY			English	Article							INDEPENDENT ANTIVIRAL RESPONSE; HEPATITIS-C VIRUS; IFN-LAMBDA-S; INNATE IMMUNITY; DENGUE VIRUS; MEMBRANE-PROTEINS; CELL LINE; GENES; INFECTION; PATHWAY	Type I interferon responses are considered the primary means by which viral infections are controlled in mammals. Despite this view, several pathogens activate antiviral responses in the absence of type I interferons. The mechanisms controlling type I interferon-independent responses are undefined. We found that RIG-I like receptors (RLRs) induce type III interferon expression in a variety of human cell types, and identified factors that differentially regulate expression of type I and type III interferons. We identified peroxisomes as a primary site of initiation of type III interferon expression, and revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells. These findings highlight the importance of different intracellular organelles in specific innate immune responses.	[Odendall, Charlotte; Dixit, Evelyn; Franz, Kate M.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [Odendall, Charlotte; Dixit, Evelyn; Franz, Kate M.; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Stavru, Fabrizia; Bierne, Helene; Cossart, Pascale] INRA USC2020, INSERM U604, Unite Interact Bacteries Cellules, Inst Pasteur, Paris, France; [Durbin, Ann Fiegen; Gehrke, Lee] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA USA; [Durbin, Ann Fiegen; Gehrke, Lee] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Boulant, Steeve] Heidelberg Univ, CellNetworks, Virol Schaller Res Grp, Dept Infect Dis, Heidelberg, Germany; [Boulant, Steeve] Heidelberg Univ, Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.	jonathan.kagan@childrens.harvard.edu	Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993; Durbin, Ann/0000-0002-7348-5243; Bierne, Helene/0000-0002-0525-0848	US National Institutes of Health [AI093589, AI072955, P30 DK34854, CA159132]; Burroughs Wellcome Fund; Crohn's and Colitis Foundation of America; Agence National de la Recherche (ANR project Mitopatho); Erwin Schrodinger Fellowship of the Austrian Science Fund (FWF); Herchel Smith Graduate Fellowship Program; Massachusetts Institute of Technology-Boston Children's Hospital Collaborative grant; European Research Council Advanced Grant [233348]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R21CA159132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R00AI072955, K99AI072955, R33AI100190, R56AI103082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; Agence National de la Recherche (ANR project Mitopatho)(French National Research Agency (ANR)); Erwin Schrodinger Fellowship of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Herchel Smith Graduate Fellowship Program; Massachusetts Institute of Technology-Boston Children's Hospital Collaborative grant; European Research Council Advanced Grant(European Research Council (ERC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Kagan laboratory for helpful discussions, M. Fransen (Katholieke Universiteit, Leuven, Belgium) for providing cell lines and reagents, and B. Nelms for bioinformatic assistance. Microarray analyses were performed by members of the Molecular Genetics Core Facility at Boston Children's Hospital. J.C.K. is supported by US National Institutes of Health grants AI093589, AI072955 and P30 DK34854, and an unrestricted gift from Mead Johnson & Company. J.C.K. received an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. C.O. is supported by a fellowship from the Crohn's and Colitis Foundation of America. F.S. is funded by the Agence National de la Recherche (ANR project Mitopatho). E.D. is supported by an Erwin Schrodinger Fellowship of the Austrian Science Fund (FWF). K.M.F. is supported through the Herchel Smith Graduate Fellowship Program. L.G. and J.C.K. are supported by a Massachusetts Institute of Technology-Boston Children's Hospital Collaborative grant. L.G. is supported by US National Institutes of Health grant CA159132. P.C. is supported by European Research Council Advanced Grant 233348 MODELIST and by Howard Hughes Medical Institute as a senior international research scholar.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; de Macedo FC, 2006, DIAGN MOL PATHOL, V15, P223, DOI 10.1097/01.pdm.0000213462.60645.cd; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Eichler F, 2007, PEDIATR NEUROL, V37, P235, DOI 10.1016/j.pediatrneurol.2007.06.011; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hermant P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087906; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lee SJ, 2012, INT J MOL MED, V30, P945, DOI 10.3892/ijmm.2012.1064; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McLaughlin-Drubin ME, 2013, VIRUSES-BASEL, V5, P1231, DOI 10.3390/v5051231; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Peltier DC, 2013, J VIROL, V87, P1821, DOI 10.1128/JVI.02858-12; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Steinberg S.J., 2003, GENEREVIEWS; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401; VEOMETT MJ, 1979, J VIROL, V31, P785, DOI 10.1128/JVI.31.3.785-794.1979; Warke RV, 2008, J GEN VIROL, V89, P1605, DOI 10.1099/vir.0.2008/000968-0; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1325, DOI 10.1016/j.bbadis.2012.06.001; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0	57	242	247	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					717	+		10.1038/ni.2915	http://dx.doi.org/10.1038/ni.2915			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24952503	Green Submitted, Green Accepted			2022-12-18	WOS:000339323000007
J	van Gils, JM; Derby, MC; Fernandes, LR; Ramkhelawon, B; Ray, TD; Rayner, KJ; Parathath, S; Distel, E; Feig, JL; Alvarez-Leite, JI; Rayner, AJ; McDonald, TO; O'Brien, KD; Stuart, LM; Fisher, EA; Lacy-Hulbert, A; Moore, KJ				van Gils, Janine M.; Derby, Merran C.; Fernandes, Luciana R.; Ramkhelawon, Bhama; Ray, Tathagat D.; Rayner, Katey J.; Parathath, Sajesh; Distel, Emilie; Feig, Jessica L.; Alvarez-Leite, Jacqueline I.; Rayner, Alistair J.; McDonald, Thomas O.; O'Brien, Kevin D.; Stuart, Lynda M.; Fisher, Edward A.; Lacy-Hulbert, Adam; Moore, Kathryn J.			The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques	NATURE IMMUNOLOGY			English	Article							MONOCYTE-DERIVED CELLS; ISCHEMIA-REPERFUSION INJURY; OXIDIZED LDL; FOAM CELLS; INFLAMMATION; EXPRESSION; MIGRATION; RESOLUTION; MOUSE; LOCALIZATION	Atherosclerotic plaque formation is fueled by the persistence of lipid-laden macrophages in the artery wall. The mechanisms by which these cells become trapped, thereby establishing chronic inflammation, remain unknown. Here we found that netrin-1, a neuroimmune guidance cue, was secreted by macrophages in human and mouse atheroma, where it inactivated the migration of macrophages toward chemokines linked to their egress from plaques. Acting via its receptor, UNC5b, netrin-1 inhibited the migration of macrophages directed by the chemokines CCL2 and CCL19, activation of the actin-remodeling GTPase Rac1 and actin polymerization. Targeted deletion of netrin-1 in macrophages resulted in much less atherosclerosis in mice deficient in the receptor for low-density lipoprotein and promoted the emigration of macrophages from plaques. Thus, netrin-1 promoted atherosclerosis by retaining macrophages in the artery wall. Our results establish a causative role for negative regulators of leukocyte migration in chronic inflammation.	[van Gils, Janine M.; Ramkhelawon, Bhama; Ray, Tathagat D.; Rayner, Katey J.; Parathath, Sajesh; Distel, Emilie; Feig, Jessica L.; Rayner, Alistair J.; Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10003 USA; [Derby, Merran C.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA; [Fernandes, Luciana R.; Alvarez-Leite, Jacqueline I.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [McDonald, Thomas O.; O'Brien, Kevin D.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Stuart, Lynda M.; Lacy-Hulbert, Adam] Harvard Univ, Sch Med, Dept Pediat, Program Dev Immunol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidade Federal de Minas Gerais; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University	Moore, KJ (corresponding author), NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10003 USA.	kathryn.moore@nyumc.org	O'Brien, Kevin/CAH-4638-2022; Fisher, Edward/ABE-7469-2020; O'Brien, Kevin Douglas/HDO-1461-2022; Rayner, Katey/K-8914-2012; Parathath, Saj/ABE-2183-2021; ALVAREZ-LEITE, JACQUELINE I/C-9175-2014; Moore, Kathryn/ABE-6416-2020	O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196; ALVAREZ-LEITE, JACQUELINE I/0000-0001-6601-9853; Moore, Kathryn/0000-0003-2505-2547; Parathath, Sajesh/0000-0003-3431-297X; Lacy-Hulbert, Adam/0000-0003-2162-0156; van Gils, Janine/0000-0003-2429-7462; Fisher, Edward/0000-0001-9802-143X; Rayner, Katey/0000-0001-6230-426X	American Heart Association [0655840T, 09POST2080250]; US National Institutes of Health [RC1HL100815, R01HL084312]; Heart and Stroke Foundation of Canada; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [01558/2007-6]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084312, P01HL092969, RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, U01AI073871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Goss and W. Groot for technical support; M. Tessier-Lavigne (Stanford University) for Ntn1<SUP>+/-</SUP> mice; and T. Kinane (Massachusetts General Hospital) for anti-UNC5b antiserum. Supported by the American Heart Association (0655840T to K. M. and 09POST2080250 to J. M. v. G.), the US National Institutes of Health (RC1HL100815 to K. J. M. and R01HL084312 to E. A. F.), the Heart and Stroke Foundation of Canada (K. J. R.) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (01558/2007-6 to L. R. F. and J. I. A.-L.).	Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Curtiss LK, 2009, NEW ENGL J MED, V360, P1144, DOI 10.1056/NEJMcibr0810383; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; GERRITY RG, 1981, AM J PATHOL, V103, P191; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Khan J.A, 2010, GENE THER; KLING D, 1993, ATHEROSCLEROSIS, V101, P79, DOI 10.1016/0021-9150(93)90104-3; LANDERS SC, 1994, VIRCHOWS ARCH, V425, P49; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Munoz JJ, 2002, J IMMUNOL, V169, P177, DOI 10.4049/jimmunol.169.1.177; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Salminen M, 2000, DEVELOPMENT, V127, P13; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616	40	242	246	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					136	143		10.1038/ni.2205	http://dx.doi.org/10.1038/ni.2205			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22231519	Green Accepted			2022-12-18	WOS:000299315000010
J	Sallusto, F; Baggiolini, M				Sallusto, Federica; Baggiolini, Marco			Chemokines and leukocyte traffic	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; LYMPH-NODES; RECEPTOR EXPRESSION; DENDRITIC CELLS; MICE LACKING; MEMORY; ACTIVATION; MECHANISM; ORGANS; HEMATOPOIESIS	Twenty years after the discovery of chemokines is an appropriate time to review leukocyte traffic and to assess the knowledge and opportunities that have arisen from countless studies of the large and tight-knit family of chemotactic proteins.	[Sallusto, Federica] Inst Biomed Res, CH-6500 Bellinzona, Switzerland; [Baggiolini, Marco] Swiss Natl Supercomp Ctr, CH-6928 Manno, Switzerland	Universita della Svizzera Italiana	Sallusto, F (corresponding author), Inst Biomed Res, CH-6500 Bellinzona, Switzerland.	sallusto@irb.unisi.ch			Helmut Horten Foundation	Helmut Horten Foundation	We thank M. Uguccioni and A. Lanzavecchia for discussions and input. The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Friedl P, 2001, TRENDS IMMUNOL, V22, P187, DOI 10.1016/S1471-4906(01)01869-5; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; THELEN M, 1988, FASEB J, V2, P2702, DOI 10.1096/fasebj.2.11.2840318; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	242	251	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					949	952		10.1038/ni.f.214	http://dx.doi.org/10.1038/ni.f.214			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711431				2022-12-18	WOS:000258559600002
J	McLachlan, JB; Hart, JP; Pizzo, SV; Shelburne, CP; Staats, HF; Gunn, MD; Abraham, SN				McLachlan, JB; Hart, JP; Pizzo, SV; Shelburne, CP; Staats, HF; Gunn, MD; Abraham, SN			Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection	NATURE IMMUNOLOGY			English	Article							TNF-ALPHA; TRANSENDOTHELIAL MIGRATION; T-LYMPHOCYTES; B-LYMPHOCYTE; ACTIVATION; BINDING; IMMUNE; MODEL; EXTRAVASATION; REQUIREMENT	Palpable swelling of regional lymph nodes is a common sequela of microbial infections but the mechanism responsible for the sequestration and subsequent coordination of lymphocyte responses within these dynamic structures remains poorly understood. Here we show that draining lymph nodes of mast cell-deficient mice did not demonstrate swelling after intradermal bacterial challenge. Testing of individual mast cell-derived products in this model indicated that tumor necrosis factor was the main mediator of nodal hypertrophy, whereas tryptase and histamine had no effect. After peripheral mast cell activation, both tumor necrosis factor concentrations and the recruitment of circulating T cells were increased within draining nodes. These results show a critical function for peripheral mast cell-derived tumor necrosis factor in regulating the hypertrophy of draining lymph nodes during infection.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	abrah006@mc.duke.edu		Staats, Herman/0000-0003-1039-1087; Gunn, Michael/0000-0003-4602-0667				ARIDOR M, 1990, J CELL BIOL, V111, P909, DOI 10.1083/jcb.111.3.909; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Burns AR, 1999, J LEUKOCYTE BIOL, V65, P299, DOI 10.1002/jlb.65.3.299; CARLOS TM, 1994, BLOOD, V84, P2068; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Diaz BL, 1996, INT ARCH ALLERGY IMM, V111, P36, DOI 10.1159/000237343; Ding ZQ, 2000, J LEUKOCYTE BIOL, V67, P825, DOI 10.1002/jlb.67.6.825; Ding ZQ, 2001, J LEUKOCYTE BIOL, V69, P458; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; Faveeuw C, 2000, INT IMMUNOL, V12, P241, DOI 10.1093/intimm/12.3.241; Finlay-Jones JJ, 1999, J LEUKOCYTE BIOL, V66, P583, DOI 10.1002/jlb.66.4.583; Getting SJ, 1997, J PHARMACOL EXP THER, V283, P123; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Guo YC, 2001, EUR J PHARMACOL, V430, P305, DOI 10.1016/S0014-2999(01)01400-5; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; KEITH BR, 1986, INFECT IMMUN, V53, P693, DOI 10.1128/IAI.53.3.693-696.1986; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Marone G, 2001, INT ARCH ALLERGY IMM, V124, P249, DOI 10.1159/000053725; MARSHALL JS, 1994, CURR OPIN IMMUNOL, V6, P853, DOI 10.1016/0952-7915(94)90004-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McLean PG, 2000, J EXP MED, V192, P367, DOI 10.1084/jem.192.3.367; PADAWER J, 1974, EXP MOL PATHOL, V20, P269, DOI 10.1016/0014-4800(74)90059-8; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; TOMOE S, 1992, INT ARCH ALLERGY IMM, V97, P237, DOI 10.1159/000236126; van der Poll T, 1999, INFECT DIS CLIN N AM, V13, P413, DOI 10.1016/S0891-5520(05)70083-0; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Watanabe C, 2002, AM J PHYSIOL-GASTR L, V283, pG1379, DOI 10.1152/ajpgi.00026.2002; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922	41	242	253	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1199	1205		10.1038/ni1005	http://dx.doi.org/10.1038/ni1005			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14595438				2022-12-18	WOS:000186769500013
J	Mullen, AC; Hutchins, AS; High, FA; Lee, HW; Sykes, KJ; Chodosh, LA; Reiner, SL				Mullen, AC; Hutchins, AS; High, FA; Lee, HW; Sykes, KJ; Chodosh, LA; Reiner, SL			Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction	NATURE IMMUNOLOGY			English	Article							HOMEO BOX GENE; TRANSCRIPTION FACTOR; CELL DIFFERENTIATION; CYTOKINE EXPRESSION; LINEAGE COMMITMENT; IFN-GAMMA; TH1 CELLS; LYMPHOCYTES; GATA-3; CYCLE	Type 1 helper T (T(H)1) cells are essential for cellular immunity, but their ontogeny, maturation and durability remain poorly understood. By constructing a dominant-negative form of T-bet, we were able to determine the role played by this lineage-inducing trans-activator in the establishment and maintenance of heritable T(H)1 gene expression. Optimal induction of interferon-gamma (IFN-gamma) expression required genetic interaction between T-bet and its target, the homeoprotein Hlx. In fully mature T(H)1 cells, reiteration of IFN-gamma expression and stable chromatin remodeling became relatively independent of T-bet activity and coincided with demethylation of DNA. In contrast, some lineage attributes, such as expression of IL-12Rbeta2 (interleukin 12 receptor beta2), required ongoing T-bet activity in mature THI cells and their progeny. These findings suggest that heritable states of gene expression might be maintained by continued expression of the inducing factor or by a mechanism that confers a stable imprint of the induced state.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.			Mullen, Alan/0000-0002-4096-3106	NIAID NIH HHS [AI42370] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; ALLEN JD, 1991, GENE DEV, V5, P509, DOI 10.1101/gad.5.4.509; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Conlon FL, 1996, DEVELOPMENT, V122, P2427; DEGUCHI Y, 1991, NEW BIOL, V3, P353; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Horb ME, 1999, DEVELOPMENT, V126, P1739; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P2271, DOI 10.1002/eji.1830241002; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; KURTJONES EA, 1987, J EXP MED, V166, P1774, DOI 10.1084/jem.166.6.1774; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; SOLOMON MJ, 1987, MOL CELL BIOL, V7, P3822, DOI 10.1128/MCB.7.10.3822; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhang DH, 1998, J IMMUNOL, V161, P3817	47	242	255	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					652	658		10.1038/ni807	http://dx.doi.org/10.1038/ni807			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055627				2022-12-18	WOS:000176441700015
J	Kalergis, AM; Boucheron, N; Doucey, MA; Palmieri, E; Goyarts, EC; Vegh, Z; Luescher, IF; Nathenson, SG				Kalergis, AM; Boucheron, N; Doucey, MA; Palmieri, E; Goyarts, EC; Vegh, Z; Luescher, IF; Nathenson, SG			Efficient cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex	NATURE IMMUNOLOGY			English	Article							CYTOTOXIC T-LYMPHOCYTES; PEPTIDE-MHC COMPLEXES; AMINO-ACID RESIDUE; ANTIGEN RECOGNITION; BETA-CHAIN; RECEPTOR; AFFINITY; LIGAND; SELECTION; MOLECULE	Cytotoxic T cell (CTL) activation by antigen requires the specific detection of peptide-major histocompatibility class I (pMHC) molecules on the target-cell surface by the T cell receptor (TCR). We examined the effect of mutations in the antigen-binding site of a K-b-restricted TCR on T cell activation, antigen binding and dissociation from antigen. These parameters were also examined for variants derived from a K-d-restricted peptide that was recognized by a CTL clone, Using these two independent systems, we show that T cell activation can be impaired by mutations that either decrease or increase the binding half-life of the TCR-pMHC interaction. Our data indicate that efficient T cell activation occurs within an optimal dwell-time range of TCR-pMHC interaction. This restricted dwell-time range is consistent with the exclusion of either extremely low or high affinity T cells from the expanded population during immune responses.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Ludwig Inst Canc Res, Lausanne Branch, Epalinges, Switzerland	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Ludwig Institute for Cancer Research	Nathenson, SG (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave,Chonin Bldg 407, Bronx, NY 10461 USA.			Boucheron, Nicole/0000-0002-4979-8311; Kalergis, Alexis/0000-0001-7622-5263	NCI NIH HHS [5T52CA09173-23] Funding Source: Medline; NIAID NIH HHS [R01 AI07289-32] Funding Source: Medline; NIAMS NIH HHS [R01 AR42533-5] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI007289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GEIER SS, 1986, J IMMUNOL, V137, P1239; Goyarts EC, 1998, MOL IMMUNOL, V35, P593, DOI 10.1016/S0161-5890(98)00056-X; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Hudrisier D, 1998, J IMMUNOL, V161, P553; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; JOYCE S, 1992, BIOCHEM BIOPH RES CO, V186, P1449, DOI 10.1016/S0006-291X(05)81569-4; Joyce S, 1996, IMMUNOL REV, V154, P59, DOI 10.1111/j.1600-065X.1996.tb00930.x; Kalergis AM, 2000, J IMMUNOL METHODS, V234, P61, DOI 10.1016/S0022-1759(99)00215-X; Kalergis AM, 1999, J IMMUNOL, V162, P7263; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kessler B, 1999, J BIOL CHEM, V274, P3622, DOI 10.1074/jbc.274.6.3622; Kessler B, 1997, J EXP MED, V186, P2033, DOI 10.1084/jem.186.12.2033; Kessler BM, 1997, J EXP MED, V185, P629, DOI 10.1084/jem.185.4.629; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; Manning TC, 1999, J EXP MED, V189, P461, DOI 10.1084/jem.189.3.461; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Ono T, 1998, J IMMUNOL, V161, P5454; PASTERNACK MS, 1986, NATURE, V322, P740, DOI 10.1038/322740a0; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; ROMERO P, 1992, J IMMUNOL, V148, P1871; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; TAKAYAMA H, 1987, J IMMUNOL, V138, P566; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VANBLEEK GM, 1990, NATURE, V348, P213; VANPEL A, 1985, SOMAT CELL MOLEC GEN, V11, P467; Wang FM, 1998, P NATL ACAD SCI USA, V95, P5217, DOI 10.1073/pnas.95.9.5217; ZEFF RA, 1986, J IMMUNOL, V137, P897	47	242	251	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					229	234		10.1038/85286	http://dx.doi.org/10.1038/85286			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224522				2022-12-18	WOS:000167413800015
J	Brennan, PJ; Tatituri, RVV; Brigl, M; Kim, EY; Tuli, A; Sanderson, JP; Gadola, SD; Hsu, FF; Besra, GS; Brenner, MB				Brennan, Patrick J.; Tatituri, Raju V. V.; Brigl, Manfred; Kim, Edy Y.; Tuli, Amit; Sanderson, Joseph P.; Gadola, Stephan D.; Hsu, Fong-Fu; Besra, Gurdyal S.; Brenner, Michael B.			Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals	NATURE IMMUNOLOGY			English	Article							NKT CELLS; GLYCOLIPID ANTIGENS; IN-VIVO; ACTIVATION; ALPHA; BETA; MODULATION; LIGANDS; INNATE; ISOGLOBOTRIHEXOSYLCERAMIDE	Invariant natural killer T cells (iNKT cells) have a prominent role during infection and other inflammatory processes, and these cells can be activated through their T cell antigen receptors by microbial lipid antigens. However, increasing evidence shows that they are also activated in situations in which foreign lipid antigens would not be present, which suggests a role for lipid self antigen. We found that an abundant endogenous lipid, beta-d-glucopyranosylceramide (beta-GlcCer), was a potent iNKT cell self antigen in mouse and human and that its activity depended on the composition of the N-acyl chain. Furthermore, beta-GlcCer accumulated during infection and in response to Toll-like receptor agonists, contributing to iNKT cell activation. Thus, we propose that recognition of beta-GlcCer by the invariant T cell antigen receptor translates innate danger signals into iNKT cell activation.	[Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Brennan, Patrick J.; Tatituri, Raju V. V.; Brigl, Manfred; Kim, Edy Y.; Tuli, Amit; Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Sanderson, Joseph P.; Gadola, Stephan D.] Univ Southampton, Fac Med, Sir Henry Wellcome & Hope Labs, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Hsu, Fong-Fu] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO USA	University of Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southampton; Washington University (WUSTL)	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	g.besra@bham.ac.uk; mbrenner@rics.bwh.harvard.edu	Sanderson, Joseph/N-8308-2019; Sanderson, Joseph/C-5169-2008; Kim, Edy/ABF-7592-2021	Sanderson, Joseph/0000-0002-1206-8833; Sanderson, Joseph/0000-0002-1206-8833; Kim, Edy/0000-0002-9095-3109; Tuli, Amit/0000-0001-5476-4127; Besra, Gurdyal/0000-0002-5605-0395; Hsu, Fong-Fu/0000-0001-5368-0183	US National Institutes of Health [R01AI063428, T32AI007306, T32HL007633, K08AI077795, P41-RR00954, P30-DK56341, P60-DK20579, P41-RR05351]; Higher Education Funding Council for England; Royal Society; Medical Research Council; Wellcome Trust [084923/B/08/Z]; MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: researchfish; Versus Arthritis [18892] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028973, T32AI007306, R01AI063428, K08AI077795, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Exley (Beth Israel Deaconess Medical Center) for Cd1d<SUP>-/-</SUP> mice on a C57BL/6 background; K. Kawakami (Tohoku University) for S. pneumoniae (stain URF918); H. Kim for assistance with flow cytometry; and the tetramer facility of the US National Institutes of Health for ongoing support. Supported by the US National Institutes of Health (R01AI063428; T32AI007306 to P.J.B.; T32HL007633 to E.Y.K.; K08AI077795 to M. B.; P41-RR00954, P30-DK56341 and P60-DK20579 to F.-F.H.; and P41-RR05351 (Research Resource for Integrated Glycotechnology) to P. Azadi at the Complex Carbohydrate Research Center for nuclear magnetic resonance spectroscopy analysis), the Higher Education Funding Council for England (S. D. G. and J.P.S.), J. Bardrick (G. S. B.), the Royal Society (G. S. B.), the Medical Research Council (G. S. B.) and The Wellcome Trust (084923/B/08/Z to G.S.B.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chiba A, 2009, IMMUNOLOGY, V128, P324, DOI 10.1111/j.1365-2567.2009.03130.x; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hsu FF, 2001, J AM SOC MASS SPECTR, V12, P61, DOI 10.1016/S1044-0305(00)00194-X; Ilan Y, 2009, CLIN EXP IMMUNOL, V158, P300, DOI 10.1111/j.1365-2249.2009.04030.x; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li YS, 2009, J PROTEOME RES, V8, P2740, DOI 10.1021/pr801040h; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Memon RA, 2001, J LIPID RES, V42, P452; Muindi K, 2010, P NATL ACAD SCI USA, V107, P6118, DOI 10.1073/pnas.1001448107; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; O'Konek JJ, 2011, J CLIN INVEST, V121, P683, DOI 10.1172/JCI42314; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Veerapen N, 2009, BIOORG MED CHEM LETT, V19, P4288, DOI 10.1016/j.bmcl.2009.05.095; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	50	241	244	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1202	U97		10.1038/ni.2143	http://dx.doi.org/10.1038/ni.2143			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22037601	Green Accepted			2022-12-18	WOS:000297202700015
J	Thelen, M; Stein, JV				Thelen, Marcus; Stein, Jens V.			How chemokines invite leukocytes to dance	NATURE IMMUNOLOGY			English	Review							PROTEIN-COUPLED RECEPTOR; NUCLEOTIDE EXCHANGE FACTOR; IN-VIVO ACTIVITY; T-CELL POLARITY; INTEGRIN ACTIVATION; LYMPH-NODE; SIGNAL-TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASES; NEUTROPHIL CHEMOTAXIS; MONOCYTE CHEMOTAXIS	A prominent activity of the chemokine system is the regulation of leukocyte trafficking. Here we summarize recent findings on the initial steps in chemokine receptor-induced signal transduction in leukocytes. In particular, we discuss the potential influences of the formation of oligomers of ligand and receptor and of coupling between chemokine signals and regulators of the cytoskeleton, such as small GTPases.	[Thelen, Marcus] Inst Biomed Res, CH-6500 Bellinzona, Switzerland; [Stein, Jens V.] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	Universita della Svizzera Italiana; University of Bern	Thelen, M (corresponding author), Inst Biomed Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	marcus.thelen@irb.unisi.ch; jens.stein@tki.unibe.ch		Stein, Jens V/0000-0002-8199-9586	Helmut Horten Foundation; Swiss National Science Foundation; European Union Sixth Framework Programme (INNOCHEM) [LSHB-CT-2005-518167]; Swiss State Secretariat for Education and Research	Helmut Horten Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union Sixth Framework Programme (INNOCHEM)(European Commission); Swiss State Secretariat for Education and Research	We apologize to colleagues whose work we were unable to cite because of space constraints. Supported by the Helmut Horten Foundation (M. T.), the Swiss National Science Foundation (M. T. and J. V. S.), the European Union Sixth Framework Programme (INNOCHEM; LSHB-CT-2005-518167 to M. T.; MEXT-CT-2005-025405 to J. V. S.) and the Swiss State Secretariat for Education and Research (J. V. S.)	Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Haraldsen G, 2006, EUR J IMMUNOL, V36, P1659, DOI 10.1002/eji.200636327; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kehrl JH, 2006, IMMUNOL RES, V34, P211, DOI 10.1385/IR:34:3:211; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Locati M, 1996, J BIOL CHEM, V271, P6010, DOI 10.1074/jbc.271.11.6010; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Missy K, 2008, MOL CELL BIOL, V28, P3776, DOI 10.1128/MCB.00507-07; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; MORIGUCHI M, 2004, J BIOL CHEM; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakanishi O, 2007, J BIOCHEM, V141, P319, DOI 10.1093/jb/mvm034; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Ogilvie P, 2004, J IMMUNOL, V172, P6715, DOI 10.4049/jimmunol.172.11.6715; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Palmesino E, 2006, IMMUNOBIOLOGY, V211, P377, DOI 10.1016/j.imbio.2005.12.003; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Sebastiani S, 2005, EUR J IMMUNOL, V35, P746, DOI 10.1002/eji.200525800; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Staudinger R, 2000, BIOCHEM BIOPH RES CO, V274, P153, DOI 10.1006/bbrc.2000.3109; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; THELEN M, 2001, SCI STKE, pPE34; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	116	241	248	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					953	959		10.1038/ni.f.207	http://dx.doi.org/10.1038/ni.f.207			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711432				2022-12-18	WOS:000258559600003
J	Suzuki, K; Kumanogoh, A; Kikutani, H				Suzuki, Kazuhiro; Kumanogoh, Atsushi; Kikutani, Hitoshi			Semaphorins and their receptors in immune cell interactions	NATURE IMMUNOLOGY			English	Review							SUPPRESSES TUMOR-FORMATION; T-CELL; B-CELL; LYMPHOCYTE SEMAPHORIN; NONREDUNDANT ROLES; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; HUMAN MONOCYTES; SOLUBLE CD100	Semaphorins are newcomers to the growing panoply of immunoregulatory proteins. Members of this family were originally identified as proteins that provide axonal guidance cues during neuronal development. However, accumulating evidence indicates that several semaphorins, called 'immune semaphorins', are crucial to various phases of the immune response, from initiation to terminal inflammatory processes. Extensive studies of immune semaphorins have shown not only differences but also parallels in semaphorin functions among physiologically distinct systems, providing unexpected but meaningful insights into the biological activities of this protein family. Here we review the present knowledge of the function of semaphorins and their receptors in the immune system, including the most recent advances in this field.	[Suzuki, Kazuhiro] Japan Sci & Technol Agcy, Dept Mole Immunol & Core Res, Evolut Sci & Technol Program, Tokyo, Japan; [Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Kikutani, Hitoshi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University	Suzuki, K (corresponding author), Japan Sci & Technol Agcy, Dept Mole Immunol & Core Res, Evolut Sci & Technol Program, Tokyo, Japan.	kikutani@ragtime.biken.osaka-u.ac.jp	Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009; Suzuki, Kazuhiro/B-3886-2012	Suzuki, Kazuhiro/0000-0002-9081-538X				Adachi T, 1998, J IMMUNOL, V160, P4662; Adachi T, 2001, J BIOL CHEM, V276, P26648, DOI 10.1074/jbc.M100997200; ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; BOUGERET C, 1992, J IMMUNOL, V148, P318; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; JANEWAY CA, 2005, IMMUNOBIOLOGY IMMUNE, P357; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; Kumanogoh A, 2005, INT IMMUNOL, V17, P1277, DOI 10.1093/intimm/dxh307; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Somani AK, 2001, J BIOL CHEM, V276, P1938, DOI 10.1074/jbc.M006820200; Spriggs MK, 1999, CURR OPIN IMMUNOL, V11, P387, DOI 10.1016/S0952-7915(99)80065-X; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Tse C, 2002, CANCER RES, V62, P542; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Xiang RH, 2002, CANCER RES, V62, P2637; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094	83	241	269	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					17	23		10.1038/ni1553	http://dx.doi.org/10.1038/ni1553			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18087252				2022-12-18	WOS:000251820800007
J	Liu, PT; Keller, JR; Ortiz, M; Tessarollo, L; Rachel, RA; Nakamura, T; Jenkins, NA; Copeland, NG				Liu, PT; Keller, JR; Ortiz, M; Tessarollo, L; Rachel, RA; Nakamura, T; Jenkins, NA; Copeland, NG			Bcl11a is essential for normal lymphoid development	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; HEMATOPOIETIC STEM-CELLS; MOUSE BONE-MARROW; CHROMOSOMAL TRANSLOCATIONS; LINEAGE DECISION; FETAL LIVER; B-CELLS; GENE; TRANSCRIPTION; NOTCH1	Bcl11a (also called Evi9) functions as a myeloid or B cell proto-oncogene in mice and humans, respectively. Here we show that Bcl11a is essential for postnatal development and normal lymphopoiesis. Bcl11a mutant embryos lack B cells and have alterations in several types of T cells. Phenotypic and expression studies show that Bcl11a functions upstream of the transcription factors Ebf1 and Pax5 in the B cell pathway. Transplantation studies show that these defects in Bcl11a mutant mice are intrinsic to fetal liver precursor cells. Mice transplanted with Bcl11a-deficient cells died from T cell leukemia derived from the host. Thus, Bcl11a may also function as a non-autonomous T cell tumor suppressor gene.	NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; NCI, SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA; Japanese Fdn Canc Res, Toshima Ku, Tokyo 1708455, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Japanese Foundation for Cancer Research	Copeland, NG (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA.		Keller, Jonathan R./O-6677-2018		NCI NIH HHS [N01-CO-12400] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010392] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010001] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jehn BM, 1999, J IMMUNOL, V162, P635; Kawamata S, 2002, J IMMUNOL, V168, P1738, DOI 10.4049/jimmunol.168.4.1738; KIMOTO H, 1993, INT IMMUNOL, V5, P1535, DOI 10.1093/intimm/5.12.1535; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KRONENBERG M, 1985, NATURE, V313, P647, DOI 10.1038/313647a0; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROLINK A, 1993, BLOOD, V81, P2290; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Saiki Y, 2000, GENOMICS, V70, P387, DOI 10.1006/geno.2000.6385; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	51	241	258	1	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					525	532		10.1038/ni925	http://dx.doi.org/10.1038/ni925			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12717432				2022-12-18	WOS:000183175500010
J	Revy, P; Sospedra, M; Barbour, B; Trautmann, A				Revy, P; Sospedra, M; Barbour, B; Trautmann, A			Functional antigen-independent synapses formed between T cells and dendritic cells	NATURE IMMUNOLOGY			English	Article							INTRACELLULAR CALCIUM; IMMUNOLOGICAL SYNAPSE; IMMUNE-RESPONSES; TRANSGENIC MICE; ACTIVATION; SURVIVAL; CD4(+); LYMPHOCYTES; RECOGNITION; NAIVE	Immunological synapse formation is usually assumed to require antigen recognition by T cell receptors. However, the immunological synapse formed at the interface between naive T cells and dendritic cells (DCs) has never been described. We show here that in the absence of antigen, and even of major histocompatibility complex molecules,T cell-DC synapses are formed and lead to several T cell responses: a local increase in tyrosine phosphorylation, small Ca2+ responses, weak proliferation and long-term survival. These responses are triggered more readily in CD4(+)T cells than in CD8(+)T cells, which express a specific isoform of the repulsive molecule CD43. These phenomena may play a major role in the maintenance of the naive T cell pool in vivo.	CNRS, UPR415, Lab Immunopharmacol Mol, Inst Cochin Genet Mol, Paris, France; Ecole Normale Super, CNRS, UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Trautmann, A (corresponding author), CNRS, UPR415, Lab Immunopharmacol Mol, Inst Cochin Genet Mol, Paris, France.		Revy, Patrick/H-8137-2017; SOSPEDRA, MIREIA/AAP-3106-2021	Barbour, Boris/0000-0002-1911-0539; Revy, Patrick/0000-0003-0758-8022; Sospedra, Mireia/0000-0001-8333-7423				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Donnadieu E, 2001, IMMUNOLOGY, V103, P417, DOI 10.1046/j.1365-2567.2001.01268.x; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Donnadieu E, 2001, J IMMUNOL, V166, P5540, DOI 10.4049/jimmunol.166.9.5540; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dorfman JR, 2001, NAT IMMUNOL, V2, P136, DOI 10.1038/84231; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; ELLIES LG, 1994, GLYCOBIOLOGY, V4, P885, DOI 10.1093/glycob/4.6.885; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; GOSGROVE D, 1991, CELL, V66, P1051; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; JONES AT, 1994, J IMMUNOL, V153, P3426; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; Kirberg J, 2001, NAT IMMUNOL, V2, P136, DOI 10.1038/84229; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; LEDBETTER JA, 1990, BLOOD, V75, P1531; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P1601, DOI 10.1002/eji.1830181020; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montes M, 1999, INT IMMUNOL, V11, P561, DOI 10.1093/intimm/11.4.561; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	38	241	245	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					925	931		10.1038/ni713	http://dx.doi.org/10.1038/ni713			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11561183				2022-12-18	WOS:000171361500011
J	Jackson, CM; Choi, J; Lim, M				Jackson, Christopher M.; Choi, John; Lim, Michael			Mechanisms of immunotherapy resistance: lessons from glioblastoma	NATURE IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; IMMUNE CHECKPOINT BLOCKADE; T-CELL EXHAUSTION; RECURRENT GLIOBLASTOMA; PD-1 BLOCKADE; INTRATUMORAL HETEROGENEITY; NEOANTIGEN LANDSCAPE; CPG OLIGONUCLEOTIDE; MYELOID CELLS; BRAIN	Glioblastoma (GBM) is the deadliest form of brain cancer, with a median survival of less than 2 years despite surgical resection, radiation, and chemotherapy. GBM's rapid progression, resistance to therapy, and inexorable recurrence have been attributed to several factors, including its rapid growth rate, its molecular heterogeneity, its propensity to infiltrate vital brain structures, the regenerative capacity of treatment-resistant cancer stem cells, and challenges in achieving high concentrations of chemotherapeutic agents in the central nervous system. Escape from immunosurveillance is increasingly recognized as a landmark event in cancer biology. Translation of this framework to clinical oncology has positioned immunotherapy as a pillar of cancer treatment. Amid the bourgeoning successes of cancer immunotherapy, GBM has emerged as a model of resistance to immunotherapy. Here we review the mechanisms of immunotherapy resistance in GBM and discuss how insights into GBM-immune system interactions might inform the next generation of immunotherapeutics for GBM and other resistant pathologies.	[Jackson, Christopher M.; Choi, John; Lim, Michael] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA	Johns Hopkins University	Lim, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	mlim3@jhmi.edu		Jackson, Christopher/0000-0002-5958-2004; Lim, Michael/0000-0003-0523-3076				Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bauer C, 2016, CANCER LETT, V381, P259, DOI 10.1016/j.canlet.2016.02.057; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Brabb T, 2000, J EXP MED, V192, P871, DOI 10.1084/jem.192.6.871; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4220; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen ZH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01004; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Cloughesy TF, 2018, NEURO-ONCOLOGY, V20, P1383, DOI 10.1093/neuonc/noy075; Comiskey MC, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0712-z; Coureuil M, 2017, NAT REV MICROBIOL, V15, P149, DOI 10.1038/nrmicro.2016.178; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Da Mesquita S, 2018, NEURON, V100, P375, DOI 10.1016/j.neuron.2018.09.022; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Danilova L, 2018, CANCER IMMUNOL RES, V6, P888, DOI 10.1158/2326-6066.CIR-18-0129; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Garzon-Muvdi Tomas, 2018, Oncotarget, V9, P20681, DOI 10.18632/oncotarget.25061; Gettinger SN, 2018, J THORAC ONCOL, V13, P831, DOI 10.1016/j.jtho.2018.03.008; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Giles A. J., 2018, J IMMUNOTHER CANCER, V6, P235; Gong J., 2018, J IMMUNOTHER CANCER, V6, P765; Grossman SA, 2011, CLIN CANCER RES, V17, P5473, DOI 10.1158/1078-0432.CCR-11-0774; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Hastings KG, 2018, ANN INTERN MED, V169, P836, DOI 10.7326/M17-0796; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Hung AL, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1466769; Hutter G, 2019, P NATL ACAD SCI USA, V116, P997, DOI 10.1073/pnas.1721434116; Jackson CM, 2018, CLIN CANCER RES, V24, P4059, DOI 10.1158/1078-0432.CCR-18-0491; Jackson CM, 2016, CLIN CANCER RES, V22, P1161, DOI 10.1158/1078-0432.CCR-15-1516; Jackson CM, 2014, CLIN CANCER RES, V20, P3651, DOI 10.1158/1078-0432.CCR-13-2057; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Johanns TM, 2016, CANCER DISCOV, V6, P1230, DOI 10.1158/2159-8290.CD-16-0575; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kim JE, 2017, CLIN CANCER RES, V23, P124, DOI 10.1158/1078-0432.CCR-15-1535; Klein RS, 2004, J IMMUNOL, V172, P550, DOI 10.4049/jimmunol.172.1.550; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Laman JD, 2013, J NEUROIMMUNE PHARM, V8, P840, DOI 10.1007/s11481-013-9470-8; Lang FF, 2018, J CLIN ONCOL, V36, P1419, DOI 10.1200/JCO.2017.75.8219; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li AN, 2016, CANCER IMMUNOL IMMUN, V65, P1545, DOI 10.1007/s00262-016-1911-9; Liau LM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1507-6; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mathios D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2942; Maxwell R, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1500108; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan T, 2019, CURR TREAT OPTION ON, V20, DOI 10.1007/s11864-019-0619-4; Memarnejadian A, 2017, J IMMUNOL, V199, P3348, DOI 10.4049/jimmunol.1700643; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Na SY, 2012, IMMUNITY, V37, P134, DOI 10.1016/j.immuni.2012.04.009; Nachman MW, 2000, GENETICS, V156, P297; Naeini KM, 2013, NEURO-ONCOLOGY, V15, P626, DOI 10.1093/neuonc/not008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Omuro A, 2018, NEURO-ONCOLOGY, V20, P674, DOI 10.1093/neuonc/nox208; Ostrom QT, 2015, CANCER TREAT RES, V163, P1, DOI 10.1007/978-3-319-12048-5_1; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qazi MA, 2017, ANN ONCOL, V28, P1448, DOI 10.1093/annonc/mdx169; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ribatti D, 2017, ONCOTARGET, V8, P7175, DOI 10.18632/oncotarget.12739; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Romo CG, 2019, DIAGN PATHOL, V14, DOI 10.1186/s13000-019-0793-5; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Sandrone S, 2019, NAT MED, V25, P538, DOI 10.1038/s41591-019-0417-3; Schafer N, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1846-y; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sosa RA, 2013, J IMMUNOL, V191, P5848, DOI 10.4049/jimmunol.1300771; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Spector R, 2009, J NEUROCHEM, V111, P315, DOI 10.1111/j.1471-4159.2009.06326.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takenaka MC, 2019, NAT NEUROSCI, V22, P729, DOI 10.1038/s41593-019-0370-y; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tomaszewski W, 2019, CLIN CANCER RES, V25, P4202, DOI 10.1158/1078-0432.CCR-18-1627; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ursu R, 2017, EUR J CANCER, V73, P30, DOI 10.1016/j.ejca.2016.12.003; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Wang Y, 2017, BIOMATERIALS, V112, P153, DOI 10.1016/j.biomaterials.2016.09.034; Weiss T, 2018, CANCER RES, V78, P1031, DOI 10.1158/0008-5472.CAN-17-1788; Weller M, 2017, LANCET ONCOL, V18, P1373, DOI 10.1016/S1470-2045(17)30517-X; Wood MD, 2016, J NEUROPATH EXP NEUR, V75, P925, DOI 10.1093/jnen/nlw068; Woroniecka K, 2018, CLIN CANCER RES, V24, P4175, DOI 10.1158/1078-0432.CCR-17-1846; Wu A., 2019, J NEUROONCOL, V13, P293; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhang M., 2016, PLOS ONE, V11; Zhao J, 2019, NAT MED, V25, P462, DOI 10.1038/s41591-019-0349-y; Zhu HY, 2017, ONCOTARGET, V8, P12145, DOI 10.18632/oncotarget.14553; Zhu XM, 2011, J NEURO-ONCOL, V104, P83, DOI 10.1007/s11060-010-0473-5	120	240	247	11	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1100	1109		10.1038/s41590-019-0433-y	http://dx.doi.org/10.1038/s41590-019-0433-y			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31358997				2022-12-18	WOS:000482212600011
J	McEwan, WA; Tam, JCH; Watkinson, RE; Bidgood, SR; Mallery, DL; James, LC				McEwan, William A.; Tam, Jerry C. H.; Watkinson, Ruth E.; Bidgood, Susanna R.; Mallery, Donna L.; James, Leo C.			Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21	NATURE IMMUNOLOGY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CYTOKINE EXPRESSION; RIG-I; ADENOVIRUS; ACTIVATION; DIFFERENTIATION; RECOGNITION; DEGRADATION; ARREST; RO52	During pathogen infection, antibodies can be carried into the infected cell, where they are detected by the ubiquitously expressed cytosolic antibody receptor TRIM21. Here we found that recognition of intracellular antibodies by TRIM21 activated immune signaling. TRIM21 catalyzed the formation of Lys63 (K63)-linked ubiquitin chains and stimulated the transcription factor pathways of NF-kappa B, AP-1, IRF3, IRF5 and IRF7. Activation resulted in the production of proinflammatory cytokines, modulation of natural killer stress ligands and induction of an antiviral state. Intracellular antibody signaling was abrogated by genetic deletion of TRIM21 and was restored by ectopic expression of TRIM21. The sensing of antibodies by TRIM21 was stimulated after infection by DNA or RNA nonenveloped viruses or intracellular bacteria. Thus, the antibody-TRIM21 detection system provides potent, comprehensive activation of the innate immune system independently of known pattern-recognition receptors.	[McEwan, William A.; Tam, Jerry C. H.; Watkinson, Ruth E.; Bidgood, Susanna R.; Mallery, Donna L.; James, Leo C.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McEwan, WA (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 2QH, England.	wmcewan@mrc-lmb.cam.ac.uk; lcj@mrc-lmb.cam.ac.uk	; Tam, Jerry/P-1995-2014	Watkinson, Ruth/0000-0001-6218-6785; Mallery, Donna/0000-0003-2713-5215; Tam, Jerry/0000-0001-7991-1568; McEwan, William/0000-0002-4408-0407; Bidgood, Susanna/0000-0002-0426-6565	Medical Research Council [U105181010]; European Research Council [281627-IAI]; Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine; MRC [MC_U105181010] Funding Source: UKRI; Medical Research Council [MC_U105181010] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Peeples (Nationwide Children's Hospital) for RSV; and D. Brown (University of Cambridge) for FCV. Supported by the Medical Research Council (U105181010), the European Research Council (281627-IAI) and the Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine (J.C.H.T.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chatterji U, 2006, J BIOL CHEM, V281, P37025, DOI 10.1074/jbc.M606066200; Cheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033969; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fuchs R, 2010, REV MED VIROL, V20, P281, DOI 10.1002/rmv.654; Hauler F, 2012, P NATL ACAD SCI USA, V109, P19733, DOI 10.1073/pnas.1210659109; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Koshiba R, 2013, BIOCHEM BIOPH RES CO, V430, P95, DOI 10.1016/j.bbrc.2012.11.006; Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McEwan WA, 2012, J VIROL, V86, P8482, DOI 10.1128/JVI.00728-12; McEwan WA, 2011, BIOESSAYS, V33, P803, DOI 10.1002/bies.201100093; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Petrovska L, 2004, CELL MICROBIOL, V6, P1071, DOI 10.1111/j.1462-5822.2004.00419.x; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288	42	240	247	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					327	336		10.1038/ni.2548	http://dx.doi.org/10.1038/ni.2548			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23455675	Green Accepted			2022-12-18	WOS:000316648700007
J	Tang, H; Cao, WP; Kasturi, SP; Ravindran, R; Nakaya, HI; Kundu, K; Murthy, N; Kepler, TB; Malissen, B; Pulendran, B				Tang, Hua; Cao, Weiping; Kasturi, Sudhir Pai; Ravindran, Rajesh; Nakaya, Helder I.; Kundu, Kousik; Murthy, Niren; Kepler, Thomas B.; Malissen, Bernard; Pulendran, Bali			The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO DEPLETION; CUTTING EDGE; OXIDATIVE STRESS; IMMUNE-RESPONSE; IL-4 PRODUCTION; DISTINCT; ANTIGEN; INNATE; DIFFERENTIATION	The mechanisms that initiate T helper type 2 (T(H)2) responses are poorly understood. Here we demonstrate that cysteine protease-induced T(H)2 responses occur via 'cooperation' between migratory dermal dendritic cells (DCs) and basophils positive for interleukin 4 (IL-4). Subcutaneous immunization with papain plus antigen induced reactive oxygen species (ROS) in lymph node DCs and in dermal DCs and epithelial cells of the skin. ROS orchestrated T(H)2 responses by inducing oxidized lipids that triggered the induction of thymic stromal lymphopoietin (TSLP) by epithelial cells mediated by Toll-like receptor 4 (TLR4) and the adaptor protein TRIF; by suppressing production of the T(H)1-inducing molecules IL-12 and CD70 in lymph node DCs; and by inducing the DC-derived chemokine CCL7, which mediated recruitment of IL-4(+) basophils to the lymph node. Thus, the T(H)2 response to cysteine proteases requires DC-basophil cooperation via ROS-mediated signaling.	[Tang, Hua; Cao, Weiping; Kasturi, Sudhir Pai; Ravindran, Rajesh; Nakaya, Helder I.; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA USA; [Kundu, Kousik; Murthy, Niren] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Kepler, Thomas B.] Duke Univ, Ctr Computat Immunol, Durham, NC USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Malissen, Bernard] Univ Mediterranee, INSERM, U631,UMR 6102, CNRS,Ctr Immunol Marseille Luminy, Marseille, France	Emory University; University System of Georgia; Georgia Institute of Technology; Duke University; Emory University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA USA.	bpulend@emory.edu	Nakaya, Helder I/A-1397-2010; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder/AAF-1738-2020; Malissen, Bernard/AAK-4659-2020	Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Kepler, Thomas/0000-0002-1383-6865; Malissen, Bernard/0000-0003-1340-9342; Cao, Weiping/0000-0002-5794-9685	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, N01 AI50019, N01 AI50025]; Bill & Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, U19AI057266, R37AI048638, N01AI050025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. A. Mertens, L. Bronner and Y. Wang for assistance with cell sorting; Y. Wang, D. Levesque and D. Bonenberger for assistance with the maintenance of mice at the Emory Vaccine Center vivarium; S. Akira (Osaka University) for Tlr2<SUP>-/-</SUP>, Tlr3<SUP>-/-</SUP>, Tlr4<SUP>-/-</SUP>, Tlr6<SUP>-/-</SUP>, Tlr7<SUP>-/-</SUP>, Tlr9<SUP>-/-</SUP>, Myd88<SUP>-/-</SUP> and Ticam1<SUP>lps-2/lps-2</SUP> mice; V. Dixit (Genentech) for Nalp3<SUP>-/-</SUP>, Ipaf<SUP>-/-</SUP> and Asc<SUP>-/-</SUP> mice; K. A. Hogquist (University of Minnesota) for Langerin-EGFP-DTR mice; and J. Witztum (University of California at San Diego) for EO6. Supported by the National Institutes of Health (U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, N01 AI50019, N01 AI50025) and the Bill & Melinda Gates Foundation.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min B, 2008, NAT IMMUNOL, V9, P223, DOI 10.1038/ni0308-223; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Niu N, 2009, J IMMUNOL, V183, P1523, DOI 10.4049/jimmunol.0901349; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	58	240	249	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					608	U80		10.1038/ni.1883	http://dx.doi.org/10.1038/ni.1883			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20495560	Green Accepted			2022-12-18	WOS:000278926400017
J	Cai, GF; Anumanthan, A; Brown, JA; Greenfield, EA; Zhu, B; Freeman, GJ				Cai, Guifang; Anumanthan, Anukanth; Brown, Julia A.; Greenfield, Edward A.; Zhu, Baogong; Freeman, Gordon J.			CD160 inhibits activation of human CD4(+) T cells through interaction with herpesvirus entry mediator	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; NK CELLS; LYMPHOCYTE ATTENUATOR; RECEPTOR FAMILY; SIMPLEX VIRUS-1; CUTTING EDGE; B-LYMPHOCYTE; HLA-C; LIGHT; HVEM	CD160, a glycosylphosphatidylinositol-anchored member of the immunoglobulin superfamily, is expressed on both cytolytic lymphocytes and some unstimulated CD4(+) T cells. Here we show that CD160 expression was increased after activation of human CD4(+) T cells and that crosslinking CD160 with monoclonal antibody strongly inhibited CD3- and CD28-mediated activation. We found that herpesvirus entry mediator (HVEM) was a ligand of CD160 that acted as a 'bidirectional switch' for T cell activation, producing a positive or negative outcome depending on the engagement of HVEM by CD160 and known HVEM ligands such as B and T lymphocyte attenuator (BTLA) and the T lymphocyte receptor LIGHT. Inhibition of CD4(+) T cell activation by HVEM-transfected cells was dependent on CD160 and BTLA; when the cysteine-rich domain 1 of HVEM was deleted, this inhibition was lost, resulting in strong T cell activation. CD160 thus serves as a negative regulator of CD4(+) T cell activation through its interaction with HVEM.	[Cai, Guifang; Anumanthan, Anukanth; Brown, Julia A.; Greenfield, Edward A.; Zhu, Baogong; Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Freeman, GJ (corresponding author), Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA.	gordon_freeman@dfci.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI056299, R01AI139671] Funding Source: NIH RePORTER; NIAID NIH HHS [AI39671, AI56299] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abecassis S, 2007, J INVEST DERMATOL, V127, P1161, DOI 10.1038/sj.jid.5700680; Agrawal S, 1999, J IMMUNOL, V162, P1223; Anumanthan A, 1998, J IMMUNOL, V161, P2780; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; Barakonyi A, 2004, J IMMUNOL, V173, P5349, DOI 10.4049/jimmunol.173.9.5349; BENSUSSAN A, 1994, P NATL ACAD SCI USA, V91, P9136, DOI 10.1073/pnas.91.19.9136; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOUSSIOTIS VA, 1993, J EXP MED, V178, P1753, DOI 10.1084/jem.178.5.1753; Chang YH, 2005, J BIOMED SCI, V12, P363, DOI 10.1007/s11373-005-1360-5; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; Gill RM, 2002, AM J PATHOL, V161, P2011, DOI 10.1016/S0002-9440(10)64479-3; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Granger SW, 2003, CYTOKINE GROWTH F R, V14, P289, DOI 10.1016/S1359-6101(03)00031-5; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; Le Bouteiller P, 2002, P NATL ACAD SCI USA, V99, P16963, DOI 10.1073/pnas.012681099; Maeda M, 2005, J IMMUNOL, V175, P4426, DOI 10.4049/jimmunol.175.7.4426; MAIZA H, 1993, J EXP MED, V178, P1121, DOI 10.1084/jem.178.3.1121; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MORGAN BP, 1993, EUR J IMMUNOL, V23, P2841, DOI 10.1002/eji.1830231118; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tamada K, 2000, NAT MED, V6, P283; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	35	240	263	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					176	185		10.1038/ni1554	http://dx.doi.org/10.1038/ni1554			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18193050				2022-12-18	WOS:000252503000014
J	Jensen, PE				Jensen, Peter E.			Recent advances in antigen processing and presentation	NATURE IMMUNOLOGY			English	Review							MHC CLASS-I; PEPTIDE-LOADING COMPLEX; PROTEIN DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; CROSS-PRESENTATION; HLA-DM; T-CELLS; B-CELLS; MEDIATED PHAGOCYTOSIS	Heterogeneous intracellular pathways and biochemical mechanisms are responsible for generating the glycoprotein complexes of peptide and major histocompatibility complex that are displayed on the surfaces of antigen-presenting cells for recognition by T lymphocytes. These pathways have a profound influence on the specificity of adaptive immunity and tolerance, as well as the context and consequences of antigen recognition by T cells in the thymus and periphery. The field of antigen processing and presentation has continued to advance since the publication of a focus issue on the topic in Nature Immunology in July 2004. Progress has been made on many fronts, including advances in understanding how proteases, accessory molecules and intracellular pathways influence peptide loading and antigen presentation in various cell types.	Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jensen, PE (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	peter.jensen@path.utah.edu						Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chen XJ, 2006, J IMMUNOL, V176, P3548, DOI 10.4049/jimmunol.176.6.3548; Chen XJ, 2002, J EXP MED, V195, P1053, DOI 10.1084/jem.20012066; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; De Wall SL, 2006, NAT CHEM BIOL, V2, P197, DOI 10.1038/nchembio773; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Fallas JL, 2007, J IMMUNOL, V178, P1488, DOI 10.4049/jimmunol.178.3.1488; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; Hornell TMC, 2006, J IMMUNOL, V176, P3536, DOI 10.4049/jimmunol.176.6.3536; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jensen PE, 1999, IMMUNOL REV, V172, P229, DOI 10.1111/j.1600-065X.1999.tb01368.x; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lovitch SB, 2007, J IMMUNOL, V178, P122, DOI 10.4049/jimmunol.178.1.122; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McFarland BJ, 2005, J MOL BIOL, V350, P170, DOI 10.1016/j.jmb.2005.04.069; Mimura Y, 2007, P NATL ACAD SCI USA, V104, P5983, DOI 10.1073/pnas.0701307104; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2005, IMMUNOL REV, V207, P8; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zook MB, 2006, J IMMUNOL, V176, P6928, DOI 10.4049/jimmunol.176.11.6928	110	240	244	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1041	1048		10.1038/ni1516	http://dx.doi.org/10.1038/ni1516			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878914				2022-12-18	WOS:000249691400018
J	Sebzda, E; Bracke, M; Tugal, T; Hogg, N; Cantrell, DA				Sebzda, E; Bracke, M; Tugal, T; Hogg, N; Cantrell, DA			Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling	NATURE IMMUNOLOGY			English	Article							RECEPTOR TRANSGENIC MICE; CD4+8+ THYMOCYTES; CD69 EXPRESSION; DEPENDENT ACTIVATION; TOLERANCE INDUCTION; NEGATIVE SELECTION; TYROSINE KINASE; SMALL GTPASE; H-RAS; R-RAS	T cell receptor (TCR) stimulation activates the small GTPase Rap1A, which is reported to antagonize Ras signaling and induces T cell anergy. To address its role in vivo, we generated transgenic mice that constitutively expressed active Rap1A within the T cell lineage. We found that active Rap1A did not interfere with the Ras signaling pathway or antagonize T cell activation. Instead of anergy, the T lymphocytes that constitutively expressed active Rap1A showed enhanced TCR-mediated responses, both in thymocytes and mature T cells. In addition, Rap1A activation was sufficient to induce strong activation of the beta(1) and beta(2) integrins via an avidity-modulation mechanism. This shows that, far from playing an inhibitory role during T cell activation, Rap1A positively influences T cells by augmenting lymphocyte responses and directing integrin activation.	Lincolns Inn Fields Labs, Lymphocyte Activat Lab, London WC2A 3PX, England; Lincolns Inn Fields Labs, Leukocyte Adhes Lab, London WC2A 3PX, England		Cantrell, DA (corresponding author), Lincolns Inn Fields Labs, Lymphocyte Activat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.			Cantrell, Doreen/0000-0001-7525-3350				AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Czyzyk J, 2000, MOL CELL BIOL, V20, P8740, DOI 10.1128/MCB.20.23.8740-8747.2000; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Epler JA, 2000, J IMMUNOL, V165, P4941, DOI 10.4049/jimmunol.165.9.4941; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hare KJ, 1999, J IMMUNOL, V162, P3978; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TaylorFishwick DA, 1995, EUR J IMMUNOL, V25, P3215, DOI 10.1002/eji.1830251203; Tissot AC, 2000, J MOL BIOL, V302, P873, DOI 10.1006/jmbi.2000.4501; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	47	240	245	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					251	258		10.1038/ni765	http://dx.doi.org/10.1038/ni765			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11836528				2022-12-18	WOS:000174074000013
J	Wong, CHY; Jenne, CN; Petri, B; Chrobok, NL; Kubes, P				Wong, Connie H. Y.; Jenne, Craig N.; Petri, Bjoern; Chrobok, Navina L.; Kubes, Paul			Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance	NATURE IMMUNOLOGY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; BACILLUS-ANTHRACIS SPORES; APOPTOSIS; SPLEEN; COAGULATION; EXPRESSION; CLODRONATE; SURVIVAL; ADHESION; LIVER	Through the use of intravital imaging of the liver, we demonstrate a collaborative role for platelets with Kupffer cells (KCs) in eradicating blood-borne bacterial infection. Under basal conditions, platelets, via the platelet-adhesion receptor GPIb, formed transient 'touch-and-go' interactions with von Willebrand factor (vWF) constitutively expressed on KCs. Bacteria such as Bacillus cereus and methicillin-resistant Staphylococcus aureus (MRSA) were rapidly caught by KCs and triggered platelets to switch from 'touch-and-go' adhesion to sustained GPIIb-mediated adhesion on the KC surface to encase the bacterium. Infected GPIb alpha-deficient mice had more endothelial and KC damage than did their wild-type counterparts, which led to more fluid leakage, substantial polycythemia and rapid mortality. Our study identifies a previously unknown surveillance mechanism by which platelets survey macrophages that rapidly converts to a critical host response to blood-borne bacteria.	[Wong, Connie H. Y.; Petri, Bjoern; Chrobok, Navina L.; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada; [Jenne, Craig N.; Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calvin Phoebe & Joan Snyder Translat Lab Crit Car, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada.	pkubes@ucalgary.ca		Wong, Connie/0000-0002-9020-1847	Canadian Foundation for Innovation; Alberta Innovates Health Solutions; Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	We thank T. Chavakis (Dresden University of Technology) for Gp1ba/mice; K. McNagny (University of British Columbia) for GPIIb-deficient mice; J. Handelsman (Yale University) for making the green fluorescent protein-expressing B. cereus strain, and R.R. Pompano (University of Chicago) and R.F. Ismagilov (California Institute of Technology) for providing that strain; The Live Cell Imaging Facility funded by the Canadian Foundation for Innovation; and P. Colarusso for training and assistance related to microscopy. Supported by Alberta Innovates Health Solutions (C.H.Y.W., C.N.J. and P.K.), the Canadian Institutes of Health Research (P.K.) and the Canada Research Chairs Program (P.K.).	Alfaro DV, 1996, RETINA-J RET VIT DIS, V16, P317, DOI 10.1097/00006982-199616040-00007; Altamura M, 2001, IMMUNOPHARM IMMUNOT, V23, P153, DOI 10.1081/IPH-100103856; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dunn AK, 1999, GENE, V226, P297, DOI 10.1016/S0378-1119(98)00544-7; Fuchs B, 2010, THROMB RES, V125, P239, DOI 10.1016/j.thromres.2009.08.020; GARCIA VV, 1982, BLOOD, V60, P1402; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Kastrup CJ, 2008, NAT CHEM BIOL, V4, P742, DOI 10.1038/nchembio.124; KATZ S, 1991, J SURG RES, V51, P267, DOI 10.1016/0022-4804(91)90105-U; Kerrigan SW, 2002, BLOOD, V100, P509, DOI 10.1182/blood.V100.2.509; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Popova TG, 2012, MICROB PATHOGENESIS, V52, P1, DOI 10.1016/j.micpath.2011.08.004; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Wellmer A, 2004, INFECT IMMUN, V72, P3113, DOI 10.1128/IAI.72.6.3113-3119.2004; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yeaman MR, 1997, INFECT IMMUN, V65, P1023, DOI 10.1128/IAI.65.3.1023-1031.1997; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962	47	239	248	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					785	+		10.1038/ni.2631	http://dx.doi.org/10.1038/ni.2631			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23770641	Green Accepted			2022-12-18	WOS:000322010600007
J	Lee, WY; Moriarty, TJ; Wong, CHY; Zhou, H; Strieter, RM; van Rooijen, N; Chaconas, G; Kubes, P				Lee, Woo-Yong; Moriarty, Tara J.; Wong, Connie H. Y.; Zhou, Hong; Strieter, Robert M.; van Rooijen, Nico; Chaconas, George; Kubes, Paul			An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; NKT CELLS; GLYCOLIPID ANTIGENS; MACROPHAGES; INFECTION; ACTIVATION; MECHANISM; MONOCYTES; MIGRATION; CYTOKINES	Here we investigate the dynamics of the hepatic intravascular immune response to a pathogen relevant to invariant natural killer T cells (iNKT cells). Immobilized Kupffer cells with highly ramified extended processes into multiple sinusoids could effectively capture blood-borne, disseminating Borrelia burgdorferi, creating a highly efficient surveillance and filtering system. After ingesting B. burgdorferi, Kupffer cells induced chemokine receptor CXCR3-dependent clustering of iNKT cells. Kupffer cells and iNKT cells formed stable contacts via the antigen-presenting molecule CD1d, which led to iNKT cell activation. An absence of iNKT cells caused B. burgdorferi to leave the blood and enter the joints more effectively. B. burgdorferi that escaped Kupffer cells entered the liver parenchyma and survived despite Ito cell responses. Kupffer cell-iNKT cell interactions induced a key intravascular immune response that diminished the dissemination of B. burgdorferi.	[Lee, Woo-Yong; Wong, Connie H. Y.; Zhou, Hong; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Moriarty, Tara J.; Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Chaconas, George] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Strieter, Robert M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [van Rooijen, Nico] Free Univ Amsterdam, Dept Mol Cell Biol, Amsterdam, Netherlands	University of Calgary; University of Calgary; University of Calgary; University of Virginia; Vrije Universiteit Amsterdam	Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada.	pkubes@ucalgary.ca	Van Rooijen, Nico/Z-1578-2019; Moriarty, Tara J./K-1684-2016	Moriarty, Tara J./0000-0002-1751-5145; Wong, Connie/0000-0002-9020-1847	Canadian Institutes of Health Research [78190, MOP-53086] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Ato M, 2006, J IMMUNOL, V176, P5486, DOI 10.4049/jimmunol.176.9.5486; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baer K, 2007, CELL MICROBIOL, V9, P397, DOI 10.1111/j.1462-5822.2006.00798.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Belperio JA, 2002, J IMMUNOL, V169, P1037, DOI 10.4049/jimmunol.169.2.1037; Benhnia MREI, 2005, J IMMUNOL, V174, P1539, DOI 10.4049/jimmunol.174.3.1539; Bernardino ALF, 2008, INFECT IMMUN, V76, P4385, DOI 10.1128/IAI.00394-08; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Faunce DE, 2005, J IMMUNOL, V175, P3102, DOI 10.4049/jimmunol.175.5.3102; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kajiwara T, 2007, TRANSPLANTATION, V83, P184, DOI 10.1097/01.tp.0000250573.50046.89; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kobayashi E, 1995, ONCOL RES, V7, P529; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; MACPHEE PJ, 1992, AM J PHYSIOL, V263, pG17, DOI 10.1152/ajpgi.1992.263.1.G17; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Norman MU, 2008, J IMMUNOL, V180, P510, DOI 10.4049/jimmunol.180.1.510; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; SCHMID GP, 1989, REV INFECT DIS, V11, pS1460; Tupin E, 2008, P NATL ACAD SCI USA, V105, P19863, DOI 10.1073/pnas.0810519105; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wake K, 2006, P JPN ACAD B-PHYS, V82, P155, DOI 10.2183/pjab.82.155; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395; Zaidi SA, 2002, CLIN INFECT DIS, V34, P1206, DOI 10.1086/339871; Zanchi AC, 2007, DIGEST DIS SCI, V52, P2629, DOI 10.1007/s10620-006-9405-9	39	239	243	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					295	U36		10.1038/ni.1855	http://dx.doi.org/10.1038/ni.1855			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20228796	Green Accepted, Green Submitted			2022-12-18	WOS:000275849500008
J	You, FP; Sun, H; Zhou, X; Sun, WX; Liang, SM; Zhai, ZH; Jiang, ZF				You, Fuping; Sun, Hui; Zhou, Xiang; Sun, Wenxiang; Liang, Shimin; Zhai, Zhonghe; Jiang, Zhengfan			PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4	NATURE IMMUNOLOGY			English	Article							RIG-I; FUNCTIONAL DIVERSITY; NEDD4 FAMILY; KAPPA-B; PROTEIN; ITCH; INNATE; IDENTIFICATION; RECOGNITION; INTERACTS	MAVS is critical in innate antiviral immunity as the sole adaptor for RIG-I-like helicases. MAVS regulation is essential for the prevention of excessive harmful immune responses. Here we identify PCBP2 as a negative regulator in MAVS-mediated signaling. Overexpression of PCBP2 abrogated cellular responses to viral infection, whereas knockdown of PCBP2 exerted the opposite effect. PCBP2 was induced after viral infection, and its interaction with MAVS led to proteasomal degradation of MAVS. PCBP2 recruited the HECT domain-containing E3 ligase AIP4 to polyubiquitinate and degrade MAVS. MAVS was degraded after viral infection in wild-type mouse embryonic fibroblasts but remained stable in AIP4-deficient (Itch(-/-)) mouse embryonic fibroblasts, coupled with greatly exaggerated and prolonged antiviral responses. The PCBP2-AIP4 axis defines a new signaling cascade for MAVS degradation and 'fine tuning' of antiviral innate immunity.	[You, Fuping; Sun, Hui; Zhou, Xiang; Sun, Wenxiang; Liang, Shimin; Zhai, Zhonghe; Jiang, Zhengfan] Peking Univ, Sch Life Sci, Educ Minist, Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China	Peking University	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, Educ Minist, Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Leung, Kathy/D-5605-2017; SUN, Wenxiang/Q-3481-2017	Leung, Kathy/0000-0003-4777-388X; Sun, Hui/0000-0002-1152-5932	National Natural Science Foundation of China [30772024, 30721064]; National Basic Research Program of China [2007CB914502]; Key Project of the Chinese Ministry of Education [108002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Key Project of the Chinese Ministry of Education(Ministry of Education, China)	We thank D. Chen and D. Gao (Peking University) for technical assistance and the 293 cDNA library for yeast two-hybrid screening; Z. Chen (University of Texas Southwestern Medical Center) for MAVS chimera expression vectors; E. Harhaj (University of Miami) for Itch<SUP>-/-</SUP>MEFs; Q. Chen (Nankai University) for antibody to Bcl-x<INF>L</INF> (anti-Bcl-x<INF>L</INF>); H. Shu (Wuhan University) for HA-UB(K48) and HA-UB(K63) (plasmids encoding ubiquitin-K48 and ubiquitin-K63); C. Zheng (Wuhan University) for SeV; and C. Wang (Shanghai Institutes for Biological Sciences) for green fluorescent protein (GFP)-tagged NDV. Supported by the National Natural Science Foundation of China (30772024, 30721064), the National Basic Research Program of China (2007CB914502) and the Key Project of the Chinese Ministry of Education (108002).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Funke B, 1996, NUCLEIC ACIDS RES, V24, P3821, DOI 10.1093/nar/24.19.3821; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HUSTAD CM, 1995, GENETICS, V140, P255; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sean P, 2008, VIROLOGY, V378, P243, DOI 10.1016/j.virol.2008.05.007; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	39	239	260	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1300	U10		10.1038/ni.1815	http://dx.doi.org/10.1038/ni.1815			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19881509				2022-12-18	WOS:000271872800014
J	Ananieva, O; Darragh, J; Johansen, C; Carr, JM; McIlrath, J; Park, JM; Wingate, A; Monk, CE; Toth, R; Santos, SG; Iversen, L; Arthur, JSC				Ananieva, Olga; Darragh, Joanne; Johansen, Claus; Carr, Julia M.; McIlrath, Joanne; Park, Jin Mo; Wingate, Andrew; Monk, Claire E.; Toth, Rachel; Santos, Susana G.; Iversen, Lars; Arthur, J. Simon C.			The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling	NATURE IMMUNOLOGY			English	Article							STRESS-INDUCED PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; POLYMICROBIAL SEPSIS; ENDOGENOUS IL-10; CECAL LIGATION; PHOSPHATASE-1; MICE; GENE; INTERLEUKIN-10; DOWNSTREAM	The kinases MSK1 and MSK2 are activated 'downstream' of the p38 and Erk1/2 mitogen-activated protein kinases. Here we found that MSK1 and MSK2 were needed to limit the production of proinflammatory cytokines in response to stimulation of primary macrophages with lipopolysaccharide. By inducing transcription of the mitogen-activated protein kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10, MSK1 and MSK2 exerted many negative feedback mechanisms. Deficiency in MSK1 and MSK2 prevented the binding of phosphorylated transcription factors CREB and ATF1 to the promoters of the genes encoding interleukin 10 and DUSP1. Mice doubly deficient in MSK1 and MSK2 were hypersensitive to lipopolysaccharide-induced endotoxic shock and showed prolonged inflammation in a model of toxic contact eczema induced by phorbol 12-myristate 13-acetate. Our results establish MSK1 and MSK2 as key components of negative feedback mechanisms needed to limit Toll-like receptor-driven inflammation.	[Ananieva, Olga; Darragh, Joanne; Carr, Julia M.; McIlrath, Joanne; Wingate, Andrew; Monk, Claire E.; Toth, Rachel; Santos, Susana G.; Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Johansen, Claus; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark; [Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Dundee; Aarhus University; Harvard University; Massachusetts General Hospital; Harvard University	Arthur, JSC (corresponding author), Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	j.s.c.arthur@dundee.ac.uk	Santos, Susana G/L-9351-2013; Arthur, J. Simon/B-8058-2010	Santos, Susana G/0000-0002-8604-2978; Arthur, J. Simon/0000-0002-8135-1958; Johansen, Claus/0000-0003-0240-5127; Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0002-5665-5212; Watt, Joanne/0000-0002-9839-134X	UK Medical Research Council; Arthritis Research Campaign; Novo Nordic Foundation; Danish Research Agency; Astra-Zeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Pfizer; MRC [MC_U127081014] Funding Source: UKRI; Medical Research Council [MC_U127081014] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research Campaign(Versus Arthritis); Novo Nordic Foundation(Novo Nordisk Foundation); Danish Research Agency; Astra-Zeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. O'Garra (National Institute of Medical Research, London) for the IL-10-neutralizing antibody. Supported by the UK Medical Research Council, Arthritis Research Campaign, Novo Nordic Foundation, Danish Research Agency, Astra-Zeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, and Pfizer.	Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dambach DM, 2005, CURR TOP MED CHEM, V5, P929, DOI 10.2174/1568026054985911; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; Echtenacher B, 2001, INFECT IMMUN, V69, P7271, DOI 10.1128/IAI.69.12.7172-7276.2001; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hildebrand F, 2003, SHOCK, V20, P338, DOI 10.1097/01.shk.0000081408.57952.22; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Moreno SE, 2006, J IMMUNOL, V177, P3218, DOI 10.4049/jimmunol.177.5.3218; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Song GY, 1999, SURGERY, V126, P378, DOI 10.1016/S0039-6060(99)70180-7; Steinhauser ML, 1999, J IMMUNOL, V162, P5437; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	50	239	253	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1028	1036		10.1038/ni.1644	http://dx.doi.org/10.1038/ni.1644			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18690222	Green Submitted			2022-12-18	WOS:000258559600015
J	Meissner, F; Molawi, K; Zychlinsky, A				Meissner, Felix; Molawi, Kaaweh; Zychlinsky, Arturo			Superoxide dismutase 1 regulates caspase-1 and endotoxic shock	NATURE IMMUNOLOGY			English	Article							REACTIVE OXYGEN; IL-1-BETA-CONVERTING ENZYME; ACTIVATION; INTERLEUKIN-1-BETA; INFLAMMASOME; APOPTOSIS; RECEPTOR; DEATH; GLUTATHIONE; EXPRESSION	Caspase-1 serves an essential function in the initiation of inflammation by proteolytically maturing the cytokines interleukin 1 beta and interleukin 18. Several Nod-like receptors activate caspase-1 in response to microbial and 'danger' signals by assembling cytosolic protein complexes called 'inflammasomes'. We show here that superoxide dismutase 1 (SOD1) regulates caspase-1 activation. In SOD1-deficient macrophages, higher superoxide production decreased the cellular redox potential and specifically inhibited caspase-1 by reversible oxidation and glutathionylation of the redox-sensitive cysteine residues Cys397 and Cys362. Conversely, hypoxic conditions abrogated caspase-1 inhibition. In vivo, SOD1-deficient mice produced less caspase-1-dependent cytokines and were less susceptible to lipopolysaccharide-induced septic shock. Our findings identify a physiological post-translational mechanism in the control of caspase-1-mediated inflammatory processes.	[Meissner, Felix; Molawi, Kaaweh; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany	Max Planck Society	Zychlinsky, A (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de	MEISSNER, Felix/C-8767-2015	MEISSNER, Felix/0000-0003-1000-7989				Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; HOPPER KE, 1986, J LEUKOCYTE BIOL, V39, P435, DOI 10.1002/jlb.39.4.435; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Laight DW, 1997, ENVIRON TOXICOL PHAR, V3, P65, DOI 10.1016/S1382-6689(96)00143-3; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	47	239	245	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					866	872		10.1038/ni.1633	http://dx.doi.org/10.1038/ni.1633			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604212				2022-12-18	WOS:000257780700009
J	Hadeiba, H; Sato, T; Habtezion, A; Oderup, C; Pan, JL; Butcher, EC				Hadeiba, Husein; Sato, Tohru; Habtezion, Aida; Oderup, Cecilia; Pan, Junliang; Butcher, Eugene C.			CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease	NATURE IMMUNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; CHEMOKINE RECEPTOR 9; TOLERANCE INDUCTION; ALLOGRAFT SURVIVAL; INTERFERON-GAMMA; SMALL-INTESTINE; NOD MICE	Dendritic cells (DCs) are 'professional' antigen-presenting cells that are key in the regulation of immune responses. Here we characterize a unique subset of tolerogenic DCs that expressed the chemokine receptor CCR9 and migrated to the CCR9 ligand CCL25, a chemokine linked to the homing of T cells and DCs to the gut. CCR9(+) DCs were of the plasmacytoid DC (pDC) lineage, had an immature phenotype and rapidly downregulated CCR9 in response to maturation-inducing pDC-restricted Toll-like receptor ligands. CCR9(+) pDCs were potent inducers of regulatory T cell function and suppressed antigen-specific immune responses both in vitro and in vivo, including inhibiting acute graft-versus-host disease induced by allogeneic CD4(+) donor T cells in irradiated recipients. Our results identify a highly immunosuppressive population of pDCs present in lymphoid tissues.	[Hadeiba, Husein; Sato, Tohru; Habtezion, Aida; Oderup, Cecilia; Pan, Junliang; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Hadeiba, Husein; Sato, Tohru; Habtezion, Aida; Oderup, Cecilia; Pan, Junliang; Butcher, Eugene C.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Butcher, EC (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	hadeiba@stanford.edu; ebutcher@stanford.edu			NIAID NIH HHS [T32 AI007290, AI07290] Funding Source: Medline; NIDDK NIH HHS [K08DK069385, R03DK069395, K08 DK069385, K08 DK069385-01A1, R01 DK084647, R03 DK069395-01A1] Funding Source: Medline; NIGMS NIH HHS [R37 GM037734-13, R37 GM037734] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084647, R03DK069395, K08DK069385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Arpinati M, 2003, TRANSPL IMMUNOL, V11, P345, DOI 10.1016/S0966-3274(03)00055-8; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Caux C, 2000, SPRINGER SEMIN IMMUN, V22, P345, DOI 10.1007/s002810000053; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Feili-Hariri M, 1999, DIABETES, V48, P2300, DOI 10.2337/diabetes.48.12.2300; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Fugier-Vivier IJ, 2005, J EXP MED, V201, P373, DOI 10.1084/jem.20041399; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochweller K, 2004, EUR J IMMUNOL, V34, P990, DOI 10.1002/eji.200324782; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Kim SH, 2001, J IMMUNOL, V166, P3499, DOI 10.4049/jimmunol.166.5.3499; Kim SH, 2002, MOL THER, V6, P584, DOI 10.1006/mthe.2002.0712; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kuwana M, 2002, HUM IMMUNOL, V63, P1156, DOI 10.1016/S0198-8859(02)00754-1; Kuwana M, 2001, EUR J IMMUNOL, V31, P2547, DOI 10.1002/1521-4141(200109)31:9<2547::AID-IMMU2547>3.0.CO;2-J; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Mach N, 2000, CANCER RES, V60, P3239; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Morel PA, 1999, J LEUKOCYTE BIOL, V66, P276, DOI 10.1002/jlb.66.2.276; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2003, IMMUNOL REV, V196, P125, DOI 10.1046/j.1600-065X.2003.00079.x; Murphy WJ, 1998, J CLIN INVEST, V102, P1742, DOI 10.1172/JCI3906; O'Connell PJ, 2002, J IMMUNOL, V168, P143, DOI 10.4049/jimmunol.168.1.143; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Popov I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2031; Rastellini C, 1995, TRANSPLANTATION, V60, P1366; Salmi M, 2005, IMMUNOL REV, V206, P100, DOI 10.1111/j.0105-2896.2005.00285.x; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zeng DF, 2002, BLOOD, V99, P1449, DOI 10.1182/blood.V99.4.1449	54	238	249	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1253	1260		10.1038/ni.1658	http://dx.doi.org/10.1038/ni.1658			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18836452	Green Accepted			2022-12-18	WOS:000260248600012
J	Stern-Ginossar, N; Gur, C; Biton, M; Horwitz, E; Elboim, M; Stanietsky, N; Mandelboim, M; Mandelboim, O				Stern-Ginossar, Noam; Gur, Chamutal; Biton, Moshe; Horwitz, Elad; Elboim, Moran; Stanietsky, Noa; Mandelboim, Michal; Mandelboim, Ofer			Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; T-CELLS; LENTIVIRAL VECTORS; ANIMAL MICRORNAS; A EXPRESSION; CHAIN-B; LIGANDS; SYSTEM; ACTIVATION; MOLECULES	MICA and MICB are stress-induced ligands recognized by the activating receptor NKG2D. A microRNA encoded by human cytomegalovirus downregulates MICB expression by targeting a specific site in the MICB 3' untranslated region. As this site is conserved among different MICB alleles and a similar site exists in the MICA 3' untranslated region, we speculated that these sites are targeted by cellular microRNAs. Here we identified microRNAs that bound to these MICA and MICB 3' untranslated region sequences and obtained data suggesting that these microRNAs maintain expression of MICA and MICB protein under a certain threshold and facilitate acute upregulation of MICA and MICB during cellular stress. These microRNAs were overexpressed in various tumors and we demonstrate here that they aided tumor avoidance of immune recognition.	[Stern-Ginossar, Noam; Gur, Chamutal; Biton, Moshe; Horwitz, Elad; Elboim, Moran; Stanietsky, Noa; Mandelboim, Ofer] Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Biomed Res Inst, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Mandelboim, Michal] Clin Virol Unit, IL-52621 Ramat Gan, Israel	Hebrew University of Jerusalem	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Biomed Res Inst, Hadassah Med Sch, IL-91120 Jerusalem, Israel.	oferm@ekmd.huji.ac.il		Biton, Moshe/0000-0001-8330-1674; Mandelboim, Ofer/0000-0002-9354-1855				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wolf DG, 2003, BLOOD, V101, P463, DOI 10.1182/blood-2002-07-1982; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238	50	238	253	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1065	1073		10.1038/ni.1642	http://dx.doi.org/10.1038/ni.1642			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18677316				2022-12-18	WOS:000258559600019
J	Wei, SH; Rosen, H; Matheu, MP; Sanna, MG; Wang, SK; Jo, EJ; Wong, CH; Parker, I; Cahalan, MD				Wei, SH; Rosen, H; Matheu, MP; Sanna, MG; Wang, SK; Jo, EJ; Wong, CH; Parker, I; Cahalan, MD			Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE RECIRCULATION; FTY720; EGRESS; SPHINGOSINE-1-PHOSPHATE; TRAFFICKING; S1P(1); EXPRESSION; EMIGRATION; SUBTYPES; ORGANS	Sphingosine 1-phosphate type 1 (S1P(1)) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood. One hypothesis proposes that agonists act as functional antagonists' by binding and internalizing S1P(1) receptors on lymphocytes; a second hypothesis proposes instead that S1P(1) agonists act on endothelial cells to prevent lymphocyte egress from lymph nodes. Here, two-photon imaging of living T cells in explanted lymph nodes after treatment with S1P(1) agonists or antagonists has provided insight into the mechanism by which S1P(1) agonists function. The selective S1P(1) agonist SEW2871 caused reversible slowing and 'log-jamming' of T cells between filled medullary cords and empty sinuses, whereas motility was unaltered in diffuse cortex. Removal or antagonist competition of SEW2871 permitted recovery of T cell motility in the parenchyma of the medulla and resumption of migration across the stromal endothelial barrier, leading to refilling of sinuses. Our results provide visualization of transendothelial migration of T cells into lymphatic sinuses and suggest that S1P(1) agonists act mainly on endothelial cell S1P(1) receptors to inhibit lymphocyte migration.	Univ Calif Irvine, Dept Phys & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Phys & Biophys, Irvine, CA 92697 USA.	hrosen@scripps.edu; mcahalan@uci.edu		Wang, Sheng-Kai/0000-0002-3827-7983; Jo, Euijung/0000-0003-1131-2723	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R37GM048071, R01GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-55509] Funding Source: Medline; NIGMS NIH HHS [GM-41514, GM-48071] Funding Source: Medline; NIMH NIH HHS [MH074404-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Brinkmann V, 2004, YONSEI MED J, V45, P991, DOI 10.3349/ymj.2004.45.6.991; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O	23	238	246	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1228	1235		10.1038/ni1269	http://dx.doi.org/10.1038/ni1269			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16273098				2022-12-18	WOS:000233371900010
J	Boursalian, TE; Golob, J; Soper, DM; Cooper, CJ; Fink, PJ				Boursalian, TE; Golob, J; Soper, DM; Cooper, CJ; Fink, PJ			Continued maturation of thymic emigrants in the periphery	NATURE IMMUNOLOGY			English	Article							T-CELLS; NAIVE CD4; B-CELLS; THYMOCYTE; SURVIVAL; RECOMBINATION; EXPRESSION; SELECTION; DISTINCT; IL-7	Developing thymocytes are selected for recognition of molecules encoded by the major histocompatibility complex, purged of self-reactive cells and committed to either the CD4 or CD8 lineage. The 1% of thymocytes that complete these tasks emigrate and join the population of peripheral lymphocytes. Whether T cell maturation is complete at the time of thymic exit has been a subject of debate. Using mice transgenic for green fluorescent protein driven by the recombination activating gene 2 promoter to identify recent thymic emigrants, we now show that T cell differentiation continues post-thymically, with progressive maturation of both surface phenotype and immune function. In addition, the relative contribution of CD4 and CD8 recent thymic emigrants was modulated as they entered the peripheral T cell pool. Thus, T cell maturation and subset contribution are both finalized in the lymphoid periphery.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fink, PJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	pfink@u.washington.edu			NCI NIH HHS [F32 CA84736] Funding Source: Medline; NIAID NIH HHS [AI44130, T32 AI07411] Funding Source: Medline; NIA NIH HHS [AG13078] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA084736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007411, R01AI044130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013078] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Boursalian TE, 1999, J IMMUNOL, V162, P3795; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Cooper CJ, 2003, J IMMUNOL, V171, P226, DOI 10.4049/jimmunol.171.1.226; DILLON SR, 1995, IMMUNITY, V3, P321, DOI 10.1016/1074-7613(95)90117-5; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; FINK PJ, 1984, J EXP MED, V159, P436, DOI 10.1084/jem.159.2.436; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; GUNTER KC, 1987, NATURE, V326, P505, DOI 10.1038/326505a0; Hassan J, 2002, TRENDS IMMUNOL, V23, P126, DOI 10.1016/S1471-4906(01)02173-1; Hassan J, 2001, J IMMUNOL, V167, P1970, DOI 10.4049/jimmunol.167.4.1970; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kong FK, 1998, IMMUNITY, V8, P97, DOI 10.1016/S1074-7613(00)80462-8; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Penit C, 1997, J IMMUNOL, V159, P4848; Rodewald HR, 1998, NATURE, V396, P630, DOI 10.1038/25251; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; SCOLLAY R, 1982, J IMMUNOL, V128, P1566; SCOLLAY R, 1984, J IMMUNOL, V132, P25; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; STUTMAN O, 1978, IMMUNOL REV, V42, P138, DOI 10.1111/j.1600-065X.1978.tb00261.x; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Suzuki I, 2000, J IMMUNOL, V165, P5537, DOI 10.4049/jimmunol.165.10.5537; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	45	236	240	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					418	425		10.1038/ni1049	http://dx.doi.org/10.1038/ni1049			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	14991052				2022-12-18	WOS:000220515900015
J	Penninger, JM; Irie-Sasaki, J; Sasaki, T; Oliveira-dos-Santos, AJ				Penninger, JM; Irie-Sasaki, J; Sasaki, T; Oliveira-dos-Santos, AJ			CD45: new jobs for an old acquaintance	NATURE IMMUNOLOGY			English	Review							T-CELL ACTIVATION; TYROSINE-PHOSPHATASE CD45; LEUKOCYTE-COMMON ANTIGEN; SEVERE COMBINED IMMUNODEFICIENCY; NEGATIVE REGULATION; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; PROTEIN-KINASE; CD45-ASSOCIATED PROTEIN; MICROGLIAL ACTIVATION	Identified as the first and prototypic transmembrane protein tyrosine phosphatase (PTPase), CD45 has been extensively studied for over two decades and is thought to be important for positively regulating antigen-receptor signaling via the dephosphorylation of Src kinases, However, new evidence indicates that CD45 can function as a Janus kinase PTPase that negatively controls cytokine-receptor signaling. A point mutation in CD45, which appears to affect CD45 dimerization, and a genetic polymorphism that affects alternative CD45 splicing are implicated in autoimmunity in mice and multiple sclerosis in humans. CD45 is expressed in multiple isoforms and the modulation of specific CD45 splice variants with antibodies can prevent transplant rejections. In addition, loss of CD45 can affect microglia activation in a mouse model for Alzheimer's disease. Thus, CD45 is moving rapidly back into the spotlight as a drug target and central regulator involved in differentiation of multiple hematopoietic cell lineages, autoimmunity and antiviral immunity.	Univ Hlth Network, Princess Margaret Hosp, Amgen Res Inst, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Penninger, JM (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68; Auersvald LA, 1997, TRANSPLANTATION, V63, P1355, DOI 10.1097/00007890-199705150-00026; AUTERO M, 1994, MOL CELL BIOL, V14, P1308, DOI 10.1128/MCB.14.2.1308; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Basadonna GP, 1998, P NATL ACAD SCI USA, V95, P3821, DOI 10.1073/pnas.95.7.3821; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; BERGER SA, 1994, J EXP MED, V180, P471, DOI 10.1084/jem.180.2.471; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bruyns E, 1995, J BIOL CHEM, V270, P31372; Bruyns E, 1998, INT IMMUNOL, V10, P185, DOI 10.1093/intimm/10.2.185; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Campbell GS, 1997, J BIOL CHEM, V272, P2591, DOI 10.1074/jbc.272.5.2591; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; D'Oro U, 1999, J IMMUNOL, V162, P1879; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Ding I, 1999, EUR J IMMUNOL, V29, P3956, DOI 10.1002/(SICI)1521-4141(199912)29:12<3956::AID-IMMU3956>3.3.CO;2-7; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eriksson O., 1983, SYSTEMA ASCOMYCETUM, V2, P1; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Felberg J, 1998, J BIOL CHEM, V273, P17839, DOI 10.1074/jbc.273.28.17839; Fialkow L, 1997, J IMMUNOL, V158, P5409; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; HOVIS RR, 1993, SCIENCE, V260, P544, DOI 10.1126/science.8475387; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ishikawa H, 2000, LEUKEMIA LYMPHOMA, V39, P51, DOI 10.3109/10428190009053538; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; JOHNSON P, 2001, MOD ASP IMMUNOLBIOL, V1, P147; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; Kung C, 1999, EUR J IMMUNOL, V29, P3951, DOI 10.1002/(SICI)1521-4141(199912)29:12<3951::AID-IMMU3951>3.0.CO;2-9; Kung C, 2000, NAT MED, V6, P343; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsuda A, 1998, J EXP MED, V187, P1863, DOI 10.1084/jem.187.11.1863; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MURRAY KA, 1990, COMPUT SYST SCI ENG, V5, P13; Neidhart M, 1996, SCHWEIZ MED WSCHR, V126, P1922; Ng DHW, 1996, J BIOL CHEM, V271, P1295, DOI 10.1074/jbc.271.3.1295; Ozdemirli M, 1996, CANCER, V77, P79, DOI 10.1002/(SICI)1097-0142(19960101)77:1<79::AID-CNCR14>3.0.CO;2-5; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; RALPH SJ, 1987, EMBO J, V6, P1251, DOI 10.1002/j.1460-2075.1987.tb02361.x; Ratei R, 1998, ANN HEMATOL, V77, P107, DOI 10.1007/s002770050424; RENNO T, 1994, INT IMMUNOL, V6, P347, DOI 10.1093/intimm/6.3.347; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SCHRAVEN B, 1994, J BIOL CHEM, V269, P29102; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; SEMPE P, 1993, INT IMMUNOL, V5, P479, DOI 10.1093/intimm/5.5.479; SGROI D, 1993, J BIOL CHEM, V268, P7011; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Socha P, 2001, IMMUNOL LETT, V75, P179, DOI 10.1016/S0165-2478(00)00305-9; Sperling AI, 1998, J IMMUNOL, V161, P6459; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; Starliper CE, 1997, J AQUAT ANIM HEALTH, V9, P1, DOI 10.1577/1548-8667(1997)009&lt;0001:VORSTS&gt;2.3.CO;2; STOVER DR, 1994, MOL CELL BIOL, V14, P5523, DOI 10.1128/MCB.14.8.5523; STOVER DR, 1991, P NATL ACAD SCI USA, V88, P7704, DOI 10.1073/pnas.88.17.7704; Symons A, 2000, GLYCOBIOLOGY, V10, P559, DOI 10.1093/glycob/10.6.559; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Tan J, 2000, J BIOL CHEM, V275, P37224, DOI 10.1074/jbc.M002006200; Tan J, 2000, J NEUROSCI, V20, P7587; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; TURKA LA, 1992, EUR J IMMUNOL, V22, P551, DOI 10.1002/eji.1830220238; UITTENBOGAART C H, 1990, International Immunology, V2, P1179, DOI 10.1093/intimm/2.12.1179; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; VOLAREVIC S, 1993, SCIENCE, V260, P541, DOI 10.1126/science.8475386; VOLAREVIC S, 1990, P NATL ACAD SCI USA, V87, P7085, DOI 10.1073/pnas.87.18.7085; WALLACE VA, 1992, J EXP MED, V176, P1657, DOI 10.1084/jem.176.6.1657; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang Y, 1999, J BIOL CHEM, V274, P7454, DOI 10.1074/jbc.274.11.7454; Yamada H, 1996, J IMMUNOL, V157, P1523; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang Z, 2000, TRANSPLANTATION, V69, P1137, DOI 10.1097/00007890-200003270-00019	102	236	247	2	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					389	396		10.1038/87687	http://dx.doi.org/10.1038/87687			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323691				2022-12-18	WOS:000168549800010
J	Heath, WR; Carbone, FR				Heath, William R.; Carbone, Francis R.			The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells	NATURE IMMUNOLOGY			English	Review							LYMPHOID STRESS-SURVEILLANCE; LANGERHANS CELLS; ANTIGEN-PRESENTATION; GENITAL HERPES; HAIR FOLLICLE; RETINOIC-ACID; SELF-ANTIGENS; RM CELLS; GAMMA; RECEPTOR	The skin is a highly complex organ interspersed with a variety of smaller organ-like structures and a plethora of cell types that together perform essential functions such as physical sensing, temperature control, barrier maintenance and immunity. In this Review, we outline many of the innate and adaptive immune cell types associated with the skin, focusing on the steady state in mice and men, and include a broad update of dendritic cell function and T cell surveillance.	[Heath, William R.; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	wrheath@unimelb.edu.au; fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Heath, William/0000-0001-9670-259X	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by the Australian Research Council (W. R. H.) and the National Health and Medical Research Council of Australia (W. R. H. and F.R.C.).	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Batista MD, 2013, EXP DERMATOL, V22, P64, DOI 10.1111/exd.12060; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Boismenu R, 1996, J IMMUNOL, V157, P985; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Cohn L, 1999, J IMMUNOL, V162, P6178; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Igyarto BZ, 2013, CURR OPIN IMMUNOL, V25, P115, DOI 10.1016/j.coi.2012.11.007; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; MATSUE H, 1993, J INVEST DERMATOL, V101, P537, DOI 10.1111/1523-1747.ep12365917; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Philip NH, 2013, IMMUNOL CELL BIOL, V91, P225, DOI 10.1038/icb.2013.2; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Segura E, 2010, MOL IMMUNOL, V47, P1765, DOI 10.1016/j.molimm.2010.02.028; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Ye SK, 2001, J IMMUNOL, V167, P1929, DOI 10.4049/jimmunol.167.4.1929; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	115	235	239	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					978	985		10.1038/ni.2680	http://dx.doi.org/10.1038/ni.2680			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048119				2022-12-18	WOS:000324584700002
J	Wang, C; Chen, TY; Zhang, J; Yang, MJ; Li, N; Xu, XF; Cao, XT				Wang, Chen; Chen, Taoyong; Zhang, Jia; Yang, Mingjin; Li, Nan; Xu, Xiongfei; Cao, Xuetao			The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon	NATURE IMMUNOLOGY			English	Article							TUMOR-SUPPRESSOR CYLD; KAPPA-B ACTIVATION; ANTIVIRAL RESPONSES; SIGNALING PATHWAYS; IMMUNE-RESPONSES; ADAPTER PROTEIN; ENZYME A20; RIG-I; KINASE; IKK	E3 ubiquitin ligases are important in both innate and adaptive immunity. Here we report that Nrdp1, an E3 ubiquitin ligase, inhibited the production of proinflammatory cytokines but increased interferon-beta production in Toll-like receptor-triggered macrophages by suppressing adaptor MyD88-dependent activation of transcription factors NF-kappa B and AP-1 while promoting activation of the kinase TBK1 and transcription factor IRF3. Nrdp1 directly bound and polyubiquitinated MyD88 and TBK1, which led to degradation of MyD88 and activation of TBK1. Knockdown of Nrdp1 inhibited the degradation of MyD88 and the activation of TBK1 and IRF3. Nrdp1-transgenic mice showed resistance to lipopolysaccharide-induced endotoxin shock and to infection with vesicular stomatitis virus. Our data suggest that Nrdp1 functions as both an adaptor protein and an E3 unbiquitin ligase to regulate TLR responses in different ways.	[Wang, Chen; Chen, Taoyong; Zhang, Jia; Yang, Mingjin; Li, Nan; Xu, Xiongfei; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Wang, Chen; Chen, Taoyong; Zhang, Jia; Yang, Mingjin; Li, Nan; Xu, Xiongfei; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@public3.sta.net.cn	Chen, Taoyong/U-1735-2017	Chen, Taoyong/0000-0002-2507-0027; Xu, Xiongfei/0000-0001-9532-4582				Abdullah JM, 2001, BLOOD CELL MOL DIS, V27, P320, DOI 10.1006/bcmd.2001.0390; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Ciavarra RP, 2005, VIROLOGY, V342, P177, DOI 10.1016/j.virol.2005.07.031; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	45	235	260	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					744	U100		10.1038/ni.1742	http://dx.doi.org/10.1038/ni.1742			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19483718				2022-12-18	WOS:000267142600014
J	Schoenborn, JR; Dorschner, MO; Sekimata, M; Santer, DM; Shnyreva, M; Fitzpatrick, DR; Stamatoyonnapoulos, JA; Wilson, CB				Schoenborn, Jamie R.; Dorschner, Michael O.; Sekimata, Masayuki; Santer, Deanna M.; Shnyreva, Maria; Fitzpatrick, David R.; Stamatoyonnapoulos, John A.; Wilson, Christopher B.			Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma	NATURE IMMUNOLOGY			English	Article							HELPER-CELL-DIFFERENTIATION; IFN-GAMMA; T-BET; INTERLEUKIN (IL)-22; HISTONE ACETYLATION; CUTTING EDGE; EXPRESSION; CHROMATIN; CYTOKINE; T(H)1	Unlike the well defined T helper type 2 cytokine locus, little is known about the regulatory elements that govern the expression of Ifng, which encodes the 'signature' T helper type 1 cytokine interferon-gamma. Here our evolutionary analysis showed that the mouse Ifng locus diverged from the ancestral locus as a result of structural rearrangements producing deletion of the neighboring gene encoding interleukin 26 and disrupting synteny 57 kilobases upstream of Ifng. Proximal to that disruption, we identified by high-resolution mapping many regions with CD4(+) T cell subset-specific epigenetic modifications. A subset of those regions represented enhancers, whereas others blocked the activity of upstream enhancers or insulated Ifng from neighboring chromatin. Our findings suggest that proper expression of Ifng is maintained through the collective action of multiple distal regulatory elements present in a region of about 100 kilobases flanking Ifng.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wilson, CB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	cbwilson@u.washington.edu		Santer, Deanna/0000-0001-6169-7735	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018184, R37HD018184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071272] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009537, CA009537, T32 CA009537-18, T32 CA009537-17] Funding Source: Medline; NIAID NIH HHS [AI071272, R01 AI071272-07, R01 AI071272, R01 AI071272-06A1] Funding Source: Medline; NICHD NIH HHS [R01 HD018184-24, R01 HD018184, R01 HD018184-25, R01 HD018184-27, HD18184, R01 HD018184-26] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; YOUNG HA, 1989, J IMMUNOL, V143, P2389; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	50	235	239	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					732	742		10.1038/ni1474	http://dx.doi.org/10.1038/ni1474			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17546033	Green Accepted			2022-12-18	WOS:000247718100014
J	Xiang, Z; Cutler, AJ; Brownlie, RJ; Fairfax, K; Lawlor, KE; Severinson, E; Walker, EU; Manz, RA; Tarlinton, DM; Smith, KGC				Xiang, Zou; Cutler, Antony J.; Brownlie, Rebecca J.; Fairfax, Kirsten; Lawlor, Kate E.; Severinson, Eva; Walker, Elizabeth U.; Manz, Rudolf A.; Tarlinton, David M.; Smith, Kenneth G. C.			Fc gamma RIIb controls bone marrow plasma cell persistence and apoptosis	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEMORY B-CELLS; ANTIBODY-FORMING-CELLS; GERMINAL CENTER; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSE; RECEPTOR EXPRESSION; PROMOTER HAPLOTYPE; MULTIPLE-MYELOMA; HUMORAL IMMUNITY	The survival of long-lived plasma cells, which produce most serum immunoglobulin, is central to humoral immunity. We found here that the inhibitory Fc receptor Fc gamma RIIb was expressed on plasma cells and controlled their persistence in the bone marrow. Crosslinking Fc gamma RIIb induced apoptosis of plasma cells, which we propose contributes to the control of their homeostasis and suggests a method for therapeutic deletion. Plasma cells from mice prone to systemic lupus erythematosus did not express Fc gamma RIIb and were protected from apoptosis. Human plasmablasts expressed Fc gamma RIIb and were killed by crosslinking, as were Fc gamma RIIb-expressing myeloma cells. Our results suggest that Fc gamma RIIb controls bone marrow plasma cell persistence and that defects in it may contribute to autoantibody production.	Univ Cambridge, Cambridge Inst Med Res, Sch Clin Med, Addenbrookes Hosp, Cambridge, England; Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge, England; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; German Arthritis Res Ctr, D-10117 Berlin, Germany; Wenner Gren Inst, Div Immunol, SE-10691 Stockholm, Sweden	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Smith, KGC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Sch Clin Med, Addenbrookes Hosp, Cambridge, England.	kgcs2@cam.ac.uk	Manz, Rudolf A/C-8340-2011	Tarlinton, David/0000-0001-9928-686X; Xiang, Zou/0000-0003-3925-0296; Fairfax, Kirsten/0000-0002-8394-137X; Cutler, Antony/0000-0002-9617-9994; Lawlor, Kate/0000-0003-0471-6842; Brownlie, Rebecca/0000-0003-4897-1044; Smith, Kenneth/0000-0003-3829-4326	Wellcome Trust [06754AIA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blank MC, 2005, HUM GENET, V117, P220, DOI 10.1007/s00439-005-1302-3; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Callanan MB, 2000, P NATL ACAD SCI USA, V97, P309, DOI 10.1073/pnas.97.1.309; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; DILOSA RM, 1991, J IMMUNOL, V146, P4071; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; HAMILTON MS, 1990, BRIT J HAEMATOL, V75, P378, DOI 10.1111/j.1365-2141.1990.tb04352.x; HAMILTON MS, 1991, BRIT J HAEMATOL, V78, P60, DOI 10.1111/j.1365-2141.1991.tb04383.x; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; HOLMES MC, 1963, ANN INTERN MED, V59, P265, DOI 10.7326/0003-4819-59-3-265; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Hunt D.J., 1998, INT J NEMATOLOGY, V7, P190; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; MCMILLAN R, 1972, J IMMUNOL, V109, P1386; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ries LA, 2002, SEER CANC STAT REV 1; Rudge EU, 2002, J EXP MED, V195, P1079, DOI 10.1084/jem.20011435; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 2006, ARTHRITIS RHEUM-US, V54, P2970, DOI 10.1002/art.22046; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Su KH, 2004, J IMMUNOL, V172, P7186, DOI 10.4049/jimmunol.172.11.7186; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Tsuchiya N, 2005, AUTOIMMUNITY, V38, P347, DOI 10.1080/08916930500123926; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Tzeng SJ, 2005, J BIOL CHEM, V280, P35247, DOI 10.1074/jbc.M505308200; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16	59	235	246	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					419	429		10.1038/ni1440	http://dx.doi.org/10.1038/ni1440			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17322888				2022-12-18	WOS:000245075900017
J	Liu, NS; Ohnishi, N; Ni, L; Akira, SZ; Bacon, KB				Liu, NS; Ohnishi, N; Ni, L; Akira, SZ; Bacon, KB			CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; TOLL-LIKE RECEPTORS; BACTERIAL-DNA; INTERFERON-GAMMA; IN-VITRO; OLIGODEOXYNUCLEOTIDES; MOTIFS; MURINE; GENE; INTERLEUKIN-12	CpG DNA has immunomodulatory effects, such as the suppression of allergic responses mediated by type II T cell help (T(H)2). Here we report that CpG, but not lipopolysaccharide (LPS), rapidly induces expression of T-bet mRNA in purified B cells. Upregulation of T-bet by CpG is abrogated in mice deficient in Toll-like receptor 9 (TLR9) and MyD88, but remains intact in B cells deficient in STAT1 (signal transducer and activator of transcription 1). Interleukin 12 (IL-12) alone does not up-regulate T-bet mRNA, but greatly enhances CpG-induced T-bet expression. Furthermore, CpG inhibits immunoglobulin G1 (IgG1) and IgE switching induced by IL-4 and CD40 signaling in purified B cells, and this effect correlates with up-regulation of T-bet. Thus, CpG triggers anti-allergic immune responses by directly regulating T-bet expression via a signaling pathway in B cells that is dependent upon TLR9, independent of interferon-gamma (IFN-gamma)-STAT1 and synergistic with IL-12.	Bayer Yakuhin Ltd, Res Ctr Kyoto, Kizu, Kyoto 6190216, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Bayer AG; Osaka University	Liu, NS (corresponding author), Bayer Yakuhin Ltd, Res Ctr Kyoto, 6-5-1-3 Kunimidai, Kizu, Kyoto 6190216, Japan.		Akira, Shizuo/C-3134-2009					Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; Ballas ZK, 1996, J IMMUNOL, V157, P1840; Bohle B, 2001, J IMMUNOL, V166, P3743, DOI 10.4049/jimmunol.166.6.3743; Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO;2-R; CHIMUSHI T, 2002, P JAP SOC IMMUNOL, V32, P238; Choudhury BK, 2002, J IMMUNOL, V169, P5955, DOI 10.4049/jimmunol.169.10.5955; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Fujieda S, 2000, AM J RESP CRIT CARE, V162, P232, DOI 10.1164/ajrccm.162.1.9906136; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kline JN, 1998, J IMMUNOL, V160, P2555; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Linehan LA, 1998, J IMMUNOL, V161, P302; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Modlin RL, 2002, ANN ALLERG ASTHMA IM, V88, P543, DOI 10.1016/S1081-1206(10)61883-2; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; Parronchi P, 1999, J IMMUNOL, V163, P5946; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Stacey KJ, 1996, J IMMUNOL, V157, P2116; Sur S, 1999, J IMMUNOL, V162, P6284; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; TOKUNAGA T, 1988, JPN J CANCER RES, V79, P682, DOI 10.1111/j.1349-7006.1988.tb02222.x; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wild JS, 2001, ALLERGY, V56, P365, DOI 10.1034/j.1398-9995.2001.056005365.x; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yi AK, 1996, J IMMUNOL, V156, P558	40	235	249	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					687	693		10.1038/ni941	http://dx.doi.org/10.1038/ni941			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12766768				2022-12-18	WOS:000183952500017
J	Wu, CY; Kirman, JR; Rotte, MJ; Davey, DF; Perfetto, SP; Rhee, EG; Freidag, BL; Hill, BJ; Douek, DC; Seder, RA				Wu, CY; Kirman, JR; Rotte, MJ; Davey, DF; Perfetto, SP; Rhee, EG; Freidag, BL; Hill, BJ; Douek, DC; Seder, RA			Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo	NATURE IMMUNOLOGY			English	Article							CD4 T-CELLS; IN-VIVO; CYTOKINE EXPRESSION; TRANSCRIPTION FACTOR; GAMMA PRODUCTION; TH1; LYMPHOCYTES; IL-12; ANTIGEN; INTERLEUKIN-12	We studied here the long-term maintenance of distinct populations of T helper type 1 (THI)-lineage cells in vivo and found that effector THI cells, defined by their secretion of interferon-gamma (IFN-gamma), are short-lived and do not efficiently develop into long-term memory THI cells. In contrast, a population of activated THI-lineage cells that did not secrete IFN-gamma after primary antigenic stimulation persisted for several months in vivo and developed the capacity to secrete IFN-gamma upon subsequent stimulation. These data suggest that a linear differentiation pathway, as defined by the transition from IFN-gamma-producing to resting memory cells, is relatively limited in vivo and support a revised model for THI memory differentiation.	NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Immunotechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Seder, RA (corresponding author), NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.			Kirman, Joanna/0000-0002-4802-7048; Rotte, Masashi/0000-0001-6088-4248				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahmadzadeh M, 2001, J IMMUNOL, V166, P926, DOI 10.4049/jimmunol.166.2.926; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Harbertson J, 2002, J IMMUNOL, V168, P1095, DOI 10.4049/jimmunol.168.3.1095; Hayashi N, 2002, P NATL ACAD SCI USA, V99, P6187, DOI 10.1073/pnas.092129899; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hong K, 2001, J IMMUNOL, V166, P4765, DOI 10.4049/jimmunol.166.7.4765; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mendel I, 2002, J NEUROIMMUNOL, V122, P65, DOI 10.1016/S0165-5728(01)00465-9; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scheffold A, 1998, EUR CYTOKINE NETW, V9, P5; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tarrant TK, 1998, J IMMUNOL, V161, P122; Trinchieri G, 1998, IMMUNOL RES, V17, P269, DOI 10.1007/BF02786451; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	50	235	253	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					852	858		10.1038/ni832	http://dx.doi.org/10.1038/ni832			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12172546				2022-12-18	WOS:000177694900014
J	De Rosa, V; Galgani, M; Porcellini, A; Colamatteo, A; Santopaolo, M; Zuchegna, C; Romano, A; De Simone, S; Procaccini, C; La Rocca, C; Carrieri, PB; Maniscalco, GT; Salvetti, M; Buscarinu, MC; Franzese, A; Mozzillo, E; La Cava, A; Matarese, G				De Rosa, Veronica; Galgani, Mario; Porcellini, Antonio; Colamatteo, Alessandra; Santopaolo, Marianna; Zuchegna, Candida; Romano, Antonella; De Simone, Salvatore; Procaccini, Claudio; La Rocca, Claudia; Carrieri, Pietro Biagio; Maniscalco, Giorgia Teresa; Salvetti, Marco; Buscarinu, Maria Chiara; Franzese, Adriana; Mozzillo, Enza; La Cava, Antonio; Matarese, Giuseppe			Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants	NATURE IMMUNOLOGY			English	Article							ALPHA-ENOLASE; IN-VIVO; EFFECTOR FUNCTION; DIFFERENTIATION; ACTIVATION; GENERATION; TOLERANCE; EXPANSION; MTOR; IDENTIFICATION	Human regulatory T cells (T-reg cells) that develop from conventional T cells (T-conv cells) cells) following suboptimal stimulation via the T cell antigen receptor (TCR) (induced T-reg cells ( iT(reg) cells)) express the transcription factor Foxp3, are suppressive, and display an active proliferative and metabolic state. Here we found that the induction and suppressive function of iT(reg) cells tightly depended on glycolysis, which controlled FOXP3 splicing variants containing exon 2 (Foxp3-E2) through the glycolytic enzyme enolase-1. The Foxp3-E2 related suppressive activity of iT(reg) cells was altered in human autoimmune diseases, including multiple sclerosis and type 1 diabetes, and was associated with impaired glycolysis and signaling via interleukin 2. This link between glycolysis and Foxp3-E2 variants via enolase-1 shows a previously unknown mechanism for controlling the induction and function of T-reg cells in health and in autoimmunity.	[De Rosa, Veronica; Galgani, Mario; De Simone, Salvatore; Procaccini, Claudio; La Rocca, Claudia] CNR, Immunol Lab, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [De Rosa, Veronica; Colamatteo, Alessandra] Fdn Santa Lucia, Unita NeuroImmunol, Rome, Italy; [Porcellini, Antonio; Zuchegna, Candida; Romano, Antonella] Univ Naples Federico II, Complesso Univ Monte St Angelo, Dipartimento Biol, Naples, Italy; [Colamatteo, Alessandra; Matarese, Giuseppe] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy; [Santopaolo, Marianna] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Carrieri, Pietro Biagio] Univ Naples Federico II, Dipartimento Neurosci & Sci Riprod & Odontostomat, Naples, Italy; [Maniscalco, Giorgia Teresa] Azienda Osped A Cardarelli, Ctr Reg Sclerosi Multiple, Dipartimento Neurol, Naples, Italy; [Salvetti, Marco; Buscarinu, Maria Chiara] Univ Roma La Sapienza, Ctr Neurol Terapie Sperimentali, Dipartimento Neurosci Salute Mentale & Organi Sen, I-00185 Rome, Italy; [Franzese, Adriana; Mozzillo, Enza] Univ Naples Federico II, Dipartimento Sci Med Traslaz, Naples, Italy; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Matarese, Giuseppe] Ist Ricovero & Cura Carattere Sci MultiMed, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Santa Lucia; University of Naples Federico II; University of Salerno; University of Naples Federico II; University of Naples Federico II; Antonio Cardarelli Hospital; Sapienza University Rome; University of Naples Federico II; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Matarese, G (corresponding author), Univ Salerno, Dipartimento Med & Chirurg, Baronissi Campus, I-84100 Salerno, Italy.	gmatarese@unisa.it	Buscarinu, Maria Chiara/K-3040-2016; De Rosa, Veronica/K-6534-2016; Matarese, Giuseppe/AAO-4077-2021; Porcellini, Antonio/AAC-6097-2019; Galgani, Mario/AAC-3298-2022; Salvetti, Marco/K-3836-2016; Procaccini, Claudio/AAB-3696-2019; Mozzillo, Enza/AAD-8437-2019; La Rocca, Claudia/AAB-2095-2022; Porcellini, Antonio/E-1900-2011; /AAG-9576-2020	Buscarinu, Maria Chiara/0000-0002-4839-1528; De Rosa, Veronica/0000-0002-9477-0991; Matarese, Giuseppe/0000-0001-9429-0616; Porcellini, Antonio/0000-0001-6882-9518; /0000-0002-8839-0933; La Rocca, Claudia/0000-0002-2003-887X; Galgani, Mario/0000-0001-8414-1676; MOZZILLO, ENZA/0000-0002-8437-8494; Zuchegna, Candida/0000-0002-8494-8602; PROCACCINI, CLAUDIO/0000-0002-2184-0442	European Union IDEAS Programme European Research Council ("menTORingTregs") [310496]; Fondazione Italiana Sclerosi Multipla [2012/R/11, 2014/R/21]; Consiglio Nazionale delle Ricerche-Medicina Personalizzata; Ministero della Salute [GR-2010-2315414]; Fondo per gli Investimenti della Ricerca di Base [RBFR12I3UB_004]; Juvenile Diabetes Research Foundation [1-PNF-2015-115-S-B]; US National Institutes of Health [AI109677]; PhD Program in Medicina Traslazionale dello Sviluppo e dell'Invecchiamento Attivo, Universita degli Studi di Salerno; PhD Program in Medicina Molecolare e Biotecnologie Mediche; PhD Program in Biologia, Universita degli Studi di Napoli "Federico II"; "Fondazione Umberto Veronesi", Milano; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109677] Funding Source: NIH RePORTER	European Union IDEAS Programme European Research Council ("menTORingTregs"); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Consiglio Nazionale delle Ricerche-Medicina Personalizzata(Consiglio Nazionale delle Ricerche (CNR)); Ministero della Salute(Ministry of Health, Italy); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhD Program in Medicina Traslazionale dello Sviluppo e dell'Invecchiamento Attivo, Universita degli Studi di Salerno; PhD Program in Medicina Molecolare e Biotecnologie Mediche; PhD Program in Biologia, Universita degli Studi di Napoli "Federico II"; "Fondazione Umberto Veronesi", Milano(Fondazione Umberto Veronesi); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M.R. Montagna for technical support, and all members of the Laboratory of Immunology at Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche for assistance and support. Supported by the European Union IDEAS Programme European Research Council ("menTORingTregs" 310496 to G.M.), the Fondazione Italiana Sclerosi Multipla (2012/R/11 to G.M.), the Consiglio Nazionale delle Ricerche-Medicina Personalizzata (G.M.), the Ministero della Salute (GR-2010-2315414 to V.D.R.), the Fondo per gli Investimenti della Ricerca di Base (RBFR12I3UB_004 to V.D.R.), the Fondazione Italiana Sclerosi Multipla (2014/R/21 to V.D.R.), the Juvenile Diabetes Research Foundation (1-PNF-2015-115-S-B to M.G.), the US National Institutes of Health (AI109677 to A.L.C.), the PhD Program in Medicina Traslazionale dello Sviluppo e dell'Invecchiamento Attivo, Universita degli Studi di Salerno (A.C.), the PhD Program in Medicina Molecolare e Biotecnologie Mediche (M.S.), the PhD Program in Biologia, Universita degli Studi di Napoli "Federico II" (A.R.) and the "Fondazione Umberto Veronesi", Milano (C.Z.).	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Carneiro-Sampaio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00185; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Goldstein JD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00155; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Kaur G, 2010, MOL IMMUNOL, V48, P321, DOI 10.1016/j.molimm.2010.07.008; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Magg T, 2012, EUR J IMMUNOL, V42, P1627, DOI 10.1002/eji.201141838; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang WY, 2005, J ENDOCRINOL, V184, P85, DOI 10.1677/joe.1.05909; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	42	234	242	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1174	1184		10.1038/ni.3269	http://dx.doi.org/10.1038/ni.3269			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26414764	Green Accepted			2022-12-18	WOS:000363096000011
J	Brown, EM; Sadarangani, M; Finlay, BB				Brown, Eric M.; Sadarangani, Manish; Finlay, B. Brett			The role of the immune system in governing host-microbe interactions in the intestine	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; PATTERN-RECOGNITION RECEPTORS; CD103(+) DENDRITIC CELLS; LECTIN REGIII-GAMMA; GUT MICROBIOTA; INNATE IMMUNITY; MAINTAIN HOMEOSTASIS; COMMENSAL MICROBIOTA; ADAPTIVE IMMUNITY; MUCUS LAYERS	The mammalian intestinal tract harbors a diverse community of trillions of microorganisms, which have co-evolved with the host immune system for millions of years. Many of these microorganisms perform functions critical for host physiology, but the host must remain vigilant to control the microbial community so that the symbiotic nature of the relationship is maintained. To facilitate homeostasis, the immune system ensures that the diverse microbial load is tolerated and anatomically contained, while remaining responsive to microbial breaches and invasion. Although the microbiota is required for intestinal immune development, immune responses also regulate the structure and composition of the intestinal microbiota. Here we discuss recent advances in our understanding of these complex interactions and their implications for human health and disease.	[Brown, Eric M.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Brown, Eric M.; Sadarangani, Manish; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Sadarangani, Manish] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Sadarangani, Manish] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; [Sadarangani, Manish] Univ Oxford, Dept Pediat, Oxford, England; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Oxford; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bfinlay@msl.ubc.ca	Sadarangani, Manish/V-5609-2019	Sadarangani, Manish/0000-0002-9985-6452	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank M. Wlodarska, L. Reynolds and N. Gill for the critical revision of this manuscript and thoughtful insights. The Finlay laboratory is supported by operating grants from Canadian Institutes of Health Research.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ellis CL, 2011, JAIDS-J ACQ IMM DEF, V57, P363, DOI 10.1097/QAI.0b013e31821a603c; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Foussat A, 2003, J IMMUNOL, V171, P5018, DOI 10.4049/jimmunol.171.10.5018; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gill N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049646; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Knoop KA, 2013, CURR OPIN GASTROEN, V29, P112, DOI 10.1097/MOG.0b013e32835cf1cd; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Malamut G, 2010, AM J GASTROENTEROL, V105, P2262, DOI 10.1038/ajg.2010.214; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Mannon PJ, 2006, GASTROENTEROLOGY, V131, P748, DOI 10.1053/j.gastro.2006.06.022; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Mestecky J, 2009, IMMUNOL LETT, V124, P57, DOI 10.1016/j.imlet.2009.03.013; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; PODOLSKY DK, 1993, J BIOL CHEM, V268, P6694; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Saxena D, 2012, CURR HIV-AIDS REP, V9, P44, DOI 10.1007/s11904-011-0103-7; Scamurra RW, 2002, J IMMUNOL, V169, P4008, DOI 10.4049/jimmunol.169.7.4008; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Willing BP, 2010, GUT MICROBES, V1, P213, DOI 10.4161/gmic.1.4.12520; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	106	234	251	2	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					660	667		10.1038/ni.2611	http://dx.doi.org/10.1038/ni.2611			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778793				2022-12-18	WOS:000320509100004
J	Dinarello, C; Arend, W; Sims, J; Smith, D; Blumberg, H; O'Neill, L; Goldbach-Mansky, R; Pizarro, T; Hoffman, H; Bufler, P; Nold, M; Ghezzi, P; Mantovani, A; Garlanda, C; Boraschi, D; Rubartelli, A; Netea, M; van der Meer, J; Joosten, L; Mandrup-Poulsen, T; Donath, M; Lewis, E; Pfeilschifter, J; Martin, M; Kracht, M; Muehl, H; Novick, D; Lukic, M; Conti, B; Solinger, A; Peyman, K; van de Veerdonk, F; Gabel, C				Dinarello, Charles; Arend, William; Sims, John; Smith, Dirk; Blumberg, Hal; O'Neill, Luke; Goldbach-Mansky, Raphaela; Pizarro, Theresa; Hoffman, H.; Bufler, Philip; Nold, Marcel; Ghezzi, Pietro; Mantovani, Alberto; Garlanda, Cecilia; Boraschi, Diana; Rubartelli, Anna; Netea, Mihai; van der Meer, Jos; Joosten, Leo; Mandrup-Poulsen, Tom; Donath, Marc; Lewis, Eli; Pfeilschifter, Josef; Martin, Michael; Kracht, Michael; Muehl, H.; Novick, Daniela; Lukic, Miodrag; Conti, Bruno; Solinger, Alan; Peyman, Kelk; van de Veerdonk, Frank; Gabel, Chiristopher			IL-1 family nomenclature	NATURE IMMUNOLOGY			English	Letter							NF-KAPPA-B; INTERLEUKIN-1 FAMILY; MEMBERS; IDENTIFICATION		[Dinarello, Charles] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Arend, William] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO USA; [Blumberg, Hal] Novo Nordisk Inflammat Res Ctr, Dept Cellular Immunol, Seattle, WA USA; [O'Neill, Luke] Trinity Coll Dublin, Dept Biochem, Dublin, Ireland; [Goldbach-Mansky, Raphaela] Natl Inst Hlth, Natl Inst Arthrit, Translat Autoinflammatory Dis Sect, Bethesda, MD USA; [Pizarro, Theresa] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hoffman, H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Bufler, Philip] Univ Munich, Dept Pediat, Munich, Germany; [Nold, Marcel] Monash Univ, Monash Inst Med Res, Melbourne, Australia; [Ghezzi, Pietro] Brighton & Sussex Med Sch, Div Clin & Lab Investigat, Falmer, England; [Mantovani, Alberto; Garlanda, Cecilia] Ist Clin Humanitas, Dept Inflammat, Milan, Italy; [Boraschi, Diana] Inst Biomed Technol, Immunol Unit, Natl Res Council, Pisa, Italy; [Rubartelli, Anna] Natl Inst Canc Res, Genoa, Italy; [Netea, Mihai; van der Meer, Jos] Radboud Univ Nijmegen Med Ctr, Dept Med, Nijmegen, Netherlands; [Joosten, Leo] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Mandrup-Poulsen, Tom] Steno Diabet Ctr, Copenhagen, Denmark; [Donath, Marc] Univ Basel Hosp, Dept Diabet Endocrinol & Metab, CH-4031 Basel, Switzerland; [Lewis, Eli] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Pfeilschifter, Josef] Goethe Univ Frankfurt, Frankfurt, Germany; [Martin, Michael] Justus Liebig Univ, Dept Biol & Chem, Giessen, Germany; [Kracht, Michael] Justus Liebig Univ, Rudolf Buchheim Inst Pharmacol, Giessen, Germany; [Muehl, H.] Univ Hosp Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Frankfurt, Germany; [Novick, Daniela] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Lukic, Miodrag] United Arab Emirates Univ, Dept Microbiol & Immunol, Al Ain, U Arab Emirates; [Conti, Bruno] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA; [Solinger, Alan] XOMA, Berkeley, CA USA; [Peyman, Kelk] Umea Univ, Umea, Sweden; [van de Veerdonk, Frank] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Novo Nordisk; Trinity College Dublin; National Institutes of Health (NIH) - USA; Case Western Reserve University; University of California System; University of California San Diego; University of Munich; Monash University; University of Brighton; University of Sussex; IRCCS Humanitas Research Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Genoa; IRCCS AOU San Martino IST; Radboud University Nijmegen; Radboud University Nijmegen; Steno Diabetes Center; University of Basel; Ben Gurion University; Goethe University Frankfurt; Justus Liebig University Giessen; Justus Liebig University Giessen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Weizmann Institute of Science; United Arab Emirates University; Scripps Research Institute; Umea University; Radboud University Nijmegen	Dinarello, C (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.		Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008; Lukic, Miodrag/U-8848-2019; Garlanda, Cecilia/K-4601-2016; Joosten, Leo AB/H-3138-2015; Dinarello, Charles/C-8524-2013; Mantovani, Alberto/HCI-7449-2022; Rubartelli, Anna/AAA-1259-2021; van der Meer, Jos W.M./C-8521-2013; Goldbach-Mansky, Raphaela/N-5917-2017; LEWIS, ELI C/F-1552-2012; Boraschi, Diana/AAA-7171-2020	van de Veerdonk, Frank L/0000-0002-1121-4894; Garlanda, Cecilia/0000-0002-1510-7703; Joosten, Leo AB/0000-0001-6166-9830; Mantovani, Alberto/0000-0001-5578-236X; van der Meer, Jos W.M./0000-0001-5120-3690; LEWIS, ELI C/0000-0002-4189-2207; Boraschi, Diana/0000-0002-3953-4056; Bufler, Philip/0000-0002-5742-8273; Kracht, Michael/0000-0002-8501-043X; O'Neill, Luke/0000-0002-4333-2748; Kelk, Peyman/0000-0003-1594-1738; Conti, Bruno/0000-0002-9185-5201; Lukic, Miodrag/0000-0002-3563-632X; Nold, Marcel/0000-0001-9682-4618; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Ghezzi, Pietro/0000-0003-0911-8358	Intramural NIH HHS [ZIA AR041138-11] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Busfield SJ, 2000, GENOMICS, V66, P213, DOI 10.1006/geno.2000.6184; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; VANASSELDONK, OBESITY, DOI DOI 10.1038/OBY.2010.55	16	234	258	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					973	973		10.1038/ni1110-973	http://dx.doi.org/10.1038/ni1110-973			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959797	Green Accepted			2022-12-18	WOS:000283127800002
J	He, B; Santamaria, R; Xu, WF; Cols, M; Chen, K; Puga, I; Shan, MM; Xiong, HB; Bussel, JB; Chiu, A; Puel, A; Reichenbach, J; Marodi, L; Doffinger, R; Vasconcelos, J; Issekutz, A; Krause, J; Davies, G; Li, XX; Grimbacher, B; Plebani, A; Meffre, E; Picard, C; Cunningham-Rundles, C; Casanova, JL; Cerutti, A				He, Bing; Santamaria, Raul; Xu, Weifeng; Cols, Montserrat; Chen, Kang; Puga, Irene; Shan, Meimei; Xiong, Huabao; Bussel, James B.; Chiu, April; Puel, Anne; Reichenbach, Jeanine; Marodi, Laszlo; Doeffinger, Rainer; Vasconcelos, Julia; Issekutz, Andrew; Krause, Jens; Davies, Graham; Li, Xiaoxia; Grimbacher, Bodo; Plebani, Alessandro; Meffre, Eric; Picard, Capucine; Cunningham-Rundles, Charlotte; Casanova, Jean-Laurent; Cerutti, Andrea			The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88	NATURE IMMUNOLOGY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; NF-KAPPA-B; PYOGENIC BACTERIAL-INFECTIONS; BAFF-R; RECEPTOR; IGA; APRIL; MUTATIONS; PATHWAY; LIGAND	BAFF and APRIL are innate immune mediators that trigger immunoglobulin G (IgG) and IgA class-switch recombination (CSR) in B cells by engaging the receptor TACI. The mechanism that underlies CSR signaling by TACI remains unknown. Here we found that the cytoplasmic domain of TACI encompasses a conserved motif that bound MyD88, an adaptor that activates transcription factor NF-kappa B signaling pathways via a Toll-interleukin 1 (IL-1) receptor (TIR) domain. TACI lacks a TIR domain, yet triggered CSR via the DNA-editing enzyme AID by activating NF-kappa B through a Toll-like receptor (TLR)-like MyD88-IRAK1-IRAK4-TRAF6-TAK1 pathway. TACI-induced CSR was impaired in mice and humans lacking MyD88 or the kinase IRAK4, which indicates that MyD88 controls a B cell-intrinsic, TIR-independent, TACI-dependent pathway for immunoglobulin diversification.	[He, Bing; Xu, Weifeng; Cols, Montserrat; Chen, Kang; Shan, Meimei; Xiong, Huabao; Cunningham-Rundles, Charlotte; Cerutti, Andrea] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Santamaria, Raul; Puga, Irene; Cerutti, Andrea] Hosp Mar, Inst Municipal Invest Med, Barcelona, Spain; [Bussel, James B.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Chiu, April] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puel, Anne; Picard, Capucine; Casanova, Jean-Laurent] Inst Natl Sante & Rech Med, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Puel, Anne; Picard, Capucine; Casanova, Jean-Laurent] Necker Enfants Malades, Sch Med, Paris, France; [Puel, Anne; Picard, Capucine; Casanova, Jean-Laurent] Paris Descartes Univ, Fac Med, Paris, France; [Reichenbach, Jeanine] Univ Childrens Hosp Zurich, Div Immunol Hematol Bone Marrow Transplantat, Zurich, Switzerland; [Marodi, Laszlo] Univ Debrecen, Dep Infect & Pediat Immunol, Med & Hlth Sci Ctr, Debrecen, Hungary; [Doeffinger, Rainer] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England; [Vasconcelos, Julia] Gen Hosp Santo Antonio, Dept Immunol, Oporto, Portugal; [Issekutz, Andrew] Izaak Walton Killam Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Krause, Jens] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Davies, Graham] Great Ormond St Hosp Sick Children, Infect Dis Unit, Natl Hlth Serv Trust, London WC1N 3JH, England; [Li, Xiaoxia] Lerner Res Inst, Dept Immunol, Cleveland, OH USA; [Grimbacher, Bodo] Royal Free Hosp, London NW3 2QG, England; [Grimbacher, Bodo] UCL, London, England; [Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Mol Med Inst A Nocivelli, Brescia, Italy; [Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, Lab Human Genet Infect Dis, New York, NY 10021 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies, Barcelona, Spain	Icahn School of Medicine at Mount Sinai; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; University of Debrecen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Dalhousie University; Vanderbilt University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cleveland Clinic Foundation; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Brescia; University of Brescia; Yale University; Rockefeller University; ICREA	Cerutti, A (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	acerutti@imim.es	Puel, Anne/H-7305-2017; Xu, Weifeng/I-7662-2019; Picard, Capucine/H-3914-2017; Plebani, Alessandro/C-8593-2011; Casanova, Jean-Laurent/I-3418-2017; Cols, Montserrat/J-3387-2013; Reichenbach, Janine/U-2171-2018; Marodi, Laszlo/AAU-9915-2020	Puel, Anne/0000-0003-2603-0323; Xu, Weifeng/0000-0001-7598-1489; Picard, Capucine/0000-0001-8788-5056; Cols, Montserrat/0000-0001-6578-8378; Reichenbach, Janine/0000-0002-9008-1312; Puga, Irene/0000-0003-2208-3196; Cerutti, Andrea/0000-0003-3026-4704; Casanova, Jean-Laurent/0000-0002-7782-4169	US National Institutes of Health [R01 AI-05753, R01 AI-074378, S10RR09145]; Catalan Institute for Research and Advanced Studies; Fundacio Institut Municipal d'Investigacio Medica; Ministerio de Ciencia e Innovacion [SAF 2008-02725]; Irma T. Hirschl Charitable Trust; Comissionat per a Universitats i Recerca del Departament d'Innovacio; Universitats i Empresa de la Generalitat de Catalunya; Programa Juan de la Cierva; Fondazione C. Golgi and Centro Immunodeficienze Mario di Martino; TAMOP [4.2.2-08/1-2008-0015]; US National Institutes of Health-National Cancer Institute [5R24 CA095823]; National Science Foundation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074378, R01AI057653] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catalan Institute for Research and Advanced Studies; Fundacio Institut Municipal d'Investigacio Medica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Irma T. Hirschl Charitable Trust; Comissionat per a Universitats i Recerca del Departament d'Innovacio; Universitats i Empresa de la Generalitat de Catalunya(Generalitat de Catalunya); Programa Juan de la Cierva; Fondazione C. Golgi and Centro Immunodeficienze Mario di Martino; TAMOP; US National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	We thank S.Y. Zhang (University Paris Descartes) for peripheral blood mononuclear cells from patients deficient in the transmembrane protein Unc93b; S. Vogel and A. Medvedev (University of Maryland) for DN-IRAK4-C877T; J.D. Li (University of South California) for DN-IKK alpha(K44M) and DN-IKK beta(K49A); J. Jun Ninomiya-Tsuji (Lerner Research Institute) for DN-TAK1(K63W); Z. Cao (Tularik) for DN-IRAK1 (1-208); and the Mount Sinai School of Medicine Microscopy Shared Resource Facility. Supported by the US National Institutes of Health (R01 AI-05753 and R01 AI-074378 to A. Cerutti and S10RR09145), Catalan Institute for Research and Advanced Studies (A. Cerutti), Fundacio Institut Municipal d'Investigacio Medica (A. Cerutti), Ministerio de Ciencia e Innovacion (SAF 2008-02725 to A. Cerutti), The Irma T. Hirschl Charitable Trust (A. Cerutti), Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya (R.S.), Programa Juan de la Cierva (I.P.), Fondazione C. Golgi and Centro Immunodeficienze Mario di Martino (A. Plebani), TAMOP (4.2.2-08/1-2008-0015 to L. M.), the US National Institutes of Health-National Cancer Institute (5R24 CA095823) and the National Science Foundation (DBI-9724504).	Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Cerutti A, 1998, J IMMUNOL, V160, P2145; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Cunningham-Rundles C, 2008, J CLIN IMMUNOL, V28, pS42, DOI 10.1007/s10875-008-9182-7; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Garibyan L, 2007, J CLIN INVEST, V117, P1550, DOI 10.1172/JCI31023; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	54	234	239	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					836	U94		10.1038/ni.1914	http://dx.doi.org/10.1038/ni.1914			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20676093	Green Accepted			2022-12-18	WOS:000281115500012
J	Terme, M; Ullrich, E; Delahaye, NF; Chaput, N; Zitvogel, L				Terme, Magali; Ullrich, Evelyn; Delahaye, Nicolas F.; Chaput, Nathalie; Zitvogel, Laurence			Natural killer cell-directed therapies: moving from unexpected results to successful strategies	NATURE IMMUNOLOGY			English	Review							PERIPHERAL-BLOOD LYMPHOCYTES; IMMUNOGLOBULIN-LIKE RECEPTOR; KIR LIGAND INCOMPATIBILITY; REGULATORY T-CELLS; HEPATITIS-C-VIRUS; PHASE-I TRIAL; ANTI-CD16/CD30 BISPECIFIC ANTIBODY; UNRELATED DONOR TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA	Natural killer (NK) cells influence innate and adaptive immune host defenses. Existing data indicate that manipulating the balance between inhibitory and activating NK receptor signals, the sensitivity of target cells to NK cell-mediated apoptosis, and NK cell cross-talk with dendritic cells might hold therapeutic promise. Efforts to modulate NK cell trafficking into inflamed tissues and/or lymph nodes, and to counteract NK cell suppressors, might also prove fruitful in the clinic. However, deeper investigation into the benefits of combination therapy, greater understanding of the functional distinctions between NK cell subsets, and design of new tools to monitor NK cell activity are needed to strengthen our ability to harness the power of NK cells for therapeutic aims.	[Terme, Magali; Ullrich, Evelyn; Delahaye, Nicolas F.; Chaput, Nathalie; Zitvogel, Laurence] Inst Gustave Roussy, INSERM, U805, Ctr Invest Clin BT 507, F-94805 Villejuif, France; [Zitvogel, Laurence] Univ Paris Sud, Fac Med, F-94276 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Zitvogel, L (corresponding author), Inst Gustave Roussy, INSERM, U805, Ctr Invest Clin BT 507, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	zitvogel@igr.fr	TERME, Magali/GZK-9661-2022	TERME, Magali/0000-0003-0857-7237; Ullrich, Evelyn/0000-0001-8530-1192; ZITVOGEL, laurence/0000-0003-1596-0998				Albertsson PA, 2003, TRENDS IMMUNOL, V24, P603, DOI 10.1016/j.it.2003.09.007; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Berdeja JG, 2007, CLIN CANCER RES, V13, P2392, DOI 10.1158/1078-0432.CCR-06-1860; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bonmort M, 2007, BIOCHIMIE, V89, P872, DOI 10.1016/j.biochi.2007.04.014; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandau S, 2001, INT J CANCER, V92, P697, DOI 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z; Brune M, 2006, BLOOD, V108, P88, DOI 10.1182/blood-2005-10-4073; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bukowski RM, 1997, CANCER-AM CANCER SOC, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Burns LJ, 2003, BONE MARROW TRANSPL, V32, P177, DOI 10.1038/sj.bmt.1704086; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chang CC, 2005, ADV CANCER RES, V93, P189, DOI 10.1016/S0065-230X(05)93006-6; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chen H, 2005, BIOL BLOOD MARROW TR, V11, P85, DOI 10.1016/j.bbmt.2004.12.252; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooley S, 2005, BLOOD, V106, P4370, DOI 10.1182/blood-2005-04-1644; Daniel D, 2007, BLOOD, V110, P4037, DOI 10.1182/blood-2007-02-076075; Davies FE, 2001, BLOOD, V98, P210, DOI 10.1182/blood.V98.1.210; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; de Castro FA, 2003, LEUKEMIA LYMPHOMA, V44, P2061, DOI 10.1080/1042819031000110973; Delahaye NF, 2007, MICROBES INFECT, V9, P160, DOI 10.1016/j.micinf.2006.11.002; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Farag SS, 2006, BIOL BLOOD MARROW TR, V12, P876, DOI 10.1016/j.bbmt.2006.05.007; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; Gluck WL, 2004, CLIN CANCER RES, V10, P2253, DOI 10.1158/1078-0432.CCR-1087-3; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; Gollob JA, 2003, J CLIN ONCOL, V21, P2564, DOI 10.1200/JCO.2003.12.119; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hartmann F, 2001, CLIN CANCER RES, V7, P1873; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hayashi T, 2006, CANCER RES, V66, P563, DOI 10.1158/0008-5472.CAN-05-2776; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Kammula US, 1998, CANCER, V83, P797, DOI 10.1002/(SICI)1097-0142(19980815)83:4<797::AID-CNCR25>3.3.CO;2-2; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khan KD, 2006, CLIN CANCER RES, V12, P7046, DOI 10.1158/1078-0432.CCR-06-1571; Kim MH, 2000, J IMMUNOL, V164, P5883, DOI 10.4049/jimmunol.164.11.5883; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Klingemann HG, 2005, CYTOTHERAPY, V7, P16, DOI 10.1080/14653240510018000; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Link BK, 2006, J IMMUNOTHER, V29, P558, DOI 10.1097/01.cji.0000211304.60126.8f; Liu RL, 2006, J IMMUNOL, V176, P5247, DOI 10.4049/jimmunol.176.9.5247; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; LOTZE MT, 1986, IMMUNOBIOLOGY, V172, P420, DOI 10.1016/S0171-2985(86)80122-X; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Mazzaferro V, 2003, CLIN CANCER RES, V9, P3235; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Meropol NJ, 1998, CANCER IMMUNOL IMMUN, V46, P318; MESERI A, 1991, BRIT J HAEMATOL, V78, P585, DOI 10.1111/j.1365-2141.1991.tb04502.x; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Parihar R, 2004, CLIN CANCER RES, V10, P5027, DOI 10.1158/1078-0432.CCR-04-0265; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Passweg JR, 2004, LEUKEMIA, V18, P1835, DOI 10.1038/sj.leu.2403524; Pilla L, 2006, CANCER IMMUNOL IMMUN, V55, P958, DOI 10.1007/s00262-005-0084-8; Pilla L, 2005, CANCER RES, V65, P3942, DOI 10.1158/0008-5472.CAN-04-3493; Renner C, 2000, CANCER IMMUNOL IMMUN, V49, P173, DOI 10.1007/s002620050617; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Robertson MJ, 1999, CLIN CANCER RES, V5, P9; Rodella L, 2001, BRIT J HAEMATOL, V115, P442, DOI 10.1046/j.1365-2141.2001.03055.x; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; Sheridan C, 2006, NAT BIOTECHNOL, V24, P597, DOI 10.1038/nbt0606-597; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Taieb J, 2006, J IMMUNOL, V176, P2722, DOI 10.4049/jimmunol.176.5.2722; Ueda Y, 1999, HEPATO-GASTROENTEROL, V46, P1274; Uherek C, 2002, BLOOD, V100, P1265, DOI 10.1182/blood.V100.4.1265.h81602001265_1265_1273; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Vetter CS, 2004, BRIT J CANCER, V91, P1495, DOI 10.1038/sj.bjc.6602123; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; WHITESIDE TL, 1998, AM J MED, V105, P27, DOI DOI 10.1016/S0002-9343(98)00155-7; Zimmer J, 2001, TRENDS IMMUNOL, V22, P300, DOI 10.1016/S1471-4906(01)01923-8	120	234	246	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					486	494		10.1038/ni1580	http://dx.doi.org/10.1038/ni1580			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425105				2022-12-18	WOS:000255153500010
J	Tanaka, T; Grusby, MJ; Kaisho, T				Tanaka, Takashi; Grusby, Michael J.; Kaisho, Tsuneyasu			PDLIM2-mediated termination of transcription factor NF-kappa B activation by intranuclear sequestration and degradation of the p65 subunit	NATURE IMMUNOLOGY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; LIM DOMAIN PROTEIN; NUCLEAR-BODIES; E3 LIGASE; LOCALIZATION; BINDING; ACTIN; CYTOSKELETON; AGGRESOMES; EXPRESSION	Activation of transcription factor NF-kappa B in the innate immune system is tightly regulated to prevent excessive inflammatory responses. How NF-kappa B activation is terminated, however, is not fully understood. Here we report that PDLIM2 negatively regulated NF-kappa B activity, acting as a nuclear ubiquitin E3 ligase targeting the p65 subunit of NF-kappa B. PDLIM2 bound to p65 and promoted p65 polyubiquitination. In addition, PDLIM2 targeted p65 to discrete intranuclear compartments where polyubiquitinated p65 was degraded by the proteasome. PDLIM2 deficiency resulted in larger amounts of nuclear p65, defective p65 ubiquitination and augmented production of proinflammatory cytokines in response to innate stimuli. Our findings delineate a pathway by which PDLIM2 terminates NF-kappa B activation through intranuclear sequestration and subsequent degradation.	RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Yokohama, Kanagawa 2300045, Japan; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard T.H. Chan School of Public Health	Kaisho, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Yokohama, Kanagawa 2300045, Japan.	tkaisho@rcai.riken.jp	Tanaka, Takashi/O-8254-2015; Kaisho, Tsuneyasu/B-4130-2012		NIAID NIH HHS [AI506296] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chen M, 2005, ARTHRITIS RHEUM-US, V52, P877, DOI 10.1002/art.20962; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Fabunmi RP, 2001, J CELL SCI, V114, P29; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gettemans J, 2005, TRAFFIC, V6, P847, DOI 10.1111/j.1600-0854.2005.00326.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; von Mikecz A, 2005, AUTOIMMUN REV, V4, P214, DOI 10.1016/j.autrev.2004.11.006; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	46	234	244	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					584	591		10.1038/ni1464	http://dx.doi.org/10.1038/ni1464			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17468759				2022-12-18	WOS:000246703300012
J	Guenechea, G; Gan, OI; Dorrell, C; Dick, JE				Guenechea, G; Gan, OI; Dorrell, C; Dick, JE			Distinct classes of human stem cells that differ in proliferative and self-renewal potential	NATURE IMMUNOLOGY			English	Article							HUMAN HEMATOPOIETIC-CELLS; COMBINED IMMUNODEFICIENT MICE; FLUORESCENT PROTEIN GENE; LONG-TERM HEMATOPOIESIS; IMMUNE-DEFICIENT MICE; CORD BLOOD-CELLS; EX-VIVO CULTURE; BONE-MARROW; REPOPULATING CELLS; PERIPHERAL-BLOOD	The composition of the human hematopoietic stem cell compartment is poorly understood due to the absence of experimental tools with which to characterize the developmental program of individual stem cells. We report here that human stem cells differ markedly in their repopulation capacity and self-renewal potential, as determined using nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice transplanted with retrovirally transduced cord blood stem cells, called SCID-repopulating cells (SRCs). Clonal stem cell analysis based on the identification of unique retroviral integration sites within serial bone marrow aspirates showed that repopulation was generally oligoclonal with extensive variability in the lifespan and proliferative capacity of individual SRCs. Most clones contributed to human cell engraftment for several weeks after transplantation and then disappeared but others appeared later and persisted. Further evidence for stem cell heterogeneity was found in the secondary transplantation capacity of SRCs. These data point to the existence of different classes of human stem cells with variable self-renewal potential and short- or long-term repopulating capacity.	Hosp Sick Children, Program Canc, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Blood Res, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Gene Therapy, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Fdn Marcelino Botin, CIEMAT, Gene Therapy Program, Madrid, Spain	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Dick, JE (corresponding author), Hosp Sick Children, Program Canc, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Guenechea, Guillermo/L-6119-2014	Guenechea, Guillermo/0000-0001-7679-0895; Dick, John/0000-0002-9527-8317				Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Barquinero J, 2000, BLOOD, V95, P3085, DOI 10.1182/blood.V95.10.3085.010k01_3085_3093; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BRENNER MK, 1993, LANCET, V342, P1134, DOI 10.1016/0140-6736(93)92122-A; Cheng L, 1997, GENE THER, V4, P1013, DOI 10.1038/sj.gt.3300507; Conneally E, 1998, BLOOD, V91, P3487, DOI 10.1182/blood.V91.9.3487.3487_3487_3493; DEISSEROTH AB, 1994, BLOOD, V83, P3068, DOI 10.1182/blood.V83.10.3068.3068; Dick J E, 1996, Semin Immunol, V8, P197, DOI 10.1006/smim.1996.0025; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dorrell C, 2000, BLOOD, V95, P102; Drize N, 1997, BLOOD, V89, P1811, DOI 10.1182/blood.V89.5.1811.1811_1811_1817; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; DUNBAR CE, 1995, BLOOD, V85, P3048, DOI 10.1182/blood.V85.11.3048.bloodjournal85113048; Gan OI, 1999, EXP HEMATOL, V27, P1097, DOI 10.1016/S0301-472X(99)00037-5; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Guenechea G, 1999, BLOOD, V93, P1097, DOI 10.1182/blood.V93.3.1097.403k04_1097_1105; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KARNELREID S, 1988, SCIENCE, V242, P1706; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kim HJ, 2000, BLOOD, V96, P1; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; LERNISCHKA IR, 1986, CELL, V45, P917; Limon A, 1997, BLOOD, V90, P3316, DOI 10.1182/blood.V90.9.3316; Marandin A, 1998, HUM GENE THER, V9, P1497, DOI 10.1089/hum.1998.9.10-1497; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Pereira DS, 1998, P NATL ACAD SCI USA, V95, P8239, DOI 10.1073/pnas.95.14.8239; Rebel VI, 1999, BLOOD, V93, P2217, DOI 10.1182/blood.V93.7.2217.407a01_2217_2224; Schilz AJ, 1998, BLOOD, V92, P3163, DOI 10.1182/blood.V92.9.3163.421k25_3163_3171; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; van Hennik PB, 1998, BLOOD, V92, P4013, DOI 10.1182/blood.V92.11.4013.423k53_4013_4022; VORMOOR J, 1994, BLOOD, V83, P2489; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang YP, 1997, J BIOL CHEM, V272, P16216, DOI 10.1074/jbc.272.26.16216; ZIJLMANS JMJM, 1995, P NATL ACAD SCI USA, V92, P8901, DOI 10.1073/pnas.92.19.8901	45	233	247	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					75	82		10.1038/83199	http://dx.doi.org/10.1038/83199			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135582				2022-12-18	WOS:000166261500018
J	Braun, A; Worbs, T; Moschovakis, GL; Halle, S; Hoffmann, K; Bolter, J; Munk, A; Forster, R				Braun, Asolina; Worbs, Tim; Moschovakis, G. Leandros; Halle, Stephan; Hoffmann, Katharina; Boelter, Jasmin; Muenk, Anika; Foerster, Reinhold			Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; IN-VIVO; PERIPHERAL-TISSUES; LANGERHANS CELLS; EGRESS; TOLERANCE; DYNAMICS; ORGANS; MICE; SKIN	Little is known about the molecular mechanisms that determine the entry into the lymph node and intranodal positioning of lymph-derived cells. By injecting cells directly into afferent lymph vessels of popliteal lymph nodes, we demonstrate that lymph-derived T cells entered lymph-node parenchyma mainly from peripheral medullary sinuses, whereas dendritic cells (DCs) transmigrated through the floor of the subcapsular sinus on the afferent side. Transmigrating DCs induced local changes that allowed the concomitant entry of T cells at these sites. Signals mediated by the chemokine receptor CCR7 were absolutely required for the directional migration of both DCs and T cells into the T cell zone but were dispensable for the parenchymal entry of lymph-derived T cells and dendrite probing of DCs. Our findings provide insight into the molecular and structural requirements for the entry into lymph nodes and intranodal migration of lymph-derived cells of the immune system.	[Braun, Asolina; Worbs, Tim; Moschovakis, G. Leandros; Halle, Stephan; Hoffmann, Katharina; Boelter, Jasmin; Muenk, Anika; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany	Hannover Medical School	Forster, R (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011	Worbs, Tim/0000-0001-9945-3103; Halle, Stephan/0000-0002-7624-7005; Braun, Asolina/0000-0002-2646-5362; Forster, Reinhold/0000-0001-6190-7923	Deutsche Forschungsgemeinschaft [SFB566-A14, SFB587-B3, EXC62]; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank M. Herberg for animal care; E. Kremmer (Helmholtz Zentrum Munchen) for antibodies; and G. Bernhardt for discussions and comments on the manuscript. Supported by Deutsche Forschungsgemeinschaft (SFB566-A14, SFB587-B3 and EXC62, 'Rebirth', to R.F.) and Boehringer Ingelheim Fonds (A.B.).	Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bakocevic N, 2010, J IMMUNOL, V184, P1317, DOI 10.4049/jimmunol.0902277; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; CAHILL R, 1974, Haematologia, V8, P321; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Saeki H, 1999, J IMMUNOL, V162, P2472; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260	38	232	235	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					879	U8		10.1038/ni.2085	http://dx.doi.org/10.1038/ni.2085			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21841786				2022-12-18	WOS:000294461200012
J	Rebeaud, F; Hailfinger, S; Posevitz-Fejfar, A; Tapernoux, M; Moser, R; Rueda, D; Gaide, O; Guzzardi, M; Iancu, EM; Rufer, N; Fasel, N; Thome, M				Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Iancu, Emanuela M.; Rufer, Nathalie; Fasel, Nicolas; Thome, Margot			The proteolytic activity of the paracaspase MALT1 is key in T cell activation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LYMPHOCYTE DEVELOPMENT; ARABIDOPSIS-THALIANA; UBIQUITIN LIGASE; IKK ACTIVATION; CARMA1; BCL10; PHOSPHORYLATION; METACASPASES; PATHWAY	The paracaspase MALT1 is pivotal in antigen receptor-mediated lymphocyte activation and lymphomagenesis. MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active. Here we report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and we identify the signaling protein Bcl-10 as a MALT1 substrate. Processing of Bcl-10 after Arg228 was required for T cell receptor-induced cell adhesion to fibronectin. In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-kappa B and production of interleukin 2. Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.	[Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Fasel, Nicolas; Thome, Margot] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Iancu, Emanuela M.; Rufer, Nathalie] Univ Lausanne Hosp, Multidisciplinary Oncol Ctr, CH-1005 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Thome, M (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	margot.thomemiazza@unil.ch	Thome, Margot/F-8167-2011; Rueda, Daniel/I-1176-2015; Fasel, Nicolas/O-4253-2016	Thome, Margot/0000-0002-5656-2139; Rueda, Daniel/0000-0002-5377-8890; Fasel, Nicolas/0000-0003-0136-7245				ANDERSON NL, 1978, ANAL BIOCHEM, V85, P341, DOI 10.1016/0003-2697(78)90230-0; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chen C, 1999, J IMMUNOL, V162, P1084; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ferch U, 2007, NAT IMMUNOL, V8, P984, DOI 10.1038/ni1493; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; MOBLEY JL, 1994, BLOOD, V83, P1039, DOI 10.1182/blood.V83.4.1039.bloodjournal8341039; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Rueda D, 2007, J IMMUNOL, V178, P4373, DOI 10.4049/jimmunol.178.7.4373; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WEGENER E, 2007, SCI STKE, pPE21; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	46	232	249	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					272	281		10.1038/ni1568	http://dx.doi.org/10.1038/ni1568			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18264101				2022-12-18	WOS:000253406700013
J	Fang, DY; Liu, YC				Fang, DY; Liu, YC			Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASE SUBSTRATE; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; C-CBL; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; RING-TYPE; PROTEIN; ASSOCIATION; ACTIVATION	Cbl-b, a ring-type E3 ubiquitin protein ligase, is implicated in setting the threshold of T lymphocyte activation. The p85 regulatory subunit of phosphatidylinositol 3 kinase (PI3K) was identified as a substrate for Cbl.b. We have shown that Cbl-b negatively regulated p85 in a proteolysis-independent manner. Cbl-b is involved in the recruitment of p85 to CD28 and T cell antigen receptor through its E3 ubiquitin ligase activity. The enhanced activation of Cbl-b(-/-)T cells was suppressed by the inhibition of PI3K. The results suggest a proteolysis-independent function for Cbl.b in the modification of protein recruitment.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	yuncail@liai.org	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; LIU, YUN-CAI/0000-0002-0996-7109	NIDDK NIH HHS [R01DK56558] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056558] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; deAos I, 1997, J BIOL CHEM, V272, P25310, DOI 10.1074/jbc.272.40.25310; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; EXLEY M, 1994, J BIOL CHEM, V269, P15140; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HU P, 1994, MOL CELL BIOL, V14, P2577, DOI 10.1128/MCB.14.4.2577; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; KEANE MM, 1995, ONCOGENE, V10, P2367; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	37	232	246	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					870	875		10.1038/ni0901-870	http://dx.doi.org/10.1038/ni0901-870			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526404				2022-12-18	WOS:000170781200028
J	Neurath, MF				Neurath, Markus F.			Targeting immune cell circuits and trafficking in inflammatory bowel disease	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; CHRONIC INTESTINAL INFLAMMATION; INNATE LYMPHOID-CELLS; SEVERE CROHNS-DISEASE; GROWTH-FACTOR-BETA; ULCERATIVE-COLITIS; DOUBLE-BLIND; MAINTENANCE THERAPY; INDUCTION THERAPY; T-CELLS	Inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis are characterized by uncontrolled activation of intestinal immune cells in a genetically susceptible host. Due to the progressive and destructive nature of the inflammatory process in IBD, complications such as fibrosis, stenosis or cancer are frequently observed, which highlights the need for effective anti-inflammatory therapy. Studies have identified altered trafficking of immune cells and pathogenic immune cell circuits as crucial drivers of mucosal inflammation and tissue destruction in IBD. A defective gut barrier and microbial dysbiosis induce such accumulation and local activation of immune cells, which results in a pro-inflammatory cytokine loop that overrides anti-inflammatory signals and causes chronic intestinal inflammation. This Review discusses pathogenic cytokine responses of immune cells as well as immune cell trafficking as a rational basis for new translational therapies in IBD.	[Neurath, Markus F.] Friedrich Alexander Univ Erlangen Nurnberg, DZI, Dept Med 1, Med Res & Translat Res Ctr, Kussmaul Campus, Erlangen, Germany	University of Erlangen Nuremberg	Neurath, MF (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, DZI, Dept Med 1, Med Res & Translat Res Ctr, Kussmaul Campus, Erlangen, Germany.	markus.neurath@uk-erlangen.de			DFG [SFB1181, TRR241, FOR2438]; Interdisciplinary Centre for Clinical Research Erlangen; FAU Emerging Fields Initiative	DFG(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research Erlangen; FAU Emerging Fields Initiative	The research of M.F.N. was funded by the DFG (SFB1181, TRR241, FOR2438, SAOT graduate school), by the Interdisciplinary Centre for Clinical Research Erlangen and by the FAU Emerging Fields Initiative.	Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Aden K, 2016, CELL REP, V16, P2208, DOI 10.1016/j.celrep.2016.07.054; Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Atreya R, 2008, CURR DRUG TARGETS, V9, P369, DOI 10.2174/138945008784221116; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atreya R, 2018, LANCET GASTROENTEROL, V3, P790, DOI 10.1016/S2468-1253(18)30265-6; Atreya R, 2018, DIGEST LIVER DIS, V50, P1019, DOI 10.1016/j.dld.2018.06.010; Atreya R, 2014, NAT MED, V20, P313, DOI 10.1038/nm.3462; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Belarif L, 2019, J CLIN INVEST, V129, P1910, DOI 10.1172/JCI121668; Biancheri P, 2015, GASTROENTEROLOGY, V149, P1564, DOI 10.1053/j.gastro.2015.07.002; Bishu S, 2019, J CROHNS COLITIS, V13, P905, DOI 10.1093/ecco-jcc/jjz010; Braat H, 2003, EXPERT OPIN BIOL TH, V3, P725, DOI 10.1517/eobt.3.5.725.21237; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Brockmann L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07581-4; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434; Castro-Dopico T, 2019, IMMUNITY, V50, P1099, DOI 10.1016/j.immuni.2019.02.006; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chang SY, 2013, IMMUNITY, V38, P153, DOI 10.1016/j.immuni.2012.09.018; Chiriac MT, 2017, GASTROENTEROLOGY, V153, P123, DOI 10.1053/j.gastro.2017.03.015; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2009, INFLAMM BOWEL DIS, V15, P1308, DOI 10.1002/ibd.20956; COMINELLI F, 1990, J CLIN INVEST, V86, P972, DOI 10.1172/JCI114799; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Danese S, 2019, GUT, V68, P40, DOI 10.1136/gutjnl-2017-314562; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Dmitrieva-Posocco O., 2019, IMMUNITY, V50; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Feagan BG, 2015, ALIMENT PHARM THER, V42, P1170, DOI 10.1111/apt.13398; Feagan BG, 2018, GASTROENTEROLOGY, V154, P61, DOI 10.1053/j.gastro.2017.08.035; Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Greuter T, 2016, UNITED EUR GASTROENT, V4, P97, DOI 10.1177/2050640615593681; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanson ML, 2014, GASTROENTEROLOGY, V146, P210, DOI 10.1053/j.gastro.2013.09.060; He ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1223-4; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kotlarz D, 2018, NAT GENET, V50, P344, DOI 10.1038/s41588-018-0063-6; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kvedaraite E, 2016, GUT, V65, P1632, DOI 10.1136/gutjnl-2014-309014; Lamb CA, 2017, J CROHNS COLITIS, V11, P610, DOI 10.1093/ecco-jcc/jjw189; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Monteleone G, 2015, NEW ENGL J MED, V372, P1104, DOI 10.1056/NEJMoa1407250; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Naganuma M, 2018, GASTROENTEROLOGY, V154, P935, DOI 10.1053/j.gastro.2017.11.024; Nalleweg N, 2015, GUT, V64, P743, DOI 10.1136/gutjnl-2013-305947; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Neumann C, 2019, NAT IMMUNOL, V20, P471, DOI 10.1038/s41590-019-0316-2; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ngo VL, 2018, P NATL ACAD SCI USA, V115, pE5076, DOI 10.1073/pnas.1718902115; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ordas I, 2011, GUT, V60, P1754, DOI 10.1136/gutjnl-2011-300934; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Parkes M, 2012, DIGEST DIS, V30, P78, DOI 10.1159/000341130; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pelczar P, 2016, SCIENCE, V354, P358, DOI 10.1126/science.aah5903; Perrier C, 2013, INFLAMM BOWEL DIS, V19, P246, DOI 10.1002/ibd.23023; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pizarro TT, 1999, J IMMUNOL, V162, P6829; PODOLSKY DK, 1993, J CLIN INVEST, V92, P372, DOI 10.1172/JCI116575; Popp V, 2017, GASTROENTEROLOGY, V152, P176, DOI 10.1053/j.gastro.2016.09.005; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Russell SE, 2016, MUCOSAL IMMUNOL, V9, P1193, DOI 10.1038/mi.2015.134; Sandborn WJ, 2019, GASTROENTEROLOGY, V156, P946, DOI 10.1053/j.gastro.2018.11.035; Sandborn WJ, 2018, GUT, V67, P1824, DOI 10.1136/gutjnl-2016-313457; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sands BE, 2017, GASTROENTEROLOGY, V153, P77, DOI 10.1053/j.gastro.2017.03.049; Scheibe K, 2019, GASTROENTEROLOGY, V156, P1082, DOI 10.1053/j.gastro.2018.11.029; Scheibe K, 2017, GUT, V66, P823, DOI 10.1136/gutjnl-2015-310374; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schleier L, 2020, GUT, V69, P252, DOI 10.1136/gutjnl-2018-316772; Schmitt H, 2019, GUT, V68, P814, DOI 10.1136/gutjnl-2017-315671; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sugiura Toshihiko, 2013, J Crohns Colitis, V7, pe533, DOI 10.1016/j.crohns.2013.03.014; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tillack C, 2014, GUT, V63, P567, DOI 10.1136/gutjnl-2012-302853; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Uzzan M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau4711; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; van Deventer SJH, 2004, GUT, V53, P1646, DOI 10.1136/gut.2003.036160; Vermeire S, 2017, LANCET, V390, P135, DOI 10.1016/S0140-6736(17)30930-3; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Vermeire S, 2014, LANCET, V384, P309, DOI 10.1016/S0140-6736(14)60661-9; Voskens CJ, 2017, INFLAMM BOWEL DIS, V23, P348, DOI 10.1097/MIB.0000000000001192; Wang WQ, 2015, ACTA PHARMACOL SIN, V36, P1377, DOI 10.1038/aps.2015.51; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wirtz S, 2002, J IMMUNOL, V168, P411, DOI 10.4049/jimmunol.168.1.411; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Wyant T, 2013, MABS-AUSTIN, V5, P842, DOI 10.4161/mabs.26392; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yilmaz B, 2019, NAT MED, V25, P323, DOI 10.1038/s41591-018-0308-z; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zundler S, 2019, NAT IMMUNOL, V20, P288, DOI 10.1038/s41590-018-0298-5; Zundler S, 2017, GASTROENTEROLOGY, V153, P898, DOI 10.1053/j.gastro.2017.07.022; Zundler S, 2017, GUT, V66, P1936, DOI 10.1136/gutjnl-2016-312439; Zundler S, 2017, INFLAMM BOWEL DIS, V23, P379, DOI 10.1097/MIB.0000000000001029	147	231	235	19	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					970	979		10.1038/s41590-019-0415-0	http://dx.doi.org/10.1038/s41590-019-0415-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31235952				2022-12-18	WOS:000476621200012
J	Mascanfroni, ID; Yeste, A; Vieira, SM; Burns, EJ; Patel, B; Sloma, I; Wu, Y; Mayo, L; Ben-Hamo, R; Efroni, S; Kuchroo, VK; Robson, SC; Quintana, FJ				Mascanfroni, Ivan D.; Yeste, Ada; Vieira, Silvio M.; Burns, Evan J.; Patel, Bonny; Sloma, Ido; Wu, Yan; Mayo, Lior; Ben-Hamo, Rotem; Efroni, Sol; Kuchroo, Vijay K.; Robson, Simon C.; Quintana, Francisco J.			IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; GENE-EXPRESSION; INTERLEUKIN-27; INFLAMMATION; ANTIGEN; CNS; DIFFERENTIATION; ENCEPHALOMYELITIS; ACTIVATION; MECHANISMS	Dendritic cells (DCs) control the balance between effector T cells and regulatory T cells in vivo. Hence, the study of DCs might identify mechanisms of disease pathogenesis and guide new therapeutic approaches for disorders mediated by the immune system. We found that interleukin 27 (IL-27) signaling in mouse DCs limited the generation of effector cells of the T(H)1 and T(H)17 subsets of helper T cells and the development of experimental autoimmune encephalomyelitis (EAE). The effects of IL-27 were mediated at least in part through induction of the immunoregulatory molecule CD39 in DCs. IL-27-induced CD39 decreased the extracellular concentration of ATP and downregulated nucleotide-dependent activation of the NLRP3 inflammasome. Finally, therapeutic vaccination with IL-27-conditioned DCs suppressed established relapsing-remitting EAE. Thus, IL-27 signaling in DCs limited pathogenic T cell responses and the development of autoimmunity.	[Mascanfroni, Ivan D.; Yeste, Ada; Vieira, Silvio M.; Burns, Evan J.; Patel, Bonny; Mayo, Lior; Kuchroo, Vijay K.; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Sloma, Ido; Ben-Hamo, Rotem; Efroni, Sol] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Wu, Yan; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol & Hepatol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Bar Ilan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Robson, Simon C./AAA-8537-2021; m, Lior/AGK-3671-2022; Quintana, Francisco Javier/AAB-6915-2020; Vieira, Silvio Manfredo/T-8283-2019; Efroni, Sol/I-6752-2012	m, Lior/0000-0002-1296-6692; Efroni, Sol/0000-0001-7927-6349; Manfredo Vieira, Silvio/0000-0001-8036-4223	US National Institutes of Health [AI075285, AI093903]; National Multiple Sclerosis Society [RG4111A1]; NATIONAL CANCER INSTITUTE [R21CA164970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R00AI075285, R56AI093903, R01AI093903] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Sharpe (Harvard Medical School) for PD-L1 deficient mice; D.J. Pinsky (University of Michigan Health Systems) for the Entpd1 promoter reporter; and D. Frank (Dana-Farber Cancer Institute, Boston) for vectors encoding constitutively active STAT3 and STAT1. Supported by the US National Institutes of Health (AI075285 and AI093903 to F.J.Q.) and the National Multiple Sclerosis Society (RG4111A1 to F.J.Q.).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Farber K, 2008, GLIA, V56, P331, DOI 10.1002/glia.20606; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jahnisch H, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/517493; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matta BM, 2012, J IMMUNOL, V188, P5227, DOI 10.4049/jimmunol.1103382; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-1; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025	50	230	250	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1054	+		10.1038/ni.2695	http://dx.doi.org/10.1038/ni.2695			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23995234	Green Accepted			2022-12-18	WOS:000324584700014
J	Bromley, SK; Iaboni, A; Davis, SJ; Whitty, A; Green, JM; Shaw, AS; Weiss, A; Dustin, ML				Bromley, SK; Iaboni, A; Davis, SJ; Whitty, A; Green, JM; Shaw, AS; Weiss, A; Dustin, ML			The immunological synapse and CD28-CD80 interactions	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; NF-KAPPA-B; MONOCLONAL-ANTIBODIES; ANTIGEN RECOGNITION; LOW-AFFINITY; CD28; RECEPTOR; ADHESION; COSTIMULATION; EXPRESSION	According to the two-signal model of T cell activation, costimulatory molecules augment T cell receptor (TCR) signaling, whereas adhesion molecules enhance TCR-MHC-peptide recognition. The structure and binding properties of CD28 imply that it may perform both functions, blurring the distinction between adhesion and costimulatory molecules. Our results show that CD28 on naive T cells does not support adhesion and has little or no capacity for directly enhancing TCR-MHC-peptide interactions. Instead of being dependent on costimulatory signaling, we propose that a key function of the immunological synapse is to generate a cellular microenvironment that favors the interactions of potent secondary signaling molecules, such as CD28.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Univ Oxford, Nuffield Dept Med, Oxford, England; Biogen Inc, Cambridge, MA 02142 USA; NYU, Sch Med, Dept Pathol, New York, NY USA; NYU, Sch Med, Program Mol Pathogenesis, New York, NY USA; Skirball Inst Biomol Med, New York, NY USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); University of Oxford; Biogen; New York University; New York University	Dustin, ML (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.		Dustin, Michael/AAM-4611-2020; Iaboni, Andrea/I-7876-2016	Iaboni, Andrea/0000-0003-4268-6832; Dustin, Michael/0000-0003-4983-6389; Green, Jonathan/0000-0002-7449-4387; Shaw, Andrey/0000-0001-5685-0272				AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BABCOCK SK, 1987, TRANSPLANT P, V19, P303; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BERG LJ, 1988, MOL CELL BIOL, V8, P5459, DOI 10.1128/MCB.8.12.5459; Bischof A, 2000, EUR J IMMUNOL, V30, P876, DOI 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; COYNE KE, 1993, J BIOL CHEM, V268, P6689; Doty RT, 1996, J IMMUNOL, V157, P3270; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kaga S, 1998, J IMMUNOL, V160, P24; Kalli K, 1998, MOL CELL BIOL, V18, P3140, DOI 10.1128/MCB.18.6.3140; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; KRENSKY AM, 1983, J IMMUNOL, V131, P611; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LIU SJ, 1995, BIOPHYS J, V68, P459, DOI 10.1016/S0006-3495(95)80207-9; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; MCHUGH RS, 1995, P NATL ACAD SCI USA, V92, P8059, DOI 10.1073/pnas.92.17.8059; Michel F, 1996, CELL IMMUNOL, V173, P165, DOI 10.1006/cimm.1996.0264; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUNSON PJ, 1983, SCIENCE, V220, P979, DOI 10.1126/science.6302842; NUNES J, 1993, INT IMMUNOL, V5, P311, DOI 10.1093/intimm/5.3.311; OLIVE D, 1986, EUR J IMMUNOL, V16, P1063, DOI 10.1002/eji.1830160906; OZATO K, 1980, J IMMUNOL, V124, P533; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; TAKEI F, 1985, J IMMUNOL, V134, P1403; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WARREN TG, 1994, PROTEIN EXPRES PURIF, V5, P498, DOI 10.1006/prep.1994.1069; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251	58	230	245	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1159	1166		10.1038/ni737	http://dx.doi.org/10.1038/ni737			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11713465				2022-12-18	WOS:000172473200019
J	Ranzani, V; Rossetti, G; Panzeri, I; Arrigoni, A; Bonnal, RJP; Curti, S; Gruarin, P; Provasi, E; Sugliano, E; Marconi, M; De Francesco, R; Geginat, J; Bodega, B; Abrignani, S; Pagani, M				Ranzani, Valeria; Rossetti, Grazisa; Panzeri, Ilaria; Arrigoni, Alberto; Bonnal, Raoul J. P.; Curti, Serena; Gruarin, Paola; Provasi, Elena; Sugliano, Elisa; Marconi, Maurizio; De Francesco, Raffaele; Geginat, Jens; Bodega, Beatrice; Abrignani, Sergio; Pagani, Massimiliano			The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4	NATURE IMMUNOLOGY			English	Article							EXPRESSION; GENE; REVEALS; PROTEIN; COMMITMENT; ACTIVATION; PLASTICITY; MICRORNAS; GENOMICS	Long noncoding RNAs are emerging as important regulators of cellular functions, but little is known of their role in the human immune system. Here we investigated long intergenic noncoding RNAs (lincRNAs) in 13 subsets of T lymphocytes and B lymphocytes by next-generation sequencing-based RNA sequencing (RNA-seq analysis) and de novo transcriptome reconstruction. We identified over 500 previously unknown lincRNAs and described lincRNA signatures. Expression of linc-MAF-4, a chromatin-associated lincRNA specific to the T(H)1 subset of helper T cells, was inversely correlated with expression of MAF, a T(H)2-associated transcription factor. Downregulation of linc-MAF-4 skewed T cell differentiation toward the T(H)2 phenotype. We identified a long-distance interaction between the genomic regions of the gene encoding linc-MAF-4 and MAF, where linc-MAF-4 associated with the chromatin modifiers LSD1 and EZH2; this suggested that linc-MAF-4 regulated MAF transcription through the recruitment of chromatin modifiers. Our results demonstrate a key role for lincRNA in T lymphocyte differentiation.	[Ranzani, Valeria; Rossetti, Grazisa; Panzeri, Ilaria; Arrigoni, Alberto; Bonnal, Raoul J. P.; Curti, Serena; Gruarin, Paola; Provasi, Elena; Sugliano, Elisa; De Francesco, Raffaele; Geginat, Jens; Bodega, Beatrice; Abrignani, Sergio; Pagani, Massimiliano] Ist Nazl Genet Mol Romeo & Enrica Inverniz, Milan, Italy; [Marconi, Maurizio] IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Pagani, M (corresponding author), Ist Nazl Genet Mol Romeo & Enrica Inverniz, Milan, Italy.	abrignani@ingm.org; pagani@ingm.org	Geginat, Jens/AAA-5818-2019; Ranzani, Valeria/AAB-8258-2019; rossetti, grazisa/C-3722-2015; Bodega, Beatrice/I-4644-2018; De Francesco, Raffaele/J-6003-2012	Geginat, Jens/0000-0003-4813-0384; rossetti, grazisa/0000-0001-6361-311X; Bodega, Beatrice/0000-0003-0527-9234; De Francesco, Raffaele/0000-0001-8754-5123; Panzeri, Ilaria/0000-0002-4139-8591; Bonnal, Raoul/0000-0002-2123-6536; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	Il Consiglio Nazionale delle Ricerche-Il Ministero dell'Istuzione dell'Universita e della Ricerca (EPIGEN), Fondazione Cariplo [2013-0955]; Associazione Italiana per la Ricerca sul Cancro [IG2013-ID14596]; European Research Council [269022, 617978]; Fondazione Romeo ed Enrica Invernizzi	Il Consiglio Nazionale delle Ricerche-Il Ministero dell'Istuzione dell'Universita e della Ricerca (EPIGEN), Fondazione Cariplo; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); European Research Council(European Research Council (ERC)European Commission); Fondazione Romeo ed Enrica Invernizzi	We thank C. Cheroni for support in statistical analysis; M. Moro and M. C. Crosti for technical assistance with cell sorting; S. Biffo, D. Gabellini, P. Della Bona and A. Lanzavecchia for discussions and critical revision of the manuscript; B.J. Haas and A. Dobin for help with the integration of genome-guided Trinity with STAR aligner; the Istituto Nazionale Genetica Molecolare Bioinformatics Facility for support; and the Google Summer of Code Project for supporting C. Wheeler in the development of a plug-in used here for the open-source bioinformatics library BioRuby that adds support for the multiple-alignment format (https://github.com/csw/bioruby-maf). Supported by Il Consiglio Nazionale delle Ricerche-Il Ministero dell'Istuzione dell'Universita e della Ricerca (EPIGEN), Fondazione Cariplo (2013-0955), the Associazione Italiana per la Ricerca sul Cancro (IG2013-ID14596), the European Research Council (269022 to S.A.; 617978 to M.P.) and Fondazione Romeo ed Enrica Invernizzi.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bonnal RJP, 2012, BIOINFORMATICS, V28, P1035, DOI 10.1093/bioinformatics/bts080; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Hrdlickova B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0088-0; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Leroy A., 1987, RROD, DOI [10.1002/0471725382, DOI 10.1002/0471725382]; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pagani M, 2013, IMMUNOL REV, V253, P82, DOI 10.1111/imr.12055; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Sato K, 2011, J BIOL CHEM, V286, P14963, DOI 10.1074/jbc.M111.218867; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	229	252	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					318	U153		10.1038/ni.3093	http://dx.doi.org/10.1038/ni.3093			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25621826	Green Accepted, Green Submitted			2022-12-18	WOS:000349842100015
J	Pruenster, M; Mudde, L; Bombosi, P; Dimitrova, S; Zsak, M; Middleton, J; Richmond, A; Graham, GJ; Segerer, S; Nibbs, RJB; Rot, A				Pruenster, Monika; Mudde, Liesbeth; Bombosi, Paula; Dimitrova, Svetla; Zsak, Marion; Middleton, Jim; Richmond, Ann; Graham, Gerard J.; Segerer, Stephan; Nibbs, Robert J. B.; Rot, Antal			The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity	NATURE IMMUNOLOGY			English	Article							BLOOD-GROUP ANTIGEN; IN-VIVO; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; RHEUMATOID-ARTHRITIS; NEGATIVE INDIVIDUALS; UP-REGULATION; BONE-MARROW; DARC; D6	The Duffy antigen receptor for chemokines (DARC) belongs to a family of 'silent' heptahelical chemokine receptors that do not couple to G proteins and fail to transmit measurable intracellular signals. DARC binds most inflammatory chemokines and is prominently expressed on venular endothelial cells, where its function has remained contentious. Here we show that DARC, like other silent receptors, internalized chemokines but did not effectively scavenge them. Instead, DARC mediated chemokine transcytosis, which led to apical retention of intact chemokines and more leukocyte migration across monolayers expressing DARC. Mice overexpressing DARC on blood vessel endothelium had enhanced chemokine-induced leukocyte extravasation and contact-hypersensitivity reactions. Thus, interactions of chemokines with DARC support their activity on apposing leukocytes in vitro and in vivo.	[Pruenster, Monika; Mudde, Liesbeth; Bombosi, Paula; Dimitrova, Svetla; Zsak, Marion; Middleton, Jim; Rot, Antal] Novartis Inst BioMed Res, A-1230 Vienna, Austria; [Middleton, Jim] Keele Univ, Robert Jones & Agnes Hunt Orthopaed Hosp, Sch Med, Oswestry SY10 7AG, Shrops, England; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37232 USA; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA; [Graham, Gerard J.; Nibbs, Robert J. B.] Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Segerer, Stephan] Univ Munich, Med Poliklin, D-80337 Munich, Germany; [Segerer, Stephan] Univ Zurich, Clin Nephrol, CH-8091 Zurich, Switzerland	Novartis; Keele University; Vanderbilt University; Vanderbilt University; University of Glasgow; University of Munich; University of Zurich	Rot, A (corresponding author), Novartis Inst BioMed Res, A-1230 Vienna, Austria.	antal@gmx.net	Pruenster, Monika/AAV-4694-2020; Graham, Gerard/D-1240-2009; Richmond, Ann/A-3048-2014	Segerer, Stephan/0000-0002-1936-9719; Graham, Gerard/0000-0002-7801-204X; Rot, Antal/0000-0002-9730-6166; RICHMOND, ANN/0000-0002-9580-900X; Nibbs, Robert/0000-0002-8150-0044	European Union Sixth Framework Programme [LSHB-CT-2005-518167]; Deutsche Forschungsgemeinschaft [SE 888/4-1]; Else-Kroner Fresenius Stiftung; NATIONAL CANCER INSTITUTE [R01CA034590, P30CA068485] Funding Source: NIH RePORTER; Medical Research Council [G0401634] Funding Source: researchfish; MRC [G0401634] Funding Source: UKRI	European Union Sixth Framework Programme(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner Fresenius Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the European Union Sixth Framework Programme (LSHB-CT-2005-518167 to M. P., L. M., P. B., G. J. G. and A. Ro.), Deutsche Forschungsgemeinschaft ( SE 888/4-1 to S. S.) and the Else-Kroner Fresenius Stiftung ( to S. S.).	Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bruhl H, 2005, RHEUMATOLOGY, V44, P309, DOI 10.1093/rheumatology/keh485; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Chakera A, 2008, MOL PHARMACOL, V73, P1362, DOI 10.1124/mol.107.040915; Chaudhuri A, 1997, BLOOD, V89, P701, DOI 10.1182/blood.V89.2.701; Christopherson KW, 2002, J PHARMACOL EXP THER, V302, P290, DOI 10.1124/jpet.302.1.290; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Du JG, 2002, J LEUKOCYTE BIOL, V71, P141; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; Gardner L, 2006, ARTHRITIS RHEUM, V54, P2022, DOI 10.1002/art.21909; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Horton LW, 2007, CANCER RES, V67, P9791, DOI 10.1158/0008-5472.CAN-07-0246; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Hub E, 1998, AM J PATHOL, V152, P749; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jilma-Stohlawetz P, 2001, TRANSFUSION, V41, P378, DOI 10.1046/j.1537-2995.2001.41030378.x; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Lee JS, 2003, J HISTOCHEM CYTOCHEM, V51, P159, DOI 10.1177/002215540305100204; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Nibbs R, 2003, SEMIN IMMUNOL, V15, P287, DOI 10.1016/j.smim.2003.08.006; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Palframan RT, 1998, BLOOD, V91, P2240, DOI 10.1182/blood.V91.7.2240.2240_2240_2248; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Segerer S, 2000, KIDNEY INT, V58, P1546, DOI 10.1046/j.1523-1755.2000.00316.x; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Smith E, 2008, ARTHRITIS RHEUM, V58, P1968, DOI 10.1002/art.23545; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634	53	229	237	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					101	108		10.1038/ni.1675	http://dx.doi.org/10.1038/ni.1675			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19060902	Green Accepted			2022-12-18	WOS:000261788800017
J	Denzel, A; Maus, UA; Gomez, MR; Moll, C; Niedermeier, M; Winter, C; Maus, R; Hollingshead, S; Briles, DE; Kunz-Schughart, LA; Talke, Y; Mack, M				Denzel, Andrea; Maus, Ulrich A.; Gomez, Manuel Rodriguez; Moll, Cordula; Niedermeier, Marianne; Winter, Christine; Maus, Regina; Hollingshead, Susan; Briles, David E.; Kunz-Schughart, Leoni A.; Talke, Yvonne; Mack, Matthias			Basophils enhance immunological memory responses	NATURE IMMUNOLOGY			English	Article							MAST-CELL DEGRANULATION; ANTIGEN-CAPTURING CELLS; FC-GAMMA RIII; NON-T CELLS; ALLERGIC INFLAMMATION; PRODUCE INTERLEUKIN-4; HISTAMINE-RELEASE; EPSILON-RI; B-CELLS; IGE	The cellular basis of immunological memory remains a controversial issue. Here we show that basophils bound large amounts of intact antigens on their surface and were the main source of interleukins 6 and 4 in the spleen and bone marrow after restimulation with a soluble antigen. Depletion of basophils resulted in a much lower humoral memory response and greater susceptibility of immunized mice to sepsis induced by Streptococcus pneumoniae. Adoptive transfer of antigen-reactive basophils significantly increased specific antibody production, and activated basophils, together with CD4(+) T cells, profoundly enhanced B cell proliferation and immunoglobulin production. These basophil-dependent effects on B cells required interleukins 6 and 4 and increased the capacity of CD4(+) T cells to provide B cell help. Thus, basophils are important contributors to humoral memory immune responses.	[Denzel, Andrea; Gomez, Manuel Rodriguez; Moll, Cordula; Niedermeier, Marianne; Talke, Yvonne; Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med 2, D-93042 Regensburg, Germany; [Maus, Ulrich A.; Winter, Christine; Maus, Regina] Hannover Med Sch, Dept Pulm Med, Lab Expt Lung Res, D-30625 Hannover, Germany; [Hollingshead, Susan; Briles, David E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kunz-Schughart, Leoni A.] Univ Hosp Regensburg, Inst Pathol, D-93042 Regensburg, Germany	University of Regensburg; Hannover Medical School; University of Alabama System; University of Alabama Birmingham; University of Regensburg	Mack, M (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, D-93042 Regensburg, Germany.	matthias.mack@klinik.uni-regensburg.de		Kunz-Schughart, Leoni/0000-0003-3912-6594				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; GEISER T, 1993, J BIOL CHEM, V268, P15419; Gibbs BF, 2005, CLIN EXP MED, V5, P43, DOI 10.1007/s10238-005-0064-5; Gor DO, 2005, INFECT IMMUN, V73, P1304, DOI 10.1128/IAI.73.3.1304-1312.2005; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hessel EM, 2005, J EXP MED, V202, P1563, DOI 10.1084/jem.20050631; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Kita H, 1999, J IMMUNOL, V162, P6901; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LANGERMANN S, 1994, J EXP MED, V180, P2277, DOI 10.1084/jem.180.6.2277; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Matsuda T, 1989, Int Rev Immunol, V5, P97, DOI 10.3109/08830188909061976; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; PICCINNI MP, 1991, P NATL ACAD SCI USA, V88, P8656, DOI 10.1073/pnas.88.19.8656; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Swiatlo E, 2003, INFECT IMMUN, V71, P7149, DOI 10.1128/IAI.71.12.7149-7153.2003; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; VALENT P, 1989, P NATL ACAD SCI USA, V86, P5542, DOI 10.1073/pnas.86.14.5542; Winter C, 2007, J IMMUNOL, V178, P5828, DOI 10.4049/jimmunol.178.9.5828; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	50	229	242	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					733	742		10.1038/ni.1621	http://dx.doi.org/10.1038/ni.1621			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18516038				2022-12-18	WOS:000256904900010
J	Andoniou, CE; van Dommelen, SLH; Voigt, V; Andrews, DM; Brizard, G; Asselin-Paturel, C; Delale, T; Stacey, KJ; Trinchieri, G; Degli-Esposti, MA				Andoniou, CE; van Dommelen, SLH; Voigt, V; Andrews, DM; Brizard, G; Asselin-Paturel, C; Delale, T; Stacey, KJ; Trinchieri, G; Degli-Esposti, MA			Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity	NATURE IMMUNOLOGY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; COLONY-STIMULATING FACTOR; IFN-ALPHA-BETA; NK CELLS; NKG2D RECEPTOR; IN-VIVO; VIRAL-INFECTIONS; INTERFERON-ALPHA/BETA; CYTOKINE RESPONSES; TUMOR-IMMUNITY	Dendritic cells (DCs) regulate various aspects of innate immunity, including natural killer (NK) cell function. Here we define the mechanisms involved in DC - NK cell interactions during viral infection. NK cells were efficiently activated by murine cytomegalovirus ( MCMV) - infected CD11b(+) DCs. NK cell cytotoxicity required interferon-alpha and interactions between the NKG2D activating receptor and NKG2D ligand, whereas the production of interferon-gamma by NK cells relied mainly on DC-derived interleukin 18. Although Toll-like receptor 9 contributes to antiviral immunity, we found that signaling pathways independent of Toll-like receptor 9 were important in generating immune responses to MCMV, including the production of interferon-alpha and the induction of NK cell cytotoxicity. Notably, adoptive transfer of MCMV-activated CD11b(+) DCs resulted in improved control of MCMV infection, indicating that these cells participate in controlling viral replication in vivo.	Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Crawley, WA 6009, Australia; Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France; Univ Queensland, Inst Mol Biosci, Cooperat Res Ctr Chron Inflammatory Dis, Brisbane, Qld 4072, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; Merck & Company; Schering Plough Corporation; University of Queensland	Degli-Esposti, MA (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Crawley, WA 6009, Australia.	mariapia@cyllene.uwa.edu.au	BRIZARD, Geraldine/C-2845-2013; Degli-Esposti, Mariapia/H-9073-2014; Degli-Esposti, Mariapia/E-9529-2013; Trinchieri, Giorgio/F-9369-2015; Andoniou, Christopher/B-6296-2013	Trinchieri, Giorgio/0000-0001-5892-7464; Andoniou, Christopher/0000-0003-0566-3180; Stacey, Katryn/0000-0002-3992-7802; Brizard-Mandin, Geraldine/0000-0003-4593-3931; Degli-Esposti, Mariapia/0000-0002-7808-5935; Andrews, Dan/0000-0002-5896-7885	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLAN JE, 1984, ARCH VIROL, V81, P139, DOI 10.1007/BF01309303; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Hasan M, 2005, J VIROL, V79, P2920, DOI 10.1128/JVI.79.5.2920-2930.2005; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Krmpotic A, 2005, J EXP MED, V201, P211, DOI 10.1084/jem.20041617; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Lodoen MB, 2004, J EXP MED, V200, P1075, DOI 10.1084/jem.20040583; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Milone MC, 1998, J IMMUNOL, V161, P2391; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Scalzo AA, 2002, TRENDS MICROBIOL, V10, P470, DOI 10.1016/S0966-842X(02)02441-1; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sun J, 2005, J IMMUNOL, V174, P742, DOI 10.4049/jimmunol.174.2.742; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; TRINCHIERI G, 1978, J EXP MED, V147, P1299, DOI 10.1084/jem.147.5.1299; van Dommelen SLH, 2003, J VIROL, V77, P1877, DOI 10.1128/JVI.77.3.1877-1884.2003; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Yu Y, 2001, J IMMUNOL, V166, P1590, DOI 10.4049/jimmunol.166.3.1590	56	229	236	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1011	1019		10.1038/ni1244	http://dx.doi.org/10.1038/ni1244			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16142239				2022-12-18	WOS:000232027200020
J	Gonzalo, JA; Tian, J; Delaney, T; Corcoran, J; Rottman, JB; Lora, J; Al-garawi, A; Kroczek, R; Gutierrez-Ramos, JC; Coyle, AJ				Gonzalo, JA; Tian, J; Delaney, T; Corcoran, J; Rottman, JB; Lora, J; Al-garawi, A; Kroczek, R; Gutierrez-Ramos, JC; Coyle, AJ			ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses	NATURE IMMUNOLOGY			English	Article							CXC CHEMOKINE RECEPTOR-5; ALLERGIC INFLAMMATION; CD28-DEFICIENT MICE; IN-VIVO; EXPRESSION; COSTIMULATION; ACTIVATION; CTLA-4; CD28; RECRUITMENT	We examined the requirement for and cooperation between CD28 and inducible costimulator (ICOS) in effective T helper (T-H) cell responses in vivo. We found that both CD28 and ICOS were critical in determining the outcome of an immune response; cytolytic T lymphocyte-associated antigen 4-immunoglobulin (CTLA-4-Ig), ICOS-Ig and/or a neutralizing ICOS monoclonal antibody attenuated T cell expansion, T(H)2 cytokine production and eosinophilic inflammation. CD28-dependent signaling was essential during priming, whereas ICOS-B7RP-I regulated T-H effector responses, and the up-regulation of chemokine receptors that determine T cell migration. Our data suggests a scenario whereby both molecules regulate the outcome of the immune response but play separate key roles: CD28 primes T cells and ICOS regulates effector responses.	Millennium Pharmaceut Inc, Dept Biol, Div Inflammat, Cambridge, MA 02139 USA; Robert Koch Inst, D-13353 Berlin, Germany	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Robert Koch Institute	Coyle, AJ (corresponding author), Millennium Pharmaceut Inc, Dept Biol, Div Inflammat, 45-75 Sidney St, Cambridge, MA 02139 USA.	yle@mpi.com						Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; CORRY DB, 1994, J IMMUNOL, V153, P4142; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2000, AM J RESP CRIT CARE, V162, pS179, DOI 10.1164/ajrccm.162.supplement_3.15tac8; COYLE AJ, 2001, NATURE IMMUNOL, V2, P1; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gause WC, 1996, EXP PARASITOL, V84, P264, DOI 10.1006/expr.1996.0112; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Gonzalo JA, 1999, J IMMUNOL, V163, P403; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Gonzalo JA, 2001, J IMMUNOL, V166, P1; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JENKINS MK, 1991, J IMMUNOL, V147, P2461; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; Mathur M, 1999, AM J RESP CELL MOL, V21, P498, DOI 10.1165/ajrcmb.21.4.3714; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Rulifson IC, 1997, J IMMUNOL, V158, P658; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tada Y, 1999, J IMMUNOL, V162, P203; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tang AM, 1996, J IMMUNOL, V157, P117; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tsuyuki S, 1997, J EXP MED, V185, P1671, DOI 10.1084/jem.185.9.1671; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	52	229	247	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					597	604		10.1038/89739	http://dx.doi.org/10.1038/89739			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429543				2022-12-18	WOS:000169682100012
J	Duerr, CU; McCarthy, CDA; Mindt, BC; Rubio, M; Meli, AP; Pothlichet, J; Eva, MM; Gauchat, JF; Qureshi, ST; Mazer, BD; Mossman, KL; Malo, D; Gamero, AM; Vidal, SM; King, IL; Sarfati, M; Fritz, JH				Duerr, Claudia U.; McCarthy, Connor D. A.; Mindt, Barbara C.; Rubio, Manuel; Meli, Alexandre P.; Pothlichet, Julien; Eva, Megan M.; Gauchat, Jean-Francois; Qureshi, Salman T.; Mazer, Bruce D.; Mossman, Karen L.; Malo, Danielle; Gamero, Ana M.; Vidal, Silvia M.; King, Irah L.; Sarfati, Marika; Fritz, Joerg H.			Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; INFLUENZA-VIRUS; T-BET; ADAPTIVE IMMUNITY; IFN-GAMMA; INDUCTION; RESPONSES; INFECTION; HOMEOSTASIS; ALPHA/BETA	Viral respiratory tract infections are the main causative agents of the onset of infection-induced asthma and asthma exacerbations that remain mechanistically unexplained. Here we found that deficiency in signaling via type I interferon receptor led to deregulated activation of group 2 innate lymphoid cells (ILC2 cells) and infection-associated type 2 immunopathology. Type I interferons directly and negatively regulated mouse and human ILC2 cells in a manner dependent on the transcriptional activator ISGF3 that led to altered cytokine production, cell proliferation and increased cell death. In addition, interferon-gamma (IFN-gamma) and interleukin 27 (IL-27) altered ILC2 function dependent on the transcription factor STAT1. These results demonstrate that type I and type II interferons, together with IL-27, regulate ILC2 cells to restrict type 2 immunopathology.	[Duerr, Claudia U.; Mindt, Barbara C.; Fritz, Joerg H.] McGill Univ, Complex Traits Grp, Dept Microbiol & Immunol, Montreal, PQ, Canada; [McCarthy, Connor D. A.; Fritz, Joerg H.] McGill Univ, Complex Traits Grp, Dept Physiol, Montreal, PQ, Canada; [Rubio, Manuel; Sarfati, Marika] CHU, Res Ctr, Immunoregulat Lab, Montreal, PQ, Canada; [Meli, Alexandre P.; King, Irah L.] McGill Univ, Microbiome & Dis Tolerance Ctr, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Pothlichet, Julien] Inst Pasteur, Diaccurate, Paris, France; [Eva, Megan M.; Malo, Danielle; Vidal, Silvia M.] McGill Univ, Complex Traits Grp, Dept Human Genet, Montreal, PQ, Canada; [Gauchat, Jean-Francois] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Qureshi, Salman T.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Qureshi, Salman T.] McGill Univ, Ctr Hlth, Res Inst, Dept Crit Care, Montreal, PQ, Canada; [Mazer, Bruce D.] McGill Univ, Ctr Hlth, Res Inst, Dept Pediat,Meakins Christie Labs, Montreal, PQ, Canada; [Mossman, Karen L.] McMaster Univ, Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Malo, Danielle; Vidal, Silvia M.] McGill Univ, Complex Traits Grp, Dept Med, Montreal, PQ, Canada; [Gamero, Ana M.] Temple Univ, Sch Med, Dept Med Genet & Mol Biochem, Philadelphia, PA 19122 USA; [Sarfati, Marika] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Universite de Montreal; McGill University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; McGill University; Universite de Montreal; McGill University; McGill University; McGill University; McMaster University; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universite de Montreal	Fritz, JH (corresponding author), McGill Univ, Complex Traits Grp, Dept Microbiol & Immunol, Montreal, PQ, Canada.	jorg.fritz@mcgill.ca		Malo, Danielle/0000-0003-3980-6610; Meli, Alexandre/0000-0002-6199-3531	Canadian Institutes of Health Research [MOP-114972, MOP-89821]; Canadian Foundation of Innovation; German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; Canada Research Chair in Host Responses to Virus Infections	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; Canada Research Chair in Host Responses to Virus Infections	We thank J.L. Gommerman (University of Toronto) for Ifnar1<SUP>-/-</SUP> (Ifnar1<SUP>tm1Agt</SUP>) mice; D. Xue and G.A. Kaufman for help with AHR measurements; and B. Charbonneau for technical support. Supported by the Canadian Institutes of Health Research (J.H.F. and C.U.D.; MOP-114972 for the J.H.F. laboratory; postdoctoral fellowship for C.U.D.; MOP-89821 operating funds for S.M.V.), the Canadian Foundation of Innovation (Leaders Opportunity Fund infrastructure grant for the J.H.F. laboratory), the German National Academy of Sciences Leopoldina (C.U.D.), The American Association of Immunologists Careers in Immunology Fellowship Program (J.H.F. and C.U.D.) and Canada Research Chair in Host Responses to Virus Infections (S.M.V.).	Barik S, 2013, CURR TOP MICROBIOL, V372, P173, DOI 10.1007/978-3-642-38919-1_9; Barlow JL, 2014, CURR OPIN ALLERGY CL, V14, P397, DOI 10.1097/ACI.0000000000000090; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Feng Q, 2014, CYTOKINE GROWTH F R, V25, P577, DOI 10.1016/j.cytogfr.2014.07.003; Flaczyk A, 2013, J IMMUNOL, V191, P2503, DOI 10.4049/jimmunol.1300426; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gupta S, 1999, J IMMUNOL, V163, P3834; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kaufman GN, 2011, CLIN EXP ALLERGY, V41, P718, DOI 10.1111/j.1365-2222.2010.03663.x; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kroegel C, 2006, RESPIRATION, V73, P566, DOI 10.1159/000088660; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumar A, 2008, GENES IMMUN, V9, P294, DOI 10.1038/gene.2008.17; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; Pinto LA, 2007, ALLERGY, V62, P1456, DOI 10.1111/j.1398-9995.2007.01479.x; Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Terai M, 2011, MICROBIOL IMMUNOL, V55, P341, DOI 10.1111/j.1348-0421.2011.00320.x; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006	54	228	234	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					65	+		10.1038/ni.3308	http://dx.doi.org/10.1038/ni.3308			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26595887	Green Accepted			2022-12-18	WOS:000366675800012
J	Bruchard, M; Rebe, C; Derangere, V; Togbe, D; Ryffel, B; Boidot, R; Humblin, E; Hamman, A; Chalmin, F; Berger, H; Chevriaux, A; Limagne, E; Apetoh, L; Vegran, F; Ghiringhelli, F				Bruchard, Melanie; Rebe, Cedric; Derangere, Valentin; Togbe, Dieudonnee; Ryffel, Bernhard; Boidot, Romain; Humblin, Etienne; Hamman, Arlette; Chalmin, Fanny; Berger, Helene; Chevriaux, Angelique; Limagne, Emeric; Apetoh, Lionel; Vegran, Frederique; Ghiringhelli, Francois			The receptor NLRP3 is a transcriptional regulator of T(H)2 differentiation	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; FACTOR IRF4; CELL; INFLAMMASOME; INTERLEUKIN-4; ACTIVATION; TH2; IDENTIFICATION; MECHANISMS; INSIGHTS	The receptor NLRP3 is involved in the formation of the NLRP3 inflammasome that activates caspase-1 and mediates the release of interleukin 1 beta (IL-1 beta) and IL-18. Whether NLRP3 can shape immunological function independently of inflammasomes is unclear. We found that NLRP3 expression in CD4(+) T cells specifically supported a T helper type 2 (T(H)2) transcriptional program in a cell-intrinsic manner. NLRP3, but not the inflammasome adaptor ASC or caspase-1, positively regulated a T(H)2 program. In T(H)2 cells, NLRP3 bound the Il4 promoter and transactivated it in conjunction with the transcription factor IRF4. Nlrp3-deficient T(H)2 cells supported melanoma tumor growth in an IL-4-dependent manner and also promoted asthma-like symptoms. Our results demonstrate the ability of NLRP3 to act as a key transcription factor in T(H)2 differentiation.	[Bruchard, Melanie; Rebe, Cedric; Derangere, Valentin; Boidot, Romain; Humblin, Etienne; Hamman, Arlette; Chalmin, Fanny; Berger, Helene; Chevriaux, Angelique; Limagne, Emeric; Apetoh, Lionel; Vegran, Frederique; Ghiringhelli, Francois] INSERM, U866, Dijon, France; [Bruchard, Melanie; Rebe, Cedric; Derangere, Valentin; Boidot, Romain; Humblin, Etienne; Hamman, Arlette; Chalmin, Fanny; Berger, Helene; Chevriaux, Angelique; Limagne, Emeric; Apetoh, Lionel; Vegran, Frederique; Ghiringhelli, Francois] Univ Bourgogne, Fac Med, Dijon, France; [Rebe, Cedric; Derangere, Valentin; Boidot, Romain; Chevriaux, Angelique; Apetoh, Lionel; Vegran, Frederique; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France; [Togbe, Dieudonnee] Artimmune, Orleans, France; [Ryffel, Bernhard] Univ Orleans, CNRS, Lab Expt & Mol Immunol & Neurogenet, UMR 7355, Orleans, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans	Ghiringhelli, F (corresponding author), INSERM, U866, Dijon, France.	fghiringhelli@cgfl.fr	VEGRAN, Frederique/O-9986-2018; Togbe, Dieudonnee/AAE-1135-2020; REBE, Cédric/AAD-4316-2019; VEGRAN, Frédérique/H-4792-2017; Apetoh, Lionel/AIC-2384-2022; Apetoh, Lionel/G-3310-2014; Bruchard, Melanie/E-6508-2017	VEGRAN, Frederique/0000-0002-4377-1441; Togbe, Dieudonnee/0000-0001-6658-414X; REBE, Cédric/0000-0001-8831-145X; Apetoh, Lionel/0000-0002-2774-438X; Apetoh, Lionel/0000-0002-2774-438X; Bruchard, Melanie/0000-0003-0004-2887; Chalmin, Fanny/0000-0002-0855-9453; Emeric, Limagne/0000-0002-1098-8441; Humblin, Etienne/0000-0002-4559-6106; ghiringhelli, francois/0000-0002-5465-8305	French National Research Agency ("Investissements d'Avenir" program) [ANR-11-LABX-0021]; Ligue nationale contre le cancer; Fondation de France; Institut National du Cancer; Fondation ARC; Conseil Regional de Bourgogne/INSERM; French National Research Agency [ANR-13-JSV3-0001]; Fondation pour l'aide a la Recherche sur la Sclerose en Plaques; Ligue Regionale contre le cancer Comite Grand-Est; European Commission [PCIG10-GA-2011-303719]; Centre National de la Recherche Scientifique; Fonds Europeen de Developpement Economique et Regional; Le Stadium; Orleans and Fondation pour la Recherche Medicale	French National Research Agency ("Investissements d'Avenir" program)(French National Research Agency (ANR)); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation ARC; Conseil Regional de Bourgogne/INSERM(Region Bourgogne-Franche-Comte); French National Research Agency(French National Research Agency (ANR)); Fondation pour l'aide a la Recherche sur la Sclerose en Plaques(Fondation pour la Recherche Medicale); Ligue Regionale contre le cancer Comite Grand-Est; European Commission(European CommissionEuropean Commission Joint Research Centre); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fonds Europeen de Developpement Economique et Regional; Le Stadium; Orleans and Fondation pour la Recherche Medicale	We thank V. Petrilli (INSERM 1052) for BALB/c Nlrp3<SUP>-/-</SUP> mice. Supported by the French National Research Agency ("Investissements d'Avenir" program; ANR-11-LABX-0021), the Ligue nationale contre le cancer (F.G. and F.V.), the Fondation de France (L.A.), the Institut National du Cancer (F.G.), the Fondation ARC (L.A.), the Conseil Regional de Bourgogne/INSERM (H.B.), the Centre National de la Recherche Scientifique, Fonds Europeen de Developpement Economique et Regional, Le Stadium, Orleans and Fondation pour la Recherche Medicale (F.G. and B.R.), the French National Research Agency (ANR-13-JSV3-0001 to L.A.), the Fondation pour l'aide a la Recherche sur la Sclerose en Plaques (L.A. and M.D.), the Ligue Regionale contre le cancer Comite Grand-Est (L.A.) and the European Commission (PCIG10-GA-2011-303719 to L.A.).	Allen IC, 2012, J IMMUNOL, V188, P2884, DOI 10.4049/jimmunol.1102488; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Boeva V, 2012, BIOINFORMATICS, V28, P2517, DOI 10.1093/bioinformatics/bts463; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; BRUHN KW, 1993, P NATL ACAD SCI USA, V90, P9707, DOI 10.1073/pnas.90.20.9707; Camp BJ, 1996, ANN SURG ONCOL, V3, P176, DOI 10.1007/BF02305798; Candido EB, 2013, REPROD SCI, V20, P828, DOI 10.1177/1933719112466299; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; De Nardo D, 2014, AM J PATHOL, V184, P42, DOI 10.1016/j.ajpath.2013.09.007; Devaiah BN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00476; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elsasser-Beile U, 1998, TUMOR BIOL, V19, P470, DOI 10.1159/000030039; Farrell G A, 1989, Nurse Educ Today, V9, P335, DOI 10.1016/0260-6917(89)90118-4; FERON VJ, 1990, ENVIRON HEALTH PERSP, V85, P305, DOI 10.2307/3430691; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Gurung P, 2015, J CLIN INVEST, V125, P1329, DOI 10.1172/JCI79526; Hallett MA, 2012, CANCER RES, V72, P6338, DOI 10.1158/0008-5472.CAN-12-3544; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Iwasaki T, 2008, BIOTECHNIQUES, V45, P445, DOI 10.2144/000112915; Kobayashi M, 1998, J IMMUNOL, V160, P5869; Koller FL, 2010, CARCINOGENESIS, V31, P1010, DOI 10.1093/carcin/bgq044; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Roca H, 2012, J CELL BIOCHEM, V113, P1569, DOI 10.1002/jcb.24025; Roth F, 2012, CANCER RES, V72, P1373, DOI 10.1158/0008-5472.CAN-11-2772; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Verma C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-16; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	51	228	241	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					859	+		10.1038/ni.3202	http://dx.doi.org/10.1038/ni.3202			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26098997				2022-12-18	WOS:000358299200013
J	Blander, JM; Medzhitov, R				Blander, J. Magarian; Medzhitov, Ruslan			On regulation of phagosome maturation and antigen presentation	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; T-CELL-ACTIVATION; DENDRITIC CELLS; MEDIATED PHAGOCYTOSIS; APOPTOTIC CELLS; INNATE IMMUNITY; NADPH OXIDASE; IN-VIVO; MACROPHAGES; ENDOCYTOSIS	Phagocytosis has essential functions in immunity. Here we highlight the presence of a subcellular level of self-non-self discrimination in dendritic cells that operates at the level of individual phagosomes. We discuss how engagement of Toll-like receptor signaling controls distinct programs of phagosome maturation. An inducible mode of phagosome maturation triggered by these receptors ensures the selection of microbial antigens for presentation by major histocompatibility class II molecules during the simultaneous phagocytosis of self and non-self.	CUNY Mt Sinai Sch Med, Ctr Immunobiol, New York, NY 10029 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Yale University; Yale University	Blander, JM (corresponding author), CUNY Mt Sinai Sch Med, Ctr Immunobiol, New York, NY 10029 USA.	julie.blander@mssm.edu; ruslan.medzhitov@yale.edu		Blander, Julie Magarian/0000-0001-9207-1700	NIAID NIH HHS [AI-46688] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BERTHIAUME EP, 1995, J CELL BIOL, V129, P989, DOI 10.1083/jcb.129.4.989; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blocker A, 1998, J CELL SCI, V111, P303; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chow AY, 2005, TRENDS IMMUNOL, V26, P72, DOI 10.1016/j.it.2004.11.008; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; HAMMALVAREZ SF, 1993, J CELL SCI, V106, P955; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; YAROVINSKY F, 2006, IN PRESS IMMUNITY; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	67	228	238	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1029	1035		10.1038/ni1006-1029	http://dx.doi.org/10.1038/ni1006-1029			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985500				2022-12-18	WOS:000241437100008
J	Biedermann, T; Zimmermann, S; Himmelrich, H; Gumy, A; Egeter, A; Sakrauski, AK; Seegmuller, I; Voigt, H; Launois, P; Levine, AD; Wagner, H; Heeg, K; Louis, JA; Rocken, M				Biedermann, T; Zimmermann, S; Himmelrich, H; Gumy, A; Egeter, A; Sakrauski, AK; Seegmuller, I; Voigt, H; Launois, P; Levine, AD; Wagner, H; Heeg, K; Louis, JA; Rocken, M			IL-4 instructs T(H)1 responses and resistance to Leishmania major in susceptible BALB/c mice	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; INFLAMMATORY AUTOIMMUNE-DISEASE; DENDRITIC CELLS; HELPER CELL; INTERLEUKIN-4-DEFICIENT MICE; MURINE LEISHMANIASIS; MOUSE INTERLEUKIN-4; IMMUNE DEVIATION; INNATE IMMUNITY; CYTOKINE	Immunity to infection with intracellular pathogens is regulated by interleukin 12 (IL-12), which mediates protective T helper type I (T(H)1) responses, or IL-4, which induces T(H)2 cells and susceptibility. Paradoxically, we show here that when present during the initial activation of dendritic cells (DCs) by infectious agents, IL-4 instructed DCs to produce IL-12 and promote T(H)1 development. This T(H)1 response established resistance to Leishmania major in susceptible BALB/c mice. When present later, during the period of T cell priming, IL-4 induced T(H)2 differentiation and progressive leishmaniasis in resistant mice. Because immune responses developed via the consecutive activation of DCs and then T cells, the contrasting effects of IL-4 on DC development and T cell differentiation led to immune responses that had opposing functional phenotypes.	Univ Lausanne, Inst Biochem, WHO Immunol Res & Training Ctr, Lausanne, Switzerland; Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; Tech Univ Munich, Dept Microbiol, D-8000 Munich, Germany; Univ Marburg, Dept Microbiol, Marburg, Germany; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	University of Lausanne; University of Munich; Technical University of Munich; Philipps University Marburg; Case Western Reserve University	Louis, JA (corresponding author), Univ Lausanne, Inst Biochem, WHO Immunol Res & Training Ctr, Lausanne, Switzerland.			Biedermann, Tilo/0000-0002-5352-5105; Rocken, Martin/0000-0003-3795-7001; burckhardt, irene/0000-0002-7610-4530				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Bagley J, 2000, NAT IMMUNOL, V1, P257, DOI 10.1038/79811; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biedermann T, 2001, EUR J IMMUNOL, V31, P1582, DOI 10.1002/1521-4141(200105)31:5<1582::AID-IMMU1582>3.0.CO;2-M; BRADLEY LM, 1995, J IMMUNOL, V155, P1713; CARTER KC, 1989, EUR J IMMUNOL, V19, P779, DOI 10.1002/eji.1830190432; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; Ebner S, 2001, J IMMUNOL, V166, P633, DOI 10.4049/jimmunol.166.1.633; Egeter O, 2000, CANCER RES, V60, P1515; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; FAVRE N, 1993, J IMMUNOL METHODS, V164, P213, DOI 10.1016/0022-1759(93)90314-W; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fort MM, 2001, J IMMUNOL, V166, P2793, DOI 10.4049/jimmunol.166.4.2793; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Himmelrich H, 2000, J IMMUNOL, V164, P4819, DOI 10.4049/jimmunol.164.9.4819; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Kacha AK, 2000, J IMMUNOL, V165, P6024, DOI 10.4049/jimmunol.165.11.6024; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LEVINE AD, 1995, J BIOL CHEM, V270, P7445, DOI 10.1074/jbc.270.13.7445; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; MOLL H, 1993, EUR J IMMUNOL, V23, P1595, DOI 10.1002/eji.1830230730; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Munder M, 1998, J IMMUNOL, V160, P5347; NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Radu DL, 2000, P NATL ACAD SCI USA, V97, P12700, DOI 10.1073/pnas.230431397; Ramanathan S, 1996, J IMMUNOL, V157, P2209; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rocken M, 1996, IMMUNOL TODAY, V17, P225, DOI 10.1016/0167-5699(96)80556-1; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SALERNO A, 1995, IMMUNOLOGY, V84, P404; Schuler T, 1999, J EXP MED, V189, P803, DOI 10.1084/jem.189.5.803; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Traidl C, 1999, J INVEST DERMATOL, V112, P476, DOI 10.1046/j.1523-1747.1999.00550.x; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Yokozeki H, 2000, J EXP MED, V191, P995, DOI 10.1084/jem.191.6.995; Zimmermann S, 1998, J IMMUNOL, V160, P3627	55	228	230	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1054	1060		10.1038/ni725	http://dx.doi.org/10.1038/ni725			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11600887				2022-12-18	WOS:000172049800019
J	Shembade, N; Harhaj, NS; Parvatiyar, K; Copeland, NG; Jenkins, NA; Matesic, LE; Harhaj, EW				Shembade, Noula; Harhaj, Nicole S.; Parvatiyar, Kislay; Copeland, Neal G.; Jenkins, Nancy A.; Matesic, Lydia E.; Harhaj, Edward W.			The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; T-CELL LEUKEMIA; VIRUS TYPE-I; ZINC-FINGER PROTEIN; TAX TRANSFORMING PROTEIN; TUMOR-SUPPRESSOR CYLD; NECROSIS-FACTOR-ALPHA; HTLV-I; ACTIVATION; KINASE	The ubiquitin-editing enzyme A20 is a critical negative regulator of inflammation and cytokine-mediated activation of the transcription factor NF-kappa B; however, little is known about the mechanisms of A20-mediated inactivation of signaling intermediates such as RIP1. Here we demonstrate that the regulatory molecule TAX1BP1 recruited the E3 ligase Itch to A20 via two 'PPXY' motifs. Itch was essential for the termination of tumor necrosis factor receptor signaling by controlling A20-mediated recruitment and inactivation of RIP1. Furthermore, the Tax oncoprotein of human T cell leukemia virus type I targeted this complex for inactivation by disrupting the interaction among TAX1BP1, A20 and Itch. Thus, our studies show a previously unappreciated complexity of A20 substrate recognition and inactivation whereby TAX1BP1 and Itch function as essential subunits of an A20 ubiquitin-editing complex.	[Shembade, Noula; Harhaj, Nicole S.; Parvatiyar, Kislay; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Copeland, Neal G.; Jenkins, Nancy A.; Matesic, Lydia E.] NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Matesic, Lydia E.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA.	eharhaj@med.miami.edu						Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158/0008-5472.CAN-06-3053; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Harhaj EW, 2005, IUBMB LIFE, V57, P83, DOI 10.1080/15216540500078715; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HUSTAD CM, 1995, GENETICS, V140, P255; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M., 1999, SCI SIGNAL TRANSDUCT, V5, P1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Storz P, 2005, BIOCHEM J, V387, P47, DOI 10.1042/BJ20041443; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	50	227	234	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					254	262		10.1038/ni1563	http://dx.doi.org/10.1038/ni1563			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18246070				2022-12-18	WOS:000253406700011
J	Tynan, FE; Burrows, SR; Buckle, AM; Clements, CS; Borg, NA; Miles, JJ; Beddoe, T; Whisstock, JC; Wilce, MC; Silins, SL; Burrows, JM; Kjer-Nielsen, L; Kostenko, L; Purcell, AW; McCluskey, J; Rossjohn, J				Tynan, FE; Burrows, SR; Buckle, AM; Clements, CS; Borg, NA; Miles, JJ; Beddoe, T; Whisstock, JC; Wilce, MC; Silins, SL; Burrows, JM; Kjer-Nielsen, L; Kostenko, L; Purcell, AW; McCluskey, J; Rossjohn, J			T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide	NATURE IMMUNOLOGY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ANTIGEN RECOGNITION; VIRAL PEPTIDES; MHC MOLECULE; CDR3 REGIONS; AMINO-ACIDS; BINDING; HLA; FLEXIBILITY	Unusually long major histocompatibility complex (MHC) class I-restricted epitopes are important in immunity, but their 'bulged' conformation represents a potential obstacle to ab T cell receptor (TCR)-MHC class I docking. To elucidate how such recognition is achieved while still preserving MHC restriction, we have determined here the structure of a TCR in complex with HLA-B*3508 presenting a peptide 13 amino acids in length. This complex was atypical of TCR-peptide-MHC class I interactions, being dominated at the interface by peptide-mediated interactions. The TCR assumed two distinct orientations, swiveling on top of the centrally bulged, rigid peptide such that only limited contacts were made with MHC class I. Although the TCR-peptide recognition resembled an antibody-antigen interaction, the TCR-MHC class I contacts defined a minimal 'generic footprint' of MHC-restriction. Thus our findings simultaneously demonstrate the considerable adaptability of the TCR and the 'shape' of MHC restriction.	Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Biochem, Parkville, Vic 3010, Australia	Monash University; QIMR Berghofer Medical Research Institute; University of Melbourne; University of Melbourne	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Miles, John/H-4975-2011; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Burrows, Scott/G-2050-2011; Purcell, Anthony/AAH-1942-2019; Buckle, Ashley/P-8366-2016; Miles, John J/ABC-1105-2020; Beddoe, Travis/F-3415-2014	McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Burrows, Scott/0000-0002-1430-0472; Purcell, Anthony/0000-0003-0532-8331; Buckle, Ashley/0000-0003-2943-9044; Miles, John J/0000-0001-5506-6304; Beddoe, Travis/0000-0003-4550-2277; Borg, Natalie/0000-0002-8677-9056; Kostenko, Lyudmila/0000-0002-8466-7966; Whisstock, James/0000-0003-4200-5611	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Baxter TK, 2004, J BIOL CHEM, V279, P29175, DOI 10.1074/jbc.M403372200; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bourcier KD, 2001, J VIROL, V75, P9836, DOI 10.1128/JVI.75.20.9836-9843.2001; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; CHEN Y, 1994, J IMMUNOL, V152, P2874; CLAVERIE JM, 1986, ANN INST PASTEUR IMM, VD137, P425; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Green KJ, 2004, EUR J IMMUNOL, V34, P2510, DOI 10.1002/eji.200425193; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Horig H, 1999, J IMMUNOL, V163, P4434; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sim BC, 1998, IMMUNOL TODAY, V19, P276, DOI 10.1016/S0167-5699(98)01257-2; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TORMO J, 1994, EMBO J, V13, P2247, DOI 10.1002/j.1460-2075.1994.tb06506.x; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	66	227	239	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1114	1122		10.1038/ni1257	http://dx.doi.org/10.1038/ni1257			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16186824				2022-12-18	WOS:000232833300012
J	Spitaler, M; Cantrell, DA				Spitaler, M; Cantrell, DA			Protein kinase C and beyond	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; KAPPA-B ACTIVATION; ANTIGEN RECEPTOR; PKC-THETA; IN-VIVO; LYMPHOCYTE ACTIVATION; TYROSINE KINASES; PHORBOL ESTER; DIACYLGLYCEROL; ALPHA	Protein kinase C molecules regulate both positive and negative signal transduction pathways essential for the initiation and homeostasis of immune responses. There are multiple isoforms of protein kinase C that are activated differently by calcium and diacylglycerol, and these are activated mainly by antigen receptors in T cells, B cells and mast cells. Additionally, mammals express several other diacylglycerol binding proteins that are linked to a network of key signal transduction pathways that control lymphocyte biology. Diacylglycerol and protein kinase C regulate a broad range of gene transcription programs but also modulate integrins, chemokine responses and antigen receptors, thereby regulating lymphocyte adhesion, migration, differentiation and proliferation.	Univ Dundee, Div Cell Biol & Immunol, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Div Cell Biol & Immunol, Sch Life Sci, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk		Cantrell, Doreen/0000-0001-7525-3350; Spitaler, Martin/0000-0002-8833-638X				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Astoul E, 2003, J BIOL CHEM, V278, P9267, DOI 10.1074/jbc.M211252200; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BAIER G, 1993, J BIOL CHEM, V268, P4997; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; BIT RA, 1993, J MED CHEM, V36, P21, DOI 10.1021/jm00053a003; Bonefeld CM, 2003, J IMMUNOL, V171, P3003, DOI 10.4049/jimmunol.171.6.3003; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Flores E, 2003, J BIOL CHEM, V278, P29208, DOI 10.1074/jbc.M303165200; Dustin ML, 2002, ADV EXP MED BIOL, V512, P191; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Geiger M, 2003, CURR OPIN MOL THER, V5, P631; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; ISAKOV N, 1987, IMMUNOL REV, V95, P89, DOI 10.1111/j.1600-065X.1987.tb00501.x; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; LI Y, 2004, EMBO J; Liu L, 2002, J BIOL CHEM, V277, P40893, DOI 10.1074/jbc.M206208200; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; McLeod S J, 2001, Int Rev Immunol, V20, P763, DOI 10.3109/08830180109045589; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Michie AM, 2001, P NATL ACAD SCI USA, V98, P609, DOI 10.1073/pnas.021288598; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishizuka Y, 2003, J BIOCHEM, V133, P155, DOI 10.1093/jb/mvg035; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Sotsios Y, 2000, IMMUNOLOGY, V101, P30, DOI 10.1046/j.1365-2567.2000.00072.x; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; WEISS A, 1984, J IMMUNOL, V133, P123; Weiss A, 1991, Semin Immunol, V3, P313; WILLIAMS DH, 1995, EUR J IMMUNOL, V25, P42, DOI 10.1002/eji.1830250109; Xing T, 1996, PLANT CELL, V8, P555, DOI 10.2307/3870332; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	77	227	234	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					785	790		10.1038/ni1097	http://dx.doi.org/10.1038/ni1097			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282562				2022-12-18	WOS:000222955600009
J	Murai, M; Yoneyama, H; Ezaki, T; Suematsu, M; Terashima, Y; Harada, A; Hamada, H; Asakura, H; Ishikawa, H; Matsushima, K				Murai, M; Yoneyama, H; Ezaki, T; Suematsu, M; Terashima, Y; Harada, A; Hamada, H; Asakura, H; Ishikawa, H; Matsushima, K			Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; T-LYMPHOCYTES; DENDRITIC CELLS; HISTOINCOMPATIBLE CELLS; THYMUS LYMPHOCYTES; FAS LIGAND; DISEASE; TUMOR; LIVER; TISSUE	Acute graft-versus-host disease (a-GVHD) is initiated primarily by immunologically competent cytotoxic T cells (CTLs) that express anti-host specificities. However, the host lymphoid compartment in which these precursor CTLs are initially stimulated remains unclear. Here we show that gut Peyer's patches (PPs) are required to activate anti-host CTL responses in a well characterized murine acute graft-versus-host reaction (a-GVHR) model, involving transfer of parent lymphocytes into F1 hybrid recipients. The a-GVHR was prevented when recruitment of donor T cells into PP was interrupted either by disrupting the gene encoding chemokine receptor CCR5 or by blocking integrin alpha(4)beta(7)-MAdCAM- 1 (mucosal vascular addressin) interactions. Mice deficient for PPs failed to develop a-GVHD in two models of disease induction. Thus, blockade of CTL generation in PPs might offer new strategies for circumventing a-GVHD.	Univ Tokyo, Dept Mol Prevent Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Niigata Univ, Dept Internal Med, Sch Med, Niigata 9518122, Japan; Tokyo Womens Med Univ, Dept Anat & Dev Biol, Sch Med, Shinjyuku Ku, Tokyo 1628666, Japan; Keio Univ, Dept Biochem, Sch Med, Shinjyuku Ku, Tokyo 1608582, Japan; Keio Univ, Dept Microbiol, Sch Med, Shinjyuku Ku, Tokyo 1608582, Japan	University of Tokyo; Niigata University; Tokyo Women's Medical University; Keio University; Keio University	Matsushima, K (corresponding author), Univ Tokyo, Dept Mol Prevent Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.	koujim@m.u-tokyo.ac.jp	ezaki, taichi/C-3502-2013; Suematsu, Makoto/O-5762-2018; Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336				Antin JH, 2001, J CLIN INVEST, V107, P1497, DOI 10.1172/JCI13259; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Baker MB, 1996, J EXP MED, V183, P2645, DOI 10.1084/jem.183.6.2645; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 2001, J CLIN INVEST, V107, P1581, DOI 10.1172/JCI12156; Dazzi F, 2001, NAT MED, V7, P769, DOI 10.1038/89874; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Elson CO, 2001, SEMIN IMMUNOL, V13, P187, DOI 10.1006/smim.2001.0312; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Garside P, 2001, SEMIN IMMUNOL, V13, P177, DOI 10.1006/smim.2001.0310; Gebert A, 1996, INT REV CYTOL, V167, P91, DOI 10.1016/S0074-7696(08)61346-7; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Ho VT, 2001, BLOOD, V98, P3192, DOI 10.1182/blood.V98.12.3192; Hurst SD, 1997, P NATL ACAD SCI USA, V94, P3920, DOI 10.1073/pnas.94.8.3920; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; KORNGOLD R, 1990, GRAFT VERSUS HOST DI, P31; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lin TS, 1998, J CLIN INVEST, V101, P570, DOI 10.1172/JCI896; MacDonald T, 2001, SEMIN IMMUNOL, V13, P159, DOI 10.1006/smim.2001.0308; Mackay CR, 1999, NATURE, V401, P659, DOI 10.1038/44309; MOWAT AM, 1990, CLIN EXP IMMUNOL, V79, P279; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; NESTEL FP, 1992, J EXP MED, V175, P405, DOI 10.1084/jem.175.2.405; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PALS ST, 1984, J IMMUNOL, V132, P1669; SAKAI T, 1995, EUR J IMMUNOL, V25, P87, DOI 10.1002/eji.1830250117; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Serody JS, 2000, BLOOD, V96, P2973; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Shustov A, 1998, J IMMUNOL, V161, P2848; Simmons CP, 2001, SEMIN IMMUNOL, V13, P201, DOI 10.1006/smim.2001.0313; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; SPRENT J, 1972, CELL IMMUNOL, V3, P385, DOI 10.1016/0008-8749(72)90245-6; SPRENT J, 1972, CELL IMMUNOL, V3, P361, DOI 10.1016/0008-8749(72)90244-4; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; SPRENT J, 1994, BONE MARROW TRANSPL, P220; Sudo N, 1997, J IMMUNOL, V159, P1739; Tamada K, 2000, NAT MED, V6, P283; Tamada K, 2002, J CLIN INVEST, V109, P549, DOI 10.1172/JCI200213604; Vossen J, 1990, GRAFT VS HOST DISEAS, P403; WEINSTEIN PD, 1991, J IMMUNOL, V147, P4126; YASMINEH WG, 1989, TRANSPLANTATION, V48, P809, DOI 10.1097/00007890-198911000-00017; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	49	227	243	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					154	160		10.1038/ni879	http://dx.doi.org/10.1038/ni879			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12524535				2022-12-18	WOS:000180686500015
J	Ohne, Y; Silver, JS; Thompson-Snipes, L; Collet, MA; Blanck, JP; Cantarel, BL; Copenhaver, AM; Humbles, AA; Liu, YJ				Ohne, Yoichiro; Silver, Jonathan S.; Thompson-Snipes, LuAnn; Collet, Magalie A.; Blanck, Jean Philippe; Cantarel, Brandi L.; Copenhaver, Alan M.; Humbles, Alison A.; Liu, Yong-Jun			IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR BCL11B; AIRWAY INFLAMMATION; TYPE-2 IMMUNITY; ALLERGIC INFLAMMATION; LUNG INFLAMMATION; FACTOR GATA3; IFN-GAMMA; ASTHMA; HOMEOSTASIS; INITIATION	Group 2 innate lymphoid cells (ILC2 cells) are important for type 2 immune responses and are activated by the epithelial cytokines interleukin 33 (IL-33), IL-25 and thymic stromal lymphopoietin (TSLP). Here we demonstrated that IL-1 beta was a critical activator of ILC2 cells, inducing proliferation and cytokine production and regulating the expression of epithelial cytokine receptors. IL-1 beta also governed ILC2 plasticity by inducing low expression of the transcription factor T-bet and the cytokine receptor chain IL-12R beta 2, which enabled the conversion of these cells into an ILC1 phenotype in response to IL-12. This transition was marked by an atypical chromatin landscape characterized by the simultaneous transcriptional accessibility of the locus encoding interferon-gamma (IFN-gamma) and the loci encoding IL-5 and IL-13. Finally, IL-1 beta potentiated ILC2 activation and plasticity in vivo, and IL-12 acted as the switch that determined an ILC2-versus-ILC1 response. Thus, we have identified a previously unknown role for IL-1 beta in facilitating ILC2 maturation and plasticity.	[Ohne, Yoichiro; Thompson-Snipes, LuAnn; Collet, Magalie A.; Blanck, Jean Philippe; Cantarel, Brandi L.; Liu, Yong-Jun] Baylor Scott & White Hlth, Baylor Res Inst, Dallas, TX USA; [Ohne, Yoichiro; Liu, Yong-Jun] Medimmune Inc, R&D Res, Gaithersburg, MD 20878 USA; [Silver, Jonathan S.; Copenhaver, Alan M.; Humbles, Alison A.] Medimmune Inc, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA	Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Liu, YJ (corresponding author), Baylor Scott & White Hlth, Baylor Res Inst, Dallas, TX USA.; Liu, YJ (corresponding author), Medimmune Inc, R&D Res, Gaithersburg, MD 20878 USA.; Humbles, AA (corresponding author), Medimmune Inc, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA.	humblesa@medimmune.com; yong-jun.liu@sanofi.com	Ohne, Yoichiro/AGE-6061-2022; Cantarel, Brandi/ABF-5756-2020	Cantarel, Brandi/0000-0003-4126-4478; Copenhaver, Alan/0000-0001-5952-0455	Cancer Prevention and Research Institute of Texas ("Targeting Dendritic Cells to Block Immunosuppression in Breast Cancer") [RP110319]; Japan Society for the Promotion of Science (KAKENHI) [23-10890]	Cancer Prevention and Research Institute of Texas ("Targeting Dendritic Cells to Block Immunosuppression in Breast Cancer"); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Ueno, S. Hanabuchi, T. Kim and M. Ramaswamy for discussions; C. Harrod and C. Kiefer for critical reading of the manuscript; N. Loof, C. Boudreaux, K. Kayembe, C. Groves and R. Rayanki for support with cell sorting; H. Lu and A. Berlin for laboratory support; the LAR staff for maintaining the experimental animals; N. Baldwin for help in depositing RNA-sequencing data; and A. O'Bar and S. Zurawski for performing Luminex experiment. Supported by the Cancer Prevention and Research Institute of Texas (RP110319 ("Targeting Dendritic Cells to Block Immunosuppression in Breast Cancer") to Y.-J.L.) and by the Japan Society for the Promotion of Science (KAKENHI Grant-in-Aid 23-10890 to Y.O.)	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318	57	226	232	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					646	+		10.1038/ni.3447	http://dx.doi.org/10.1038/ni.3447			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27111142				2022-12-18	WOS:000376162200009
J	Freigang, S; Ampenberger, F; Weiss, A; Kanneganti, TD; Iwakura, Y; Hersberger, M; Kopf, M				Freigang, Stefan; Ampenberger, Franziska; Weiss, Adrienne; Kanneganti, Thirumala-Devi; Iwakura, Yoichiro; Hersberger, Martin; Kopf, Manfred			Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1 alpha and sterile vascular inflammation in atherosclerosis	NATURE IMMUNOLOGY			English	Article							IL-1 RECEPTOR ANTAGONIST; NLRP3 INFLAMMASOME; CASPASE-1 ACTIVATION; MICE DEFICIENT; IL-1-BETA; ATHEROGENESIS; MACROPHAGES; METABOLISM; SECRETION; PATHWAYS	Chronic inflammation is a fundamental aspect of metabolic disorders such as obesity, diabetes and cardiovascular disease. Cholesterol crystals are metabolic signals that trigger sterile inflammation in atherosclerosis, presumably by activating inflammasomes for IL-1 beta production. We found here that atherogenesis was mediated by IL-1 alpha and we identified fatty acids as potent inducers of IL-1 alpha-driven vascular inflammation. Fatty acids selectively stimulated the release of IL-1 alpha but not of IL-1 beta by uncoupling mitochondrial respiration. Fatty acid-induced mitochondrial uncoupling abrogated IL-1 beta secretion, which deviated the cholesterol crystal-elicited response toward selective production of IL-1 alpha. Our findings delineate a previously unknown pathway for vascular immunopathology that links the cellular response to metabolic stress with innate inflammation, and suggest that IL-1 alpha, not IL-1 beta, should be targeted in patients with cardiovascular disease.	[Freigang, Stefan; Ampenberger, Franziska; Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Weiss, Adrienne; Hersberger, Martin] Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich; St Jude Children's Research Hospital; Tokyo University of Science	Freigang, S (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland.	stefan.freigang@gmx.net; manfred.kopf@biol.ethz.ch	Iwakura, Yoichiro/E-5457-2011; Kopf, Manfred/B-6907-2009; Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Iwakura, Yoichiro/0000-0002-9934-5775; Kopf, Manfred/0000-0002-0628-7140; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Freigang, Stefan/0000-0003-4438-7828; Hersberger, Martin/0000-0002-4472-329X	Swiss National Science Foundation [310030-124922/1]; Swiss Federal Institute of Technology Zurich [ETH-18 09-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Technology Zurich(ETH Zurich)	We thank W.-D. Hardt (Swiss Federal Institute of Technology (ETH) Zurich) for Casp1<SUP>-/-</SUP> (Casp1<SUP>tm1Sesh</SUP>) mice; J. Tschopp (University of Lausanne) for Nlrp3<SUP>-/-</SUP> (Nlrp3<SUP>tm1Tsc</SUP>) mice; M. Labow (Novartis) for Il1r1<SUP>-/-</SUP> (Il1r1<SUP>tm1Roml</SUP>) mice; H. Edlund (Umea University) for Ffar1<SUP>-/-</SUP> (Ffar1<SUP>tm1Heed</SUP>) bone marrow; W. Wahli (University of Lausanne) for Ppara<SUP>-/-</SUP> (Pparatm1Gonz) mice; S. Ibrahim (University of Lunbeck for Ucp2<SUP>-/-</SUP> (Ucp2<SUP>tm1Lowl</SUP>) mice; and the personnel of the animal facilities for technical assistance. Supported by the Swiss National Science Foundation (310030-124922/1 to M. K.) and the Swiss Federal Institute of Technology Zurich (ETH-18 09-1 to M. K. and S.F.).	Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Devlin CM, 2002, P NATL ACAD SCI USA, V99, P6280, DOI 10.1073/pnas.092324399; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Isoda K, 2004, ARTERIOSCL THROM VAS, V24, P1068, DOI 10.1161/01.ATV.0000127025.48140.a3; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; LEPAGE G, 1986, J LIPID RES, V27, P114; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsuki T, 2005, CIRCULATION, V112, P1323, DOI 10.1161/CIRCULATIONAHA.105.564658; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Van De Parre T.J.L., 2007, CARDIOVASC RES, V77, P425; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	50	226	234	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1045	+		10.1038/ni.2704	http://dx.doi.org/10.1038/ni.2704			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23995233				2022-12-18	WOS:000324584700013
J	Huber-Lang, M; Lambris, JD; Ward, PA				Huber-Lang, Markus; Lambris, John D.; Ward, Peter A.			Innate immune responses to trauma	NATURE IMMUNOLOGY			English	Review							ACUTE LUNG INJURY; ENDOTHELIAL GLYCOCALYX DEGRADATION; CENTRAL-NERVOUS-SYSTEM; ACUTE KIDNEY INJURY; BRAIN-INJURY; INFLAMMATORY RESPONSE; HEMORRHAGIC-SHOCK; MOLECULAR-PATTERNS; MULTIPLE INJURIES; ALVEOLAR MACROPHAGES	Trauma can affect any individual at any location and at any time over a lifespan. The disruption of macrobarriers and microbarriers induces instant activation of innate immunity. The subsequent complex response, designed to limit further damage and induce healing, also represents a major driver of complications and fatal outcome after injury. This Review aims to provide basic concepts about the posttraumatic response and is focused on the interactive events of innate immunity at frequent sites of injury: the endothelium at large, and sites within the lungs, inside and outside the brain and at the gut barrier.	[Huber-Lang, Markus] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Ulm University; University of Pennsylvania; University of Michigan System; University of Michigan	Huber-Lang, M (corresponding author), Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany.	markus.huber-lang@uniklinik-ulm.de	Lambris, John/Q-5633-2018; Huber-Lang, Markus/AAJ-2209-2020	Lambris, John/0000-0002-9370-5776; 	NIAID NIH HHS [R01 AI030040, P01 AI068730, N01 AI030040] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040, R01AI030040, P01AI068730] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe C, 2017, NAT NEUROSCI, V20, P700, DOI 10.1038/nn.4526; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Aufmkolk M, 1999, CRIT CARE MED, V27, P1441, DOI 10.1097/00003246-199908000-00005; Bastian OW, 2016, J INFLAMM RES, V9, DOI 10.2147/JIR.S101064; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Billiar TR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002342; Bird L, 2017, NAT REV IMMUNOL, V17, P278, DOI 10.1038/nri.2017.43; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Buttenschoen K, 1996, EUR J SURG, V162, P853; Cabrera CP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002352; Callcut RA, 2016, J TRAUMA ACUTE CARE, V80, P210, DOI 10.1097/TA.0000000000000930; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Charbonney E, 2016, CRIT CARE MED, V44, P335, DOI 10.1097/CCM.0000000000001404; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Dai HL, 2013, INJURY, V44, P1521, DOI 10.1016/j.injury.2013.03.015; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Deitch EA, 2014, CRIT CARE MED, V42, pE200, DOI 10.1097/CCM.0000000000000119; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; DeLano E A., 2013, SCI TRANSL MED, V5; Denk S, 2018, SHOCK, V49, P154, DOI 10.1097/SHK.0000000000000925; Denk S, 2017, J IMMUNOL, V198, P4846, DOI 10.4049/jimmunol.1700393; Denk S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/463950; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Diamond B, 2011, P NATL ACAD SCI USA, V108, P3461, DOI 10.1073/pnas.1100329108; Dijkink S, 2018, INJURY, V49, P104, DOI 10.1016/j.injury.2017.10.021; Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; Fishman JE, 2014, ANN SURG, V260, P1112, DOI 10.1097/SLA.0000000000000631; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gadani SP, 2017, J EXP MED, V214, P285, DOI 10.1084/jem.20161982; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; Gao M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45989; Gebhard F, 2008, LANGENBECK ARCH SURG, V393, P825, DOI 10.1007/s00423-008-0334-2; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Giannoudis PV, 2017, INJURY, V48, P1279, DOI 10.1016/j.injury.2017.05.026; Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Grootjans J, 2011, GASTROENTEROLOGY, V140, P529, DOI 10.1053/j.gastro.2010.10.040; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Heeres M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-223; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hietbrink F, 2015, SHOCK, V44, P209, DOI 10.1097/SHK.0000000000000405; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hoth JJ, 2014, J TRAUMA ACUTE CARE, V76, P601, DOI 10.1097/TA.0000000000000129; Hoth JJ, 2012, SHOCK, V37, P385, DOI 10.1097/SHK.0b013e3182478478; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Husecken Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13019-6; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kalbitz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18088-1; Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368; Kanakaris NK, 2017, INJURY, V48, pS10, DOI 10.1016/j.injury.2017.04.017; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kenawy HI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00215; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Koeppen M, 2013, MUCOSAL IMMUNOL, V6, P762, DOI 10.1038/mi.2012.114; Kojima M, 2018, FASEB J, V32, P97, DOI 10.1096/fj.201700488R; Kojima M, 2017, J TRAUMA ACUTE CARE, V82, P42, DOI 10.1097/TA.0000000000001296; Kottke MA, 2016, SHOCK, V46, P20, DOI 10.1097/SHK.0000000000000666; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Langness S, 2017, AM J PHYSIOL-GASTR L, V312, pG274, DOI 10.1152/ajpgi.00371.2016; Langness S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168322; Laplante P, 2017, J INVEST DERMATOL, V137, P2005, DOI 10.1016/j.jid.2017.04.030; Lederer JA, 2008, PHYSIOL GENOMICS, V32, P299, DOI 10.1152/physiolgenomics.00086.2007; Lee MA, 2008, INT J CLIN EXP MED, V1, P171; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Li HP, 2015, J TRAUMA ACUTE CARE, V78, P272, DOI 10.1097/TA.0000000000000509; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lissauer ME, 2007, J TRAUMA, V62, P1082, DOI 10.1097/TA.0b013e31804d23e1; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lu RH, 2015, NAT REV NEPHROL, V11, P707, DOI 10.1038/nrneph.2015.131; Lucca JJD, 2012, SHOCK, V38, P82, DOI 10.1097/SHK.0b013e31825a3522; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Ma J, 2017, CELL MOL NEUROBIOL, V37, P111, DOI 10.1007/s10571-016-0351-6; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Matijevic N, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29338; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Mira JC, 2017, CRIT CARE MED, V45, P1989, DOI 10.1097/CCM.0000000000002697; Mitchell TA, 2017, SHOCK, V47, P680, DOI 10.1097/SHK.0000000000000819; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morishita K, 2015, AM J PHYSIOL-GASTR L, V309, pG202, DOI 10.1152/ajpgi.00097.2015; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Muroya T, 2014, CRIT CARE MED, V42, pE364, DOI 10.1097/CCM.0000000000000231; Naumann D. N., 2017, SHOCK; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Niesler U, 2014, SHOCK, V42, P3, DOI 10.1097/SHK.0000000000000167; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Okusa MD, 2017, NAT REV NEPHROL, V13, P669, DOI 10.1038/nrneph.2017.132; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Pape HC, 2007, ANN SURG, V246, P491, DOI 10.1097/SLA.0b013e3181485750; Pape HC, 2003, J TRAUMA, V55, P7, DOI 10.1097/01.TA.0000075787.69695.4E; Patel JJ, 2016, CURR OPIN CRIT CARE, V22, P339, DOI 10.1097/MCC.0000000000000331; Paunel-Gorgulu A, 2012, MOL MED, V18, P325, DOI 10.2119/molmed.2011.00380; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Pfeifer R, 2017, J TRAUMA ACUTE CARE, V83, P496, DOI 10.1097/TA.0000000000001571; Prin M., 2016, INJURY EPIDEMIOL, V3, P18, DOI [10.1186/s40621-016-0084-5, DOI 10.1186/S40621-016-0084-5]; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Raghavendran K, 2009, SHOCK, V32, P122, DOI 10.1097/SHK.0b013e31819c385c; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Rittirsch D, 2016, ANN SURG, V264, P1125, DOI 10.1097/SLA.0000000000001553; Rixen D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1162-2; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Robb CT, 2016, SEMIN IMMUNOPATHOL, V38, P425, DOI 10.1007/s00281-016-0560-6; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruan XC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/458626; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sauaia A, 2017, CRIT CARE CLIN, V33, P167, DOI 10.1016/j.ccc.2016.08.006; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Seshadri A, 2017, CRIT CARE MED, V45, P1523, DOI 10.1097/CCM.0000000000002577; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sodhi CP, 2015, J IMMUNOL, V194, P4931, DOI 10.4049/jimmunol.1402490; Sordi R, 2017, ANN SURG, V265, P408, DOI 10.1097/SLA.0000000000001664; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tiesi G, 2013, SHOCK, V39, P507, DOI 10.1097/SHK.0b013e318293d020; Timmermans K, 2016, INTENS CARE MED, V42, P551, DOI 10.1007/s00134-015-4205-3; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; van Wessem KJP, 2013, J SURG RES, V183, P377, DOI 10.1016/j.jss.2012.12.042; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wen ZM, 2014, J IMMUNOL, V193, P4623, DOI 10.4049/jimmunol.1400899; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; White NJ, 2017, J TRAUMA ACUTE CARE, V82, pS41, DOI 10.1097/TA.0000000000001436; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wilson NM, 2017, SHOCK, V48, P401, DOI 10.1097/SHK.0000000000000882; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xu J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002365; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yamada N, 2018, ANN SURG, V268, P348, DOI 10.1097/SLA.0000000000002186; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao C, 2014, J TRAUMA ACUTE CARE, V76, P1222, DOI 10.1097/TA.0000000000000220; Zhao HL, 2016, CRIT CARE MED, V44, P1000, DOI 10.1097/CCM.0000000000001603	198	225	238	8	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					327	341		10.1038/s41590-018-0064-8	http://dx.doi.org/10.1038/s41590-018-0064-8			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29507356	Green Accepted			2022-12-18	WOS:000428151000013
J	Liu, GW; Yang, K; Burns, S; Shrestha, S; Chi, HB				Liu, Guangwei; Yang, Kai; Burns, Samir; Shrestha, Sharad; Chi, Hongbo			The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T-reg cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TGF-BETA; FOXP3 EXPRESSION; LYMPHOCYTE EGRESS; INDUCTION; MTOR; AKT; SPHINGOSINE-1-PHOSPHATE; GENERATION; CONVERSION	Naive CD4(+) T cells differentiate into diverse effector and regulatory lineages to orchestrate immunity and tolerance. Here we found that the differentiation of proinflammatory T helper type 1 (T(H)1) cells and anti-inflammatory Foxp3(+) regulatory T cells (T-reg cells) was reciprocally regulated by S1P(1), a receptor for the bioactive lipid sphingosine 1-phosphate (S1P). S1P(1) inhibited the generation of extrathymic and natural T-reg cells while driving T(H)1 development in a reciprocal manner and disrupted immune homeostasis. S1P(1) signaled through the kinase mTOR and antagonized the function of transforming growth factor-beta mainly by attenuating sustained activity of the signal transducer Smad3. S1P(1) function was dependent on endogenous sphingosine kinase activity. Notably, two seemingly unrelated immunosuppressants, FTY720 and rapamycin, targeted the same S1P(1) and mTOR pathway to regulate the dichotomy between T(H)1 cells and T-reg cells. Our studies establish an S1P(1)-mTOR axis that controls T cell lineage specification.	[Liu, Guangwei; Yang, Kai; Burns, Samir; Shrestha, Sharad; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Yang, Kai/E-2785-2013	Chi, Hongbo/0000-0002-9997-2496; 	US National Institutes of Health [K01 AR053573, R01 NS064599, CA021765]; Arthritis Foundation; Lupus Research Institute; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Lupus Research Institute; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Proia (US National Institutes of Health) for S1pr1<SUP>flox/flox</SUP> mice; A. Rudensky (Memorial Sloan-Kettering Institute) for Foxp3<SUP>gfp</SUP> knock-in mice; T. Ludwig (Columbia University) for Rosa26-Cre-ER<SUP>T2</SUP> mice; D. Littman (New York University) for Foxp3-expressing retroviral constructs; D. Green (St. Jude Children's Research Hospital) for Bcl-2-transgenic mice and discussions; and R. Cross, G. Lennon and S. Morgan for cell sorting. Supported by US National Institutes of Health (K01 AR053573 and administrative supplement, R01 NS064599, and Cancer Center Support Grant CA021765), the Arthritis Foundation, the Lupus Research Institute and the American Lebanese Syrian Associated Charities (H.C.).	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Huang MC, 2007, J IMMUNOL, V178, P6806, DOI 10.4049/jimmunol.178.11.6806; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang WG, 2007, J IMMUNOL, V178, P4885, DOI 10.4049/jimmunol.178.8.4885; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	49	225	236	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1047	U103		10.1038/ni.1939	http://dx.doi.org/10.1038/ni.1939			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI		Green Accepted			2022-12-18	WOS:000283127800015
J	Xu, WF; He, B; Chiu, A; Chadburn, A; Shan, MM; Buldys, M; Ding, AH; Knowles, DM; Santini, PA; Cerutti, A				Xu, Weifeng; He, Bing; Chiu, April; Chadburn, Amy; Shan, Meimei; Buldys, Malwina; Ding, Aihao; Knowles, Daniel M.; Santini, Paul A.; Cerutti, Andrea			Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; TOLL-LIKE RECEPTORS; GUT LAMINA PROPRIA; DENDRITIC CELLS; B-CELLS; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; MUCOSAL; IGA; TRANSPORT	Epithelial cells (ECs) transport class-switched immunoglobulin G (IgG) and IgA antibodies across mucous membranes. Whether ECs initiate class switching remains unknown. Here we found that ECs lining tonsillar crypts formed pockets populated by B cells expressing activation-induced cytidine deaminase (AID), an enzyme associated with ongoing class switching. ECs released B cell-activating AID-inducing factors after sensing microbial products through Toll-like receptors. The resulting class switching was amplified by thymic stromal lymphopoietin, an epithelial interleukin 7-like cytokine that enhanced the B cell 'licensing' function of dendritic cells, and was restrained by secretory leukocyte protease inhibitor, an epithelial homeostatic protein that inhibited AID induction in B cells. Thus, ECs may function as mucosal 'guardians' orchestrating frontline IgG and IgA class switching through a Toll-like receptor-inducible signaling program regulated by secretory leukocyte protease inhibitor.	Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Immunol & Microbiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Cerutti, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	acerutti@med.cornell.edu		Cerutti, Andrea/0000-0003-3026-4704; Xu, Weifeng/0000-0001-7598-1489	NIAID NIH HHS [T32 AI07621, R21 AI057130, R01 AI057653, AI057653, R01 AI074378] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057130, T32AI007621, R01AI074378, R01AI057653] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cerutti A, 2005, IMMUNOL CELL BIOL, V83, P554, DOI 10.1111/j.1440-1711.2005.01389.x; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; GRAEMECOOK F, 1993, AM J PATHOL, V143, P1416; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Hiemstra PS, 2004, CURR PHARM DESIGN, V10, P2891, DOI 10.2174/1381612043383566; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; MOSTOV KE, 1985, CELL, V43, P389, DOI 10.1016/0092-8674(85)90166-7; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	50	225	234	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					294	303		10.1038/ni1434	http://dx.doi.org/10.1038/ni1434			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17259987				2022-12-18	WOS:000244275100015
J	Iizuka, K; Naidenko, OV; Plougastel, BFM; Fremont, DH; Yokoyama, WM				Iizuka, K; Naidenko, OV; Plougastel, BFM; Fremont, DH; Yokoyama, WM			Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors	NATURE IMMUNOLOGY			English	Article							HOST-RESISTANCE LOCUS; CLASS-I MOLECULES; NK CELLS; GENE-COMPLEX; ACTIVATION RECEPTOR; MONOCLONAL-ANTIBODY; MULTIGENE FAMILY; IMMUNE-SYSTEM; C57BL/6 MICE; RECOGNITION	The natural killer (NK) gene complex (NKC) encodes orphan lectin-like NK cell receptors that may explain uncharacterized NK cell specificities. Unlike other NKC-encoded receptors that recognize molecules with major histocompatibility complex (MHC) class I folds, here we show that mouse Nkrp1d and Nkrp1f bind specific C-type lectin-related (Clr) molecules. Nkrp1d mediated inhibition when recognizing Clrb, a molecule expressed in dendritic cells and macrophages. Nkrp1 (official gene name, Kirb1) and Clr are intertwined in a genetically conserved NKC region showing recombination suppression, reminiscent of plant self-incompatibility loci. Thus, these findings broaden the 'missing-self' hypothesis from solely involving MHC class I to including related NK cell receptors for lectin-like ligands, and reflect genetic strategies for biological self-recognition processes in other species.	Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst,Rheumatol Div, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Barnes Jewish Hosp, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst,Rheumatol Div, St Louis, MO 63110 USA.	yokoyama@imgate.wustl.edu	Plougastel-Douglas, Beatrice/Q-3186-2019	Plougastel-Douglas, Beatrice/0000-0002-6389-561X; Fremont, Daved/0000-0002-8544-2689				Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; Brown MG, 2001, IMMUNOGENETICS, V53, P584, DOI 10.1007/s002510100365; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; Colonna M, 1996, CURR OPIN IMMUNOL, V8, P101, DOI 10.1016/S0952-7915(96)80112-9; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Felsenstein J., 2005, CLADISTICS; Ferris PJ, 2002, GENETICS, V160, P181; Forbes CA, 1997, GENOMICS, V41, P406, DOI 10.1006/geno.1997.4667; Furukawa H, 2002, J IMMUNOL, V169, P126, DOI 10.4049/jimmunol.169.1.126; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; HACKETT J, 1986, J IMMUNOL, V136, P3124; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1998, NATURE, V391, P740, DOI 10.1038/35739; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; Mehta IK, 2001, IMMUNOGENETICS, V53, P572, DOI 10.1007/s002510100355; Mehta IK, 2001, CELL IMMUNOL, V209, P29, DOI 10.1006/cimm.2001.1786; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; Plougastel B, 2001, IMMUNOGENETICS, V53, P592, DOI 10.1007/s002510100367; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Sambrook J, 2001, MOL CLONING LAB MANU; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Vitale M, 2002, BLOOD, V99, P1723, DOI 10.1182/blood.V99.5.1723; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wilhelm BT, 2002, GENOMICS, V80, P646, DOI 10.1006/geno.2002.7004; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; YOKOYAMA WM, 1993, CURR OPIN IMMUNOL, V5, P67, DOI 10.1016/0952-7915(93)90083-5; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	46	225	234	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					801	807		10.1038/ni954	http://dx.doi.org/10.1038/ni954			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12858173				2022-12-18	WOS:000184441500018
J	Nagao, K; Kobayashi, T; Moro, K; Ohyama, M; Adachi, T; Kitashima, DY; Ueha, S; Horiuchi, K; Tanizaki, H; Kabashima, K; Kubo, A; Cho, YH; Clausen, BE; Matsushima, K; Suematsu, M; Furtado, GC; Lira, SA; Farber, JM; Udey, MC; Amagai, M				Nagao, Keisuke; Kobayashi, Tetsuro; Moro, Kazuyo; Ohyama, Manabu; Adachi, Takeya; Kitashima, Daniela Y.; Ueha, Satoshi; Horiuchi, Keisuke; Tanizaki, Hideaki; Kabashima, Kenji; Kubo, Akiharu; Cho, Young-hun; Clausen, Bjorn E.; Matsushima, Kouji; Suematsu, Makoto; Furtado, Glaucia C.; Lira, Sergio A.; Farber, Joshua M.; Udey, Mark C.; Amagai, Masayuki			Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin	NATURE IMMUNOLOGY			English	Article							LANGERHANS CELLS; LYMPHOCYTE EGRESS; IMMUNE-RESPONSE; STEM-CELLS; T-CELLS; BULGE; POPULATION; DISTINCT; MICE; SPHINGOSINE-1-PHOSPHATE	Langerhans cells (LCs) are epidermal dendritic cells with incompletely understood origins that associate with hair follicles for unknown reasons. Here we show that in response to external stress, mouse hair follicles recruited Gr-1(hi) monocyte-derived precursors of LCs whose epidermal entry was dependent on the chemokine receptors CCR2 and CCR6, whereas the chemokine receptor CCR8 inhibited the recruitment of LCs. Distinct hair-follicle regions had differences in their expression of ligands for CCR2 and CCR6. The isthmus expressed the chemokine CCL2; the infundibulum expressed the chemokine CCL20; and keratinocytes in the bulge produced the chemokine CCL8, which is the ligand for CCR8. Thus, distinct hair-follicle keratinocyte subpopulations promoted or inhibited repopulation with LCs via differences in chemokine production, a feature also noted in humans. Pre-LCs failed to enter hairless skin in mice or humans, which establishes hair follicles as portals for LCs.	[Nagao, Keisuke; Kobayashi, Tetsuro; Ohyama, Manabu; Adachi, Takeya; Kitashima, Daniela Y.; Kubo, Akiharu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Moro, Kazuyo] RIKEN Res Ctr Allergy & Immunol, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Dept Prevent Med, Tokyo, Japan; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped, Tokyo, Japan; [Horiuchi, Keisuke; Kubo, Akiharu] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Tanizaki, Hideaki; Kabashima, Kenji] Kyoto Univ, Fac Med, Dept Dermatol, Kyoto 606, Japan; [Cho, Young-hun; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Clausen, Bjorn E.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Suematsu, Makoto] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Suematsu Gas Biol Project, Tokyo, Japan; [Furtado, Glaucia C.; Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Farber, Joshua M.] NIAID, Lab Mol Immunol, US Natl Inst Hlth, Bethesda, MD 20892 USA	Keio University; RIKEN; University of Tokyo; Keio University; Keio University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC; Keio University; Japan Science & Technology Agency (JST); Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nagao, K (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	nagaok@med.keio.ac.jp	CLAUSEN, Björn Erik/A-8229-2010; Suematsu, Makoto/I-8135-2013; ADACHI, Takeya/C-4996-2018; Nagao, Keisuke/J-5116-2013; Nagao, Keisuke/P-3837-2018; Moro, Kazuyo/A-5987-2016; Ohyama, Manabu/J-5524-2014; Kubo, Akiharu/I-2711-2014; Amagai, Masayuki/K-5325-2013; Suematsu, Makoto/O-5762-2018; Horiuchi, Keisuke/L-2277-2013; Kabashima, Kenji/G-2521-2014	CLAUSEN, Björn Erik/0000-0002-2484-7842; Suematsu, Makoto/0000-0002-7165-6336; ADACHI, Takeya/0000-0002-5289-5980; Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138; Ohyama, Manabu/0000-0002-2662-5717; Kubo, Akiharu/0000-0003-0902-3586; Amagai, Masayuki/0000-0003-3314-7052; Suematsu, Makoto/0000-0002-7165-6336; Horiuchi, Keisuke/0000-0001-7063-9609; Kabashima, Kenji/0000-0002-0773-0554; Ueha, Satoshi/0000-0002-3871-9921; Kobayashi, Tetsuro/0000-0003-2316-4748; Moro, Kazuyo/0000-0002-7377-1303	Japan Society for the Promotion of Science; Kanae Foundation for the Promotion of Medical Science; Japaneses Dermatological Association; Netherlands Organization for Scientific Research; Intramural Research Program of the Center for Cancer Research of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIASC003669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201, R01DK067381] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23790432, 24659216, 22390095] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for the Promotion of Medical Science; Japaneses Dermatological Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Intramural Research Program of the Center for Cancer Research of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Eguchi and H. Ito for assistance, and M. Kajimura for assistance with multiphoton microscopy. Supported by the Japan Society for the Promotion of Science (K.N. and M.A.), The Kanae Foundation for the Promotion of Medical Science, and Japaneses Dermatological Association (K.N.), The Netherlands Organization for Scientific Research (B.E.C.) and the Intramural Research Program of the Center for Cancer Research of the National Cancer Institute (M.C.U.).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BELSITO DV, 1988, J INVEST DERMATOL, V91, P219, DOI 10.1111/1523-1747.ep12465012; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ghoreishi M, 2010, BRIT J DERMATOL, V163, P57, DOI 10.1111/j.1365-2133.2010.09775.x; Gilliam AC, 1998, J INVEST DERMATOL, V110, P422, DOI 10.1046/j.1523-1747.1998.00162.x; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kobayashi T, 2010, J INVEST DERMATOL, V130, P1988, DOI 10.1038/jid.2010.68; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lyle S, 1998, J CELL SCI, V111, P3179; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Mian A, 2005, MOL GENET METAB, V84, P278, DOI 10.1016/j.ymgme.2004.11.005; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; Nagao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008543; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Stefanato CM, 2010, HISTOPATHOLOGY, V56, P24, DOI 10.1111/j.1365-2559.2009.03439.x; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880	48	224	227	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					744	+		10.1038/ni.2353	http://dx.doi.org/10.1038/ni.2353			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22729248	Green Accepted			2022-12-18	WOS:000306569600010
J	Rogozin, IB; Iyer, LM; Liang, LZ; Glazko, GV; Liston, VG; Pavlov, YI; Aravind, L; Pancer, Z				Rogozin, Igor B.; Iyer, Lakshminarayan M.; Liang, Lizhi; Glazko, Galina V.; Liston, Victoria G.; Pavlov, Youri I.; Aravind, L.; Pancer, Zeev			Evolution and diversification of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; POLYNUCLEOTIDE (DEOXY)CYTIDINE DEAMINASES; IMMUNOGLOBULIN GENE CONVERSION; VARIABLE LYMPHOCYTE RECEPTORS; SOMATIC DIVERSIFICATION; AID/APOBEC FAMILY; RECOMBINATION; HYPERMUTATION; MUTATIONS; REPERTOIRE	The variable lymphocyte receptors (VLRs) of jawless vertebrates such as lamprey and hagfish are composed of highly diverse modular leucine-rich repeats. Each lymphocyte assembles a unique VLR by rearrangement of the germline gene. In the lamprey genome, we identify here about 850 distinct cassettes encoding leucine-rich repeat modules that serve as sequence templates for the hypervariable VLR repertoires. The data indicate a gene conversion-like process in VLR diversification. Genomic analysis suggested a link between the VLR and platelet glycoprotein receptors. Lamprey lymphocytes express two putative deaminases of the AID-APOBEC family that may be involved in VLR diversification, as indicated by in vitro mutagenesis and recombination assays. Vertebrate acquired immunity could have therefore originated from lymphocyte receptor diversification by an ancestral AID-like DNA cytosine deaminase.	Univ Maryland, Inst Biotechnol, Ctr Marine Biotechnol, Baltimore, MD 21202 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Rochester; University of Nebraska System; University of Nebraska Medical Center	Pancer, Z (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Marine Biotechnol, 600 E Lombard St, Baltimore, MD 21202 USA.	pancer@comb.umbi.umb.edu	Iyer, Lakshminarayan M./H-2996-2019; Pavlov, Youri/T-7532-2017	Aravind, L/0000-0003-0771-253X; Rogozin, Igor/0000-0003-0802-4851; Pavlov, Youri/0000-0003-1179-5796	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Butler JE, 1998, REV SCI TECH OIE, V17, P43, DOI 10.20506/rst.17.1.1096; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Litman GW, 2005, ADV IMMUNOL, V87, P209, DOI 10.1016/S0065-2776(05)87006-3; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Mayorov VI, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-10; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Rogozin IB, 1996, BBA-GENE STRUCT EXPR, V1306, P171, DOI 10.1016/0167-4781(95)00241-3; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0	49	224	246	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					647	656		10.1038/ni1463	http://dx.doi.org/10.1038/ni1463			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17468760				2022-12-18	WOS:000246703300019
J	Yoshida, T; Ng, SYM; Zuniga-Pflucker, JC; Georgopoulos, K				Yoshida, T; Ng, SYM; Zuniga-Pflucker, JC; Georgopoulos, K			Early hematopoietic lineage restrictions directed by Ikaros	NATURE IMMUNOLOGY			English	Article							COMMON LYMPHOID PROGENITORS; T-CELL DEVELOPMENT; STEM-CELLS; BONE-MARROW; TRANSCRIPTIONAL REGULATION; GENE LEADS; IDENTIFICATION; COMMITMENT; DEFECTS; MICE	Ikaros is expressed in early hematopoietic progenitors and is required for lymphoid differentiation. In the absence of Ikaros, there is a lack of markers defining fate restriction along lympho-myeloid pathways, but it is unclear whether formation of specific progenitors or expression of their markers is affected. Here we use a reporter based on Ikaros regulatory elements to separate early progenitors in wild-type and Ikaros-null mice. We found previously undetected Ikaros-null lympho-myeloid progenitors lacking the receptor tyrosine kinase Flt3 that were capable of myeloid but not lymphoid differentiation. In contrast, lack of Ikaros in the common myeloid progenitor resulted in increased formation of erythro-megakaryocytes at the expense of myeloid progenitors. Using this approach, we identify previously unknown pivotal functions for Ikaros in distinct fate 'decisions' in the early hematopoietic hierarchy.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Immunol, Toronto, ON M4N 3M5, Canada	Harvard University; Massachusetts General Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Georgopoulos, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Yoshida, Toshimi/GSN-8717-2022; Zuniga-Pflucker, Juan C/H-1295-2012	Yoshida, Toshimi/0000-0001-7080-6913; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178	NIAID NIH HHS [R37 AI033062-09A1, 5R37 R01 AI33062, 5T32 AI07529, R01 AI042254, R01 AI033062, R37 AI033062, R01 AI042254-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033062, R01AI033062, T32AI007529, R01AI042254] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kaufmann C, 2003, EMBO J, V22, P2211, DOI 10.1093/emboj/cdg186; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lemischka I R, 1991, Semin Immunol, V3, P349; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Lopez RA, 2002, P NATL ACAD SCI USA, V99, P602, DOI 10.1073/pnas.022412699; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; METCALF D, 1979, J CELL PHYSIOL, V98, P401, DOI 10.1002/jcp.1040980216; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; NAKAHATA T, 1982, J CELL PHYSIOL, V111, P239, DOI 10.1002/jcp.1041110304; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	43	224	233	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					382	391		10.1038/ni1314	http://dx.doi.org/10.1038/ni1314			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16518393	Green Submitted, Green Accepted			2022-12-18	WOS:000236171000012
J	Saijo, K; Schmedt, C; Su, I; Karasuyama, H; Lowell, CA; Reth, M; Adachi, T; Patke, A; Santana, A; Tarakhovsky, A				Saijo, K; Schmedt, C; Su, I; Karasuyama, H; Lowell, CA; Reth, M; Adachi, T; Patke, A; Santana, A; Tarakhovsky, A			Essential role of Src-family protein tyrosine kinases in NF-kappa B activation during B cell development	NATURE IMMUNOLOGY			English	Article							LYN-DEFICIENT MICE; SIGNAL-TRANSDUCTION; HEMATOPOIETIC-CELLS; AUTOIMMUNE-DISEASE; ANTIGEN RECEPTOR; LIGHT-CHAIN; BETA; SYK; PHOSPHORYLATION; DIFFERENTIATION	The nature of signals that govern the development of immunoglobulin heavy chain-dependent B cells is largely unknown. Using mice deficient for the B cell-expressed Src-family protein tyrosine kinases (SFKs) Blk, Fyn and Lyn, we show an essential role of these kinases in pre-B cell receptor (pre-BCR)-mediated NF-kappaB activation and B cell development. This signaling defect is SFK specific, as a deficiency in Syk, which controls pre-B cell development, does not affect NF-kappaB induction. Impaired NF-kappaB induction was overcome by the activation of protein kinase C (PKC)-lambda, thus suggesting the involvement of PKC-lambda in pre-BCR-mediated SFK-dependent activation of NF-kappaB. Our data show the existence of a functionally distinct SFK signaling module responsible for pre-BCR-mediated NF-kappaB activation and B cell development.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138519, Japan; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Freiburg, Dept Mol Immunol, D-79108 Freiburg, Germany; Max Planck Inst Immunol, D-79108 Freiburg, Germany	Rockefeller University; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Francisco; University of Freiburg; Max Planck Society	Saijo, K (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	saijok@mail.rockefeller.edu; tarakho@mail.rockefeller.edu	Su, I-hsin/A-2207-2011; Karasuyama, Hajime/A-7966-2011	Su, I-hsin/0000-0002-5894-9580; Karasuyama, Hajime/0000-0003-0689-0836	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058066] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54476] Funding Source: Medline; NIAID NIH HHS [AI053545-01] Funding Source: Medline; NIDDK NIH HHS [DK58066] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Horikawa K, 1999, INT IMMUNOL, V11, P1441, DOI 10.1093/intimm/11.9.1441; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kistler B, 1998, J IMMUNOL, V160, P2308; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LAW DA, 1992, MOL IMMUNOL, V29, P917, DOI 10.1016/0161-5890(92)90130-P; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lu Y, 2001, ONCOGENE, V20, P4777, DOI 10.1038/sj.onc.1204607; Maki K, 2000, J EXP MED, V191, P1333, DOI 10.1084/jem.191.8.1333; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; MISCHAK H, 1991, J IMMUNOL, V147, P3981; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WECHSLER RJ, 1995, J IMMUNOL, V154, P1919; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Wooten MW, 2001, MOL CELL BIOL, V21, P8414, DOI 10.1128/MCB.21.24.8414-8427.2001; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zoller KE, 1997, J IMMUNOL, V158, P1650	49	224	229	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					274	279		10.1038/ni893	http://dx.doi.org/10.1038/ni893			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12563261				2022-12-18	WOS:000181201000017
J	Rottman, JB; Smith, T; Tonra, JR; Ganley, K; Bloom, T; Silva, R; Pierce, B; Gutierrez-Ramos, JC; Ozkaynak, E; Coyle, AJ				Rottman, JB; Smith, T; Tonra, JR; Ganley, K; Bloom, T; Silva, R; Pierce, B; Gutierrez-Ramos, JC; Ozkaynak, E; Coyle, AJ			The costimulatory molecule ICOS plays an important role in immunopathogenesis of EAE	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; ENCEPHALITOGENIC T-CELLS; IL-6-DEFICIENT MICE; CD28; ACTIVATION; RECEPTOR; DISEASE; DIFFERENTIATION	The inducible costimulatory molecule (ICOS) is expressed on activated T cells and participates in a variety of important immunoregulatory functions. After the induction of experimental allergic encephalomyelitis in SJL mice with proteolipid protein (PLP), brain ICOS mRNA and protein were up-regulated on infiltrating CD3(+) T cells before disease onset. ICOS blockade during the efferent immune response (9-20 days after immunization) abrogated disease, but blockade during antigen priming (1-10 days after immunization) exacerbated disease. Upon culture with PLP and compared with immunized controls, splenocytes produced either decreased interferon-gamma (IFN-gamma, in efferent blockade) or excessive IFN-gamma (in priming blockade). PLP-specific immunoglobulin GI was decreased in animals treated with anti-ICOS during antigen priming, but not in other groups.	Millennium Pharmaceut, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Rottman, JB (corresponding author), Millennium Pharmaceut, 640 Mem Dr, Cambridge, MA 02139 USA.							Aloisi F, 1998, J IMMUNOL, V160, P4671; Boddeke EWGM, 1999, J NEUROIMMUNOL, V98, P176, DOI 10.1016/S0165-5728(99)00096-X; BOOM WH, 1988, J EXP MED, V167, P1350, DOI 10.1084/jem.167.4.1350; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Constantinescu CS, 2001, CLIN IMMUNOL, V98, P23, DOI 10.1006/clim.2000.4944; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; CROSS AH, 1990, LAB INVEST, V63, P162; Das MP, 1997, J EXP MED, V186, P867, DOI 10.1084/jem.186.6.867; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Glabinski AR, 1997, AM J PATHOL, V150, P617; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; JACOBS CA, 1991, J IMMUNOL, V146, P2983; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; KRAKOWSKI ML, 1997, EUR J IMMUNOL, V27, P284; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; Mathur M, 1999, AM J RESP CELL MOL, V21, P498, DOI 10.1165/ajrcmb.21.4.3714; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McColl SR, 1999, J IMMUNOL, V163, P2829; Okuda Y, 2000, J NEUROIMMUNOL, V105, P120, DOI 10.1016/S0165-5728(00)00192-2; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Perrin PJ, 1999, J IMMUNOL, V163, P1704; Perrin PJ, 1996, J IMMUNOL, V157, P1333; Perrin PJ, 1996, J NEUROIMMUNOL, V65, P31, DOI 10.1016/0165-5728(95)00172-7; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Ransohoff Richard M., 1996, Cytokine and Growth Factor Reviews, V7, P35, DOI 10.1016/1359-6101(96)00003-2; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Tada Y, 1999, J IMMUNOL, V162, P203; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Wekerle H, 1991, Acta Neurol (Napoli), V13, P197; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	39	224	261	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					605	611		10.1038/89750	http://dx.doi.org/10.1038/89750			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429544				2022-12-18	WOS:000169682100013
J	Meunier, E; Wallet, P; Dreier, RF; Costanzo, S; Anton, L; Ruhl, S; Dussurgey, S; Dick, MS; Kistner, A; Rigard, M; Degrandi, D; Pfeffer, K; Yamamoto, M; Henry, T; Broz, P				Meunier, Etienne; Wallet, Pierre; Dreier, Roland F.; Costanzo, Stephanie; Anton, Leonie; Ruehl, Sebastian; Dussurgey, Sebastien; Dick, Mathias S.; Kistner, Anne; Rigard, Melanie; Degrandi, Daniel; Pfeffer, Klaus; Yamamoto, Masahiro; Henry, Thomas; Broz, Petr			Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; RESISTANCE MECHANISM; MGBP2 CONTROLS; HOST-DEFENSE; MELANOMA 2; TULARENSIS; DNA; GTPASES	The AIM2 inflammasome detects double-stranded DNA in the cytosol and induces caspase-1-dependent pyroptosis as well as release of the inflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18. AIM2 is critical for host defense against DNA viruses and bacteria that replicate in the cytosol, such as Francisella tularensis subspecies novicida (F. novicida). The activation of AIM2 by F. novicida requires bacteriolysis, yet whether this process is accidental or is a host-driven immunological mechanism has remained unclear. By screening nearly 500 interferon-stimulated genes (ISGs) through the use of small interfering RNA (siRNA), we identified guanylate-binding proteins GBP2 and GBP5 as key activators of AIM2 during infection with F. novicida. We confirmed their prominent role in vitro and in a mouse model of tularemia. Mechanistically, these two GBPs targeted cytosolic F. novicida and promoted bacteriolysis. Thus, in addition to their role in host defense against vacuolar pathogens, GBPs also facilitate the presentation of ligands by directly attacking cytosolic bacteria.	[Meunier, Etienne; Dreier, Roland F.; Anton, Leonie; Ruehl, Sebastian; Dick, Mathias S.; Kistner, Anne; Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Wallet, Pierre; Costanzo, Stephanie; Rigard, Melanie; Henry, Thomas] Univ Lyon 1, Ctr Int Rech Infectiol, Inserm U1111, CNRS UMR 5308,Ecole Normale Super, F-69365 Lyon, France; [Dussurgey, Sebastien] Univ Lyon 1, Struct Federat Rech Biosci, UMS344 US8, INSERM,CNRS,Ecole Normale Super, F-69365 Lyon, France; [Degrandi, Daniel; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Osaka, Japan	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Heinrich Heine University Dusseldorf; Osaka University	Henry, T (corresponding author), Univ Lyon 1, Ctr Int Rech Infectiol, Inserm U1111, CNRS UMR 5308,Ecole Normale Super, F-69365 Lyon, France.	thomas.henry@inserm.fr; petr.broz@unibas.ch	Broz, Petr/AAC-7940-2019; Ruehl, Sebastian/AAJ-7903-2020; Henry, Thomas/G-3160-2013	Broz, Petr/0000-0002-2334-7790; Henry, Thomas/0000-0002-0687-8565; Dick, Mathias/0000-0002-4070-9749; Wallet, Pierre/0000-0001-6639-9526; Pfeffer, Klaus/0000-0002-5652-6330	Swiss National Science Foundation [PP00P3_139120/1]; University of Basel [ID2153162]; European Research Council [311542]; Deleguation Generale de l'Armement	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; European Research Council(European Research Council (ERC)European Commission); Deleguation Generale de l'Armement	We thank N. Gekara (Umea University) for Sting<SUP>Gt/Gt</SUP> mice; M. Roth and S. Hofer for support with mouse experiments; D. Monack (Stanford University) for chicken antibody to F. novicida; N. Kayagaki (Genentech) and V. Dixit (Genentech) for Gbp5<SUP>-/-</SUP> and Aim<SUP>2-/-</SUP> mice, rat antibody to ASC and rat antibody to caspase-1; L. Gallagher and C. Manoil (University of Washington) for plasmid pFFlp; O. Allatif for statistical analysis; the Imaging and FACS Core Facilities of the Biozentrum, University of Basel, for technical assistance; and the Plateau de Biologie Experimentale de la Souris and the flow cytometry platform of SFR Biosciences Gerland-Lyon Sud. Supported by Swiss National Science Foundation (PP00P3_139120/1 to P.B.), the University of Basel (ID2153162 to P.B.), the European Research Council (311542 to T.H.) and the Deleguation Generale de l'Armement (M.R.).	Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2012, AUTOPHAGY, V8, P1342, DOI 10.4161/auto.20808; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jones JW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00016; Juruj C, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00014; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nothelfer K, 2011, VIRULENCE, V2, P54, DOI 10.4161/viru.2.1.14666; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zhou HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031752	48	223	231	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					476	U185		10.1038/ni.3119	http://dx.doi.org/10.1038/ni.3119			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25774716	Green Accepted			2022-12-18	WOS:000353305200010
J	De Santo, C; Arscott, R; Booth, S; Karydis, I; Jones, M; Asher, R; Salio, M; Middleton, M; Cerundolo, V				De Santo, Carmela; Arscott, Ramon; Booth, Sarah; Karydis, Ioannis; Jones, Margaret; Asher, Ruth; Salio, Mariolina; Middleton, Mark; Cerundolo, Vincenzo			Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; DENDRITIC CELLS; CUTTING EDGE; ONCOSTATIN-M; IN-VIVO; RECEPTOR; ACTIVATION; RESPONSES; CD1D; IDENTIFICATION	Neutrophils are the main effector cells during inflammation, but they can also control excessive inflammatory responses by secreting anti-inflammatory cytokines. However, the mechanisms that modulate their plasticity remain unclear. We now show that systemic serum amyloid A 1 (SAA-1) controls the plasticity of neutrophil differentiation. SAA-1 not only induced anti-inflammatory interleukin 10 (IL-10)-secreting neutrophils but also promoted the interaction of invariant natural killer T cells (iNKT cells) with those neutrophils, a process that limited their suppressive activity by diminishing the production of IL-10 and enhancing the production of IL-12. Because SAA-1-producing melanomas promoted differentiation of IL-10-secreting neutrophils, harnessing iNKT cells could be useful therapeutically by decreasing the frequency of immunosuppressive neutrophils and restoring tumor-specific immune responses.	[De Santo, Carmela; Arscott, Ramon; Booth, Sarah; Karydis, Ioannis; Salio, Mariolina; Cerundolo, Vincenzo] Univ Oxford, Nuffield Dept Med, MRC, Weatherall Inst Mol Med,Human Immunol Unit, Oxford, England; [Jones, Margaret] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Asher, Ruth] Univ Oxford, John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England; [Middleton, Mark] Univ Oxford, Churchill Hosp, Dept Med Oncol, Oxford Canc & Haematol Ctr, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Cerundolo, V (corresponding author), Univ Oxford, Nuffield Dept Med, MRC, Weatherall Inst Mol Med,Human Immunol Unit, Oxford, England.	vincenzo.cerundolo@imm.ox.ac.uk	Jones, Margaret/B-4083-2009	Karydis, Ioannis/0000-0003-0284-3549; Cerundolo, Vincenzo/0000-0003-0040-3793; Karydis, Ioannis/0000-0002-8308-3141; Salio, Mariolina/0000-0002-4821-3801	Cancer Research UK [C399/A2291]; UK Medical Research Council; The Wellcome Trust [084923/Z/08/Z]; Cancer Research Institute; Ludwig Institute for Cancer Research; Oxford National Institute for Health Research Biomedical Research Centre; Oxford Experimental Cancer Medicine Centre; MRC [G0501975, G1000800] Funding Source: UKRI; Cancer Research UK [8466] Funding Source: researchfish; Medical Research Council [G1000800, G1000800e, G0501975] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research Institute; Ludwig Institute for Cancer Research; Oxford National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Van Kaer (Vanderbilt University School of Medicine) for Cd1d<SUP>-/-</SUP> (CD45.2<SUP>+/+</SUP>) mice; R. Lisle and K. Hollowood for help in preparing melanoma sample sections and analyzing stained samples; G. Napolitani, A. Stock and M. Johnson for discussions and critical reading of the manuscript; and P. Polzella for technical support. Supported by Cancer Research UK (C399/A2291), the UK Medical Research Council, The Wellcome Trust (084923/Z/08/Z), the Cancer Research Institute, the Ludwig Institute for Cancer Research (V.C.), the Oxford National Institute for Health Research Biomedical Research Centre (M.M., R. Asher and M.J.) and the Oxford Experimental Cancer Medicine Centre (for clinical sample processing).	Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Cross A, 2004, ARTHRITIS RHEUM-US, V50, P1430, DOI 10.1002/art.20166; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; De Santo C, 2005, P NATL ACAD SCI USA, V102, P4185, DOI 10.1073/pnas.0409783102; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Dunbar PR, 2000, J IMMUNOL, V165, P6644, DOI 10.4049/jimmunol.165.11.6644; Findeisen P, 2009, J CLIN ONCOL, V27, P2199, DOI 10.1200/JCO.2008.18.0554; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; He R, 2006, J IMMUNOL, V177, P4072, DOI 10.4049/jimmunol.177.6.4072; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; JACOBS DM, 1977, J IMMUNOL, V118, P21; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Morris ES, 2009, NAT MED, V15, P436, DOI 10.1038/nm.1948; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paret C, 2010, EUR UROL, V57, P859, DOI 10.1016/j.eururo.2009.08.014; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Raghuraman G, 2006, J IMMUNOL, V177, P7841, DOI 10.4049/jimmunol.177.11.7841; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Salio M, 2001, J IMMUNOL, V167, P1188, DOI 10.4049/jimmunol.167.3.1188; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Salio M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000226; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Skold M, 2005, J IMMUNOL, V175, P3584, DOI 10.4049/jimmunol.175.6.3584; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uhlar CM, 1999, SCAND J IMMUNOL, V49, P399; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; van der Vliet HJJ, 2008, J IMMUNOL, V180, P7287, DOI 10.4049/jimmunol.180.11.7287; WHICHER JT, 1985, J CLIN PATHOL, V38, P312, DOI 10.1136/jcp.38.3.312; Wislez M, 2003, CANCER RES, V63, P1405; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; [No title captured]	62	223	227	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1039	U92		10.1038/ni.1942	http://dx.doi.org/10.1038/ni.1942			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20890286	Green Accepted			2022-12-18	WOS:000283127800014
J	Ha, EM; Lee, KA; Seo, YY; Kim, SH; Lim, JH; Oh, BH; Kim, J; Lee, WJ				Ha, Eun-Mi; Lee, Kyung-Ah; Seo, You Yeong; Kim, Sung-Hee; Lim, Jae-Hong; Oh, Byung-Ha; Kim, Jaesang; Lee, Won-Jae			Coordination of multiple dual oxidase-regulatory pathways in responses to commensal and infectious microbes in drosophila gut	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; IMMUNE-RESPONSE; NEGATIVE REGULATOR; P38; PEPTIDOGLYCAN; RECOGNITION; CALCINEURIN; PHOSPHATASE; EXPRESSION; IDENTIFICATION	All metazoan guts are in permanent contact with the microbial realm. However, understanding of the exact mechanisms by which the strength of gut immune responses is regulated to achieve gut-microbe mutualism is far from complete. Here we identify a signaling network composed of complex positive and negative mechanisms that controlled the expression and activity of dual oxidase (DUOX), which 'fine tuned' the production of microbicidal reactive oxygen species depending on whether the gut encountered infectious or commensal microbes. Genetic analyses demonstrated that negative and positive regulation of DUOX was required for normal host survival in response to colonization with commensal and infectious microbes, respectively. Thus, the coordinated regulation of DUOX enables the host to achieve gut-microbe homeostasis by efficiently combating infection while tolerating commensal microbes.	[Ha, Eun-Mi; Lee, Kyung-Ah; Seo, You Yeong; Kim, Sung-Hee; Kim, Jaesang; Lee, Won-Jae] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Ha, Eun-Mi; Lee, Kyung-Ah; Seo, You Yeong; Kim, Sung-Hee; Lee, Won-Jae] Ewha Womans Univ, Natl Creat Res Initiat Ctr Symbiosyst, Seoul, South Korea; [Lim, Jae-Hong] Pohang Inst Sci & Technol, Pohang Accelerator Lab, Beamline Div, Pohang 790600, Kyungbuk, South Korea; [Oh, Byung-Ha] Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang, Kyungbuk, South Korea; [Oh, Byung-Ha] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Kim, Jaesang; Lee, Won-Jae] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Lee, Won-Jae] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Ewha Womans University; Ewha Womans University	Lee, WJ (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	lwj@ewha.ac.kr	Oh, Byung-Ha/C-2061-2011		Korean Ministry of Education, Science and Technology, World Class University [R31-2008-000-10010-0]; Global Research Laboratory program [K20815000001]; Brain Korea 21 project	Korean Ministry of Education, Science and Technology, World Class University(Ministry of Education, Science & Technology (MEST), Republic of Korea); Global Research Laboratory program; Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	We thank J. Chung (Korea Advanced Institute of Science and Technology) for fly stocks. Supported by the National Creative Research Initiative Program of the Korean Ministry of Education, Science and Technology, World Class University project (R31-2008-000-10010-0), Global Research Laboratory program (K20815000001 to B.-H. O.), and Brain Korea 21 project (E.-M. H., K.-A. L. and Y. Y. S.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Kim M, 2004, MOL CELL BIOL, V24, P573, DOI 10.1128/MCB.24.2.573-583.2004; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kim SH, 2002, BIOCHEM J, V361, P143, DOI 10.1042/bj3610143; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee WJ, 2000, BIOCHEM J, V349, P821, DOI 10.1042/bj3490821; Lee WJ, 2008, CELL HOST MICROBE, V4, P91, DOI 10.1016/j.chom.2008.07.007; Lee WJ, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe24; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sullivan KMC, 2002, GENETICS, V161, P183; Sun L, 2008, CELL SIGNAL, V20, P1329, DOI 10.1016/j.cellsig.2008.03.003; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhuang ZH, 2006, CELL SIGNAL, V18, P441, DOI 10.1016/j.cellsig.2005.05.013	50	223	230	6	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					949	U19		10.1038/ni.1765	http://dx.doi.org/10.1038/ni.1765			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19668222				2022-12-18	WOS:000269120900008
J	Binder, RJ; Srivastava, PK				Binder, RJ; Srivastava, PK			Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; PLASMA-MEMBRANE; IN-VIVO; PROCESSING PATHWAY; PRESENTING CELLS; CTL RESPONSES; CUTTING EDGE; DYING CELLS; GP96; EXPRESSION	The form in which antigens are transferred from cancer cells or infected cells to antigen-presenting cells as a part of the process of priming CD8(+) T cells has been a longstanding unresolved issue. Intact proteins or protein fragments in the form of free peptides or peptides chaperoned by heat-shock protein are possible sources of antigen. We address this here using beta-galactosidase and ovalbumin. Immunization with cell lysates containing intact proteins and heat-shock protein - peptide complexes or with cell lysates depleted of either component demonstrated that protein fragments chaperoned by heat-shock protein and not intact protein were the necessary and sufficient source of antigen transferred to antigen-presenting cells for priming CD8(+) T cell responses.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA	University of Connecticut	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA.	srivastava@nso2.uchc.edu		Srivastava, Pramod/0000-0003-2837-2861	NCI NIH HHS [CA84479-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084479] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Chandawarkar RY, 1999, J EXP MED, V189, P1437, DOI 10.1084/jem.189.9.1437; Chandawarkar RY, 2004, INT IMMUNOL, V16, P615, DOI 10.1093/intimm/dxh063; Cicconi R, 2004, MOL CELL BIOCHEM, V259, P1, DOI 10.1023/B:MCBI.0000021335.52162.51; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DENIS M, 1988, ANAL BIOCHEM, V173, P405, DOI 10.1016/0003-2697(88)90207-2; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Fonteneau JF, 2002, CURR OPIN IMMUNOL, V14, P471, DOI 10.1016/S0952-7915(02)00358-8; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Hirai I, 1998, CELL STRUCT FUNCT, V23, P153, DOI 10.1247/csf.23.153; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Ishii T, 1999, J IMMUNOL, V162, P1303; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kovar J, 2004, CELL PHYSIOL BIOCHEM, V14, P41, DOI 10.1159/000076925; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Menoret A, 1999, BIOCHEM BIOPH RES CO, V262, P813, DOI 10.1006/bbrc.1999.1306; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Overwijk WW, 1997, METHODS, V12, P117, DOI 10.1006/meth.1997.0461; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Peng P, 1997, J IMMUNOL METHODS, V204, P13, DOI 10.1016/S0022-1759(97)00017-3; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wang XY, 2001, J IMMUNOL, V166, P490, DOI 10.4049/jimmunol.166.1.490	43	223	246	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					593	599		10.1038/ni1201	http://dx.doi.org/10.1038/ni1201			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15864309				2022-12-18	WOS:000229385900014
J	Gill, J; Malin, M; Hollander, GA; Boyd, R				Gill, J; Malin, M; Hollander, GA; Boyd, R			Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells	NATURE IMMUNOLOGY			English	Article							EARLY THYMOCYTE DEVELOPMENT; NEURAL CREST; STEM-CELL; HEMATOPOIETIC PROGENITORS; MEDULLARY EPITHELIUM; PRESENTATION PATHWAY; POSITIVE SELECTION; STROMAL CELLS; DIFFERENTIATION; EXPRESSION	The epithelial component of the thymic microenvironment is indispensable for the generation of T lymphocytes. Although the heterogeneity of this epithelium is well documented, little is known about precursor-progeny relationships between distinct thymic epithelial lineages. Here we characterized a thymic epithelial cell subpopulation identified by the cell surface glycoprotein MTS24. These cells contained epithelial progenitor cells that were competent and sufficient to fully reconstitute the complex thymic epithelial microenvironment that supported normal T cell development.	Monash Univ, Sch Med, Dept Pathol & Immunol, Melbourne, Vic 3181, Australia; Univ Basel, Childrens Univ Hosp, Basel, Switzerland; Univ Basel, Dept Clin Biol Sci, Basel, Switzerland	Monash University; University of Basel; University of Basel	Gill, J (corresponding author), Monash Univ, Sch Med, Dept Pathol & Immunol, Commercial Rd, Melbourne, Vic 3181, Australia.			Hollander, Georg/0000-0002-8790-0874; Gill, Jason/0000-0003-0955-6470				Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9; BENNETT AR, 2002, IN PRESS IMMUNITY; Berzins SP, 1999, J IMMUNOL, V162, P5119; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; Conway SJ, 1997, DEVELOPMENT, V124, P505; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Godfrey D I, 1988, Adv Exp Med Biol, V237, P269; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hare KJ, 1999, J IMMUNOL, V162, P3978; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kasai M, 1996, EUR J IMMUNOL, V26, P2101, DOI 10.1002/eji.1830260921; Kasai M, 1998, EUR J IMMUNOL, V28, P1867, DOI 10.1002/(SICI)1521-4141(199806)28:06<1867::AID-IMMU1867>3.0.CO;2-K; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Lee YN, 2001, MOL CELL BIOL, V21, P7696, DOI 10.1128/MCB.21.22.7696-7706.2001; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Oukka M, 1997, EUR J IMMUNOL, V27, P855, DOI 10.1002/eji.1830270408; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; ROPKE C, 1995, DEV IMMUNOL, V4, P149, DOI 10.1155/1995/23168; Simmons PJ, 2001, ANN NY ACAD SCI, V938, P196; SIMMONS PJ, 2001, ANN NY ACAD SCI, V938, P206; Su DM, 2000, J IMMUNOL, V164, P5753, DOI 10.4049/jimmunol.164.11.5753; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Zannettino ACW, 1998, BLOOD, V92, P2613, DOI 10.1182/blood.V92.8.2613.420k15_2613_2628; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	50	223	228	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					635	642		10.1038/ni812	http://dx.doi.org/10.1038/ni812			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12068292				2022-12-18	WOS:000176441700013
J	Diebold, BA; Bokoch, GM				Diebold, BA; Bokoch, GM			Molecular basis for Rac2 regulation of phagocyte NADPH oxidase	NATURE IMMUNOLOGY			English	Article							SUPEROXIDE-GENERATING SYSTEM; NEUTROPHIL RESPIRATORY BURST; GTP-BINDING PROTEINS; CELL-FREE SYSTEM; ELECTRON FLOW; FLAVOCYTOCHROME B(558); ACTIVATION DOMAIN; EFFECTOR REGION; INSERT REGION; P67(PHOX)	A pac GTPase-regulated multiprotein NADPH oxidase is critical for the formation of reactive oxygen species (ROS) in phagocytic leukocytes and other nonphagocytic cells. NADPH oxidase reduces molecular oxygen to form superoxide anion in a two-step process. Electrons are initially transferred from NADPH to cytochrome b-associated FAD, then to cytochrome b heme and finally to molecular oxygen. We show here that pac is required for both electron-transfer reactions. Mutational and biophysical analysis shows that pac and p67(phox) independently regulate cytochrome b to catalyze the transfer of electrons from NADPH to FAD. However, they must interact with each other to induce the subsequent transfer of electrons from FAD to cytochrome b heme and molecular oxygen. This two-step model of regulation by pac GTPase may provide a means of more effectively controlling the inflammatory responses of phagocytic leukocytes.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Diebold, BA (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NCRR NIH HHS [M01 RR00833] Funding Source: Medline; NHLBI NIH HHS [HL48008] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1992, J BIOL CHEM, V267, P16767; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; CROSS AR, 1995, J BIOL CHEM, V270, P6543, DOI 10.1074/jbc.270.12.6543; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; Cross AR, 1999, J BIOL CHEM, V274, P15519, DOI 10.1074/jbc.274.22.15519; CROSS AR, 1994, J BIOL CHEM, V269, P21448; CROSS AR, 1995, J BIOL CHEM, V270, P8194, DOI 10.1074/jbc.270.14.8194; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; PHILIPS MR, 1995, J BIOL CHEM, V270, P11514, DOI 10.1074/jbc.270.19.11514; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; XU XM, 1994, J BIOL CHEM, V269, P23569	35	223	225	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					211	215		10.1038/85259	http://dx.doi.org/10.1038/85259			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224519				2022-12-18	WOS:000167413800012
J	Wessel, F; Winderlich, M; Holm, M; Frye, M; Rivera-Galdos, R; Vockel, M; Linnepe, R; Ipe, U; Stadtmann, A; Zarbock, A; Nottebaum, AF; Vestweber, D				Wessel, Florian; Winderlich, Mark; Holm, Maren; Frye, Maike; Rivera-Galdos, Ronmy; Vockel, Matthias; Linnepe, Ruth; Ipe, Ute; Stadtmann, Anika; Zarbock, Alexander; Nottebaum, Astrid F.; Vestweber, Dietmar			Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin	NATURE IMMUNOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ENDOTHELIAL GROWTH-FACTOR; TRANSENDOTHELIAL MIGRATION; PHOSPHORYLATION; JUNCTIONS; PTP; ANGIOGENESIS; INFLAMMATION; MAINTAINS; ADHERENS	Tyrosine phosphorylation of the adhesion molecule VE-cadherin is assumed to affect endothelial junction integrity. However, it remains unclear whether tyrosine residues of VE-cadherin are required for the induction of vascular permeability and the regulation of leukocyte extravasation in vivo. We found here that knock-in mice expressing a Y685F mutant of VE-cadherin had impaired induction of vascular permeability, but those expressing a Y731F mutant did not. In contrast, mice expressing the Y731F VE-cadherin mutant showed decreased neutrophil-extravasation in cremaster tissue, but those expressing the Y685F mutant did not. Whereas inflammatory mediators induced the phosphorylation of Tyr685 in vivo, Tyr731 showed high baseline phosphorylation. Leukocytes triggered dephosphorylation of Tyr731 via the tyrosine phosphatase SHP-2, which allowed the adaptin AP-2 to bind and initiate endocytosis of VE-cadherin. Thus, Tyr685 and Tyr731 of VE-cadherin distinctly and selectively regulate the induction of vascular permeability or leukocyte extravasation.	[Wessel, Florian; Winderlich, Mark; Holm, Maren; Frye, Maike; Rivera-Galdos, Ronmy; Vockel, Matthias; Linnepe, Ruth; Ipe, Ute; Zarbock, Alexander; Nottebaum, Astrid F.; Vestweber, Dietmar] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Stadtmann, Anika; Zarbock, Alexander] Univ Munster, Dept Anesthesiol & Crit Care Med, Munster, Germany	Max Planck Society; University of Munster	Vestweber, D (corresponding author), Max Planck Inst Mol Biomed, D-48149 Munster, Germany.	vestweb@mpi-muenster.mpg.de	Frye, Maike/ABH-3349-2021	Frye, Maike/0000-0002-6257-7636; Vestweber, Dietmar/0000-0002-3517-732X; Nottebaum, Astrid Fee/0000-0003-2246-7851	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 629]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank B. Kempe and B. Waschk for the transfection and cultivation of embryonic stem cells; D. Brandhorst for help with intravital microscopy; and F. Kiefer for supervising work with embryonic stem cells and for critically reading the manuscript. Supported by the Max Planck Society (D.V.) and the Deutsche Forschungsgemeinschaft SFB 629 to (D.V.).	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Baluk P, 1998, AM J PATHOL, V152, P1463; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gotsch U, 1997, J CELL SCI, V110, P583; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062	30	222	225	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					223	230		10.1038/ni.2824	http://dx.doi.org/10.1038/ni.2824			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24487320				2022-12-18	WOS:000331683100007
J	Litvak, V; Ramsey, SA; Rust, AG; Zak, DE; Kennedy, KA; Lampano, AE; Nykter, M; Shmulevich, I; Aderem, A				Litvak, Vladimir; Ramsey, Stephen A.; Rust, Alistair G.; Zak, Daniel E.; Kennedy, Kathleen A.; Lampano, Aaron E.; Nykter, Matti; Shmulevich, Ilya; Aderem, Alan			Function of C/EBP delta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; BINDING PROTEIN FAMILY; INNATE IMMUNE-RESPONSE; SYSTEMS BIOLOGY; KAPPA-B; PATHOGEN RECOGNITION; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; GENE-EXPRESSION; ACTIVATION	The innate immune system is like a double-edged sword: it is absolutely required for host defense against infection, but when uncontrolled, it can trigger a plethora of inflammatory diseases. Here we use systems- biology approaches to predict and confirm the existence of a gene- regulatory network involving dynamic interaction among the transcription factors NF-kappa B, C/EBP Omega and ATF3 that controls inflammatory responses. We mathematically modeled transcriptional regulation of the genes encoding interleukin 6 and C/EBP delta and experimentally confirmed the prediction that the combination of an initiator (NF-kappa B), an amplifier (C/EBP delta) and an attenuator (ATF3) forms a regulatory circuit that discriminates between transient and persistent Toll-like receptor 4-induced signals. Our results suggest a mechanism that enables the innate immune system to detect the duration of infection and to respond appropriately.	[Litvak, Vladimir; Ramsey, Stephen A.; Rust, Alistair G.; Zak, Daniel E.; Kennedy, Kathleen A.; Lampano, Aaron E.; Nykter, Matti; Shmulevich, Ilya; Aderem, Alan] Inst Syst Biol, Seattle, WA USA	Institute for Systems Biology (ISB)	Aderem, A (corresponding author), Inst Syst Biol, Seattle, WA USA.	aaderem@systemsbiology.org		Nykter, Matti/0000-0001-6956-2843; Rust, Alistair/0000-0001-7287-192X	Irvington Institute Fellowship Program of the Cancer Research Institute; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025032, R01AI032972] Funding Source: NIH RePORTER	Irvington Institute Fellowship Program of the Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Irvington Institute Fellowship Program of the Cancer Research Institute (V. L.) and the National Institutes of Health (A. A.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816	37	222	230	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					437	443		10.1038/ni.1721	http://dx.doi.org/10.1038/ni.1721			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19270711	Green Accepted			2022-12-18	WOS:000264425800018
J	Gadola, SD; Zaccai, NR; Harlos, K; Shepherd, D; Castro-Palomino, JC; Ritter, G; Schmidt, RR; Jones, EY; Cerundolo, V				Gadola, SD; Zaccai, NR; Harlos, K; Shepherd, D; Castro-Palomino, JC; Ritter, G; Schmidt, RR; Jones, EY; Cerundolo, V			Structure of human CD1b with bound ligands at 2.3 angstrom, a maze for alkyl chains	NATURE IMMUNOLOGY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; ELECTRON-DENSITY MAPS; LYMPHOCYTES-T; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; RECOGNITION; CELLS; GLYCOLIPIDS; COMPLEXES; PROGRAM	The human genome encodes five nonpolymorphic major histocompatibility complex class I-like glycoproteins, CD1a to CD1e, that present lipid antigens for specific recognition by T lymphocytes. Using single alkyl chain detergents, we developed a protocol to generate recombinant human CD1b-lipid complexes. We present here the crystal structures of CD1b in complex with either phosphatidylinositol or ganglioside GM2 at 2.3 Angstrom and 2.8 Angstrom resolutions, respectively. The antigen-binding groove houses four interlinked hydrophobic channels that are occupied by the alkyl chains of the glycolipid plus two detergent molecules. A distinct exit beneath the 2 helix further contributes to the plasticity of the binding groove. These structures reveal the mechanism by which two alkyl chain lipids bind to CD1b, and how CD1b can adapt to ligands of different alkyl chain length. They also suggest how very long alkyl chains, such as those of mycolic acid, could be fully contained within the binding groove. These results extend the spectrum of potential CD1b ligands by revealing that, in addition to two alkyl chain lipids, mono-alkyl and triple-alkyl chain lipids can be accommodated in the binding groove.	Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, Canc Res UK Tumour Immunol Grp, Oxford OX3 9DS, England; Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England; Univ Konstanz, Dept Chem, D-78457 Constance, Germany; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	University of Oxford; Cancer Research UK; University of Konstanz; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Gadola, SD (corresponding author), Univ Bern, Inselspital, Dept Rheumatol & Clin Immunol, PKT2 D584, CH-3010 Bern, Switzerland.		Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Cerundolo, Vincenzo/0000-0003-0040-3793; Zaccai, Nathan/0000-0002-1476-2044; Shepherd, Dawn/0000-0003-1304-6051				Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Briken V, 2000, SEMIN IMMUNOL, V12, P517, DOI 10.1006/smim.2000.0274; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CastroPalomino JC, 1997, ANGEW CHEM INT EDIT, V36, P1998, DOI 10.1002/anie.199719981; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; HANSSON GK, 1989, AM J PATHOL, V135, P169; HARLOS K, 1992, J APPL CRYSTALLOGR, V25, P536, DOI 10.1107/S0021889892002656; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hopkins AL, 1996, J MED CHEM, V39, P1589, DOI 10.1021/jm960056x; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Melian A, 1999, AM J PATHOL, V155, P775, DOI 10.1016/S0002-9440(10)65176-0; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Niazi KR, 2001, J IMMUNOL, V166, P2562, DOI 10.4049/jimmunol.166.4.2562; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascher I, 1996, CURR OPIN STRUC BIOL, V6, P439, DOI 10.1016/S0959-440X(96)80107-2; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rosat JP, 1999, J IMMUNOL, V162, P366; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wu R, 1996, SCAND J IMMUNOL, V43, P381, DOI 10.1046/j.1365-3083.1996.d01-51.x; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	42	222	229	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					721	726		10.1038/ni821	http://dx.doi.org/10.1038/ni821			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12118248				2022-12-18	WOS:000177118500010
J	Bain, G; Cravatt, CB; Loomans, C; Alberola-Ila, J; Hedrick, SM; Murre, C				Bain, G; Cravatt, CB; Loomans, C; Alberola-Ila, J; Hedrick, SM; Murre, C			Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade	NATURE IMMUNOLOGY			English	Article							T-CELL LYMPHOMAS; THYMIC SELECTION; THYMOCYTE DIFFERENTIATION; PHOSPHOLIPASE C-GAMMA-1; TRANSCRIPTION FACTORS; NEGATIVE SELECTION; KINASE ACTIVATION; SIGNALING PATHWAY; ANTIGEN RECEPTOR; TRANSGENIC MICE	Activation of mitogen-activated protein kinase (MAPK) pathways leads to cellular differentiation and/or proliferation in a wide variety of cell types, including developing thymocytes. The basic helix-loop-helix (bHLH) proteins E12 and E47 and an inhibitor HLH protein, Id3, play key roles in thymocyte differentiation. We show here that E2A DNA binding is lowered in primary immature thymocytes consequent to T cell receptor (TCR)-mediated ligation. Whereas expression of E2A mRNA and protein are unaltered, Id3 transcripts are rapidly induced upon signaling from the TCR. Activation of Id3 transcription is regulated in a dose-dependent manner by the extracellular signal-regulated kinase (ERK) MAPK module. These observations directly connect the ERK MAPK cascade and HLH proteins in a linear pathway.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; California Institute of Technology	Murre, C (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751; Bain, Gretchen/0000-0001-7513-9486; alberola-ila, Jose/0000-0003-2439-553X	NIAID NIH HHS [R01 AI045072-05, R01 AI045072] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045072] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Barndt R, 1999, J IMMUNOL, V163, P3331; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Engel I, 1999, CURR OPIN GENET DEV, V9, P575, DOI 10.1016/S0959-437X(99)00008-8; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Griffith CE, 1998, J BIOL CHEM, V273, P10771, DOI 10.1074/jbc.273.17.10771; Hagemann D, 1999, ONCOGENE, V18, P1391, DOI 10.1038/sj.onc.1202431; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim D, 1999, MOL CELL BIOL, V19, P8240; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Law CL, 1996, MOL CELL BIOL, V16, P1305; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; MARQUARDT B, 1994, ONCOGENE, V9, P3213; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Park ST, 1999, J EXP MED, V189, P501, DOI 10.1084/jem.189.3.501; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; QUI ZH, 1994, J BIOL CHEM, V269, P19480; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Shao H, 1999, J IMMUNOL, V163, P603; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	53	222	224	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					165	171		10.1038/84273	http://dx.doi.org/10.1038/84273			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175815				2022-12-18	WOS:000166778700017
J	Mucida, D; Husain, MM; Muroi, S; van Wijk, F; Shinnakasu, R; Naoe, Y; Reis, BS; Huang, YJ; Lambolez, F; Docherty, M; Attinger, A; Shui, JW; Kim, G; Lena, CJ; Sakaguchi, S; Miyamoto, C; Wang, P; Atarashi, K; Park, Y; Nakayama, T; Honda, K; Ellmeier, W; Kronenberg, M; Taniuchi, I; Cheroutre, H				Mucida, Daniel; Husain, Mohammad Mushtaq; Muroi, Sawako; van Wijk, Femke; Shinnakasu, Ryo; Naoe, Yoshinori; Reis, Bernardo Sgarbi; Huang, Yujun; Lambolez, Florence; Docherty, Michael; Attinger, Antoine; Shui, Jr-Wen; Kim, Gisen; Lena, Christopher J.; Sakaguchi, Shinya; Miyamoto, Chizuko; Wang, Peng; Atarashi, Koji; Park, Yunji; Nakayama, Toshinori; Honda, Kenya; Ellmeier, Wilfried; Kronenberg, Mitchell; Taniuchi, Ichiro; Cheroutre, Hilde			Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes	NATURE IMMUNOLOGY			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; CD8; INTERLEUKIN-15; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; REPRESSION; RESPONSES; GATA-3; THPOK	TCR alpha beta thymocytes differentiate into either CD8 alpha beta(+) cytotoxic T lymphocytes or CD4(+) helper T cells. This functional dichotomy is controlled by key transcription factors, including the helper T cell master regulator ThPOK, which suppresses the cytolytic program in major histocompatibility complex (MHC) class II-restricted CD4(+) thymocytes. ThPOK continues to repress genes of the CD8 lineage in mature CD4(+) T cells, even as they differentiate into effector helper T cell subsets. Here we found that the helper T cell fate was not fixed and that mature, antigen-stimulated CD4(+) T cells terminated expression of the gene encoding ThPOK and reactivated genes of the CD8 lineage. This unexpected plasticity resulted in the post-thymic termination of the helper T cell program and the functional differentiation of distinct MHC class II-restricted CD4(+) cytotoxic T lymphocytes.	[Mucida, Daniel; Husain, Mohammad Mushtaq; van Wijk, Femke; Shinnakasu, Ryo; Huang, Yujun; Lambolez, Florence; Docherty, Michael; Attinger, Antoine; Shui, Jr-Wen; Kim, Gisen; Lena, Christopher J.; Park, Yunji; Kronenberg, Mitchell; Cheroutre, Hilde] La Jolla Inst Allergy Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Muroi, Sawako; Naoe, Yoshinori; Miyamoto, Chizuko; Taniuchi, Ichiro] RIKEN Res Ctr Allergy & Immunol, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Reis, Bernardo Sgarbi] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10021 USA; [Sakaguchi, Shinya; Ellmeier, Wilfried] Med Univ Vienna, Ctr Physiol Pathophysiol & Immunol, Inst Immunol, Vienna, Austria; [Wang, Peng] La Jolla Inst Allergy Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Atarashi, Koji; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan	La Jolla Institute for Immunology; RIKEN; Rockefeller University; Medical University of Vienna; La Jolla Institute for Immunology; University of Tokyo; Chiba University	Cheroutre, H (corresponding author), La Jolla Inst Allergy Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.	taniuchi@rcai.riken.jp; hilde@liai.org	Honda, Kenya/N-5297-2015; Kronenberg, Mitchell/AAT-6078-2021; Reis, Bernardo S/E-3448-2012; Shui, Jr-Wen/Q-2617-2018; Taniuchi, Ichiro/N-6399-2015; Nakayama, Toshinori/E-1067-2017; Atarashi, Koji/I-5363-2014; docherty, michael/AAQ-1551-2020; HUSAIN, MOHD MUSHTAQ/I-2280-2016	Reis, Bernardo S/0000-0002-6841-116X; Shui, Jr-Wen/0000-0002-5243-3727; Taniuchi, Ichiro/0000-0002-9853-9068; Nakayama, Toshinori/0000-0002-1434-2007; Atarashi, Koji/0000-0001-5422-0736; Sakaguchi, Shinya/0000-0002-0591-2469; Park, Yunji/0000-0003-0042-202X; wang, peng/0000-0002-2972-7495; Ellmeier, Wilfried/0000-0001-8192-8481	US National Institutes of Health [R01 AI050265, DP1 OD006433, F32 DK082249, P01 DK46763]; Research Center for Allergy and Immunology; Japan Society for the Promotion of Science; Ter Meulen fund; Crohn's & Colitis Foundation of America; Austrian Science Fund (FWF) [P 23669, I 698, P 23641] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, F32DK082249, R01DK093674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105384] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006433] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Center for Allergy and Immunology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ter Meulen fund; Crohn's & Colitis Foundation of America; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Larange and I. Vicente-Suarez for discussions and critical reading of the manuscript; M. Cheroutre for contributions in conceiving of the project; Y. Wang-Zhu for preparing tetramers of the thymic leukemia antigen and breeding Rag1<SUP>-/-</SUP> mice; C. Kim and K. Van Gunst for cell sorting; D. Littman (New York University) for E8<INF>I</INF>-deficient mice; and D. Kappes (Fox Chase Cancer Center) for Thpok vectors. Supported by the US National Institutes of Health (R01 AI050265 and DP1 OD006433 to H.C.; F32 DK082249 to J.-W.S.; and P01 DK46763 to M.K. and H.C.), the Research Center for Allergy and Immunology (H.C. and I.T.), the Japan Society for the Promotion of Science (I.T.), Ter Meulen fund (F.v.W.) and the Crohn's & Colitis Foundation of America (D.M.). This is manuscript 1263 from the La Jolla Institute for Allergy and Immunology.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Aliahmad P, 2011, J IMMUNOL, V187, P5931, DOI 10.4049/jimmunol.1101474; Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Ebert EC, 1998, GASTROENTEROLOGY, V115, P1439, DOI 10.1016/S0016-5085(98)70022-8; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; GUYGRAND D, 1991, J EXP MED, V173, P1549, DOI 10.1084/jem.173.6.1549; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hirose K, 1998, INFECT IMMUN, V66, P5677, DOI 10.1128/IAI.66.12.5677-5683.1998; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Khanna R, 1997, J IMMUNOL, V158, P3619; KO HS, 1979, J EXP MED, V150, P246, DOI 10.1084/jem.150.2.246; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; SASAHARA T, 1994, MICROBIOL IMMUNOL, V38, P191, DOI 10.1111/j.1348-0421.1994.tb01764.x; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Strutt TM, 2009, J CLIN IMMUNOL, V29, P145, DOI 10.1007/s10875-008-9266-4; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SYDORA BC, 1993, J IMMUNOL, V150, P2179; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Ye WG, 1996, CELL IMMUNOL, V174, P54, DOI 10.1006/cimm.1996.0293	43	221	233	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					281	289		10.1038/ni.2523	http://dx.doi.org/10.1038/ni.2523			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23334788	Green Accepted			2022-12-18	WOS:000315065400018
J	Schneider, M; Zimmermann, AG; Roberts, RA; Zhang, L; Swanson, KV; Wen, HT; Davis, BK; Allen, IC; Holl, EK; Ye, ZM; Rahman, AH; Conti, BJ; Eitas, TK; Koller, BH; Ting, JPY				Schneider, Monika; Zimmermann, Albert G.; Roberts, Reid A.; Zhang, Lu; Swanson, Karen V.; Wen, Haitao; Davis, Beckley K.; Allen, Irving C.; Holl, Eda K.; Ye, Zhengmao; Rahman, Adeeb H.; Conti, Brian J.; Eitas, Timothy K.; Koller, Beverly H.; Ting, Jenny P-Y			The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kappa B	NATURE IMMUNOLOGY			English	Article							COLON INFLAMMATION; HOST RECOGNITION; ZINC-FINGER; ACTIVATION; BACTERIAL; UBIQUITIN; ENZYME; NLRX1; NOD1; POLYUBIQUITINATION	Several members of the NLR family of sensors activate innate immunity. In contrast, we found here that NLRC3 inhibited Toll-like receptor (TLR)-dependent activation of the transcription factor NF-kappa B by interacting with the TLR signaling adaptor TRAF6 to attenuate Lys63 (K63)-linked ubiquitination of TRAF6 and activation of NE-kappa B. We used bioinformatics to predict interactions between NLR and TRAF proteins, including interactions of TRAF with NLRC3. In vivo, macrophage expression of Nlc3 mRNA was diminished by the administration of lipopolysaccharide (LPS) but was restored when cellular activation subsided. To assess biologic relevance, we generated Nlrc3(-/-) mice. LPS-treated Nlrc3(-/-) macrophages had more K63-ubiquitinated TRAF6, nuclear NF-kappa B and proinflammatory cytokines. Finally, LPS-treated Nlrc3(-/-) mice had more signs of inflammation. Thus, signaling via NLRC3 and TLR constitutes a negative feedback loop. Furthermore, prevalent NLR-TRAF interactions suggest the formation of a 'TRAFasome' complex.	[Schneider, Monika; Roberts, Reid A.; Holl, Eda K.; Ye, Zhengmao; Conti, Brian J.; Ting, Jenny P-Y] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Zimmermann, Albert G.; Swanson, Karen V.; Wen, Haitao; Davis, Beckley K.; Allen, Irving C.; Rahman, Adeeb H.; Eitas, Timothy K.; Ting, Jenny P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Zhang, Lu; Koller, Beverly H.] Univ N Carolina, Sch Dent, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Inst Inflammatory Dis, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu	Zhang, Lu/P-6929-2015; Wen, Haitao/AAJ-7621-2020	Allen, Irving/0000-0001-9573-5250; Rahman, Adeeb/0000-0002-8620-3161; Swanson, Karen V/0000-0003-3105-0599	US National Institutes of Health [R37-AI029564, U54-AI057157, U19-AI1077437, T32-AR007416]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564, U19AI077437, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092355] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Ghosh (Columbia University New York) for hemagglutinin-tagged MyD88 and Flag-tagged IRAK; Y. Xiong (University of North Carolina) for plasmids encoding hemagglutinin-tagged K48-linked ubiquitin and K63-linked ubiquitin; A. Baldwin (University of North Carolina) for Flag-tagged IKK alpha; and R. Thresher (University of North Carolina) for the targeting vector pOS. Supported by the US National Institutes of Health (R37-AI029564, U54-AI057157, U19-AI1077437 and T32-AR007416).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Horie R, 1998, INT IMMUNOL, V10, P203, DOI 10.1093/intimm/10.2.203; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Marinis JM, 2011, J BIOL CHEM, V286, P1938, DOI 10.1074/jbc.M110.189308; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	49	221	227	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					823	831		10.1038/ni.2378	http://dx.doi.org/10.1038/ni.2378			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22863753	Green Published, Green Accepted			2022-12-18	WOS:000307863600010
J	Tauszig-Delamasure, S; Bilak, H; Capovilla, M; Hoffmann, JA; Imler, JL				Tauszig-Delamasure, S; Bilak, H; Capovilla, M; Hoffmann, JA; Imler, JL			Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections	NATURE IMMUNOLOGY			English	Article							ANTIMICROBIAL PEPTIDE GENES; TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; MYD88-DEFICIENT MICE; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; HOST-DEFENSE; PELLE KINASE; CPG-DNA; ACTIVATION	We report here the identification and functional characterization of DmMyD88, a gene encoding the Drosophila homolog of mammalian MyD88. DmMyD88 combines a Toll-IL-IR homology (TIR) domain and a death domain. Overexpression of DmMyD88 was sufficient to induce expression of the antifungal peptide Drosomycin, and induction of Drosomycin was markedly reduced in DmMyD88-mutant flies. DmMyD88 interacted with Toll through its TIR domain and required the death domain proteins Tube and Pelle to activate expression of Drs, which encodes Drosomycin. DmMyD88-mutant flies were highly susceptible to infection by fungi and Gram-positive bacteria, but resisted Gram-negative bacterial infection much as did wild-type flies. Phenotypic comparison of DmMyD88-mutant flies and MyD88-deficient mice showed essential differences in the control of Gram-negative infection in insects and mammals.	CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Imler, JL (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9022, 15 Rue Rene Descartes, F-67000 Strasbourg, France.	JLImler@ibmc.u-strasbg.fr	Tauszig-Delamasure, Servane/G-7192-2017; Capovilla, Maria/O-8483-2016; Tauszig-Delamasure, Servane/AAJ-6493-2020; Imler, Jean-Luc/GXH-4323-2022	Tauszig-Delamasure, Servane/0000-0003-4926-0199; Tauszig-Delamasure, Servane/0000-0003-4926-0199; Capovilla, Maria/0000-0002-1308-7964				AKLRA S, 2001, NATURE IMMUNOL, V2, P675; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHIANG C, 1994, MECH DEVELOP, V47, P225; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Edwards DN, 1997, DEVELOPMENT, V124, P3855; ELDON E, 1994, DEVELOPMENT, V120, P885; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; GALINDO RL, 1995, DEVELOPMENT, V121, P2209; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; GERTTULA S, 1988, GENETICS, V119, P123; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; MICHEL T, 2001, IN PRESS NATURE, V414; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P1519; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shen BH, 1998, DEVELOPMENT, V125, P4719; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wasserman SA, 2000, CURR OPIN GENET DEV, V10, P497, DOI 10.1016/S0959-437X(00)00118-0; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	50	221	232	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					91	97		10.1038/ni747	http://dx.doi.org/10.1038/ni747			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11743586				2022-12-18	WOS:000173148700020
J	Hogan, SP; Mishra, A; Brandt, EB; Royalty, MP; Pope, SM; Zimmermann, N; Foster, PS; Rothenberg, ME				Hogan, SP; Mishra, A; Brandt, EB; Royalty, MP; Pope, SM; Zimmermann, N; Foster, PS; Rothenberg, ME			A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation	NATURE IMMUNOLOGY			English	Article							MAJOR BASIC-PROTEIN; IN-VIVO; MUCOSAL EOSINOPHILS; TISSUE EOSINOPHILIA; CHEMOKINE EOTAXIN; INTERFERON-GAMMA; FOOD ALLERGY; GASTROENTERITIS; DISEASE; INTERLEUKIN-5	Although eosinophils have been implicated in the pathogenesis of gastrointestinal disorders, their function has not been established. Using a murine model of oral antigen-induced eosinophil-associated gastrointestinal disease, we report the pathological consequences of eosinophilic inflammation and the involvement of eotaxin and eosinophils, Exposure of mice to enteric-coated antigen promotes an extensive T helper 2-associated eosinophilic inflammatory response involving the esophagus, stomach, small intestine and Peyer's patches as well as the development of gastric dysmotility, gastromegaly and cachexia. Electron microscopy shows eosinophils in proximity to damaged axons, which indicated that eosinophils were mediating a pathologic response. In addition, mice deficient in eotaxin have impaired eosinophil recruitment and are protected from gastromegaly and cachexia. These results establish a critical pathological function for eotaxin and eosinophils in gastrointestinal allergic hypersensitivity.	Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA; Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Cincinnati Children's Hospital Medical Center; Australian National University; John Curtin School of Medical Research	Rothenberg, ME (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA.	Rothenberg@chrmcc.org	MISHRA, ANIL/S-7983-2017; Foster, Paul/G-5057-2013	MISHRA, ANIL/0000-0003-4266-4684; Brandt, Eric/0000-0003-0617-4100; , Paul/0000-0002-0827-8299; Pope, Sam/0000-0002-7724-9141	NIAID NIH HHS [R01 AI42242-02, R01 AI45898-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045898, R01AI042242] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABUGHAZALEH RI, 1989, J IMMUNOL, V142, P2393; Adamko DJ, 1999, J EXP MED, V190, P1465, DOI 10.1084/jem.190.10.1465; CELLO JP, 1979, AM J MED, V67, P1097, DOI 10.1016/0002-9343(79)90652-1; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Desreumaux P, 1996, GASTROENTEROLOGY, V110, P768, DOI 10.1053/gast.1996.v110.pm8608886; DOBBINS JW, 1977, GASTROENTEROLOGY, V72, P1312; DVORAK AM, 1993, INT ARCH ALLERGY IMM, V102, P33, DOI 10.1159/000236548; Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; FURUTA GT, 1995, CURR OPIN GASTROEN, V11, P541, DOI 10.1097/00001574-199511000-00013; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gleich GJ, 1997, P NATL ACAD SCI USA, V94, P2101, DOI 10.1073/pnas.94.6.2101; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; GLEICH GJ, 1979, J IMMUNOL, V123, P2925; Grimaldi JC, 1999, J LEUKOCYTE BIOL, V65, P846, DOI 10.1002/jlb.65.6.846; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; Hogan SP, 2000, P NATL ACAD SCI USA, V97, P6681, DOI 10.1073/pnas.97.12.6681; JAFFE JS, 1994, J CLIN IMMUNOL, V14, P299, DOI 10.1007/BF01540983; Kelly KJ, 2000, J PEDIATR GASTR NUTR, V30, pS28, DOI 10.1097/00005176-200001001-00005; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; KESHAVARZIAN A, 1985, GASTROENTEROLOGY, V88, P1041, DOI 10.1016/S0016-5085(85)80026-3; KLEIN NC, 1970, MEDICINE, V49, P299, DOI 10.1097/00005792-197007000-00003; LEE RG, 1985, AM J SURG PATHOL, V9, P475, DOI 10.1097/00000478-198507000-00002; Lin S, 1997, DIGEST DIS SCI, V42, P907, DOI 10.1023/A:1018808329603; Litwin A, 1998, BIODRUGS, V9, P261, DOI 10.2165/00063030-199809040-00001; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Lowichik A, 1996, MODERN PATHOL, V9, P110; MESTECKY J, 1978, J CLIN INVEST, V61, P731, DOI 10.1172/JCI108986; MICHAEL JG, 1989, IMMUNOL INVEST, V18, P1049, DOI 10.3109/08820138909030606; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Mishra A, 2000, BLOOD, V96, P1538, DOI 10.1182/blood.V96.4.1538.h8001538_1538_1544; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Sampson HA, 1997, JAMA-J AM MED ASSOC, V278, P1888, DOI 10.1001/jama.278.22.1888; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Schleimer RP, 1998, CLIN EXP ALLERGY, V28, P15; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Stelts D, 1998, AM J RESP CELL MOL, V18, P463, DOI 10.1165/ajrcmb.18.4.2957; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; TALLEY NJ, 1992, GASTROENTEROLOGY, V103, P137, DOI 10.1016/0016-5085(92)91106-E; TORPIER G, 1988, CLIN EXP IMMUNOL, V74, P404; van den Bos GAM, 1995, EUR J PUBLIC HEALTH, V5, P29, DOI DOI 10.1093/EURPUB/5.1.29; Weller PF, 1996, EUR RESPIR J, V9, pS109; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487	47	221	228	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					353	360		10.1038/86365	http://dx.doi.org/10.1038/86365			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276207				2022-12-18	WOS:000167982900017
J	Nguyen, KB; Cousens, LP; Doughty, LA; Pien, GC; Durbin, JE; Biron, CA				Nguyen, KB; Cousens, LP; Doughty, LA; Pien, GC; Durbin, JE; Biron, CA			Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STATI resolves a paradox	NATURE IMMUNOLOGY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER; ANTIVIRAL DEFENSE; VIRAL-INFECTIONS; IFN-GAMMA; TYROSINE PHOSPHATASE; TARGETED DISRUPTION; CELL RESPONSES; INDUCTION; CYTOKINE	Induction of high systemic levels of type I interferons (IFNs) IFN-alpha and IFN-beta is a hallmark of many viral infections. In addition to their potent antiviral effects, these cytokines mediate a number of immunoregulatory functions and can promote IFN-gamma expression in T cells. However, during viral infections of mice IFN-gamma production is not always observed at the same time as systemic IFN-alpha/beta production and when, elicited at these times, is IFN-alp-independent. We demonstrate that type I interferons not only fail to induce, but also act to inhibit, IFN-gamma expression by both NK and T cells,The mechanism of inhibition is dependent upon the IFN-alpha/beta receptor and the signal transducer and activator of transcription I (STATI). In the absence of STATI, not only are the IFN-alpha/beta-mediated inhibitory effects completely abrogated, but the cytokines themselves can induce IFN-gamma expression. These results indicate that endogenous biochemical pathways are in place to negatively regulate NK and T cell IFN-gamma expression elicited by IFN-alpha/beta or other stimuli, at times of innate responses to viral infections. They also show that type I interferon signaling can occur through STATI-dependent and independent mechanisms and suggest that efficient induction of IFN-gamma expression by IFN-alpha/beta requires STATI regulation. Such immunoregulatory pathways may be critical for shaping the endogenous innate and virus-specific adaptive immune responses to viral infections.	Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; Brown Univ, Dept Pediat, Div Biol & Med, Providence, RI 02912 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	Brown University; Brown University; University System of Ohio; Ohio State University	Biron, CA (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.				NATIONAL CANCER INSTITUTE [R01CA041268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA041268, R01-CA41268] Funding Source: Medline; NIEHS NIH HHS [T32-ES07272] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; BRUNDA MJ, 1984, CANCER RES, V44, P597; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; HAQUE SJ, 1995, J BIOL CHEM, V270, P25709, DOI 10.1074/jbc.270.43.25709; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Klimstra WB, 1999, J VIROL, V73, P10387, DOI 10.1128/JVI.73.12.10387-10398.1999; Lee CK, 1997, J BIOL CHEM, V272, P21872, DOI 10.1074/jbc.272.35.21872; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nguyen KB, 1999, J IMMUNOL, V162, P5238; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; ORANGE JS, 1995, J EXP MED, V181, P901, DOI 10.1084/jem.181.3.901; Orange JS, 1996, J IMMUNOL, V156, P1138; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Orange JS, 1996, J IMMUNOL, V156, P4746; Pfeffer LM, 1998, CANCER RES, V58, P2489; PLEN GC, 2000, J IMMUNOL, V164, P994; POLITIS AD, 1992, J IMMUNOL, V148, P801; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rogge L, 1998, J IMMUNOL, V161, P6567; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Wu CY, 1998, J IMMUNOL, V161, P2723; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; YOSHIDA R, 1988, J EXP MED, V167, P1171, DOI 10.1084/jem.167.3.1171; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416	40	221	227	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					70	76		10.1038/76940	http://dx.doi.org/10.1038/76940			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881178				2022-12-18	WOS:000089814800017
J	Chang, CH; Pearce, EL				Chang, Chih-Hao; Pearce, Erika L.			Emerging concepts of T cell metabolism as a target of immunotherapy	NATURE IMMUNOLOGY			English	Article							GLYCOLYTIC METABOLISM; EFFECTOR RESPONSES; REGULATORY T; MEMORY; ACID; ACTIVATION; KINASE; CANCER; DIFFERENTIATION; MTOR	T cells have a pivotal protective role in defense against infection and cancer but also are instrumental in the development of many autoimmune diseases. The regulation of nutrient uptake and utilization in T cells is critically important for the control of their differentiation, and manipulating metabolic pathways in these cells can alter their function and longevity. While the importance of T cell metabolic remodeling in different physiological settings is not fully understood, there is a growing realization that inappropriate metabolic remodeling underlies many aberrant immune responses and that manipulating cellular metabolism can beneficially enhance or temper immunity. Here we comment on the basic metabolic pathways in T cells, followed by a discussion on up-to-date findings about the relationship between metabolism and T cell function and longevity. Furthermore, we expand on potential approaches and applications in which T cells might be manipulated by the reprogramming of metabolic pathways for therapeutic purposes.	[Chang, Chih-Hao] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany	Washington University (WUSTL); Max Planck Society	Chang, CH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.; Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany.	chchang@pathology.wustl.edu; pearce@ie-freiburg.mpg.de		CHANG, CHIH-HAO/0000-0002-0139-7439	US National Institutes of Health [R01CA181125]; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA181125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (R01CA181125) and the Burroughs Wellcome Fund.	Ananieva EA, 2014, J BIOL CHEM, V289, P18793, DOI 10.1074/jbc.M114.554113; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Calvaresi EC, 2013, CHEMBIOCHEM, V14, P2263, DOI 10.1002/cbic.201300562; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chaoul N, 2015, CANCER RES, V75, P3279, DOI 10.1158/0008-5472.CAN-15-0454; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Lameris R, 2014, CRIT REV ONCOL HEMAT, V92, P153, DOI 10.1016/j.critrevonc.2014.08.003; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mundra V, 2015, NANOMEDICINE-UK, V10, P2613, DOI [10.2217/NNM.15.111, 10.2217/nnm.15.111]; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang Y, 2011, BRIT J CANCER, V104, P643, DOI 10.1038/bjc.2011.15; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007	50	220	246	5	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					364	368		10.1038/ni.3415	http://dx.doi.org/10.1038/ni.3415			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002844	Green Accepted			2022-12-18	WOS:000372508000008
J	Schmitt, N; Liu, Y; Bentebibel, SE; Munagala, I; Bourdery, L; Venuprasad, K; Banchereau, J; Ueno, H				Schmitt, Nathalie; Liu, Yang; Bentebibel, Salah-Eddine; Munagala, Indira; Bourdery, Laure; Venuprasad, K.; Banchereau, Jacques; Ueno, Hideki			The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of human T-FH cells	NATURE IMMUNOLOGY			English	Article							FOLLICULAR-HELPER-CELLS; FACTOR BATF CONTROLS; GERMINAL-CENTERS; B-CELLS; SJOGRENS-SYNDROME; I INTERFERONS; AUTOIMMUNITY; INDUCTION; IL-12; VIVO	Understanding the developmental mechanisms of follicular helper T cells (T-FH cells) in humans is relevant to the clinic. However, the factors that drive the differentiation of human CD4(+) helper T cells into T-FH cells remain largely undefined. Here we found that transforming growth factor-beta (TGF-beta) provided critical additional signals for the transcription factors STAT3 and STAT4 to promote initial T-FH differentiation in humans. This mechanism did not appear to be shared by mouse helper T cells. Developing human T-FH cells that expressed the transcriptional repressor Bcl-6 also expressed ROR gamma t, a transcription factor typically expressed by the T(H)17 subset of helper T cells. Our study documents a mechanism by which T-FH cells and T(H)17 cells emerge together in inflammatory environments in humans, as is often observed in many human autoimmune diseases.	[Schmitt, Nathalie; Liu, Yang; Bentebibel, Salah-Eddine; Munagala, Indira; Bourdery, Laure; Venuprasad, K.; Banchereau, Jacques; Ueno, Hideki] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health; Baylor University Medical Center	Ueno, H (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	hidekiu@baylorhealth.edu	Bentebibel, Salah-Eddine/AAS-9766-2021; Ueno, Hideki/L-1237-2016	Ueno, Hideki/0000-0001-7747-0738; Schmitt, Nathalie/0000-0001-9993-2788; poojary, venuprasd/0000-0001-8986-9092	US National Institutes of Health [U19-AI057234, U19-AI082715, U19-AI089987]; Alliance for Lupus Research; Baylor Health Care System; American Cancer Society [122713-RSG-12-260-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987, U19AI057234, U19AI082715] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Baylor Health Care System; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Trahan, S. Coquery, N. Loaf and K. Kayembe for cell sorting; K. Palucka, V. Pascual and Y.-J. Liu for discussions; S. Clayton for confocal imaging; C. Quinn for development of the heat map-generation software; Y. Kanno for advice about chromatin immunoprecipitation; Y.C. Lin for discussions about chromatin-immunoprecipitation data analysis; and M. Kathania for technical help with mouse experiments. Supported by the US National Institutes of Health (U19-AI057234, U19-AI082715 and U19-AI089987), the Alliance for Lupus Research, the Baylor Health Care System (H.U.) and the American Cancer Society (122713-RSG-12-260-01-LIB to K.V.).	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	46	220	224	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					856	865		10.1038/ni.2947	http://dx.doi.org/10.1038/ni.2947			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25064073	Green Accepted			2022-12-18	WOS:000340739400013
J	Peperzak, V; Vikstrom, I; Walker, J; Glaser, SP; LePage, M; Coquery, CM; Erickson, LD; Fairfax, K; Mackay, F; Strasser, A; Nutt, SL; Tarlinton, DM				Peperzak, Victor; Vikstroem, Ingela; Walker, Jennifer; Glaser, Stefan P.; LePage, Melanie; Coquery, Christine M.; Erickson, Loren D.; Fairfax, Kirsten; Mackay, Fabienne; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.			Mcl-1 is essential for the survival of plasma cells	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; BONE-MARROW; MULTIPLE-MYELOMA; SMALLPOX VACCINATION; RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE; CUTTING EDGE; PHASE-II; EXPRESSION; APRIL	The long-term survival of plasma cells is entirely dependent on signals derived from their environment. These extrinsic factors presumably induce and sustain the expression of antiapoptotic proteins of the Bcl-2 family. It is uncertain whether there is specificity among Bcl-2 family members in the survival of plasma cells and whether their expression is linked to specific extrinsic factors. We found here that deletion of the gene encoding the antiapoptotic protein Mcl-1 in plasma cells resulted in rapid depletion of this population in vivo. Furthermore, we found that the receptor BCMA was needed to establish high expression of Mcl-1 in bone marrow but not spleen plasma cells and that establishing this survival pathway preceded the component of plasma cell differentiation that depends on the transcriptional repressor Blimp-1. Our results identify a critical role for Mcl-1 in the maintenance of plasma cells.	[Peperzak, Victor; Vikstroem, Ingela; Walker, Jennifer; Glaser, Stefan P.; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Peperzak, Victor; Glaser, Stefan P.; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [LePage, Melanie; Fairfax, Kirsten; Mackay, Fabienne] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Coquery, Christine M.; Erickson, Loren D.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University; University of Virginia	Tarlinton, DM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	tarlinton@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Strasser, Andreas/C-7581-2013; Mackay, Fabienne/B-7440-2008	Nutt, Stephen L/0000-0002-0020-6637; Strasser, Andreas/0000-0002-5020-4891; Mackay, Fabienne/0000-0002-6074-2693; Tarlinton, David/0000-0001-9928-686X; Fairfax, Kirsten/0000-0002-8394-137X	Australia National Health and Medical Research Council (Independent Research Institute Infrastructure Support Scheme) [1043414, 356202, 461221, 637326, 516786]; Multiple Myeloma Research Foundation USA; European Molecular Biology Organization; US National Institutes of Health [AI093722]; Victorian State Government Operational Infrastructure Support; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI093722] Funding Source: NIH RePORTER	Australia National Health and Medical Research Council (Independent Research Institute Infrastructure Support Scheme); Multiple Myeloma Research Foundation USA; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian State Government Operational Infrastructure Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry; and C. Wellard, S. Chevrier, D. Segal, D. Huang, S. Heinzel, J. Marchingo, S. Willis and P. Bouillet for assistance. Supported by the Australia National Health and Medical Research Council (1043414 to I.V.; 356202 to D.M.T. and S.L.N.; 461221 to A.S.; 637326 to S.P.G.; 516786 to K.F.; and the Independent Research Institute Infrastructure Support Scheme), the Multiple Myeloma Research Foundation USA (V.P.), the European Molecular Biology Organization (V.P.), the US National Institutes of Health (AI093722 to L.D.E.) and Victorian State Government Operational Infrastructure Support.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P1793, DOI 10.1002/art.30373; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Jiang C, 2011, J IMMUNOL, V186, P6136, DOI 10.4049/jimmunol.1001931; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tarte K, 2004, BRIT J HAEMATOL, V125, P373, DOI 10.1111/j.1365-2141.2004.04908.x; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; van Vollenhoven RF, 2011, ARTHRITIS RHEUM-US, V63, P1782, DOI 10.1002/art.30372; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784	46	220	223	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					290	297		10.1038/ni.2527	http://dx.doi.org/10.1038/ni.2527			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23377201	Green Accepted			2022-12-18	WOS:000315065400019
J	Huang, QJ; Yang, JH; Lin, Y; Walker, C; Cheng, JK; Liu, ZG; Su, B				Huang, QJ; Yang, JH; Lin, Y; Walker, C; Cheng, JK; Liu, ZG; Su, B			Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ERK KINASE; ADAPTER; JNK; INDUCTION; ALPHA; TAK1; TNF; PHOSPHORYLATION	Interleukin 1 receptor (IL-1R) and Toll-like receptors (TLRs) induce inflammatory genes through the complex of MyD88, IL-1R-associated protein kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6), which is believed to function 'upstream' of the cascades of IkappaB kinase (IKK) and nuclear factor-kappaB (NF-kappaB); extracellular signal-regulated protein kinase (ERK); c-Jun N-terminal kinase (JNK); and p38 mitogen-activated protein kinase (MAPK). Here we show that MAPK-ERK kinase kinase (MEKK3) is an essential signal transducer of the MyD88-IRAK-TRAF6 complex in IL-1R-TLR4 signaling. MEKK3 forms a complex with TRAF6 in response to IL-1 and lipopolysaccharide (LPS) but not CpG, and is required for IL-1R- and TLR4-induced IL-6 production. Furthermore, MEKK3 is crucial for IL-1- and LPS-induced activation of NF-kappaB and JNK-p38 but not ERK, indicating that MAPKs are differentially activated during IL-1R-TLR4 signaling. These data demonstrate that MEKK3 is crucial for IL-1R and TLR4 signaling through the IKK-NF-kappaB and JNK-p38 MAPK pathways.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; NCI, Dept Cell & Canc Biol, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Su, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	bingsu@odin.mdacc.tmc.edu			NATIONAL CANCER INSTITUTE [Z01SC010376, ZIASC010376, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044016] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NHLBI NIH HHS [HL070225] Funding Source: Medline; NIAID NIH HHS [AI44016] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	35	220	244	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					98	103		10.1038/ni1014	http://dx.doi.org/10.1038/ni1014			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14661019				2022-12-18	WOS:000187635800019
J	Swamy, M; Jamora, C; Havran, W; Hayday, A				Swamy, Mahima; Jamora, Colin; Havran, Wendy; Hayday, Adrian			Epithelial decision makers: in search of the 'epimmunome'	NATURE IMMUNOLOGY			English	Review							DELTA T-CELLS; THYMIC STROMAL LYMPHOPOIETIN; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; ENDOPLASMIC-RETICULUM STRESS; INNATE IMMUNE RECOGNITION; SODIUM-SULFATE COLITIS; NF-KAPPA-B; ADAPTIVE IMMUNITY; ULCERATIVE-COLITIS	Frequent microbial and nonmicrobial challenges to epithelial cells trigger discrete pathways, promoting molecular changes such as the secretion of specific cytokines and chemokines and alterations to molecules displayed at the epithelial cell surface. In combination, these molecules impose key decisions on innate and adaptive immune cells. Depending on context, those decisions can be as diverse as those imposed by professional antigen-presenting cells, benefiting the host by balancing immune competence with the avoidance of immunopathology. Nonetheless, this potency of epithelial cells is also consistent with the causal contribution of epithelial dysregulation to myriad inflammatory diseases. This pathogenic axis provides an attractive target for tissue-specific clinical manipulation. In this context, a research goal should be to identify all molecules used by epithelial cells to instruct immune cells. We term this the 'epimmunome'.	[Havran, Wendy] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Swamy, Mahima; Hayday, Adrian] Canc Res UK, London Res Inst, London, England; [Swamy, Mahima; Hayday, Adrian] Guys Hosp, Univ London Kings Coll, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Jamora, Colin] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	Scripps Research Institute; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of California System; University of California San Diego	Havran, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	havran@scripps.edu; adrian.hayday@kcl.ac.uk	Swamy, Mahima/J-7046-2019	Swamy, Mahima/0000-0003-3977-3425; HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust; UK Medical Research Council program; European Molecular Biology Organization; Marie Curie Program; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036964, R01AI064811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080301] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Program(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank many colleagues for insight. Supported by the Wellcome Trust and an UK Medical Research Council program grant for psoriasis research (A.H.); the European Molecular Biology Organization and the Marie Curie Program (M.S.), and the US National Institutes of Health (C.J., W.H.).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Bando M, 2007, IMMUNOL CELL BIOL, V85, P532, DOI 10.1038/sj.icb.7100078; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; BRUYNZEEL I, 1993, J INVEST DERMATOL, V100, P424, DOI 10.1111/1523-1747.ep12472106; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gong JF, 2010, CLIN IMMUNOL, V136, P245, DOI 10.1016/j.clim.2010.04.001; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jerde TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000338; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KASER A, 2010, ANNU REV IMMUNOL, V573, P621; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kim J, 2005, AM J RESP CELL MOL, V33, P280, DOI 10.1165/rcmb.2004-0129OC; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kronenberg M, 2007, IMMUNOL REV, V215, P5, DOI 10.1111/j.1600-065X.2006.00489.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lai YG, 1999, J IMMUNOL, V163, P5843; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Lian YY, 2010, INFECT GENET EVOL, V10, P517, DOI 10.1016/j.meegid.2010.02.006; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Renne J, 2010, BRIT J DERMATOL, V162, P1198, DOI 10.1111/j.1365-2133.2010.09662.x; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SCHRODER K, 2010, J INFLAMMASOMES CELL, V140, P821; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spagnolo P, 2007, TISSUE ANTIGENS, V70, P219, DOI 10.1111/j.1399-0039.2007.00879.x; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2009, SEMIN IMMUNOL, V21, P110, DOI 10.1016/j.smim.2009.03.002; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; VERDINO P, SCIENCE IN PRESS; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; WITHERDEN DA, SCIENCE IN PRESS; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yang Y, 2007, J IMMUNOL, V178, P3661, DOI 10.4049/jimmunol.178.6.3661; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	116	219	222	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					656	665		10.1038/ni.1905	http://dx.doi.org/10.1038/ni.1905			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644571	Green Accepted			2022-12-18	WOS:000280149400003
J	Orabona, C; Grohmann, U; Belladonna, ML; Fallarino, F; Vacca, C; Bianchi, R; Bozza, S; Volpi, C; Salomon, BT; Fioretti, MC; Romani, L; Puccetti, P				Orabona, C; Grohmann, U; Belladonna, ML; Fallarino, F; Vacca, C; Bianchi, R; Bozza, S; Volpi, C; Salomon, BT; Fioretti, MC; Romani, L; Puccetti, P			CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; COSTIMULATORY PATHWAYS; TRYPTOPHAN CATABOLISM; CTLA-4; ACTIVATION; IMMUNITY; ANTIGEN; CD40; TOLERANCE	Bidirectional signaling along the B7-CTLA-4 coreceptor pathway enables reciprocal conditioning of T cells and dendritic cells. Although T cells can instruct dendritic cells to manifest tolerogenic properties after CTLA-4 engagement of B7, such a B7-mediated signaling is not known to occur in response to CD28. Here we show that mouse dendritic cells were induced by soluble CD28 to express interleukin 6 and interferon-gamma. Production of interleukin 6 required B7-1 (CD80), B7-2 (CD86) and p38 mitogen-activated protein kinase and prevented interferon-gamma-driven expression of immunosuppressive tryptophan catabolism. In vivo, an adjuvant activity of soluble CD28 was demonstrated as enhanced T cell-mediated immunity to tumor and self peptides and protection against microbial and tumor challenge. Thus, different ligands of B7 can signal dendritic cells to express functionally distinct effector responses.	Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy; Hop La Pitie Salpetriere, CNRS, UMR 7087, F-75013 Paris, France	University of Perugia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy.	plopcc@tin.it	Romani, Luigina/O-9987-2018; Grohmann, Ursula/T-6545-2019; Orabona, Ciriana/L-8725-2015; Salomon, Benoit L/M-2421-2017; Vacca, Carmine/AAE-7046-2019; Salomon, Benoit/AAP-5209-2021; Fallarino, Francesca/O-3358-2013	Orabona, Ciriana/0000-0003-3113-0572; Salomon, Benoit L/0000-0001-9673-5578; Vacca, Carmine/0000-0002-3799-8164; Salomon, Benoit/0000-0001-9673-5578; Fallarino, Francesca/0000-0002-8501-2136; Belladonna, Maria Laura/0000-0001-6522-0870; Bianchi, Roberta/0000-0001-5914-4701; Grohmann, Ursula/0000-0001-7952-1850; Romani, Luigina/0000-0002-1356-525X; VOLPI, CLAUDIA/0000-0002-3967-7954; Puccetti, Paolo/0000-0001-6674-2128				Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Chen CY, 2003, B MATH BIOL, V65, P933, DOI 10.1016/S0092-8240(03)00055-7; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Gajewski TF, 1996, J IMMUNOL, V156, P2909; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; GROHMANN U, 1995, EUR J IMMUNOL, V25, P2797, DOI 10.1002/eji.1830251013; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Kondo S, 1996, J IMMUNOL, V157, P4822; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; LANIER LL, 1995, J IMMUNOL, V154, P97; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Nishibori T, 2004, J EXP MED, V199, P25, DOI 10.1084/jem.20020509; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; PUCCETTI P, 1995, TRENDS MICROBIOL, V3, P237, DOI 10.1016/S0966-842X(00)88931-3; Richard M, 1999, BLOOD, V93, P4318, DOI 10.1182/blood.V93.12.4318.412k09_4318_4327; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Rothstein DM, 2003, IMMUNOL REV, V196, P85, DOI 10.1046/j.1600-065X.2003.00088.x; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	54	219	253	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1134	1142		10.1038/ni1124	http://dx.doi.org/10.1038/ni1124			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15467723				2022-12-18	WOS:000224692700010
J	Yang, JF; Zhu, H; Murphy, TL; Ouyang, WJ; Murphy, KM				Yang, JF; Zhu, H; Murphy, TL; Ouyang, WJ; Murphy, KM			IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; HELPER TYPE-1 CELLS; CD4(+) T-CELLS; TH1 CELLS; SELECTIVE EXPRESSION; INTERFERON PROMOTER; SIGNAL TRANSDUCER; NUCLEAR FACTOR; CUTTING EDGE; ACTIVATION	Interleukin-12 (IL-12) and IL-18 induce synergistic transcription of interferon gamma (IFN-gamma) that is T cell receptor (TCR)-independent, not inhibited by cyclosporin A and requires new protein synthesis. To characterize this pathway, we screened for genes that are induced in IL-12- and IL-18-treated T helper type I cells. GADD45 beta, which activates mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase kinase 4 (MEKK4), was induced by IL-18 and augmented by IL-12, GADD45 beta expression in naive CD4(+)T cells activated p38 MAPK and selectively increased cytokine-induced, but not TCR-induced, IFN-gamma production. Kinase-inactive MEKK4 and inhibition of the p38 MAPK pathway both selectively inhibit cytokine-induced, but not BCR-induced, IFN-gamma production. Thus, the synergy between IL-12 and IL-18 may involve GADD45 beta induction, which can maintain the MEKK4 and p38 MAPK activation that is necessary for cytokine-induced, but not TCR-induced, IFN-gamma production.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864				Ahn HJ, 1997, J IMMUNOL, V159, P2125; Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Aune TM, 1997, MOL CELL BIOL, V17, P199, DOI 10.1128/MCB.17.1.199; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Barbulescu K, 1997, EUR J IMMUNOL, V27, P1098, DOI 10.1002/eji.1830270509; Barbulescu K, 1998, J IMMUNOL, V160, P3642; BARBULESCU K, 1997, EUR J IMMUNOL, V27, P1830; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CICCARONE VC, 1990, J IMMUNOL, V144, P725; DeSilva DR, 1997, CELL IMMUNOL, V180, P116, DOI 10.1006/cimm.1997.1182; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guler ML, 1997, J IMMUNOL, V159, P1767; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; MANETTI R, 1993, J EXP MED, V177, P199; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SZABO SJ, 1993, MOL CELL BIOL, V13, P5928; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Ten RM, 1999, J IMMUNOL, V163, P3851; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRIPP CS, 1994, J IMMUNOL, V152, P1883; Tsuji-Takayama K, 1999, CELL IMMUNOL, V196, P41, DOI 10.1006/cimm.1999.1542; TsujiTakayama K, 1997, BIOCHEM BIOPH RES CO, V237, P126, DOI 10.1006/bbrc.1997.7099; Vairapandi M, 1996, ONCOGENE, V12, P2579; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Yoshikawa T, 1998, J VAC SCI TECHNOL B, V16, P1, DOI 10.1116/1.589779; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374	67	219	220	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					157	164		10.1038/84264	http://dx.doi.org/10.1038/84264			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175814				2022-12-18	WOS:000166778700016
J	Marrack, P; Bender, J; Hildeman, D; Jordan, M; Mitchell, T; Murakami, M; Sakamoto, A; Schaefer, BC; Swanson, B; Kappler, J				Marrack, P; Bender, J; Hildeman, D; Jordan, M; Mitchell, T; Murakami, M; Sakamoto, A; Schaefer, BC; Swanson, B; Kappler, J			Homeostasis of alpha beta TCR+ T cells	NATURE IMMUNOLOGY			English	Review							RECEPTOR TRANSGENIC MICE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PERIPHERAL LYMPHOID ORGANS; MHC CLASS-II; IN-VIVO; POSITIVE SELECTION; DEFICIENT MICE; MATURE CD8(+); MEMORY CELLS; LIFE-SPAN	Cytokines contribute to T cell homeostasis at all stages of T cell existence. However, the particular cytokine involved varies as T cells progress from a naive through an activated to a memory state. In many cases the important cytokines are members of the interleukin 2 subfamily of the short-chain type I cytokines. A case is made for the idea that the evolutionary divergence of the short-chain family allowed for concurrent divergence in leukocytes.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Biol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.	marrackp@nuc.org	Hildeman, David/I-4884-2015; Mitchell, Thomas C/B-4193-2013; Hildeman, David/AAA-1757-2020; Marrack, Philippa/AHE-6316-2022	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Marrack, Philippa/0000-0003-1883-3687				Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; ARANEO BA, 1977, J IMMUNOL, V119, P765; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; ASKONAS BA, 1982, IMMUNOLOGY, V45, P79; BACHMANN MF, 1995, J IMMUNOL, V155, P3727; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Boise LH, 1995, ANN NY ACAD SCI, V766, P70, DOI 10.1111/j.1749-6632.1995.tb26650.x; BOISE LH, 1995, P NATL ACAD SCI USA, V92, P5491, DOI 10.1073/pnas.92.12.5491; Boursalian TE, 1999, J IMMUNOL, V162, P3795; BREITMEYER JB, 1987, J IMMUNOL, V139, P2899; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BROWN GR, 1995, J IMMUNOL, V154, P3686; Bui JD, 2000, CELL, V100, P457, DOI 10.1016/S0092-8674(00)80681-9; Butz E, 1998, ADV EXP MED BIOL, V452, P111; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FREITAS AA, 1986, IMMUNOL REV, V91, P5, DOI 10.1111/j.1600-065X.1986.tb01482.x; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2986, DOI 10.1002/eji.1830271135; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hassan J, 1998, EUR J IMMUNOL, V28, P3057, DOI 10.1002/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.3.CO;2-Q; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; IGNATOWICZ L, 1992, J EXP MED, V175, P917, DOI 10.1084/jem.175.4.917; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Jensen PL, 2000, STEM CELLS, V18, P61, DOI 10.1634/stemcells.18-1-61; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KELLY KA, 1993, EUR J IMMUNOL, V23, P1922, DOI 10.1002/eji.1830230829; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUHLMAN P, 1991, J IMMUNOL, V146, P1773; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lortat-Jacob H, 1997, CYTOKINE, V9, P101, DOI 10.1006/cyto.1996.0142; Mangi MH, 1999, CYTOKINES CELL MOL T, V5, P87; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; MILLER RA, 1984, J IMMUNOL, V133, P2925; Mitchell T, 1999, J IMMUNOL, V162, P4527; MODIGLIANI Y, 1994, EUR J IMMUNOL, V24, P1223, DOI 10.1002/eji.1830240533; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; OWEN JA, 1982, CELL IMMUNOL, V67, P49, DOI 10.1016/0008-8749(82)90198-8; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PEREIRA P, 1991, INT IMMUNOL, V3, P1077, DOI 10.1093/intimm/3.11.1077; PIGUET PF, 1981, J EXP MED, V154, P581, DOI 10.1084/jem.154.3.581; POLLOK KE, 1993, J IMMUNOL, V150, P771; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; PULLEN AM, 1990, J EXP MED, V171, P49, DOI 10.1084/jem.171.1.49; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; ROCHA B, 1990, EUR J IMMUNOL, V20, P1697, DOI 10.1002/eji.1830200812; ROCHA B, 1983, J IMMUNOL, V131, P2158; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; SMITH H, 1992, J IMMUNOL, V149, P2212; Soares MVD, 1998, J IMMUNOL, V161, P5909; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; STUTMAN O, 1978, IMMUNOL REV, V42, P138, DOI 10.1111/j.1600-065X.1978.tb00261.x; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Teague TK, 1997, J IMMUNOL, V158, P5791; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TOUGH DF, 1995, STEM CELLS, V13, P242, DOI 10.1002/stem.5530130305; Umeda S, 1996, AM J PATHOL, V149, P559; van Meerwijk JPM, 1998, J IMMUNOL, V160, P2730; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Varga SM, 1998, J IMMUNOL, V161, P3215; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Vicari AP, 1996, INT IMMUNOL, V8, P1759, DOI 10.1093/intimm/8.11.1759; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WALLIS VJ, 1979, IMMUNOLOGY, V38, P163; Webb LMC, 1999, IMMUNOLOGY, V98, P400, DOI 10.1046/j.1365-2567.1999.00906.x; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wrenshall LE, 1999, J IMMUNOL, V163, P3793; Xiang R, 1999, J IMMUNOL, V163, P3676; Yu X, 2000, J IMMUNOL, V164, P3543, DOI 10.4049/jimmunol.164.7.3543; Zhan Y, 2000, IMMUNOL CELL BIOL, V78, P118, DOI 10.1046/j.1440-1711.2000.00891.x; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	110	219	221	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					107	111		10.1038/77778	http://dx.doi.org/10.1038/77778			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248801				2022-12-18	WOS:000089814900009
J	Huang, D; Chen, JN; Yang, LB; Ouyang, Q; Li, JQ; Lao, LY; Zhao, JH; Liu, J; Lu, YW; Xing, Y; Chen, F; Su, FX; Yao, HR; Liu, Q; Su, SC; Song, EW				Huang, Di; Chen, Jianing; Yang, Linbin; Ouyang, Qian; Li, Jiaqian; Lao, Liyan; Zhao, Jinghua; Liu, Jiang; Lu, Yiwen; Xing, Yue; Chen, Fei; Su, Fengxi; Yao, Herui; Liu, Qiang; Su, Shicheng; Song, Erwei			NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death	NATURE IMMUNOLOGY			English	Article							LONG NONCODING RNAS; BREAST-CANCER METASTASIS; NF-KAPPA-B; COLORECTAL-CANCER; LUNG-CANCER; EXPRESSION; LYMPHOCYTES; DIFFERENTIATION; IMMUNOTHERAPY; MECHANISMS	Activation-induced cell death (AICD) of T lymphocytes can be exploited by cancers to escape immunological destruction. We demonstrated that tumor-specific cytotoxic T lymphocytes (CTLs) and type 1 helper T (T(H)1) cells, rather than type 2 helper T cells and regulatory T cells, were sensitive to AICD in breast and lung cancer microenvironments. NKILA, an NF-kappa B-interacting long noncoding RNA (lncRNA), regulates T cell sensitivity to AICD by inhibiting NF-kappa B activity. Mechanistically, calcium influx in stimulated T cells via T cell-receptor signaling activates calmodulin, thereby removing deacetylase from the NKILA promoter and enhancing STAT1-mediated transcription. Administering CTLs with NKILA knockdown effectively inhibited growth of breast cancer patient-derived xenografts in mice by increasing CTL infiltration. Clinically, NKILA overexpression in tumorspecific CTLs and T(H)1 cells correlated with their apoptosis and shorter patient survival. Our findings underscore the importance of lncRNAs in determining tumor-mediated T cell AICD and suggest that engineering lncRNAs in adoptively transferred T cells might provide a novel antitumor immunotherapy.	[Huang, Di; Chen, Jianing; Yang, Linbin; Ouyang, Qian; Li, Jiaqian; Lao, Liyan; Zhao, Jinghua; Liu, Jiang; Lu, Yiwen; Xing, Yue; Chen, Fei; Su, Fengxi; Liu, Qiang; Su, Shicheng; Song, Erwei] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Huang, Di; Chen, Jianing; Yang, Linbin; Ouyang, Qian; Li, Jiaqian; Lao, Liyan; Zhao, Jinghua; Liu, Jiang; Lu, Yiwen; Xing, Yue; Chen, Fei; Su, Fengxi; Liu, Qiang; Su, Shicheng; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Guangdong, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Song, Erwei] Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, SC; Song, EW (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.; Su, SC; Song, EW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Guangdong, Peoples R China.; Song, EW (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou, Guangdong, Peoples R China.	sushch@mail.sysu.edu.cn; songew@mail.sysu.edu.cn		Liu, Qiang/0000-0002-5451-4862	National Key Research and Development Program of China [2017YFA0106300, 2016YFC1302300]; Natural Science Foundation of China [81720108029, 81622036, 81472468, 81672614, 81621004, 81490750]; Guangdong Science and Technology Department [2016A030306023, 2017A030313878, 2016B030229004, 2015B050501004, 201710010083]; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program [2016TQ03R553]; Guangzhou Science Technology and Innovation Commission [201508020008, 201508020249]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program; Guangzhou Science Technology and Innovation Commission	This work was supported by grants from the National Key Research and Development Program of China (2017YFA0106300 (S.S.) and 2016YFC1302300 (E.S.)), Natural Science Foundation of China (81720108029 (E.S.), 81622036 (S.S.), 81472468 (S.S.), 81672614 (S.S.), 81621004 (E.S.), and 81490750 (E.S.)), Guangdong Science and Technology Department (2016A030306023 (S.S.), 2017A030313878 (S.S.), 2016B030229004 (E.S.), 2015B050501004 (E.S.), and 201710010083 (E.S.)), Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program (2016TQ03R553 (S.S.)), and Guangzhou Science Technology and Innovation Commission (201508020008 (E.S.) and 201508020249 (E.S.)).	Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Becker C, 2001, NAT MED, V7, P1159, DOI 10.1038/nm1001-1159; Beckhove P, 2004, J CLIN INVEST, V114, P67, DOI 10.1172/JC1200420278; Beil-Wagner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21377; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chhabra A, 2011, THESCIENTIFICWORLDJO, V11, P121, DOI 10.1100/tsw.2011.10; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Disis ML, 2009, J CLIN ONCOL, V27, P4685, DOI 10.1200/JCO.2008.20.6789; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Feuerer M, 2001, NAT MED, V7, P452, DOI 10.1038/86523; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gati A, 2003, CANCER RES, V63, P7475; Grimm M, 2010, EUR J CANCER, V46, P2314, DOI 10.1016/j.ejca.2010.05.025; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Jiang RQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15129; Kassouf N, 2008, ORAL ONCOL, V44, P672, DOI 10.1016/j.oraloncology.2007.08.013; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lee HJ, 2015, ONCOLOGY-BASEL, V89, P337, DOI 10.1159/000439535; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Mansfield AS, 2011, MODERN PATHOL, V24, P487, DOI 10.1038/modpathol.2010.227; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; Norell H, 2009, CANCER RES, V69, P6282, DOI 10.1158/0008-5472.CAN-09-1176; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Rentzsch C, 2003, CLIN CANCER RES, V9, P4376; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Stagg J, 2007, IMMUNOL REV, V220, P82, DOI 10.1111/j.1600-065X.2007.00566.x; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Tang J, 2005, CLIN CANCER RES, V11, P5292, DOI 10.1158/1078-0432.CCR-05-0545; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Wang GL, 2006, ACTA PHARMACOL SIN, V27, P437, DOI 10.1111/j.1745-7254.2006.00297.x; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Yao YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003601; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	55	218	229	7	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1112	+		10.1038/s41590-018-0207-y	http://dx.doi.org/10.1038/s41590-018-0207-y			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30224822				2022-12-18	WOS:000445968600017
J	Grajales-Reyes, GE; Iwata, A; Albring, J; Wu, XD; Tussiwand, R; Wumesh, KC; Kretzer, NM; Briseno, CG; Durai, V; Bagadia, P; Haldar, M; Schonheit, J; Rosenbauer, F; Murphy, TL; Murphy, KM				Grajales-Reyes, Gary E.; Iwata, Arifumi; Albring, Joern; Wu, Xiaodi; Tussiwand, Roxane; Wumesh, K. C.; Kretzer, Nicole M.; Briseno, Carlos G.; Durai, Vivek; Bagadia, Prachi; Haldar, Malay; Schoenheit, Joerg; Rosenbauer, Frank; Murphy, Theresa L.; Murphy, Kenneth M.			Batf3 maintains autoactivation of Irf8 for commitment of a CD8 alpha(+) conventional DC clonogenic progenitor	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL-DEVELOPMENT; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; BONE-MARROW; IN-VIVO; REGULATORY FACTOR-4; SUBSET DEVELOPMENT; STEM-CELLS; T-CELLS; EXPRESSION	The transcription factors Batf3 and IRF8 are required for the development of CD8 alpha(+) conventional dendritic cells (cDCs), but the basis for their actions has remained unclear. Here we identified two progenitor cells positive for the transcription factor Zbtb46 that separately generated CD8 alpha(+) cDCs and CD4(+) cDCs and arose directly from the common DC progenitor (CDP). Irf8 expression in CDPs required prior autoactivation of Irf8 that was dependent on the transcription factor PU. 1. Specification of the clonogenic progenitor of CD8 alpha(+) cDCs (the pre-CD8 DC) required IRF8 but not Batf3. However, after specification of pre-CD8 DCs, autoactivation of Irf8 became Batf3 dependent at a CD8 alpha(+) cDC-specific enhancer with multiple transcription factor AP1-IRF composite elements (AICEs) within the Irf8 superenhancer. CDPs from Batf3(-/-) mice that were specified toward development into pre-CD8 DCs failed to complete their development into CD8 alpha(+) cDCs due to decay of Irf8 autoactivation and diverted to the CD4(+) cDC lineage.	[Grajales-Reyes, Gary E.; Iwata, Arifumi; Wu, Xiaodi; Tussiwand, Roxane; Wumesh, K. C.; Kretzer, Nicole M.; Briseno, Carlos G.; Durai, Vivek; Bagadia, Prachi; Haldar, Malay; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Albring, Joern] Univ Munster, Dept Med Hematol & Oncol A, D-48149 Munster, Germany; [Tussiwand, Roxane] Univ Basel, Dept Biomed, Basel, Switzerland; [Schoenheit, Joerg] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Rosenbauer, Frank] Univ Munster, Inst Mol Tumor Biol, D-48149 Munster, Germany; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Munster; University of Basel; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munster; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu		Tussiwand, Roxane/0000-0002-1712-868X; Rosenbauer, Frank/0000-0001-7977-9421; Briseno, Carlos/0000-0002-4159-3864	Howard Hughes Medical Institute; US National Institutes of Health [1F31CA189491-01, K08AI106953]; American Heart Association [12PRE12050419]; National Cancer Institute [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, F31CA189491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, K08AI106953] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. Supported by the Howard Hughes Medical Institute, the US National Institutes of Health (1F31CA189491-01 to G.E.G.-R. and K08AI106953 to M.H.), the American Heart Association (12PRE12050419 to W.K.), and the National Cancer Institute (P30 CA91842; for support of the Alvin J. Siteman Cancer Center).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Kanbe E, 2004, BLOOD CELL MOL DIS, V33, P64, DOI 10.1016/j.bcmd.2004.04.001; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HYS, 2012, BLOOD, V120, P4363, DOI 10.1182/blood-2012-07-441311; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Merad M, 2007, NAT IMMUNOL, V8, P1199, DOI 10.1038/ni1107-1199; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wumesh KC, 2014, NATURE, V507, P243, DOI 10.1038/nature12967; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	61	218	222	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					708	+		10.1038/ni.3197	http://dx.doi.org/10.1038/ni.3197			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26054719	Green Accepted			2022-12-18	WOS:000356445600007
J	Man, SM; Karki, R; Malireddi, RKS; Neale, G; Vogel, P; Yamamoto, M; Lamkanfi, M; Kanneganti, TD				Man, Si Ming; Karki, Rajendra; Malireddi, R. K. Subbarao; Neale, Geoffrey; Vogel, Peter; Yamamoto, Masahiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; HOST-DEFENSE; TULARENSIS; INDUCTION; NLRP3; TOLL; DISRUPTION; MECHANISMS; REGULATOR; CASPASE-1	Inflammasomes are critical for mounting host defense against pathogens. The molecular mechanisms that control activation of the AIM2 inflammasome in response to different cytosolic pathogens remain unclear. Here we found that the transcription factor IRF1 was required for activation of the AIM2 inflammasome during infection with the Francisella tularensis subspecies novicida (F. novicida), whereas engagement of the AIM2 inflammasome by mouse cytomegalovirus (MCMV) or transfected double-stranded DNA did not require IRF1. Infection of F. novicida detected by the DNA sensor cGAS and its adaptor STING induced type I interferon-dependent expression of IRF1, which drove the expression of guanylate-binding proteins (GBPs); this led to intracellular killing of bacteria and DNA release. Our results reveal a specific requirement for IRF1 and GBPs in the liberation of DNA for sensing by AIM2 depending on the pathogen encountered by the cell.	[Man, Si Ming; Karki, Rajendra; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Man, Si Ming] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Osaka, Japan; [Lamkanfi, Mohamed] Vlaams Inst Biotechnol, Dept Med Prot Res, Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; University of New South Wales Sydney; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Osaka University; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Karki, Rajendra/H-6647-2019; Kanneganti, Thirumala-Devi/Y-2503-2019; Man, Si Ming/AAE-9168-2019; Malireddi, RKSubbarao/C-5804-2013; Vogel, Peter/N-2490-2018; Man, Si Ming/O-6223-2015; Kanneganti, Thirumala-Devi/M-9435-2018	Karki, Rajendra/0000-0003-4436-9128; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Man, Si Ming/0000-0002-5079-2857; Malireddi, RKSubbarao/0000-0001-8855-9447; Vogel, Peter/0000-0002-7535-0545; Man, Si Ming/0000-0002-5079-2857; Kanneganti, Thirumala-Devi/0000-0002-6395-6443	US National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; European Research Council [281600]; Fund for Scientific Research-Flanders [G030212N]; St. Jude Children's Research Hospital; National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); St. Jude Children's Research Hospital; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank V.M. Dixit (Genentech) and N. Kayagaki (Genentech) for Aim2-deficient mice and Gbp5-deficient mice; K.A. Fitzgerald (University of Massachusetts Medical School) for femurs from cGAS-deficient mice; P. Broz (University of Basel) for femurs from Gbp<SUP>chr3</SUP>-deficient mice; K. Pfeffer (Heinrich-Heine-University Duesseldorf) for femurs from GBP2-deficient mice; P.G. Thomas (St. Jude Children's Research Hospital) for the MCMV Smith MSGV strain; and X. Qi and M. Barr for technical assistance. Supported by the US National Institutes of Health (AR056296, CA163507 and AI101935), the American Lebanese Syrian Associated Charities (T.-D.K.), European Research Council (281600), the Fund for Scientific Research-Flanders (C030212N to M.L.), St. Jude Children's Research Hospital and the National Health and Medical Research Council (Neoma Boadway Endowed Fellowship and R.G. Menzies Early Career Fellowship to S.M.M.).	Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009	50	218	225	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					467	U174		10.1038/ni.3118	http://dx.doi.org/10.1038/ni.3118			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25774715	Green Accepted			2022-12-18	WOS:000353305200009
J	Chakraborty, AK; Weiss, A				Chakraborty, Arup K.; Weiss, Arthur			Insights into the initiation of TCR signaling	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; TYROSINE-PROTEIN-KINASE; PROLINE-RICH SEQUENCE; ANTIGEN RECEPTOR; NEGATIVE REGULATION; PHOSPHATASE CD45; STRUCTURAL BASIS; B-CELL; ACTIVATION; PEPTIDE	The initiation of T cell antigen receptor signaling is a key step that can result in T cell activation and the orchestration of an adaptive immune response. Early events in T cell receptor signaling can distinguish between agonist and endogenous ligands with exquisite selectivity, and show extraordinary sensitivity to minute numbers of agonists in a sea of endogenous ligands. We review our current knowledge of models and crucial molecules that aim to provide a mechanistic explanation for these observations. Building on current understanding and a discussion of unresolved issues, we propose a molecular model for initiation of T cell receptor signaling that may serve as a useful guide for future studies.	[Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, Div Rheumatol, Dept of Med, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, Div Rheumatol, Dept of Med, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu			US National Institutes of Health [PO1 AI091580]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Fruschicheva for help with the references. We also thank K. Vicari of the Nature Publishing Group for her artistic work on the figures in this article. This work was supported, in part, by a grant from the US National Institutes of Health (PO1 AI091580 to A.K.C. and A.W.).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Borroto A, 2014, J IMMUNOL, V192, P2042, DOI 10.4049/jimmunol.1203414; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Charles A, 2001, IMMUNOBIOL IMMUNE SY, V5; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Cordoba SP, 2013, BLOOD, V121, P4295, DOI 10.1182/blood-2012-07-442251; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; Gao GF, 2002, TRENDS IMMUNOL, V23, P408, DOI 10.1016/S1471-4906(02)02282-2; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hoerter JAH, 2013, J EXP MED, V210, P1807, DOI 10.1084/jem.20122528; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2010, J IMMUNOL, V185, P2951, DOI 10.4049/jimmunol.1000732; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Lalanne JB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.218102; LANIER LL, 1986, J IMMUNOL, V137, P2286; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Pingel S, 1999, EUR J IMMUNOL, V29, P2376; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; SAMELSON LE, 1986, NATURE, V324, P674, DOI 10.1038/324674a0; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Xie JM, 2012, NAT IMMUNOL, V13, P674, DOI 10.1038/ni.2344; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; YOON ST, 1994, IMMUNITY, V1, P563; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	100	218	222	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					798	807		10.1038/ni.2940	http://dx.doi.org/10.1038/ni.2940			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137454	Green Accepted			2022-12-18	WOS:000340739400003
J	Natoli, G; Saccani, S; Bosisio, D; Marazzi, I				Natoli, G; Saccani, S; Bosisio, D; Marazzi, I			Interactions of NF-kappa B with chromatin: the art of being at the right place at the right time	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR-BINDING; DEPENDENT GENE-EXPRESSION; RNA-POLYMERASE-II; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; CRYSTAL-STRUCTURE; RESPONSE ELEMENT; IKK-ALPHA; HISTONE ACETYLATION; FACILITATED BINDING	Transcription factors of the NF-kappa B family are essential regulators of the inflammatory and immune responses. The main 'switch' in NF-kappa B activation is cytoplasmic and leads to the release of NF-kappa B proteins from I kappa B molecules, specific inhibitors that prevent their nuclear accumulation. However, it is becoming increasingly apparent that in addition to this required activation step, both recruitment of NF-kappa B to target genes and NF-kappa B-induced transcriptional events after recruitment are actively controlled. Regulated recruitment of NF-kappa B to chromatin generates kinetic complexity in NF-kappa B-dependent gene induction and 'wires' NF-kappa B-regulated gene activity to simultaneously activated pathways and transcription factors.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Natoli, G (corresponding author), Inst Biomed Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	gioacchino.natoli@irb.unisi.ch	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Natoli, Gioacchino/0000-0003-0711-2411; Saccani, Simona/0000-0001-7572-3308; marazzi, ivan/0000-0003-3376-0922; BOSISIO, Daniela/0000-0001-6276-5365				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Algarte M, 1999, MOL CELL BIOL, V19, P6140; Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Angelov D, 2004, J BIOL CHEM, V279, P42374, DOI 10.1074/jbc.M407235200; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; GRILLI M, 1993, INT REV CYTOL, V143, P1; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; HANSEN SK, 1994, J BIOL CHEM, V269, P22230; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Huxford T, 1999, COLD SPRING HARB SYM, V64, P533, DOI 10.1101/sqb.1999.64.533; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LI BY, 1994, J BIOL CHEM, V269, P7756; LI Q, 1995, MOL CELL BIOL, V15, P4375; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Natoli G, 2004, CELL, V118, P406, DOI 10.1016/j.cell.2004.08.003; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Phelps CB, 2000, J BIOL CHEM, V275, P24392, DOI 10.1074/jbc.M003784200; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Steger DJ, 1997, EMBO J, V16, P2463, DOI 10.1093/emboj/16.9.2463; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; WALKER S, 1994, CELL, V79, P841, DOI 10.1016/0092-8674(94)90073-6; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	83	218	227	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					439	445		10.1038/ni1196	http://dx.doi.org/10.1038/ni1196			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843800				2022-12-18	WOS:000228634300015
J	Daniels, MA; Hogquist, KA; Jameson, SC				Daniels, MA; Hogquist, KA; Jameson, SC			Sweet 'n' sour: the impact of differential glycosylation on T cell responses	NATURE IMMUNOLOGY			English	Review							O-LINKED OLIGOSACCHARIDES; P56(LCK) TYROSINE KINASE; THYMIC EPITHELIAL-CELLS; NEGATIVE REGULATION; B-CELL; CORE 2; IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; ALPHA(1,3)-FUCOSYL-TRANSFERASE VII; RECEPTOR EXPRESSION	The fate and functional activity of T lymphocytes depend largely on the precise timing of gene expression and protein production. However, it is clear that post-translational modification of proteins affects their functional properties. Although modifications such as phosphorylation have been intensely studied by immunologists, less attention has been paid to the impact that changes in glycosylation have on protein function. However, there is considerable evidence that glycosylation plays a key role in immune regulation. We will focus here on examples in which differential glycosylation affects the development, survival or reactivity of T cells.	Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687; Daniels, Mark/0000-0002-5175-9901				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Baldwin KK, 1999, J IMMUNOL, V163, P689; Baldwin TA, 2001, J IMMUNOL, V167, P3829, DOI 10.4049/jimmunol.167.7.3829; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Baum LG, 2002, IMMUNITY, V16, P5, DOI 10.1016/S1074-7613(02)00265-0; Blander JM, 1999, J IMMUNOL, V163, P3746; BOOG CJP, 1989, EUR J IMMUNOL, V19, P537, DOI 10.1002/eji.1830190319; Carlow DA, 1999, J IMMUNOL, V163, P1441; Carlow DA, 2001, J IMMUNOL, V167, P6841, DOI 10.4049/jimmunol.167.12.6841; Carlow DA, 2001, J IMMUNOL, V166, P256, DOI 10.4049/jimmunol.166.1.256; CASABO LG, 1994, J IMMUNOL, V152, P397; Chen XP, 1997, J IMMUNOL, V158, P3070; Chen XP, 2000, CYTOKINE, V12, P972, DOI 10.1006/cyto.1999.0596; CHERVENAK R, 1982, THYMUS, V4, P61; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; Chung CD, 1997, J IMMUNOL, V159, P1758; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; Cornall RJ, 1999, CURR TOP MICROBIOL, V244, P57; COWING C, 1983, P NATL ACAD SCI-BIOL, V80, P6000, DOI 10.1073/pnas.80.19.6000; Cramer SO, 2000, INT IMMUNOL, V12, P1347, DOI 10.1093/intimm/12.9.1347; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; CULLEN SE, 1981, J IMMUNOL, V127, P1478; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Deck MB, 1999, J IMMUNOL, V162, P4740; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis JW, 2001, CURR OPIN STRUC BIOL, V11, P601, DOI 10.1016/S0959-440X(00)00254-2; DESPONT JP, 1975, CELL IMMUNOL, V17, P487, DOI 10.1016/S0008-8749(75)80052-9; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; ELLIES LG, 1994, GLYCOBIOLOGY, V4, P885, DOI 10.1093/glycob/4.6.885; Ellies LG, 1996, BLOOD, V88, P1725, DOI 10.1182/blood.V88.5.1725.bloodjournal8851725; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; FOWLKES BJ, 1980, J IMMUNOL, V125, P623; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; FUKUDA M, 1986, MED BIOL, V64, P335; Galvan M, 1998, J IMMUNOL, V161, P641; Gascoigne NRJ, 2002, CURR BIOL, V12, pR99, DOI 10.1016/S0960-9822(02)00671-1; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Grogan MJ, 2002, ANNU REV BIOCHEM, V71, P593, DOI 10.1146/annurev.biochem.71.110601.135334; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; He YW, 1999, J EXP MED, V190, P1903, DOI 10.1084/jem.190.12.1903; Hebert E, 2000, BIOSCIENCE REP, V20, P213, DOI 10.1023/A:1026484722248; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hughes RC, 2001, BIOCHIMIE, V83, P667; HUNIG T, 1983, EUR J IMMUNOL, V13, P596, DOI 10.1002/eji.1830130716; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; JONES AT, 1994, J IMMUNOL, V153, P3426; Kaufmann M, 1999, INT IMMUNOL, V11, P731, DOI 10.1093/intimm/11.5.731; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; KNOP J, 1980, IMMUNOBIOLOGY, V157, P474, DOI 10.1016/S0171-2985(80)80016-7; Krishna M, 1997, J EXP MED, V185, P1997, DOI 10.1084/jem.185.11.1997; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; LANDOLFI NF, 1985, IMMUNOGENETICS, V22, P159, DOI 10.1007/BF00563513; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; LEFRANCOIS L, 1987, J IMMUNOL, V139, P2220; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Lim YC, 1999, J IMMUNOL, V162, P3193; Lim YC, 2001, J IMMUNOL, V167, P4476, DOI 10.4049/jimmunol.167.8.4476; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; LOWE JB, 2003, IN PRESS ANN REV BIO; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; LUQMAN M, 1992, J IMMUNOL, V149, P2300; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; MARTH JD, 1994, GLYCOCONJUGATE J, V11, P3, DOI 10.1007/BF00732424; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; MARTIN PT, 2002, GLYCOBIOLOGY, V12, P1; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; OROURKE AM, 1993, IMMUNOL TODAY, V14, P183; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; PILLER F, 1988, J BIOL CHEM, V263, P15146; PINK JRL, 1983, CONTEMP TOP MOLEC IM, V9, P89; POIRIER F, 1993, DEVELOPMENT, V119, P1229; POWELL LD, 1987, J IMMUNOL, V139, P262; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; Rottier RJ, 1998, HUM MOL GENET, V7, P313, DOI 10.1093/hmg/7.2.313; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Scholler N, 2002, J IMMUNOL, V168, P2599, DOI 10.4049/jimmunol.168.6.2599; Scholler N, 2001, J IMMUNOL, V166, P3865, DOI 10.4049/jimmunol.166.6.3865; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shaw AS, 2001, NAT IMMUNOL, V2, P575, DOI 10.1038/89712; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sperling AI, 1998, J IMMUNOL, V161, P6459; SPERLING AI, 1995, J EXP MED, V182, P139, DOI 10.1084/jem.182.1.139; SPRENT J, 1990, IMMUNOL REV, V117, P213, DOI 10.1111/j.1600-065X.1990.tb00574.x; Stockton BM, 1998, IMMUNITY, V8, P373, DOI 10.1016/S1074-7613(00)80542-7; TAIRA S, 1988, J IMMUNOL, V141, P440; Todeschini AR, 2002, J IMMUNOL, V168, P5192, DOI 10.4049/jimmunol.168.10.5192; TOPOROWICZ A, 1986, CELL IMMUNOL, V100, P10, DOI 10.1016/0008-8749(86)90002-X; Trautmann A, 2001, SCIENCE, V292, P1667, DOI 10.1126/science.1061542; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vespa GNR, 1999, J IMMUNOL, V162, P799; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wagers AJ, 2000, J IMMUNOL, V165, P5011, DOI 10.4049/jimmunol.165.9.5011; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; WOMACK JE, 1981, SCIENCE, V212, P63, DOI 10.1126/science.7209520; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215	137	218	225	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					903	910		10.1038/ni1002-903	http://dx.doi.org/10.1038/ni1002-903			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352967				2022-12-18	WOS:000178242100009
J	Rutschmann, S; Jung, AC; Zhou, R; Silverman, N; Hoffmann, JA; Ferrandon, D				Rutschmann, S; Jung, AC; Zhou, R; Silverman, N; Hoffmann, JA; Ferrandon, D			Role of Drosophila IKK gamma in a Toll-independent antibacterial immune response	NATURE IMMUNOLOGY			English	Article							ANTIMICROBIAL PEPTIDE GENES; KAPPA-B ACTIVATION; INSECT IMMUNITY; NUCLEAR IMPORT; KINASE COMPLEX; HOST-DEFENSE; REL PROTEINS; DORSAL; DIF; METCHNIKOWIN	We have generated, by ethylmethane sulfonate mutagenesis, loss-of-function mutants in the Drosophila homolog of the mammalian I-kappa B kinase (IKK) complex component IKK gamma (also called NEMO). Our data show that Drosophila IKK gamma is required for the Relish-dependent immune induction of the genes encoding antibacterial peptides and for resistance to infections by Escherichia coli. However, it is not required for the Toll-Dip-dependent antifungal host: defense,The results indicate distinct control mechanisms of the Rel-like transactivators DIF and Relish in the Drosophila innate immune response and show that Drosophila Toll does not signal through a IKK gamma-dependent signaling complex. Thus, in contrast to the vertebrate inflammatory response, IKK gamma is required for the activation of only one immune signaling pathway in Drosophila.	CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9022, 15 Rue R Descartes, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Jung, Alain/AAC-6598-2019; Jung, Alain/X-5384-2019	Jung, Alain/0000-0002-4049-4151; FERRANDON, Dominique/0000-0001-7680-7773; Silverman, Neal/0000-0002-4259-456X; Rutschmann, Sophie/0000-0003-3932-1162	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029379, R01GM059919] Funding Source: NIH RePORTER; NIAID NIH HHS [1PO1 AI44220-02] Funding Source: Medline; NIGMS NIH HHS [GM29379, GM59919] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Corbo JC, 1996, MECH DEVELOP, V55, P211, DOI 10.1016/0925-4773(96)00506-0; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; ELRODERERICKSON M, 2000, CURR BIOL, P10871; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; FLYG C, 1988, GENET RES, V52, P51, DOI 10.1017/S0016672300027300; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim YS, 2000, J BIOL CHEM, V275, P2071, DOI 10.1074/jbc.275.3.2071; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; LEULIER F, 2000, IN PRESS EMBO R; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; LU Y, 1999, 40 ANN DROS RES C SE, P143; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; MEISTER M, 1994, EMBO J, V13, P5958, DOI 10.1002/j.1460-2075.1994.tb06941.x; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; SILVERMAN N, 2000, IN PRESS GENES DEV; Smahi A, 2000, NATURE, V405, P466; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STOVENS S, 2000, IN PRESS EMBO R; TATEI K, 1995, MOL CELL BIOL, V15, P3627; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	49	218	226	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					342	347		10.1038/79801	http://dx.doi.org/10.1038/79801			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017107				2022-12-18	WOS:000089869700018
J	Manthiram, K; Zhou, Q; Aksentijevich, I; Kastner, DL				Manthiram, Kalpana; Zhou, Qing; Aksentijevich, Ivona; Kastner, Daniel L.			The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation	NATURE IMMUNOLOGY			English	Review							FAMILIAL MEDITERRANEAN FEVER; AICARDI-GOUTIERES-SYNDROME; NF-KAPPA-B; RILONACEPT INTERLEUKIN-1 TRAP; ENCODING MEVALONATE KINASE; OF-FUNCTION MUTATIONS; FACTOR-H POLYMORPHISM; CYCLIC GMP-AMP; NLRP3 INFLAMMASOME; PYRIN INFLAMMASOME	Autoinflammatory diseases were first recognized nearly 20 years ago as distinct clinical and immunological entities caused by dysregulation in the innate immune system. Since then, advances in genomic techniques have led to the identification of new monogenic disorders and their corresponding signaling pathways. Here we review these monogenic autoinflammatory diseases, ranging from periodic fever syndromes caused by dysregulated inflammasome-mediated production of the cytokine IL-1 beta to disorders arising from perturbations in signaling by the transcription factor NF-kappa B, ubiquitination, cytokine signaling, protein folding, type I interferon production and complement activation, and we further examine their molecular mechanisms. We also explore the overlap among autoinflammation, autoimmunity and immunodeficiency, and pose a series of unanswered questions that are expected to be central in autoinflammatory disease research in the coming decade.	[Manthiram, Kalpana; Zhou, Qing; Aksentijevich, Ivona; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Manthiram, K; Kastner, DL (corresponding author), NHGRI, Inflammatory Dis Sect, Metab Cardiovasc & Inflammatory Dis Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA.	kalpana.manthiram@nih.gov; kastnerd@mail.nih.gov	Aksentijevich, Ivona/AAF-1335-2019		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200372] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 1997, CELL, V90, P797; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Aubert DF, 2016, CELL HOST MICROBE, V19, P664, DOI 10.1016/j.chom.2016.04.004; Baines A. C., 2017, BLOOD REV; Bernot A, 1997, NAT GENET, V17, P25; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; Boyden SE, 2016, NEW ENGL J MED, V374, P656, DOI 10.1056/NEJMoa1500611; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Canna SW, 2015, SEMIN IMMUNOPATHOL, V37, P387, DOI 10.1007/s00281-015-0493-5; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2015, ARTHRITIS RHEUMATOL, V67, P563, DOI 10.1002/art.38961; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; de Koning HD, 2015, J ALLERGY CLIN IMMUN, V135, P561, DOI 10.1016/j.jaci.2014.07.050; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Fuchs-Telem D, 2012, AM J HUM GENET, V91, P163, DOI 10.1016/j.ajhg.2012.05.010; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Giardino S, 2015, PEDIATRICS, V135, pE211, DOI 10.1542/peds.2014-2553; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldbach-Mansky R, 2008, ARTHRITIS RHEUM-US, V58, P2432, DOI 10.1002/art.23620; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Grandemange S., 2016, ANN RHEUM DIS; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hashkes PJ, 2012, ANN INTERN MED, V157, P533, DOI 10.7326/0003-4819-157-8-201210160-00003; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holt BF, 2000, CURR BIOL, V10, pR5, DOI 10.1016/S0960-9822(99)00273-0; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P1459, DOI 10.1002/art.30241; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kawasaki Y, 2017, ARTHRITIS RHEUMATOL, V69, P447, DOI 10.1002/art.39960; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Levy R, 2015, ANN RHEUM DIS, V74, P2043, DOI 10.1136/annrheumdis-2013-204991; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Liu Y, 2016, CLIN CHIM ACTA, V454, P124, DOI 10.1016/j.cca.2016.01.009; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Loock J, 2010, J ALLERGY CLIN IMMUN, V125, P500, DOI 10.1016/j.jaci.2009.10.066; Lorden G, 2017, J EXP MED, V214, P511, DOI 10.1084/jem.20161452; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mensa-Vilaro A, 2016, ARTHRITIS RHEUMATOL, V68, P3035, DOI 10.1002/art.39770; Mensa-Vilaro A, 2016, ARTHRITIS RHEUMATOL, V68, P1039, DOI 10.1002/art.39519; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Neven B, 2007, NEW ENGL J MED, V356, P2700, DOI 10.1056/NEJMoa070715; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Omenetti A, 2016, RHEUMATOLOGY, V55, P1325, DOI 10.1093/rheumatology/kew031; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Padeh S, 2003, J RHEUMATOL, V30, P185; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Ratner D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006035; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Saito M, 2005, ARTHRITIS RHEUM-US, V52, P3579, DOI 10.1002/art.21404; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shen M., 2016, CLIN RHEUMATOL; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Sibley CH, 2015, ANN RHEUM DIS, V74, P1714, DOI 10.1136/annrheumdis-2013-204877; Sidiq T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00367; Simon A, 2010, P NATL ACAD SCI USA, V107, P9801, DOI 10.1073/pnas.0914118107; Standing ASI, 2017, J EXP MED, V214, P59, DOI 10.1084/jem.20161228; Starnes TW, 2014, BLOOD, V123, P2703, DOI 10.1182/blood-2013-07-516948; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Van Eyck L, 2015, J ALLERGY CLIN IMMUN, V135, P283, DOI 10.1016/j.jaci.2014.10.010; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; Van Montfrans JM, 2016, RHEUMATOLOGY, V55, P902, DOI 10.1093/rheumatology/kev439; Nuffel E, 2017, J INVEST DERMATOL, V137, P569, DOI 10.1016/j.jid.2016.09.031; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang Y., 2017, NATURE; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P10127, DOI 10.1073/pnas.1612594113; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhou Q, 2015, ARTHRITIS RHEUMATOL, V67, P2482, DOI 10.1002/art.39190; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	163	217	223	7	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					832	842		10.1038/ni.3777	http://dx.doi.org/10.1038/ni.3777			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722725				2022-12-18	WOS:000405821100003
J	Weinstein, JS; Herman, EI; Lainez, B; Licona-Limon, P; Esplugues, E; Flavell, R; Craft, J				Weinstein, Jason S.; Herman, Edward I.; Lainez, Begona; Licona-Limon, Paula; Esplugues, Enric; Flavell, Richard; Craft, Joe			T-FH cells progressively differentiate to regulate the germinal center response	NATURE IMMUNOLOGY			English	Article							B-CELLS; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; HELPER-CELLS; IN-VIVO; IL-21; EXPRESSION; SELECTION; BLIMP-1; MICE	Germinal center (GC) B cells undergo affinity selection, which depends on interactions with CD4(+) follicular helper T cells (T-FH cells). We found that T-FH cells progressed through transcriptionally and functionally distinct stages and provided differential signals for GC regulation. They initially localized proximally to mutating B cells, secreted interleukin 21 (IL-21), induced expression of the transcription factor Bcl-6 and selected high-affinity B cell clones. As the GC response evolved, T-FH cells extinguished IL-21 production and switched to IL-4 production, showed robust expression of the co-stimulatory molecule CD40L, and promoted the development of antibody-secreting B cells via upregulation of the transcription factor Blimp-1. Thus, T-FH cells in the B cell follicle progressively differentiate through stages of localization, cytokine production and surface ligand expression to 'fine tune' the GC reaction.	[Weinstein, Jason S.; Lainez, Begona; Craft, Joe] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT USA; [Herman, Edward I.; Licona-Limon, Paula; Esplugues, Enric; Flavell, Richard; Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Licona-Limon, Paula] Univ Nacl Autonoma Mexico, Dept Biol Celular & Desarrollo, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Yale University; Yale University; Howard Hughes Medical Institute; Universidad Nacional Autonoma de Mexico	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT USA.; Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.	joseph.craft@yale.edu	Esplugues, Enric/AAD-4245-2020	Esplugues, Enric/0000-0002-8130-0413	Arthritis Foundation; US National Institutes of Health [5 T32 AR07107, K01AR067892, T32GM07205, F30HL120497, R37AR40072, P30AR053495, R21AR063942]; Alliance for Lupus Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL120497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR067892, T32AR007107, R21AR063942, R37AR040072, R21AR068662, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Arthritis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our departments for critical review of the manuscript; J. Henao-Mejia for assistance in generating the IL-21 reporter construct; L. Evangelisti for generating embryonic stem cells; C. Hughes for generating chimeric mice; J. Stein for help with the screening of knock-in mice; E. Nevius and J. Pereira for assistance with migration assays; and S. Kaech (Yale University) for B6. Tg(TcrLCMV) 1Aox (Smarta; Stg) mice. Supported by the Arthritis Foundation (J.S.W.), the US National Institutes of Health (5 T32 AR07107 and K01AR067892 to J.S.W.; T32GM07205 and F30HL120497 to E.I.H.; R37AR40072, P30AR053495 and R21AR063942 (NIAMS) to J.C.), the Alliance for Lupus Research (J.C.) and the Howard Hughes Medical Institute (R.A.F.).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Bolduc A, 2010, J IMMUNOL, V185, P220, DOI 10.4049/jimmunol.0901689; Casola S, 2006, CURR TOP MICROBIOL, V308, P155; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Fairfax KC, 2015, J IMMUNOL, V194, P2999, DOI 10.4049/jimmunol.1401225; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ismail N, 1999, J IMMUNOL, V163, P4842; Jin H, 2006, J LEUKOCYTE BIOL, V80, P1416, DOI 10.1189/jlb.0206096; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; McGuire HM, 2015, J IMMUNOL, V195, P5123, DOI 10.4049/jimmunol.1501463; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Oprea M, 1997, J IMMUNOL, V158, P5155; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Weinstein JS, 2014, J IMMUNOL, V192, P3166, DOI 10.4049/jimmunol.1302617; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	55	217	225	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1197	+		10.1038/ni.3554	http://dx.doi.org/10.1038/ni.3554			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27573866	Green Accepted			2022-12-18	WOS:000384302900011
J	Takahashi, H; Kanno, T; Nakayamada, S; Hirahara, K; Sciume, G; Muljo, SA; Kuchen, S; Casellas, R; Wei, L; Kanno, Y; O'Shea, JJ				Takahashi, Hayato; Kanno, Tomohiko; Nakayamada, Shingo; Hirahara, Kiyoshi; Sciume, Giuseppe; Muljo, Stefan A.; Kuchen, Stefan; Casellas, Rafael; Wei, Lai; Kanno, Yuka; O'Shea, John J.			TGF-beta and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER RESPONSE; ROR-GAMMA-T; IN-VIVO; INTERFERON-GAMMA; TH17 CELLS; DIFFERENTIATION; LINEAGE; GENERATION; T(H)17; ABSENCE	Distinct CD4(+) T cell subsets are critical for host defense and immunoregulation. Although these subsets can act as terminally differentiated lineages, they have been increasingly noted to demonstrated plasticity. MicroRNAs are factors that control T cell stability and plasticity. Here we report that naturally occurring regulatory T cells (T-reg cells) had high expression of the microRNA miR-10a and that miR-10a was induced by retinoic acid and transforming growth factor-beta (TGF-beta) in inducible T-reg cells. By simultaneously targeting the transcriptional repressor Bcl-6 and the corepressor Ncor2, miR-10a attenuated the phenotypic conversion of inducible T-reg cells into follicular helper T cells. We also found that miR-10a limited differentiation into the T(H)17 subset of helper T cells and therefore represents a factor that can fine-tune the plasticity and fate of helper T cells.	[Takahashi, Hayato; Nakayamada, Shingo; Hirahara, Kiyoshi; Sciume, Giuseppe; Wei, Lai; Kanno, Yuka; O'Shea, John J.] Natl Inst Arthrit Musculoskeletal & Skin Dis, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Kanno, Tomohiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Kuchen, Stefan; Casellas, Rafael] Natl Inst Arthrit Musculoskeletal & Skin Dis, Immunogenet Mol Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), Natl Inst Arthrit Musculoskeletal & Skin Dis, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov	Kanno, Yuka/B-5802-2013; Muljo, Stefan A/F-5671-2015; Hirahara, Kiyoshi/E-2460-2017; Wei, Lai/D-1088-2014; Sciume, Giuseppe/K-8985-2016; Takahashi, Hayato/AAV-7707-2021	Kanno, Yuka/0000-0001-5668-9319; Muljo, Stefan A/0000-0003-1013-446X; Hirahara, Kiyoshi/0000-0002-9128-9449; Sciume, Giuseppe/0000-0003-0131-512X; Takahashi, Hayato/0000-0001-6768-8821; Kuchen, Stefan/0000-0003-4899-8132	Japan Society for the Promotion of Science; Instituto Pasteur-Fondazione Cenci-Bolognetti; National Institute of Arthritis, Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041148] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Instituto Pasteur-Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Y. Belkaid, W. Chen and A. Villarino for reading this manuscript; K. Moro and T. Tamachi for advice on manipulating Peyer's patches; L. Naldini (San Raffaele Institute) for the LV-SFFV lentiviral vector; and J. Simone and J. Lay for cell sorting. Supported by the Japan Society for the Promotion of Science (Research Fellowship for Japanese Biomedical and Behavioral Researchers at the US National Institutes of Health to H. T. and K. H.), the Instituto Pasteur-Fondazione Cenci-Bolognetti (G. S.) and the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases.	Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kikuchi M, 2000, ONCOGENE, V19, P4941, DOI 10.1038/sj.onc.1203864; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	54	217	241	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					587	+		10.1038/ni.2286	http://dx.doi.org/10.1038/ni.2286			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22544395	Green Accepted			2022-12-18	WOS:000304203900013
J	Pepper, M; Linehan, JL; Pagan, AJ; Zell, T; Dileepan, T; Cleary, PP; Jenkins, MK				Pepper, Marion; Linehan, Jonathan L.; Pagan, Antonio J.; Zell, Traci; Dileepan, Thamotharampillai; Cleary, P. Patrick; Jenkins, Marc K.			Different routes of bacterial infection induce long-lived T(H)1 memory cells and short-lived T(H)17 cells	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; DENDRITIC CELLS; IN-VIVO; CD8(+); EFFECTOR; GENERATION; NAIVE; LINEAGE; GAMMA; CD27	We used a sensitive method based on tetramers of peptide and major histocompatibility complex II (pMHCII) to determine whether CD4(+) memory T cells resemble the T helper type 1 (T(H)1) and interleukin 17 (IL-17)-producing T helper (T(H)17) subsets described in vitro. Intravenous or intranasal infection with Listeria monocytogenes induced pMHCII-specific CD4(+) naive T cells to proliferate and produce effector cells, about 10% of which resembled T(H)1 or T(H)17 cells, respectively. T(H)1 cells were also present among the memory cells that survived 3 months after infection, whereas T(H)17 cells disappeared. The short lifespan of T(H)17 cells was associated with small amounts of the antiapoptotic protein Bcl-2, the IL-15 receptor and the receptor CD27, and little homeostatic proliferation. These results suggest that T(H)1 cells induced by intravenous infection are more efficient at entering the memory pool than are T(H)17 cells induced by intranasal infection.	[Pepper, Marion; Linehan, Jonathan L.; Pagan, Antonio J.; Zell, Traci; Dileepan, Thamotharampillai; Cleary, P. Patrick; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Pagan, Antonio/AAB-1604-2019; Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996	US National Institutes of Health [AI39614, AI66016, AI27998, T32-AI07313, T32-CA9138]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R37AI027998, P01AI035296, R01AI039614, R01AI027998] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Jameson, H. Chu and J. Taylor for reviewing the manuscript; J. Walter, J. McLachlan and A. Schmidt for technical assistance; and P. Champoux and N. Shah for flow cytometry sorting. Supported by the US National Institutes of Health (AI39614, AI66016 and AI27998 to M. K. J.; T32-AI07313 to A. J. P.; and T32-CA9138 to M. P.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Allam A, 2009, BLOOD, V114, P2121, DOI 10.1182/blood-2009-05-220087; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keller AM, 2008, IMMUNITY, V29, P934, DOI 10.1016/j.immuni.2008.10.009; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Muller WJ, 2008, ARCH VIROL, V153, P1165, DOI 10.1007/s00705-008-0089-7; Pape KA, 1998, J IMMUNOL, V160, P4719; Park HS, 2004, EUR J IMMUNOL, V34, P2843, DOI 10.1002/eji.200425242; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; van Osterk MF, 2007, INT IMMUNOL, V19, P713, DOI 10.1093/intimm/dxm033; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	57	217	224	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					83	U2		10.1038/ni.1826	http://dx.doi.org/10.1038/ni.1826			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	19935657	Green Accepted			2022-12-18	WOS:000272855300017
J	Xu, Z; Weiss, A				Xu, Z; Weiss, A			Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CELL ANTIGEN RECEPTOR; T-CELLS; MULTIPLE-SCLEROSIS; POINT MUTATION; DISTINCT ISOFORMS; INHIBITORY WEDGE; MESSENGER-RNA; ACTIVATION; DIMERIZATION		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35297] Funding Source: Medline; NIGMS NIH HHS [GM39553] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; BIANCA M, 2002, BIOMED CENTRAL MED G, V3, P3; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; DAUM G, 1994, J BIOL CHEM, V269, P10524; DEANS JP, 1989, J IMMUNOL, V143, P1233; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; Hall SR, 1999, EUR J IMMUNOL, V29, P2098, DOI 10.1002/(SICI)1521-4141(199907)29:07<2098::AID-IMMU2098>3.3.CO;2-2; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; MCKENNEY DW, 1995, J BIOL CHEM, V270, P24949, DOI 10.1074/jbc.270.42.24949; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Petrone A, 2000, J CELL SCI, V113, P2345; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; Symons A, 1999, PROTEIN ENG, V12, P885, DOI 10.1093/protein/12.10.885; Symons A, 2000, GLYCOBIOLOGY, V10, P559, DOI 10.1093/glycob/10.6.559; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	42	217	229	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					764	771		10.1038/ni822	http://dx.doi.org/10.1038/ni822			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12134145				2022-12-18	WOS:000177118500016
J	Shih, TAY; Meffre, E; Roederer, M; Nussenzweig, MC				Shih, TAY; Meffre, E; Roederer, M; Nussenzweig, MC			Role of BCR affinity in T cell-dependent antibody responses in vivo	NATURE IMMUNOLOGY			English	Article							PRIMARY IMMUNE-RESPONSE; INFLUENZA-VIRUS HEMAGGLUTININ; CENTER B-CELLS; GERMINAL-CENTERS; SOMATIC HYPERMUTATION; PRIMARY IMMUNIZATION; SECONDARY RESPONSES; CLONAL SELECTION; MATURATION; MEMORY	Antibody affinity for antigen is believed to govern B lymphocyte selection during T-dependent immune responses. To examine antibody affinity in T cell-dependent immune responses, we compared mice that carry targeted V(H)B1-8 antibody genes with high or low antigen-binding affinity. We found that high- and low-affinity B cells had the same intrinsic capacity to respond to antigen, but in experiments where limiting numbers of high- and low-affinity B cells were mixed in wild-type recipient mice, only the high- affinity B cells accumulated in germinal centers (GCs). In GCs, high-affinity B cells accumulated fewer V-H somatic mutations than low affinity B cells. This effect was due to selections as the frequency of mutation in noncoding immunoglobulin gene DNA is the same in high- and low-affinity B cells. Thus, B cells recruited to the GC appeared to undergo a fixed mutation program, regardless of initial B cell receptor affinity. We conclude that in addition to the selection that occurs in GCs, stringent selection for high- affinity clones is also imposed in the early stages of the T cell-dependent immune response in vivo.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019; Roederer, Mario/G-1887-2011		NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; CLARKE SH, 1990, J IMMUNOL, V144, P2795; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JERNE N K, 1951, Acta Pathol Microbiol Scand Suppl, V87, P1; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Neuberger MS, 2000, PHILOS T ROY SOC B, V355, P357, DOI 10.1098/rstb.2000.0573; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Watanabe D, 1995, INT IMMUNOL, V7, P1949, DOI 10.1093/intimm/7.12.1949; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020	50	217	226	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					570	575		10.1038/ni803	http://dx.doi.org/10.1038/ni803			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021782				2022-12-18	WOS:000175874700017
J	Barkal, AA; Weiskopf, K; Kao, KS; Gordon, SR; Rosental, B; Yiu, YY; George, BM; Markovic, M; Ring, NG; Tsai, JM; McKenna, KM; Ho, PY; Cheng, RZ; Chen, JY; Barkal, LJ; Ring, AM; Weissman, IL; Maute, RL				Barkal, Amira A.; Weiskopf, Kipp; Kao, Kevin S.; Gordon, Sydney R.; Rosental, Benyamin; Yiu, Ying Y.; George, Benson M.; Markovic, Maxim; Ring, Nan G.; Tsai, Jonathan M.; McKenna, Kelly M.; Ho, Po Yi; Cheng, Robin Z.; Chen, James Y.; Barkal, Layla J.; Ring, Aaron M.; Weissman, Irving L.; Maute, Roy L.			Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; HLA SYSTEM; T-CELLS; 2 PARTS; COMPLEX; CD47; PHAGOCYTOSIS; LEUKEMIA	Exciting progress in the field of cancer immunotherapy has renewed the urgency of the need for basic studies of immunoregulation in both adaptive cell lineages and innate cell lineages. Here we found a central role for major histocompatibility complex (MHC) class I in controlling the phagocytic function of macrophages. Our results demonstrated that expression of the common MHC class I component beta(2)-microglobulin (beta 2M) by cancer cells directly protected them from phagocytosis. We further showed that this protection was mediated by the inhibitory receptor LILRB1, whose expression was upregulated on the surface of macrophages, including tumor-associated macrophages. Disruption of either MHC class I or LILRB1 potentiated phagocytosis of tumor cells both in vitro and in vivo, which defines the MHC class I-LILRB1 signaling axis as an important regulator of the effector function of innate immune cells, a potential biomarker for therapeutic response to agents directed against the signal-regulatory protein CD47 and a potential target of anti-cancer immunotherapy.	[Barkal, Amira A.; Weiskopf, Kipp; Kao, Kevin S.; Gordon, Sydney R.; Rosental, Benyamin; Yiu, Ying Y.; George, Benson M.; Markovic, Maxim; Ring, Nan G.; Tsai, Jonathan M.; McKenna, Kelly M.; Ho, Po Yi; Cheng, Robin Z.; Chen, James Y.; Weissman, Irving L.; Maute, Roy L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weiskopf, Kipp] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Barkal, Layla J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Ring, Aaron M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Weissman, Irving L.] Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Maute, Roy L.] Ab Initio Biotherapeut, San Francisco, CA 94080 USA	Stanford University; Harvard University; Brigham & Women's Hospital; University of Wisconsin System; University of Wisconsin Madison; Yale University; Stanford Cancer Institute; Stanford University; Stanford University	Weissman, IL; Maute, RL (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Maute, RL (corresponding author), Ab Initio Biotherapeut, San Francisco, CA 94080 USA.	irv@stanford.edu; rmaute@stanford.edu	Rosental, Benyamin/X-5400-2019	Rosental, Benyamin/0000-0002-3974-3296; Markovic, Maxim/0000-0001-9949-794X; Barkal, Layla/0000-0002-4734-7197; Tsai, Jonathan/0000-0001-5868-2305; Ring, Aaron/0000-0003-3699-2446; Cheng, Robin/0000-0001-7294-8907; McKenna, Kelly/0000-0002-9158-822X	D.K. Ludwig Fund for Cancer Research [NIH R01CA086017, NIHG R01GM100315]; Cancer Research Institute; Human Frontier Science Program Organization; NIH [T32 HL120824-03]; University of Wisconsin Medical Scientists Training Program [GM008692]; National Research Service Award [1F30DK108561]; Paul and Daisy Soros Fellowship for New Americans; Stanford Medical Scientist Training Program [NIH GM07365]; NATIONAL CANCER INSTITUTE [R01CA086017, F30CA232472, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, R01GM100315, T32GM007365] Funding Source: NIH RePORTER	D.K. Ludwig Fund for Cancer Research; Cancer Research Institute; Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Medical Scientists Training Program; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Weissman laboratory and the Stanford Stem Cell Center community for discussion and assistance; J.P. Volkmer, R. Majeti, K. Loh, N. Fernhoff, M. McCracken and J. Zee for input and advice; T. Storm, T. Naik, A. McCarty, F. Khameneh, J. Ho and P. Lovelace for logistical support; and G. Krampitz (Stanford University) for the APL1 cell line. Supported by the D.K. Ludwig Fund for Cancer Research (NIH R01CA086017 and NIHG R01GM100315 to I.L.W.), the Cancer Research Institute (Irvington Fellowship to R.L.M.), the Human Frontier Science Program Organization (postdoctoral fellowship to B.R.), the NIH (hematology training grant T32 HL120824-03 to B.R.), the University of Wisconsin Medical Scientists Training Program (GM008692 to L.J.B.), the National Research Service Award 1F30DK108561, the Paul and Daisy Soros Fellowship for New Americans (to J.M.T.) and the Stanford Medical Scientist Training Program (NIH GM07365 to A.A.B., K.W., A.M.R., J.M.T., B.M.G. and J.Y.C.).	Allan DSJ, 1999, J EXP MED, V189, P1149, DOI 10.1084/jem.189.7.1149; Baia D, 2016, EUR J IMMUNOL, V46, P1681, DOI 10.1002/eji.201546149; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BICKNELL DC, 1994, P NATL ACAD SCI USA, V91, P4751, DOI 10.1073/pnas.91.11.4751; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borges L, 1997, J IMMUNOL, V159, P5192; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Krampitz GW, 2016, P NATL ACAD SCI USA, V113, P4464, DOI 10.1073/pnas.1600007113; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Lv ZY, 2015, J IMMUNOL, V195, P661, DOI 10.4049/jimmunol.1401719; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Prod'homme V, 2007, J IMMUNOL, V178, P4473, DOI 10.4049/jimmunol.178.7.4473; PULFORD K, 1991, CLIN EXP IMMUNOL, V85, P429; SANDERSON AR, 1977, NATURE, V269, P414, DOI 10.1038/269414a0; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013; Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	41	216	232	10	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					76	+		10.1038/s41590-017-0004-z	http://dx.doi.org/10.1038/s41590-017-0004-z			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29180808	Green Accepted			2022-12-18	WOS:000419765300015
J	Sun, GP; Liu, XL; Mercado, P; Jenkinson, SR; Kypriotou, M; Feigenbaum, L; Galera, P; Bosselut, R				Sun, GP; Liu, XL; Mercado, P; Jenkinson, SR; Kypriotou, M; Feigenbaum, L; Galera, P; Bosselut, R			The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection	NATURE IMMUNOLOGY			English	Article							THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; GENE-EXPRESSION; C-KROX; RECEPTOR; COMMITMENT; TRANSCRIPTION; BTB/POZ; SIGNALS; THYMUS	The genetic programs directing CD4 or CD8 T cell differentiation in the thymus remain poorly understood. While analyzing gene expression during intrathymic T cell selection, we found that Zfp67, encoding the zinc finger transcription factor cKrox, was upregulated during the differentiation of CD4(+) but not CD8(+) T cells. Expression of a cKrox transgene impaired CD8 T cell development and caused major histocompatibility complex class I - restricted thymocytes to differentiate into CD4(+) T cells with helper properties rather than into cytotoxic CD8(+) T cells, as normally found. CD4 lineage differentiation mediated by cKrox required its N-terminal BTB (bric-a-brac, tramtrack, broad complex) domain. These findings identify cKrox as a chief CD4 differentiation factor during positive selection.	NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; CHU Caen, Fac Med, Lab Biochim Tissu Conjonctif, F-14000 Caen, France; NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CHU de Caen NORMANDIE; Universite de Caen Normandie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010671, Z01BC010671] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; DUTZ JP, 1995, J IMMUNOL, V154, P2588; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P212, DOI 10.1002/eji.1830230133; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Ghayor C, 2000, J BIOL CHEM, V275, P27421; HE X, IN PRESS NATURE; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROY M, 1993, J IMMUNOL, V151, P2497; Singer A, 2004, ADV IMMUNOL, V83, P91; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	50	216	221	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					373	381		10.1038/ni1183	http://dx.doi.org/10.1038/ni1183			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15750595				2022-12-18	WOS:000227860000011
J	Wack, A; Terczynska-Dyla, E; Hartmann, R				Wack, Andreas; Terczynska-Dyla, Ewa; Hartmann, Rune			Guarding the frontiers: the biology of type III interferons	NATURE IMMUNOLOGY			English	Review							IFN-LAMBDA RECEPTOR; CHRONIC HEPATITIS-C; ANTIVIRAL ACTIVITY; GENETIC-VARIATION; DIFFERENTIAL EXPRESSION; VIRUS-REPLICATION; STIMULATED GENES; EPITHELIAL-CELLS; I INTERFERONS; HCV CLEARANCE	Type III interferons (IFNs) or IFN-lambda s regulate a similar set of genes as type I IFNs, but whereas type I IFNs act globally, IFN-lambda s primarily target mucosal epithelial cells and protect them against the frequent viral attacks that are typical for barrier tissues. IFN-lambda s thereby help to maintain healthy mucosal surfaces through immune protection, without the significant immune-related pathogenic risk associated with type I IFN responses. Type III IFNs also target the human liver, with dual effects: they induce an antiviral state in hepatocytes, but specific IFN-lambda 4 action impairs the clearance of hepatitis C virus and could influence inflammatory responses. This constitutes a paradox that has yet to be resolved.	[Wack, Andreas] Francis Crick Inst, Mill Hill Lab, London, England; [Terczynska-Dyla, Ewa; Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Francis Crick Institute; Aarhus University	Hartmann, R (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	rh@mbg.au.dk		Wack, Andreas/0000-0001-5226-2991; Hartmann, Rune/0000-0003-1159-066X	Medical Research Council [MC_U117597139] Funding Source: Medline; Novo Nordisk Fonden [NNF12OC0002082] Funding Source: researchfish; The Francis Crick Institute [10206] Funding Source: researchfish; MRC [MC_U117597139] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Fonden(Novo Nordisk Foundation); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahlenstiel G, 2012, ANTIVIR THER, V17, P1163, DOI 10.3851/IMP2427; Anggakusuma, 2015, J VIROL, V89, P3833, DOI 10.1128/JVI.03129-14; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bibert S, 2014, AIDS, V28, P1885, DOI 10.1097/QAD.0000000000000379; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Davidson S, 2015, J INTERF CYTOK RES, V35, P252, DOI 10.1089/jir.2014.0227; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; de Groen RA, 2015, EUR J IMMUNOL, V45, P250, DOI 10.1002/eji.201444903; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Edwards MR, 2011, EMBO MOL MED, V3, P306, DOI 10.1002/emmm.201100143; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Hermant P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087906; Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109; Holmes JA, 2012, J VIRAL HEPATITIS, V19, P677, DOI 10.1111/jvh.12003; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Jouvin-Marche E, 2014, J INFECT DIS, V209, P1907, DOI 10.1093/infdis/jiu016; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kramer B, 2011, P NATL ACAD SCI USA, V108, pE519, DOI 10.1073/pnas.1108850108; Lauber C, 2015, GENES IMMUN, V16, P414, DOI 10.1038/gene.2015.23; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102; Liu BS, 2011, BLOOD, V117, P2385, DOI 10.1182/blood-2010-07-298976; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Manuel O, 2015, J INFECT DIS, V211, P906, DOI 10.1093/infdis/jiu557; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Muir AJ, 2013, J CLIN GASTROENTEROL, V47, P222, DOI 10.1097/MCG.0b013e3182680221; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Swider A, 2014, CYTOKINE, V65, P17, DOI 10.1016/j.cyto.2013.09.020; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	110	215	220	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					802	809		10.1038/ni.3212	http://dx.doi.org/10.1038/ni.3212			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194286	Green Published, Bronze			2022-12-18	WOS:000358299200007
J	Belkaid, Y; Naik, S				Belkaid, Yasmine; Naik, Shruti			Compartmentalized and systemic control of tissue immunity by commensals	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; INTESTINAL MICROBIOTA; GUT MICROBIOTA; GERM-FREE; SKIN; BACTERIA; DISEASE; DIVERSITY; DEFENSE; INFLAMMATION	The body is composed of various tissue microenvironments with finely tuned local immunosurveillance systems, many of which are in close apposition with distinct commensal niches. Mammals have formed an evolutionary partnership with the microbiota that is critical for metabolism, tissue development and host defense. Despite our growing understanding of the impact of this host-microbe alliance on immunity in the gastrointestinal tract, the extent to which individual microenvironments are controlled by resident microbiota remains unclear. In this Perspective, we discuss how resident commensals outside the gastrointestinal tract can control unique physiological niches and the potential implications of the dialog between these commensals and the host for the establishment of immune homeostasis, protective responses and tissue pathology.	[Belkaid, Yasmine; Naik, Shruti] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health. We thank members of the Belkaid laboratory for helpful discussions, particularly S. Spencer and J. Grainger for critical reading of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bigorgne AE, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/618260; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dixon DR, 2004, J PERIODONTOL, V75, P1486, DOI 10.1902/jop.2004.75.11.1486; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Garcia-Crespo KE, 2013, ANTIVIR RES, V97, P270, DOI 10.1016/j.antiviral.2012.12.022; Genc MR, 2004, AM J OBSTET GYNECOL, V191, P1324, DOI 10.1016/j.ajog.2004.05.074; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Owens BMJ, 2013, MUCOSAL IMMUNOL, V6, P224, DOI 10.1038/mi.2012.125; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rose WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032728; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Walton KLW, 2006, IMMUNOL LETT, V102, P16, DOI 10.1016/j.imlet.2005.07.001; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Witkin SS, 2011, FEMS IMMUNOL MED MIC, V61, P153, DOI 10.1111/j.1574-695X.2010.00757.x; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0	102	215	224	3	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					646	653		10.1038/ni.2604	http://dx.doi.org/10.1038/ni.2604			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778791	Green Accepted			2022-12-18	WOS:000320509100002
J	Boulton, IC; Gray-Owen, SD				Boulton, IC; Gray-Owen, SD			Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4(+) T lymphocytes	NATURE IMMUNOLOGY			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PROTEIN-TYROSINE-PHOSPHATASE; BILIARY GLYCOPROTEIN CD66A; CELL-ADHESION MOLECULE; INHIBITORY RECEPTOR; ANTIGEN RECEPTOR; OPA PROTEINS; SIGNAL-TRANSDUCTION; ANTIBODY-RESPONSES; OPACITY PROTEINS	Infection with Neisseria gonorrhoeae can trigger an intense inflammatory response, yet there is little specific immune response or development of immune memory. In addition, gonorrhea typically correlates with a transient reduction in T lymphocyte counts in blood, and these populations recover when gonococcal infection is resolved. Such observations suggest that the gonococci have a suppressive effect on the host immune response. We report here that N. gonorrhoeae O pa proteins were able to bind CEACAM1 expressed by primary CD4(+)T lymphocytes and suppress their activation and proliferation. CEACAM1 bound by gonococcal Opa(52) associated with the tyrosine phosphatases SHP-1 and SHP-2, which implicates the receptor's ITIM (immunoreceptor tyrosine-based inhibitory motif) in this effect.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Med Sci Bldg Rm 4381,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.gray.owen@utoronto.ca	Boulton, Ian/A-9196-2010; Gray-Owen, Scott/AAG-7337-2022; Gray-Owen, Scott/AFL-7380-2022	Gray-Owen, Scott D./0000-0002-1477-3616				ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; ALSULEIMAN SA, 1983, OBSTET GYNECOL, V61, P48; Anzala AO, 2000, J INFECT DIS, V182, P459, DOI 10.1086/315733; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; BRUMMER J, 1995, ONCOGENE, V11, P1649; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; CHEN WJ, 1994, J IMMUNOL, V152, P3991; Christensen MD, 2000, SCAND J IMMUNOL, V51, P557; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cohen MS, 1999, J INFECT DIS, V179, pS375, DOI 10.1086/513847; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Dennehy KM, 1997, EUR J IMMUNOL, V27, P679, DOI 10.1002/eji.1830270316; Dillard JP, 1997, MOL MICROBIOL, V25, P893, DOI 10.1111/j.1365-2958.1997.mmi522.x; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; HANDSFIELD HH, 1990, NEISSERIA GONORRHOEA, P1613; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; HILLIS SD, 1994, AM J OBSTET GYNECOL, V170, P801, DOI 10.1016/S0002-9378(94)70286-1; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Janssen O, 2000, INT ARCH ALLERGY IMM, V121, P183, DOI 10.1159/000024316; Janssen O, 2000, CELL TISSUE RES, V301, P85, DOI 10.1007/s004419900155; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999; KAMAL M, 1991, EUR J IMMUNOL, V21, P1419, DOI 10.1002/eji.1830210614; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LAMMEL CJ, 1985, J INFECT DIS, V152, P990, DOI 10.1093/infdis/152.5.990; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; Mardiney M, 1996, CYTOMETRY, V26, P305, DOI 10.1002/(SICI)1097-0320(19961215)26:4<305::AID-CYTO11>3.0.CO;2-V; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Morales VM, 1999, J IMMUNOL, V163, P1363; Muraille E, 2000, IMMUNOL LETT, V72, P7, DOI 10.1016/S0165-2478(00)00162-0; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Pluskota E, 2000, J BIOL CHEM, V275, P30029, DOI 10.1074/jbc.M000240200; Schmidt KA, 2000, SEX TRANSM DIS, V27, P278, DOI 10.1097/00007435-200005000-00008; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Taylor L S, 2000, Rev Immunogenet, V2, P204; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Vilanova M, 1996, SCAND J IMMUNOL, V43, P155, DOI 10.1046/j.1365-3083.1996.d01-25.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x	60	215	225	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					229	236		10.1038/ni769	http://dx.doi.org/10.1038/ni769			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11850628				2022-12-18	WOS:000174074000010
J	Tzachanis, D; Freeman, GJ; Hirano, N; van Puijenbroek, AAFL; Delfs, MW; Berezovskaya, A; Nadler, LM; Boussiotis, VA				Tzachanis, D; Freeman, GJ; Hirano, N; van Puijenbroek, AAFL; Delfs, MW; Berezovskaya, A; Nadler, LM; Boussiotis, VA			Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION; TOB/BTG1 FAMILY; MESSENGER-RNA; PROTEIN; COMPONENT; IDENTIFICATION; ANTIGEN	During a search for genes that maintain T cell quiescence, we determined that Tob, a member of an anti-proliferative gene family, was highly expressed in anergic T cell clones. Tob was also expressed in unstimulated peripheral blood T lymphocytes and down-regulated during activation. Forced expression of Tob inhibited T cell proliferation and transcription of cytokines and cyclins. In contrast, suppression of Tob with an antisense oligonucleotide augmented CD3-mediated responses and abrogated the requirement of costimulation for maximal proliferation and cytokine secretion. Tob associated with Smad2 and Smad4 and enhanced Smad DNA-binding. The inhibitory effect of Tob on interleukin 2 (IL-2) transcription was not mediated by blockade of NFAT, AP-1 or NF-kappaB transactivation but by enhancement of Smad binding on the -105 negative regulatory element of the IL-2 promoter. Thus,T cell quiescence is an actively maintained phenotype that must be suppressed for T cell activation to occur.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol,Div Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Boussiotis, VA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol,Div Med Oncol, Boston, MA 02115 USA.	vassiliki_boussiotis@dfci.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043552, R56AI043552, R01AI043552, P01AI041584] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 54786] Funding Source: Medline; NIAID NIH HHS [AI 41584, AI 43552] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1795, DOI 10.1073/pnas.89.5.1795; DENT CL, 1994, TRANSCRIPTION FACTOR, P1; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Matsuda S, 1996, ONCOGENE, V12, P705; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MUELLER DL, 1989, J IMMUNOL, V142, P2617; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; QUILL H, 1992, J IMMUNOL, V149, P2887; RIMOKH R, 1991, GENE CHROMOSOME CANC, V3, P24, DOI 10.1002/gcc.2870030106; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805	47	215	222	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1174	1182		10.1038/ni730	http://dx.doi.org/10.1038/ni730			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11694881				2022-12-18	WOS:000172473200021
J	van de Pavert, SA; Olivier, BJ; Goverse, G; Vondenhoff, MF; Greuter, M; Beke, P; Kusser, K; Hopken, UE; Lipp, M; Niederreither, K; Blomhoff, R; Sitnik, K; Agace, WW; Randall, TD; de Jonge, WJ; Mebius, RE				van de Pavert, Serge A.; Olivier, Brenda J.; Goverse, Gera; Vondenhoff, Mark F.; Greuter, Mascha; Beke, Patrick; Kusser, Kim; Hoepken, Uta E.; Lipp, Martin; Niederreither, Karen; Blomhoff, Rune; Sitnik, Kasia; Agace, William W.; Randall, Troy D.; de Jonge, Wouter J.; Mebius, Reina E.			Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HOMING T-CELLS; B-CELL; VAGUS NERVE; ORGAN DEVELOPMENT; DENDRITIC CELLS; RECEPTOR-ALPHA; ROR-GAMMA; EXPRESSION; BETA	The location of embryonic lymph node development is determined by the initial clustering of lymphoid tissue-inducer (LTi) cells. Here we demonstrate that both the chemokine CXCL13 and the chemokine CCL21 attracted LTi cells at embryonic days 12.5-14.5 and that initial clustering depended exclusively on CXCL13. Retinoic acid (RA) induced early CXCL13 expression in stromal organizer cells independently of lymphotoxin signaling. Notably, neurons adjacent to the lymph node anlagen expressed enzymes essential for RA synthesis. Furthermore, stimulation of parasymphathetic neural output in adults led to RA receptor (RAR)-dependent induction of CXCL13 in the gut. Therefore, our data show that the initiation of lymph node development is controlled by RA-mediated expression of CXCL13 and suggest that RA may be provided by adjacent neurons.	[van de Pavert, Serge A.; Olivier, Brenda J.; Goverse, Gera; Vondenhoff, Mark F.; Greuter, Mascha; Beke, Patrick; Mebius, Reina E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Kusser, Kim; Randall, Troy D.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Hoepken, Uta E.; Lipp, Martin] Max Delbruck Ctr Mol Med, Berlin, Germany; [Niederreither, Karen] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway; [Sitnik, Kasia; Agace, William W.] Lund Univ, Dept Expt Med Sci, Immunol Sect, Lund, Sweden; [de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Rochester; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Baylor College of Medicine; University of Oslo; Lund University; University of Amsterdam; Academic Medical Center Amsterdam	Mebius, RE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	r.mebius@vumc.nl	van de Pavert, Serge A./A-7307-2008	van de Pavert, Serge A./0000-0002-7147-4380; Mebius, Reina/0000-0003-0451-7464; Lipp, Martin/0000-0002-0087-2672; Sitnik, Katarzyna/0000-0002-6965-0322; Agace, william/0000-0003-3823-5772	US National Institutes of Health [HL69409, AI072689]; Netherlands Organization for Scientific Research [016.096.310, 918.56.612, 050-10-120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072689] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank animal caretakers for care of the animals; G. Kraal and T. Geijtenbeek for critically reading the manuscript; R. Molenaar for help; H. Kalay for labeling antibodies; D. Littman (Skirball Institute of Biomolecular Medicine), S. Nishikawa (Riken Center for Developmental Biology) and K. van Gisbergen (Academic Medical Center, Amsterdam) for antibodies; and J. van der Meulen (Centraal Bureau voor de Statistiek, The Netherlands) for help with statistical analysis. Supported by the US National Institutes of Health (HL69409 and AI072689 to T. D. R.) and the Netherlands Organization for Scientific Research (VIDI grant 016.096.310 to W. J. d. J.; VICI grant 918.56.612 to R. E. M. and S. A. v. d. P.; and Genomics grant 050-10-120 to R. E. M. and M. F. V.).	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bagaeva LV, 2006, J IMMUNOL, V176, P7676, DOI 10.4049/jimmunol.176.12.7676; Batchelor PE, 2008, BRAIN RES, V1209, P49, DOI 10.1016/j.brainres.2008.02.098; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; DE TP, 1994, SCIENCE, V264, P703; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Mebius RE, 2007, NAT IMMUNOL, V8, P229, DOI 10.1038/ni0307-229; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Steinmetz OM, 2005, KIDNEY INT, V67, P1616, DOI 10.1111/j.1523-1755.2005.00244.x; Sugiura H, 1997, ARCH DERMATOL RES, V289, P125, DOI 10.1007/s004030050167; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MFR, 2008, J LEUKOCYTE BIOL, V84, P152, DOI 10.1189/jlb.0907659; Wengner AM, 2007, ARTHRITIS RHEUM-US, V56, P3271, DOI 10.1002/art.22939; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	51	214	220	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1193	U78		10.1038/ni.1789	http://dx.doi.org/10.1038/ni.1789			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19783990	Green Accepted			2022-12-18	WOS:000270955900012
J	Yamamoto, M; Okamoto, T; Takeda, K; Sato, S; Sanjo, H; Uematsu, S; Saitoh, T; Yamamoto, N; Sakurai, H; Ishii, KJ; Yamaoka, S; Kawai, T; Matsuura, Y; Takeuchi, O; Akira, S				Yamamoto, Masahiro; Okamoto, Toru; Takeda, Kiyoshi; Sato, Shintaro; Sanjo, Hideki; Uematsu, Satoshi; Saitoh, Tatsuya; Yamamoto, Naoki; Sakurai, Hiroaki; Ishii, Ken J.; Yamaoka, Shoji; Kawai, Taro; Matsuura, Yoshiharu; Takeuchi, Osamu; Akira, Shizuo			Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; T-CELL-RECEPTOR; POLYUBIQUITIN CHAINS; IKK ACTIVATION; KINASE COMPLEX; TAK1; LYMPHOCYTE; BCL10; BETA; REGULATOR	The Ubc13 E2 ubiquitin-conjugating enzyme is key in the process of 'tagging' target proteins with lysine 63-linked polyubiquitin chains, which are essential for the transmission of immune receptor signals culminating in activation of the transcription factor NF-kappa B. Here we demonstrate that conditional ablation of Ubc13 resulted in defective B cell development and in impaired B cell and macrophage activation. In response to all tested stimuli except tumor necrosis factor, Ubc13-deficient cells showed almost normal NF-kappa B activation but considerably impaired activation of mitogen- activated protein kinase. Ubc13-induced activation of mitogen- activated protein kinase required, at least in part, ubiquitination of the adaptor protein IKKc. These results show that Ubc13 is key in the mammalian immune response.	Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Suita, Osaka 5650871, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Embryon & Genet Engn, Fukuoka 8128582, Japan; ERATO, Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan; Toyama Med & Pharmaceut Univ, Inst Nat Med, Div Pathogen Biochem, Century Ctr Excellence Progam 21, Toyama 9300194, Japan	Osaka University; Osaka University; Kyushu University; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); University of Toyama	Akira, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Host Def, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009; Takeuchi, Osamu/D-6007-2011; Sakurai, Hiroaki/AAE-4294-2019; Ishii, Ken J/B-1685-2012; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019	Ishii, Ken J/0000-0002-6728-3872; Takeuchi, Osamu/0000-0002-1260-6232; Sakurai, Hiroaki/0000-0003-0657-9570; Takeda, Kiyoshi/0000-0002-1778-6332; Sato, Shintaro/0000-0001-5156-3354; Kawai, Taro/0000-0001-7510-4662				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2002, J CELL SCI, V115, P679; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Krappmann D, 2001, MOL CELL BIOL, V21, P6640, DOI 10.1128/MCB.21.19.6640-6650.2001; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scherle PA, 1998, J IMMUNOL, V161, P5681; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weil R, 2004, CURR OPIN IMMUNOL, V16, P374, DOI 10.1016/j.coi.2004.03.003; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200	57	214	227	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					962	970		10.1038/ni1367	http://dx.doi.org/10.1038/ni1367			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16862162				2022-12-18	WOS:000239942300015
J	Latour, S; Gish, G; Helgason, CD; Humphries, RK; Pawson, T; Veillette, A				Latour, S; Gish, G; Helgason, CD; Humphries, RK; Pawson, T; Veillette, A			Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product	NATURE IMMUNOLOGY			English	Article							TYROSINE PROTEIN-KINASE; ACTIVATION MOLECULE SLAM; SH2 DOMAIN; NEGATIVE REGULATION; CELL-PROLIFERATION; DOCKING PROTEIN; ENCODING GENE; T-CELLS; RECEPTOR; DISEASE	Signaling lymphocyte activation molecule (SLAM)-associated protein (SAP) is a short intracellular molecule that is mutated in humans with X-linked lymphoproliferative (XLP) disease. Although the exact role and mechanism of action of SAP are not known, it has the capacity to interact with the cytoplasmic region of SLAM and other related immune cell receptors. As SAP is composed almost exclusively of a Src homology 2 (SH2) domain, it has been proposed that it functions as a natural blocker of SH2 domain-mediated interactions. We report here that the SLAM receptor is capable of triggering a protein tyrosine phosphorylation signal in T cells via a mechanism that is strictly dependent on SAP expression. This signal involves the SH2 domain-containing inositol phosphatase (SHIP);the adaptor molecules Dok2, Dok1 and Shc;and Ras GTPase-activating protein RasGAP. SAP is essential for this pathway because it facilitates the selective recruitment and activation of the Src-related protein tyrosine kinase FynT. We also show that signaling via the SLAM-SAP pathway in an established T cell line can alter the profile of cytokine production during T cell activation. These findings identify a mechanism by which a putative adaptor molecule is required for receptor-mediated signaling events in the immune system. They also provide insights into the pathophysiology of a severe human lymphoproliferative disease.	Inst Rech Clin Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada; Hop Necker Enfants Malad, Unite INSERM U429, Paris, France; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; British Columbia Cancer Agency	Veillette, A (corresponding author), Inst Rech Clin Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.		Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013; Latour, Sylvain/H-3652-2017	Humphries, Richard/0000-0003-0540-7005; Latour, Sylvain/0000-0001-8238-4391				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Aversa G, 1997, J IMMUNOL, V158, P4036; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Castro AG, 1999, J IMMUNOL, V163, P5860; Chow L M, 1995, Semin Immunol, V7, P207, DOI 10.1006/smim.1995.0026; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; COOKE M P, 1989, New Biologist, V1, P66; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Miceli M C, 1991, Semin Immunol, V3, P133; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Nakajima H, 2000, HUM IMMUNOL, V61, P39, DOI 10.1016/S0198-8859(99)00170-6; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; PERI KG, 1993, ONCOGENE, V8, P2765; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Sayos J, 2000, INT IMMUNOL, V12, P1749, DOI 10.1093/intimm/12.12.1749; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schuster V, 2000, IMMUNOL REV, V178, P21, DOI 10.1034/j.1600-065X.2000.17819.x; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Thompson AD, 1996, ONCOGENE, V13, P2649; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILDE DB, 1983, J IMMUNOL, V131, P2178; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2	46	214	226	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					681	690		10.1038/90615	http://dx.doi.org/10.1038/90615			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477403				2022-12-18	WOS:000170230100009
J	Yao, C; Sun, HW; Lacey, NE; Ji, Y; Moseman, EA; Shih, HY; Heuston, EF; Kirby, M; Anderson, S; Cheng, J; Khan, O; Handon, R; Reilley, J; Fioravanti, J; Hu, JH; Gossa, S; Wherry, EJ; Gattinoni, L; McGavern, DB; O'Shea, JJ; Schwartzberg, PL; Wu, TQ				Yao, Chen; Sun, Hong-Wei; Lacey, Neal E.; Ji, Yun; Moseman, E. Ashley; Shih, Han-Yu; Heuston, Elisabeth F.; Kirby, Martha; Anderson, Stacie; Cheng, Jun; Khan, Omar; Handon, Robin; Reilley, Julie; Fioravanti, Jessica; Hu, Jinhui; Gossa, Selamawit; Wherry, E. John; Gattinoni, Luca; McGavern, Dorian B.; O'Shea, John J.; Schwartzberg, Pamela L.; Wu, Tuoqi			Single-cell RNA-seq reveals TOX as a key regulator of CD8(+) T cell persistence in chronic infection	NATURE IMMUNOLOGY			English	Article							FATE DECISIONS; MEMORY; EFFECTOR; EXHAUSTION; DIFFERENTIATION; EXPRESSION; PROMOTES; IMMUNOTHERAPY; VIRUS; MICE	Progenitor-like CD8(+) T cells mediate long-term immunity to chronic infection and cancer and respond potently to immune checkpoint blockade. These cells share transcriptional regulators with memory precursor cells, including T cell-specific transcription factor 1 (TCF1), but it is unclear whether they adopt distinct programs to adapt to the immunosuppressive environment. By comparing the single-cell transcriptomes and epigenetic profiles of CD8(+) Tcells responding to acute and chronic viral infections, we found that progenitor-like CD8(+) T cells became distinct from memory precursor cells before the peak of the T cell response. We discovered a coexpression gene module containing Tox that exhibited higher transcriptional activity associated with more abundant active histone marks in progenitor-like cells than memory precursor cells. Moreover, thymocyte selection-associated high mobility group box protein TOX (TOX) promoted the persistence of antiviral CD8(+) T cells and was required for the programming of progenitor-like CD8(+) T cells. Thus, long-term CD8+ T cell immunity to chronic viral infection requires unique transcriptional and epigenetic programs associated with the transcription factor TOX.	[Yao, Chen; Sun, Hong-Wei; Shih, Han-Yu; O'Shea, John J.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Lacey, Neal E.; Ji, Yun; Fioravanti, Jessica; Hu, Jinhui; Gattinoni, Luca] NCI, NIH, Bethesda, MD 20892 USA; [Moseman, E. Ashley; Gossa, Selamawit; McGavern, Dorian B.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Heuston, Elisabeth F.; Kirby, Martha; Anderson, Stacie; Cheng, Jun; Handon, Robin; Reilley, Julie; Schwartzberg, Pamela L.; Wu, Tuoqi] NHGRI, NIH, Bethesda, MD 20892 USA; [Khan, Omar; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Reilley, Julie; Schwartzberg, Pamela L.; Wu, Tuoqi] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ji, Yun] Cellular Biomed Grp, Gaithersburg, MD USA; [Moseman, E. Ashley] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Wu, Tuoqi] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80309 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	O'Shea, JJ (corresponding author), NIAMSD, NIH, Bethesda, MD 20892 USA.; Schwartzberg, PL; Wu, TQ (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.; Schwartzberg, PL; Wu, TQ (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Wu, TQ (corresponding author), Univ Colorado, Dept Immunol & Microbiol, Sch Med, Aurora, CO 80309 USA.	osheaj@arb.niams.nih.gov; pams@nih.gov; tuoqi.wu@ucdenver.edu	Hu, Jinhui/AAG-9000-2021; Gattinoni, Luca/A-2281-2008; McGavern, Dorian/HCH-3601-2022; Wherry, John/ABI-1280-2020; Fioravanti, Jessica/AAS-1245-2020	Gattinoni, Luca/0000-0003-2239-3282; McGavern, Dorian/0000-0001-9568-545X; Fioravanti, Jessica/0000-0001-6263-4306; Kirby, Martha/0000-0001-7157-7964; Khan, Omar/0000-0002-7641-6163; Yao, Chen/0000-0001-6852-5661; Shih, Han-Yu/0000-0002-7525-5433; Lacey, Neal/0000-0002-3633-5924	G. Gutierrez-Cruz (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)); NHGRI, National Institute of Allergy and Infectious Diseases, NIAMS; National Institute of Neurological Disorders and Stroke; National Cancer Institute, National Institutes of Health (NIH); NIH [AG056524]; University of Pennsylvania cancer immunotherapy program; NATIONAL CANCER INSTITUTE [ZIABC011480] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG056524] Funding Source: NIH RePORTER	G. Gutierrez-Cruz (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)); NHGRI, National Institute of Allergy and Infectious Diseases, NIAMS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania cancer immunotherapy program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Garrett (NHGRI), E. Escobar (NHGRI), C. Rivas (NHGRI), I. Ginty (NHGRI), W. Pridgen (NHGRI), G. Gutierrez-Cruz (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) and S. Dell'Orso (NIAMS) for their excellent technical support and J. Kaye for the Tox<SUP>loxP/loxP</SUP> mice. This work was supported in part by the intramural programs of the NHGRI, National Institute of Allergy and Infectious Diseases, NIAMS and National Institute of Neurological Disorders and Stroke, and the National Cancer Institute, National Institutes of Health (NIH) and DDIR Innovation Awards to P.L.S., J.J.O. and L. G., and NIH grant (no. AG056524 to T.W). E.J.W. is a member of the Parker Institute for Cancer Immunotherapy, which supported the University of Pennsylvania cancer immunotherapy program.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Araki K, 2010, J EXP MED, V207, P2355, DOI 10.1084/jem.20100124; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cox MA, 2013, VIROLOGY, V435, P157, DOI 10.1016/j.virol.2012.09.012; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fooksman DR, 2014, J IMMUNOL, V192, P1004, DOI 10.4049/jimmunol.1300977; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Page N, 2018, IMMUNITY, V48, P937, DOI 10.1016/j.immuni.2018.04.005; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singer M, 2017, CELL, V171, P1221, DOI 10.1016/j.cell.2017.11.006; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	55	213	214	8	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					890	+		10.1038/s41590-019-0403-4	http://dx.doi.org/10.1038/s41590-019-0403-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31209400	Green Accepted			2022-12-18	WOS:000471891900019
J	Ricardo-Gonzalez, RR; Van Dyken, SJ; Schneider, C; Lee, J; Nussbaum, JC; Liang, HE; Vaka, D; Eckalbar, WL; Molofsky, AB; Erle, DJ; Locksley, RM				Ricardo-Gonzalez, Roberto R.; Van Dyken, Steven J.; Schneider, Christoph; Lee, Jinwoo; Nussbaum, Jesse C.; Liang, Hong-Erh; Vaka, Dedeepya; Eckalbar, Walter L.; Molofsky, Ari B.; Erle, David J.; Locksley, Richard M.			Tissue signals imprint ILC2 identity with anticipatory function	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ATOPIC-DERMATITIS; TYPE-2 IMMUNITY; ACTIVATION; ASTHMA	Group 2 innate lymphoid cells (ILC2s) are distributed systemically and produce type 2 cytokines in response to a variety of stimuli, including the epithelial cytokines interleukin (IL)-25, IL-33, and thymic stromal lymphopoietin (TSLP). Transcriptional profiling of ILC2s from different tissues, however, grouped ILC2s according to their tissue of origin, even in the setting of combined IL-25-, IL-33-receptor-, and TSLP-receptor-deficiency. Single-cell profiling confirmed a tissue-organizing transcriptome and identified ILC2 subsets expressing distinct activating receptors, including the major subset of skin ILC2s, which were activated preferentially by IL-18. Tissue ILC2 subsets were unaltered in number and expression in germ-free mice, suggesting that endogenous, tissue-derived signals drive the maturation of ILC2 subsets by controlling expression of distinct patterns of activating receptors, thus anticipating tissue-specific perturbations occurring later in life.	[Ricardo-Gonzalez, Roberto R.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Van Dyken, Steven J.; Schneider, Christoph; Lee, Jinwoo; Nussbaum, Jesse C.; Liang, Hong-Erh; Eckalbar, Walter L.; Erle, David J.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Vaka, Dedeepya] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Eckalbar, Walter L.; Erle, David J.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Van Dyken, Steven J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Washington University (WUSTL)	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Richard.Locksley@ucsf.edu	Lee, Jinwoo/AAA-9510-2020	Lee, Jinwoo/0000-0003-2991-4183; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035; Van Dyken, Steven/0000-0002-9787-0883; Schneider, Christoph/0000-0002-0452-2960; Molofsky, Ari/0000-0003-0764-3175	National Institutes of Health [AI030663, HL128903, AI122702, DK101604, AI113143]; Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation; Swiss National Science Foundation [P2EZP3_162266, P300PA_171591]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128903, P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663, K08AI113143, T32AI007334, R01AI026918, F30AI122702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722, K08DK101604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Consengco and M. Ji for technical expertise; Z. Wang for cell sorting; A. Barczak, R. Barbeau, and J. Pollack for assistance with RNA-seq; E. Wan for assistance with scRNA-seq; J. Turnbaugh (University of California San Francisco) for providing germ-free mice; and M. Ansel and A. Marson for comments on the manuscript. This work was supported by the National Institutes of Health (AI030663 and HL128903 to R.M.L., AI122702 to J.L., DK101604 to A.B.M., and AI113143 to J.C.N.), Dermatology Foundation (R.R.R.-G.), A.P. Giannini Foundation (R.R.R.-G.), Robert Wood Johnson Foundation (R.R.R.-G.), Swiss National Science Foundation (P2EZP3_162266 and P300PA_171591 to C.S.), Howard Hughes Medical Institute (R.M.L.), and the Sandler Asthma Basic Research Center at the University of California San Francisco (R.M.L).	Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; von Moltke J, 2014, CURR OPIN IMMUNOL, V31, P58, DOI 10.1016/j.coi.2014.09.009; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Zedan K, 2015, J CLIN DIAGN RES, V9, pWC1, DOI 10.7860/JCDR/2015/12261.5742	37	213	215	3	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1093	+		10.1038/s41590-018-0201-4	http://dx.doi.org/10.1038/s41590-018-0201-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30201992	Green Accepted, Green Submitted			2022-12-18	WOS:000445968600015
J	Rankin, LC; Groom, JR; Chopin, M; Herold, MJ; Walker, JA; Mielke, LA; McKenzie, ANJ; Carotta, S; Nutt, SL; Belz, GT				Rankin, Lucille C.; Groom, Joanna R.; Chopin, Michael; Herold, Marco J.; Walker, Jennifer A.; Mielke, Lisa A.; McKenzie, Andrew N. J.; Carotta, Sebastian; Nutt, Stephen L.; Belz, Gabrielle T.			The transcription factor T-bet is essential for the development of NKp46(+) innate lymphocytes via the Notch pathway	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; CELLS; EXPRESSION; IMMUNITY; FETAL; FATE; INFLAMMATION; CHECKPOINTS; COLITIS; GUT	NKp46(+) innate lymphoid cells (ILCs) serve important roles in regulating the intestinal microbiota and defense against pathogens. Whether NKp46(+) ILCs arise directly from lymphoid tissue-inducer (LTi) cells or represent a separate lineage remains controversial. We report here that the transcription factor 1-bet (encoded by Tbx21) was essential for the development of NKp46(+) ILCs but not of LTi cells or nuocytes. Deficiency in interleukin 22 (IL-22)-producing NKp46(+) ILCs resulted in greater susceptibility of Tbx21(-/-) mice to intestinal infection. Haploinsufficient 1-bet expression resulted in lower expression of the signaling molecule Notch, and Notch signaling was necessary for the transition of LTi cells into NKp46(+) ILCs. Furthermore, NKp46(+) ILCs differentiated solely from the CD4(-) LTi population, not the CD4(+) LTi population. Our results pinpoint the regulation of Notch signaling by 1-bet as a distinct molecular pathway that guides the development of NKp46(+) ILCs.	[Rankin, Lucille C.; Groom, Joanna R.; Chopin, Michael; Herold, Marco J.; Mielke, Lisa A.; Carotta, Sebastian; Nutt, Stephen L.; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Rankin, Lucille C.; Groom, Joanna R.; Chopin, Michael; Herold, Marco J.; Mielke, Lisa A.; Carotta, Sebastian; Nutt, Stephen L.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Walker, Jennifer A.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Walter & Eliza Hall Institute; University of Melbourne; MRC Laboratory Molecular Biology	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au	Chopin, Michael/AAD-3661-2020; Herold, Marco J/C-8039-2013; Belz, Gabrielle T/C-9350-2013; Nutt, Stephen L/C-9256-2013	Herold, Marco J/0000-0001-7539-7581; Belz, Gabrielle T/0000-0002-9660-9587; Nutt, Stephen L/0000-0002-0020-6637; Groom, Joanna/0000-0001-5251-7835; Michael, Chopin/0000-0001-8812-2763; Mielke, Lisa/0000-0002-9522-9320; Rankin, Lucille/0000-0002-3699-1569	National Health and Medical Research Council of Australia; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute; Australian Research Council; Leukaemia Foundation; American Asthma Foundation; Medical Research Council; Victorian State Government Operational Infrastructure Support; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); Leukaemia Foundation; American Asthma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Victorian State Government Operational Infrastructure Support; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Robins-Browne, M. Camilleri, R. Cole, J. Cruickshank and the staff of the animal and flow cytometry facilities of the Walter and Eliza Hall Institute and Medical Research Council Laboratory of Molecular Biology for technical assistance. Supported by the National Health and Medical Research Council of Australia (G.T.B., S.L.N., S.C., L.R. and J.R.G.), the Sylvia and Charles Viertel Foundation (G.T.B.), the Howard Hughes Medical Institute (G.T.B.), the Australian Research Council (S.L.N.), the Leukaemia Foundation (M.J.H.), the American Asthma Foundation (J.A.W.), the Medical Research Council, the American Asthma Foundation (A.N.J.M.) and Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2012, CURR OPIN IMMUNOL, V24, P290, DOI 10.1016/j.coi.2012.04.004; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	35	213	218	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					389	395		10.1038/ni.2545	http://dx.doi.org/10.1038/ni.2545			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23455676	Green Accepted			2022-12-18	WOS:000316648700014
J	Di Pucchio, T; Chatterjee, B; Smed-Sorensen, A; Clayton, S; Palazzo, A; Montes, M; Xue, Y; Mellman, I; Banchereau, J; Connolly, JE				Di Pucchio, Tiziana; Chatterjee, Bithi; Smed-Sorensen, Anna; Clayton, Sandra; Palazzo, Adam; Montes, Monica; Xue, Yaming; Mellman, Ira; Banchereau, Jacques; Connolly, John E.			Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; INTERFERON-PRODUCING CELLS; T-CELLS; REGULATORY-CELLS; MOLECULES; ACTIVATION; VIVO; TRANSPORT; IMMUNITY; VIRUS	Although plasmacytoid dendritic cells (pDCs) respond to virus replication in a nonspecific way by producing large amounts of type I interferon, a rapid, direct function for pDCs in activating antiviral lymphocytes is less apparent. Here we show that pDCs were able to rapidly initiate antigen-specific antiviral CD8(+) T cell responses. After being exposed to virus, pDCs efficiently and rapidly internalized exogenous viral antigens and then presented those antigens on major histocompatibility complex (MHC) class I to CD8(+) T cells. Processing of exogenous antigen occurred in endocytic organelles and did not require transit of antigen to the cytosol. Intracellular stores of MHC class I partially localized together with the transferrin receptor and internalized transferrin in endosomes, which suggested that such recycling endosomes are sites for loading peptide onto MHC class I or for peptide transit. Our data demonstrate that pDCs use `ready-made' stores of MHC class I to rapidly present exogenous antigen to CD8(+) T cells.	[Di Pucchio, Tiziana; Clayton, Sandra; Palazzo, Adam; Montes, Monica; Xue, Yaming; Banchereau, Jacques; Connolly, John E.] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Di Pucchio, Tiziana; Clayton, Sandra; Palazzo, Adam; Montes, Monica; Xue, Yaming; Banchereau, Jacques; Connolly, John E.] Baylor Res Inst, Dallas, TX 75204 USA; [Di Pucchio, Tiziana] Ist Super Sanita, Dept Cell Biol & Neurosci, I-299 Rome, Italy; [Chatterjee, Bithi; Smed-Sorensen, Anna; Mellman, Ira] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Chatterjee, Bithi; Smed-Sorensen, Anna; Mellman, Ira] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Chatterjee, Bithi; Smed-Sorensen, Anna; Mellman, Ira] Genentech Inc, Res Drug Discovery, San Francisco, CA 94080 USA	Baylor Scott & White Health; Baylor Scott & White Health; Baylor University Medical Center; Istituto Superiore di Sanita (ISS); Yale University; Yale University; Roche Holding; Genentech	Connolly, JE (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu; johnconn@baylorhealth.edu	Connolly, John/B-8099-2014; Mellman, Ira/ABG-5896-2020		NCI NIH HHS [R01 CA078846-08, R01 CA078846] Funding Source: Medline; NIAID NIH HHS [U19 AI057234, R01 R37AI34098, R01 AI068842, R01 AI068842-01, R37 AI034098, U19 AI057234-01, R37 AI034098-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098, R01AI068842, U19AI057234, R01AI034098] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Kuchtey J, 2005, J IMMUNOL, V175, P2244, DOI 10.4049/jimmunol.175.4.2244; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	41	213	219	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					551	557		10.1038/ni.1602	http://dx.doi.org/10.1038/ni.1602			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18376401	Green Accepted			2022-12-18	WOS:000255153500017
J	Ott, VL; Cambier, JC; Kappler, J; Marrack, P; Swanson, BJ				Ott, VL; Cambier, JC; Kappler, J; Marrack, P; Swanson, BJ			Mast cell-dependent migration of effector CD8(+) T cells through production of leukotriene B-4	NATURE IMMUNOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; IN-VITRO; 5-LIPOXYGENASE-ACTIVATING PROTEIN; AIRWAY HYPERRESPONSIVENESS; NEUTROPHIL RECRUITMENT; ARACHIDONIC-ACID; DEFICIENT MICE; MURINE MODEL; RECEPTOR; SUBSETS	Studies in both humans and rodents indicate that CD8(+) T cells may be important in allergic inflammation. However, neither the mechanisms that mediate CD8(+) T cell recruitment to inflamed tissues nor the relative participation of effector and central memory CD8(+) T cells is known. Here we report that activated mast cells induced chemotaxis of effector, but not central memory, CD8(+) T cells through production of leukotriene B-4 (LTB4). These studies indicate that LTB4 production by activated peripheral leukocytes could be important for the recruitment of effector CD8(+) T cells to sites of inflammation.	Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA	National Jewish Health; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ott, VL (corresponding author), Natl Jewish Med & Res Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Cambier, John/0000-0002-7803-242X; Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI-52225, AI-22295, AI-39773, AI-18785, AI-17134] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, R01AI052225, R37AI018785, R56AI017134, R56AI018785, P01AI022295, R01AI017134, R01AI039773, R01AI018785] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki M, 2003, INT ARCH ALLERGY IMM, V130, P216, DOI 10.1159/000069515; Bailie MB, 1996, J IMMUNOL, V157, P5221; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; FREELAND HS, 1988, AM REV RESPIR DIS, V138, P389, DOI 10.1164/ajrccm/138.2.389; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; GUALDE N, 1985, J IMMUNOL, V134, P1125; HACZKU A, 1995, IMMUNOLOGY, V85, P591; Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; IWAMOTO I, 1993, J IMMUNOL, V151, P2116; KATZ HR, 1992, J IMMUNOL, V148, P868; Kimura Y, 2002, CLIN EXP ALLERGY, V32, P1787, DOI 10.1046/j.1365-2222.2002.01552.x; KOCH K, 1994, J MED CHEM, V37, P3197, DOI 10.1021/jm00046a001; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; LEPPERT D, 1995, FASEB J, V9, P1473, DOI 10.1096/fasebj.9.14.7589989; Mackarel AJ, 2000, AM J RESP CELL MOL, V23, P154, DOI 10.1165/ajrcmb.23.2.3853; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Morita H, 1999, BIOCHEM BIOPH RES CO, V264, P321, DOI 10.1006/bbrc.1999.1523; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Ott VL, 2002, J IMMUNOL, V168, P4430, DOI 10.4049/jimmunol.168.9.4430; PAYAN DG, 1984, P NATL ACAD SCI-BIOL, V81, P3501, DOI 10.1073/pnas.81.11.3501; RAMOS BF, 1991, J IMMUNOL, V147, P1636; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sayama Koichi, 2002, BMC Immunol, V3, P5, DOI 10.1186/1471-2172-3-5; Showell HJ, 1996, BRIT J PHARMACOL, V117, P1127, DOI 10.1111/j.1476-5381.1996.tb16706.x; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yokomizo T, 2000, AM J RESP CRIT CARE, V161, pS51, DOI 10.1164/ajrccm.161.supplement_1.ltta-11; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200	43	213	226	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					974	981		10.1038/ni971	http://dx.doi.org/10.1038/ni971			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12949532				2022-12-18	WOS:000185590100013
J	Aliberti, J; Hieny, S; Sousa, CRE; Serhan, CN; Sher, A				Aliberti, J; Hieny, S; Sousa, CRE; Serhan, CN; Sher, A			Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CCR5; DENDRITIC CELLS; PEPTIDE RECEPTOR; IFN-GAMMA; T-CELLS; 5-LIPOXYGENASE; INTERLEUKIN-12; ACTIVATION; EXPRESSION; RESPONSES	Lipoxins are eicosanoid mediators that show potent inhibitory effects on the acute inflammatory process. We show here that the induction of lipoxin A(4) (LXA(4)) accompanied the In vivo suppression of interleukin 12 (IL-12) responsiveness of murine splenic dendritic cells (DCs) after microbial stimulation with an extract of Toxoplasma gondii. This paralysis of DC function could not be triggered in mice that were deficient in a key lipoxygenase involved in LXA4 biosynthesis. In addition, DCs pre-treated with LXA4 became refractory to microbial stimulation for IL-12 production In vitro and mice injected with a stable LXA(4) analog showed reduced splenic DC mobilization and IL-12 responses in vivo. Together, these findings indicate that the induction of lipoxins in response to microbial stimulation can provide a potent mechanism for regulating DC function during the innate response to pathogens.	Natl Inst Allergy & Infect Dis, Lab Parasit Dis, Immunobiol Sect, NIH, Bethesda, MD 20892 USA; Imperial Canc Res Fund, Immunobiol Lab, London, England; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, Boston, MA USA; Imperial Canc Res Fund, Immunobiol Lab, London, England; Natl Allergy & Infect Dis, Lab Parasit Dis, Immunobiol Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cancer Research UK; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cancer Research UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Aliberti, J (corresponding author), Natl Inst Allergy & Infect Dis, Lab Parasit Dis, Immunobiol Sect, NIH, Bethesda, MD 20892 USA.	jaliberti@niaid.nih.gov	Reis e Sousa, Caetano/ABD-7322-2021; Aliberti, Julio/I-7354-2013; Aliberti, Julio/G-4565-2012; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Aliberti, Julio/0000-0003-3420-8478; Reis e Sousa, Caetano/0000-0001-7392-2119	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, ZIAAI000579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765, R29GM038765] Funding Source: NIH RePORTER; NIDCR NIH HHS [P01-DE13499] Funding Source: Medline; NIGMS NIH HHS [GM-38765] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Braun MC, 2001, BLOOD, V97, P3531, DOI 10.1182/blood.V97.11.3531; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Calorini L, 2000, BBA-MOL CELL BIOL L, V1484, P87, DOI 10.1016/S1388-1981(00)00015-9; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; Deng XY, 1999, BLOOD, V94, P1165, DOI 10.1182/blood.V94.4.1165.416k23_1165_1173; FUNK CD, 1995, ADV PROSTAG THROMB L, V23, P145; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Kelsall BL, 2001, MICROBES INFECT, V3, P97, DOI 10.1016/S1286-4579(00)01356-3; KNIGHT J, 1993, J LEUKOCYTE BIOL, V54, P518, DOI 10.1002/jlb.54.6.518; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Maddox JF, 1998, FASEB J, V12, P487, DOI 10.1096/fasebj.12.6.487; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; RAMSTEDT U, 1987, J IMMUNOL, V138, P266; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SCHADE UF, 1991, PROG CLIN BIOL RES, V367, P73; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2000, AM J RESP CRIT CARE, V161, pS95, DOI 10.1164/ajrccm.161.supplement_1.ltta-19; Shen WP, 2000, BIOCHEM BIOPH RES CO, V272, P276, DOI 10.1006/bbrc.2000.2770; Shevach EM, 1999, SPRINGER SEMIN IMMUN, V21, P249, DOI 10.1007/s002810050066; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Spanbroek R, 2000, BLOOD, V96, P3857, DOI 10.1182/blood.V96.12.3857.h8003857_3857_3865; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; SURETTE ME, 1993, J EXP MED, V178, P1347, DOI 10.1084/jem.178.4.1347; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	32	213	228	3	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					76	82		10.1038/ni745	http://dx.doi.org/10.1038/ni745			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11743584				2022-12-18	WOS:000173148700018
J	Andrews, DM; Andoniou, CE; Granucci, F; Ricciardi-Castagnoli, P; Degli-Esposti, MA				Andrews, DM; Andoniou, CE; Granucci, F; Ricciardi-Castagnoli, P; Degli-Esposti, MA			Infection of dendritic cells by murine cytomegalovirus induces functional paralysis	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CLASS-II EXPRESSION; INTERLEUKIN-2 PRODUCTION; ANTIGEN PRESENTATION; GENE-EXPRESSION; CD8 EXPRESSION; MOUSE THYMUS; T-CELLS; MACROPHAGES; COMPLEX	Cytomegalovirus (CMV), measles and HIV are the main human pathogens known to induce immunosuppression. Unlike measles and HIV, and despite the availability of a well studied animal model, little is known about the mechanisms that control CMV-induced immunosuppression. We hypothesized that dendritic cells (DCs), which are crucial in generating and maintaining immune responses, represent a target for CMV and that the transient, but profound, immunosuppression that accompanies CMV infection results from viral interference with DC functions. Here we show that DCs were permissive to murine CMV infection. In addition, DC infection prevented delivery of the signals required for T cell activation. Thus, CMV-mediated impairment of DC function may be crucial for virally induced immunosuppression and interleukin 2 is implicated as a key factor.	Univ Western Australia, Dept Microbiol, QEII Med Ctr, Nedlands, WA 6009, Australia; Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Western Australia; University of Milano-Bicocca	Degli-Esposti, MA (corresponding author), Univ Western Australia, Dept Microbiol, QEII Med Ctr, Nedlands, WA 6009, Australia.	mariapia@cyllene.uwa.edu.au	Castagnoli, Paola/E-8288-2010; Andoniou, Christopher/B-6296-2013; Degli-Esposti, Mariapia/E-9529-2013; GRANUCCI, Francesca/K-6150-2019; Degli-Esposti, Mariapia/H-9073-2014	Degli-Esposti, Mariapia/0000-0002-7808-5935; Andoniou, Christopher/0000-0003-0566-3180; granucci, francesca/0000-0002-7046-4914; Andrews, Dan/0000-0002-5896-7885				ALFORD CA, 1996, VIROLOGY, P2493; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BLACKETT S, 1988, ARCH VIROL, V99, P1, DOI 10.1007/BF01311018; CARNEY WP, 1981, J INFECT DIS, V144, P47, DOI 10.1093/infdis/144.1.47; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; COLLINS TM, 1994, J VIROL, V68, P6305, DOI 10.1128/JVI.68.10.6305-6311.1994; Cretney E, 1999, J EXP MED, V190, P435, DOI 10.1084/jem.190.3.435; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Farrell HE, 1999, IMMUNOL REV, V168, P187, DOI 10.1111/j.1600-065X.1999.tb01293.x; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Hanson LK, 1999, J VIROL, V73, P5970, DOI 10.1128/JVI.73.7.5970-5980.1999; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; Heise MT, 1998, J EXP MED, V187, P1037, DOI 10.1084/jem.187.7.1037; Hengel H, 1999, IMMUNOL REV, V168, P167, DOI 10.1111/j.1600-065X.1999.tb01291.x; Hengel H, 1998, TRENDS MICROBIOL, V6, P190, DOI 10.1016/S0966-842X(98)01255-4; Hengel H, 2000, J VIROL, V74, P7861, DOI 10.1128/JVI.74.17.7861-7868.2000; HIRSCH MS, 1984, ANN NY ACAD SCI, V437, P8, DOI 10.1111/j.1749-6632.1984.tb37117.x; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; KAPASI K, 1988, J VIROL, V62, P3603, DOI 10.1128/JVI.62.10.3603-3607.1988; KAPASI K, 1986, J INFECT DIS, V154, P881, DOI 10.1093/infdis/154.5.881; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KOSZINOWSKI UH, 1994, SEMIN VIROL, V5, P297, DOI 10.1006/smvy.1994.1033; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Naniche D, 2000, CELL MOL LIFE SCI, V57, P1399, DOI 10.1007/PL00000625; REDDEHASE MJ, 1987, J EXP MED, V165, P650, DOI 10.1084/jem.165.3.650; Redpath S, 1999, J IMMUNOL, V162, P6701; Rescigno M, 1999, IMMUNOL CELL BIOL, V77, P404, DOI 10.1046/j.1440-1711.1999.00854.x; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; RINALDO CR, 1990, ANNU REV MED, V41, P331; RUBIN RH, 1988, CLIN APPROACH INFECT, P557; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; SLATER JS, 1991, VIROLOGY, V185, P132, DOI 10.1016/0042-6822(91)90761-Y; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Suri RM, 1998, J IMMUNOL METHODS, V214, P149, DOI 10.1016/S0022-1759(98)00048-9; TIMON M, 1993, CLIN EXP IMMUNOL, V94, P38; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; YOSHIDA H, 1995, J VIROL, V69, P4769, DOI 10.1128/JVI.69.8.4769-4775.1995	50	213	218	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1077	1084		10.1038/ni724	http://dx.doi.org/10.1038/ni724			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668340				2022-12-18	WOS:000172049800022
J	Wang, XQ; Jiang, W; Yan, YQ; Gong, T; Han, JH; Tian, ZG; Zhou, RB				Wang, Xiaqiong; Jiang, Wei; Yan, Yiqing; Gong, Tao; Han, Jiahuai; Tian, Zhigang; Zhou, Rongbin			RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway	NATURE IMMUNOLOGY			English	Article							INFLUENZA-VIRUS; CELL-DEATH; CASPASE-8; KINASE; RIP3; APOPTOSIS; NECROSIS; IMMUNITY; DRP1; DNA	The NLRP3 inflammasome functions as a crucial component of the innate immune system in recognizing viral infection, but the mechanism by which viruses activate this inflammasome remains unclear. Here we found that inhibition of the serine-threonine kinases RIP1 (RIPK1) or RIP3 (RIPK3) suppressed RNA virus-induced activation of the NLRP3 inflammasome. Infection with an RNA virus initiated assembly of the RIP1-RIP3 complex, which promoted activation of the GTPase DRP1 and its translocation to mitochondria to drive mitochondrial damage and activation of the NLRP3 inflammasome. Notably, the RIP1-RIP3 complex drove the NLRP3 inflammasome independently of MLKL, an essential downstream effector of RIP1-RIP3-dependent necrosis. Together our results reveal a specific role for the RIP1-RIP3-DRP1 pathway in RNA virus-induced activation of the NLRP3 inflammasome and establish a direct link between inflammation and cell-death signaling pathways.	[Wang, Xiaqiong; Jiang, Wei; Yan, Yiqing; Gong, Tao; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Peoples R China; [Wang, Xiaqiong; Jiang, Wei; Yan, Yiqing; Gong, Tao; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei 230026, Peoples R China; [Wang, Xiaqiong; Jiang, Wei; Yan, Yiqing; Gong, Tao; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Med Ctr, Hefei 230026, Peoples R China; [Han, Jiahuai] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Tian, Zhigang; Zhou, Rongbin] Innovat Ctr Cell Biol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xiamen University	Zhou, RB (corresponding author), Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Peoples R China.	tzg@ustc.edu.cn; zrb1980@ustc.edu.cn	Jiang, Wei/C-7986-2018; Han, J/G-4671-2010; Tian, Zhigang/J-3512-2013; Gong, Tao/AAC-6849-2019; Zhou, Rongbin/B-1430-2013	Jiang, Wei/0000-0001-8327-3079; Gong, Tao/0000-0002-9414-6902; 	National Basic Research Program of China [2014CB910800]; National Natural Science Foundation of China [81330078, 81222040]; Doctoral Fund of the Ministry of Education of China [20123402120001, 20123402110010]; One Hundred Person Project; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); One Hundred Person Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank J. Tschopp (University of Lausanne) for Nlrp3<SUP>-/-</SUP> mice; S. Akira (Osaka University) for Rig-I<SUP>-/-</SUP> mice; V.M. Dixit (Genentech) for Rip3<SUP>-/-</SUP> mice; M. Colonna (Washington University) for Mda5<SUP>-/-</SUP> mice; Z. Jiang (Peking University) for Sendai virus and VSV (Indiana strain); and Z. Song (Wuhan University) for the DRP1 construct. Supported by the National Basic Research Program of China (2014CB910800), the National Natural Science Foundation of China (81330078 and 81222040), the Doctoral Fund of the Ministry of Education of China (20123402120001, 20123402110010), the One Hundred Person Project (R.Z.) and the Fundamental Research Funds for the Central Universities (R.Z. and W.J.).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Stout-Delgado HW, 2012, J IMMUNOL, V188, P2815, DOI 10.4049/jimmunol.1103051; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	43	212	226	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1126	1133		10.1038/ni.3015	http://dx.doi.org/10.1038/ni.3015			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25326752				2022-12-18	WOS:000344841900009
J	Strainic, MG; Shevach, EM; An, FQ; Lin, F; Medof, ME				Strainic, Michael G.; Shevach, Ethan M.; An, Fengqi; Lin, Feng; Medof, M. Edward			Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta 1 signaling and induction of Foxp3(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							COMPLEMENT FRAGMENTS C5A; DENDRITIC CELLS; IMMUNE-RESPONSES; RECEPTOR; EXPRESSION; C5L2; PROTEIN; TOLERANCE; PATHWAYS; KINASE	Signaling through the G protein coupled receptors for the complement fragments C3a and C5a (C3aR and C5aR, respectively) by dendritic cells and CD4(+) cells provides costimulatory and survival signals to effector T cells. Here we found that when signals from C3aR and C5aR were not transduced into CD4(+) cells, signaling via the kinases PI(3)K gamma, Akt and mTOR ceased, activation of the kinase PKA increased, autoinductive signaling by transforming growth factor-beta 1 (TGF-beta 1) initiated and CD4(+) T cells became Foxp3(+) induced regulatory T cells (iT(reg) cells). Endogenous TGF-beta 1 suppressed signaling through C3aR and C5aR by preventing the production of C3a and C5a and upregulating C5L2, an alternative receptor for C5a. The absence of signaling via C3aR and C5aR resulted in lower expression of costimulatory molecules and interleukin 6 (IL-6) and more production of IL-10. The resulting iT(reg) cells exerted robust suppression, had enhanced stability and suppressed ongoing autoimmune disease. Antagonism of C3aR and C5aR can also induce functional human iT(reg) cells.	[Strainic, Michael G.; An, Fengqi; Lin, Feng; Medof, M. Edward] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Shevach, Ethan M.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Medof, ME (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	mxm16@case.edu		Strainic, Michael/0000-0003-2438-8540	US National Institutes of Health [R0123598, EY011288, T32 HL083823-03, AI071125]; US Department of Defense [BC085077]; NATIONAL EYE INSTITUTE [R01EY011288] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109561, T32HL083823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023598, ZIAAI000959] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lambris (University of Pennsylvania) for C5aR-A synthetic peptide; C. Gerard (Harvard University) for C3ar1<SUP>-/-</SUP>, C3ar1<SUP>-/-</SUP> and Gpr77<SUP>-/-</SUP> mice; V.J. Kuchroo (Harvard University) for Foxp3-GFP mice; Michael Caroll (Harvard University) for C3<SUP>-/-</SUP> mice; B. Cobb, S.v.n. Prasad, G. Dubyak and D. Anthony Jr. for critical reading; M. Sramkoski for help with six-color flow cytometry in vivo suppression assays; H.S. Kim for immunoblot analysis; J. Letterio (Case Western Reserve University) for the inhibitor of TGF-beta R1, mAb to TGF-beta 1 and inhibitor of Smad3 and for discussions; and P. Heeger for discussions. Supported by the US National Institutes of Health (R0123598 and EY011288 to M.E.M.; T32 HL083823-03 to M.G.S.; and AI071125 to P. Heeger) and the US Department of Defense (BC085077 to M.E.M.).	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; FLANDERS KC, 1995, J MOL CELL CARDIOL, V27, P805, DOI 10.1016/0022-2828(95)90087-X; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Honczarenko M, 2005, LEUKEMIA, V19, P1682, DOI 10.1038/sj.leu.2403862; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Itoh S, 2011, CIRCULATION, V124, pS187, DOI 10.1161/CIRCULATIONAHA.110.014852; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KIM SJ, 1989, J BIOL CHEM, V264, P7041; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pothoven KL, 2010, AM J TRANSPLANT, V10, P1774, DOI 10.1111/j.1600-6143.2010.03199.x; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yaqub Sheraz, 2008, Critical Reviews in Oncogenesis, V14, P57; Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636	48	212	224	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					162	171		10.1038/ni.2499	http://dx.doi.org/10.1038/ni.2499			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23263555	Green Accepted			2022-12-18	WOS:000313918400011
J	Song, XY; Zhu, S; Shi, PQ; Liu, Y; Shi, YF; Levin, SD; Qian, YC				Song, Xinyang; Zhu, Shu; Shi, Peiqing; Liu, Yan; Shi, Yufang; Levin, Steven D.; Qian, Youcun			IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens	NATURE IMMUNOLOGY			English	Article							HOST-DEFENSE; INTERLEUKIN-17 RECEPTOR; IDENTIFICATION; EXPRESSION; AUTOIMMUNE; CYTOKINES; CELLS; ACT1; REQUIREMENT; SUPPRESSION	Interleukin 17 receptor E (IL-17RE) is an orphan receptor of the IL-17 receptor family. Here we show that IL-17RE is a receptor specific to IL-17C and has an essential role in host mucosal defense against infection. IL-17C activated downstream signaling through IL-17RE-IL-17RA complex for the induction of genes encoding antibacterial peptides as well as proinflammatory molecules. IL-17C was upregulated in colon epithelial cells during infection with Citrobacter rodentium and acted in synergy with IL-22 to induce the expression of antibacterial peptides in colon epithelial cells. Loss of IL-17C-mediated signaling in IL-17RE-deficient mice led to lower expression of genes encoding antibacterial molecules, greater bacterial burden and early mortality during infection. Together our data identify IL-17RE as a receptor of IL-17C that regulates early innate immunity to intestinal pathogens.	[Song, Xinyang; Zhu, Shu; Shi, Peiqing; Liu, Yan; Shi, Yufang; Qian, Youcun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Song, Xinyang; Zhu, Shu; Shi, Peiqing; Liu, Yan; Shi, Yufang; Qian, Youcun] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Levin, Steven D.] ZymoGenetics, Dept Immunol, Seattle, WA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Zymogenet Inc.	Qian, YC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	ycqian@sibs.ac.cn	Shi, Yufang/AAE-4431-2020; Zhu, Shu/P-6163-2018; Song, Xinyang/AAL-7495-2021	Shi, Yufang/0000-0001-8964-319X; Zhu, Shu/0000-0002-8163-0869; Song, Xinyang/0000-0002-3422-6927	National Natural Science Foundation of China [30930084, 91029708, 30871298]; 973 program [2010CB529705]; Chinese Academy of Sciences [KSCX2-YW-R-146]; Science and Technology Commission of Shanghai Municipality [10JC1416600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We thank ZymoGenetics for Il17re<SUP>-/-</SUP> mice. Supported by the National Natural Science Foundation of China (30930084, 91029708 and 30871298), the 973 program (2010CB529705), the Chinese Academy of Sciences (KSCX2-YW-R-146) and the Science and Technology Commission of Shanghai Municipality (10JC1416600).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johansen C, 2011, J BIOL CHEM, V286, P25487, DOI 10.1074/jbc.M111.240671; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li TS, 2006, CELL SIGNAL, V18, P1287, DOI 10.1016/j.cellsig.2005.10.010; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qian YC, 2010, CELL MOL IMMUNOL, V7, P328, DOI 10.1038/cmi.2010.27; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Strong SA, 1998, GASTROENTEROLOGY, V114, P1244, DOI 10.1016/S0016-5085(98)70431-7; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	43	212	240	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1151	U		10.1038/ni.2155	http://dx.doi.org/10.1038/ni.2155			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	21993849				2022-12-18	WOS:000297202700009
J	Yamane, A; Resch, W; Kuo, N; Kuchen, S; Li, ZY; Sun, HW; Robbiani, DF; McBride, K; Nussenzweig, MC; Casellas, R				Yamane, Arito; Resch, Wolfgang; Kuo, Nan; Kuchen, Stefan; Li, Zhiyu; Sun, Hong-wei; Robbiani, Davide F.; McBride, Kevin; Nussenzweig, Michel C.; Casellas, Rafael			Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes	NATURE IMMUNOLOGY			English	Article							CLASS-SWITCH RECOMBINATION; RNA-POLYMERASE-II; ACTIVATION-INDUCED DEAMINASE; REPLICATION PROTEIN-A; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; CELL LYMPHOMAS; KINASE-A; IG GENES	The cytidine deaminase AID hypermutates immunoglobulin genes but can also target oncogenes, leading to tumorigenesis. The extent of AID's promiscuity and its predilection for immunoglobulin genes are unknown. We report here that AID interacted broadly with promoter-proximal sequences associated with stalled polymerases and chromatin-activating marks. In contrast, genomic occupancy of replication protein A (RPA), an AID cofactor, was restricted to immunoglobulin genes. The recruitment of RPA to the immunoglobulin loci was facilitated by phosphorylation of AID at Ser38 and Thr140. We propose that stalled polymerases recruit AID, thereby resulting in low frequencies of hypermutation across the B cell genome. Efficient hypermutation and switch recombination required AID phosphorylation and correlated with recruitment of RPA. Our findings provide a rationale for the oncogenic role of AID in B cell malignancy.	[Robbiani, Davide F.; McBride, Kevin; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA; [Yamane, Arito; Resch, Wolfgang; Kuo, Nan; Kuchen, Stefan; Li, Zhiyu; Sun, Hong-wei; Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA.	nussen@mail.rockefeller.edu; casellar@mail.nih.gov	mcbride, kevin/E-8230-2011; Robbiani, Davide F./AAF-7662-2019; Yamane, Arito/A-2959-2013; Nussenzweig, Michel/AAE-7292-2019	Robbiani, Davide F./0000-0001-7379-3484; Kuchen, Stefan/0000-0003-4899-8132; Resch, Wolfgang/0000-0001-7594-5963	National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AI037526]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148, ZIAAR041149, ZIHAR041173] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Schatz for comments on the manuscript; J. Chaudhuri (Memorial Sloan-Kettering Cancer Center) and F. Alt (Harvard University) for antibodies to AID; J. Simone for cell sorting; G. Gutierrez for technical assistance with the genome analyzer; and C. Ansarah-Sobrinho and S. Nelson for help with sequencing. Supported by the National Institutes of Health (Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; and AI037526 to M.C.N.) and the Howard Hughes Medical Institute (M.C.N.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bhutani N., 2010, NATURE; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Malynn BA, 2000, GENE DEV, V14, P1390; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Storb U, 2007, ADV EXP MED BIOL, V596, P83; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067	50	212	215	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					62	U85		10.1038/ni.1964	http://dx.doi.org/10.1038/ni.1964			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21113164	Green Accepted			2022-12-18	WOS:000285465100014
J	Arellano-Reynoso, B; Lapaque, N; Salcedo, S; Briones, G; Ciocchini, AE; Ugalde, R; Moreno, E; Moriyon, I; Gorvel, JP				Arellano-Reynoso, B; Lapaque, N; Salcedo, S; Briones, G; Ciocchini, AE; Ugalde, R; Moreno, E; Moriyon, I; Gorvel, JP			Cyclic beta-1,2-glucan is a brucella virulence factor required for intracellular survival	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; RAFT MEMBRANE DOMAINS; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; MURINE MACROPHAGES; BETA-CYCLODEXTRINS; SPERM CAPACITATION; CHOLESTEROL; ABORTUS; CELLS	Pathogenic brucella bacteria have developed strategies to persist for prolonged periods of time in host cells, avoiding innate immune responses. Here we show that the cyclic beta-1,2-glucans (CbG) synthesized by brucella is important for circumventing host cell defenses. CbG acted in lipid rafts found on host cell membranes. CbG-deficient mutants failed to prevent phagosome-lysosome fusion and could not replicate. However, when treated with purified CbG or synthetic methyl-beta-cyclodextrin, the mutants were able to control vacuole maturation by avoiding lysosome fusion, and this allowed intracellular brucella to survive and reach the endoplasmic reticulum. Fusion between the endoplasmic reticulum and the brucella-containing vacuole depended on the brucella virulence type IV secretion system but not on CbG. Brucella CbG is thus a virulence factor that interacts with lipid rafts and contributes to pathogen survival.	CNRS, INSERM, Ctr Immunol, F-13288 Marseille, France; Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; Univ Nacl Gen San Martin, Inst Invest Biotecnol, RA-1650 Buenos Aires, DF, Argentina; Natl Univ, Sch Vet, Trop Dis Res Program, Heredia, Costa Rica; Univ Navarra, Dept Microbiol, Pamplona 31008, Spain	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; University of Navarra	Gorvel, JP (corresponding author), CNRS, INSERM, Ctr Immunol, Case 906, F-13288 Marseille, France.	gorvel@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Lapaque, Nicolas/AAB-4530-2021; salcedo, suzana/P-9830-2019; Salcedo, Suzana P/C-2853-2014; Moriyon, Ignacio/N-4764-2016; Lapaque, Nicolas/D-5377-2014	Gorvel, Jean-Pierre/0000-0002-2829-9804; Lapaque, Nicolas/0000-0003-0824-0108; salcedo, suzana/0000-0001-5149-7756; Salcedo, Suzana P/0000-0001-5149-7756; Moriyon, Ignacio/0000-0002-4288-0195; Lapaque, Nicolas/0000-0003-0824-0108; Briones, Gabriel/0000-0002-4500-9848				ANDO S, 1987, CHROMATOGRAPHY LIPID, P270; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Bhagwat AA, 1999, PLANT PHYSIOL, V119, P1057, DOI 10.1104/pp.119.3.1057; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Briones G, 1997, MICROBIOL-SGM, V143, P1115, DOI 10.1099/00221287-143-4-1115; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; De Iannino NI, 1998, J BACTERIOL, V180, P4392; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Fauvelle F, 1997, J PHARM SCI, V86, P935, DOI 10.1021/js9602453; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gross A, 2003, J IMMUNOL, V170, P5607, DOI 10.4049/jimmunol.170.11.5607; Harder T, 2001, ADV IMMUNOL, V77, P45, DOI 10.1016/S0065-2776(01)77014-9; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; MIAO L, 1995, BIOCHEMISTRY-US, V34, P4676, DOI 10.1021/bi00014a022; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Verger JM, 1988, TECHNIQUES BRUCELLOS; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Vitas AI, 1996, ANTIMICROB AGENTS CH, V40, P146, DOI 10.1128/AAC.40.1.146	46	212	221	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					618	625		10.1038/ni1202	http://dx.doi.org/10.1038/ni1202			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15880113				2022-12-18	WOS:000229385900017
J	Vely, F; Barlogis, V; Vallentin, B; Neven, B; Piperoglou, C; Perchet, T; Petit, M; Yessaad, N; Touzot, F; Bruneau, J; Mahlaoui, N; Zucchini, N; Farnarier, C; Michel, G; Moshous, D; Blanche, S; Dujardin, A; Spits, H; Distler, JHW; Ramming, A; Picard, C; Golub, R; Fischer, A; Vivier, E				Vely, Frederic; Barlogis, Vincent; Vallentin, Blandine; Neven, Benedicte; Piperoglou, Christelle; Perchet, Thibaut; Petit, Maxime; Yessaad, Nadia; Touzot, Fabien; Bruneau, Julie; Mahlaoui, Nizar; Zucchini, Nicolas; Farnarier, Catherine; Michel, Gerard; Moshous, Despina; Blanche, Stephane; Dujardin, Arnaud; Spits, Hergen; Distler, Joerg H. W.; Ramming, Andreas; Picard, Capucine; Golub, Rachel; Fischer, Alain; Vivier, Eric			Evidence of innate lymphoid cell redundancy in humans	NATURE IMMUNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; DIFFERENTIATION IN-VIVO; SYSTEMIC-SCLEROSIS; SINGLE-CENTER; TRANSPLANTATION; DISEASE; INFLAMMATION; IMMUNITY; SUBSETS; RECONSTITUTION	Innate lymphoid cells (ILCs) have potent immunological functions in experimental conditions in mice, but their contributions to immunity in natural conditions in humans have remained unclear. We investigated the presence of ILCs in a cohort of patients with severe combined immunodeficiency (SCID). All ILC subsets were absent in patients with SCID who had mutation of the gene encoding the common gamma-chain cytokine receptor subunit IL-2R gamma or the gene encoding the tyrosine kinase JAK3. T cell reconstitution was observed in patients with SCID after hematopoietic stem cell transplantation (HSCT), but the patients still had considerably fewer ILCs in the absence of myeloablation than did healthy control subjects, with the exception of rare cases of reconstitution of the ILC1 subset of ILCs. Notably, the ILC deficiencies observed were not associated with any particular susceptibility to disease, with follow-up extending from 7 years to 39 years after HSCT. We thus report here selective ILC deficiency in humans and show that ILCs might be dispensable in natural conditions, if T cells are present and B cell function is preserved.	[Vely, Frederic; Piperoglou, Christelle; Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Vely, Frederic; Piperoglou, Christelle; Farnarier, Catherine; Vivier, Eric] Hop Conception, APHM, Serv Immunol, Marseille, France; [Barlogis, Vincent; Vallentin, Blandine; Michel, Gerard] Hop La Timone, APHM, Serv Hematol & Oncol Pediat, Marseille, France; [Neven, Benedicte; Mahlaoui, Nizar; Moshous, Despina; Blanche, Stephane; Picard, Capucine; Fischer, Alain] Hop Univ Necker Enfants Malades, AP HP, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France; [Neven, Benedicte; Touzot, Fabien; Bruneau, Julie; Moshous, Despina; Blanche, Stephane; Picard, Capucine; Fischer, Alain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Neven, Benedicte; Mahlaoui, Nizar; Moshous, Despina; Blanche, Stephane; Picard, Capucine; Fischer, Alain] INSERM, Paris, France; [Neven, Benedicte; Mahlaoui, Nizar; Moshous, Despina; Blanche, Stephane; Picard, Capucine; Fischer, Alain] Univ Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Perchet, Thibaut; Petit, Maxime; Golub, Rachel] INSERM, Inst Pasteur, Unite Lymphopoiese, Paris, France; [Perchet, Thibaut; Petit, Maxime; Golub, Rachel] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Yessaad, Nadia] Aix Marseille Univ, Ml mAbs Consortium, Marseille, France; [Touzot, Fabien] Hop Necker Enfants Malad, AP HP, Biotherapy Unit, Paris, France; [Bruneau, Julie] Hop Necker Enfants Malad, AP HP, Serv Anatomopathol, Paris, France; [Zucchini, Nicolas] BD Biosci, Le Pont De Claix, France; [Dujardin, Arnaud] Innate Pharma, Marseille, France; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Arizona Amsterdam, Netherlands; [Distler, Joerg H. W.; Ramming, Andreas] Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol, Erlangen, Germany; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Immunodeficiencies, Paris, France; [Fischer, Alain] Coll France, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; University of Erlangen Nuremberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Vivier, E (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.; Vivier, E (corresponding author), Hop Conception, APHM, Serv Immunol, Marseille, France.; Fischer, A (corresponding author), Hop Univ Necker Enfants Malades, AP HP, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France.; Fischer, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France.; Fischer, A (corresponding author), INSERM, Paris, France.; Fischer, A (corresponding author), Univ Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France.; Fischer, A (corresponding author), Coll France, Paris, France.	alain.fischer@aphp.fr; vivier@ciml.univ-mrs.fr	Distler, Oliver/AAE-6225-2019; Vély, Frédéric/HHM-3894-2022; Mahlaoui, Nizar/J-7928-2017; Vivier, Eric/F-8939-2010; Rachel, GOLUB/M-7188-2014; MAHLAOUI, Nizar/AAH-6103-2020; Spits, Hergen/N-2581-2019; Touzot, Fabien/T-7797-2018; Moshous, Despina/B-7507-2017; GOLUB, rachel/X-8717-2019	Distler, Oliver/0000-0002-0546-8310; Mahlaoui, Nizar/0000-0002-0030-8094; Vivier, Eric/0000-0001-7022-8287; Rachel, GOLUB/0000-0002-2306-5363; MAHLAOUI, Nizar/0000-0002-0030-8094; Spits, Hergen/0000-0003-3269-8338; Touzot, Fabien/0000-0002-0889-4905; Moshous, Despina/0000-0001-6719-3693; GOLUB, rachel/0000-0002-2306-5363; Bruneau, Julie/0000-0001-5519-8489	European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee); INSERM; CNRS; Aix-Marseille University; Institut Universitaire de France; European Research Council; Paris Descartes University; College de France; Investissements d'Avenir Instituts Hospitaliers Universitaires; Institut Pasteur; Universite Paris Diderot; Agence Nationale de la Recherche ("Myeloten"); Institut National du Cancer; Universite Sorbonne Paris Cite ("Mucocell")	European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Institut Universitaire de France; European Research Council(European Research Council (ERC)European Commission); Paris Descartes University; College de France; Investissements d'Avenir Instituts Hospitaliers Universitaires(French National Research Agency (ANR)); Institut Pasteur(European Commission); Universite Paris Diderot; Agence Nationale de la Recherche ("Myeloten")(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Universite Sorbonne Paris Cite ("Mucocell")	We thank all patients and their families for participating in the study; C. Bonnafous and N. Anceriz (Innate-Pharma) for monoclonal antibody to NKp46; F. Suarez (Paris), N. Schleinitz (Marseille) and Y. Bertrand (Lyon) for enrolling patients in the study; and the Laboratory of Hematology (RE. Morange, Marseille) for sample storage. Supported by the European Research Council (THINK Advanced Grant for the E.V. laboratory), the Ligue Nationale contre le Cancer (Equipe Labellisee; E.V. laboratory), institutional grants from INSERM, CNRS and Aix-Marseille University to CIML (E.V. laboratory), the Institut Universitaire de France (E.V.), the European Research Council (Pidimmune Advanced Grant for the A.F. laboratory), institutional grants from INSERM, Paris Descartes University and College de France (A.F. laboratory), Investissements d'Avenir Instituts Hospitaliers Universitaires (A.F. laboratory), institutional grants from Institut Pasteur, INSERM, Universite Paris Diderot and the Agence Nationale de la Recherche ("Myeloten"; R.G. group), the Institut National du Cancer (R.G. group) and Universite Sorbonne Paris Cite ("Mucocell"; R.G. group).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Boulenouar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00043; Buckley RH, 2011, IMMUNOL RES, V49, P25, DOI 10.1007/s12026-010-8191-9; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; Fischer A, 2011, J ALLERGY CLIN IMMUN, V127, P1356, DOI 10.1016/j.jaci.2011.04.030; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Goldschmidt MH, 2006, J VIROL, V80, P6621, DOI 10.1128/JVI.02571-05; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Huntington ND, 2016, CURR OPIN IMMUNOL, V38, P86, DOI 10.1016/j.coi.2015.11.008; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Juelke K, 2016, CURR OPIN IMMUNOL, V38, P75, DOI 10.1016/j.coi.2015.11.005; Kang J, 2012, SEMIN IMMUNOL, V24, P190, DOI 10.1016/j.smim.2012.02.003; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Koyasu S, 2015, NAT IMMUNOL, V16, P133, DOI 10.1038/ni.3080; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Nishio H, 2001, J ANAT, V198, P581, DOI 10.1046/j.1469-7580.2001.19850581.x; Parry DA, 2016, J ALLERGY CLIN IMMUN, V137, P955, DOI 10.1016/j.jaci.2015.08.051; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Railey MD, 2009, J PEDIATR-US, V155, P834, DOI 10.1016/j.jpeds.2009.07.049; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; Vallentin B, 2015, CANCER IMMUNOL RES, V3, P1109, DOI 10.1158/2326-6066.CIR-15-0222; Wohlfahrt T, 2016, ANN RHEUM DIS, V75, P623, DOI 10.1136/annrheumdis-2015-207388	49	211	215	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1291	1299		10.1038/ni.3553	http://dx.doi.org/10.1038/ni.3553			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27618553	Green Accepted			2022-12-18	WOS:000386193200009
J	Wan, YSY; Chi, H; Xie, M; Schneider, MD; Flavell, RA				Wan, Yisong Y.; Chi, Hongbo; Xie, Min; Schneider, Michael D.; Flavell, Richard A.			The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LYMPHOCYTE DEVELOPMENT; MEDIATED ACTIVATION; IKK ACTIVATION; PROLIFERATION; INTERLEUKIN-2; INNATE; MEMORY; ROLES; MALT1	The kinase TAK1 is critical for innate and B cell immunity. The function of TAK1 in T cells is unclear, however. We show here that T cell-specific deletion of the gene encoding TAK1 resulted in reduced development of thymocytes, especially of regulatory T cells expressing the transcription factor Foxp3. In mature thymocytes, TAK1 was required for interleukin 7-mediated survival and T cell receptor-dependent activation of transcription factor NF-kappa B and the kinase Jnk. In effector T cells, TAK1 was dispensable for T cell receptor-dependent NF-kappa B activation and cytokine production, but was important for proliferation and activation of the kinase p38 in response to interleukins 2, 7 and 15. Thus, TAK1 is essential for the integration of T cell receptor and cytokine signals to regulate the development, survival and function of T cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Chi, Hongbo/M-9397-2018; Xie, Min/AAY-3426-2020; Wan, Yisong/ABE-1200-2021	Chi, Hongbo/0000-0002-9997-2496; Xie, Min/0000-0002-2967-3490; Wan, Yisong/0000-0003-4346-9717; Schneider, Michael/0000-0001-9645-1938				Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; DeGregori J, 2004, J CELL SCI, V117, P3411, DOI 10.1242/jcs.01189; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Ruland J, 2003, SEMIN IMMUNOL, V15, P177, DOI 10.1016/S1044-5323(03)00034-4; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; SEN J, 1995, J IMMUNOL, V154, P3213; Sen J, 1996, J IMMUNOL, V156, P4535; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Weil R, 2004, CURR OPIN IMMUNOL, V16, P374, DOI 10.1016/j.coi.2004.03.003; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	38	211	230	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					851	858		10.1038/ni1355	http://dx.doi.org/10.1038/ni1355			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16799562				2022-12-18	WOS:000239147200021
J	Little, TJ; Hultmark, D; Read, AF				Little, TJ; Hultmark, D; Read, AF			Invertebrate immunity and the limits of mechanistic immunology	NATURE IMMUNOLOGY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; ANOPHELES-GAMBIAE; INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; DISEASE RESISTANCE; TENEBRIO-MOLITOR; PENAEUS-MONODON; MEALWORM BEETLE; SOCIAL INSECT; INFECTION	Rapid progress is being made in elucidating the molecular mechanisms involved in invertebrate immunity. This search for molecules runs the risk of missing important phenomena. In vertebrates, acquired protection and pathogen-specific responses were demonstrated experimentally long before the mechanisms responsible were elucidated. Without analogous experiments, mechanism-driven work may not demonstrate the full richness of invertebrate immunity.	Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Sch Biol, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden	University of Edinburgh; University of Edinburgh; Umea University	Little, TJ (corresponding author), Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3JT, Midlothian, Scotland.	tom.little@ed.ac.uk	Little, Tom J/B-7890-2009; Hultmark, Dan/C-5058-2013	Little, Tom J/0000-0002-8945-0416; Hultmark, Dan/0000-0002-6506-5855	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Basset A, 2003, EMBO REP, V4, P205, DOI 10.1038/sj.embor.embor730; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COOPER EL, 1986, TRANSPLANTATION, V41, P514; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Decaestecker E, 2003, EVOLUTION, V57, P784, DOI 10.1111/j.0014-3820.2003.tb00290.x; Elliot SL, 2003, ECOL LETT, V6, P830, DOI 10.1046/j.1461-0248.2003.00487.x; HARTMAN RS, 1989, TRANSPLANTATION, V37, P478; HILDEMANN WH, 1979, SCIENCE, V204, P420, DOI 10.1126/science.441730; HILDEMANN WH, 1977, NATURE, V270, P219, DOI 10.1038/270219a0; Hoffmann JA, 2004, IMMUNOL REV, V198, P5, DOI 10.1111/j.0105-2896.2004.0134.x; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang CC, 1999, DEV COMP IMMUNOL, V23, P545, DOI 10.1016/S0145-305X(99)00038-5; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Khush RS, 2002, SCIENCE, V296, P273, DOI 10.1126/science.1071208; Klein J, 1997, SCAND J IMMUNOL, V46, P558, DOI 10.1046/j.1365-3083.1997.d01-164.x; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Rathjen JP, 2003, CURR OPIN PLANT BIOL, V6, P300, DOI 10.1016/S1369-5266(03)00057-8; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P588, DOI 10.1007/s001140050679; Schlenke TA, 2003, GENETICS, V164, P1471; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Smith VJ, 2003, FISH SHELLFISH IMMUN, V15, P71, DOI 10.1016/S1050-4648(02)00140-7; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Wedekind C, 2000, EVOL ECOL RES, V2, P1031; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	50	211	217	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					651	654		10.1038/ni1219	http://dx.doi.org/10.1038/ni1219			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970937				2022-12-18	WOS:000229975500007
J	Jordan, MS; Singer, AL; Koretzky, GA				Jordan, MS; Singer, AL; Koretzky, GA			Adaptors as central mediators of signal transduction in immune cells	NATURE IMMUNOLOGY			English	Review							LINKED LYMPHOPROLIFERATIVE-DISEASE; PROTEIN-TYROSINE KINASE; T-CELL; ANTIGEN RECEPTOR; B-CELLS; IMMUNOLOGICAL SYNAPSE; NEGATIVE REGULATION; DOCKING PROTEIN; EXCHANGE FACTOR; MICE DEFICIENT	Adaptors are molecular scaffolds that recruit effectors, which are critical for immune cell activation. Recent work has underscored the requirement for adaptors in propagating stimulatory signals as well as their ability to inhibit immune cell function. The mechanisms by which adaptors function rely not only on the intermolecular interactions they mediate, but also on where they are localized within the cell. The use of sophisticated genetic, biochemical, cellular and imaging approaches has provided important new insights into the biology of adaptor protein function. Here we focus on T lymphocytes as a model to illustrate the critical roles adaptors play as regulators of cellular activation.	Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Koretzky, GA (corresponding author), Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Koretzky, Gary/AAU-5381-2021					Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Burack WR, 2002, CURR OPIN IMMUNOL, V14, P312, DOI 10.1016/S0952-7915(02)00347-3; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Cassard S, 1996, J BIOL CHEM, V271, P23786, DOI 10.1074/jbc.271.39.23786; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Geng LP, 2002, BRIT J HAEMATOL, V116, P19, DOI 10.1046/j.1365-2141.2002.03243.x; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Jones N, 1998, ONCOGENE, V17, P1097, DOI 10.1038/sj.onc.1202115; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; Judd BA, 2002, J EXP MED, V195, P705, DOI 10.1084/jem.20011583; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kumar L, 2002, P NATL ACAD SCI USA, V99, P884, DOI 10.1073/pnas.022619199; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Leo A, 2001, CURR OPIN IMMUNOL, V13, P307, DOI 10.1016/S0952-7915(00)00220-X; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rafnar T, 1998, MOL IMMUNOL, V35, P249, DOI 10.1016/S0161-5890(98)00028-5; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veri MC, 2001, MOL CELL BIOL, V21, P6939, DOI 10.1128/MCB.21.20.6939-6950.2001; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Xu SL, 2000, J IMMUNOL, V165, P4153, DOI 10.4049/jimmunol.165.8.4153; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamanashi Y, 2000, GENE DEV, V14, P11; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	89	211	219	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					110	116		10.1038/ni0203-110	http://dx.doi.org/10.1038/ni0203-110			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555096				2022-12-18	WOS:000180686500009
J	Wu, CB; Nguyen, KB; Pien, GC; Wang, NH; Gullo, C; Howie, D; Sosa, MR; Edwards, MJ; Borrow, P; Satoskar, AR; Sharpe, AH; Biron, CA; Terhorst, C				Wu, CB; Nguyen, KB; Pien, GC; Wang, NH; Gullo, C; Howie, D; Sosa, MR; Edwards, MJ; Borrow, P; Satoskar, AR; Sharpe, AH; Biron, CA; Terhorst, C			SAP controls T cell responses to virus and terminal differentiation of T(H)2 cells	NATURE IMMUNOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PROMPTLY PRODUCE INTERLEUKIN-4; LEISHMANIA-MAJOR; VIRAL-INFECTION; NATURAL-KILLER; ENCODING GENE; CUTTING EDGE; BALB/C MICE; ACTIVATION	SH2DIA, which encodes signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), is altered in patients with X-linked lymphoproliferative disease (XLP), a primary immunodeficiency, SAP-deficient mice infected with lymphocytic choriomeningitis virus had greatly increased numbers of CD8(+) and CD4(+) interferon-gamma -producing spleen and liver cells compared to wild-type mice. The immune responses of SAP-deficient mice to infection with Leishmania major together with in vitro studies showed that activated SAP-deficient T cells had an impaired ability to differentiate into T helper 2 cells,The aberrant immune responses in SAP-deficient mice show that SAP controls several distinct key T cell signal transduction pathways, which explains in pare the complexity of the XLP phenotypes.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Terhorst, C (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA.		Satoskar, Abhay/AAB-7748-2019	WU, CHENGBIN/0000-0001-6160-5327; Borrow, Persephone/0000-0002-3877-9780; Gullo, Charles/0000-0002-4221-0087				Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Himmelrich H, 1998, J IMMUNOL, V161, P6156; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Maia DM, 1999, PEDIATR DEVEL PATHOL, V2, P72, DOI 10.1007/s100249900093; MCINTYRE KW, 1986, J EXP MED, V164, P1667, DOI 10.1084/jem.164.5.1667; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; MORRA M, 2001, UNPUB J EXP MED; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pien GC, 2000, J IMMUNOL, V164, P994, DOI 10.4049/jimmunol.164.2.994; PURTILO D T, 1991, Pediatric Pathology, V11, P685; Satoskar AR, 1999, J IMMUNOL, V162, P6747; Satoskar AR, 1999, J IMMUNOL, V163, P5298; Sayos J, 2000, INT IMMUNOL, V12, P1749, DOI 10.1093/intimm/12.12.1749; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SAYOS J, 2001, IN PRESS BLOOD; SEEMAYER TA, 1995, PEDIATR RES, V38, P471, DOI 10.1203/00006450-199510000-00001; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Wu CB, 2000, IMMUNOGENETICS, V51, P805, DOI 10.1007/s002510000215; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	29	211	215	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					410	414		10.1038/87713	http://dx.doi.org/10.1038/87713			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323694				2022-12-18	WOS:000168549800013
J	Ensan, S; Li, A; Besla, R; Degousee, N; Cosme, J; Roufaiel, M; Shikatani, EA; El-Maldizil, M; Williams, JW; Robins, L; Li, C; Lewis, B; Yun, TJ; Lees, JS; Wieghofer, P; Khattar, R; Farrokhil, K; Byrne, J; Ouzounian, M; Zavitz, CCJ; Levy, GA; Bauer, CMT; Libby, P; Husain, M; Swirski, FK; Cheong, C; Prinz, M; Hilgendorf, I; Randolph, GJ; Epelman, S; Gramolini, AO; Cybulsky, MI; Rubin, BB; Robbins, CS				Ensan, Sherine; Li, Angela; Besla, Rickvinder; Degousee, Norbert; Cosme, Jake; Roufaiel, Mark; Shikatani, Eric A.; El-Maldizil, Mahmoud; Williams, Jesse W.; Robins, Lauren; Li, Cedric; Lewis, Bonnie; Yun, Tae Jin; Lees, Jun Seong; Wieghofer, Peter; Khattar, Ramzi; Farrokhil, Kaveh; Byrne, John; Ouzounian, Maral; Zavitz, Caleb C. J.; Levy, Gary A.; Bauer, Carla M. T.; Libby, Peter; Husain, Mansoor; Swirski, Filip K.; Cheong, Cheolho; Prinz, Marco; Hilgendorf, Ingo; Randolph, Gwendalyn J.; Epelman, Slava; Gramolini, Anthony O.; Cybulsky, Myron I.; Rubin, Barry B.; Robbins, Clinton S.			Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; YOLK-SAC; COMMITTED PROGENITORS; CARDIAC MACROPHAGES; FETAL MONOCYTES; STEADY-STATE; MICROGLIA; EXPRESSION; REVEALS; DIFFERENTIATION	Resident macrophages densely populate the normal arterial wall, yet their origins and the mechanisms that sustain them are poorly understood. Here we use gene-expression profiling to show that arterial macrophages constitute a distinct population among macrophages. Using multiple fate-mapping approaches, we show that arterial macrophages arise embryonically from CX3CR1(+) precursors and postnatally from bone marrow derived monocytes that colonize the tissue immediately after birth. In adulthood, proliferation (rather than monocyte recruitment) sustains arterial macrophages in the steady state and after severe depletion following sepsis. After infection, arterial macrophages return rapidly to functional homeostasis. Finally, survival of resident arterial macrophages depends on a CX3CR1-CX3CL1 axis within the vascular niche.	[Ensan, Sherine; Li, Angela; El-Maldizil, Mahmoud; Farrokhil, Kaveh; Epelman, Slava; Robbins, Clinton S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Besla, Rickvinder; Shikatani, Eric A.; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Degousee, Norbert; Cosme, Jake; Roufaiel, Mark; Robins, Lauren; Li, Cedric; Lewis, Bonnie; Khattar, Ramzi; Ouzounian, Maral; Zavitz, Caleb C. J.; Levy, Gary A.; Husain, Mansoor; Epelman, Slava; Gramolini, Anthony O.; Cybulsky, Myron I.; Rubin, Barry B.; Robbins, Clinton S.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Williams, Jesse W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Yun, Tae Jin; Lees, Jun Seong] Inst Rech Clin Montreal, Lab Cellular Physiol & Immunol, Montreal, PQ H2W 1R7, Canada; [Yun, Tae Jin; Lees, Jun Seong] Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Bauer, Carla M. T.] Hoffmann La Roche Inc, pRED, Pharma Res & Early Dev, DTA Inflammat, 340 Kingsland St, Nutley, NJ 07110 USA; [Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Swirski, Filip K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Prinz, Marco] Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany; [Hilgendorf, Ingo] Univ Freiburg, Dept Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany; [Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Byrne, John; Ouzounian, Maral; Husain, Mansoor; Epelman, Slava; Gramolini, Anthony O.; Cybulsky, Myron I.; Rubin, Barry B.; Robbins, Clinton S.] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Washington University (WUSTL); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Freiburg; University of Freiburg; Roche Holding; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Freiburg; University of Freiburg; University of Freiburg; University of Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto	Robbins, CS (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Robbins, CS (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Robbins, CS (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	clint.robbins@utoronto.ca	Epelman, Slava/AAO-1728-2020; Cybulsky, Myron I./AAD-6539-2019; Libby, Peter/AAY-6404-2021; Wieghofer, Peter/AAV-9572-2020; Zavitz, Caleb CJ/D-4659-2009; Swirski, Filip/AAF-1340-2019; Hilgendorf, Ingo/AFM-6379-2022; Cosme, Jake/G-9756-2013	Epelman, Slava/0000-0003-3400-4475; Libby, Peter/0000-0002-1502-502X; Zavitz, Caleb CJ/0000-0002-1097-041X; Hilgendorf, Ingo/0000-0002-0024-1643; Cosme, Jake/0000-0001-8923-9824; Robbins, Clinton/0000-0001-9848-1495; Swirski, Filip/0000-0002-3163-9152; Williams, Jesse/0000-0003-3815-0891; Husain, Mansoor/0000-0002-3740-6739; El-Maklizi, Mahmoud/0000-0002-1229-5198; Cybulsky, Myron/0000-0002-1696-2867	Canadian Institutes of Health Research (CIHR) [MSH136670]; CIHR [MOP133390]; Ontario Lung Association/Pfizer Award; Peter Munk Chair in Aortic Disease Research; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Lung Association/Pfizer Award; Peter Munk Chair in Aortic Disease Research; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	We acknowledge the administrative assistance of B. Bali. Supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award (MSH136670), a CIHR operating grant (MOP133390), an Ontario Lung Association/Pfizer Award and the Peter Munk Chair in Aortic Disease Research (C.S.R.) and an Ontario Graduate Scholarship (S.E.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; AKAZAKI K, 1962, TOHOKU J EXP MED, V76, P107, DOI 10.1620/tjem.76.107; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; NAITO M, 1989, J LEUKOCYTE BIOL, V46, P1; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zheng J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-141	45	210	216	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					159	168		10.1038/ni.3343	http://dx.doi.org/10.1038/ni.3343			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26642357	Green Submitted			2022-12-18	WOS:000368571500009
J	Best, JA; Blair, DA; Knell, J; Yang, E; Mayya, V; Doedens, A; Dustin, ML; Goldrath, AW				Best, J. Adam; Blair, David A.; Knell, Jamie; Yang, Edward; Mayya, Viveka; Doedens, Andrew; Dustin, Michael L.; Goldrath, Ananda W.		Immunological Genome Project	Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation	NATURE IMMUNOLOGY			English	Article							SELECTIVE EXPRESSION; GENE-EXPRESSION; CUTTING EDGE; E-CADHERIN; EFFECTOR; ANTIGEN; DIFFERENTIATION; PRECURSOR; RECEPTOR; IDENTIFICATION	After infection, many factors coordinate the population expansion and differentiation of CD8(+) effector and memory T cells. Using data of unparalleled breadth from the Immunological Genome Project, we analyzed the CD8(+) T cell transcriptome throughout infection to establish gene-expression signatures and identify putative transcriptional regulators. Notably, we found that the expression of key gene signatures can be used to predict the memory-precursor potential of CD8(+) effector cells. Long-lived memory CD8(+) cells ultimately expressed a small subset of genes shared by natural killer T and TB T cells. Although distinct inflammatory milieu and T cell precursor frequencies influenced the differentiation of CD8(+) effector and memory populations, core transcriptional signatures were regulated similarly, whether polyclonal or transgenic, and whether responding to bacterial or viral model pathogens. Our results provide insights into the transcriptional regulation that influence memory formation and CD8(+) T cell immunity.	[Best, J. Adam; Knell, Jamie; Yang, Edward; Doedens, Andrew; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Blair, David A.; Mayya, Viveka; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA	University of California System; University of California San Diego; New York University	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu	Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/B-9847-2015; Heng, Tracy/AAR-5712-2021; Mingueneau, Michael/O-5313-2019; Gazit, Roi/J-3352-2017; Dustin, Michael/AAM-4611-2020	Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Mingueneau, Michael/0000-0002-3873-7329; Kim, Charles/0000-0001-6474-8227; Tata, Nageswara Rao/0000-0002-9928-5944; Gazit, Roi/0000-0002-0548-2147; Doedens, Andrew/0000-0003-2461-3496; Monach, Paul/0000-0003-4937-0515; Miller, Jennifer/0000-0002-3591-369X; Fletcher, Anne/0000-0003-1534-1142; Mayya, Viveka/0000-0001-5668-9124; Malhotra, Deepali/0000-0002-8215-7639; kang, joonsoo/0000-0001-8419-7995; Dustin, Michael/0000-0003-4983-6389	eBioscience, Affymetrix and Expression Analysis; US National Institutes of Health [AI072117, AI067545, T32 AI060536, PN2 EY016586, P30 CA016087, R24 AI072073]; Pew Scholars program; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073, R01AI072117, R01AI067545, T32AI060536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, P30DK063720] Funding Source: NIH RePORTER	eBioscience, Affymetrix and Expression Analysis; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars program; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank eBioscience, Affymetrix and Expression Analysis for support of the ImmGen Project. Supported by the US National Institutes of Health (AI072117 and AI067545 to A.W.G.; T32 AI060536 to J.A.B.; PN2 EY016586 to D.A.B. and M.L.D.; P30 CA016087 for cell sorting; and R24 AI072073 (National Institute of Allergy and Infectious Diseases) to the ImmGen Consortium), the Pew Scholars program (A.W.G.) and the Cancer Research Institute (A.W.G. and V.M.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; Busch DH, 2000, J IMMUNOL, V164, P4063, DOI 10.4049/jimmunol.164.8.4063; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; D'Cruz LM, 2012, EUR J IMMUNOL, V42, P2031, DOI 10.1002/eji.201242497; Dietz SB, 1996, J CUTAN PATHOL, V23, P312, DOI 10.1111/j.1600-0560.1996.tb01303.x; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sacerdote P, 2000, J NEUROIMMUNOL, V109, P155, DOI 10.1016/S0165-5728(00)00307-6; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sundrud MS, 2008, IMMUNITY, V28, P5, DOI 10.1016/j.immuni.2007.12.006; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158	35	210	217	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					404	412		10.1038/ni.2536	http://dx.doi.org/10.1038/ni.2536			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23396170	Green Published, Green Accepted			2022-12-18	WOS:000316648700016
J	Faure, S; Salazar-Fontana, LI; Semichon, M; Tybulewicz, VLJ; Bismuth, G; Trautmann, A; Germain, RN; Delon, J				Faure, S; Salazar-Fontana, LI; Semichon, M; Tybulewicz, VLJ; Bismuth, G; Trautmann, A; Germain, RN; Delon, J			ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTING CELLS; EXCHANGE FACTOR VAV; IMMUNOLOGICAL SYNAPSE; INTRACELLULAR CALCIUM; ACTIN POLYMERIZATION; RECEPTOR SIGNALS; RHO-GTPASES; IN-VIVO; RECOGNITION; ACTIVATION	During activation, T cells associate with antigen-presenting cells, a dynamic process that involves the formation of a broad area of intimate membrane contact known as the immunological synapse. The molecular intermediates that link initial antigen recognition to the cytoskeletal changes involved in this phenomenon have not yet been defined. Here we demonstrate that ezrin-radixin-moesin proteins are rapidly inactivated after antigen recognition through a Vav1-Rac1 pathway. The resulting disanchoring of the cortical actin cytoskeleton from the plasma membrane decreased cellular rigidity, leading to more efficient T cell-antigen-presenting cell conjugate formation. These findings identify an antigen-dependent molecular pathway that favors immunological synapse formation and the subsequent development of an effective immune response.	Univ Paris 05, Inst Cochin, Dept Biol Cellulaire, INSERM,U567,CNRS,UMR 8104, F-75014 Paris, France; NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MRC National Institute for Medical Research	Delon, J (corresponding author), Univ Paris 05, Inst Cochin, Dept Biol Cellulaire, INSERM,U567,CNRS,UMR 8104, 22 Rue Mechain, F-75014 Paris, France.	delon@cochin.inserm.fr	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Tybulewicz, Victor/0000-0003-2439-0798; Delon, Jerome/0000-0003-0222-1192	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000403, ZIAAI000403] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Amieva MR, 1999, J CELL SCI, V112, P111; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Lee SJE, 2002, TRENDS IMMUNOL, V23, P500, DOI 10.1016/S1471-4906(02)02325-6; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; NOBES CD, 1995, J CELL SCI, V108, P225; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571	50	210	219	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					272	279		10.1038/ni1039	http://dx.doi.org/10.1038/ni1039			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14758359				2022-12-18	WOS:000189344600010
J	Heink, S; Yogev, N; Garbers, C; Herwerth, M; Aly, L; Gasperi, C; Husterer, V; Croxford, AL; Moller-Hackbarth, K; Bartsch, HS; Sotlar, K; Krebs, S; Regen, T; Blum, H; Hemmer, B; Misgeld, T; Wunderlich, TF; Hidalgo, J; Oulcka, M; Rose-John, S; Schmidt-Supprian, M; Waisman, A; Korn, T				Heink, Sylvia; Yogev, Nir; Garbers, Christoph; Herwerth, Marina; Aly, Lilian; Gasperi, Christiane; Husterer, Veronika; Croxford, Andrew L.; Moeller-Hackbarth, Katja; Bartsch, Harald S.; Sotlar, Karl; Krebs, Stefan; Regen, Tommy; Blum, Helmut; Hemmer, Bernhard; Misgeld, Thomas; Wunderlich, Thomas F.; Hidalgo, Juan; Oulcka, Mohamed; Rose-John, Stefan; Schmidt-Supprian, Marc; Waisman, Ari; Korn, Thomas			Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T(H)17 cells	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; SOLUBLE INTERLEUKIN-6; TH17 CELLS; TGF-BETA; GENERATION; CYTOKINES; DIFFERENTIATION; POPULATIONS; INHIBITION; INDUCTION	The cellular sources of interleukin 6 (IL-6) that are relevant for differentiation of the T(H)17 subset of helper T cells remain unclear. Here we used a novel strategy for the conditional deletion of distinct IL-6-producing cell types to show that dendritic cells (DCs) positive for the signaling regulator Sirp alpha were essential for the generation of pathogenic T(H)17 cells. Using their IL-6 receptor a-chain (IL-6R alpha), Sirp alpha(+) DCs trans-presented IL-6 to T cells during the process of cognate interaction. While ambient IL-6 was sufficient to suppress the induction of expression of the transcription factor Foxp3 in T cells, trans-presentation of IL-6 by DC-bound IL-6R alpha (called 'IL-6 cluster signaling' here) was needed to prevent premature induction of interferon-gamma (IFN-gamma) expression in T cells and to generate pathogenic T(H)17 cells in vivo. Our findings should guide therapeutic approaches for the treatment of T(H)17-cell-mediated autoimmune diseases.	[Heink, Sylvia; Herwerth, Marina; Aly, Lilian; Gasperi, Christiane; Husterer, Veronika; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Yogev, Nir; Croxford, Andrew L.; Regen, Tommy; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Garbers, Christoph; Moeller-Hackbarth, Katja; Rose-John, Stefan] Univ Kiel, Inst Biochem, Kiel, Germany; [Herwerth, Marina; Misgeld, Thomas] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Bartsch, Harald S.; Sotlar, Karl] Ludwig Maximilians Univ Munchen, Sch Med, Inst Pathol, Munich, Germany; [Krebs, Stefan; Blum, Helmut] Ludwig Maximilians Univ Munchen, Gene Ctr, Lafuga, Munich, Germany; [Hemmer, Bernhard; Misgeld, Thomas; Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Wunderlich, Thomas F.] Max Planck Inst Metab Res, Cologne, Germany; [Hidalgo, Juan] Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Oulcka, Mohamed] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Oulcka, Mohamed] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Schmidt-Supprian, Marc] Tech Univ Munich, Dept Hematol & Oncol, Klinikum Rechts Isar, Munich, Germany; [Yogev, Nir] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, Mainz, Germany	Technical University of Munich; Johannes Gutenberg University of Mainz; University of Kiel; Technical University of Munich; University of Munich; University of Munich; University of Munich; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Technical University of Munich; Johannes Gutenberg University of Mainz	Korn, T (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	thomas.korn@um.de	Korn, Thomas/AAE-6960-2019; Hemmer, Bernhard/GPX-8451-2022; Gasperi, Christiane/AAB-3628-2021; Schmidt-Supprian, Marc/F-5893-2011; Regen, Tommy/GQH-6929-2022; Rose-John, Stefan/A-7998-2010; Garbers, Christoph/D-9932-2015; Hidalgo, Juan/C-9082-2011; Hemmer, Bernhard/AAT-8388-2021	Korn, Thomas/0000-0002-3633-0955; Hemmer, Bernhard/0000-0001-5985-6784; Schmidt-Supprian, Marc/0000-0002-8543-6166; Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; Hidalgo, Juan/0000-0003-0921-1122; Herwerth, Marina/0000-0001-5125-4594; Gasperi, Christiane/0000-0002-0524-6005; Heink, Sylvia/0000-0002-3276-6313; Aly, Lilian/0000-0002-7051-124X; Regen, Tommy/0000-0002-7275-3330	Deutsche Forschungsgemeinschaft [TRR128, TRR156, WA1600/8-1, SFB1054-B07, SFB877-A01, SFB877-A10]; European Research Council [647215]; Spanish Ministerio de Economia y Competitividad [SAF2011-23272, SAF2014-56546-R]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124735] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Korn laboratory for input; B. Kunze, B. Lunk and colleagues for mouse care; D. Busch (Technical University of Munich) for OT-II mice (TeTcraTcrb)<SUP>425Cbn</SUP>) expressing the congenic marker CD45.1; F. Greten (Georg-Speyer Haus) for Stat3<SUP>flox/flox</SUP> (Staf3<SUP>tm2Aki</SUP>) mice; B. Stockinger (MRC National Institute for Medical Research) for the 19E12 hybridoma; and M. Kopf (ETH, Zurich) for Il21r<SUP>-/-</SUP> mice. Supported by the Deutsche Forschungsgemeinschaft (TRR128 to A.W. and T.K.; TRR156 and WA1600/8-1 to A.W.; SFB1054-B07 and SyNergy to T.K.; SFB877-A01 to S.R.-J.; SFB877-A10 to C. Gar.; and the cluster of excellence 'Inflammation at interfaces' to S.R.-J. and C. Gar.), the European Research Council (Consolidator Grant 647215 to T.K.), and the Spanish Ministerio de Economia y Competitividad (SAF2011-23272 and SAF2014-56546-R to J.H.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Babon JJ, 2014, SEMIN IMMUNOL, V26, P13, DOI 10.1016/j.smim.2013.12.004; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Linker RA, 2008, J NEUROIMMUNOL, V205, P64, DOI 10.1016/j.jneuroim.2008.09.007; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tanaka T, 2001, CYTOKINE, V13, P193, DOI 10.1006/cyto.2000.0828; Tussiwand R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00533; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004	35	209	218	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					74	85		10.1038/ni.3632	http://dx.doi.org/10.1038/ni.3632			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27893700	Green Accepted			2022-12-18	WOS:000390080000012
J	Ouimet, M; Koster, S; Sakowski, E; Ramkhelawon, B; van Solingen, C; Oldebeken, S; Karunakaran, D; Portal-Celhay, C; Sheedy, FJ; Ray, TD; Cecchini, K; Zamore, PD; Rayner, KJ; Marcel, YL; Philips, JA; Moore, KJ				Ouimet, Mireille; Koster, Stefan; Sakowski, Erik; Ramkhelawon, Bhama; van Solingen, Coen; Oldebeken, Scott; Karunakaran, Denuja; Portal-Celhay, Cynthia; Sheedy, Frederick J.; Ray, Tathagat Dutta; Cecchini, Katharine; Zamore, Philip D.; Rayner, Katey J.; Marcel, Yves L.; Philips, Jennifer A.; Moore, Kathryn J.			Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism	NATURE IMMUNOLOGY			English	Article							CELLS; CGAS; DNA; INFLAMMATION; MICRORNA-33; RESISTANCE; PROMOTES; BACTERIA; REVEALS; CYTOSOL	Mycobacterium tuberculosis (Mtb) survives in macrophages by evading delivery to the lysosome and promoting the accumulation of lipid bodies, which serve as a bacterial source of nutrients. We found that by inducing the microRNA (miRNA) miR-33 and its passenger strand miR-33*, Mtb inhibited integrated pathways involved in autophagy, lysosomal function and fatty acid oxidation to support bacterial replication. Silencing of miR-33 and miR-33* by genetic or pharmacological means promoted autophagy flux through derepression of key autophagy effectors (such as ATG5, ATG12, LC3B and LAMP1) and AMPK-dependent activation of the transcription factors FOXO3 and TFEB, which enhanced lipid catabolism and Mtb xenophagy. These data define a mammalian miRNA circuit used by Mtb to coordinately inhibit autophagy and reprogram host lipid metabolism to enable intracellular survival and persistence in the host.	[Ouimet, Mireille; Ramkhelawon, Bhama; van Solingen, Coen; Oldebeken, Scott; Ray, Tathagat Dutta; Moore, Kathryn J.] NYU Med Ctr, Dept Med, Leon H Charney Div Cardiol, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA; [Koster, Stefan; Sakowski, Erik; Portal-Celhay, Cynthia; Philips, Jennifer A.] NYU Med Ctr, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA; [Karunakaran, Denuja; Rayner, Katey J.; Marcel, Yves L.] Univ Ottawa, Inst Heart, Ottawa, ON K1N 6N5, Canada; [Karunakaran, Denuja; Rayner, Katey J.; Marcel, Yves L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; [Sheedy, Frederick J.] Univ Dublin Trinity Coll, Sch Med, Dept Clin Med, Dublin 2, Ireland; [Cecchini, Katharine; Zamore, Philip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA; [Cecchini, Katharine; Zamore, Philip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Philips, Jennifer A.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA	New York University; New York University; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Trinity College Dublin; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL)	Moore, KJ (corresponding author), NYU Med Ctr, Dept Med, Leon H Charney Div Cardiol, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA.; Philips, JA (corresponding author), NYU Med Ctr, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA.; Philips, JA (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	philips.j.a@wustl.edu; kathryn.moore@nyumc.org	Moore, Kathryn/ABE-6416-2020; Karunakaran, Denuja/G-2275-2010	Moore, Kathryn/0000-0003-2505-2547; Karunakaran, Denuja/0000-0002-4789-8634; Zamore, Phillip/0000-0002-4505-9618; van Solingen, Coen/0000-0002-5817-2003; Sheedy, Frederick/0000-0003-2645-8493; Rayner, Katey/0000-0001-6230-426X; Sheedy, Frederick/0000-0002-4722-3135	NYU-HHC CTSI grant [UL1 TR000038]; NYU Cancer Institute's Cancer Center Support grant [P30CA016087]; US National Institutes of Health [R01 HL108182, HL119047, R01 AI087682, R21 AI105298]; American Heart Association [13POST14490016, 14POST20180018]; NYU Physician-Scientist Training Program; Potts Memorial Foundation; Edward J. Mallinckrodt, Jr. Foundation; Science Foundation Ireland [13/SIRG/2136]; Canadian Institutes of Health Research [MOP130365, MSH130157]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108182, R01HL119047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087682, R21AI105298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862] Funding Source: NIH RePORTER	NYU-HHC CTSI grant; NYU Cancer Institute's Cancer Center Support grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NYU Physician-Scientist Training Program; Potts Memorial Foundation; Edward J. Mallinckrodt, Jr. Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Virgin (Washington University School of Medicine) and D. MacDuff (Washington University School of Medicine) for Cgas<SUP>-/-</SUP> mice; K. Caldwell (New York University) for Atg16l1<SUP>flox/flox</SUP> mice; B. Norris for help with flow cytometry; C. O'Shaughnessy for help with mouse harvests; New York University Langone Medical Center Immune Monitoring Core for use of the XF<SUP>e</SUP>24 Extracellular Flux Analyzer (supported by the NYU-HHC CTSI grant UL1 TR000038 and the NYU Cancer Institute's Cancer Center Support grant P30CA016087). Supported by the US National Institutes of Health (R01 HL108182 and HL119047 to K.J.M.; R01 AI087682 and R21 AI105298 to J.A.P.), the American Heart Association (13POST14490016 to B.R., 14POST20180018 to C.v.S.), the NYU Physician-Scientist Training Program (C.P.-C.), the Potts Memorial Foundation (S.K.), Edward J. Mallinckrodt, Jr. Foundation (J.A.P.), Science Foundation Ireland (13/SIRG/2136 to F.J.S.), and the Canadian Institutes of Health Research (postdoctoral fellowship to M.O.; MOP130365 and MSH130157 to K.J.R.).	Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Goedeke L, 2013, MOL CELL BIOL, V33, P2339, DOI 10.1128/MCB.01714-12; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Listenberger L.L., 2007, CURR PROTOC CELL BIO, V24; Majlessi L, 2015, CELL HOST MICROBE, V17, P733, DOI 10.1016/j.chom.2015.05.017; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rodriguez JG, 2014, MBIO, V5, DOI 10.1128/mBio.01125-14; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sakowski ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005076; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Singh V, 2012, CELL HOST MICROBE, V12, P669, DOI 10.1016/j.chom.2012.09.012; Stanley SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003946; Stanley SA, 2014, CURR TOP MICROBIOL, V374, P211, DOI 10.1007/82_2013_332; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zhao GJ, 2014, INT J CARDIOL, V171, pE93, DOI 10.1016/j.ijcard.2013.11.093	55	209	229	5	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					677	+		10.1038/ni.3434	http://dx.doi.org/10.1038/ni.3434			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27089382	Green Accepted			2022-12-18	WOS:000376162200012
J	Xu, WF; Santini, PA; Sullivan, JS; He, B; Shan, MM; Ball, SC; Dyer, WB; Ketas, TJ; Chadburn, A; Cohen-Gould, L; Knowles, DM; Chiu, A; Sanders, RW; Chen, K; Cerutti, A				Xu, Weifeng; Santini, Paul A.; Sullivan, John S.; He, Bing; Shan, Meimei; Ball, Susan C.; Dyer, Wayne B.; Ketas, Thomas J.; Chadburn, Amy; Cohen-Gould, Leona; Knowles, Daniel M.; Chiu, April; Sanders, Rogier W.; Chen, Kang; Cerutti, Andrea			HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits	NATURE IMMUNOLOGY			English	Article							DILEUCINE MOTIF; CD4 ENDOCYTOSIS; LYMPH-NODES; NEF; INFECTION; MECHANISM; PROTEINS; DISEASE; ANTIGEN; MEMORY	Contact-dependent communication between immune cells generates protection but also facilitates viral spread. Here we found that macrophages formed long-range actin-propelled conduits in response to negative factor (Nef), a human immunodeficiency virus type 1 (HIV-1) protein with immunosuppressive functions. Conduits attenuated immunoglobulin G2 (IgG2) and IgA class switching in systemic and intestinal lymphoid follicles by shuttling Nef from infected macrophages to B cells through a guanine-exchange factor-dependent pathway involving the amino-terminal anchor, central core and carboxy-terminal flexible loop of Nef. By showing stronger virus-specific IgG2 and IgA responses in patients with Nef-deficient virions, our data suggest that HIV-1 exploits intercellular 'highways' as a 'Trojan horse' to deliver Nef to B cells and evade humoral immunity systemically and at mucosal sites of entry.	[Xu, Weifeng; Santini, Paul A.; He, Bing; Knowles, Daniel M.; Chen, Kang; Cerutti, Andrea] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Santini, Paul A.; Chen, Kang; Cerutti, Andrea] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Sullivan, John S.; Dyer, Wayne B.] Univ Sydney, Fac Med, Cent Clin Sch, Viral Immunol Lab,Australian Red Cross Blood Serv, Sydney, NSW 2006, Australia; [Shan, Meimei] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Ball, Susan C.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [Ketas, Thomas J.] Cornell Univ, Weill Med Coll, Dept Immunol & Microbiol, New York, NY 10021 USA; [Chadburn, Amy; Chiu, April] Northwestern Univ, Feinberg Sch Med, Dept Pathol & Lab Med, Chicago, IL 60611 USA; [Cohen-Gould, Leona] Cornell Univ, Weill Med Coll, Electron Microscopy & Histol Core Facil, New York, NY 10021 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; Cornell University; Australian Red Cross Blood Service; University of Sydney; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University; Northwestern University; Feinberg School of Medicine; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam	Cerutti, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	acerutti@med.cornell.edu		Cerutti, Andrea/0000-0003-3026-4704	US National Institutes of Health [AI07621, R01 AI057653, R01 AI057653-S1, R01 AI074378]; Irma T. Hirschl Charitable Trust; Cornell Comprehensive Cancer Center; Ministerio de Ciencia e Innovacion; Desarollo e Innovacion Tecnologica [SAF 2008-02725]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621, R01AI057653, R01AI074378] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; Cornell Comprehensive Cancer Center; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Desarollo e Innovacion Tecnologica; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Stevenson (University of Massachusetts Medical School) for the Delta Nef-ADA plasmid; B. Berkhout (Academic Medical Center) for the Delta Nef-LAI plasmid; S. J. Burakoff (New York University) for the Nef-dsRED vector; M. G. Caron, (Duke University) for dominant negative dynamin-K44A and beta-arrestin-2-V54D; J. G. Donaldson (National Institutes of Health) for dominant negative ARF6-T27N; Y. Zheng (Cincinnati Children's Hospital Medical Center) for dominant negative RhoA-N19, Cdc42-N17 and Rac1-N17; P. Marignani (Dalhousie University) for dominant negative Vav2-R/S; J. P. Moore (Weill Medical College of Cornell University) for the Delta Nef-HIV-1-expressing NL4-3/9-7-dsRed plasmid; A. Pernis (Columbia University) for reagents; and all reagent donors for discussions. Supported by the US National Institutes of Health (AI07621 to W. X.; and R01 AI057653, R01 AI057653-S1 and R01 AI074378 to A. Ce.), The Irma T. Hirschl Charitable Trust (to A. Ce.), the Cornell Comprehensive Cancer Center (Chronic Lymphocytic Leukemia Research Center Award; to A. Ce.), the Ministerio de Ciencia e Innovacion (Plan Nacional de Investigacion Cientifica, Desarollo e Innovacion Tecnologica SAF 2008-02725 to A. Ce.) and the Cancer Research Institute (to P. A. S.).	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Conboy IM, 1999, P NATL ACAD SCI USA, V96, P6324, DOI 10.1073/pnas.96.11.6324; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mann J, 2005, J IMMUNOL, V175, P6560, DOI 10.4049/jimmunol.175.10.6560; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Muratori C, 2007, J VIROL, V81, P9078, DOI 10.1128/JVI.00675-07; Peng B, 2001, IMMUNOL LETT, V78, P195, DOI 10.1016/S0165-2478(01)00250-4; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Regulier EG, 2005, JAIDS-J ACQ IMM DEF, V40, P1, DOI 10.1097/01.qai.0000173702.05308.c4; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434	56	209	216	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					1008	U106		10.1038/ni.1753	http://dx.doi.org/10.1038/ni.1753			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19648924	Green Accepted			2022-12-18	WOS:000269120900015
J	Salvador, JM; Mittelstadt, PR; Guszczynski, T; Copeland, TD; Yamaguchi, H; Appella, E; Fornace, AJ; Ashwell, JD				Salvador, JM; Mittelstadt, PR; Guszczynski, T; Copeland, TD; Yamaguchi, H; Appella, E; Fornace, AJ; Ashwell, JD			Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases	NATURE IMMUNOLOGY			English	Article							SIGNAL-TRANSDUCTION; PROTEIN-KINASE; MAP KINASES; PHOSPHORYLATION; JNK; AUTOPHOSPHORYLATION; PROLIFERATION; LYMPHOCYTES; ZAP-70; SYK	Signaling-responsive MAP kinases (MAPKs) are key in mediating immune responses and are activated through the phosphorylation of a Thr-X-Tyr motif by upstream MAPK kinases. Here we show that T cells stimulated through the T cell receptor (TCR) used an alternative mechanism in which p38 was phosphorylated on Tyr323 and subsequently autophosphorylated residues Thr180 and Tyr182. This required the TCR-proximal tyrosine kinase Zap70 but not the adaptor protein LAT, which was required for activation of extracellular signal - regulated protein kinase MAPKs. TCR activation of p38 lacking Tyr323 was diminished, and blocking of p38 activity prevented p38 dual phosphorylation in normal T cells but not in B cells. Thus, phosphorylation of Tyr323 dependent on the tyrosine kinase Lck and mediated by Zap70 serves as an important mechanism for TCR activation of p38 in T cells.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; NCI, Gene Response Sect, NIH, Bethesda, MD 20892 USA; NCI, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Salvador, Jesus Maria/0000-0002-1087-9675; Yamaguchi, Hiroshi/0000-0003-1022-0413	DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC003229] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Doro U, 1996, MOL CELL BIOL, V16, P4996; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Haeryfar SMM, 2001, INT IMMUNOPHARMACOL, V1, P689, DOI 10.1016/S1567-5769(01)00002-9; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Jiang Y, 1997, J BIOL CHEM, V272, P11096; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rincon M, 2000, IMMUNOL CELL BIOL, V78, P166, DOI 10.1046/j.1440-1711.2000.00900.x; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Salojin KV, 1999, J IMMUNOL, V163, P844; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; SALVADOR JM, 2005, NAT IMMUNOL     0227; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Steinberg M, 2004, BLOOD, V104, P760, DOI 10.1182/blood-2003-12-4314; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Ward SG, 1997, BIOCHEM SOC T, V25, pS304, DOI 10.1042/bst025304s; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Zhang J, 1999, J IMMUNOL, V162, P3819	35	209	226	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					390	395		10.1038/ni1177	http://dx.doi.org/10.1038/ni1177			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15735648				2022-12-18	WOS:000227860000013
J	Brehm, MA; Pinto, AK; Daniels, KA; Schneck, JP; Welsh, RM; Selin, LK				Brehm, MA; Pinto, AK; Daniels, KA; Schneck, JP; Welsh, RM; Selin, LK			T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HETEROLOGOUS ANTIVIRAL IMMUNITY; CLASS-I MOLECULES; SYNTHETIC PEPTIDE; EPITOPE; RESPONSES; INFECTION; CTL; ANTIGEN; MICE	We show here that T cell cross-reactivity between heterologous viruses influences the immuno-dominance of virus-specific CD8(+) T cells by two mechanisms. First, T cells specific for cross-reactive epitopes dominate acute responses to viral infections; second, within the memory pool, T cells specific for cross-reactive epitopes are maintained while those specific for non-cross-reactive epitopes are selectively lost. These findings suggest an immunological paradigm in which viral infections shape the available T cell repertoire, causing alterations in the hierarchies of both the primary and memory CD8(+) T cell responses elicited by subsequent viral infections. Thus, immunodominance is a function of the host's previous exposure to unrelated pathogens, and this may have an impact on protective immunity and immunopathology.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01655 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University	Selin, LK (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	liisa.selin@umassmed.edu	Pinto, Amelia K/O-6658-2018; Pinto, Amelia/AAD-7059-2020	Pinto, Amelia K/0000-0002-7147-3978; Pinto, Amelia/0000-0002-7147-3978; Selin, Liisa/0000-0002-6993-4333; Brehm, Michael/0000-0001-6813-3262	NIAID NIH HHS [AI-46578, AI29575, AI-46629, AI-17672, AI-07439] Funding Source: Medline; NIAMS NIH HHS [AR-35506] Funding Source: Medline; NIDDK NIH HHS [DK-32520] Funding Source: Medline; CSR NIH HHS [RG 2637 A2/1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017672, R01AI046578, F35AI007439, P01AI046629, R37AI017672, R01AI029575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSR NIH HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RW, 1992, MOL IMMUNOL, V29, P1089, DOI 10.1016/0161-5890(92)90041-U; Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Boesteanu A, 1998, J IMMUNOL, V161, P4719; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Cole GA, 1997, J IMMUNOL, V158, P4301; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Deng YP, 1997, J IMMUNOL, V158, P1507; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Gallimore A, 1998, J EXP MED, V187, P1647; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; HOWARD CR, 1987, CURR TOP MICROBIOL, V134, P117; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; MYLIN LM, 1995, J VIROL, V69, P6665, DOI 10.1128/JVI.69.11.6665-6677.1995; Oldstone MBA, 2001, J VIROL, V75, P6273, DOI 10.1128/JVI.75.14.6273-6278.2001; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Rodriguez F, 2001, J VIROL, V75, P7399, DOI 10.1128/JVI.75.16.7399-7409.2001; Roy-Proulx G, 2001, EUR J IMMUNOL, V31, P2284, DOI 10.1002/1521-4141(200108)31:8<2284::AID-IMMU2284>3.0.CO;2-E; Schneck Jonathan P., 2000, Immunological Investigations, V29, P163, DOI 10.3109/08820130009062300; Selin LK, 1997, J IMMUNOL, V158, P5366; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; SHIMOJO N, 1989, J IMMUNOL, V143, P2939; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Southern P. J., 1996, FIELDS VIROL, V2, P1505; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; TANAKA Y, 1989, VIROLOGY, V171, P205, DOI 10.1016/0042-6822(89)90527-8; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; VANBLEEK GM, 1990, NATURE, V348, P213; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Weidt G, 1998, J IMMUNOL, V160, P2923; WEINSTEIN L, 1956, ARCH INTERN MED, V98, P91, DOI 10.1001/archinte.1956.00250250097013; WHITTON JL, 1988, J VIROL, V62, P687, DOI 10.1128/JVI.62.3.687-695.1988; Wilson CS, 1999, J IMMUNOL, V162, P3933; WULFF H, 1978, INTERVIROLOGY, V9, P344, DOI 10.1159/000148956; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	50	209	213	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					627	634		10.1038/ni806	http://dx.doi.org/10.1038/ni806			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055626				2022-12-18	WOS:000176441700012
J	Galani, IE; Rovina, N; Lampropoulou, V; Triantafyllia, V; Manioudaki, M; Pavlos, E; Koukaki, E; Fragkou, PC; Panou, V; Rapti, V; Koltsida, O; Mentis, A; Koulouris, N; Tsiodras, S; Koutsoukou, A; Andreakos, E				Galani, Ioanna-Evdokia; Rovina, Nikoletta; Lampropoulou, Vicky; Triantafyllia, Vasiliki; Manioudaki, Maria; Pavlos, Eleftherios; Koukaki, Evangelia; Fragkou, Paraskevi C.; Panou, Vasiliki; Rapti, Vasiliki; Koltsida, Ourania; Mentis, Andreas; Koulouris, Nikolaos; Tsiodras, Sotirios; Koutsoukou, Antonia; Andreakos, Evangelos			Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison	NATURE IMMUNOLOGY			English	Article							VIRAL-INFECTIONS; PNEUMONIA; VIRUSES	Andreakos and colleagues provide a longitudinal study comparing patients with COVID-19 to patients infected with influenza. They report a dysregulated interferon response whereby IFN-lambda and type I IFN production were diminished and delayed in patients with COVID-19, exhibiting a response that is 'untuned' with other inflammatory cytokines. A central paradigm of immunity is that interferon (IFN)-mediated antiviral responses precede pro-inflammatory ones, optimizing host protection and minimizing collateral damage(1,2). Here, we report that for coronavirus disease 2019 (COVID-19) this paradigm does not apply. By investigating temporal IFN and inflammatory cytokine patterns in 32 moderate-to-severe patients with COVID-19 hospitalized for pneumonia and longitudinally followed for the development of respiratory failure and death, we reveal that IFN-lambda and type I IFN production were both diminished and delayed, induced only in a fraction of patients as they became critically ill. On the contrary, pro-inflammatory cytokines such as tumor necrosis factor (TNF), interleukin (IL)-6 and IL-8 were produced before IFNs in all patients and persisted for a prolonged time. This condition was reflected in blood transcriptomes wherein prominent IFN signatures were only seen in critically ill patients who also exhibited augmented inflammation. By comparison, in 16 patients with influenza (flu) hospitalized for pneumonia with similar clinicopathological characteristics to those of COVID-19 and 24 nonhospitalized patients with flu with milder symptoms, IFN-lambda and type I IFN were robustly induced earlier, at higher levels and independently of disease severity, whereas pro-inflammatory cytokines were only acutely produced. Notably, higher IFN-lambda concentrations in patients with COVID-19 correlated with lower viral load in bronchial aspirates and faster viral clearance and a higher IFN-lambda to type I IFN ratio correlated with improved outcome for critically ill patients. Moreover, altered cytokine patterns in patients with COVID-19 correlated with longer hospitalization and higher incidence of critical disease and mortality compared to flu. These data point to an untuned antiviral response in COVID-19, contributing to persistent viral presence, hyperinflammation and respiratory failure.	[Galani, Ioanna-Evdokia; Lampropoulou, Vicky; Triantafyllia, Vasiliki; Manioudaki, Maria; Pavlos, Eleftherios; Andreakos, Evangelos] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece; [Rovina, Nikoletta; Koutsoukou, Antonia] Natl & Kapodistrian Univ Athens, Med Sch, Sotiria Gen Hosp Chest Dis, ICU,Dept Resp Med 1, Athens, Greece; [Koukaki, Evangelia; Panou, Vasiliki; Koulouris, Nikolaos] Natl & Kapodistrian Univ Athens, Med Sch, Sotiria Gen Hosp Chest Dis, Dept Resp Med 1, Athens, Greece; [Fragkou, Paraskevi C.; Rapti, Vasiliki; Tsiodras, Sotirios] Univ Athens, Attikon Univ Hosp, Dept Internal Med 4, Med Sch, Athens, Greece; [Koltsida, Ourania] Sotiria Gen Hosp Chest Dis, Resp Clin 2, Athens, Greece; [Mentis, Andreas] Hellenic Pasteur Inst, Dept Microbiol, Athens, Greece; [Andreakos, Evangelos] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England	Academy of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University Hospital Attikon; Imperial College London	Andreakos, E (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece.; Andreakos, E (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England.	vandreakos@bioacademy.gr	Galani, Ioanna Evdokia/AAM-3546-2021; Rapti, Vasiliki/AGY-3601-2022; Koukaki, Evangelia/AIE-7542-2022	Galani, Ioanna Evdokia/0000-0002-0965-3863; Rapti, Vasiliki/0000-0002-8322-635X; Koukaki, Evangelia/0000-0002-9770-173X; Rovina, Nikoletta/0000-0003-0138-5582; Triantafyllia, Vasiliki/0000-0001-5832-4014; Fragkou, Paraskevi/0000-0003-2022-2949; Tsiodras, Sotirios/0000-0002-0463-4321	European Commission [779295, 767015]; Hellenic Foundation for Research and Innovation [1574]; Janssen Pharmaceuticals; Hellenic Thoracic Society; Hellenic Foundation for Research and Innovation (RELIEVE) [506]	European Commission(European CommissionEuropean Commission Joint Research Centre); Hellenic Foundation for Research and Innovation; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Hellenic Thoracic Society; Hellenic Foundation for Research and Innovation (RELIEVE)	The authors thank A. Gavriil and G. Vatsellas for technical assistance and P. Katsikis (Erasmus Medical Center, the Netherlands) and V. Soumelis (Institut de Recherche Saint-Louis, Universite de Paris, France) for critically reading the manuscript. E.A. is supported by research grants from the European Commission (IMMUNAID, no. 779295 and CURE, no. 767015), the Hellenic Foundation for Research and Innovation (INTERFLU, no. 1574) and Janssen Pharmaceuticals. I.E.G. is supported by a research grant from the Hellenic Foundation for Research and Innovation (RELIEVE, no. 506). This work was supported by a grant from the Hellenic Thoracic Society and a donation from Jorge Andres Sanchez Papaspiliou family and friends.	Andreakos E, 2019, CURR OPIN IMMUNOL, V56, P67, DOI 10.1016/j.coi.2018.10.007; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Comar CE, 2019, MBIO, V10, DOI 10.1128/mBio.00319-19; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Liu T, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012421; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mangalmurti N, 2020, IMMUNITY, V53, P19, DOI 10.1016/j.immuni.2020.06.017; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI [10.1093/cid/ciy874, 10.1093/cid/ciy866]; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Wei PF, 2020, CHINESE MED J-PEKING, V133, P1087, DOI 10.1097/CM9.0000000000000819; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, 2020, SMOK COVID 19, DOI DOI 10.15557/PIMR.2020.0004; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443	38	208	211	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					32	40		10.1038/s41590-020-00840-x	http://dx.doi.org/10.1038/s41590-020-00840-x		DEC 2020	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33277638	Green Submitted, Bronze			2022-12-18	WOS:000599055500001
J	Kumagai, S; Togashi, Y; Kamada, T; Sugiyama, E; Nishinakamura, H; Takeuchi, Y; Vitaly, K; Itahashi, K; Maeda, Y; Matsui, S; Shibahara, T; Yamashita, Y; Irie, T; Tsuge, A; Fukuoka, S; Kawazoe, A; Udagawa, H; Kirita, K; Aokage, K; Ishii, G; Kuwata, T; Nakama, K; Kawazu, M; Ueno, T; Yamazaki, N; Goto, K; Tsuboi, M; Mano, H; Doi, T; Shitara, K; Nishikawa, H				Kumagai, Shogo; Togashi, Yosuke; Kamada, Takahiro; Sugiyama, Eri; Nishinakamura, Hitomi; Takeuchi, Yoshiko; Vitaly, Kochin; Itahashi, Kota; Maeda, Yuka; Matsui, Shigeyuki; Shibahara, Takuma; Yamashita, Yasuho; Irie, Takuma; Tsuge, Ayaka; Fukuoka, Shota; Kawazoe, Akihito; Udagawa, Hibiki; Kirita, Keisuke; Aokage, Keiju; Ishii, Genichiro; Kuwata, Takeshi; Nakama, Kenta; Kawazu, Masahito; Ueno, Toshihide; Yamazaki, Naoya; Goto, Koichi; Tsuboi, Masahiro; Mano, Hiroyuki; Doi, Toshihiko; Shitara, Kohei; Nishikawa, Hiroyoshi			The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies	NATURE IMMUNOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSES; CD28; TCR; PHOSPHATASE; DIFFERENTIATION; STIMULATION; ASSOCIATION; P110-DELTA; SURVIVAL	Checkpoint blockade is effective in only a subset of patients; therefore, biomarkers that can predict efficacy would be clinically highly valuable. Nishkawa and colleagues develop a biomarker based on PD-1 positivity of effector and regulatory T cells in the tumor microenvironment that accurately predicts the effectiveness of checkpoint blockade in patients. Immune checkpoint blockade has provided a paradigm shift in cancer therapy, but the success of this approach is very variable; therefore, biomarkers predictive of clinical efficacy are urgently required. Here, we show that the frequency of PD-1(+)CD8(+)T cells relative to that of PD-1(+)regulatory T (T-reg) cells in the tumor microenvironment can predict the clinical efficacy of programmed cell death protein 1 (PD-1) blockade therapies and is superior to other predictors, including PD ligand 1 (PD-L1) expression or tumor mutational burden. PD-1 expression by CD8(+)T cells and T(reg)cells negatively impacts effector and immunosuppressive functions, respectively. PD-1 blockade induces both recovery of dysfunctional PD-1(+)CD8(+)T cells and enhanced PD-1(+)T(reg)cell-mediated immunosuppression. A profound reactivation of effector PD-1(+)CD8(+)T cells rather than PD-1(+)T(reg)cells by PD-1 blockade is necessary for tumor regression. These findings provide a promising predictive biomarker for PD-1 blockade therapies.	[Kumagai, Shogo; Togashi, Yosuke; Kamada, Takahiro; Sugiyama, Eri; Nishinakamura, Hitomi; Takeuchi, Yoshiko; Itahashi, Kota; Maeda, Yuka; Irie, Takuma; Tsuge, Ayaka; Fukuoka, Shota; Nishikawa, Hiroyoshi] Natl Canc Ctr, Div Canc Immunol, Res Inst, Exploratory Oncol Res & Clin Trial Ctr EPOC, Chiba, Japan; [Kumagai, Shogo; Kamada, Takahiro; Sugiyama, Eri; Vitaly, Kochin; Tsuge, Ayaka; Nishikawa, Hiroyoshi] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi, Japan; [Matsui, Shigeyuki] Nagoya Univ, Dept Biostat, Grad Sch Med, Nagoya, Aichi, Japan; [Shibahara, Takuma; Yamashita, Yasuho] Hitachi Ltd, Res & Dev Grp, Tokyo, Japan; [Kawazoe, Akihito; Doi, Toshihiko; Shitara, Kohei] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan; [Udagawa, Hibiki; Kirita, Keisuke; Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Chiba, Japan; [Aokage, Keiju; Tsuboi, Masahiro] Natl Canc Ctr Hosp East, Dept Thorac Surg, Chiba, Japan; [Ishii, Genichiro; Kuwata, Takeshi] Natl Canc Ctr Hosp East, Pathol & Clin Labs, Chiba, Japan; [Nakama, Kenta; Yamazaki, Naoya] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan; [Kawazu, Masahito; Ueno, Toshihide; Mano, Hiroyuki] Natl Canc Ctr, Div Cellular Signaling, Tokyo, Japan	National Cancer Center - Japan; Nagoya University; Nagoya University; Hitachi Limited; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Nishikawa, H (corresponding author), Natl Canc Ctr, Div Canc Immunol, Res Inst, Exploratory Oncol Res & Clin Trial Ctr EPOC, Chiba, Japan.; Nishikawa, H (corresponding author), Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi, Japan.	hnishika@ncc.go.jp	Shitara, Kohei/AAA-3877-2021; Kawazu, Masahito/AAE-6143-2022; Takeuchi, Yoshiko/GQP-2497-2022; Takeuchi, Yoshiko/ABA-5417-2020	Kawazu, Masahito/0000-0003-4146-3629; Takeuchi, Yoshiko/0000-0002-2637-7696; Togashi, Yosuke/0000-0001-9910-0164	JSPS [17K18388, 18J21161]; Ministry of Education, Culture, Sports, Science and Technology of Japan [18J21551]; Project for Cancer Research and Therapeutic Evolution (P-CREATE) [16cm0106301h0001, 18cm0106502s0403, 18cm0106340h0001]; Development of Technology for Patient Stratification Biomarker Discovery grant [19ae0101074s0401]; Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED) [18am0001001h9905]; National Cancer Center Research and Development Fund [28-A-7, 31-A-7]; Naito Foundation; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Novartis; Bristol-Myers Squibb; SGH Foundation; Ono Pharmaceutical Co. Ltd.;  [17H06162];  [16K15551];  [17J09900]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Cancer Research and Therapeutic Evolution (P-CREATE); Development of Technology for Patient Stratification Biomarker Discovery grant; Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); SGH Foundation; Ono Pharmaceutical Co. Ltd.(Ono Pharmaceutical Co Ltd); ; ; 	This article is dedicated to the memory of T. Kamada. We thank T. Kobayashi, Y. Tada, T. Takaku, M. Nakai, K. Onagawa, M. Takemura, C. Haijima, M. Hoshino, K. Yoshida, M. Sugaya, Y. Ishige, E. Tanji, M. Ozawa and C. Notake for their technical assistance. This study was supported by Grants-in-Aid for Scientific Research (S grant 17H06162 (H. Nishikawa), Challenging Exploratory Research grant 16K15551 (H. Nishikawa), Young Scientists grant 17J09900 (Y. Togashi), JSPS Research Fellowship 17K18388 (Y. Togashi) and JSPS Research Fellowship 18J21161 (T. Kamada) and 18J21551 (S.K.)) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by the Project for Cancer Research and Therapeutic Evolution (P-CREATE, 16cm0106301h0001 (H. Nishikawa), 16cm0106301h0001 (H.M.), 18cm0106502s0403 (M.K.) and 18cm0106340h0001 (Y. Togashi)); by a Development of Technology for Patient Stratification Biomarker Discovery grant (19ae0101074s0401 (H. Nishikawa)) and Leading Advanced Projects for Medical Innovation (LEAP, 18am0001001h9905 (H.M.)) from the Japan Agency for Medical Research and Development (AMED); by the National Cancer Center Research and Development Fund (28-A-7 and 31-A-7 (H. Nishikawa)); by the Naito Foundation (Y. Togashi and H. Nishikawa); by the Takeda Science Foundation (Y. Togashi); by the Kobayashi Foundation for Cancer Research (Y. Togashi); by a Novartis research grant (Y. Togashi); by a Bristol-Myers Squibb research grant (Y. Togashi) and by the SGH Foundation (Y. Togashi). This study was executed in part as a research program supported by Ono Pharmaceutical Co. Ltd.	Abu-Eid R, 2014, CANCER IMMUNOL RES, V2, P1080, DOI 10.1158/2326-6066.CIR-14-0095; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kansy BA, 2017, CANCER RES, V77, P6353, DOI 10.1158/0008-5472.CAN-16-3167; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nguyen TV, 2006, J IMMUNOL, V177, P5990, DOI 10.4049/jimmunol.177.9.5990; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Passerini L, 2020, J ALLERGY CLIN IMMUN, V145, P1262, DOI 10.1016/j.jaci.2019.11.043; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Soond DR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00244; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Subrahmanyam PB, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0328-8; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Sugiyama E, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav3937; Tada Y, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0403-1; Takeuchi Y, 2018, INT IMMUNOL, V30, P13, DOI 10.1093/intimm/dxx073; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wang LP, 2007, IEEE ACM T COMPUT BI, V4, P40, DOI 10.1109/TCBB.2007.1006; Wang SN, 2004, IEEE T CIRCUITS-I, V51, P1889, DOI 10.1109/TCSI.2004.834521; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	58	208	213	17	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1346	+		10.1038/s41590-020-0769-3	http://dx.doi.org/10.1038/s41590-020-0769-3		AUG 2020	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32868929				2022-12-18	WOS:000565239800004
J	Winkler, R; Gillis, E; Lasman, L; Safra, M; Geula, S; Soyris, C; Nachshon, A; Tai-Schmiedel, J; Friedman, N; Le-Trilling, VTK; Trilling, M; Mandelboim, M; Hanna, JH; Schwartz, S; Stern-Ginossar, N				Winkler, Roni; Gillis, Ella; Lasman, Lior; Safra, Modi; Geula, Shay; Soyris, Clara; Nachshon, Aharon; Tai-Schmiedel, Julie; Friedman, Nehemya; Le-Trilling, Vu Thuy Khanh; Trilling, Mirko; Mandelboim, Michal; Hanna, Jacob H.; Schwartz, Schraga; Stern-Ginossar, Noam			m(6)A modification controls the innate immune response to infection by targeting type I interferons	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA METHYLATION; GENE-EXPRESSION; NUCLEAR-RNA; TRANSLATION; REVEALS; N6-METHYLADENOSINE; RECOGNITION; METHYLOMES; RECEPTORS; DYNAMICS	N-6-methyladenosine (m(6)A) is the most common mRNA modification. Recent studies have revealed that depletion of m(6)A machinery leads to alterations in the propagation of diverse viruses. These effects were proposed to be mediated through dysregulated methylation of viral RNA. Here we show that following viral infection or stimulation of cells with an inactivated virus, deletion of the m(6)A 'writer' METTL3 or 'reader' YTHDF2 led to an increase in the induction of interferon-stimulated genes. Consequently, propagation of different viruses was suppressed in an interferon-signaling-dependent manner. Significantly, the mRNA of IFNB, the gene encoding the main cytokine that drives the type I interferon response, was m(6)A modified and was stabilized following repression of METTL3 or YTHDF2. Furthermore, we show that m(6)A-mediated regulation of interferon genes was conserved in mice. Together, our findings uncover the role m(6)A serves as a negative regulator of interferon response by dictating the fast turnover of interferon mRNAs and consequently facilitating viral propagation.	[Winkler, Roni; Gillis, Ella; Lasman, Lior; Safra, Modi; Geula, Shay; Soyris, Clara; Nachshon, Aharon; Tai-Schmiedel, Julie; Hanna, Jacob H.; Schwartz, Schraga; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Friedman, Nehemya; Mandelboim, Michal] Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Ramat Gan, Israel; [Friedman, Nehemya; Mandelboim, Michal] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel; [Le-Trilling, Vu Thuy Khanh; Trilling, Mirko] Univ Duisburg Essen, Univ Klinikum Essen, Inst Virol, Essen, Germany	Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Duisburg Essen	Stern-Ginossar, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	noam.stern-ginossar@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019; Lasman, Lior/ABH-9947-2020; Trilling, Mirko/AAL-3533-2021; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Trilling, Mirko/0000-0003-3659-3541; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; , Noam/0000-0003-3583-5932	European Research Council [StG-2014-638142]; EU-FP7-PEOPLE Career integration grant; ICORE (Chromatin and RNA Gene Regulation); Israeli Science Foundation [1073/14]	European Research Council(European Research Council (ERC)European Commission); EU-FP7-PEOPLE Career integration grant; ICORE (Chromatin and RNA Gene Regulation); Israeli Science Foundation(Israel Science Foundation)	We thank M. Schwartz and the rest of the Stern-Ginossar laboratory members for discussions and critical reading of the manuscript. This research was supported by the European Research Council starting grant (StG-2014-638142), the EU-FP7-PEOPLE Career integration grant, the ICORE (Chromatin and RNA Gene Regulation) and the Israeli Science Foundation (1073/14). N.S.-G. is incumbent of the Skirball career development chair in new scientists.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Durbin AF, 2016, MBIO, V7, DOI 10.1128/mBio.00833-16; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lin QY, 2009, ORG LETT, V11, P1999, DOI 10.1021/ol900350k; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; O'Connor CM, 2014, J VIROL, V88, P5524, DOI 10.1128/JVI.00481-14; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8; Tirosh O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005288; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XQ, 2003, J VIROL, V77, P7182, DOI 10.1128/JVI.77.13.7182-7192.2003; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Ye J, 2017, J VIROL, V91, DOI [10.1128/JVI.00039-17, 10.1128/jvi.00039-17]; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	58	208	215	7	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					173	+		10.1038/s41590-018-0275-z	http://dx.doi.org/10.1038/s41590-018-0275-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30559377				2022-12-18	WOS:000456279100015
J	Uldrich, AP; Le Nours, J; Pellicci, DG; Gherardin, NA; McPherson, KG; Lim, RT; Patel, O; Beddoe, T; Gras, S; Rossjohn, J; Godfrey, DI				Uldrich, Adam P.; Le Nours, Jerome; Pellicci, Daniel G.; Gherardin, Nicholas A.; McPherson, Kirsty G.; Lim, Ricky T.; Patel, Onisha; Beddoe, Travis; Gras, Stephanie; Rossjohn, Jamie; Godfrey, Dale I.			CD1d-lipid antigen recognition by the gamma delta TCR	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CD1D; REACTIVITY; COMPLEXES; SELECTION; FEATURES; BINDING; INNATE	The T cell repertoire comprises alpha beta and gamma delta T cell lineages. Although it is established how alpha beta T cell antigen receptors (TCRs) interact with antigen presented by antigen-presenting molecules, this is unknown for gamma delta TCRs. We describe a population of human V(delta)1(+) gamma delta T cells that exhibit autoreactivity to CD1d and provide a molecular basis for how a gamma delta TCR binds CD1d-alpha-galactosylceramide (alpha-GalCer). The gamma delta TCR docked orthogonally, over the A' pocket of CD1d, in which the V(delta)1-chain, and in particular the germ line-encoded CDR1 delta loop, dominated interactions with CD1d. The TCR gamma-chain sat peripherally to the interface, with the CDR3 gamma loop representing the principal determinant for alpha-GalCer specificity. Accordingly, we provide insight into how a gamma delta TCR binds specifically to a lipid-loaded antigen-presenting molecule.	[Uldrich, Adam P.; Pellicci, Daniel G.; Gherardin, Nicholas A.; McPherson, Kirsty G.; Lim, Ricky T.; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Le Nours, Jerome; Patel, Onisha; Beddoe, Travis; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	University of Melbourne; Monash University; Monash University; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	jamie.rossjohn@monash.edu; godfrey@unimelb.edu.au	Gherardin, Nicholas/P-6853-2019; Uldrich, Adam/AAX-3785-2020; gras, stephanie/C-8307-2013; Pellicci, Daniel/AAX-8539-2020; McPherson, Kirsty G/E-6331-2017; Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014	McPherson, Kirsty G/0000-0003-3083-6303; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Patel, Onisha/0000-0001-6701-7139; Pellicci, Daniel/0000-0001-5305-2398; ULDRICH, ADAM/0000-0002-6350-5976; gras, stephanie/0000-0001-7416-038X; Gherardin, Nicholas/0000-0003-4690-2571; Godfrey, Dale/0000-0002-3009-5472; Le Nours, Jerome/0000-0002-2221-7636	Australian Research Council; National Health and Medical Research Council of Australia (NHMRC); Leukaemia Foundation of Australia; Pfizer Australia; NHMRC; NHMRC Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia; Pfizer Australia(PfizerPfizer Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the staff at the MX1 and MX2 beamlines of the Australian Synchrotron for assistance with data collection, M. Sandoval, M. Ciula, D. Littler, R. Berry, J. Waddington, P. Neeson and D. Ritchie for technical assistance, provision of reagents and/or advice, staff from the flow cytometry facilities in the Melbourne Brain Centre and the Department of Microbiology and Immunology at The University of Melbourne and D. Maksel from the Macromolecular Crystallization Facility at Monash University for technical assistance, P. Savage (Brigham Young University) for providing PBS44 glycolipid, G. Besra (University of Birmingham, UK) and S. Porcelli (Albert Einstein College of Medicine) for providing alpha-glucosylceramide and the alpha-GalCer analog OCH, and D. Vignali (St. Jude Children's Research Hospital) and S. Turner (The University of Melbourne) for providing pMIG expression vector. This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia (NHMRC). N.A.G. is supported by a Leukaemia Foundation of Australia Postgraduate Scholarship; T. B. is supported by a Pfizer Australia Fellowship; S. G. and O.P. are supported by Australian Research Council Future Fellowships; D. G. P. is supported by an NHMRC Peter Doherty Fellowship; J.R. is supported by an NHMRC Australia Fellowship; D. I. G. is supported by an NHMRC Senior Principal Research Fellowship.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2011, J EXP MED, V208, P1121, DOI 10.1084/jem.20110983; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Holst M, 2000, J COMPUT CHEM, V21, P1319, DOI 10.1002/1096-987X(20001130)21:15<1319::AID-JCC1>3.0.CO;2-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; NICK S, 1995, EUR J IMMUNOL, V25, P355, DOI 10.1002/eji.1830250208; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Russano AM, 2007, J IMMUNOL, V178, P3620, DOI 10.4049/jimmunol.178.6.3620; Russano AM, 2006, J ALLERGY CLIN IMMUN, V117, P1178, DOI 10.1016/j.jaci.2006.01.001; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SHIMA EA, 1986, P NATL ACAD SCI USA, V83, P3439, DOI 10.1073/pnas.83.10.3439; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wieland Brown L.C., 2013, PLOS BIOL, V11; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108	48	208	213	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1137	U125		10.1038/ni.2713	http://dx.doi.org/10.1038/ni.2713			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24076636				2022-12-18	WOS:000326023400010
J	Lukacs-Kornek, V; Malhotra, D; Fletcher, AL; Acton, SE; Elpek, KG; Tayalia, P; Collier, AR; Turley, SJ				Lukacs-Kornek, Veronika; Malhotra, Deepali; Fletcher, Anne L.; Acton, Sophie E.; Elpek, Kutlu G.; Tayalia, Prakriti; Collier, Ai-ris; Turley, Shannon J.			Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes	NATURE IMMUNOLOGY			English	Article							MESENCHYMAL STEM-CELLS; FIBROBLASTIC RETICULAR CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSES; ANTIGEN PRESENTATION; IFN-GAMMA; SYNTHASE; TOLERANCE; HOMEOSTASIS; SELF	Fibroblastic reticular cells (FRCs) and lymphatic endothelial cells (LECs) are nonhematopoietic stromal cells of lymphoid organs. They influence the migration and homeostasis of naive T cells; however, their influence on activated T cells remains undescribed. Here we report that FRCs and LECs inhibited T cell proliferation through a tightly regulated mechanism dependent on nitric oxide synthase 2 (NOS2). Expression of NOS2 and production of nitric oxide paralleled the activation of T cells and required a tripartite synergism of interferon-gamma, tumor necrosis factor and direct contact with activated T cells. Notably, in vivo expression of NOS2 by FRCs and LECs regulated the size of the activated T cell pool. Our study elucidates an as-yet-unrecognized role for the lymph node stromal niche in controlling T cell responses.	[Lukacs-Kornek, Veronika; Malhotra, Deepali; Fletcher, Anne L.; Acton, Sophie E.; Elpek, Kutlu G.; Collier, Ai-ris; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Malhotra, Deepali] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Tayalia, Prakriti] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu	Acton, Sophie/G-9784-2012	Acton, Sophie/0000-0003-2704-716X; Fletcher, Anne/0000-0003-1534-1142; Tayalia, Prakriti/0000-0002-4056-2628; Malhotra, Deepali/0000-0002-8215-7639	US National Institutes of Health [R01 DK074500, P01 AI045757]; Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Curry for technical assistance at the Dana-Farber Cancer Institute Flow Cytometry Core Facility; A. Sharpe (Harvard Medical School) for PD-L1-deficient mice; L. Lefrancois (University of Connecticut) for iFABP-tOVA mice; L.-H. Ang, Y. Zheng and S.J. Hagen for technical assistance at the Imaging Microscopy Core of Beth Israel Deaconess Medical Center; and J. Astarita and A. Bellemare-Pelletier for critically reading the manuscript. Supported by the US National Institutes of Health (R01 DK074500 and P01 AI045757 to S.J.T.) and the Dana-Farber Cancer Institute (V.L.-K).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barcellos LF, 2008, GENES IMMUN, V9, P493, DOI 10.1038/gene.2008.41; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Buettner M, 2011, EUR J IMMUNOL, V41, P624, DOI 10.1002/eji.201040681; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Duthoit CT, 2005, J IMMUNOL, V174, P155, DOI 10.4049/jimmunol.174.1.155; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Feuerer M, 2006, J IMMUNOL, V176, P2857, DOI 10.4049/jimmunol.176.5.2857; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kahn DA, 2001, J EXP MED, V193, P1261, DOI 10.1084/jem.193.11.1261; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kato H, 2003, J RHEUMATOL, V30, P247; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Magnusson FC, 2008, GASTROENTEROLOGY, V134, P1028, DOI 10.1053/j.gastro.2008.01.070; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Niedbala W, 2006, ANN RHEUM DIS, V65, P37, DOI 10.1136/ard.2006.058446; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Reynoso ED, 2009, J IMMUNOL, V182, P2102, DOI 10.4049/jimmunol.0802769; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Thomas S, 2007, J IMMUNOL, V178, P5802, DOI 10.4049/jimmunol.178.9.5802; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0	50	208	212	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1096	U105		10.1038/ni.2112	http://dx.doi.org/10.1038/ni.2112			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21926986	Green Published, Green Accepted			2022-12-18	WOS:000296500100015
J	Cyster, JG				Cyster, Jason G.			B cell follicles and antigen encounters of the third kind	NATURE IMMUNOLOGY			English	Review							SUBCAPSULAR SINUS MACROPHAGES; FOLLICULAR DENDRITIC CELLS; HIGH ENDOTHELIAL VENULES; SECONDARY LYMPHOID ORGANS; CYSTEINE-RICH DOMAIN; CD8(+) T-CELLS; IN-VIVO; IMMUNE-COMPLEXES; MANNOSE RECEPTOR; ANTIBODY-RESPONSES	Defining where and in what form lymphocytes encounter antigen is fundamental to understanding how immune responses occur. Although knowledge of the recognition of antigen by CD4(+) and CD8(+) T cells has advanced greatly, understanding of the dynamics of B cell-antigen encounters has lagged. With the application of advanced imaging approaches, encounters of this third kind are now being brought into focus. Multiple processes facilitate these encounters, from the filtering functions of lymphoid tissues and migration paths of B cells to the antigen-presenting properties of macrophages and follicular dendritic cells. This Review will discuss how these factors work together in the lymph node to ensure efficient and persistent exposure of B cells to diverse forms of antigen and thus effective triggering of the humoral response.	[Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu			Howard Hughes Medical Institute; US National Institutes of Health [AI45073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank E. Gray, I. Grigorova, L. Kelly and T. Phan for contributing to unpublished studies cited here; all members of the laboratory for discussions; and C. Allen, A. Defranco, E. Gray, T. Phan and K. Suzuki for comments on the manuscript. Supported by the Howard Hughes Medical Institute and the US National Institutes of Health (AI45073).	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; BROWN JC, 1970, NATURE, V228, P367, DOI 10.1038/228367a0; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Catron DM, 2010, J IMMUNOL, V184, P3609, DOI 10.4049/jimmunol.1000077; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; CLARK SL, 1962, AM J ANAT, V110, P217, DOI 10.1002/aja.1001100303; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; Cyster JG, 2010, IMMUNOL CELL BIOL, V88, P617, DOI 10.1038/icb.2010.74; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DELEMARRE FGA, 1990, IMMUNOBIOLOGY, V180, P395, DOI 10.1016/S0171-2985(11)80301-3; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FOSSUM S, 1983, ANAT EMBRYOL, V167, P229, DOI 10.1007/BF00298513; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gardner JM, 2009, CURR OPIN IMMUNOL, V21, P582, DOI 10.1016/j.coi.2009.08.007; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gonzalez SF, 2009, CURR OPIN IMMUNOL, V21, P251, DOI 10.1016/j.coi.2009.05.013; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; HEINEN E, 1986, EUR J IMMUNOL, V16, P167, DOI 10.1002/eji.1830160211; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI 10.1099/vir.0.006668-0; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Kratzer R, 2010, J IMMUNOL, V184, P6855, DOI 10.4049/jimmunol.0902555; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MacPherson G, 1999, IMMUNOL REV, V172, P325, DOI 10.1111/j.1600-065X.1999.tb01376.x; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; MEBIUS RE, 1990, EUR J IMMUNOL, V20, P1615, DOI 10.1002/eji.1830200732; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, CURR OPIN IMMUNOL, V21, P258, DOI 10.1016/j.coi.2009.05.006; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shinohara H, 1997, ANAT RECORD, V249, P6, DOI 10.1002/(SICI)1097-0185(199709)249:1<6::AID-AR2>3.0.CO;2-P; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; SLOOP CH, 1987, J LIPID RES, V28, P225; Song HF, 1998, IMMUNOL REV, V162, P211, DOI 10.1111/j.1600-065X.1998.tb01443.x; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; SZMUNESS W, 1981, HEPATOLOGY, V1, P377, DOI 10.1002/hep.1840010502; Taylor PR, 2004, P NATL ACAD SCI USA, V101, P1963, DOI 10.1073/pnas.0308490100; TEW JG, 1993, ADV EXP MED BIOL, V329, P461; TEW JG, 1978, J IMMUNOL, V120, P1063; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Wilke G, 2010, EUR J IMMUNOL, V40, P2165, DOI 10.1002/eji.200940202; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376	108	208	208	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					989	996		10.1038/ni.1946	http://dx.doi.org/10.1038/ni.1946			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20959804				2022-12-18	WOS:000283127800008
J	Fenner, JE; Starr, R; Cornish, AL; Zhang, JG; Metcalf, D; Schreiber, RD; Sheehan, K; Hilton, DJ; Alexander, WS; Hertzog, PJ				Fenner, JE; Starr, R; Cornish, AL; Zhang, JG; Metcalf, D; Schreiber, RD; Sheehan, K; Hilton, DJ; Alexander, WS; Hertzog, PJ			Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity	NATURE IMMUNOLOGY			English	Article							JANUS TYROSINE KINASE; SOCS BOX; INDUCIBLE GENE; GAMMA; RECEPTOR; PROTEINS; CELLS; BINDS; MICE; LIPOPOLYSACCHARIDE	Suppressor of cytokine signaling 1 (SOCS1) is a critical regulator of cytokine signaling and immune responses. SOCS1-deficient mice develop severe inflammatory disease, but are very resistant to viral infections. Using neutralizing antibody to type I interferon (IFN-alpha and IFN-beta) and mice deficient in interferon-gamma or type I interferon receptor components (IFNAR1 or IFNAR2), we demonstrate here that SOCS1 deficiency amplified type I interferon antiviral and proinflammatory actions independently of interferon-gamma. The mechanism of the suppression of type I interferon responses by SOCS1 was distinct from that of other cytokines. SOCS1 associated with and regulated IFNAR1- but not IFNAR2-specific signals, abrogating tyrosine phosphorylation of transcription factor STAT1 and reducing the duration of antiviral gene expression. Thus, SOCS1 is an important in vivo inhibitor of type I interferon signaling and contributes to balancing its beneficial antiviral versus detrimental proinflammatory effects on innate immunity.	Monash Univ, Monash Inst Med Res, Ctr Funct Gen & Human Dis, Melbourne, Vic 3168, Australia; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Cooperat Res Ctr Cellular Growth Factors, Parkville, Vic 3050, Australia; Washington Univ, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA	Monash University; Walter & Eliza Hall Institute; Washington University (WUSTL)	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Funct Gen & Human Dis, Melbourne, Vic 3168, Australia.	paul.hertzog@med.monash.edu.au	Schreiber, Robert/Q-7550-2019; Hertzog, Paul J/G-6734-2013; Hilton, Douglas J/C-7250-2013; Hertzog, Paul J/I-7053-2013; Schreiber, Robert D/A-1276-2013	Hertzog, Paul J/0000-0002-1373-8472; Hilton, Douglas J/0000-0002-7698-2392; Hertzog, Paul J/0000-0002-1373-8472; Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341				Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BIRON CA, 1994, CURR OPIN IMMUNOL, V6, P530, DOI 10.1016/0952-7915(94)90137-6; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Bullen DVR, 2001, IMMUNOLOGY, V104, P92, DOI 10.1046/j.1365-2567.2001.01294.x; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; GRESSER I, 1982, PHILOS T ROY SOC B, V299, P69, DOI 10.1098/rstb.1982.0107; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hamilton JA, 1996, J IMMUNOL, V156, P2553; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; HERTZOG PJ, 1988, CLIN IMMUNOL IMMUNOP, V48, P192, DOI 10.1016/0090-1229(88)90083-9; HERTZOG PJ, 1994, J BIOL CHEM, V269, P14088; HERZOG PJ, 2001, METHOD MOL BIOL, V158, P205; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2003, P NATL ACAD SCI USA, V100, P8436, DOI 10.1073/pnas.1032925100; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	52	208	218	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					33	39		10.1038/ni1287	http://dx.doi.org/10.1038/ni1287			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16311601				2022-12-18	WOS:000234139700016
J	Koff, WC; Johnson, PR; Watkins, DI; Burton, DR; Lifson, JD; Hasenkrug, KJ; McDermott, AB; Schultz, A; Zamb, TJ; Boyle, R; Desrosiers, RC				Koff, WC; Johnson, PR; Watkins, DI; Burton, DR; Lifson, JD; Hasenkrug, KJ; McDermott, AB; Schultz, A; Zamb, TJ; Boyle, R; Desrosiers, RC			HIV vaccine design: insights from live attenuated SIV vaccines	NATURE IMMUNOLOGY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MUCOSAL IMMUNE-RESPONSES; CYTOTOXIC T-LYMPHOCYTES; LONG-TERM CONTROL; RHESUS MACAQUES; VIRAL REPLICATION; SIVMAC251 CHALLENGE; EFFECTIVE INDUCTION; VAGINAL CHALLENGE; CELL RESPONSES	The International AIDS Vaccine Initiative has established a consortium to elucidate mechanisms of protection conferred by live attenuated simian immunodeficiency virus vaccines in monkeys. Here, the strategies defining key components of the protective immune response elicited by these vaccines are discussed.	Int AIDS Vaccine Initiat, New York, NY 10038 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Wisconsin, Wisconsin Primate Res Ctr, Madison, WI 53706 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; NCI, Sci Applicat Int Corp, AID Vaccine Program, Retroviral Pathogenesis Lab, Ft Detrick, MD 21702 USA; NIAID, Rocky Mt Lab, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Southborough, MA 01772 USA	International AIDS Vaccine Initiative; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University	Koff, WC (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10038 USA.	wkoff@iavi.org	Johnson, Philip R/A-6892-2009	McDermott, Adrian/0000-0003-0616-9117	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Almond N, 1997, J GEN VIROL, V78, P1919, DOI 10.1099/0022-1317-78-8-1919; Benson J, 1998, J VIROL, V72, P4170, DOI 10.1128/JVI.72.5.4170-4182.1998; Boyer JD, 2005, VIROLOGY, V333, P88, DOI 10.1016/j.virol.2004.12.026; Buge SL, 1997, J VIROL, V71, P8531, DOI 10.1128/JVI.71.11.8531-8541.1997; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005; Evans DT, 2003, J VIROL, V77, P2400, DOI 10.1128/JVI.77.4.2400-2409.2003; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Gauduin MC, 1999, J MED PRIMATOL, V28, P233, DOI 10.1111/j.1600-0684.1999.tb00274.x; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Johnson PR, 2005, J VIROL, V79, P955, DOI 10.1128/JVI.79.2.955-965.2005; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Koopman G, 2004, J GEN VIROL, V85, P2915, DOI 10.1099/vir.0.80226-0; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lu XS, 1998, AIDS, V12, P1, DOI 10.1097/00002030-199801000-00001; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mori K, 2001, J VIROL, V75, P4023, DOI 10.1128/JVI.75.9.4023-4028.2001; Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Norley S, 1996, VIROLOGY, V219, P195, DOI 10.1006/viro.1996.0237; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Patterson LJ, 2001, AIDS RES HUM RETROV, V17, P837, DOI 10.1089/088922201750252034; Seth A, 2000, J VIROL, V74, P2502, DOI 10.1128/JVI.74.6.2502-2509.2000; Tenner-Racz K, 2004, P NATL ACAD SCI USA, V101, P3017, DOI 10.1073/pnas.0308677101; Van Rompay KKA, 2003, J VIROL, V77, P179, DOI 10.1128/JVI.77.1.179-190.2003; Veazey Ronald, 2003, AIDS Rev, V5, P245; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Vogel TU, 2002, J GEN VIROL, V83, P81, DOI 10.1099/0022-1317-83-1-81; Wang SW, 2000, J VIROL, V74, P10514, DOI 10.1128/JVI.74.22.10514-10522.2000; Wodarz D, 2000, PHILOS T R SOC B, V355, P1021, DOI 10.1098/rstb.2000.0639; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Zhao J, 2003, J VIROL, V77, P8354, DOI 10.1128/JVI.77.15.8354-8365.2003	46	208	212	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					19	23		10.1038/ni1296	http://dx.doi.org/10.1038/ni1296			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357854				2022-12-18	WOS:000234139700014
